PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Charbonnier, Y; Barbaro, L; Theillout, A; Jactel, H				Charbonnier, Yohan; Barbaro, Luc; Theillout, Amandine; Jactel, Herve			Numerical and Functional Responses of Forest Bats to a Major Insect Pest in Pine Plantations	PLOS ONE			English	Article							PROCESSIONARY MOTH; INSECTIVOROUS BATS; HABITAT SELECTION; PREY ABUNDANCE; PREDATION; ECOLOGY; IDENTIFICATION; ECHOLOCATION; EXPANSION; CONSUMER	Global change is expected to modify the frequency and magnitude of defoliating insect outbreaks in forest ecosystems. Bats are increasingly acknowledged as effective biocontrol agents for pest insect populations. However, a better understanding is required of whether and how bat communities contribute to the resilience of forests to man-and climate-driven biotic disturbances. We studied the responses of forest insectivorous bats to a major pine defoliator, the pine processionary moth pityocampa, which is currently expanding its range in response to global warming. We used pheromone traps and ultrasound bat recorders to estimate the abundance and activity of moths and predatory bats along the edge of infested pine stands. We used synthetic pheromone to evaluate the effects of experimentally increased moth availability on bat foraging activity. We also evaluated the top-down regulation of moth population by estimating T. pityocampa larval colonies abundance on the same edges the following winter. We observed a close spatio-temporal matching between emergent moths and foraging bats, with bat activity significantly increasing with moth abundance. The foraging activity of some bat species was significantly higher near pheromone lures, i.e. in areas of expected increased prey availability. Furthermore moth reproductive success significantly decreased with increasing bat activity during the flight period of adult moths. These findings suggest that bats, at least in condition of low prey density, exhibit numerical and functional responses to a specific and abundant prey, which may ultimately result in an effective top-down regulation of the population of the prey. These observations are consistent with bats being useful agents for the biocontrol of insect pest populations in plantation forests.	[Charbonnier, Yohan; Barbaro, Luc; Jactel, Herve] INRA, UMR BIOGECO 1202, Cestas, France; [Charbonnier, Yohan; Barbaro, Luc; Jactel, Herve] Univ Bordeaux, BIOGECO, UMR 1202, Pessac, France; [Theillout, Amandine] LPO Aquitaine, Villenave Dornon, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux	Charbonnier, Y (corresponding author), INRA, UMR BIOGECO 1202, Cestas, France.	yohan.charbonnier@pierroton.inra.fr						Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Agosta SJ, 2003, J ZOOL, V260, P169, DOI 10.1017/S0952836903003601; Andreas M, 2012, ACTA CHIROPTEROL, V14, P81, DOI 10.3161/150811012X654295; Ashrafi S, 2011, EUR J WILDLIFE RES, V57, P843, DOI 10.1007/s10344-011-0496-z; Barataud M, 2012, ECOLOGIE ACOUSTIQUE; Barbaro L, 2008, BIODIVERS CONSERV, V17, P1073, DOI 10.1007/s10531-007-9241-z; Barbaro L, 2011, BIOL CONTROL, V56, P107, DOI 10.1016/j.biocontrol.2010.10.009; Bates D., 2012, LINEAR MIXED MODEL I; Battisti A, 2006, GLOBAL CHANGE BIOL, V12, P662, DOI 10.1111/j.1365-2486.2006.01124.x; Battisti A, 2005, ECOL APPL, V15, P2084, DOI 10.1890/04-1903; BATTISTI A, 1989, ENTOMOPHAGA, V34, P29, DOI 10.1007/BF02372584; Bloss J, 1999, ACTA CHIROPTEROL, V1, P31; Bohm SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017857; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bretagnolle Vincent, 2010, P227; BUCKNER CH, 1966, ANNU REV ENTOMOL, V11, P449, DOI 10.1146/annurev.en.11.010166.002313; Castagneyrol B, 2014, AGR FOREST ENTOMOL, V16, P284, DOI 10.1111/afe.12056; de Sassi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040557; DEMOLIN G, 1969, Annales des Sciences Forestieres (Paris), V26, P81; DEMPSTER JP, 1983, BIOL REV, V58, P461, DOI 10.1111/j.1469-185X.1983.tb00396.x; Dietz C., 2009, BATS BRITAIN EUROPE; Dodd LE, 2012, J MAMMAL, V93, P1119, DOI 10.1644/11-MAMM-A-218.1; Dulaurent AM, 2011, FOREST ECOL MANAG, V261, P1069, DOI 10.1016/j.foreco.2010.12.029; Dulaurent AM, 2012, AGR FOREST ENTOMOL, V14, P19, DOI 10.1111/j.1461-9563.2011.00549.x; Fellows I, 2012, PACKAGE DEDUCER; FENTON MB, 1990, CAN J ZOOL, V68, P411, DOI 10.1139/z90-061; Fossette S, 2012, BIOL LETTERS, V8, P351, DOI 10.1098/rsbl.2011.0965; Fukui D, 2006, J ANIM ECOL, V75, P1252, DOI 10.1111/j.1365-2656.2006.01146.x; Glen DM, 2004, INSECT AND BIRD INTERACTIONS, P89; Gonzalez Cano J.M., 1981, Boletin de la Estacion Central de Ecologia, V10, P53; GOSSCUSTARD JD, 1970, J ANIM ECOL, V39, P91, DOI 10.2307/2891; Hagen EM, 2012, J ARID ENVIRON, V84, P1, DOI 10.1016/j.jaridenv.2012.03.007; Hodar JA, 2012, CLIMATIC CHANGE, V113, P699, DOI 10.1007/s10584-011-0371-7; Jacquet JS, 2012, ANN FOREST SCI, V69, P857, DOI 10.1007/s13595-012-0209-0; Jactel H, 2006, FOREST ECOL MANAG, V235, P96, DOI 10.1016/j.foreco.2006.08.002; Jactel H, 2012, GLOBAL CHANGE BIOL, V18, P267, DOI 10.1111/j.1365-2486.2011.02512.x; Jantzen MK, 2013, CAN J ZOOL, V91, P287, DOI 10.1139/cjz-2012-0282; Jeschke JM, 2004, BIOL REV, V79, P337, DOI 10.1017/S1464793103006286; Jung K, 2012, J APPL ECOL, V49, P523, DOI 10.1111/j.1365-2664.2012.02116.x; Kalcounis MC, 1999, J MAMMAL, V80, P673, DOI 10.2307/1383311; Kalka M, 2006, J TROP ECOL, V22, P1, DOI 10.1017/S0266467405002920; Kalka MB, 2008, SCIENCE, V320, P71, DOI 10.1126/science.1153352; Klapwijk Maartje J., 2012, P429; Klinger R, 2009, ECOLOGY, V90, P1549, DOI 10.1890/07-2146.1; Kunz T, 1995, MATERNAL INVESTMENT; Kunz T. H., 2005, BAT ECOLOGY; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; McCracken GF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043839; Morris AD, 2010, J WILDLIFE MANAGE, V74, P26, DOI 10.2193/2008-471; Muller J, 2012, OECOLOGIA, V169, P673, DOI 10.1007/s00442-011-2247-y; Nixon AE, 2012, ECOL ENTOMOL, V37, P13, DOI 10.1111/j.1365-2311.2011.01330.x; Parsons K, 2007, BAT SURVEYS GOOD PRA; Robinet C, 2010, INTEGR ZOOL, V5, P132, DOI 10.1111/j.1749-4877.2010.00196.x; Russ J, 2021, BAT CALLS BRITAIN EU; Russo D, 2002, J ZOOL, V258, P91, DOI 10.1017/S0952836902001231; Ruys T, 2014, ATLAS MAMMIFERES SAU; Rydell J, 1996, OIKOS, V76, P243, DOI 10.2307/3546196; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Sierro A, 1997, ACTA OECOL, V18, P91, DOI 10.1016/S1146-609X(97)80067-7; Sierro A, 1999, J ZOOL, V248, P429, DOI 10.1111/j.1469-7998.1999.tb01042.x; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Twardochleb LA, 2012, ECOL APPL, V22, P1162, DOI 10.1890/11-0871.1; Williams-Guillen K, 2008, SCIENCE, V320, P70, DOI 10.1126/science.1152944	64	51	52	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109488	10.1371/journal.pone.0109488	http://dx.doi.org/10.1371/journal.pone.0109488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285523	Green Published, gold			2022-12-27	WOS:000345743700068
J	Itoh, K; Sokol, SY				Itoh, Keiji; Sokol, Sergei Y.			Expression Cloning of Camelid Nanobodies Specific for Xenopus Embryonic Antigens	PLOS ONE			English	Article							SINGLE-DOMAIN ANTIBODIES; CHAIN ANTIBODIES; HUMAN PROTEOME; PHAGE DISPLAY; GENERATION; PROTEINS; FRAGMENTS; LIBRARY; LAEVIS	Developmental biology relies heavily on the use of conventional antibodies, but their production and maintenance involves significant effort. Here we use an expression cloning approach to identify variable regions of llama single domain antibodies (known as nanobodies), which recognize specific embryonic antigens. A nanobody cDNA library was prepared from lymphocytes of a llama immunized with Xenopus embryo lysates. Pools of bacterially expressed cDNAs were sib-selected for the ability to produce specific staining patterns in gastrula embryos. Three different nanobodies were isolated: NbP1 and NbP3 stained yolk granules, while the reactivity of NbP7 was predominantly restricted to the cytoplasm and the cortex. The isolated nanobodies recognized specific protein bands in immunoblot analysis. A reverse proteomic approach identified NbP1 target antigen as EP45/Seryp, a serine protease inhibitor. Given the unique stability of nanobodies and the ease of their expression in diverse systems, we propose that nanobody cDNA libraries represent a promising resource for molecular markers for developmental biology.	[Itoh, Keiji; Sokol, Sergei Y.] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sokol, SY (corresponding author), Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	sergei.sokol@mssm.edu		Sokol, Sergei/0000-0002-3963-9202	National Institutes of Health [NS40972, HD80622]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD080622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040972, R56NS040972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study has been supported by the National Institutes of Health grants NS40972 and HD80622. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler LL, 2003, GENESIS, V35, P107, DOI 10.1002/gene.10171; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; Conway JO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008818; De Meyer T, 2014, TRENDS BIOTECHNOL; De Meyer T, 2014, PLANT MOL BIOL, V84, P83, DOI 10.1007/s11103-013-0118-0; Dollar GL, 2005, NATURE, V437, P1376, DOI 10.1038/nature04116; Dubel S, 2010, TRENDS BIOTECHNOL, V28, P333, DOI 10.1016/j.tibtech.2010.05.001; Goldman ER, 2006, ANAL CHEM, V78, P8245, DOI 10.1021/ac0610053; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harlow E., 1988, ANTIBODIES LAB MANUA; Hikasa H, 2010, DEV CELL, V19, P521, DOI 10.1016/j.devcel.2010.09.005; HOLLAND LJ, 1992, J BIOL CHEM, V267, P7053; ITOH K, 1988, DEVELOPMENT, V104, P1; Itoh K, 2000, MOL CELL BIOL, V20, P2228, DOI 10.1128/MCB.20.6.2228-2238.2000; Jorgensen P, 2009, DEVELOPMENT, V136, P1539, DOI 10.1242/dev.032425; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; KLYMKOWSKY MW, 1992, P NATL ACAD SCI USA, V89, P8736, DOI 10.1073/pnas.89.18.8736; Ladenson RC, 2006, ANAL CHEM, V78, P4501, DOI 10.1021/ac058044j; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Marteil G, 2010, J CELL SCI, V123, P1805, DOI 10.1242/jcs.063305; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Ossipova O, 2009, DEV CELL, V17, P222, DOI 10.1016/j.devcel.2009.06.010; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; PENG HB, 1991, METHOD CELL BIOL, V36, P657; PORATH J, 1992, PROTEIN EXPRES PURIF, V3, P263, DOI 10.1016/1046-5928(92)90001-D; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Roovers RC, 2007, CANCER IMMUNOL IMMUN, V56, P303, DOI 10.1007/s00262-006-0180-4; Ryckaert S, 2010, J BIOTECHNOL, V145, P93, DOI 10.1016/j.jbiotec.2009.10.010; Schofield DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r254; Sheets MD, 1998, P NATL ACAD SCI USA, V95, P6157, DOI 10.1073/pnas.95.11.6157; Tang JCY, 2013, CELL, V154, P928, DOI 10.1016/j.cell.2013.07.021; Tanha J, 2002, J IMMUNOL METHODS, V263, P97, DOI 10.1016/S0022-1759(02)00027-3; Taussig MJ, 2007, NAT METHODS, V4, P13, DOI 10.1038/nmeth0107-13; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; Vercruysse T, 2010, J BIOL CHEM, V285, P21768, DOI 10.1074/jbc.M110.112490; Vincke Cecile, 2012, Methods Mol Biol, V907, P145, DOI 10.1007/978-1-61779-974-7_8; Witte MD, 2013, NAT PROTOC, V8, P1808, DOI 10.1038/nprot.2013.103	40	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e107521	10.1371/journal.pone.0107521	http://dx.doi.org/10.1371/journal.pone.0107521			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285446	Green Submitted, Green Published, gold			2022-12-27	WOS:000345743700008
J	Rana, KD; Vaina, LM				Rana, Kunjan D.; Vaina, Lucia M.			Functional Roles of 10 Hz Alpha-Band Power Modulating Engagement and Disengagement of Cortical Networks in a Complex Visual Motion Task	PLOS ONE			English	Article							FRONTAL EYE-FIELD; SURFACE-BASED ANALYSIS; SPATIAL ATTENTION; PARIETAL CORTEX; OBJECT MOVEMENT; NEURAL BASIS; OSCILLATIONS; AREAS; DIRECTION; MEG	Alpha band power, particularly at the 10 Hz frequency, is significantly involved in sensory inhibition, attention modulation, and working memory. However, the interactions between cortical areas and their relationship to the different functional roles of the alpha band oscillations are still poorly understood. Here we examined alpha band power and the cortico-cortical interregional phase synchrony in a psychophysical task involving the detection of an object moving in depth by an observer in forward self-motion. Wavelet filtering at the 10 Hz frequency revealed differences in the profile of cortical activation in the visual processing regions (occipital and parietal lobes) and in the frontoparietal regions. The alpha rhythm driving the visual processing areas was found to be asynchronous with the frontoparietal regions. These findings suggest a decoupling of the 10 Hz frequency into separate functional roles: sensory inhibition in the visual processing regions and spatial attention in the frontoparietal regions.	[Rana, Kunjan D.; Vaina, Lucia M.] Boston Univ, Dept Biomed Engn, Brain & Vis Res Lab, Boston, MA 02215 USA; [Vaina, Lucia M.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Vaina, Lucia M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA	Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Vaina, LM (corresponding author), Boston Univ, Dept Biomed Engn, Brain & Vis Res Lab, Boston, MA 02215 USA.	vaina@bu.edu			National Institutes of Health (NIH) [R01NS064100]; Computational Neuroscience Training Grant [T90DA032484]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA032484] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Computational Neuroscience Training Grant; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) Grant R01NS064100 to LMV and the Computational Neuroscience Training Grant, T90DA032484, "Training in computational neuroscience: Integrating experiment, theory, and technology" to KDR. MEG data was acquired at the Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, using resources provided by the Center for Functional Neuroimaging Technologies, P41EB015896, National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1941, J PHYSIOL-LONDON, V100, P159, DOI 10.1113/jphysiol.1941.sp003932; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Babiloni C, 1999, NEUROIMAGE, V10, P658, DOI 10.1006/nimg.1999.0504; Basar E, 1997, INT J PSYCHOPHYSIOL, V26, P5, DOI 10.1016/S0167-8760(97)00753-8; Basar E, 2012, INT J PSYCHOPHYSIOL, V86, P1, DOI 10.1016/j.ijpsycho.2012.07.002; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Blanke O, 2000, NEUROREPORT, V11, P1907, DOI 10.1097/00001756-200006260-00021; Buschman TJ, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00194; Calabro FJ, 2012, EXP BRAIN RES, V221, P177, DOI 10.1007/s00221-012-3159-8; Calabro FJ, 2011, P ROY SOC B-BIOL SCI, V278, P2840, DOI 10.1098/rspb.2010.2757; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Doesburg SM, 2009, BRAIN RES, V1303, P97, DOI 10.1016/j.brainres.2009.09.069; Donner T, 2000, EUR J NEUROSCI, V12, P3407, DOI 10.1046/j.1460-9568.2000.00223.x; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; Handel BF, 2011, J COGNITIVE NEUROSCI, V23, P2494, DOI 10.1162/jocn.2010.21557; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; JASIUKAITIS P, 1988, PSYCHOPHYSIOLOGY, V25, P157, DOI 10.1111/j.1469-8986.1988.tb00979.x; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Kelley TA, 2007, CEREB CORTEX; Kelly SP, 2009, EUR J NEUROSCI, V30, P2224, DOI 10.1111/j.1460-9568.2009.06980.x; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Kronland-Martinet R, 1987, INT J PATTERN RECOGN, V1, P273, DOI DOI 10.1142/S0218001487000205; Lee JH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003164; Linkenkaer-Hansen K, 2004, J NEUROSCI, V24, P10186, DOI 10.1523/JNEUROSCI.2584-04.2004; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Novikov E, 1997, PHYS REV E, V56, pR2387, DOI 10.1103/PhysRevE.56.R2387; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Osipova D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003990; Palva S, 2005, J NEUROSCI, V25, P5248, DOI 10.1523/JNEUROSCI.0141-05.2005; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Penfield W, 1954, EPILEPSY FUNCTIONAL; PFURTSCHELLER G, 1994, INT J PSYCHOPHYSIOL, V16, P147, DOI 10.1016/0167-8760(89)90041-X; Pfurtscheller G, 2001, VISION RES, V41, P1257, DOI 10.1016/S0042-6989(00)00235-2; Pitzalis S, 2013, NEUROIMAGE, V67, P89, DOI 10.1016/j.neuroimage.2012.11.022; Rao SM, 1997, J NEUROSCI, V17, P5528; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Romei V, 2008, CEREB CORTEX, V18, P2010, DOI 10.1093/cercor/bhm229; Romei V, 2008, NEUROREPORT, V19, P203, DOI 10.1097/WNR.0b013e3282f454c4; Romei V, 2010, J NEUROSCI, V30, P8692, DOI 10.1523/JNEUROSCI.0160-10.2010; Rosen AC, 1999, J COGNITIVE NEUROSCI, V11, P135, DOI 10.1162/089892999563283; Rushton SK, 2007, VISION RES, V47, P899, DOI 10.1016/j.visres.2006.11.019; Rushton SK, 2005, CURR BIOL, V15, pR542, DOI 10.1016/j.cub.2005.07.020; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Sewards TV, 1999, INT J PSYCHOPHYSIOL, V32, P35, DOI 10.1016/S0167-8760(98)00062-2; Silver MA, 2009, TRENDS COGN SCI, V13, P488, DOI 10.1016/j.tics.2009.08.005; Stouffer S, 1949, STUDIES SOCIAL PSYCH, V1; Tukey JW, 1958, BIAS CONFIDENCE NOT, P614; Vaina LM, 2014, MED SCI MONITOR, V20, P1563, DOI 10.12659/MSM.892199; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Voytek B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00191; Warren PA, 2007, J VISION, V7, DOI 10.1167/7.11.2; Warren PA, 2009, VISION RES, V49, P1406, DOI 10.1016/j.visres.2009.01.016; Worden MS, 2000, J NEUROSCI, V20; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921	75	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e107715	10.1371/journal.pone.0107715	http://dx.doi.org/10.1371/journal.pone.0107715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285560	Green Published, gold			2022-12-27	WOS:000345743700009
J	Inoue, T; Nagai, S; Yamashita, S; Fadaei, H; Ishii, R; Okabe, K; Taki, H; Honda, Y; Kajiwara, K; Suzuki, R				Inoue, Tomoharu; Nagai, Shin; Yamashita, Satoshi; Fadaei, Hadi; Ishii, Reiichiro; Okabe, Kimiko; Taki, Hisatomo; Honda, Yoshiaki; Kajiwara, Koji; Suzuki, Rikie			Unmanned Aerial Survey of Fallen Trees in a Deciduous Broadleaved Forest in Eastern Japan	PLOS ONE			English	Article							COARSE WOODY DEBRIS; AIRCRAFT SYSTEMS; AUTONOMOUS HELICOPTER; VEHICLES; ECOLOGY; DYNAMICS; PATTERNS; VOLCANO; RESERVE	Since fallen trees are a key factor in biodiversity and biogeochemical cycling, information about their spatial distribution is of use in determining species distribution and nutrient and carbon cycling in forest ecosystems. Ground-based surveys are both time consuming and labour intensive. Remote-sensing technology can reduce these costs. Here, we used high-spatial-resolution aerial photographs (0.5-1.0 cm per pixel) taken from an unmanned aerial vehicle (UAV) to survey fallen trees in a deciduous broadleaved forest in eastern Japan. In nine sub-plots we found a total of 44 fallen trees by ground survey. From the aerial photographs, we identified 80% to 90% of fallen trees that were >30 cm in diameter or >10 m in length, but missed many that were narrower or shorter. This failure may be due to the similarity of fallen trees to trunks and branches of standing trees or masking by standing trees. Views of the same point from different angles may improve the detection rate because they would provide more opportunity to detect fallen trees hidden by standing trees. Our results suggest that UAV surveys will make it possible to monitor the spatial and temporal variations in forest structure and function at lower cost.	[Inoue, Tomoharu; Nagai, Shin; Fadaei, Hadi; Ishii, Reiichiro; Suzuki, Rikie] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Environm Geochem Cycle Res, Yokohama, Japan; [Yamashita, Satoshi; Okabe, Kimiko; Taki, Hisatomo] Forestry & Forest Prod Res Inst FFPRI, Dept Forest Entomol, Tsukuba, Ibaraki, Japan; [Honda, Yoshiaki; Kajiwara, Koji] Chiba Univ, Ctr Environm Remote Sensing, Chiba, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Forestry & Forest Products Research Institute - Japan; Chiba University	Inoue, T (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Environm Geochem Cycle Res, Yokohama, Japan.	tomoharu@jamstec.go.jp	Nagai, Shin/G-9902-2011		Environment Research and Technology Development Fund of Ministry of the Environment of Japan [S-9]	Environment Research and Technology Development Fund of Ministry of the Environment of Japan	This study was funded by the Environment Research and Technology Development Fund (S-9) of the Ministry of the Environment of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; Bunnell FL, 2010, ENVIRON REV, V18, P397, DOI 10.1139/A10-019; Butler R, 2004, FOREST ECOL MANAG, V195, P325, DOI 10.1016/j.foreco.2004.02.042; Chambers JQ, 2007, SCIENCE, V318, P1107, DOI 10.1126/science.1148913; Edman M, 2001, J VEG SCI, V12, P609, DOI 10.2307/3236900; EEA (European Environment Agency), 2012, 112012 EEA, DOI [10.2800/55751, DOI 10.2800/55751]; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Getzin S, 2014, REMOTE SENS-BASEL, V6, P6988, DOI 10.3390/rs6086988; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Herrmann S, 2008, CAN J FOREST RES, V38, P125, DOI 10.1139/X07-144; Hodgson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079556; Kaneko T, 2011, INT J REMOTE SENS, V32, P1491, DOI 10.1080/01431160903559770; Koh LP, 2012, TROP CONSERV SCI, V5, P121, DOI 10.1177/194008291200500202; Koyama T, 2013, EARTH PLANETS SPACE, V65, P657, DOI 10.5047/eps.2013.03.005; Kupfer JA, 2008, ECOSYSTEMS, V11, P45, DOI 10.1007/s10021-007-9106-z; MASAKI T, 1992, VEGETATIO, V98, P97, DOI 10.1007/BF00045549; Meentemeyer RK, 2008, BIOL INVASIONS, V10, P1243, DOI 10.1007/s10530-007-9199-5; NAKASHIZUKA T, 1992, VEGETATIO, V103, P105; Nakashizuka T, 2002, ECOLOGICAL STUDIES, V158; Ohtsuka T, 2014, ECOL RES, V29, P91, DOI 10.1007/s11284-013-1102-5; Pasher J, 2009, FOREST ECOL MANAG, V258, P1536, DOI 10.1016/j.foreco.2009.07.009; Rango A, 2009, J APPL REMOTE SENS, V3, DOI 10.1117/1.3216822; Sanada Y, 2014, EXPLOR GEOPHYS, V45, P3, DOI 10.1071/EG13004; Sarda-Palomera F, 2012, IBIS, V154, P177, DOI 10.1111/j.1474-919X.2011.01177.x; Stahl Goran, 2001, Ecological Bulletins, V49, P57; Stokland J.N., 2012, BIODIVERSITY DEAD WO; Valavanis K. P., 2007, ADV UNMANNED AERIAL; Vermeulen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054700; Wang FG, 2010, ENVIRON MONIT ASSESS, V162, P311, DOI 10.1007/s10661-009-0798-8; Wang WT, 2010, AGR FOREST METEOROL, V150, P122, DOI 10.1016/j.agrformet.2009.09.009; Watts AC, 2012, REMOTE SENS-BASEL, V4, P1671, DOI 10.3390/rs4061671; Watts AC, 2010, J WILDLIFE MANAGE, V74, P1614, DOI 10.2193/2009-425; Wu Jia-bing, 2005, Journal of Forestry Research (Harbin), V16, P247, DOI 10.1007/BF02856826	33	19	23	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109881	10.1371/journal.pone.0109881	http://dx.doi.org/10.1371/journal.pone.0109881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279817	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800102
J	Zuccolotto, G; Fracasso, G; Merlo, A; Montagner, IM; Rondina, M; Bobisse, S; Figini, M; Cingarlini, S; Colombatti, M; Zanovello, P; Rosato, A				Zuccolotto, Gaia; Fracasso, Giulio; Merlo, Anna; Montagner, Isabella Monia; Rondina, Maria; Bobisse, Sara; Figini, Mariangela; Cingarlini, Sara; Colombatti, Marco; Zanovello, Paola; Rosato, Antonio			PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models	PLOS ONE			English	Article							CHIMERIC ANTIGEN RECEPTOR; MEMBRANE ANTIGEN; ADOPTIVE IMMUNOTHERAPY; ANTITUMOR-ACTIVITY; ENHANCED SURVIVAL; CD28; PERSISTENCE; KINETICS	Immunology-based interventions have been proposed as a promising curative chance to effectively attack postoperative minimal residual disease and distant metastatic localizations of prostate tumors. We developed a chimeric antigen receptor (CAR) construct targeting the human prostate-specific membrane antigen (hPSMA), based on a novel and high affinity specific mAb. As a transfer method, we employed last-generation lentiviral vectors (LV) carrying a synthetic bidirectional promoter capable of robust and coordinated expression of the CAR molecule, and a bioluminescent reporter gene to allow the tracking of transgenic T cells after in vivo adoptive transfer. Overall, we demonstrated that CAR-expressing LV efficiently transduced short-term activated PBMC, which in turn were readily stimulated to produce cytokines and to exert a relevant cytotoxic activity by engagement with PSMA(+) prostate tumor cells. Upon in vivo transfer in tumor-bearing mice, CAR-transduced T cells were capable to completely eradicate a disseminated neoplasia in the majority of treated animals, thus supporting the translation of such approach in the clinical setting.	[Zuccolotto, Gaia] Univ Padua, Dept Med, Padua, Italy; [Fracasso, Giulio; Colombatti, Marco] Univ Verona, Dept Pathol & Diagnost, Immunol Sect, I-37100 Verona, Italy; [Merlo, Anna; Montagner, Isabella Monia; Zanovello, Paola; Rosato, Antonio] IRCCS, Veneto Inst Oncol IOV, Padua, Italy; [Rondina, Maria; Zanovello, Paola; Rosato, Antonio] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy; [Bobisse, Sara] Univ Lausanne, Ludwig Ctr Canc Res, Lausanne, Switzerland; [Figini, Mariangela] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Mol Therapies Unit, Milan, Italy; [Cingarlini, Sara] AOUI, Med Oncol, Verona, Italy	University of Padua; University of Verona; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; University of Lausanne; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Rosato, A (corresponding author), IRCCS, Veneto Inst Oncol IOV, Padua, Italy.	antonio.rosato@unipd.it	Montagner, Isabella Monia/AAI-2317-2019; ZUCCOLOTTO, GAIA/K-1654-2016; Fracasso, Giulio/O-3955-2019; Fracasso, Giulio/E-1271-2013; cingarlini, sara/ABB-5280-2020; Cingarlini, Sara/AAJ-5263-2021; montagner, isabella monia/K-1653-2016; Merlo, Anna/FCK-4327-2022; Figini, Mariangela/K-8753-2016; Rosato, Antonio/E-8626-2010	Montagner, Isabella Monia/0000-0002-5778-2221; ZUCCOLOTTO, GAIA/0000-0002-2002-8807; Fracasso, Giulio/0000-0003-3024-0307; Fracasso, Giulio/0000-0003-3024-0307; Cingarlini, Sara/0000-0003-4786-4781; montagner, isabella monia/0000-0002-5778-2221; Merlo, Anna/0000-0002-2741-9624; Figini, Mariangela/0000-0001-9001-8754; Rosato, Antonio/0000-0002-5263-8386; Zanovello, Paola/0000-0002-9996-2669	Italian Association for Cancer Research (AIRC) [IG-13121]; Italian Association for Cancer Research (Special Program Molecular Clinical Oncology 5 per mille) [ID 10016]; University of Padua, "Progetti Strategici di Ateneo"	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Association for Cancer Research (Special Program Molecular Clinical Oncology 5 per mille)(Fondazione AIRC per la ricerca sul cancro); University of Padua, "Progetti Strategici di Ateneo"	This work was partly supported by grants from the Italian Association for Cancer Research (AIRC, IG-13121; and Special Program Molecular Clinical Oncology 5 per mille ID 10016 to AR) and University of Padua, "Progetti Strategici di Ateneo 2011'' to AR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Daga D., 2014, HUM GENE THER; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Anurathapan U, 2014, MOL THER, V22, P623, DOI 10.1038/mt.2013.262; Biffi A, 2011, BLOOD, V117, P5332, DOI 10.1182/blood-2010-09-306761; Bobisse S, 2009, CANCER RES, V69, P9385, DOI 10.1158/0008-5472.CAN-09-0494; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Casucci M, 2013, BLOOD, V122, P3461, DOI 10.1182/blood-2013-04-493361; Cesana D, 2014, MOL THER, V22, P774, DOI 10.1038/mt.2014.3; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Frigerio B, 2013, EUR J CANCER, V49, P2223, DOI 10.1016/j.ejca.2013.01.024; Gade TPF, 2005, CANCER RES, V65, P9080, DOI 10.1158/0008-5472.CAN-05-0436; Gilham DE, 2012, TRENDS MOL MED, V18, P377, DOI 10.1016/j.molmed.2012.04.009; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hillerdal V, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-30; Hombach AA, 2013, MOL THER, V21, P2268, DOI 10.1038/mt.2013.192; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Keyaerts M, 2008, EUR J NUCL MED MOL I, V35, P999, DOI 10.1007/s00259-007-0664-2; Kloss CC, 2013, NAT BIOTECHNOL, V31, P71, DOI 10.1038/nbt.2459; Kochenderfer JN, 2013, NAT REV CLIN ONCOL, V10, P267, DOI 10.1038/nrclinonc.2013.46; Lamers CHJ, 2013, MOL THER, V21, P904, DOI 10.1038/mt.2013.17; Louis CU, 2011, BLOOD, V118, P6050, DOI 10.1182/blood-2011-05-354449; Ma QZ, 2014, PROSTATE, V74, P286, DOI 10.1002/pros.22749; Merlo A, 2010, J IMMUNOL, V184, P5895, DOI 10.4049/jimmunol.0902850; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Ristau BT, 2014, UROL ONCOL-SEMIN ORI, V32, P272, DOI 10.1016/j.urolonc.2013.09.003; ROCHFORD R, 1993, P NATL ACAD SCI USA, V90, P352, DOI 10.1073/pnas.90.1.352; Rosato A, 1999, METHODS, V19, P187, DOI 10.1006/meth.1999.0844; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sampson JH, 2014, CLIN CANCER RES, V20, P972, DOI 10.1158/1078-0432.CCR-13-0709; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Simons JW, 2006, UROL ONCOL-SEMIN ORI, V24, P419, DOI 10.1016/j.urolonc.2005.08.021; Till BG, 2012, BLOOD, V119, P3940, DOI 10.1182/blood-2011-10-387969; Turrini R, 2011, CANCER IMMUNOL IMMUN, V60, P1639, DOI 10.1007/s00262-011-1086-3; Zhang Q, 2013, CURR GENE THER, V13, P65, DOI 10.2174/156652313804806570; Zhao YB, 2009, J IMMUNOL, V183, P5563, DOI 10.4049/jimmunol.0900447; Zhong XS, 2010, MOL THER, V18, P413, DOI 10.1038/mt.2009.210	42	50	54	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109427	10.1371/journal.pone.0109427	http://dx.doi.org/10.1371/journal.pone.0109427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279468	gold, Green Submitted, Green Published			2022-12-27	WOS:000342670800081
J	Lin, IC; Wang, YH; Wang, TJ; Wang, IJ; Shen, YD; Chi, NF; Chien, LN				Lin, I-Chan; Wang, Yuan-Hung; Wang, Tsung-Jen; Wang, I-Jong; Shen, Yun-Den; Chi, Nai-Fang; Chien, Li-Nien			Glaucoma, Alzheimer's Disease, and Parkinson's Disease: An 8-Year Population-Based Follow-Up Study	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; PROPENSITY-SCORE; PSEUDOEXFOLIATION SYNDROME; RISK-FACTORS; DEMENTIA; ABILITY	Background: Glaucoma is the leading cause of irreversible blindness worldwide and primary open-angle glaucoma (POAG) is the most common type of glaucoma. An association between POAG and the subsequent risk of Alzheimer's disease (AD) and Parkinson's disease (PD) was unclear. Objective: To investigate the association between POAG (including normal-tension glaucoma) and the subsequent risk of AD or PD 8 years following a diagnosis of POAG. Methods: We performed a retrospective, propensity-score-matched analysis of a population-based cohort consisting of patients with and without POAG aged 60 years and older. Control patients without POAG were propensity-score matched to POAG patients based on their baseline characteristics. Results: The incidence rates and confidence intervals (CIs) of AD among the patients with and without POAG were 2.85 (95% CI: 2.19-3.70) and 1.98 (95% CI: 1.68-2.31) per 1000 person-years, respectively. The incidence rates of PD among the POAG and non-POAG cohorts were 4.36 (95% CI: 3.52-5.39) and 4.37 (95% CI: 3.92-4.86) per 1000 person-years, respectively. Kaplan-Meier failure curves showed that the POAG patients had a higher risk of AD than the control patients did (log-rank test, P = .0189). However, the cumulative PD hazard ratios for the POAG and non-POAG patients did not differ significantly (log-rank test, P = .9953). Conclusion: In elderly patients, POAG is a significant predictor of AD, but POAG is not a predictor of PD.	[Lin, I-Chan; Shen, Yun-Den] Taipei Med Univ, Shuang Ho Hosp, Dept Ophthalmol, Taipei, Taiwan; [Wang, Yuan-Hung] Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Div Urol, Taipei, Taiwan; [Wang, Yuan-Hung] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Wang, Tsung-Jen] Taipei Med Univ, Taipei Med Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Wang, I-Jong] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Sch Med, Dept Ophthalmol, Taipei 10764, Taiwan; [Chi, Nai-Fang] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, Taipei, Taiwan; [Chi, Nai-Fang] Taipei Med Univ, Sch Med, Dept Neurol, Taipei, Taiwan; [Chien, Li-Nien] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Hlth Care Adm, Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University	Chi, NF (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, Taipei, Taiwan.	naifangchi@tmu.edu.tw; lnchien@tmu.edu.tw	Chi, Nai-Fang/G-3561-2016; Chi, Nai-Fang/E-2851-2017	Chi, Nai-Fang/0000-0002-2204-4923; Chi, Nai-Fang/0000-0002-2204-4923; Wang, I-Jong/0000-0002-3045-0614	Health and Clinical Research Data Center, Taipei Medical University; National Science Council, Taiwan [NSC 102-2314-B-038-054-MY3]	Health and Clinical Research Data Center, Taipei Medical University; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the Health and Clinical Research Data Center, Taipei Medical University; National Science Council (NSC 102-2314-B-038-054-MY3), Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Bach-Holm D, 2012, ACTA OPHTHALMOL, V90, P683, DOI 10.1111/j.1755-3768.2011.02125.x; Bayer AU, 2002, EUR NEUROL, V47, P165, DOI 10.1159/000047976; Bayer AU, 2002, AM J OPHTHALMOL, V133, P135, DOI 10.1016/S0002-9394(01)01196-5; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; Buys YM, 2013, CAN J OPHTHALMOL, V48, P83, DOI 10.1016/j.jcjo.2012.10.003; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cho HK, 2014, SURV OPHTHALMOL, V59, P434, DOI 10.1016/j.survophthal.2013.09.003; Coleman AL, 2011, EXPERT REV OPHTHALMO, V6, P295, DOI 10.1586/EOP.11.35; Cumurcu T, 2013, SEMIN OPHTHALMOL, V28, P224, DOI 10.3109/08820538.2013.793726; Department of Health Executive Yuan Taiwan (R.O.C.), 2011, NAT HLTH INS REV LEG; Ekstrom C, 2014, ACTA OPHTHALMOL, V92, P355, DOI 10.1111/aos.12184; Faries D, 2010, ANAL OBSERVATIONAL H; Fraser S, 1999, INVEST OPHTH VIS SCI, V40, P2251; Fraser S, 2001, BMJ-BRIT MED J, V322, P639, DOI 10.1136/bmj.322.7287.639; Garcia-Martin E, 2012, OPHTHALMOLOGY, V119, P2161, DOI 10.1016/j.ophtha.2012.05.003; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Griffin BA, 2009, AM J OPHTHALMOL, V148, P925, DOI 10.1016/j.ajo.2009.07.010; Guo S.Y., 2014, PROPENSITY SCORE ANA; Helmer C, 2013, ANN NEUROL, V74, P171, DOI 10.1002/ana.23926; HINTON DR, 1986, NEW ENGL J MED, V315, P485, DOI 10.1056/NEJM198608213150804; Kessing LV, 2007, J GLAUCOMA, V16, P47, DOI 10.1097/IJG.0b013e31802b3527; Kim JM, 2013, AM J OPHTHALMOL, V155, P852, DOI 10.1016/j.ajo.2012.11.020; Leske MC, 2007, OPHTHAL EPIDEMIOL, V14, P166, DOI 10.1080/09286580701501931; McKinnon SJ, 2002, INVEST OPHTH VIS SCI, V43, P1077; Moschos MM, 2011, EUR J OPHTHALMOL, V21, P24, DOI 10.5301/EJO.2010.1318; Ng WS, 2010, BRIT J OPHTHALMOL, V94, P85, DOI 10.1136/bjo.2008.153312; Ou Y, 2012, OPHTHAL EPIDEMIOL, V19, P285, DOI 10.3109/09286586.2011.649228; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; SADUN AA, 1990, OPHTHALMOLOGY, V97, P9; Schlotzer-Schrehardt U, 2006, AM J OPHTHALMOL, V141, P921, DOI 10.1016/j.ajo.2006.01.047; Tamura H, 2006, J NEUROL SCI, V246, P79, DOI 10.1016/j.jns.2006.02.009; Tseng K, 1986, GEOGRAPHICAL RES, V12, P287; Tsironi EE, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-54; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wolbers M, 2009, EPIDEMIOLOGY, V20, P555, DOI 10.1097/EDE.0b013e3181a39056; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P506, DOI 10.1136/bjo.2005.083733; Yenice O, 2008, PARKINSONISM RELAT D, V14, P193, DOI 10.1016/j.parkreldis.2007.07.018	44	55	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108938	10.1371/journal.pone.0108938	http://dx.doi.org/10.1371/journal.pone.0108938			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275530	Green Submitted, gold, Green Published			2022-12-27	WOS:000342591500043
J	Soler, M; Perez-Contreras, T; Ibanez-Alamo, JD; Roncalli, G; Macias-Sanchez, E; de Neve, L				Soler, Manuel; Perez-Contreras, Tomas; Ibanez-Alamo, Juan Diego; Roncalli, Gianluca; Macias-Sanchez, Elena; de Neve, Liesbeth			Great Spotted Cuckoo Fledglings Often Receive Feedings from Other Magpie Adults than Their Foster Parents: Which Magpies Accept to Feed Foreign Cuckoo Fledglings?	PLOS ONE			English	Article							AVIAN EGG-RECOGNITION; CLAMATOR-GLANDARIUS; OFFSPRING RECOGNITION; CHICK RECOGNITION; BROOD PARASITES; BEGGING CALLS; CARE; HOST; REJECTION; NESTLINGS	Natural selection penalizes individuals that provide costly parental care to non-relatives. However, feedings to brood-parasitic fledglings by individuals other than their foster parents, although anecdotic, have been commonly observed, also in the great spotted cuckoo (Clamator glandarius) - magpie (Pica pica) system, but this behaviour has never been studied in depth. In a first experiment, we here show that great spotted cuckoo fledglings that were translocated to a distant territory managed to survive. This implies that obtaining food from foreign magpies is a frequent and efficient strategy used by great spotted cuckoo fledglings. A second experiment, in which we presented a stuffed-cuckoo fledgling in magpie territories, showed that adult magpies caring for magpie fledglings responded aggressively in most of the trials and never tried to feed the stuffed cuckoo, whereas magpies that were caring for cuckoo fledglings reacted rarely with aggressive behavior and were sometimes disposed to feed the stuffed cuckoo. In a third experiment we observed feedings to post-fledgling cuckoos by marked adult magpies belonging to four different possibilities with respect to breeding status (i.e. composition of the brood: only cuckoos, only magpies, mixed, or failed breeding attempt). All non-parental feeding events to cuckoos were provided by magpies that were caring only for cuckoo fledglings. These results strongly support the conclusion that cuckoo fledglings that abandon their foster parents get fed by other adult magpies that are currently caring for other cuckoo fledglings. These findings are crucial to understand the co-evolutionary arms race between brood parasites and their hosts because they show that the presence of the host's own nestlings for comparison is likely a key clue to favour the evolution of fledgling discrimination and provide new insights on several relevant points such as learning mechanisms and multiparasitism.	[Soler, Manuel; Perez-Contreras, Tomas; Ibanez-Alamo, Juan Diego; Roncalli, Gianluca; Macias-Sanchez, Elena; de Neve, Liesbeth] Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain; [Soler, Manuel; Perez-Contreras, Tomas] Univ Granada, CSIC, Grp Coevoluc, Unidad Asociada, Granada, Spain; [de Neve, Liesbeth] Univ Ghent, Dept Biol, Terr Ecol Unit, B-9000 Ghent, Belgium	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); University of Granada; Ghent University	Soler, M (corresponding author), Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain.	msoler@ugr.es	Macías-Sánchez, Elena/U-5286-2017; De Neve, Liesbeth/F-7896-2011; Roncalli, Gianluca/AFX-9281-2022; Pérez-Contreras, Tomás/N-2523-2019; Pérez-Contreras, Tomás/M-8065-2014; Ibáñez-Álamo, Juan Diego/H-7624-2019	Macías-Sánchez, Elena/0000-0003-1569-8088; De Neve, Liesbeth/0000-0003-0041-9824; Roncalli, Gianluca/0000-0002-0593-115X; Pérez-Contreras, Tomás/0000-0002-2271-1706; Pérez-Contreras, Tomás/0000-0002-2271-1706; Ibanez Alamo, Juan Diego/0000-0002-2136-1767	Spanish Ministerio de Economia y Competitividad/FEDER [CGL2011-25634/BOS]	Spanish Ministerio de Economia y Competitividad/FEDER	This work was supported by the Spanish Ministerio de Economia y Competitividad/FEDER (research project CGL2011-25634/BOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2003, BEHAV ECOL SOCIOBIOL, V54, P264, DOI 10.1007/s00265-003-0628-x; Alonso-Alvarez C, 2012, EVOLUTION OF PARENTAL CARE, P40; BEECHER MD, 1981, ANIM BEHAV, V29, P86, DOI 10.1016/S0003-3472(81)80155-8; BEECHER MD, 1988, BEHAV GENET, V18, P465, DOI 10.1007/BF01065515; Birkhead T. R., 1991, MAGPIES ECOLOGY BEHA; Bize P, 2006, P R SOC B, V273, P2063, DOI 10.1098/rspb.2006.3546; Brooker M.G., 1989, Australian Zoological Reviews, P1; Canestrari D, 2007, ANIM BEHAV, V73, P349, DOI 10.1016/j.anbehav.2006.04.013; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Davies NB, 2011, J ZOOL, V284, P1, DOI 10.1111/j.1469-7998.2011.00810.x; DAVIES NB, 1988, ANIM BEHAV, V36, P262, DOI 10.1016/S0003-3472(88)80269-0; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; De Marsico MC, 2012, P ROY SOC B-BIOL SCI, V279, P3401, DOI 10.1098/rspb.2012.0612; Dearborn DC, 1998, BEHAV ECOL SOCIOBIOL, V43, P259, DOI 10.1007/s002650050490; Delhey K, 2011, J AVIAN BIOL, V42, P463, DOI 10.1111/j.1600-048X.2011.05439.x; Diaz-Ruiz F, 2010, EUR J WILDLIFE RES, V56, P239, DOI 10.1007/s10344-009-0310-3; Draganoiu TI, 2006, ANIM BEHAV, V71, P1039, DOI 10.1016/j.anbehav.2005.06.022; EASTZER D, 1980, CONDOR, V82, P417, DOI 10.2307/1367567; EISNER ERICA, 1960, ANIMAL BEHAVIOUR, V8, P155, DOI 10.1016/0003-3472(60)90023-3; ERPINO MJ, 1969, CONDOR, V71, P267, DOI 10.2307/1366303; Fitzpatrick J.W., 1986, P137; Fraga RM, 1998, OX ORN SER, V9, P173; Friedmann H., 1929, COWBIRDS STUDY BIOL; Griggio M, 2009, J EVOLUTION BIOL, V22, P2077, DOI 10.1111/j.1420-9101.2009.01823.x; Grim T, 2006, EVOL ECOL RES, V8, P785; Grim T, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-14; Gruebler MU, 2010, J ANIM ECOL, V79, P334, DOI 10.1111/j.1365-2656.2009.01650.x; Hatton AIG, 1989, AUST BIRDS, V22, P81; Hauber ME, 2001, TRENDS NEUROSCI, V24, P609, DOI 10.1016/S0166-2236(00)01916-0; Hill IF, 1999, J AVIAN BIOL, V30, P135, DOI 10.2307/3677122; Hodge SJ, 2007, ANIM BEHAV, V74, P957, DOI 10.1016/j.anbehav.2006.10.029; HUSBY M, 1992, ORNIS SCAND, V23, P483, DOI 10.2307/3676680; Jennions MD, 2001, BEHAV ECOL, V12, P84, DOI 10.1093/oxfordjournals.beheco.a000383; Jubb R, 1966, BOKMAKIERIE, V18, P66; Karasov WH, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P199, DOI 10.1007/0-306-47660-6_11; KLEIN NK, 1986, AUK, V103, P213; Lack D., 1968, pvii; Langmore NE, 2009, BEHAV ECOL, V20, P978, DOI 10.1093/beheco/arp086; LESSELLS CM, 1991, ANIM BEHAV, V42, P1031, DOI 10.1016/S0003-3472(05)80160-5; Levrero F, 2009, CR BIOL, V332, P579, DOI 10.1016/j.crvi.2009.02.006; LOTEM A, 1992, BEHAV ECOL, V3, P128, DOI 10.1093/beheco/3.2.128; LOTEM A, 1995, ANIM BEHAV, V49, P1185, DOI 10.1006/anbe.1995.0152; LOTEM A, 1993, NATURE, V362, P743, DOI 10.1038/362743a0; Martinez JG, 1998, MOL ECOL, V7, P289, DOI 10.1046/j.1365-294X.1998.00348.x; MCGOWAN KJ, 1990, J ANIM ECOL, V59, P691, DOI 10.2307/4889; MEDVIN MB, 1993, ANIM BEHAV, V45, P841, DOI 10.1006/anbe.1993.1105; Moller AP, 2000, BEHAV ECOL, V11, P472, DOI 10.1093/beheco/11.5.472; Moskat C, 2007, ANIM COGN, V10, P377, DOI 10.1007/s10071-007-0071-x; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; Neff BD, 2003, NATURE, V422, P716, DOI 10.1038/nature01528; PROFFITT FM, 1991, BIRD BEHAV, V9, P103, DOI 10.3727/015613890791749118; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Reers H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018466; REESE KP, 1982, J FIELD ORNITHOL, V53, P417; RIEDMAN ML, 1982, Q REV BIOL, V57, P405, DOI 10.1086/412936; Roldan M, 2013, IBIS, V155, P867, DOI 10.1111/ibi.12088; Roldan M, 2011, BEHAV ECOL, V22, P679, DOI 10.1093/beheco/arr041; ROTHSTEIN SI, 1978, ANIM BEHAV, V26, P671, DOI 10.1016/0003-3472(78)90133-1; ROTHSTEIN SI, 1975, ANIM BEHAV, V23, P268, DOI 10.1016/0003-3472(75)90075-5; ROTHSTEIN SI, 1974, AUK, V91, P796, DOI 10.2307/4084731; Roulin A, 2002, ANIM BEHAV, V63, P201, DOI 10.1006/anbe.2001.1895; Rytkonen S, 2002, BEHAV ECOL SOCIOBIOL, V52, P379, DOI 10.1007/s00265-002-0530-y; Sato NJ, 2010, BIOL LETTERS, V6, P67, DOI 10.1098/rsbl.2009.0540; Sealy SG, 1997, CAN J ZOOL, V75, P1739, DOI 10.1139/z97-804; Sheldon BC, 1997, BEHAV ECOL, V8, P421, DOI 10.1093/beheco/8.4.421; Smith L.H., 1989, Australian Bird Watcher, V13, P99; SOLER M, 1995, CONDOR, V97, P804, DOI 10.2307/1369188; SOLER M, 1995, BEHAV ECOL SOCIOBIOL, V37, P7, DOI 10.1007/BF00173893; SOLER M, 1995, BEHAV ECOL SOCIOBIOL, V37, P243, DOI 10.1007/s002650050187; SOLER M, 1994, CONDOR, V96, P802, DOI 10.2307/1369485; Soler M, 1998, OX ORN SER, V9, P113; SOLER M, 1990, ORNIS SCAND, V21, P212, DOI 10.2307/3676781; Soler Manuel, 1999, Animal Cognition, V2, P97, DOI 10.1007/s100710050029; Soler M, 2014, BIOL REV, V89, P688, DOI 10.1111/brv.12075; Soler M, 2014, BEHAV ECOL SOCIOBIOL, V68, P333, DOI 10.1007/s00265-013-1648-9; Soler M, 2013, BEHAV ECOL SOCIOBIOL, V67, P601, DOI 10.1007/s00265-013-1479-8; Soler M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2518; Soler M, 2012, ETHOLOGY, V118, P1036, DOI 10.1111/eth.12004; Soler M, 2012, ANIM BEHAV, V83, P163, DOI 10.1016/j.anbehav.2011.10.022; Soler M, 2009, J AVIAN BIOL, V40, P237, DOI 10.1111/j.1600-048X.2009.04676.x; Soler Manuel, 1996, Ardeola, V43, P87; STODDARD PK, 1983, AUK, V100, P795, DOI 10.1093/auk/100.4.795; Szekely Tamas, 1996, Current Ornithology, V13, P271; Thompson AM, 2013, BEHAV ECOL SOCIOBIOL, V67, P69, DOI 10.1007/s00265-012-1426-0; Thorogood R, 2011, P ROY SOC B-BIOL SCI, V278, P2638, DOI 10.1098/rspb.2010.2594; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Tokue K, 2010, IBIS, V152, P835, DOI 10.1111/j.1474-919X.2010.01056.x; Ward RJS, 2009, BEHAV ECOL, V20, P1274, DOI 10.1093/beheco/arp132; Winkler DW, 1991, BEHAV ECOL, V2, P133, DOI 10.1093/beheco/2.2.133; WOODWARD PW, 1983, CONDOR, V85, P151, DOI 10.2307/1367248; ZEH DW, 1985, AM ZOOL, V25, P785; Zink AG, 2003, BEHAV ECOL, V14, P687, DOI 10.1093/beheco/arg044; ZUNIGA JM, 1992, BIRD STUDY, V39, P200, DOI 10.1080/00063659209477119	93	12	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e107412	10.1371/journal.pone.0107412	http://dx.doi.org/10.1371/journal.pone.0107412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272009	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600009
J	Zhang, Y; Huang, Z; Zhu, ZQ; Zheng, X; Liu, JW; Han, ZY; Ma, XT; Zhang, YH				Zhang, Yu; Huang, Zhen; Zhu, Zhiqiang; Zheng, Xin; Liu, Jianwei; Han, Zhiyou; Ma, Xuetao; Zhang, Yuhai			Upregulated UHRF1 Promotes Bladder Cancer Cell Invasion by Epigenetic Silencing of KiSS1	PLOS ONE			English	Article							DNA METHYLATION; PROGRESSION; METASTASIS; EXPRESSION; TARGETS; PROTEIN; MARKER	Ubiquitin-like with PHD and RING finger domains 1 (UHRF1), as an epigenetic regulator, plays important roles in the tumorigenesis and cancer progression. KiSS1 functions as a metastasis suppressor in various cancers, and epigenetic silencing of KiSS1 increases the metastatic potential of cancer cells. We therefore investigated whether UHRF1 promotes bladder cancer cell invasion by inhibiting KiSS1. The expression levels of UHRF1 and KiSS1 were examined by quantitative real-time PCR assay in vitro and in vivo. The role of UHRF1 in regulating bladder cancer metastasis was evaluated in bladder cancer cell. We found that UHRF1 levels are upregulated in most clinical specimens of bladder cancer when compared with paired normal tissues, and UHRF1 expression levels are significantly increased in primary tumors that subsequently metastasized compared with non-metastatic tumors. Forced expression of UHRF1 promotes bladder cancer cell invasion, whereas UHRF1 knockdown decreases cell invasion. Overexpression of UHRF1 increases the methylation of CpG nucleotides and reduces the expression of KiSS1. UHRF1 and KiSS1 expression level is negatively correlated in vivo and in vitro. Knockdown of KiSS1 promotes bladder cancer cell invasion. Importantly, forced expression of KiSS1 partly abrogates UHRF1-induced cell invasion. These data demonstrated that upregulated UHRF1 increases bladder cancer cell invasion by epigenetic silencing of KiSS1.	[Zhang, Yu; Zhang, Yuhai] Capital Med Univ, Beijing Friendship Hosp, Dept Urol, Beijing, Peoples R China; [Zhang, Yu; Huang, Zhen; Zhu, Zhiqiang; Zheng, Xin; Liu, Jianwei] Capital Med Univ, Beijing You An Hosp, Dept Urol, Beijing, Peoples R China; [Han, Zhiyou; Ma, Xuetao] Beijing Univ Chinese Med, Dept Urol, Dongzhimen Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Beijing University of Chinese Medicine	Zhang, Y (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Urol, Beijing, Peoples R China.	zhangyud@hotmail.com; zhangyuhaizyh@sohu.com						Babbio F, 2012, ONCOGENE, V31, P4878, DOI 10.1038/onc.2011.641; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Cebrian V, 2011, AM J PATHOL, V179, P540, DOI 10.1016/j.ajpath.2011.05.009; Cho SG, 2009, J CELL BIOCHEM, V107, P1139, DOI 10.1002/jcb.22216; Chu J, 2012, MOL BIOL CELL, V23, P59, DOI 10.1091/mbc.E11-06-0487; Connor KM, 2007, CANCER RES, V67, P10260, DOI 10.1158/0008-5472.CAN-07-1204; Fernandez-Fernandez R, 2006, MOL CELL ENDOCRINOL, V254, P127, DOI 10.1016/j.mce.2006.04.026; Hussain SA, 2003, LANCET ONCOL, V4, P489, DOI 10.1016/S1470-2045(03)01168-9; Jeanblanc M, 2005, ONCOGENE, V24, P7337, DOI 10.1038/sj.onc.1208878; Jenkins Y, 2005, MOL BIOL CELL, V16, P5621, DOI 10.1091/mbc.E05-03-0194; Karouzakis E, 2011, GENES IMMUN, V12, P643, DOI 10.1038/gene.2011.45; Liu XL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2562; Mardin WA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-264; Moya P, 2013, TUMOR BIOL, V34, P471, DOI 10.1007/s13277-012-0572-3; Mudbhary R, 2014, CANCER CELL, V25, P196, DOI 10.1016/j.ccr.2014.01.003; Overdevest JB, 2011, CANCER RES, V71, P3802, DOI 10.1158/0008-5472.CAN-11-0519; Sabatino L, 2012, ONCOGENE, V31, P5061, DOI 10.1038/onc.2012.3; Sanchez-Carbayo M, 2003, AM J PATHOL, V162, P609, DOI 10.1016/S0002-9440(10)63854-0; Sukackaite R, 2012, NUCLEIC ACIDS RES, V40, P7552, DOI 10.1093/nar/gks332; Unoki M, 2010, BRIT J CANCER, V103, P217, DOI 10.1038/sj.bjc.6605717; Unoki M, 2009, BRIT J CANCER, V101, P98, DOI 10.1038/sj.bjc.6605123; Unoki M, 2008, RADIAT RES, V169, P240, DOI 10.1667/RR1209.1; Wang F, 2012, ANN SURG ONCOL, V19, P2753, DOI 10.1245/s10434-011-2194-1; Zhou L, 2013, FASEB J, V27, P4929, DOI 10.1096/fj.13-233387	25	14	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e104252	10.1371/journal.pone.0104252	http://dx.doi.org/10.1371/journal.pone.0104252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272010	Green Submitted, Green Published, gold			2022-12-27	WOS:000343729600001
J	Aldrich, JC; Maggert, KA				Aldrich, John C.; Maggert, Keith A.			Simple Quantitative PCR Approach to Reveal Naturally Occurring and Mutation-Induced Repetitive Sequence Variation on the Drosophila Y Chromosome	PLOS ONE			English	Article							POSITION-EFFECT VARIEGATION; SATELLITE DNA; RIBOSOMAL DNA; MELANOGASTER HETEROCHROMATIN; HUMAN GENOME; GENES; RNA; ORGANIZATION; DETERMINANT; POPULATIONS	Heterochromatin is a significant component of the human genome and the genomes of most model organisms. Although heterochromatin is thought to be largely non-coding, it is clear that it plays an important role in chromosome structure and gene regulation. Despite a growing awareness of its functional significance, the repetitive sequences underlying some heterochromatin remain relatively uncharacterized. We have developed a real-time quantitative PCR-based method for quantifying simple repetitive satellite sequences and have used this technique to characterize the heterochromatic Y chromosome of Drosophila melanogaster. In this report, we validate the approach, identify previously unknown satellite sequence copy number polymorphisms in Y chromosomes from different geographic sources, and show that a defect in heterochromatin formation can induce similar copy number polymorphisms in a laboratory strain. These findings provide a simple method to investigate the dynamic nature of repetitive sequences and characterize conditions which might give rise to long-lasting alterations in DNA sequence.	[Aldrich, John C.; Maggert, Keith A.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Maggert, KA (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	kmaggert@tamu.edu		Aldrich, John/0000-0002-4885-924X; Maggert, Keith/0000-0002-9291-9481				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; AKKAYA MS, 1992, GENETICS, V132, P1131; BONACCORSI S, 1991, GENETICS, V129, P177; Bosco G, 2007, GENETICS, V177, P1277, DOI 10.1534/genetics.107.075069; Bridges CB, 1916, GENETICS, V1, P1; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carvalho AB, 2002, CURR OPIN GENET DEV, V12, P664, DOI 10.1016/S0959-437X(02)00356-8; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P5677, DOI 10.1073/pnas.101456898; Cohen S, 2003, GENOME RES, V13, P1133, DOI 10.1101/gr.907603; Cuadrado A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-205; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; DIMITRI P, 1989, GENETICS, V122, P793; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Ferree PM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000234; Ferree PM, 2014, FLY AUSTIN, V8; GATTI M, 1992, ANNU REV GENET, V26, P239, DOI 10.1146/annurev.ge.26.120192.001323; Graur D, 2013, GENOME BIOL EVOL, V5, P578, DOI 10.1093/gbe/evt028; Greil F, 2012, GENETICS; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Jiang PP, 2010, GENETICS; Kapranov Philipp, 2012, Frontiers in Genetics, V3, P60, DOI 10.3389/fgene.2012.00060; Krassovsky K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-105; Lecuyer Eric, 2008, V420, P289, DOI 10.1007/978-1-59745-583-1_18; Lemos B, 2010, P NATL ACAD SCI US; Lemos B, 2008, SCIENCE, V319, P91, DOI 10.1126/science.1148861; LINDSLEY DL, 1972, GENETICS, V71, P157; LOHE AR, 1993, GENETICS, V134, P1149; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063056; LYCKEGAARD EMS, 1989, P NATL ACAD SCI USA, V86, P1944, DOI 10.1073/pnas.86.6.1944; Maggert KA, 2005, GENETICS, V171, P1103, DOI 10.1534/genetics.104.040071; Maggert KA, 2014, REDUCED RDNA COPY NU; Messier W, 1996, NATURE, V381, P483, DOI 10.1038/381483a0; Paredes S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001376; Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106; Paredes S, 2009, GENETICS, V181, P1661, DOI 10.1534/genetics.108.099093; PEACOCK WJ, 1973, COLD SPRING HARB SYM, V38, P405, DOI 10.1101/SQB.1974.038.01.043; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Pietrzak M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022585; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; RITOSSA FM, 1968, P NATL ACAD SCI USA, V60, P509, DOI 10.1073/pnas.60.2.509; Rohmer C, 2004, J EXP BIOL, V207, P2735, DOI 10.1242/jeb.01087; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sage BT, 2003, GENETICS, V165, P1183; SPOFFORD JB, 1991, GENET RES, V57, P245, DOI 10.1017/S0016672300029396; Sun XP, 2003, GENOME RES, V13, P182, DOI 10.1101/gr.681703; Takeuchi Y, 2003, GENE DEV, V17, P1497, DOI 10.1101/gad.1085403; TARTOF KD, 1973, COLD SPRING HARB SYM, V38, P491, DOI 10.1101/SQB.1974.038.01.053; TARTOF KD, 1973, GENETICS, V73, P57; Vermaak D, 2009, ANNU REV GENET, V43, P467, DOI 10.1146/annurev-genet-102108-134802; YUNIS JJ, 1971, SCIENCE, V174, P1200, DOI 10.1126/science.174.4015.1200; Zhou J, 2012, P NATL ACAD SCI USA, V109, P9941, DOI 10.1073/pnas.1207367109	59	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109906	10.1371/journal.pone.0109906	http://dx.doi.org/10.1371/journal.pone.0109906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285439	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700097
J	Schimmer, AD; Raza, A; Carter, TH; Claxton, D; Erba, H; DeAngelo, DJ; Tallman, MS; Goard, C; Borthakur, G				Schimmer, Aaron D.; Raza, Azra; Carter, Thomas H.; Claxton, David; Erba, Harry; DeAngelo, Daniel J.; Tallman, Martin S.; Goard, Carolyn; Borthakur, Gautam			A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3-or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia	PLOS ONE			English	Article							PAN-BCL-2 FAMILY ANTAGONIST; CHRONIC LYMPHOCYTIC-LEUKEMIA; BCL-2; APOPTOSIS; GX15-070; INHIBITION; MCL-1; NAVITOCLAX; RESISTANCE	Purpose: An open-label phase I/II study of single-agent obatoclax determined a maximum tolerated dose (MTD) and schedule, safety, and efficacy in older patients (>= 70 yr) with untreated acute myeloid leukemia (AML). Experimental Design: Phase I evaluated the safety of obatoclax infused for 3 hours on 3 consecutive days (3 hx3 d) in 2-week cycles. Initial obatoclax dose was 30 mg/day (3 hx3 d; n = 3). Obatoclax was increased to 45 mg/day (3 hx3 d) if <= 1 patient had a dose-limiting toxicity (DLT) and decreased to 20 mg/day (3 hx3 d) if DLT occurred in >= 2 patients. In the phase II study, 12 patients were randomized to receive obatoclax at the dose identified during phase I (3 hx3 d) or 60 mg/day administered by continuous infusion over 24 hours for 3 days (24 hx3 d) to determine the morphologic complete response rate. Results: In phase I, two of three patients receiving obatoclax 30 mg/day (3 hx3 d) experienced grade 3 neurologic DLTs (confusion, ataxia, and somnolence). Obatoclax was decreased to 20 mg/day (3 hx3 d). In phase II, no clinically relevant safety differences were observed between the 20 mg/day (3 hx3 d; n = 7) and 60 mg/day (24 hx3 d; n = 5) arms. Neurologic and psychiatric adverse events were most common and were generally transient and reversible. Complete response was not achieved in any patient. Conclusions: Obatoclax 20 mg/day was the MTD (3 hx3 d) in older patients with AML. In the schedules tested, single-agent obatoclax was not associated with an objective response. Evaluation in additional subgroups or in combination with other chemotherapy modalities may be considered for future study.	[Schimmer, Aaron D.; Goard, Carolyn] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Raza, Azra] Columbia Univ, Med Ctr, New York, NY USA; [Carter, Thomas H.] Univ Iowa, Iowa City, IA USA; [Claxton, David] Penn State, Hershey, PA USA; [Erba, Harry] Univ Alabama Birmingham, Birmingham, AL USA; [DeAngelo, Daniel J.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Tallman, Martin S.] Weill Cornell Med Coll, Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY USA; [Borthakur, Gautam] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Columbia University; University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Alabama System; University of Alabama Birmingham; Harvard University; Dana-Farber Cancer Institute; Cornell University; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Schimmer, AD (corresponding author), Princess Margaret Canc Ctr, Toronto, ON, Canada.	aaron.schimmer@utoronto.ca	Borthakur, Gautam/AAQ-4490-2021	Schimmer, Aaron/0000-0003-4023-3899; Carter, Thomas/0000-0001-7796-2986	Gemin X Pharmaceuticals, Inc; Cephalon, Inc.	Gemin X Pharmaceuticals, Inc; Cephalon, Inc.(Teva Pharmaceutical Industries)	The study that is the subject of this manuscript was sponsored by Gemin X Pharmaceuticals, Inc., which was acquired by Cephalon, Inc., a wholly-owned subsidiary of Teva Pharmaceutical Industries, Ltd (TEVA). The development and publication of this manuscript has been financially supported by TEVA. Employees of TEVA were actively involved in the development of the manuscript, including providing data as well as review and comment of manuscript drafts. Powered 4 Significance LLC was contracted by TEVA to provide medical writing assistance in preparing an initial draft of the manuscript and editorial assistance.	Brem EA, 2011, BRIT J HAEMATOL, V153, P599, DOI 10.1111/j.1365-2141.2011.08669.x; Campas C, 2006, EXP HEMATOL, V34, P1663, DOI 10.1016/j.exphem.2006.07.008; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dewson G, 2010, CELL HEALTH CYTOSKEL, V2, P9; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Glaser SP, 2012, GENE DEV, V26, P120, DOI 10.1101/gad.182980.111; Hwang JJ, 2010, CLIN CANCER RES, V16, P4038, DOI 10.1158/1078-0432.CCR-10-0822; Izon DJ, 1998, BLOOD, V92, P383, DOI 10.1182/blood.V92.2.383.414k41_383_393; Konopleva M, 2008, CANCER RES, V68, P3413, DOI 10.1158/0008-5472.CAN-07-1919; Li H, 2008, P NATL ACAD SCI USA, V105, P2169, DOI 10.1073/pnas.0711647105; National Cancer Institute, SEER STAT FACT SHEET; National Cancer Institute National Institutes of Health, COMM TERM CRIT ADV E; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; O'Brien SM, 2009, BLOOD, V113, P299, DOI 10.1182/blood-2008-02-137943; Offen D, 1998, P NATL ACAD SCI USA, V95, P5789, DOI 10.1073/pnas.95.10.5789; Oki Y, 2012, BLOOD, V119, P2171, DOI 10.1182/blood-2011-11-391037; Paik PK, 2011, LUNG CANCER, V74, P481, DOI 10.1016/j.lungcan.2011.05.005; Parikh SA, 2010, CL LYMPH MYELOM LEUK, V10, P285, DOI 10.3816/CLML.2010.n.059; Rahmani M, 2012, BLOOD, V119, P6089, DOI 10.1182/blood-2011-09-378141; Raza A, 2009, J CLIN ONCOL, V27; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Rooswinkel RW, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.109; Schimmer AD, 2008, CLIN CANCER RES, V14, P8295, DOI 10.1158/1078-0432.CCR-08-0999; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Thomas M, 2005, BLOOD, V106, P3559, DOI 10.1182/blood-2005-03-1283; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Vogler M, 2011, BLOOD, V117, P7145, DOI 10.1182/blood-2011-03-344812; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937	32	60	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108694	10.1371/journal.pone.0108694	http://dx.doi.org/10.1371/journal.pone.0108694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285531	gold, Green Submitted, Green Published			2022-12-27	WOS:000345743700029
J	Ericson, JA; Duffau, P; Yasuda, K; Ortiz-Lopez, A; Rothamel, K; Rifkin, IR; Monach, PA				Ericson, Jeffrey A.; Duffau, Pierre; Yasuda, Kei; Ortiz-Lopez, Adriana; Rothamel, Katherine; Rifkin, Ian R.; Monach, Paul A.		ImmGen Consortium	Gene Expression during the Generation and Activation of Mouse Neutrophils: Implication of Novel Functional and Regulatory Pathways	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; T-CELL DIFFERENTIATION; NF-KAPPA-B; INFLAMMATORY STIMULI; POLYMORPHONUCLEAR LEUKOCYTES; TRANSCRIPTIONAL REGULATORS; EXTRACELLULAR HISTONES; BLOOD NEUTROPHILS; MESSENGER-RNA; BONE-MARROW	As part of the Immunological Genome Project (ImmGen), gene expression was determined in unstimulated (circulating) mouse neutrophils and three populations of neutrophils activated in vivo, with comparison among these populations and to other leukocytes. Activation conditions included serum-transfer arthritis (mediated by immune complexes), thioglycollate-induced peritonitis, and uric acid-induced peritonitis. Neutrophils expressed fewer genes than any other leukocyte population studied in ImmGen, and down-regulation of genes related to translation was particularly striking. However, genes with expression relatively specific to neutrophils were also identified, particularly three genes of unknown function: Stfa2l1, Mrgpr2a and Mrgpr2b. Comparison of genes up-regulated in activated neutrophils led to several novel findings: increased expression of genes related to synthesis and use of glutathione and of genes related to uptake and metabolism of modified lipoproteins, particularly in neutrophils elicited by thioglycollate; increased expression of genes for transcription factors in the Nr4a family, only in neutrophils elicited by serum-transfer arthritis; and increased expression of genes important in synthesis of prostaglandins and response to leukotrienes, particularly in neutrophils elicited by uric acid. Up-regulation of genes related to apoptosis, response to microbial products, NFkB family members and their regulators, and MHC class II expression was also seen, in agreement with previous studies. A regulatory model developed from the ImmGen data was used to infer regulatory genes involved in the changes in gene expression during neutrophil activation. Among 64, mostly novel, regulatory genes predicted to influence these changes in gene expression, Irf5 was shown to be important for optimal secretion of IL-10, IP-10, MIP-1 alpha, MIP-1 beta, and TNF-alpha by mouse neutrophils in vitro after stimulation through TLR9. This data-set and its analysis using the ImmGen regulatory model provide a basis for additional hypothesis-based research on the importance of changes in gene expression in neutrophils in different conditions.	[Ericson, Jeffrey A.; Ortiz-Lopez, Adriana; Rothamel, Katherine] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Div Immunol, Boston, MA 02115 USA; [Duffau, Pierre; Yasuda, Kei; Rifkin, Ian R.; Monach, Paul A.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Harvard University; Harvard Medical School; Boston University	Monach, PA (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	pmonach@bu.edu	Gazit, Roi/J-3352-2017; Gautier, Emmanuel L./E-2259-2017; Heng, Tracy/AAR-5712-2021; Heng, Tracy/B-9847-2015	Gautier, Emmanuel L./0000-0003-2976-7566; Heng, Tracy/0000-0003-4147-8986; Heng, Tracy/0000-0003-4147-8986; Rothamel, Katherine/0000-0001-9896-485X; Gazit, Roi/0000-0002-0548-2147; kang, joonsoo/0000-0001-8419-7995; Fletcher, Anne/0000-0003-1534-1142; Tata, Nageswara Rao/0000-0002-9928-5944; Malhotra, Deepali/0000-0002-8215-7639; Yasuda, Kei/0000-0002-6791-4531	NIH/NIAID [R24 AI072073]; Arthritis Foundation; NIH/NIAMS [P01 AR050256, 1K01AR060857]; Societe Francaise de Medecine Interne; CHU de Bordeaux; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI072073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR060857, P01AR050256] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Arthritis Foundation; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Societe Francaise de Medecine Interne; CHU de Bordeaux; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work received support from R24 AI072073 from NIH/NIAID to the ImmGen consortium; Arthritis Investigator Award from the Arthritis Foundation to P.A.M.; P01 AR050256 from NIH/NIAMS to I.R.R.; 1K01AR060857 from NIH/NIAMS to K.Y.; and grants from Societe Francaise de Medecine Interne and CHU de Bordeaux to P.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah DSA, 2011, INT IMMUNOL, V23, P317, DOI 10.1093/intimm/dxr007; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Aoki N, 2009, J LEUKOCYTE BIOL, V85, P508, DOI 10.1189/jlb.0508329; BAEHNER R L, 1979, American Journal of Pediatric Hematology Oncology, V1, P71; BAINTON DF, 1971, J EXP MED, V134, P907, DOI 10.1084/jem.134.4.907; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; BORGEAT P, 1989, CAN J PHYSIOL PHARM, V67, P936, DOI 10.1139/y89-147; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cassatella MA, 1999, ADV IMMUNOL, V73, P369, DOI 10.1016/S0065-2776(08)60791-9; Chen M, 2008, ARTHRITIS RHEUM, V58, P1354, DOI 10.1002/art.23453; Choe JY, 2003, J EXP MED, V197, P537, DOI 10.1084/jem.20021850; Coffey MJ, 2004, PROSTAG LEUKOTR ESS, V71, P185, DOI 10.1016/j.plefa.2004.03.012; Cohen NR, 2013, NAT IMMUNOL, V14, P90, DOI 10.1038/ni.2490; Couzinet A, 2008, P NATL ACAD SCI USA, V105, P2556, DOI 10.1073/pnas.0712295105; de Villiers WJS, 1999, J LEUKOCYTE BIOL, V66, P740, DOI 10.1002/jlb.66.5.740; DEAPODACA MAO, 1992, J INHERIT METAB DIS, V15, P213, DOI 10.1007/BF01799633; Diaz-Sotomayor M, 2013, J PEDIATR GASTR NUTR, V57, P704, DOI 10.1097/MPG.0b013e3182a27438; Elliott ER, 2011, J IMMUNOL, V187, P4319, DOI 10.4049/jimmunol.1100341; Fessler MB, 2002, J BIOL CHEM, V277, P31291, DOI 10.1074/jbc.M200755200; Filep JG, 2009, J CELL BIOCHEM, V108, P1039, DOI 10.1002/jcb.22351; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Friggeri A, 2012, MOL MED, V18, P825, DOI 10.2119/molmed.2012.00005; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gilbert C, 2003, ARTHRITIS RHEUM-US, V48, P1137, DOI 10.1002/art.10851; Gowda S, 2011, AM J PHYSIOL-LUNG C, V300, pL430, DOI 10.1152/ajplung.00208.2010; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Halene S, 2010, EXP HEMATOL, V38, P90, DOI 10.1016/j.exphem.2009.11.004; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Hu GD, 2009, J BIOL CHEM, V284, P2767, DOI 10.1074/jbc.M804744200; Hume DA, 2010, GENOMICS, V95, P328, DOI 10.1016/j.ygeno.2010.03.002; Itou T, 2006, CLIN VACCINE IMMUNOL, V13, P575, DOI 10.1128/CVI.13.5.575-583.2006; JACK RM, 1988, J IMMUNOL, V140, P4286; Jarvis JN, 2009, ARTHRITIS RHEUM-US, V60, P1488, DOI 10.1002/art.24450; Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587; Kim JS, 2001, DIGEST DIS SCI, V46, P2277, DOI 10.1023/A:1011939704802; Kobayashi SD, 2005, J LEUKOCYTE BIOL, V78, P1408, DOI 10.1189/jlb.0605289; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kotz KT, 2010, NAT MED, V16, P1042, DOI 10.1038/nm.2205; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lindau D, 2013, EUR J IMMUNOL, V43, P2101, DOI 10.1002/eji.201142143; Lundequist A, 2011, MOL IMMUNOL, V48, P1753, DOI 10.1016/j.molimm.2011.04.017; Luo HBR, 2008, AM J HEMATOL, V83, P288, DOI 10.1002/ajh.21078; Mabbott NA, 2010, IMMUNOBIOLOGY, V215, P724, DOI 10.1016/j.imbio.2010.05.012; Malcolm KC, 2003, AM J PHYSIOL-LUNG C, V284, pL663, DOI 10.1152/ajplung.00094.2002; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Malhotra N, 2013, IMMUNITY, V38, P681, DOI 10.1016/j.immuni.2013.01.010; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; McDonald PP, 1997, BLOOD, V89, P3421, DOI 10.1182/blood.V89.9.3421; McDonald PP, 2004, ADV IMMUNOL, V82, P1, DOI 10.1016/S0065-2776(04)82001-7; McLaren JE, 2011, PROG LIPID RES, V50, P331, DOI 10.1016/j.plipres.2011.04.002; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; Oh SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003351; Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695; Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Paun A, 2008, J BIOL CHEM, V283, P14295, DOI 10.1074/jbc.M800501200; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Qureshi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015587; Radom-Aizik S, 2008, J APPL PHYSIOL, V104, P236, DOI 10.1152/japplphysiol.00872.2007; Ringsholt M, 2007, J MOL HISTOL, V38, P33, DOI 10.1007/s10735-006-9075-0; Sasmono RT, 2007, J LEUKOCYTE BIOL, V82, P111, DOI 10.1189/jlb.1206713; SERHAN CN, 1984, PROSTAG OTH LIPID M, V27, P563, DOI 10.1016/0090-6980(84)90092-3; Shah D, 2013, AUTOIMMUN REV, V12, P741, DOI 10.1016/j.autrev.2012.12.007; Subrahmanyam YVBK, 2001, BLOOD, V97, P2457, DOI 10.1182/blood.V97.8.2457; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Tansho-Nagakawa S, 2012, J INFECT CHEMOTHER, V18, P646, DOI 10.1007/s10156-012-0386-7; Theilgaard-Monch K, 2004, J IMMUNOL, V172, P7684, DOI 10.4049/jimmunol.172.12.7684; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Utomo A, 2006, J IMMUNOL, V177, P6388, DOI 10.4049/jimmunol.177.9.6388; WEISSMANN G, 1984, ADV EXP MED BIOL, V172, P527; Wen T, 2012, J IMMUNOL, V188, P1075, DOI 10.4049/jimmunol.1102222; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Xu J, 2011, J IMMUNOL, V187, P2626, DOI 10.4049/jimmunol.1003930; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Yasuda K, 2007, J IMMUNOL, V178, P6876, DOI 10.4049/jimmunol.178.11.6876; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016; Zhang XQ, 2004, J LEUKOCYTE BIOL, V75, P358, DOI 10.1189/jlb.0903412; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	92	55	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108553	10.1371/journal.pone.0108553	http://dx.doi.org/10.1371/journal.pone.0108553			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279834	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800022
J	Nguyen, HL; Nguyen, QN; Ha, DA; Phan, DT; Nguyen, NH; Goldberg, RJ				Hoa L. Nguyen; Quang Ngoc Nguyen; Duc Anh Ha; Dat Tuan Phan; Nguyen Hanh Nguyen; Goldberg, Robert J.			Prevalence of Comorbidities and Their Impact on Hospital Management and Short-Term Outcomes in Vietnamese Patients Hospitalized with a First Acute Myocardial Infarction	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; WORLD HEALTH SURVEY; NONCOMMUNICABLE DISEASES; MORTALITY; GENDER; TRENDS; REGISTRY; REPERFUSION; POPULATION; COUNTRIES	Background: Cardiovascular disease is one of the leading causes of morbidity and mortality in Vietnam. We conducted a pilot study of Hanoi residents hospitalized with a first acute myocardial infarction (AMI) at the Vietnam National Heart Institute in Hanoi for purposes of describing the prevalence of cardiovascular (CVD) and non-CVD comorbidities and their impact on hospital management, in-hospital clinical complications, and short-term mortality in these patients. Methods: The study population consisted of 302 Hanoi residents hospitalized with a first AMI at the largest tertiary care medical center in Hanoi in 2010. Results: The average age of study patients was 66 years and one third were women. The proportions of patients with none, any 1, and >= 2 CVD comorbidities were 34%, 42%, and 24%, respectively. Among the CVD comorbidities, hypertension was the most commonly reported (59%). There were decreasing trends in the proportion of patients who were treated with effective cardiac medications and coronary interventions as the number of CVD comorbidities increased. Patients with multiple CVD comorbidities tended to develop acute clinical complications and die at higher rates during hospitalization compared with patients with no CVD comorbidities (Odds Ratio: 1.40; 95% Confidence Interval: 0.40-4.84). Conclusions: Our data suggest that patients with multiple cardiac comorbidities tended to experience high in-hospital death rates in the setting of AMI. Full-scale surveillance of Hanoi residents hospitalized with AMI at all Hanoi hospitals is needed to confirm these findings. Effective strategies to manage Vietnamese patients hospitalized with AMI who have multiple comorbidities are warranted to improve their short-term prognosis.	[Hoa L. Nguyen; Nguyen Hanh Nguyen] Inst Populat Hlth & Dev, Hanoi, Vietnam; [Hoa L. Nguyen] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Quang Ngoc Nguyen; Dat Tuan Phan] Viet Nam Natl Heart Inst, Hanoi, Vietnam; [Duc Anh Ha] Minist Hlth, Hanoi, Vietnam; [Goldberg, Robert J.] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01605 USA	University of Oxford; University of Massachusetts System; University of Massachusetts Worcester	Nguyen, HL (corresponding author), Inst Populat Hlth & Dev, Hanoi, Vietnam.	hoanguyen@phad.org	Nguyen, Hoa/AAA-5685-2020	Nguyen, Hoa/0000-0002-4998-8510	Global Health Office, University of Massachusetts Medical School, Worcester, MA, USA	Global Health Office, University of Massachusetts Medical School, Worcester, MA, USA	This study was partially funded by the Global Health Office, University of Massachusetts Medical School, Worcester, MA, USA. Additional support was provided by internal funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutayeb A, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-60; Boyd CM, 2010, PUBLIC HEALTH REV, V32, P451, DOI 10.1007/BF03391611; Butala NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025904; Chen HY, 2013, CLIN EPIDEMIOL, V5, P439, DOI [DOI 10.2147/CLEP.S49485, 10.2147/CLEP.S49485]; Clarke B, 2011, CAN J CARDIOL, V27, P254, DOI 10.1016/j.cjca.2010.12.053; Gili M, 2011, REV ESP CARDIOL, V64, P1130, DOI [10.1016/j.recesp.2011.07.010, 10.1016/j.rec.2011.07.009]; Heer T, 2002, AM J CARDIOL, V89, P511, DOI 10.1016/S0002-9149(01)02289-5; Hosseinpoor AR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-474; McManus David D, 2012, Clin Epidemiol, V4, P115, DOI 10.2147/CLEP.S30883; McManus DD, 2011, AM J MED, V124, P40, DOI 10.1016/j.amjmed.2010.07.023; Ministry of Health, 2010, HLTH STAT YB 2009; Miszkurka M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-24; Nguyen HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095631; Nguyen HL, 2011, AM J MED, V124, P939, DOI 10.1016/j.amjmed.2011.05.023; Pagidipati NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062061; Parker AB, 2006, CAN J CARDIOL, V22, P131, DOI 10.1016/S0828-282X(06)70252-5; Radovanovic D, 2014, HEART, V100, P288, DOI 10.1136/heartjnl-2013-304588; Schmidt M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e356; Sinnige J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079641; Song XT, 2007, CHINESE MED J-PEKING, V120, P1063, DOI 10.1097/00029330-200706020-00007; Srichaiveth Boonchu, 2007, Journal of the Medical Association of Thailand, V90, P65; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Van Minh Hoang, 2008, Prev Chronic Dis, V5, pA86; Wenger N, 2008, CLIN PHARMACOL THER, V83, P37, DOI 10.1038/sj.clpt.6100447	25	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108998	10.1371/journal.pone.0108998	http://dx.doi.org/10.1371/journal.pone.0108998			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279964	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800047
J	Mossuto, MF; Sannino, S; Mazza, D; Fagioli, C; Vitale, M; Yoboue, ED; Sitia, R; Anelli, T				Mossuto, Maria Francesca; Sannino, Sara; Mazza, Davide; Fagioli, Claudio; Vitale, Milena; Yoboue, Edgar Djaha; Sitia, Roberto; Anelli, Tiziana			A Dynamic Study of Protein Secretion and Aggregation in the Secretory Pathway	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; LIVE CELLS; DISULFIDE BONDS; RUSSELL BODIES; DEGRADATION; ERP44; IMMUNOGLOBULIN; DISLOCATION; TECHNOLOGY	Precise coordination of protein biogenesis, traffic and homeostasis within the early secretory compartment (ESC) is key for cell physiology. As a consequence, disturbances in these processes underlie many genetic and chronic diseases. Dynamic imaging methods are needed to follow the fate of cargo proteins and their interactions with resident enzymes and folding assistants. Here we applied the Halotag labelling system to study the behavior of proteins with different fates and roles in ESC: a chaperone, an ERAD substrate and an aggregation-prone molecule. Exploiting the Halo property of binding covalently ligands labelled with different fluorochromes, we developed and performed non-radioactive pulse and chase assays to follow sequential waves of proteins in ESC, discriminating between young and old molecules at the single cell level. In this way, we could monitor secretion and degradation of ER proteins in living cells. We can also follow the biogenesis, growth, accumulation and movements of protein aggregates in the ESC. Our data show that protein deposits within ESC grow by sequential apposition of molecules up to a given size, after which novel seeds are detected. The possibility of using ligands with distinct optical and physical properties offers a novel possibility to dynamically follow the fate of proteins in the ESC.	[Mossuto, Maria Francesca; Sannino, Sara; Fagioli, Claudio; Vitale, Milena; Yoboue, Edgar Djaha; Sitia, Roberto; Anelli, Tiziana] Univ Milan, Osped San Raffaele, IRCCS, Div Genet & Cell Biol, I-20127 Milan, Italy; [Sannino, Sara] Univ Milan, Dept Biosci, Milan, Italy; [Mazza, Davide; Vitale, Milena; Sitia, Roberto; Anelli, Tiziana] Univ Vita Salute San Raffaele, Milan, Italy; [Mazza, Davide] Univ Milan, Osped San Raffaele, IRCCS, Expt Imaging Ctr, I-20127 Milan, Italy	University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Vita-Salute San Raffaele University; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Anelli, T (corresponding author), Univ Milan, Osped San Raffaele, IRCCS, Div Genet & Cell Biol, Via Prinetti 29, I-20127 Milan, Italy.	anelli.tiziana@hsr.it	YOBOUE, Edgar D./AAA-7706-2019; Vitale, Milena/GPX-6640-2022; Sitia, Roberto/AAB-5005-2019; Mazza, Davide/R-5340-2016; Anelli, Tiziana/AAN-3717-2020; Fagioli, Claudio/AAN-4147-2020	Vitale, Milena/0000-0001-7007-402X; Sitia, Roberto/0000-0001-7086-4152; Mazza, Davide/0000-0003-2776-4142; Anelli, Tiziana/0000-0002-9159-9164; Fagioli, Claudio/0000-0001-9889-4695; Sannino, Sara/0000-0002-9125-9098	Telethon [GGP11077]; AIRC; FEBS Long-Term Fellowship	Telethon(Fondazione Telethon); AIRC(Fondazione AIRC per la ricerca sul cancro); FEBS Long-Term Fellowship	This work was supported by Telethon (GGP11077), AIRC (IG and 5x1000 Special Project) to RS. MFM was supported by a FEBS Long-Term Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Castelao B, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/823597; Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Anelli T, 2007, EMBO J; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Anelli T, 2012, ANTIOXID REDOX SIGN, V16, P1077, DOI 10.1089/ars.2011.4004; Anelli T, 2010, SEMIN CELL DEV BIOL, V21, P520, DOI 10.1016/j.semcdb.2010.02.006; BALIGA BS, 1969, J BIOL CHEM, V244, P4480; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Bianchi G, 2014, ONCOLOGY J HEMA 0115, V15; Calamini B, 2012, CURR TOP MED CHEM, V12, P2623; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; Cortini M, 2010, DIABETES OBES METAB, V12, P39, DOI 10.1111/j.1463-1326.2010.01272.x; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Emborg ME, 2008, CELL TRANSPLANT, V17, P383; Fagioli C, 2001, J BIOL CHEM, V276, P40962, DOI 10.1074/jbc.M107456200; Fujita-Yoshigaki J, 2013, AM J PHYSIOL-GASTR L, V305, pG685, DOI 10.1152/ajpgi.00093.2013; Gallo S, 2011, IN VITRO CELL DEV-AN, V47, P132, DOI 10.1007/s11626-010-9370-7; Gidalevitz T, 2013, BBA-MOL CELL RES, V1833, P2410, DOI 10.1016/j.bbamcr.2013.03.007; Gooptu B, 2014, TRENDS MOL MED, V20, P116, DOI 10.1016/j.molmed.2013.10.007; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Grotzke JE, 2013, P NATL ACAD SCI USA, V110, P3393, DOI 10.1073/pnas.1300328110; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; Hendershot L, 2005, MOL BIOL B CELLS; Kakihana T, 2013, J BIOL CHEM, V288, P29586, DOI 10.1074/jbc.M113.467845; Leippe DM, 2010, ANAL CHEM INSIGHTS, V5, P25; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Maji SK, 2009, FEBS LETT, V583, P2610, DOI 10.1016/j.febslet.2009.07.003; Mancini R, 2000, FASEB J, V14, P769, DOI 10.1096/fasebj.14.5.769; Martincova E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036314; Mattioli L, 2006, J CELL SCI, V119, P2532, DOI 10.1242/jcs.02977; Mazza D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks701; Medrano-Fernandez I, 2014, BIOCHEM CELL BIOL, V92, P113, DOI 10.1139/bcb-2013-0090; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Ohana RF, 2011, PROTEIN EXPRES PURIF, V76, P154, DOI 10.1016/j.pep.2010.11.014; Ordonez A, 2013, HEPATOLOGY, V57, P2049, DOI 10.1002/hep.26173; Otsu M, 2006, ANTIOXID REDOX SIGN, V8, P274, DOI 10.1089/ars.2006.8.274; Ronzoni R, 2010, TRAFFIC, V11, P947, DOI 10.1111/j.1600-0854.2010.01071.x; Sannino S, 2014, J CELL SCI IN PRESS; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031232; SIKORSKI RS, 1989, GENETICS, V122, P19; Snapp EL, 2006, P NATL ACAD SCI USA, V103, P6536, DOI 10.1073/pnas.0510657103; Stagge F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078745; Svendsen S, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-17; Tukachinsky H, 2012, CELL REPORTS, V2, P308, DOI 10.1016/j.celrep.2012.07.010; VALETTI C, 1991, J CELL BIOL, V115, P983, DOI 10.1083/jcb.115.4.983; Vavassori S, 2013, MOL CELL, V50, P783, DOI 10.1016/j.molcel.2013.04.016; Wei DG, 2010, J CHEM INF MODEL, V50, P1855, DOI 10.1021/ci900463u; Zhong YW, 2012, J BIOL CHEM, V287, P28057, DOI 10.1074/jbc.M112.381798; Zhou Pengbo, 2004, Methods Mol Biol, V284, P67	51	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108496	10.1371/journal.pone.0108496	http://dx.doi.org/10.1371/journal.pone.0108496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279560	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800018
J	Xu, XL; Wen, WB; Li, B; Gao, F; Zhang, ZB; Jonas, JB				Xu, Xiaolin; Wei, Wen Bin; Li, Bin; Gao, Fei; Zhang, Zhibao; Jonas, Jost B.			Oncogenic GNAQ and GNA11 Mutations in Uveal Melanoma in Chinese	PLOS ONE			English	Article							NRAS MUTATIONS; BRAF; SURVIVAL; CANCER	Purpose: To examine whether GNAQ and GNA11 somatic mutations previously identified in uveal melanomas of Caucasians are associated with uveal melanomas in Chinese patients. Methods: Uveal melanomas treated by primary enucleation in Chinese patients underwent a mutation analysis of GNAQ and GNA11 with sequencing of exon 5 and exon 4. Results: The study included 50 patients with uveal melanoma and with a mean age of 47.6 +/- 13.0 years. During the follow-up of at least 3 years, 20 (40%) patients developed extraocular metastases. The frequencies of GNAQ and GNA11 somatic mutations in uveal melanoma were 18% (9/50) and 20% (10/50), respectively. The mutations occurred exclusively in codon 209 of exon 5. No mutations were detected in exon 4. Mutations affecting codon 209 in GNAQ were c.626A>C(Q209P) (78%) and c.626A>T(Q209L) (22%). Mutations affecting codon 209 in GNA11 were exclusively c.626A>T(Q209L) (100%). In none of the tumors, mutations of BRAF and NRAS were detected. GNAQ/11 mutations were marginally (P = 0.045) associated with optic disc involvement. In Kaplan-Meier analysis, metastasis-free survival was not significantly (P = 0.94) associated with GNAQ/11 mutations. Conclusions: Mutations of GNAQ and GNA11 can be found in Chinese patients as in Caucasian patients with uveal melanoma, with a higher frequency reported for Caucasian patients.	[Xu, Xiaolin; Li, Bin; Gao, Fei; Zhang, Zhibao; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol,Beijing Ophthalmol Visual, Beijing, Peoples R China; [Wei, Wen Bin] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Seegartenklin Heidelberg, Heidelberg, Germany	Capital Medical University; Capital Medical University; Ruprecht Karls University Heidelberg	Wen, WB (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China.	tr_weiwenbin@163.com	温, 家琦/GYV-3177-2022; fei, Gao/GQQ-8024-2022		National Natural Science Foundation of China [81272981]; Beijing Nova Program [2008B46]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	The study was supported by National Natural Science Foundation of China (Grant No. 81272981) and Beijing Nova Program (Grant No. 2008B46). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brose MS, 2002, CANCER RES, V62, P6997; Cruz F, 2003, CANCER RES, V63, P5761; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; EGAN KM, 1988, SURV OPHTHALMOL, V32, P239, DOI 10.1016/0039-6257(88)90173-7; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; Kong Y, 2011, CLIN CANCER RES, V17, P1684, DOI 10.1158/1078-0432.CCR-10-2346; Koopmans AE, 2013, BRIT J CANCER, V109, P493, DOI 10.1038/bjc.2013.299; McArthur GA, 2012, LANCET ONCOL, V13, P744, DOI 10.1016/S1470-2045(12)70317-0; Mudhar HS, 2013, BRIT J OPHTHALMOL, V97, P924, DOI 10.1136/bjophthalmol-2013-303291; Mudhar HS, 2004, HISTOPATHOLOGY, V45, P1, DOI 10.1111/j.1365-2559.2004.01874.x; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Onken MD, 2008, INVEST OPHTH VIS SCI, V49, P5230, DOI 10.1167/iovs.08-2145; Rietschel P, 2005, J CLIN ONCOL, V23, P8076, DOI 10.1200/JCO.2005.02.6534; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Si L, 2012, EUR J CANCER, V48, P94, DOI 10.1016/j.ejca.2011.06.056; Singh AD, 2003, OPHTHALMOLOGY, V110, P962, DOI 10.1016/S0161-6420(03)00077-0; Singh Arun D, 2005, Ophthalmol Clin North Am, V18, P75, DOI 10.1016/j.ohc.2004.07.002; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412	24	18	18	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109699	10.1371/journal.pone.0109699	http://dx.doi.org/10.1371/journal.pone.0109699			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25280020	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800096
J	Kondo, S; Yoshida, K; Suzuki, M; Saito, I; Kanegae, Y				Kondo, Saki; Yoshida, Kenji; Suzuki, Mariko; Saito, Izumu; Kanegae, Yumi			Adenovirus-Encoding Virus-Associated RNAs Suppress HDGF Gene Expression to Support Efficient Viral Replication	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; MEDIATED CASSETTE EXCHANGE; IN-VITRO; PROTEIN-SYNTHESIS; CELL-LINES; GROWTH; MODULATION; INITIATION; VECTORS; CTBP	Non-coding small RNAs are involved in many physiological responses including viral life cycles. Adenovirus-encoding small RNAs, known as virus-associated RNAs (VA RNAs), are transcribed throughout the replication process in the host cells, and their transcript levels depend on the copy numbers of the viral genome. Therefore, VA RNAs are abundant in infected cells after genome replication, i.e. during the late phase of viral infection. Their function during the late phase is the inhibition of interferon-inducible protein kinase R (PKR) activity to prevent antiviral responses; recently, mivaRNAs, the microRNAs processed from VA RNAs, have been reported to inhibit cellular gene expression. Although VA RNA transcription starts during the early phase, little is known about its function. The reason may be because much smaller amount of VA RNAs are transcribed during the early phase than the late phase. In this study, we applied replication-deficient adenovirus vectors (AdVs) and novel AdVs lacking VA RNA genes to analyze the expression changes in cellular genes mediated by VA RNAs using microarray analysis. AdVs are suitable to examine the function of VA RNAs during the early phase, since they constitutively express VA RNAs but do not replicate except in 293 cells. We found that the expression level of hepatoma-derived growth factor (HDGF) significantly decreased in response to the VA RNAs under replication-deficient condition, and this suppression was also observed during the early phase under replication-competent conditions. The suppression was independent of mivaRNA-induced downregulation, suggesting that the function of VA RNAs during the early phase differs from that during the late phase. Notably, overexpression of HDGF inhibited AdV growth. This is the first report to show the function, in part, of VA RNAs during the early phase that may be contribute to efficient viral growth.	[Kondo, Saki; Suzuki, Mariko; Saito, Izumu; Kanegae, Yumi] Univ Tokyo, Inst Med Sci, Mol Genet Lab, Minato Ku, Tokyo, Japan; [Yoshida, Kenji] Sumitomo Dainippon Pharma Co Ltd, Regenerat & Cellular Med Off, Chuo Ku, Kobe, Hyogo, Japan	University of Tokyo; Dainippon Sumitomo Pharmaceutical Company	Kanegae, Y (corresponding author), Univ Tokyo, Inst Med Sci, Mol Genet Lab, Minato Ku, Tokyo, Japan.	kanegae@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare; JST; Practical Application of New Drugs for Hepatitis B; Grants-in-Aid for Scientific Research [26670221] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); JST(Japan Science & Technology Agency (JST)); Practical Application of New Drugs for Hepatitis B; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (http://www.jsps.go.jp/english/index.html) to S.K. and Y.K. and the Ministry of Health, Labour and Welfare (http://www.mhlw.go.jp/english/index.html) for Research on the Innovative Development and the Practical Application of New Drugs for Hepatitis B to I. S. This work was supported in part by the Program for Intractable Disease Research utilizing Disease-specific iPS Cells from JST to Y.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Aparicio O, 2006, J VIROL, V80, P1376, DOI 10.1128/JVI.80.3.1376-1384.2006; Aparicio O, 2010, NUCLEIC ACIDS RES, V38, P750, DOI 10.1093/nar/gkp1028; Baba Y, 2005, MICROBIOL IMMUNOL, V49, P559, DOI 10.1111/j.1348-0421.2005.tb03753.x; Bennasser Y, 2011, NAT STRUCT MOL BIOL, V18, P323, DOI 10.1038/nsmb.1987; Bornkamm GW, 2009, SEMIN CANCER BIOL, V19, P351, DOI 10.1016/j.semcancer.2009.07.002; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Fukuda H, 2006, MICROBIOL IMMUNOL, V50, P643, DOI 10.1111/j.1348-0421.2006.tb03829.x; Fukuhara T, 2013, J GASTROENTEROL, V48, P169, DOI 10.1007/s00535-012-0661-5; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Greifenegger N, 1998, J VIROL, V72, P9323, DOI 10.1128/JVI.72.11.9323-9328.1998; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Heishi M, 2006, DIABETOLOGIA, V49, P1647, DOI 10.1007/s00125-006-0271-y; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kaushal Deepak, 2004, Curr Protoc Bioinformatics, VChapter 7, DOI 10.1002/0471250953.bi0709s7; Kondo S, 2009, J MOL BIOL, V390, P221, DOI 10.1016/j.jmb.2009.04.057; LERNER MR, 1981, P NATL ACAD SCI-BIOL, V78, P805, DOI 10.1073/pnas.78.2.805; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Maekawa A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01136; Mathews M B, 1995, Curr Top Microbiol Immunol, V199 ( Pt 2), P173; Matsui T, 2012, STEM CELLS, V30, P1109, DOI 10.1002/stem.1091; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakai M, 2007, HUM GENE THER, V18, P925, DOI 10.1089/hum.2007.085; Nakano M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni074; Narayanan A, 2011, EXPERT OPIN BIOL TH, V11, P17, DOI 10.1517/14712598.2011.540564; OMALLEY RP, 1989, VIROLOGY, V168, P112, DOI 10.1016/0042-6822(89)90409-1; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Pei Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep03575; Pei Z, 2012, BIOCHEM BIOPH RES CO, V417, P945, DOI 10.1016/j.bbrc.2011.12.016; REICHEL PA, 1985, NATURE, V313, P196, DOI 10.1038/313196a0; SAITO I, 1989, MOL CELL BIOL, V9, P2445, DOI 10.1128/MCB.9.6.2445; SCHNEIDER RJ, 1984, CELL, V37, P291, DOI 10.1016/0092-8674(84)90325-8; Subramanian T, 2013, VIROLOGY, V443, P313, DOI 10.1016/j.virol.2013.05.018; Takata Y, 2011, GENES CELLS, V16, P765, DOI 10.1111/j.1365-2443.2011.01526.x; Turner J, 2001, BIOESSAYS, V23, P683, DOI 10.1002/bies.1097; Yajima M, 2005, J VIROL, V79, P4298, DOI 10.1128/JVI.79.7.4298-4307.2005; Yang J, 2009, J MOL BIOL, V386, P938, DOI 10.1016/j.jmb.2008.12.080; Zhou R, 2013, IMMUNOL REV, V253, P97, DOI 10.1111/imr.12053	42	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108627	10.1371/journal.pone.0108627	http://dx.doi.org/10.1371/journal.pone.0108627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275311	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500023
J	Hanley, QS; Khatun, S; Yosef, A; Dyer, RM				Hanley, Quentin S.; Khatun, Suniya; Yosef, Amal; Dyer, Rachel-May			Fluctuation Scaling, Taylor's Law, and Crime	PLOS ONE			English	Article							POWER-LAW; VARIANCE; DISTRIBUTIONS; DEPENDENCE; DYNAMICS; DENSITY; GROWTH	Fluctuation scaling relationships have been observed in a wide range of processes ranging from internet router traffic to measles cases. Taylor's law is one such scaling relationship and has been widely applied in ecology to understand communities including trees, birds, human populations, and insects. We show that monthly crime reports in the UK show complex fluctuation scaling which can be approximated by Taylor's law relationships corresponding to local policing neighborhoods and larger regional and countrywide scales. Regression models applied to local scale data from Derbyshire and Nottinghamshire found that different categories of crime exhibited different scaling exponents with no significant difference between the two regions. On this scale, violence reports were close to a Poisson distribution (alpha = 1.057 +/- 0.026) while burglary exhibited a greater exponent (alpha = 1.292 +/- 0.029) indicative of temporal clustering. These two regions exhibited significantly different pre-exponential factors for the categories of anti-social behavior and burglary indicating that local variations in crime reports can be assessed using fluctuation scaling methods. At regional and countrywide scales, all categories exhibited scaling behavior indicative of temporal clustering evidenced by Taylor's law exponents from 1.43 +/- 0.12 (Drugs) to 2.094 +/- 0081 (Other Crimes). Investigating crime behavior via fluctuation scaling gives insight beyond that of raw numbers and is unique in reporting on all processes contributing to the observed variance and is either robust to or exhibits signs of many types of data manipulation.	[Hanley, Quentin S.; Khatun, Suniya; Yosef, Amal; Dyer, Rachel-May] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England	Nottingham Trent University	Hanley, QS (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England.	quentin.hanley@ntu.ac.uk	Hanley, Quentin/N-2253-2019	Hanley, Quentin/0000-0002-8189-9550; Dyer, Rachel-May/0000-0002-5577-6864				Alves LGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069580; Alves LGA, 2013, PHYSICA A, V392, P2672, DOI 10.1016/j.physa.2013.02.002; [Anonymous], 2014, POLICE FORCE AREA DA; [Anonymous], 2014, 268 OFF NAT STAT; [Anonymous], 2013, REGION COUNTRY PROFI; [Anonymous], 2014, MONTHLY FIGURES DEAT; [Anonymous], 2013, DERBYSHIRE CONSTABUL; [Anonymous], 2013, NOTTINGHAMSHIRE POLI; BARNETT A, 1981, OPER RES, V29, P346, DOI 10.1287/opre.29.2.346; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Cattadori IM, 2003, OIKOS, V100, P439, DOI 10.1034/j.1600-0706.2003.12072.x; Chen P, 2013, SECUR J, V26, P1, DOI 10.1057/sj.2011.4; Cohen Joel E., 2013, Genus, V69, P25; Cohen JE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2955; de Menezes MA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.028701; Eisler Z, 2008, ADV PHYS, V57, P89, DOI 10.1080/00018730801893043; Gaffeo E, 2012, ECOL COMPLEX, V11, P109, DOI 10.1016/j.ecocom.2012.05.001; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; Johnson SD, 2004, BRIT J CRIMINOL, V44, P55, DOI 10.1093/bjc/44.1.55; Keeling M, 1999, PHILOS T R SOC B, V354, P769, DOI 10.1098/rstb.1999.0429; Kendal WS, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066115; Kilpatrick AM, 2003, NATURE, V422, P65, DOI 10.1038/nature01471; Maltz MD, 1996, J QUANT CRIMINOL, V12, P3, DOI 10.1007/BF02354470; MORTARA L, 1981, P SOC PHOTO-OPT INST, V290, P28; Perry J. N., 1981, Applied Statistics, V30, P254, DOI 10.2307/2346349; PERRY JN, 1985, J ANIM ECOL, V54, P931, DOI 10.2307/4388; Petri G, 2013, SCIENTIFIC REPORTS, V3, P1; Rybski D, 2009, P NATL ACAD SCI USA, V106, P12640, DOI 10.1073/pnas.0902667106; SAWYER AJ, 1989, RES POPUL ECOL, V31, P11, DOI 10.1007/BF02515802; Smith HF, 1938, J AGR SCI, V28, P1, DOI 10.1017/S0021859600050516; Sperline RP, 2005, APPL SPECTROSC, V59, P1315, DOI 10.1366/000370205774783250; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; TAYLOR LR, 1984, ANNU REV ENTOMOL, V29, P321, DOI 10.1146/annurev.en.29.010184.001541; TAYLOR LR, 1978, J ANIM ECOL, V47, P383, DOI 10.2307/3790; YAMAMURA K, 1990, OIKOS, V59, P121, DOI 10.2307/3545131	36	25	25	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109004	10.1371/journal.pone.0109004	http://dx.doi.org/10.1371/journal.pone.0109004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271781	Green Published, gold, Green Accepted			2022-12-27	WOS:000343729600086
J	Lai, CD; Wu, XL; Chen, C; Huang, T; Xiong, XL; Wu, SJ; Gu, MJ; Deng, ZX; Chen, X; Chen, S; Wang, LR				Lai, Chongde; Wu, Xiaolin; Chen, Chao; Huang, Teng; Xiong, Xiaolin; Wu, Shuangju; Gu, Meijia; Deng, Zixin; Chen, Xi; Chen, Shi; Wang, Lianrong			In Vivo Mutational Characterization of DndE Involved in DNA Phosphorothioate Modification	PLOS ONE			English	Article							STREPTOMYCES-LIVIDANS; S-MODIFICATION; RESTRICTION; BIOLOGY; SULFUR; BACTERIA; INSIGHTS; SYSTEM; GENES	DNA phosphorothioate (PT) modification is a recently identified epigenetic modification that occurs in the sugar-phosphate backbone of prokaryotic DNA. Previous studies have demonstrated that DNA PT modification is governed by the five DndABCDE proteins in a sequence-selective and R-P stereo-specific manner. Bacteria may have acquired this physiological modification along with dndFGH as a restriction-modification system. However, little is known about the biological function of Dnd proteins, especially the smallest protein, DndE, in the PT modification pathway. DndE was reported to be a DNA-binding protein with a preference for nicked dsDNA in vitro; the binding of DndE to DNA occurs via six positively charged lysine residues on its surface. The substitution of these key lysine residues significantly decreased the DNA binding affinities of DndE proteins to undetectable levels. In this study, we conducted site-directed mutagenesis of dndE on a plasmid and measured DNA PT modifications under physiological conditions by mass spectrometry. We observed distinctive differences from the in vitro binding assays. Several mutants with lysine residues mutated to alanine decreased the total frequency of PT modifications, but none of the mutants completely eliminated PT modification. Our results suggest that the nicked dsDNA-binding capacity of DndE may not be crucial for PT modification and/or that DndE may have other biological functions in addition to binding to dsDNA.	[Lai, Chongde; Wu, Xiaolin; Chen, Chao; Huang, Teng; Xiong, Xiaolin; Wu, Shuangju; Gu, Meijia; Deng, Zixin; Chen, Xi; Chen, Shi; Wang, Lianrong] Wuhan Univ, Minist Educ, Key Lab Combinatorial Biosynthesis & Drug Discove, Wuhan 430072, Peoples R China; [Lai, Chongde; Wu, Xiaolin; Chen, Chao; Huang, Teng; Xiong, Xiaolin; Wu, Shuangju; Gu, Meijia; Deng, Zixin; Chen, Xi; Chen, Shi; Wang, Lianrong] Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430072, Peoples R China; [Wu, Xiaolin] Hubei Univ Med, Taihe Hosp, Shiyan, Hubei, Peoples R China; [Lai, Chongde] Jiangxi Agr Univ, Coll Biosci & Bioengn, Nanchang, Peoples R China	Wuhan University; Wuhan University; Hubei University of Medicine; Jiangxi Agricultural University	Chen, S (corresponding author), Wuhan Univ, Minist Educ, Key Lab Combinatorial Biosynthesis & Drug Discove, Wuhan 430072, Peoples R China.	shichen@whu.edu.cn; lianrong@whu.edu.cn	熊, 啸林/AHB-8408-2022	熊, 啸林/0000-0003-1899-339X; wang, lianrong/0000-0003-1669-6340; Wu, Xiaolin/0000-0001-6924-292X	973 programs of the Ministry of Science and Technology of China [2012CB721004, 2013CB734003]; National Natural Science Foundation of China [31170049, 31300038]; Foundation for the Author of National Excellent Doctoral Dissertation of China; Program for New Century Excellent Talents in University; Hubei Province's Outstanding Medical Academic Leader program; Scientific Research Funds of the Education Department of Jiangxi Province, China [GJJ13257]	973 programs of the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Hubei Province's Outstanding Medical Academic Leader program; Scientific Research Funds of the Education Department of Jiangxi Province, China	This work was supported by grants from the 973 programs of the Ministry of Science and Technology of China (2012CB721004, 2013CB734003), National Natural Science Foundation of China (31170049, 31300038), Foundation for the Author of National Excellent Doctoral Dissertation of China, the Program for New Century Excellent Talents in University, Hubei Province's Outstanding Medical Academic Leader program, the Scientific Research Funds of the Education Department of Jiangxi Province, China (GJJ13257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTINGMEES MA, 1989, NUCLEIC ACIDS RES, V17, P9494, DOI 10.1093/nar/17.22.9494; An XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051265; Cao B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4951; Chen S, 2010, PROTEIN CELL, V1, P14, DOI 10.1007/s13238-010-0009-y; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Dyson P, 1998, NUCLEIC ACIDS RES, V26, P1248, DOI 10.1093/nar/26.5.1248; ECKSTEIN F, 1989, TRENDS BIOCHEM SCI, V14, P97, DOI 10.1016/0968-0004(89)90130-8; He X, 2007, MOL MICROBIOL, V65, P1034, DOI 10.1111/j.1365-2958.2007.05846.x; Hu W, 2012, CELL RES, V22, P1203, DOI 10.1038/cr.2012.66; Tock MR, 2005, CURR OPIN MICROBIOL, V8, P466, DOI 10.1016/j.mib.2005.06.003; Wang L., 2011, DNA REPLICATION CURR; Wang LR, 2007, NAT CHEM BIOL, V3, P709, DOI 10.1038/nchembio.2007.39; Wang LR, 2011, P NATL ACAD SCI USA, V108, P2963, DOI 10.1073/pnas.1017261108; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; Xu TG, 2010, NUCLEIC ACIDS RES, V38, P7133, DOI 10.1093/nar/gkq610; Yao F, 2009, FEBS LETT, V583, P729, DOI 10.1016/j.febslet.2009.01.029; You DL, 2007, BIOCHEMISTRY-US, V46, P6126, DOI 10.1021/bi602615k; Zhou XF, 2005, MOL MICROBIOL, V57, P1428, DOI 10.1111/j.1365-2958.2005.04764.x	18	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107981	10.1371/journal.pone.0107981	http://dx.doi.org/10.1371/journal.pone.0107981			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25269084	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700057
J	Leentjens, J; Quintin, J; Gerretsen, J; Kox, M; Pickkers, P; Netea, MG				Leentjens, Jenneke; Quintin, Jessica; Gerretsen, Jelle; Kox, Matthijs; Pickkers, Peter; Netea, Mihai G.			The Effects of Orally Administered Beta-Glucan on Innate Immune Responses in Humans, a Randomized Open-Label Intervention Pilot-Study	PLOS ONE			English	Article							COMBINATION THERAPY; MONOCYTES; INFECTION; DECTIN-1; CANCER	Rationale: To prevent or combat infection, increasing the effectiveness of the immune response is highly desirable, especially in case of compromised immune system function. However, immunostimulatory therapies are scarce, expensive, and often have unwanted side-effects. beta-glucans have been shown to exert immunostimulatory effects in vitro and in vivo in experimental animal models. Oral beta-glucan is inexpensive and well-tolerated, and therefore may represent a promising immunostimulatory compound for human use. Methods: We performed a randomized open-label intervention pilot-study in 15 healthy male volunteers. Subjects were randomized to either the beta-glucan (n = 10) or the control group (n = 5). Subjects in the beta-glucan group ingested beta-glucan 1000 mg once daily for 7 days. Blood was sampled at various time-points to determine beta-glucan serum levels, perform ex vivo stimulation of leukocytes, and analyze microbicidal activity. Results: beta-glucan was barely detectable in serum of volunteers at all time-points. Furthermore, neither cytokine production nor microbicidal activity of leukocytes were affected by orally administered beta-glucan. Conclusion: The present study does not support the use of oral beta-glucan to enhance innate immune responses in humans.	[Leentjens, Jenneke; Quintin, Jessica; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Leentjens, Jenneke; Gerretsen, Jelle; Kox, Matthijs; Pickkers, Peter] Radboud Univ Nijmegen, Med Ctr, Dept Intens Care Med, NL-6525 ED Nijmegen, Netherlands; [Leentjens, Jenneke; Quintin, Jessica; Gerretsen, Jelle; Kox, Matthijs; Pickkers, Peter; Netea, Mihai G.] Radboud Inst Infect Dis, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands.	mihai.netea@radboudumc.nl	Kox, Matthijs/L-4454-2015; Leentjens, Jenneke/P-8300-2015; Pickkers, P./H-8080-2014; Netea, Mihai/N-5155-2014	Leentjens, Jenneke/0000-0003-3356-3910; Pickkers, P./0000-0002-1104-4303; 	Vici grant of the Netherlands Organization for Scientific Research	Vici grant of the Netherlands Organization for Scientific Research	M.G.N. was supported by a Vici grant of the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EL, 2008, J PHARMACOL EXP THER, V325, P115, DOI 10.1124/jpet.107.133124; Auinger A, 2013, EUR J NUTR, V52, P1913, DOI 10.1007/s00394-013-0492-z; Brown GD, 2003, IMMUNITY, V19, P311, DOI 10.1016/S1074-7613(03)00233-4; Chang ST, 1989, EDIBLE MUSHROOMS THE, P27, DOI [10.1201/9780203492086.ch2, DOI 10.1201/9780203492086.CH2]; Dellinger EP, 1999, ARCH SURG-CHICAGO, V134, P977, DOI 10.1001/archsurg.134.9.977; Demir G, 2007, INT IMMUNOPHARMACOL, V7, P113, DOI 10.1016/j.intimp.2006.08.011; Frey A, 1996, J EXP MED, V184, P1045, DOI 10.1084/jem.184.3.1045; Graubaum H. J., 2012, Food and Nutrition Sciences, V3, P738, DOI 10.4236/fns.2012.36100; Higashi D, 2012, ANTICANCER RES, V32, P2365; INOUE M, 1993, BIOTHERAPY, V6, P13, DOI 10.1007/BF01877381; JONG SC, 1992, ADV APPL MICROBIOL, V37, P101, DOI 10.1016/S0065-2164(08)70253-3; Kournikakis Bill, 2003, MedGenMed, V5, P1; Li J, 2006, J ANIM SCI, V84, P2374, DOI 10.2527/jas.2004-541; Nelson Robert P. Jr., 2003, Journal of Allergy and Clinical Immunology, V111, pS720; Netea MG, 2003, J INFECT DIS, V188, P320, DOI 10.1086/376456; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Pickering JW, 2005, J CLIN MICROBIOL, V43, P5957, DOI 10.1128/JCM.43.12.5957-5962.2005; Qi CJ, 2011, BLOOD, V117, P6825, DOI 10.1182/blood-2011-02-339812; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Volman JJ, 2008, PHYSIOL BEHAV, V94, P276, DOI 10.1016/j.physbeh.2007.11.045; Wang JL, 2012, MOL MED REP, V5, P745, DOI 10.3892/mmr.2011.718; Williams DL, 1997, MEDIAT INFLAMM, V6, P247, DOI 10.1080/09629359791550; Zekovic DB, 2005, CRIT REV BIOTECHNOL, V25, P205, DOI 10.1080/07388550500376166	23	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108794	10.1371/journal.pone.0108794	http://dx.doi.org/10.1371/journal.pone.0108794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268806	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700164
J	Lu, M; Jiang, YL; Wang, S; Jin, H; Zhang, RG; Virolle, MJ; Chen, YX; Zhou, CZ				Lu, Mo; Jiang, Yong-Liang; Wang, Shu; Jin, Hua; Zhang, Rong-Guang; Virolle, Marie-Joelle; Chen, Yuxing; Zhou, Cong-Zhao			Streptomyces coelicolor SCO4226 Is a Nickel Binding Protein	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NIKR; HELICOBACTER-PYLORI; BRADYRHIZOBIUM-JAPONICUM; METAL-BINDING; SUPEROXIDE DISMUTASES; RESPONSIVE REGULATOR; STRUCTURAL BASIS; HYPB PROTEIN; EXPRESSION; TRANSPORT	The open reading frame SCO4226 of Streptomyces coelicolor A3(2) encodes an 82-residue hypothetical protein. Biochemical assays revealed that each SCO4226 dimer binds four nickel ions. To decipher the molecular function, we solved the crystal structures of SCO4226 in both apo- and nickel-bound (Ni-SCO4226) forms at 1.30 and 2.04 angstrom resolution, respectively. Each subunit of SCO4226 dimer adopts a canonical ferredoxin-like fold with five beta-strands flanked by two alpha-helices. In the structure of Ni-SCO4226, four nickel ions are coordinated at the surface of the dimer. Further biochemical assays suggested that the binding of Ni2+ triggers the self-aggregation of SCO4226 in vitro. In addition, RT-qPCR assays demonstrated that the expression of SCO4226 gene in S. coelicolor is specifically up-regulated by the addition of Ni2+, but not other divalent ions such as Cu2+, Mn2+ or Co2+. All these results suggested that SCO4226 acts as a nickel binding protein, probably required for nickel sequestration and/or detoxification.	[Lu, Mo; Jiang, Yong-Liang; Wang, Shu; Jin, Hua; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Lu, Mo; Jiang, Yong-Liang; Wang, Shu; Jin, Hua; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Zhang, Rong-Guang] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [Virolle, Marie-Joelle] Univ Paris 11, CNRS, UMR8621, Inst Genet & Microbiol, F-91405 Orsay, France; [Lu, Mo] South Univ Sci & Technol China, Dept Biol, Shenzhen, Guangdong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Southern University of Science & Technology	Jiang, YL (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	jyl@mail.ustc.edu.cn; zcz@ustc.edu.cn	Zhou, Cong-Zhao/E-9174-2011; Chen, Yuxing/P-4156-2014	Zhou, Cong-Zhao/0000-0002-6881-7151; Chen, Yuxing/0000-0002-7560-1922; Jiang, YongLiang/0000-0001-5441-4936; virolle, marie-joelle/0000-0001-9509-4115	Ministry of Science and Technology of China [2012CB911000]; Program for Changjiang Scholars and Innovative Research Team in University	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was funded by the project 2012CB911000 from the Ministry of Science and Technology of China (http://www.most.gov.cn/) and the Program for Changjiang Scholars and Innovative Research Team in University (http://www.moe.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham LO, 2006, J INORG BIOCHEM, V100, P1005, DOI 10.1016/j.jinorgbio.2005.10.014; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahn BE, 2006, MOL MICROBIOL, V59, P1848, DOI 10.1111/j.1365-2958.2006.05065.x; Bahlawane C, 2010, NUCLEIC ACIDS RES, V38, P3106, DOI 10.1093/nar/gkp1216; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTHA R, 1965, J BACTERIOL, V89, P1015, DOI 10.1128/JB.89.4.1015-1019.1965; Benanti EL, 2007, J BIOL CHEM, V282, P20365, DOI 10.1074/jbc.M702982200; Brodersen DE, 2000, ACTA CRYSTALLOGR D, V56, P431, DOI 10.1107/S0907444900000834; Chivers PT, 2000, J BIOL CHEM, V275, P19735, DOI 10.1074/jbc.M002232200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Pina K, 1999, J BACTERIOL, V181, P670, DOI 10.1128/JB.181.2.670-674.1999; Degen O, 1999, ARCH MICROBIOL, V171, P139, DOI 10.1007/s002030050691; Eitinger T, 2005, BIOMETALS, V18, P399, DOI 10.1007/s10534-005-3714-x; Eitinger T, 2000, ARCH MICROBIOL, V173, P1, DOI 10.1007/s002030050001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flardh K, 2009, NAT REV MICROBIOL, V7, P36, DOI 10.1038/nrmicro1968; FU CL, 1995, P NATL ACAD SCI USA, V92, P2333, DOI 10.1073/pnas.92.6.2333; GILBERT JV, 1995, INFECT IMMUN, V63, P2682, DOI 10.1128/IAI.63.7.2682-2688.1995; Grass G, 2005, BIOMETALS, V18, P437, DOI 10.1007/s10534-005-3718-6; Grass G, 2001, J BACTERIOL, V183, P2803, DOI 10.1128/JB.183.9.2803-2807.2001; Higgins KA, 2012, BIOCHEMISTRY-US, V51, P7816, DOI 10.1021/bi300981m; Hodgson DA, 2000, ADV MICROB PHYSIOL, V42, P47, DOI 10.1016/S0065-2911(00)42003-5; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Kerosuo H, 1996, AM J ORTHOD DENTOFAC, V109, P148, DOI 10.1016/S0889-5406(96)70175-0; Kieser T, 2000, PRACTICAL STREPTOMYC, P248; Kim EJ, 1996, EUR J BIOCHEM, V241, P178, DOI 10.1111/j.1432-1033.1996.0178t.x; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Lever A.B.P, 1968, INORGANIC ELECT SPEC; Li YJ, 2009, CHEM REV, V109, P4617, DOI 10.1021/cr900010n; Mulrooney SB, 2003, FEMS MICROBIOL REV, V27, P239, DOI 10.1016/S0168-6445(03)00042-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Muyssen B. T. A., 2004, Environmental Reviews, V12, P113, DOI 10.1139/a04-004; Olson JW, 1997, MOL MICROBIOL, V24, P119, DOI 10.1046/j.1365-2958.1997.3251690.x; Olson JW, 2000, J BACTERIOL, V182, P1702, DOI 10.1128/JB.182.6.1702-1705.2000; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 2001, INT TABLES CRYSTALLO, V276, P226; Phillips CM, 2010, BIOCHEMISTRY-US, V49, P7830, DOI 10.1021/bi100923j; Ronning DR, 2005, MOL CELL, V20, P143, DOI 10.1016/j.molcel.2005.07.026; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; SCHMIDT T, 1989, FEMS MICROBIOL ECOL, V62, P315, DOI 10.1111/j.1574-6968.1989.tb03386.x; SINIGAGLIA F, 1985, J IMMUNOL, V135, P3929; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang S, 2008, ACTA CRYSTALLOGR F, V64, P847, DOI 10.1107/S174430910802575X; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Youn HD, 1996, BIOCHEM J, V318, P889, DOI 10.1042/bj3180889	48	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109660	10.1371/journal.pone.0109660	http://dx.doi.org/10.1371/journal.pone.0109660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285530	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700078
J	Ammerdorffer, A; Roest, HIJ; Dinkla, A; Post, J; Schoffelen, T; van Deuren, M; Sprong, T; Rebel, JM				Ammerdorffer, Anne; Roest, Hendrik-I J.; Dinkla, Annemieke; Post, Jacob; Schoffelen, Teske; van Deuren, Marcel; Sprong, Tom; Rebel, Johanna M.			The Effect of C-burnetii Infection on the Cytokine Response of PBMCs from Pregnant Goats	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; Q-FEVER ENDOCARDITIS; T-CELLS; FACTOR-ALPHA; GAMMA; INTERLEUKIN-10; INTERFERON; MICE; MONOCYTES	In humans, infection with Coxiella burnetii, the causative agent of Q fever, leads to acute or chronic infection, both associated with specific clinical symptoms. In contrast, no symptoms are observed in goats during C. burnetii infection, although infection of the placenta eventually leads to premature delivery, stillbirth and abortion. It is unknown whether these differences in clinical outcome are due to the early immune responses of the goats. Therefore, peripheral blood mononuclear cells (PBMCs) were isolated from pregnant goats. In total, 17 goats were included in the study. Six goats remained naive, while eleven goats were infected with C. burnetii. Toll-like receptor (TLR) and cytokine mRNA expression were measured after in vitro stimulation with heat-killed C. burnetii at different time points (prior infection, day 7, 35 and 56 after infection). In naive goats an increased expression of interleukin (IL)-1 beta, tumor necrosis factor (TNF)-alpha, IL-10 and interferon (IFN)-gamma mRNA upon C. burnetii stimulation was detected. In addition, TLR2 expression was strongly up-regulated. In goats infected with C. burnetii, PBMCs re-stimulated in vitro with C. burnetii, expressed significantly more TNF-alpha mRNA and IFN-gamma mRNA compared to naive goats. In contrast, IL-10 mRNA production capacity was down-regulated during C. burnetii infection. Interestingly, at day 7 after inoculation a decreased IFN-gamma protein level was observed in stimulated leukocytes in whole blood from infected goats, whereas at other time-points increased production of IFN-gamma protein was seen. Our study shows that goats initiate a robust pro-inflammatory immune response against C. burnetii in vitro. Furthermore, PBMCs from C. burnetii infected goats show augmented pro-inflammatory cytokine responses compared to PBMCs from non-infected goats. However, despite this pro-inflammatory response, goats are not capable of clearing the C. burnetii infection.	[Ammerdorffer, Anne; Schoffelen, Teske; van Deuren, Marcel; Sprong, Tom] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands; [Ammerdorffer, Anne; Roest, Hendrik-I J.; Dinkla, Annemieke] Cent Vet Inst Wageningen UR, Dept Bacteriol, Lelystad, Netherlands; [Ammerdorffer, Anne; Roest, Hendrik-I J.; Dinkla, Annemieke] Cent Vet Inst Wageningen UR, TSEs, Lelystad, Netherlands; [Post, Jacob] Cent Vet Inst Wageningen UR, Dept Infect Biol, Lelystad, Netherlands; [Sprong, Tom] Canisius Wilhelmina Hosp, Dept Internal Med, Nijmegen, Netherlands; [Sprong, Tom] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands	Radboud University Nijmegen; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Canisius-Wilhelmina Hospital; Canisius-Wilhelmina Hospital	Ammerdorffer, A (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands.	annemarie.rebel@wur.nl	Ammerdorffer, Anne/G-8508-2016	Ammerdorffer, Anne/0000-0002-1059-061X; Rebel, Annemarie/0000-0003-4765-4215	Netherlands Organisation for Health Research and Development [205520004]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This work was supported by The Netherlands Organisation for Health Research and Development (grant 205520004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh M, 2007, INFECT IMMUN, V75, P3245, DOI 10.1128/IAI.01767-06; Arricau-Bouvery N, 2005, VACCINE, V23, P4392, DOI 10.1016/j.vaccine.2005.04.010; Arricau-Bouvery N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-38; Ben Amara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015315; Capo C, 1996, INFECT IMMUN, V64, P1638, DOI 10.1128/IAI.64.5.1638-1642.1996; Capo C, 1996, INFECT IMMUN, V64, P4143, DOI 10.1128/IAI.64.10.4143-4147.1996; Dellacasagrande J, 2000, INFECT IMMUN, V68, P160, DOI 10.1128/IAI.68.10.5673-5678.2000; Ghigo E, 2001, INFECT IMMUN, V69, P2345, DOI 10.1128/IAI.69.4.2345-2352.2001; Graham JG, 2013, CELL MICROBIOL, V15, P1012, DOI 10.1111/cmi.12096; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Honstettre AL, 2003, J INFECT DIS, V187, P956, DOI 10.1086/368129; IZZO AA, 1993, CLIN EXP IMMUNOL, V94, P507, DOI 10.1111/j.1365-2249.1993.tb08226.x; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Meghari S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040023; Netea MG, 2003, TRENDS IMMUNOL, V24, P254, DOI 10.1016/S1471-4906(03)00079-6; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Rocha PN, 1999, J INFECT DIS, V180, P1731, DOI 10.1086/315071; Roest HIJ, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-67; Roest HIJ, 2011, EMERG INFECT DIS, V17, P668, DOI 10.3201/eid1704.101562; Roest HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048949; Schoffelen T, 2013, CLIN MICROBIOL INFEC; Schoffelen T, 2013, CLIN INFECT DIS, V56, P1742, DOI 10.1093/cid/cit129; SCHRAMEK S, 1981, ACTA VIROL, V25, P230; Segal G, 1999, MOL MICROBIOL, V33, P669, DOI 10.1046/j.1365-2958.1999.01512.x; Wang XS, 2009, J IMMUNOL, V182, P3668, DOI 10.4049/jimmunol.0803579; Wang Y, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-52; Zhang GQ, 2007, J IMMUNOL, V179, P8372, DOI 10.4049/jimmunol.179.12.8372; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030841	28	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109283	10.1371/journal.pone.0109283	http://dx.doi.org/10.1371/journal.pone.0109283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279829	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800070
J	Nowakowska, M; Nowicki, M; Klosinska, U; Maciorowski, R; Kozik, EU				Nowakowska, Marzena; Nowicki, Marcin; Klosinska, Urszula; Maciorowski, Robert; Kozik, Elzbieta U.			Appraisal of Artificial Screening Techniques of Tomato to Accurately Reflect Field Performance of the Late Blight Resistance	PLOS ONE			English	Article							PHYTOPHTHORA-INFESTANS; RACE COMPOSITION; PH-3 GENE; POTATO; POPULATIONS; INHERITANCE; LEAFLET; FOLIAGE; TAIWAN; ASSAY	Late blight (LB) caused by the oomycete Phytophthora infestans continues to thwart global tomato production, while only few resistant cultivars have been introduced locally. In order to gain from the released tomato germplasm with LB resistance, we compared the 5-year field performance of LB resistance in several tomato cultigens, with the results of controlled conditions testing (i.e., detached leaflet/leaf, whole plant). In case of these artificial screening techniques, the effects of plant age and inoculum concentration were additionally considered. In the field trials, LA 1033, L 3707, L 3708 displayed the highest LB resistance, and could be used for cultivar development under Polish conditions. Of the three methods using controlled conditions, the detached leaf and the whole plant tests had the highest correlation with thefield experiments. The plant age effect on LB resistance in tomato reported here, irrespective of the cultigen tested or inoculum concentration used, makes it important to standardize the test parameters when screening for resistance. Our results help show why other reports disagree on LB resistance in tomato.	[Nowakowska, Marzena; Nowicki, Marcin; Klosinska, Urszula; Kozik, Elzbieta U.] Inst Hort Res, Dept Genet Breeding & Biotechnol Vegetable Crops, Skierniewice, Poland; [Maciorowski, Robert] Inst Hort Res, Unit Econ & Stat, Skierniewice, Poland	Research Institute of Horticulture; Research Institute of Horticulture	Kozik, EU (corresponding author), Inst Hort Res, Dept Genet Breeding & Biotechnol Vegetable Crops, Skierniewice, Poland.	elzbieta.kozik@inhort.pl	Kłosińska, Urszula/U-6326-2018; Nowakowska, Marzena/U-5137-2018; Nowicki, Marcin/B-4212-2011; Maciorowski, Robert/U-2331-2018	Kłosińska, Urszula/0000-0003-2690-5986; Nowakowska, Marzena/0000-0002-6825-7756; Nowicki, Marcin/0000-0002-2655-5464; Maciorowski, Robert/0000-0003-1059-4239; Kozik, Elzbieta/0000-0002-1233-9410; Nowakowska, Marzena/0000-0001-9830-0076	Polish Ministry of Agriculture and Rural Development [HOR hn-801-15/13]	Polish Ministry of Agriculture and Rural Development	This research was supported by The Polish Ministry of Agriculture and Rural Development (Grant # HOR hn-801-15/13; "Searching for new sources of resistance to tomato late blight with regard to pathogenicity changes in Phytophthora infestans populations and attempts of markers identification linked with resistance genes''), carried out in the period 2008-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar KP, 2012, PAK J BOT, V44, P1141; [Anonymous], 2011, FAOSTAT FINAL 2011 D; AVDRC, 2005, 2005 PROGR REP, P49; Black L. L., 1996, Phytopathology, V86, pS24; BONDE R., 1952, Bulletin. Maine Agricultural Experiment Station, V497; Chen CH, 2008, PLANT DIS, V92, P751, DOI 10.1094/PDIS-92-5-0751; Chunwongse J, 2002, J HORTIC SCI BIOTECH, V77, P281, DOI 10.1080/14620316.2002.11511493; Chunwongse J, 1998, REP TOMATO GENET COO, V48, P13; Cohen Y, 2002, PHYTOPATHOLOGY, V92, P300, DOI 10.1094/PHYTO.2002.92.3.300; Darsow U., 2004, POTATO RES, V47, P163; Dorrance AE, 1997, PLANT DIS, V81, P1206, DOI 10.1094/PDIS.1997.81.10.1206; Dorrance AE, 1998, PLANT DIS, V82, P442, DOI 10.1094/PDIS.1998.82.4.442; Douches DS, 2002, POTATO RES, V45, P215, DOI 10.1007/BF02736116; Frary A, 1998, TOMATO GENETIC COOPE, V48, P19; Gallegly M. E., 1960, Proceedings of Plant Science Seminar, Camden, New Jersey 1960., P113; GALLEGLY ME, 1955, PHYTOPATHOLOGY, V45, P103; Gallegly ME, 1952, PHYTOPATHOLOGY, V42; Gardner RG, 2010, HORTSCIENCE, V45, P975, DOI 10.21273/HORTSCI.45.6.975; Gardner RG, 2010, HORTSCIENCE, V45, P824, DOI 10.21273/HORTSCI.45.5.824; Hardy A, 2009, MYCOTA, P4; Huang S, 2005, PLANT DIS, V89, P1263, DOI 10.1094/PD-89-1263; Irzhansky I, 2006, EUPHYTICA, V149, P309, DOI 10.1007/s10681-005-9079-y; Kim BS, 2012, RES PLANT DIS, V18, P342; Kim M, 2000, EXPLORATION WILD REL, V540, P23; Kim MJ, 2006, J AM SOC HORTIC SCI, V131, P637, DOI 10.21273/JASHS.131.5.637; Kim MJ, 2005, J AM SOC HORTIC SCI, V130, P877, DOI 10.21273/JASHS.130.6.877; Klarfeld S, 2009, PLANT DIS, V93, P947, DOI 10.1094/PDIS-93-9-0947; LATERROT H, 1975, ANN AMELIOR PLANT, V25, P129; Legard DE, 1996, MYCOLOGIA, V88, P608, DOI 10.2307/3761155; Li JM, 2011, EUPHYTICA, V179, P427, DOI 10.1007/s10681-010-0340-7; LOUGH RC, 2003, INHERITANCE TOMATO L; Lough Rebecca C., 2000, Hortscience, V35, P490; Luo D, 2013, ADV MATER RES-SWITZ, V610-613, P3472, DOI 10.4028/www.scientific.net/AMR.610-613.3472; Merk HL, 2012, EUPHYTICA, V187, P63, DOI 10.1007/s10681-012-0729-6; Michalska AM, 2011, AM J POTATO RES, V88, P367, DOI 10.1007/s12230-011-9202-7; Michalska Anna Maria, 2002, Plant Breeding and Seed Science, V46, P3; Michalska Anna Maria, 2005, Plant Breeding and Seed Science, V51, P31; Mizubuti ESG, 1998, PHYTOPATHOLOGY, V88, P837, DOI 10.1094/PHYTO.1998.88.8.837; Moreau P, 1998, MOL PLANT MICROBE IN, V11, P259, DOI 10.1094/MPMI.1998.11.4.259; Nelson HE, 2006, AUSTRALAS PLANT PATH, V35, P297, DOI 10.1071/AP06020; Nowicki M., 2012, Vegetable Crops Research Bulletin, V77, P61, DOI 10.2478/v10032-012-0016-z; Nowicki M., 2013, TRANSLATIONAL GENOMI, V1, P241, DOI DOI 10.1002/9781118728475.CH13; Nowicki M, 2012, PLANT DIS, V96, P4, DOI 10.1094/PDIS-05-11-0458; Ojiewo C. O., 2010, International Journal of Vegetable Science, V16, P134, DOI 10.1080/19315260903340040; Paik PueHee, 2010, Korean Journal of Breeding Science, V42, P139; Panthee DR, 2010, HORTSCIENCE, V45, P1547, DOI 10.21273/HORTSCI.45.10.1547; Park TH, 2005, EUPHYTICA, V143, P75, DOI 10.1007/s10681-005-2658-0; Platt HW, 1998, AM J POTATO RES, V75, P173, DOI 10.1007/BF02853569; Scott JW, 2007, GENETIC IMPROVEMENT, P421; Sharma BP, 2013, J AGR SCI, V5, P148; Sliwka J, 2006, THEOR APPL GENET, V113, P685, DOI 10.1007/s00122-006-0336-9; Smart CD, 2003, MOL PLANT MICROBE IN, V16, P141, DOI 10.1094/MPMI.2003.16.2.141; Smart CD, 2007, PLANT DIS, V91, P1045, DOI 10.1094/PDIS-91-8-1045; Sobkowiak S., 2009, Biuletyn Instytutu Hodowli i Aklimatyzacji Roslin, P253; Stefanczyk E, 2013, OG K NAUK NAUK HOD N, P67; Tai G, 2005, ASS LATE BLIGHT RESI, V75, P173; TURKENSTEEN LJ, 1973, PARTIAL RESISTANCE T; Vleeshouwers VGAA, 1999, EUR J PLANT PATHOL, V105, P241, DOI 10.1023/A:1008710700363; Wang T, 2005, PHYTOPATHOLOGY, V95, pS109; wiatek M, OG K NAUK NAUK HOD N, P67; Zarzycka H., 2001, MONOGRAFIE ROZPRAW A, V10a, P75; Zhang CZ, 2014, THEOR APPL GENET, V127, P1353, DOI 10.1007/s00122-014-2303-1	62	19	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109328	10.1371/journal.pone.0109328	http://dx.doi.org/10.1371/journal.pone.0109328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279467	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800073
J	Piotrowska, M; Otlewska, A; Rajkowska, K; Kozirog, A; Hachulka, M; Nowicka-Krawczyk, P; Wolski, GJ; Gutarowska, B; Kunicka-Styczynska, A; Zydzik-Bialek, A				Piotrowska, Malgorzata; Otlewska, Anna; Rajkowska, Katarzyna; Kozirog, Anna; Hachulka, Mariusz; Nowicka-Krawczyk, Paulina; Wolski, Grzegorz J.; Gutarowska, Beata; Kunicka-Styczynska, Alina; Zydzik-Bialek, Agnieszka			Abiotic Determinants of the Historical Buildings Biodeterioration in the Former Auschwitz II - Birkenau Concentration and Extermination Camp	PLOS ONE			English	Article							CULTURAL-HERITAGE; DETERIORATION; REVISION; MOISTURE	The paper presents the results of a study conducted at the Auschwitz-Birkenau State Museum in Oswiecim on the occurrence of biodeterioration. Visual assessment of the buildings revealed signs of deterioration of the buildings in the form of dampness, bulging and crumbling plaster, and wood fiber splitting. The external surfaces, and especially the concrete strips and ground immediately adjoining the buildings, were colonized by bryophytes, lichens, and algae. These organisms developed most intensively close to the ground on the northern sides of the buildings. Inside the buildings, molds and bacteria were not found to develop actively, while algae and wood-decaying fungi occurred locally. The factors conducive to biological corrosion in the studied buildings were excessive dampness of structural partitions close to the ground and a relative air humidity of above 70%, which was connected to ineffective moisture insulation. The influence of temperature was smaller, as it mostly affected the quantitative composition of the microorganisms and the qualitative composition of the algae. Also the impact of light was not very strong, but it was conducive to algae growth.	[Piotrowska, Malgorzata; Otlewska, Anna; Rajkowska, Katarzyna; Kozirog, Anna; Gutarowska, Beata; Kunicka-Styczynska, Alina] Lodz Univ Technol, Inst Fermentat Technol & Microbiol, Lodz, Poland; [Hachulka, Mariusz; Nowicka-Krawczyk, Paulina] Univ Lodz, Dept Algol & Mycol, PL-90131 Lodz, Poland; [Wolski, Grzegorz J.] Univ Lodz, Dept Geobotany & Plant Ecol, PL-90131 Lodz, Poland; [Zydzik-Bialek, Agnieszka] Auschwitz Birkenau State Museum, Oswiecim, Poland	Lodz University of Technology; University of Lodz; University of Lodz	Piotrowska, M (corresponding author), Lodz Univ Technol, Inst Fermentat Technol & Microbiol, Lodz, Poland.	malgorzata.piotrowska@p.lodz.pl	Piotrowska, Małgorzata/G-3499-2014; Kunicka-Styczyńska, Alina/S-5805-2019; Wolski, Grzegorz J./O-8568-2019; Gutarowska, Beata/N-6620-2018; Kunicka-Styczynska, Alina/N-6147-2018; Koziróg, Anna/M-1943-2018; Rajkowska, Katarzyna/M-3520-2018; Wolski, Grzegorz/K-8817-2018; Otlewska, Anna/N-6143-2018	Piotrowska, Małgorzata/0000-0002-6918-6996; Kunicka-Styczyńska, Alina/0000-0002-4611-9109; Wolski, Grzegorz J./0000-0003-1480-8003; Gutarowska, Beata/0000-0002-9523-2001; Kunicka-Styczynska, Alina/0000-0002-4611-9109; Koziróg, Anna/0000-0002-8967-5076; Rajkowska, Katarzyna/0000-0002-6943-8639; Wolski, Grzegorz/0000-0003-1480-8003; Otlewska, Anna/0000-0002-3536-3560; Nowicka-Krawczyk, Paulina/0000-0002-7722-9132; Hachulka, Mariusz/0000-0003-3553-0223	Auschwitz-Birkenau Foundation	Auschwitz-Birkenau Foundation	The study was conducted as a part of the Auschwitz-Birkenau Preservation Plan and funded by the Auschwitz-Birkenau Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen B, 2011, APPL ENVIRON MICROB, V77, P4180, DOI 10.1128/AEM.02513-10; [Anonymous], 2001, DIATOMS EUROPE DIATO; BLANCHETTE RA, 1991, INT BIODETERIOR, V28, P3, DOI 10.1016/0265-3036(91)90030-U; Chen J, 2000, CATENA, V39, P121, DOI 10.1016/S0341-8162(99)00085-5; Ciardo DE, 2007, DIAGN MICR INFEC DIS, V59, P49, DOI 10.1016/j.diagmicrobio.2007.04.020; Crispim CA, 2005, MICROB ECOL, V49, P1, DOI 10.1007/s00248-003-1052-5; Cwalina B, 2008, ARCHIT CIV ENG ENVIR, V1, P133; Dakal Tikam Chand, 2012, Environmental Sciences Europe, V24, P1, DOI 10.1186/2190-4715-24-36; Domsch K.H., 1993, COMPENDIUM SOIL FUNG, V1; Flannigan B, 2001, MICROORGANISMS HOME, P35; Gaylarde C, 2003, MATER STRUCT, V36, P342, DOI 10.1007/BF02480875; Gutarowska B, 2009, ANN MICROBIOL, V59, P807, DOI 10.1007/BF03179227; Hindak F, 2008, COLOR ATLAS CYANOPHY; Johansson P, 2013, BUILD ENVIRON, V65, P178, DOI 10.1016/j.buildenv.2013.04.004; Klama H., 2006, ANNOTATED CHECKLIST, P83; Komarek J, 1999, SUSSWASSERFLORA MITT, V19; Komarek J, 2007, SUSSWASSER MITTELEUR, P1; Koscielniak M, 2012, OCHR PRZED KOROZ, V55, P130; Kowalewska Agnieszka, 2008, Herzogia, V21, P61; Kozirog A, 2014, INT BIODETER BIODEGR, V86, P171, DOI 10.1016/j.ibiod.2013.08.004; Krzewcka Beata, 2012, Polish Botanical Studies, V27, P3; Kukwa M, 2006, LICHENOLOGIST, V38, P293, DOI 10.1017/S0024282906005962; Lisci M, 2003, INT BIODETER BIODEGR, V51, P1, DOI 10.1016/S0964-8305(02)00071-9; Ochyra R., 2003, CENSUS CATALOGUE POL; Otlewska A, 2013, PROTECTING BUILDINGS, P226; Piotrowska M., 2010, PROTECTING BUILDINGS, VVII, P133; Piotrowska M., 2011, PROTECTING BUILDINGS, P89; Plinski M, 2010, FLORA GULF GDANSK AD, P1; Rodriguez-Navarro C, 2007, GEOCHIM COSMOCHIM AC, V71, P1197, DOI 10.1016/j.gca.2006.11.031; Samson R.A., 1996, INTRO FOOD BORNE FUN; Schabereiter-Gurtner C, 2001, J MICROBIOL METH, V45, P77, DOI 10.1016/S0167-7012(01)00227-5; Schmidt O, 2011, FUNDAMENTALS OF MOLD GROWTH IN INDOOR ENVIRONMENTS AND STRATEGIES FOR HEALTHY LIVING, P117; Sliwa Lucyna, 2007, Polish Botanical Journal, V52, P1; Sterflinger K, 2013, APPL MICROBIOL BIOT, V97, P9637, DOI 10.1007/s00253-013-5283-1; Viitanen H, 2010, J BUILD PHYS, V33, P201, DOI 10.1177/1744259109343511; Wazny J., 2001, OCHRONA BUDYNKOW PRZ, P52; Webster A, 2006, TRENDS BIOTECHNOL, V24, P255, DOI 10.1016/j.tibtech.2006.04.005	37	23	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109402	10.1371/journal.pone.0109402	http://dx.doi.org/10.1371/journal.pone.0109402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279789	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800077
J	Alam, T; Medvedeva, YA; Jia, H; Brown, JB; Lipovich, L; Bajic, VB				Alam, Tanvir; Medvedeva, Yulia A.; Jia, Hui; Brown, James B.; Lipovich, Leonard; Bajic, Vladimir B.			Promoter Analysis Reveals Globally Differential Regulation of Human Long Non-Coding RNA and Protein-Coding Genes	PLOS ONE			English	Article							HUMAN TRANSCRIPTION FACTORS; EMBRYONIC STEM-CELLS; GENOME-WIDE ANALYSIS; CHROMATIN-STRUCTURE; SEQUENCE FEATURES; BINDING-SITES; CPG ISLANDS; EXPRESSION; ANTISENSE; RECEPTOR	Transcriptional regulation of protein-coding genes is increasingly well-understood on a global scale, yet no comparable information exists for long non-coding RNA (lncRNA) genes, which were recently recognized to be as numerous as protein-coding genes in mammalian genomes. We performed a genome-wide comparative analysis of the promoters of human lncRNA and protein-coding genes, finding global differences in specific genetic and epigenetic features relevant to transcriptional regulation. These two groups of genes are hence subject to separate transcriptional regulatory programs, including distinct transcription factor (TF) proteins that significantly favor lncRNA, rather than coding-gene, promoters. We report a specific signature of promoter-proximal transcriptional regulation of lncRNA genes, including several distinct transcription factor binding sites (TFBS). Experimental DNase I hypersensitive site profiles are consistent with active configurations of these lncRNA TFBS sets in diverse human cell types. TFBS ChIP-seq datasets confirm the binding events that we predicted using computational approaches for a subset of factors. For several TFs known to be directly regulated by lncRNAs, we find that their putative TFBSs are enriched at lncRNA promoters, suggesting that the TFs and the lncRNAs may participate in a bidirectional feedback loop regulatory network. Accordingly, cells may be able to modulate lncRNA expression levels independently of mRNA levels via distinct regulatory pathways. Our results also raise the possibility that, given the historical reliance on protein-coding gene catalogs to define the chromatin states of active promoters, a revision of these chromatin signature profiles to incorporate expressed lncRNA genes is warranted in the future.	[Alam, Tanvir; Medvedeva, Yulia A.; Bajic, Vladimir B.] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Comp Elect & Math Sci & Engn Div CEMSE, Thuwal, Saudi Arabia; [Jia, Hui; Lipovich, Leonard] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48202 USA; [Brown, James B.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Dept Genome Dynam, Berkeley, CA 94720 USA; [Lipovich, Leonard] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA	King Abdullah University of Science & Technology; Wayne State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Wayne State University	Lipovich, L (corresponding author), Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48202 USA.	llipovich@med.wayne.edu; vladimir.bajic@kaust.edu.sa	Medvedva, Yulia A/H-5947-2016; Lipovich, Leonard/B-2355-2019; Bajic, Vladimir/D-2810-2009	Medvedva, Yulia A/0000-0002-7587-1666; Lipovich, Leonard/0000-0002-0531-3570; Bajic, Vladimir/0000-0001-5435-4750; Alam, Tanvir/0000-0003-4844-0171; Alam, Tanvir/0000-0001-7033-3693	KAUST Base Research Fund; ENCODE Consortium through NIH [1U01-HG007031]; NHGRI [K99 HG006698]; Wayne State University Perinatal Initiative; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K99HG006698, U01HG007031] Funding Source: NIH RePORTER	KAUST Base Research Fund; ENCODE Consortium through NIH; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wayne State University Perinatal Initiative; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	TA and VBB were supported by KAUST Base Research Fund to VBB. LL was supported by the ENCODE Consortium through NIH 1U01-HG007031 to Peter Bickel, University of California, Berkeley. JBB's work was supported by NHGRI K99 HG006698. HJ was supported by the Wayne State University Perinatal Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrial RT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-239; Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson DA, 1997, NUCLEIC ACIDS RES, V25, P1, DOI 10.1093/nar/25.1.1; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bond AM, 2009, NAT NEUROSCI, V12, P1020, DOI 10.1038/nn.2371; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Breiman L., 1984, CLASSIFICATION REGRE; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Chu YJ, 2010, NUCLEIC ACIDS RES, V38, P7736, DOI 10.1093/nar/gkq648; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Di Ruscio A, 2013, NATURE, V503, P371, DOI 10.1038/nature12598; Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Grinchuk OV, 2010, NUCLEIC ACIDS RES, V38, P534, DOI 10.1093/nar/gkp954; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hu GQ, 2013, NAT IMMUNOL, V14, P1190, DOI 10.1038/ni.2712; Huynh KD, 2005, NAT REV GENET, V6, P410, DOI 10.1038/nrg1604; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Johnson R, 2009, RNA, V15, P85, DOI 10.1261/rna.1127009; Kamanu Frederick Kinyua, 2012, Frontiers in Genetics, V3, P100, DOI 10.3389/fgene.2012.00100; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Khare SP, 2012, NUCLEIC ACIDS RES, V40, pD337, DOI 10.1093/nar/gkr1125; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kulakovskiy IV, 2013, NUCLEIC ACIDS RES, V41, pD195, DOI 10.1093/nar/gks1089; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lercher MJ, 2003, HUM MOL GENET, V12, P2411, DOI 10.1093/hmg/ddg251; Lipovich L, 2006, GENOME RES, V16, P45, DOI 10.1101/gr.3883606; Lipovich L, 2012, GENETICS, V192, P1133, DOI 10.1534/genetics.112.145128; Lipovich L, 2010, BBA-GENE REGUL MECH, V1799, P597, DOI 10.1016/j.bbagrm.2010.10.001; Liu JL, 2012, J BIOL CHEM, V287, P13899, DOI 10.1074/jbc.M111.301275; Liu JF, 2006, PLOS GENET, V2, P529, DOI 10.1371/journal.pgen.0020029; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu L, 2007, FUNCT INTEGR GENOMIC, V7, P221, DOI 10.1007/s10142-007-0047-6; Lv J, 2013, NUCLEIC ACIDS RES, V41, P10044, DOI 10.1093/nar/gkt818; Marchand B, 2011, P 2011 INT C HIGH PE, P1; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Medvedeva Yulia A., 2011, Bioinformatics - Trends and Methodologies, P449; Medvedeva YA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-48; Mohamed JS, 2010, RNA, V16, P324, DOI 10.1261/rna.1441510; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pardo LM, 2013, NEUROBIOL AGING, V34, P1825, DOI 10.1016/j.neurobiolaging.2013.01.005; Rybtsova N, 2007, NUCLEIC ACIDS RES, V35, P3431, DOI 10.1093/nar/gkm214; Santoni FA, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1214; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Sun K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S2-S7; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tochitani S, 2008, BIOCHEM BIOPH RES CO, V372, P691, DOI 10.1016/j.bbrc.2008.05.127; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vavouri T, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r110; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wood Emily J., 2013, Frontiers in Genetics, V4, P183, DOI 10.3389/fgene.2013.00183; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; Zhang H, 2013, J ALLERGY CLIN IMMUN, V132, P1005, DOI 10.1016/j.jaci.2013.05.033; Zhao H, 2013, J CELL BIOCHEM, V114, P2375, DOI 10.1002/jcb.24586	79	60	62	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109443	10.1371/journal.pone.0109443	http://dx.doi.org/10.1371/journal.pone.0109443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275320	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500103
J	Fedder, MDK; Jakobsen, HB; Giversen, I; Christensen, LP; Parner, ET; Fedder, J				Fedder, Maja D. K.; Jakobsen, Henrik B.; Giversen, Ina; Christensen, Lars P.; Parner, Erik T.; Fedder, Jens			An Extract of Pomegranate Fruit and Galangal Rhizome Increases the Numbers of Motile Sperm: A Prospective, Randomised, Controlled, Double-Blinded Trial	PLOS ONE			English	Article							1'-ACETOXYCHAVICOL ACETATE; 1-ACETOXYCHAVICOL ACETATE; MALE-INFERTILITY; ANTIOXIDANT ACTIVITY; SEMEN QUALITY; OXIDATIVE STRESS; ALPINIA-GALANGA; INHIBITOR; FERTILITY; JUICE	Pomegranate fruit (Punica granatum) and galangal (Alpinia galanga) have separately been shown to stimulate spermatogenesis and to increase sperm counts and motility in rodents. Within traditional medicine, pomegranate fruit has long been used to increase fertility, however studies on the effect on spermatogenesis in humans have never been published. With this study we investigated whether oral intake of tablets containing standardised amounts of extract of pomegranate fruit and powder of greater galangal rhizome (Punalpin) would increase the total number of motile spermatozoa. The study was designed as a prospective, randomized, controlled, double-blinded trial. Enrolment was based on the mean total number of motile spermatozoa of two ejaculates. The participants delivered an ejaculate after 4-8 days of tablet intake and two ejaculates just before they stopped taking the tablets. Seventy adult men with a semen quality not meeting the standards for commercial application at Nordic Cryobank, but without azoospermia, were included in the study. Participants were randomized to take tablets containing extract of pomegranate fruit (standardised with respect to punicalagin A+B, punicalin and ellagic acid) and freeze-dried rhizome of greater galangal (standardised with respect to 1'S-1'-acetoxychavicol acetate) or placebo on a daily basis for three months. Sixty-six participants completed the intervention (active treatment: n = 34; placebo: n = 32). After the intervention the total number of motile spermatozoa was increased in participants treated with plant extracts compared with the placebo group (p = 0.026). After three months of active treatment, the average total number of motile sperm increased by 62% (from 23.4 to 37.8 millions), while for the placebo group, the number of motile sperm increased by 20%. Sperm morphology was not affected by the treatment. Our findings may help subfertile men to gain an improved amount of motile ejaculated sperm by taking tablets containing preparations of pomegranate fruit extract and rhizome of greater galangal.	[Fedder, Maja D. K.; Fedder, Jens] Reg Hosp Horsens, Sci Unit, Reprod Biol Lab, Horsens, Denmark; [Jakobsen, Henrik B.; Giversen, Ina] Nerthus ApS, Lejre, Denmark; [Christensen, Lars P.] Univ Southern Denmark, Dept Chem Engn Biotechnol & Environm Technol, Fac Engn, Odense, Denmark; [Parner, Erik T.] Univ Aarhus, Dept Publ Hlth, Biostat Sect, Aarhus, Denmark; [Fedder, Jens] Odense Univ Hosp, Fertil Clin, Ctr Androl, Dept D, DK-5000 Odense, Denmark	University of Southern Denmark; Aarhus University; University of Southern Denmark; Odense University Hospital	Fedder, J (corresponding author), Reg Hosp Horsens, Sci Unit, Reprod Biol Lab, Horsens, Denmark.	fedder@dadlnet.dk	Christensen, Lars P./I-7011-2016; Parner, Erik Thorlund/F-5532-2010	Christensen, Lars P./0000-0002-5035-9201; Parner, Erik Thorlund/0000-0003-3661-1922	Centre for Science and Research of Alternative Treatment (VIFAB);  [1002282]	Centre for Science and Research of Alternative Treatment (VIFAB); 	The study was funded by Centre for Science and Research of Alternative Treatment (VIFAB), who played no other role in the study. Grant number 1002282. VIFAB does not exist anymore. Nerthus ApS is owned by authors Ina Giversen (IG) and Henrik Byrial Jakobsen (HBJ). Nerthus ApS did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ando S, 2005, BIOORGAN MED CHEM, V13, P3289, DOI 10.1016/j.bmc.2005.02.022; Ayala C, 1996, J ANDROL, V17, P718; Birringer M, 2011, PHARM RES-DORDR, V28, P2680, DOI 10.1007/s11095-011-0551-1; Bonde JPE, 1998, LANCET, V352, P1172, DOI 10.1016/S0140-6736(97)10514-1; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, pS128, DOI 10.1002/mnfr.200700195; Eslamian G, 2012, HUM REPROD, V27, P3328, DOI 10.1093/humrep/des311; Fedder J, 1996, ARCH ANDROLOGY, V36, P41, DOI 10.3109/01485019608987883; Gharagozloo P, 2011, HUM REPROD, V26, P1628, DOI 10.1093/humrep/der132; Gil MI, 2000, J AGR FOOD CHEM, V48, P4581, DOI 10.1021/jf000404a; Guo CJ, 2008, NUTR RES, V28, P72, DOI 10.1016/j.nutres.2007.12.001; Hajimahmoodi M., 2009, Acta Medica Iranica, V47, P125; Higashida M, 2009, AMINO ACIDS, V36, P107, DOI 10.1007/s00726-008-0038-5; Islam M. W., 2000, Journal of Pharmacy and Pharmacology, V52, P278; Ito K, 2005, CANCER RES, V65, P4417, DOI 10.1158/0008-5472.CAN-05-0072; Jorgensen N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000990; Khani B, 2013, J RES MED SCI, V18, P184; Kubota K, 2001, ROY SOC CH, P601, DOI 10.1039/9781847550859-00601; Lee CC, 2005, J ETHNOPHARMACOL, V100, P237, DOI 10.1016/j.jep.2005.01.064; Lombardo F, 2011, ASIAN J ANDROL, V13, P690, DOI 10.1038/aja.2010.183; Mansour Sherif W., 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P563, DOI 10.1016/S2221-1691(13)60114-8; Mayer W, 1977, LIEBIGS ANN CHEM, V11-12, P1976; Miyauchi M, 2000, JPN J CANCER RES, V91, P477, DOI 10.1111/j.1349-7006.2000.tb00970.x; Moffatt J, 2000, CARCINOGENESIS, V21, P2151, DOI 10.1093/carcin/21.12.2151; Murakami A, 1996, ONCOLOGY, V53, P386; Nakamura Y, 2010, BIOSCI BIOTECH BIOCH, V74, P242, DOI 10.1271/bbb.90731; Ohnishi M, 1996, JPN J CANCER RES, V87, P349, DOI 10.1111/j.1349-7006.1996.tb00229.x; Leiva KP, 2011, TOXICOL MECH METHOD, V21, P495, DOI 10.3109/15376516.2011.555789; QURESHI S, 1992, PLANTA MED, V58, P124, DOI 10.1055/s-2006-961412; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Satish R., 2003, Biomedicine, V23, P91; Swaha Satpathy, 2013, Asian Pacific Journal of Reproduction, V2, P19, DOI 10.1016/S2305-0500(13)60109-8; Swan SH, 1997, ENVIRON HEALTH PERSP, V105, P1228; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; Turk G, 2008, CLIN NUTR, V27, P289, DOI 10.1016/j.clnu.2007.12.006; TURNER TT, 1995, J ANDROL, V16, P292; Tzulker R, 2007, J AGR FOOD CHEM, V55, P9559, DOI 10.1021/jf071413n; Wirleitner B, 2012, INT J VITAM NUTR RES, V82, P391, DOI 10.1024/0300-9831/a000136; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Yaku K, 2013, MOL NUTR FOOD RES, V57, P1198, DOI 10.1002/mnfr.201200809; Yaku K, 2011, AM J CHINESE MED, V39, P789, DOI 10.1142/S0192415X11009196; Zareba P, 2013, FERTIL STERIL, V100, P1572, DOI 10.1016/j.fertnstert.2013.08.032; Zhang YJ, 2009, J AGR FOOD CHEM, V57, P7395, DOI 10.1021/jf9010017; Zini A, 2011, ASIAN J ANDROL, V13, P374, DOI 10.1038/aja.2010.182	46	16	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108532	10.1371/journal.pone.0108532	http://dx.doi.org/10.1371/journal.pone.0108532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275520	Green Submitted, gold, Green Published			2022-12-27	WOS:000342591500020
J	Hamilla, SM; Stroka, KM; Aranda-Espinoza, H				Hamilla, Susan M.; Stroka, Kimberly M.; Aranda-Espinoza, Helim			VE-Cadherin-Independent Cancer Cell Incorporation into the Vascular Endothelium Precedes Transmigration	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SUBSTRATE STIFFNESS; TRANSENDOTHELIAL MIGRATION; NEUTROPHIL TRANSMIGRATION; BARRIER FUNCTION; LEUKOCYTE TRANSMIGRATION; BIOMECHANICAL PROPERTIES; CARCINOMA CELLS; TUMOR-CELLS; IN-VITRO	Metastasis is accountable for 90% of cancer deaths. During metastasis, tumor cells break away from the primary tumor, enter the blood and the lymph vessels, and use them as highways to travel to distant sites in the body to form secondary tumors. Cancer cell migration through the endothelium and into the basement membrane represents a critical step in the metastatic cascade, yet it is not well understood. This process is well characterized for immune cells that routinely transmigrate through the endothelium to sites of infection, inflammation, or injury. Previous studies with leukocytes have demonstrated that this step depends heavily on the activation status of the endothelium and subendothelial substrate stiffness. Here, we used a previously established in vitro model of the endothelium and live cell imaging, in order to observe cancer cell transmigration and compare this process to leukocytes. Interestingly, cancer cell transmigration includes an additional step, which we term 'incorporation', into the endothelial cell (EC) monolayer. During this phase, cancer cells physically displace ECs, leading to the dislocation of EC VE-cadherin away from EC junctions bordering cancer cells, and spread into the monolayer. In some cases, ECs completely detach from the matrix. Furthermore, cancer cell incorporation occurs independently of the activation status and the subendothelial substrate stiffness for breast cancer and melanoma cells, a notable difference from the process by which leukocytes transmigrate. Meanwhile, pancreatic cancer cell incorporation was dependent on the activation status of the endothelium and changed on very stiff subendothelial substrates. Collectively, our results provide mechanistic insights into tumor cell extravasation and demonstrate that incorporation is one of the earliest steps.	[Hamilla, Susan M.; Stroka, Kimberly M.; Aranda-Espinoza, Helim] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Aranda-Espinoza, H (corresponding author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.	helim@umd.edu			National Institutes of Health National Research Service Award [F31NS068028]; Human Frontier Science Project Award [RGP0058/2011]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS068028] Funding Source: NIH RePORTER	National Institutes of Health National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Project Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a National Institutes of Health National Research Service Award F31NS068028 (K. M. S.) and a Human Frontier Science Project Award RGP0058/2011 (H. A. E.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide P, 2012, AM J PHYSIOL-CELL PH, V303, pC385, DOI 10.1152/ajpcell.00126.2012; Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001; Brandt B, 2005, SEMIN CANCER BIOL, V15, P387, DOI 10.1016/j.semcancer.2005.06.006; BREVIARIO F, 1995, ARTERIOSCL THROM VAS, V15, P1229, DOI 10.1161/01.ATV.15.8.1229; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; CRISSMAN JD, 1985, LAB INVEST, V53, P470; Fazakas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020758; Ghislin S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-455; Hayenga HN, 2013, CELL MOL BIOENG, V6, P253, DOI 10.1007/s12195-013-0284-9; Heyder C, 2002, J CANCER RES CLIN, V128, P533, DOI 10.1007/s00432-002-0377-7; Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010; Jannat RA, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194117; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Langer HF, 2009, J MOL CELL CARDIOL, V47, P315, DOI 10.1016/j.yjmcc.2009.03.011; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; LAPIS K, 1988, CLIN EXP METASTAS, V6, P73, DOI 10.1007/BF01580408; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Mierke CT, 2012, MOL BIOSYST, V8, P1639, DOI 10.1039/c2mb25024a; Mierke CT, 2008, BIOPHYS J, V94, P2832, DOI 10.1529/biophysj.107.113613; Mierke CT, 2011, J BIOL CHEM, V286, P40025, DOI 10.1074/jbc.M111.256172; Mierke CT, 2008, J BIOPHYS, V2008; Mukhopadhyay R, 1999, CLIN EXP METASTAS, V17, P325; Navarro P, 1995, J BIOL CHEM, V270, P30965, DOI 10.1074/jbc.270.52.30965; Norman L, 2011, EUR J CELL BIOL, V90, P37, DOI 10.1016/j.ejcb.2010.09.013; Norman LL, 2010, CELL MOL BIOENG, V3, P398, DOI 10.1007/s12195-010-0137-8; Norman LL, 2010, BIOPHYS J, V99, P1726, DOI 10.1016/j.bpj.2010.07.031; Norman LL, 2010, CELL MOL BIOENG, V3, P151, DOI 10.1007/s12195-010-0119-x; Oakes PW, 2009, BLOOD, V114, P1387, DOI 10.1182/blood-2008-11-191445; Owens DM, 2003, J CELL SCI, V116, P3783, DOI 10.1242/jcs.00725; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Schmidt A, 2006, EUR J CELL BIOL, V85, P1179, DOI 10.1016/j.ejcb.2006.05.015; Shaw SK, 2001, J IMMUNOL, V167, P2323, DOI 10.4049/jimmunol.167.4.2323; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Strell C, 2007, CELL MOL LIFE SCI, V64, P3306, DOI 10.1007/s00018-007-7402-6; Stroka KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061377; Stroka KM, 2012, EUR BIOPHYS J BIOPHY, V41, P939, DOI 10.1007/s00249-012-0851-3; Stroka KM, 2012, J BIOMECH, V45, P1828, DOI 10.1016/j.jbiomech.2012.04.011; Stroka KM, 2011, BLOOD, V118, P1632, DOI 10.1182/blood-2010-11-321125; Stroka KM, 2011, CELL MOL BIOENG, V4, P9, DOI 10.1007/s12195-010-0142-y; Stroka KM, 2010, FEBS J, V277, P1145, DOI 10.1111/j.1742-4658.2009.07545.x; Stroka KM, 2009, CELL MOTIL CYTOSKEL, V66, P328, DOI 10.1002/cm.20363; Teo GSL, 2012, STEM CELLS, V30, P2472, DOI 10.1002/stem.1198; van Grevenstein WMU, 2006, PANCREAS, V32, P396, DOI 10.1097/01.mpa.0000220865.80034.2a; Voura EB, 2001, MOL BIOL CELL, V12, P2699, DOI 10.1091/mbc.12.9.2699; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; WEISS L, 1986, J PATHOL, V150, P195, DOI 10.1002/path.1711500308; Wittchen ES, 2005, J BIOL CHEM, V280, P11675, DOI 10.1074/jbc.M412595200; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109; Zhang Q, 2012, LAB CHIP, V12, P2837, DOI 10.1039/c2lc00030j	51	23	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109748	10.1371/journal.pone.0109748	http://dx.doi.org/10.1371/journal.pone.0109748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275457	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500113
J	Hamlyn, JM; Linde, CI; Gao, JJ; Huang, BS; Golovina, VA; Blaustein, MP; Leenen, FHH				Hamlyn, John M.; Linde, Cristina I.; Gao, Junjie; Huang, Bing S.; Golovina, Vera A.; Blaustein, Mordecai P.; Leenen, Frans H. H.			Neuroendocrine Humoral and Vascular Components in the Pressor Pathway for Brain Angiotensin II: A New Axis in Long Term Blood Pressure Control	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ARTERIAL SMOOTH-MUSCLE; OUABAIN-INDUCED HYPERTENSION; SODIUM-CALCIUM EXCHANGE; ALDOSTERONE SYNTHASE; ENDOGENOUS OUABAIN; NA+/CA2+ EXCHANGER; UP-REGULATION; SALT; RAT	Central nervous system (CNS) administration of angiotensin II (Ang II) raises blood pressure (BP). The rise in BP reflects increased sympathetic outflow and a slower neuromodulatory pressor mechanism mediated by CNS mineralocorticoid receptors (MR). We investigated the hypothesis that the sustained phase of hypertension is associated also with elevated circulating levels of endogenous ouabain (EO), and chronic stimulation of arterial calcium transport proteins including the sodium-calcium exchanger (NCX1), the type 6 canonical transient receptor potential protein (TRPC6), and the sarcoplasmic reticulum calcium ATPase (SERCA2). Wistar rats received a chronic intra-cerebroventricular infusion of vehicle (C) or Ang II (A, 2.5 ng/min, for 14 days) alone or combined with the MR blocker, eplerenone (A+E, 5 mu g/day), or the aldosterone synthase inhibitor, FAD286 (A+F, 25 mu g/day). Conscious mean BP increased (P<0.05) in A (123 +/- 4 mm Hg) vs all other groups. Blood, pituitary and adrenal samples were taken for EO radioimmunoassay (RIA), and aortas for NCX1, TRPC6 and SERCA2 immunoblotting. Central infusion of Ang II raised plasma EO (0.58 +/- 0.08 vs C 0.34 +/- 0.07 nM (P<0.05), but not in A + E and A + F groups as confirmed by off-line liquid chromatography (LC)-RIA and LC-multistage mass spectrometry. Two novel isomers of EO were elevated by Ang II; the second less polar isomer increased >50-fold in the A+F group. Central Ang II increased arterial expression of NCX1, TRPC6 and SERCA2 (2.6, 1.75 and 3.7-fold, respectively; P<0.01)) but not when co-infused with E or F. Adrenal and pituitary EO were unchanged. We conclude that brain Ang II activates a CNS-humoral axis involving plasma EO. The elevated EO reprograms peripheral ion transport pathways known to control arterial Na+ and Ca2+ homeostasis; this increases contractility and augments sympathetic effects. The new axis likely contributes to the chronic pressor effect of brain Ang II.	[Hamlyn, John M.; Linde, Cristina I.; Gao, Junjie; Golovina, Vera A.; Blaustein, Mordecai P.] Univ Maryland, Dept Physiol, Baltimore, MD 21201 USA; [Blaustein, Mordecai P.] Univ Maryland, Dept Med, Baltimore, MD 21201 USA; [Huang, Bing S.; Leenen, Frans H. H.] Univ Ottawa, Inst Heart, Ottawa, ON, Canada	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Ottawa; University of Ottawa Heart Institute	Hamlyn, JM (corresponding author), Univ Maryland, Dept Physiol, Baltimore, MD 21201 USA.	jhamlyn@umaryland.edu			Canadian Institutes of Health Research [MOP 74432]; National Institutes of Health [HL107555, HL 45215]; University of Maryland School of Medicine Deans Funds; Pfizer Canada; University of Ottawa Heart Institute Foundation; Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107555, R01HL045215] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland School of Medicine Deans Funds; Pfizer Canada(Pfizer); University of Ottawa Heart Institute Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by operating grants from the Canadian Institutes of Health Research (MOP 74432 to FHHL), and in part by the National Institutes of Health Grants HL107555, and HL 45215 (MPB, JMH) and by the University of Maryland School of Medicine Deans Funds. FHHL holds the Pfizer Chair in Hypertension Research, an endowed research chair funded jointly by Pfizer Canada, the University of Ottawa Heart Institute Foundation, and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aileru AA, 2001, AM J PHYSIOL-REG I, V281, pR635, DOI 10.1152/ajpregu.2001.281.2.R635; BALDA MS, 1986, CLIN EXP HYPERTENS A, V8, P997, DOI 10.3109/10641968609044082; BEALER SL, 1983, AM J PHYSIOL, V244, pR51, DOI 10.1152/ajpregu.1983.244.1.R51; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Blaustein MP, 2012, AM J PHYSIOL-HEART C, V302, pH1031, DOI 10.1152/ajpheart.00899.2011; Bohr DF, 1965, ANGIOTENSIN, P424; Brody MJ, 1998, CLIN PHYSIOL BIOCH, V6, P230; BROWN JJ, 1979, HYPERTENSION, V1, P159, DOI 10.1161/01.HYP.1.3.159; BROWN JJ, 1964, CLIN SCI, V26, P165; BRUNER CA, 1985, AM J PHYSIOL, V249, pH321, DOI 10.1152/ajpheart.1985.249.2.H321; BUMPUS FM, 1984, CLIN EXP HYPERTENS A, V6, P2101, DOI 10.3109/10641968409046136; Cao CH, 2009, AM J PHYSIOL-RENAL, V296, pF98, DOI 10.1152/ajprenal.90429.2008; COWLEY AW, 1976, CIRC RES, V39, P788, DOI 10.1161/01.RES.39.6.788; DICKINSON CJ, 1963, LANCET, V1, P1354; DORIS PA, 1994, AM J PHYSIOL, V266, pH360, DOI 10.1152/ajpheart.1994.266.1.H360; Dostanic I, 2005, AM J PHYSIOL-HEART C, V288, pH477, DOI 10.1152/ajpheart.00083.2004; DOURSOUT MF, 1992, CLIN EXP HYPERTENS A, V14, P393, DOI 10.3109/10641969209036197; Funder JW, 2002, AM HEART J, V144, pS8, DOI 10.1067/mhj.2002.129971; GANONG WF, 1979, HYPERTENSION, V1, P207, DOI 10.1161/01.HYP.1.3.207; Ganten D, 1984, Contrib Nephrol, V43, P114; Gomez-Sanchez EP, 2010, EXP PHYSIOL, V95, P120, DOI 10.1113/expphysiol.2009.048900; Gomez-Sanchez EP, 2005, AM J PHYSIOL-ENDOC M, V288, pE342, DOI 10.1152/ajpendo.00355.2004; GomezSanchez CE, 1997, ENDOCRINOLOGY, V138, P3369, DOI 10.1210/en.138.8.3369; GOMEZSANCHEZ EP, 1992, AM J PHYSIOL, V262, pE96, DOI 10.1152/ajpendo.1992.262.1.E96; Hamlyn JM, 2003, ANN NY ACAD SCI, V986, P685, DOI 10.1111/j.1749-6632.2003.tb07283.x; HAMLYN JM, 1991, P NATL ACAD SCI USA, V88, P6259, DOI 10.1073/pnas.88.14.6259; HARRIS DW, 1991, HYPERTENSION, V17, P936, DOI 10.1161/01.HYP.17.6.936; Huang BS, 2008, AM J PHYSIOL-REG I, V295, pR166, DOI 10.1152/ajpregu.90352.2008; Huang BS, 2006, CURR OPIN CARDIOL, V21, P295, DOI 10.1097/01.hco.0000231398.64362.94; Huang BS, 2013, HYPERTENSION, V62, P564, DOI 10.1161/HYPERTENSIONAHA.113.01557; Huang BS, 2010, AM J PHYSIOL-HEART C, V299, pH422, DOI 10.1152/ajpheart.00256.2010; Huang BS, 2009, AM J PHYSIOL-REG I, V296, pR994, DOI 10.1152/ajpregu.90903.2008; HUANG BS, 1994, HYPERTENSION, V23, P1087, DOI 10.1161/01.HYP.23.6.1087; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; Jacobs BE, 2012, AM J PHYSIOL-HEART C, V302, pH1317, DOI 10.1152/ajpheart.00532.2011; KHAIRALLAH PA, 1962, SCIENCE, V138, P523, DOI 10.1126/science.138.3539.523; Komiyama Y, 1996, J HYPERTENS, V14, P447; Korner P., 2007, ESSENTIAL HYPERTENSI; Kurashina T, 1996, CLIN SCI, V91, P497, DOI 10.1042/cs0910497; LAREDO J, 1994, ENDOCRINOLOGY, V135, P794, DOI 10.1210/en.135.2.794; LEENEN FHH, 1993, AM J PHYSIOL, V265, pH421, DOI 10.1152/ajpheart.1993.265.1.H421; Leenen FHH, 2010, BBA-MOL BASIS DIS, V1802, P1132, DOI 10.1016/j.bbadis.2010.03.004; Linde CI, 2012, AM J PHYSIOL-HEART C, V303, pH784, DOI 10.1152/ajpheart.00399.2012; Linde CI, 2012, AM J PHYSIOL-HEART C, V302, pH611, DOI 10.1152/ajpheart.00950.2011; Lorenz JN, 2008, AM J PHYSIOL-HEART C, V295, pH273, DOI 10.1152/ajpheart.00183.2008; MANN JFE, 1987, J HYPERTENS, V5, P543, DOI 10.1097/00004872-198710000-00006; MANUNTA P, 1994, J HYPERTENS, V12, P549; Manunta P, 2009, J HYPERTENS, V27, P9, DOI 10.1097/HJH.0b013e32831cf2c6; Mellon SH, 2001, BRAIN RES REV, V37, P3, DOI 10.1016/S0165-0173(01)00109-6; Muller-Vieira U, 2005, J STEROID BIOCHEM, V96, P259, DOI 10.1016/j.jsbmb.2005.04.032; Nelson LD, 1996, KIDNEY INT, V50, P1889, DOI 10.1038/ki.1996.510; Osborn JW, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.245; Pitzalis MV, 2006, EUR J HEART FAIL, V8, P179, DOI 10.1016/j.ejheart.2005.07.010; Pulina MV, 2010, AM J PHYSIOL-HEART C, V298, pH263, DOI 10.1152/ajpheart.00784.2009; Raina H, 2010, AM J PHYSIOL-HEART C, V298, pH2093, DOI 10.1152/ajpheart.01045.2009; Reid I A, 1976, Prog Biochem Pharmacol, V12, P117; REIS DJ, 1974, PROG CARDIOVASC DIS, V17, P51, DOI 10.1016/0033-0620(74)90038-3; Rigel DF, 2010, J PHARMACOL EXP THER, V334, P232, DOI 10.1124/jpet.110.167148; ROSSI GP, 1995, J HYPERTENS, V13, P1181, DOI 10.1097/00004872-199510000-00013; SEKIHARA H, 1992, ENDOCRINOLOGY, V131, P3077, DOI 10.1210/en.131.6.3077; SEVERS WB, 1973, PHARMACOL REV, V25, P415; STRUTHERS AD, 1985, EUR J CLIN PHARMACOL, V28, P3, DOI 10.1007/BF00543703; TAKAHASHI H, 1984, JPN CIRC J, V48, P1243, DOI 10.1253/jcj.48.1243; Takahashi H, 2011, HYPERTENS RES, V34, P1147, DOI 10.1038/hr.2011.105; Vinson GP, 2004, MOL CELL ENDOCRINOL, V217, P59, DOI 10.1016/j.mce.2003.10.010; Wang Y, 2013, HYPERTENSION, V60, pA518; Wang YH, 2013, J PHYSIOL-LONDON, V591, P5321, DOI 10.1113/jphysiol.2013.257808; YAMADA K, 1995, FEBS LETT, V360, P67, DOI 10.1016/0014-5793(95)00078-N; Ye P, 2003, ENDOCRINOLOGY, V144, P3321, DOI 10.1210/en.2003-0109; YUAN CM, 1993, HYPERTENSION, V22, P178, DOI 10.1161/01.HYP.22.2.178; Zulian A, 2010, AM J PHYSIOL-HEART C, V299, pH624, DOI 10.1152/ajpheart.00356.2010	71	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108916	10.1371/journal.pone.0108916	http://dx.doi.org/10.1371/journal.pone.0108916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275393	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500040
J	Lauteri, M; Haworth, M; Serraj, R; Monteverdi, MC; Centritto, M				Lauteri, Marco; Haworth, Matthew; Serraj, Rachid; Monteverdi, Maria Cristina; Centritto, Mauro			Photosynthetic Diffusional Constraints Affect Yield in Drought Stressed Rice Cultivars during Flowering	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; WATER-USE EFFICIENCY; QUANTITATIVE TRAIT LOCI; DIFFERENT DEVELOPMENTAL-STAGES; MESOPHYLL CONDUCTANCE; LEAF PHOTOSYNTHESIS; GENETIC-VARIATION; CO2 DIFFUSION; ORYZA-SATIVA; ELECTRON-TRANSPORT	Global production of rice (Oryza sativa) grain is limited by water availability and the low 'leaf-level' photosynthetic capacity of many cultivars. Oryza sativa is extremely susceptible to water-deficits; therefore, predicted increases in the frequency and duration of drought events, combined with future rises in global temperatures and food demand, necessitate the development of more productive and drought tolerant cultivars. We investigated the underlying physiological, isotopic and morphological responses to water-deficit in seven common varieties of O. sativa, subjected to prolonged drought of varying intensities, for phenotyping purposes in open field conditions. Significant variation was observed in leaf-level photosynthesis rates (A) under both water treatments. Yield and A were influenced by the conductance of the mesophyll layer to CO2 (g(m)) and not by stomatal conductance (g(s)). Mesophyll conductance declined during drought to differing extents among the cultivars; those varieties that maintained gm during water-deficit sustained A and yield to a greater extent. However, the variety with the highest g(m) and yield under well-watered conditions (IR55419-04) was distinct from the most effective cultivar under drought (Vandana). Mesophyll conductance most effectively characterises the photosynthetic capacity and yield of O. sativa cultivars under both well-watered and water-deficit conditions; however, the desired attributes of high g(m) during optimal growth conditions and the capacity for g(m) to remain constant during water-deficit may be mutually exclusive. Nonetheless, future genetic and physiological studies aimed at enhancing O. sativa yield and drought stress tolerance should investigate the biochemistry and morphology of the interface between the sub-stomatal pore and mesophyll layer.	[Lauteri, Marco] CNR, Inst Agroenvironm & Forest Biol, Porano, Italy; [Haworth, Matthew; Centritto, Mauro] CNR, IVALSA Ist Valorizzaz Legno & Specie Arboree, Trees & Timber Inst, Florence, Italy; [Serraj, Rachid] Food & Agr Org United Nations, Consultat Grp Int Agr Res, Independent Sci & Council Secretariat, Rome, Italy; [Serraj, Rachid] Int Rice Res Inst, Los Banos, Philippines; [Monteverdi, Maria Cristina] CNR, Forestry Res Ctr, Arezzo, Italy	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per la Valorizzazione del Legno e delle Specie Arboree (IVALSA-CNR); Food & Agriculture Organization of the United Nations (FAO); CGIAR; International Rice Research Institute (IRRI); Consiglio Nazionale delle Ricerche (CNR)	Haworth, M (corresponding author), CNR, IVALSA Ist Valorizzaz Legno & Specie Arboree, Trees & Timber Inst, Florence, Italy.	matthew.haworth@hotmail.com	Haworth, Matthew/B-7817-2013; Lauteri, Marco/AAX-3486-2020; Monteverdi, Maria Cristina/C-9687-2016	Lauteri, Marco/0000-0003-1071-7999; Haworth, Matthew/0000-0002-3225-6620; Monteverdi, Maria Cristina/0000-0003-1786-4713	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (PRIN); Marie Curie Intra European Fellowship [2010-275626]	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (PRIN); Marie Curie Intra European Fellowship(European Commission)	This work was funded by: Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (PRIN) grant: "Going to the root of plant productivity: how the rhizosphere interact with the aboveground armament for indirect and direct defense against abiotic and biotic stressors (PRO-ROOT)" URL: http://hubmiur.pubblica.istruzione.it/web/universita/home and Marie Curie Intra European Fellowship (2010-275626) - HAWORTH - Evoutionary adaptation to atmospheric carbon dioxide, URL: http://ec.europa.eu/research/mariecurieactions/about-mca/actions/ief/index_en.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2013, J EXP BOT, V64, P1061, DOI 10.1093/jxb/ers382; Blum A, 2005, AUST J AGR RES, V56, P1159, DOI 10.1071/AR05069; Bois JF, 1985, ACTA HORTIC, V171, P297; Boonjung H, 1996, FIELD CROP RES, V48, P47, DOI 10.1016/0378-4290(96)00039-1; Centritto M, 2003, PLANT CELL ENVIRON, V26, P585, DOI 10.1046/j.1365-3040.2003.00993.x; Centritto M, 2011, ECOL STUD-ANAL SYNTH, V212, P31, DOI 10.1007/978-90-481-9834-4_3; Centritto M, 2009, J EXP BOT, V60, P2325, DOI 10.1093/jxb/erp123; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Cornic G, 2000, TRENDS PLANT SCI, V5, P187, DOI 10.1016/S1360-1385(00)01625-3; EVANS JR, 1986, AUST J PLANT PHYSIOL, V13, P281, DOI 10.1071/PP9860281; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Flexas J, 2013, PHOTOSYNTH RES, V117, P45, DOI 10.1007/s11120-013-9844-z; Furbank RT, 2009, FUNCT PLANT BIOL, V36, P845, DOI 10.1071/FP09185; Galmes J, 2005, PLANT CELL ENVIRON, V28, P571, DOI 10.1111/j.1365-3040.2005.01300.x; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gilbert ME, 2012, J EXP BOT, V63, P413, DOI 10.1093/jxb/err288; Giuliani R, 2013, PLANT PHYSIOL, V162, P1632, DOI 10.1104/pp.113.217497; Gu JF, 2014, PLANT CELL ENVIRON, V37, P22, DOI 10.1111/pce.12173; Gu JF, 2012, J EXP BOT, V63, P5137, DOI 10.1093/jxb/ers170; Gu JF, 2012, J EXP BOT, V63, P455, DOI 10.1093/jxb/err292; Hanba YT, 2004, PLANT CELL PHYSIOL, V45, P521, DOI 10.1093/pcp/pch070; HARLEY PC, 1992, PLANT PHYSIOL, V98, P1429, DOI 10.1104/pp.98.4.1429; Haworth M, 2013, OECOLOGIA, V171, P71, DOI 10.1007/s00442-012-2406-9; Haworth M, 2011, J EXP BOT, V62, P2419, DOI 10.1093/jxb/err086; Haworth M, 2010, NEW PHYTOL, V188, P845, DOI 10.1111/j.1469-8137.2010.03403.x; Hu LX, 2010, PHYSIOL PLANTARUM, V139, P93, DOI 10.1111/j.1399-3054.2010.01350.x; Hu SP, 2009, J INTEGR PLANT BIOL, V51, P879, DOI 10.1111/j.1744-7909.2009.00846.x; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; Hubbart S, 2007, J EXP BOT, V58, P3429, DOI 10.1093/jxb/erm192; Kaldenhoff R, 2012, CURR OPIN PLANT BIOL, V15, P276, DOI 10.1016/j.pbi.2012.01.011; Kamoshita A, 2004, PLANT PROD SCI, V7, P406, DOI 10.1626/pps.7.406; Karaba A, 2007, P NATL ACAD SCI USA, V104, P15270, DOI 10.1073/pnas.0707294104; Kiran TV, 2013, PHOTOSYNTHETICA, V51, P350, DOI 10.1007/s11099-013-0032-3; Koyama K, 2009, AM NAT, V173, P640, DOI 10.1086/597604; KUBISKE ME, 1993, PLANT CELL ENVIRON, V16, P1123, DOI 10.1111/j.1365-3040.1996.tb02070.x; Laisk A, 1996, PLANT PHYSIOL, V110, P903, DOI 10.1104/pp.110.3.903; Lanceras JC, 2004, PLANT PHYSIOL, V135, P384, DOI 10.1104/pp.103.035527; Lauteri M, 1997, FUNCT ECOL, V11, P675, DOI 10.1046/j.1365-2435.1997.00140.x; LLOYD J, 1992, PLANT CELL ENVIRON, V15, P873, DOI 10.1111/j.1365-3040.1992.tb01021.x; Long SP, 2014, PLANT CELL ENVIRON, V37, P19, DOI 10.1111/pce.12193; LORETO F, 1994, PHOTOSYNTH RES, V41, P397, DOI 10.1007/BF02183042; LORETO F, 1992, PLANT PHYSIOL, V98, P1437, DOI 10.1104/pp.98.4.1437; Loreto F, 2008, PLANT BIOSYST, V142, P154, DOI 10.1080/11263500701872937; Manickavelu A, 2006, PLANT GROWTH REGUL, V50, P121, DOI 10.1007/s10725-006-9109-3; Mott KA, 2000, TRENDS PLANT SCI, V5, P258, DOI 10.1016/S1360-1385(00)01648-4; Niinemets U, 2009, J EXP BOT, V60, P2249, DOI 10.1093/jxb/erp036; Pallozzi E, 2013, PHYSIOL PLANTARUM, V148, P51, DOI 10.1111/j.1399-3054.2012.01687.x; Pandey S, 2007, AGR ECON-BLACKWELL, V37, P213, DOI 10.1111/j.1574-0862.2007.00246.x; Pantuwan G, 2002, FIELD CROP RES, V73, P153, DOI 10.1016/S0378-4290(01)00187-3; Parent B, 2010, PLANT CELL ENVIRON, V33, P1256, DOI 10.1111/j.1365-3040.2010.02145.x; Peng S, 1999, CROP SCI, V39, P1552, DOI 10.2135/cropsci1999.3961552x; Pinelli P, 2003, J EXP BOT, V54, P1761, DOI 10.1093/jxb/erg187; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Pons TL, 2009, J EXP BOT, V60, P2217, DOI 10.1093/jxb/erp081; QUICK WP, 1992, PLANT CELL ENVIRON, V15, P25, DOI 10.1111/j.1365-3040.1992.tb01455.x; Richter A, 2009, RAPID COMMUN MASS SP, V23, P2476, DOI 10.1002/rcm.4088; Rodeghiero M, 2007, PLANT CELL ENVIRON, V30, P1006, DOI 10.1111/j.1365-3040.2007.001689.x; Scafaro AP, 2011, PLANT CELL ENVIRON, V34, P1999, DOI 10.1111/j.1365-3040.2011.02398.x; Scartazza A, 1998, AUST J PLANT PHYSIOL, V25, P489, DOI 10.1071/PP98017; Scheidegger Y, 2000, OECOLOGIA, V125, P350, DOI 10.1007/s004420000466; SCHMITT MR, 1981, J EXP BOT, V32, P459, DOI 10.1093/jxb/32.3.459; Serraj R, 2011, PLANT PROD SCI, V14, P1, DOI 10.1626/pps.14.1; SIDDIQUE KHM, 1989, FIELD CROP RES, V21, P59, DOI 10.1016/0378-4290(89)90041-5; Sun PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105165; TERASHIMA I, 1992, PHOTOSYNTH RES, V31, P195, DOI 10.1007/BF00035537; Tipple BJ, 2013, P NATL ACAD SCI USA, V110, P2659, DOI 10.1073/pnas.1213875110; Tomas M, 2013, J EXP BOT, V64, P2269, DOI 10.1093/jxb/ert086; Tsonev T, 2014, INT J AGRIC BIOL, V16, P335; Tyerman SD, 2002, PLANT CELL ENVIRON, V25, P173, DOI 10.1046/j.0016-8025.2001.00791.x; Venuprasad R, 2007, CROP SCI, V47, P285, DOI 10.2135/cropsci2006.03.0181; VONCAEMMERER S, 1991, AUST J PLANT PHYSIOL, V18, P287, DOI 10.1071/pp9910287; Warren CR, 2007, STAND ASIDE STOMATA, P1475; Wassmann R, 2009, ADV AGRON, V101, P59, DOI 10.1016/S0065-2113(08)00802-X; Xu YB, 2009, THEOR APPL GENET, V118, P1065, DOI 10.1007/s00122-009-0963-z; Yang JC, 2001, J EXP BOT, V52, P2169, DOI 10.1093/jexbot/52.364.2169; Zhao BZ, 2004, PLANT SOIL, V261, P61, DOI 10.1023/B:PLSO.0000035562.79099.55	78	62	69	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109054	10.1371/journal.pone.0109054	http://dx.doi.org/10.1371/journal.pone.0109054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275452	Green Submitted, Green Published, gold			2022-12-27	WOS:000342591500049
J	Aksentijevic, D; Zervou, S; Faller, KME; McAndrew, DJ; Schneider, JE; Neubauer, S; Lygate, CA				Aksentijevic, Dunja; Zervou, Sevasti; Faller, Kiterie M. E.; McAndrew, Debra J.; Schneider, Jurgen E.; Neubauer, Stefan; Lygate, Craig A.			Myocardial Creatine Levels Do Not Influence Response to Acute Oxidative Stress in Isolated Perfused Heart	PLOS ONE			English	Article							ISOLATED RAT-HEART; HYDROGEN-PEROXIDE; KNOCKOUT MICE; DOXORUBICIN; MITOCHONDRIAL; TRANSPORTER; PHOSPHOCREATINE; SUPPLEMENTATION; CARDIOTOXICITY; METABOLISM	Background: Multiple studies suggest creatine mediates anti-oxidant activity in addition to its established role in cellular energy metabolism. The functional significance for the heart has yet to be established, but antioxidant activity could contribute to the cardioprotective effect of creatine in ischaemia/reperfusion injury. Objectives: To determine whether intracellular creatine levels influence responses to acute reactive oxygen species (ROS) exposure in the intact beating heart. We hypothesised that mice with elevated creatine due to over-expression of the creatine transporter (CrT-OE) would be relatively protected, while mice with creatine-deficiency (GAMT KO) would fare worse. Methods and Results: CrT-OE mice were pre-selected for creatine levels 20-100% above wild-type using in vivo H-1-MRS. Hearts were perfused in isovolumic Langendorff mode and cardiac function monitored throughout. After 20 min equilibration, hearts were perfused with either H2O2 0.5 mu M (30 min), or the anti-neoplastic drug doxorubicin 15 mM (100 min). Protein carbonylation, creatine kinase isoenzyme activities and phospho-PKCd expression were quantified in perfused hearts as markers of oxidative damage and apoptotic signalling. Wild-type hearts responded to ROS challenge with a profound decline in contractile function that was ameliorated by co-administration of catalase or dexrazoxane as positive controls. In contrast, the functional deterioration in CrT-OE and GAMT KO hearts was indistinguishable from wildtype controls, as was the extent of oxidative damage and apoptosis. Exogenous creatine supplementation also failed to protect hearts from doxorubicin-induced dysfunction. Conclusions: Intracellular creatine levels do not influence the response to acute ROS challenge in the intact beating heart, arguing against creatine exerting (patho-) physiologically relevant anti-oxidant activity.	[Lygate, Craig A.] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England; Univ Oxford, British Heart Fdn Ctr Res Excellence, Oxford, England	University of Oxford; University of Oxford	Lygate, CA (corresponding author), Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England.	clygate@well.ox.ac.uk	Lygate, Craig/AAO-4731-2020	Lygate, Craig/0000-0001-6079-0284; Neubauer, Stefan/0000-0001-9017-5645; Aksentijevic, Dunja/0000-0002-8480-6727; Faller, Kiterie ME/0000-0002-4525-7059	British Heart Foundation Programme Grant [RG/13/8/30266]; BHF Senior Basic Science Research Fellow [FS/11/50/29038]; Wellcome Trust Core Award [075491/Z/04]; British Heart Foundation [RG/13/8/30266, FS/11/50/29038] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10005] Funding Source: researchfish	British Heart Foundation Programme Grant; BHF Senior Basic Science Research Fellow; Wellcome Trust Core Award(Wellcome Trust); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the British Heart Foundation Programme Grant RG/13/8/30266 to SN and CAL. JES is BHF Senior Basic Science Research Fellow (FS/11/50/29038). We would also like to acknowledge Wellcome Trust Core Award Grant 075491/Z/04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide P, 2011, HUM MUTAT, V32, P282, DOI 10.1002/humu.21421; Ali SS, 2006, AGING CELL, V5, P565, DOI 10.1111/j.1474-9726.2006.00252.x; ANYUKHOVSKY EP, 1986, BIOCHEM MED METAB B, V35, P327, DOI 10.1016/0885-4505(86)90090-3; Avner BS, 2010, AM J PHYSIOL-HEART C, V299, pH723, DOI 10.1152/ajpheart.00050.2010; Bender A, 2008, NEUROBIOL AGING, V29, P1404, DOI 10.1016/j.neurobiolaging.2007.03.001; Berneburg M, 2005, J INVEST DERMATOL, V125, P213, DOI 10.1111/j.0022-202X.2005.23806.x; Boehm E, 2003, AM J PHYSIOL-ENDOC M, V284, pE399, DOI 10.1152/ajpendo.00259.2002; Canton M, 2004, AM J PHYSIOL-HEART C, V286, pH870, DOI 10.1152/ajpheart.00714.2003; Cardinale D, 2010, J AM COLL CARDIOL, V55, P213, DOI 10.1016/j.jacc.2009.03.095; CHATHAM JC, 1989, EUR J BIOCHEM, V184, P657, DOI 10.1111/j.1432-1033.1989.tb15063.x; Darrabie MD, 2012, AM J PHYSIOL-HEART C, V303, pH539, DOI 10.1152/ajpheart.00108.2012; Deschamps AM, 2010, TRENDS CARDIOVAS MED, V20, P73, DOI 10.1016/j.tcm.2010.05.001; Divald A, 2010, CIRC RES, V106, P1829, DOI 10.1161/CIRCRESAHA.110.219485; Fimognari C, 2009, MUTAT RES-FUND MOL M, V670, P59, DOI 10.1016/j.mrfmmm.2009.07.005; Gratia S, 2012, CARDIOVASC RES, V95, P290, DOI 10.1093/cvr/cvs134; Guidi C, 2008, BBA-GEN SUBJECTS, V1780, P16, DOI 10.1016/j.bbagen.2007.09.018; Gupta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074675; Hausenloy DJ, 2010, BASIC RES CARDIOL, V105, P677, DOI 10.1007/s00395-010-0121-4; JANERO DR, 1991, J CELL PHYSIOL, V149, P347, DOI 10.1002/jcp.1041490302; Lawler JM, 2002, BIOCHEM BIOPH RES CO, V290, P47, DOI 10.1006/bbrc.2001.6164; Lygate CA, 2013, CIRC RES, V112, P945, DOI 10.1161/CIRCRESAHA.112.300725; Lygate CA, 2012, CARDIOVASC RES, V96, P466, DOI 10.1093/cvr/cvs272; Lygate CA, 2009, J MOL CELL CARDIOL, V46, P93, DOI 10.1016/j.yjmcc.2008.09.710; Maslov MY, 2010, AM J PHYSIOL-HEART C, V299, pH332, DOI 10.1152/ajpheart.00727.2009; MULLER M, 1985, J BIOL CHEM, V260, P3839; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; NICE, 2010, MAN CHR HEART FAIL A; Ogino H, 1996, ANN THORAC SURG, V62, P469, DOI 10.1016/0003-4975(96)00310-4; PELIKAN PCD, 1986, J CARDIOVASC PHARM, V8, P1058, DOI 10.1097/00005344-198609000-00026; Santos RVT, 2007, CLIN EXP PHARMACOL P, V34, P1294, DOI 10.1111/j.1440-1681.2007.04717.x; Schmidt A, 2004, HUM MOL GENET, V13, P905, DOI 10.1093/hmg/ddh112; Schneider JE, 2004, MAGNET RESON MED, V52, P1029, DOI 10.1002/mrm.20257; Schroder E, 2008, CURR OPIN PHARMACOL, V8, P153, DOI 10.1016/j.coph.2007.12.012; Sestili P, 2006, FREE RADICAL BIO MED, V40, P837, DOI 10.1016/j.freeradbiomed.2005.10.035; Snow RJ, 2001, MOL CELL BIOCHEM, V224, P169, DOI 10.1023/A:1011908606819; Streijger F, 2009, PHYSIOL BEHAV, V97, P76, DOI 10.1016/j.physbeh.2009.02.003; Sun LJ, 2014, INT J INFECT DIS, V23, P75, DOI 10.1016/j.ijid.2013.12.017; ten Hove M, 2005, CIRCULATION, V111, P2477, DOI 10.1161/01.CIR.0000165147.99592.01; ten Hove M, 2008, J MOL CELL CARDIOL, V45, P453, DOI 10.1016/j.yjmcc.2008.05.023; Tokarska-Schlattner M, 2002, MOL PHARMACOL, V61, P516, DOI 10.1124/mol.61.3.516; Tokarska-Schlattner M, 2006, J MOL CELL CARDIOL, V41, P389, DOI 10.1016/j.yjmcc.2006.06.009; Tokarska-Schlattner M, 2006, CR BIOL, V329, P657, DOI 10.1016/j.crvi.2005.08.007; Tokarska-Schlattner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043178; Wallis J, 2005, CIRCULATION, V112, P3131, DOI 10.1161/CIRCULATIONAHA.105.572990; Wang P, 2010, FREE RADICAL BIO MED, V49, P119, DOI 10.1016/j.freeradbiomed.2010.03.005; Young JF, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-9; ZUCCHI R, 1989, J MOL CELL CARDIOL, V21, P67, DOI 10.1016/0022-2828(89)91494-6; Zugno AI, 2008, NEUROCHEM RES, V33, P1804, DOI 10.1007/s11064-008-9636-6	48	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109021	10.1371/journal.pone.0109021	http://dx.doi.org/10.1371/journal.pone.0109021			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272153	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000343729600090
J	Raza, K; Larsen, T; Samaratunga, N; Price, AP; Meyer, C; Matson, A; Ehrhardt, MJ; Fogas, S; Tolar, J; Hertz, MI; Panoskaltsis-Mortari, A				Raza, Kashif; Larsen, Trevor; Samaratunga, Nath; Price, Andrew P.; Meyer, Carolyn; Matson, Amy; Ehrhardt, Michael J.; Fogas, Samuel; Tolar, Jakub; Hertz, Marshall I.; Panoskaltsis-Mortari, Angela			MSC Therapy Attenuates Obliterative Bronchiolitis after Murine Bone Marrow Transplant	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; REGULATORY T-CELLS; VERSUS-HOST-DISEASE; ACUTE LUNG INJURY; STROMAL CELLS; ALTERNATIVE ACTIVATION; MICE; MACROPHAGES; TOLERANCE; HEART	Rationale: Obliterative bronchiolitis (OB) is a significant cause of morbidity and mortality after lung transplant and hematopoietic cell transplant. Mesenchymal stromal cells (MSCs) have been shown to possess immunomodulatory properties in chronic inflammatory disease. Objective: Administration of MSCs was evaluated for the ability to ameliorate OB in mice using our established allogeneic bone marrow transplant (BMT) model. Methods: Mice were lethally conditioned and received allogeneic bone marrow without (BM) or with spleen cells (BMS), as a source of OB-causing T-cells. Cell therapy was started at 2 weeks post-transplant, or delayed to 4 weeks when mice developed airway injury, defined as increased airway resistance measured by pulmonary function test (PFT). BM-derived MSC or control cells [mouse pulmonary vein endothelial cells (PVECs) or lung fibroblasts (LFs)] were administered. Route of administration [intratracheally (IT) and IV] and frequency (every 1, 2 or 3 weeks) were compared. Mice were evaluated at 3 months post-BMT. Measurements and Main Results: No ectopic tissue formation was identified in any mice. When compared to BMS mice receiving control cells or no cells, those receiving MSCs showed improved resistance, compliance and inspiratory capacity. Interim PFT analysis showed no difference in route of administration. Improvements in PFTs were found regardless of dose frequency; but once per week worked best even when administration began late. Mice given MSC also had decreased peribronchiolar inflammation, lower levels of hydroxyproline (collagen) and higher frequencies of macrophages staining for the alternatively activated macrophage (AAM) marker CD206. Conclusions: These results warrant study of MSCs as a potential management option for OB in lung transplant and BMT recipients.	[Raza, Kashif; Hertz, Marshall I.; Panoskaltsis-Mortari, Angela] Univ Minnesota, Minneapolis, MN 55455 USA; [Larsen, Trevor; Samaratunga, Nath] Breck High Sch, Edina, MN USA; [Price, Andrew P.; Meyer, Carolyn; Matson, Amy; Ehrhardt, Michael J.; Fogas, Samuel; Tolar, Jakub; Panoskaltsis-Mortari, Angela] Univ Minnesota, Ctr Canc, Pediat Blood & Bone Marrow Transplant Program, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Panoskaltsis-Mortari, A (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.	panos001@umn.edu		Samaratunga, Nath/0000-0003-1129-4027; Tolar, Jakub/0000-0002-0957-4380	National Heart, Lung and Blood Institute [R01HL55209]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR063070, R01 AR059947, T32 HL07741]; NCRR Shared instrumentation grant (National Center for Research Resources) [1S10RR16851]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016851] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007741, R01HL055209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063070, R01AR059947] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR Shared instrumentation grant (National Center for Research Resources); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Heart, Lung and Blood Institute R01HL55209 (APM), National Institute of Arthritis and Musculoskeletal and Skin Diseases R01 AR063070 (JT), R01 AR059947 (JT), and T32 HL07741 ("Training in Lung Science" training grant support of KR). The confocal microscope was purchased through an NCRR Shared instrumentation grant (National Center for Research Resources grant 1S10RR16851). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes MA, 2014, J CELL BIOCHEM, V115, P1023, DOI 10.1002/jcb.24783; Baglole CJ, 2005, METH MOLEC MED, V117, P115; Behr J, 2000, TRANSPLANTATION, V69, P1856, DOI 10.1097/00007890-200005150-00020; Belperio John A, 2009, Proc Am Thorac Soc, V6, P108, DOI 10.1513/pats.200807-073GO; Betancourt AM, 2013, ADV BIOCHEM ENG BIOT, V130, P163, DOI 10.1007/10_2012_141; Bucher C, 2009, BLOOD, V114, P5375, DOI 10.1182/blood-2009-05-221135; Burr SP, 2013, IMMUNOL CELL BIOL, V91, P12, DOI 10.1038/icb.2012.60; Casiraghi F, 2008, J IMMUNOL, V181, P3933, DOI 10.4049/jimmunol.181.6.3933; Chambers DC, 2014, RESPIROLOGY; Christie JD, 2010, J HEART LUNG TRANSPL, V29, P1104, DOI 10.1016/j.healun.2010.08.004; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Foskett AM, 2014, AM J PHYSIOL-LUNG C, V306, pL120, DOI 10.1152/ajplung.00240.2013; Ge W, 2009, AM J TRANSPLANT, V9, P1760, DOI 10.1111/j.1600-6143.2009.02721.x; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Grove DA, 2011, J HEART LUNG TRANSPL, V30, P341, DOI 10.1016/j.healun.2010.09.012; Guo ZX, 2013, INT IMMUNOPHARMACOL, V15, P726, DOI 10.1016/j.intimp.2013.03.002; Guth AM, 2009, AM J PHYSIOL-LUNG C, V296, pL936, DOI 10.1152/ajplung.90625.2008; Hebbel RP, 2010, BLOOD, V115, P2483, DOI 10.1182/blood-2009-02-204990; Isakova IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087238; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Kebriaei P, 2011, FRONT ONCOL, V1, DOI 10.3389/fonc.2011.00016; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Madec AM, 2009, DIABETOLOGIA, V52, P1391, DOI 10.1007/s00125-009-1374-z; Madill Janet, 2009, Transplant Rev (Orlando), V23, P103, DOI 10.1016/j.trre.2009.01.003; Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252; McAuley DF, 2014, AM J PHYSIOL-LUNG C, V306, pL809, DOI 10.1152/ajplung.00358.2013; Meisel R, 2011, LEUKEMIA, V25, P648, DOI 10.1038/leu.2010.310; Moermans C, 2014, TRANSPLANTATION; Moodley Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069299; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Panoskaltsis-Mortari A, 2000, AM J PHYSIOL-LUNG C, V278, pL988, DOI 10.1152/ajplung.2000.278.5.L988; Panoskaltsis-Mortari A, 2007, AM J RESP CRIT CARE, V176, P713, DOI 10.1164/rccm.200702-335OC; Panoskaltsis-Mortari A, 2011, AM J RESP CRIT CARE, V183, P1262, DOI 10.1164/rccm.2007-413ST; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Perico N, 2011, CLIN J AM SOC NEPHRO, V6, P412, DOI 10.2215/CJN.04950610; Qi Y, 2014, J INVEST DERMATOL, V134, P526, DOI 10.1038/jid.2013.328; Sinclair K, 2013, RESPIROLOGY, V18, P397, DOI 10.1111/resp.12050; Sivanathan KN, 2014, STEM CELL REV REP, V10, P351, DOI 10.1007/s12015-014-9495-2; Stober VP, 2014, AM J PHYSIOL-LUNG C, V306, pL1045, DOI 10.1152/ajplung.00353.2013; Sundin M, 2009, J IMMUNOTHER, V32, P755, DOI 10.1097/CJI.0b013e3181ab1807; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620; Tzouvelekis A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-171; Vaes B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00345; Ware LB, 2002, AM J PHYSIOL-LUNG C, V282, pL924, DOI 10.1152/ajplung.00439.2001; Weiss Daniel J, 2013, Ann Am Thorac Soc, V10, pS25, DOI 10.1513/AnnalsATS.201304-089AW; Weiss DJ, 2013, CHEST, V143, P1590, DOI 10.1378/chest.12-2094; Weiss Daniel J, 2008, Proc Am Thorac Soc, V5, P637, DOI 10.1513/pats.200804-037DW; Williams KM, 2014, BONE MARROW TRANSPL, V49, P561, DOI 10.1038/bmt.2013.222; Workman CJ, 2009, CELL MOL LIFE SCI, V66, P2603, DOI 10.1007/s00018-009-0026-2; Yin F, 2014, STEM CELLS, V32, P1278, DOI 10.1002/stem.1638; Zhao YG, 2014, J THORAC CARDIOV SUR, V147, P1668, DOI 10.1016/j.jtcvs.2013.09.041; Ziegler TR, 2001, TRANSPLANTATION, V72, P1354, DOI 10.1097/00007890-200110270-00004	57	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109034	10.1371/journal.pone.0109034	http://dx.doi.org/10.1371/journal.pone.0109034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272285	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600091
J	Wong, D; Winter, O; Hartig, C; Siebels, S; Szyska, M; Tiburzy, B; Meng, LZ; Kulkarni, U; Fahnrich, A; Bommert, K; Bargou, R; Berek, C; Chu, VT; Bogen, B; Jundt, F; Manz, RA				Wong, David; Winter, Oliver; Hartig, Christina; Siebels, Svenja; Szyska, Martin; Tiburzy, Benjamin; Meng, Lingzhang; Kulkarni, Upasana; Faehnrich, Anke; Bommert, Kurt; Bargou, Ralf; Berek, Claudia; Van Trung Chu; Bogen, Bjarne; Jundt, Franziska; Manz, Rudolf Armin			Eosinophils and Megakaryocytes Support the Early Growth of Murine MOPC315 Myeloma Cells in Their Bone Marrow Niches	PLOS ONE			English	Article							HUMAN MULTIPLE-MYELOMA; PLASMA-CELLS; RECEPTOR EXPRESSION; IMMUNE-RESPONSE; STROMAL CELLS; B-CELLS; SURVIVAL; APRIL; DEXAMETHASONE; INTERLEUKIN-5	Multiple myeloma is a bone marrow plasma cell tumor which is supported by the external growth factors APRIL and IL-6, among others. Recently, we identified eosinophils and megakaryocytes to be functional components of the micro-environmental niches of benign bone marrow plasma cells and to be important local sources of these cytokines. Here, we investigated whether eosinophils and megakaryocytes also support the growth of tumor plasma cells in the MOPC315. BM model for multiple myeloma. As it was shown for benign plasma cells and multiple myeloma cells, IL-6 and APRIL also supported MOPC315. BM cell growth in vitro, IL-5 had no effect. Depletion of eosinophils in vivo by IL-5 blockade led to a reduction of the early myeloma load. Consistent with this, myeloma growth in early stages was retarded in eosinophil-deficient Delta dblGATA-1 mice. Late myeloma stages were unaffected, possibly due to megakaryocytes compensating for the loss of eosinophils, since megakaryocytes were found to be in contact with myeloma cells in vivo and supported myeloma growth in vitro. We conclude that eosinophils and megakaryocytes in the niches for benign bone marrow plasma cells support the growth of malignant plasma cells. Further investigations are required to test whether perturbation of these niches represents a potential strategy for the treatment of multiple myeloma.	[Wong, David; Hartig, Christina; Siebels, Svenja; Szyska, Martin; Tiburzy, Benjamin; Meng, Lingzhang; Kulkarni, Upasana; Manz, Rudolf Armin] Med Univ Lubeck, Inst System Inflammat Res, ISEF, D-23538 Lubeck, Germany; [Winter, Oliver] Charite, Dept Rheumatol, D-13353 Berlin, Germany; [Winter, Oliver] Charite, German Arthrit Res Ctr DRFZ, D-13353 Berlin, Germany; [Faehnrich, Anke] Med Univ Lubeck, Inst Anat, D-23538 Lubeck, Germany; [Bommert, Kurt] Univ Hosp Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany; [Bargou, Ralf; Jundt, Franziska] Univ Hosp Wurzburg, Dept Internal Med 2, Div Haematol & Med Oncol, Wurzburg, Germany; [Berek, Claudia; Van Trung Chu] German Arthrit Res Ctr DRFZ Berlin, Berlin, Germany; [Bogen, Bjarne] Univ Oslo, Inst Immunol, Ctr Immune Regulat, Oslo, Norway; [Bogen, Bjarne] Oslo Univ Hosp, Oslo, Norway	University of Lubeck; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lubeck; University of Wurzburg; University of Wurzburg; University of Oslo; University of Oslo	Manz, RA (corresponding author), Med Univ Lubeck, Inst System Inflammat Res, ISEF, D-23538 Lubeck, Germany.	Rudolf.Manz@uksh.de	Manz, Rudolf A/C-8340-2011; Bommert, Kurt/G-9247-2011; Jundt, Franziska/E-9748-2014	Jundt, Franziska/0000-0002-8661-7110; Chu, Van Trung/0000-0003-1327-8696	Deutsche Krebshilfe [108658]; Werner und Klara Kreitz-Stiftung; Excellence Cluster Inflammation at Interfaces; University of Luebeck; GRK "Modulation of Autoimmunity" [GRK1727]; DFG [WI 3895/1-1]; Clinical Research Unit 216 [KFO216]	Deutsche Krebshilfe(Deutsche Krebshilfe); Werner und Klara Kreitz-Stiftung; Excellence Cluster Inflammation at Interfaces; University of Luebeck; GRK "Modulation of Autoimmunity"; DFG(German Research Foundation (DFG)); Clinical Research Unit 216	This work was supported by the Deutsche Krebshilfe (project 108658), the Werner und Klara Kreitz-Stiftung and the Excellence Cluster Inflammation at Interfaces. David Wong and Upasana Kulkarni were supported by an internal program grant of the University of Luebeck. Ben Tiburzy was funded by the GRK1727 vertical bar GRK "Modulation of Autoimmunity". Oliver Winter received support from DFG Grant WI 3895/1-1. Ralf Bargou and Kurt Bommert were supported by the Clinical Research Unit 216 (KFO216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Anderson KC, 2011, ANNU REV PATHOL-MECH, V6, P249, DOI 10.1146/annurev-pathol-011110-130249; Bataille R, 1997, NEW ENGL J MED, V336, P1657, DOI 10.1056/NEJM199706053362307; Bommert K, 2006, EUR J CANCER, V42, P1574, DOI 10.1016/j.ejca.2005.12.026; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Chatterjee M, 2004, BLOOD, V104, P3712, DOI 10.1182/blood-2004-04-1670; Chu VT, 2013, IMMUNOL REV, V251, P177, DOI 10.1111/imr.12011; Chu VT, 2012, EUR J IMMUNOL, V42, P130, DOI 10.1002/eji.201141953; Chu VT, 2009, ARTHRITIS RHEUM-US, V60, P2083, DOI 10.1002/art.24628; Corren J, 2012, DISCOV MED, V13, P305; Edwards CM, 2008, BONE, V42, P1007, DOI 10.1016/j.bone.2008.01.027; Fowler JA, 2012, CANCER RES, V72, P2183, DOI 10.1158/0008-5472.CAN-11-2067; Gerlo S, 2008, CELL SIGNAL, V20, P1489, DOI 10.1016/j.cellsig.2008.04.004; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hauser AE, 2002, J IMMUNOL, V169, P1277, DOI 10.4049/jimmunol.169.3.1277; Hofgaard PO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051892; Honemann D, 2001, INT J CANCER, V93, P674, DOI 10.1002/ijc.1388; Hov H, 2009, EUR J HAEMATOL, V82, P277, DOI 10.1111/j.1600-0609.2009.01212.x; JERNBERGWIKLUND H, 1992, LEUKEMIA, V6, P310; Jundt F, 2004, BLOOD, V103, P3511, DOI 10.1182/blood-2003-07-2254; Katz BZ, 2010, SEMIN CANCER BIOL, V20, P186, DOI 10.1016/j.semcancer.2010.04.003; Kortuem KM, 2013, BLOOD, V121, P893, DOI 10.1182/blood-2012-10-459883; Kuehl WM, 2012, J CLIN INVEST, V122, P3456, DOI 10.1172/JCI61188; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Ludwig H, 2012, BLOOD, V119, P3003, DOI 10.1182/blood-2011-11-374249; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Molfino NA, 2012, CLIN EXP ALLERGY, V42, P712, DOI 10.1111/j.1365-2222.2011.03854.x; Moller C, 2003, LEUKEMIA, V17, P203, DOI 10.1038/sj.leu.2402717; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Moreaux J, 2004, BLOOD, V103, P3148, DOI 10.1182/blood-2003-06-1984; Moreaux J, 2009, EUR J HAEMATOL, V83, P119, DOI 10.1111/j.1600-0609.2009.01262.x; Moser K, 2006, CURR OPIN IMMUNOL, V18, P265, DOI 10.1016/j.coi.2006.03.004; Muehlinghaus G, 2005, BLOOD, V105, P3965, DOI 10.1182/blood-2004-08-2992; Mumtaz IM, 2012, J AUTOIMMUN, V39, P180, DOI 10.1016/j.jaut.2012.05.010; Nakayama T, 2003, J IMMUNOL, V170, P1136, DOI 10.4049/jimmunol.170.3.1136; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; Oracki SA, 2010, IMMUNOL REV, V237, P140, DOI 10.1111/j.1600-065X.2010.00940.x; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; PARSONS JC, 1993, PARASITE IMMUNOL, V15, P501, DOI 10.1111/j.1365-3024.1993.tb00637.x; Quinn J, 2011, BLOOD, V117, P890, DOI 10.1182/blood-2010-01-264424; Miguel JS, 2013, LANCET ONCOL, V14, P1055, DOI 10.1016/S1470-2045(13)70380-2; Sanz-Rodriguez F, 2001, BLOOD, V97, P346, DOI 10.1182/blood.V97.2.346; Schwartz LB, 2010, CURR MED RES OPIN, V26, P1933, DOI 10.1185/03007995.2010.493132; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Sprynski AC, 2009, ROLE IGF 1 MAJOR GRO; Tagoug I, 2011, INHIBITION IGF 1 SIG; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Tokoyoda K, 2010, NAT REV IMMUNOL, V10, P193, DOI 10.1038/nri2727; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; Winter O, 2011, IMMUNOL LETT, V141, P145, DOI 10.1016/j.imlet.2011.07.006; Winter O, 2010, BLOOD, V116, P1867, DOI 10.1182/blood-2009-12-259457; Wong TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070554; Zhu YX, 2013, LEUKEMIA LYMPHOMA, V54, P683, DOI 10.3109/10428194.2012.728597	55	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109018	10.1371/journal.pone.0109018	http://dx.doi.org/10.1371/journal.pone.0109018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272036	Green Submitted, Green Published, gold			2022-12-27	WOS:000343729600089
J	Chen, YL; Jian, Y; Liu, MJ; Zhong, L; Zhang, F; Yang, WF; Xu, Z; Chen, GF; Liu, YH				Chen, Yulin; Jian, Ying; Liu, Minjie; Zhong, Liang; Zhang, Fang; Yang, Weifeng; Xu, Zhao; Chen, Guofan; Liu, Yuhua			Gr-1(+)CD11b(+) Immature Myeloid Cells (IMC) Promote Resistance of Pro-Inflammatory T Cells to Suppression by Regulatory T Cells in Atherosclerotic Apo E-Deficient Mice	PLOS ONE			English	Article							INTERLEUKIN-6; ATHEROGENESIS	Accumulating evidence indicates that both defects in Treg numbers and/or function as well as resistance of effector T cells to suppression may contribute to the development of human chronic inflammatory diseases. However, which mechanism involved in the progression of atherosclerosis remains unclear. In this study, we evaluated the production and function of CD4(+) inflammatory and regulatory T cells in atherosclerosis-prone mice. We found that the hyperactivity and unresponsiveness to Treg-mediated suppression of inflammatory CD4(+) T cells occurred in the progression of atherosclerosis, though Treg cells were present in very large numbers and fully functional. We further found that Gr-1(+)CD11b(+) immature myeloid cells were significantly accumulated in atherosclerotic Apo E-/- mice, and they promoted resistance of inflammatory CD4(+) T cells to Treg-mediated suppression in vitro and in vivo. we further confirmed that Gr-1(+)CD11b(+) immature myeloid cells produced high level of interleukin 6 which was at least partially responsible for inducing unresponsiveness of inflammatory CD4(+) T cells to suppression via activation of Jak/Stat signaling pathway. Taken together, these findings might provide new insights to explore potential targets for immune therapeutic intervention in atherosclerosis.	[Chen, Yulin; Jian, Ying; Liu, Minjie; Zhong, Liang; Zhang, Fang; Yang, Weifeng; Xu, Zhao; Chen, Guofan] Hangzhou Normal Univ, Affiliated Hosp, Dept Cardiol, Hangzhou, Zhejiang, Peoples R China; [Liu, Yuhua] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University; Hangzhou Normal University	Jian, Y (corresponding author), Hangzhou Normal Univ, Affiliated Hosp, Dept Cardiol, Hangzhou, Zhejiang, Peoples R China.	janejianying@126.com; yuhua801229@163.com			Hangzhou Foundation for Development of Science and Technology [20120533Q29, 20110733Q14]; Hangzhou Medical and Health Science and Technology Program [2010B010]; Zhejiang Provincial Natural Science Foundation [Y2100526]; Science and Technology Projects of Zhejiang Province [2009C33149]; Zhejiang Major Medical and Health Science and Technology Program [2009B123]	Hangzhou Foundation for Development of Science and Technology; Hangzhou Medical and Health Science and Technology Program; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Science and Technology Projects of Zhejiang Province; Zhejiang Major Medical and Health Science and Technology Program	This work was supported by Hangzhou Foundation for Development of Science and Technology (20120533Q29, 20110733Q14) (YL, YC), Hangzhou Medical and Health Science and Technology Program (2010B010) (YL) www.hzst.gov.cn. This work is also supported by grants from the Zhejiang Provincial Natural Science Foundation, (Y2100526) (YC), the Science and Technology Projects of Zhejiang Province (2009C33149) (YJ), Zhejiang Major Medical and Health Science and Technology Program, (2009B123) (YC) www.zjnsf.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeywardena MY, 2009, CURR PHARM DESIGN, V15, P1809, DOI 10.2174/138161209788186290; Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Dugast AS, 2008, J IMMUNOL, V180, P7898, DOI 10.4049/jimmunol.180.12.7898; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Gao Q, 2010, J IMMUNOL, V185, P5820, DOI 10.4049/jimmunol.1000116; Ishigaki Y, 2008, CIRCULATION, V118, P75, DOI 10.1161/CIRCULATIONAHA.107.745174; Kallberg E, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-69; Laurat E, 2001, CIRCULATION, V104, P197, DOI 10.1161/01.CIR.104.2.197; Liu Y, 2012, J IMMUNOL, V188, P5500, DOI 10.4049/jimmunol.1103505; Madhur MS, 2011, ARTERIOSCL THROM VAS, V31, P1565, DOI 10.1161/ATVBAHA.111.227629; Maganto-Garcia E, 2011, CIRCULATION, V124, P185, DOI 10.1161/CIRCULATIONAHA.110.006411; Marhaba R, 2007, J IMMUNOL, V179, P5071, DOI 10.4049/jimmunol.179.8.5071; Randolph GJ, 2013, NAT MED, V19, P1094, DOI 10.1038/nm.3316; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Schuett H, 2009, THROMB HAEMOSTASIS, V102, P215, DOI 10.1160/TH09-05-0297; Schulte S, 2008, AM J PATHOL, V172, P1500, DOI 10.2353/ajpath.2008.070776; Skogsberg J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000036; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Xie JJ, 2010, CYTOKINE, V49, P185, DOI 10.1016/j.cyto.2009.09.007; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228	23	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108620	10.1371/journal.pone.0108620	http://dx.doi.org/10.1371/journal.pone.0108620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25269085	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700127
J	Galbraith, H; DesRochers, DW; Brown, S; Reed, JM				Galbraith, Hector; DesRochers, David W.; Brown, Stephen; Reed, J. Michael			Predicting Vulnerabilities of North American Shorebirds to Climate Change	PLOS ONE			English	Article							SEA-LEVEL RISE; TUNDRA VEGETATION CHANGE; ARCTIC TUNDRA; TEMPERATURE SENSITIVITY; SEMIPALMATED SANDPIPERS; POPULATION DECLINES; OCEAN ACIDIFICATION; EXTINCTION RISK; IMPACT MODELS; GLOBAL-CHANGE	Despite an increase in conservation efforts for shorebirds, there are widespread declines of many species of North American shorebirds. We wanted to know whether these declines would be exacerbated by climate change, and whether relatively secure species might become at-risk species. Virtually all of the shorebird species breeding in the USA and Canada are migratory, which means climate change could affect extinction risk via changes on the breeding, wintering, and/or migratory refueling grounds, and that ecological synchronicities could be disrupted at multiple sites. To predict the effects of climate change on shorebird extinction risks, we created a categorical risk model complementary to that used by Partners-in-Flight and the U.S. Shorebird Conservation Plan. The model is based on anticipated changes in breeding, migration, and wintering habitat, degree of dependence on ecological synchronicities, migration distance, and degree of specialization on breeding, migration, or wintering habitat. We evaluated 49 species, and for 3 species we evaluated 2 distinct populations each, and found that 47 (90%) taxa are predicted to experience an increase in risk of extinction. No species was reclassified into a lower-risk category, although 6 species had at least one risk factor decrease in association with climate change. The number of species that changed risk categories in our assessment is sensitive to how much of an effect of climate change is required to cause the shift, but even at its least sensitive, 20 species were at the highest risk category for extinction. Based on our results it appears that shorebirds are likely to be highly vulnerable to climate change. Finally, we discuss both how our approach can be integrated with existing risk assessments and potential future directions for predicting change in extinction risk due to climate change.	[Galbraith, Hector; Brown, Stephen] Manomet Ctr Conservat Sci, Manomet, MA USA; [DesRochers, David W.] Dalton State Coll, Dept Nat Sci, Dalton, GA USA; [Reed, J. Michael] Tufts Univ, Dept Biol, Medford, MA 02155 USA; [Galbraith, Hector] Natl Wildlife Federat, Springfield, MA USA	University System of Georgia; Dalton State College; Tufts University	Reed, JM (corresponding author), Tufts Univ, Dept Biol, Medford, MA 02155 USA.	michael.reed@tufts.edu			Manomet Center for Conservation Sciences; National Wildlife Federation; Dalton State College; Tufts University	Manomet Center for Conservation Sciences; National Wildlife Federation; Dalton State College; Tufts University	This study was internally funded. Each of the authors were supported primarily by their employers; Galbraith's time was supported by Manomet Center for Conservation Sciences and by the National Wildlife Federation; DesRochers was supported by Dalton State College; Brown was supported by Manomet Center for Conservation Sciences; and Reed was supported by Tufts University and by Manomet Center for Conservation Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HD, 2009, P NATL ACAD SCI USA, V106, P7063, DOI 10.1073/pnas.0901438106; Aiello-Lammens ME, 2011, GLOBAL CHANGE BIOL, V17, P3644, DOI 10.1111/j.1365-2486.2011.02497.x; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anagnostopoulos GG, 2010, HYDROLOG SCI J, V55, P1094, DOI 10.1080/02626667.2010.513518; [Anonymous], 2006, FED REG, V71; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Arctic Climate Impact Assessment, 2004, IMPACTS WARMING ARCT; Assini J, 2012, HYDROLOG SCI J, V57, P738, DOI 10.1080/02626667.2012.666853; Austin Graham E., 2003, Journal for Nature Conservation (Jena), V11, P43, DOI 10.1078/1617-1381-00029; Baker AJ, 2004, P ROY SOC B-BIOL SCI, V271, P875, DOI 10.1098/rspb.2003.2663; Bart J, 2007, J AVIAN BIOL, V38, P73, DOI 10.1111/j.2007.0908-8857.03698.x; Bhatt US, 2010, EARTH INTERACT, V14, DOI 10.1175/2010EI315.1; Blackford JC, 2010, J MARINE SYST, V81, P12, DOI 10.1016/j.jmarsys.2009.12.016; Boruff BJ, 2005, J COASTAL RES, V21, P932, DOI 10.2112/04-0172.1; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; Brantley S, 2013, ECOL APPL, V23, P777, DOI 10.1890/12-0616.1; Brown S, 2001, US SHOREBIRD CONSERV; Cahill AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1890; CASTRO G, 1993, AUK, V110, P927, DOI 10.2307/4088650; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Chu-Agor ML, 2011, ENVIRON MODELL SOFTW, V26, P593, DOI 10.1016/j.envsoft.2010.12.003; Colwell MA, 2010, SHOREBIRD ECOLOGY, CONSERVATION, AND MANAGEMENT, P1; CONVERTINO M, 2012, ECOL PROCESS, V1, pNIL1, DOI DOI 10.1186/2192-1709-1-9; Convertino M, 2012, ECOL MODEL, V240, P1, DOI 10.1016/j.ecolmodel.2012.04.012; Correa-Metrio A, 2012, QUATERNARY SCI REV, V38, P63, DOI 10.1016/j.quascirev.2012.01.025; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Elmendorf SC, 2012, NAT CLIM CHANGE, V2, P453, DOI 10.1038/NCLIMATE1465; Elphick CS, 2010, BIOL CONSERV, V143, P617, DOI 10.1016/j.biocon.2009.11.026; Essl F, 2013, GLOBAL ECOL BIOGEOGR, V22, P29, DOI 10.1111/j.1466-8238.2012.00787.x; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Flinn KM, 2005, FRONT ECOL ENVIRON, V3, P243, DOI 10.2307/3868486; Flynn KJ, 2012, NAT CLIM CHANGE, V2, P510, DOI 10.1038/NCLIMATE1489; Galbraith H, 2002, WATERBIRDS, V25, P173, DOI 10.1675/1524-4695(2002)025[0173:GCCASL]2.0.CO;2; Galbraith H, 2009, EPA600R09011; Gardali T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029507; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Godet L, 2011, BIOL LETTERS, V7, P714, DOI 10.1098/rsbl.2011.0152; Gratto-Trevor CL, 1997, CLIMATE CHANGE PROPO, P205; He Y, 2010, ATMOS SCI LETT, V11, P132, DOI 10.1002/asl.270; Hedenstrom A, 2007, CLIM RES, V35, P79, DOI 10.3354/cr00715; Herman T. B., 1994, P13; Higdon JW, 2006, CAN J FOREST RES, V36, P467, DOI 10.1139/X05-260; Hirota M, 2010, NEW PHYTOL, V187, P707, DOI 10.1111/j.1469-8137.2010.03352.x; Hodkinson ID, 1998, ARCTIC ALPINE RES, V30, P306, DOI 10.2307/1551978; HOWE MA, 1989, BIOL CONSERV, V49, P185, DOI 10.1016/0006-3207(89)90035-9; International Union for Conservation of Nature, 2013, IUCN RED LIST THREAT; International Wader Study Group, 2003, WADER STUDY GROUP B, V101/102, P8; Iwamura T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0325; Jactel H, 2012, GLOBAL CHANGE BIOL, V18, P267, DOI 10.1111/j.1365-2486.2011.02512.x; Jehl JR, 2007, CONDOR, V109, P351, DOI 10.1650/0010-5422(2007)109[351:DOBSSF]2.0.CO;2; Johnson WC, 2010, BIOSCIENCE, V60, P128, DOI 10.1525/bio.2010.60.2.7; Jones T, 2010, J ANIM ECOL, V79, P98, DOI 10.1111/j.1365-2656.2009.01610.x; Karl T. R., 2009, Global climate change impacts in the United States; Karlsson JM, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014015; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Keppie DM, 1994, BIRDS N AM, V100; Khailani DK, 2013, LAND USE POLICY, V30, P615, DOI 10.1016/j.landusepol.2012.05.003; Klaassen M, 2012, PHILOS T R SOC B, V367, P1719, DOI 10.1098/rstb.2012.0008; Knudsen E, 2011, BIOL REV, V86, P928, DOI 10.1111/j.1469-185X.2011.00179.x; Kundzewicz ZW, 2010, HYDROLOG SCI J, V55, P1085, DOI 10.1080/02626667.2010.513211; Lee TM, 2008, P ROY SOC B-BIOL SCI, V275, P1261, DOI 10.1098/rspb.2007.1732; Lee TM, 2011, P ROY SOC B-BIOL SCI, V278, P1329, DOI 10.1098/rspb.2010.1877; Liebezeit JR, 2014, POLAR BIOL, V37, P1309, DOI 10.1007/s00300-014-1522-x; Lloyd MG, 2013, LAND USE POLICY, V30, P925, DOI 10.1016/j.landusepol.2012.06.012; da Costa ACL, 2010, NEW PHYTOL, V187, P579, DOI 10.1111/j.1469-8137.2010.03309.x; Lucht W, 2002, SCIENCE, V296, P1687, DOI 10.1126/science.1071828; M-K Woo, 2012, CHANGING COLD ENV CA, P105; MacDonald LA, 2012, HYDROL PROCESS, V26, P117, DOI 10.1002/hyp.8116; Maclean IMD, 2008, GLOBAL CHANGE BIOL, V14, P2489, DOI 10.1111/j.1365-2486.2008.01666.x; Magrin G, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P581; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Martin P.D., 2009, WILDLIFE RESPONSE EN, P1; McKinnon L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01816; Mcleod E, 2010, OCEAN COAST MANAGE, V53, P507, DOI 10.1016/j.ocecoaman.2010.06.009; Meltofte Hans, 2007, Meddelelser om Gronland Bioscience, V59, P1; Menon S, 2010, BIODIVERS CONSERV, V19, P1599, DOI 10.1007/s10531-010-9790-4; Metz B., 2007, CLIMATE CHANGE 2007, DOI DOI 10.1017/CBO9780511546013; Milligan AJ, 2012, NAT CLIM CHANGE, V2, P489, DOI 10.1038/nclimate1606; MILLSAP BA, 1990, WILDLIFE MONOGR, P1; Milton David, 2003, Wader Study Group Bulletin, V100, P105; Mizrahi DS, 2009, BIOLOGY AND CONSERVATION OF HORSESHOE CRABS, P65, DOI 10.1007/978-0-387-89959-6_4; Morrison R.I. Guy, 2006, Wader Study Group Bulletin, V111, P67; Morrison RIG, 2012, WATERBIRDS, V35, P120, DOI 10.1675/063.035.0112; Morrison RIG, 2004, CONDOR, V106, P60; Moss RH, 2001, CROSS CUTTING ISSUES; Nebel S, 2008, BIOL CONSERV, V141, P971, DOI 10.1016/j.biocon.2008.01.017; Nicholls RJ, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P315; North American Bird Conservation Initiative (nabci) U.S. Committee, 2010, STAT BIRDS 2010 REP; O'Gorman PA, 2012, NAT GEOSCI, V5, P697, DOI [10.1038/ngeo1568, 10.1038/NGEO1568]; Olesen JE, 2011, EUR J AGRON, V34, P96, DOI 10.1016/j.eja.2010.11.003; Panjabi A.O., 2005, PARTNERS FLIGHT TECH; Parmesan C, 2004, OBSERVED ECOLOGICAL; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parry ML, 2007, CLIMATE CHANGE 2007; Pe'er G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022355; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pfeffer WT, 2008, SCIENCE, V321, P1340, DOI 10.1126/science.1159099; Piersma T, 2004, IBIS, V146, P61, DOI 10.1111/j.1474-919X.2004.00329.x; Prowse T, 2012, CHANGING COLD ENV CA, P163, DOI DOI 10.1002/9781119950172.CH9; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Raven J., 2005, OCEAN ACIDIFICATION; Raynolds MK, 2012, REMOTE SENS LETT, V3, P403, DOI 10.1080/01431161.2011.609188; Reed J. Michael, 2006, P164; REED JM, 1995, GREAT BASIN NAT, V55, P342; Rehfisch MM, 2004, IBIS, V146, P70, DOI 10.1111/j.1474-919X.2004.00330.x; Ridgely R. S, 2007, DIGITAL DISTRIBUTION; Robinson Robert A., 2009, Endangered Species Research, V7, P87, DOI 10.3354/esr00095; Rotenberry JT, 2009, CONDOR, V111, P401, DOI 10.1525/cond.2009.090015; Russell BD, 2012, BIOL LETTERS, V8, P164, DOI 10.1098/rsbl.2011.0779; Ruz M.H., 1998, GEOL SURV CAN, DOI [10.4095/210075, DOI 10.4095/210075]; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; Schmidt NM, 2012, P ROY SOC B-BIOL SCI, V279, P4417, DOI 10.1098/rspb.2012.1490; Seavey JR, 2011, BIOL CONSERV, V144, P393, DOI 10.1016/j.biocon.2010.09.017; Senner NR, 2012, AUK, V129, P670, DOI 10.1525/auk.2012.12029; Sheffield J, 2008, CLIM DYNAM, V31, P79, DOI 10.1007/s00382-007-0340-z; Small-Lorenz SL, 2013, NAT CLIM CHANGE, V3, P91, DOI 10.1038/nclimate1810; Smith PA, 2010, J AVIAN BIOL, V41, P292, DOI 10.1111/j.1600-048X.2009.04815.x; Snyder MA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017647; Stralberg D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027388; Strauss BH, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014033; Stroud D.A., 2004, International Wader Studies, V15, P1; Strzepek K, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/044012; Sturm M, 2005, BIOSCIENCE, V55, P17, DOI 10.1641/0006-3568(2005)055[0017:WBPCHC]2.0.CO;2; SWEENEY BW, 1992, GLOBAL CLIMATE CHANGE AND FRESHWATER ECOSYSTEMS, P143; Taylor AR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001085; Thomas GH, 2006, ANIM CONSERV, V9, P252, DOI 10.1111/j.1469-1795.2006.00029.x; Titus JG, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044008; Tulp I, 2008, ARCTIC, V61, P48; Vano JA, 2014, B AM METEOROL SOC, V95, P59, DOI 10.1175/BAMS-D-12-00228.1; Veloz SD, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00341.1; Veloz SD, 2012, GLOBAL CHANGE BIOL, V18, P1698, DOI 10.1111/j.1365-2486.2011.02635.x; WARNOCK N., 2002, BIOL MARINE BIRDS; Warnock N, 2010, J AVIAN BIOL, V41, P621, DOI 10.1111/j.1600-048X.2010.05155.x; Wilby RL, 2010, HYDROLOG SCI J, V55, P1090, DOI 10.1080/02626667.2010.513212; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	140	40	47	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108899	10.1371/journal.pone.0108899	http://dx.doi.org/10.1371/journal.pone.0108899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268907	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700185
J	Gaskill, PJ; Yano, HH; Kalpana, GV; Javitch, JA; Berman, JW				Gaskill, Peter J.; Yano, Hideaki H.; Kalpana, Ganjam V.; Javitch, Jonathan A.; Berman, Joan W.			Dopamine Receptor Activation Increases HIV Entry into Primary Human Macrophages	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; SERIOUS MENTAL-ILLNESS; AIDS DEMENTIA COMPLEX; FREELY MOVING RATS; INJECTING DRUG-USE; CHEMOKINE RECEPTORS; NUCLEUS-ACCUMBENS; BASAL GANGLIA; EXTRACELLULAR DOPAMINE	Macrophages are the primary cell type infected with HIV in the central nervous system, and infection of these cells is a major component in the development of neuropathogenesis and HIV-associated neurocognitive disorders. Within the brains of drug abusers, macrophages are exposed to increased levels of dopamine, a neurotransmitter that mediates the addictive and reinforcing effects of drugs of abuse such as cocaine and methamphetamine. In this study we examined the effects of dopamine on HIV entry into primary human macrophages. Exposure to dopamine during infection increased the entry of R5 tropic HIV into macrophages, irrespective of the concentration of the viral inoculum. The entry pathway affected was CCR5 dependent, as antagonizing CCR5 with the small molecule inhibitor TAK779 completely blocked entry. The effect was dose-dependent and had a steep threshold, only occurring above 10(8) M dopamine. The dopamine-mediated increase in entry required dopamine receptor activation, as it was abrogated by the pan-dopamine receptor antagonist flupenthixol, and could be mediated through both subtypes of dopamine receptors. These findings indicate that the effects of dopamine on macrophages may have a significant impact on HIV pathogenesis. They also suggest that drug-induced increases in CNS dopamine may be a common mechanism by which drugs of abuse with distinct modes of action exacerbate neuroinflammation and contribute to HIV-associated neurocognitive disorders in infected drug abusers.	[Gaskill, Peter J.; Berman, Joan W.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Yano, Hideaki H.; Javitch, Jonathan A.] Columbia Univ, Dept Pharmacol & Psychiat, New York, NY USA; [Kalpana, Ganjam V.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Kalpana, Ganjam V.; Berman, Joan W.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Columbia University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Gaskill, PJ (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	peter.gaskill@einstein.yu.edu	Gaskill, Peter Jesse/O-5096-2019	Gaskill, Peter Jesse/0000-0003-0095-5424; Javitch, Jonathan/0000-0001-7395-2967; Yano, Hideaki/0000-0001-9242-3884; Kalpana, Ganjam/0000-0003-4111-0604	National Institutes of Drug Abuse [DA029476, K05DA022413, DA025567]; National Institutes of Allergy and Infectious Disease [AI095171-01]; National Institutes of Mental Health [R01 MH54137, MH090958, MH075679]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA029476] Funding Source: NIH RePORTER	National Institutes of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	These studies were funded by grants from the National Institutes of Drug Abuse, DA029476 (PJG), K05DA022413 (JAJ) and DA025567 (JWB), the National Institutes of Allergy and Infectious Disease, AI095171-01 (GVK) and the National Institutes of Mental Health, R01 MH54137 (JAJ), MH090958 (JWB) and MH075679 (JWB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2003, EUR NEUROPSYCHOPHARM, V13, P459, DOI 10.1016/j.euroneuro.2003.08.007; Arai H, 1996, J BIOL CHEM, V271, P21814, DOI 10.1074/jbc.271.36.21814; Arhel N, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-96; Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; Arthos J, 2000, J VIROL, V74, P6418, DOI 10.1128/JVI.74.14.6418-6424.2000; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; AYLWARD EH, 1995, AM J PSYCHIAT, V152, P987; AYLWARD EH, 1993, NEUROLOGY, V43, P2099, DOI 10.1212/WNL.43.10.2099; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Berg KM, 2012, AIDS BEHAV, V16, P461, DOI 10.1007/s10461-010-9864-z; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Berger JR, 2000, J PSYCHOPHARMACOL, V14, P214, DOI 10.1177/026988110001400304; BERGER JR, 1994, AIDS, V8, P67, DOI 10.1097/00002030-199401000-00010; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Beyrer C, 2010, JAIDS-J ACQ IMM DEF, V55, pS10, DOI 10.1097/QAI.0b013e3181f9c0c9; Bing EG, 2001, ARCH GEN PSYCHIAT, V58, P721, DOI 10.1001/archpsyc.58.8.721; Blank MB, 2002, PSYCHIATR SERV, V53, P868, DOI 10.1176/appi.ps.53.7.868; Blanpain C, 2002, MOL BIOL CELL, V13, P723, DOI 10.1091/mbc.01-03-0129; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Bonaventura J, 2014, NEUROPHARMACOLOGY, V79, P90, DOI 10.1016/j.neuropharm.2013.10.036; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; BROWN GR, 1992, PSYCHOSOM MED, V54, P588, DOI 10.1097/00006842-199209000-00006; Burris KD, 2002, J PHARMACOL EXP THER, V302, P381, DOI 10.1124/jpet.102.033175; CARBONI E, 1989, NEUROSCIENCE, V28, P653, DOI 10.1016/0306-4522(89)90012-2; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; [Center for Behavioral Health Statistics & Quality Substance Abuse and Mental Health Services Administration], 2010, NSDUH REP HIV AIDS S; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Chun LS, 2013, MOL PHARMACOL, V84, P190, DOI 10.1124/mol.113.085175; Churchill M, 2013, CURR OPIN HIV AIDS, V8, P165, DOI 10.1097/COH.0b013e32835fc601; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; Cragg SJ, 2004, TRENDS NEUROSCI, V27, P270, DOI 10.1016/j.tins.2004.03.011; Cragg SJ, 2001, J NEUROPHYSIOL, V85, P1761, DOI 10.1152/jn.2001.85.4.1761; Cysique LA, 2004, J NEUROVIROL, V10, P350, DOI 10.1080/13550280490521078; Czub S, 2004, ACTA NEUROPATHOL, V107, P216, DOI 10.1007/s00401-003-0801-3; Czub S, 2001, ACTA NEUROPATHOL, V101, P85; Dai R, 2008, NEUROSIGNALS, V16, P112, DOI 10.1159/000111557; de Voux A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054532; Di Rocco A, 2000, CLIN NEUROPHARMACOL, V23, P190, DOI 10.1097/00002826-200007000-00004; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Dick AD, 1997, AIDS, V11, P1699, DOI 10.1097/00002030-199714000-00006; Eugenin EA, 2007, J NEUROSCI, V27, P12844, DOI 10.1523/JNEUROSCI.4154-07.2007; Flanagan Colleen A, 2014, Adv Pharmacol, V70, P215, DOI 10.1016/B978-0-12-417197-8.00008-0; Ford CP, 2010, J NEUROSCI, V30, P6975, DOI 10.1523/JNEUROSCI.1020-10.2010; Franco R, 2007, J NEURAL TRANSM, V114, P93, DOI 10.1007/s00702-006-0566-7; Fregeau MO, 2013, CELL SIGNAL, V25, P2871, DOI 10.1016/j.cellsig.2013.08.021; Fujimura RK, 1997, J ACQ IMMUN DEF SYND, V16, P146, DOI 10.1097/00042560-199711010-00002; Fuxe K, 2007, J NEURAL TRANSM, V114, P49, DOI 10.1007/s00702-006-0589-0; Fuxe K, 2013, CHIN J INTEGR MED, V19, P323, DOI 10.1007/s11655-013-1455-1; Gabuzda D, 2000, J NEUROVIROL, V6, pS24; Gabuzda D, 1999, J NEUROVIROL, V5, P643, DOI 10.3109/13550289909021293; GARRIS PA, 1994, J NEUROSCI, V14, P6084; GARRIS PA, 1994, J PHYSIOL-LONDON, V478, P239, DOI 10.1113/jphysiol.1994.sp020246; Gaskill P. J., 2013, J NEUROIMMUNE PHARM; Gaskill PJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-203; Gaskill PJ, 2009, AM J PATHOL, V175, P1148, DOI 10.2353/ajpath.2009.081067; Gelman BB, 2006, J NEUROIMMUNE PHARM, V1, P410, DOI 10.1007/s11481-006-9030-6; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Georgiou MF, 2008, J NUCL MED, V49, P1999, DOI 10.2967/jnumed.108.052688; Girault JA, 2004, ARCH NEUROL-CHICAGO, V61, P641, DOI 10.1001/archneur.61.5.641; Gorry PR, 2001, J VIROL, V75, P10073, DOI 10.1128/JVI.75.21.10073-10089.2001; Gorry PR, 2002, J VIROL, V76, P6277, DOI 10.1128/JVI.76.12.6277-6292.2002; GRACE AA, 1995, DRUG ALCOHOL DEPEN, V37, P111, DOI 10.1016/0376-8716(94)01066-T; Gray F, 1996, BRAIN PATHOL, V6, P1, DOI 10.1111/j.1750-3639.1996.tb00775.x; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Harmon B, 2008, J VIROL, V82, P9191, DOI 10.1128/JVI.00424-08; Hasbi A, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-26; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Hasko G, 2002, J NEUROIMMUNOL, V122, P34, DOI 10.1016/S0165-5728(01)00459-3; Hazleton JE, 2012, J IMMUNOL, V188, P4488, DOI 10.4049/jimmunol.1102482; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Himelhoch S, 2007, PSYCHIAT SERV, V58, P1165, DOI 10.1176/appi.ps.58.9.1165; Hinkin CH, 2007, AIDS BEHAV, V11, P185, DOI 10.1007/s10461-006-9152-0; Horn A, 2013, J NEURAL TRANSM, V120, P1411, DOI 10.1007/s00702-013-1086-x; Hult B, 2008, INT REV PSYCHIATR, V20, P3, DOI 10.1080/09540260701862086; Itoh K, 2000, ACTA NEUROPATHOL, V99, P376, DOI 10.1007/s004010051139; Jiang CL, 2011, J VIROL, V85, P10669, DOI 10.1128/JVI.05249-11; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; Koppensteiner H, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-82; Koutsilieri E, 2001, J NEURAL TRANSM, V108, P767, DOI 10.1007/s007020170051; Kraft-Terry SD, 2009, NEURON, V64, P133, DOI 10.1016/j.neuron.2009.09.042; Kumar AM, 2011, J NEUROVIROL, V17, P26, DOI 10.1007/s13365-010-0003-4; Kumar AM, 2009, J NEUROVIROL, V15, P257, DOI 10.1080/13550280902973952; LARSSON M, 1991, J NEUROSCI RES, V28, P406, DOI 10.1002/jnr.490280313; Lee C, 2003, J LEUKOCYTE BIOL, V74, P676, DOI 10.1189/jlb.0503206; Lee T, 2014, SCIENCE, V344, P533, DOI 10.1126/science.1249380; Lewin SR, 1996, AIDS RES HUM RETROV, V12, P877, DOI 10.1089/aid.1996.12.877; Li WG, 2006, JAIDS-J ACQ IMM DEF, V43, P516; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; Lin Y, 2008, SYNAPSE, V62, P516, DOI 10.1002/syn.20517; Liu QH, 2000, P NATL ACAD SCI USA, V97, P4832, DOI 10.1073/pnas.090521697; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Marcondes MCG, 2010, AM J PATHOL, V177, P355, DOI 10.2353/ajpath.2010.090953; Martin-Garcia J, 2006, VIROLOGY, V346, P169, DOI 10.1016/j.virol.2005.10.031; Martinez D, 2007, AM J PSYCHIAT, V164, P622, DOI 10.1176/appi.ajp.164.4.622; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Meissner WG, 2011, NAT REV DRUG DISCOV, V10, P377, DOI 10.1038/nrd3430; Melar M, 2007, J VIROL, V81, P1773, DOI 10.1128/JVI.01316-06; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Moore DJ, 2012, AIDS CARE, V24, P1504, DOI 10.1080/09540121.2012.672718; Morner A, 1999, J VIROL, V73, P2343; Naif HM, 1997, J IMMUNOL, V158, P501; NAVIA BA, 1986, ANN NEUROL, V19, P517, DOI 10.1002/ana.410190602; Olive MF, 2013, SUBSTANCE ABUSE REHA, P29; Papakostas GI, 2006, EUR NEUROPSYCHOPHARM, V16, P391, DOI 10.1016/j.euroneuro.2005.12.002; Peters PJ, 2004, J VIROL, V78, P6915, DOI 10.1128/JVI.78.13.6915-6926.2004; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Purohit V, 2011, MOL NEUROBIOL, V44, P102, DOI 10.1007/s12035-011-8195-z; Rana S, 1997, J VIROL, V71, P3219, DOI 10.1128/JVI.71.4.3219-3227.1997; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; REYES MG, 1991, ACTA NEUROPATHOL, V82, P39, DOI 10.1007/BF00310921; Rice ME, 2011, NEUROSCIENCE, V198, P112, DOI 10.1016/j.neuroscience.2011.08.066; Rice ME, 2008, BRAIN RES REV, V58, P303, DOI 10.1016/j.brainresrev.2008.02.004; Rosen MI, 2013, AIDS BEHAV, V17, P142, DOI 10.1007/s10461-011-0124-7; Rosenberg SD, 2001, AM J PUBLIC HEALTH, V91, P31, DOI 10.2105/AJPH.91.1.31; Rottenberg DA, 1996, J NUCL MED, V37, P1133; ROTTENBERG DA, 1987, ANN NEUROL, V22, P700, DOI 10.1002/ana.410220605; Salimi H, 2012, J LEUKOC BIOL; Sardar AM, 1996, NEUROREPORT, V7, P910, DOI 10.1097/00001756-199603220-00015; Sartori E, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-166; Scheller C, 2010, J NEURAL TRANSM, V117, P699, DOI 10.1007/s00702-010-0415-6; Schnell G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002286; Seeman P, 1998, Adv Pharmacol, V42, P478; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Sozzani S, 1998, J EXP MED, V187, P439, DOI 10.1084/jem.187.3.439; Spudich S, 2011, J INFECT DIS, V204, P753, DOI 10.1093/infdis/jir387; Spuhler IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071615; STAMFORD JA, 1988, BRAIN RES, V448, P381, DOI 10.1016/0006-8993(88)91282-6; STEHNOBITTEL L, 1995, J BIOL CHEM, V270, P30068; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; SUNAHARA RK, 1991, NATURE, V350, P614, DOI 10.1038/350614a0; Takahashi K, 1996, ANN NEUROL, V39, P705, DOI 10.1002/ana.410390606; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Toll L, 1998, NIDA Res Monogr, V178, P440; Tozzi V, 2005, AIDS RES HUM RETROV, V21, P706, DOI 10.1089/aid.2005.21.706; Trueta C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00319; Tuttle DL, 1998, J VIROL, V72, P4962, DOI 10.1128/JVI.72.6.4962-4969.1998; Urban NBL, 2012, BIOL PSYCHIAT, V71, P677, DOI 10.1016/j.biopsych.2011.12.018; Urban NBL, 2010, BIOL PSYCHIAT, V68, P689, DOI 10.1016/j.biopsych.2010.06.005; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; VANGORP WG, 1992, J NEUROPSYCH CLIN N, V4, P280; Venton BJ, 2003, J NEUROCHEM, V87, P1284, DOI 10.1046/j.1471-4159.2003.02109.x; Verani A, 1998, J IMMUNOL, V161, P2084; Vizi ES, 2010, BRIT J PHARMACOL, V160, P785, DOI 10.1111/j.1476-5381.2009.00624.x; Volkow N D, 2001, J Neurosci, V21, pRC121; Volkow ND, 1997, NATURE, V386, P830, DOI 10.1038/386830a0; Volkow ND, 2012, J NEUROSCI, V32, P841, DOI 10.1523/JNEUROSCI.4461-11.2012; Volkow ND, 2012, ANNU REV PHARMACOL, V52, P321, DOI 10.1146/annurev-pharmtox-010611-134625; Volkow ND, 2011, P NATL ACAD SCI USA, V108, P15037, DOI 10.1073/pnas.1010654108; Wang JB, 2002, J INFECT DIS, V185, P885, DOI 10.1086/339522; Weber E, 2013, J NEUROVIROL, V19, P65, DOI 10.1007/s13365-012-0141-y; Wightman PAGRM, 1995, NEUROMETHODS, P349; Wightman RM, 2002, J NEUROCHEM, V82, P721, DOI 10.1046/j.1471-4159.2002.01005.x; Williams D.W, 2014, CURR HIV RES; Williams KC, 2002, ANNU REV NEUROSCI, V25, P537, DOI 10.1146/annurev.neuro.25.112701.142822; Williams KC, 2001, J EXP MED, V193, P905, DOI 10.1084/jem.193.8.905; Xi ZX, 2009, NEUROSCIENCE, V161, P392, DOI 10.1016/j.neuroscience.2009.03.060; Yadav A, 2009, J NEUROIMMUNE PHARM, V4, P430, DOI 10.1007/s11481-009-9174-2; Zachek MK, 2010, BIOSENS BIOELECTRON, V25, P1179, DOI 10.1016/j.bios.2009.10.008; Zhang LF, 2012, BIOL PSYCHIAT, V71, P184, DOI 10.1016/j.biopsych.2011.07.024	165	49	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108232	10.1371/journal.pone.0108232	http://dx.doi.org/10.1371/journal.pone.0108232			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268786	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700074
J	Tarantino, G; Costantini, S; Finelli, C; Capone, F; Guerriero, E; La Sala, N; Gioia, S; Castello, G				Tarantino, Giovanni; Costantini, Susan; Finelli, Carmine; Capone, Francesca; Guerriero, Eliana; La Sala, Nicolina; Gioia, Saverio; Castello, Giuseppe			Carotid Intima-Media Thickness Is Predicted by Combined Eotaxin Levels and Severity of Hepatic Steatosis at Ultrasonography in Obese Patients with Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; SMOOTH-MUSCLE-CELLS; INSULIN-RESISTANCE; METABOLIC SYNDROME; HEART-DISEASE; ATHEROSCLEROSIS; INFLAMMATION; ULTRASOUND; EXPRESSION; IDENTIFY	Background: Non-Alcoholic Fatty Liver Disease (NAFLD) is a distinct coronary artery disease (CAD) risk factor. The atherosclerotic process predisposing to CAD includes altered lipid profile and inflammatory processes. The available evidence suggests that increased circulating levels of eotaxin, an eosinophil chemoattractant cytokine implicated in allergic responses, are detected in the serum of patients with CAD. Relationships were sought between serum eotaxin on the one hand, and intima-media thickness-an early predictor of the atherosclerotic process, hepatic steatosis, arterial blood pressure values, as well as inflammation/immune markers and angiogenetic factors-on the other. Methods: Eighty obese patients with NAFLD, diagnosed at ultrasonography, without evident cytolysis, formed our study population. Anthropometric measures, metabolic profile, serum concentrations of interleukin-1 beta, C-reactive protein, interleukin-6, fibrinogen, ferritin, TNF-alpha, spleen size, vascular endothelial growth factor, platelet-derived growth factor-BB and heat shock protein-70 were evaluated. Results: Serum eotaxin concentrations were distinctly associated with TNF alpha, IL-6, IL-1 beta, VEGF and PDGF-BB levels but not with CRP, fibrinogen, heat shock protein-70 or spleen size. Among the metabolic and anthropometric parameters, a significant predictive power emerged when comparing eotaxin to insulin resistance, expressed as HOMA. NAFLD was distinctly associated with HOMA (P = 0.0005). Intima-media thickness was well predicted by both eotaxin levels and severity of NAFLD at ultrasonography, although no relation was detected between these last two variables. Discussion and Conclusion: A role for insulin resistance in mediating the interplay between eotaxin and other inflammation/immune parameters could be evidenced in the induction/maintenance of atherosclerosis of obese patients with NAFLD.	[Tarantino, Giovanni] Univ Naples Federico II, Dept Clin Med & Surg, Med Sch Naples, Naples, Italy; [Tarantino, Giovanni; Costantini, Susan; Capone, Francesca; Guerriero, Eliana; Castello, Giuseppe] IRCCS, Ist Nazl Studio & Cura Tumori, Fdn Giovanni Pascale, Ctr Ric Oncol Mercogliano, Mercogliano, Italy; [Finelli, Carmine; La Sala, Nicolina; Gioia, Saverio] Stella Maris Mediterraneum Fdn, Ctr Obes & Eating Disorders, Potenza, Italy	University of Naples Federico II; IRCCS Fondazione Pascale; IRCCS Fondazione Stella Maris	Tarantino, G (corresponding author), Univ Naples Federico II, Dept Clin Med & Surg, Med Sch Naples, Naples, Italy.	tarantin@unina.it	Tarantino, Giovanni/AAW-2007-2021; Capone, Francesca/AAS-7458-2021; Costantini, Susan/J-9914-2018	Costantini, Susan/0000-0002-7538-4657; Capone, Francesca/0000-0002-5402-6228				Ardigo D, 2007, PHYSIOL GENOMICS, V31, P402, DOI 10.1152/physiolgenomics.00104.2007; Arellano-Garcia MT, 2008, ORAL DIS, V14, P705, DOI 10.1111/j.1601-0825.2008.01488.x; Barter P, 2011, ATHEROSCLEROSIS SUPP, V12, P267, DOI 10.1016/S1567-5688(11)70885-6; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; Bhagat K, 1999, CURR OPIN NEPHROL HY, V8, P89, DOI 10.1097/00041552-199901000-00014; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224; Emanuele E, 2006, ATHEROSCLEROSIS, V186, P140, DOI 10.1016/j.atherosclerosis.2005.07.002; Fathi R, 2001, AM HEART J, V141, P694, DOI 10.1067/mhj.2001.114972; Ghaffar O, 1999, AM J RESP CRIT CARE, V159, P1933, DOI 10.1164/ajrccm.159.6.9805039; Haley KJ, 2000, CIRCULATION, V102, P2185; Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x; HECKMATT JZ, 1982, J PEDIATR-US, V101, P656, DOI 10.1016/S0022-3476(82)80286-2; Heinonen SE, 2013, CARDIOVASC RES, V99, P716, DOI 10.1093/cvr/cvt148; Jeevarethinam A, 2014, ANGIOLOGY       0226; Ledee N, 2010, J REPROD IMMUNOL, V86, P126, DOI 10.1016/j.jri.2010.05.003; Mohanraj L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055084; Nordestgaard BG, 2009, NUTR METAB CARDIOVAS, V19, P521, DOI 10.1016/j.numecd.2009.07.005; Pakala Rajbabu, 2002, Cardiovasc Radiat Med, V3, P95; Pillen S, 2008, MUSCLE NERVE, V37, P679, DOI 10.1002/mus.21015; Qi YX, 2011, P NATL ACAD SCI USA, V108, P1908, DOI 10.1073/pnas.1019219108; Rabol R, 2009, METABOLISM, V58, P1145, DOI 10.1016/j.metabol.2009.03.014; Rothenbacher D, 2006, ARTERIOSCL THROM VAS, V26, P194, DOI 10.1161/01.ATV.0000191633.52585.14; Savastano S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-136; Schroeder B, 2013, CAN J CARDIOL, V29, P1687, DOI 10.1016/j.cjca.2013.10.003; Shimabukuro M, 2013, J MED INVESTIG, V60, P1, DOI 10.2152/jmi.60.1; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Tarantino G, 2013, WORLD J GASTROENTERO, V19, P3375, DOI 10.3748/wjg.v19.i22.3375; Tarantino G, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-50; Tarantino G, 2011, WORLD J GASTROENTERO, V17, P3785, DOI 10.3748/wjg.v17.i33.3785; Tarantino G, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-6; Thompson RC, 2013, LANCET, V381, P1211, DOI 10.1016/S0140-6736(13)60598-X; Wang J, 2011, J CLIN INVEST, V121, P3564, DOI 10.1172/JCI46028; Wang L, 2013, ATHEROSCLEROSIS, V227, P267, DOI 10.1016/j.atherosclerosis.2013.01.039; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Wong ND, 2011, ATHEROSCLEROSIS, V214, P436, DOI 10.1016/j.atherosclerosis.2010.09.011; Xu JM, 2012, ENDOCR REV, V33, P71, DOI 10.1210/er.2011-0013	37	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e105610	10.1371/journal.pone.0105610	http://dx.doi.org/10.1371/journal.pone.0105610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268946	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700006
J	Van Rie, A; Clouse, K; Hanrahan, C; Selibas, K; Sanne, I; Williams, S; Kim, P; Bassett, J				Van Rie, Annelies; Clouse, Kate; Hanrahan, Colleen; Selibas, Katerina; Sanne, Ian; Williams, Sharon; Kim, Peter; Bassett, Jean			High Uptake of Systematic HIV Counseling and Testing and TB Symptom Screening at a Primary Care Clinic in South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; TUBERCULOSIS-CONTROL; PREVALENCE; FACILITIES; DIAGNOSIS; COMMUNITY	Background: Timely diagnosis and treatment of tuberculosis (TB) and HIV is important to reduce morbidity and mortality, and break the cycle of ongoing transmission. Methods: We performed an implementation research study to develop a model for systematic TB symptom screening and HIV counseling and testing (HCT) for all adult clients at a primary care clinic and prospectively evaluate the 6-month coverage and yield, and 18-month sustainability at a primary care clinic in Johannesburg, South Africa. Results: During the first 6 months, 26,515 visits occurred among 12,078 adults. The proportion of adults aware of their HIV status was 43.7% at the start of the first visit, increased to 84.6% at the end of the first visit, and to 90% at end of any visit during the first 6 months. During these 6 months, 1042 clients were newly diagnosed with HIV. HIV prevalence was 22.9% among those newly tested, and 58.9% among all adult clinic clients. High coverage of systematic HCT was sustained across all 18 months. Coverage of systematic HIV-stratified TB symptom screening during first 6-months was also high (89.6%) but only 35.0% of those symptomatic were screened by sputum. During these 6-months, 90 clients had a positive Xpert MTB/RIF assay, corresponding to a TB prevalence of 0.4% among all 23,534 clients TB symptom-screened and 2.8% among the 3,284 clients with a positive TB symptom screen. The initial high coverage of TB symptom screening was not sustained, with coverage of TB symptom screening dropping after the first six months to 70% and assessment by sputum dropping to 15%. Conclusion: Routine, systematic HCT and HIV-stratified TB symptom screening is feasible at primary care level. Systematic HCT doubled the proportion of clients with known HIV status. While HCT was sustainable, coverage of systematic TB screening dropped significantly after the first 6 months of implementation.	[Van Rie, Annelies; Clouse, Kate; Hanrahan, Colleen] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Selibas, Katerina; Sanne, Ian] Univ Witwatersrand, Clin HIV Res Unit, Johannesburg, South Africa; [Williams, Sharon; Kim, Peter] NIAID, NIH, Bethesda, MD 20892 USA; [Bassett, Jean] Witkoppen Hlth & Welf Ctr, Johannesburg, South Africa	University of North Carolina; University of North Carolina Chapel Hill; University of Witwatersrand; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Van Rie, A (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.	Vanrie@email.unc.edu	Sanne, Ian/ABH-2231-2020; Van Rie, Annelies/C-2082-2017	Van Rie, Annelies/0000-0001-7666-3263; Clouse, Kate/0000-0002-0190-7398; Hanrahan, Colleen/0000-0002-4544-4591	PEPFAR; National Institutes of Health [UM1 AI069463]; United States Agency for International Development [674-A-00-08-00007, 674-A-12-00020]; Welfare Center [674-A-12-00033]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069463, UM1AI069463] Funding Source: NIH RePORTER	PEPFAR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Agency for International Development(United States Agency for International Development (USAID)); Welfare Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by PEPFAR and the National Institutes of Health grant UM1 AI069463, and by the United States Agency for International Development grants to Right to Care: 674-A-00-08-00007 and 674-A-12-00020, and to Witkoppen Health and Welfare Center: 674-A-12-00033. The funders had no role in data collection, analysis, or decision to publish.	[Anonymous], GUID INT TUB CAS FIN; Ayles H, 2013, LANCET; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Bassett IV, 2010, CLIN INFECT DIS, V51, P823, DOI 10.1086/656282; Bloss E, 2012, INT J TUBERC LUNG D, V16, P1030, DOI 10.5588/ijtld.11.0736; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Claassens MM, 2013, INT J TUBERC LUNG D, V17, P608, DOI 10.5588/ijtld.12.0506; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; De Wet T., 2008, JOHANNESBURG POVERTY; Fetene NW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-362; Health SANDo, 2012, NAT ANT SENT HIV SYP; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Kranzer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001281; Roura M, 2013, AIDS, V27, P617, DOI 10.1097/QAD.0b013e32835b7048; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; UNAIDS, 2012, REP GLOB AIDS EP; Uplekar M, 2013, INT J TUBERC LUNG D, V17, P1248, DOI 10.5588/ijtld.13.0199; Voss De Lima YP-S, 2010, ROUTINE SCREENING TB, pS111; WHO, 2012, WHOINTTB20129; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organization, 2007, GUID PROV IN HIV TES; World Health Organization, 2021, 10 THREATS GLOB HLTH	23	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e105428	10.1371/journal.pone.0105428	http://dx.doi.org/10.1371/journal.pone.0105428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268851	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700005
J	Dawson, A; Tran, NT; Westley, E; Mangiaterra, V; Festin, M				Dawson, Angela; Nguyen-Toan Tran; Westley, Elizabeth; Mangiaterra, Viviana; Festin, Mario			Improving Access to Emergency Contraception Pills through Strengthening Service Delivery and Demand Generation: A Systematic Review of Current Evidence in Low and Middle-Income Countries	PLOS ONE			English	Review							REPRODUCTIVE HEALTH; INJECTABLE CONTRACEPTIVES; UNINTENDED PREGNANCY; SCALING-UP; PROVISION; ABORTION; TRENDS	Objectives: Emergency contraception pills (ECP) are among the 13 essential commodities in the framework for action established by the UN Commission on Life-Saving Commodities for Women and Children. Despite having been on the market for nearly 20 years, a number of barriers still limit women's access to ECP in low-and middle-income countries (LMIC) including limited consumer knowledge and poor availability. This paper reports the results of a review to synthesise the current evidence on service delivery strategies to improve access to ECP. Methods: A narrative synthesis methodology was used to examine peer reviewed research literature (2003 to 2013) from diverse methodological traditions to provide critical insights into strategies to improve access from a service delivery perspective. The studies were appraised using established scoring systems and the findings of included papers thematically analysed and patterns mapped across all findings using concept mapping. Findings: Ten papers were included in the review. Despite limited research of adequate quality, promising strategies to improve access were identified including: advance provision of ECP; task shifting and sharing; intersectoral collaboration for sexual assault; m-health for information provision; and scale up through national family planning programs. Conclusion: There are a number of gaps in the research concerning service delivery and ECP in LMIC. These include a lack of knowledge concerning private/commercial sector contributions to improving access, the needs of vulnerable groups of women, approaches to enhancing intersectoral collaboration, evidence for social marketing models and investment cases for ECP.	[Dawson, Angela] Univ Technol Sydney, World Hlth Org, Collaborating Ctr Nursing Midwifery & Hlth Dev, Fac Hlth, Sydney, NSW 2007, Australia; [Nguyen-Toan Tran] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Westley, Elizabeth] Int Consortium Emergency Contracept, New York, NY USA; [Mangiaterra, Viviana] Global Fund Fight AIDS TB & Malaria, RMNCH & HSS Tech Advice & Partnerships Dept, Vernier Geneva, Switzerland; [Festin, Mario] World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland	University of Technology Sydney; World Health Organization; University of New South Wales Sydney; World Health Organization	Dawson, A (corresponding author), Univ Technol Sydney, World Hlth Org, Collaborating Ctr Nursing Midwifery & Hlth Dev, Fac Hlth, Sydney, NSW 2007, Australia.	angela.dawson@uts.edu.au	Festin, Mario Philip/GQQ-9749-2022; Dawson, Angela/A-6872-2011	Dawson, Angela/0000-0003-0926-2202; Tran, Nguyen-Toan/0000-0001-7134-7878; MANGIATERRA, VIVIANA/0000-0002-8815-0841	WHO Department of Reproductive Health and Research	WHO Department of Reproductive Health and Research	This study was funded by WHO Department of Reproductive Health and Research on behalf of the Technical Resource Team for Emergency Contraceptive Pills of the United Nations Commission on Life-Saving Commodities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2006, HUM REPROD, V21, P272, DOI 10.1093/humrep/dei287; Arai L., 2007, EVID POLICY, V3, P361, DOI DOI 10.1332/174426407781738029; Awoonor-Williams JK, 2013, GLOB HEALTH-SCI PRAC, V1, P117, DOI 10.9745/GHSP-D-12-00012; Centre for Reviews and Disssemination, 2008, SYSTEMATIC REV CRDS; Cooper H., 2009, HDB RES SYNTHESIS; Curry L, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-39; d'Arcangues CM, 2013, EUROPEAN J CONTRACEP, V0, P1; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Fernandez-Cerdeno A, 2009, POPULATION REV, V48; Frost L, 2013, DO GOOD HLTH TECHNOL; Gertler PJ, 2011, IMPACT EVALUATION IN PRACTICE, P1, DOI 10.1596/978-0-8213-8541-8; Gulliford Martin, 2002, J Health Serv Res Policy, V7, P186, DOI 10.1258/135581902760082517; Heimburger A, 2003, REPROD HEALTH MATTER, V11, P150, DOI 10.1016/S0968-8080(03)02172-4; Hoke TH, 2012, HEALTH POLICY PLANN, V27, P52, DOI 10.1093/heapol/czr003; ICEC, 2006, PARTN PROV EC ACC SE; ICEC, 2013, UNF AG NEXT STEPS IN; Jackson RA, 2003, OBSTET GYNECOL, V102, P8, DOI 10.1016/S0029-7844(03)00478-2; Janovsky K, 2006, WHOEPIHEALTHSYSTEMS2; Kassa M., 2009, ETHIOPIAN J REPROD H, V3, P24; Keesbury J, 2007, POPULATION COUNCIL E; Keesbury J, 2009, COPPERBELT MODEL INT; Keesbury J, 2009, ETHIOPIAN J REPROD H, V3, P4; Kennedy CE, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-26; Khan ME, 2008, SITUATION ANAL CARE; Khan ME, 2008, FRONTIERS REPROD HLT; Khan ME, 2008, INTRO SCALING DELIVE; Kumar S, 2007, PROVISION EMERGENCY; L'Engle KL, 2013, CONTRACEPTION, V87, P251, DOI 10.1016/j.contraception.2012.07.009; Lucas PJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-4; Mahmood A, 2012, INTRO EMERGENCY CONT; Marek T., 2005, TRENDS OPPORTUNITIES; Mbizvo MT, 2010, INT J GYNECOL OBSTET, V110, pS3, DOI 10.1016/j.ijgo.2010.04.001; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nations U., 2012, COMMISSION LIFE SAVI; Ngo AD, 2009, SOC MARK Q, V15, P71, DOI 10.1080/15245000802632417; NHS, 2006, CRIT APPR SKILLS PRO; Ononge Samuel, 2005, Afr Health Sci, V5, P50; Parker C., 2005, ADOLESCENTS EMERGENC; Patouillard Edith, 2007, Int J Equity Health, V6, P17, DOI 10.1186/1475-9276-6-17; Peters DH, 2004, HEALTH POLICY PLANN, V19, pI5, DOI 10.1093/heapol/czh041; Peters DH, 2009, DIR DEV, P1, DOI 10.1596/978-0-8213-7888-5; Pluye P, 2009, INT J NURS STUD, V46, P529, DOI 10.1016/j.ijnurstu.2009.01.009; Popay J, 2005, J EPIDEMIOLOLGY COMM, V59; Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, 2012, WORLD POP PROSP 2012; Prata N, 2011, B WORLD HEALTH ORGAN, V89, P556, DOI 10.2471/BLT.11.086710; Raine TR, 2005, JAMA-J AM MED ASSOC, V293, P54, DOI 10.1001/jama.293.1.54; Rodgers M., 2009, EVALUATION-US, V15, P49, DOI [10.1177/1356389008097871, DOI 10.1177/1356389008097871]; Rutta Edmund, 2009, Prog Community Health Partnersh, V3, P145, DOI 10.1353/cpr.0.0063; Sedgh G, 2007, LANCET, V370, P1338, DOI 10.1016/S0140-6736(07)61575-X; Shrestha MP, 2008, STRENGTHENING EMERGE; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; Tyndall, 2010, THE AACODS CHECKLIST; UN, 2013, TECHN REF TEAM COMM; Walsh TL, 2006, CONTRACEPTION, V74, P110, DOI 10.1016/j.contraception.2006.02.005; Westley E, 2013, INT J GYNECOL OBSTET, V123, P4, DOI 10.1016/j.ijgo.2013.04.019; WHO, 2013, HLTH SYST; WHO, 2004, MAT MORT 2000 EST DE; WHO/EMRO, 2006, STRAT DIR PROM AD HL; WHO/UNFPA/UNAIDS/FHI, 2011, TCU380A INTR CONTR D; World Health Organization, 2004, EQ ACC ESS MED FRAM	61	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109315	10.1371/journal.pone.0109315	http://dx.doi.org/10.1371/journal.pone.0109315			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6XC	25285438	Green Published, gold			2022-12-27	WOS:000345743700058
J	Lind, M; Tuomilehto, J; Uusitupa, M; Nerman, O; Eriksson, J; Ilanne-Parikka, P; Keinanen-Kiukaanniemi, S; Peltonen, M; Pivodic, A; Lindstrom, J				Lind, Marcus; Tuomilehto, Jaakko; Uusitupa, Matti; Nerman, Olle; Eriksson, Johan; Ilanne-Parikka, Pirjo; Keinanen-Kiukaanniemi, Sirkka; Peltonen, Markku; Pivodic, Aldina; Lindstrom, Jaana			The Association between HbA1c, Fasting Glucose, 1-Hour Glucose and 2-Hour Glucose during an Oral Glucose Tolerance Test and Cardiovascular Disease in Individuals with Elevated Risk for Diabetes	PLOS ONE			English	Article							LIFE-STYLE; ALL-CAUSE; PREVENTION; MORTALITY; HYPERGLYCEMIA; INSULIN; GLYCEMIA; MELLITUS; BASAL	Objective: To determine the association between HbA1c, fasting plasma glucose (FPG), 1-hour (1 hPG) and 2-hour (2 hPG) glucose after an oral glucose tolerance test (OGTT) and cardiovascular disease in individuals with elevated risk for diabetes. Design: We studied the relationship between baseline, updated mean and updated (last) value of HbA1c, FPG, 1 hPG and 2 hPG after an oral 75 g glucose tolerance test (OGTT) and acute CVD events in 504 individuals with impaired glucose tolerance (IGT) at baseline enrolled in the Finnish Diabetes Prevention Study. Settings: Follow-up of clinical trial. Participants: 504 individuals with IGT were followed with yearly evaluations with OGTT, FPG and HbA1c. Main Outcome Measure: Relative risk of CVD. Results: Over a median follow-up of 9.0 years 34 (6.7%) participants had a CVD event, which increased to 52 (10.3%) over a median follow-up of 13.0 years when including events that occurred among participants following a diagnosis of diabetes. Updated mean HbA1c, 1 hPG and 2 hPG, HR per 1 unit SD of 1.57 (95% CI 1.16 to 2.11), p = 0.0032, 1.51 (1.03 to 2.23), p = 0.036 and 1.60 (1.10 to 2.34), p = 0.014, respectively, but not FPG (p = 0.11), were related to CVD. In analyses of the last value prior to the CVD event the same three glycaemic measurements were associated with the CVD events, with HRs per 1 unit SD of 1.45 (1.06 to 1.98), p = 0.020, 1.55 (1.04 to 2.29), p = 0.030 and 2.19 (1.51 to 3.18), p < 0.0001, respectively but only 2 hPG remained significant in pairwise comparisons. Including the follow-up period after diabetes onset updated 2 hPG (p = 0.003) but not updated mean HbA1c (p = 0.08) was related to CVD. Conclusions and Relevance: Current 2 hPG level in people with IGT is associated with increased risk of CVD. This supports its use in screening for prediabetes and monitoring glycaemic levels of people with prediabetes.	[Lind, Marcus] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko; Peltonen, Markku; Lindstrom, Jaana] Natl Inst Hlth & Welf, Helsinki, Finland; [Tuomilehto, Jaakko] King Abdulizaz Univ, Jeddah, Saudi Arabia; [Uusitupa, Matti] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Uusitupa, Matti] Kuopio Univ Hosp, Res Unit, SF-70210 Kuopio, Finland; [Nerman, Olle] Univ Gothenburg, Chalmers Univ Technol, Gothenburg, Sweden; [Eriksson, Johan] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Eriksson, Johan] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Finland Vasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Ilanne-Parikka, Pirjo] Finnish Diabet Assoc, Tampere, Finland; [Keinanen-Kiukaanniemi, Sirkka] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Keinanen-Kiukaanniemi, Sirkka] Oulu Univ Hosp, Unit Gen Practice, Oulu, Finland; [Pivodic, Aldina] Stat Konsultgrp, Gothenburg, Sweden	University of Gothenburg; Danube University Krems; Finland National Institute for Health & Welfare; King Abdulaziz University; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Chalmers University of Technology; University of Gothenburg; Finland National Institute for Health & Welfare; University of Helsinki; Vaasa Central Hospital; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Oulu	Lind, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden.	lind.marcus@telia.com	Lind, Marcus/AAI-6733-2021; Uusitupa, Matti Ilmari Julius/AAX-4929-2020; Peltonen, Markku/F-3037-2015; Lind, Marcus/GRJ-4946-2022	Peltonen, Markku/0000-0002-3767-4223; Eriksson, Johan/0000-0002-2516-2060; Lind, Marcus/0000-0002-3796-9283; Lindstrom, Jaana/0000-0001-9255-020X	Academy of Finland; AstraZeneca; Novonordisk Scandinavia; Ministry of Education; Novo Nordisk Foundation; Yrjo Jahnsson Foundation; Juho Vainio Foundation; Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Tampere Hospital; Kuopio Hospital; Oulu University Hospital	Academy of Finland(Academy of Finland); AstraZeneca(AstraZeneca); Novonordisk Scandinavia(Novo Nordisk); Ministry of Education; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Yrjo Jahnsson Foundation; Juho Vainio Foundation; Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Tampere Hospital; Kuopio Hospital; Oulu University Hospital	The current DPS analysis has been financially supported by the Academy of Finland, an unrestricted grant from AstraZeneca, an unrestricted grant from Novonordisk Scandinavia, Ministry of Education, Novo Nordisk Foundation, Yrjo Jahnsson Foundation, Juho Vainio Foundation, Finnish Diabetes Research Foundation, Finnish Foundation for Cardiovascular Research, and Competitive Research Funding from Tampere, Kuopio, and Oulu University Hospitals. The funders had no role in the design of the study, analysis of results, or the decision to submit the report.	Barr ELM, 2009, DIABETOLOGIA, V52, P415, DOI 10.1007/s00125-008-1246-y; Borch-Johnsen K, 1999, LANCET, V354, P617; Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486; Costa B, 2011, DIABETIC MED, V28, P1234, DOI 10.1111/j.1464-5491.2011.03304.x; de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lind M, 2008, DIABETES METAB SYND, V2, P282, DOI 10.1016/j.dsx.2008.04.006; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; Monnier L, 2006, DIABETES METAB, V32; Pajunen P, 2011, DIABETIC MED, V28, P36, DOI 10.1111/j.1464-5491.2010.03183.x; Park S, 1996, DIABETES CARE, V19, P450, DOI 10.2337/diacare.19.5.450; PARMAR M, 1995, SURVIVAL ANAL PRACTI; Qiao Q, 2004, J CLIN EPIDEMIOL, V57, P590, DOI 10.1016/j.jclinepi.2003.10.007; Qiao Q, 2003, DIABETES CARE, V26, P2910, DOI 10.2337/diacare.26.10.2910; Qiao Q, 2003, DIABETES CARE, V26, P688; Riddle M, 2011, DIABETES CARE, V34, P2508, DOI 10.2337/dc11-0632; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Saito T, 2011, ARCH INTERN MED, V171, P1352, DOI 10.1001/archinternmed.2011.275; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Uusitupa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005656; UUSITUPA MIJ, 1993, DIABETOLOGIA, V36, P1175, DOI 10.1007/BF00401063; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029	29	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109506	10.1371/journal.pone.0109506	http://dx.doi.org/10.1371/journal.pone.0109506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285769	Green Submitted, Green Published, gold			2022-12-27	WOS:000345743700070
J	Barbano, R; Palumbo, O; Pasculli, B; Galasso, M; Volinia, S; D'Angelo, V; Icolaro, N; Coco, M; Dimitri, L; Graziano, P; Copetti, M; Valori, VM; Maiello, E; Carella, M; Fazio, VM; Parrella, P				Barbano, Raffaela; Palumbo, Orazio; Pasculli, Barbara; Galasso, Marco; Volinia, Stefano; D'Angelo, Vincenzo; Icolaro, Nadia; Coco, Michelina; Dimitri, Lucia; Graziano, Paolo; Copetti, Massimiliano; Valori, Vanna Maria; Maiello, Evaristo; Carella, Massimo; Fazio, Vito Michele; Parrella, Paola			A MiRNA Signature for Defining Aggressive Phenotype and Prognosis in Gliomas	PLOS ONE			English	Article							HYPOXIA; EXPRESSION; MIR-210; CANCER	Gliomas represent a disparate group of tumours for which there are to date no cure. Thus, there is a recognized need for new diagnostic and therapeutic approaches based on increased understanding of their molecular nature. We performed the comparison of the microRNA (miRNA) profile of 8 WHO grade II gliomas and 24 higher grade tumours (2 WHO grade III and 22 glioblastomas) by using the Affymetrix GeneChip miRNA Array v. 1.0. A relative quantification method (RT-qPCR) with standard curve was used to confirm the 22 miRNA signature resulted by array analysis. The prognostic performances of the confirmed miRNAs were estimated on the Tumor Cancer Genome Atlas (TCGA) datasets. We identified 22 miRNAs distinguishing grade II gliomas from higher grade tumours. RT-qPCR confirmed the differential expression in the two patients' groups for 13 out of the 22 miRNAs. The analysis of the Glioblastoma Multiforme (GBM) and Lower Grade Glioma (LGG) datasets from TCGA demonstrated the association with prognosis for 6 of those miRNAs. Moreover, in the GBM dataset miR-21 and miR-210 were predictors of worse prognosis in both univariable and multivariable Cox regression analyses (HR 1.19, p = 0.04, and HR 1.18, p = 0.029 respectively). Our results support a direct contribution of miRNAs to glioma cancerogenesis and suggest that miR-21 and miR-210 may play a role in the aggressive clinical behaviour of glioblastomas.	[Barbano, Raffaela; Coco, Michelina; Fazio, Vito Michele; Parrella, Paola] IRCCS Casa Sollievo Sofferenza, Lab Oncol, San Giovanni Rotondo, FG, Italy; [Palumbo, Orazio; Carella, Massimo] IRCCS Casa Sollievo Sofferenza, Genet Lab, San Giovanni Rotondo, FG, Italy; [Pasculli, Barbara] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Galasso, Marco; Volinia, Stefano] Univ Ferrara, Human Anat Branch, Dept Morphol Surg & Expt Med, LTTA, I-44100 Ferrara, Italy; [D'Angelo, Vincenzo; Icolaro, Nadia] IRCCS Casa Sollievo Sofferenza, Dept Neurosurg, San Giovanni Rotondo, FG, Italy; [Dimitri, Lucia; Graziano, Paolo] IRCCS Casa Sollievo Sofferenza, Dept Pathol, San Giovanni Rotondo, FG, Italy; [Copetti, Massimiliano] IRCCS Casa Sollievo Sofferenza, Unit Biostat, San Giovanni Rotondo, FG, Italy; [Valori, Vanna Maria; Maiello, Evaristo] IRCCS Casa Sollievo Sofferenza, Dept Oncol, San Giovanni Rotondo, FG, Italy; [Fazio, Vito Michele] Univ Campus Biomed, Lab Mol Med & Biotechnol, CIR, Rome, Italy	IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; Universita degli Studi di Bari Aldo Moro; University of Ferrara; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; University Campus Bio-Medico - Rome Italy	Parrella, P (corresponding author), IRCCS Casa Sollievo Sofferenza, Lab Oncol, San Giovanni Rotondo, FG, Italy.	pparrella@operapadrepio.it	Barbano, Raffaela/H-3640-2016; Volinia, Stefano/AAA-9264-2019; COPETTI, MASSIMILIANO/AAG-1473-2021; Copetti, Massimiliano/K-3186-2016; Volinia, Stefano/A-3029-2010; Fazio, Vito Michele VMF/H-3007-2016; PALUMBO, ORAZIO/C-1133-2014; Graziano, Paolo/AAC-9802-2022; Pasculli, Barbara/H-3646-2016; Parrella, Paola/D-8895-2011; Maiello, Evaristo/C-5224-2017; Galasso, Marco/K-2037-2016; Carella, Massimo/A-2804-2014	Barbano, Raffaela/0000-0002-4533-4157; Volinia, Stefano/0000-0003-0910-3893; COPETTI, MASSIMILIANO/0000-0002-7960-5947; Copetti, Massimiliano/0000-0002-7960-5947; Volinia, Stefano/0000-0003-0910-3893; Fazio, Vito Michele VMF/0000-0002-7751-1867; PALUMBO, ORAZIO/0000-0001-6583-3482; Graziano, Paolo/0000-0001-7066-7896; Pasculli, Barbara/0000-0002-3333-0255; Parrella, Paola/0000-0001-6031-9636; Maiello, Evaristo/0000-0003-3890-3435; Galasso, Marco/0000-0003-2655-4792; Carella, Massimo/0000-0002-6830-6829	Italian Ministry of Health; Associazione Italiana per la Ricerca sul Cancro [AIRC - IG13585]; Ministero dell'Istruzione, dell'Universita e della Ricerca Progetti di Ricerca di Interesse Nazionale; National Council of Research of Italy CNR EPIGEN grants	Italian Ministry of Health(Ministry of Health, Italy); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, dell'Universita e della Ricerca Progetti di Ricerca di Interesse Nazionale; National Council of Research of Italy CNR EPIGEN grants	Ricerca Corrente 2013 funding was granted by the Italian Ministry of Health. This work was also supported by "5x1000'' voluntary contributions, "Progetto Operativo Nazionale,''PON 2011-2014 VIRTUALAB (PON01_01297). S. V. is supported by Associazione Italiana per la Ricerca sul Cancro (AIRC - IG13585) and Ministero dell'Istruzione, dell'Universita e della Ricerca Progetti di Ricerca di Interesse Nazionale (PRIN 2010) and The National Council of Research of Italy CNR EPIGEN grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao B, 2012, BBA-REV CANCER, V1826, P272, DOI 10.1016/j.bbcan.2012.04.008; Bao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043726; Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193; Fasanaro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044651; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Galasso M, 2012, CANCER J, V18, P238, DOI 10.1097/PPO.0b013e318258b5f4; Gee HE, 2010, CANCER-AM CANCER SOC, V116, P2148, DOI 10.1002/cncr.25009; Hermansen SK, 2013, J NEURO-ONCOL, V111, P71, DOI 10.1007/s11060-012-0992-3; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim TM, 2011, CANCER RES, V71, P3387, DOI 10.1158/0008-5472.CAN-10-4117; Lages E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020600; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Muscarella LA, 2011, EPIGENETICS-US, V6, P317, DOI 10.4161/epi.6.3.14408; Nobusawa S, 2009, CLIN CANCER RES, V15, P6002, DOI 10.1158/1078-0432.CCR-09-0715; Parrella P, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-142; Parrella P, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/531692; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Weller M, 2011, GLIA, V59, P1200, DOI 10.1002/glia.21130; Zhang Z, 2009, CELL CYCLE, V8, P2756, DOI 10.4161/cc.8.17.9387	21	55	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108950	10.1371/journal.pone.0108950	http://dx.doi.org/10.1371/journal.pone.0108950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279461	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800041
J	Paavolainen, L; Acar, E; Tuna, U; Peltonen, S; Moriya, T; Soonsawad, P; Marjomaki, V; Cheng, RH; Ruotsalainen, U				Paavolainen, Lassi; Acar, Erman; Tuna, Uygar; Peltonen, Sari; Moriya, Toshio; Soonsawad, Pan; Marjomaki, Varpu; Cheng, R. Holland; Ruotsalainen, Ulla			Compensation of Missing Wedge Effects with Sequential Statistical Reconstruction in Electron Tomography	PLOS ONE			English	Article							IMAGE-RECONSTRUCTION; BAYESIAN-APPROACH; ALGORITHM; MAXIMUM	Electron tomography (ET) of biological samples is used to study the organization and the structure of the whole cell and subcellular complexes in great detail. However, projections cannot be acquired over full tilt angle range with biological samples in electron microscopy. ET image reconstruction can be considered an ill-posed problem because of this missing information. This results in artifacts, seen as the loss of three-dimensional (3D) resolution in the reconstructed images. The goal of this study was to achieve isotropic resolution with a statistical reconstruction method, sequential maximum a posteriori expectation maximization (sMAP-EM), using no prior morphological knowledge about the specimen. The missing wedge effects on sMAP-EM were examined with a synthetic cell phantom to assess the effects of noise. An experimental dataset of a multivesicular body was evaluated with a number of gold particles. An ellipsoid fitting based method was developed to realize the quantitative measures elongation and contrast in an automated, objective, and reliable way. The method statistically evaluates the sub-volumes containing gold particles randomly located in various parts of the whole volume, thus giving information about the robustness of the volume reconstruction. The quantitative results were also compared with reconstructions made with widely-used weighted backprojection and simultaneous iterative reconstruction technique methods. The results showed that the proposed sMAP-EM method significantly suppresses the effects of the missing information producing isotropic resolution. Furthermore, this method improves the contrast ratio, enhancing the applicability of further automatic and semi-automatic analysis. These improvements in ET reconstruction by sMAP-EM enable analysis of subcellular structures with higher three-dimensional resolution and contrast than conventional methods.	[Paavolainen, Lassi; Marjomaki, Varpu] Univ Jyvaskyla, Nanosci Ctr, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Acar, Erman; Tuna, Uygar; Peltonen, Sari; Moriya, Toshio; Ruotsalainen, Ulla] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Acar, Erman; Peltonen, Sari; Moriya, Toshio; Ruotsalainen, Ulla] Tampere Univ Technol, BioMediTech, FIN-33101 Tampere, Finland; [Soonsawad, Pan; Cheng, R. Holland] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Soonsawad, Pan] Mahidol Univ, Fac Dent, Dept Anat, Bangkok 10700, Thailand	University of Jyvaskyla; Tampere University; Tampere University; University of California System; University of California Davis; Mahidol University	Cheng, RH (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	rhch@ucdavis.edu; ulla.ruotsalainen@tut.fi	Ruotsalainen, Ulla/J-5678-2014; Cheng, Holland/A-8973-2008; Peltonen, Sari/C-9698-2016	Ruotsalainen, Ulla/0000-0001-7775-3412; Marjomaki, Varpu/0000-0002-4592-5926; Peltonen, Sari Susanna/0000-0003-0947-466X	National Institute of Health [AI095382]; National Institute of Food and Agriculture; Tekes FiDiPro [1913/31/2012]; Tampere University of Technology Internal Grant;  [UCDG178969]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Tekes FiDiPro(Finnish Funding Agency for Technology & Innovation (TEKES)); Tampere University of Technology Internal Grant; 	Funding provided by National Institute of Health (AI095382) http://www.nih.gov/, National Institute of Food and Agriculture http://www.csrees.usda.gov/, Tekes FiDiPro, (1913/31/2012) http://www.tekes.fi/en/fidipro/, Discovery Grant (UCDG178969) and Tampere University of Technology Internal Grant http://www.tut.fi/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganj L, 2007, I S BIOMED IMAGING, P217, DOI 10.1109/ISBI.2007.356827; Agulleiro JI, 2011, BIOINFORMATICS, V27, P582, DOI 10.1093/bioinformatics/btq692; Agulleiro JI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048261; Alenius S, 2002, IEEE T MED IMAGING, V21, P1413, DOI 10.1109/TMI.2002.806415; Bertalmio M, 2000, COMP GRAPH, P417, DOI 10.1145/344779.344972; Delaney AH, 1998, IEEE T IMAGE PROCESS, V7, P204, DOI 10.1109/83.660997; FESSLER JA, 1995, IEEE T IMAGE PROCESS, V4, P1417, DOI 10.1109/83.465106; Gopinath A, 2012, IEEE T MED IMAGING, V31, P2241, DOI 10.1109/TMI.2012.2214229; Goris B, 2012, ULTRAMICROSCOPY, V113, P120, DOI 10.1016/j.ultramic.2011.11.004; HANSON KM, 1983, J OPT SOC AM, V73, P1501, DOI 10.1364/JOSA.73.001501; HEBERT T, 1989, IEEE T MED IMAGING, V8, P194, DOI 10.1109/42.24868; HERMAN GT, 1979, INFORM CONTROL, V42, P60, DOI 10.1016/S0019-9958(79)90160-8; HERMAN GT, 1991, IEEE T MED IMAGING, V10, P336, DOI 10.1109/42.97583; HURWITZ H, 1975, PHYS REV A, V12, P698, DOI 10.1103/PhysRevA.12.698; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Koster AJ, 1997, J STRUCT BIOL, V120, P276, DOI 10.1006/jsbi.1997.3933; Lanzavecchia S, 2005, J STRUCT BIOL, V149, P87, DOI 10.1016/j.jsb.2004.09.004; Leary R, 2013, ULTRAMICROSCOPY, V131, P70, DOI 10.1016/j.ultramic.2013.03.019; LEVITAN E, 1987, IEEE T MED IMAGING, V6, P185, DOI 10.1109/TMI.1987.4307826; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Maiorca M, 2012, J STRUCT BIOL, V180, P132, DOI 10.1016/j.jsb.2012.05.019; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; McEwen BF, 2001, J HISTOCHEM CYTOCHEM, V49, P553, DOI 10.1177/002215540104900502; Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0; Orlov IM, 2006, J STRUCT BIOL, V154, P287, DOI 10.1016/j.jsb.2006.03.007; PENCZEK P, 1995, ULTRAMICROSCOPY, V60, P393, DOI 10.1016/0304-3991(95)00078-X; Penczek PA, 2010, METHOD ENZYMOL, V482, P1, DOI 10.1016/S0076-6879(10)82001-4; Radermacher M., 2006, ELECT TOMOGRAPHY MET, P245, DOI DOI 10.1007/978-0-387-69008-7_9; Shepp L A, 1982, IEEE Trans Med Imaging, V1, P113, DOI 10.1109/TMI.1982.4307558; Soonsawad P, 2010, J VIROL, V84, P11145, DOI 10.1128/JVI.00036-10; Tuna U, 2013, J PATTERN RECOGNITIO, V1, P54; van Velden FHP, 2008, IEEE T MED IMAGING, V27, P934, DOI 10.1109/TMI.2008.922702; Wolf D, 2014, ULTRAMICROSCOPY, V136, P15, DOI 10.1016/j.ultramic.2013.07.016; Xu W, 2010, J STRUCT BIOL, V171, P142, DOI 10.1016/j.jsb.2010.03.018; You JS, 2007, IEEE T NUCL SCI, V54, P1696, DOI 10.1109/TNS.2007.901198; Zurner A, 2012, ULTRAMICROSCOPY, V115, P41, DOI 10.1016/j.ultramic.2012.01.015	36	18	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108978	10.1371/journal.pone.0108978	http://dx.doi.org/10.1371/journal.pone.0108978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279759	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800044
J	Ruiz-Lafuente, N; Alcaraz-Garcia, MJ; Sebastian-Ruiz, S; Gomez-Espuch, J; Funes, C; Moraleda, JM; Garcia-Garay, MC; Montes-Barqueros, N; Minguela, A; Alvarez-Lopez, MR; Parrado, A				Ruiz-Lafuente, Natalia; Alcaraz-Garcia, Maria-Jose; Sebastian-Ruiz, Silvia; Gomez-Espuch, Joaquin; Funes, Consuelo; Moraleda, Jose-Maria; Garcia-Garay, Maria-Carmen; Montes-Barqueros, Natividad; Minguela, Alfredo; Alvarez-Lopez, Maria-Rocio; Parrado, Antonio			The Gene Expression Response of Chronic Lymphocytic Leukemia Cells to IL-4 Is Specific, Depends on ZAP-70 Status and Is Differentially Affected by an NF kappa B Inhibitor	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; RECEPTOR EXPRESSION; PROGNOSTIC MARKERS; ACTIVATION; APOPTOSIS; SURVIVAL; INTERLEUKIN-4; KINASE; IDENTIFICATION; MODULATION	Interleukin 4 (IL-4), an essential mediator of B cell development, plays a role in survival of chronic lymphocytic leukemia (CLL) cells. To obtain new insights into the function of the IL-4 pathway in CLL, we analyzed the gene expression response to IL-4 in CLL and in normal B cells (NBC) by oligonucleotide microarrays, resulting in the identification of 232 nonredundant entities in CLL and 146 in NBC (95 common, 283 altogether), of which 189 were well-defined genes in CLL and 123 in NBC (83 common, 229 altogether) (p<0.05, 2-fold cut-off). To the best of our knowledge, most of them were novel IL-4 targets for CLL (98%), B cells of any source (83%), or any cell type (70%). Responses were significantly higher for 54 and 11 genes in CLL and NBC compared to each other, respectively. In CLL, ZAP-70 status had an impact on IL-4 response, since different sets of IL-4 targets correlated positively or negatively with baseline expression of ZAP-70. In addition, the NF kappa B inhibitor 6-Amino-4-(4-phenoxyphenethylamino)quinazoline, which reversed the anti-apoptotic effect of IL-4, preferentially blocked the response of genes positively correlated with ZAP-70 (e.g. CCR2, SUSD2), but enhanced the response of genes negatively correlated with ZAP-70 (e.g. AUH, BCL6, LY75, NFIL3). Dissection of the gene expression response to IL-4 in CLL and NBC contributes to the understanding of the anti-apoptotic response. Initial evidence of a connection between ZAP-70 and NF kappa B supports further exploration of targeting NF kappa B in the context of the assessment of inhibition of the IL-4 pathway as a therapeutic strategy in CLL, especially in patients expressing bad prognostic markers.	[Ruiz-Lafuente, Natalia; Alcaraz-Garcia, Maria-Jose; Sebastian-Ruiz, Silvia; Montes-Barqueros, Natividad; Minguela, Alfredo; Alvarez-Lopez, Maria-Rocio; Parrado, Antonio] Univ Virgen Arrixaca, Hosp Clin, Serv Inmunol, Murcia, Spain; [Gomez-Espuch, Joaquin; Funes, Consuelo; Moraleda, Jose-Maria] Univ Virgen Arrixaca, Hosp Clin, Serv Hematol & Hemoterapia, Murcia, Spain; [Garcia-Garay, Maria-Carmen] Hosp Gen Univ Santa Lucia, Serv Hematol & Hemoterapia, Cartagena, Spain; [Moraleda, Jose-Maria] Univ Murcia, Murcia, Spain; [Minguela, Alfredo; Alvarez-Lopez, Maria-Rocio] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Murcia, Spain; [Ruiz-Lafuente, Natalia; Alcaraz-Garcia, Maria-Jose; Sebastian-Ruiz, Silvia; Gomez-Espuch, Joaquin; Funes, Consuelo; Moraleda, Jose-Maria; Montes-Barqueros, Natividad; Minguela, Alfredo; Alvarez-Lopez, Maria-Rocio; Parrado, Antonio] Inst Murciano Invest Biosanitaria Virgen Arrixaca, Murcia, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Clinico Universitario Virgen de la Arrixaca	Parrado, A (corresponding author), Univ Virgen Arrixaca, Hosp Clin, Serv Inmunol, Murcia, Spain.	antonio.parrado@carm.es	Moraleda, José María/AAB-4119-2020; Minguela, Alfredo/Q-9783-2019; Parrado, Antonio/K-9591-2014; García, Maria Jose Alcaraz/ABH-2338-2020; Ruiz-Lafuente, Natalia/R-5449-2019	Minguela, Alfredo/0000-0003-2472-5893; Parrado, Antonio/0000-0002-7660-018X; Ruiz-Lafuente, Natalia/0000-0003-4628-7038; Alcaraz/0000-0002-1057-0299	Plan Nacional de I+D+I; Programa de Promocion de la Investigacion Biomedica y en Ciencias de la Salud del Ministerio de Sanidad y Consumo [PI07/0135]; Accion Estrategica en Salud [PI10/01226]; European Regional Development Funds; II PCTRM; Fundacion Seneca; Agencia de Ciencia y Tecnologia de la Region de Murcia [08721/PI/08, 04487/GERM/06]; ISCIII Spanish Cell Therapy Network [RD06/0010/0023]; CIBERehd scientific program	Plan Nacional de I+D+I; Programa de Promocion de la Investigacion Biomedica y en Ciencias de la Salud del Ministerio de Sanidad y Consumo; Accion Estrategica en Salud; European Regional Development Funds(European Commission); II PCTRM; Fundacion Seneca(Fundacion Seneca); Agencia de Ciencia y Tecnologia de la Region de Murcia; ISCIII Spanish Cell Therapy Network; CIBERehd scientific program	This work was supported by grants from Plan Nacional de I+D+I 2004-2007, Programa de Promocion de la Investigacion Biomedica y en Ciencias de la Salud del Ministerio de Sanidad y Consumo (PI07/0135 to AP) and Plan Nacional de I+D+I 2008-2011, Accion Estrategica en Salud (PI10/01226 to AP) (Instituto de Salud Carlos III (ISCIII) co-financed with European Regional Development Funds, "Una manera de hacer Europa''), II PCTRM 2007-2010, Fundacion Seneca, Agencia de Ciencia y Tecnologia de la Region de Murcia (08721/PI/08 to AP, and 04487/GERM/06 to MRAL), ISCIII Spanish Cell Therapy Network (Tercel; RD06/0010/0023 to JMM), and the CIBERehd scientific program to MRAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya N, 2015, INT J CANCER, V136, P65, DOI 10.1002/ijc.28974; Burger JA, 2013, BLOOD, V121, P1501, DOI 10.1182/blood-2012-08-452607; Burgess M, 2012, LEUKEMIA LYMPHOMA, V53, P1988, DOI 10.3109/10428194.2012.672735; Calpe E, 2011, BLOOD, V118, P4401, DOI 10.1182/blood-2011-01-333682; Chen LG, 2008, BLOOD, V111, P2685, DOI 10.1182/blood-2006-12-062265; Chiorazzi N, 2012, HEMATOL-AM SOC HEMAT, P76, DOI 10.1182/asheducation-2012.1.76; Coscia M, 2011, LEUKEMIA, V25, P828, DOI 10.1038/leu.2011.12; Cosimo E, 2013, CLIN CANCER RES, V19, P2393, DOI 10.1158/1078-0432.CCR-12-2170; Cuni S, 2004, LEUKEMIA, V18, P1391, DOI 10.1038/sj.leu.2403398; DANCESCU M, 1992, J EXP MED, V176, P1319, DOI 10.1084/jem.176.5.1319; Douglas RS, 1997, BLOOD, V89, P941, DOI 10.1182/blood.V89.3.941; Durig J, 2003, BLOOD, V101, P2748, DOI 10.1182/blood-2002-09-2683; Early SB, 2007, AM J RESP CELL MOL, V36, P715, DOI 10.1165/rcmb.2006-0252OC; FINKELMAN FD, 1986, P NATL ACAD SCI USA, V83, P9675, DOI 10.1073/pnas.83.24.9675; Furman RR, 2000, J IMMUNOL, V164, P2200, DOI 10.4049/jimmunol.164.4.2200; Hewamana S, 2008, BLOOD, V111, P4681, DOI 10.1182/blood-2007-11-125278; Huang GN, 2008, SCIENCE, V319, P476, DOI 10.1126/science.1151227; Ikushima S, 1997, P NATL ACAD SCI USA, V94, P2609, DOI 10.1073/pnas.94.6.2609; Jelinek DF, 2003, MOL CANCER RES, V1, P346; Alcaraz-Garcia MJ, 2011, HUM IMMUNOL, V72, P531, DOI 10.1016/j.humimm.2011.03.024; Kaminski A, 1998, BLOOD, V92, P2188, DOI 10.1182/blood.V92.6.2188.splL5_2188_2189; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Lafarge ST, 2014, LEUKEMIA RES, V38, P109, DOI 10.1016/j.leukres.2013.08.001; Lopez-Guerra M, 2009, CLIN CANCER RES, V15, P2767, DOI 10.1158/1078-0432.CCR-08-2382; Lu XQ, 2005, BLOOD, V105, P2924, DOI 10.1182/blood-2004-10-3820; Mainou-Fowler T, 2001, LEUKEMIA LYMPHOMA, V42, P689, DOI 10.3109/10428190109099331; Messner B, 1997, J IMMUNOL, V159, P3330; Moskalev EA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-213; Okada H, 2003, CYTOKINE HDB, VI, P227; Pangault C, 2010, LEUKEMIA, V24, P2080, DOI 10.1038/leu.2010.223; Pickering BM, 2007, ONCOGENE, V26, P1166, DOI 10.1038/sj.onc.1209897; Rodriguez A, 2007, LEUKEMIA, V21, P1984, DOI 10.1038/sj.leu.2404831; Rong R, 2003, NAT NEUROSCI, V6, P1153, DOI 10.1038/nn1134; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Schroder AJ, 2002, J IMMUNOL, V168, P996, DOI 10.4049/jimmunol.168.3.996; Seifert M, 2012, J EXP MED, V209, P2183, DOI 10.1084/jem.20120833; Shen CH, 1998, MOL CELL BIOL, V18, P3395, DOI 10.1128/MCB.18.6.3395; Stamatopoulos B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012780; Stankovic T, 2004, BLOOD, V103, P291, DOI 10.1182/blood-2003-04-1161; Steele AJ, 2010, BLOOD, V116, P4569, DOI 10.1182/blood-2009-09-245811; Stratowa C, 2001, INT J CANCER, V91, P474, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1078>3.0.CO;2-C; Thieu VT, 2007, J LEUKOCYTE BIOL, V82, P370, DOI 10.1189/jlb.1106707; Tobe M, 2003, BIOORGAN MED CHEM, V11, P3869, DOI 10.1016/S0968-0896(03)00438-3; Wang J, 2004, BIOINFORMATICS, V20, P3166, DOI 10.1093/bioinformatics/bth381; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; Willimott S, 2007, BRIT J HAEMATOL, V138, P721, DOI 10.1111/j.1365-2141.2007.06717.x; Zamorano J, 2001, INT IMMUNOL, V13, P1479, DOI 10.1093/intimm/13.12.1479; Zheng Z, 2002, LEUKEMIA, V16, P2429, DOI 10.1038/sj.leu.2402711	50	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109533	10.1371/journal.pone.0109533	http://dx.doi.org/10.1371/journal.pone.0109533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25280001	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800088
J	Golomb, D				Golomb, David			Mechanism and Function of Mixed-Mode Oscillations in Vibrissa Motoneurons	PLOS ONE			English	Article							SUBTHRESHOLD OSCILLATIONS; DIFFERENTIAL ELECTRORESPONSIVENESS; RHYTHMIC WHISKING; IONIC MECHANISMS; SYNAPTIC INPUTS; STELLATE; NEURONS; RAT; FREQUENCY; CELLS	Vibrissa motoneurons in the facial nucleus innervate the intrinsic and extrinsic muscles that move the whiskers. Their intrinsic properties affect the way they process fast synaptic input from the vIRT and Botzinger nuclei together with serotonergic neuromodulation. In response to constant current (I-app) injection, vibrissa motoneurons may respond with mixed mode oscillations (MMOs), in which sub-threshold oscillations (STOs) are intermittently mixed with spikes. This study investigates the mechanisms involved in generating MMOs in vibrissa motoneurons and their function in motor control. It presents a conductance-based model that includes the M-type K+ conductance, g(M), the persistent Na+ conductance, g(NaP), and the cationic h conductance, g(h). For g(h) = 0 and moderate values of g(M) and g(NaP), the model neuron generates STOs, but not MMOs, in response to I-app injection. STOs transform abruptly to tonic spiking as the current increases. In addition to STOs, MMOs are generated for g(h) = 0 for larger values of I-app; the I-app range in which MMOs appear increases linearly with g(h). In the MMOs regime, the firing rate increases with I-app like a Devil's staircase. Stochastic noise disrupts the temporal structure of the MMOs, but for a moderate noise level, the coefficient of variation (CV) is much less than one and varies nonmonotonically with I-app. Furthermore, the estimated time period between voltage peaks, based on Bernoulli process statistics, is much higher in the MMOs regime than in the tonic regime. These two phenomena do not appear when moderate noise generates MMOs without an intrinsic MMO mechanism. Therefore, and since STOs do not appear in spinal motoneurons, the analysis can be used to differentiate different MMOs mechanisms. MMO firing activity in vibrissa motoneurons suggests a scenario in which moderate periodic inputs from the vIRT and Botzinger nuclei control whisking frequency, whereas serotonergic neuromodulation controls whisking amplitude.	[Golomb, David] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, Dept Phys, Beer Sheva, Israel; [Golomb, David] Ben Gurion Univ Negev, Fac Hlth Sci, Zlotowski Ctr Neurosci, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Golomb, D (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, Dept Phys, Beer Sheva, Israel.	golomb@bgu.ac.il		Golomb, David/0000-0001-6575-3685	Israel Science Foundation [88/13]	Israel Science Foundation(Israel Science Foundation)	This research was supported by the Israel Science Foundation (grant No. 88/13), http://www.isf.org.il. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; Brons M, 2008, CHAOS, V18, DOI 10.1063/1.2903177; Cramer NP, 2007, J NEUROPHYSIOL, V97, P2148, DOI 10.1152/jn.01187.2006; Cramer NP, 2006, J NEUROPHYSIOL, V96, P209, DOI 10.1152/jn.00071.2006; Dickson CT, 2000, J NEUROPHYSIOL, V83, P2562, DOI 10.1152/jn.2000.83.5.2562; DORFL J, 1982, J ANAT, V135, P147; Dorval AD, 2005, J NEUROSCI, V25, P10025, DOI 10.1523/JNEUROSCI.3557-05.2005; Dudman JT, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000290; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Ermentrout B, 2009, SIAM J APPL DYN SYST, V8, P253, DOI 10.1137/080724010; Fransen E, 2004, HIPPOCAMPUS, V14, P368, DOI 10.1002/hipo.10198; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; Golomb D, 2000, NEURAL COMPUT, V12, P1095, DOI 10.1162/089976600300015529; Golomb D, 1998, J NEUROPHYSIOL, V79, P1; Golomb D, 2007, PLOS COMPUT BIOL, V3, P1498, DOI 10.1371/journal.pcbi.0030156; Grant RA, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00039; Guckenheimer J, 2013, APPL MATH SCI, V42; GUTFREUND Y, 1995, J PHYSIOL-LONDON, V483, P621, DOI 10.1113/jphysiol.1995.sp020611; Haidarliu S, 2010, ANAT REC, V293, P1192, DOI 10.1002/ar.21156; Harish O, 2010, J NEUROPHYSIOL, V103, P2684, DOI 10.1152/jn.01016.2009; Hattox A, 2003, NEURON, V39, P343, DOI 10.1016/S0896-6273(03)00391-X; Hattox AM, 2002, J COMP NEUROL, V442, P266, DOI 10.1002/cne.10089; Herfst LJ, 2008, J NEUROPHYSIOL, V99, P2821, DOI 10.1152/jn.01014.2007; Hill DN, 2008, J NEUROSCI, V28, P3438, DOI 10.1523/JNEUROSCI.5008-07.2008; HODGKIN AL, 1948, J PHYSIOL-LONDON, V107, P165, DOI 10.1113/jphysiol.1948.sp004260; Iglesias C, 2011, J NEUROSCI, V31, P5829, DOI 10.1523/JNEUROSCI.6363-10.2011; Kleinfeld D, 2014, NAT NEUROSCI, V17, P647, DOI 10.1038/nn.3693; KLINK R, 1993, J NEUROPHYSIOL, V70, P144, DOI 10.1152/jn.1993.70.1.144; LLINAS RR, 1991, P NATL ACAD SCI USA, V88, P897, DOI 10.1073/pnas.88.3.897; Manuel M, 2009, J NEUROSCI, V29, P11246, DOI 10.1523/JNEUROSCI.3260-09.2009; Moore JD, 2013, NATURE, V497, P205, DOI 10.1038/nature12076; Nguyen QT, 2004, J PHYSIOL-LONDON, V556, P203, DOI 10.1113/jphysiol.2003.060087; Nguyen QT, 2005, NEURON, V45, P447, DOI 10.1016/j.neuron.2004.12.042; Pietr MD, 2010, J NEUROPHYSIOL, V104, P2532, DOI 10.1152/jn.01039.2009; Pikovsky A., 2007, SCHOLARPEDIA, V2, P1459, DOI [10.4249/scholarpedia.1459, DOI 10.4249/SCHOLARPEDIA.1459]; Prescott SA, 2008, J NEUROSCI, V28, P13649, DOI 10.1523/JNEUROSCI.1792-08.2008; Press W. H., 1992, ART SCI COMPUTING; Rinzel J., 1998, METHODS NEURONAL MOD, V2, P251; Rotstein HG, 2008, SIAM J APPL DYN SYST, V7, P1582, DOI 10.1137/070699093; Rubin J, 2007, BIOL CYBERN, V97, P5, DOI 10.1007/s00422-007-0153-5; Schneidman E, 1998, NEURAL COMPUT, V10, P1679, DOI 10.1162/089976698300017089; Simon A, 2005, J NEUROSCI, V25, P6278, DOI 10.1523/JNEUROSCI.1431-05.2005; Simony E., 2011, Society for Neuroscience Abstract Viewer and Itinerary Planner, V41; Simony E, 2010, J NEUROSCI, V30, P8935, DOI 10.1523/JNEUROSCI.0172-10.2010; Terrell G.R., 1999, MATH STAT UNIFIED IN; Towal RB, 2006, J NEUROSCI, V26, P8838, DOI 10.1523/JNEUROSCI.0581-06.2006; Turkin VV, 2010, J NEUROPHYSIOL, V104, P1549, DOI 10.1152/jn.00379.2010; WANG XJ, 1993, NEUROREPORT, V5, P221, DOI 10.1097/00001756-199312000-00008; Wechselberger M, 2005, SIAM J APPL DYN SYST, V4, P101, DOI 10.1137/030601995; WECHSELBERGER M., 2007, SCHOLARPEDIA, V2, P1356, DOI [10.4249/scholarpedia.1356, DOI 10.4249/SCHOLARPEDIA.1356, DOI 10.4249/SCH0LARPEDIA.1356]; Yarom Y, 2011, PHYSIOL REV, V91, P917, DOI 10.1152/physrev.00019.2010	53	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109205	10.1371/journal.pone.0109205	http://dx.doi.org/10.1371/journal.pone.0109205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275462	Green Submitted, Green Published, gold			2022-12-27	WOS:000342591500074
J	Warta, R; Theile, D; Mogler, C; Herpel, E; Grabe, N; Lahrmann, B; Plinkert, PK; Herold-Mende, C; Weiss, J; Dyckhoff, G				Warta, Rolf; Theile, Dirk; Mogler, Carolin; Herpel, Esther; Grabe, Niels; Lahrmann, Bernd; Plinkert, Peter K.; Herold-Mende, Christel; Weiss, Johanna; Dyckhoff, Gerhard			Association of Drug Transporter Expression with Mortality and Progression-Free Survival in Stage IV Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							ADENOSINE-TRIPHOSPHATASE ATP7B; MULTIDRUG-RESISTANCE GENE-1; P-GLYCOPROTEIN EXPRESSION; OVARIAN-CANCER CELLS; BREAST-CANCER; LUNG-CANCER; IMMUNOCYTOCHEMICAL DETECTION; NASOPHARYNGEAL CARCINOMA; CHEMORESISTANCE MARKER; CISPLATIN	Drug transporters such as P-glycoprotein (ABCB1) have been associated with chemotherapy resistance and are considered unfavorable prognostic factors for survival of cancer patients. Analyzing mRNA expression levels of a subset of drug transporters by quantitative reverse transcription polymerase chain reaction (qRT-PCR) or protein expression by tissue microarray (TMA) in tumor samples of therapy naive stage IV head and neck squamous cell carcinoma (HNSCC) (qRT-PCR, n = 40; TMA, n = 61), this in situ study re-examined the significance of transporter expression for progression-free survival (PFS) and overall survival (OS). Data from The Cancer Genome Atlas database was used to externally validate the respective findings (n = 317). In general, HNSCC tended to lower expression of drug transporters compared to normal epithelium. High ABCB1 mRNA tumor expression was associated with both favorable progression-free survival (PFS, p = 0.0357) and overall survival (OS, p = 0.0535). Similar results were obtained for the mRNA of ABCC1 (MRP1, multidrug resistance-associated protein 1; PFS, p = 0.0183; OS, p = 0.038). In contrast, protein expression of ATP7b (copper transporter ATP7b), mRNA expression of ABCG2 (BCRP, breast cancer resistance protein), ABCC2 (MRP2), and SLC31A1 (hCTR1, human copper transporter 1) did not correlate with survival. Cluster analysis however revealed that simultaneous high expression of SLC31A1, ABCC2, and ABCG2 indicates poor survival of HNSCC patients. In conclusion, this study militates against the intuitive dogma where high expression of drug efflux transporters indicates poor survival, but demonstrates that expression of single drug transporters might indicate even improved survival. Prospectively, combined analysis of the 'transportome' should rather be performed as it likely unravels meaningful data on the impact of drug transporters on survival of patients with HNSCC.	[Warta, Rolf; Herold-Mende, Christel] Heidelberg Univ, Dept Neurosurg, Heidelberg, Germany; [Warta, Rolf; Plinkert, Peter K.; Herold-Mende, Christel; Dyckhoff, Gerhard] Heidelberg Univ, Dept Otorhinolaryngol Head & Neck Surg, Mol Cell Biol Grp, Heidelberg, Germany; [Theile, Dirk; Weiss, Johanna] Heidelberg Univ, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany; [Mogler, Carolin; Herpel, Esther] Heidelberg Univ, Natl Ctr Tumor Dis NCT, Tissue Bank, Heidelberg, Germany; [Mogler, Carolin; Herpel, Esther; Lahrmann, Bernd] Heidelberg Univ, Inst Pathol, Heidelberg, Germany; [Grabe, Niels] Heidelberg Univ, Natl Ctr Tumor Dis, Dept Med Oncol, Heidelberg, Germany; [Grabe, Niels; Lahrmann, Bernd] Heidelberg Univ, BIOQUANT, Hamamatsu Tissue Imaging & Anal Ctr, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Weiss, J (corresponding author), Heidelberg Univ, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany.	johanna.weiss@med.uni-heidelberg.de	Grabe, Niels/I-6214-2016; Grabe, Niels/AAP-6493-2020	Grabe, Niels/0000-0003-1732-3706	German Research Foundation [WE 4135/3-1, HE 2357/2-1]	German Research Foundation(German Research Foundation (DFG))	This project was funded by grant WE 4135/3-1 und HE 2357/2-1 from the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albermann N, 2005, BIOCHEM PHARMACOL, V70, P949, DOI 10.1016/j.bcp.2005.06.018; Brozek W, 2005, EUR J CANCER, V41, P2347, DOI 10.1016/j.ejca.2005.07.014; Burger H, 2003, CLIN CANCER RES, V9, P827; Chen CL, 2001, HUM PATHOL, V32, P1240, DOI 10.1053/hupa.2001.28950; Colevas AD, 2006, J CLIN ONCOL, V24, P2644, DOI 10.1200/JCO.2005.05.3348; Duan ZF, 2004, MOL CANCER THER, V3, P833; DUENSING S, 1994, ONCOLOGY, V51, P309; Freier K, 2003, ANTICANCER RES, V23, P3971; Furusak T, 2013, ACTA OTO-LARYNGOL, V133, P552, DOI 10.3109/00016489.2012.749521; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Guminski AD, 2006, GYNECOL ONCOL, V100, P239, DOI 10.1016/j.ygyno.2005.08.046; Jain V, 1997, INT J CANCER, V74, P128, DOI 10.1002/(SICI)1097-0215(19970220)74:1<128::AID-IJC21>3.0.CO;2-A; Kamazawa S, 2000, ONCOLOGY-BASEL, V59, P329, DOI 10.1159/000012191; Karcher S, 2006, INT J CANCER, V118, P2182, DOI 10.1002/ijc.21648; Lagas JS, 2006, CLIN CANCER RES, V12, P6125, DOI 10.1158/1078-0432.CCR-06-1352; Larkharoensub N, 2008, HUM PATHOL, V39, P837, DOI 10.1016/j.humpath.2007.10.009; Lee SH, 2013, EUR J CANCER, V49, P3210, DOI 10.1016/j.ejca.2013.06.025; Lo Muzio L, 2000, ANTICANCER RES, V20, P2891; Miyashita H, 2003, ORAL ONCOL, V39, P157, DOI 10.1016/S1368-8375(02)00038-6; Morgan ET, 2008, DRUG METAB DISPOS, V36, P205, DOI 10.1124/dmd.107.018747; Nakayama K, 2002, INT J CANCER, V101, P488, DOI 10.1002/ijc.10608; Pratt S, 2005, MOL CANCER THER, V4, P855, DOI 10.1158/1535-7163.MCT-04-0291; Ralhan R, 1997, INT J CANCER, V72, P728, DOI 10.1002/(SICI)1097-0215(19970904)72:5<728::AID-IJC4>3.3.CO;2-K; Rassouli A, 2013, HEAD NECK 2013, V2013; REMMELE W, 1987, PATHOLOGE, V8, P138; Royuela M, 2004, J PATHOL, V202, P41, DOI 10.1002/path.1476; Soini Y, 1996, J CLIN PATHOL, V49, P470, DOI 10.1136/jcp.49.6.470; Song IS, 2004, MOL CANCER THER, V3, P1543; Surowiak P, 2005, BREAST CANCER RES, V7, pR862, DOI 10.1186/bcr1313; Theile D, 2011, HEAD NECK-J SCI SPEC, V33, P959, DOI 10.1002/hed.21559; Theile D, 2009, BIOCHEM PHARMACOL, V78, P1366, DOI 10.1016/j.bcp.2009.07.006; Thomas GR, 2005, INT J EXP PATHOL, V86, P347, DOI 10.1111/j.0959-9673.2005.00447.x; Tsuzuki H, 1998, CANCER LETT, V126, P89, DOI 10.1016/S0304-3835(97)00540-5; Uematsu T, 2001, INT J CANCER, V92, P187, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1180>3.0.CO;2-T; van den Broek GB, 2009, INT J CANCER, V124, P2643, DOI 10.1002/ijc.24254; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Weaver DA, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-18; Yeh JJ, 2005, LUNG, V183, P177, DOI 10.1007/s00408-004-2532-1; Yoh K, 2004, CLIN CANCER RES, V10, P1691, DOI 10.1158/1078-0432.CCR-0937-3	40	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108908	10.1371/journal.pone.0108908	http://dx.doi.org/10.1371/journal.pone.0108908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275603	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500038
J	Tang, HM; Xiao, XP; Tang, WG; Wang, K; Sun, JM; Li, WY; Yang, GL				Tang, Hai-Ming; Xiao, Xiao-Ping; Tang, Wen-Guang; Wang, Ke; Sun, Ji-Min; Li, Wei-Yan; Yang, Guang-Li			Effects of Winter Cover Crops Straws Incorporation on CH4 and N2O Emission from Double-Cropping Paddy Fields in Southern China	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; NITROUS-OXIDE EMISSIONS; METHANE EMISSION; WATER MANAGEMENT; ORGANIC-MATTER; LAND-USE; SOIL; TILLAGE; FLUXES; OXIDATION	Residue management in cropping systems is believed to improve soil quality. However, the effects of residue management on methane (CH4) and nitrous oxide (N2O) emissions from paddy field in Southern China have not been well researched. The emissions of CH4 and N2O were investigated in double cropping rice (Oryza sativa L.) systems with straw returning of different winter cover crops by using the static chamber-gas chromatography technique. A randomized block experiment with three replications was established in 2004 in Hunan Province, China, including rice-rice-ryegrass (Lolium multiflorum L.) (Ry-R-R), rice-rice-Chinese milk vetch (Astragalus sinicus L.) (Mv-R-R) and rice-rice with winter fallow (Fa-R-R). The results showed that straw returning of winter crops significantly increased the CH4 emission during both rice growing seasons when compared with Fa-R-R. Ry-R-R plots had the largest CH4 emissions during the early rice growing season with 14.235 and 15.906 g m(-2) in 2012 and 2013, respectively, when Ry-R-R plots had the largest CH4 emission during the later rice growing season with 35.673 and 38.606 g m(-2) in 2012 and 2013, respectively. The Ry-R-R and Mv-R-R also had larger N2O emissions than Fa-R-R in both rice seasons. When compared to Fa-R-R, total N2O emissions in the early rice growing season were increased by 0.05 g m(-2) in Ry-R-R and 0.063 g m(-2) in Mv-R-R in 2012, and by 0.058 g m(-2) in Ry-R-R and 0.068 g m(-2) in Mv-R-R in 2013, respectively. Similar result were obtained in the late rice growing season, and the total N2O emissions were increased by 0.104 g m(-2) in Ry-R-R and 0.073 g m(-2) in Mv-R-R in 2012, and by 0.108 g m(-2) in Ry-R-R and 0.076 g m(-2) in Mv-R-R in 2013, respectively. The global warming potentials (GWPs) from paddy fields were ranked as Ry-R-R>Mv-R-R> Fa-R-R. As a result, straw returning of winter cover crops has significant effects on increase of CH4 and N2O emission from paddy field in double cropping rice system.	[Tang, Hai-Ming; Xiao, Xiao-Ping; Tang, Wen-Guang; Wang, Ke; Sun, Ji-Min; Li, Wei-Yan; Yang, Guang-Li] Hunan Soil & Fertilizer Inst, Changsha, Hunan, Peoples R China		Tang, HM (corresponding author), Hunan Soil & Fertilizer Inst, Changsha, Hunan, Peoples R China.	tanghaiming66@163.com; hntfsxxping@163.com			National Natural Science Foundation of China [31201178]; Public Research Funds Projects of Agriculture, Ministry of Agriculture of the P.R. China [201103001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Research Funds Projects of Agriculture, Ministry of Agriculture of the P.R. China	This study was supported by the National Natural Science Foundation of China (No. 31201178), and the Public Research Funds Projects of Agriculture, Ministry of Agriculture of the P.R. China (No. 201103001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kaisi MM, 2005, J ENVIRON QUAL, V34, P437, DOI 10.2134/jeq2005.0437; BARNES JP, 1983, J CHEM ECOL, V9, P1045, DOI 10.1007/BF00982210; Bhatia A, 2005, ATMOS ENVIRON, V39, P6976, DOI 10.1016/j.atmosenv.2005.07.052; Bouwman AF, 1998, NATURE, V392, P866, DOI 10.1038/31809; Cai Z, 2001, CHEMOSPHERE, V42, P113, DOI 10.1016/S0045-6535(00)00116-8; Chidthaisong A, 1999, SOIL BIOL BIOCHEM, V31, P135, DOI 10.1016/S0038-0717(98)00114-X; Groot TT, 2003, BIOGEOCHEMISTRY, V64, P355, DOI 10.1023/A:1024921714852; Hermawan B, 1997, SOIL TILL RES, V44, P109, DOI 10.1016/S0167-1987(97)00043-3; Hernandez-Ramirez G, 2009, J ENVIRON QUAL, V38, P841, DOI 10.2134/jeq2007.0565; Huang Y, 2004, SOIL BIOL BIOCHEM, V36, P973, DOI 10.1016/j.soilbio.2004.02.009; Kallenbach CM, 2010, AGR ECOSYST ENVIRON, V137, P251, DOI 10.1016/j.agee.2010.02.010; 郑循华, 1998, Advances in Atmospheric Sciences, V15, P569; Lee CH, 2010, AGR ECOSYST ENVIRON, V138, P343, DOI 10.1016/j.agee.2010.05.011; Levy PE, 2007, AGR ECOSYST ENVIRON, V121, P186, DOI 10.1016/j.agee.2006.12.019; Liu H, 2008, AGR ECOSYST ENVIRON, V124, P125, DOI 10.1016/j.agee.2007.09.002; Lokupitiya E, 2006, J ENVIRON QUAL, V35, P1413, DOI 10.2134/jeq2005.0157; Ma J, 2008, PLANT SOIL, V313, P167, DOI 10.1007/s11104-008-9689-y; MCCRACKEN DV, 1994, SOIL SCI SOC AM J, V58, P1476, DOI 10.2136/sssaj1994.03615995005800050029x; Mitchell JP, 2000, AGR WATER MANAGE, V45, P55, DOI 10.1016/S0378-3774(99)00070-0; Nishimura S, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002207; Pandey D, 2012, AGR ECOSYST ENVIRON, V159, P133, DOI 10.1016/j.agee.2012.07.008; PARASHAR DC, 1993, CHEMOSPHERE, V26, P247, DOI 10.1016/0045-6535(93)90425-5; Petersen SO, 2011, SOIL BIOL BIOCHEM, V43, P1509, DOI 10.1016/j.soilbio.2011.03.028; POWLSON DS, 1987, SOIL BIOL BIOCHEM, V19, P159, DOI 10.1016/0038-0717(87)90076-9; Ritter WF, 1998, J CONTAM HYDROL, V34, P1, DOI 10.1016/S0169-7722(98)00087-4; Saggar S, 2007, AGR ECOSYST ENVIRON, V122, P357, DOI 10.1016/j.agee.2007.02.006; Salmeron M, 2011, FIELD CROP RES, V123, P89, DOI 10.1016/j.fcr.2011.05.006; SAS Institute, 2003, SAS VERS 9 1 2 2002; Sethunathan N, 2000, NUTR CYCL AGROECOSYS, V58, P377, DOI 10.1023/A:1009891913511; Singh JS, 1996, PLANT SOIL, V183, P323, DOI 10.1007/BF00011448; Tan ZX, 2009, AGR ECOSYST ENVIRON, V130, P171, DOI 10.1016/j.agee.2009.01.004; Verge XPC, 2007, AGR FOREST METEOROL, V142, P255, DOI 10.1016/j.agrformet.2006.06.011; Verma A, 2006, AGR ECOSYST ENVIRON, V116, P209, DOI 10.1016/j.agee.2006.02.005; Wassmann R., 2004, TROPICAL AGR TRANSIT, V6, P65, DOI DOI 10.1007/978-94-017-3604-6_4; Yagi K, 1996, GLOBAL BIOGEOCHEM CY, V10, P255, DOI 10.1029/96GB00517; YAGI K, 1990, SOIL SCI PLANT NUTR, V36, P599, DOI 10.1080/00380768.1990.10416797; Yang X, 2010, AGR ECOSYST ENVIRON, V137, P308, DOI 10.1016/j.agee.2010.03.001; Yao ZS, 2009, SOIL BIOL BIOCHEM, V41, P2131, DOI 10.1016/j.soilbio.2009.07.025; Yu KW, 2007, SOIL SCI SOC AM J, V71, P1406, DOI 10.2136/sssaj2006.0155; Yue J, 2005, NUTR CYCL AGROECOSYS, V73, P293, DOI 10.1007/s10705-005-3815-5; Zhang HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065277; Zhu B, 2012, J INTEGR AGR, V11, P1537, DOI 10.1016/S2095-3119(12)60154-3	42	9	11	12	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108322	10.1371/journal.pone.0108322	http://dx.doi.org/10.1371/journal.pone.0108322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271923	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600040
J	Wilschanski, M; Abbasi, M; Blanco, E; Lindberg, I; Yourshaw, M; Zangen, D; Berger, I; Shteyer, E; Pappo, O; Bar-Oz, B; Martin, MG; Elpeleg, O				Wilschanski, Michael; Abbasi, Montaser; Blanco, Elias; Lindberg, Iris; Yourshaw, Michael; Zangen, David; Berger, Itai; Shteyer, Eyal; Pappo, Orit; Bar-Oz, Benjamin; Martin, Martin G.; Elpeleg, Orly			A Novel Familial Mutation in the PCSK1 Gene That Alters the Oxyanion Hole Residue of Proprotein Convertase 1/3 and Impairs Its Enzymatic Activity	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; NON-SYNONYMOUS VARIANTS; MALABSORPTIVE DIARRHEA; HUMAN GENOMES; IDENTIFICATION; DEFICIENCY; OBESITY; ENTEROPATHY; DYSFUNCTION; PROPEPTIDE	Four siblings presented with congenital diarrhea and various endocrinopathies. Exome sequencing and homozygosity mapping identified five regions, comprising 337 protein-coding genes that were shared by three affected siblings. Exome sequencing identified a novel homozygous N309K mutation in the proprotein convertase subtilisin/kexin type 1 (PCSK1) gene, encoding the neuroendocrine convertase 1 precursor (PC1/3) which was recently reported as a cause of Congenital Diarrhea Disorder (CDD). The PCSK1 mutation affected the oxyanion hole transition state-stabilizing amino acid within the active site, which is critical for appropriate proprotein maturation and enzyme activity. Unexpectedly, the N309K mutant protein exhibited normal, though slowed, prodomain removal and was secreted from both HEK293 and Neuro2A cells. However, the secreted enzyme showed no catalytic activity, and was not processed into the 66 kDa form. We conclude that the N309K enzyme is able to cleave its own propeptide but is catalytically inert against in trans substrates, and that this variant accounts for the enteric and systemic endocrinopathies seen in this large consanguineous kindred.	[Wilschanski, Michael; Abbasi, Montaser; Shteyer, Eyal] Hadassah Hebrew Univ Hosp, Div Pediat, Gastroenterol Unit, Jerusalem, Israel; [Blanco, Elias; Lindberg, Iris] Univ Maryland, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Blanco, Elias; Yourshaw, Michael; Martin, Martin G.] Univ Calif Los Angeles, Mattel Childrens Hosp, Dept Pediat, Div Gastroenterol & Nutr, Los Angeles, CA USA; [Blanco, Elias; Yourshaw, Michael; Martin, Martin G.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Zangen, David] Hadassah Hebrew Univ Hosp, Div Pediat, Endocrinol Unit, Jerusalem, Israel; [Berger, Itai] Hadassah Hebrew Univ Hosp, Div Pediat, Neurol Unit, Jerusalem, Israel; [Pappo, Orit] Hadassah Hebrew Univ Hosp, Dept Pathol, Jerusalem, Israel; [Bar-Oz, Benjamin] Hadassah Hebrew Univ Hosp, Dept Neonatol, Jerusalem, Israel; [Elpeleg, Orly] Hadassah Hebrew Univ Hosp, Monique & Jacques Roboh Dept Genet Res, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; University System of Maryland; University of Maryland Baltimore; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Wilschanski, M (corresponding author), Hadassah Hebrew Univ Hosp, Div Pediat, Gastroenterol Unit, Jerusalem, Israel.	michaelwil@hadassah.org.il	Berger, Itai/D-9729-2017; Martín, María/HDL-9512-2022; Lindberg, Iris/Q-3825-2019; Yourshaw, Michael/F-9807-2015	Berger, Itai/0000-0002-7577-4444; Yourshaw, Michael/0000-0001-7612-0437	National Institute of Diabetes and Digestive and Kidney Diseases [DK083762]; California Institute of Regenerative Medicine (CIRM) [RT2-01985, DA05084]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083762, P30DK041301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA005084, R01DA005084] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding provided by the National Institute of Diabetes and Digestive and Kidney Diseases (#DK083762), and California Institute of Regenerative Medicine (CIRM), RT2-01985 to MM and DA05084 to IL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bennett CL, 2001, CURR OPIN PEDIATR, V13, P533, DOI 10.1097/00008480-200112000-00007; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Berger I, 2012, EPILEPSIA, V53, P1436, DOI 10.1111/j.1528-1167.2012.03536.x; Blanco EH, 2014, ENDOCRINOLOGY; BRENNER C, 1993, CURR BIOL, V3, P498, DOI 10.1016/0960-9822(93)90040-U; BRYAN P, 1986, P NATL ACAD SCI USA, V83, P3743, DOI 10.1073/pnas.83.11.3743; Canani Roberto Berni, 2011, Curr Gastroenterol Rep, V13, P257, DOI 10.1007/s11894-011-0188-6; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; GOODMAN LJ, 1994, BIOCHEM BIOPH RES CO, V201, P795, DOI 10.1006/bbrc.1994.1771; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lopes MC, 2012, HUM HERED, V73, P47, DOI 10.1159/000334984; Martin MG, 2013, GASTROENTEROLOGY, V145, P138, DOI 10.1053/j.gastro.2013.03.048; Mastrangelo M, 2012, PEDIATR NEUROL, V46, P24, DOI 10.1016/j.pediatrneurol.2011.11.003; McKusick-Nathans Institute of Genetic Medicine, ONL MEND INH MAN OMI; Muller T, 2008, NAT GENET, V40, P1163, DOI 10.1038/ng.225; NHLBI Exome Sequencing Project, 2011, EXOM VAR SERV; Ouwendijk J, 1996, J CLIN INVEST, V97, P633, DOI 10.1172/JCI118459; Pickett LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055065; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Scougall K, 1998, BIOCHEM J, V334, P531, DOI 10.1042/bj3340531; Sivagnanam M, 2008, GASTROENTEROLOGY, V135, P429, DOI 10.1053/j.gastro.2008.05.036; Taylor NA, 1997, BIOCHEM J, V321, P367, DOI 10.1042/bj3210367; Terrin G, 2012, INT J MOL SCI, V13, P4168, DOI 10.3390/ijms13044168; TURK E, 1991, NATURE, V350, P354, DOI 10.1038/350354a0; Wang JF, 2006, NEW ENGL J MED, V355, P270, DOI 10.1056/NEJMoa054288; Yourshaw M, 2013, J PEDIATR GASTR NUTR, V57, P759, DOI 10.1097/MPG.0b013e3182a8ae6c; ZHOU A, 1995, J BIOL CHEM, V270, P21509, DOI 10.1074/jbc.270.37.21509; Zupanc ML, 2009, J CHILD NEUROL, V24, p6S, DOI 10.1177/0883073809338151	36	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108878	10.1371/journal.pone.0108878	http://dx.doi.org/10.1371/journal.pone.0108878			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272002	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600072
J	Mielcarek, M; Bondulich, MK; Inuabasi, L; Franklin, SA; Muller, T; Bates, GP				Mielcarek, Michal; Bondulich, Marie K.; Inuabasi, Linda; Franklin, Sophie A.; Muller, Thomas; Bates, Gillian P.			The Huntington's Disease-Related Cardiomyopathy Prevents a Hypertrophic Response in the R6/2 Mouse Model	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; CARDIAC MYOCYTES; HEART-FAILURE; GENE-EXPRESSION; RAT; PROTEIN; MICE; OVEREXPRESSION; DYSFUNCTION; INFUSION	Huntington's disease (HD) is neurodegenerative disorder for which the mutation results in an extra-long tract of glutamines that causes the huntingtin protein to aggregate. It is characterized by neurological symptoms and brain pathology that is associated with nuclear and cytoplasmic aggregates and with transcriptional deregulation. Despite the fact that HD has been recognized principally as a neurological disease, there are multiple epidemiological studies showing that HD patients exhibit a high rate of cardiovascular events leading to heart failure. To unravel the mechanistic basis of cardiac dysfunction in HD, we employed a wide range of molecular techniques using the well-established genetic R6/2 mouse model that develop a considerable degree of the cardiac atrophy at end stage disease. We found that chronic treatment with isoproterenol, a potent beta-adrenoreceptor agonist, did not change the overall gross morphology of the HD murine hearts. However, there was a partial response to the beta-adrenergenic stimulation by the further re-expression of foetal genes. In addition we have profiled the expression level of Hdacs in the R6/2 murine hearts and found that the isoproterenol stimulation of Hdac expression was partially blocked. For the first time we established the Hdac transcriptional profile under hypertrophic conditions and found 10 out of 18 Hdacs to be markedly deregulated. Therefore, we conclude that R6/2 murine hearts are not able to respond to the chronic isoproterenol treatment to the same degree as wild type hearts and some of the hypertrophic signals are likely attenuated in the symptomatic HD animals.	[Mielcarek, Michal; Bondulich, Marie K.; Inuabasi, Linda; Franklin, Sophie A.; Muller, Thomas; Bates, Gillian P.] Kings Coll London, Dept Med & Mol Genet, London, England	University of London; King's College London	Mielcarek, M (corresponding author), Kings Coll London, Dept Med & Mol Genet, London, England.	michal.mielcarek@kcl.ac.uk; gillian.bates@kacl.ac.uk	Mielcarek, Michal/M-6302-2018; Bates, Gillian/E-1146-2012	Mielcarek, Michal/0000-0002-9874-6753; Bates, Gillian/0000-0002-4041-6305	CHDI Foundation	CHDI Foundation	This work was supported by the CHDI Foundation, a not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. Research conducted at King's College London was performed in collaboration with and funded by the CHDI Foundation. In these cases, the funder, through CHDI Management, fully participated in study design, data collection and analysis, the decision to publish, and preparation of the manuscript. TM is currently an employee of Affimed Therapeutics AG. Affimed Therapeutics AG provided no support for this work. They did not provide salary support for TM when he was working at King's College London and they did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors is articulated in the 'author contributions' section.	Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Benn CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-17; BOLUYT MO, 1995, AM J PHYSIOL-HEART C, V269, pH638; Bush EW, 2009, EXPERT OPIN THER TAR, V13, P767, DOI 10.1517/14728220902939161; Cardinale JP, 2010, HYPERTENSION, V56, P437, DOI 10.1161/HYPERTENSIONAHA.110.154567; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chen HH, 2004, J BIOL CHEM, V279, P30800, DOI 10.1074/jbc.M400154200; CHIU E, 1982, MED J AUSTRALIA, V1, P153, DOI 10.5694/j.1326-5377.1982.tb132224.x; Colussi C, 2010, PHARMACOL RES, V62, P3, DOI 10.1016/j.phrs.2010.02.014; Granger A, 2008, FASEB J, V22, P3549, DOI 10.1096/fj.08-108548; Grimm D, 1998, CARDIOVASC RES, V37, P91, DOI 10.1016/S0008-6363(97)00212-5; Gunther S, 2004, NUCLEIC ACIDS RES, V32, P791, DOI 10.1093/nar/gkh248; Gupta MP, 2008, J BIOL CHEM, V283, P10135, DOI 10.1074/jbc.M710277200; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Jin YT, 2007, AM J PHYSIOL-HEART C, V292, pH1593, DOI 10.1152/ajpheart.00985.2006; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kiriazis H, 2012, J PHYSIOL-LONDON, V590, P5845, DOI 10.1113/jphysiol.2012.238113; Kook H, 2003, J CLIN INVEST, V112, P863, DOI 10.1172/JCI200319137; LANSKA DJ, 1988, NEUROLOGY, V38, P769, DOI 10.1212/WNL.38.5.769; Lee TM, 2007, AM J PHYSIOL-HEART C, V293, pH968, DOI 10.1152/ajpheart.00891.2006; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; Li W, 2006, J BIOL CHEM, V281, P15916, DOI 10.1074/jbc.M511007200; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; McKinsey TA, 2012, ANNU REV PHARMACOL, V52, P303, DOI 10.1146/annurev-pharmtox-010611-134712; McLean BG, 2003, J MOL CELL CARDIOL, V35, P461, DOI 10.1016/S0022-2828(03)00049-X; Melkani GC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004024; Mielcarek M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004550; Mielcarek M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001717; Mielcarek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080849; Mielcarek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027746; Mielcarek M, 2002, MECH DEVELOP, V119, pS269, DOI 10.1016/S0925-4773(03)00127-8; Mielcarek M, 2009, GENE EXPR PATTERNS, V9, P129, DOI 10.1016/j.gep.2008.12.002; Mihm MJ, 2007, NEUROBIOL DIS, V25, P297, DOI 10.1016/j.nbd.2006.09.016; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Pattison JS, 2008, CIRCULATION, V117, P2743, DOI 10.1161/CIRCULATIONAHA.107.750232; Sassone J, 2009, EXP NEUROL, V219, P385, DOI 10.1016/j.expneurol.2009.05.012; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Snowden J., 2014, HUNTINGTONS DIS, P36; SORENSEN SA, 1992, J MED GENET, V29, P911, DOI 10.1136/jmg.29.12.911; Stewart AFR, 1998, CIRC RES, V83, P43, DOI 10.1161/01.RES.83.1.43; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; Trivedi CM, 2008, J BIOL CHEM, V283, P26484, DOI 10.1074/jbc.M803686200; Tsika RW, 2010, J BIOL CHEM, V285, P13721, DOI 10.1074/jbc.M109.063057; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	49	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108961	10.1371/journal.pone.0108961	http://dx.doi.org/10.1371/journal.pone.0108961			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268775	Green Submitted, gold, Green Published			2022-12-27	WOS:000343671700204
J	Xiong, JQ; Li, Y; Huang, KC; Lu, MX; Shi, H; Ma, LF; Luo, AY; Yang, SH; Lu, ZY; Zhang, J; Yang, LL; Wang, SX				Xiong, Jiaqiang; Li, Ya; Huang, Kecheng; Lu, Meixia; Shi, Hao; Ma, Lanfang; Luo, Aiyue; Yang, Shuhong; Lu, Zhiyong; Zhang, Jinjin; Yang, Lilan; Wang, Shixuan			Association between DAPK1 Promoter Methylation and Cervical Cancer: A Meta-Analysis	PLOS ONE			English	Article							DNA METHYLATION; UTERINE CERVIX; GRAPHICAL TEST; HYPERMETHYLATION; GENES; HETEROGENEITY; NEOPLASIA; PATTERNS; KINASE; ASSAY	Background: Death-associated protein kinase1 (DAPK1) is an important tumor suppressor gene. DNA methylation can inactivate genes, which has often been observed in the carcinogenesis of cervical cancer. During the past several decades, many studies have explored the association between DAPK1 promoter methylation and cervical cancer. However, many studies were limited by the small samples size and the findings were inconsistent among them. Thus, we conducted a meta-analysis to assess the association between DAPK1 promoter methylation and cervical cancer. Methods: We systematically searched eligible studies in the PubMed, Web of Science, EMBASE and CNKI databases. Using meta-regression, subgroup analysis and sensitivity analysis, we explored the potential sources of heterogeneity. The odds ratio (OR) and 95% confidence interval (95% CI) were calculated by Meta-Analysis in R. Results: A total of 15 studies from 2001 to 2012, comprising 818 tumor tissues samples and 671 normal tissues samples, were analyzed in this meta-analysis. The frequencies of DAPK1 promoter methylation ranged from 30.0% to 78.6% (median, 59.3%) in cervical cancer tissue and 0.0% to 46.7% (median, 7.8%) in normal cervical tissue. The pooled OR was 19.66 (95% CI = 8.72-44.31) with the random effects model, and heterogeneity was found through the sensitivity analysis. The I 2 = 60% (P = 0.002) decreased to I-2 = 29.2% (P = 0.144) when one heterogeneous study was excluded, and the pooled OR increased to 21.80 (95% CI = 13.44-35.36) with the fixed effects model. Conclusion: The results suggested a strong association between DAPK1 promoter methylation and cervical cancer. This study also indicated that DAPK1 promoter methylation may be a biomarker during cervical carcinogenesis that might serve as an early indication of cervical cancer.	[Xiong, Jiaqiang; Li, Ya; Huang, Kecheng; Ma, Lanfang; Luo, Aiyue; Yang, Shuhong; Lu, Zhiyong; Zhang, Jinjin; Wang, Shixuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan 430074, Hubei, Peoples R China; [Lu, Meixia; Shi, Hao] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China; [Lu, Meixia; Shi, Hao] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ,Key Lab Environm & Hlth, Wuhan 430074, Hubei, Peoples R China; [Yang, Lilan] Nanchang Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Nanchang, Jiangxi, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Nanchang University	Wang, SX (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan 430074, Hubei, Peoples R China.	sxwang@tjh.tjmu.edu.cn		Xiong, Jiaqiang/0000-0002-8490-6613	National Natural Science Foundation of China [81071663]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81071663). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton CA, 2008, GYNECOL ONCOL, V109, P129, DOI 10.1016/j.ygyno.2007.12.017; Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687; Dong SM, 2001, CLIN CANCER RES, V7, P1982; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feng QH, 2007, CANCER EPIDEM BIOMAR, V16, P1178, DOI 10.1158/1055-9965.EPI-06-0694; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Flatley JE, 2009, CANCER EPIDEM BIOMAR, V18, P2782, DOI 10.1158/1055-9965.EPI-09-0493; Hesson LB, 2007, DIS MARKERS, V23, P73, DOI 10.1155/2007/291538; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hiraga J, 2006, INT J HEMATOL, V84, P248, DOI 10.1532/IJH97.06087; Hoque MO, 2006, J CLIN ONCOL, V24, P4262, DOI 10.1200/JCO.2005.01.3516; Iliopoulos D, 2009, ONCOL REP, V22, P199, DOI 10.3892/or_00000425; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Jeong DH, 2006, INT J GYNECOL CANCER, V16, P1234, DOI 10.1111/j.1525-1438.2006.00522.x; Kang S, 2005, GYNECOL ONCOL, V96, P173, DOI 10.1016/j.ygyno.2004.09.031; Kim JH, 2010, GYNECOL ONCOL, V116, P99, DOI 10.1016/j.ygyno.2009.09.032; Leung RCY, 2008, ONCOL REP, V19, P1339; Missaoui N, 2011, PATHOL RES PRACT, V207, P37, DOI 10.1016/j.prp.2010.11.001; Niyazi Mayinuer, 2012, Zhonghua Zhong Liu Za Zhi, V34, P31; Reesink-Peters N, 2004, MOL CANCER RES, V2, P289; Schiffman Mark H, 2003, J Natl Cancer Inst, V95, pE2; Shivapurkar N, 2007, GYNECOL ONCOL, V107, P549, DOI 10.1016/j.ygyno.2007.08.057; Stuck AE, 1998, BRIT MED J, V316, P469, DOI 10.1136/bmj.316.7129.469; Sun LL, 2012, ARCH GYNECOL OBSTET, V285, P1433, DOI 10.1007/s00404-011-2149-6; Yang N, 2010, CELL ONCOL, V32, P131, DOI 10.3233/CLO-2009-0510; Zhao Xian-Lan, 2008, Ai Zheng, V27, P919	28	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107272	10.1371/journal.pone.0107272	http://dx.doi.org/10.1371/journal.pone.0107272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268905	gold, Green Submitted, Green Published			2022-12-27	WOS:000343671700035
J	Zhang, H; Han, MQ; Zhang, XN; Sun, XT; Ling, F				Zhang, Hao; Han, Mengqi; Zhang, Xiaonian; Sun, Xinting; Ling, Feng			The Effect and Mechanism of Growth Hormone Replacement on Cognitive Function in Rats with Traumatic Brain Injury	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; SYNAPTIC PLASTICITY; GH DEFICIENCY; PERFORMANCE; THERAPY; NEURONS; MEMORY; MODEL; HYPOPITUITARISM; EXPRESSION	Objective: The effects of growth hormone on cognitive dysfunction were observed in a controlled cortical impact (CCI) rat model and the underlying mechanism was explored. Method: Three-month-old male SD rats were randomly divided into sham (n = 10), control (n = 10), and CCI groups (n = 40) The parameters were set as follows: striking speed, 3.5 m/s; impact depth, 1.5 mm; and dwell time, 400 msec. Eight and ten weeks post-injury, the GH levels were measured the water maze test and novel object recognition test were performed. CCI rats were divided into normal and decreased GH groups, and further randomly divided into two sub-groups (rhGH treatment and saline vehicle groups). All rats were tested for SYN, BDNF, and TrkB mRNA in the prefrontal cortex and hippocampus by RT-PCR. Results: CCI rats 8 weeks post-injury had cognitive dysfunction regardless of the GH level (P, 0.05). rhGH treatment improved cognitive function in CCI rats. There was a positive correlation between the expression of prefrontal BDNF and SYN mRNA in CCI rats after rhGH therapy and the water maze test score (r = 0.773 and 0.534, respectively; P<0.05). Furthermore, the expression of BDNF, TrkB, and SYN mRNA in the hippocampus was negatively correlated with the water maze test score (r = 0.602, 0.773, 0.672, and 0.783, respectively; P<0.05). There was a difference in the expression of hippocampal and prefrontal BDNF, TrkB, and SYN mRNA (P<0.05) Conclusion: rhGH treatment had a positive effect on cognitive function, which was more evident in GH-deficient rats. The increased expression of hippocampal and prefrontal BDNF and TrkB mRNA is implicated in rhGH therapy to improve cognitive function. Changes in the expression of hippocampal SYN mRNA following rhGH therapy may also play a role in improving cognitive function.	[Zhang, Hao; Zhang, Xiaonian; Sun, Xinting] Capital Med Univ, China Rehabil Res Ctr, Beijing, Peoples R China; [Han, Mengqi] Beijing Jishuitan Hosp, Beijing, Peoples R China; [Ling, Feng] Capital Med Univ, Beijing Xuanwu Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Ling, F (corresponding author), Capital Med Univ, China Rehabil Res Ctr, Beijing, Peoples R China.	crrck3@sina.com			Chinese central public research institutes [2011CZ-6, 2012CZ-5]	Chinese central public research institutes	The special basic research fund for Chinese central public research institutes (2011CZ-6,2012CZ-5) http://www.most.gov.cn/ztzl/gjzctx/ptzckjtr/200802/t20080222_59209.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beca SG, 2012, PITUITARY, V15, P10, DOI 10.1007/s11102-008-0133-3; Bhagia V, 2010, BRAIN INJURY, V24, P560, DOI 10.3109/02699051003601705; Brandoli C, 1998, J NEUROSCI, V18, P7953; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Christophidis LJ, 2009, GROWTH HORM IGF RES, V19, P497, DOI 10.1016/j.ghir.2009.05.001; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Creyghton Wouter M, 2004, Semin Vasc Med, V4, P167, DOI 10.1055/s-2004-835375; Crispino M, 1999, EXP NEUROL, V159, P574, DOI 10.1006/exnr.1999.7186; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Deijen JB, 1998, PSYCHONEUROENDOCRINO, V23, P45, DOI 10.1016/S0306-4530(97)00092-9; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DOU Yi, 2009, Zhonghua Shao Shang Za Zhi, V25, P275; Doulah AH, 2009, NEUROSCI LETT, V466, P47, DOI 10.1016/j.neulet.2009.09.016; Eastwood SL, 2000, BRIT J PSYCHIAT, V176, P236, DOI 10.1192/bjp.176.3.236; Falleti MG, 2006, PSYCHONEUROENDOCRINO, V31, P681, DOI 10.1016/j.psyneuen.2006.01.005; Ferrer I, 1999, DEMENT GERIATR COGN, V10, P55, DOI 10.1159/000051214; GRANON S, 1995, BEHAV NEUROSCI, V109, P474, DOI 10.1037/0735-7044.109.3.474; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Hao LY, 2010, NEUROSCIENCE, V166, P763, DOI 10.1016/j.neuroscience.2010.01.006; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Isgaard J, 2007, Minerva Endocrinol, V32, P103; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kinney BA, 2001, PHYSIOL BEHAV, V72, P653, DOI 10.1016/S0031-9384(01)00423-1; Kurihara M, 2011, GEN COMP ENDOCR, V170, P156, DOI 10.1016/j.ygcen.2010.09.020; Kwak MJ, 2009, J KOREAN MED SCI, V24, P729, DOI 10.3346/jkms.2009.24.4.729; LAI ZN, 1993, BRAIN RES, V621, P260, DOI 10.1016/0006-8993(93)90114-3; Leeds P, 2005, NEUROCHEM INT, V46, P61, DOI 10.1016/j.neuint.2004.07.001; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359, DOI 10.33549/physiolres.930971; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Maric NP, 2010, J ENDOCRINOL INVEST, V33, P770, DOI [10.1007/BF03350340, 10.3275/7045]; Miladi-Gorji H, 2011, NEUROBIOL LEARN MEM, V96, P479, DOI 10.1016/j.nlm.2011.08.001; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Morris GM, 2008, SCHOLARPEDIA US, V3, P6315; Morselli L L, 2008, J Endocrinol Invest, V31, P39; Nieuwpoort IC, 2008, EUR J ENDOCRINOL ENG, V159, pS53; Oertel H, 2004, PSYCHONEUROENDOCRINO, V29, P839, DOI 10.1016/S0306-4530(03)00151-3; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; Pathipati P, 2009, BEHAV BRAIN RES, V204, P93, DOI 10.1016/j.bbr.2009.05.023; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Quik EH, 2012, GROWTH HORM IGF RES, V22, P42, DOI 10.1016/j.ghir.2011.12.007; Rocha M, 1999, BRAIN RES, V827, P79, DOI 10.1016/S0006-8993(99)01307-4; Schober ME, 2012, METAB BRAIN DIS, V27, P167, DOI 10.1007/s11011-012-9309-7; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; Thornton PL, 2000, J GERONTOL A-BIOL, V55, pB106; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; Urban RJ, 2006, GROWTH HORM IGF RES, V16, pS25, DOI 10.1016/j.ghir.2006.03.017; VanGuilder HD, 2011, NEUROBIOL DIS, V43, P201, DOI 10.1016/j.nbd.2011.03.012; Wass JAH, 2010, J ENDOCRINOL, V207, P125, DOI 10.1677/JOE-10-0126; Ying XG, 2004, J CLIN CARDIOVASCU D, V10, P613; Zhou JP, 2007, INFLUENCE GNRH ANALO	54	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108518	10.1371/journal.pone.0108518	http://dx.doi.org/10.1371/journal.pone.0108518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268832	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700105
J	Zhao, RZ; Huang, Y; Cheng, G; Liu, JL; Shao, PF; Qin, C; Hua, LX; Yin, CJ				Zhao, Ruizhe; Huang, Yuan; Cheng, Gong; Liu, Jinliang; Shao, Pengfei; Qin, Chao; Hua, Lixin; Yin, Changjun			Developing a Follow-Up Strategy for Patients with PSA Ranging from 4 to 10 ng/ml via a New Model to Reduce Unnecessary Prostate Biopsies	PLOS ONE			English	Article							CANCER SURVEILLANCE SERIES; DIGITAL RECTAL EXAMINATION; ANTIGEN DENSITY; INTERPRETING TRENDS; RISK; POPULATION; MORTALITY; CARCINOMA; NOMOGRAM; COHORT	Objective: The aim of this study was to develop a follow-up strategy based on the new model to reduce unnecessary prostate biopsies in patients with prostate specific antigen (PSA) ranging from 4 to 10 ng/ml. Methods: A total of 436 patients with PSA ranging from 4 to 10 ng/ml who had undergone transrectal ultrasound (TRUS)-guided prostate biopsy were evaluated during the first stage. Age, PSA, free PSA (fPSA), digital rectal examination (DRE) findings, ultrasonic hypoechoic mass, ultrasonic microcalcifications, prostate volume (PV) and PSA density (PSAD) were considered as predictive factors. A multiple logistic regression analysis involving a backward elimination selection procedure was applied to select independent predictors. After a comprehensive analysis of all results, we developed a new model to assess the risk of prostate cancer and an effective follow-up strategy. Results: Age, PSA, PV, fPSA, rate of abnormal DRE findings and rate of hypoechoic masses detected by TRUS were included in our model. A significantly greater area under the receiver-operating characteristic curve was obtained in our model when compared with using PSA alone (0.782 vs. 0.566). Patients were grouped according to the value of prostate cancer risk (PCaR). In the second stage of our study, patients with PCaR >0.52 were recommended to undergo biopsies immediately while the rest of the patients continued close follow-up observation. Compared with the first stage, the detection rate of PCa in the second stage was significantly increased (33.0% vs 21.1%, p = 0.012). There was no significant difference between the two stages in distribution of the Gleason score (p = 0.808). Conclusions: We developed a follow-up strategy based on the new model, which reduced unnecessary prostate biopsies without delaying patients' diagnoses and treatments.	[Zhao, Ruizhe; Huang, Yuan; Cheng, Gong; Liu, Jinliang; Shao, Pengfei; Qin, Chao; Hua, Lixin; Yin, Changjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Hua, LX (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	drlxhua@126.com			Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Provincial Special Program of Medical Science [BL2012027]; Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; National Natural Science Foundation of China [81171963, 81201998, 81201571]	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Provincial Special Program of Medical Science; Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), by the Jiangsu Provincial Special Program of Medical Science (BL2012027), by the Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University and by the National Natural Science Foundation of China (grant numbers 81171963, 81201998 and 81201571). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2014, J KOREAN MED SCI, V29, P338, DOI 10.3346/jkms.2014.29.3.338; BAZINET M, 1994, UROLOGY, V43, P44, DOI 10.1016/S0090-4295(94)80260-2; BENSON MC, 1992, J UROLOGY, V147, P815, DOI 10.1016/S0022-5347(17)37393-7; BENSON MC, 1992, J UROLOGY, V147, P817, DOI 10.1016/S0022-5347(17)37394-9; Cavadas V, 2010, EUR UROL, V58, P551, DOI 10.1016/j.eururo.2010.06.023; Chavan PR, 2009, J POSTGRAD MED, V55, P17, DOI 10.4103/0022-3859.43548; Etzioni R, 1999, J NATL CANCER I, V91, P1033, DOI 10.1093/jnci/91.12.1033; Feuer EJ, 1999, JNCI-J NATL CANCER I, V91, P1025, DOI 10.1093/jnci/91.12.1025; Garzotto M, 2003, CANCER, V98, P1417, DOI 10.1002/cncr.11668; Inahara M, 2006, UROLOGY, V68, P815, DOI 10.1016/j.urology.2006.05.010; Iremashvili V, 2013, BJU INT, V112, P39, DOI 10.1111/bju.12112; Lazzeri M, 2014, UROLOGY, V83, P606, DOI 10.1016/j.urology.2013.10.016; LITTRUP PJ, 1994, J UROLOGY, V152, P1873, DOI 10.1016/S0022-5347(17)32405-9; Loeb S, 2007, CANCER LETT, V249, P30, DOI 10.1016/j.canlet.2006.12.022; Lughezzani G, 2013, EUROPEAN UROLOGY; Matsuda T, 2009, JPN J CLIN ONCOL, V39, P435, DOI [10.1093/jjco/hyp047, 10.1093/jjco/hyp077]; Newschaffer CJ, 2000, JNCI-J NATL CANCER I, V92, P613, DOI 10.1093/jnci/92.8.613; Ruffion A, 2013, INT J MOL SCI, V14, P17767, DOI 10.3390/ijms140917767; Schroder F, 2008, EUR UROL, V54, P274, DOI 10.1016/j.eururo.2008.05.022; Tang P, 2013, UROL ONCOL-SEMIN ORI, V31, P744, DOI 10.1016/j.urolonc.2011.06.012; Yoon DK, 2012, PROSTATE, V72, P721, DOI 10.1002/pros.21475; Zhu Y, 2012, ASIAN J ANDROL, V14, P738, DOI 10.1038/aja.2012.28	22	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e106933	10.1371/journal.pone.0106933	http://dx.doi.org/10.1371/journal.pone.0106933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268808	gold, Green Published			2022-12-27	WOS:000343671700024
J	Kowallick, JT; Lamata, P; Hussain, ST; Kutty, S; Steinmetz, M; Sohns, JM; Fasshauer, M; Staab, W; Unterberg-Buchwald, C; Bigalke, B; Lotz, J; Hasenfuss, G; Schuster, A				Kowallick, Johannes T.; Lamata, Pablo; Hussain, Shazia T.; Kutty, Shelby; Steinmetz, Michael; Sohns, Jan M.; Fasshauer, Martin; Staab, Wieland; Unterberg-Buchwald, Christina; Bigalke, Boris; Lotz, Joachim; Hasenfuss, Gerd; Schuster, Andreas			Quantification of Left Ventricular Torsion and Diastolic Recoil Using Cardiovascular Magnetic Resonance Myocardial Feature Tracking	PLOS ONE			English	Article							INTER-STUDY REPRODUCIBILITY; STIMULATED ECHOES FAST; HEART-FAILURE; INTRAOBSERVER REPRODUCIBILITY; QUANTITATIVE ASSESSMENT; ROTATIONAL DEFORMATION; INOTROPIC STIMULATION; DOBUTAMINE STRESS; EJECTION FRACTION; FOURIER-ANALYSIS	Objectives: Cardiovascular magnetic resonance feature tracking (CMR-FT) offers quantification of myocardial deformation from routine cine images. However, data using CMR-FT to quantify left ventricular (LV) torsion and diastolic recoil are not yet available. We therefore sought to evaluate the feasibility and reproducibility of CMR-FT to quantify LV torsion and peak recoil rate using an optimal anatomical approach. Methods: Short-axis cine stacks were acquired at rest and during dobutamine stimulation (10 and 20 mu g.kg(-1).min(-1)) in 10 healthy volunteers. Rotational displacement was analysed for all slices. A complete 3D-LV rotational model was developed using linear interpolation between adjacent slices. Torsion was defined as the difference between apical and basal rotation, divided by slice distance. Depending on the distance between the most apical (defined as 0% LV distance) and basal (defined as 100% LV distance) slices, four different models for the calculation of torsion were examined: Model-1 (25-75%), Model-2 (0-100%), Model-3 (25-100%) and Model-4 (0-75%). Analysis included subendocardial, subepicardial and global torsion and recoil rate (mean of subendocardial and subepicardial values). Results: Quantification of torsion and recoil rate was feasible in all subjects. There was no significant difference between the different models at rest. However, only Model-1 (25-75%) discriminated between rest and stress (Global Torsion: 2.7 +/- 1.5 degrees cm(-1), 3.6 +/- 2.0 degrees cm(-1), 5.1 +/- 2.2 degrees cm(-1), p<0.01; Global Recoil Rate: -30.1 +/- 11.1 degrees cm(-1) s (-1), -469 +/- 15.0 degrees cm (-1) s (-1), -68.9 +/- 32.3 degrees cm(-1) s(-1), p<0.01; for rest, 10 and 20 mu g.kg(-1).min(-1) of dobutamine, respectively). Reproducibility was sufficient for all parameters as determined by Bland-Altman analysis, intraclass correlation coefficients and coefficient of variation. Conclusions: CMR-FT based derivation of myocardial torsion and recoil rate is feasible and reproducible at rest and with dobutamine stress. Using an optimal anatomical approach measuring rotation at 25% and 75% apical and basal LV locations allows effective quantification of torsion and recoil dynamics. Application of these new measures of deformation by CMR-FT should next be explored in disease states.	[Kowallick, Johannes T.; Sohns, Jan M.; Fasshauer, Martin; Staab, Wieland; Lotz, Joachim] Univ Gottingen, Inst Diagnost & Intervent Radiol, D-37073 Gottingen, Germany; [Lamata, Pablo] Univ Oxford, Dept Comp Sci, Oxford, England; [Hussain, Shazia T.] Papworth Hosp NHS Trust, Papworth Everard, Cambs, England; [Kutty, Shelby] Univ Nebraska, Coll Med, Childrens Hosp & Med Ctr, Omaha, NE 68198 USA; [Steinmetz, Michael] Univ Gottingen, Dept Pediat Cardiol & Intens Care Med, D-37073 Gottingen, Germany; [Unterberg-Buchwald, Christina; Hasenfuss, Gerd; Schuster, Andreas] Univ Gottingen, Dept Cardiol & Pneumol, D-37073 Gottingen, Germany; [Lamata, Pablo; Bigalke, Boris; Schuster, Andreas] Kings Coll London, St Thomas Hosp, Div Imaging Sci & Biomed Engn, Rayne Inst, London WC2R 2LS, England; [Kowallick, Johannes T.; Steinmetz, Michael; Sohns, Jan M.; Fasshauer, Martin; Staab, Wieland; Unterberg-Buchwald, Christina; Lotz, Joachim; Hasenfuss, Gerd; Schuster, Andreas] DZHK German Ctr Cardiovasc Res, Gottingen, Germany; [Bigalke, Boris] Univ Tubingen, Med Klin 2, Tubingen, Germany	University of Gottingen; University of Oxford; Papworth Hospital; University of Nebraska System; University of Gottingen; University of Gottingen; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; German Centre for Cardiovascular Research; Eberhard Karls University of Tubingen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schuster, A (corresponding author), Univ Gottingen, Dept Cardiol & Pneumol, D-37073 Gottingen, Germany.	andreas_schuster@gmx.net	Lamata, Pablo/AAE-7884-2020; Lotz, Joachim/G-3376-2015; Lamata, Pablo/E-3251-2010	Lamata, Pablo/0000-0002-3097-4928; Lotz, Joachim/0000-0002-1412-2741; Lamata, Pablo/0000-0002-3097-4928; KUTTY, SHELBY/0000-0001-9428-0979; Sommerlath Sohns, Jan/0000-0001-6644-2563	Research program of the Faculty of Medicine of the Georg-August-University in Gottingen; Wellcome Trust [099973/Z/12/Z]; Royal Society [099973/Z/12/Z]; DZHK (German Centre for Cardiovascular Research)	Research program of the Faculty of Medicine of the Georg-August-University in Gottingen; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); DZHK (German Centre for Cardiovascular Research)	AS was funded by the Research program of the Faculty of Medicine of the Georg-August-University in Gottingen. PL holds a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant Number 099973/Z/12/Z). The authors are grateful for the financial support provided by the DZHK (German Centre for Cardiovascular Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abozguia K, 2010, AM HEART J, V159, P825, DOI 10.1016/j.ahj.2010.02.002; Akagawa E, 2007, CIRC J, V71, P661, DOI 10.1253/circj.71.661; Bansal M, 2008, J AM SOC ECHOCARDIOG, V21, P887, DOI 10.1016/j.echo.2008.01.011; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BUCHALTER MB, 1990, CIRCULATION, V81, P1236, DOI 10.1161/01.CIR.81.4.1236; BUCHALTER MB, 1994, CARDIOVASC RES, V28, P629, DOI 10.1093/cvr/28.5.629; Burns AT, 2009, JACC-CARDIOVASC IMAG, V2, P709, DOI 10.1016/j.jcmg.2009.01.015; Codreanu I, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-48; Delhaas T, 2004, MAGNET RESON MED, V51, P135, DOI 10.1002/mrm.10679; Donekal S, 2014, CIRC-CARDIOVASC IMAG, V7, P292, DOI 10.1161/CIRCIMAGING.113.001073; Donekal S, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-37; Dong SJ, 2001, AM J PHYSIOL-HEART C, V281, pH2002, DOI 10.1152/ajpheart.2001.281.5.H2002; Esch BT, 2009, J APPL PHYSIOL, V106, P362, DOI 10.1152/japplphysiol.00144.2008; Goffinet C, 2009, EUR HEART J, V30, P608, DOI 10.1093/eurheartj/ehn511; Grothues F, 2002, AM J CARDIOL, V90, P29, DOI 10.1016/S0002-9149(02)02381-0; Haggerty CM, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-71; Hor KN, 2010, JACC-CARDIOVASC IMAG, V3, P144, DOI 10.1016/j.jcmg.2009.11.006; Karabay CY, 2011, ECHOCARDIOGR-J CARD, V24, pe815; Karamitsos TD, 2009, J AM COLL CARDIOL, V54, P1407, DOI 10.1016/j.jacc.2009.04.094; Kowallick JT, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0060-6; Kowallick JT, 2014, J CARDIOL THER, V1, P58, DOI DOI 10.6051/J; Lamata P, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1023; MOON MR, 1994, CIRCULATION, V89, P142, DOI 10.1161/01.CIR.89.1.142; Morton G, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-43; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nagel E, 1999, CIRCULATION, V99, P763, DOI 10.1161/01.CIR.99.6.763; Notomi Y, 2005, J AM COLL CARDIOL, V45, P2034, DOI 10.1016/j.jacc.2005.02.082; Notomi Y, 2006, CIRCULATION, V113, P2524, DOI 10.1161/CIRCULATIONAHA.105.596502; Opdahl A, 2012, CIRCULATION, V126, P1441, DOI 10.1161/CIRCULATIONAHA.111.080861; Oppo K, 1998, RADIOLOGY, V208, P453, DOI 10.1148/radiology.208.2.9680575; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Park SJ, 2008, J AM SOC ECHOCARDIOG, V21, P1129, DOI 10.1016/j.echo.2008.04.002; Pennell DJ, 2010, CIRCULATION, V121, P692, DOI 10.1161/CIRCULATIONAHA.108.811547; RADEMAKERS FE, 1992, CIRCULATION, V85, P1572, DOI 10.1161/01.CIR.85.4.1572; Reyhan M, 2013, J MAGN RESON IMAGING, V37, P678, DOI 10.1002/jmri.23849; Reyhan M, 2012, J MAGN RESON IMAGING, V35, P587, DOI 10.1002/jmri.22863; Russel IK, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-26; Russel IK, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-8; Schuster A, 2013, EUR J RADIOL, V82, P296, DOI 10.1016/j.ejrad.2012.11.012; Schuster A, 2013, INT J CARDIOL, V166, P413, DOI 10.1016/j.ijcard.2011.10.137; Schuster A, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-58; Singh A, 2014, J MAGNETIC RESONANCE; Sorger JM, 2003, J CARDIOVASC MAGN R, V5, P521, DOI 10.1081/JCMR-120025227; Wang J, 2008, EUR HEART J, V29, P1283, DOI 10.1093/eurheartj/ehn141; Wu LN, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-10; Yoneyama K, 2012, CIRCULATION, V126, P2481, DOI 10.1161/CIRCULATIONAHA.112.093146; Young AA, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-49	47	35	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109164	10.1371/journal.pone.0109164	http://dx.doi.org/10.1371/journal.pone.0109164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285656	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700050
J	Liu, J; Bu, CP; Wipfler, B; Liang, AP				Liu, Jie; Bu, Cuiping; Wipfler, Benjamin; Liang, Aiping			Comparative Analysis of the Mitochondrial Genomes of Callitettixini Spittlebugs (Hemiptera: Cercopidae) Confirms the Overall High Evolutionary Speed of the AT-Rich Region but Reveals the Presence of Short Conservative Elements at the Tribal Level	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DNA; ORGANIZATION; PHYLOGENY; INSECTA; AUCHENORRHYNCHA; TRANSCRIPTION; COMPILATION; CICADOIDEA; INFERENCE	The present study compares the mitochondrial genomes of five species of the spittlebug tribe Callitettixini (Hemiptera: Cercopoidea: Cercopidae) from eastern Asia. All genomes of the five species sequenced are circular double-stranded DNA molecules and range from 15,222 to 15,637 bp in length. They contain 22 tRNA genes, 13 protein coding genes (PCGs) and 2 rRNA genes and share the putative ancestral gene arrangement of insects. The PCGs show an extreme bias of nucleotide and amino acid composition. Significant differences of the substitution rates among the different genes as well as the different codon position of each PCG are revealed by the comparative evolutionary analyses. The substitution speeds of the first and second codon position of different PCGs are negatively correlated with their GC content. Among the five species, the AT-rich region features great differences in length and pattern and generally shows a 2-5 times higher substitution rate than the fastest PCG in the mitochondrial genome, atp8. Despite the significant variability in length, short conservative segments were identified in the AT-rich region within Callitettixini, although absent from the other groups of the spittlebug superfamily Cercopoidea.	[Liu, Jie; Bu, Cuiping; Wipfler, Benjamin; Liang, Aiping] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Liu, Jie] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Bu, Cuiping] Huaiyin Normal Univ, Jiangsu Key Lab Ecoagr Biotechnol Hongze Lake, Huaian, Jiangsu, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Huaiyin Normal University	Liang, AP (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	liangap@ioz.ac.cn	Wipfler, Benjamin/M-2926-2015		National Basic Research Program of China (973 Program) [2011CB302102]; National Natural Science Foundation of China [30970400, 31172128, 30530110]; Chinese Academy of Sciences [2011Y2SB05]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Basic Research Program of China (973 Program) (grant no 2011CB302102) and the National Natural Science Foundation of China (grant nos 30970400, 31172128 and 30530110), both awarded to APL. BW is supported by the Chinese Academy of Sciences Fellowship for Young International Scientist (grant number 2011Y2SB05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Bachtrog D, 2006, EVOLUTION, V60, P292, DOI 10.1111/j.0014-3820.2006.tb01107.x; Ballard JWO, 2000, J MOL EVOL, V51, P48, DOI 10.1007/s002390010066; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Broughton RE, 2001, GENOME RES, V11, P1958, DOI 10.1101/gr.156801; Burrows M, 2003, NATURE, V424, P509, DOI 10.1038/424509a; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Cook CE, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-105; Cryan JR, 2010, SYST ENTOMOL, V35, P393, DOI 10.1111/j.1365-3113.2009.00520.x; Cryan JR, 2005, SYST ENTOMOL, V30, P563, DOI 10.1111/j.1365-3113.2004.00285.x; DEBRUIJN MHL, 1983, NATURE, V304, P234, DOI 10.1038/304234a0; Dotson EM, 2001, INSECT MOL BIOL, V10, P205, DOI 10.1046/j.1365-2583.2001.00258.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Foster PG, 1997, J MOL EVOL, V44, P282, DOI 10.1007/PL00006145; GARESSE R, 1988, GENETICS, V118, P649; Gorb SN, 2004, ARTHROPOD STRUCT DEV, V33, P201, DOI 10.1016/j.asd.2004.05.008; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hua JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-610; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inoue JG, 2001, MOL PHYLOGENET EVOL, V20, P275, DOI 10.1006/mpev.2001.0970; Kang D, 2002, CURR GENET, V41, P311, DOI 10.1007/s00294-002-0312-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; LEWIS DL, 1994, MOL BIOL EVOL, V11, P523; Li J, 2001, J SW AGR U, V23, P154; Liang Ai-Ping, 1998, Acta Zootaxonomica Sinica, V23, P132; Liu J, 2013, ACTA BIOCH BIOPH SIN, V45, P309, DOI 10.1093/abbs/gmt009; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lynch M, 1997, MOL BIOL EVOL, V14, P914, DOI 10.1093/oxfordjournals.molbev.a025834; Lynch M, 2007, ORIGINS GENOME ARCHI; Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Podsiadlowski L, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-284; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rakitov RA, 2002, ZOOL ANZ, V241, P117, DOI 10.1078/0044-5231-00025; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; SANKOFF D, 1992, P NATL ACAD SCI USA, V89, P6575, DOI 10.1073/pnas.89.14.6575; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Song N, 2009, ACTA BIOCH BIOPH SIN, V41, P206, DOI 10.1093/abbs/gmp003; STEINBERG S, 1994, NAT STRUCT BIOL, V1, P507, DOI 10.1038/nsb0894-507; Stewart JB, 2005, GENOME, V48, P46, DOI 10.1139/G04-090; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thao ML, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-25; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON V, 1994, ECOL ENTOMOL, V19, P391, DOI 10.1111/j.1365-2311.1994.tb00257.x; Thompson V, 1999, CAN J BOT, V77, P1387, DOI 10.1139/cjb-77-9-1387; Xia XH, 1996, GENETICS, V144, P1309; Yukuhiro K, 2002, MOL BIOL EVOL, V19, P1385, DOI 10.1093/oxfordjournals.molbev.a004200; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; Zhou ZJ, 2007, GENOME, V50, P855, DOI 10.1139/G07-057; Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11; Zwickl D. J, 2006, GENETIC ALGORITHM AP	60	25	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109140	10.1371/journal.pone.0109140	http://dx.doi.org/10.1371/journal.pone.0109140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285442	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700048
J	Zhao, EP; Amir, M; Lin, Y; Czaja, MJ				Zhao, Enpeng; Amir, Muhammad; Lin, Yu; Czaja, Mark J.			Stathmin Mediates Hepatocyte Resistance to Death from Oxidative Stress by down Regulating JNK	PLOS ONE			English	Article							DEPENDENT ANION CHANNEL; INDUCED LIVER-INJURY; C-JUN; PROTEIN-KINASE; HEPATOCELLULAR-CARCINOMA; SENSITIZES HEPATOCYTES; POTENTIAL TARGET; POOR-PROGNOSIS; ONCOPROTEIN 18; CELL-DEATH	Stathmin 1 performs a critical function in cell proliferation by regulating microtubule polymerization. This proliferative function is thought to explain the frequent overexpression of stathmin in human cancer and its correlation with a bad prognosis. Whether stathmin also functions in cell death pathways is unclear. Stathmin regulates microtubules in part by binding free tubulin, a process inhibited by stathmin phosphorylation from kinases including c-Jun N-terminal kinase (JNK). The involvement of JNK activation both in stathmin phosphorylation, and in hepatocellular resistance to oxidative stress, led to an examination of the role of stathmin/JNK crosstalk in oxidant-induced hepatocyte death. Oxidative stress from menadione-generated superoxide induced JNK-dependent stathmin phosphorylation at Ser-16, Ser-25 and Ser-38 in hepatocytes. A stathmin knockdown sensitized hepatocytes to both apoptotic and necrotic cell death from menadione without altering levels of oxidant generation. The absence of stathmin during oxidative stress led to JNK overactivation that was the mechanism of cell death as a concomitant knockdown of JNK1 or JNK2 blocked death. Hepatocyte death from JNK overactivation was mediated by the effects of JNK on mitochondria. Mitochondrial outer membrane permeabilization occurred in stathmin knockdown cells at low concentrations of menadione that triggered apoptosis, whereas mitochondrial beta-oxidation and ATP homeostasis were compromised at higher, necrotic menadione concentrations. Stathmin therefore mediates hepatocyte resistance to death from oxidative stress by down regulating JNK and maintaining mitochondrial integrity. These findings demonstrate a new mechanism by which stathmin promotes cell survival and potentially tumor growth.	[Czaja, Mark J.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Czaja, MJ (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	mark.czaja@einstein.yu.edu			NIH [R01DK044234]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044234] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIH grant R01DK044234 (MJC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alli E, 2007, MOL PHARMACOL, V71, P1233, DOI 10.1124/mol.106.029702; Amir M, 2012, J CELL BIOCHEM, V113, P3254, DOI 10.1002/jcb.24203; Bai JX, 2001, J BIOL CHEM, V276, P4315, DOI 10.1074/jbc.M008895200; Belletti B, 2011, EXPERT OPIN THER TAR, V15, P1249, DOI 10.1517/14728222.2011.620951; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BERETTA L, 1993, J BIOL CHEM, V268, P20076; Bradham CA, 2001, AM J PHYSIOL-GASTR L, V281, pG1279, DOI 10.1152/ajpgi.2001.281.5.G1279; BRATTSAND G, 1993, LEUKEMIA, V7, P569; Bubici C, 2014, BRIT J PHARMACOL, V171, P24, DOI 10.1111/bph.12432; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; CHOU JY, 1983, MOL CELL BIOL, V3, P1013, DOI 10.1128/MCB.3.6.1013; Conde de la Rosa L, 2006, J HEPATOL, V44, P918, DOI DOI 10.1016/J.JHEP.2005.07.034; Czaja MJ, 2007, SEMIN LIVER DIS, V27, P378, DOI 10.1055/s-2007-991514; Czaja MJ, 2010, TRENDS ENDOCRIN MET, V21, P707, DOI 10.1016/j.tem.2010.08.010; Czaja MJ, 2003, HEPATOLOGY, V37, P1405, DOI 10.1053/jhep.2003.50233; Czaja MJ, 2003, AM J PHYSIOL-GASTR L, V284, pG875, DOI 10.1152/ajpgi.00549.2002; Das M, 2011, GENE DEV, V25, P634, DOI 10.1101/gad.1989311; Ghosh R, 2007, PROSTATE, V67, P1038, DOI 10.1002/pros.20601; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; Jones BE, 2000, J BIOL CHEM, V275, P705, DOI 10.1074/jbc.275.1.705; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; KOPPEL J, 1993, FEBS LETT, V331, P65, DOI 10.1016/0014-5793(93)80298-9; LARSSON N, 1995, J BIOL CHEM, V270, P14175, DOI 10.1074/jbc.270.23.14175; Liedtke C, 2002, HEPATOLOGY, V36, P315, DOI 10.1053/jhep.2002.34615; Liu HL, 2002, HEPATOLOGY, V35, P772, DOI 10.1053/jhep.2002.32534; Lovric J, 1998, J BIOL CHEM, V273, P22848; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Mizumura K, 2006, J CELL PHYSIOL, V206, P363, DOI 10.1002/jcp.20465; Ng DCH, 2010, J BIOL CHEM, V285, P29001, DOI 10.1074/jbc.M110.128454; NISHIKAWA Y, 1995, J BIOL CHEM, V270, P28304, DOI 10.1074/jbc.270.47.28304; OKAZAKI T, 1993, FEBS LETT, V336, P8, DOI 10.1016/0014-5793(93)81598-T; Piva R, 2006, BLOOD, V107, P689, DOI 10.1182/blood-2005-05-2125; Rostovtseva TK, 2012, J BIOL CHEM, V287, P29589, DOI 10.1074/jbc.M112.378778; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; SCHUBART UK, 1992, DIFFERENTIATION, V51, P21, DOI 10.1111/j.1432-0436.1992.tb00676.x; Schwabe RF, 2004, FASEB J, V18, P720, DOI 10.1096/fj.03-0771fje; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Singh R, 2007, J GASTROEN HEPATOL, V22, pS45, DOI 10.1111/j.1440-1746.2006.04646.x; Singh R, 2009, AM J PHYSIOL-GASTR L, V297, pG907, DOI 10.1152/ajpgi.00151.2009; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Vancompernolle K, 2000, J BIOL CHEM, V275, P33876, DOI 10.1074/jbc.M004785200; Wang YJ, 2004, J BIOL CHEM, V279, P31089, DOI 10.1074/jbc.M404170200; Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200; Wang YJ, 2010, HEPATOLOGY, V52, P266, DOI 10.1002/hep.23645; Win S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.522; Xu J, 1996, AM J PHYSIOL-GASTR L, V270, pG60, DOI 10.1152/ajpgi.1996.270.1.G60; Xu Y, 1998, AM J PHYSIOL-CELL PH, V275, pC1058, DOI 10.1152/ajpcell.1998.275.4.C1058; Yeap YYC, 2010, BIOCHEM J, V430, P345, DOI 10.1042/BJ20100425; Yuan RH, 2006, J PATHOL, V209, P549, DOI 10.1002/path.2011	54	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109750	10.1371/journal.pone.0109750	http://dx.doi.org/10.1371/journal.pone.0109750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285524	Green Submitted, Green Published, gold			2022-12-27	WOS:000345743700088
J	Everaert, G; De Neve, J; Boets, P; Dominguez-Granda, L; Mereta, ST; Ambelu, A; Hoang, TH; Goethals, PLM; Thas, O				Everaert, Gert; De Neve, Jan; Boets, Pieter; Dominguez-Granda, Luis; Mereta, Seid Tiku; Ambelu, Argaw; Hoang, Thu Huong; Goethals, Peter L. M.; Thas, Olivier			Comparison of the Abiotic Preferences of Macroinvertebrates in Tropical River Basins	PLOS ONE			English	Article							DECISION TREE MODELS; WATER-QUALITY; BENTHIC MACROINVERTEBRATES; MULTIMETRIC INDEX; NATURAL WETLANDS; ASSEMBLAGES; STREAMS; ABUNDANCE; SYSTEM; COMMUNITIES	We assessed and compared abiotic preferences of aquatic macroinvertebrates in three river basins located in Ecuador, Ethiopia and Vietnam. Upon using logistic regression models we analyzed the relationship between the probability of occurrence of five macroinvertebrate families, ranging from pollution tolerant to pollution sensitive, (Chironomidae, Baetidae, Hydroptilidae, Libellulidae and Leptophlebiidae) and physical-chemical water quality conditions. Within the investigated physical-chemical ranges, nine out of twenty-five interaction effects were significant. Our analyses suggested river basin dependent associations between the macroinvertebrate families and the corresponding physical-chemical conditions. It was found that pollution tolerant families showed no clear abiotic preference and occurred at most sampling locations, i.e. Chironomidae were present in 91%, 84% and 93% of the samples taken in Ecuador, Ethiopia and Vietnam. Pollution sensitive families were strongly associated with dissolved oxygen and stream velocity, e.g. Leptophlebiidae were only present in 48%, 2% and 18% of the samples in Ecuador, Ethiopia and Vietnam. Despite some limitations in the study design, we concluded that associations between macroinvertebrates and abiotic conditions can be river basin-specific and hence are not automatically transferable across river basins in the tropics.	[Everaert, Gert; Boets, Pieter; Goethals, Peter L. M.] Univ Ghent, Dept Appl Ecol & Environm Biol, Aquat Ecol Res Unit, B-9000 Ghent, Belgium; [Everaert, Gert] Univ Ghent, Dept Appl Ecol & Environm Biol, Environm Toxicol Res Grp, B-9000 Ghent, Belgium; [De Neve, Jan; Thas, Olivier] Univ Ghent, Dept Math Modelling Stat & Bioinformat, B-9000 Ghent, Belgium; [Dominguez-Granda, Luis] ESPOL, Dept Chem & Environm Sci, Guayaquil, Ecuador; [Mereta, Seid Tiku; Ambelu, Argaw] Jimma Univ, Dept Environm Hlth Sci & Technol, Jimma, Ethiopia; [Hoang, Thu Huong] Hanoi Univ Sci & Technol, Sch Environm Sci & Technol, Hanoi, Vietnam; [Thas, Olivier] Univ Wollongong, Sch Math & Appl Stat, NIASRA, Wollongong, NSW, Australia	Ghent University; Ghent University; Ghent University; Escuela Superior Politecnica del Litoral; Jimma University; Hanoi University of Science & Technology; University of Wollongong	Everaert, G (corresponding author), Univ Ghent, Dept Appl Ecol & Environm Biol, Aquat Ecol Res Unit, B-9000 Ghent, Belgium.	Gert.Everaert@UGent.be	Goethals, Peter LM/A-1116-2008; Everaert, Gert/B-7707-2017; Ambelu, Argaw/GQA-6114-2022; Mereta, Seid Tiku/HIA-0661-2022; Ambelu, Argaw/V-8317-2018	Everaert, Gert/0000-0003-4305-0617; Ambelu, Argaw/0000-0003-1898-4100; Ambelu, Argaw/0000-0003-1898-4100; Dominguez-Granda, Luis/0000-0001-6527-4828; Thas, Olivier/0000-0001-6442-4089; Hoang, Thu Huong/0000-0003-1132-2884	VLIR ESPOL IUC program in Ecuador; SENACYT; ICP-PhD scholarship from VLIR-UOS; IUC-PhD scholarship from VLIR-UOS; Belgian Technical Cooperation (BTC); VLIR Ecuador Biodiversity Network	VLIR ESPOL IUC program in Ecuador; SENACYT; ICP-PhD scholarship from VLIR-UOS; IUC-PhD scholarship from VLIR-UOS; Belgian Technical Cooperation (BTC); VLIR Ecuador Biodiversity Network	Pieter Boets is a postdoctoral research fellow from the Research Foundation Flanders (FWO - http://www.fwo.be/en/). Luis Dominguez-Granda received financial support of the VLIR ESPOL IUC program in Ecuador and SENACYT (http://www.vliruos.be/en/project-funding/programdetail/institutional-university-cooperation_3948/and http://www.educacionsuperior.gob.ec/). Argaw Ambelu was a recipient of an ICP-PhD scholarship from VLIR-UOS(http://www.vliruos.be/en/countries/countrydetail/ethiopia_3854/). Seid Tiku Mereta was a recipient of a IUC-PhD scholarship from VLIR-UOS (http://www.iucju.ugent.be/). Thu Huong Hoang received financial aid from the Belgian Technical Cooperation (BTC - http://www.btcctb.org/en/countries/vietnam). Marie Anne Eurie Forio and Minar Naomi Damanik Ambarita cooperated with financial support of the VLIR Ecuador Biodiversity Network (http://www.vliruos.be/en/ongoing-projects/overview-of-ongoing-projects/network-cooperation/network-biodev-ecuador/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shami SA, 2013, FRESHWATER BIOL, V58, P1126, DOI 10.1111/fwb.12113; ALBATERCEDOR J, 1988, LIMNETICA, V4, P51; Ambelu A, 2010, ECOL INFORM, V5, P147, DOI 10.1016/j.ecoinf.2009.12.004; Armitage P. D., 1995, CHIRONOMIDAE BIOL EC; ARMITAGE PD, 1983, WATER RES, V17, P333, DOI 10.1016/0043-1354(83)90188-4; Blanchette ML, 2012, FRESHW SCI, V31, P865, DOI 10.1899/11-068.1; Boets P, 2013, ECOL INFORM, V18, P49, DOI 10.1016/j.ecoinf.2013.06.008; Bonada N, 2008, FRESHWATER BIOL, V53, P772, DOI 10.1111/j.1365-2427.2007.01940.x; Broothaerts N, 2012, CATENA, V97, P127, DOI 10.1016/j.catena.2012.05.011; Cairns John Jr., 1993, P10; Chapman G, 1986, 440586003 EPA; Chapman LJ, 2004, BIOTROPICA, V36, P572, DOI 10.1646/1598; Chler J.R., 1970, WATER POLLUT CONTROL, V69, P415; Chutter FM, 1994, CLASSIFICATION RIVER, P217; Colombo D, 2004, A4511403 CESI; Connolly NM, 2004, J N AM BENTHOL SOC, V23, P251, DOI 10.1899/0887-3593(2004)023&lt;0251:EOLDOO&gt;2.0.CO;2; Couceiro SRM, 2012, ECOL INDIC, V18, P118, DOI 10.1016/j.ecolind.2011.11.001; D'heygere T, 2003, ECOL MODEL, V160, P291, DOI 10.1016/S0304-3800(02)00260-0; Dakou E, 2007, AQUAT ECOL, V41, P399, DOI 10.1007/s10452-006-9058-y; Demissie TA, 2013, EUROPEAN INT J SCI T, V2, P64; Dominguez-Granda L, 2007, THESIS GHENT U GENT; Dominguez-Granda L, 2011, ECOL INFORM, V6, P303, DOI 10.1016/j.ecoinf.2011.05.004; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Everaert G, 2013, ECOL ENG, V53, P144, DOI 10.1016/j.ecoleng.2012.12.034; Everaert G, 2011, ECOL MODEL, V222, P2202, DOI 10.1016/j.ecolmodel.2010.08.013; FLECKER AS, 1994, FRESHWATER BIOL, V31, P131, DOI 10.1111/j.1365-2427.1994.tb00847.x; Fukuda S, 2012, ENVIRON MONIT ASSESS, V184, P6159, DOI 10.1007/s10661-011-2410-2; Gabriels W, 2010, LIMNOLOGICA, V40, P199, DOI 10.1016/j.limno.2009.10.001; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Helson JE, 2013, ECOL INDIC, V29, P167, DOI 10.1016/j.ecolind.2012.12.030; Hoang TH, 2010, ECOL INFORM, V5, P140, DOI 10.1016/j.ecoinf.2009.12.001; Holguin-Gonzalez JE, 2013, ENVIRON MODELL SOFTW, V48, P27, DOI 10.1016/j.envsoft.2013.06.004; Nguyen HH, 2014, LIMNOLOGICA, V45, P16, DOI 10.1016/j.limno.2013.10.001; Horton NJ, 1999, STAT MED, V18, P213, DOI 10.1002/(SICI)1097-0258(19990130)18:2<213::AID-SIM999>3.0.CO;2-E; Howard C, 2014, METHODS ECOL EVOL, V5, P506, DOI 10.1111/2041-210X.12184; Hynes HBN., 1970, ECOLOGY RUNNING WATE; Kasangaki A, 2008, FRESHWATER BIOL, V53, P681, DOI 10.1111/j.1365-2427.2007.01925.x; KERANS BL, 1994, ECOL APPL, V4, P768, DOI 10.2307/1942007; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Marques MM, 2001, HYDROBIOLOGIA, V457, P69, DOI 10.1023/A:1012297915323; Matamoros D, 2004, THESIS GHENT U GENT; Melo AS, 2009, ZOOLOGIA, V26, P79, DOI 10.1590/S1984-46702009000100013; Menezes S, 2010, J APPL ECOL, V47, P711, DOI 10.1111/j.1365-2664.2010.01819.x; Mereta ST, 2013, ECOL INDIC, V29, P510, DOI 10.1016/j.ecolind.2013.01.026; Mereta ST, 2012, ECOL INFORM, V7, P52, DOI 10.1016/j.ecoinf.2011.11.005; Molozzi J, 2012, ECOL INDIC, V23, P155, DOI 10.1016/j.ecolind.2012.03.023; MONRE, 2006, NAT STRAT WAT RES 20; Mouton AM, 2009, ECOL MODEL, V220, P1776, DOI 10.1016/j.ecolmodel.2009.04.020; Moya N, 2007, HYDROBIOLOGIA, V589, P107, DOI 10.1007/s10750-007-0725-3; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rawi CSM, 2014, ECOHYDROLOGY, V7, P496, DOI 10.1002/eco.1368; Rios-Touma B, 2011, INT REV HYDROBIOL, V96, P667, DOI 10.1002/iroh.201111342; Rosenberg David M., 1993, P1; Rushton SP, 2004, J APPL ECOL, V41, P193, DOI 10.1111/j.0021-8901.2004.00903.x; Thorne RS, 1997, FRESHWATER BIOL, V37, P671, DOI 10.1046/j.1365-2427.1997.00181.x; Tixier G, 2009, FUND APPL LIMNOL, V174, P227, DOI 10.1127/1863-9135/2009/0174-0227; Tomanova S, 2006, HYDROBIOLOGIA, V556, P251, DOI 10.1007/s10750-005-1255-5; Turak E, 1999, FRESHWATER BIOL, V41, P283, DOI 10.1046/j.1365-2427.1999.00431.x; Uhlenbrook S, 2010, HYDROL EARTH SYST SC, V14, P2153, DOI 10.5194/hess-14-2153-2010; Vaughan IP, 2005, J APPL ECOL, V42, P720, DOI 10.1111/j.1365-2664.2005.01052.x; Zuellig RE, 2012, FRESHW SCI, V31, P1042, DOI 10.1899/11-150.1; Zuur Alain F., 2009, P1	64	21	21	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108898	10.1371/journal.pone.0108898	http://dx.doi.org/10.1371/journal.pone.0108898			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279673	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800035
J	Iwamune, M; Nakamura, K; Kitahara, Y; Minegishi, T				Iwamune, Masayuki; Nakamura, Kazuto; Kitahara, Yoshikazu; Minegishi, Takashi			MicroRNA-376a Regulates 78-Kilodalton Glucose-Regulated Protein Expression in Rat Granulosa Cells	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; MESSENGER-RNAS; BINDING SITES; MIRNAS; CANCER; PROLIFERATION; BIOGENESIS; MECHANISMS; TARGETS	The 78-kilodalton glucose-regulated protein (GRP78) is a molecular chaperone that assists in protein assembly, folding, and translocation. Recently, our laboratory reported that GRP78 regulates the expression of luteinizing hormone-human chorionic gonadotropin receptor (LHR) in the early stage of corpus luteum formation. In this study, we investigated whether microRNAs (miRNAs), which post-transcriptionally regulate mRNA, are involved in the regulation mechanism of GRP78 in the ovary. A miRNA microarray was performed to analyze the overall miRNA expression profile, and the results indicated that 44 miRNAs were expressed highly after ovulation was induced. The results from a bio-informative database analysis and in vitro granulosa cell culture studies led us to focus on rno-miR-376a for further analysis. In both in vivo and in vitro studies, rno-miR- 376a levels increased 12 h after human chorionic gonadotropin (hCG) administration. To elucidate whether rno-miR-376a induced mRNA destabilization or translational repression of GRP78, rno-miR-376a was transfected into cultured granulosa cells, resulting in decreased GPR78 protein levels without an alteration in GRP78 mRNA levels. To confirm that rno-miR-376a binds to GRP78 mRNA, we cloned the 3'-end of GRP78 mRNA (nucleotides 2439-2459) into a reporter vector that contained a Renilla luciferase coding region upstream of the cloning site. The luciferase assays revealed that rno-miR-376a bound to the 3'-end of GRP78 mRNA. From these data, we conclude that rno-miR-376a potentially negatively regulates GRP78 protein expression through translational repression at an early stage transition from the follicular phase to luteinization.	[Iwamune, Masayuki; Kitahara, Yoshikazu; Minegishi, Takashi] Gunma Univ, Grad Sch Med, Dept Obstet & Gynecol, Maebashi, Gunma 371, Japan; [Nakamura, Kazuto] Gunma Prefectural Canc Ctr, Dept Gynecol, Ota, Gunma, Japan	Gunma University	Nakamura, K (corresponding author), Gunma Prefectural Canc Ctr, Dept Gynecol, Ota, Gunma, Japan.	nkazuto@gunma-cc.jp						Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; Carletti MZ, 2010, BIOL REPROD, V83, P286, DOI 10.1095/biolreprod.109.081448; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Espey LL, 2002, BIOL REPROD, V67, P1662, DOI 10.1095/biolreprod.102.005173; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kitahara Y, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109207; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; Kogure K, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.101873; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038640; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; McBride D, 2012, REPRODUCTION, V144, P221, DOI 10.1530/REP-12-0025; Menon KMJ, 2005, ENDOCRINE, V26, P249, DOI 10.1385/ENDO:26:3:249; Otsuka M, 2008, J CLIN INVEST, V118, P1944, DOI 10.1172/JCI33680; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Richards JS, 2002, ANNU REV PHYSIOL, V64, P69, DOI 10.1146/annurev.physiol.64.081501.131029; Ruddon RW, 1997, J BIOL CHEM, V272, P3125, DOI 10.1074/jbc.272.6.3125; Sangokoya C, 2010, BLOOD, V116, P4338, DOI 10.1182/blood-2009-04-214817; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Yao GD, 2010, MOL ENDOCRINOL, V24, P540, DOI 10.1210/me.2009-0432; ZELEZNIK AJ, 1974, ENDOCRINOLOGY, V95, P818, DOI 10.1210/endo-95-3-818; ZELEZNIK AJ, 1981, ENDOCRINOLOGY, V109, P356, DOI 10.1210/endo-109-2-356	35	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108997	10.1371/journal.pone.0108997	http://dx.doi.org/10.1371/journal.pone.0108997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279841	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800046
J	Jakimska, A; Sliwka-Kaszynska, M; Nagorski, P; Namiesnik, J; Kot-Wasik, A				Jakimska, Anna; Sliwka-Kaszynska, Magdalena; Nagorski, Piotr; Namiesnik, Jacek; Kot-Wasik, Agata			Phototransformation of Amlodipine: Degradation Kinetics and Identification of Its Photoproducts	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; TRANSFORMATION PRODUCTS; AQUATIC ENVIRONMENT; WASTE-WATER; PHARMACEUTICALS; PHOTODEGRADATION; ELUCIDATION; IBUPROFEN; SURFACE; BIOTRANSFORMATION	Nowadays, monitoring focuses on the primary compounds and does not include degradation products formed during various biological and chemical processes. Transformation products may have the same effects to human health and the environment or sometimes they can be more toxic than the parent compound. Unfortunately, knowledge about the formation of degradation products is still limited, however, can be very important for the environmental risk assessment. Firstly, the photodegradation kinetic of amlodipine was investigated in two experimental conditions: during the exposure to solar radiation and during the exposure to the light emitted by the xenon lamp. In all cases degradation of amlodipine followed a pseudo-first-order kinetics. In the next step, identification of transformation products of amlodipine formed during the exposure to xenon lamp irradiation was performed using ultra high performance liquid chromatography quadrupole time-of-flight mass spectrometry (UHPLC-QTOF-MS). As a result sixteen photoproducts were identified, their structures were elucidated and ultimately the transformation pathway was proposed. Fifteen compounds (out of 16 photoproducts) were newly identified and reported here for the first time; some of those compounds were formed from the first photoproduct, amlodipine pyridine derivative. Several analytes were formed only in acidic or basic conditions. Furthermore, the occurrence of amlodipine and its identified degradation products was investigated in environmental waters. Only one out of 16 compounds was found in wastewater effluent. The possibility of the sorption of examined analytes to sewage sludge particles was discussed based on QSAR.	[Jakimska, Anna; Nagorski, Piotr; Namiesnik, Jacek; Kot-Wasik, Agata] Gdansk Univ Technol, Fac Chem, Dept Analyt Chem, Gdansk, Poland; [Sliwka-Kaszynska, Magdalena] Gdansk Univ Technol, Fac Chem, Dept Organ Chem, Gdansk, Poland	Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Gdansk University of Technology	Jakimska, A (corresponding author), Gdansk Univ Technol, Fac Chem, Dept Analyt Chem, Gdansk, Poland.	anik.jakimus@interia.pl	Kot-Wasik, Agata/GQZ-4091-2022	Kot-Wasik, Agata/0000-0002-2546-3779; Sliwka-Kaszynska, Magdalena/0000-0002-9717-3893; Namiesnik, Jacek/0000-0001-9598-2198	Polish National Science Centre [2012/05/N/ST4/01991, 2013/08/T/ST4/00637]	Polish National Science Centre	This scientific work (as research project no. 2012/05/N/ST4/01991) has been financially supported within the framework of a grant awarded by the Polish National Science Centre (in the years 2013-2014). AJ has been financially supported for the preparation of a doctoral dissertation (that includes the research presented in the manuscript) within the funding of a doctoral scholarship awarded by the Polish National Science Centre on the basis of the decision number 2013/08/T/ST4/00637. The authors also acknowledge Professor Adriana Zaleska for providing access to xenon lamp used during the experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alapi T, 2007, J PHOTOCH PHOTOBIO A, V188, P409, DOI 10.1016/j.jphotochem.2007.01.002; Andreozzi R, 2003, CHEMOSPHERE, V50, P1319, DOI 10.1016/S0045-6535(02)00769-5; Azzouz A, 2013, CHEMOSPHERE, V93, P2046, DOI 10.1016/j.chemosphere.2013.07.037; Boreen AL, 2003, AQUAT SCI, V65, P320, DOI 10.1007/s00027-003-0672-7; Boxall ABA, 2004, ENVIRON SCI TECHNOL, V38, p368A, DOI 10.1021/es040624v; Collado N, 2012, SCI TOTAL ENVIRON, V433, P296, DOI 10.1016/j.scitotenv.2012.06.060; Damale S, 2013, CHARACTERIZATION PRO; DellaGreca M, 2007, INT J PHOTOENERGY, V2007, P1; Devi ASL, 2007, MAGN RESON CHEM, V45, P688, DOI 10.1002/mrc.2022; Eranki RJV, 2013, AM J ANAL CHEM, V4, P715, DOI DOI 10.4236/ajac.2013.412086; Fasani E, 2008, INT J PHARM, V352, P197, DOI 10.1016/j.ijpharm.2007.10.040; Fatta-Kassinos D, 2011, CHEMOSPHERE, V85, P693, DOI 10.1016/j.chemosphere.2011.06.082; Gorska P, 2009, SEP PURIF TECHNOL, V68, P90, DOI 10.1016/j.seppur.2009.04.012; Gros M, 2012, J CHROMATOGR A, V1248, P104, DOI 10.1016/j.chroma.2012.05.084; Halling-Sorensen B, 2002, ARCH ENVIRON CON TOX, V42, P263, DOI 10.1007/s00244-001-0017-2; Horsing M, 2011, WATER RES, V45, P4470, DOI 10.1016/j.watres.2011.05.033; Huntscha S, 2014, ENVIRON SCI TECHNOL, V48, P4435, DOI 10.1021/es405694z; Illes E, 2013, SCI TOTAL ENVIRON, V447, P286, DOI 10.1016/j.scitotenv.2013.01.007; Jakimska A, 2014, ANAL BIOANAL CHEM, V406, P3667, DOI 10.1007/s00216-014-7614-1; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kim I, 2009, ENVIRON INT, V35, P793, DOI 10.1016/j.envint.2009.01.003; Kosjek T, 2007, TRAC-TREND ANAL CHEM, V26, P1076, DOI 10.1016/j.trac.2007.10.005; Krauss M, 2010, ANAL BIOANAL CHEM, V397, P943, DOI 10.1007/s00216-010-3608-9; Kreutz R, 2011, VASC HEALTH RISK MAN, V7, P183, DOI 10.2147/VHRM.S16852; Lin AYC, 2005, ENVIRON TOXICOL CHEM, V24, P1303, DOI 10.1897/04-236R.1; Michael I, 2014, ADV MASS SPECTROM, P413; Naidu HR, 2005, J PHARM BIOMED ANAL, V39, P147; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Pascoe D, 2003, CHEMOSPHERE, V51, P521, DOI 10.1016/S0045-6535(02)00860-3; Qi WY, 2013, J CHROMATOGR B, V938, P27, DOI 10.1016/j.jchromb.2013.08.026; Ragno G, 2002, J PHARMACEUT BIOMED, V27, P19, DOI 10.1016/S0731-7085(01)00556-8; Santos LHMLM, 2013, SCI TOTAL ENVIRON, V461, P302, DOI 10.1016/j.scitotenv.2013.04.077; Santos LHMLM, 2010, J HAZARD MATER, V175, P45, DOI 10.1016/j.jhazmat.2009.10.100; Schymanski EL, 2014, ENVIRON SCI TECHNOL, V48, P2097, DOI 10.1021/es5002105; U. S. Environmental Protection Agency, 2014, EST PROGR INT SUIT M; Yan Q, 2014, SCI TOTAL ENVIRON, V470, P618, DOI 10.1016/j.scitotenv.2013.09.032; Yu Q, 2011, CHROMATOGRAPHIA, V73, P257, DOI 10.1007/s10337-010-1883-4	37	9	9	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109206	10.1371/journal.pone.0109206	http://dx.doi.org/10.1371/journal.pone.0109206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279815	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800062
J	Bauman, TM; Nicholson, TM; Abler, LL; Eliceiri, KW; Huang, W; Vezina, CM; Ricke, WA				Bauman, Tyler M.; Nicholson, Tristan M.; Abler, Lisa L.; Eliceiri, Kevin W.; Huang, Wei; Vezina, Chad M.; Ricke, William A.			Characterization of Fibrillar Collagens and Extracellular Matrix of Glandular Benign Prostatic Hyperplasia Nodules	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; IMAGE-ANALYSIS; RECEPTOR EXPRESSION; FIBROSIS; CANCER; MEN; INFLAMMATION; FINASTERIDE; THERAPY; CELLS	Objective: Recent studies have associated lower urinary tract symptoms (LUTS) in men with prostatic fibrosis, but a definitive link between collagen deposition and LUTS has yet to be demonstrated. The objective of this study was to evaluate ECM and collagen content within normal glandular prostate tissue and glandular BPH, and to evaluate the association of clinical parameters of LUTS with collagen content. Methods: Fibrillar collagen and ECM content was assessed in normal prostate (48 patients) and glandular BPH nodules (24 patients) using Masson's trichrome stain and Picrosirius red stain. Second harmonic generation (SHG) imaging was used to evaluate collagen content. Additional BPH tissues (n = 47) were stained with Picrosirius red and the association between clinical parameters of BPH/LUTS and collagen content was assessed. Results: ECM was similar in normal prostate and BPH (p = 0.44). Total collagen content between normal prostate and glandular BPH was similar (p = 0.27), but a significant increase in thicker collagen bundles was observed in BPH (p = 0.045). Using SHG imaging, collagen content in BPH (mean intensity = 62.52; SEM = 2.74) was significantly higher than in normal prostate (51.77 +/- 3.49; p = 0.02). Total collagen content was not associated with treatment with finasteride (p = 0.47) or alpha-blockers (p = 0.52), pre-TURP AUA symptom index (p = 0.90), prostate-specific antigen (p = 0.86), post-void residual (PVR; p = 0.32), prostate size (p = 0.21), or post-TURP PVR (p = 0.51). Collagen content was not associated with patient age in patients with BPH, however as men aged normal prostatic tissue had a decreased proportion of thick collagen bundles. Conclusions: The proportion of larger bundles of collagen, but not total collagen, is increased in BPH nodules, suggesting that these large fibers may play a role in BPH/LUTS. Total collagen content is independent of clinical parameters of BPH and LUTS. If fibrosis and overall ECM deposition are associated with BPH/LUTS, this relationship likely exists in regions of the prostate other than glandular hyperplasia.	[Bauman, Tyler M.; Nicholson, Tristan M.; Ricke, William A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Urol, Madison, WI 53706 USA; [Abler, Lisa L.; Vezina, Chad M.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA; [Eliceiri, Kevin W.] Univ Wisconsin, Grad Sch, Lab Opt & Computat Instrumentat, Madison, WI 53706 USA; [Huang, Wei] Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth, Madison, WI USA; [Ricke, William A.] Univ Wisconsin, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ricke, WA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Urol, Madison, WI 53706 USA.	rickew@urology.wisc.edu	Bauman, Tyler/F-3647-2014; Vezina, Chad/GRO-2299-2022; Eliceiri, Kevin/ABD-4516-2020	Bauman, Tyler/0000-0002-1183-4233; Eliceiri, Kevin/0000-0001-8678-670X; Vezina, Chad/0000-0001-7058-5399; Ricke, William/0000-0002-9807-2090	National Institutes of Health [R01-CA123199, R01-DK093690, K01-DK083425, T32-GM07356, F30-DK093173]; NATIONAL CANCER INSTITUTE [R01CA123199, P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093690, F30DK093173, K01DK083425, U54DK104310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health: R01-CA123199 (WAR), R01-DK093690 (WAR), K01-DK083425 (CMV), T32-GM07356 (TMN), and F30-DK093173 (TMN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Aida-Yasuoka K, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4140; Barcus CE, 2013, J BIOL CHEM, V288, P12722, DOI 10.1074/jbc.M112.447631; Bauman TM, 2014, PROSTATE, V74, P923, DOI 10.1002/pros.22810; Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103; Cantiello F, 2013, UROLOGY, V81, P1018, DOI 10.1016/j.urology.2013.01.053; Chapple CR, 2006, EUR UROL, V49, P651, DOI 10.1016/j.eururo.2006.02.018; Cox G, 2003, J STRUCT BIOL, V141, P53, DOI 10.1016/S1047-8477(02)00576-2; Drifka CR, 2013, LAB CHIP, V13, P3965, DOI 10.1039/c3lc50487e; Encarnacion MMD, 2004, AM J TRANSPLANT, V4, P248, DOI 10.1046/j.1600-6143.2003.00311.x; Grewal P, 2009, CLIN LIVER DIS, V13, P331, DOI 10.1016/j.cld.2009.02.006; Grimm PC, 2003, J AM SOC NEPHROL, V14, P1662, DOI 10.1097/01.ASN.0000066143.02832.5E; Hanson KP, 2013, TISSUE ENG PT A, V19, P1132, DOI [10.1089/ten.tea.2012.0316, 10.1089/ten.TEA.2012.0316]; Hollingsworth John M, 2006, Rev Urol, V8 Suppl 3, pS9; Huang W, 2013, HUM PATHOL, V44, P29, DOI 10.1016/j.humpath.2012.05.009; Irwin DE, 2011, BJU INT, V108, P1132, DOI 10.1111/j.1464-410X.2010.09993.x; Juodziukyniene N, 2010, POL J VET SCI, V13, P479; KruithofDekker IG, 1996, J UROLOGY, V156, P1194, DOI 10.1016/S0022-5347(01)65749-5; Lee NG, 2012, CAN J UROL, V19, P6170; Ma JJ, 2012, J UROLOGY, V188, P1375, DOI 10.1016/j.juro.2012.06.007; Masson P., 1929, J TECH METHODS, V12, P75; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Nicholson TM, 2013, DIFFERENTIATION, V85, P140, DOI 10.1016/j.diff.2013.02.006; Nickel JC, 2006, AM J MANAG CARE, V12, pS141; Parsons JK, 2008, UROLOGY, V72, P318, DOI 10.1016/j.urology.2008.03.057; PUCHTLER H, 1973, BEITR PATHOL, V150, P174, DOI 10.1016/S0005-8165(73)80016-2; Reusch LM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.031110; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; RIFKIN MD, 1989, RADIOLOGY, V170, P549, DOI 10.1148/radiology.170.2.2643148; Rodriguez-Nieves JA, 2013, NAT REV UROL, V10, P546, DOI 10.1038/nrurol.2013.149; Roehrborn CG, 2002, UROLOGY, V60, P434, DOI 10.1016/S0090-4295(02)01905-2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sfanos KS, 2012, HISTOPATHOLOGY, V60, P199, DOI 10.1111/j.1365-2559.2011.04033.x; Smith RD, 2011, CURR OPIN UROL, V21, P36, DOI 10.1097/MOU.0b013e3283411455; Tsai MR, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3365943; Vogel WF, 2001, EUR J DERMATOL, V11, P506; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743	39	61	63	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109102	10.1371/journal.pone.0109102	http://dx.doi.org/10.1371/journal.pone.0109102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275645	Green Submitted, Green Published, gold			2022-12-27	WOS:000342591500061
J	Deifl, S; Zwicker, C; Vejvar, E; Kitzmuller, C; Gadermaier, G; Nagl, B; Vrtala, S; Briza, P; Zlabinger, GJ; Jahn-Schmid, B; Ferreira, F; Bohle, B				Deifl, Stephan; Zwicker, Christian; Vejvar, Eva; Kitzmueller, Claudia; Gadermaier, Gabriele; Nagl, Birgit; Vrtala, Susanne; Briza, Peter; Zlabinger, Gerhard J.; Jahn-Schmid, Beatrice; Ferreira, Fatima; Bohle, Barbara			Glutathione-S-Transferase: A Minor Allergen in Birch Pollen due to Limited Release from Hydrated Pollen	PLOS ONE			English	Article							CROSS-REACTIVITY; MOLECULAR CHARACTERIZATION; EPITOPE ANALYSIS; MAJOR ALLERGEN; IGE-BINDING; DUST-MITE; COCKROACH; EXPRESSION; FAMILY; CLONING	Background: Recently, a protein homologous to glutathione-S-transferases (GST) was detected in prominent amounts in birch pollen by proteomic profiling. As members of the GST family are relevant allergens in mites, cockroach and fungi we investigated the allergenic relevance of GST from birch (bGST). Methodology: bGST was expressed in Escherichia coli, purified and characterized by mass spectrometry. Sera from 217 birch pollen-allergic patients were tested for IgE-reactivity to bGST by ELISA. The mediator-releasing activity of bGST was analysed with IgE-loaded rat basophil leukaemia cells (RBL) expressing human Fc epsilon RI. BALB/c mice were immunized with bGST or Bet v 1. Antibody and T cell responses to either protein were assessed. IgE-cross-reactivity between bGST with GST from house dust mite, Der p 8, was studied with murine and human sera in ELISA. The release kinetics of bGST and Bet v 1 from birch pollen were assessed in water, simulated lung fluid, 0.9% NaCl and PBS. Eluted proteins were quantified by ELISA and analysed by immunoblotting. Principle findings: Only 13% of 217 birch pollen-allergic patients showed IgE-reactivity to bGST. In RBL assays bGST induced mediator release. Immunization of mice with bGST induced specific IgE and a Th2-dominated cellular immune response comparably to immunization with Bet v 1. bGST did not cross-react with Der p 8. In contrast to Bet v 1, only low amounts of bGST were released from pollen grains upon incubation in water and the different physiological solutions. Conclusion/Significance: Although bGST is abundant in birch pollen, immunogenic in mice and able to induce mediator release from effector cells passively loaded with specific IgE, it is a minor allergen for birch pollen-allergic patients. We refer this discrepancy to its limited release from hydrated pollen. Hence, bGST is an example demonstrating that allergenicity depends mainly on rapid elution from airborne particles.	[Deifl, Stephan; Zwicker, Christian; Kitzmueller, Claudia; Bohle, Barbara] Med Univ Vienna, Christian Doppler Lab Immunomodulat, Vienna, Austria; [Deifl, Stephan; Zwicker, Christian; Kitzmueller, Claudia; Nagl, Birgit; Vrtala, Susanne; Jahn-Schmid, Beatrice; Bohle, Barbara] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Vejvar, Eva; Gadermaier, Gabriele; Ferreira, Fatima] Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria; [Briza, Peter] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Zlabinger, Gerhard J.] Med Univ Vienna, Inst Immunol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Salzburg University; Salzburg University; Medical University of Vienna	Bohle, B (corresponding author), Med Univ Vienna, Christian Doppler Lab Immunomodulat, Vienna, Austria.	barbara.bohle@meduniwien.ac.at	Gadermaier, Gabriele/L-5997-2015; Ferreira, Fatima/E-4889-2011; Ferreira, Fatima/AAB-4321-2019; Briza, Peter/D-7309-2012	Gadermaier, Gabriele/0000-0002-4886-417X; Ferreira, Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335; Briza, Peter/0000-0002-4941-6782; Kitzmuller, Claudia/0000-0002-3829-8020; Zwicker, Christian/0000-0001-7724-1361; Bohle, Barbara/0000-0002-5105-7985; Vrtala, Susanne/0000-0003-4250-8243; Zlabinger, Gerhard/0000-0002-7478-4173	Biomay AG; Christian Doppler Research Association, Austria; Austrian Science Fund [SFB-F4610-B19]	Biomay AG; Christian Doppler Research Association, Austria; Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by Biomay AG, the Christian Doppler Research Association, Austria, and the Austrian Science Fund, project SFB-F4610-B19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda LK, 1997, J BIOL CHEM, V272, P20907, DOI 10.1074/jbc.272.33.20907; Cadot P, 2006, MOL IMMUNOL, V43, P226, DOI 10.1016/j.molimm.2005.02.001; Carnes J, 2002, ALLERGY, V57, P798, DOI 10.1034/j.1398-9995.2002.23568.x; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; Erler A, 2011, PROTEOMICS, V11, P1486, DOI 10.1002/pmic.201000624; Galindo PA, 2001, ALLERGY, V56, P195, DOI 10.1034/j.1398-9995.2001.056002195.x; Geroldinger-Simic M, 2011, J ALLERGY CLIN IMMUN, V127, P616, DOI 10.1016/j.jaci.2010.10.027; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Huang CH, 2006, CLIN EXP ALLERGY, V36, P369, DOI 10.1111/j.1365-2222.2006.02447.x; Jeong KY, 2009, INT ARCH ALLERGY IMM, V148, P59, DOI 10.1159/000151506; Jeong KJ, 2010, PROTEIN PEPTIDE LETT, V17, P573, DOI 10.2174/092986610791112765; Karamloo F, 2001, EUR J BIOCHEM, V268, P5310, DOI 10.1046/j.0014-2956.2001.02463.x; Karamloo F, 1999, J ALLERGY CLIN IMMUN, V104, P991, DOI 10.1016/S0091-6749(99)70080-1; Liao EC, 2013, CLIN VACCINE IMMUNOL, V20, P506, DOI 10.1128/CVI.00633-12; Marques MRC, 2011, DISSOLUT TECHNOL, V18, P15, DOI 10.14227/DT180311P15; MARSH DG, 1981, J ALLERGY CLIN IMMUN, V67, P206, DOI 10.1016/0091-6749(81)90063-4; ONeill GM, 1995, IMMUNOL LETT, V48, P103, DOI 10.1016/0165-2478(95)02452-2; Pahr S, 2012, CLIN EXP ALLERGY, V42, P597, DOI 10.1111/j.1365-2222.2012.03961.x; Radauer C, 2007, J ALLERGY CLIN IMMUN, V120, P518, DOI 10.1016/j.jaci.2007.07.024; Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286; Santiago HC, 2012, J ALLERGY CLIN IMMUN, V130, P248, DOI 10.1016/j.jaci.2012.02.045; Satinover SM, 2005, J ALLERGY CLIN IMMUN, V115, P803, DOI 10.1016/j.jaci.2005.01.018; SEIBERLER S, 1994, EMBO J, V13, P3481, DOI 10.1002/j.1460-2075.1994.tb06654.x; Shankar J, 2006, MOL IMMUNOL, V43, P1927, DOI 10.1016/j.molimm.2005.12.006; Shankar J, 2005, IMMUNOL INVEST, V34, P37, DOI 10.1081/IMM-200047383; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Tinghino R, 2002, J ALLERGY CLIN IMMUN, V109, P314, DOI 10.1067/mai.2002.121528; TOVEY ER, 1981, NATURE, V289, P592, DOI 10.1038/289592a0; Twardosz A, 1997, BIOCHEM BIOPH RES CO, V239, P197, DOI 10.1006/bbrc.1997.6860; VALENTA R, 1992, J EXP MED, V175, P377, DOI 10.1084/jem.175.2.377; Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x; VRTALA S, 1993, INT ARCH ALLERGY IMM, V102, P160, DOI 10.1159/000236567; Wallner M, 2011, J ALLERGY CLIN IMMUN, V127, P1571, DOI 10.1016/j.jaci.2011.01.064; Weghofer M, 2008, EUR J CLIN INVEST, V38, P959, DOI 10.1111/j.1365-2362.2008.02048.x; Wills-Karp M, 2010, MUCOSAL IMMUNOL, V3, P104, DOI 10.1038/mi.2009.138	35	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109075	10.1371/journal.pone.0109075	http://dx.doi.org/10.1371/journal.pone.0109075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275548	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500053
J	Iwata, M; Torok-Storb, B; Wayner, EA; Carter, WG				Iwata, Mineo; Torok-Storb, Beverly; Wayner, Elizabeth A.; Carter, William G.			CDCP1 Identifies a CD146 Negative Subset of Marrow Fibroblasts Involved with Cytokine Production	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; DOMAIN-CONTAINING PROTEIN-1; BONE-MARROW; STROMAL CELLS; EXPRESSION; ADHESION; SRC; DIFFERENTIATION; MAINTENANCE; RECEPTORS	In vitro expanded bone marrow stromal cells contain at least two populations of fibroblasts, a CD146/MCAM positive population, previously reported to be critical for establishing the stem cell niche and a CD146-negative population that expresses CUB domain-containing protein 1 (CDCP1)/CD318. Immunohistochemistry of marrow biopsies shows that clusters of CDCP1+ cells are present in discrete areas distinct from areas of fibroblasts expressing CD146. Using a stromal cell line, HS5, which approximates primary CDCP1+ stromal cells, we show that binding of an activating antibody against CDCP1 results in tyrosine-phosphorylation of CDCP1, paralleled by phosphorylation of Src Family Kinases (SFKs) Protein Kinase C delta (PKC-delta). When CDCP1 expression is knocked-down by siRNA, the expression and secretion of myelopoietic cytokines is increased. These data suggest CDCP1 expression can be used to identify a subset of marrow fibroblasts functionally distinct from CD146+ fibroblasts. Furthermore the CDCP1 protein may contribute to the defining function of these cells by regulating cytokine expression.	[Iwata, Mineo; Torok-Storb, Beverly; Wayner, Elizabeth A.; Carter, William G.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center	Iwata, M (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	miwata@fhcrc.org			NIH [HL099993, DK056465]; CDMRP [W81XWH-08-0269]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL064190, P01HL110860, U01HL099656, U01HL099993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CDMRP(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants HL099993 and DK056465 to BTS, and CDMRP W81XWH-08-0269 to WC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares SM, 2008, BBA-GEN SUBJECTS, V1780, P486, DOI 10.1016/j.bbagen.2008.01.010; Awaya N, 2002, EXP HEMATOL, V30, P937, DOI 10.1016/S0301-472X(02)00821-4; Benes CH, 2012, ONCOGENE, V31, P653, DOI 10.1038/onc.2011.262; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200; Buhring HJ, 2004, STEM CELLS, V22, P334, DOI 10.1634/stemcells.22-3-334; Casar B, 2012, ONCOGENE, V31, P3924, DOI 10.1038/onc.2011.555; Chan CKF, 2013, P NATL ACAD SCI USA, V110, P12643, DOI 10.1073/pnas.1310212110; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Cummings R, 2004, J BIOL CHEM, V279, P41085, DOI 10.1074/jbc.M404045200; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; GARTNER S, 1980, P NATL ACAD SCI-BIOL, V77, P4756, DOI 10.1073/pnas.77.8.4756; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Iwata M, 2002, BLOOD, V100, P1318, DOI 10.1182/blood-2002-01-0062; Iwata M, 2007, BLOOD, V109, P85, DOI 10.1182/blood-2006-05-020289; Iwata M, 2014, STEM CELLS DEV, V23, P729, DOI 10.1089/scd.2013.0300; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Jones EA, 2002, ARTHRITIS RHEUM-US, V46, P3349, DOI 10.1002/art.10696; Kollmorgen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053050; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Maijenburg MW, 2012, HAEMATOL-HEMATOL J, V97, P179, DOI 10.3324/haematol.2011.047753; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Miyazawa Y, 2013, MOL CANCER RES, V11, P628, DOI 10.1158/1541-7786.MCR-12-0544; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Pillai M, 2004, LEUKEMIA LYMPHOMA, V45, P2403, DOI 10.1080/10428190412331283189; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Ren GW, 2010, J IMMUNOL, V184, P2321, DOI 10.4049/jimmunol.0902023; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shimazaki C, 2003, BLOOD, V101, P3334, DOI 10.1182/blood-2002-09-2883; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; TAVASSOLI M, 1983, AM J HEMATOL, V15, P195, DOI 10.1002/ajh.2830150211; Tormin A, 2011, BLOOD, V117, P5067, DOI 10.1182/blood-2010-08-304287; Ueno H, 2003, NAT IMMUNOL, V4, P457, DOI 10.1038/ni916; Viswanathan S, 2014, STEM CELLS DEV, V23, P1157, DOI 10.1089/scd.2013.0591; WEISS L, 1976, ANAT RECORD, V186, P161, DOI 10.1002/ar.1091860204; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190; Zhao YT, 2009, CELL SIGNAL, V21, P367, DOI 10.1016/j.cellsig.2008.10.010	51	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109304	10.1371/journal.pone.0109304	http://dx.doi.org/10.1371/journal.pone.0109304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275584	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500093
J	Pinhas-Hamiel, O; Hamiel, U; Boyko, V; Graph-Barel, C; Reichman, B; Lerner-Geva, L				Pinhas-Hamiel, Orit; Hamiel, Uri; Boyko, Valentina; Graph-Barel, Chana; Reichman, Brian; Lerner-Geva, Liat			Trajectories of HbA1c Levels in Children and Youth with Type 1 Diabetes	PLOS ONE			English	Article							GLYCEMIC CONTROL; METABOLIC-CONTROL; INTENSIVE TREATMENT; PUMP THERAPY; ADOLESCENTS; CHILDHOOD; BEHAVIORS; KNOWLEDGE	Purpose: To illustrate the distribution of Hemoglobin A1c (HbA1c) levels according to age and gender among children, adolescents and youth with type 1 diabetes (T1DM). Methods: Consecutive HbA1c measurements of 349 patients, aged 2 to 30 years with T1DM were obtained from 1995 through 2010. Measurement from patients diagnosed with celiac disease (n = 20), eating disorders (n = 41) and hemoglobinopathy (n = 1) were excluded. The study sample comprised 4815 measurements of HbA1c from 287 patients. Regression percentiles of HbA1c were calculated as a function of age and gender by the quantile regression method using the SAS procedure QUANTREG. Results: Crude percentiles of HbA1c as a function of age and gender, and the modeled curves produced using quantile regression showed good concordance. The curves show a decline in HbA1c levels from age 2 to 4 years at each percentile. Thereafter, there is a gradual increase during the prepubertal years with a peak at ages 12 to 14 years. HbA1c levels subsequently decline to the lowest values in the third decade. Curves of females and males followed closely, with females having HbA1c levels about 0.1% (1.1 mmol/mol) higher in the 25th 50th and 75th percentiles. Conclusion: We constructed age-specific distribution curves for HbA1c levels for patients with T1DM. These percentiles may be used to demonstrate the individual patient's measurements longitudinally compared with age-matched patients.	[Pinhas-Hamiel, Orit; Graph-Barel, Chana] Maccabi Juvenile Diabet Ctr, Raanana, Israel; [Pinhas-Hamiel, Orit] Chaim Sheba Med Ctr, Pediat Endocrine & Diabet Unit, Edmond & Lily Safra Childrens Hosp, IL-52621 Tel Hashomer, Israel; [Pinhas-Hamiel, Orit; Hamiel, Uri; Reichman, Brian; Lerner-Geva, Liat] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Boyko, Valentina; Reichman, Brian; Lerner-Geva, Liat] Gertner Inst, Women & Childrens Hlth Res Unit, Tel Hashomer, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Pinhas-Hamiel, O (corresponding author), Maccabi Juvenile Diabet Ctr, Raanana, Israel.	orithami@sheba.health.gov.il	hamiel, uri/ABD-3269-2020; Pinhas-Hamiel, Orit/K-5198-2013	Hamiel, Uri/0000-0001-8983-464X				[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Brown A, 2010, NAT REV CARDIOL, V7, P369, DOI 10.1038/nrcardio.2010.35; Dabadghao P, 2001, DIABETIC MED, V18, P889, DOI 10.1046/j.1464-5491.2001.00593.x; DeVries JH, 2004, DIABETIC MED, V21, P1263, DOI 10.1111/j.1464-5491.2004.01386.x; Du Pasquier-Fediaevsky L, 2005, DIABETIC MED, V22, P427, DOI 10.1111/j.1464-5491.2005.01429.x; Gerstl EM, 2008, EUR J PEDIATR, V167, P447, DOI 10.1007/s00431-007-0586-9; Hanberger L, 2008, DIABETES CARE, V31, P927, DOI 10.2337/dc07-1863; Hildon Z, 2011, INT J QUALITY HLTH C; Hilliard ME, 2013, J ADOLESCENT HEALTH, V52, P28, DOI 10.1016/j.jadohealth.2012.05.009; Holl RW, 2003, EUR J PEDIATR, V162, P22, DOI 10.1007/s00431-002-1037-2; Insabella G, 2007, PEDIATR DIABETES, V8, P228, DOI 10.1111/j.1399-5448.2007.00266.x; Iqbal N, 2008, ANN CLIN BIOCHEM, V45, P504, DOI 10.1258/acb.2008.008034; Kiess W, 1998, ACTA PAEDIATR, V87, P67; Mameli C, 2014, ACTA DIABETOL, V51, P205, DOI 10.1007/s00592-013-0481-y; Neumark-Sztainer D, 2002, DIABETES CARE, V25, P1289, DOI 10.2337/diacare.25.8.1289; Nicolucci A, 2000, DIABETES NUTR METAB, V13, P276; Petitti DB, 2009, J PEDIATR-US, V155, P668, DOI 10.1016/j.jpeds.2009.05.025; Pinhas-Hamiel O, 2014, DIABETES METABOLISM; Pinhas-Hamiel O, 2013, INT J EATING DISORDE; Pinhas-Hamiel O, 2010, DIABETES TECHNOL THE, V12, P567, DOI 10.1089/dia.2010.0006; Rewers M, 2009, PEDIATR DIABETES, V10, P71, DOI 10.1111/j.1399-5448.2009.00582.x; SAS Institute Inc, 2010, SAS STAT 9 2 US GUID; Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Tonella P, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13057; Vanelli M, 2005, J ENDOCRINOL INVEST, V28, P692, DOI 10.1007/BF03347551; Casarin RCV, 2010, ARCH ORAL BIOL, V55, P902, DOI 10.1016/j.archoralbio.2010.07.009; Wood JR, 2013, DIABETES CARE	28	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109109	10.1371/journal.pone.0109109	http://dx.doi.org/10.1371/journal.pone.0109109			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275650	Green Submitted, Green Published, gold			2022-12-27	WOS:000342591500062
J	Zhao, S; Wang, XP; Jiang, JF; Chai, YS; Tian, Y; Feng, TS; Ding, Y; Huang, J; Lei, F; Xing, DM; Du, LJ				Zhao, Shuang; Wang, Xin-Pei; Jiang, Jing-Fei; Chai, Yu-Shuang; Tian, Yu; Feng, Tian-Shi; Ding, Yi; Huang, Jing; Lei, Fan; Xing, Dong-Ming; Du, Li-Jun			Transport and Metabolism Behavior of Brazilein during Its Entrance into Neural Cells	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; CAESALPINIA-SAPPAN L; CRYSTAL-STRUCTURE; COMT INHIBITORS; SCIATIC-NERVE; CONSTITUENTS; PROTEIN; SUPPRESSION; ACTIVATION; KINETICS	Brazilein, a natural small molecule, shows a variety of pharmacological activities, especially on nervous system and immune system. As a potential multifunctional drug, we studied the distribution and the transport behavior and metabolic behavior of brazilein in vivo and in vitro. Brazilein was found to be able to distribute in the mouse brain and transport into neural cells. A metabolite was found in the brain and in the cells. Positive and negative mode-MS/MS and Q-TOF were used to identify the metabolite. MS/MS fragmentation mechanisms showed the methylation occurred at the 10-hydroxyl of brazilein (10-O-methylbrazilein). Further, catechol-O-methyltransferase (COMT) was confirmed as a crucial enzyme correlated with the methylated metabolite generation by molecular docking and pharmacological experiment.	[Zhao, Shuang; Wang, Xin-Pei; Jiang, Jing-Fei; Chai, Yu-Shuang; Feng, Tian-Shi; Lei, Fan; Xing, Dong-Ming; Du, Li-Jun] Tsinghua Univ, Sch Life Sci, MOE Key Lab Prot Sci, Lab Mol Pharmacol & Pharmaceut Sci, Beijing 100084, Peoples R China; [Zhao, Shuang; Wang, Xin-Pei; Jiang, Jing-Fei; Chai, Yu-Shuang; Feng, Tian-Shi; Lei, Fan; Xing, Dong-Ming; Du, Li-Jun] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Tian, Yu; Ding, Yi] Tsinghua Univ, Sch Life Sci, Drug Discovery Facil, Beijing 100084, Peoples R China; [Huang, Jing] Virginia Polytech Inst & State Univ, Dept Chem, Blacksburg, VA 24061 USA	Tsinghua University; Tsinghua University; Tsinghua University; Virginia Polytechnic Institute & State University	Du, LJ (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Prot Sci, Lab Mol Pharmacol & Pharmaceut Sci, Beijing 100084, Peoples R China.	lijundu@mail.tsinghua.edu.cn	Huang, Jing/M-2078-2017	Huang, Jing/0000-0002-1175-7012	National S&T Major Special Project for New Drug R&D Program of China [2012ZX09102-201-008, 2011ZX09101-002-11, 2012ZX09103-201-041]; National Natural Science Foundation of China [81073092, 81374006]	National S&T Major Special Project for New Drug R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National S&T Major Special Project for New Drug R&D Program of China (2012ZX09102-201-008, 2011ZX09101-002-11 and 2012ZX09103-201-041) and the National Natural Science Foundation of China (81073092 and 81374006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonifacio MJ, 2002, MOL PHARMACOL, V62, P795, DOI 10.1124/mol.62.4.795; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao J, 2011, CHEM RES CHINESE U, V27, P254; DAVIS FA, 1993, J ORG CHEM, V58, P1751, DOI 10.1021/jo00059a026; de Oliveira LFC, 2002, VIB SPECTROSC, V28, P243, DOI 10.1016/S0924-2031(01)00138-2; Ellermann M, 2011, CHEM-EUR J, V17, P6369, DOI 10.1002/chem.201003648; Haasio K, 2010, INT REV NEUROBIOL, V95, P163, DOI [10.1016/B978-0-12-381326-8-00007-7, 10.1016/B978-0-12-381326-8.00007-7]; Hsieh CY, 2013, CHEM-BIOL INTERACT, V204, P105, DOI 10.1016/j.cbi.2013.05.005; Hu J, 2008, TSINGHUA SCI TECHNOL, V13, P474, DOI 10.1016/S1007-0214(08)70076-2; Huang YD, 2005, ORG LETT, V7, P5841, DOI 10.1021/ol0523749; Hulme AN, 2005, PHYTOCHEMISTRY, V66, P2766, DOI 10.1016/j.phytochem.2005.09.001; Kabbash A., 2008, Saudi Pharmaceutical Journal, V16, P25; Kim DS, 1997, PHYTOCHEMISTRY, V46, P177, DOI 10.1016/S0031-9422(96)00874-6; Lan JQ, 2008, BIOMED CHROMATOGR, V22, P1201, DOI 10.1002/bmc.1045; Liang CH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/864892; Liu AL, 2009, PLANTA MED, V75, P337, DOI 10.1055/s-0028-1112208; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Mitani K, 2013, PLANTA MED, V79, P37, DOI 10.1055/s-0032-1327897; NAMIKOSHI M, 1987, CHEM PHARM BULL, V35, P2761; Oh SR, 1998, PLANTA MED, V64, P456, DOI 10.1055/s-2006-957481; Pan CX, 2012, CHINESE J ORG CHEM, V32, P1116, DOI 10.6023/cjoc1109042; Shen J, 2008, EUR J PHARMACOL, V580, P366, DOI 10.1016/j.ejphar.2007.11.012; Shen J, 2007, EUR J PHARMACOL, V558, P88, DOI 10.1016/j.ejphar.2006.11.059; Tao LY, 2011, AFR J PHARM PHARMACO, V5, P1937, DOI 10.5897/AJPP11.099; VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0; Wang Xiu-Kun, 2011, Chinese Journal of Natural Medicines, V9, P338, DOI 10.3724/SP.J.1009.2011.00338; Wang XQ, 2013, CHEM COMMUN, V49, P5405, DOI 10.1039/c3cc42385a; Wang ZX, 2008, CENT S PHARM, V6, P460; Ye M, 2006, INT IMMUNOPHARMACOL, V6, P426, DOI 10.1016/j.intimp.2005.09.012; Yen CT, 2010, BIOORG MED CHEM LETT, V20, P1037, DOI 10.1016/j.bmcl.2009.12.041; Zhang Z, 2011, NEURAL REGEN RES, V6, P908, DOI 10.3969/j.issn.1673-5374.2011.12.005; Zhao YN, 2006, PHARMACOLOGY, V76, P76, DOI 10.1159/000089721; Zheng YJ, 1997, J AM CHEM SOC, V119, P8137, DOI 10.1021/ja971019d; Zhong X, 2009, NEOPLASMA, V56, P387, DOI 10.4149/neo_2009_05_387	35	58	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108000	10.1371/journal.pone.0108000	http://dx.doi.org/10.1371/journal.pone.0108000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275506	gold, Green Published, Green Submitted			2022-12-27	WOS:000342591500011
J	Miyagi, MYS; Seelaender, M; Castoldi, A; de Almeida, DC; Bacurau, AVN; Andrade-Oliveira, V; Enjiu, LM; Pisciottano, M; Hayashida, CY; Hiyane, MI; Brum, PC; Camara, NOS; Amano, MT				Saito Miyagi, Mariana Yasue; Seelaender, Marilia; Castoldi, Angela; de Almeida, Danilo Candido; Nova Bacurau, Aline Villa; Andrade-Oliveira, Vinicius; Enjiu, Lucas Maceratesi; Pisciottano, Marcus; Hayashida, Caroline Yuri; Hiyane, Meire Ioshie; Brum, Patricia Chakur; Saraiva Camara, Niels Olsen; Amano, Mariane Tami			Long-Term Aerobic Exercise Protects against Cisplatin-Induced Nephrotoxicity by Modulating the Expression of IL-6 and HO-1	PLOS ONE			English	Article							HEME OXYGENASE-1; ADIPOSE-TISSUE; RENAL INJURY; CELLS; APOPTOSIS; CANCER; INTERLEUKIN-6; CHEMOTHERAPY; LYMPHOCYTES; MACROPHAGES	Nephrotoxicity is substantial side effect for 30% of patients undergoing cancer therapy with cisplatin and may force them to change or even abandon the treatment. Studies regarding aerobic exercise have shown its efficacy for the treatment of many types of diseases and its capacity to reduce tumors. However, little is known about the impact of physical exercise on cisplatin-induced acute kidney injury (AKI). In the present study, our aim was to investigate the role of physical exercise in AKI induced by cisplatin. We submitted C57Bl6 male mice to seven weeks of chronic exercise on a training treadmill and treated them with single i.p. injection of cisplatin (20 mg/kg) in the last week. Exercise efficacy was confirmed by an increased capillary-to-fiber ratio in the gastrocnemius muscle of exercised groups (EX and CIS-EX). The group submitted to exercise before cisplatin administration (CIS-EX) exhibited less weight loss and decreased serum urea levels compared to the cisplatin group (CIS). Exercise also showed a protective role against cisplatin-induced cell death in the kidney. The CIS-EX group showed a lower inflammatory response, with less TNF and IL-10 expression in the kidney and serum. In the same group, we observed an increase of IL-6 and HO-1 expression in the kidney. Taken together, our results indicate that chronic aerobic exercise is able to attenuate AKI by inducing IL-6 and HO-1 production, which results in lower inflammatory and apoptotic profiles in the kidney.	[Saito Miyagi, Mariana Yasue; Castoldi, Angela; de Almeida, Danilo Candido; Andrade-Oliveira, Vinicius; Hayashida, Caroline Yuri; Hiyane, Meire Ioshie; Saraiva Camara, Niels Olsen; Amano, Mariane Tami] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Lab Immunobiol Transplants, Sao Paulo, Brazil; [Seelaender, Marilia; Enjiu, Lucas Maceratesi; Pisciottano, Marcus] Univ Sao Paulo, Dept Cell Biol, Canc Metab Res Grp, Inst Biomed Sci, Sao Paulo, Brazil; [Nova Bacurau, Aline Villa; Brum, Patricia Chakur] Univ Sao Paulo, Sch Phys Educ & Sport, Lab Mol & Cellular Exercise Physiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Amano, MT (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Lab Immunobiol Transplants, Sao Paulo, Brazil.	marianeamano.usp@gmail.com	Bacurau, Aline Villa Nova/AAK-7446-2021; Castoldi, Angela/K-1889-2015; Camara, Niels OS/G-8336-2011; de Almeida, Danilo/AAK-2399-2021; camara, niels olsen saraiva/AAX-3269-2020; de Andrade Oliveira, Vinicius/S-1176-2019; Brum, Patricia C/E-6605-2011; AMANO, MARIANE TAMI/D-1361-2012; de Almeida, Danilo Candido/R-2646-2019; Seelaender, Marilia Cerqueira Leite/B-9101-2011	Bacurau, Aline Villa Nova/0000-0002-5129-5115; Camara, Niels OS/0000-0001-5436-1248; camara, niels olsen saraiva/0000-0001-5436-1248; de Andrade Oliveira, Vinicius/0000-0002-0426-1828; Brum, Patricia C/0000-0002-4750-6506; AMANO, MARIANE TAMI/0000-0003-4321-3375; de Almeida, Danilo Candido/0000-0003-3661-2124; Seelaender, Marilia Cerqueira Leite/0000-0002-9999-8020; Castoldi, Angela/0000-0002-8434-7989	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP: 11/10349-5, 12/02270-2, 12/10435-1, 12/50079-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (INCT Complex Fluids and Renal Immunopathology Laboratory INSERM/CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (INCT Complex Fluids and Renal Immunopathology Laboratory INSERM/CNPq)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP: 11/10349-5, 12/02270-2, 12/10435-1, 12/50079-0) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, INCT Complex Fluids and Renal Immunopathology Laboratory INSERM/CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda AP, 2010, ENDOCRINOLOGY, V151, P683, DOI 10.1210/en.2009-0865; Bacurau RFP, 2000, CELL BIOCHEM FUNCT, V18, P249; Benedetti G, 2013, BIOCHEM PHARMACOL, V85, P274, DOI 10.1016/j.bcp.2012.10.012; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; Correa-Costa Matheus, 2012, World J Nephrol, V1, P4, DOI 10.5527/wjn.v1.i1.4; Deng JP, 2001, KIDNEY INT, V60, P2118, DOI 10.1046/j.1523-1755.2001.00043.x; Eickmeyer SM, 2012, PM&R, V4, P874, DOI 10.1016/j.pmrj.2012.09.588; Garcia JM, 2013, ENDOCRINOLOGY, V154, P3118, DOI 10.1210/en.2013-1179; Gholamnezhad Z, 2014, IRAN J BASIC MED SCI, V17, P1; Hopps E, 2011, ACTA DIABETOL, V48, P183, DOI 10.1007/s00592-011-0278-9; Jenkins NT, 2012, J APPL PHYSIOL, V113, P1873, DOI 10.1152/japplphysiol.00936.2012; Jensen W, 2014, SUPPORT CARE CANC; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; Lira FS, 2009, CELL BIOCHEM FUNCT, V27, P71, DOI 10.1002/cbf.1540; Liu MC, 2006, J AM SOC NEPHROL, V17, P765, DOI 10.1681/ASN.2005010102; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Mitazaki S, 2009, TOXICOLOGY, V265, P115, DOI 10.1016/j.tox.2009.10.005; Mitazaki S, 2013, LIFE SCI, V92, P694, DOI 10.1016/j.lfs.2013.01.026; Mitazaki S, 2011, LIFE SCI, V88, P1142, DOI 10.1016/j.lfs.2011.04.016; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Pan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086057; Pedersen BK, 2001, J PHYSIOL-LONDON, V536, P329, DOI 10.1111/j.1469-7793.2001.0329c.xd; Pereira WO, 2011, SCAND J IMMUNOL, V73, P401, DOI 10.1111/j.1365-3083.2011.02513.x; Petersen AMW, 2006, J PHYSIOL PHARMACOL, V57, P43; Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606; Ramesh G, 2006, RENAL FAILURE, V28, P583, DOI 10.1080/08860220600843839; Roudier E, 2012, FASEB J, V26, P4530, DOI 10.1096/fj.12-212720; Sahin K, 2014, BIOL TRACE ELEM RES, V157, P156, DOI 10.1007/s12011-014-9886-x; Sahin K, 2010, FOOD CHEM TOXICOL, V48, P2670, DOI 10.1016/j.fct.2010.06.038; Schwartz AL, 2001, MED SCI SPORT EXER, V33, P718; Shiraishi F, 2000, AM J PHYSIOL-RENAL, V278, pF726, DOI 10.1152/ajprenal.2000.278.5.F726; Tadagavadi RK, 2010, J IMMUNOL, V185, P4904, DOI 10.4049/jimmunol.1000383; Taub R, 2003, J CLIN INVEST, V112, P978, DOI 10.1172/JCI20031200319974; Tayem Y, 2014, PHARMACOL RES, V81, P1, DOI 10.1016/j.phrs.2014.01.001; Verstappen CCP, 2003, DRUGS, V63, P1549, DOI 10.2165/00003495-200363150-00003; Wang SX, 2013, BBA-MOL BASIS DIS, V1832, P1582, DOI 10.1016/j.bbadis.2013.05.023; Wensing KU, 2013, ANTICANCER RES, V33, P4183; Wruck CJ, 2011, J BIOL CHEM, V286, P4493, DOI 10.1074/jbc.M110.162008; Yao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e; Zhang B, 2007, KIDNEY INT, V72, P37, DOI 10.1038/sj.ki.5002242	42	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108543	10.1371/journal.pone.0108543	http://dx.doi.org/10.1371/journal.pone.0108543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272046	gold, Green Published, Green Submitted			2022-12-27	WOS:000343729600050
J	Huhe; Borjigin, S; Cheng, YX; Nomura, N; Nakajima, T; Nakamura, T; Uchiyama, H				Huhe; Borjigin, Shinchilelt; Cheng, Yunxiang; Nomura, Nobukiko; Nakajima, Toshiaki; Nakamura, Toru; Uchiyama, Hiroo			Effect of Abandonment on Diversity and Abundance of Free-Living Nitrogen-Fixing Bacteria and Total Bacteria in the Cropland Soils of Hulun Buir, Inner Mongolia	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; NIFH GENE; MICROBIAL COMMUNITIES; ENVIRONMENTAL-FACTORS; ECOSYSTEM FUNCTION; TRIFOLIUM-REPENS; PLANT DIVERSITY; LOLIUM-PERENNE; GRASSLAND; IMPACT	In Inner Mongolia, steppe grasslands face desertification or degradation because of human over activity. One of the reasons for this condition is that croplands have been abandoned after inappropriate agricultural management. The soils in these croplands present heterogeneous environments in which conditions affecting microbial growth and diversity fluctuate widely in space and time. In this study, we assessed the molecular ecology of total and free-living nitrogen-fixing bacterial communities in soils from steppe grasslands and croplands that were abandoned for different periods (1, 5, and 25 years) and compared the degree of recovery. The abandoned croplands included in the study were natural restoration areas without human activity. Denaturing gradient gel electrophoresis and quantitative PCR (qPCR) were used to analyze the nifH and 16S rRNA genes to study free-living diazotrophs and the total bacterial community, respectively. The diversities of free-living nitrogen fixers and total bacteria were significantly different between each site (P<0.001). Neither the total bacteria nor nifH gene community structure of a cropland abandoned for 25 years was significantly different from those of steppe grasslands. In contrast, results of qPCR analysis of free-living nitrogen fixers and total bacteria showed significantly high abundance levels in steppe grassland (P<0.01 and P<0.03, respectively). In this study, the microbial communities and their gene abundances were assessed in croplands that had been abandoned for different periods. An understanding of how environmental factors and changes in microbial communities affect abandoned croplands could aid in appropriate soil management to optimize the structures of soil microorganisms.	[Huhe; Borjigin, Shinchilelt; Nomura, Nobukiko; Nakajima, Toshiaki; Nakamura, Toru; Uchiyama, Hiroo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Cheng, Yunxiang] Lanzhou Univ, State Key Lab Grassland Agroecosyst, Coll Pastoral Agr Sci & Technol, Lanzhou 730000, Peoples R China	University of Tsukuba; Lanzhou University	Uchiyama, H (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	uchiyama.hiroo.fw@u.tsukuba.ac.jp	周, 呼和/GXH-5843-2022	周, 呼和/0000-0002-7971-465X	Japan Science and Technology Corporation (JST) [21310050]	Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST))	This work was supported by a Grant-in-Aid for Scientific Research (B) (No. 21310050 to HU) and CREST program of Japan Science and Technology Corporation (JST; http://www.jst.go.jp/EN/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibold OW, 1995, ECOLOGY WORLD VEGETA, P1; Baxter J, 2008, J APPL MICROBIOL, V104, P1605, DOI 10.1111/j.1365-2672.2007.03709.x; Baxter J, 2006, BIODEGRADATION, V17, P207, DOI 10.1007/s10532-005-4219-6; Belnap J, 2001, ECOL STU AN, V150, P241; Braun-Blanquet J., 1964, PLANT SOCIOLOGY BASI, DOI [10.1086/333232, DOI 10.1007/978-3-7091-8110-2_1]; Burgmann H, 2004, APPL ENVIRON MICROB, V70, P240, DOI 10.1128/AEM.70.1.240-247.2004; Carney KM, 2005, ECOSYSTEMS, V8, P928, DOI 10.1007/s10021-005-0047-0; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; CHAN YK, 1994, FEMS MICROBIOL REV, V13, P95; Cheng Yunxiang, 2007, Grassland Science, V53, P172, DOI 10.1111/j.1744-697X.2007.00090.x; Clayton SJ, 2005, BIOL FERT SOILS, V41, P109, DOI 10.1007/s00374-004-0811-x; Coelho MRR, 2009, APPL SOIL ECOL, V42, P48, DOI 10.1016/j.apsoil.2009.01.010; Coelho MRR, 2008, FEMS MICROBIOL LETT, V279, P15, DOI 10.1111/j.1574-6968.2007.00975.x; Cogger C, 2000, SOIL MANAGEMENT SMAL; CONWAY T, 1989, J BACTERIOL, V171, P3754, DOI 10.1128/jb.171.7.3754-3759.1989; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; Day P.R., 1965, METHODS SOIL ANAL PA, V9, P545, DOI [10.2134/agronmonogr9.1.c43, DOI 10.2134/AGRONMONOGR9.1.C43]; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Drennan CL, 2001, P NATL ACAD SCI USA, V98, P11973, DOI 10.1073/pnas.211429998; El-Sheikh MA, 2005, J ARID ENVIRON, V61, P461, DOI 10.1016/j.jaridenv.2004.10.006; Gaby JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042149; GAVINI N, 1992, J BIOL CHEM, V267, P21179; He C, 2005, J ARID ENVIRON, V63, P814, DOI 10.1016/j.jaridenv.2005.03.028; Kahindi JHP, 1997, APPL SOIL ECOL, V6, P55, DOI 10.1016/S0929-1393(96)00151-5; Kennedy N, 2004, ENVIRON MICROBIOL, V6, P1070, DOI 10.1111/j.1462-2920.2004.00638.x; Larkin RP, 2006, PHYTOPATHOLOGY, V96, P68, DOI 10.1094/PHYTO-96-0068; Li JH, 2007, PLANT ECOL, V191, P1, DOI 10.1007/s11258-006-9209-1; Marilley L, 1998, PLANT SOIL, V198, P219, DOI 10.1023/A:1004309008799; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Matsuura K., 2009, TERRESTRAIL PRECIPIT; Merino L, 2009, FOOD ANAL METHOD, V2, P212, DOI 10.1007/s12161-008-9052-1; Motsara M., 2008, GUIDE LAB ESTABLISHM; MUELLERDOMBOIS D, 1974, AIMS METHODS VEGETAT, P1; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Naether A, 2012, APPL ENVIRON MICROB, V78, P7398, DOI 10.1128/AEM.01325-12; Niklaus PA, 2003, GLOBAL CHANGE BIOL, V9, P585, DOI 10.1046/j.1365-2486.2003.00614.x; Noll M, 2008, SOIL BIOL BIOCHEM, V40, P2611, DOI 10.1016/j.soilbio.2008.07.012; Nunan N, 2005, APPL ENVIRON MICROB, V71, P6784, DOI 10.1128/AEM.71.11.6784-6792.2005; Orr CH, 2011, APPL ENVIRON MICROB, V77, P911, DOI 10.1128/AEM.01250-10; Ortiz-Castro R, 2009, PLANT SIGNAL BEHAV, V4, P701, DOI 10.4161/psb.4.8.9047; PEOPLES MB, 1995, PLANT SOIL, V174, P3, DOI 10.1007/BF00032239; Poly F, 2001, RES MICROBIOL, V152, P95, DOI 10.1016/S0923-2508(00)01172-4; Prevosto B, 2011, FOLIA GEOBOT, V46, P303, DOI 10.1007/s12224-010-9096-z; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Reed SC, 2007, APPL SOIL ECOL, V36, P238, DOI 10.1016/j.apsoil.2007.02.002; Roeselers G, 2007, J MICROBIOL METH, V70, P550, DOI 10.1016/j.mimet.2007.06.011; Rosado AS, 1998, APPL ENVIRON MICROB, V64, P2770; Rosch C, 2002, APPL ENVIRON MICROB, V68, P3818, DOI 10.1128/AEM.68.8.3818-3829.2002; SAYWELL L. G., 1937, Industrial and Engineering Chemistry. Analytical edition, V9, P67, DOI 10.1021/ac50106a005; Schumacher B., 2002, METHODS DETERMINATIO; Siosemarde M, 2011, WORLD ACAD SCI ENG T, V74, P521; Stephen JR, 1996, APPL ENVIRON MICROB, V62, P4147, DOI 10.1128/AEM.62.11.4147-4154.1996; Steward GF, 2004, MICROB ECOL, V47, P30, DOI 10.1007/s00248-003-1017-8; Stolcova Jindra, 2002, Plant Protection Science, V38, P149; Sugio T, 2007, BIOSCI BIOTECH BIOCH, V71, P2663, DOI 10.1271/bbb.70253; SZE ISY, 1984, J BACTERIOL, V159, P353, DOI 10.1128/JB.159.1.353-359.1984; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Tong C, 2004, J ARID ENVIRON, V59, P133, DOI 10.1016/j.jaridenv.2004.01.004; Tremaroli V, 2009, APPL ENVIRON MICROB, V75, P719, DOI 10.1128/AEM.01771-08; Truog E., 1929, IND ENGNG CHEM ANALY, V1, P136, DOI [10.1021/ac50067a011, DOI 10.1021/AC50067A011]; Umetrics AB, 2005, SIMCA P V 11 ANAL AD; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Van der Putten WH, 2000, OECOLOGIA, V124, P91, DOI 10.1007/s004420050028; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wakelin SA, 2008, SOIL BIOL BIOCHEM, V40, P803, DOI 10.1016/j.soilbio.2007.10.015; Widmer F, 1999, APPL ENVIRON MICROB, V65, P374; [薛智德 Xue Zhide], 2002, [西北林学院学报, Journal of Northwest Forestry College], V17, P26; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; ZEHR JP, 1989, APPL ENVIRON MICROB, V55, P2522, DOI 10.1128/AEM.55.10.2522-2526.1989; Zhang Jin-tun, 2000, Journal of Plant Resources and Environment, V9, P34; ZOU HY, 1998, RES SOIL WATER CONSE, V5, P126	71	9	11	7	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e106714	10.1371/journal.pone.0106714	http://dx.doi.org/10.1371/journal.pone.0106714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268844	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700015
J	Wu, S; Aksoy, M; Shi, JT; Houbaviy, HB				Wu, Shuang; Aksoy, Munevver; Shi, Jianting; Houbaviy, Hristo Botev			Evolution of the miR-290-295/miR-371-373 Cluster Family Seed Repertoire	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENOME-WIDE IDENTIFICATION; MICRORNAS; MAINTENANCE; SPECIFICITY; DISCOVERY; SELECTION; MIR-302; TARGETS; MIRNAS	Expression of the mouse miR-290-295 cluster and its miR-371-373 homolog in human is restricted to early embryos, primordial germ cells, the germ line stem cell compartment of the adult testis and to stem cell lines derived from the early embryonic lineages. Sequencing data suggest considerable seed diversification between the seven homologous pre-miRNAs of miR-290-295 but it is not clear if all of the implied miR-290-295 seeds are also conserved in the human miR-371-373 cluster, which consists of only three homologous pre-miRNAs. By employing miRNA target reporters we show that most, if not all, seeds in miR-290-295 are represented in miR-371-373. In the mouse, pre-miR-290, pre-miR-292 and pre-miR-293 express subsets of the miRNA isoforms processed from the single human pre-miR-371. Comparison of the possible miR-290-295/miR-371-373 seed repertoires in placental mammals suggests a model for the evolution of this miRNA cluster family, which would be otherwise difficult to deduce based solely on pre-miRNA sequence comparisons. The conservation of co-expressed seeds that is characteristic of miR-290-295/miR-371-373 should be taken into account in models of the corresponding miRNA-target interaction networks.	[Wu, Shuang; Aksoy, Munevver; Shi, Jianting; Houbaviy, Hristo Botev] Rowan Univ, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine	Houbaviy, HB (corresponding author), Rowan Univ, Sch Osteopath Med, Dept Cell Biol, Two Med Ctr Dr, Stratford, NJ 08084 USA.	houbavhr@rowan.edu	Aksoy, Munevver/X-2693-2018	Aksoy, Munevver/0000-0002-0798-5805; Shi, Jianting/0000-0003-1558-7791	Annual Grant Program of the Foundation of the University of Medicine and Dentistry of New Jersey; Stem Cell Grant from the New Jersey Commission on Science and Technology	Annual Grant Program of the Foundation of the University of Medicine and Dentistry of New Jersey; Stem Cell Grant from the New Jersey Commission on Science and Technology	This research was supported in part by the Annual Grant Program of the Foundation of the University of Medicine and Dentistry of New Jersey and a Stem Cell Grant from the New Jersey Commission on Science and Technology to HBH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Campo-Paysaa F, 2011, EVOL DEV, V13, P15, DOI 10.1111/j.1525-142X.2010.00452.x; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eddy S R, 1995, J Comput Biol, V2, P9, DOI 10.1089/cmb.1995.2.9; Fukunaga R, 2012, CELL, V151, P533, DOI 10.1016/j.cell.2012.09.027; GASSMANN M, 1995, P NATL ACAD SCI USA, V92, P1292, DOI 10.1073/pnas.92.5.1292; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2011, EMBO REP, V12, P172, DOI 10.1038/embor.2010.191; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; JUDSON RL, 2009, NAT BIOTECHNOL; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Leung AKL, 2011, NAT STRUCT MOL BIOL, V18, P237, DOI 10.1038/nsmb.1991; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lipchina I, 2011, GENE DEV, V25, P2173, DOI 10.1101/gad.17221311; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Medeiros LA, 2011, P NATL ACAD SCI USA, V108, P14163, DOI 10.1073/pnas.1111241108; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Nagy A, 2003, LAB MANUAL, ppp399; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Spruce T, 2010, DEV CELL, V19, P207, DOI 10.1016/j.devcel.2010.07.014; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Zheng GXY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002054	45	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108519	10.1371/journal.pone.0108519	http://dx.doi.org/10.1371/journal.pone.0108519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268927	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700106
J	Ye, LW; Zheng, MM; Chen, QW; Li, GQ; Deng, W; Ke, DZ				Ye, Liwen; Zheng, Minming; Chen, Qingwei; Li, Guiqion; Deng, Wei; Ke, Dazhi			Effects of Intra-Aortic Balloon Counterpulsation Pump on Mortality of Acute Myocardial Infarction	PLOS ONE			English	Article							HIGH-RISK PATIENTS; CARDIOGENIC-SHOCK; TRIAL; THROMBOLYSIS; ANGIOPLASTY; SURVIVAL; FAILURE; IMPACT	Background: Several randomized controlled trials (RCTs) have evaluated the effect of intra-aortic balloon counterpulsation pump(IABP) on the mortality of acute myocardial infarction (AMI). Objectives: To analyze the relevant RCT data on the effect of IABP on mortality and the occurrence of bleeding in AMI. Data Sources: Published RCTs on the treatment of AMI by IABP were retrieved in searches of Medline, EMBASE, Cochrane and other related databases. The last search was conducted on July 20, 2014. Study Eligibility Criteria: Randomized clinical trials comparing IABP to controls as treatment for AMI. Participants: Patients with AMI. Synthesis Methods: The primary endpoint was mortality, and the secondary endpoint was bleeding events. To account for to heterogeneity, a random-effects model was used to analyze the study data. Results: Ten trials with a total population of 973 patients that were included in the analysis showed no significant difference in 2-month mortality between the IABP and the control groups. The 6-month mortality in the IABP group was not significantly lower than in the control group in the four RCTs that enrolled 59 AMI patients with CS. But in the four that enrolled AMI 66 patients without CS, the data showed opposite conclusion. Conclusions: IABP cannot reduce within 2 months and 6-12 months mortality of AMI patients with CS as well as within 2 months mortality of AMI patients without CS, but can reduce 6-12 months mortality of AMI patients without CS. In addition, IABP can increase the risk of bleeding.	[Ye, Liwen; Chen, Qingwei; Li, Guiqion; Deng, Wei; Ke, Dazhi] Chongqing Med Univ, Affiliated Hosp 2, Dept Geriatr Cardiol, Chongqing, Peoples R China; [Zheng, Minming] Chongqing Med Univ, Affiliated Hosp 2, Chongqing Ophthalmol Res Ctr Senile, Chongqing, Peoples R China; [Zheng, Minming] Chongqing Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Chen, QW (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Geriatr Cardiol, Chongqing, Peoples R China.	chenqwcq@126.com	Deng, Wei/GWC-9207-2022					Anderson JL, 2011, CIRCULATION, V123, pE426, DOI 10.1161/CIR.0b013e318212bb8b; Bahekar A, 2012, J CARDIOVASC PHARM T, V17, P44, DOI 10.1177/1074248410395019; Barron HV, 2001, AM HEART J, V141, P933, DOI 10.1067/mhj.2001.115295; Brodie BR, 1999, AM J CARDIOL, V84, P18, DOI 10.1016/S0002-9149(99)00185-X; Cassese S, 2012, AM HEART J, V164, P58, DOI 10.1016/j.ahj.2012.05.001; Chang J, 2013, DIAGN HISTOPATHOL, V19, P7, DOI DOI 10.1016/J.MPDHP.2012.11.001; FLAHERTY JT, 1985, J AM COLL CARDIOL, V6, P434, DOI 10.1016/S0735-1097(85)80183-2; Gu J, 2011, ACTA CARDIOL, V66, P499, DOI 10.1080/AC.66.4.2126599; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; KANTROWITZ A, 1968, J AMER MED ASSOC, V203, P113, DOI 10.1001/jama.203.2.113; KERN MJ, 1993, CIRCULATION, V87, P500, DOI 10.1161/01.CIR.87.2.500; Kono T, 1996, J AM COLL CARDIOL, V28, P876, DOI 10.1016/S0735-1097(96)00240-9; Li JL, 2007, MED SCI MONITOR, V13, pCR270; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Ohman EM, 2005, J THROMB THROMBOLYS, V19, P33, DOI 10.1007/s11239-005-0938-0; OHMAN EM, 1994, CIRCULATION, V90, P792, DOI 10.1161/01.CIR.90.2.792; Patel MR, 2011, JAMA-J AM MED ASSOC, V306, P1329, DOI 10.1001/jama.2011.1280; Perera D, 2010, JAMA-J AM MED ASSOC, V304, P867, DOI 10.1001/jama.2010.1190; Prondzinsky R, 2010, CRIT CARE MED, V38, P152, DOI 10.1097/CCM.0b013e3181b78671; Sanborn TA, 2000, J AM COLL CARDIOL, V36, P1123, DOI 10.1016/S0735-1097(00)00875-5; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Stone GW, 1997, J AM COLL CARDIOL, V29, P1459, DOI 10.1016/S0735-1097(97)00088-0; Thiele H, 2013, LANCET, V382, P1638, DOI 10.1016/S0140-6736(13)61783-3; Unverzagt S, 2011, COCHRANE DB SYST REV, P7; Valk SDA, 2011, NETH HEART J, V19, P112, DOI 10.1007/s12471-010-0066-0; van 't Hof AWJ, 1999, EUR HEART J, V20, P659, DOI 10.1053/euhj.1998.1348; Vijayalakshmi Kunadian, 2007, J Invasive Cardiol, V19, P339; WAKSMAN R, 1993, EUR HEART J, V14, P71, DOI 10.1093/eurheartj/14.1.71; Zeymer U, 2013, CLIN RES CARDIOL, V102, P223, DOI 10.1007/s00392-012-0523-4; Zeymer U, 2011, EUROINTERVENTION, V7, P437, DOI 10.4244/EIJV7I4A72	30	5	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108356	10.1371/journal.pone.0108356	http://dx.doi.org/10.1371/journal.pone.0108356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268800	Green Submitted, gold, Green Published			2022-12-27	WOS:000343671700084
J	Quan, JN; Zhang, S; Zhang, CX; Meng, S; Zhao, Z; Xu, XX				Quan, Jine; Zhang, Sheng; Zhang, Chunxia; Meng, Sen; Zhao, Zhong; Xu, Xuexuan			Molecular Cloning, Characterization and Expression Analysis of the SAMS Gene during Adventitious Root Development in IBA-Induced Tetraploid Black Locust	PLOS ONE			English	Article							L-METHIONINE SYNTHETASE; S-ADENOSYLMETHIONINE DECARBOXYLASE; ENDOGENOUS PLANT HORMONES; ETHYLENE SYNTHESIS; POLYAMINES; CUTTINGS; AUXIN; IDENTIFICATION; HYPOCOTYL; RADIATA	S-Adenosylmethionine synthetase (SAMS) catalyzes the synthesis of S-adenosylmethionine (SAM), a precursor for ethylene and polyamine biosynthesis. Here, we report the isolation of the 1498 bp full-length cDNA sequence encoding tetraploid black locust (Robinia pseudoacacia L.) SAMS (TrbSAMS), which contains an open reading frame of 1179 bp encoding 392 amino acids. The amino acid sequence of TrbSAMS has more than 94% sequence identity to SAMSs from other plants, with a closer phylogenetic relationship to SAMSs from legumes than to SAMS from other plants. The TrbSAMS monomer consists of N-terminal, central, and C-terminal domains. Subcellular localization analysis revealed that the TrbSAMS protein localizes mainly to in the cell membrane and cytoplasm of onion epidermal cells and Arabidopsis mesophyll cell protoplasts. Indole-3-butyric acid (IBA)-treated cuttings showed higher levels of TrbSAMS transcript than untreated control cuttings during root primordium and adventitious root formation. TrbSAMS and its downstream genes showed differential expression in shoots, leaves, bark, and roots, with the highest expression observed in bark. IBA-treated cuttings also showed higher SAMS activity than control cuttings during root primordium and adventitious root formation. These results indicate that TrbSAMS might play an important role in the regulation of IBA-induced adventitious root development in tetraploid black locust cuttings.	[Quan, Jine; Zhang, Sheng; Zhang, Chunxia; Meng, Sen; Zhao, Zhong; Xu, Xuexuan] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China	Northwest A&F University - China	Zhao, Z (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China.	zhaozh@nwsuaf.edu.cn; xuxuexuan@nwsuaf.edu.cn			Innovation Projects in Institute of Soil and Water Conservation, Northwest AF University [A315021398]; National Natural Science Foundation of China [30972352]	Innovation Projects in Institute of Soil and Water Conservation, Northwest AF University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Innovation Projects in Institute of Soil and Water Conservation, Northwest A&F University (A315021398); and the National Natural Science Foundation of China (30972352). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DO, 1979, P NATL ACAD SCI USA, V76, P170, DOI 10.1073/pnas.76.1.170; Argueso CT, 2007, J PLANT GROWTH REGUL, V26, P92, DOI 10.1007/s00344-007-0013-5; BATTEN DJ, 1978, PLANTA, V138, P193, DOI 10.1007/BF00386810; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; BOERJAN W, 1994, PLANT CELL, V6, P1401, DOI 10.1105/tpc.6.10.1401; BOLLER T, 1979, PLANTA, V145, P293, DOI 10.1007/BF00454455; BOLLMARK M, 1990, PHYSIOL PLANTARUM, V80, P534, DOI 10.1111/j.1399-3054.1990.tb05675.x; Brinker M, 2004, PLANT PHYSIOL, V135, P1526, DOI 10.1104/pp.103.032235; [柴兴苹 Chai Xingping], 2013, [植物生理学报, Plant Physiology Journal], V49, P375; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; COLEMAN WK, 1980, PHYSIOL PLANTARUM, V48, P519, DOI 10.1111/j.1399-3054.1980.tb03298.x; DEKEYSER RA, 1990, PLANT CELL, V2, P591, DOI 10.1105/tpc.2.7.591; Detchanamurthy S, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue4-fulltext-2; Frankowski K, 2009, J PLANT PHYSIOL, V166, P192, DOI 10.1016/j.jplph.2008.02.013; Ge CM, 2006, CELL RES, V16, P446, DOI 10.1038/sj.cr.7310056; Goldfarb B, 2003, TREE PHYSIOL, V23, P1181, DOI 10.1093/treephys/23.17.1181; Goldfarb B, 1998, PHYSIOL PLANTARUM, V102, P513, DOI 10.1034/j.1399-3054.1998.1020405.x; Gomez-Gomez L, 1998, PLANT PHYSIOL, V117, P397, DOI 10.1104/pp.117.2.397; GOOD X, 1994, PLANT MOL BIOL, V26, P781, DOI 10.1007/BF00028848; [关军锋 Guan Junfeng], 2003, [植物生态学报, Acta Phytoecologica Sinica], V27, P655; Heloir MC, 1996, TREE PHYSIOL, V16, P515; JARVIS BC, 1983, PLANT CELL PHYSIOL, V24, P677, DOI 10.1093/oxfordjournals.pcp.a076564; Kim SB, 2012, HORTIC ENVIRON BIOTE, V53, P57, DOI 10.1007/s13580-012-0084-5; Kumar A, 1997, TRENDS PLANT SCI, V2, P124, DOI 10.1016/S1360-1385(97)01013-3; Kumar A, 1996, PLANT J, V9, P147, DOI 10.1046/j.1365-313X.1996.09020147.x; Li CZ, 2004, PLANT GROWTH REGUL, V42, P55, DOI 10.1023/B:GROW.0000014890.97789.fe; Li XD, 2013, MOL BIOL REP, V40, P1255, DOI 10.1007/s11033-012-2168-9; Lim CC, 2002, PHYSIOL PLANTARUM, V116, P522, DOI 10.1034/j.1399-3054.2002.1160411.x; Lindroth AM, 2001, PLANT PHYSIOL BIOCH, V39, P107, DOI 10.1016/S0981-9428(00)01229-8; Lindroth AM, 2001, PLANT MOL BIOL, V46, P335, DOI 10.1023/A:1010637012528; Ling WX, 2012, TURK J AGRIC FOR, V36, P257, DOI 10.3906/tar-1011-1511; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mare C, 2004, PLANT MOL BIOL, V55, P399, DOI 10.1007/s11103-004-0906-7; Mo H, 2002, PHYSIOL PLANTARUM, V114, P439, DOI 10.1034/j.1399-3054.2002.1140314.x; Negi S, 2010, PLANT J, V61, P3, DOI 10.1111/j.1365-313X.2009.04027.x; PELEMAN J, 1989, PLANT CELL, V1, P81, DOI 10.1105/tpc.1.1.81; PELEMAN J, 1989, GENE, V84, P359, DOI 10.1016/0378-1119(89)90510-6; Pommerrenig B, 2011, PLANT CELL, V23, P1904, DOI 10.1105/tpc.110.079657; Ragonezi C, 2010, TREES-STRUCT FUNCT, V24, P975, DOI 10.1007/s00468-010-0488-8; Ricci A, 2008, PLANT SCI, V175, P356, DOI 10.1016/j.plantsci.2008.05.009; RIOV J, 1989, J PLANT GROWTH REGUL, V8, P131, DOI 10.1007/BF02025280; ROY BN, 1972, PLANT CELL PHYSIOL, V13, P1123; Sanchez C, 2007, TREE PHYSIOL, V27, P1459, DOI 10.1093/treephys/27.10.1459; Sedira M, 2005, PLANT SCI, V168, P1193, DOI 10.1016/j.plantsci.2004.12.017; Shafqat N, 2013, BIOCHEM J, V452, P27, DOI 10.1042/BJ20121580; Sodabeh JG, 2013, J INFORM TECHNOL, V1, P12; Sorin C, 2006, PLANT PHYSIOL, V140, P349, DOI 10.1104/pp.105.067868; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; VANDOORSSELAERE J, 1993, PLANT PHYSIOL, V102, P1365, DOI 10.1104/pp.102.4.1365; Wang XL, 2011, PHYTON-INT J EXP BOT, V80, P93; Wu TY, 2003, J BIOL CHEM, V278, P20514, DOI 10.1074/jbc.M302149200; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu JG, 2012, HORTIC ENVIRON BIOTE, V53, P247, DOI 10.1007/s13580-012-0021-7	53	12	16	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108709	10.1371/journal.pone.0108709	http://dx.doi.org/10.1371/journal.pone.0108709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285660	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700030
J	Amaral, NO; de Oliveira, TS; Naves, LM; Filgueira, FP; Ferreira-Neto, ML; Schoorlemmer, GHM; de Castro, CH; Freiria-Oliveira, AH; Xavier, CH; Colugnati, DB; Rosa, DA; Blanch, GT; Borges, CL; Soares, CMA; Reis, AAS; Cravo, SL; Pedrino, GR				Amaral, Nathalia O.; de Oliveira, Thiago S.; Naves, Lara M.; Filgueira, Fernando P.; Ferreira-Neto, Marcos L.; Schoorlemmer, Gerard H. M.; de Castro, Carlos H.; Freiria-Oliveira, Andre H.; Xavier, Carlos H.; Colugnati, Diego B.; Rosa, Daniel A.; Blanch, Graziela T.; Borges, Clayton L.; Soares, Celia M. A.; Reis, Angela A. S.; Cravo, Sergio L.; Pedrino, Gustavo R.			Efferent Pathways in Sodium Overload-Induced Renal Vasodilation in Rats	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; HYPERTONIC SALINE INFUSION; SYMPATHETIC-NERVE ACTIVITY; CARDIOVASCULAR-RESPONSES; BARORECEPTOR INFLUENCES; VASOPRESSIN SECRETION; CIRCULATING VOLUME; ARTERIAL-PRESSURE; RENIN SECRETION; BLOOD-PRESSURE	Hypernatremia stimulates the secretion of oxytocin (OT), but the physiological role of OT remains unclear. The present study sought to determine the involvement of OT and renal nerves in the renal responses to an intravenous infusion of hypertonic saline. Male Wistar rats (280-350 g) were anesthetized with sodium thiopental (40 mg. kg(-1), i.v.). A bladder cannula was implanted for collection of urine. Animals were also instrumented for measurement of mean arterial pressure (MAP) and renal blood flow (RBF). Renal vascular conductance (RVC) was calculated as the ratio of RBF by MAP. In anesthetized rats (n = 6), OT infusion (0.03 mu g . kg(-1), i.v.) induced renal vasodilation. Consistent with this result, ex vivo experiments demonstrated that OT caused renal artery relaxation. Blockade of OT receptors (OXTR) reduced these responses to OT, indicating a direct effect of this peptide on OXTR on this artery. Hypertonic saline (3 M NaCl, 1.8 ml . kg(-1) b.wt., i.v.) was infused over 60 s. In sham rats (n = 6), hypertonic saline induced renal vasodilation. The OXTR antagonist (AT; atosiban, 40 mu g . kg(-1) . h(-1), i.v.; n = 7) and renal denervation (RX) reduced the renal vasodilation induced by hypernatremia. The combination of atosiban and renal denervation (RX+AT; n = 7) completely abolished the renal vasodilation induced by sodium overload. Intact rats excreted 51% of the injected sodium within 90 min. Natriuresis was slightly blunted by atosiban and renal denervation (42% and 39% of load, respectively), whereas atosiban with renal denervation reduced sodium excretion to 16% of the load. These results suggest that OT and renal nerves are involved in renal vasodilation and natriuresis induced by acute plasma hypernatremia.	[Amaral, Nathalia O.; de Oliveira, Thiago S.; Naves, Lara M.; Filgueira, Fernando P.; de Castro, Carlos H.; Freiria-Oliveira, Andre H.; Xavier, Carlos H.; Colugnati, Diego B.; Rosa, Daniel A.; Blanch, Graziela T.; Pedrino, Gustavo R.] Univ Fed Goias, Ctr Neurosci & Cardiovasc Physiol, Inst Biol Sci, Dept Physiol Sci, Goiania, Go, Brazil; [Ferreira-Neto, Marcos L.] Univ Fed Uberlandia, Fac Phys Educ, Inst Biol Sci, BR-38400 Uberlandia, MG, Brazil; [Schoorlemmer, Gerard H. M.; Cravo, Sergio L.] Univ Fed Sao Paulo, Dept Physiol, Sao Paulo, Brazil; [Borges, Clayton L.; Soares, Celia M. A.] Univ Fed Goias, Inst Biol Sci, Mol Biol Lab, Goiania, Go, Brazil; [Reis, Angela A. S.] Univ Fed Goias, Inst Biol Sci, Dept Biochem & Mol Biol, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Uberlandia; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Goias; Universidade Federal de Goias	Pedrino, GR (corresponding author), Univ Fed Goias, Ctr Neurosci & Cardiovasc Physiol, Inst Biol Sci, Dept Physiol Sci, Goiania, Go, Brazil.	pedrino@pq.cnpq.br	Filgueira, Fernando/C-5668-2013; FERREIRA-NETO, MARCOS LUIZ/O-3368-2014; Pedrino, Gustavo R/I-5614-2015; Colugnati, Diego/AAD-2977-2019; Rosa, Daniel A/E-5429-2018; Freiria-Oliveira, Andre/F-2756-2012; Ferreira-Neto, Marcos Luiz/AHC-8135-2022; DA SILVA, ANGELA ADAMSKI/AAJ-1403-2021; de Oliveira, Thiago Sardinha/W-7145-2018; Xavier, Carlos Henrique/AAE-8390-2022; Naves, Lara/ABC-4334-2021; Xavier, Carlos H/C-8561-2013; BORGES, CLAYTON LUIZ/GQB-5595-2022; Custodio, Carlos Henrique Xavier/F-8450-2010	Filgueira, Fernando/0000-0001-8910-1796; Pedrino, Gustavo R/0000-0003-0488-5400; Colugnati, Diego/0000-0002-6565-0042; Rosa, Daniel A/0000-0002-7036-0840; Ferreira-Neto, Marcos Luiz/0000-0002-9695-7100; DA SILVA, ANGELA ADAMSKI/0000-0002-8281-7334; de Oliveira, Thiago Sardinha/0000-0002-2825-5959; Xavier, Carlos Henrique/0000-0003-4006-8213; Naves, Lara/0000-0002-4749-869X; Xavier, Carlos H/0000-0003-4006-8213; Freiria-Oliveira, Andre Henrique/0000-0002-7511-5035; Schoorlemmer, Gus/0000-0002-2966-1457	Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG) [2012/0055431086, 2009/10267000352]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [477832/2010-5, 483411/2012-4]	Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG)(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG; www.fapeg.go.gov.br) grants 2012/0055431086 (GRP) and 2009/10267000352 (GRP) and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; www.cnpq.br) grants 477832/2010-5 (GRP) and 483411/2012-4 (GRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badoer E, 2003, AM J PHYSIOL-RENAL, V285, pF640, DOI 10.1152/ajprenal.00372.2002; BALMENT RJ, 1980, J PHYSIOL-LONDON, V308, P439, DOI 10.1113/jphysiol.1980.sp013481; BEALER SL, 1983, AM J PHYSIOL, V244, pR815, DOI 10.1152/ajpregu.1983.244.6.R815; BEALER SL, 1988, AM J PHYSIOL, V254, pR84, DOI 10.1152/ajpregu.1988.254.1.R84; Blanch GT, 2013, AM J PHYSIOL-REG I, V304, pR531, DOI 10.1152/ajpregu.00191.2012; Boer PA, 2005, LIFE SCI, V76, P1805, DOI 10.1016/j.lfs.2004.09.029; Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; BOURQUE CW, 1994, FRONT NEUROENDOCRIN, V15, P231, DOI 10.1006/frne.1994.1010; Callahan MF, 1997, NEUROENDOCRINOLOGY, V65, P238, DOI 10.1159/000127181; CONRAD KP, 1986, AM J PHYSIOL, V251, pF290, DOI 10.1152/ajprenal.1986.251.2.F290; CONRAD KP, 1993, ANN NY ACAD SCI, V689, P346, DOI 10.1111/j.1749-6632.1993.tb55559.x; Cravo SL, 2011, BRAZ J MED BIOL RES, V44, P877, DOI 10.1590/S0100-879X2011000900008; da Silva EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073187; Dale HH, 1906, J PHYSIOL-LONDON, V34, P163; DiBona GF, 1997, PHYSIOL REV, V77, P75, DOI 10.1152/physrev.1997.77.1.75; FUJITA T, 1991, JPN J PHYSIOL, V41, P653, DOI 10.2170/jjphysiol.41.653; Godino A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074689; Guadagnini D, 2006, LIFE SCI, V79, P1666, DOI 10.1016/j.lfs.2006.06.005; Gutkowska J, 1997, P NATL ACAD SCI USA, V94, P11704, DOI 10.1073/pnas.94.21.11704; HAANWINCKEL MA, 1995, P NATL ACAD SCI USA, V92, P7902, DOI 10.1073/pnas.92.17.7902; HORAN MJ, 1985, HYPERTENSION, V7, P818, DOI 10.1161/01.HYP.7.5.818; HUANG W, 1995, AM J PHYSIOL-REG I, V268, pR634, DOI 10.1152/ajpregu.1995.268.3.R634; HUANG W, 1994, KIDNEY INT, V45, P692, DOI 10.1038/ki.1994.93; Huang W, 2000, AM J PHYSIOL-REG I, V278, pR226, DOI 10.1152/ajpregu.2000.278.1.R226; Jacob F, 2005, CLIN EXP PHARMACOL P, V32, P255, DOI 10.1111/j.1440-1681.2005.04179.x; Jacob F, 2003, AM J PHYSIOL-HEART C, V284, pH2302, DOI 10.1152/ajpheart.01029.2002; Khan SA, 2014, ACTA PHYSIOL, V210, P690, DOI 10.1111/apha.12237; LAW MR, 1991, BMJ-BRIT MED J, V302, P819, DOI 10.1136/bmj.302.6780.819; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; MORRIS M, 1989, HYPERTENSION, V13, P110, DOI 10.1161/01.HYP.13.2.110; MORRIS M, 1988, ENDOCRINOLOGY, V122, P373, DOI 10.1210/endo-122-1-373; Nishida Y, 1998, AM J PHYSIOL-REG I, V274, pR97, DOI 10.1152/ajpregu.1998.274.1.R97; Ott I, 1910, P SOC EXP BIOL, V8, P48; Pedrino GR, 2005, AUTON NEUROSCI-BASIC, V117, P9, DOI 10.1016/j.autneu.2004.09.005; Pedrino GR, 2009, CLIN EXP PHARMACOL P, V36, pe83, DOI 10.1111/j.1440-1681.2009.05280.x; Pedrino GR, 2008, AUTON NEUROSCI-BASIC, V142, P55, DOI 10.1016/j.autneu.2008.06.006; Pedrino GR, 2006, EXP PHYSIOL, V91, P995, DOI 10.1113/expphysiol.2006.034611; Pedrino GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037587; RAUCH AL, 1990, AM J PHYSIOL, V258, pR531, DOI 10.1152/ajpregu.1990.258.2.R531; Schoorlemmer GHM, 2000, AM J PHYSIOL-REG I, V278, pR917, DOI 10.1152/ajpregu.2000.278.4.R917; SimonsMorton DG, 1997, PEDIATR NEPHROL, V11, P244, DOI 10.1007/s004670050271; Sjoquist M, 1999, ENDOCRINOLOGY, V140, P2814, DOI 10.1210/en.140.6.2814; Soares TJ, 1999, P NATL ACAD SCI USA, V96, P278, DOI 10.1073/pnas.96.1.278; Stoop R, 2012, NEURON, V76, P142, DOI 10.1016/j.neuron.2012.09.025; Strange K, 1993, CELLULAR MOL PHYSL C; Toney GM, 2003, ACTA PHYSIOL SCAND, V177, P43, DOI 10.1046/j.1365-201X.2003.01046.x; TROSTEL KA, 1992, AM J PHYSIOL, V263, pR1265, DOI 10.1152/ajpregu.1992.263.6.R1265; VERBALIS JG, 1991, ENDOCRINOLOGY, V128, P1317, DOI 10.1210/endo-128-3-1317; Weiss ML, 1996, J AUTONOM NERV SYST, V57, P109, DOI 10.1016/0165-1838(95)00108-5; Young WS, 2003, NEUROENDOCRINOLOGY, V78, P185, DOI 10.1159/000073702	51	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109620	10.1371/journal.pone.0109620	http://dx.doi.org/10.1371/journal.pone.0109620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279805	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800093
J	Fu, Y; Zhang, HC; Dong, WJ; Yuan, WP				Fu, Yang; Zhang, Haicheng; Dong, Wenjie; Yuan, Wenping			Comparison of Phenology Models for Predicting the Onset of Growing Season over the Northern Hemisphere	PLOS ONE			English	Article							CLIMATE-CHANGE; VEGETATION PHENOLOGY; DORMANCY RELEASE; PLANT PHENOLOGY; CARBON BALANCE; SATELLITE DATA; WATER-BALANCE; BUD DORMANCY; FRUIT-TREES; BUDBURST	Vegetation phenology models are important for examining the impact of climate change on the length of the growing season and carbon cycles in terrestrial ecosystems. However, large uncertainties in present phenology models make accurate assessment of the beginning of the growing season (BGS) a challenge. In this study, based on the satellite-based phenology product (i.e. the V005 MODIS Land Cover Dynamics (MCD12Q2) product), we calibrated four phenology models, compared their relative strength to predict vegetation phenology; and assessed the spatial pattern and interannual variability of BGS in the Northern Hemisphere. The results indicated that parameter calibration significantly influences the models' accuracy. All models showed good performance in cool regions but poor performance in warm regions. On average, they explained about 67% (the Growing Degree Day model), 79% (the Biome-BGC phenology model), 73% (the Number of Growing Days model) and 68% (the Number of Chilling Days-Growing Degree Day model) of the BGS variations over the Northern Hemisphere. There were substantial differences in BGS simulations among the four phenology models. Overall, the Biome-BGC phenology model performed best in predicting the BGS, and showed low biases in most boreal and cool regions. Compared with the other three models, the two-phase phenology model (NCD-GDD) showed the lowest correlation and largest biases with the MODIS phenology product, although it could catch the interannual variations well for some vegetation types. Our study highlights the need for further improvements by integrating the effects of water availability, especially for plants growing in low latitudes, and the physiological adaptation of plants into phenology models.	[Fu, Yang; Zhang, Haicheng; Dong, Wenjie; Yuan, Wenping] Beijing Normal Univ, State Key Lab Earth Surface Processes & Resource, Beijing, Peoples R China; [Yuan, Wenping] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, State Key Lab Cryospher Sci, Lanzhou, Gansu, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Yuan, WP (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Processes & Resource, Beijing, Peoples R China.	yuanwpcn@126.com		Zhang, Haicheng/0000-0002-9313-5953	National Science Foundation [41322005]; National Natural Science Foundation of China [41201078]; Program for New Century Excellent Talents in University [NCET-12-0060]; Fundamental Research Funds for the Central Universities	National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Science Foundation for Excellent Young Scholars of China (41322005), National Natural Science Foundation of China (41201078), Program for New Century Excellent Talents in University (NCET-12-0060) and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernal M, 2011, PLANT BIOLOGY, V13, P252, DOI 10.1111/j.1438-8677.2010.00358.x; Biome-BGC, 2010, BIOME BGC VERS 4 2 T; Botta A, 2000, GLOBAL CHANGE BIOL, V6, P709, DOI 10.1046/j.1365-2486.2000.00362.x; Brown ME, 2012, REMOTE SENS ENVIRON, V126, P174, DOI 10.1016/j.rse.2012.08.009; Cai WW, 2014, J GEOPHYS RES-BIOGEO, V119, P110, DOI 10.1002/2013JG002456; CANNELL MGR, 1983, J APPL ECOL, V20, P951, DOI 10.2307/2403139; Cesaraccio C, 2004, AGR FOREST METEOROL, V126, P1, DOI 10.1016/j.agrformet.2004.03.002; Chen XQ, 2000, INT J BIOMETEOROL, V44, P97, DOI 10.1007/s004840000056; Chmielewski FM, 2004, AGR FOREST METEOROL, V121, P69, DOI 10.1016/S0168-1923(03)00161-8; Chuine I, 2001, ECOL LETT, V4, P500, DOI 10.1046/j.1461-0248.2001.00261.x; Chuine I, 1999, NEW PHYTOL, V143, P339, DOI 10.1046/j.1469-8137.1999.00445.x; Chuine I, 2000, J THEOR BIOL, V207, P337, DOI 10.1006/jtbi.2000.2178; Chuine I, 2010, PHILOS T R SOC B, V365, P3149, DOI 10.1098/rstb.2010.0142; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; FALUSI M, 1990, TREE PHYSIOL, V6, P429, DOI 10.1093/treephys/6.4.429; Faust M, 1997, HORTSCIENCE, V32, P623, DOI 10.21273/HORTSCI.32.4.623; Foley JA, 1996, GLOBAL BIOGEOCHEM CY, V10, P603, DOI 10.1029/96GB02692; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; Ganguly S, 2010, REMOTE SENS ENVIRON, V114, P1805, DOI 10.1016/j.rse.2010.04.005; HEIDE OM, 1993, PHYSIOL PLANTARUM, V89, P187, DOI 10.1111/j.1399-3054.1993.tb01804.x; Hmimina G, 2013, REMOTE SENS ENVIRON, V132, P145, DOI 10.1016/j.rse.2013.01.010; Karlsen SR, 2008, INT J APPL EARTH OBS, V10, P253, DOI 10.1016/j.jag.2007.10.005; KRAMER K, 1994, J APPL ECOL, V31, P172, DOI 10.2307/2404609; Kramer K, 2000, INT J BIOMETEOROL, V44, P67, DOI 10.1007/s004840000066; Kross A, 2011, REMOTE SENS ENVIRON, V115, P1564, DOI 10.1016/j.rse.2011.02.015; Kucharik CJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P795, DOI 10.1029/1999GB001138; LANG GA, 1987, HORTSCIENCE, V22, P371; Leinonen I, 2002, CLIMATIC CHANGE, V55, P99, DOI 10.1023/A:1020251507469; Llorens L, 2004, ANN BOT-LONDON, V94, P843, DOI 10.1093/aob/mch211; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Menzel A, 2002, CLIMATIC CHANGE, V54, P379, DOI 10.1023/A:1016125215496; Morin X, 2009, GLOBAL CHANGE BIOL, V15, P961, DOI 10.1111/j.1365-2486.2008.01735.x; MURRAY MB, 1989, J APPL ECOL, V26, P693, DOI 10.2307/2404093; Orlandi F, 2004, PLANT BIOSYST, V138, P111, DOI 10.1080/11263500412331283762; Penuelas J, 2004, NEW PHYTOL, V161, P837, DOI 10.1111/j.1469-8137.2004.01003.x; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Richardson AD, 2012, GLOBAL CHANGE BIOL, V18, P566, DOI 10.1111/j.1365-2486.2011.02562.x; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Schwartz MD, 2000, INT J CLIMATOL, V20, P929, DOI 10.1002/1097-0088(20000630)20:8&lt;929::AID-JOC557&gt;3.0.CO;2-5; Schwartz MD, 1998, NATURE, V394, P839, DOI 10.1038/29670; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9; VERSEGHY DL, 1993, INT J CLIMATOL, V13, P347, DOI 10.1002/joc.3370130402; VEZINA PE, 1965, ECOLOGY, V46, P869, DOI 10.2307/1934022; Vitasse Y, 2011, AGR FOREST METEOROL, V151, P969, DOI 10.1016/j.agrformet.2011.03.003; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; White MA, 1997, GLOBAL BIOGEOCHEM CY, V11, P217, DOI 10.1029/97GB00330; White MA, 1999, INT J BIOMETEOROL, V42, P139, DOI 10.1007/s004840050097; White MA, 2009, GLOBAL CHANGE BIOL, V15, P2335, DOI 10.1111/j.1365-2486.2009.01910.x; Yang X, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001977; Yuan WP, 2007, ECOL RES, V22, P784, DOI 10.1007/s11284-006-0318-z; Yuan WP, 2012, ECOL MODEL, V240, P29, DOI 10.1016/j.ecolmodel.2012.04.027; Yuan WP, 2012, WATER RESOUR MANAG, V26, P2147, DOI 10.1007/s11269-012-0007-3; Zhang HC, 2014, ECOL COMPLEX, V20, P240, DOI 10.1016/j.ecocom.2014.01.003; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9; Zhao MF, 2013, ENVIRON REV, V21, P1, DOI 10.1139/er-2012-0036; Zheng Daolan, 1993, Climate Research, V2, P183, DOI 10.3354/cr002183; Zhu WQ, 2012, GLOBAL ECOL BIOGEOGR, V21, P260, DOI 10.1111/j.1466-8238.2011.00675.x	58	34	37	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109544	10.1371/journal.pone.0109544	http://dx.doi.org/10.1371/journal.pone.0109544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279567	gold, Green Published, Green Submitted			2022-12-27	WOS:000342670800090
J	Gatterer, H; Schenk, K; Laninschegg, L; Schlemmer, P; Lukaski, H; Burtscher, M				Gatterer, Hannes; Schenk, Kai; Laninschegg, Lisa; Schlemmer, Philipp; Lukaski, Henry; Burtscher, Martin			Bioimpedance Identifies Body Fluid Loss after Exercise in the Heat: A Pilot Study with Body Cooling	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE; HYDRATION; DEHYDRATION; VALIDATION; VECTOR	Purpose: Assessment of post-exercise changes in hydration with bioimpedance (BI) is complicated by physiological adaptations that affect resistance (R) and reactance (Xc) values. This study investigated exercise-induced changes in R and Xc, independently and in bioelectrical impedance vector analysis, when factors such as increased skin temperature and blood flow and surface electrolyte accumulation are eliminated with a cold shower. Methods: Healthy males (n = 14, 24.1 +/- 1.7 yr; height (H): 182.4 +/- 5.6 cm, body mass: 72.3 +/- 6.3 kg) exercised for 1 hr at a self-rated intensity (15 BORG) in an environmental chamber (33 degrees C and 50% relative humidity), then had a cold shower (15 min). Before the run BI, body mass, hematocrit and Posm were measured. After the shower body mass was measured; BI measurements were performed continuously every 20 minutes until R reached a stable level, then hematocrit and Posm were measured again. Results: Compared to pre-trial measurements body mass decreased after the run and Posm, Hct, R/H and Xc/H increased (p<0.05) with a corresponding lengthening of the impedance vector along the major axis of the tolerance ellipse (p<0.001). Changes in Posm were negatively related to changes in body mass (r = -0.564, p = 0.036) and changes in Xc/H (r = -0.577, p = 0.041). Conclusions: Present findings showed that after a bout of exercise-induced dehydration followed by cold shower the impedance vector lengthened that indicates fluid loss. Additionally, BI values might be useful to evaluate fluid shifts between compartments as lower intracellular fluid loss (changed Xc/R) indicated greater Posm increase.	[Gatterer, Hannes; Schenk, Kai; Laninschegg, Lisa; Schlemmer, Philipp; Burtscher, Martin] Univ Innsbruck, Dept Sport Sci, A-6020 Innsbruck, Austria; [Lukaski, Henry] Univ N Dakota, Dept Kinesiol & Publ Hlth Educ, Grand Forks, ND 58201 USA	University of Innsbruck; University of North Dakota Grand Forks	Gatterer, H (corresponding author), Univ Innsbruck, Dept Sport Sci, A-6020 Innsbruck, Austria.	hannes.gatterer@uibk.ac.at	Gatterer, Hannes/S-7848-2017; Burtscher, Martin/M-7015-2019	Gatterer, Hannes/0000-0002-5084-2930; Burtscher, Martin/0000-0002-5232-3632				Armstrong LE, 2007, J AM COLL NUTR, V26, p575S, DOI 10.1080/07315724.2007.10719661; Armstrong LE, 2013, AM J CLIN NUTR, V98, P503, DOI 10.3945/ajcn.113.065466; Armstrong LE, 2012, NUTR TODAY, V47, P3, DOI DOI 10.1097/NT.0B013E31826266CF; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Buono MJ, 2004, PHYSIOL MEAS, V25, P119, DOI 10.1088/0967-3334/25/1/011; Cheuvront SN, 2013, AM J CLIN NUTR, V97, P455, DOI 10.3945/ajcn.112.044172; Cheuvront SN, 2010, AM J CLIN NUTR, V92, P565, DOI 10.3945/ajcn.2010.29490; Gatterer H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073185; Higgins KJ, 2007, MED SCI SPORT EXER, V39, P984, DOI 10.1249/mss.0b013e31803bb4d4; Koulmann N, 2000, MED SCI SPORT EXER, V32, P857, DOI 10.1097/00005768-200004000-00020; Koury JC, 2014, INT J SPORT PHYSIOL, V9, P798, DOI [10.1123/IJSPP.2013-0397, 10.1123/ijspp.2013-0397]; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Lukaski HC, 2013, EUR J CLIN NUTR, V67, pS2, DOI 10.1038/ejcn.2012.149; Lukaski H.C., 2012, HDB ANTHROPOMETRY, P287, DOI [10.1007/978-1-4419-1788-1_16, DOI 10.1007/978-1-4419-1788-1]; LUKASKI HC, 1986, J APPL PHYSIOL, V60, P1327, DOI 10.1152/jappl.1986.60.4.1327; Lukaski HC, 1996, AM J CLIN NUTR, V64, P397, DOI 10.1093/ajcn/64.3.397S; Lukaski HC, 2007, NUTRITION, V23, P543, DOI 10.1016/j.nut.2007.05.001; Maughan RJ, 2010, SCAND J MED SCI SPOR, V20, P40, DOI 10.1111/j.1600-0838.2010.01207.x; Maughan RJ, 2007, J SPORT SCI, V25, P797, DOI 10.1080/02640410600875143; Micheli ML, 2014, INT J SPORT PHYSIOL, V9, P532, DOI [10.1123/ijspp.2013-0119, 10.1123/IJSPP.2013-0119]; O'Brien C, 2002, INT J SPORTS MED, V23, P361, DOI 10.1055/s-2002-33145; O'Brien C, 1999, MED SCI SPORT EXER, V31, P1466, DOI 10.1097/00005768-199910000-00017; Peiffer JJ, 2009, J SCI MED SPORT, V12, P91, DOI 10.1016/j.jsams.2007.10.011; Piccoli A, 1996, MED SCI SPORT EXER, V28, P1517, DOI 10.1097/00005768-199612000-00012; PICCOLI A, 1995, AM J CLIN NUTR, V61, P269, DOI 10.1093/ajcn/61.2.269; PICCOLI A, 1994, KIDNEY INT, V46, P534, DOI 10.1038/ki.1994.305; Versey NG, 2013, SPORTS MED, V43, P1101, DOI 10.1007/s40279-013-0063-8	27	35	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109729	10.1371/journal.pone.0109729	http://dx.doi.org/10.1371/journal.pone.0109729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279660	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800099
J	Maruhashi, T; Noma, K; Iwamoto, Y; Iwamoto, A; Oda, N; Kajikawa, M; Matsumoto, T; Hidaka, T; Kihara, Y; Chayama, K; Nakashima, A; Goto, C; Liao, JK; Higashi, Y				Maruhashi, Tatsuya; Noma, Kensuke; Iwamoto, Yumiko; Iwamoto, Akimichi; Oda, Nozomu; Kajikawa, Masato; Matsumoto, Takeshi; Hidaka, Takayuki; Kihara, Yasuki; Chayama, Kazuaki; Nakashima, Ayumu; Goto, Chikara; Liao, James K.; Higashi, Yukihito			Critical Role of Exogenous Nitric Oxide in ROCK Activity in Vascular Smooth Muscle Cells	PLOS ONE			English	Article							PROTEIN-KINASE; NEOINTIMAL FORMATION; IN-VIVO; RHO; INHIBITION; SYNTHASE; PHOSPHORYLATION; SENSITIZATION; ENDOTHELIUM; SUPPRESSION	Objective: Rho-associated kinase (ROCK) signaling pathway has been shown to mediate various cellular functions including cell proliferation, migration, adhesion, apoptosis, and contraction, all of which may be involved in pathogenesis of atherosclerosis. Endogenous nitric oxide (NO) is well known to have an anti-atherosclerotic effect, whereas the exogenous NO-mediated cardiovascular effect still remains controversial. The purpose of this study was to evaluate the effect of exogenous NO on ROCK activity in vascular smooth muscle cells (VSMCs) in vitro and in vivo. Methods: VSMCs migration was evaluated using a modified Boyden chamber assay. ROCK activities were measured by Western blot analysis in murine and human VSMCs and aorta of mice treated with or without angiotensin II (Ang II) and/or sodium nitroprusside (SNP), an NO donor. Results: Co-treatment with SNP inhibited the Ang II-induced cell migration and increases in ROCK activity in murine and human VSMCs. Similarly, the increased ROCK activity 2 weeks after Ang II infusion in the mouse aorta was substantially inhibited by subcutaneous injection of SNP. Conclusions: These findings suggest that administration of exogenous NO can inhibit ROCK activity in VSMCs in vitro and in vivo.	[Maruhashi, Tatsuya; Iwamoto, Yumiko; Iwamoto, Akimichi; Oda, Nozomu; Kajikawa, Masato; Matsumoto, Takeshi; Hidaka, Takayuki; Kihara, Yasuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Hiroshima, Japan; [Noma, Kensuke; Higashi, Yukihito] Hiroshima Univ, Res Inst Radiat Biol & Med RIRBM, Res Ctr Radiat Genome Med, Dept Regenerat & Med, Hiroshima, Japan; [Chayama, Kazuaki] Hiroshima Univ, Dept Med & Mol Sci, Hiroshima, Japan; [Nakashima, Ayumu; Higashi, Yukihito] Hiroshima Univ Hosp, Med Ctr Translat & Clin Res, Dept Regenerat & Med, Hiroshima, Japan; [Goto, Chikara] Hiroshima Int Univ, Dept Integrated Rehabil, Hiroshima, Japan; [Liao, James K.] Univ Chicago, Med Ctr, Cardiol Sect, Chicago, IL 60637 USA	Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; University of Chicago; University of Chicago Medical Center	Higashi, Y (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med RIRBM, Res Ctr Radiat Genome Med, Dept Regenerat & Med, Hiroshima, Japan.	yhigashi@hiroshima-u.ac.jp	Nakashima, Ayumu/CAF-0274-2022; Nakashima, Ayumu/N-9158-2017; Higashi, Yukihito/G-5343-2019; Chayama, Kazuaki/B-2493-2016	Nakashima, Ayumu/0000-0002-7838-1494; Nakashima, Ayumu/0000-0002-7838-1494; Chayama, Kazuaki/0000-0002-5530-5341	Ministry of Education, Science and Culture of Japan [23591043, 1859081500, 21590898]; Japan Heart Foundation/Novartis Grant; Tsuchiya Foundation Grant, Japan; Japanese Arteriosclerosis Prevention Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Heart Foundation/Novartis Grant; Tsuchiya Foundation Grant, Japan; Japanese Arteriosclerosis Prevention Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (23591043 to K.N.), Japan Heart Foundation/Novartis Grant, and Tsuchiya Foundation Grant, Japan (to K.N.). This study also was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (1859081500 and 21590898 to Y.H.) and a Grant in Aid of Japanese Arteriosclerosis Prevention Fund (to Y.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Chitaley K, 2002, HYPERTENSION, V39, P438, DOI 10.1161/hy02t2.102960; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; FORSTERMANN U, 1994, HYPERTENSION, V23, P1121, DOI 10.1161/01.HYP.23.6.1121; Gori T, 2008, J AM COLL CARDIOL, V52, P251, DOI 10.1016/j.jacc.2008.04.019; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Higashi M, 2003, CIRC RES, V93, P767, DOI 10.1161/01.RES.0000096650.91688.28; Largiader T, 2008, J CARDIOVASC PHARM, V52, P369, DOI 10.1097/FJC.0b013e31818953d0; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Mallat Z, 2003, CIRC RES, V93, P884, DOI 10.1161/01.RES.0000099062.55042.9A; Masumoto A, 2002, CIRCULATION, V105, P1545, DOI 10.1161/hc1002.105938; Ming XF, 2002, MOL CELL BIOL, V22, P8467, DOI 10.1128/MCB.22.24.8467-8477.2002; Nakamura S, 2009, HYPERTENSION, V53, P674, DOI 10.1161/HYPERTENSIONAHA.108.126078; NAKASHIMA T, 1994, HEARING RES, V80, P241, DOI 10.1016/0378-5955(94)90115-5; Noma K, 2006, AM J PHYSIOL-CELL PH, V290, pC661, DOI 10.1152/ajpcell.00459.2005; Noma K, 2008, J CLIN INVEST, V118, P1632, DOI 10.1172/JCI29226; PACKER M, 1987, NEW ENGL J MED, V317, P799, DOI 10.1056/NEJM198709243171304; Perticone F, 2001, CIRCULATION, V104, P191, DOI 10.1161/01.CIR.104.2.191; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; Sakata Y, 2004, ARTERIOSCL THROM VAS, V24, P2069, DOI 10.1161/01.ATV.0000143936.77094.a4; Sato M, 2000, CIRC RES, V87, P195, DOI 10.1161/01.RES.87.3.195; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Sawada N, 2000, CIRCULATION, V101, P2030, DOI 10.1161/01.CIR.101.17.2030; Sawada N, 2001, BIOCHEM BIOPH RES CO, V280, P798, DOI 10.1006/bbrc.2000.4194; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Shimizu T, 2013, ARTERIOSCL THROM VAS, V33, P2780, DOI 10.1161/ATVBAHA.113.301357; Shimokawa H, 2002, J CARDIOVASC PHARM, V40, P749; Suzuki H, 2009, ARTERIOSCL THROM VAS, V29, P217, DOI 10.1161/ATVBAHA.108.181024; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; THADANI U, 1987, Rational Drug Therapy, V21, P1; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; VANHOUTTE PM, 1989, HYPERTENSION, V13, P658, DOI 10.1161/01.HYP.13.6.658; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Wolfrum S, 2004, ARTERIOSCL THROM VAS, V24, P1842, DOI 10.1161/01.ATV.0000142813.33538.82	34	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109017	10.1371/journal.pone.0109017	http://dx.doi.org/10.1371/journal.pone.0109017			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25280018	gold, Green Published, Green Submitted			2022-12-27	WOS:000342670800048
J	Noli, B; Brancia, C; D'Amato, F; Ferri, GL; Cocco, C				Noli, Barbara; Brancia, Carla; D'Amato, Filomena; Ferri, Gian-Luca; Cocco, Cristina			VGF Changes during the Estrous Cycle: A Novel Endocrine Role for TLQP Peptides?	PLOS ONE			English	Article							IN-VIVO; MESSENGER-RNA; MOLECULAR-CLONING; SEX-DIFFERENCES; GROWTH-FACTOR; EXPRESSION; GENE; IDENTIFICATION; MODULATION; MATURATION	Although the VGF derived peptide TLQP-21 stimulates gonadotropin-releasing hormone (GnRH) and gonadotropin secretion, available data on VGF peptides and reproduction are limited. We used antibodies specific for the two ends of the VGF precursor, and for two VGF derived peptides namely TLQP and PGH, to be used in immunohistochemistry and enzyme-linked immunosorbent assay complemented with gel chromatography. In cycling female rats, VGF C-/N-terminus and PGH peptide antibodies selectively labelled neurones containing either GnRH, or kisspeptin (VGF N-terminus only), pituitary gonadotrophs and lactotrophs, or oocytes (PGH peptides only). Conversely, TLQP peptides were restricted to somatostatin neurones, gonadotrophs, and ovarian granulosa, interstitial and theca cells. TLQP levels were highest, especially in plasma and ovary, with several molecular forms shown in chromatography including one compatible with TLQP-21. Among the cycle phases, TLQP levels were higher during metestrus-diestrus in median eminence and pituitary, while increased in the ovary and decreased in plasma during proestrus. VGF N- and C-terminus peptides also showed modulations over the estrous cycle, in median eminence, pituitary and plasma, while PGH peptides did not. In ovariectomised rats, plasmatic TLQP peptide levels showed distinct reduction suggestive of a major origin from the ovary, while the estrogen-progesterone treatment modulated VGF C-terminus and TLQP peptides in the hypothalamus-pituitary complex. In in vitro hypothalamus, TLQP-21 stimulated release of growth hormone releasing hormone but not of somatostatin. In conclusion, various VGF peptides may regulate the hypothalamus-pituitary complex via specific neuroendocrine mechanisms while TLQP peptides may act at further, multiple levels via endocrine mechanisms involving the ovary.	[Noli, Barbara; Brancia, Carla; D'Amato, Filomena; Ferri, Gian-Luca; Cocco, Cristina] Univ Cagliari, Dept Biomed Sci, Monserrato, Cagliari, Italy	University of Cagliari	Ferri, GL (corresponding author), Univ Cagliari, Dept Biomed Sci, Monserrato, Cagliari, Italy.	cristina.cocco@unica.it; ferri@unica.it	Ferri, Luca Angelo/AAC-5890-2022	Ferri, Luca Angelo/0000-0001-9031-6284; FERRI, Gian-Luca/0000-0003-2768-349X; BRANCIA, CARLA/0000-0002-0716-3983	ARS (Autonomous Region of Sardinia) through the 'Sardinia PO FSE' funds [L.R. 7/2007]	ARS (Autonomous Region of Sardinia) through the 'Sardinia PO FSE' funds	This study was sponsored by the ARS (Autonomous Region of Sardinia) through the 'Sardinia PO FSE 2007-1013' funds (the L.R. 7/2007 for the 'Promotion of the Scientific Research and of the Technological Innovation in Sardinia'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2007, J REPROD DEVELOP, V53, P367, DOI 10.1262/jrd.18146; Aguilar E, 2013, NEUROENDOCRINOLOGY, V98, P38, DOI 10.1159/000350323; Asano T, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-101; Babbitt CC, 2012, GENOME BIOL EVOL, V4, P102, DOI 10.1093/gbe/evr134; Bai Y, 2005, MOL CELL PROTEOMICS, P15; Bartolomucci A, 2007, GROWTH HORM IGF RES, V17, P342, DOI 10.1016/j.ghir.2007.02.002; Bartolomucci A, 2006, P NATL ACAD SCI USA, V103, P14584, DOI 10.1073/pnas.0606102103; Bernay B, 2009, MOL CELL PROTEOMICS, V8, P946, DOI 10.1074/mcp.M800501-MCP200; Bozdagi O, 2008, J NEUROSCI, V28, P9857, DOI 10.1523/JNEUROSCI.3145-08.2008; Brancia C, 2005, J ENDOCRINOL, V186, P97, DOI 10.1677/joe.1.05992; Brancia C, 2010, J ENDOCRINOL, V207, P329, DOI 10.1677/JOE-10-0189; Busse S, 2012, EUR ARCH PSY CLIN N, V262, P365, DOI 10.1007/s00406-011-0282-7; Canu N, 1997, J NEUROCHEM, V68, P1390; Carrette O, 2003, PROTEOMICS, V3, P1486, DOI 10.1002/pmic.200300470; Chen YC, 2013, J BIOL CHEM, V288, P34638, DOI 10.1074/jbc.M113.510917; Cocco C, 2003, APPL IMMUNOHISTO M M, V11, P274; Cocco C, 2007, J HISTOCHEM CYTOCHEM, V55, P619, DOI 10.1369/jhc.6A7040.2007; Cocco C, 2010, J ANAT, V217, P683, DOI 10.1111/j.1469-7580.2010.01309.x; D'Amato F, 2008, J ENDOCRINOL, V197, P359, DOI 10.1677/JOE-07-0346; FERRI GL, 1995, ENDOCRINOLOGY, V136, P2244, DOI 10.1210/en.136.5.2244; Ferri GL, 2002, APPL IMMUNOHISTO M M, V10, P381, DOI 10.1097/00022744-200212000-00016; Francis K, 2003, FASEB J, V17, P2266, DOI 10.1096/fj.02-1103fje; Fujihara H, 2012, ENDOCRINOLOGY, V153, P1377, DOI 10.1210/en.2011-1539; Hahm S, 1999, NEURON, V23, P537, DOI 10.1016/S0896-6273(00)80806-5; Hannedouche S, 2013, J BIOL CHEM, V288, P27434, DOI 10.1074/jbc.M113.497214; Levi A, 2004, CELL MOL NEUROBIOL, V24, P517, DOI 10.1023/B:CEMN.0000023627.79947.22; LEVI A, 1985, SCIENCE, V229, P393, DOI 10.1126/science.3839317; Navarro VM, 2005, ENDOCRINOLOGY, V146, P1689, DOI 10.1210/en.2004-1353; Pinilla L, 2011, AM J PHYSIOL-ENDOC M, V300, pE837, DOI 10.1152/ajpendo.00598.2010; Possenti R, 1999, ENDOCRINOLOGY, V140, P3727, DOI 10.1210/en.140.8.3727; Razzoli M, 2012, BEHAV BRAIN RES, V229, P333, DOI 10.1016/j.bbr.2012.01.038; Rizzi R, 2008, NEUROSCI LETT, V441, P129, DOI 10.1016/j.neulet.2008.06.018; Rozek W, 2013, TUMOR BIOL, V34, P1773, DOI 10.1007/s13277-013-0716-0; Ruetschi U, 2005, EXP NEUROL, V196, P273, DOI 10.1016/j.expneurol.2005.08.002; SALTON SRJ, 1991, MOL CELL BIOL, V11, P2335, DOI 10.1128/MCB.11.5.2335; Salton SRJ, 2000, FRONT NEUROENDOCRIN, V21, P199, DOI 10.1006/frne.2000.0199; Sasaki K, 2013, MOL CELL PROTEOMICS, V12, P700, DOI 10.1074/mcp.M112.017400; Sasaki K, 2010, J PROTEOME RES, V9, P5047, DOI 10.1021/pr1003455; Severini C, 2009, BRIT J PHARMACOL, V157, P984, DOI 10.1111/j.1476-5381.2009.00192.x; Snyder SE, 1998, J COMP NEUROL, V394, P64; Snyder SE, 1998, J COMP NEUROL, V394, P91; Trani E, 2002, J NEUROCHEM, V81, P565, DOI 10.1046/j.1471-4159.2002.00842.x; TRANI E, 1995, J NEUROCHEM, V65, P2441; Van Vugt HH, 2008, EXP BRAIN RES, V188, P483, DOI 10.1007/s00221-008-1381-1; VANDENPOL AN, 1994, J COMP NEUROL, V347, P455, DOI 10.1002/cne.903470311; VANDENPOL AN, 1989, J NEUROSCI, V9, P4122; Wijte D, 2012, METHODS, V56, P500, DOI 10.1016/j.ymeth.2012.03.018; Yamaguchi H, 2007, J BIOL CHEM, V282, P26354, DOI 10.1074/jbc.M701665200; Yuan XL, 2005, J MASS SPECTROM, V40, P176, DOI 10.1002/jms.737	49	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108456	10.1371/journal.pone.0108456	http://dx.doi.org/10.1371/journal.pone.0108456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25280008	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800016
J	Ramond, JB; Pienaar, A; Armstrong, A; Seely, M; Cowan, DA				Ramond, Jean-Baptiste; Pienaar, Annelize; Armstrong, Alacia; Seely, Mary; Cowan, Don A.			Niche-Partitioning of Edaphic Microbial Communities in the Namib Desert Gravel Plain Fairy Circles	PLOS ONE			English	Article							MYSTERIOUS CIRCLES; SOIL; NITROGEN; ORIGIN; VEGETATION; KAOKOLAND; PATCHES; CARBON; RNA	Endemic to the Namib Desert, Fairy Circles (FCs) are vegetation-free circular patterns surrounded and delineated by grass species. Since first reported the 1970's, many theories have been proposed to explain their appearance, but none provide a fully satisfactory explanation of their origin(s) and/or causative agent(s). In this study, we have evaluated an early hypothesis stating that edaphic microorganisms could be involved in their formation and/or maintenance. Surface soils (0-5cm) from three different zones (FC center, FC margin and external, grass-covered soils) of five independent FCs were collected in April 2013 in the Namib Desert gravel plains. T-RFLP fingerprinting of the bacterial (16S rRNA gene) and fungal (ITS region) communities, in parallel with two-way crossed ANOSIM, showed that FC communities were significantly different to those of external control vegetated soil and that each FC was also characterized by significantly different communities. Intra-FC communities (margin and centre) presented higher variability than the controls. Together, these results provide clear evidence that edaphic microorganisms are involved in the Namib Desert FC phenomenon. However, we are, as yet, unable to confirm whether bacteria and/or fungi communities are responsible for the appearance and development of FCs or are a general consequence of the presence of the grass-free circles.	[Ramond, Jean-Baptiste; Pienaar, Annelize; Armstrong, Alacia; Cowan, Don A.] Univ Pretoria, CMEG, Genom Res Inst, ZA-0002 Pretoria, South Africa; [Seely, Mary] GRTC, Walvis Bay, Namibia	University of Pretoria	Cowan, DA (corresponding author), Univ Pretoria, CMEG, Genom Res Inst, ZA-0002 Pretoria, South Africa.	don.cowan@up.ac.za	Ramond, Jean-Baptiste/AAI-8087-2020; Seely, Mary Kathryn/AAI-1072-2019; Cowan, Don/E-3991-2012	Ramond, Jean-Baptiste/0000-0003-4790-6232; Cowan, Don/0000-0001-8059-861X	National Research Foundation of South Africa [81779]	National Research Foundation of South Africa(National Research Foundation - South Africa)	This research was funded by the National Research Foundation (http://www.nrf.ac.za/) of South Africa: Grant No 81779, Microbial Ecology of the Namib Desert. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht CF, 2001, S AFR J SCI, V97, P23; Arrebola E, 2011, TOXINS, V3, P1089, DOI 10.3390/toxins3091089; Becker T, 2007, BASIC APPL DRYLAND R, V1, P121; Becker T, 2000, BASIC APPL ECOL, V1, P149, DOI 10.1078/1439-1791-00021; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; BREMNER JM, 1966, SOIL SCI SOC AM PRO, V30, P577, DOI 10.2136/sssaj1966.03615995003000050015x; Clarke K.R., 1994, CHANGE MARINE COMMUN; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Clarke KR, 2006, DROP; COX GW, 1987, J ARID ENVIRON, V13, P237; Cramer MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070876; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; EICKER A, 1982, S AFR J BOT, V1, P69, DOI 10.1016/S0022-4618(16)30180-2; Ferrenberg S, 2013, ISME J, V7, P1102, DOI 10.1038/ismej.2013.11; FRALEY L, 1987, ENVIRON EXP BOT, V27, P193, DOI 10.1016/0098-8472(87)90070-0; Gorley C.K., 2006, GETTING STARTED PRIM; Graham EB, 2014, SOIL BIOL BIOCHEM, V68, P279, DOI 10.1016/j.soilbio.2013.08.023; Grossi V, 2008, ORG GEOCHEM, V39, P1197, DOI 10.1016/j.orggeochem.2008.02.010; Gunnigle E, 2014, J MICROBIOL METH, V103, P118, DOI 10.1016/j.mimet.2014.06.004; Hoagland R. E., 2001, Ecology of desert environments, P139; Horbach R, 2011, J PLANT PHYSIOL, V168, P51, DOI 10.1016/j.jplph.2010.06.014; Hovatter SR, 2011, ECOLOGY, V92, P57, DOI 10.1890/10-0332.1; Jankowitz WJ, 2008, S AFR J BOT, V74, P332, DOI 10.1016/j.sajb.2007.10.010; Jansson JK, 2013, NATURE, V494, P40, DOI 10.1038/494040a; Juergens N, 2013, SCIENCE, V339, P1618, DOI 10.1126/science.1222999; Keeney D. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P643; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lejeune O, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.010901; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Moll E.J., 1994, P 13 PLENARY M AETFA, P1203; Naude Y, 2011, J ARID ENVIRON, V75, P446, DOI 10.1016/j.jaridenv.2010.12.018; Picker MD, 2012, ECOL ENTOMOL, V37, P33, DOI 10.1111/j.1365-2311.2011.01332.x; Pointing SB, 2012, NAT REV MICROBIOL, V10, P551, DOI 10.1038/nrmicro2831; Ramond JB, 2013, PLANT SOIL, V372, P265, DOI 10.1007/s11104-013-1737-6; Reynolds HL, 2003, ECOLOGY, V84, P2281, DOI 10.1890/02-0298; SSSA, 1996, METHODS SOIL ANAL 3; Theron G.K., 1979, J S AFRICAN BIOL SOC, V20, P43; Tinley K.L., 1971, AFR WILDLIFE, V25, P1, DOI [10.1111/j.1468-0483.1971.tb00784.x, DOI 10.1111/J.1468-0483.1971.TB00784.X]; Tschinkel WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038056; van Rooyen MW, 2004, J ARID ENVIRON, V57, P467, DOI 10.1016/S0140-1963(03)00111-3; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Walkley A, 1935, J AGR SCI, V25, P598, DOI 10.1017/S0021859600019687; Walsh B, 1999, HORTSCIENCE, V34, P13, DOI 10.21273/HORTSCI.34.1.13; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wieder WR, 2013, NAT CLIM CHANGE, V3, P909, DOI [10.1038/nclimate1951, 10.1038/NCLIMATE1951]	46	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109539	10.1371/journal.pone.0109539	http://dx.doi.org/10.1371/journal.pone.0109539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279514	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800089
J	Silva, AP; Greco, M; Fausto, MA; Greco, DB; Carneiro, M				Silva, Ana Paula; Greco, Marilia; Fausto, Maria Arlene; Greco, Dirceu B.; Carneiro, Mariangela			Risk Factors Associated with HIV Infection among Male Homosexuals and Bisexuals Followed in an Open Cohort Study: Project Horizonte, Brazil (1994-2010)	PLOS ONE			English	Article							UNPROTECTED ANAL INTERCOURSE; RIO-DE-JANEIRO; REDUCTION PRACTICES; MEN; SEX; GAY; TRANSMISSION; PARTNERS; SWITZERLAND; PREVENTION	Background: There has recently been an increase in HIV infection rates among men who have sex with men (MSM). This study aimed at investigating risk factors associated with incident HIV infection in a MSM cohort-Project Horizonte, Belo Horizonte, Minas Gerais, Brazil. Methodology: This is a nested case-control study in an ongoing open cohort of homosexual and bisexual men, carried out in 1994-2010, during which 1,085 volunteers were enrolled. Each HIV seroconverted volunteer (case) was compared with three randomly selected HIV negative controls, matched by admission date and age (+/- 3 years). During follow-up, 93 volunteers seroconverted and were compared with 279 controls. Principal Findings: The risk factors associated with HIV seroconversion were: contact with partner's blood during sexual relations (OR 3.7; 95% CI 1.2-11.6), attendance at gay saunas in search for sexual partners (OR 2.6; 95% CI 1.3-5.4), occasional intake of alcohol when flirting and engaging in sexual activity (OR 2.5; 95% CI 1.3-5.1), inconsistent use of condoms in receptive anal sex (OR 2.4; 95% CI 1.1-5.4), little interest to look up information about AIDS (OR 2.6; 95% CI 1.0-6.7) particularly in newspapers (OR 3.4; 95% CI 1.4-8.1). Conclusions: This study shows that MSM are still engaging in risk behavior, such as unprotected anal intercourse, despite taking part in a cohort study on various preventive measures. New preventive strategies in touch with the epidemic's development and the specificities of this particular population are needed.	[Silva, Ana Paula; Greco, Dirceu B.; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil; [Silva, Ana Paula; Greco, Marilia; Carneiro, Mariangela] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Fausto, Maria Arlene] Univ Fed Ouro Preto, Escola Nutr, Dept Alimentos, Ouro Preto, Brazil; [Greco, Dirceu B.] Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Belo Horizonte, MG, Brazil; [Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Carneiro, M (corresponding author), Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil.	mcarneir@icb.ufmg.br	Greco, Dirceu/AAR-4714-2020	Silva, Ana Paula/0000-0003-1839-272X; Greco, Dirceu/0000-0002-4419-5634	Brazilian Ministry of Health, Department of STD, AIDS and Viral Hepatitis [19288]; CNPq; FAPEMIG/PPM research fellowship	Brazilian Ministry of Health, Department of STD, AIDS and Viral Hepatitis; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG/PPM research fellowship	Project Horizonte is supported by the Brazilian Ministry of Health, Department of STD, AIDS and Viral Hepatitis, grant number 19288. MC is grateful for the CNPq and the FAPEMIG/PPM research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034972; Andrade LT, 2004, CAD METROPOLE, V11, P137; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Balthasar H, 2010, JAIDS-J ACQ IMM DEF, V54, P542, DOI 10.1097/QAI.0b013e3181e19a6b; Beyrer C, 2010, CLIN INFECT DIS, V50, pS108, DOI 10.1086/651481; Binson D, 2001, AM J PUBLIC HEALTH, V91, P1482, DOI 10.2105/AJPH.91.9.1482; Brasil. Ministerio da Saude (MS), 2007, PLAN NAC ENFR EP AID; Brasil Ministerio da Saude Secretaria de Vigilancia em Saude Departamento de DST/AIDS e Hepatites Virais, 2011, B EP AIDS; Brasil Ministerio da Saude Secretaria de Vigilancia em Saude Departamento de DST/AIDS e Hepatites Virais, 2000, BEL VIST HOR EST COM; Brignol Sandra, 2011, Rev. bras. epidemiol., V14, P423, DOI 10.1590/S1415-790X2011000300007; Burt RD, 2012, AIDS BEHAV, V16, P599, DOI 10.1007/s10461-011-9979-x; Carneiro M, 2000, J ACQ IMMUN DEF SYND, V25, P182, DOI 10.1097/00126334-200010010-00013; Chamratrithirong A, 2006, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0042009; de Souza CTV, 1999, AIDS CARE, V11, P567, DOI 10.1080/09540129947721; Cardoso LRD, 2008, REV PSIQ CLIN-BRAZIL, V35, P70, DOI 10.1590/S0101-60832008000700015; Dubois-Arber F, 2012, ARCH SEX BEHAV, V41, P1263, DOI 10.1007/s10508-011-9868-4; Ekstrand ML, 1999, AIDS, V13, P1525, DOI 10.1097/00002030-199908200-00013; Foss AM, 2004, BRIT MED J, V329, P185, DOI 10.1136/bmj.329.7459.185; Gondim RC, 2000, REV BRAS EPIDEMIOL, V3, P38; Holliday CS, 2006, THESIS GEORGIA STATE, P27; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Liu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050493; Mansergh G, 2006, AIDS BEHAV, V10, P743, DOI 10.1007/s10461-006-9108-4; McDaid LM, 2010, CURR OPIN HIV AIDS, V5, P311, DOI 10.1097/COH.0b013e32833a0b86; Mirandola M, 2009, EUROSURVEILLANCE, V14, P22; Mitchell JW, 2012, AIDS BEHAV, V16, P404, DOI 10.1007/s10461-011-9976-0; Perez Lilli Ann, 2010, Calif J Health Promot, V8, P63; Raymond HF, 2009, AIDS BEHAV, V13, P677, DOI 10.1007/s10461-009-9557-7; Rocha GM, 2013, AIDS BEHAV, V17, P1288, DOI 10.1007/s10461-012-0398-4; Rodrigues J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-39; Rosenberg ES, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-189; Ruan SM, 2008, AIDS BEHAV, V12, P469, DOI 10.1007/s10461-008-9361-9; Stata Corporation, 2009, STAT STAT SOFTW REL; Strathdee SA, 2000, CAN MED ASSOC J, V162, P21; Vallabhaneni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045718; WHO, 2005, ALC US SEX RISK BEH; Wolitski RJ, 2011, AIDS BEHAV, V15, pS9, DOI 10.1007/s10461-011-9901-6; Woolf SE, 2009, AIDS BEHAV, V13, P757, DOI 10.1007/s10461-007-9354-0; Yang HT, 2010, SEX TRANSM DIS, V37, P208, DOI 10.1097/OLQ.0b013e3181d13c59	41	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109390	10.1371/journal.pone.0109390	http://dx.doi.org/10.1371/journal.pone.0109390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3DZ	25279670	gold, Green Published			2022-12-27	WOS:000342670800075
J	Barchitta, M; Quattrocchi, A; Maugeri, A; Vinciguerra, M; Agodi, A				Barchitta, Martina; Quattrocchi, Annalisa; Maugeri, Andrea; Vinciguerra, Manlio; Agodi, Antonella			LINE-1 Hypomethylation in Blood and Tissue Samples as an Epigenetic Marker for Cancer Risk: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							DNA METHYLATION; MULTIPLE-MYELOMA; POOR-PROGNOSIS; GLOBAL METHYLATION; COLORECTAL-CANCER; LEUKOCYTE DNA; CELL; ASSOCIATION; TUMOR; ALU	Objective: A systematic review and a meta-analysis were carried out in order to summarize the current published studies and to evaluate LINE-1 hypomethylation in blood and other tissues as an epigenetic marker for cancer risk. Methods: A systematic literature search in the Medline database, using PubMed, was conducted for epidemiological studies, published before March 2014. The random-effects model was used to estimate weighted mean differences (MDs) with 95% Confidence Intervals (CIs). Furthermore, subgroup analyses were conducted by sample type (tissue or blood samples), cancer types, and by assays used to measure global DNA methylation levels. The Cochrane software package Review Manager 5.2 was used. Results: A total of 19 unique articles on 6107 samples (2554 from cancer patients and 3553 control samples) were included in the meta-analysis. LINE-1 methylation levels were significantly lower in cancer patients than in controls (MD: -6.40, 95% CI: -7.71, -5.09; p<0.001). The significant difference in methylation levels was confirmed in tissue samples (MD -7.55; 95% CI: -9.14, -65.95; p<0.001), but not in blood samples (MD: -0.26, 95% CI: -0.69, 0.17; p = 0.23). LINE-1 methylation levels were significantly lower in colorectal and gastric cancer patients than in controls (MD: -8.33; 95% CI: -10.56, -6.10; p<0.001 and MD: -5.75; 95% CI: -7.75, -3.74; p<0.001) whereas, no significant difference was observed for hepatocellular cancer. Conclusions: The present meta-analysis adds new evidence to the growing literature on the role of LINE-1 hypomethylation in human cancer and demonstrates that LINE-1 methylation levels were significantly lower in cancer patients than in control samples, especially in certain cancer types. This result was confirmed in tissue samples, both fresh/frozen or FFPE specimens, but not in blood. Further studies are needed to better clarify the role of LINE-1 methylation in specific subgroups, considering both cancer and sample type, and the methods of measurement.	[Barchitta, Martina; Quattrocchi, Annalisa; Maugeri, Andrea; Agodi, Antonella] Univ Catania, Dept GF Ingrassia, Catania, Italy; [Vinciguerra, Manlio] UCL, Inst Liver & Digest Hlth, London, England; [Vinciguerra, Manlio] IRCCS Casa Sollievo Sofferenza, Dept Med Sci, Gastroenterol Unit, San Giovanni Rotondo, Italy	University of Catania; University of London; University College London; IRCCS Casa Sollievo Della Sofferenza	Vinciguerra, M (corresponding author), UCL, Inst Liver & Digest Hlth, Royal Free Campus, London, England.	m.vinciguerra@ucl.ac.uk; agodia@unict.it	Quattrocchi, Annalisa/S-8119-2019; Maugeri, Andrea/K-1018-2017; Quattrocchi, Annalisa/AAU-5458-2020; Agodi, Antonella/AIF-3938-2022; Agodi, Antonella/B-3501-2011; Vinciguerra, Manlio/N-1309-2015; Barchitta, Martina/AFV-8723-2022; Barchitta, Martina/A-1362-2015	Quattrocchi, Annalisa/0000-0002-5764-6721; Maugeri, Andrea/0000-0003-2655-8574; Agodi, Antonella/0000-0002-4405-8162; Agodi, Antonella/0000-0002-4405-8162; Vinciguerra, Manlio/0000-0002-1768-3894; Barchitta, Martina/0000-0002-0905-5003				Agnelli L, 2005, J CLIN ONCOL, V23, P7296, DOI 10.1200/JCO.2005.01.3870; Antelo M, 2012, J TRANSL MED, V7; Baba Y, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-125; Bae JM, 2012, INT J CANCER, V131, P1323, DOI 10.1002/ijc.27369; Beck S, 2008, TRENDS GENET, V24, P231, DOI 10.1016/j.tig.2008.01.006; Bollati V, 2009, CARCINOGENESIS, V30, P1330, DOI 10.1093/carcin/bgp149; Brennan K, 2012, CANCER PREV RES, V5, P1345, DOI 10.1158/1940-6207.CAPR-12-0316; Cash HL, 2012, INT J CANCER, V130, P1151, DOI 10.1002/ijc.26098; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Choi IS, 2007, MODERN PATHOL, V20, P802, DOI 10.1038/modpathol.3800825; Choi JY, 2009, CARCINOGENESIS, V30, P1889, DOI 10.1093/carcin/bgp143; Dammann RH, 2010, INT J ONCOL, V36, P171, DOI 10.3892/ijo_00000488; Daskalos A, 2009, INT J CANCER, V124, P81, DOI 10.1002/ijc.23849; Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002; Di JZ, 2011, J ZHEJIANG UNIV-SC B, V12, P805, DOI 10.1631/jzus.B1000422; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Fabris S, 2007, LEUKEMIA, V21, P1113, DOI 10.1038/sj.leu.2404616; Fabris S, 2011, EPIGENETICS-US, V6, P188, DOI 10.4161/epi.6.2.13528; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Gao XD, 2014, LIVER INT, V34, P136, DOI 10.1111/liv.12264; Gao Y, 2012, BRIT J CANCER, V106, P585, DOI 10.1038/bjc.2011.562; Geli J, 2008, CLIN CANCER RES, V14, P2551, DOI 10.1158/1078-0432.CCR-07-1867; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hou LF, 2010, INT J CANCER, V127, P1866, DOI 10.1002/ijc.25190; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Hur K, 2014, GUT, V63, P635, DOI 10.1136/gutjnl-2012-304219; Igarashi S, 2010, CLIN CANCER RES, V16, P5114, DOI 10.1158/1078-0432.CCR-10-0581; Iwagami S, 2013, ANN SURG, V257, P449, DOI 10.1097/SLA.0b013e31826d8602; Jones PA, 1996, CANCER RES, V56, P2463; Kreimer U, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00255; LAIRD PW, 1994, HUM MOL GENET, V3, P1487, DOI 10.1093/hmg/3.suppl_1.1487; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JR, 2011, GUT LIVER, V5, P149, DOI 10.5009/gnl.2011.5.2.149; Lee JJ, 2008, INT J ONCOL, V33, P861, DOI 10.3892/ijo_00000074; Liao LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027361; Liu L, 2003, MECH AGEING DEV, V124, P989, DOI 10.1016/j.mad.2003.08.001; Matsunoki A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-574; Mirabello L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-77; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nelson HH, 2011, ENVIRON HEALTH PERSP, V119, P1528, DOI 10.1289/ehp.1103423; Ogino S, 2012, JNCI-J NATL CANCER I, V100, P1734; Pavicic W, 2012, J MOL MED, V90, P827, DOI 10.1007/s00109-011-0854-z; Phokaew C, 2008, NUCLEIC ACIDS RES, V36, P5704, DOI 10.1093/nar/gkn571; Piyathilake CJ, 2011, NUTRITION, V27, P513, DOI 10.1016/j.nut.2010.08.018; Pobsook T, 2011, CLIN CHIM ACTA, V412, P314, DOI 10.1016/j.cca.2010.10.030; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Ramzy Iman I, 2011, Arab J Gastroenterol, V12, P139, DOI 10.1016/j.ajg.2011.07.002; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Saito K, 2010, CLIN CANCER RES, V16, P2418, DOI 10.1158/1078-0432.CCR-09-2819; Shigaki H, 2013, GASTRIC CANCER, V16, P480, DOI 10.1007/s10120-012-0209-7; Shuangshoti S, 2007, ASIAN PAC J CANCER P, V8, P307; Sigalotti L, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-78; Subbalekha K, 2009, ORAL ONCOL, V45, P184, DOI 10.1016/j.oraloncology.2008.05.002; Sunami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018884; Suter CM, 2004, INT J COLORECTAL DIS, V19, P95, DOI 10.1007/s00384-003-0539-3; Tangkijvanich P, 2007, CLIN CHIM ACTA, V379, P127, DOI 10.1016/j.cca.2006.12.029; Trankenschuh W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013688; van Bemmel D, 2012, CANCER EPIDEM BIOMAR, V21, P1143, DOI 10.1158/1055-9965.EPI-11-1030; van Hoesel AQ, 2012, BREAST CANCER RES TR, V134, P1103, DOI 10.1007/s10549-012-2038-0; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; Woo HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034615; Wu HC, 2012, CARCINOGENESIS, V33, P1340, DOI 10.1093/carcin/bgs160; Yegnasubramanian S, 2008, CANCER RES, V68, P8954, DOI 10.1158/0008-5472.CAN-07-6088; Zhu ZZ, 2012, INT J EPIDEMIOL, V41, P126, DOI 10.1093/ije/dyq154; Zhu ZZ, 2011, CANCER CAUSE CONTROL, V22, P437, DOI 10.1007/s10552-010-9715-2	69	97	102	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109478	10.1371/journal.pone.0109478	http://dx.doi.org/10.1371/journal.pone.0109478			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275447	Green Published, gold			2022-12-27	WOS:000342591500105
J	Du, YK; Pei, MS; He, YJ; Yu, FQ; Guo, WJ; Wang, LY				Du, Yankai; Pei, Meishan; He, Youjun; Yu, Faqi; Guo, Wenjuan; Wang, Luyan			Preparation, Characterization and Application of Magnetic Fe3O4-CS for the Adsorption of Orange I from Aqueous Solutions	PLOS ONE			English	Article							PHOTOCATALYTIC DEGRADATION; REMOVAL; DYES; CHITOSAN; DECOLOURIZATION; EQUILIBRIUM; ADSORBENTS; WATER; RED	Fe3O4 (Fe3O4-CS) coated with magnetic chitosan was prepared as an adsorbent for the removal of Orange I from aqueous solutions and characterized by FTIR, XRD, SEM, TEM and TGA measurements. The effects of pH, initial concentration and contact time on the adsorption of Orange I from aqueous solutions were investigated. The decoloration rate was higher than 94% in the initial concentration range of 50-150 mg L-1 at pH 2.0. The maximum adsorption amount was 183.2 mg g(-1) and was obtained at an initial concentration of 400 mg L-1 at pH 2.0. The adsorption equilibrium was reached in 30 minutes, demonstrating that the obtained adsorbent has the potential for practical application. The equilibrium adsorption isotherm was analyzed by the Freundlich and Langmuir models, and the adsorption kinetics were analyzed by the pseudo-first-order and pseudo-second-order kinetic models. The higher linear correlation coefficients showed that the Langmuir model (R-2 = 0.9995) and pseudo-second-order model (R-2 = 0.9561) offered the better fits.	[Du, Yankai; Pei, Meishan; He, Youjun; Yu, Faqi; Guo, Wenjuan; Wang, Luyan] Univ Jinan, Sch Chem & Chem Engn, Jinan, Shandong, Peoples R China	University of Jinan	Pei, MS (corresponding author), Univ Jinan, Sch Chem & Chem Engn, Jinan, Shandong, Peoples R China.	chm_peims@126.com		Guo, Wenjuan/0000-0002-6429-2896				Alila S, 2009, IND CROP PROD, V30, P93, DOI 10.1016/j.indcrop.2009.02.005; Anbia M, 2010, DESALINATION, V261, P61, DOI 10.1016/j.desal.2010.05.030; Atenas GM, 2005, J COLLOID INTERF SCI, V289, P171, DOI 10.1016/j.jcis.2005.03.042; Atia AA, 2009, CHEM ENG J, V150, P55, DOI 10.1016/j.cej.2008.12.004; Banat IM, 1996, BIORESOURCE TECHNOL, V58, P217, DOI 10.1016/S0960-8524(96)00113-7; Borhana AI, 2014, J PHOTOCH PHOTOBIO A, V279, P17, DOI 10.1016/j.jphotochem.2014.01.010; Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001; Elizalde-Gonzalez M P, 2009, J HAZARD MATER, V161, P515; Fan LL, 2012, J HAZARD MATER, V215, P272, DOI 10.1016/j.jhazmat.2012.02.068; Fan LL, 2012, COLLOID SURFACE B, V91, P250, DOI 10.1016/j.colsurfb.2011.11.014; Gomez V, 2007, CHEMOSPHERE, V69, P1151, DOI 10.1016/j.chemosphere.2007.03.076; Gupta VK, 2006, IND ENG CHEM RES, V45, P1446, DOI 10.1021/ie051111f; Hamzeh Y, 2012, MAT SCI ENG C-MATER, V32, P1394, DOI 10.1016/j.msec.2012.04.015; He C, 2011, IND ENG CHEM RES, V50, P14070, DOI 10.1021/ie201469p; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Jiang R, 2009, CHEM ENG J, V152, P537, DOI 10.1016/j.cej.2009.05.037; Lian LL, 2013, J TAIWAN INST CHEM E, V44, P67, DOI 10.1016/j.jtice.2012.08.004; Lin YF, 2011, J HAZARD MATER, V185, P1124, DOI 10.1016/j.jhazmat.2010.10.022; Mahanta D, 2008, J PHYS CHEM B, V112, P10153, DOI 10.1021/jp803903x; Marcal L, 2011, IND ENG CHEM RES, V50, P239, DOI 10.1021/ie101650h; Monteagudo JM, 2010, APPL CATAL B-ENVIRON, V95, P120, DOI 10.1016/j.apcatb.2009.12.018; Monvisade P, 2009, APPL CLAY SCI, V42, P427, DOI 10.1016/j.clay.2008.04.013; NASSAR MM, 1991, J CHEM TECHNOL BIOT, V50, P257; O'Neill C, 1999, J CHEM TECHNOL BIOT, V74, P1009, DOI 10.1002/(SICI)1097-4660(199911)74:11<1009::AID-JCTB153>3.0.CO;2-N; Ozdes D, 2010, SEP SCI TECHNOL, V45, P2076, DOI 10.1080/01496395.2010.504479; PAGGA U, 1994, WATER RES, V28, P1051, DOI 10.1016/0043-1354(94)90190-2; Rafatullah M, 2010, J HAZARD MATER, V177, P70, DOI 10.1016/j.jhazmat.2009.12.047; Roy A, 2013, IND ENG CHEM RES, V52, P6502, DOI 10.1021/ie400236s; Saquib M, 2003, DYES PIGMENTS, V56, P37, DOI 10.1016/S0143-7208(02)00101-8; Selvam K, 2003, BIORESOURCE TECHNOL, V88, P115, DOI 10.1016/S0960-8524(02)00280-8; Shenai VA, 2001, INDIAN J FIBRE TEXT, V26, P50; Shi BY, 2007, J HAZARD MATER, V143, P567, DOI 10.1016/j.jhazmat.2006.09.076; Tumsek F, 2013, J CHEM ENG DATA, V58, P551, DOI 10.1021/je301215s; Wang JH, 2010, J COLLOID INTERF SCI, V349, P293, DOI 10.1016/j.jcis.2010.05.010; Wang YR, 2011, IND ENG CHEM RES, V50, P8734, DOI 10.1021/ie1024497; Wong YC, 2003, LANGMUIR, V19, P7888, DOI 10.1021/la030064y; Wu ZJ, 2006, COLLOID SURFACE A, V279, P167, DOI 10.1016/j.colsurfa.2005.12.054; Zhang L, 2014, J MOL LIQ, V197, P353, DOI 10.1016/j.molliq.2014.06.007; Zhu HY, 2012, BIORESOURCE TECHNOL, V105, P24, DOI 10.1016/j.biortech.2011.11.057	39	21	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108647	10.1371/journal.pone.0108647	http://dx.doi.org/10.1371/journal.pone.0108647			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271644	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600053
J	Mir, K; Schober, S				Mir, Katharina; Schober, Steffen			Selection Pressure in Alternative Reading Frames	PLOS ONE			English	Article							ESTIMATING EVOLUTIONARY RATES; OVERLAPPING GENES; NUCLEOTIDE SUBSTITUTION; LIKELIHOOD APPROACH; SEQUENCES; DNA; STABILITY; MODEL	Overlapping genes are two protein-coding sequences sharing a significant part of the same DNA locus in different reading frames. Although in recent times an increasing number of examples have been found in bacteria the underlying mechanisms of their evolution are unknown. In this work we explore how selective pressure in a protein-coding sequence influences its overlapping genes in alternative reading frames. We model evolution using a time-continuous Markov process and derive the corresponding model for the remaining frames to quantify selection pressure and genetic noise. Our findings lead to the presumption that, once information is embedded in the reverse reading frame -2 (relative to the mother gene in +1) purifying selection in the protein-coding reading frame automatically protects the sequences in both frames. We also found that this coincides with the fact that the genetic noise measured using the conditional entropy is minimal in frame -2 under selection in the coding frame.	[Mir, Katharina; Schober, Steffen] Univ Ulm, Inst Commun Engn, D-89069 Ulm, Germany	Ulm University	Mir, K (corresponding author), Univ Ulm, Inst Commun Engn, D-89069 Ulm, Germany.	katharina.mir@uni-ulm.de			Deutsche Forschungsgemeinschaft (DFG) [BO867/23-3, SCHO 1576/1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Katharina Mir is funded by the Deutsche Forschungsgemeinschaft (DFG) under the grants BO867/23-3 in the priority program {SPP 1395}. Steffen Schober is supported by the DFG grant SCHO 1576/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens M, 2002, INFECT IMMUN, V70, P2915, DOI 10.1128/IAI.70.6.2915-2925.2002; Chirico N, 2010, P ROY SOC B-BIOL SCI, V277, P3809, DOI 10.1098/rspb.2010.1052; Cock PJA, 2007, J MOL EVOL, V64, P457, DOI 10.1007/s00239-006-0180-1; Cock PJA, 2010, MOL BIOL EVOL, V27, P753, DOI 10.1093/molbev/msp302; Cover TM., 2006, WILEY SERIES TELECOM; DArgenio P.R., 2001, LNCS, V2165, P39, DOI DOI 10.1007/3-540-44804-7; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Fellner L, 2013, FEMS MICROBIOLOGY LE, P1; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fonseca MM, 2014, G3-GENES GENOM GENET, V4, P19, DOI 10.1534/g3.113.005652; Fukuda Y, 1999, NUCLEIC ACIDS RES, V27, P1847, DOI 10.1093/nar/27.8.1847; Fukuda Y, 2003, GENE, V323, P181, DOI 10.1016/j.gene.2003.09.021; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guyader S, 2002, J GEN VIROL, V83, P1799, DOI 10.1099/0022-1317-83-7-1799; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Haughton D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-121; HEIN J, 1995, J MOL EVOL, V40, P181, DOI 10.1007/BF00167112; Hughes AL, 2005, VIRUS RES, V113, P81, DOI 10.1016/j.virusres.2005.03.030; Hughes AL, 2001, J VIROL, V75, P7966, DOI 10.1128/JVI.75.17.7966-7972.2001; Johnson ZI, 2004, GENOME RES, V14, P2268, DOI 10.1101/gr.2433104; JUKES T H, 1969, P21; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krakauer DC, 2000, EVOLUTION, V54, P731, DOI 10.1111/j.0014-3820.2000.tb00075.x; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; McVeigh A, 2000, INFECT IMMUN, V68, P5710, DOI 10.1128/IAI.68.10.5710-5715.2000; MIYATA T, 1980, J MOL EVOL, V16, P23, DOI 10.1007/BF01732067; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Pedersen AMK, 2001, MOL BIOL EVOL, V18, P763, DOI 10.1093/oxfordjournals.molbev.a003859; Rogozin IB, 2002, TRENDS GENET, V18, P228, DOI 10.1016/S0168-9525(02)02649-5; Sabath N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003996; Sabath N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-36; Schneider A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-134; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Silby MW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000094; Tunca S, 2009, FEBS J, V276, P4814, DOI 10.1111/j.1742-4658.2009.07182.x; Warren AS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-131; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; YOCKEY HP, 1992, INFORM THEORY MOL BI; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zhang Z, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-44	42	16	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108768	10.1371/journal.pone.0108768	http://dx.doi.org/10.1371/journal.pone.0108768			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271416	gold, Green Published, Green Submitted			2022-12-27	WOS:000343729600060
J	Chiu, CC; Shi, YF; Yang, JJ; Hsiao, YC; Tzang, BS; Hsu, TC				Chiu, Chun-Ching; Shi, Ya-Fang; Yang, Jiann-Jou; Hsiao, Yuan-Chao; Tzang, Bor-Show; Hsu, Tsai-Ching			Effects of Human Parvovirus B19 and Bocavirus VP1 Unique Region on Tight Junction of Human Airway Epithelial A549 Cells	PLOS ONE			English	Article							DIFFERENTIATION-DEPENDENT REGULATION; SECRETED PHOSPHOLIPASES A(2); RESPIRATORY-TRACT INFECTION; MECHANISMS; EXPRESSION; INDUCTION; CHILDREN; ANTIBODY	As is widely recognized, human parvovirus B19 (B19) and human bocavirus (HBoV) are important human pathogens. Obviously, both VP1 unique region (VP1u) of B19 and HBoV exhibit the secreted phospholipase A2 (sPLA2)-like enzymatic activity and are recognized to participate in the pathogenesis of lower respiratory tract illnesses. However, exactly how, both VP1u from B19 and HBoV affect tight junction has seldom been addressed. Therefore, this study investigates how B19-VP1u and HBoV-VP1u may affect the tight junction of the airway epithelial A549 cells by examining phospholipase A2 activity and transepithelial electrical resistance (TEER) as well as performing immunoblotting analyses. Experimental results indicate that TEER is more significantly decreased in A549 cells by treatment with TNF-alpha (10 ng), two dosages of B19-VP1u and BoV-VP1u (400 ng and 4000 ng) or bee venom PLA2 (10 ng) than that of the control. Accordingly, more significantly increased claudin-1 and decreased occludin are detected in A549 cells by treatment with TNF-alpha or both dosages of HBoV-VP1u than that of the control. Additionally, more significantly decreased Na+/K+ ATPase is observed in A549 cells by treatment with TNF-alpha, high dosage of B19-VP1u or both dosages of BoV-VP1u than that of the control. Above findings suggest that HBoV-VP1u rather than B19 VP1u likely plays more important roles in the disruption of tight junction in the airway tract. Meanwhile, this discrepancy appears not to be associated with the secreted phospholipase A2 (sPLA2)-like enzymatic activity.	[Chiu, Chun-Ching; Shi, Ya-Fang; Hsiao, Yuan-Chao; Hsu, Tsai-Ching] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Chiu, Chun-Ching] Chunghua Christian Hosp, Dept Neurol, Chunghua, Taiwan; [Chiu, Chun-Ching] Chunghua Christian Hosp, Dept Med Intens Care Unit, Chunghua, Taiwan; [Yang, Jiann-Jou] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Tzang, Bor-Show] Chung Shan Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan; [Tzang, Bor-Show] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Tzang, Bor-Show; Hsu, Tsai-Ching] Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan	Chung Shan Medical University; Changhua Christian Hospital; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Tzang, BS (corresponding author), Chung Shan Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan.	bstzang@csmu.edu.tw; htc@csmu.edu.tw	Yang, Jiann-Jou/E-9502-2011	Yang, Jiann-Jou/0000-0002-9019-2178; Bor-Show, Tzang/0000-0003-0140-9943	National Science Council (NSC) [101-2314-B-040-008]; Chunghua Christian Hospital [101-CCH-IRP-09]; Chung Shan Medical University, Taiwan [CSMU-INT-102-01]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Chunghua Christian Hospital; Chung Shan Medical University, Taiwan	This study was supported by grants from National Science Council (NSC 101-2314-B-040-008), Chunghua Christian Hospital (101-CCH-IRP-09) and Chung Shan Medical University (CSMU-INT-102-01), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Attalah HL, 2003, EUR RESPIR J, V21, P1040, DOI 10.1183/09031936.03.00093002; Bohmer A, 2009, J VIROL METHODS, V158, P199, DOI 10.1016/j.jviromet.2009.02.010; Brandner JM, 2009, EUR J PHARM BIOPHARM, V72, P289, DOI 10.1016/j.ejpb.2008.08.007; Broliden K, 2006, J INTERN MED, V260, P285, DOI 10.1111/j.1365-2796.2006.01697.x; Chen AY, 2010, VIROLOGY, V403, P145, DOI 10.1016/j.virol.2010.04.014; Chen HL, 2009, INHAL TOXICOL, V21, P374, DOI [10.1080/08958370802449712 , 10.1080/08958370802449712]; Chen ZR, 2014, J MED VIROL, V86, P2154, DOI 10.1002/jmv.23952; Chow BDW, 2009, CLIN LAB MED, V29, P695, DOI 10.1016/j.cll.2009.07.010; Costa C, 2009, J CLIN VIROL, V46, P150, DOI 10.1016/j.jcv.2009.06.026; Deng XF, 2013, J VIROL, V87, P4097, DOI 10.1128/JVI.03132-12; Dijkman R, 2009, J VIROL, V83, P7739, DOI 10.1128/JVI.00614-09; Dorsch S, 2002, J VIROL, V76, P2014, DOI 10.1128/JVI.76.4.2014-2018.2002; Eyigor H, 2013, CLIN LAB, V59, P139, DOI 10.7754/Clin.Lab.2012.120229; Filippone C, 2008, VIROLOGY, V374, P444, DOI 10.1016/j.virol.2008.01.002; Gilroy DW, 2004, FASEB J, V18, P489, DOI 10.1096/fj.03-0837com; Gurrieri S, 2003, J INVEST DERMATOL, V121, P156, DOI 10.1046/j.1523-1747.2003.12315.x; Haas U, 2005, J INVEST DERMATOL, V124, P204, DOI 10.1111/j.0022-202X.2004.23513.x; Hallstrand TS, 2013, AM J RESP CRIT CARE, V188, P42, DOI 10.1164/rccm.201301-0084OC; Harkema JR, 1999, AM J RESP CELL MOL, V20, P517, DOI 10.1165/ajrcmb.20.3.3227; Hsu TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068393; Huang QF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002899; Kawabata K, 2010, J CARDIOVASC PHARM, V56, P369, DOI 10.1097/FJC.0b013e3181ef1aab; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Lehmann HW, 2003, AUTOIMMUN REV, V2, P218, DOI 10.1016/S1568-9972(03)00014-4; Leisi R, 2013, J VIROL, V87, P13161, DOI 10.1128/JVI.02548-13; Lin JH, 2009, J CLIN VIROL, V44, P219, DOI 10.1016/j.jcv.2008.12.018; Meyer O, 2003, JOINT BONE SPINE, V70, P6, DOI 10.1016/S1297-319X(02)00004-0; Morris CN, 1998, CLIN INFECT DIS, V27, P900, DOI 10.1086/517164; MULLIN JM, 1990, CANCER RES, V50, P2172; Petecchia L, 2012, LAB INVEST, V92, P1140, DOI 10.1038/labinvest.2012.67; Qu XW, 2008, BIOCHEM BIOPH RES CO, V365, P158, DOI 10.1016/j.bbrc.2007.10.164; Soderlund-Venermo M, 2002, PATHOL BIOL, V50, P307, DOI 10.1016/S0369-8114(02)00307-3; Tolfvenstam T, 2009, SEMIN FETAL NEONAT M, V14, P218, DOI 10.1016/j.siny.2009.01.007; Triggiani M, 2000, J IMMUNOL, V164, P4908, DOI 10.4049/jimmunol.164.9.4908; Tsai CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059724; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Tzang BS, 2008, CLIN CHIM ACTA, V395, P77, DOI 10.1016/j.cca.2008.05.012; Tzang BS, 2007, CLIN CHIM ACTA, V378, P59, DOI 10.1016/j.cca.2006.10.016; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840	41	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107970	10.1371/journal.pone.0107970	http://dx.doi.org/10.1371/journal.pone.0107970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268969	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700056
J	Thida, A; Tun, STT; Zaw, SKK; Lover, AA; Cavailler, P; Chunn, J; Aye, MM; Par, P; Naing, KW; Zan, KN; Shwe, M; Kyaw, TT; Waing, ZH; Clevenbergh, P				Thida, Aye; Tun, Sai Thein Than; Zaw, Sai Ko Ko; Lover, Andrew A.; Cavailler, Philippe; Chunn, Jennifer; Aye, Mar Mar; Par, Par; Naing, Kyaw Win; Zan, Kaung Nyunt; Shwe, Myint; Kyaw, Thar Tun; Waing, Zaw Htoon; Clevenbergh, Philippe			Retention and Risk Factors for Attrition in a Large Public Health ART Program in Myanmar: A Retrospective Cohort Analysis	PLOS ONE			English	Article							STARTING ANTIRETROVIRAL THERAPY; HIV-INFECTED PATIENTS; TREATMENT OUTCOMES; SURVIVAL; MORTALITY; CARE; HAART; ASIA	Background: The outcomes from an antiretroviral treatment (ART) program within the public sector in Myanmar have not been reported. This study documents retention and the risk factors for attrition in a large ART public health program in Myanmar. Methods: A retrospective analysis of a cohort of adult patients enrolled in the Integrated HIV Care (IHC) Program between June 2005 and October 2011 and followed up until April 2012 is presented. The primary outcome was attrition (death or loss-follow up); a total of 10,223 patients were included in the 5-year cumulative survival analysis. Overall 5,718 patients were analyzed for the risk factors for attrition using both logistic regression and flexible parametric survival models. Result: The mean age was 36 years, 61% of patients were male, and the median follow up was 13.7 months. Overall 8,564 (84%) patients were retained in ART program: 750 (7%) were lost to follow-up and 909 (9%) died. During the 3 years follow-up, 1,542 attritions occurred over 17,524 person years at risk, giving an incidence density of 8.8% per year. The retention rates of participants at 12, 24, 36, 48 and 60 months were 86, 82, 80, 77 and 74% respectively. In multivariate analysis, being male, having high WHO staging, a low CD4 count, being anaemic or having low BMI at baseline were independent risk factors for attrition; tuberculosis (TB) treatment at ART initiation, a prior ART course before program enrollment and literacy were predictors for retention in the program. Conclusion: High retention rate of IHC program was documented within the public sector in Myanmar. Early diagnosis of HIV, nutritional support, proper investigation and treatment for patients with low CD4 counts and for those presenting with anaemia are crucial issues towards improvement of HIV program outcomes in resource-limited settings.	[Thida, Aye; Tun, Sai Thein Than; Zaw, Sai Ko Ko; Waing, Zaw Htoon; Clevenbergh, Philippe] Int Union TB & Lung Dis, Union Off Myanmar, Mandalay, Myanmar; [Lover, Andrew A.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Infect Dis Programme, Singapore 117548, Singapore; [Cavailler, Philippe] Medecins Sans Frontieres, Innovat Unit, Geneva, Switzerland; [Chunn, Jennifer] James Cook Univ, Maths & Stat Help Ctr, Singapore, Singapore; [Aye, Mar Mar; Par, Par; Naing, Kyaw Win; Zan, Kaung Nyunt] Dept Hlth, Med Care Div, Mandalay, Myanmar; [Shwe, Myint] Dept Hlth, Natl AIDS Program, Nay Pyi Taw, Myanmar; [Kyaw, Thar Tun] Dept Hlth, Dis Control Div, Nay Pyi Taw, Myanmar	National University of Singapore; Doctors Without Borders	Thida, A (corresponding author), Int Union TB & Lung Dis, Union Off Myanmar, Mandalay, Myanmar.	ayethida0612@gmail.com	Cavailler, Philippe/G-4138-2017	Tun, Sai Thein Than/0000-0001-9733-8304	Total Yadana, GF round 9 and 3 Diseases Fund	Total Yadana, GF round 9 and 3 Diseases Fund(Total SA)	Total Yadana, GF round 9 and 3 Diseases Fund have supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abgrall S, 2013, AIDS, V27, P803, DOI 10.1097/QAD.0b013e32835cb997; [Anonymous], 2010, WHO IND HIV DRUG RES; Argemi X, 2012, AIDS, V26, P1161, DOI 10.1097/QAD.0b013e328353f363; Biadgilign S, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-15; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Chi BH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001111; Clouse K, 2013, JAIDS-J ACQ IMM DEF, V62, pE39, DOI 10.1097/QAI.0b013e318273ac48; Crawford Timothy N, 2014, J Int Assoc Provid AIDS Care, V13, P242, DOI 10.1177/2325957413491431; Cuong DD, 2012, SCAND J INFECT DIS, V44, P201, DOI 10.3109/00365548.2011.631937; Nguyen DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055750; Ferradini L, 2007, AIDS, V21, P2293, DOI 10.1097/QAD.0b013e32828cc8b7; Fokam J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-308; Fox MP, 2010, AIDS, V24, P2041, DOI 10.1097/QAD.0b013e32833c703e; Gabillard D, 2013, JAIDS-J ACQ IMM DEF, V62, P555, DOI 10.1097/QAI.0b013e3182821821; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Giordano Thomas P, 2011, Top Antivir Med, V19, P12; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Kunutsor S, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/872396; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Morineau G, 2009, AIDS PATIENT CARE ST, V23, P669, DOI 10.1089/apc.2008.0241; Mosoko JJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-32; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P574, DOI 10.1097/QAI.0b013e318273762f; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; National AIDS Programme, 2012, GLOB AIDS RESP PROGR; Neogi U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055421; Piliero Peter J, 2003, J Int Assoc Physicians AIDS Care (Chic), V2, P10, DOI 10.1177/154510970300200102; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Sabapathy K, 2012, JAIDS-J ACQ IMM DEF, V60, pE53, DOI 10.1097/QAI.0b013e31824d5689; Somi G, 2012, TROP MED INT HEALTH, V17, P497, DOI 10.1111/j.1365-3156.2011.02952.x; Srikantiah P, 2010, AIDS, V24, pS62, DOI 10.1097/01.aids.0000390091.45435.ea; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Tam LWY, 2008, JAIDS-J ACQ IMM DEF, V49, P266, DOI 10.1097/QAI.0b013e318189a753; Thai S, 2009, TROP MED INT HEALTH, V14, P1048, DOI 10.1111/j.1365-3156.2009.02334.x; Duong T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043375; UNAIDS, 2012, GLOBAL REPORT UNAIDS; United Nations, 2013, MILL DEV GOALS REP; van Griensven J, 2011, T ROY SOC TROP MED H, V105, P694, DOI 10.1016/j.trstmh.2011.08.007; Varma JK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-42; Velen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064459; Vella V, 2010, JAIDS-J ACQ IMM DEF, V55, P109, DOI 10.1097/QAI.0b013e3181e7744e; Zaragoza-Macias E, 2010, AIDS RES HUM RETROV, V26, P133, DOI 10.1089/aid.2009.0001; Zhu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039414	43	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108615	10.1371/journal.pone.0108615	http://dx.doi.org/10.1371/journal.pone.0108615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268903	Green Published, Green Accepted, gold			2022-12-27	WOS:000343671700125
J	Xu, ZR; Tan, ZJ; Zhang, Q; Gui, QF; Yang, YM				Xu, Zhe-rong; Tan, Zhong-ju; Zhang, Qin; Gui, Qi-feng; Yang, Yun-mei			Clinical Effectiveness of Protein and Amino Acid Supplementation on Building Muscle Mass in Elderly People: A Meta-Analysis	PLOS ONE			English	Article							RESISTANCE EXERCISE; PHYSICAL FUNCTION; LEAN MASS; NUTRITIONAL INTERVENTIONS; LEUCINE SUPPLEMENTATION; BODY-COMPOSITION; SYNTHESIS RATES; CO-INGESTION; DOUBLE-BLIND; SARCOPENIA	Objective: A major reason for the loss of mobility in elderly people is the gradual loss of lean body mass known as sarcopenia. Sarcopenia is associated with a lower quality of life and higher healthcare costs. The benefit of strategies that include nutritional intervention, timing of intervention, and physical exercise to improve muscle loss unclear as finding from studies investigating this issue have been inconsistent. We have performed a systematic review and meta-analysis to assess the ability of protein or amino acid supplementation to augment lean body mass or strength of leg muscles in elderly patients. Methods: Nine studies met the inclusion criteria of being a prospective comparative study or randomized controlled trial (RCT) that compared the efficacy of an amino acid or protein supplement intervention with that of a placebo in elderly people (>= 65 years) for the improvement of lean body mass (LBM), leg muscle strength or reduction associated with sarcopenia. Results: The overall difference in mean change from baseline to the end of study in LBM between the treatment and placebo groups was 0.34 kg which was not significant (P = 0.386). The overall differences in mean change from baseline in double leg press and leg extension were 2.14 kg (P = 0.748) and 2.28 kg (P = 0.265), respectively, between the treatment group and the placebo group. Conclusions: These results indicate that amino acid/protein supplements did not increase lean body mass gain and muscle strength significantly more than placebo in a diverse elderly population.	[Xu, Zhe-rong; Tan, Zhong-ju; Zhang, Qin; Gui, Qi-feng] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Geriatr, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Yun-mei] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Dept Ge, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yang, YM (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Dept Ge, Hangzhou 310003, Zhejiang, Peoples R China.	gbbf2000@sina.com	yang, yang/GWB-9426-2022; Lang, Ming/HIK-0758-2022					Aleman-Mateo H, 2012, CLIN INTERV AGING, V7, P225, DOI 10.2147/CIA.S32356; Baier S, 2009, JPEN-PARENTER ENTER, V33, P71, DOI 10.1177/0148607108322403; Borsheim E, 2008, CLIN NUTR, V27, P189, DOI 10.1016/j.clnu.2008.01.001; Candow DG, 2012, BIOGERONTOLOGY, V13, P345, DOI 10.1007/s10522-012-9385-4; Cermak NM, 2012, AM J CLIN NUTR, V96, P1454, DOI 10.3945/ajcn.112.037556; Chale A, 2013, J GERONTOL A-BIOL, V68, P682, DOI 10.1093/gerona/gls221; Cheng Q, 2014, J BONE MINER METAB, V32, P78, DOI 10.1007/s00774-013-0468-3; Cuthbertson D, 2004, FASEB J, V18, P422, DOI 10.1096/fj.04-2640fje; Daly RM, 2014, AM J CLIN NUTR, V99, P899, DOI 10.3945/ajcn.113.064154; Dideriksen KJ, 2011, SCAND J MED SCI SPOR, V21, pE372, DOI 10.1111/j.1600-0838.2011.01318.x; Dillon EL, 2009, J CLIN ENDOCR METAB, V94, P1630, DOI 10.1210/jc.2008-1564; Ferrando AA, 2010, CLIN NUTR, V29, P18, DOI 10.1016/j.clnu.2009.03.009; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Forbes SC, 2012, ENDOCRINE, V42, P29, DOI 10.1007/s12020-012-9676-1; Groen BBL, 2012, AM J PHYSIOL-ENDOC M, V302, pE52, DOI 10.1152/ajpendo.00321.2011; Hays NP, 2009, J AM DIET ASSOC, V109, P1082, DOI 10.1016/j.jada.2009.03.003; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Katsanos CS, 2008, NUTR RES, V28, P651, DOI 10.1016/j.nutres.2008.06.007; Kim HK, 2012, J AM GERIATR SOC, V60, P16, DOI 10.1111/j.1532-5415.2011.03776.x; Koopman R, 2008, BRIT J NUTR, V99, P571, DOI 10.1017/S0007114507812013; Koopman R, 2006, AM J CLIN NUTR, V84, P623, DOI 10.1093/ajcn/84.3.623; Landi F, 2012, J GERONTOL A-BIOL, V67, P48, DOI 10.1093/gerona/glr035; Leenders M, 2011, NUTR REV, V69, P675, DOI 10.1111/j.1753-4887.2011.00443.x; Leenders M, 2011, J NUTR, V141, P1070, DOI 10.3945/jn.111.138495; Masanes F, 2012, J NUTR HEALTH AGING, V16, P184, DOI 10.1007/s12603-011-0108-3; Milne AC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003288.pub2; Nissen SL, 2003, J APPL PHYSIOL, V94, P651, DOI 10.1152/japplphysiol.00755.2002; Paddon-Jones D, 2006, EXP GERONTOL, V41, P215, DOI 10.1016/j.exger.2005.10.006; Phillips SM, 2012, MEAT SCI, V92, P174, DOI 10.1016/j.meatsci.2012.04.027; Solerte SB, 2008, AM J CARDIOL, V101, p69E, DOI 10.1016/j.amjcard.2008.03.004; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Tieland M, 2012, J AM MED DIR ASSOC, V13, P720, DOI 10.1016/j.jamda.2012.07.005; Tieland M, 2012, J AM MED DIR ASSOC, V13, P713, DOI 10.1016/j.jamda.2012.05.020; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Verhoeven S, 2009, AM J CLIN NUTR, V89, P1468, DOI 10.3945/ajcn.2008.26668; Vermeeren MAP, 2004, CLIN NUTR, V23, P1184, DOI 10.1016/j.clnu.2004.03.008	36	83	85	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e109141	10.1371/journal.pone.0109141	http://dx.doi.org/10.1371/journal.pone.0109141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268791	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700224
J	Zhang, XN; Tian, H; Wang, W; Ru, SG				Zhang, Xiaona; Tian, Hua; Wang, Wei; Ru, Shaoguo			Monocrotophos Pesticide Decreases the Plasma Levels of Total 3,3 ',5-Triiodo-L-Thyronine and Alters the Expression of Genes Associated with the Thyroidal Axis in Female Goldfish (Carassius auratus)	PLOS ONE			English	Article							IODOTHYRONINE DEIODINASE; HORMONE DEIODINATION; BETA-SUBUNIT; RED DRUM; ROLES; TRANSTHYRETIN; THYROTROPIN; DISRUPTION; PITUITARY; EXPOSURE	Our recent study showed that monocrotophos (MCP) pesticide disrupted the hypothalamic-pituitary-thyroid (HPT) axis in male goldfish (Carassius auratus); however, the effects of MCP on the thyroid system in female goldfish are remain unclear. In the present study, plasma thyroid hormone (TH) and thyroid-stimulating hormone (TSH) levels were evaluated in female goldfish exposed to 0.01, 0.10, and 1.00 mg/L of 40% MCP-based pesticide for 21 days in a semi-static exposure system. Expression profiles of HPT axis-responsive genes, including transthyretin (ttr), deiodinases (d1, d2, and d3), tsh beta, thyrotropin-releasing hormone (trh), and corticotrophin-releasing hormone (crh), were determined. The results indicated that MCP decreased the plasma levels of total 3,3',5-triiodo-L-thyronine (TT3) and the ratio of TT3 to total 3,3',5,5'-L-thyroxine (TT4), and induced alternative expression of TH-related genes. Exposure to 0.01 and 0.10 mg/L MCP pesticide resulted in the up-regulation of ttr mRNA. The reduction of plasma TT3 levels was partly attributed to an increase in the metabolism of T-3 in the liver, as revealed by the highly elevated hepatic d1 and d3 mRNA levels in the MCP treatment groups, and the expression of hepatic d3 showed a negative correlation with the plasma TT3/TT4 levels in females. Moreover, the plasma TSH levels were lower in females exposed to 0.01 and 0.10 mg/L MCP pesticide, whereas the up-regulation of tsh beta mRNA levels was compensated by the decreased plasma TT3 levels. These results indicated that MCP had the potential to influence several pathways of HPT axis homeostasis in female goldfish.	[Zhang, Xiaona; Tian, Hua; Wang, Wei; Ru, Shaoguo] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China	Ocean University of China	Ru, SG (corresponding author), Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China.	rusg@ouc.edu.cn	Tian, Hua/GPP-4477-2022		National Natural Science Foundation of China [31202001]; Natural Science Foundation of Shandong Province [ZR2012CQ010]; Innovation and Research Foundation of Ocean University of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Innovation and Research Foundation of Ocean University of China	This work was supported by the National Natural Science Foundation of China (31202001), www.nsfc.gov.cn, the Natural Science Foundation of Shandong Province (ZR2012CQ010), www.sdnsf.gov.cn, and the Innovation and Research Foundation of Ocean University of China, http://www.moe.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott M, 2011, HORM BEHAV, V59, P236, DOI 10.1016/j.yhbeh.2010.12.008; Anjum R, 2013, ENVIRON TOXICOL PHAR, V35, P284, DOI 10.1016/j.etap.2012.12.013; Becker KB, 1997, ENDOCRINOLOGY, V138, P2989, DOI 10.1210/en.138.7.2989; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bing X, 2003, THESIS OCEAN U CHINA; Brown SB, 2004, ENVIRON TOXICOL CHEM, V23, P1680, DOI 10.1897/03-242; Cyr DG, 1996, REV FISH BIOL FISHER, V6, P165, DOI 10.1007/BF00182342; Darras VM, 2012, J ENDOCRINOL, V215, P189, DOI 10.1530/JOE-12-0204; De Groef B, 2006, GEN COMP ENDOCR, V146, P62, DOI 10.1016/j.ygcen.2005.10.014; DECUYPERE E, 1983, HORM METAB RES, V15, P233, DOI 10.1055/s-2007-1018680; Desaulniers D, 1999, TOXICOL SCI, V47, P158, DOI 10.1093/toxsci/47.2.158; DeWitt J, 2009, CRIT REV TOXICOL, V39, P76, DOI [10.1080/10408440802209804, 10.1080/10408440802209804 ]; EALES JG, 1993, GEN COMP ENDOCR, V90, P157, DOI 10.1006/gcen.1993.1070; Habibi HR, 2012, GEN COMP ENDOCR, V175, P19, DOI 10.1016/j.ygcen.2011.11.003; HONTELA A, 1992, ARCH ENVIRON CON TOX, V22, P278, DOI 10.1007/bf00212086; Huising M, 2004, J MOL ENDOCRINOL, V32, P627, DOI 10.1677/jme.0.0320627; HURLBURT ME, 1977, CAN J ZOOL, V55, P1906, DOI 10.1139/z77-244; Jahnke GD, 2004, ENVIRON HEALTH PERSP, V112, P363, DOI 10.1289/ehp.6637; Jin YX, 2011, GEN COMP ENDOCR, V170, P487, DOI 10.1016/j.ygcen.2010.11.001; Kalsbeek A, 2005, ENDOCRINOLOGY, V146, P1418, DOI 10.1210/en.2004-0763; Kang YueHui, 2000, China Environmental Science, V20, P1; Kawakami Y, 2006, ZOOL SCI, V23, P443, DOI 10.2108/zsj.23.443; Kohrle J, 1999, MOL CELL ENDOCRINOL, V151, P103, DOI 10.1016/S0303-7207(99)00040-4; Kumari B, 2007, ENVIRON MONIT ASSESS, V133, P467, DOI 10.1007/s10661-006-9601-2; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Leiner KA, 2000, GEN COMP ENDOCR, V120, P88, DOI 10.1006/gcen.2000.7539; Li DP, 2008, CHEMOSPHERE, V74, P13, DOI 10.1016/j.chemosphere.2008.09.065; Li W, 2009, AQUAT TOXICOL, V92, P50, DOI 10.1016/j.aquatox.2009.01.006; Maia AL, 2011, J ENDOCRINOL, V209, P283, DOI 10.1530/JOE-10-0481; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; MORENO M, 1994, FEBS LETT, V344, P143, DOI 10.1016/0014-5793(94)00365-3; Morgado I, 2007, CHEMOSPHERE, V69, P155, DOI 10.1016/j.chemosphere.2007.04.010; NG TB, 1982, GEN COMP ENDOCR, V48, P372, DOI 10.1016/0016-6480(82)90150-2; Oommen O. V, 2006, Journal of Endocrinology and Reproduction, V10, P96; Orozco A, 2005, THYROID, V15, P799, DOI 10.1089/thy.2005.15.799; Park BJ, 2011, ENVIRON SCI TECHNOL, V45, P7923, DOI 10.1021/es201530m; Power DM, 2000, GEN COMP ENDOCR, V119, P241, DOI 10.1006/gcen.2000.7520; Power DM, 2001, COMP BIOCHEM PHYS C, V130, P447, DOI 10.1016/S1532-0456(01)00271-X; Ru SG, 2003, WATER AIR SOIL POLL, V149, P17, DOI 10.1023/A:1025607702964; Sanders JP, 1997, ENDOCRINOLOGY, V138, P5153, DOI 10.1210/en.138.12.5153; Schreiber G, 2002, J ENDOCRINOL, V175, P61, DOI 10.1677/joe.0.1750061; Sohn YC, 1999, GEN COMP ENDOCR, V115, P463, DOI 10.1006/gcen.1999.7342; St Germain DL, 2009, ENDOCRINOLOGY, V150, P1097, DOI 10.1210/en.2008-1588; Sutija M, 2004, GEN COMP ENDOCR, V136, P152, DOI 10.1016/j.ygcen.2003.12.013; Thangavel P, 2005, CHEMOSPHERE, V61, P1083, DOI 10.1016/j.chemosphere.2005.03.045; Tian H, 2010, COMP BIOCHEM PHYS C, V152, P107, DOI 10.1016/j.cbpc.2010.03.004; Tian H, 2010, AQUAT TOXICOL, V98, P67, DOI 10.1016/j.aquatox.2010.01.011; TRAN TN, 1989, PEPTIDES, V10, P835, DOI 10.1016/0196-9781(89)90122-8; Ulbrich B, 2004, ARCH TOXICOL, V78, P252, DOI 10.1007/s00204-003-0519-y; ValverdeR C, 1997, ENDOCRINOLOGY, V138, P642, DOI 10.1210/en.138.2.642; Van der Geyten S, 1998, FISH PHYSIOL BIOCHEM, V19, P135, DOI 10.1023/A:1007790527748; Van der Geyten S, 2005, J ENDOCRINOL, V184, P467, DOI 10.1677/joe.1.05986; Van der Geyten S, 2001, GEN COMP ENDOCR, V124, P333, DOI 10.1006/gcen.2001.7722; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yoshiura Y, 1999, FISH PHYSIOL BIOCHEM, V21, P201, DOI 10.1023/A:1007884527397; Zhang XN, 2013, GEN COMP ENDOCR, V193, P158, DOI 10.1016/j.ygcen.2013.08.003; Zhong Y, 2014, THESIS OCEAN U CHINA	57	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108972	10.1371/journal.pone.0108972	http://dx.doi.org/10.1371/journal.pone.0108972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268935	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700206
J	Zhu, LB; Zhou, L; Huang, N; Cui, WJ; Liu, ZM; Xiao, K; Zhou, ZM				Zhu, Longbao; Zhou, Li; Huang, Nan; Cui, Wenjing; Liu, Zhongmei; Xiao, Ke; Zhou, Zhemin			Efficient Preparation of Enantiopure D-Phenylalanine through Asymmetric Resolution Using Immobilized Phenylalanine Ammonia-Lyase from Rhodotorula glutinis JN-1 in a Recirculating Packed-Bed Reactor	PLOS ONE			English	Article							D-AMINO-ACID; PENICILLIN-G ACYLASE; HYDANTOIN RACEMASE; D-CARBAMOYLASE; MUTAGENESIS	An efficient enzymatic process was developed to produce optically pure D-phenylalanine through asymmetric resolution of the racemic DL-phenylalanine using immobilized phenylalanine ammonia-lyase (RgPAL) from Rhodotorula glutinis JN-1. RgPAL was immobilized on a modified mesoporous silica support (MCM-41-NH-GA). The resulting MCM-41-NH-GA-RgPAL showed high activity and stability. The resolution efficiency using MCM-41-NH-GA-RgPAL in a recirculating packed-bed reactor (RPBR) was higher than that in a stirred-tank reactor. Under optimal operational conditions, the volumetric conversion rate of L-phenylalanine and the productivity of D-phenylalanine reached 96.7 mM h(-1) and 0.32 g L-1 h(-1), respectively. The optical purity (ee(D)) of D-phenylalanine exceeded 99%. The RPBR ran continuously for 16 batches, the conversion ratio did not decrease. The reactor was scaled up 25-fold, and the productivity of D-phenylalanine (ee(D)>99%) in the scaled-up reactor reached 7.2 g L-1 h(-1) These results suggest that the resolution process is an alternative method to produce highly pure D-phenylalanine.	[Zhu, Longbao; Zhou, Li; Huang, Nan; Cui, Wenjing; Liu, Zhongmei; Xiao, Ke; Zhou, Zhemin] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China; [Zhu, Longbao] Anhui Polytech Univ, Sch Biochem Engn, Wuhu, Anhui, Peoples R China	Jiangnan University; Anhui Polytechnic University	Zhou, ZM (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China.	zhmzhou@jiangnan.edu.cn	Cui, Wenjing/HIR-1471-2022	Zhou, Li/0000-0001-8448-2040	111 Project [111-2-06]; Jiangsu province ''Collaborative Innovation Center for Advanced Industrial Fermentation'' industry development program; National High Technology Research and Development Program of China (863 Program) [2014AA021304]; Key Project of Chinese Ministry of Education [311023]; Public Project for Key Laboratory of Industrial Biotechnology, Ministry of Education, Jiangnan University [KLIB-KF201107, KLIB-KF201203]; National Natural Science Foundation of China [31300087]; Natural Sciences Foundation of Jiangsu [BK20130131, BK20130139]; High Foreign Experts Project [GDW20123200114]; Priority Academic Program Development of Jiangsu Higher Education Institutions	111 Project(Ministry of Education, China - 111 Project); Jiangsu province ''Collaborative Innovation Center for Advanced Industrial Fermentation'' industry development program; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Key Project of Chinese Ministry of Education(Ministry of Education, China); Public Project for Key Laboratory of Industrial Biotechnology, Ministry of Education, Jiangnan University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences Foundation of Jiangsu; High Foreign Experts Project; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was financially supported by a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, the 111 Project (No. 111-2-06), and the Jiangsu province ''Collaborative Innovation Center for Advanced Industrial Fermentation'' industry development program, the National High Technology Research and Development Program of China (863 Program, 2014AA021304), the High Foreign Experts Project (GDW20123200114), the Key Project of Chinese Ministry of Education (311023), the Public Project for Key Laboratory of Industrial Biotechnology, Ministry of Education, Jiangnan University (KLIB-KF201107, KLIB-KF201203), National Natural Science Foundation of China (31300087), Natural Sciences Foundation of Jiangsu (BK20130131, BK20130139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek DH, 2003, ENZYME MICROB TECH, V32, P131, DOI 10.1016/S0141-0229(02)00268-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breuer M, 2004, ANGEW CHEM INT EDIT, V43, P788, DOI 10.1002/anie.200300599; Chao YP, 2000, BIOTECHNOL LETT, V22, P99, DOI 10.1023/A:1005689202685; Engineer AS, 2013, J IND MICROBIOL BIOT, V40, P1367, DOI 10.1007/s10295-013-1333-z; Foster IM, 2003, BIOTECHNOL LETT, V25, P67, DOI 10.1023/A:1021798602499; FUKUHARA T, 1990, J CHROMATOGR SCI, V28, P114, DOI 10.1093/chromsci/28.3.114; Gao SL, 2010, BIORESOURCE TECHNOL, V101, P3830, DOI 10.1016/j.biortech.2010.01.023; Gao XZ, 2013, APPL ENVIRON MICROB, V79, P5078, DOI 10.1128/AEM.01049-13; Hanson RL, 2008, ORG PROCESS RES DEV, V12, P1119, DOI 10.1021/op800149q; Hartmann M, 2013, CHEM SOC REV, V42, P6277, DOI 10.1039/c3cs60021a; Heras-Vazquez FJL, 2003, BIOCHEM BIOPH RES CO, V303, P541, DOI 10.1016/S0006-291X(03)00377-2; Isobe Kimiyasu, 2010, Enzyme Res, V2010, P567210, DOI 10.4061/2010/567210; Jung D, 2010, INT J MOL SCI, V11, P762, DOI 10.3390/ijms11020762; Kannan K, 2009, J MOL CATAL B-ENZYM, V56, P34, DOI 10.1016/j.molcatb.2008.04.007; Leng Y, 2006, PROCESS BIOCHEM, V41, P1669, DOI 10.1016/j.procbio.2006.01.019; Liu WM, 2014, BIOCHEM ENG J, V83, P116, DOI 10.1016/j.bej.2013.12.016; Liu YQ, 2008, ENZYME MICROB TECH, V42, P589, DOI 10.1016/j.enzmictec.2008.02.013; MacDonald MJ, 2007, BIOCHEM CELL BIOL, V85, P273, DOI 10.1139/O07-018; Magner E, 2013, CHEM SOC REV, V42, P6213, DOI 10.1039/c2cs35450k; Martinez-Rodriguez S, 2004, BIOCHIMIE, V86, P77, DOI 10.1016/j.biochi.2004.01.004; Martinez-Rodriguez S, 2006, PROTEIN SCI, V15, P2729, DOI 10.1110/ps.062452106; Mureseanu M, 2005, LANGMUIR, V21, P4648, DOI 10.1021/la0502241; Murray RG, 2008, ORG BIOMOL CHEM, V6, P988, DOI 10.1039/b719675j; Nakkharat P, 2007, WORLD J MICROB BIOT, V23, P759, DOI 10.1007/s11274-006-9292-4; Nozaki H, 2005, J MOL CATAL B-ENZYM, V32, P213, DOI 10.1016/j.molcatb.2004.12.004; Oh KH, 2002, BIOTECHNOL PROGR, V18, P413, DOI 10.1021/bp0101942; Pandya PH, 2005, MICROPOR MESOPOR MAT, V77, P67, DOI 10.1016/j.micromeso.2004.08.018; Parida KM, 2009, J MOL CATAL A-CHEM, V310, P93, DOI 10.1016/j.molcata.2009.06.001; Ruilope LM, 2003, CARDIOVASC DRUG THER, V17, P151, DOI 10.1023/A:1025391803121; Singh S, 2011, CURR MICROBIOL, V63, P94, DOI 10.1007/s00284-011-9955-8; Suan CL, 2004, J MOL CATAL B-ENZYM, V28, P111, DOI 10.1016/j.molcatb.2004.02.004; Takahashi E, 1997, BIOTECHNOL TECH, V11, P913, DOI 10.1023/A:1018470502118; Xue YP, 2013, BIOCHEM ENG J, V74, P88, DOI 10.1016/j.bej.2013.03.005; Zhao JQ, 2011, BIORESOURCE TECHNOL, V102, P529, DOI 10.1016/j.biortech.2010.09.076; Zhu LB, 2013, BIOTECHNOL LETT, V35, P751, DOI 10.1007/s10529-013-1140-7	36	16	16	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108586	10.1371/journal.pone.0108586	http://dx.doi.org/10.1371/journal.pone.0108586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268937	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700116
J	Chaabane, SC; de Brachene, AC; Essaghir, A; Velghe, A; Lo Re, S; Stockis, J; Lucas, S; Khachigian, LM; Huaux, F; Demoulin, JB				Chaabane, Saima Charni; de Brachene, Alexandra Coomans; Essaghir, Ahmed; Velghe, Amelie; Lo Re, Sandra; Stockis, Julie; Lucas, Sophie; Khachigian, Levon M.; Huaux, Francois; Demoulin, Jean-Baptiste			PDGF-D Expression Is Down-Regulated by TGF beta in Fibroblasts	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LIVER FIBROSIS; CARDIAC FIBROBLASTS; SIGNAL-TRANSDUCTION; PANCREATIC-CANCER; ANGIOTENSIN-II; LUNG FIBROSIS; KAPPA-B; ACTIVATION; CELLS	Transforming growth factor-beta (TGF beta) is a key mediator of fibrogenesis. TGF beta is overexpressed and activated in fibrotic diseases, regulates fibroblast differentiation into myofibroblasts and induces extracellular matrix deposition. Platelet-derived growth factor (PDGF) is also a regulator of fibrogenesis. Some studies showed a link between TGF beta and PDGF in certain fibrotic diseases. TGF beta induces PDGF receptor alpha expression in scleroderma fibroblasts. PDGF-C and -D are the most recently discovered ligands and also play a role in fibrosis. In this study, we report the first link between TGF beta and PDGF-D and -C ligands. In normal fibroblasts, TGF beta down-regulated PDGF-D expression and up-regulated PDGF-C expression at the mRNA and protein levels. This phenomenon is not limited to TGF beta since other growth factors implicated in fibrosis, such as FGF, EGF and PDGF-B, also regulated PDGF-D and PDGF-C expression. Among different kinase inhibitors, only TGF beta receptor inhibitors and the I kappa B kinase (IKK) inhibitor BMS-345541 blocked the effect of TGF beta. However, activation of the classical NF-kappa B pathway was not involved. Interestingly, in a model of lung fibrosis induced by either bleomycin or silica, PDGF-D was down-regulated, which correlates with the production of TGF beta and other fibrotic growth factors. In conclusion, the down-regulation of PDGF-D by TGF beta and other growth factors may serve as a negative feedback in the network of cytokines that control fibrosis.	[Chaabane, Saima Charni; de Brachene, Alexandra Coomans; Essaghir, Ahmed; Velghe, Amelie; Stockis, Julie; Lucas, Sophie; Demoulin, Jean-Baptiste] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Lo Re, Sandra; Huaux, Francois] Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol, Inst Expt & Clin Res, B-1200 Brussels, Belgium; [Lucas, Sophie] Walloon Excellence Life Sci & Biotechnol WELBIO, Wallonia, Belgium; [Khachigian, Levon M.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia	Universite Catholique Louvain; Universite Catholique Louvain; WELBIO; University of New South Wales Sydney	Demoulin, JB (corresponding author), Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium.	jb.demoulin@uclouvain.be	Khachigian, Levon/AAZ-7458-2020	Lucas, Sophie/0000-0003-1287-7996; Khachigian, Levon/0000-0003-3446-0323; Stockis, Julie/0000-0003-4911-6891; Demoulin, Jean-Baptiste/0000-0002-8016-6689	Fonds Speciaux de Recherche (UCL) - European Commission; Fonds pour la recherche Scientifique en Rhumatologie; Fonds Maurange	Fonds Speciaux de Recherche (UCL) - European Commission; Fonds pour la recherche Scientifique en Rhumatologie; Fonds Maurange	This work was supported by: Fonds Speciaux de Recherche (UCL) co-funded by the Marie-Curie Actions of the European Commission; Fonds pour la recherche Scientifique en Rhumatologie [http://www.frsr.be/]; SCC was supported by a fellowship from the Fonds Maurange managed by the King Baudouin Foundation [http://www.kbs-frb.be/fund.aspx?id=293710&langtype=2060]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi Y, 2004, BRIT J CANCER, V91, P1316, DOI 10.1038/sj.bjc.6602141; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Bonello MR, 2004, J BIOL CHEM, V279, P2377, DOI 10.1074/jbc.M308254200; Campbell JS, 2005, P NATL ACAD SCI USA, V102, P3389, DOI 10.1073/pnas.0409722102; Cho HY, 2003, TOXICOL LETT, V143, P323, DOI 10.1016/S0378-4274(03)00193-0; Chow JYC, 2010, AM J PHYSIOL-GASTR L, V298, pG275, DOI 10.1152/ajpgi.00344.2009; Czochra P, 2006, J HEPATOL, V45, P419, DOI 10.1016/j.jhep.2006.04.010; Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558; Demoulin JB, 2004, J BIOL CHEM, V279, P35392, DOI 10.1074/jbc.M405924200; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dosanjh A, 2012, J INTERF CYTOK RES, V32, P111, DOI 10.1089/jir.2011.0079; Dusa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011157; Eitner F, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134910; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Frey RS, 1997, CANCER RES, V57, P628; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Inagaki Y, 2012, J GASTROEN HEPATOL, V27, P85, DOI 10.1111/j.1440-1746.2011.07006.x; Irvine SA, 2005, NUCLEIC ACIDS RES, V33, P1423, DOI 10.1093/nar/gki280; Leeb SN, 2002, GROWTH FACTORS, V20, P81, DOI 10.1080/08977190290031941; Li Y, 2012, MOL CELL BIOCHEM, V361, P79, DOI 10.1007/s11010-011-1091-z; Lian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044946; Liu MYX, 2006, BLOOD, V107, P2322, DOI 10.1182/blood-2005-06-2377; Liu N, 2012, J AM SOC NEPHROL, V23, P854, DOI 10.1681/ASN.2011050493; Masola V, 2012, J BIOL CHEM, V287, P1478, DOI 10.1074/jbc.M111.279836; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Ostendorf T, 2003, J AM SOC NEPHROL, V14, P2237, DOI 10.1097/01.ASN.0000083393.00959.02; Palacios RS, 2008, LAB INVEST, V88, P1192, DOI 10.1038/labinvest.2008.91; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; PINZANI M, 1989, J CLIN INVEST, V84, P1786, DOI 10.1172/JCI114363; Rabolli V, 2011, TOXICOL LETT, V203, P127, DOI 10.1016/j.toxlet.2011.03.009; Rice AB, 1999, AM J PATHOL, V155, P213, DOI 10.1016/S0002-9440(10)65115-2; Simm A, 1998, BASIC RES CARDIOL, V93, P40; Tan NY, 2008, CIRC RES, V102, pE38, DOI 10.1161/CIRCRESAHA.107.167395; Tripurani SK, 2012, ONCOGENE; Uutela M, 2001, CIRCULATION, V103, P2242; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Wang M, 2010, J CELL BIOCHEM, V111, P75, DOI 10.1002/jcb.22664; Wang SN, 2010, AM J PHYSIOL-RENAL, V298, pF142, DOI 10.1152/ajprenal.00320.2009; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; YAMAKAGE A, 1992, J EXP MED, V175, P1227, DOI 10.1084/jem.175.5.1227; Yang DC, 2005, EUR HEART J, V26, P642, DOI 10.1093/eurheartj/ehi201; Zhuo Y, 2004, AM J PHYSIOL-LUNG C, V286, pL182, DOI 10.1152/ajplung.00083.2003	48	12	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108656	10.1371/journal.pone.0108656	http://dx.doi.org/10.1371/journal.pone.0108656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25280005	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800024
J	Husebo, GR; Bakke, PS; Aanerud, M; Hardie, JA; Ueland, T; Gronseth, R; Persson, LJP; Aukrust, P; Eagan, TM				Husebo, Gunnar R.; Bakke, Per S.; Aanerud, Marianne; Hardie, Jon A.; Ueland, Thor; Gronseth, Rune; Persson, Louise J. P.; Aukrust, Pal; Eagan, Tomas M.			Predictors of Exacerbations in Chronic Obstructive Pulmonary Disease - Results from the Bergen COPD Cohort Study	PLOS ONE			English	Article							INFLAMMATORY BIOMARKERS; RISK; MORTALITY; FREQUENCY; RECOVERY	Background: COPD exacerbations accelerate disease progression. Aims: To examine if COPD characteristics and systemic inflammatory markers predict the risk for acute COPD exacerbation (AECOPD) frequency and duration. Methods: 403 COPD patients, GOLD stage II-IV, aged 44-76 years were included in the Bergen COPD Cohort Study in 2006/07, and followed for 3 years. Examined baseline predictors were sex, age, body composition, smoking, AECOPD the last year, GOLD stage, Charlson comorbidity score (CCS), hypoxemia (PaO2<8 kPa), cough, use of inhaled steroids, and the inflammatory markers leucocytes, C-reactive protein (CRP), neutrophil gelatinase associated lipocalin (NGAL), soluble tumor necrosis factor receptor 1 (sTNF-R1), and osteoprotegrin (OPG). Negative binomial models with random effects were fitted to estimate the annual incidence rate ratios (IRR). For analysis of AECOPD duration, a generalized estimation equation logistic regression model was fitted, also adjusting for season, time since inclusion and AECOPD severity. Results: After multivariate adjustment, significant predictors of AECOPD were: female sex [IRR 1.45 (1.14-1.84)], age per 10 year increase [1.23 (1.03-1.47)], >1 AECOPD last year before baseline [1.65 (1.24-2.21)], GOLD III [1.36 (1.07-1.74)], GOLD IV [2.90 (1.98-4.25)], chronic cough [1.64 (1.30-2.06)] and use of inhaled steroids [1.57 (1.21-2.05)]. For AECOPD duration more than three weeks, significant predictors after adjustment were: hypoxemia [0.60 (0.39-0.92)], years since inclusion [1.19 (1.03-1.37)], AECOPD severity; moderate [OR 1.58 (1.14-2.18)] and severe [2.34 (1.58-3.49)], season; winter [1.51 (1.08-2.12)], spring [1.45 (1.02-2.05)] and sTNF-R1 per SD increase [1.16 (1.00-1.35)]. Conclusion: Several COPD characteristics were independent predictors of both AECOPD frequency and duration.	[Husebo, Gunnar R.; Aanerud, Marianne; Gronseth, Rune; Persson, Louise J. P.; Eagan, Tomas M.] Haukeland Hosp, Dept Thorac Med, N-5021 Bergen, Norway; [Bakke, Per S.; Hardie, Jon A.; Eagan, Tomas M.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Ueland, Thor; Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Ueland, Thor; Aukrust, Pal] Univ Oslo, KG Jebsen Inflammatory Res Ctr, Oslo, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; National Hospital Norway; University of Oslo	Husebo, GR (corresponding author), Haukeland Hosp, Dept Thorac Med, N-5021 Bergen, Norway.	gunnar.husebo@med.uib.no	Eagan, Tomas Mikal/AHC-9127-2022; Nielsen, Rune/O-3131-2016; Eagan, Tomas ML/P-3554-2014	Nielsen, Rune/0000-0003-2799-0430; Eagan, Tomas ML/0000-0001-8725-9960; Husebo, Gunnar Reksten/0000-0001-6880-8215	GlaxoSmithKline; Pfizer; Novartis; AstraZeneca; Boehringer Ingelheim; MAa; Norwegian Association of Heart and Lung Patients; EXTRA funds from the Norwegian Foundation for Health and Rehabilitation; InterMune	GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Novartis(Novartis); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); MAa; Norwegian Association of Heart and Lung Patients; EXTRA funds from the Norwegian Foundation for Health and Rehabilitation; InterMune	PSB has within the last 5 years received lecture fees from GlaxoSmithKline, Pfizer, Novartis, AstraZeneca, and Boehringer Ingelheim, and received research grants from GlaxoSmithKline and Novartis, MAa has within the last 5 years received lecture fees from GlaxoSmithKline, Boehringer Ingelheim, and AstraZeneca, RG reports grants from The Norwegian Association of Heart and Lung Patients and EXTRA funds from the Norwegian Foundation for Health and Rehabilitation; grants from Boehringer Ingelheim, personal fees from GlaxoSmithKline; and travel grants from AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim and Pfizer, TME has within the last 5 years received lecture fees from GlaxoSmithKline and Boehringer Ingelheim, and received travel grants from InterMune. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Aaron SD, 2012, THORAX, V67, P238, DOI 10.1136/thoraxjnl-2011-200768; Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Anzueto A, 2012, RESP MED, V106, P1258, DOI 10.1016/j.rmed.2012.06.002; Au DH, 2009, J GEN INTERN MED, V24, P457, DOI 10.1007/s11606-009-0907-y; Bartziokas K, 2014, EUR RESPIR J, V43, P43, DOI 10.1183/09031936.00209212; Bowler R. P., 2014, CHEST; Brusse-Keizer M, 2011, CLIN RESPIR J, V5, P227, DOI 10.1111/j.1752-699X.2010.00234.x; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Celli B, 2011, AM J RESP CRIT CARE, V183, P317, DOI 10.1164/rccm.201004-0665OC; Donaldson GC, 2012, CHEST, V141, P94, DOI 10.1378/chest.11-0281; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Eagan TML, 2010, EUR RESPIR J, V35, P540, DOI 10.1183/09031936.00088209; Eagan TM, 2010, CHEST, V138, P888, DOI 10.1378/chest.09-2718; Groenewegen KH, 2008, CHEST, V133, P350, DOI 10.1378/chest.07-1342; Halpin DMG, 2012, INT J CHRONIC OBSTR, V7, P653, DOI 10.2147/COPD.S34186; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Hurst JR, 2009, AM J RESP CRIT CARE, V179, P369, DOI 10.1164/rccm.200807-1067OC; Hurst JR, 2006, AM J RESP CRIT CARE, V173, P71, DOI 10.1164/rccm.200505-704OC; Hurst JR, 2005, EUR RESPIR J, V26, P846, DOI 10.1183/09031936.05.00043405; Jenkins CR, 2012, EUR RESPIR J, V39, P38, DOI 10.1183/09031936.00194610; Johannessen A, 2006, AM J RESP CRIT CARE, V173, P1316, DOI 10.1164/rccm.200601-023OC; Keene ON, 2008, EUR RESPIR J, V32, P17, DOI 10.1183/09031936.00161507; Kessler R, 1999, AM J RESP CRIT CARE, V159, P158, DOI 10.1164/ajrccm.159.1.9803117; Kew KM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010115.pub2; Langsetmo L, 2008, AM J RESP CRIT CARE, V177, P396, DOI 10.1164/rccm.200708-1290OC; Perera WR, 2007, EUR RESPIR J, V29, P527, DOI 10.1183/09031936.00092506; Quint JK, 2008, EUR RESPIR J, V32, P53, DOI 10.1183/09031936.00120107; Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S; Sakae TM, 2013, J BRAS PNEUMOL, V39, P259, DOI 10.1590/S1806-37132013000300002; Saure EW, 2012, CLIN RESPIR J, V6, P72, DOI 10.1111/j.1752-699X.2011.00248.x; Schutz Y, 2002, INT J OBESITY, V26, P953, DOI 10.1038/sj.ijo.0802037; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Suissa S, 2013, THORAX, V68, P1029, DOI 10.1136/thoraxjnl-2012-202872; Suissa S, 2012, THORAX, V67, P957, DOI 10.1136/thoraxjnl-2011-201518; Tashkin DP, 2012, COPD, V9, P289, DOI 10.3109/15412555.2012.656211; Thomsen M, 2013, JAMA-J AM MED ASSOC, V309, P2353, DOI 10.1001/jama.2013.5732; Tseng CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057066; Tufvesson E, 2013, LUNG, V191, P413, DOI 10.1007/s00408-013-9473-5; Wedzicha JA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-181; Wells JM, 2012, NEW ENGL J MED, V367, P913, DOI 10.1056/NEJMoa1203830	41	52	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109721	10.1371/journal.pone.0109721	http://dx.doi.org/10.1371/journal.pone.0109721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279458	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800097
J	Muthamilarasan, M; Khandelwal, R; Yadav, CB; Bonthala, VS; Khan, Y; Prasad, M				Muthamilarasan, Mehanathan; Khandelwal, Rohit; Yadav, Chandra Bhan; Bonthala, Venkata Suresh; Khan, Yusuf; Prasad, Manoj			Identification and Molecular Characterization of MYB Transcription Factor Superfamily in C-4 Model Plant Foxtail Millet (Setaria italica L.)	PLOS ONE			English	Article							SCALE GENOTYPING APPLICATIONS; GENOME-WIDE IDENTIFICATION; LENGTH POLYMORPHIC MARKERS; ABIOTIC STRESS; GENE FAMILY; EXPRESSION ANALYSIS; ARABIDOPSIS; R2R3-MYB; SEQUENCE; PROTEIN	MYB proteins represent one of the largest transcription factor families in plants, playing important roles in diverse developmental and stress-responsive processes. Considering its significance, several genome-wide analyses have been conducted in almost all land plants except foxtail millet. Foxtail millet (Setaria italica L.) is a model crop for investigating systems biology of millets and bioenergy grasses. Further, the crop is also known for its potential abiotic stress-tolerance. In this context, a comprehensive genome-wide survey was conducted and 209 MYB protein-encoding genes were identified in foxtail millet. All 209 S. italica MYB (SiMYB) genes were physically mapped onto nine chromosomes of foxtail millet. Gene duplication study showed that segmental-and tandem-duplication have occurred in genome resulting in expansion of this gene family. The protein domain investigation classified SiMYB proteins into three classes according to number of MYB repeats present. The phylogenetic analysis categorized SiMYBs into ten groups (I - X). SiMYB-based comparative mapping revealed a maximum orthology between foxtail millet and sorghum, followed by maize, rice and Brachypodium. Heat map analysis showed tissue-specific expression pattern of predominant SiMYB genes. Expression profiling of candidate MYB genes against abiotic stresses and hormone treatments using qRT-PCR revealed specific and/or overlapping expression patterns of SiMYBs. Taken together, the present study provides a foundation for evolutionary and functional characterization of MYB TFs in foxtail millet to dissect their functions in response to environmental stimuli.	[Muthamilarasan, Mehanathan; Khandelwal, Rohit; Yadav, Chandra Bhan; Bonthala, Venkata Suresh; Khan, Yusuf; Prasad, Manoj] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Prasad, M (corresponding author), Natl Inst Plant Genome Res, New Delhi, India.	manoj_prasad@nipgr.ac.in	Prasad, Manoj/AAE-8540-2019; khan, yusuf/E-6726-2015; Bonthala, Venkata Suresh/G-9852-2013; khan, yusuf/AAQ-9470-2021; Muthamilarasan, Mehanathan/H-9340-2017	Prasad, Manoj/0000-0003-0691-0163; khan, yusuf/0000-0001-6986-4657; Bonthala, Venkata Suresh/0000-0001-6550-1648; Muthamilarasan, Mehanathan/0000-0001-7589-6372; Yadav, Chandra Bhan/0000-0001-9613-2232	National Institute of Plant Genome Research (NIPGR), New Delhi, India	National Institute of Plant Genome Research (NIPGR), New Delhi, India	This work was financially supported by the core grant of National Institute of Plant Genome Research (NIPGR), New Delhi, India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Adler G, 2010, PLANTA, V232, P187, DOI 10.1007/s00425-010-1160-7; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Bedon F, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-17; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bonthala VS, 2014, MOL BIOL REP, V41, P6343, DOI 10.1007/s11033-014-3574-y; Cao ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069955; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Cochrane G, 2013, NUCLEIC ACIDS RES, V41, pD30, DOI 10.1093/nar/gks1175; Da GP, 2006, P NATL ACAD SCI USA, V103, P2057, DOI 10.1073/pnas.0510949103; Dai X, 2013, NUCLEIC ACIDS RES, V39, pW155; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dias AP, 2003, PLANT PHYSIOL, V131, P610, DOI 10.1104/pp.012047; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Du DL, 2013, MOL BIOL REP, V40, P1937, DOI 10.1007/s11033-012-2250-3; Du H, 2013, DNA RES, V20, P437, DOI 10.1093/dnares/dst021; Du H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-106; Du H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037463; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Filichkin SA, 2004, PLANT PHYSIOL, V134, P1080, DOI 10.1104/pp.103.035998; Gocal GFW, 1999, PLANT PHYSIOL, V119, P1271, DOI 10.1104/pp.119.4.1271; Goicoechea M, 2005, PLANT J, V43, P553, DOI 10.1111/j.1365-313X.2005.02480.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gowik U, 2004, PLANT CELL, V16, P1077, DOI 10.1105/tpc.019729; GROTEWOLD E, 1994, CELL, V76, P543, DOI 10.1016/0092-8674(94)90117-1; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Gupta S, 2012, PLANT CELL REP, V31, P323, DOI 10.1007/s00299-011-1168-x; Gupta S, 2011, GENOME, V54, P586, DOI [10.1139/G11-020, 10.1139/g11-020]; Hartmann U, 2005, PLANT MOL BIOL, V57, P155, DOI 10.1007/s11103-004-6910-0; Higginson T, 2003, PLANT J, V35, P177, DOI 10.1046/j.1365-313X.2003.01791.x; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hobo T, 2008, PLANT CELL PHYSIOL, V49, P1417, DOI 10.1093/pcp/pcn128; Jiang CH, 2004, GENE, V326, P13, DOI 10.1016/j.gene.2003.09.049; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khan Y, 2014, PLANT CELL TISS ORG, V118, P279, DOI 10.1007/s11240-014-0480-x; Kumar K, 2013, PLANT CELL TISS ORG, V115, P13, DOI 10.1007/s11240-013-0335-x; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Lata C, 2011, J EXP BOT, V62, P3387, DOI 10.1093/jxb/err016; Lata C, 2010, BIOCHEM BIOPH RES CO, V393, P720, DOI 10.1016/j.bbrc.2010.02.068; Li Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047576; Lipsick JS, 1996, ONCOGENE, V13, P223; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Matus JT, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-83; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; Mishra AM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095280, 10.1371/journal.pone.0086852]; Muthamilarasan M, 2014, FUNCT INTEGR GENOMIC, V14, P531, DOI 10.1007/s10142-014-0383-2; Muthamilarasan M, 2014, DNA RES, V21, P41, DOI 10.1093/dnares/dst039; Muthamilarasan M, 2013, CURR SCI INDIA, V105, P155; Nishiuchi T, 2004, J BIOL CHEM, V279, P55355, DOI 10.1074/jbc.M409674200; OGATA K, 1995, NAT STRUCT BIOL, V2, P309, DOI 10.1038/nsb0495-309; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pattanaik S, 2010, PLANTA, V231, P1061, DOI 10.1007/s00425-010-1108-y; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; Perez-Rodriguez M, 2005, DEVELOPMENT, V132, P359, DOI 10.1242/dev.01584; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P11, DOI 10.1016/0968-0004(96)80878-4; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Puranik S, 2011, J PLANT PHYSIOL, V168, P280, DOI 10.1016/j.jplph.2010.07.005; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Roberts RG, 2001, GENOME BIOL, V2; Rosinski JA, 1998, J MOL EVOL, V46, P74, DOI 10.1007/PL00006285; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Suresh BV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071418; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Villain P, 1996, J BIOL CHEM, V271, P32593, DOI 10.1074/jbc.271.51.32593; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Yadav CB, 2015, PLANT MOL BIOL REP, V33, P43, DOI 10.1007/s11105-014-0736-y; Yanagisawa S, 1999, PLANT J, V17, P209, DOI 10.1046/j.1365-313X.1999.00363.x; Yang ZF, 2008, J MOL EVOL, V67, P266, DOI 10.1007/s00239-008-9143-z; Yi F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-212; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang ZL, 2004, PLANT PHYSIOL, V134, P1500, DOI 10.1104/pp.103.034967	89	59	64	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109920	10.1371/journal.pone.0109920	http://dx.doi.org/10.1371/journal.pone.0109920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279462	gold, Green Submitted, Green Published			2022-12-27	WOS:000342670800105
J	Godycki-Cwirko, M; Cals, JWL; Francis, N; Verheij, T; Butler, CC; Goossens, H; Zakowska, I; Panasiuk, L				Godycki-Cwirko, Maciek; Cals, Jochen W. L.; Francis, Nick; Verheij, Theo; Butler, Christopher C.; Goossens, Herman; Zakowska, Izabela; Panasiuk, Lech			Public Beliefs on Antibiotics and Symptoms of Respiratory Tract Infections among Rural and Urban Population in Poland: A Questionnaire Study	PLOS ONE			English	Article							PATIENTS EXPECTATIONS; DOCTORS PERCEPTIONS; PRIMARY-CARE; MANAGEMENT; PRESCRIPTION; KNOWLEDGE; ILLNESS	Introduction: General public views and expectations around the use of antibiotics can influence general practitioners' antibiotic prescribing decisions. We set out to describe the knowledge, attitudes and beliefs about the use of antibiotics for respiratory tract infections in adults in Poland, and explore differences according to where people live in an urban-rural continuum. Material and Methods: Face to face survey among a stratified random sample of adults from the general population. Results: 1,210 adults completed the questionnaire (87% response rate); 44.3% were rural; 57.9% were women. 49.4% of rural respondents and 44.4% of urban respondents had used an antibiotic in the last 2 years. Rural participants were less likely to agree with the statement "usually I know when I need an antibiotic,'' (53.5% vs. 61.3% respectively; p = 0.015) and reported that they would consult with a physician for a cough with yellow/green phlegm (69.2% vs. 74.9% respectively; p = 0.004), and were more likely to state that they would leave the decision about antibiotic prescribing to their doctor (87.5% vs. 85.6% respectively; p = 0.026). However, rural participants were more likely to believe that antibiotics accelerate recovery from sore throat (45.7% vs. 37.1% respectively; p = 0.017). Use of antibiotic in the last 2 years, level of education, number of children and awareness of the problem of developing antimicrobial resistance predicted accurate knowledge about antibiotic effectiveness. Conclusions: There were no major differences in beliefs about antibiotics between urban and rural responders, although rural responders were slightly less confident in their knowledge about antibiotics and self-reported greater use of antibiotics. Despite differences in the level of education between rural and urban responders, there were no significant differences in their knowledge about antibiotic effectiveness.	[Godycki-Cwirko, Maciek; Zakowska, Izabela] Med Univ Lodz, Ctr Family & Community Med, Lodz, Poland; [Cals, Jochen W. L.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, Maastricht, Netherlands; [Francis, Nick] Cardiff Univ, Cochrane Inst Primary Care & Publ Hlth, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Verheij, Theo] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Butler, Christopher C.] Cardiff Univ, Cochrane Inst Primary Care & Publ Hlth, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Butler, Christopher C.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Goossens, Herman] Univ Antwerp, Lab Med Microbiol, Vaccine & Infect Dis Inst VAXINFECTIO, B-2020 Antwerp, Belgium; [Panasiuk, Lech] Med Univ Lublin, Chair & Dept Family Med, Inst Rural Hlth, Dept Family Med, Lublin, Poland; [Panasiuk, Lech] Univ Econ & Innovat, Lublin, Poland	Medical University Lodz; Maastricht University; Cardiff University; Utrecht University; Utrecht University Medical Center; Cardiff University; University of Oxford; University of Antwerp; Institute of Rural Health in Lublin, Poland; Medical University of Lublin	Godycki-Cwirko, M (corresponding author), Med Univ Lodz, Ctr Family & Community Med, Lodz, Poland.	maciej.godycki-cwirko@umed.lodz.pl	Francis, Nick/B-7413-2009; Cals, Jochen WL/A-1262-2007	Francis, Nick/0000-0001-8939-7312; Cals, Jochen WL/0000-0001-9550-5674; Butler, Christopher/0000-0002-0102-3453; Godycki-Cwirko, Maciej/0000-0002-9204-5518; Panasiuk, Lech/0000-0001-6210-2887	Sixth Framework Programme of the European Commission [SP5A-CT-2007-044317]; Ministry of Science and Higher Education [577/6.PR UE/2008/7, 577-1/6.PR UE/08/2010/7]	Sixth Framework Programme of the European Commission(European Commission); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Sixth Framework Programme of the European Commission (contract no. SP5A-CT-2007-044317) and funding for science from the Ministry of Science and Higher Education for performing international project in 2008-2011 (decisions no. 577/6.PR UE/2008/7; 577-1/6.PR UE/08/2010/7) in the context of the international collaborative study "Changing Behaviour of Health Care Professionals and the General Public Towards a More Prudent Use of Anti-microbial Agents-CHAMP.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belongia EA, 2002, PREV MED, V34, P346, DOI 10.1006/pmed.2001.0992; Britten N, 1997, BRIT MED J, V315, P1506, DOI 10.1136/bmj.315.7121.1506; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; BUTLER CC, 2009, BRIT MED J, V338; Cals JWL, 2007, BRIT J GEN PRACT, V57, P942, DOI 10.3399/096016407782605027; Chlabicz S, 2004, INT J ANTIMICROB AG, V23, P446, DOI 10.1016/j.ijantimicag.2003.10.009; Cockburn J, 1997, BRIT MED J, V315, P520, DOI 10.1136/bmj.315.7107.520; Coenen S, 2006, BRIT J GEN PRACT, V56, P183; Cosby JL, 2007, LANCET INFECT DIS, V7, P749, DOI 10.1016/S1473-3099(07)70263-3; Currie J, 2011, J HEALTH ECON, V30, P933, DOI 10.1016/j.jhealeco.2011.05.009; Davey P, 2002, CLIN MICROBIOL INFEC, V8, P43, DOI 10.1046/j.1469-0691.8.s.2.6.x; Emslie Margaret J, 2003, Eur J Gen Pract, V9, P84; Godycki-Cwirko M, 2011, FAM PRACT, V28, P608, DOI 10.1093/fampra/cmr019; Hart AM, 2013, J AM ASSOC NURSE PRA, V25, P431, DOI 10.1111/j.1745-7599.2012.00802.x; KI S, 2008, INDIAN J MED RES, V128, P165; Little P, 2004, BMJ-BRIT MED J, V328, P444, DOI 10.1136/bmj.38013.644086.7C; Macfarlane J, 1997, BMJ-BRIT MED J, V315, P1211, DOI 10.1136/bmj.315.7117.1211; Panasiuk L, 2010, J CLIN PHARM THER, V35, P665, DOI 10.1111/j.1365-2710.2009.01136.x; Welschen I, 2004, FAM PRACT, V21, P234, DOI 10.1093/fampra/cmh303; Wilson AA, 1999, J GEN INTERN MED, V14, P658, DOI 10.1046/j.1525-1497.1999.08118.x; Wonca Working Party on Rural Practice, 2001, WHO ORG FAM DOCT POL	21	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109248	10.1371/journal.pone.0109248	http://dx.doi.org/10.1371/journal.pone.0109248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275516	Green Submitted, gold, Green Published			2022-12-27	WOS:000342591500084
J	Kosaka, T; Fukui, R; Matsui, M; Kurosaka, Y; Nishimura, H; Tanabe, M; Takakura, Y; Iwai, K; Waki, T; Fujita, T				Kosaka, Tatsuya; Fukui, Rino; Matsui, Mio; Kurosaka, Yuko; Nishimura, Haruka; Tanabe, Motoki; Takakura, Yuuki; Iwai, Keisuke; Waki, Takuya; Fujita, Takashi			RAGE, Receptor of Advanced Glycation Endoproducts, Negatively Regulates Chondrocytes Differentiation	PLOS ONE			English	Article							GLYCOSYLATION END-PRODUCTS; FACTOR-KAPPA-B; SIGNALING PATHWAYS; CAUDAL GENES; BONE LOSS; AGE RAGE; IN-VIVO; EXPRESSION; GROWTH; CDX1	RAGE, receptor for advanced glycation endoproducts (AGE), has been characterized as an activator of osteoclastgenesis. However, whether RAGE directly regulates chondrocyte proliferation and differentiation is unclear. Here, we show that RAGE has an inhibitory role in chondrocyte differentiation. RAGE expression was observed in chondrocytes from the prehypertrophic to hypertrophic regions. In cultured cells, overexpression of RAGE or dominant-negative-RAGE (DN-RAGE) demonstrated that RAGE inhibited cartilaginous matrix production, while DN-RAGE promoted production. Additionally, RAGE regulated Ihh and Col10a1 negatively but upregulated PTHrP receptor. Ihh promoter analysis and real-time PCR analysis suggested that downregulation of Cdxs was the key for RAGE-induced inhibition of chondrocyte differentiation. Overexpression of the NF-kappa B inhibitor I-kappa B-SR inhibited RAGE-induced NF-kappa B activation, but did not influence inhibition of cartilaginous matrix production by RAGE. The inhibitory action of RAGE was restored by the Rho family GTPases inhibitor Toxin B. Furthermore, inhibitory action on Ihh, Col10a1 and Cdxs was reproduced by constitutively active forms, L63RhoA, L61Rac, and L61Cdc42, but not by I-kappa B-SR. Cdx1 induced Ihh and Col10a1 expressions and directly interacted with Ihh promoter. Retinoic acid (RA) partially rescued the inhibitory action of RAGE. These data combined suggests that RAGE negatively regulates chondrocyte differentiation at the prehypertrophic stage by modulating NF-kappa B-independent and Rho family GTPases-dependent mechanisms.	[Kosaka, Tatsuya; Fukui, Rino; Matsui, Mio; Kurosaka, Yuko; Nishimura, Haruka; Tanabe, Motoki; Takakura, Yuuki; Iwai, Keisuke; Waki, Takuya; Fujita, Takashi] Ritsumeikan Univ, Dept Pharmaceut Sci, Mol Toxicol Lab, Kyoto, Shiga, Japan	Ritsumeikan University	Fujita, T (corresponding author), Ritsumeikan Univ, Dept Pharmaceut Sci, Mol Toxicol Lab, Kyoto, Shiga, Japan.	fujitat@fc.ritsumei.ac.jp			Ministry of Education, Science and Culture, Japan	Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Science and Culture, Japan (T.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beier F, 2010, J CELL BIOCHEM, V110, P573, DOI 10.1002/jcb.22604; Bidwell JP, 2008, J CELL BIOCHEM, V103, P1671, DOI 10.1002/jcb.21572; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; Charite J, 1998, DEVELOPMENT, V125, P4349; Clynes R, 2007, CURR MOL MED, V7, P743; DeGroot J, 2001, OSTEOARTHR CARTILAGE, V9, P720, DOI 10.1053/joca.2001.0469; Ding KH, 2006, BIOCHEM BIOPH RES CO, V340, P1091, DOI 10.1016/j.bbrc.2005.12.107; Epstein M, 1997, DEVELOPMENT, V124, P3805; Franke S, 2011, CLIN EXP RHEUMATOL, V29, P650; Fujita T, 2001, JPN J PHARMACOL, V85, P278, DOI 10.1254/jjp.85.278; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Gaunt SJ, 2008, DEVELOPMENT, V135, P2511, DOI 10.1242/dev.015909; Gilbert SF., 1997, DEV BIOL, P351; Guo RJ, 2010, CARCINOGENESIS, V31, P159, DOI 10.1093/carcin/bgp213; Hein GE, 2006, CLIN CHIM ACTA, V371, P32, DOI 10.1016/j.cca.2006.03.017; Houle M, 2000, MOL CELL BIOL, V20, P6579, DOI 10.1128/MCB.20.17.6579-6586.2000; Houle M, 2003, DEVELOPMENT, V130, P6555, DOI 10.1242/dev.00889; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lalla E, 2000, J CLIN INVEST, V105, P1117, DOI 10.1172/JCI8942; Li YM, 1996, P NATL ACAD SCI USA, V93, P11047, DOI 10.1073/pnas.93.20.11047; Lickert H, 2002, DEV DYNAM, V225, P216, DOI 10.1002/dvdy.10149; Lin L, 2006, CELL MOL IMMUNOL, V3, P351; Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199; Marom K, 1997, MECH DEVELOP, V64, P41, DOI 10.1016/S0925-4773(97)00043-9; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Ohgami N, 2001, J BIOL CHEM, V276, P13348, DOI 10.1074/jbc.M011613200; Owen WF, 1998, KIDNEY INT, V53, P1365, DOI 10.1046/j.1523-1755.1998.00882.x; Pilon N, 2007, DEVELOPMENT, V134, P2315, DOI 10.1242/dev.001206; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Rojas A, 2010, CARCINOGENESIS, V31, P334, DOI 10.1093/carcin/bgp322; Rokutanda S, 2009, DEV BIOL, V328, P78, DOI 10.1016/j.ydbio.2009.01.009; Sakaguchi T, 2003, J CLIN INVEST, V111, P959, DOI 10.1172/JCI200317115; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tanaka N, 2000, J BIOL CHEM, V275, P25781, DOI 10.1074/jbc.M001235200; Tang SY, 2010, BONE, V46, P148, DOI 10.1016/j.bone.2009.09.003; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Wang ZQ, 2012, ATHEROSCLEROSIS, V221, P387, DOI 10.1016/j.atherosclerosis.2012.01.019; Yamagishi S, 1997, J BIOL CHEM, V272, P8723, DOI 10.1074/jbc.272.13.8723; Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Young T, 2009, DEV CELL, V17, P516, DOI 10.1016/j.devcel.2009.08.010; Zhou Z, 2006, J EXP MED, V203, P1067, DOI 10.1084/jem.20051947	46	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108819	10.1371/journal.pone.0108819	http://dx.doi.org/10.1371/journal.pone.0108819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275461	Green Submitted, gold, Green Published			2022-12-27	WOS:000342591500034
J	Sapp, AM; Mogen, AB; Almand, EA; Rivera, FE; Shaw, LN; Richardson, AR; Rice, KC				Sapp, April M.; Mogen, Austin B.; Almand, Erin A.; Rivera, Frances E.; Shaw, Lindsey N.; Richardson, Anthony R.; Rice, Kelly C.			Contribution of the nos-pdt Operon to Virulence Phenotypes in Methicillin-Sensitive Staphylococcus aureus	PLOS ONE			English	Article							NITRIC-OXIDE-SYNTHASE; OXIDATIVE STRESS; FLUORESCENT INDICATORS; TRANSCRIPTOME ANALYSIS; HYDROGEN-PEROXIDE; BACILLUS-SUBTILIS; BIOFILM FORMATION; ESCHERICHIA-COLI; GENE; PYRUVATE	Nitric oxide (NO) is emerging as an important regulator of bacterial stress resistance, biofilm development, and virulence. One potential source of endogenous NO production in the pathogen Staphylococcus aureus is its NO-synthase (saNOS) enzyme, encoded by the nos gene. Although a role for saNOS in oxidative stress resistance, antibiotic resistance, and virulence has been recently-described, insights into the regulation of nos expression and saNOS enzyme activity remain elusive. To this end, transcriptional analysis of the nos gene in S. aureus strain UAMS-1 was performed, which revealed that nos expression increases during low-oxygen growth and is growth-phase dependent. Furthermore, nos is co-transcribed with a downstream gene, designated pdt, which encodes a prephenate dehydratase (PDT) enzyme involved in phenylalanine biosynthesis. Deletion of pdt significantly impaired the ability of UAMS-1 to grow in chemically-defined media lacking phenylalanine, confirming the function of this enzyme. Bioinformatics analysis revealed that the operon organization of nos-pdt appears to be unique to the staphylococci. As described for other S. aureus nos mutants, inactivation of nos in UAMS-1 conferred sensitivity to oxidative stress, while deletion of pdt did not affect this phenotype. The nos mutant also displayed reduced virulence in a murine sepsis infection model, and increased carotenoid pigmentation when cultured on agar plates, both previously-undescribed nos mutant phenotypes. Utilizing the fluorescent stain 4-Amino-5Methylamino-2',7'-Difluorofluorescein (DAF-FM) diacetate, decreased levels of intracellular NO/reactive nitrogen species (RNS) were detected in the nos mutant on agar plates. These results reinforce the important role of saNOS in S. aureus physiology and virulence, and have identified an in vitro growth condition under which saNOS activity appears to be upregulated. However, the significance of the operon organization of nos-pdt and potential relationship between these two enzymes remains to be elucidated.	[Sapp, April M.; Mogen, Austin B.; Rice, Kelly C.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Almand, Erin A.] N Carolina State Univ, Dept Microbiol, Raleigh, NC 27695 USA; [Rivera, Frances E.; Shaw, Lindsey N.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL USA; [Richardson, Anthony R.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	State University System of Florida; University of Florida; University of North Carolina; North Carolina State University; State University System of Florida; University of South Florida; University of North Carolina; University of North Carolina Chapel Hill	Rice, KC (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	kcrice@ufl.edu	Shaw, Lindsey/AAI-1741-2020	Shaw, Lindsey/0000-0002-0629-8990	Air Force Institute of Technology Civilian Institution Program Scholarship; National Institute of Allergy and Infectious Diseases [1P01AI083211, AI093613, AI080626]; University of Florida Emerging Pathogens Institute; UF Institute of Food and Agricultural Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080626, P01AI083211, R01AI093613] Funding Source: NIH RePORTER	Air Force Institute of Technology Civilian Institution Program Scholarship; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Florida Emerging Pathogens Institute; UF Institute of Food and Agricultural Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the following sources: Air Force Institute of Technology Civilian Institution Program Scholarship (http://m.airforce.com/benefits/air-force-institute-of-technology) to EAA, National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx) 1P01AI083211 sub-award to KCR, Resubmission funding from the University of Florida Emerging Pathogens Institute (http://epi.ufl.edu/news-and-events/episeed-funding-and-resubmission-support/) to KCR, UF Institute of Food and Agricultural Sciences Early Career Award to KCR, National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx) grant AI093613 to ARR, and National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx) grant AI080626 to LNS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; CDC U, 2013, ANTIBIOTIC RESISTANC; CHAMBERLAIN NR, 1991, INFECT IMMUN, V59, P4332, DOI 10.1128/IAI.59.12.4332-4337.1991; Chang MW, 2007, ENVIRON SCI TECHNOL, V41, P7570, DOI 10.1021/es070929k; Chang W, 2006, J BACTERIOL, V188, P1648, DOI 10.1128/JB.188.4.1648-1659.2006; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; CLEWELL DB, 1995, TRENDS MICROBIOL, V3, P229, DOI 10.1016/S0966-842X(00)88930-1; Crane BR, 2010, ANNU REV BIOCHEM, V79, P445, DOI 10.1146/annurev-biochem-062608-103436; Crawford NM, 2006, J EXP BOT, V57, P471, DOI 10.1093/jxb/erj050; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; GABR I, 1995, J CHEM SOC CHEM COMM, P915, DOI 10.1039/c39950000915; Gertz S, 1999, MOL GEN GENET, V261, P558, DOI 10.1007/s004380051001; Giachino P, 2001, J BACTERIOL, V183, P1843, DOI 10.1128/JB.183.6.1843-1852.2001; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Gusarov I, 2008, J BIOL CHEM, V283, P13140, DOI 10.1074/jbc.M710178200; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Holden JK, 2013, P NATL ACAD SCI USA, V110, P18127, DOI 10.1073/pnas.1314080110; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jett BD, 1997, BIOTECHNIQUES, V23, P648, DOI 10.2144/97234bm22; Kers JA, 2004, NATURE, V429, P79, DOI 10.1038/nature02504; Kojima H, 1998, CHEM PHARM BULL, V46, P373; Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Kolar SL, 2013, MICROBIOLOGYOPEN, V2, P18, DOI 10.1002/mbo3.55; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lan LF, 2010, J BACTERIOL, V192, P3068, DOI 10.1128/JB.00928-09; Lancaster JR, 1997, NITRIC OXIDE-BIOL CH, V1, P18, DOI 10.1006/niox.1996.0112; Lim MH, 2006, INORG CHEM, V45, P8980, DOI 10.1021/ic0609913; Lim MH, 2006, NAT CHEM BIOL, V2, P375, DOI 10.1038/nchembio794; LINCOLN RA, 1995, VET MICROBIOL, V45, P275, DOI 10.1016/0378-1135(95)00041-8; Lipton SA, 2001, NATURE, V413, P118, DOI 10.1038/35093186; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Liu PL, 2012, CAN J MICROBIOL, V58, P336, DOI [10.1139/w11-141, 10.1139/W11-141]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MALINSKI T, 1992, NATURE, V358, P676, DOI 10.1038/358676a0; Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P526, DOI 10.1128/AAC.00680-10; Morikawa K, 2001, BIOCHEM BIOPH RES CO, V288, P385, DOI 10.1006/bbrc.2001.5774; Nagarajan V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-351; NEUMAN RE, 1958, P SOC EXP BIOL MED, V98, P303, DOI 10.3181/00379727-98-24025; ODONNELLTORMEY J, 1987, J EXP MED, V165, P500, DOI 10.1084/jem.165.2.500; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; Patton TG, 2005, MOL MICROBIOL, V56, P1664, DOI 10.1111/j.1365-2958.2005.04653.x; Perera A, 1997, FREE RADICAL RES, V26, P145, DOI 10.3109/10715769709097793; Pietiainen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-429; Reiss S, 2012, ANTIMICROB AGENTS CH, V56, P787, DOI 10.1128/AAC.05363-11; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Schreiber F, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-111; SHAFER WM, 1979, INFECT IMMUN, V25, P902, DOI 10.1128/IAI.25.3.902-911.1979; Sharma-Kuinkel BK, 2009, J BACTERIOL, V191, P4767, DOI 10.1128/JB.00348-09; Shatalin K, 2008, P NATL ACAD SCI USA, V105, P1009, DOI 10.1073/pnas.0710950105; Sudhamsu J, 2009, TRENDS MICROBIOL, V17, P212, DOI 10.1016/j.tim.2009.02.003; SULLIVAN MA, 1984, GENE, V29, P21, DOI 10.1016/0378-1119(84)90161-6; Tan KM, 2008, J STRUCT BIOL, V162, P94, DOI 10.1016/j.jsb.2007.11.009; Toledo JC, 2012, CHEM RES TOXICOL, V25, P975, DOI 10.1021/tx300042g; Vaish Manisha, 2013, Int J Microbiol, V2013, P312146, DOI 10.1155/2013/312146; van Sorge NM, 2013, J BIOL CHEM, V288, P6417, DOI 10.1074/jbc.M112.448738; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wach MJ, 2005, NITRIC OXIDE-BIOL CH, V12, P46, DOI 10.1016/j.niox.2004.11.004; Walter MH, 2011, NAT PROD REP, V28, P663, DOI 10.1039/c0np00036a; Weiss A, 2014, INFECT IMMUN, V82, P1424, DOI 10.1128/IAI.01508-14; WIELAND B, 1994, J BACTERIOL, V176, P7719, DOI 10.1128/JB.176.24.7719-7726.1994; Wink DA, 1996, METHOD ENZYMOL, V268, P12; Yun HY, 1996, CRIT REV NEUROBIOL, V10, P291, DOI 10.1615/CritRevNeurobiol.v10.i3-4.20	70	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108868	10.1371/journal.pone.0108868	http://dx.doi.org/10.1371/journal.pone.0108868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275514	gold, Green Published, Green Submitted			2022-12-27	WOS:000342591500036
J	Tanaka, N; Yamaguchi, H; Mano, N				Tanaka, Nobuaki; Yamaguchi, Hiroaki; Mano, Nariyasu			Transport of Eicosapentaenoic Acid-Derived PGE(3), PGF(3 alpha), and TXB3 by ABCC4	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE PROTEIN-4; PROSTAGLANDIN E-2 TRANSPORT; POLYUNSATURATED FATTY-ACIDS; EFFLUX TRANSPORTER; PROSTANOIDS; MRP4/ABCC4; EICOSANOIDS; EXPRESSION; DRUG	Background: Eicosapentaenoic acid-derived prostaglandin (PG) E-3, PGF(3 alpha), and thromboxane (TX) B-3 are bioactive lipid mediators which have anti-cancer and anti-inflammatory effects. To exert their effects, PGE(3), PGF(3 alpha), and TXB3 must be released to the extracellular space from cells, but the release mechanism has been unclear. We therefore investigated the contribution of ATP-binding cassette transporter C4 (ABCC4), which has been known as a prostanoids efflux transporter, to the release of PGE(3), PGF(3 alpha), and TXB3. Materials and Methods: ATP-dependent transport of PGE(3), PGF(3 alpha), and TXB3 via ABCC4 was investigated by using inside-out membrane vesicles prepared from ABCC4-overexpressing HEK293 cells. To evaluate the contribution of ABCC4 to the release of PGE(3), PGF(3 alpha), and TXB3, we measured the extracellular and intracellular levels of PGE(3), PGF(3 alpha), and TXB3 in A549 cells when we used ABCC4 inhibitors (dipyridamole, MK571, and probenecid) or ABCC4 siRNAs. The quantification of PGE(3), PGF(3 alpha), and TXB3 was performed by using liquid chromatography-tandem mass spectrometry. Results: The apparent K-m values for ABCC4-mediated transport were 2.9 +/- 0.1 mM for PGE(3), 12.1 +/- 1.3 mM for PGF(3 alpha), and 11.9 +/- 1.4 mM for TXB3 and the ATP-dependent accumulation of PGE(3), PGF(3 alpha), and TXB3 into vesicles was decreased by using typical substrates and inhibitors of ABCC4. ABCC4 inhibitors and ABCC4 knockdown showed the reduction of extracellular/intracellular ratio of PGE(3) (40-60% of control) and PGF(3 alpha) (60-80% of control) in A549 cells. Conclusions: Our results suggest that PGE(3), PGF3 alpha, and TXB3 are substrates of ABCC4 and ABCC4 partially contributes to the release of PGE(3) and PGF(3 alpha).	[Tanaka, Nobuaki; Yamaguchi, Hiroaki; Mano, Nariyasu] Tohoku Univ Hosp, Dept Pharmaceut Sci, Sendai, Miyagi, Japan	Tohoku University	Yamaguchi, H (corresponding author), Tohoku Univ Hosp, Dept Pharmaceut Sci, Sendai, Miyagi, Japan.	yamaguchi@hosp.tohoku.ac.jp	Yamaguchi, Hiroaki/G-9969-2012; Mano, Nariyasu/AAS-9994-2020	Yamaguchi, Hiroaki/0000-0003-3021-6120; Mano, Nariyasu/0000-0003-1679-9024	Japan Society for the Promotion of Science (JSPS) KAKENHI [25460184]; Towa Foundation for Food Research; Grants-in-Aid for Scientific Research [25460184] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Towa Foundation for Food Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was in part supported by Japan Society for the Promotion of Science (JSPS) KAKENHI grant number 25460184 (HY) and the Towa Foundation for Food Research (HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2012, TRENDS PHARMACOL SCI, V33, P304, DOI 10.1016/j.tips.2012.02.004; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; Chan BS, 1998, J BIOL CHEM, V273, P6689, DOI 10.1074/jbc.273.12.6689; Chen ZS, 2001, J BIOL CHEM, V276, P33747, DOI 10.1074/jbc.M104833200; El-Sheikh AAK, 2008, MOL PHARMACOL, V74, P964, DOI 10.1124/mol.107.043661; Endter S, 2009, J PHARM PHARMACOL, V61, P583, DOI 10.1211/jpp/61.05.0006; Enomoto A, 2002, J PHARMACOL EXP THER, V301, P797, DOI 10.1124/jpet.301.3.797; Furugen A, 2013, PROSTAG OTH LIPID M, V106, P37, DOI 10.1016/j.prostaglandins.2013.08.002; Hajjaji N, 2013, CANCER TREAT REV, V39, P473, DOI 10.1016/j.ctrv.2012.07.001; Hall WL, 2008, J NUTR, V138, P287, DOI 10.1093/jn/138.2.287; Hawcroft G, 2010, NEOPLASIA, V12, P618, DOI 10.1593/neo.10388; Karlgren M, 2012, J MED CHEM, V55, P4740, DOI 10.1021/jm300212s; Kimura H, 2002, J PHARMACOL EXP THER, V301, P293, DOI 10.1124/jpet.301.1.293; Lin ZP, 2008, MOL PHARMACOL, V73, P243, DOI 10.1124/mol.107.039594; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Moreno JJ, 2009, J PHARMACOL EXP THER, V331, P1111, DOI 10.1124/jpet.109.157891; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Paruchuri S, 2008, J BIOL CHEM, V283, P16477, DOI 10.1074/jbc.M705822200; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Reid G, 2003, P NATL ACAD SCI USA, V100, P9244, DOI 10.1073/pnas.1033060100; Rius M, 2006, AM J PHYSIOL-GASTR L, V290, pG640, DOI 10.1152/ajpgi.00354.2005; Rius M, 2005, J UROLOGY, V174, P2409, DOI 10.1097/01.ju.0000180411.03808.cb; Rius M, 2008, J PHARMACOL EXP THER, V324, P86, DOI 10.1124/jpet.107.131342; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Salvado MD, 2012, TRENDS MOL MED, V18, P233, DOI 10.1016/j.molmed.2012.02.002; Seki S, 2009, BBA-BIOMEMBRANES, V1788, P911, DOI 10.1016/j.bbamem.2009.03.003; Smith WL, 2005, CURR OPIN CELL BIOL, V17, P174, DOI 10.1016/j.ceb.2005.02.005; Tamai I, 2000, BIOCHEM BIOPH RES CO, V273, P251, DOI 10.1006/bbrc.2000.2922; Tanaka N, 2014, PROSTAG LEUKOTR ESS, V91, P61, DOI 10.1016/j.plefa.2014.04.005; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; Vaughan VC, 2013, BRIT J CANCER, V108, P486, DOI 10.1038/bjc.2012.586; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang S, 2008, HYPERTENS RES, V31, P623, DOI 10.1291/hypres.31.623; Wittgen HGM, 2012, BIOCHEM PHARMACOL, V84, P366, DOI 10.1016/j.bcp.2012.04.012; Yang PY, 2014, MOL CARCINOGEN, V53, P566, DOI 10.1002/mc.22008; Yang PY, 2014, CANCER LETT, V348, P1, DOI 10.1016/j.canlet.2014.03.010; Yang PY, 2002, ANAL BIOCHEM, V308, P168, DOI 10.1016/S0003-2697(02)00218-X; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	41	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109270	10.1371/journal.pone.0109270	http://dx.doi.org/10.1371/journal.pone.0109270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275481	gold, Green Published, Green Submitted			2022-12-27	WOS:000342591500090
J	Gallego-Garcia, A; Mirassou, Y; Garcia-Moreno, D; Elias-Arnanz, M; Jimenez, MA; Padmanabhan, S				Gallego-Garcia, Aranzazu; Mirassou, Yasmina; Garcia-Moreno, Diana; Elias-Arnanz, Montserrat; Angeles Jimenez, Maria; Padmanabhan, S.			Structural Insights into RNA Polymerase Recognition and Essential Function of Myxococcus xanthus CdnL	PLOS ONE			English	Article							BINDING-PROTEIN; CARA REPRESSOR; TRANSCRIPTION; DNA; DOMAINS; REVEALS; COMPLEX; RBPA; EXPRESSION; REGULATOR	CdnL and CarD are two functionally distinct members of the CarD_CdnL_TRCF family of bacterial RNA polymerase (RNAP)-interacting proteins, which co-exist in Myxococcus xanthus. While CarD, found exclusively in myxobacteria, has been implicated in the activity of various extracytoplasmic function (ECF) sigma-factors, the function and mode of action of the essential CdnL, whose homologs are widespread among bacteria, remain to be elucidated in M. xanthus. Here, we report the NMR solution structure of CdnL and present a structure-based mutational analysis of its function. An N-terminal five-stranded beta-sheet Tudor-like module in the two-domain CdnL mediates binding to RNAP-beta, and mutations that disrupt this interaction impair cell growth. The compact CdnL C-terminal domain consists of five alpha-helices folded as in some tetratricopeptide repeat-like protein-protein interaction domains, and contains a patch of solvent-exposed nonpolar and basic residues, among which a set of basic residues is shown to be crucial for CdnL function. We show that CdnL, but not its loss-of-function mutants, stabilizes formation of transcriptionally competent, open complexes by the primary sigma(A)-RNAP holoenzyme at an rRNA promoter in vitro. Consistent with this, CdnL is present at rRNA promoters in vivo. Implication of CdnL in RNAP-sigma(A) activity and of CarD in ECF-sigma function in M. xanthus exemplifies how two related members within a widespread bacterial protein family have evolved to enable distinct sigma-dependent promoter activity.	[Gallego-Garcia, Aranzazu; Garcia-Moreno, Diana; Elias-Arnanz, Montserrat] Univ Murcia, Fac Biol, Unidad Asociada IQFR CSIC, Dept Genet & Microbiol,Area Genet, Murcia, Spain; [Mirassou, Yasmina; Angeles Jimenez, Maria; Padmanabhan, S.] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Elias-Arnanz, M (corresponding author), Univ Murcia, Fac Biol, Unidad Asociada IQFR CSIC, Dept Genet & Microbiol,Area Genet, Murcia, Spain.	melias@um.es; majimenez@iqfr.csic.es; padhu@iqfr.csic.es	Padmanabhan, S./E-8943-2017; Garcia-Moreno, Diana/ABG-2131-2020; Jimenez, M. Angeles/C-7193-2008; Elías-Arnanz, Montserrat/H-4707-2015	Jimenez, M. Angeles/0000-0001-6835-5850; Elías-Arnanz, Montserrat/0000-0003-1980-3092; Gallego Garcia, Aranzazu/0000-0001-6149-0742; Garcia, Diana/0000-0002-1521-2327; Padmanabhan, S./0000-0002-8772-0152	Spanish Ministerio de Ciencia e Innovacion and Ministerio de Economia y Competitividad [BFU2009-12445-C02-02, BFU2012-40184-C02-02, BFU2009-12445-C02-01, BFU2012-40184-C02-01, CTQ2011-22514]; European Union; Ministerio de Ciencia e Innovacion (Spain); Consejo Superior de Investigaciones Cientificas (Spain)	Spanish Ministerio de Ciencia e Innovacion and Ministerio de Economia y Competitividad; European Union(European Commission); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Superior de Investigaciones Cientificas (Spain)	Supported by the Spanish Ministerio de Ciencia e Innovacion and Ministerio de Economia y Competitividad grants BFU2009-12445-C02-02 and BFU2012-40184-C02-02 to SP, BFU2009-12445-C02-01 and BFU2012-40184-C02-01 (both co-financed by the European Union) to MEA, CTQ2011-22514 to MAJ; Ph.D. fellowships from the Ministerio de Ciencia e Innovacion (Spain) to AGG and DGM, and the Consejo Superior de Investigaciones Cientificas (Spain) to YM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellon-Ruiz J, 2014, ENVIRON MICROBIOL, V16, P2475, DOI 10.1111/1462-2920.12386; Arkov AL, 2010, TRENDS CELL BIOL, V20, P482, DOI 10.1016/j.tcb.2010.05.004; BALSALOBRE JM, 1987, P NATL ACAD SCI USA, V84, P2359, DOI 10.1073/pnas.84.8.2359; Banta AB, 2013, P NATL ACAD SCI USA, V110, P15955, DOI 10.1073/pnas.1311642110; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bortoluzzi A, 2013, J BIOL CHEM, V288, P14438, DOI 10.1074/jbc.M113.459883; Cayuela ML, 2003, J BACTERIOL, V185, P3527, DOI 10.1128/JB.185.12.3527-3537.2003; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Deaconescu AM, 2007, CURR OPIN STRUC BIOL, V17, P96, DOI 10.1016/j.sbi.2007.01.005; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Eichinger A, 2011, PROTEIN SCI, V20, P656, DOI 10.1002/pro.594; Elias-Arnanz M, 2010, FEMS MICROBIOL REV, V34, P764, DOI 10.1111/j.1574-6976.2010.00235.x; Elias-Arnanz M, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P211; Gallego-Garcia A, 2012, J BIOMOL NMR, V53, P355, DOI 10.1007/s10858-012-9648-z; Garcia-Heras F, 2013, J BACTERIOL, V195, P378, DOI 10.1128/JB.01766-12; Garcia-Heras F, 2009, P NATL ACAD SCI USA, V106, P13546, DOI 10.1073/pnas.0902233106; Garcia-Mayoral MF, 2005, EUR BIOPHYS J BIOPHY, V34, P1057, DOI 10.1007/s00249-005-0473-0; Garcia-Moreno D, 2010, NUCLEIC ACIDS RES, V38, P4586, DOI 10.1093/nar/gkq214; Garcia-Moreno D, 2009, J BACTERIOL, V191, P3108, DOI 10.1128/JB.01737-08; Gulten G, 2013, STRUCTURE, V21, P1859, DOI 10.1016/j.str.2013.08.014; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu YB, 2012, NUCLEIC ACIDS RES, V40, P6547, DOI 10.1093/nar/gks346; Karimova G, 2000, METHOD ENZYMOL, V328, P59, DOI 10.1016/S0076-6879(00)28390-0; Kaur G, 2014, PROTEINS, V82, P879, DOI 10.1002/prot.24419; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee DJ, 2012, ANNU REV MICROBIOL, V66, P125, DOI 10.1146/annurev-micro-092611-150012; Lemke JJ, 2011, P NATL ACAD SCI USA, V108, P5712, DOI 10.1073/pnas.1019383108; Lopez-Rubio JJ, 2004, J BIOL CHEM, V279, P28945, DOI 10.1074/jbc.M403459200; Mirassou Y, 2013, BIOMOL NMR ASSIGN, V7, P51, DOI 10.1007/s12104-012-9375-0; Mirassou Y, 2009, BIOMOL NMR ASSIGN, V3, P9, DOI 10.1007/s12104-008-9128-2; Nicolas FJ, 1996, P NATL ACAD SCI USA, V93, P6881, DOI 10.1073/pnas.93.14.6881; Padmanabhan S, 2001, J BIOL CHEM, V276, P41566, DOI 10.1074/jbc.M106352200; Penalver-Mellado M, 2006, MOL MICROBIOL, V61, P910, DOI 10.1111/j.1365-2958.2006.05289.x; Perez-Marin MC, 2004, J BIOL CHEM, V279, P33093, DOI 10.1074/jbc.M405225200; Ponting CP, 1997, TRENDS BIOCHEM SCI, V22, P51, DOI 10.1016/S0968-0004(96)30049-2; Rohl CA, 1997, BIOCHEMISTRY-US, V36, P8435, DOI 10.1021/bi9706677; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; Sinars CR, 2003, P NATL ACAD SCI USA, V100, P868, DOI 10.1073/pnas.0231020100; Smith AJ, 2005, NUCLEIC ACIDS RES, V33, P755, DOI 10.1093/nar/gki225; Srivastava DB, 2013, P NATL ACAD SCI USA, V110, P12619, DOI 10.1073/pnas.1308270110; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; Tabib-Salazar A, 2013, NUCLEIC ACIDS RES, V41, P5679, DOI 10.1093/nar/gkt277; Weiss LA, 2012, J BACTERIOL, V194, P5621, DOI 10.1128/JB.00879-12; Westblade LF, 2010, NUCLEIC ACIDS RES, V38, P8357, DOI 10.1093/nar/gkq692; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006	50	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108946	10.1371/journal.pone.0108946	http://dx.doi.org/10.1371/journal.pone.0108946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272012	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600081
J	Casonato, S; Provvedi, R; Dainese, E; Palu, G; Manganelli, R				Casonato, Stefano; Provvedi, Roberta; Dainese, Elisa; Palu, Giorgio; Manganelli, Riccardo			Mycobacterium tuberculosis Requires the ECF Sigma Factor SigE to Arrest Phagosome Maturation	PLOS ONE			English	Article							ANTIGEN 85B; VACCINE; MUTANT; MACROPHAGES	SigE represents one of the best characterized alternative sigma factors of Mycobacterium tuberculosis, playing a major role in the response to several environmental stresses and essential for growth in macrophages and virulence. In previous work we demonstrated that a mutant of M. tuberculosis in which the sigE gene was disrupted by a cassette conferring hygromycin resistance is a promising vaccine candidate conferring better protection than Mycobacterium bovis BCG in a mouse model of infection. In this work we describe the construction of a new unmarked mutant in which the entire sigE gene was disrupted in order to fulfill the requirements of the Geneva consensus to enter clinical trials. After showing that the phenotype of this mutant is superimposable to that of the previous one, we further characterized the role of SigE in the M tuberculosis intracellular behavior showing that it is dispensable for replication in human pneumocytes, while it is essential for the arrest of phagosome maturation in THP-1-derived macrophages.	[Casonato, Stefano; Provvedi, Roberta; Dainese, Elisa; Palu, Giorgio; Manganelli, Riccardo] Univ Padua, Dept Mol Med, Padua, Italy	University of Padua	Manganelli, R (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.	riccardo.manganelli@unipd.it	Manganelli, Riccardo/A-7361-2009	Manganelli, Riccardo/0000-0003-0940-7336; PROVVEDI, ROBERTA/0000-0003-1164-9676	European Community Seventh Framework Programme (FP7) [241745]	European Community Seventh Framework Programme (FP7)	This work was supported by the European Community Seventh Framework Programme (FP7/2007-2013) under grant agreements 241745. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando M, 2003, INFECT IMMUN, V71, P7170, DOI 10.1128/IAI.71.12.7170-7172.2003; Arbues A, 2013, VACCINE, V31, P4867, DOI 10.1016/j.vaccine.2013.07.051; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Delogu G, 2014, CLIN MICROBIOL INFEC, V20, P59, DOI 10.1111/1469-0691.12460; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Ferrer NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012978; Fontan PA, 2008, J INFECT DIS, V198, P877, DOI 10.1086/591098; Giacomini E, 2006, INFECT IMMUN, V74, P3296, DOI 10.1128/IAI.01687-05; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jung JY, 2013, INFECT IMMUN, V81, P3198, DOI 10.1128/IAI.00611-13; Manganelli R, 2004, INFECT IMMUN, V72, P3038, DOI 10.1128/IAI.72.5.3038-3041.2004; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; Manganelli R, 2010, MOL MICROBIOL, V75, P538, DOI 10.1111/j.1365-2958.2009.07009.x; Morandi M, 2013, J INFECT DEV COUNTR, V7, P169, DOI 10.3855/jidc.3114; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Orme IM, 2013, DRUGS, V73, P1015, DOI 10.1007/s40265-013-0081-8; Pando RH, 2010, INFECT IMMUN, V78, P3168, DOI 10.1128/IAI.00023-10; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pethe K, 2004, P NATL ACAD SCI US; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Ramachandra L, 2005, INFECT IMMUN, V73, P1097, DOI 10.1128/IAI.73.2.1097-1105.2005; Singh CR, 2006, J IMMUNOL, V177, P3250, DOI 10.4049/jimmunol.177.5.3250; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Walker K B, 2010, Vaccine, V28, P2259, DOI 10.1016/j.vaccine.2009.12.083; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	26	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108893	10.1371/journal.pone.0108893	http://dx.doi.org/10.1371/journal.pone.0108893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268826	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700184
J	Jaiswal, N; Singh, M; Das, RR; Jindal, I; Agarwal, A; Thumburu, KK; Kumar, A; Chauhan, A				Jaiswal, Nishant; Singh, Meenu; Das, Rashmi Ranjan; Jindal, Ishita; Agarwal, Amit; Thumburu, Kiran Kumar; Kumar, Ajay; Chauhan, Anil			Distribution of Serotypes, Vaccine Coverage, and Antimicrobial Susceptibility Pattern of Streptococcus Pneumoniae in Children Living in SAARC Countries: A Systematic Review	PLOS ONE			English	Review							INVASIVE PNEUMOCOCCAL DISEASE; CONJUGATE VACCINES; COST-EFFECTIVENESS; ANTIBIOTIC-RESISTANCE; CHILDHOOD INFECTIONS; SURVEILLANCE; BANGLADESH; 13-VALENT; TRENDS; BURDEN	Introduction: Each SAARC nation falls in the zone of high incidence of pneumococcal disease but there is a paucity of literature estimating the burden of pneumococcal disease in this region. Objective: To identify the prevalent serotypes causing invasive pneumococcal disease in children of SAARC countries, to determine the coverage of these serotypes by the available vaccines, and to determine the antibiotic resistance pattern of Streptococcus pneumoniae. Methods: We searched major electronic databases using a comprehensive search strategy, and additionally searched the bibliography of the included studies and retrieved articles till July 2014. Both community and hospital based observational studies which included children aged <= 12 years as/or part of the studied population in SAARC countries were included. Results: A total of 17 studies were included in the final analysis. The period of surveillance varied from 12-96 months (median, 24 months). The most common serotypes country-wise were as follows: serotype 1 in Nepal; serotype 14 in Bangladesh and India; serotype 19F in Sri Lanka and Pakistan. PCV-10 was found to be suitable for countries like India, Nepal, Bangladesh, and Sri Lanka, whereas PCV-13 may be more suitable for Pakistan. An increasing trend of non-susceptibility to antibiotics was noted for co-trimoxazole, erythromycin and chloramphenicol, whereas an increasing trend of susceptibility was noted for penicillin. Conclusion: Due to paucity of recent data in majority of the SAARC countries, urgent large size prospective studies are needed to formulate recommendations for specific pneumococcal vaccine introduction and usage of antimicrobial agents in these regions.	[Jaiswal, Nishant; Jindal, Ishita; Agarwal, Amit; Thumburu, Kiran Kumar] Postgrad Inst Med Educ & Res, Dept Pediat, ICMR Adv Ctr Evidence Based Child Hlth, Chandigarh 160012, India; [Singh, Meenu; Chauhan, Anil] Postgrad Inst Med Educ & Res, Dept Pediat, Chandigarh 160012, India; [Das, Rashmi Ranjan] All India Inst Med Sci, Dept Pediat, Bhubaneswar, Orissa, India; [Kumar, Ajay] Wayne State Univ, Dept Ophthalmol, Detroit, MI USA	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; All India Institute of Medical Sciences (AIIMS) Bhubaneswar; Wayne State University	Singh, M (corresponding author), Postgrad Inst Med Educ & Res, Dept Pediat, Chandigarh 160012, India.	meenusingh4@gmail.com	Das, Rashmi Ranjan/AAB-3313-2021; Agarwal, Amit/HIK-0172-2022; Jaiswal, Nishant/GPW-5502-2022	Das, Rashmi Ranjan/0000-0001-9587-0508; Agarwal, Amit/0000-0001-7136-8206; Jaiswal, Nishant/0000-0001-5511-4572; Chauhan, Anil/0000-0002-8853-7317	ICMR, New Delhi [5/7/592/11-RHN]	ICMR, New Delhi(Indian Council of Medical Research (ICMR))	The review was supported and funded by ICMR, New Delhi (grant number 5/7/592/11-RHN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gomez JA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1025; Ampofo K, 2008, PEDIATRICS, V122, P229, DOI 10.1542/peds.2007-3192; Arifeen SE, 2009, CLIN INFECT DIS, V48, pS103, DOI 10.1086/596543; Ayieko P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067324; Batuwanthudawe R, 2009, CLIN INFECT DIS, V48, pS136, DOI 10.1086/596492; Brooks WA, 2007, AM J TROP MED HYG, V77, P795, DOI 10.4269/ajtmh.2007.77.795; Castaneda-Orjuela C, 2012, VACCINE, V30, P1936, DOI 10.1016/j.vaccine.2012.01.031; Child Health Epidemiology Reference Group (CHERG), UND CAUS CHILD DEATH; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; Earnshaw SR, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-101; GAVI Alliance, PAK TACKL TOP CHILD; Giebink GS, 2001, NEW ENGL J MED, V345, P1177, DOI 10.1056/NEJMra010462; Hausdorff WP, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-4; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Kelly DF, 2011, INT J INFECT DIS, V15, pE17, DOI 10.1016/j.ijid.2010.05.021; Kim SH, 2012, ANTIMICROB AGENTS CH, V56, P1418, DOI 10.1128/AAC.05658-11; Kim SY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-260; Klok RM, 2013, CLIN THER, V35, P119, DOI 10.1016/j.clinthera.2012.12.006; Kumar KLR, 2013, J CLIN DIAGN RES, V7, P2716, DOI [10.7860/JCDR/2013/6384.3741, 10.7860/JCDR/2013/5339.3062]; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Manoharan A, 2013, 31 M EUR SOC PAED IN; MASTRO TD, 1991, LANCET, V337, P156, DOI 10.1016/0140-6736(91)90813-5; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Rijal B, 2010, Kathmandu Univ Med J (KUMJ), V8, P164; Saha SK, 2009, CLIN INFECT DIS, V48, pS75, DOI 10.1086/596544; Saha SK, 1999, J CLIN MICROBIOL, V37, P798, DOI 10.1128/JCM.37.3.798-800.1999; Saha SK, 2003, J CLIN MICROBIOL, V41, P5582, DOI 10.1128/JCM.41.12.5582-5587.2003; Saha SK, 1997, J CLIN MICROBIOL, V35, P785, DOI 10.1128/JCM.35.3.785-787.1997; Shah AS, 2009, CLIN INFECT DIS, V48, pS123, DOI 10.1086/596490; Shakoor S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098796; Thomas K, 1999, LANCET, V353, P1216, DOI 10.1016/S0140-6736(98)07228-6; Thomas K, PROSPECTIVE MULTICEN; Uruena A, 2011, VACCINE, V29, P4963, DOI 10.1016/j.vaccine.2011.04.111; Williams EJ, 2009, CLIN INFECT DIS, V48, pS114, DOI 10.1086/596488; World Health Organization, 2006, WORLD HLTH STAT 2006	35	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108617	10.1371/journal.pone.0108617	http://dx.doi.org/10.1371/journal.pone.0108617			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268974	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000343671700126
J	Kim, JW; Ha, SH				Kim, Jun Woo; Ha, Sung Ho			Price Comparisons on the Internet Based on Computational Intelligence	PLOS ONE			English	Article							SOFTWARE AGENTS; E-COMMERCE; DISPERSION; SHOPBOT; PRODUCT; SEARCH; SYSTEM; IMPACT; WEB; DESIGN	Information-intensive Web services such as price comparison sites have recently been gaining popularity. However, most users including novice shoppers have difficulty in browsing such sites because of the massive amount of information gathered and the uncertainty surrounding Web environments. Even conventional price comparison sites face various problems, which suggests the necessity of a new approach to address these problems. Therefore, for this study, an intelligent product search system was developed that enables price comparisons for online shoppers in a more effective manner. In particular, the developed system adopts linguistic price ratings based on fuzzy logic to accommodate user-defined price ranges, and personalizes product recommendations based on linguistic product clusters, which help online shoppers find desired items in a convenient manner.	[Kim, Jun Woo] Dong A Univ, Dept Ind & Management Syst Engn, Pusan, South Korea; [Ha, Sung Ho] Kyungpook Natl Univ, Sch Business Adm, Taegu, South Korea	Dong A University; Kyungpook National University	Ha, SH (corresponding author), Kyungpook Natl Univ, Sch Business Adm, Taegu, South Korea.	hsh@mail.knu.ac.kr	Kim, Junwoo/AAF-7561-2020		Dong-A University	Dong-A University	This research was supported by Dong-A University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baye MR, 2004, J INTERACT MARK, V18, P101, DOI 10.1002/dir.20016; Baye MR, 2004, J IND ECON, V52, P463, DOI 10.1111/j.0022-1821.2004.00236.x; Castellano G., 2008, Web Intelligence and Agent Systems, V6, P253, DOI 10.3233/WIA-2008-0140; Diehl K, 2005, J MARKETING RES, V42, P313, DOI 10.1509/jmkr.2005.42.3.313; Diehl K, 2005, J CONSUM RES, V31, P824, DOI 10.1086/426618; Garcia R, 2008, J WEB SEMANT, V6, P151, DOI 10.1016/j.websem.2008.01.002; Garfinkel R, 2006, DECIS SUPPORT SYST, V42, P1974, DOI 10.1016/j.dss.2006.05.005; Garfinkel R, 2008, DECIS SUPPORT SYST, V46, P61, DOI 10.1016/j.dss.2008.05.006; Gentry L, 2002, PSYCHOL MARKET, V19, P945, DOI 10.1002/mar.10045; Hajaj C, 2014, P ASS ADV ART INT QU; Haynes M, 2008, INT J IND ORGAN, V26, P459, DOI 10.1016/j.ijindorg.2007.02.003; Hong SY, 2011, J COMPUT INFORM SYST, V52, P96; Lim GG, 2011, ELECTRON COMMER R A, V10, P637, DOI 10.1016/j.elerap.2011.07.002; Lu J, 2013, COMPUT INTELL-US, V29, P37, DOI 10.1111/j.1467-8640.2012.00427.x; Ma ZM, 2010, INFORM SYST MANAGE, V27, P3, DOI 10.1080/10580530903455072; Montgomery AL, 2004, MARKET SCI, V23, P579, DOI 10.1287/mksc.1040.0073; Park YA, 2010, J ELECTRON COMMER RE, V11, P342; Passyn KA, 2013, J BUSINESS EC RES, V11, P401; Pathak B, 2010, J ELECTRON COMMER RE, V11, P178; Pedersen PE, 2000, INT J ELECTRON COMM, V5, P125; Prasad RVVSV, 2009, P INT C INT AG MULT; Rowley J, 2000, J CONSUM MARK, V17, P20, DOI 10.1108/07363760010309528; Smith MD, 2002, J ACAD MARKET SCI, V30, P446, DOI 10.1177/009207002236916; Sproule S, 2000, INTERNET RES, V10, P396, DOI 10.1108/10662240010349408; Tan P., 2006, INTRO DATA MINING; Tang ZL, 2010, INT J IND ORGAN, V28, P579, DOI 10.1016/j.ijindorg.2010.03.014; Vachon F, 2011, INT J BUSINESS MANAG, V6, P1016; Walther J., 2011, NETWORKED SELF IDENT; Wan Y, 2010, COMPUTER, V43, P20, DOI 10.1109/MC.2010.93; Wei Y, 2009, P IEEE INT C COMP SC; Xiao B, 2007, MIS QUART, V31, P137; Xu YJ, 2008, J RETAILING, V84, P477, DOI 10.1016/j.jretai.2008.09.007; Yuan ST, 2003, DECIS SUPPORT SYST, V34, P139, DOI 10.1016/S0167-9236(02)00077-5; Zadeh L.A., 1975, SYNTHESE, V30, P407, DOI DOI 10.1007/BF00485052; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zhang Y-Q, 2002, P IEEE INT C FUZZ SY	36	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e106946	10.1371/journal.pone.0106946	http://dx.doi.org/10.1371/journal.pone.0106946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268901	gold, Green Submitted, Green Published			2022-12-27	WOS:000343671700025
J	Sha, S; Devineni, D; Ghosh, A; Polidori, D; Hompesch, M				Sha, S.; Devineni, D.; Ghosh, A.; Polidori, D.; Hompesch, M.			Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes (vol 9, e105638, 2014)	PLOS ONE			English	Correction													Hompesch, Marcus/AAC-9858-2019	Hompesch, Marcus/0000-0001-5867-2131				Sha S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105638	1	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e110069	10.1371/journal.pone.0110069	http://dx.doi.org/10.1371/journal.pone.0110069			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268802	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700234
J	Xing, YH; Gu, Y; Bresnahan, JJ; Paul, EM; Donahue, HJ; You, J				Xing, Yanghui; Gu, Yan; Bresnahan, James J.; Paul, Emmanuel M.; Donahue, Henry J.; You, Jun			The Roles of P2Y(2) Purinergic Receptors in Osteoblasts and Mechanotransduction	PLOS ONE			English	Article							OSCILLATORY FLUID-FLOW; INTRACELLULAR CALCIUM MOBILIZATION; ACTIVATED PROTEIN-KINASE; IN-VITRO; EXTRACELLULAR NUCLEOTIDES; SIGNALING PATHWAY; CELLS; ATP; DIFFERENTIATION; PROLIFERATION	We previously demonstrated, using osteoblastic MC3T3-E1 cells, that P2Y(2) purinergic receptors are involved in osteoblast mechanotransduction. In this study, our objective was to further investigate, using a knockout mouse model, the roles of P2Y(2) receptors in bone mechanobiology. We first examined bone structure with micro-CT and measured bone mechanical properties with three point bending experiments in both wild type mice and P2Y(2) knockout mice. We found that bones from P2Y(2) knockout mice have significantly decreased bone volume, bone thickness, bone stiffness and bone ultimate breaking force at 17 week old age. In order to elucidate the mechanisms by which P2Y(2) receptors contribute to bone biology, we examined differentiation and mineralization of bone marrow cells from wild type and P2Y(2) knockout mice. We found that P2Y(2) receptor deficiency reduces the differentiation and mineralization of bone marrow cells. Next, we compared the response of primary osteoblasts, from both wild type and P2Y(2) knockout mice, to ATP and mechanical stimulation (oscillatory fluid flow), and found that osteoblasts from wild type mice have a stronger response, in terms of ERK1/2 phosphorylation, to both ATP and fluid flow, relative to P2Y(2) knockout mice. However, we did not detect any difference in ATP release in response to fluid flow between wild type and P2Y(2) knock out osteoblasts. Our findings suggest that P2Y(2) receptors play important roles in bone marrow cell differentiation and mineralization as well as in bone cell mechanotransduction, leading to an osteopenic phenotype in P2Y(2) knockout mice.	[Xing, Yanghui; Gu, Yan; Bresnahan, James J.; Paul, Emmanuel M.; Donahue, Henry J.; You, Jun] Penn State Univ, Coll Med, Dept Orthopaed & Rehabil, Div Musculoskeletal Sci, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	You, J (corresponding author), Penn State Univ, Coll Med, Dept Orthopaed & Rehabil, Div Musculoskeletal Sci, Hershey, PA 17033 USA.	jxy118@psu.edu			National Institutes of Health [AR054851]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054851] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant AR054851 (to J.Y.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagchi S, 2005, J BIOL CHEM, V280, P39050, DOI 10.1074/jbc.M504819200; Berenbaum F, 2003, J BIOL CHEM, V278, P13680, DOI 10.1074/jbc.M211570200; Bonewald LF, 2007, ANN NY ACAD SCI, V1116, P281, DOI 10.1196/annals.1402.018; Bowler WB, 1999, J BIOL CHEM, V274, P14315, DOI 10.1074/jbc.274.20.14315; Chen XW, 2010, J NEUROSCI, V30, P2365, DOI 10.1523/JNEUROSCI.5462-09.2010; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Genetos DC, 2007, J CELL PHYSL; Glaser T, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-12; Grol MW, 2013, J CELL SCI, V126, P3615, DOI 10.1242/jcs.122705; Jaasma MJ, 2008, TISSUE ENG PT A, V14, P1213, DOI [10.1089/ten.tea.2007.0321, 10.1089/tea.2007.0321]; Jekir MG, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005201; Jorgensen NR, 1997, J CELL BIOL, V139, P497, DOI 10.1083/jcb.139.2.497; Jorgensen NR, 2000, J BONE MINER RES, V15, P1024, DOI 10.1359/jbmr.2000.15.6.1024; Klein-Nulend J, 2005, PATHOL BIOL, V53, P576, DOI 10.1016/j.patbio.2004.12.005; Li JL, 2005, J BIOL CHEM, V280, P42952, DOI 10.1074/jbc.M506415200; Li YJ, 2004, J ORTHOP RES, V22, P1283, DOI 10.1016/j.orthres.2004.04.002; Liu CL, 2004, AM J PHYSIOL-HEART C, V286, pH1688, DOI 10.1152/ajpheart.00576.2003; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Okumura H, 2008, BIOCHEM BIOPH RES CO, V372, P486, DOI 10.1016/j.bbrc.2008.05.066; Orriss Isabel, 2011, Front Biosci (Schol Ed), V3, P1038; Orriss IR, 2007, ENDOCRINOLOGY, V148, P4208, DOI 10.1210/en.2007-0066; Orriss IR, 2006, BONE, V39, P300, DOI 10.1016/j.bone.2006.02.063; Ponik SM, 2007, J CELL BIOCHEM, V100, P794, DOI 10.1002/jcb.21089; Riddle RC, 2007, J BONE MINER RES, V22, P589, DOI 10.1359/JBMR.070113; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Scott A, 2008, SPORTS MED, V38, P139, DOI 10.2165/00007256-200838020-00004; Takasaki J, 2001, MOL PHARMACOL, V60, P432; Wadhwa S, 2002, J BONE MINER RES, V17, P266, DOI 10.1359/jbmr.2002.17.2.266; Xing YH, 2011, J ORTHOP RES, V29, P828, DOI 10.1002/jor.21319; Xing YH, 2011, J CELL PHYSIOL, V226, P2350, DOI 10.1002/jcp.22579; Yamamoto K, 2003, AM J PHYSIOL-HEART C, V285, pH793, DOI 10.1152/ajpheart.01155.2002; Yamazaki S, 2003, J CELL BIOCHEM, V90, P812, DOI 10.1002/jcb.10681; You J, 2002, J BIOL CHEM, V277, P48724, DOI 10.1074/jbc.M209245200; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Yu N, 2008, CIRC RES, V102, P581, DOI 10.1161/CIRCRESAHA.107.162271	35	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108417	10.1371/journal.pone.0108417	http://dx.doi.org/10.1371/journal.pone.0108417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268784	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700094
J	Zhang, DX; Spiering, MJ; Nuss, DL				Zhang, Dong-Xiu; Spiering, Martin J.; Nuss, Donald L.			Characterizing the Roles of Cryphonectria parasitica RNA-Dependent RNA Polymerase-Like Genes in Antiviral Defense, Viral Recombination and Transposon Transcript Accumulation	PLOS ONE			English	Article							CHESTNUT BLIGHT FUNGUS; VIRUS TRANSMISSION; DNA METHYLATION; NEUROSPORA; INTERFERENCE; MACHINERY; HOST; TAD; RETROTRANSPOSON; AMPLIFICATION	An inducible RNA-silencing pathway, involving a single Dicer protein, DCL2, and a single Argonaute protein, AGL2, was recently shown to serve as an effective antiviral defense response in the chestnut blight fungus Cryphonectria parasitica. Eukaryotic RNA-dependent RNA polymerases (RdRPs) are frequently involved in transcriptional and posttranscriptional gene silencing and antiviral defense. We report here the identification and characterization of four RdRP genes (rdr1-4) in the C. parasitica genome. Sequence relationships with other eukaryotic RdRPs indicated that RDR1 and RDR2 were closely related to QDE-1, an RdRP involved in RNA silencing ("quelling") in Neurospora crassa, whereas RDR3 was more closely related to the meiotic silencing gene SAD-1 in N. crassa. The RdRP domain of RDR4, related to N. crassa RRP-3 of unknown function, was truncated and showed evidence of alternative splicing. Similar to reports for dcl2 and agl2, the expression levels for rdr3 and rdr4 increased after hypovirus CHV-1/EP713 infection, while expression levels of rdr1 and rdr2 were unchanged. The virus-responsive induction patterns for rdr3 and rdr4 were altered in the Delta dcl2 and Delta agl2 strains, suggesting some level of interaction between rdr3 and rdr4 and the dcl2/agl2 silencing pathway. Single rdr gene knockouts Delta rdr1-4, double knockouts Delta rdr1/2, Delta rdr2/3, Delta rdr1/3, and a triple knockout, Delta rdr1/2/3, were generated and evaluated for effects on fungal phenotype, the antiviral defense response, viral RNA recombination activity and transposon expression. None of the single or multiple rdr knockout strains displayed any phenotypic differences from the parental strains with or without viral infection or any significant changes in viral RNA accumulation or recombination activity or transposon RNA accumulation, indicating no detectable contribution by the C. parasitica rdr genes to these processes.	[Nuss, Donald L.] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; Univ Maryland, Dept Cell Biol & Mol Genet, Rockville, MD USA		Nuss, DL (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA.	dnuss@umd.edu		Spiering, Martin/0000-0002-9160-5296	Public Health Service [GM555981, AI076219]; University of Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076219] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the University of Maryland and by Public Health Service grants GM555981 and AI076219 (to DLN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biella S, 2002, P ROY SOC B-BIOL SCI, V269, P2269, DOI 10.1098/rspb.2002.2148; Calo S, 2012, MOL MICROBIOL, V83, P379, DOI 10.1111/j.1365-2958.2011.07939.x; Carreras-Villasenor N, 2013, MOL MICROBIOL, V89, P96, DOI 10.1111/mmi.12261; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; CHEN BS, 1994, SCIENCE, V264, P1762, DOI 10.1126/science.8209256; Chicas A, 2004, NUCLEIC ACIDS RES, V32, P4237, DOI 10.1093/nar/gkh764; Choi GH, 2012, GENETICS, V190, P113, DOI 10.1534/genetics.111.133983; Choudhary S, 2007, MOL CELL BIOL, V27, P3995, DOI 10.1128/MCB.00186-07; CHURCHILL ACL, 1990, CURR GENET, V17, P25, DOI 10.1007/BF00313245; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Cortesi P, 2001, GENETICS, V159, P107; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dang YK, 2011, EUKARYOT CELL, V10, P1148, DOI 10.1128/EC.05109-11; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Florea S, 2009, FUNGAL GENET BIOL, V46, P721, DOI 10.1016/j.fgb.2009.06.010; Garcia-Ruiz H, 2010, PLANT CELL; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Hammond TM, 2008, EUKARYOT CELL, V7, P350, DOI 10.1128/EC.00356-07; Hammond TM, 2005, GENETICS, V169, P607, DOI 10.1534/genetics.104.035964; HILLMAN BI, 1990, PHYTOPATHOLOGY, V80, P950, DOI 10.1094/Phyto-80-950; Janbon G, 2010, FUNGAL GENET BIOL, V47, P1070, DOI 10.1016/j.fgb.2010.10.005; Kempken F, 1998, CURR GENET, V34, P200, DOI 10.1007/s002940050386; KINSEY JA, 1990, GENETICS, V126, P317; KINSEY JA, 1994, GENETICS, V138, P657; Kuhn Ralf, 2002, Methods Mol Biol, V180, P175; Lan XW, 2008, CURR GENET, V53, P59, DOI 10.1007/s00294-007-0162-x; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Lu R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000286; Murata T, 2007, NUCLEIC ACIDS RES, V35, P5987, DOI 10.1093/nar/gkm646; Nakayashiki H, 2006, J MOL EVOL, V63, P127, DOI 10.1007/s00239-005-0257-2; Nicolas FE, 2010, NUCLEIC ACIDS RES, V38, P5535, DOI 10.1093/nar/gkq301; Nolan T, 2005, NUCLEIC ACIDS RES, V33, P1564, DOI 10.1093/nar/gki300; Nunes CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-288; Nuss DL, 2011, ADV VIRUS RES, V80, P25, DOI 10.1016/B978-0-12-385987-7.00002-6; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Segers GC, 2006, EUKARYOT CELL, V5, P896, DOI 10.1128/EC.00373-05; Segers GC, 2007, P NATL ACAD SCI USA, V104, P12902, DOI 10.1073/pnas.0702500104; Shiu PKT, 2002, GENETICS, V161, P1483; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Spiering MJ, 2008, FUNGAL GENET BIOL, V45, P1307, DOI 10.1016/j.fgb.2008.07.001; Sun QH, 2009, P NATL ACAD SCI USA, V106, P17927, DOI 10.1073/pnas.0907552106; Suzuki N, 2000, J VIROL, V74, P7568, DOI 10.1128/JVI.74.16.7568-7577.2000; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Wang XY, 2010, GENE DEV, V24, P2566, DOI 10.1101/gad.1970910; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zhang DX, 2014, GENETICS, V197, P701, DOI 10.1534/genetics.114.164574; Zhang DX, 2013, FUNGAL GENET BIOL, V61, P1, DOI 10.1016/j.fgb.2013.08.013; Zhang DX, 2009, FUNGAL GENET BIOL, V46, P517, DOI 10.1016/j.fgb.2009.03.010; Zhang XM, 2008, P NATL ACAD SCI USA, V105, P16749, DOI 10.1073/pnas.0807225105; Zhang XM, 2008, J VIROL, V82, P2613, DOI 10.1128/JVI.02324-07; Zhou Y, 2001, MOL GENET GENOMICS, V265, P748, DOI 10.1007/s004380100472	56	26	27	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108653	10.1371/journal.pone.0108653	http://dx.doi.org/10.1371/journal.pone.0108653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268858	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700135
J	Anderson, RE; Sogin, ML; Baross, JA				Anderson, Rika E.; Sogin, Mitchell L.; Baross, John A.			Evolutionary Strategies of Viruses, Bacteria and Archaea in Hydrothermal Vent Ecosystems Revealed through Metagenomics	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; PHOTOSYNTHESIS GENES; MARINE VIRUS; DEEP; DIVERSITY; PHAGE; CLASSIFICATION; MICROORGANISMS; PROKARYOTES; INTEGRATION	The deep-sea hydrothermal vent habitat hosts a diverse community of archaea and bacteria that withstand extreme fluctuations in environmental conditions. Abundant viruses in these systems, a high proportion of which are lysogenic, must also withstand these environmental extremes. Here, we explore the evolutionary strategies of both microorganisms and viruses in hydrothermal systems through comparative analysis of a cellular and viral metagenome, collected by size fractionation of high temperature fluids from a diffuse flow hydrothermal vent. We detected a high enrichment of mobile elements and proviruses in the cellular fraction relative to microorganisms in other environments. We observed a relatively high abundance of genes related to energy metabolism as well as cofactors and vitamins in the viral fraction compared to the cellular fraction, which suggest encoding of auxiliary metabolic genes on viral genomes. Moreover, the observation of stronger purifying selection in the viral versus cellular gene pool suggests viral strategies that promote prolonged host integration. Our results demonstrate that there is great potential for hydrothermal vent viruses to integrate into hosts, facilitate horizontal gene transfer, and express or transfer genes that manipulate the hosts' functional capabilities.	[Anderson, Rika E.; Baross, John A.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Anderson, Rika E.; Baross, John A.] Univ Washington, Astrobiol Program, Seattle, WA 98195 USA; [Sogin, Mitchell L.] Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA 02543 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Marine Biological Laboratory - Woods Hole	Anderson, RE (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	rikander@u.washington.edu	Sogin, Mitchell/AAE-7186-2019	Anderson, Rika/0000-0001-5946-7922	Gordon and Betty Moore Foundation; NASA Astrobiology Institute grant [NNA04CC09A]; NSF Graduate Research Fellowship through NSF grant [DGE-0718124]; NSF IGERT grant; ARCS Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NASA Astrobiology Institute grant; NSF Graduate Research Fellowship through NSF grant; NSF IGERT grant; ARCS Foundation	Funding for sequencing of the viral metagenome was provided by the Gordon and Betty Moore Foundation. All other funding was provided by a NASA Astrobiology Institute grant through Cooperative Agreement NNA04CC09A to the Geophysical Laboratory at the Carnegie Institution for Science. R. A. was funded by a NSF Graduate Research Fellowship through NSF grant number DGE-0718124, an NSF IGERT grant to the University of Washington Astrobiology Program, and the ARCS Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RE, 2013, REV MINERAL GEOCHEM, V75, P649, DOI 10.2138/rmg.2013.75.20; Anderson RE, 2013, FEMS MICROBIOL ECOL, V83, P324, DOI 10.1111/j.1574-6941.2012.01478.x; Anderson RE, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00219; Anderson RE, 2011, FEMS MICROBIOL ECOL, V77, P120, DOI 10.1111/j.1574-6941.2011.01090.x; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Bragg JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003550; Brazelton WJ, 2009, ISME J, V3, P1420, DOI 10.1038/ismej.2009.79; Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805; Breitbart M, 2007, OCEANOGRAPHY, V20, P135, DOI 10.5670/oceanog.2007.58; Campbell BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000362; Clokie MRJ, 2006, ENVIRON MICROBIOL, V8, P2074, DOI 10.1111/j.1462-2920.2006.01171.x; Clokie MRJ, 2006, ENVIRON MICROBIOL, V8, P827, DOI 10.1111/j.1462-2920.2005.00969.x; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Cuadros-Orellana S, 2007, ISME J, V1, P235, DOI 10.1038/ismej.2007.35; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; DRUMMOND AJ, 2009, GENEIOUS V4 7; Elsaied H, 2007, ENVIRON MICROBIOL, V9, P2298, DOI 10.1111/j.1462-2920.2007.01344.x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Hellweger FL, 2009, ENVIRON MICROBIOL, V11, P1386, DOI 10.1111/j.1462-2920.2009.01866.x; Holden JF, 1998, FEMS MICROBIOL ECOL, V25, P33, DOI 10.1111/j.1574-6941.1998.tb00458.x; Huber JA, 2003, FEMS MICROBIOL ECOL, V43, P393, DOI 10.1111/j.1574-6941.2003.tb01080.x; Huber JA, 2002, APPL ENVIRON MICROB, V68, P1585, DOI 10.1128/AEM.68.4.1585-1594.2002; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hurwitz BL, 2013, ENVIRON MICROBIOL, V15, P1428, DOI 10.1111/j.1462-2920.2012.02836.x; Jiang SC, 1998, APPL ENVIRON MICROB, V64, P2780; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Kristensen DM, 2010, TRENDS MICROBIOL, V18, P11, DOI 10.1016/j.tim.2009.11.003; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Leplae R, 2010, NUCLEIC ACIDS RES, V38, pD57, DOI 10.1093/nar/gkp938; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Lindell D, 2007, NATURE, V449, P83, DOI 10.1038/nature06130; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; McDaniel LD, 2010, SCIENCE, V330, P50, DOI 10.1126/science.1192243; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Ortmann AC, 2005, DEEP-SEA RES PT I, V52, P1515, DOI 10.1016/j.dsr.2005.04.002; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; REITER WD, 1989, NUCLEIC ACIDS RES, V17, P1907, DOI 10.1093/nar/17.5.1907; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Schrenk MO, 2003, APPL ENVIRON MICROB, V69, P3580, DOI 10.1128/AEM.69.6.3580-3592.2003; Sharon I, 2009, NATURE, V461, P258, DOI 10.1038/nature08284; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Summit M, 2001, P NATL ACAD SCI USA, V98, P2158, DOI 10.1073/pnas.051516098; Tai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024249; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thompson LR, 2011, P NATL ACAD SCI USA, V108, pE757, DOI 10.1073/pnas.1102164108; Voordeckers JW, 2005, INT J SYST EVOL MICR, V55, P773, DOI 10.1099/ijs.0.63430-0; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Weinbauer MG, 2003, LIMNOL OCEANOGR, V48, P1457, DOI 10.4319/lo.2003.48.4.1457; Wilke A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-141; Williamson SJ, 2008, ISME J, V2, P1112, DOI 10.1038/ismej.2008.73; Williamson SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042047	64	33	35	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109696	10.1371/journal.pone.0109696	http://dx.doi.org/10.1371/journal.pone.0109696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279954	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800095
J	Wright, AM; Hillis, DM				Wright, April M.; Hillis, David M.			Bayesian Analysis Using a Simple Likelihood Model Outperforms Parsimony for Estimation of Phylogeny from Discrete Morphological Data	PLOS ONE			English	Article							DIVERGENCE TIMES; TERMINAL TAXA; FOSSILS; EVOLUTION; ARCHAEOPTERYX; RADIATION; INFERENCE; MRBAYES; BIRDS	Despite the introduction of likelihood-based methods for estimating phylogenetic trees from phenotypic data, parsimony remains the most widely-used optimality criterion for building trees from discrete morphological data. However, it has been known for decades that there are regions of solution space in which parsimony is a poor estimator of tree topology. Numerous software implementations of likelihood-based models for the estimation of phylogeny from discrete morphological data exist, especially for the Mk model of discrete character evolution. Here we explore the efficacy of Bayesian estimation of phylogeny, using the Mk model, under conditions that are commonly encountered in paleontological studies. Using simulated data, we describe the relative performances of parsimony and the Mk model under a range of realistic conditions that include common scenarios of missing data and rate heterogeneity.	[Wright, April M.; Hillis, David M.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Wright, AM (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	wright.aprilm@gmail.com	Hillis, David/L-5421-2019		National Science Foundation [201203267-001]	National Science Foundation(National Science Foundation (NSF))	AMW received financial support for material purchases related to this project from the National Science Foundation's Doctoral Dissertation Improvement Grant (number 201203267-001; http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5234). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman ES, 2010, J THEOR BIOL, V263, P108, DOI 10.1016/j.jtbi.2009.12.001; Asher RJ, 2006, SYST BIOL, V55, P181, DOI 10.1080/10635150500433649; Bapst DW, 2014, PALEOBIOLOGY, V40, P331, DOI 10.1666/13033; Bapst DW, 2013, METHODS ECOL EVOL, V4, P724, DOI 10.1111/2041-210X.12081; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Clarke JA, 2008, SYST BIOL, V57, P185, DOI 10.1080/10635150802022231; de Beer G., 1954, CRAFTSMANS HDB; FELSENSTEIN J, 1992, EVOLUTION, V46, P159, DOI [10.2307/2409811, 10.1111/j.1558-5646.1992.tb01991.x]; Fenwick AM, 2009, ZOOL J LINN SOC-LOND, V156, P617, DOI 10.1111/j.1096-3642.2008.00495.x; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Goloboff Pablo A., 2005, P148; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HUELSENBECK JP, 1991, SYST ZOOL, V40, P458, DOI 10.2307/2992240; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Lee MSY, 2012, BIOL LETTERS, V8, P299, DOI 10.1098/rsbl.2011.0884; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pol D, 2006, SYST BIOL, V55, P512, DOI 10.1080/10635150600755446; Pyron RA, 2011, SYST BIOL, V60, P466, DOI 10.1093/sysbio/syr047; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2011, MRBAYES VER IN PRESS; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Rothwell GW, 2006, INT J PLANT SCI, V167, P737, DOI 10.1086/503298; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Santini F, 2004, INTEGR COMP BIOL, V44, P349, DOI 10.1093/icb/44.5.349; Slater GJ, 2012, EVOLUTION, V66, P3931, DOI 10.1111/j.1558-5646.2012.01723.x; SMITH AB, 1994, SYSTEMATICS FOSSIL R; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Swofford DL, 2002, PAUP PHYLOGENETIC AN, DOI [10.1234/12345678, DOI 10.1234/12345678]; Wagner PJ, 2012, BIOL LETTERS, V8, P143, DOI 10.1098/rsbl.2011.0523; Wiens JJ, 2005, SYST BIOL, V54, P731, DOI 10.1080/10635150500234583; Wiens JJ, 2010, SYST BIOL, V59, P674, DOI 10.1093/sysbio/syq048; Wood HM, 2013, SYST BIOL, V62, P264, DOI 10.1093/sysbio/sys092; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288	42	158	159	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109210	10.1371/journal.pone.0109210	http://dx.doi.org/10.1371/journal.pone.0109210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279853	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800063
J	Johnstone, J; Parsons, R; Botelho, F; Millar, J; McNeil, S; Fulop, T; McElhaney, J; Andrew, MK; Walter, SD; Devereaux, PJ; Malekesmaeili, M; Brinkman, RR; Mahony, J; Bramson, J; Loeb, M				Johnstone, Jennie; Parsons, Robin; Botelho, Fernando; Millar, Jamie; McNeil, Shelly; Fulop, Tamas; McElhaney, Janet; Andrew, Melissa K.; Walter, Stephen D.; Devereaux, P. J.; Malekesmaeili, Mehrnoush; Brinkman, Ryan R.; Mahony, James; Bramson, Jonathan; Loeb, Mark			Immune Biomarkers Predictive of Respiratory Viral Infection in Elderly Nursing Home Residents	PLOS ONE			English	Article							REGULATORY T-CELLS; CYTOMEGALOVIRUS-INFECTION; INFLUENZA VACCINATION; OLDER PERSONS; IMMUNOSENESCENCE; ASSOCIATION; FRAILTY; MORTALITY; RISK; AGE	Objective: To determine if immune phenotypes associated with immunosenescence predict risk of respiratory viral infection in elderly nursing home residents. Methods: Residents >= 65 years from 32 nursing homes in 4 Canadian cities were enrolled in Fall 2009, 2010 and 2011, and followed for one influenza season. Following influenza vaccination, peripheral blood mononuclear cells (PBMCs) were obtained and analysed by flow cytometry for T-regs, CD4+ and CD8+ T-cell subsets (CCR7+ CD45RA+, CCR7-CD45RA+ and CD28-CD57+) and CMV-reactive CD4+ and CD8+ T-cells. Nasopharyngeal swabs were obtained and tested for viruses in symptomatic residents. A Cox proportional hazards model adjusted for age, sex and frailty, determined the relationship between immune phenotypes and time to viral infection. Results: 1072 residents were enrolled; median age 86 years and 72% female. 269 swabs were obtained, 87 were positive for virus: influenza (24%), RSV (14%), coronavirus (32%), rhinovirus (17%), human metapneumovirus (9%) and parainfluenza (5%). In multivariable analysis, high T-reg% (HR 0.41, 95% CI 0.20-0.81) and high CMV-reactive CD4+ T-cell% (HR 1.69, 95% CI 1.03-2.78) were predictive of respiratory viral infection. Conclusions: In elderly nursing home residents, high CMV-reactive CD4+ T-cells were associated with an increased risk and high T-regs were associated with a reduced risk of respiratory viral infection.	[Johnstone, Jennie; Walter, Stephen D.; Devereaux, P. J.; Loeb, Mark] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Parsons, Robin; Botelho, Fernando; Millar, Jamie; Bramson, Jonathan] McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada; [McNeil, Shelly] Dalhousie Univ, Canadian Ctr Vaccinol, IWK Hlth Ctr & Capital Hlth, Halifax, NS, Canada; [Fulop, Tamas] Univ Sherbrooke, Div Geriatr, Dept Med, Res Ctr Aging, Sherbrooke, PQ J1K 2R1, Canada; [McElhaney, Janet] Northern Ontario Sch Med, Dept Med, Sudbury, ON, Canada; [Andrew, Melissa K.] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Devereaux, P. J.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Malekesmaeili, Mehrnoush; Brinkman, Ryan R.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Brinkman, Ryan R.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Mahony, James; Bramson, Jonathan; Loeb, Mark] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Mahony, James; Bramson, Jonathan; Loeb, Mark] McMaster Univ, Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University; McMaster University; Dalhousie University; University of Sherbrooke; Northern Ontario School of Medicine; Dalhousie University; McMaster University; British Columbia Cancer Agency; University of British Columbia; McMaster University; McMaster University	Johnstone, J (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	johnsj48@mcmaster.ca; loebm@mcmaster.ca	Devereaux, PJ/AAF-2862-2019; Walter, Stephen/AAB-5548-2022; Devereaux, PJ/AAY-1757-2021; Andrew, Melissa/AAR-7052-2021; Brinkman, Ryan/B-1108-2008	Walter, Stephen/0000-0003-4157-8928; Brinkman, Ryan/0000-0002-9765-2990; Devereaux, PJ/0000-0003-2935-637X; Andrew, Melissa/0000-0001-7514-8972; Bramson, Jonathan/0000-0003-2874-6886; McNeil, Shelly/0000-0001-5444-4166	Canadian Institutes of Health Research (CIHR); Public Health Agency of Canada (PHAC)/CIHR Influenza Research Network (PCIRN); National Institues of Health [R01 EB008400/EB/NIBIB]; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008400] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada (PHAC)/CIHR Influenza Research Network (PCIRN); National Institues of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by Canadian Institutes of Health Research (CIHR), Public Health Agency of Canada (PHAC)/CIHR Influenza Research Network (PCIRN), National Institues of Health (R01 EB008400/EB/NIBIB), Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennette C, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-21; Berry SD, 2010, J AM GERIATR SOC, V58, P783, DOI 10.1111/j.1532-5415.2010.02767.x; Betts RJ, 2012, J VIROL, V86, P2817, DOI 10.1128/JVI.05685-11; Boivin G, 2007, CLIN INFECT DIS, V44, P1152, DOI 10.1086/513204; Boucher N, 1998, EXP GERONTOL, V33, P267, DOI 10.1016/S0531-5565(97)00132-0; Collerton J, 2012, MECH AGEING DEV, V133, P456, DOI 10.1016/j.mad.2012.05.005; den Elzen WPJ, 2011, VACCINE, V29, P4869, DOI 10.1016/j.vaccine.2011.03.086; Derhovanessian E, 2013, VACCINE, V31, P685, DOI 10.1016/j.vaccine.2012.11.041; Disis ML, 2006, J IMMUNOL METHODS, V308, P13, DOI 10.1016/j.jim.2005.09.011; Drinka PJ, 1999, INFECT CONT HOSP EP, V20, P812, DOI 10.1086/501589; EFFROS RB, 1994, EXP GERONTOL, V29, P601, DOI 10.1016/0531-5565(94)90073-6; Fahey JL, 2000, MECH AGEING DEV, V115, P1, DOI 10.1016/S0047-6374(00)00094-4; Falsey AR, 2008, J AM GERIATR SOC, V56, P1281, DOI 10.1111/j.1532-5415.2008.01775.x; Falsey AR, 1997, J AM GERIATR SOC, V45, P706, DOI 10.1111/j.1532-5415.1997.tb01474.x; Fulop T, 2005, DRUG AGING, V22, P589, DOI 10.2165/00002512-200522070-00005; Fulop T, 2010, BIOGERONTOLOGY, V11, P547, DOI 10.1007/s10522-010-9287-2; Fulop T, 2009, CLIN INFECT DIS, V48, P443, DOI 10.1086/596475; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; Goronzy JJ, 2001, J VIROL, V75, P12182, DOI 10.1128/JVI.75.24.12182-12187.2001; Hicks LA, 2006, J AM GERIATR SOC, V54, P284, DOI 10.1111/j.1532-5415.2005.00529.x; Izaks GJ, 2003, J AM GERIATR SOC, V51, P1461, DOI 10.1046/j.1532-5415.2003.51467.x; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Johnstone J, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-50; Keynan Y, 2008, CLIN INFECT DIS, V46, P1046, DOI 10.1086/529379; Koch S, 2007, ANN NY ACAD SCI, V1114, P23, DOI 10.1196/annals.1396.043; Krause PR, 2013, VACCINE, V32, P4, DOI 10.1016/j.vaccine.2013.09.042; Lages CS, 2008, J IMMUNOL, V181, P1835, DOI 10.4049/jimmunol.181.3.1835; Langley J, 2010, CCDR, V36, pACS; Langley J, 2009, CCDR, V35, pACS; Langley J, 2011, CCDR, V37, pACS; Lelic A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003076; Leng SX, 2009, EXP GERONTOL, V44, P511, DOI 10.1016/j.exger.2009.05.005; Loeb M, 2000, CAN MED ASSOC J, V162, P1133; Looney RJ, 1999, CLIN IMMUNOL, V90, P213, DOI 10.1006/clim.1998.4638; Louie JK, 2005, CLIN INFECT DIS, V41, P262, DOI 10.1086/430915; Marshall A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-112; Mathei C, 2011, J AM GERIATR SOC, V59, P2201, DOI 10.1111/j.1532-5415.2011.03719.x; McElhaney JE, 2012, VACCINE, V30, P2060, DOI 10.1016/j.vaccine.2012.01.015; Mitchell R, 2013, AM J INFECT CONTROL, V41, P1032, DOI 10.1016/j.ajic.2013.06.008; Pawelec G, 2009, REV MED VIROL, V19, P47, DOI 10.1002/rmv.598; R Core Team, 2021, R LANGUAGE ENV STAT; Rockwood K, 2007, J AM MED DIR ASSOC, V8, P595, DOI 10.1016/j.jamda.2007.07.012; Rowe JH, 2012, IMMUNOLOGY, V136, P1, DOI 10.1111/j.1365-2567.2011.03551.x; Saule P, 2006, MECH AGEING DEV, V127, P274, DOI 10.1016/j.mad.2005.11.001; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Sehrawat S, 2011, J LEUKOCYTE BIOL, V90, P1079, DOI 10.1189/jlb.0611271; Smith PW, 2008, AM J INFECT CONTROL, V36, P504, DOI 10.1016/j.ajic.2008.06.001; Trzonkowski P, 2003, VACCINE, V21, P3826, DOI 10.1016/S0264-410X(03)00309-8; Verschoor CP, 2013, J LEUKOCYTE BIOL, V93, P633, DOI 10.1189/jlb.0912461; Wang GC, 2010, AM J EPIDEMIOL, V171, P1144, DOI 10.1093/aje/kwq062; Wang L, 2010, BIOMED ENVIRON SCI, V23, P327, DOI 10.1016/S0895-3988(10)60072-4; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Wikby A, 2002, EXP GERONTOL, V37, P445, DOI 10.1016/S0531-5565(01)00212-1; Williams-Bey Y, 2011, MECH AGEING DEV, V132, P163, DOI 10.1016/j.mad.2011.03.001	55	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108481	10.1371/journal.pone.0108481	http://dx.doi.org/10.1371/journal.pone.0108481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275464	gold, Green Published, Green Submitted			2022-12-27	WOS:000342591500018
J	Ouaissi, M; Silvy, F; Loncle, C; da Silva, DF; Abreu, CM; Martinez, E; Berthezene, P; Cadra, S; Le Treut, YP; Hardwigsen, J; Sastre, B; Sielezneff, I; Benkoel, L; Delgrande, J; Ouaissi, A; Iovanna, J; Lombardo, D; Mas, E				Ouaissi, Mehdi; Silvy, Francoise; Loncle, Celine; da Silva, Diva Ferraz; Abreu, Carla Martins; Martinez, Emmanuelle; Berthezene, Patrick; Cadra, Sophie; Le Treut, Yves Patrice; Hardwigsen, Jean; Sastre, Bernard; Sielezneff, Igor; Benkoel, Liliane; Delgrande, Jean; Ouaissi, Ali; Iovanna, Juan; Lombardo, Dominique; Mas, Eric			Further Characterization of HDAC and SIRT Gene Expression Patterns in Pancreatic Cancer and Their Relation to Disease Outcome	PLOS ONE			English	Article							HISTONE DEACETYLASE; CARCINOMA; RESECTION; PANCREATICODUODENECTOMY; ADENOCARCINOMAS; CLASSIFICATION; TRANSCRIPTION; SURVIVAL; CELLS; NUR77	Ductal adenocarcinoma of the pancreas is ranking 4 for patient' death from malignant disease in Western countries, with no satisfactory treatment. We re-examined more precisely the histone deacetylases (HDAC) and Sirtuin (SIRT) gene expression patterns in pancreatic cancer with more pancreatic tumors and normal tissues. We also examinedthe possible relationship between HDAC gene expression levels and long term disease outcome. Moreover, we have evaluated by using an in vitro model system of human pancreatic tumor cell line whether HDAC7 knockdown may affect the cell behavior. We analyzed 29 pancreatic adenocarcinoma (PA), 9 chronic pancreatitis (CP), 8 benign pancreatic (BP) and 11 normal pancreatic tissues. Concerning pancreatic adenocarcinoma, we were able to collect biopsies at the tumor periphery. To assess the possible involvement of HDAC7 in cell proliferation capacity, we have generated recombinant human Panc-1 tumor which underexpressed or overexpressed HDAC7. The expression of HDAC1,2,3,4,7 and Nur77 increased in PA samples at levels significantly higher than those observed in the CP group (p = 0.0160; 0.0114; 0.0227; 0.0440; 0.0136; 0.0004, respectively). The expression of HDAC7, was significantly greater in the PA compared with BP tissue samples (p = 0.05). Mean mRNA transcription levels of PA for HDAC7 and HDAC2 were higher when compared to their counterpart biopsies taken at the tumor periphery (p = 0.0346, 0.0053, respectively). Moreover, the data obtained using confocal microscopy and a quantitative method of immunofluorescence staining strongly support the HDAC7 overexpression in PA surgical specimens. The number of deaths and recurrences at the end of follow up were significantly greater in patients with overexpression of HDAC7. Interestingly, the rate of growth was significantly reduced in the case of cell carrying shRNA construct targeting HDAC7 encoding gene when compared to the parental Panc-1 tumor cells (p = 0.0015) at 48 h and 96 h (p = 0.0021). This study strongly support the notion that HDAC7play a role in pancreatic adenocarcinoma progression.	[Ouaissi, Mehdi; Silvy, Francoise; da Silva, Diva Ferraz; Abreu, Carla Martins; Martinez, Emmanuelle; Sastre, Bernard; Lombardo, Dominique; Mas, Eric] Aix Marseille Univ, UMR S 911, CRO2, Marseille, France; [Ouaissi, Mehdi; Silvy, Francoise; da Silva, Diva Ferraz; Abreu, Carla Martins; Martinez, Emmanuelle; Sastre, Bernard; Benkoel, Liliane; Lombardo, Dominique; Mas, Eric] INSERM, UMR 911, F-13258 Marseille, France; [Ouaissi, Mehdi; Sastre, Bernard; Sielezneff, Igor] Timone Hosp, Dept Digest & Visceral Surg, AP HM, Marseille, France; [da Silva, Diva Ferraz; Abreu, Carla Martins; Ouaissi, Ali] Univ Porto, Fac Farm, P-4100 Oporto, Portugal; [Loncle, Celine; Berthezene, Patrick; Cadra, Sophie; Iovanna, Juan] Aix Marseille Univ, Inst J Paoli I Calmettes, CRCM, UMR S 1068,CNRS,UMR7258, Marseille, France; [Loncle, Celine; Berthezene, Patrick; Cadra, Sophie; Iovanna, Juan] INSERM, UMR 1068, F-13258 Marseille, France; [Le Treut, Yves Patrice; Hardwigsen, Jean] Conception Hosp, Dept Hepat Transplantat & Gen Surg, AP HM, Marseille, France; [Le Treut, Yves Patrice; Hardwigsen, Jean; Sielezneff, Igor] Aix Marseille Univ, Marseille, France; [Delgrande, Jean] Timone Hosp, Dept Histopathol, AP HM, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universidade do Porto; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Ouaissi, M (corresponding author), Aix Marseille Univ, UMR S 911, CRO2, Marseille, France.	mehdi.ouaissi@mail.ap-hm.fr	Abreu, Carla/AAY-7760-2020; Mas, Eric/O-9569-2017; ouaissi, Mehdi/S-8713-2019; Iovanna, Juan/M-9805-2017; Mas, Eric/AAC-9837-2022	Abreu, Carla/0000-0003-2026-9595; Mas, Eric/0000-0002-8925-9195; ouaissi, Mehdi/0000-0002-0906-4428; Iovanna, Juan/0000-0003-1822-2237; 	INSERM (Paris, France); Aix-Marseille Universite (Marseille, France); Sites de Recherche Integree sur le Cancer (SIRIC) [INCa-DGSO-INSERM 6038]	INSERM (Paris, France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Aix-Marseille Universite (Marseille, France); Sites de Recherche Integree sur le Cancer (SIRIC)	This work was supported by institutional funding from INSERM (Paris, France) and the Aix-Marseille Universite (Marseille, France) and by a grant INCa-DGSO-INSERM 6038 from Sites de Recherche Integree sur le Cancer (SIRIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdassi A, 2012, GUT, V61, P439, DOI 10.1136/gutjnl-2011-300060; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Benkoel L, 2009, MOL CANCER THER, V8, P282, DOI 10.1158/1535-7163.MCT-08-0471; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Choi JH, 2001, JPN J CANCER RES, V92, P1300, DOI 10.1111/j.1349-7006.2001.tb02153.x; Crnogorac-Jurcevic T, 2003, J PATHOL, V201, P63, DOI 10.1002/path.1418; de Nigris F, 2002, BRIT J CANCER, V86, P917, DOI 10.1038/sj.bjc.6600156; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Fitzgerald M, 2003, NEOPLASIA, V5, P427, DOI 10.1016/S1476-5586(03)80045-3; FREY CF, 1987, PANCREAS, V2, P701, DOI 10.1097/00006676-198711000-00014; Fritsche P, 2009, GUT, V58, P1399, DOI 10.1136/gut.2009.180711; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Greene FL, 2002, AJCC CANC STAGING HD; Gress TM, 1996, ONCOGENE, V13, P1819; Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Li Y, 1998, MOL CELL BIOL, V18, P4719, DOI 10.1128/MCB.18.8.4719; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowenfels AB, 2004, JPN J CLIN ONCOL, V34, P238, DOI 10.1093/jjco/hyh045; Luttges J, 1998, VIRCHOWS ARCH, V433, P237, DOI 10.1007/s004280050242; Mottet D, 2007, CIRC RES, V101, P1237, DOI 10.1161/CIRCRESAHA.107.149377; Nakao A, 2006, WORLD J SURG, V30, P976, DOI 10.1007/s00268-005-0438-6; Ouaissi M, 2008, ANN SURG ONCOL, V15, P2318, DOI 10.1245/s10434-008-9940-z; Ouaissi M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/315939; Ouaissi M, 2008, HEPATO-GASTROENTEROL, V55, P2242; Peulen O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075102; Rosenberg L, 2000, DRUGS, V59, P1071, DOI 10.2165/00003495-200059050-00004; Strasberg SM, 2012, CANCER J, V18, P562, DOI 10.1097/PPO.0b013e31827596c5; Verbeke CS, 2006, BRIT J SURG, V93, P1232, DOI 10.1002/bjs.5397; Vimalachandran D, 2005, CANCER RES, V65, P3218, DOI 10.1158/0008-5472.CAN-04-4311; Wittekind C, 2002, CANCER-AM CANCER SOC, V94, P2511, DOI 10.1002/cncr.10492; Wu Q, 1997, EMBO J, V16, P1656, DOI 10.1093/emboj/16.7.1656; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X	38	33	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108520	10.1371/journal.pone.0108520	http://dx.doi.org/10.1371/journal.pone.0108520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275504	gold, Green Submitted, Green Published			2022-12-27	WOS:000342591500019
J	Wong, HM; Peng, SM; Wen, YF; King, NM; McGrath, CPJ				Wong, Hai Ming; Peng, Si-Min; Wen, Yi Feng; King, Nigel M.; McGrath, Colman P. J.			Risk Factors of Developmental Defects of Enamel-A Prospective Cohort Study	PLOS ONE			English	Article							EARLY-CHILDHOOD CARIES; 1ST PERMANENT MOLARS; NEW-ZEALAND CHILDREN; ETIOLOGIC FACTORS; PREVALENCE; AUSTRALIA; OPACITIES; SCHOOLCHILDREN; TEETH; ASSOCIATION	Background and objective: Current studies on the aetiology of developmental defects of enamel (DDE) are subject to recall bias because of the retrospective collection of information. Our objective was to investigate potential risk factors associated with the occurrence of DDE through a prospective cohort study. Methods: Using a random community sample of Hong Kong children born in 1997, we performed a cohort study in which the subjects' background information, medical and dental records were prospectively collected. A clinical examination to identify DDE was conducted in 2010 when the subjects were 12 years old. The central incisor, lateral incisor and first molar in each quadrant were chosen as the index teeth and were examined 'wet' by two trained and calibrated examiners using the modified FDI (DDE) Index. Results: With a response rate of 74.9%, the 514 examined subjects had matched data for background information. Diffuse opacites were the most common type of DDE. Of the various possible aetiological factors considered, only experience of severe diseases during the period 0-3 years was associated with the occurrence of 'any defect' (p = 0.017) and diffuse opacities (p = 0.044). The children with experience of severe diseases before 3 years of age were 7.89 times more likely to be affected by ` any defect' compared with those who did not have the experience (OR 7.89; 95% CI 1.07, 58.14; p = 0.043). However, after adjusting for confounding factors, the association no longer existed. Conclusion: No variables could be identified as risk factors of DDE in this Hong Kong birth cohort.	[Wong, Hai Ming; Peng, Si-Min; Wen, Yi Feng; McGrath, Colman P. J.] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [King, Nigel M.] Univ Western Australia, Sch Dent, Perth, WA 6009, Australia; [Peng, Si-Min] Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Dept Paediat Dent, Guangzhou 510275, Guangdong, Peoples R China	University of Hong Kong; University of Western Australia; Sun Yat Sen University	Wong, HM (corresponding author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.	wonghmg@hku.hk	Wen, Yi Feng/ABT-7086-2022	Wen, Yi Feng/0000-0002-5950-9456	Research Grants Council of the Hong Kong Special Administrative Region, China [782811]; HMW	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); HMW	The work described in this paper was supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. 782811; http://www.ugc.edu.hk/eng/rgc/). HMW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaluusua S, 1999, LANCET, V353, P206, DOI 10.1016/S0140-6736(05)77214-7; Alaluusua S, 1996, EUR J ORAL SCI, V104, P493, DOI 10.1111/j.1600-0722.1996.tb00131.x; Arnadottir IB, 2005, COMMUNITY DENT HLTH, V22, P279; Arrow P, 2009, COMMUNITY DENT ORAL, V37, P405, DOI 10.1111/j.1600-0528.2009.00480.x; Beentjes V E, 2002, Eur J Paediatr Dent, V3, P9; Billings RJ, 2004, PEDIATRICS, V113, P1120; Elley K M, 1993, Community Dent Health, V10, P11; Ellwood R P, 1994, Community Dent Health, V11, P192; FDI Commission on Oral Health Research and Epidemiology, 1992, INT DENT J, V42, P411; Ford D, 2009, PEDIATR DENT, V31, P382; Haavikko K, 1970, Suom Hammaslaak Toim, V66, P103; Hong L, 2005, ARCH PEDIAT ADOL MED, V159, P943, DOI 10.1001/archpedi.159.10.943; Jalevik B, 2002, Int J Paediatr Dent, V12, P24, DOI 10.1046/j.0960-7439 .2001.00318.x; Jalevik B, 2001, EUR J ORAL SCI, V109, P230, DOI 10.1034/j.1600-0722.2001.00047.x; Kazoullis S, 2007, PEDIATR DENT, V29, P33; King N M, 1989, Adv Dent Res, V3, P120; LOGAN WILLIAM H. G., 1933, JOUR AMER DENTAL ASSOC, V20, P379; Oliveira AFB, 2006, CARIES RES, V40, P296, DOI 10.1159/000093188; PINDBORG JJ, 1982, INT DENT J, V32, P123; Robles MJ, 2013, MED ORAL PATOL ORAL, V18, pE187, DOI 10.4317/medoral.18580; Schooling CM, 2012, INT J EPIDEMIOL, V41, P611, DOI 10.1093/ije/dyq243; Seow WK, 2009, CARIES RES, V43, P25, DOI 10.1159/000189704; Seow WK, 2011, PEDIATR DENT, V33, P207; SMALL BW, 1978, J DENT, V6, P33, DOI 10.1016/0300-5712(78)90004-0; Suckling G W, 1989, Adv Dent Res, V3, P87; SUCKLING GW, 1984, COMMUNITY DENT ORAL, V12, P177, DOI 10.1111/j.1600-0528.1984.tb01434.x; SUCKLING GW, 1987, J DENT RES, V66, P1466, DOI 10.1177/00220345870660091101; Tapias-Ledesma Miguel Angel, 2003, J Dent Child (Chic), V70, P215; VANAMERONGEN WE, 1995, J DENT CHILD, V62, P266; Whatling R, 2008, INT J PAEDIATR DENT, V18, P155, DOI 10.1111/j.1365-263X.2007.00901.x; Wong HM, 2006, CARIES RES, V40, P481, DOI 10.1159/000095646; Wong HM, 2007, COMMUNITY DENT ORAL, V35, P130, DOI 10.1111/j.1600-0528.2007.00309.x; Wong HM, 2014, COMMUNITY DENT ORAL, V42, P61, DOI 10.1111/cdoe.12064	33	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109351	10.1371/journal.pone.0109351	http://dx.doi.org/10.1371/journal.pone.0109351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275499	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500098
J	Burchiel, SW; Lauer, FT; Beswick, EJ; Gandolfi, AJ; Parvez, F; Liu, KJ; Hudson, LG				Burchiel, Scott W.; Lauer, Fredine T.; Beswick, Ellen J.; Gandolfi, A. Jay; Parvez, Faruque; Liu, Ke Jian; Hudson, Laurie G.			Differential Susceptibility of Human Peripheral Blood T Cells to Suppression by Environmental Levels of Sodium Arsenite and Monomethylarsonous Acid	PLOS ONE			English	Article							CYTOKINE SECRETION; EXPRESSION; PROLIFERATION; LYMPHOCYTES; METABOLISM; ACTIVATION; MITOGENS; SIGNAL	Human exposure to arsenic in drinking water is known to contribute to many different health outcomes such as cancer, diabetes, and cardiopulmonary disease. Several epidemiological studies suggest that T cell function is also altered by drinking water arsenic exposure. However, it is unclear how individual responses differ to various levels of exposure to arsenic. Our laboratory has recently identified differential responses of human peripheral blood mononuclear cell (HPMBC) T cells as measured by polyclonal T cell activation by mitogens during sodium arsenite exposure. T cells from certain healthy individuals exposed to various concentrations (1-100 nM) of arsenite in vitro showed a dose-dependent suppression at these extremely low concentrations (similar to 0.1-10 ppb) of arsenite, whereas other individuals were not suppressed at low concentrations. In a series of more than 30 normal donors, two individuals were found to be sensitive to low concentration (10 nM equivalent similar to 1 ppb drinking water exposure) to sodium arsenite-induced inhibition of T cell proliferation produced by phytohemagglutinin (PHA) and anti-CD3/anti-CD28. In an arsenite-susceptible individual, arsenite suppressed the activation of Th1 (Tbet) cells, and decreased the percentage of cells in the double positive Th17 (ROR gamma t) and Treg (FoxP3) population. While the majority of normal blood donors tested were not susceptible to inhibition of proliferation at the 1-100 nM concentrations of As+3, it was found that all donors were sensitive to suppression by 100 nM monomethylarsonous acid (MMA(+3)), a key metabolite of arsenite. Thus, our studies demonstrate for the first time that low ppb-equivalent concentrations of As+3 are immunosuppressive to HPBMC T cells in some individuals, but that most donor HPBMC are sensitive to suppression by MMA(+3) at environmentally relevant exposure levels.	[Burchiel, Scott W.; Lauer, Fredine T.; Liu, Ke Jian; Hudson, Laurie G.] Univ New Mexico, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA; [Beswick, Ellen J.] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Gandolfi, A. Jay] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Parvez, Faruque] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY USA	University of New Mexico; University of New Mexico; University of Arizona; Columbia University	Burchiel, SW (corresponding author), Univ New Mexico, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA.	sburchiel@salud.unm.edu			National Institute of Environmental Health Sciences (NIEHS) [RO1-ES019968, S1]; NIEHS-Environmental Protection Agency (EPA) Basic Superfund Research Program [ES004940]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694, R01ES019968, P42ES004940] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS-Environmental Protection Agency (EPA) Basic Superfund Research Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (NIEHS) Grant No. RO1-ES019968 and S1 and NIEHS-Environmental Protection Agency (EPA) Basic Superfund Research Program Grant No. ES004940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argos M, 2010, LANCET, V376, P252, DOI 10.1016/S0140-6736(10)60481-3; BAROJA ML, 1989, CELL IMMUNOL, V120, P205, DOI 10.1016/0008-8749(89)90188-3; Biswas R, 2008, HUM EXP TOXICOL, V27, P381, DOI 10.1177/0960327108094607; Chowdhury R, 2010, TOXICOL LETT, V198, P263, DOI 10.1016/j.toxlet.2010.07.006; Davila DR, 1996, TOXICOL APPL PHARM, V139, P333, DOI 10.1006/taap.1996.0173; Drobna Z, 2009, CHEM RES TOXICOL, V22, P1713, DOI 10.1021/tx900179r; Eblin KE, 2007, TOXICOL SCI, V95, P321, DOI 10.1093/toxsci/kfl160; Engstrom K, 2011, ENVIRON HEALTH PERSP, V119, P182, DOI 10.1289/ehp.1002471; Ezeh PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093920; GERY I, 1972, J EXP MED, V136, P128, DOI 10.1084/jem.136.1.128; Gonsebatt ME, 1992, TOXICOL APPL PHARM, V245, P244; Hall M, 2006, TOXICOLOGY, V225, P225, DOI 10.1016/j.tox.2006.06.010; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1441, DOI 10.1289/ehp.0900911; Li Q, 2010, TOXICOL APPL PHARM, V245, P344, DOI 10.1016/j.taap.2010.03.020; Luna AL, 2010, MUTAT RES, V283, P91; Milstein LS, 2003, ENVIRON HEALTH PERSP, V111, P293, DOI 10.1289/ehp.5525; Morzadec C, 2012, TOXICOLOGY, V300, P46, DOI 10.1016/j.tox.2012.05.025; Morzadec C, 2012, TOXICOL APPL PHARM, V262, P217, DOI 10.1016/j.taap.2012.05.004; Pierce BL, 2013, INT J EPIDEMIOL, V42, P1862, DOI 10.1093/ije/dyt182; Pierce BL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002522; Soto-Pena GA, 2008, TOXICOL APPL PHARM, V230, P216, DOI 10.1016/j.taap.2008.02.029; Soto-Pena GA, 2006, FASEB J, V20, P779, DOI 10.1096/fj.05-4860fje	22	29	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109192	10.1371/journal.pone.0109192	http://dx.doi.org/10.1371/journal.pone.0109192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271956	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600104
J	Chen, MS; Zhao, YX; Si, L				Chen, Mingsheng; Zhao, Yuxin; Si, Lei			Who Pays for Health Care in China? The Case of Heilongjiang Province	PLOS ONE			English	Article							UNIVERSAL COVERAGE; MEDICAL INSURANCE; ASIA; COUNTRIES; EQUITY; SYSTEM; REFORM; PROGRESSIVITY; CHALLENGES; POVERTY	Background: Health spending by the Chinese government has declined and traditional social health insurance collapsed after economic reforms in the early 1980s; accordingly, the low-income population is exposed to potentially significant healthcare costs. Financing an equitable healthcare system represents a major policy objective in China's current healthcare reform efforts. The current research presents an examination of the distribution of healthcare financing in a north-eastern Chinese province to compare equity status between urban and rural areas at two different times. Methods: To analyze the progressivity of healthcare financing in terms of ability-to-pay, the Kakwani index was used to assess four healthcare financing channels: general taxes, social and commercial health insurance, and out-of-pocket payments. Two rounds of surveys were conducted in 2003 (11,572 individuals in 3841 households) and 2008 (15,817 individuals in 5530 households). Household socioeconomic status, healthcare payment, and utilization information were recorded using household interviews. Results: China's healthcare financing equity is unsound. Kakwani indices for general taxation were -0.0212 (urban) and -0.0297 (rural) in 2002, and -0.0097 (urban) and -0.0112 (rural) in 2007. Social health insurance coverage has expanded, however different financing distributions were found with respect to urban (0.0969 in 2002 vs. 0.0984 in 2007) and rural (0.0283 in 2002 vs. -0.3119 in 2007) areas. While progressivity of out-of-pocket payments decreased in both areas, the equity of financing was found to have improved among poorer respondents. Conclusions: Overall, China's healthcare financing distribution is unequal. Given the inequity of general taxes, decreasing the proportion of indirect taxes would considerably improve healthcare financing equity. Financial contribution mechanisms to social health insurance are equally significant to coverage extension. The use of flat rate contributions for healthcare funding places a disproportionate pressure upon the poor. Out-of-pocket payments have become equitable, but progressivity has decreased.	[Chen, Mingsheng] Nanjing Med Univ, Sch Hlth Policy & Management, Nanjing, Jiangsu, Peoples R China; [Chen, Mingsheng] Nanjing Med Univ, Cooperat Hlth Human Initiat, Nanjing, Jiangsu, Peoples R China; [Zhao, Yuxin] Minist Hlth Peoples Republ China, Natl Hlth Dev Res Ctr, Beijing, Peoples R China; [Si, Lei] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Si, Lei] Anhui Med Univ, Sch Hlth Adm, Hefei, Peoples R China	Nanjing Medical University; Nanjing Medical University; University of Tasmania; Anhui Medical University	Si, L (corresponding author), Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia.	lei.si@utas.edu.au	Si, Lei/AAM-3218-2020	Si, Lei/0000-0002-3044-170X	Research Foundation for Bright Scholars, Nanjing Medical University [KY107RC011306]	Research Foundation for Bright Scholars, Nanjing Medical University	This study was supported by the Research Foundation for Bright Scholars, Nanjing Medical University (No. KY107RC011306). The sponsor had no influence on the study design, data collection, analysis, interpretation, or writing of the manuscript.	[Anonymous], 2008, ANAL HLTH EQUITY USI; BEACH CM, 1985, INT ECON REV, V26, P439, DOI 10.2307/2526594; Center for China Cooperative Medical Scheme, 2008, CHIN COOP MED SCHEM; China's Ministry of Health, 2004, AN REP 3 NAT HLTH SE; Cisse B, 2007, HEALTH POLICY, V80, P51, DOI 10.1016/j.healthpol.2006.02.011; Dardanoni V., 1999, ECONOMETRICS J, V2, P49, DOI DOI 10.1111/1368-423X.00020; Davidson R, 1997, ECONOMETRICA, V65, P1453, DOI 10.2307/2171744; Deaton A., 1997, The analysis of household surveys: a microeconometric approach to development policy.; Evans DB, 2010, B WORLD HEALTH ORGAN, V88, P402, DOI 10.2471/BLT.10.078741; Gilson L, 2001, HEALTH POLICY, V58, P37, DOI 10.1016/S0168-8510(01)00153-1; GU XY, 1995, HEALTH POLICY, V32, P181, DOI 10.1016/0168-8510(95)00735-B; Gustafsson B, 2004, CHINA ECON REV, V15, P292, DOI 10.1016/j.chieco.2003.07.004; Gwatkin DR, 2011, LANCET, V377, P2160, DOI 10.1016/S0140-6736(10)62058-2; HENDERSON G, 1995, SOC SCI MED, V41, P1119, DOI 10.1016/0277-9536(94)00420-X; Hsiao WC, 2009, HEALTH ECON, V18, pS1, DOI 10.1002/hec.1516; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; James CD, 2010, LANCET, V375, P1417, DOI 10.1016/S0140-6736(10)60552-1; JENKINS S, 1988, NATL TAX J, V41, P139; KAKWANI NC, 1977, ECON J, V87, P71, DOI 10.2307/2231833; Lagomarsino G, 2012, LANCET, V380, P933, DOI 10.1016/S0140-6736(12)61147-7; LERMAN RI, 1989, J ECONOMETRICS, V42, P43, DOI 10.1016/0304-4076(89)90074-2; Lin WC, 2009, HEALTH ECON, V18, pS83, DOI 10.1002/hec.1500; Lou J, 2008, PUBLIC FINANCE IN CHINA: REFORM AND GROWTH FOR A HARMONIOUS SOCIETY, P1, DOI 10.1596/978-0-8213-6927-2; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; National Bureau of Statistics of China, 2008, CHIN LAB STAT YB 200; National Health Development Research Center, 2012, CHIN NAT HLTH ACC RE; O'Donnell O, 2008, J HEALTH ECON, V27, P460, DOI 10.1016/j.jhealeco.2007.08.005; O'Donnell O, 2007, CAD SAUDE PUBLICA, V23, P2820, DOI 10.1590/S0102-311X2007001200003; O'Donnell O, 2007, WORLD BANK ECON REV, V21, P93, DOI 10.1093/wber/lhl009; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Wagstaff A., 1989, OXFORD REV EC, V5, P89, DOI DOI 10.1093/oxrep/5.1.89; Wagstaff A, 2009, HEALTH ECON, V18, pS7, DOI 10.1002/hec.1518; WHO, 2010, WORLD MALARIA REPORT 2010, P1; World Health Organization, 2000, WORLD HLTH REP 2000; XG Wei, 2007, HLTH SERVICES SURVEY; Yip W, 2008, HEALTH AFFAIR, V27, P921, DOI 10.1377/hlthaff.27.4.921; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; You XD, 2009, HEALTH POLICY, V91, P1, DOI 10.1016/j.healthpol.2008.11.012	38	13	13	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108867	10.1371/journal.pone.0108867	http://dx.doi.org/10.1371/journal.pone.0108867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZM	25271768	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600070
J	Nakatsu, CH; Armstrong, A; Clavijo, AP; Martin, BR; Barnes, S; Weaver, CM				Nakatsu, Cindy H.; Armstrong, Arthur; Clavijo, Andrea P.; Martin, Berdine R.; Barnes, Stephen; Weaver, Connie M.			Fecal Bacterial Community Changes Associated with Isoflavone Metabolites in Postmenopausal Women after Soy Bar Consumption	PLOS ONE			English	Article							MULTIVARIATE-ANALYSIS; EQUOL; PHYTOESTROGENS; MICROBIOTA; DAIDZEIN; RATIO; BETA	Soy isoflavones and their metabolism by intestinal microbiota have gained attention because of potential health benefits, such as the alleviation of estrogen/hormone-related conditions in postmenopausal women, associated with some of these compounds. However, overall changes in gut bacterial community structure and composition in response to addition of soy isoflavones to diets and their association with excreted isoflavone metabolites in postmenopausal women has not been studied. The aim of this study was to determine fecal bacterial community changes in 17 postmenopausal women after a week of diet supplementation with soy bars containing isoflavones, and to determine correlations between microbial community changes and excreted isoflavone metabolites. Using DGGE profiles of PCR amplified 16S rRNA genes (V3 region) to compare microbial communities in fecal samples collected one week before and one week during soy supplementation revealed significant differences (ANOSIM p<0.03) before and after soy supplementation in all subjects. However, between subjects comparisons showed high inter-individual variation that resulted in clustering of profiles by subjects. Urinary excretion of isoflavone ( daidzein) metabolites indicated four subjects were equol producers and all subjects produced O-desmethylangolensin (ODMA). Comparison of relative proportions of 16S rRNA genes from 454 pyrosequencing of the last fecal samples of each treatment session revealed significant increases in average proportions of Bifidobacterium after soy consumption, and Bifidobacterium and Eubacterium were significantly greater in equol vs non-S-(-) equol producers. This is the first in vivo study using pyrosequencing to characterize significant differences in fecal community structure and composition in postmenopausal women after a week of soy diet-supplementation, and relate these changes to differences in soy isoflavones and isoflavone metabolites.	[Nakatsu, Cindy H.; Armstrong, Arthur; Clavijo, Andrea P.] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Martin, Berdine R.; Weaver, Connie M.] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA; [Barnes, Stephen] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Alabama System; University of Alabama Birmingham	Nakatsu, CH (corresponding author), Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA.	cnakatsu@purdue.edu			Purdue University/University of Alabama Botanicals Research Center (National Institute of Health) [P50-AT00477]; University of Alabama at Birmingham Health Services Foundation General Endowment Fund; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P50AT000477] Funding Source: NIH RePORTER	Purdue University/University of Alabama Botanicals Research Center (National Institute of Health); University of Alabama at Birmingham Health Services Foundation General Endowment Fund; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This research was funded by the Purdue University/University of Alabama Botanicals Research Center (National Institute of Health grant P50-AT00477). Funds for the mass spectrometer used in this study were provided by a grant from the University of Alabama at Birmingham Health Services Foundation General Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Ariefdjohan MW, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-23; Atkinson C, 2005, EXP BIOL MED, V230, P155, DOI 10.1177/153537020523000302; Bahl MI, 2012, FEMS MICROBIOL LETT, V329, P193, DOI 10.1111/j.1574-6968.2012.02523.x; Barnes S, 1998, P SOC EXP BIOL MED, V217, P254; Behloul N, 2013, EUR J PHARMACOL, V698, P31, DOI 10.1016/j.ejphar.2012.11.013; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Bolca S, 2007, J NUTR, V137, P2242, DOI 10.1093/jn/137.10.2242; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cassidy A, 2006, P NUTR SOC, V65, P76, DOI 10.1079/PNS2005476; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clavel T, 2005, J NUTR, V135, P2786, DOI 10.1093/jn/135.12.2786; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; David LA, 2013, NATURE ADV ONLINE PU; Decroos K, 2006, J NUTR, V136, P946, DOI 10.1093/jn/136.4.946; Decroos K, 2005, ARCH MICROBIOL, V183, P45, DOI 10.1007/s00203-004-0747-4; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Frankenfeld CL, 2011, ADV NUTR, V2, P317, DOI 10.3945/an.111.000539; Guo KP, 2010, BRIT J NUTR, V104, P118, DOI 10.1017/S0007114510000279; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Jin JS, 2010, INT J SYST EVOL MICR, V60, P1721, DOI 10.1099/ijs.0.016774-0; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Maruo T, 2008, INT J SYST EVOL MICR, V58, P1221, DOI 10.1099/ijs.0.65404-0; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mueller SO, 2004, TOXICOL SCI, V80, P14, DOI 10.1093/toxsci/kfh147; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Poulsen RC, 2008, NUTR REV, V66, P359, DOI 10.1111/j.1753-4887.2008.00046.x; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Setchell KDR, 2005, AM J CLIN NUTR, V81, P1072; Setchell KDR, 2006, J NUTR, V136, P2188, DOI 10.1093/jn/136.8.2188; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weaver CM, 2006, J CLIN ENDOCR METAB, V94, P3798; Weaver CM, 2008, AM J CLIN NUTR, V87, p493S, DOI 10.1093/ajcn/87.2.493S; Whisner CM, 2014, BRIT J NUTR, V112, P446, DOI 10.1017/S0007114514000981; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yokoyama SI, 2010, ARCH MICROBIOL, V192, P15, DOI 10.1007/s00203-009-0524-5	43	63	69	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108924	10.1371/journal.pone.0108924	http://dx.doi.org/10.1371/journal.pone.0108924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271941	gold, Green Published, Green Submitted			2022-12-27	WOS:000343729600080
J	van der Ham, JL; de Mutsert, K				van der Ham, Joris L.; de Mutsert, Kim			Abundance and Size of Gulf Shrimp in Louisiana's Coastal Estuaries following the Deepwater Horizon Oil Spill	PLOS ONE			English	Article							SEDIMENT-ASSOCIATED PAHS; PALAEMONETES-PUGIO; REPRODUCTION; TOXICITY; REGENERATION; SURVIVAL	The Deepwater Horizon oil spill impacted Louisiana's coastal estuaries physically, chemically, and biologically. To better understand the ecological consequences of this oil spill on Louisiana estuaries, we compared the abundance and size of two Gulf shrimp species (Farfantepeneus aztecus and Litopeneus setiferus) in heavily affected and relatively unaffected estuaries, before and after the oil spill. Two datasets were used to conduct this study: data on shrimp abundance and size before the spill were available from Louisiana Department of Wildlife and Fisheries (LDWF). Data on shrimp abundance and size from after the spill were independently collected by the authors and by LDWF. Using a Before-After-Control-Impact with Paired sampling (BACIP) design with monthly samples of two selected basins, we found brown shrimp to become more abundant and the mean size of white shrimp to become smaller. Using a BACIP with data on successive shrimp year-classes of multiple basins, we found both species to become more abundant in basins that were affected by the spill, while mean shrimp size either not change after the spill, or increased in both affected and unaffected basins. We conclude that following the oil spill abundances of both species increased within affected estuaries, whereas mean size may have been unaffected. We propose two factors that may have caused these results: 1) exposure to polycyclic aromatic hydrocarbons (PAHs) may have reduced the growth rate of shrimp, resulting in a delayed movement of shrimp to offshore habitats, and an increase of within-estuary shrimp abundance, and 2) fishing closures established immediately after the spill, may have resulted in decreased fishing effort and an increase in shrimp abundance. This study accentuates the complexities in determining ecological effects of oil spills, and the need of studies on the organismal level to reveal cause-and-effect relationships of such events.	[van der Ham, Joris L.; de Mutsert, Kim] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA	George Mason University	van der Ham, JL (corresponding author), George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA.	jvanderh@gmu.edu	de Mutsert, Kim/AAV-1035-2020	de Mutsert, Kim/0000-0002-7902-3787	Louisiana Sea Grant [R/OS-04-PD]; George Mason University Libraries Open Access Publishing Fund	Louisiana Sea Grant; George Mason University Libraries Open Access Publishing Fund	This work was funded by Louisiana Sea Grant (R/OS-04-PD) and by the George Mason University Libraries Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	[Anonymous], 2014, ENV RESP MAN APPL; Beazley MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041305; Bellas J, 2007, ECOTOXICOLOGY, V16, P465, DOI 10.1007/s10646-007-0152-2; CANTELMO AC, 1981, MAR BIOL LETT, V2, P333; Dissanayake A, 2009, J EXP MAR BIOL ECOL, V375, P57, DOI 10.1016/j.jembe.2009.05.007; Downes B.J., 2002, MONITORING ECOLOGICA; Larson SC, 1989, SPECIES PROFILES LIF; Lisle JT, 2011, 20111059 US GEOL SUR; Lotufo GR, 1997, MAR ENVIRON RES, V44, P149, DOI 10.1016/S0141-1136(96)00108-0; McCall BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032735; Mishra DR, 2012, REMOTE SENS ENVIRON, V118, P176, DOI 10.1016/j.rse.2011.11.007; Muncy R.J., 1984, SPECIES PROFILES LIF; Nowell L.H., 2013, 20125228 US GEOL SUR; Oberdorster E, 2000, ENVIRON HEALTH PERSP, V108, P641, DOI 10.2307/3434885; Oleszczuk P, 2008, SCI TOTAL ENVIRON, V404, P94, DOI 10.1016/j.scitotenv.2008.06.014; OSENBERG CW, 1994, ECOL APPL, V4, P16, DOI 10.2307/1942111; Pattillo M. E., 1997, DISTRIBUTION ABUNDAN; Rozas LP, 2014, ESTUAR COAST, V37, P1403, DOI 10.1007/s12237-013-9766-1; SAS Institure I, 2012, JMP, V10; Schwarz Carl James, 2011, SAMPLING REGRESSION; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; Tunnell JW., 2011, GULF COAST CLAIMS FA; WANG SY, 1988, MAR BIOL, V98, P23, DOI 10.1007/BF00392655; WEIS JS, 1992, AM ZOOL, V32, P495; Whitehead A, 2012, P NATL ACAD SCI USA, V109, P20298, DOI 10.1073/pnas.1109545108; Wirth EF, 1998, B ENVIRON CONTAM TOX, V61, P637	26	16	16	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108884	10.1371/journal.pone.0108884	http://dx.doi.org/10.1371/journal.pone.0108884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272142	gold, Green Published			2022-12-27	WOS:000343729600074
J	Zhou, KK; Benyajati, S; Le, Y; Cheng, R; Zhang, WB; Ma, JX				Zhou, Kelu Kevin; Benyajati, Siribhinya; Le, Yun; Cheng, Rui; Zhang, Wenbo; Ma, Jian-xing			Interruption of Wnt Signaling in Muller Cells Ameliorates Ischemia-Induced Retinal Neovascularization	PLOS ONE			English	Article							OXYGEN-INDUCED RETINOPATHY; WNT/BETA-CATENIN PATHWAY; DIABETIC-RETINOPATHY; ENDOTHELIAL DYSFUNCTION; PATHOGENIC ROLE; PERICYTE LOSS; GROWTH-FACTOR; BETA-CATENIN; INFLAMMATION; MARKERS	Retinal Muller cells are major producers of inflammatory and angiogenic cytokines which contribute to diabetic retinopathy (DR). Over-activation of the Wnt/beta-catenin pathway has been shown to play an important pathogenic role in DR. However, the roles of Muller cell-derived Wnt/beta-catenin signaling in retinal neovascularization (NV) and DR remain undefined. In the present study, mice with conditional beta-catenin knockout (KO) in Muller cells were generated and subjected to oxygeninduced retinopathy (OIR) and streptozotocin (STZ)-induced diabetes. Wnt signaling was evaluated by measuring levels of beta-catenin and expression of its target genes using immunoblotting. Retinal vascular permeability was measured using Evans blue as a tracer. Retinal NV was visualized by angiography and quantified by counting pre-retinal nuclei. Retinal pericyte loss was evaluated using retinal trypsin digestion. Electroretinography was performed to examine visual function. No abnormalities were detected in the beta-catenin KO mice under normal conditions. In OIR, retinal levels of beta-catenin and VEGF were significantly lower in the beta-catenin KO mice than in littermate controls. The KO mice also had decreased retinal NV and vascular leakage in the OIR model. In the STZ-induced diabetic model, disruption of beta-catenin in Muller cells attenuated over-expression of inflammatory cytokines and ameliorated pericyte dropout in the retina. These findings suggest that Wnt signaling activation in Muller cells contributes to retinal NV, vascular leakage and inflammation and represents a potential therapeutic target for DR.	[Zhou, Kelu Kevin; Benyajati, Siribhinya; Cheng, Rui; Ma, Jian-xing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Harold Hamm Diabet Ctr, Oklahoma City, OK 73104 USA; [Le, Yun] Univ Oklahoma, Hlth Sci Ctr, Dept Med Endocrinol, Harold Hamm Diabet Ctr, Oklahoma City, OK USA; [Zhang, Wenbo] Univ Texas Med Branch, Dept Ophthalmol & Visual Sci, Galveston, TX 77555 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Texas System; University of Texas Medical Branch Galveston	Ma, JX (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Harold Hamm Diabet Ctr, Oklahoma City, OK 73104 USA.	jian-xing-ma@ouhsc.edu	Zhou, Kelu/C-1322-2017	Zhou, Kelu/0000-0001-6751-942X	National Institutes of Health [EY012231, EY018659, EY019309, GM104934]; Juvenile Diabetes Research Foundation [2-SRA-2014-147-Q-R]; Internationals Retinal Research Foundation; Oklahoma Center for the Advancement of Science & Technology (OCAST) [HR12-103, HR13-076]; NATIONAL EYE INSTITUTE [P30EY021721, R01EY012231, R01EY019309, R01EY018659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Internationals Retinal Research Foundation; Oklahoma Center for the Advancement of Science & Technology (OCAST); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health grants EY012231, EY018659, EY019309, and GM104934, a grant from Juvenile Diabetes Research Foundation 2-SRA-2014-147-Q-R, a grant from The Internationals Retinal Research Foundation and grants from Oklahoma Center for the Advancement of Science & Technology (OCAST), HR12-103 and HR13-076. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Bai YY, 2009, J PATHOL, V219, P446, DOI 10.1002/path.2611; Bandello F, 2013, ACTA DIABETOL, V50, P1, DOI 10.1007/s00592-012-0449-3; Barber AJ, 2003, INVEST OPHTH VIS SCI, V44, P5410, DOI 10.1167/iovs.03-0244; Bordonaro M, 2009, VITAM HORM, V80, P563, DOI 10.1016/S0083-6729(08)00619-5; Browning J, 1997, INVEST OPHTH VIS SCI, V38, P1168; Cakir Gundogan Fatih, 2013, Med Glas (Zenica), V10, P197; Chen Y, 2006, INVEST OPHTH VIS SCI, V47, P1177, DOI 10.1167/iovs.05-0965; Chen Y, 2009, AM J PATHOL, V175, P2676, DOI 10.2353/ajpath.2009.080945; Chen Y, 2009, MICROVASC RES, V78, P119, DOI 10.1016/j.mvr.2009.02.005; Das AV, 2006, DEV BIOL, V299, P283, DOI 10.1016/j.ydbio.2006.07.029; Ejaz S, 2008, DIABETES OBES METAB, V10, P53, DOI 10.1111/j.1463-1326.2007.00795.x; Funatsu H, 2003, OPHTHAL PHYSL OPT, V23, P495, DOI 10.1046/j.1475-1313.2003.00134.x; Hu Y, 2013, INVEST OPHTH VIS SCI, V54, P141, DOI 10.1167/iovs.12-10281; Klein BEK, 2009, ARCH OPHTHALMOL-CHIC, V127, P1175, DOI 10.1001/archophthalmol.2009.172; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; Lee K, 2012, DIABETES, V61, P2948, DOI 10.2337/db11-0300; Lin M, 2011, DIABETOLOGIA, V54, P1554, DOI 10.1007/s00125-011-2081-0; Lorenzi M, 2007, EXP DIABETES RES, DOI 10.1155/2007/61038; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Ng ZX, 2013, GENE, V521, P227, DOI 10.1016/j.gene.2013.03.062; Park K, 2011, MOL CELL BIOL, V31, P3038, DOI 10.1128/MCB.01211-10; Pfister F, 2008, DIABETES, V57, pA234, DOI 10.2337/db08-0325; Portal-Nunez S, 2010, FEBS LETT, V584, P3095, DOI 10.1016/j.febslet.2010.05.047; RICCI B, 1991, DOC OPHTHALMOL, V76, P241, DOI 10.1007/BF00142683; RICCI B, 1990, DOC OPHTHALMOL, V74, P287, DOI 10.1007/BF00145813; Skondra D, 2008, INVEST OPHTH VIS SCI, V49, P726, DOI 10.1167/iovs.07-0405; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Spijkerman AMW, 2007, DIABETIC MED, V24, P969, DOI 10.1111/j.1464-5491.2007.02217.x; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Ueki Y, 2009, VISION RES, V49, P615, DOI 10.1016/j.visres.2009.01.012; Valenta T, 2011, GENE DEV, V25, P2631, DOI 10.1101/gad.181289.111; van Hecke MV, 2005, DIABETOLOGIA, V48, P1300, DOI 10.1007/s00125-005-1799-y; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; Xu Hui-Zhuo, 2011, J Ocul Biol Dis Infor, V4, P83, DOI 10.1007/s12177-011-9068-4; Yang Y, 2013, MOL CELL ENDOCRINOL, V378, P46, DOI 10.1016/j.mce.2013.04.021; Yanyali A, 2005, AM J OPHTHALMOL, V139, P795, DOI 10.1016/j.ajo.2004.12.017; Zerbini G, 2012, DIABETES, V61, P908, DOI 10.2337/db11-1197; Zhang B, 2010, DIABETES, V59, P1809, DOI 10.2337/db09-1056; Zhang XB, 2001, CANCER RES, V61, P6050; Zhou T, 2011, DIABETOLOGIA, V54, P459, DOI 10.1007/s00125-010-1943-1; Zhou T, 2010, INVEST OPHTH VIS SCI, V51, P4371, DOI 10.1167/iovs.09-4278	42	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108454	10.1371/journal.pone.0108454	http://dx.doi.org/10.1371/journal.pone.0108454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271989	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600048
J	Gandhi, PK; Thompson, LA; Tuli, SY; Revicki, DA; Shenkman, E; Huang, IC				Gandhi, Pranav K.; Thompson, Lindsay A.; Tuli, Sanjeev Y.; Revicki, Dennis A.; Shenkman, Elizabeth; Huang, I-Chan			Developing Item Banks for Measuring Pediatric Generic Health-Related Quality of Life: An Application of the International Classification of Functioning, Disability and Health for Children and Youth and Item Response Theory	PLOS ONE			English	Article							LIMITED-INFORMATION; OUTCOME MEASURES; PARENT-PROXY; SELF-REPORT; ICF; INSTRUMENTS; LINKING; ADOLESCENTS; MODEL	The purpose of this study was to develop item banks by linking items from three pediatric health-related quality of life (HRQoL) instruments using a mixed methodology. Secondary data were collected from 469 parents of children aged 8-16 years. The International Classification of Functioning, Disability and Health-Children and Youth (ICF-CY) served as a framework to compare the concepts of items from three HRQoL instruments. The structural validity of the individual domains was examined using confirmatory factor analyses. Samejima's Graded Response Model was used to calibrate items from different instruments. The known-groups validity of each domain was examined using the status of children with special health care needs (CSHCN). Concepts represented by the items in the three instruments were linked to 24 different second-level categories of the ICF-CY. Eight item banks representing eight unidimensional domains were created based on the linkage of the concepts measured by the items of the three instruments to the ICF-CY. The HRQoL results of CSHCN in seven out of eight domains (except personality) were significantly lower compared with children without special health care needs (p<0.05). This study demonstrates a useful approach to compare the item concepts from the three instruments and to generate item banks for a pediatric population.	[Gandhi, Pranav K.] South Coll, Sch Pharm, Dept Pharm Practice, Knoxville, TN USA; [Thompson, Lindsay A.; Tuli, Sanjeev Y.] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA; [Revicki, Dennis A.] Evidera, Outcomes Res, Bethesda, MD USA; [Shenkman, Elizabeth; Huang, I-Chan] Univ Florida, Coll Med, Dept Hlth Outcomes & Policy, Gainesville, FL 32611 USA; [Shenkman, Elizabeth; Huang, I-Chan] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA	State University System of Florida; University of Florida; Evidera; State University System of Florida; University of Florida; St Jude Children's Research Hospital	Huang, IC (corresponding author), Univ Florida, Coll Med, Dept Hlth Outcomes & Policy, Gainesville, FL 32611 USA.	I-Chan.Huang@StJude.org		Thompson, Lindsay/0000-0003-1082-2801	National Institutes of Health [U01 AR052181]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR052181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study is supported by a grant from the National Institutes of Health U01 AR052181 (LAT, EAS, ICH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendixen RM, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-43; Bethell CD, 2002, AMBUL PEDIATR, V2, P38, DOI 10.1367/1539-4409(2002)002<0038:ICWSHC>2.0.CO;2; Brown T.A., 2015, CONFIRMATORY FACTOR, V2nd ed., DOI DOI 10.5860/CHOICE.44-2769; Cai L., 2011, IRTPRO COMPUTER SOFT; Chen WH, 1997, J EDUC BEHAV STAT, V22, P265, DOI 10.2307/1165285; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2005, QUAL LIFE RES, V14, P1225, DOI 10.1007/s11136-004-4773-0; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davis E, 2007, QUAL LIFE RES, V16, P863, DOI 10.1007/s11136-007-9187-3; De Civita M, 2005, PHARMACOECONOMICS, V23, P659, DOI 10.2165/00019053-200523070-00003; Fava L, 2009, DISABIL REHABIL, V31, P1943, DOI 10.1080/09638280902874188; Fayed N, 2012, AM J PHYS MED REHAB, V91, pS189, DOI 10.1097/PHM.0b013e31823d53cf; FDA Ctr Drug Evaluation Res, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-79; Geyh S, 2007, QUAL LIFE RES, V16, P833, DOI 10.1007/s11136-007-9174-8; Hambleton RK, 1993, EDUC MEAS-ISSUES PRA, V12, P38, DOI DOI 10.1111/J.1745-3992.1993.TB00543.X; Hays RD, 2000, MED CARE, V38, P28; Huang IC, 2011, VALUE HEALTH, V14, P872, DOI 10.1016/j.jval.2011.03.004; Huang IC, 2011, CHILD INDIC RES, V4, P145, DOI 10.1007/s12187-010-9079-x; Huang IC, 2009, VALUE HEALTH, V12, P773, DOI 10.1111/j.1524-4733.2008.00487.x; Huang IC, 2009, J CLIN EPIDEMIOL, V62, P337, DOI 10.1016/j.jclinepi.2008.06.012; Ingerski LM, 2007, J PEDIATR PSYCHOL, V32, P869, DOI 10.1093/jpepsy/jsm026; Joreskog K.G., 1993, LISREL 8 STRUCTURAL; Kenzik KM, 2014, MED DECIS MAKING, V34, P590, DOI 10.1177/0272989X14529846; Kenzik KM, 2011, QUAL LIFE RES SUPPL, V98; Krasuska M, 2012, AM J PHYS MED REHAB, V91, pS74, DOI 10.1097/PHM.0b013e31823d4f35; Landgraf JM, 1996, CHILD HEALTH QUESTIO; Lee AM, 2011, DISABIL REHABIL, V33, P605, DOI 10.3109/09638288.2010.505993; Petersson C, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-75; Ravens-Sieberer U, 1998, QUAL LIFE RES, V7, P399, DOI 10.1023/A:1008853819715; Ravens-Sieberer Ulrike, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P353, DOI 10.1586/14737167.5.3.353; Riley AW, 2004, AMBUL PEDIATR, V4, P371, DOI 10.1367/A03-178R.1; Riva S, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-139; Rosenbaum Peter, 2004, Semin Pediatr Neurol, V11, P5, DOI 10.1016/j.spen.2004.01.002; SAS Institute, 2004, SAS USERS GUIDE VERS; Solans M, 2008, VALUE HEALTH, V11, P742, DOI 10.1111/j.1524-4733.2007.00293.x; STARFIELD B, 1995, MED CARE, V33, P553, DOI 10.1097/00005650-199505000-00008; The KIDSCREEN Group Europe, 2006, THE KIDSCREEN QUESTI; The World Health Organization's (WHO), 2014, INTERNATIONAL CLASSI; Theunissen NCM, 1998, QUAL LIFE RES, V7, P387, DOI 10.1023/A:1008801802877; Todd J, 2006, PEDIATRICS, V118, P577, DOI 10.1542/peds.2006-0162; Valderas JM, 2008, QUAL LIFE RES, V17, P1125, DOI 10.1007/s11136-008-9396-4; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-2; Varni James W, 2005, Health Qual Life Outcomes, V3, P34, DOI 10.1186/1477-7525-3-34; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Waters E, 2009, DEV MED CHILD NEUROL, V51, P660, DOI 10.1111/j.1469-8749.2009.03324.x; World Health Organization, 2007, INT CLASS FUNCT DIS; World Health Organization (WHO), 2001, INTERNATIONAL CLASSI	49	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107771	10.1371/journal.pone.0107771	http://dx.doi.org/10.1371/journal.pone.0107771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268926	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700046
J	Victor, B; Blevins, M; Green, AF; Ndatimana, E; Gonzalez-Calvo, L; Fischer, EF; Vergara, AE; Vermund, SH; Olupona, O; Moon, TD				Victor, Bart; Blevins, Meridith; Green, Ann F.; Ndatimana, Elisee; Gonzalez-Calvo, Lazaro; Fischer, Edward F.; Vergara, Alfredo E.; Vermund, Sten H.; Olupona, Omo; Moon, Troy D.			Multidimensional Poverty in Rural Mozambique: A New Metric for Evaluating Public Health Interventions	PLOS ONE			English	Article							INEQUALITY	Background: Poverty is a multidimensional phenomenon and unidimensional measurements have proven inadequate to the challenge of assessing its dynamics. Dynamics between poverty and public health intervention is among the most difficult yet important problems faced in development. We sought to demonstrate how multidimensional poverty measures can be utilized in the evaluation of public health interventions; and to create geospatial maps of poverty deprivation to aid implementers in prioritizing program planning. Methods: Survey teams interviewed a representative sample of 3,749 female heads of household in 259 enumeration areas across Zambezia in August-September 2010. We estimated a multidimensional poverty index, which can be disaggregated into context-specific indicators. We produced an MPI comprised of 3 dimensions and 11 weighted indicators selected from the survey. Households were identified as "poor'' if were deprived in >33% of indicators. Our MPI is an adjusted headcount, calculated by multiplying the proportion identified as poor (headcount) and the poverty gap (average deprivation). Geospatial visualizations of poverty deprivation were created as a contextual baseline for future evaluation. Results: In our rural (96%) and urban (4%) interviewees, the 33% deprivation cut-off suggested 58.2% of households were poor (29.3% of urban vs. 59.5% of rural). Among the poor, households experienced an average deprivation of 46%; thus the MPI/adjusted headcount is 0.27 (= 0.58x0.46). Of households where a local language was the primary language, 58.6% were considered poor versus Portuguese-speaking households where 73.5% were considered non-poor. Living standard is the dominant deprivation, followed by health, and then education. Conclusions: Multidimensional poverty measurement can be integrated into program design for public health interventions, and geospatial visualization helps examine the impact of intervention deployment within the context of distinct poverty conditions. Both permit program implementers to focus resources and critically explore linkages between poverty and its social determinants, thus deriving useful findings for evidence-based planning.	[Victor, Bart] Vanderbilt Univ, Owen Grad Sch Management, Nashville, TN 37235 USA; [Victor, Bart; Blevins, Meridith; Green, Ann F.; Vergara, Alfredo E.; Vermund, Sten H.; Moon, Troy D.] Vanderbilt Univ, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA; [Blevins, Meridith] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37235 USA; [Vergara, Alfredo E.] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37235 USA; [Vermund, Sten H.; Moon, Troy D.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37235 USA; [Ndatimana, Elisee; Gonzalez-Calvo, Lazaro; Vermund, Sten H.; Moon, Troy D.] Friends Global Hlth, Maputo, Mozambique; [Fischer, Edward F.] Vanderbilt Univ, Vanderbilt Ctr Latin Amer Studies, Nashville, TN 37235 USA; [Fischer, Edward F.] Vanderbilt Univ, Dept Anthropol, Nashville, TN 37235 USA; [Olupona, Omo] World Vis Int, Maputo, Mozambique	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Moon, TD (corresponding author), Vanderbilt Univ, Vanderbilt Inst Global Hlth, 221 Kirkland Hall, Nashville, TN 37235 USA.	troy.moon@vanderbilt.edu	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698; Fischer, Edward/0000-0002-7272-9832; Gonzalez Calvo, Lazaro/0000-0002-5376-929X; Green, Ann/0000-0002-9248-2216; Blevins, Meridith/0000-0002-3861-9859; Moon, Troy/0000-0002-1637-829X	United States Agency for International Development (USAID)-Mozambique through a sub-grant from World Vision, Inc. [656-A-00-09-00141-00]; Vanderbilt University through the endowment of the Amos Christie Chair in Global Health	United States Agency for International Development (USAID)-Mozambique through a sub-grant from World Vision, Inc.(United States Agency for International Development (USAID)); Vanderbilt University through the endowment of the Amos Christie Chair in Global Health	The Ogumaniha-SCIP baseline survey was supported by the United States Agency for International Development (USAID)-Mozambique (Award No. 656-A-00-09-00141-00) through a sub-grant from World Vision, Inc. Funding support for the secondary data analysis is from Vanderbilt University through the endowment of the Amos Christie Chair in Global Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire S, 2011, P GERM DEV EC C BERL; Alkire S, 2011, J PUBLIC ECON, V95, P476, DOI 10.1016/j.jpubeco.2010.11.006; Anand S, CONCEPTS HUMAN DEV P; [Anonymous], 2010, LANCET, V375, P526, DOI 10.1016/S0140-6736(10)60056-6; Bourguignon F., 2003, J ECON INEQUAL, V1, P25, DOI DOI 10.1023/A:1023913831342; Ciampa PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039391; Cook RE, 2011, JAIDS-J ACQ IMM DEF, V56, pE104, DOI 10.1097/QAI.0b013e318207a535; Deutsch J, 2005, REV INCOME WEALTH, P145; Dodd R, 2006, ANN TROP MED PARASIT, V100, P379, DOI 10.1179/136485906X97471; Fanzo JC, 2011, FOOD NUTR BULL, V32, P144, DOI 10.1177/156482651103200207; Ferguson J, 1999, EXPECTATIONS MODERNI; Friedman M.A., 1957, THEORY CONSUMPTION F; Gaffikin Lynne, 2007, MedGenMed, V9, P17; Guedes GR, 2012, HUM ECOL, V40, P41, DOI 10.1007/s10745-011-9444-5; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Moon TD, 2011, INT J STD AIDS, V22, P621, DOI 10.1258/ijsa.2011.010442; Moon Troy D, 2010, Retrovirology (Auckl), V3, P1; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Sagar AD, 1998, ECOL ECON, V25, P249, DOI 10.1016/S0921-8009(97)00168-7; Saith A, 2011, DEV CHANGE, V42, P70, DOI 10.1111/j.1467-7660.2011.01705.x; Sen A., 2000, J HUMAN DEV, V1, P17, DOI [10.1080/14649880050008746, DOI 10.1080/14649880050008746]; The United Nations Development Agenda, DEV ALL; Victor B, 2013, WORLD DEV, V47, P30, DOI 10.1016/j.worlddev.2013.02.005	23	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108654	10.1371/journal.pone.0108654	http://dx.doi.org/10.1371/journal.pone.0108654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268951	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700136
J	Kawasaki, A; Furukawa, H; Nishida, N; Warabi, E; Kondo, Y; Ito, S; Matsumoto, I; Kusaoi, M; Amano, H; Suda, A; Nagaoka, S; Setoguchi, K; Nagai, T; Hirohata, S; Shimada, K; Sugii, S; Okamoto, A; Chiba, N; Suematsu, E; Ohno, S; Katayama, M; Okamoto, A; Kono, H; Tokunaga, K; Takasaki, Y; Hashimoto, H; Sumida, T; Tohma, S; Tsuchiya, N				Kawasaki, Aya; Furukawa, Hiroshi; Nishida, Nao; Warabi, Eiji; Kondo, Yuya; Ito, Satoshi; Matsumoto, Isao; Kusaoi, Makio; Amano, Hirofumi; Suda, Akiko; Nagaoka, Shouhei; Setoguchi, Keigo; Nagai, Tatsuo; Hirohata, Shunsei; Shimada, Kota; Sugii, Shoji; Okamoto, Akira; Chiba, Noriyuki; Suematsu, Eiichi; Ohno, Shigeru; Katayama, Masao; Okamoto, Akiko; Kono, Hajime; Tokunaga, Katsushi; Takasaki, Yoshinari; Hashimoto, Hiroshi; Sumida, Takayuki; Tohma, Shigeto; Tsuchiya, Naoyuki			Association of Functional Polymorphisms in Interferon Regulatory Factor 2 (IRF2) with Susceptibility to Systemic Lupus Erythematosus: A Case-Control Association Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; REGULATORY FACTOR (IRF)-2; IFN-GAMMA; I INTERFERON; GENETICS; RISK; LOCI; TRANSCRIPTION; ACTIVATION; EXPRESSION	Interferon regulatory factor 2 (IRF2) negatively regulates type I interferon (IFN) responses, while it plays a role in induction of Th1 differentiation. Previous linkage and association studies in European-American populations suggested genetic role of IRF2 in systemic lupus erythematosus (SLE); however, this observation has not yet been confirmed. No studies have been reported in the Asian populations. Here we investigated whether IRF2 polymorphisms contribute to susceptibility to SLE in a Japanese population. Association study of 46 IRF2 tag single nucleotide polymorphisms (SNPs) detected association of an intronic SNP, rs13146124, with SLE. When the association was analyzed in 834 Japanese patients with SLE and 817 healthy controls, rs13146124 T was significantly increased in SLE compared with healthy controls (dominant model, P = 5.4610(-4), Bonferroni-corrected P [Pc] = 0.026, odds ratio [OR] 1.48, 95% confidence interval [CI] 1.18-1.85). To find causal SNPs, resequencing was performed by next-generation sequencing. Twelve polymorphisms in linkage disequilibrium with rs13146124 (r(2) : 0.30-1.00) were identified, among which significant association was observed for rs66801661 (allele model, P = 7.7x10(-4), Pc = 0.037, OR 1.53, 95% CI 1.19-1.96) and rs62339994 (dominant model, P = 9.0x10(-4), Pc = 0.043, OR 1.46, 95% CI 1.17-1.82). The haplotype carrying both of the risk alleles (rs66801661A-rs62339994A) was significantly increased in SLE (P = 9.9x10(-4)), while the haplotype constituted by both of the non-risk alleles (rs66801661G-rs62339994G) was decreased (P = 0.0020). A reporter assay was carried out to examine the effect of the IRF2 haplotypes on the transcriptional activity, and association of the IRF2 risk haplotype with higher transcriptional activity was detected in Jurkat T cells under IFN gamma stimulation (Tukey's test, P = 1.2x10(-4)). In conclusion, our observations supported the association of IRF2 with susceptibility to SLE, and the risk haplotype was suggested to be associated with transcriptional activation of IRF2.	[Kawasaki, Aya; Tsuchiya, Naoyuki] Univ Tsukuba, Fac Med, Mol & Genet Epidemiol Lab, Tsukuba, Ibaraki, Japan; [Furukawa, Hiroshi; Tohma, Shigeto] Natl Hosp Org, Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan; [Nishida, Nao] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Chiba, Japan; [Warabi, Eiji] Univ Tsukuba, Fac Med, Environm Mol Biol Lab, Tsukuba, Ibaraki, Japan; [Kondo, Yuya; Matsumoto, Isao; Sumida, Takayuki] Univ Tsukuba, Fac Med, Dept Internal Med, Tsukuba, Ibaraki, Japan; [Ito, Satoshi] Niigata Rheumat Ctr, Dept Rheumatol, Shibata, Niigata, Japan; [Kusaoi, Makio; Amano, Hirofumi; Takasaki, Yoshinari] Juntendo Univ, Sch Med, Dept Internal Med & Rheumatol, Tokyo 113, Japan; [Suda, Akiko; Nagaoka, Shouhei] Yokohama Minami Kyosai Hosp, Dept Rheumatol, Yokohama, Kanagawa, Japan; [Suda, Akiko; Ohno, Shigeru] Yokohama City Univ, Med Ctr, Ctr Rheumat Dis, Yokohama, Kanagawa 232, Japan; [Setoguchi, Keigo] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan; [Nagai, Tatsuo; Hirohata, Shunsei] Kitasato Univ, Sch Med, Dept Rheumatol & Infect Dis, Sagamihara, Kanagawa 228, Japan; [Shimada, Kota; Sugii, Shoji] Tokyo Metropolitan Tama Med Ctr, Dept Rheumatol, Fuchu, Tokyo, Japan; [Okamoto, Akira] Natl Hosp Org, Himeji Med Ctr, Dept Rheumatol, Himeji, Hyogo, Japan; [Chiba, Noriyuki] Natl Hosp Org, Morioka Hosp, Dept Rheumatol, Morioka, Iwate, Japan; [Suematsu, Eiichi] Natl Hosp Org, Kyushu Med Ctr, Clin Res Inst, Dept Internal Med & Rheumatol, Fukuoka, Japan; [Katayama, Masao] Natl Hosp Org, Nagoya Med Ctr, Dept Internal Med, Nagoya, Aichi, Japan; [Okamoto, Akiko; Kono, Hajime] Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan; [Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan; [Hashimoto, Hiroshi] Juntendo Univ, Sch Med, Tokyo 113, Japan	University of Tsukuba; National Center for Global Health & Medicine - Japan; University of Tsukuba; University of Tsukuba; Juntendo University; Yokohama City University; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Kitasato University; Nagoya Medical Center; Teikyo University; University of Tokyo; Juntendo University	Tsuchiya, N (corresponding author), Univ Tsukuba, Fac Med, Mol & Genet Epidemiol Lab, Tsukuba, Ibaraki, Japan.	tsuchiya-tky@umin.net	Hashimoto, Hiroshi/AAD-3667-2020; Ito, Satoshi/AAL-9615-2020; Tsuchiya, Naoyuki/CAA-4545-2022	Tsuchiya, Naoyuki/0000-0002-6776-5580; Kono, Hajime/0000-0002-4578-8677	Japan Society for the Promotion of Science [22390199, 23659495, 2379110]; Ministry of Health, Labour and Welfare of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Japan Society for the Promotion of Science (JSPS; http://www.jsps.go.jp/) KAKENHI (Grants-in-Aid for Scientific Research) grant numbers 22390199 (NT), 23659495 (NT) and 23791101 (AK), Health and Labour Science Research Grants for the Research on intractable diseases from the Ministry of Health, Labour and Welfare of Japan (http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/) (NT), Japan Allergy Foundation (http://www.jaanet.org/) (NT), and Cooperative Research Grant of the Plant Transgenic Design Initiative, Gene Research Center, University of Tsukuba (http://ptrad.gene.tsukuba.ac.jp/)(for the facility). No individuals employed or contracted by the funders played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentham J, 2013, LUPUS, V22, P1205, DOI 10.1177/0961203313492870; Bronson PG, 2012, CURR OPIN IMMUNOL, V24, P530, DOI 10.1016/j.coi.2012.07.008; CHA Y, 1994, J BIOL CHEM, V269, P5279; Costa-Reis P, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0369-4; Cui Y, 2013, J AUTOIMMUN, V41, P25, DOI 10.1016/j.jaut.2013.01.008; Deb A, 2001, J IMMUNOL, V166, P6170, DOI 10.4049/jimmunol.166.10.6170; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fu QO, 2011, ARTHRITIS RHEUM-US, V63, P749, DOI 10.1002/art.30193; Gao PS, 2012, J INVEST DERMATOL, V132, P650, DOI 10.1038/jid.2011.374; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Graham DSC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002341; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Guerra SG, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3844; Haas C, 1998, J IMMUNOL, V160, P3713; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harigai M, 2008, J IMMUNOL, V181, P2211, DOI 10.4049/jimmunol.181.3.2211; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hida S, 2000, IMMUNITY, V13, P643, DOI 10.1016/S1074-7613(00)00064-9; Hikami K, 2011, ARTHRITIS RHEUM-US, V63, P755, DOI 10.1002/art.30188; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Huang WQ, 2007, J BIOL CHEM, V282, P6629, DOI 10.1074/jbc.M607760200; JACOB CO, 1987, J EXP MED, V166, P798, DOI 10.1084/jem.166.3.798; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Karonitsch T, 2009, ARTHRITIS RHEUM, V60, P1463, DOI 10.1002/art.24449; Kawasaki A, 2008, ARTHRITIS RHEUM-US, V58, P826, DOI 10.1002/art.23216; Kyogoku C, 2007, GENES IMMUN, V8, P445, DOI 10.1038/sj.gene.6364409; Lessard CJ, 2012, AM J HUM GENET, V90, P648, DOI 10.1016/j.ajhg.2012.02.023; Lohoff M, 2000, J EXP MED, V192, P325, DOI 10.1084/jem.192.3.325; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Masutani K, 2001, ARTHRITIS RHEUM, V44, P2097, DOI 10.1002/1529-0131(200109)44:9<2097::AID-ART360>3.0.CO;2-6; Murata H, 2002, ARTHRITIS RHEUM, V46, P2141, DOI 10.1002/art.10432; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; Ramos P, 2006, 2006 AM COLL RHEUM A; Ramos PS, 2006, GENES IMMUN, V7, P417, DOI 10.1038/sj.gene.6364316; Ramos PS, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/203435; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Rullo OJ, 2013, ANN RHEUM DIS, V72, P56, DOI 10.1136/annrheumdis-2012-202351; Savitsky D, 2010, CANCER IMMUNOL IMMUN, V59, P489, DOI 10.1007/s00262-009-0804-6; Weckerle CE, 2011, ARTHRITIS RHEUM-US, V63, P1044, DOI 10.1002/art.30187	41	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109764	10.1371/journal.pone.0109764	http://dx.doi.org/10.1371/journal.pone.0109764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285625	Green Submitted, Green Published, gold			2022-12-27	WOS:000345743700089
J	Cheng, DJ; Qian, WL; Wang, YH; Meng, M; Wei, L; Li, ZQ; Kang, LX; Peng, J; Xia, QY				Cheng, Daojun; Qian, Wenliang; Wang, Yonghu; Meng, Meng; Wei, Ling; Li, Zhiqing; Kang, Lixia; Peng, Jian; Xia, Qingyou			Nuclear Import of Transcription Factor BR-C Is Mediated by Its Interaction with RACK1	PLOS ONE			English	Article							PROTEIN-KINASE-C; BROAD-COMPLEX FUNCTION; CENTRAL-NERVOUS-SYSTEM; DROSOPHILA-MELANOGASTER; BOMBYX-MORI; JUVENILE-HORMONE; INDUCED EXPRESSION; BTB DOMAIN; CELL-DEATH; METAMORPHOSIS	The transcription factor Broad Complex (BR-C) is an early ecdysone response gene in insects and contains two types of domains: two zinc finger domains for the activation of gene transcription and a Bric-a-brac/Tramtrack/Broad complex (BTB) domain for protein-protein interaction. Although the mechanism of zinc finger-mediated gene transcription is well studied, the partners interacting with the BTB domain of BR-C has not been elucidated until now. Here, we performed a yeast two-hybrid screen using the BTB domain of silkworm BR-C as bait and identified the receptor for activated C-kinase 1 (RACK1), a scaffolding/anchoring protein, as the novel partner capable of interacting with BR-C. The interaction between BR-C and RACK1 was further confirmed by far-western blotting and pull-down assays. Importantly, the disruption of this interaction, via RNAi against the endogenous RACK1 gene or deletion of the BTB domain, abolished the nuclear import of BR-C in BmN4 cells. In addition, RNAi against the endogenous PKC gene as well as phosphorylation-deficient mutation of the predicted PKC phosphorylation sites at either Ser373 or Thr406 in BR-C phenocopied RACK1 RNAi and altered the nuclear localization of BR-C. However, when BTB domain was deleted, phosphorylation mimics of either Ser373 or Thr406 had no effect on the nuclear import of BR-C. Moreover, mutating the PKC phosphorylation sites at Ser373 and Thr406 or deleting the BTB domain significantly decreased the transcriptional activation of a BR-C target gene. Given that RACK1 is necessary for recruiting PKC to close and phosphorylate target proteins, we suggest that the PKC-mediated phosphorylation and nuclear import of BR-C is determined by its interaction with RACK1. This novel finding will be helpful for further deciphering the mechanism underlying the role of BR-C proteins during insect development.	[Cheng, Daojun; Qian, Wenliang; Wang, Yonghu; Meng, Meng; Kang, Lixia; Peng, Jian; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Wei, Ling] Southwest Univ, Sch Life Sci, Chongqing, Peoples R China; [Li, Zhiqing] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Silkworm Sci, Fukuoka 812, Japan	Southwest University - China; Southwest University - China; Kyushu University	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn			National Basic Research Program of China [2012CB114600]; National Natural Science Foundation of China [31272503, 31172267]; National Hi-Tech Research and Development Program of China [2011AA100306]; Municipal Natural Science Foundation of Chongqing [cstc2012jjA80023]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Municipal Natural Science Foundation of Chongqing	Support was provided by the National Basic Research Program of China (no. 2012CB114600), the National Natural Science Foundation of China (no. 31272503 and no. 31172267), the National Hi-Tech Research and Development Program of China (no. 2011AA100306), and the Municipal Natural Science Foundation of Chongqing (no. cstc2012jjA80023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Brennan CA, 2001, DEVELOPMENT, V128, P1; Cakouros D, 2002, J CELL BIOL, V157, P985, DOI 10.1083/jcb.200201034; Cui HY, 2009, INSECT MOL BIOL, V18, P421, DOI 10.1111/j.1365-2583.2009.00889.x; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; DIBELLO PR, 1991, GENETICS, V129, P385; Drier EA, 1999, GENE DEV, V13, P556, DOI 10.1101/gad.13.5.556; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Erezyilmaz DF, 2009, DEV GENES EVOL, V219, P535, DOI 10.1007/s00427-009-0315-7; Erezyilmaz DF, 2006, P NATL ACAD SCI USA, V103, P6925, DOI 10.1073/pnas.0509983103; Faucheux M, 2003, MOL CELL BIOL, V23, P1181, DOI 10.1128/MCB.23.4.1181-1195.2003; Fedele M, 2000, J BIOL CHEM, V275, P7894, DOI 10.1074/jbc.275.11.7894; Gaboreanu AM, 2007, J CELL BIOL, V177, P707, DOI 10.1083/jcb.200608060; HUANG RY, 1992, DEV GENET, V13, P277, DOI 10.1002/dvg.1020130405; Jun JH, 2013, J CELL PHYSIOL, V228, P190, DOI 10.1002/jcp.24121; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Laezza F, 2008, NEUROPHARMACOLOGY, V55, P1131, DOI 10.1016/j.neuropharm.2008.07.021; Lee CY, 2002, DEV BIOL, V250, P101, DOI 10.1006/dbio.2002.0784; Li ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034330; Liu W, 2014, J BIOL CHEM, V289, P13026, DOI 10.1074/jbc.M113.547018; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Mihlan S, 2013, ONCOGENE, V32, P2107, DOI 10.1038/onc.2012.216; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Nery FC, 2004, J BIOL CHEM, V279, P11444, DOI 10.1074/jbc.M306672200; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Nishita Y, 2004, GENE, V339, P161, DOI 10.1016/j.gene.2004.06.039; Nishita Y, 2014, INSECT MOL BIOL, V23, P341, DOI 10.1111/imb.12085; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Piulachs MD, 2010, INSECT BIOCHEM MOLEC, V40, P468, DOI 10.1016/j.ibmb.2010.04.006; Renault N, 2001, DEVELOPMENT, V128, P3729; RESTIFO LL, 1991, DEV BIOL, V148, P174, DOI 10.1016/0012-1606(91)90328-Z; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Ron D, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-53; Rubio M, 2013, J INSECT PHYSIOL, V59, P1089, DOI 10.1016/j.jinsphys.2013.09.003; Sandstrom DJ, 1999, J CELL SCI, V112, P4051; Sandstrom DJ, 1997, DEV BIOL, V181, P168, DOI 10.1006/dbio.1996.8469; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Spokony RF, 2009, J COMP NEUROL, V517, P15, DOI 10.1002/cne.22119; Tzolovsky G, 1999, GENETICS, V153, P1371; Uhlirova M, 2003, P NATL ACAD SCI USA, V100, P15607, DOI 10.1073/pnas.2136837100; Vani K, 1997, BBA-MOL CELL RES, V1358, P67, DOI 10.1016/S0167-4889(97)00079-7; VONKALM L, 1994, EMBO J, V13, P3505, DOI 10.1002/j.1460-2075.1994.tb06657.x; Wang HB, 2009, INSECT BIOCHEM MOLEC, V39, P624, DOI 10.1016/j.ibmb.2009.06.007; Wang HB, 2009, INSECT BIOCHEM MOLEC, V39, P615, DOI 10.1016/j.ibmb.2009.06.008; Wang S, 2012, J PROTEOME RES, V11, P6187, DOI 10.1021/pr3008804; White DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066510; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Xia QY, 2014, ANNU REV ENTOMOL, V59, P513, DOI 10.1146/annurev-ento-011613-161940; Yun CY, 2003, J BIOL CHEM, V278, P18050, DOI 10.1074/jbc.M211714200; Zeng XK, 2012, DEVELOPMENT, V139, P3917, DOI 10.1242/dev.083030; Zhang XY, 2013, AM J PATHOL, V182, P796, DOI 10.1016/j.ajpath.2012.11.020; Zhou BH, 1998, DEV BIOL, V203, P233, DOI 10.1006/dbio.1998.9059; Zhou XF, 2002, DEVELOPMENT, V129, P2259; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	57	6	9	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109111	10.1371/journal.pone.0109111	http://dx.doi.org/10.1371/journal.pone.0109111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25280016	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800056
J	Wei, LQ; Zhang, JQ; Long, ZL; Wu, GR; Hu, XF; Zhang, YL; Wang, J				Wei, Luqing; Zhang, Jiuquan; Long, Zhiliang; Wu, Guo-Rong; Hu, Xiaofei; Zhang, Yanling; Wang, Jian			Reduced Topological Efficiency in Cortical-Basal Ganglia Motor Network of Parkinson's Disease: A Resting State fMRI Study	PLOS ONE			English	Article							CONNECTIVITY BRAIN NETWORKS; FUNCTIONAL CONNECTIVITY; SUBTHALAMIC NUCLEUS; MRI; DISORDERS; PATHOLOGY; SYMPTOMS; LEVODOPA; MODELS; STIMULATION	Parkinson's disease (PD) is mainly characterized by dopamine depletion of the cortico-basal ganglia (CBG) motor circuit. Given that dopamine dysfunction could affect functional brain network efficiency, the present study utilized resting-state fMRI (rs-fMRI) and graph theoretical approach to investigate the topological efficiency changes of the CBG motor network in patients with PD during a relatively hypodopaminergic state (12 hours after a last dose of dopamimetic treatment). We found that PD compared with controls had remarkable decreased efficiency in the CBG motor network, with the most pronounced changes observed in rostral supplementary motor area (pre-SMA), caudal SMA (SMA-proper), primary motor cortex (M1), primary somatosensory cortex (S1), thalamus (THA), globus pallidus (GP), and putamen (PUT). Furthermore, reduced efficiency in pre-SMA, M1, THA and GP was significantly correlated with Unified Parkinson's Disease Rating Scale (UPDRS) motor scores in PD patients. Together, our results demonstrate that individuals with PD appear to be less effective at information transfer within the CBG motor pathway, which provides a novel perspective on neurobiological explanation for the motor symptoms in patients. These findings are in line with the pathophysiology of PD, suggesting that network efficiency metrics may be used to identify and track the pathology of PD.	[Wei, Luqing; Zhang, Jiuquan; Hu, Xiaofei; Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Long, Zhiliang] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab Neuroinformat, Minist Educ, Chengdu 610054, Peoples R China; [Wu, Guo-Rong] Southwest Univ, Fac Psychol, Key Lab Personal & Cognit, Chongqing, Peoples R China; [Wu, Guo-Rong] Univ Ghent, Fac Psychol & Educ Sci, Dept Data Anal, B-9000 Ghent, Belgium; [Zhang, Yanling] Third Mil Med Univ, Southwest Hosp, Dept Neurol, Chongqing, Peoples R China	Army Medical University; University of Electronic Science & Technology of China; Southwest University - China; Ghent University; Army Medical University	Zhang, YL (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Neurol, Chongqing, Peoples R China.	zhangyanlingtmmu@126.com; wangjian_811@gmail.com	ZHANG, JIUQUAN/X-8389-2019	Zhang, Jiuquan/0000-0003-0239-6988				Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Benamer HTS, 2003, MOVEMENT DISORD, V18, P977, DOI 10.1002/mds.10482; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BROOKS DJ, 1990, ANN NEUROL, V28, P547, DOI 10.1002/ana.410280412; Buhmann C, 2003, BRAIN, V126, P451, DOI 10.1093/brain/awg033; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Cheron G, 2000, J CLIN NEUROPHYSIOL, V17, P280, DOI 10.1097/00004691-200005000-00006; Choe I-H, 2013, BRAIN RES; Conte A, 2013, NATURE REV NEUROLOGY; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Eggers C, 2011, MOVEMENT DISORD, V26, P416, DOI 10.1002/mds.23468; Esposito F, 2013, BRAIN, V136, P710, DOI 10.1093/brain/awt007; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Gottlich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077336; Grafton ST, 2004, CURR OPIN NEUROBIOL, V14, P715, DOI 10.1016/j.conb.2004.10.010; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; Halliday GM, 2009, PARKINSONISM RELAT D, V15, pS152, DOI 10.1016/S1353-8020(09)70804-1; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Haslinger B, 2001, BRAIN, V124, P558, DOI 10.1093/brain/124.3.558; Helmich RC, 2011, ANN NEUROL, V69, P269, DOI 10.1002/ana.22361; Helmich RC, 2010, CEREB CORTEX, V20, P1175, DOI 10.1093/cercor/bhp178; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Johnson MD, 2012, J NEUROPHYSIOL, V108, P567, DOI 10.1152/jn.00039.2012; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lewis MM, 2011, NEUROSCIENCE, V177, P230, DOI 10.1016/j.neuroscience.2010.12.060; Martinu K, 2013, BEHAV NEUROSCI, V127, P222, DOI 10.1037/a0031226; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; McKeown MJ, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-8; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Peterson DS, 2014, CLIN NEUROPHYSIOL, V125, P995, DOI 10.1016/j.clinph.2013.10.008; Pievani M, 2011, LANCET NEUROL, V10, P829, DOI 10.1016/S1474-4422(11)70158-2; Pifl C, 2012, MOVEMENT DISORD, V27, P1618, DOI 10.1002/mds.25109; Planetta P, 2012, AM J NEURORADIOLOGY; PLAYFORD ED, 1992, ANN NEUROL, V32, P151, DOI 10.1002/ana.410320206; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Prodoehl J, 2010, MOVEMENT DISORD, V25, P2035, DOI 10.1002/mds.23360; Rub U, 2002, NEUROBIOL AGING, V23, P245, DOI 10.1016/S0197-4580(01)00269-X; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Sharman M, 2012, MOVEMENT DISORDERS; Skidmore F, 2011, NEUROSCI LETT, V499, P47, DOI 10.1016/j.neulet.2011.05.030; Skidmore FM, 2011, NEUROIMAGE; Summerlin JL., 1997, NEUROIMAGE, V5, pS633, DOI DOI 10.1002/(SICI)1097-0193(1997)5:4<238:AID-HBM6>3.0.C0;2-4; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011; WICHMANN T, 1994, J NEUROPHYSIOL, V72, P521, DOI 10.1152/jn.1994.72.2.521; Wu GR, 2013, MED IMAGE ANAL, V17, P365, DOI 10.1016/j.media.2013.01.003; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Wu T, 2011, HUM BRAIN MAPP, V32, P1443, DOI 10.1002/hbm.21118; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yates D, 2012, NAT REV NEUROSCI, V13, P290, DOI [10.1038/nrn3235, 10.1038/nrn3248, 10.1038/nrd3731]; Yu RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059717; Zhan W, 2012, MOVEMENT DISORD, V27, P90, DOI 10.1002/mds.23917; Zhang JQ, 2013, BEHAV BRAIN RES, V252, P18, DOI 10.1016/j.bbr.2013.05.039	62	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108124	10.1371/journal.pone.0108124	http://dx.doi.org/10.1371/journal.pone.0108124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279557	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800010
J	Athamanolap, P; Parekh, V; Fraley, SI; Agarwal, V; Shin, DJ; Jacobs, MA; Wang, TH; Yang, S				Athamanolap, Pornpat; Parekh, Vishwa; Fraley, Stephanie I.; Agarwal, Vatsal; Shin, Dong J.; Jacobs, Michael A.; Wang, Tza-Huei; Yang, Samuel			Trainable High Resolution Melt Curve Machine Learning Classifier for Large-Scale Reliable Genotyping of Sequence Variants	PLOS ONE			English	Article							REAL-TIME PCR; RAPID IDENTIFICATION; SMALL AMPLICONS; DIGITAL PCR; DIFFERENTIATION; METHYLATION; GENERATION; SEROTYPE; ACCURATE; ASSAY	High resolution melt (HRM) is gaining considerable popularity as a simple and robust method for genotyping sequence variants. However, accurate genotyping of an unknown sample for which a large number of possible variants may exist will require an automated HRM curve identification method capable of comparing unknowns against a large cohort of known sequence variants. Herein, we describe a new method for automated HRM curve classification based on machine learning methods and learned tolerance for reaction condition deviations. We tested this method in silico through multiple cross-validations using curves generated from 9 different simulated experimental conditions to classify 92 known serotypes of Streptococcus pneumoniae and demonstrated over 99% accuracy with 8 training curves per serotype. In vitro verification of the algorithm was tested using sequence variants of a cancer-related gene and demonstrated 100% accuracy with 3 training curves per sequence variant. The machine learning algorithm enabled reliable, scalable, and automated HRM genotyping analysis with broad potential clinical and epidemiological applications.	[Athamanolap, Pornpat; Fraley, Stephanie I.; Agarwal, Vatsal; Shin, Dong J.; Wang, Tza-Huei] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Fraley, Stephanie I.; Yang, Samuel] Johns Hopkins Med, Dept Emergency Med, Baltimore, MD USA; [Parekh, Vishwa] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Wang, Tza-Huei] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Parekh, Vishwa; Jacobs, Michael A.] Johns Hopkins Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Jacobs, Michael A.] Johns Hopkins Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Wang, TH (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	thwang@jhu.edu; syang10@jhmi.edu	Wang, Tza-Huei/A-3337-2010; Fraley, Stephanie/GSN-9847-2022; Fraley, Stephanie I./S-6162-2019; Jacobs, Michael A/G-2901-2010	Jacobs, Michael A/0000-0002-1125-1644; Athamanolap, Pornpat/0000-0001-6124-4955; Yang, Samuel/0000-0003-1123-9036; Wang, Tza-Huei/0000-0002-3540-9354; Fraley, Stephanie/0000-0003-1548-4442	E. W. "Al'' Thrasher Research Award; National Science Foundation [1159771, 1033744]; National Institutes of Health [R01CA15305, U01CA140204]; Burroughs Wellcome Fund Career Award; NATIONAL CANCER INSTITUTE [U01CA140204] Funding Source: NIH RePORTER	E. W. "Al'' Thrasher Research Award; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the E. W. "Al'' Thrasher Research Award, National Science Foundation [1159771 and 1033744] and National Institutes of Health [R01CA15305, U01CA140204]. SF is supported by a Burroughs Wellcome Fund Career Award at the Scientific Interface. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arvia R, 2013, J VIROL METHODS, V189, P265, DOI 10.1016/j.jviromet.2013.02.016; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bidet P, 2012, EUR J CLIN MICROBIOL, V31, P2817, DOI 10.1007/s10096-012-1635-5; Bougel S, 2013, CLIN CANCER RES, V19, P2216, DOI 10.1158/1078-0432.CCR-12-1246; Bratcher PE, 2010, MICROBIOL-SGM, V156, P555, DOI 10.1099/mic.0.034116-0; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; DIEFFENBACH CW, 1993, PCR METH APPL, V3, pS30; Dwight Z, 2011, BIOINFORMATICS, V27, P1019, DOI 10.1093/bioinformatics/btr065; Er TK, 2012, CLIN CHIM ACTA, V414, P197, DOI 10.1016/j.cca.2012.09.012; Erali Maria, 2008, V429, P199, DOI 10.1007/978-1-60327-040-3_14; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Fraley SI, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt684; Gori A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030199; Gundry CN, 2008, NUCLEIC ACIDS RES, V36, P3401, DOI 10.1093/nar/gkn204; Gurtler V, 2012, J MICROBIOL METH, V90, P167, DOI 10.1016/j.mimet.2012.05.002; Hayden RT, 2013, J CLIN MICROBIOL, V51, P540, DOI 10.1128/JCM.02620-12; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Jeng K, 2012, J CLIN MICROBIOL, V50, P1122, DOI 10.1128/JCM.05121-11; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Li BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028078; Lievens A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047112; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Lo PK, 2009, J MOL DIAGN, V11, P400, DOI 10.2353/jmoldx.2009.080126; Lopez C.M. Rodriguez, 2010, ANAL CHEM; Newman MR, 2012, EPIGENETICS-US, V7, P92, DOI 10.4161/epi.7.1.18815; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Pang Y, 2013, J MICROBIOL METH, V93, P32, DOI 10.1016/j.mimet.2013.01.008; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Pichon B, 2013, J CLIN MICROBIOL, V51, P820, DOI 10.1128/JCM.01917-12; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Reja V, 2010, METHODS, V50, pS10, DOI 10.1016/j.ymeth.2010.02.006; Renz KG, 2013, J VIROL METHODS, V187, P144, DOI 10.1016/j.jviromet.2012.09.018; Roth AL, 2013, J CLIN MICROBIOL, V51, P61, DOI 10.1128/JCM.02193-12; Tong SYC, 2012, J CLIN MICROBIOL, V50, P3418, DOI 10.1128/JCM.01709-12; Tricarico R, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-305; Vapnik V., 2013, NATURE STAT LAERNING; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Vondrackova A, 2012, J HUM GENET, V57, P442, DOI 10.1038/jhg.2012.49; Weinberger KQ, 2009, J MACH LEARN RES, V10, P207; Whale AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058177; Yang S, 2009, J CLIN MICROBIOL, V47, P2252, DOI 10.1128/JCM.00033-09; Zeinzinger J, 2012, APPL ENVIRON MICROB, V78, P3352, DOI 10.1128/AEM.07668-11; Zou HZ, 2009, GASTROENTEROLOGY, V136, P459, DOI 10.1053/j.gastro.2008.10.023	48	29	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109094	10.1371/journal.pone.0109094	http://dx.doi.org/10.1371/journal.pone.0109094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275518	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500058
J	Lima, GZD; Lobao-Soares, B; do Nascimento, GC; Franca, ASC; Muratori, L; Ribeiro, S; Corso, G				dos Santos Lima, G. Z.; Lobao-Soares, B.; do Nascimento, G. C.; Franca, Arthur S. C.; Muratori, L.; Ribeiro, S.; Corso, G.			Mouse Activity across Time Scales: Fractal Scenarios	PLOS ONE			English	Article							DETRENDED FLUCTUATION ANALYSIS; SCALING BEHAVIOR; CIRCADIAN-RHYTHM; HUMAN HEARTBEAT; DYNAMICS; SLEEP; MULTIFRACTALITY; PHYSIOLOGY; NOISE; MICE	In this work we devise a classification of mouse activity patterns based on accelerometer data using Detrended Fluctuation Analysis. We use two characteristic mouse behavioural states as benchmarks in this study: waking in free activity and slow-wave sleep (SWS). In both situations we find roughly the same pattern: for short time intervals we observe high correlation in activity - a typical 1/f complex pattern - while for large time intervals there is anti-correlation. High correlation of short intervals (0.01 s to 2 s: waking state and 0.01 s to 0.1 s: SWS) is related to highly coordinated muscle activity. In the waking state we associate high correlation both to muscle activity and to mouse stereotyped movements (grooming, waking, etc.). On the other side, the observed anti-correlation over large time scales (30 s to 300 s: waking state and 0.3 s to 5 s: SWS) during SWS appears related to a feedback autonomic response. The transition from correlated regime at short scales to an anti-correlated regime at large scales during SWS is given by the respiratory cycle interval, while during the waking state this transition occurs at the time scale corresponding to the duration of the stereotyped mouse movements. Furthermore, we find that the waking state is characterized by longer time scales than SWS and by a softer transition from correlation to anti-correlation. Moreover, this soft transition in the waking state encompass a behavioural time scale window that gives rise to a multifractal pattern. We believe that the observed multifractality in mouse activity is formed by the integration of several stereotyped movements each one with a characteristic time correlation. Finally, we compare scaling properties of body acceleration fluctuation time series during sleep and wake periods for healthy mice. Interestingly, differences between sleep and wake in the scaling exponents are comparable to previous works regarding human heartbeat. Complementarily, the nature of these sleep-wake dynamics could lead to a better understanding of neuroautonomic regulation mechanisms.	[dos Santos Lima, G. Z.] Univ Fed Rio Grande do Norte, Fac Ciencias & Tecnol, BR-59072970 Natal, RN, Brazil; [Lobao-Soares, B.; Muratori, L.; Corso, G.] Univ Fed Rio Grande do Norte, Ctr Biofis, BR-59072970 Natal, RN, Brazil; [do Nascimento, G. C.] Univ Fed Rio Grande do Norte, Dept Biomed Engn, BR-59072970 Natal, RN, Brazil; [Franca, Arthur S. C.; Ribeiro, S.] Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil; [dos Santos Lima, G. Z.] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; [dos Santos Lima, G. Z.] Boston Univ, Dept Phys, Boston, MA 02215 USA	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Boston University; Boston University	Corso, G (corresponding author), Univ Fed Rio Grande do Norte, Ctr Biofis, BR-59072970 Natal, RN, Brazil.	gcorso@bf.ufrn.br	França, Arthur S. C./J-1576-2015; Corso, Gilberto/G-6160-2012; dos Santos Lima, Gustavo Zampier/S-6984-2019; Soares, Bruno L/N-1142-2018; França, Arthur/F-2667-2014; Corso, Gilberto/AAE-9056-2021; Ribeiro, Sidarta/C-5794-2016	França, Arthur S. C./0000-0002-5836-1672; Corso, Gilberto/0000-0003-1748-4040; dos Santos Lima, Gustavo Zampier/0000-0002-4462-0522; Soares, Bruno L/0000-0003-4564-2288; Corso, Gilberto/0000-0003-1748-4040; Ribeiro, Sidarta/0000-0001-9325-9545	Capes; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; FINEP; Programa Primeiros Projetos of Fundacao de Apoio a Pesquisa do RN (PPP-FAPERN) [05/2011]; CAPES [BEX 11264/13-6]	Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FINEP(Financiadora de Inovacao e Pesquisa (Finep)); Programa Primeiros Projetos of Fundacao de Apoio a Pesquisa do RN (PPP-FAPERN); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Financial support from Capes and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and FINEP are acknowledged. Gustavo Zampier dos Santos Lima and Bruno Lobao Soares was supported by Programa Primeiros Projetos of Fundacao de Apoio a Pesquisa do RN (PPP-FAPERN Grant No 05/2011) and CAPES (Proc. No. BEX 11264/13-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anteneodo C, 2009, CHAOS, V19, DOI 10.1063/1.3211189; Ashkenazy Y, 2002, PHYSICA A, V316, P662, DOI 10.1016/S0378-4371(02)01453-X; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Bashan A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1705; Bassingthwaighte J. B., 1994, FRACTAL PHYSL; Beck TW, 2007, J ELECTROMYOGR KINES, V17, P1, DOI 10.1016/j.jelekin.2005.12.002; Boyett MR, 2009, EXP PHYSIOL, V24, P654; Bunde A, 2000, PHYS REV LETT, V85, P3736, DOI 10.1103/PhysRevLett.85.3736; Chakravarthy VS, 2010, BIOL CYBERN, V103, P237, DOI 10.1007/s00422-010-0401-y; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; Chen Z, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011104; Lima GZD, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.066117; Fowler SC, 2001, J NEUROSCI METH, V107, P107, DOI 10.1016/S0165-0270(01)00359-4; Garcia AJ, 2010, J NEUROSCI, V30, P8251; Gieraltowski J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.021915; Hausdorff JM, 2001, PHYSICA A, V302, P138, DOI 10.1016/S0378-4371(01)00460-5; Heneghan C, 2000, PHYS REV E, V62, P6103, DOI 10.1103/PhysRevE.62.6103; Houston AI, 2014, J ANIM ECOL, V83, P30, DOI 10.1111/1365-2656.12096; Hu K, 2007, NEUROSCIENCE, V149, P508, DOI 10.1016/j.neuroscience.2007.03.058; Hu K, 2004, PHYSICA A, V337, P307, DOI 10.1016/j.physa.2004.01.042; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; Ihlen EAF, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00141; Islam A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072258; Ivanov PC, 1998, EUROPHYS LETT, V43, P363, DOI 10.1209/epl/i1998-00366-3; Ivanov PC, 1999, EUROPHYS LETT, V48, P594, DOI 10.1209/epl/i1999-00525-0; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; Ivanov PC, 2001, CHAOS, V11, P641, DOI 10.1063/1.1395631; Ivanov PC, 2007, P NATL ACAD SCI USA, V104, P20702, DOI 10.1073/pnas.0709957104; Ivanov PC, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041920; Kantelhardt JW, 2001, PHYSICA A, V295, P441, DOI 10.1016/S0378-4371(01)00144-3; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; Kantelhardt JW, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051908; Kantelhardt JW, 2003, PHYSICA A, V319, P447, DOI 10.1016/S0378-4371(02)01502-9; Karasik R, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.062902; Knab AM, 2009, PHYSIOL BEHAV, V98, P433, DOI 10.1016/j.physbeh.2009.07.006; Ludescher J, 2011, PHYSICA A, V390, P2480, DOI 10.1016/j.physa.2011.03.008; Ma QDY, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031101; Ma XY, 2003, CLIN EXP PHARMACOL P, V30, P885, DOI 10.1046/j.1440-1681.2003.03927.x; MANDELBROT BB, 1989, P ROY SOC LOND A MAT, V423, P3, DOI 10.1098/rspa.1989.0038; McAuley JH, 1997, EXP BRAIN RES, V114, P525, DOI 10.1007/PL00005662; Mora T, 2011, J STAT PHYS, V144, P268, DOI 10.1007/s10955-011-0229-4; Nakamura T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138103; Nakamura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002050; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Peng CK, 2002, ANN BIOMED ENG, V30, P683, DOI 10.1114/1.1481053; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Pittman-Polletta BR, 2013, BIOL REV, V88, P873, DOI 10.1111/brv.12032; Ramirez JM, 2011, J BIOL PHYS, V37, P241, DOI 10.1007/s10867-011-9214-z; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; Scafetta N, 2009, CHAOS, V19, DOI 10.1063/1.3143035; Schmitt DT, 2007, AM J PHYSIOL-REG I, V293, pR1923, DOI 10.1152/ajpregu.00372.2007; Schmitt DT, 2009, IEEE T BIO-MED ENG, V56, P1564, DOI 10.1109/TBME.2009.2014819; Schumann AY, 2010, SLEEP, V33, P943, DOI 10.1093/sleep/33.7.943; Smith JC, 2013, TRENDS NEUROSCI, V36, P152, DOI 10.1016/j.tins.2012.11.004; Stanley HE, 1999, PHYSICA A, V270, P309, DOI 10.1016/S0378-4371(99)00230-7; Talkner P, 2000, PHYS REV E, V62, P150, DOI 10.1103/PhysRevE.62.150; Tang YY, 2012, TRENDS COGN SCI, V16, P330, DOI 10.1016/j.tics.2012.05.001; Taqqu MS, 1995, FRACTALS, V3, P785, DOI 10.1142/S0218348X95000692; Tou JCL, 2002, EXP BIOL MED, V227, P587, DOI 10.1177/153537020222700806; Venkatraman S, 2010, J NEUROPHYSIOL, V104, P569, DOI 10.1152/jn.00121.2010; Williams Rhiannan H., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000823; Xu LM, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051101; Xu YL, 2011, PHYSICA A, V390, P4057, DOI 10.1016/j.physa.2011.05.015; Young CN, 2011, AM J PHYSIOL-HEART C, V24, P654	64	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e105092	10.1371/journal.pone.0105092	http://dx.doi.org/10.1371/journal.pone.0105092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275515	Green Submitted, gold, Green Published			2022-12-27	WOS:000342591500003
J	Marfa, S; Crespo, G; Reichenbach, V; Forns, X; Casals, G; Morales-Ruiz, M; Navasa, M; Jimenez, W				Marfa, Santiago; Crespo, Gonzalo; Reichenbach, Vedrana; Forns, Xavier; Casals, Gregori; Morales-Ruiz, Manuel; Navasa, Miquel; Jimenez, Wladimiro			Lack of a 5.9 kDa Peptide C-Terminal Fragment of Fibrinogen alpha Chain Precedes Fibrosis Progression in Patients with Liver Disease	PLOS ONE			English	Article							CHRONIC HEPATITIS; FEATURES; COMBINATIONS; BIOMARKERS; DIAGNOSIS; MARKERS; TIME; ELF	Early detection of fibrosis progression is of major relevance for the diagnosis and management of patients with liver disease. This study was designed to find non-invasive biomarkers for fibrosis in a clinical context where this process occurs rapidly, HCV-positive patients who underwent liver transplantation (LT). We analyzed 93 LT patients with HCV recurrence, 41 non-LT patients with liver disease showing a fibrosis stage F >= 1 and 9 patients without HCV recurrence who received antiviral treatment before LT, as control group. Blood obtained from 16 healthy subjects was also analyzed. Serum samples were fractionated by ion exchange chromatography and their proteomic profile was analyzed by SELDI-TOF-MS. Characterization of the peptide of interest was performed by ion chromatography and electrophoresis, followed by tandem mass spectrometry identification. Marked differences were observed between the serum proteome profile of LT patients with early fibrosis recurrence and non-recurrent LT patients. A robust peak intensity located at 5905 m/z was the distinguishing feature of non-recurrent LT patients. However, the same peak was barely detected in recurrent LT patients. Similar results were found when comparing samples of healthy subjects with those of non-LT fibrotic patients, indicating that our findings were not related to either LT or HCV infection. Using tandem mass-spectrometry, we identified the protein peak as a C-terminal fragment of the fibrinogen a chain. Cell culture experiments demonstrated that TGF-beta reduces alpha-fibrinogen mRNA expression and 5905 m/z peak intensity in HepG2 cells, suggesting that TGF-beta activity regulates the circulating levels of this protein fragment. In conclusion, we identified a 5.9 kDa C-terminal fragment of the fibrinogen alpha chain as an early serum biomarker of fibrogenic processes in patients with liver disease.	[Marfa, Santiago; Reichenbach, Vedrana; Casals, Gregori; Morales-Ruiz, Manuel; Jimenez, Wladimiro] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Hosp Clin, Biochem & Mol Genet Serv,Ctr Invest Biomed Enferm, Barcelona, Spain; [Crespo, Gonzalo; Forns, Xavier; Navasa, Miquel] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Hosp Clin, Liver Unit,Ctr Invest Biomed Red Enfermedades Hep, Barcelona, Spain; [Jimenez, Wladimiro] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Hosp Clin, Dept Ciencies Fisiol 1,Ctr Invest Biomed Red Enfe, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Jimenez, W (corresponding author), Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Hosp Clin, Biochem & Mol Genet Serv,Ctr Invest Biomed Enferm, Barcelona, Spain.	wjimenez@clinic.ub.es	Morales-Ruiz, Manuel/Z-2332-2019; Morales-Ruiz, Manuel/L-1031-2014; Navasa, Miquel/G-7958-2016; Casals, Gregori/F-6506-2012; Morales-Ruiz, Manuel/AAM-1487-2020	Morales-Ruiz, Manuel/0000-0002-9074-2272; Morales-Ruiz, Manuel/0000-0002-9074-2272; Navasa, Miquel/0000-0002-3130-9604; Casals, Gregori/0000-0002-3271-1371; Marfa, Santiago/0000-0002-5862-9560; Jimenez, Wladimiro/0000-0002-9376-0214; Crespo, Gonzalo/0000-0002-1178-4897; Forns, Xavier/0000-0002-8188-1764	Direccion General de Investigacion Cientifica y Tecnica [SAF 2009-08839, SAF 2012-35979, SAF 2010-19025]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [SGR2009/1496]; Instituto de Salud Carlos III; European Union through the European Regional Development Fund (ERDF)	Direccion General de Investigacion Cientifica y Tecnica(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Union through the European Regional Development Fund (ERDF)	This work was supported by grants Direccion General de Investigacion Cientifica y Tecnica (SAF 2009-08839 and SAF 2012-35979 to W. Jimenez and SAF 2010-19025 to M. Morales-Ruiz) and from the Agencia de Gestio d'Ajuts Universitaris i de Recerca (SGR2009/1496). CIBEREHD is funded by the Instituto de Salud Carlos III. This work is co-financed by the European Union through the European Regional Development Fund (ERDF), "A way of making Europe''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal NH, 2004, AM J GASTROENTEROL, V99, P1160, DOI 10.1111/j.1572-0241.2004.30110.x; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Belluco C, 2007, ANN SURG ONCOL, V14, P2470, DOI 10.1245/s10434-007-9354-3; Berenguer M, 2013, J HEPATOL, V58, P1028, DOI 10.1016/j.jhep.2012.12.014; Blasco A, 2006, HEPATOLOGY, V43, P492, DOI 10.1002/hep.21090; Buenemann CL, 2001, CARCINOGENESIS, V22, P447, DOI 10.1093/carcin/22.3.447; Castera L, 2010, GUT, V59, P861, DOI 10.1136/gut.2010.214650; Crespo G, 2012, J HEPATOL, V57, P281, DOI 10.1016/j.jhep.2012.03.016; Dituri F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067109; Engwegen JYMN, 2006, TRENDS PHARMACOL SCI, V27, P251, DOI 10.1016/j.tips.2006.03.003; FARRELL DH, 1991, BIOCHEMISTRY-US, V30, P9414, DOI 10.1021/bi00103a004; Fernandez-Varo G, 2011, EUROP GASTR HEPATOL, V7, P93; Gressner OA, 2007, J CELL MOL MED, V11, P1031, DOI 10.1111/j.1582-4934.2007.00092.x; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Herrick S, 1999, INT J BIOCHEM CELL B, V31, P741, DOI 10.1016/S1357-2725(99)00032-1; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Koopmann J, 2004, CLIN CANCER RES, V10, P860, DOI 10.1158/1078-0432.CCR-1167-3; Lichtinghagen R, 2013, J HEPATOL, V59, P236, DOI 10.1016/j.jhep.2013.03.016; Liu PC, 2000, INT J ONCOL, V16, P599; MACKIEWICZ A, 1991, J IMMUNOL, V146, P3032; MACKIEWICZ A, 1990, P NATL ACAD SCI USA, V87, P1491, DOI 10.1073/pnas.87.4.1491; Martinez SM, 2011, ALIMENT PHARM THER, V33, P138, DOI 10.1111/j.1365-2036.2010.04500.x; Martinez SM, 2011, HEPATOLOGY, V53, P325, DOI 10.1002/hep.24013; Melgar-Lesmes P, 2011, GUT, V60, P1404, DOI 10.1136/gut.2010.234690; Melgar-Lesmes P, 2010, ENDOCRINOLOGY, V151, P5306, DOI 10.1210/en.2010-0754; Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11; Nguyen D, 2011, HEPATOLOGY, V53, P2107, DOI 10.1002/hep.24401; Nomura F, 2004, PROTEOMICS, V4, P1187, DOI 10.1002/pmic.200300674; Pang RTK, 2006, CLIN CHEM, V52, P421, DOI 10.1373/clinchem.2005.061689; Pinzani M, 2008, CLIN LIVER DIS, V12, P901, DOI 10.1016/j.cld.2008.07.006; Reichenbach V, 2013, GUT, V62, P1089, DOI 10.1136/gutjnl-2012-303662; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Rudchenko S, 1996, J BIOL CHEM, V271, P2523, DOI 10.1074/jbc.271.5.2523; Scarlett CJ, 2006, HEPATOLOGY, V44, P658, DOI 10.1002/hep.21294; SCHEUER PJ, 1995, J HEPATOL, V22, P112, DOI 10.1016/0168-8278(95)80269-X; Semmes OJ, 2005, CLIN CHEM, V51, P102, DOI 10.1373/clinchem.2004.038950; Sogawa K, 2013, PROTEOM CLIN APPL, V7, P424, DOI 10.1002/prca.201200094; Tennent GA, 2007, BLOOD, V109, P1971, DOI 10.1182/blood-2006-08-040956; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X	39	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109254	10.1371/journal.pone.0109254	http://dx.doi.org/10.1371/journal.pone.0109254			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275549	gold, Green Published			2022-12-27	WOS:000342591500085
J	Mena-Ulecia, K; Vergara-Jaque, A; Poblete, H; Tiznado, W; Caballero, J				Mena-Ulecia, Karel; Vergara-Jaque, Ariela; Poblete, Horacio; Tiznado, William; Caballero, Julio			Study of the Affinity between the Protein Kinase PKA and Peptide Substrates Derived from Kemptide Using Molecular Dynamics Simulations and MM/GBSA	PLOS ONE			English	Article							DRUG-RESISTANCE; FREE-ENERGY; K+ CHANNEL; BINDING; PHOSPHORYLATION; SPECIFICITY; MECHANISM; RECTIFICATION; ARABIDOPSIS; INHIBITORS	We have carried out a protocol in computational biochemistry including molecular dynamics (MD) simulations and MM/GBSA free energy calculations on the complex between the protein kinase A (PKA) and the specific peptide substrate Kemptide (LRRASLG). We made the same calculations on other PKA complexes that contain Kemptide derivatives (with mutations of the arginines, and with deletions of N and C-terminal amino acids). We predicted shifts in the free energy changes from the free PKA to PKA-substrate complex (DDGERES) when Kemptide structure is modified (we consider that the calculated shifts correlate with the experimental shifts of the free energy changes from the free PKA to the transition states (DDGERTS) determined by the catalytic efficiency (kcat/KM) changes). Our results demonstrate that it is possible to predict the kinetic properties of protein kinases using simple computational biochemistry methods. As an additional benefit, these methods give detailed molecular information that permit the analysis of the atomic forces that contribute to the affinity between protein kinases and their substrates.	[Mena-Ulecia, Karel; Tiznado, William] Univ Andres Bello, Fac Ciencias Exactas, Dept Ciencias Quim, Santiago, Chile; [Vergara-Jaque, Ariela; Poblete, Horacio; Caballero, Julio] Univ Talca, Fac Ingn, Ctr Bioinformat & Simulac Mol, Talca, Chile	Universidad Andres Bello; Universidad de Talca	Caballero, J (corresponding author), Univ Talca, Fac Ingn, Ctr Bioinformat & Simulac Mol, Talca, Chile.	jcaballero@utalca.cl	Vergara-Jaque, Ariela/AAJ-1645-2020; Tiznado, william/G-7479-2014; Vergara, Ariela/AAD-3594-2020; Poblete, Horacio/J-9781-2012; Vergara-Jaque, Ariela/H-1275-2017; Caballero, Julio/G-3654-2014; Poblete, Horacio N/E-4974-2012	Vergara-Jaque, Ariela/0000-0002-1236-013X; Tiznado, william/0000-0002-6061-8879; Vergara-Jaque, Ariela/0000-0002-1236-013X; Caballero, Julio/0000-0003-0182-1444; Poblete, Horacio N/0000-0003-2650-3565	Fondecyt, Chile [1130141]; Universidad Andres Bello [DI-395-13/I]	Fondecyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Universidad Andres Bello	This work was supported by the grant no. 1130141 (J.C.) from Fondecyt, Chile. KMU and WT also wish thank to Universidad Andres Bello for funding through internal project # DI-395-13/I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Adasme-Carreno F, 2014, PHYS CHEM CHEM PHYS, V16, P14047, DOI 10.1039/c4cp01378f; Ben-Shimon A, 2013, CURR PHARM DESIGN, V19, P4173; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Cai ZY, 2012, NEUROMOL MED, V14, P1, DOI 10.1007/s12017-012-8173-2; Cheng YH, 2005, J AM CHEM SOC, V127, P1553, DOI 10.1021/ja0464084; COLBRAN JL, 1992, J BIOL CHEM, V267, P9589; Deeken R, 2000, PLANT J, V23, P285, DOI 10.1046/j.1365-313x.2000.00791.x; Diaz N, 2004, J AM CHEM SOC, V126, P529, DOI 10.1021/ja037277u; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; GLASS DB, 1979, J BIOL CHEM, V254, P9728; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Hou TJ, 2007, J MED CHEM, V50, P1177, DOI 10.1021/jm0609162; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KEMP BE, 1977, J BIOL CHEM, V252, P4888; Kemp BE, 1990, PEPTIDES PROTEIN PHO; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Lacombe B, 2000, PLANT CELL, V12, P837, DOI 10.1105/tpc.12.6.837; Li CQ, 2014, J PHYS CHEM B, V118, P1273, DOI 10.1021/jp411111g; Lu SY, 2011, BIOPOLYMERS, V95, P669, DOI 10.1002/bip.21629; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Michard E, 2005, PLANT J, V44, P783, DOI 10.1111/j.1365-313X.2005.02566.x; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Tanner DE, 2012, J CHEM THEORY COMPUT, V8, P2521, DOI 10.1021/ct3003089; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; THOMAS MK, 1990, J BIOL CHEM, V265, P14971; TSIEN RW, 1972, NATURE-NEW BIOL, V240, P181, DOI 10.1038/newbio240181a0; WALSH KB, 1988, SCIENCE, V242, P67, DOI 10.1126/science.2845575; Wang W, 2001, P NATL ACAD SCI USA, V98, P14937, DOI 10.1073/pnas.251265598; Yang TY, 2011, PROTEINS, V79, P1940, DOI 10.1002/prot.23018; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	38	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109639	10.1371/journal.pone.0109639	http://dx.doi.org/10.1371/journal.pone.0109639			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275314	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500111
J	Morrison, AC; Bis, JC; Hwang, SJ; Ehret, GB; Lumley, T; Rice, K; Muzny, D; Gibbs, RA; Boerwinkle, E; Psaty, BM; Chakravarti, A; Levy, D				Morrison, Alanna C.; Bis, Joshua C.; Hwang, Shih-Jen; Ehret, Georg B.; Lumley, Thomas; Rice, Kenneth; Muzny, Donna; Gibbs, Richard A.; Boerwinkle, Eric; Psaty, Bruce M.; Chakravarti, Aravinda; Levy, Daniel			Sequence Analysis of Six Blood Pressure Candidate Regions in 4,178 Individuals: The Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Targeted Sequencing Study	PLOS ONE			English	Article							WIDE ASSOCIATION; DESIGN; HYPERTENSION; RISK	Background: Genome-wide association studies (GWAS) identified multiple loci for blood pressure (BP) and hypertension. Six genes - ATP2B1, CACNB2, CYP17A1, JAG1, PLEKHA7, and SH2B3 - were evaluated for sequence variation with large effects on systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse pressure (PP), and mean arterial pressure (MAP). Methods and Results: Targeted genomic sequence was determined in 4,178 European ancestry participants from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium. Common variants (>= 50 minor allele copies) were evaluated individually and rare variants (minor allele frequency, MAF <= 1%) were aggregated by locus. 464 common variants were identified across the 6 genes. An upstream CYP17A1 variant, rs11191416 (MAF = 0.09), was the most significant association for SBP (P = 0.0005); however the association was attenuated (P = 0.0469) after conditioning on the GWAS index single nucleotide polymorphism (SNP). A PLEKHA7 intronic variant was the strongest DBP association (rs12806040, MAF = 0.007, P = 0.0006) and was not in LD (r(2) = 0.01) with the GWAS SNP. A CACNB2 intronic SNP, rs1571787, was the most significant association with PP (MAF = 0.27, P = 0.0003), but was not independent from the GWAS SNP (r(2) = 0.34). Three variants (rs6163 and rs743572 in the CYP17A1 region and rs112467382 in PLEKHA7) were associated with BP traits (P<0.001). Rare variation, aggregately assessed in the 6 regions, was not significantly associated with BP measures. Conclusion: Six targeted gene regions, previously identified by GWAS, did not harbor novel variation with large effects on BP in this sample.	[Morrison, Alanna C.; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Bis, Joshua C.; Rice, Kenneth; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Hwang, Shih-Jen; Levy, Daniel] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Hwang, Shih-Jen; Levy, Daniel] NHLBI, Populat Sci Branch, NIH, Bethesda, MD 20892 USA; [Ehret, Georg B.] Univ Hosp Geneva, Dept Med Specialties, Geneva, Switzerland; [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [Ehret, Georg B.; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, Inst Med Genet, Ctr Complex Dis Genom, Baltimore, MD USA; [Muzny, Donna; Gibbs, Richard A.; Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA	University of Texas System; University of Texas Health Science Center Houston; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Geneva; University of Auckland; Johns Hopkins University; Baylor College of Medicine; Group Health Cooperative	Morrison, AC (corresponding author), Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA.	Alanna.C.Morrison@uth.tmc.edu	Hwang, Shih-Jen/HGU-5826-2022; Levy, Daniel/ABF-6873-2021; EHRET, Georg B/A-9532-2009; Levy, Daniel/ABB-2752-2021	Levy, Daniel/0000-0003-1843-8724; EHRET, Georg B/0000-0002-5730-0675; Morrison, Alanna/0000-0001-6381-4296	National Institutes of Health (NIH) through the American Recovery and Reinvestment Act (ARRA) [5RC2HL102419]; National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; NHLBI [HL080295, HL087652, HL105756]; Boston University [N01-HC-25195]; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Boston Medical Center; NIA [AG-023629, AG-15928, AG-20098, AG-027058];  [U54 HG003273]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC045133, N01HC085084, N01HC085079, N01HC085085, N01HC085086, N01HC085082, N01HC055222, N01HC075150, N01HC015103, N01HC025195, N01HC085080, N01HC085081, N01HC085083, N01HC035129] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102419, U01HL080295, ZIAHL006001, R01HL064278, R01HL080295, R01HL105756, R01HL087652] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020098, R56AG023629, R01AG027058, R01AG023629, R56AG020098, R01AG015928] Funding Source: NIH RePORTER	National Institutes of Health (NIH) through the American Recovery and Reinvestment Act (ARRA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Boston Medical Center; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding support for "Building on GWAS for NHLBI-diseases: the U.S. CHARGE Consortium'' was provided by the National Institutes of Health (NIH) through the American Recovery and Reinvestment Act of 2009 (ARRA) (5RC2HL102419). The Human Genome Sequencing Center at Baylor College of Medicine is supported by U54 HG003273. Data for "Building on GWAS for NHLBI-diseases: the U.S. CHARGE Consortium'' was provided by Eric Boerwinkle on behalf of the Atherosclerosis Risk in Communities (ARIC) Study, L. Adrienne Cupples, principal investigator for the Framingham Heart Study, and Bruce Psaty, principal investigator for the Cardiovascular Health Study. The ARIC Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute (NHLBI) contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). The Framingham Heart Study is conducted and supported by the NHLBI in collaboration with Boston University (Contract No. N01-HC-25195), and its contract with Affymetrix, Inc., for genome-wide genotyping services (Contract No. N02-HL-6-4278), for quality control by Framingham Heart Study investigators using genotypes in the SNP Health Association Resource (SHARe) project. A portion of this research was conducted using the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. This CHS research was supported by NHLBI contracts N01-HC-85239, N01-HC-85079, N01-HC-85080, N01-HC-85081, N01-HC-85082, N01-HC-85083, N01-HC-85084, N01-HC-85085, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC- 45133, HHSN268201200036C and NHLBI grants HL080295, HL087652, HL105756, with additional contribution from NINDS. Additional support was provided through AG-023629, AG-15928, AG-20098, and AG-027058 from the NIA. See also http://www.chs-nhlbi.org/pi.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerwinkle E, 2014, CIRC-CARDIOVASC GENE, V7, P332, DOI 10.1161/CIRCGENETICS.113.000078; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; KANNEL WB, 1974, PROG CARDIOVASC DIS, V17, P5, DOI 10.1016/0033-0620(74)90034-6; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lin HH, 2014, CIRC-CARDIOVASC GENE, V7, P335, DOI 10.1161/CIRCGENETICS.113.000350; Mussig K, 2005, J CLIN ENDOCR METAB, V90, P4362, DOI 10.1210/jc.2005-0136; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wu J, 2005, AM J HYPERTENS, V18, P935, DOI 10.1016/j.amjhyper.2005.01.011	17	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109155	10.1371/journal.pone.0109155	http://dx.doi.org/10.1371/journal.pone.0109155			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275628	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500069
J	Pandey, G; Arora, S; Manocha, S; Whalen, S				Pandey, Gaurav; Arora, Sonali; Manocha, Sahil; Whalen, Sean			Enhancing the Functional Content of Eukaryotic Protein Interaction Networks	PLOS ONE			English	Article							YEAST; PREDICTIONS; TOPOLOGY; BIOLOGY	Protein interaction networks are a promising type of data for studying complex biological systems. However, despite the rich information embedded in these networks, these networks face important data quality challenges of noise and incompleteness that adversely affect the results obtained from their analysis. Here, we apply a robust measure of local network structure called common neighborhood similarity (CNS) to address these challenges. Although several CNS measures have been proposed in the literature, an understanding of their relative efficacies for the analysis of interaction networks has been lacking. We follow the framework of graph transformation to convert the given interaction network into a transformed network corresponding to a variety of CNS measures evaluated. The effectiveness of each measure is then estimated by comparing the quality of protein function predictions obtained from its corresponding transformed network with those from the original network. Using a large set of human and fly protein interactions, and a set of over 100 GO terms for both, we find that several of the transformed networks produce more accurate predictions than those obtained from the original network. In particular, the HC: cont measure and other continuous CNS measures perform well this task, especially for large networks. Further investigation reveals that the two major factors contributing to this improvement are the abilities of CNS measures to prune out noisy edges and enhance functional coherence in the transformed networks.	[Pandey, Gaurav; Arora, Sonali; Whalen, Sean] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Pandey, Gaurav; Arora, Sonali; Whalen, Sean] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Pandey, Gaurav] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Arora, Sonali] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Manocha, Sahil] JP Morgan Secur Plc, London, England; [Whalen, Sean] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Fred Hutchinson Cancer Center; University of California System; University of California San Francisco; The J David Gladstone Institutes	Pandey, G (corresponding author), Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA.	gaurav.pandey@mssm.edu	Arora, Sonali/AAE-9407-2021	Arora, Sonali/0000-0002-6661-3024	Icahn Institute for Genomics and Multiscale Biology at the Icahn School of Medicine at Mount Sinai; JP Morgan Securities Plc.	Icahn Institute for Genomics and Multiscale Biology at the Icahn School of Medicine at Mount Sinai; JP Morgan Securities Plc.	The authors gratefully acknowledge the financial and technical support of the Icahn Institute for Genomics and Multiscale Biology at the Icahn School of Medicine at Mount Sinai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JP Morgan Securities Plc. provided support in the form of a salary for author SM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Brun C, 2004, GENOME BIOL, V5; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; de Silva E, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-39; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; Deng Minghua, 2003, Pac Symp Biocomput, P140; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Hakes L, 2008, NAT BIOTECHNOL, V26, P69, DOI 10.1038/nbt0108-69; Han JDJ, 2005, NAT BIOTECHNOL, V23, P839, DOI 10.1038/nbt1116; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Pandey G, 2012, ARXIV12106912; Pandey G., 2006, 06028 U MINN DEP COM; Pandey G, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P540; Pandey G, 2013, J IMMUNOL METHODS, V387, P71, DOI 10.1016/j.jim.2012.09.012; Radivojac P, 2013, NATURE METHODS; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Samanta MP, 2003, P NATL ACAD SCI USA, V100, P12579, DOI 10.1073/pnas.2132527100; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Suthram S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-360; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Winterbach W, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-90; Xiong H, 2006, DATA MIN KNOWL DISC, V13, P219, DOI 10.1007/s10618-006-0043-9; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109130	10.1371/journal.pone.0109130	http://dx.doi.org/10.1371/journal.pone.0109130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275489	gold, Green Published, Green Submitted			2022-12-27	WOS:000342591500066
J	Wiggin, TD; Peck, JH; Masino, MA				Wiggin, Timothy D.; Peck, Jack H.; Masino, Mark A.			Coordination of Fictive Motor Activity in the Larval Zebrafish Is Generated by Non-Segmental Mechanisms	PLOS ONE			English	Article							RAT SPINAL-CORD; INTERSEGMENTAL COORDINATION; UNDERLYING LOCOMOTION; PATTERN GENERATION; FUNCTIONAL-ORGANIZATION; IN-VITRO; CIRCUITS; NETWORK; INTERNEURONS; BEHAVIOR	The cellular and network basis for most vertebrate locomotor central pattern generators (CPGs) is incompletely characterized, but organizational models based on known CPG architectures have been proposed. Segmental models propose that each spinal segment contains a circuit that controls local coordination and sends longer projections to coordinate activity between segments. Unsegmented/continuous models propose that patterned motor output is driven by gradients of neurons and synapses that do not have segmental boundaries. We tested these ideas in the larval zebrafish, an animal that swims in discrete episodes, each of which is composed of coordinated motor bursts that progress rostrocaudally and alternate from side to side. We perturbed the spinal cord using spinal transections or strychnine application and measured the effect on fictive motor output. Spinal transections eliminated episode structure, and reduced both rostrocaudal and side-to-side coordination. Preparations with fewer intact segments were more severely affected, and preparations consisting of midbody and caudal segments were more severely affected than those consisting of rostral segments. In reduced preparations with the same number of intact spinal segments, side-to-side coordination was more severely disrupted than rostrocaudal coordination. Reducing glycine receptor signaling with strychnine reversibly disrupted both rostrocaudal and side-to-side coordination in spinalized larvae without disrupting episodic structure. Both spinal transection and strychnine decreased the stability of the motor rhythm, but this effect was not causal in reducing coordination. These results are inconsistent with a segmented model of the spinal cord and are better explained by a continuous model in which motor neuron coordination is controlled by segment-spanning microcircuits.	[Wiggin, Timothy D.; Masino, Mark A.] Univ Minnesota, Grad Program Neurosci, Minneapolis, MN 55455 USA; [Peck, Jack H.; Masino, Mark A.] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Masino, MA (corresponding author), Univ Minnesota, Grad Program Neurosci, Minneapolis, MN 55455 USA.	masino@umn.edu		Wiggin, Timothy/0000-0003-4432-1626	National Institutes of Health [R01 NS065054, F31 NS083110, T32 NS048944]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065054, R01NS048944, F31NS083110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (http://www.nih.gov/) Grants R01 NS065054 (MAM), F31 NS083110 (TDW) and T32 NS048944 (T. J. Ebner). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Bagnall MW, 2014, SCIENCE, V343, P197, DOI 10.1126/science.1245629; BATTY RS, 1984, J EXP BIOL, V110, P217; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Borla MA, 2002, BRAIN BEHAV EVOLUT, V60, P207, DOI 10.1159/000066699; Buss RR, 2001, J NEUROPHYSIOL, V86, P197, DOI 10.1152/jn.2001.86.1.197; Cangiano L, 2003, J NEUROPHYSIOL, V89, P2931, DOI 10.1152/jn.01100.2002; Cazalets JR, 2005, J PHYSIOL-LONDON, V568, P583, DOI 10.1113/jphysiol.2005.086850; Charrier V, 2013, NEUROSCIENCE, V255, P191, DOI 10.1016/j.neuroscience.2013.10.020; COWLEY KC, 1995, J NEUROPHYSIOL, V74, P1109, DOI 10.1152/jn.1995.74.3.1109; Dougherty KJ, 2013, NEURON, V80, P920, DOI 10.1016/j.neuron.2013.08.015; Dougherty KJ, 2010, ANN NY ACAD SCI, V1198, P85, DOI 10.1111/j.1749-6632.2010.05502.x; Drapeau P, 1999, J NEUROSCI METH, V88, P1, DOI 10.1016/S0165-0270(99)00008-4; Eklof-Ljunggren E, 2012, P NATL ACAD SCI USA, V109, P5511, DOI 10.1073/pnas.1115377109; Fetcho JR, 2010, ANN NY ACAD SCI, V1198, P94, DOI 10.1111/j.1749-6632.2010.05539.x; FUIMAN LA, 1988, ANIM BEHAV, V36, P250, DOI 10.1016/S0003-3472(88)80268-9; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 2002, BRAIN RES REV, V40, P92, DOI 10.1016/S0165-0173(02)00193-5; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Hagglund M, 2013, P NATL ACAD SCI USA, V110, P11589, DOI 10.1073/pnas.1304365110; HAMPEL FR, 1974, J AM STAT ASSOC, V69, P383, DOI 10.2307/2285666; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Higashijima S, 2004, J NEUROSCI, V24, P5827, DOI 10.1523/JNEUROSCI.5342-03.2004; Hill AAV, 2003, J NEUROPHYSIOL, V90, P531, DOI 10.1152/jn.00338.2003; Hirata H, 2005, P NATL ACAD SCI USA, V102, P8345, DOI 10.1073/pnas.0500862102; HO S, 1993, J NEUROSCI, V13, P1354; Kimura Y, 2013, CURR BIOL, V23, P843, DOI 10.1016/j.cub.2013.03.066; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Kristan WB, 2005, PROG NEUROBIOL, V76, P279, DOI 10.1016/j.pneurobio.2005.09.004; Lambert AM, 2012, J NEUROSCI, V32, P13488, DOI 10.1523/JNEUROSCI.1638-12.2012; LEGENDRE P, 1994, EUR J NEUROSCI, V6, P1544, DOI 10.1111/j.1460-9568.1994.tb00545.x; Liao JC, 2008, J NEUROSCI, V28, P12982, DOI 10.1523/JNEUROSCI.3330-08.2008; Liew WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034397; Ljunggren EE, 2014, J NEUROSCI, V34, P134, DOI 10.1523/JNEUROSCI.4087-13.2014; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Masino MA, 2005, J NEUROPHYSIOL, V93, P3177, DOI 10.1152/jn.01248.2004; Matsushima T, 1990, Neuroreport, V1, P97, DOI 10.1097/00001756-199010000-00003; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; McDearmid JR, 2006, J NEUROPHYSIOL, V95, P401, DOI 10.1152/jn.00844.2005; Mirat O, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00107; Moult PR, 2013, NEURON, V77, P129, DOI 10.1016/j.neuron.2012.10.040; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; Mulloney B, 2012, PROG NEUROBIOL, V96, P242, DOI 10.1016/j.pneurobio.2012.01.002; Rabe N, 2009, J NEUROSCI, V29, P15642, DOI 10.1523/JNEUROSCI.5096-09.2009; Roberts A, 1998, ANN NY ACAD SCI, V860, P19, DOI 10.1111/j.1749-6632.1998.tb09036.x; Roberts A, 2014, J NEUROSCI, V34, P608, DOI 10.1523/JNEUROSCI.3248-13.2014; Smarandache-Wellmann C, 2014, J NEUROSCI, V34, P793, DOI 10.1523/JNEUROSCI.2642-13.2014; Stepien AE, 2008, NEURON, V60, P1, DOI 10.1016/j.neuron.2008.09.030; Wadden T, 1997, BIOL CYBERN, V76, P1, DOI 10.1007/s004220050316; WALLEN P, 1985, J NEUROSCI, V5, P654; Wiggin TD, 2012, J NEUROPHYSIOL, V108, P925, DOI 10.1152/jn.00233.2012; Wolf E, 2009, J COMPUT NEUROSCI, V27, P291, DOI 10.1007/s10827-009-0143-9; Zhong GS, 2012, J PHYSIOL-LONDON, V590, P4735, DOI 10.1113/jphysiol.2012.240895	55	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109117	10.1371/journal.pone.0109117	http://dx.doi.org/10.1371/journal.pone.0109117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275377	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500064
J	Agapie, A; Andreica, A; Chira, C; Giuclea, M				Agapie, Alexandru; Andreica, Anca; Chira, Camelia; Giuclea, Marius			Predictability in Cellular Automata	PLOS ONE			English	Article							VOTER MODEL; STATIONARY DISTRIBUTION	Modelled as finite homogeneous Markov chains, probabilistic cellular automata with local transition probabilities in (0, 1) always posses a stationary distribution. This result alone is not very helpful when it comes to predicting the final configuration; one needs also a formula connecting the probabilities in the stationary distribution to some intrinsic feature of the lattice configuration. Previous results on the asynchronous cellular automata have showed that such feature really exists. It is the number of zero-one borders within the automaton's binary configuration. An exponential formula in the number of zero-one borders has been proved for the 1-D, 2-D and 3-D asynchronous automata with neighborhood three, five and seven, respectively. We perform computer experiments on a synchronous cellular automaton to check whether the empirical distribution obeys also that theoretical formula. The numerical results indicate a perfect fit for neighbourhood three and five, which opens the way for a rigorous proof of the formula in this new, synchronous case.	[Agapie, Alexandru] Bucharest Univ Econ Studies, Dept Appl Math, Bucharest, Romania; [Agapie, Alexandru] Inst Math Stat & Appl Math, Bucharest, Romania; [Andreica, Anca; Chira, Camelia] Univ Babes Bolyai, Fac Math & Informat, R-3400 Cluj Napoca, Romania; [Giuclea, Marius] Bucharest Univ Econ Studies, Dept Appl Math, Bucharest, Romania	Bucharest University of Economic Studies; Romanian Academy of Sciences; Institute of Mathematical Statistics & Applied Mathematics of Romanian Academy; Babes Bolyai University from Cluj; Bucharest University of Economic Studies	Agapie, A (corresponding author), Bucharest Univ Econ Studies, Dept Appl Math, Bucharest, Romania.	agapie@clicknet.ro	Agapie, Alexandru/AAQ-4628-2020; Giuclea, Marius/AAF-8399-2020; Andreica, Anca M./C-4082-2011; Chira, Camelia/AAO-7860-2020; Chira, Camelia/B-5566-2015	Chira, Camelia/0000-0002-1949-1298; Andreica, Anca/0000-0003-2363-5757	Romanian National Authority for Scientific Research [AA PNII-ID-PCCE-2011-0015, PNII-TE-320]	Romanian National Authority for Scientific Research	Funding provided by AA PNII-ID-PCCE-2011-0015, Romanian National Authority for Scientific Research, http://uefiscdi.gov.ro/, AA Grant PNII-TE-320, Romanian National Authority for Scientific Research, http://uefiscdi.gov.ro/ and CC Grant PNII-TE-320, Romanian National Authority for Scientific Research, http://uefiscdi.gov.ro/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapie A, 2004, METHODOL COMPUT APPL, V6, P181, DOI 10.1023/B:MCAP.0000017712.55431.96; Agapie A, 2008, STOCH MODELS, V24, P503, DOI 10.1080/15326340802427364; Agapie A, 2010, MATH SOC SCI, V59, P271, DOI 10.1016/j.mathsocsci.2009.10.005; Agapie A, 2010, PHYSICA A, V389, P2495, DOI 10.1016/j.physa.2010.03.011; [Anonymous], 1988, LECT NOTES PARTICLE; Chua LO, 2004, INT J BIFURCAT CHAOS, V14, P3689, DOI 10.1142/S0218127404011764; Chua LO, 2002, INT J BIFURCAT CHAOS, V12; CLIFFORD P, 1973, BIOMETRIKA, V60, P581, DOI 10.2307/2335008; Gog A, 2009, LECT NOTES ARTIF INT, V5572, P261, DOI 10.1007/978-3-642-02319-4_31; HOLLEY RA, 1975, ANN PROBAB, V3, P643, DOI 10.1214/aop/1176996306; Iosifescu M., 2007, FINITE MARKOV PROCES; Liggett, 2005, INTERACTING PARTICLE; Parzen E., 1999, STOCHASTIC PROCESSES; Seneta E., 1981, NONNEGATIVE MATRICES; Shilnikov L.P., 1998, METHODS QUALITATIV 1; Shilnikov LP, 2001, METHODS QUALITATIV 2; Wolfram S., 2002, NEW KIND SCI	17	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108177	10.1371/journal.pone.0108177	http://dx.doi.org/10.1371/journal.pone.0108177			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271778	gold, Green Submitted, Green Published			2022-12-27	WOS:000343729600030
J	Ahmed, LA; Shehata, NI; Abdelkader, NF; Khattab, MM				Ahmed, Lamiaa A.; Shehata, Nagwa I.; Abdelkader, Noha F.; Khattab, Mahmoud M.			Tempol, a Superoxide Dismutase Mimetic Agent, Ameliorates Cisplatin-Induced Nephrotoxicity through Alleviation of Mitochondrial Dysfunction in Mice	PLOS ONE			English	Article							OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; ANTIOXIDANT DEFENSE; RADICAL SCAVENGER; INDUCED TOXICITY; TUBULAR CELLS; LIPOIC ACID; IN-VIVO; PROTECTION; INJURY	Background: Mitochondrial dysfunction is a crucial mechanism by which cisplatin, a potent chemotherapeutic agent, causes nephrotoxicity where mitochondrial electron transport complexes are shifted mostly toward imbalanced reactive oxygen species versus energy production. In the present study, the protective role of tempol, a membrane-permeable superoxide dismutase mimetic agent, was evaluated on mitochondrial dysfunction and the subsequent damage induced by cisplatin nephrotoxicity in mice. Methods and Findings: Nephrotoxicity was assessed 72 h after a single i.p. injection of cisplatin (25 mg/kg) with or without oral administration of tempol (100 mg/kg/day). Serum creatinine and urea as well as glucosuria and proteinuria were evaluated. Both kidneys were isolated for estimation of oxidative stress markers, adenosine triphosphate (ATP) content and caspase-3 activity. Moreover, mitochondrial oxidative phosphorylation capacity, complexes I-IV activities and mitochondrial nitric oxide synthase (mNOS) protein expression were measured along with histological examinations of renal tubular damage and mitochondrial ultrastructural changes. Tempol was effective against cisplatin-induced elevation of serum creatinine and urea as well as glucosuria and proteinuria. Moreover, pretreatment with tempol notably inhibited cisplatin-induced oxidative stress and disruption of mitochondrial function by restoring mitochondrial oxidative phosphorylation, complexes I and III activities, mNOS protein expression and ATP content. Tempol also provided significant protection against apoptosis, tubular damage and mitochondrial ultrastructural changes. Interestingly, tempol did not interfere with the cytotoxic effect of cisplatin against the growth of solid Ehrlich carcinoma. Conclusion: This study highlights the potential role of tempol in inhibiting cisplatin-induced nephrotoxicity without affecting its antitumor activity via amelioration of oxidative stress and mitochondrial dysfunction.	[Ahmed, Lamiaa A.; Abdelkader, Noha F.; Khattab, Mahmoud M.] Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt; [Shehata, Nagwa I.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Ahmed, LA (corresponding author), Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt.	lamiaa.ahmed@pharma.cu.edu.eg	Abdelkader, Noha/AID-1932-2022	Abdelkader, Noha/0000-0001-7026-283X; Khattab, Mahmoud/0000-0002-3217-5417; Ahmed, Lamiaa/0000-0003-3476-2815				Aebi H, 1984, Methods Enzymol, V105, P121; Ahmed LA, 2013, BIOCHEM PHARMACOL, V86, P1301, DOI 10.1016/j.bcp.2013.07.005; Alpert E, 2004, BIOCHEM PHARMACOL, V67, P1985, DOI 10.1016/j.bcp.2004.02.005; ANDERSON ME, 1990, FASEB J, V4, P3251, DOI 10.1096/fasebj.4.14.2227215; Bagh M, 2008, BIOGERONTOLOGY, V9, P421, DOI 10.1007/s10522-008-9175-1; Banerjee K, 2010, FEBS LETT, V584, P1571, DOI 10.1016/j.febslet.2010.03.012; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Buege J A, 1978, Methods Enzymol, V52, P302; Chatterjee PK, 2000, KIDNEY INT, V58, P658, DOI 10.1046/j.1523-1755.2000.00212.x; Cuzzocrea S, 2004, FREE RADICAL RES, V38, P813, DOI 10.1080/10715760410001710829; EASTGATE J, 1993, BLOOD, V81, P639; Galley HF, 2011, BRIT J ANAESTH, V107, P57, DOI 10.1093/bja/aer093; Gao X, 2008, AM J PHYSIOL-HEART C, V295, pH491, DOI 10.1152/ajpheart.00464.2008; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; GORDON JA, 1986, AM J PHYSIOL, V250, pF991, DOI 10.1152/ajprenal.1986.250.6.F991; dos Santos NAG, 2012, ARCH TOXICOL, V86, P1233, DOI 10.1007/s00204-012-0821-7; Hassan I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036273; Hinkle PC, 1995, BIOENERGETICS PRACTI, P1; Ho YS, 1998, AM J RESP CELL MOL, V18, P538, DOI 10.1165/ajrcmb.18.4.2959; Horvath B, 2012, FREE RADICAL BIO MED, V52, P1325, DOI 10.1016/j.freeradbiomed.2012.01.014; Husain K, 1996, FUND APPL TOXICOL, V32, P278, DOI 10.1006/faat.1996.0131; Joy J, 2008, J CANC RES THER, V4, P111; Karatas Y, 2004, FUND CLIN PHARMACOL, V18, P79, DOI 10.1046/j.0767-3981.2003.00211.x; Kaushal GP, 2001, KIDNEY INT, V60, P1726, DOI 10.1046/j.1523-1755.2001.00026.x; Kawai Y, 2007, P 6 WORLD C ALT AN U, P453; Kidera Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101902; Kilic U, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-7; KLONER RA, 1978, AM J CARDIOL, V41, P880, DOI 10.1016/0002-9149(78)90728-2; Kruidering M, 1996, ATLA-ALTERN LAB ANIM, V24, P161; Kuhlmann MK, 1997, NEPHROL DIAL TRANSPL, V12, P2478, DOI 10.1093/ndt/12.12.2478; Lahoti TS, 2012, CURR NEUROVASC RES, V9, P282; Langerak A. D., 2001, CHEMOTHERAPY REGIMEN; Lieberthal W, 1996, AM J PHYSIOL-RENAL, V270, pF700, DOI 10.1152/ajprenal.1996.270.4.F700; Liu L, 2010, BIOCHEM PHARMACOL, V79, P137, DOI 10.1016/j.bcp.2009.08.015; LOWRY OH, 1964, J BIOL CHEM, V239, P18; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marklund, 1985, HDB METHODS OXYGEN R, V243, P247; Marullo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081162; MASUDA H, 1994, BIOCHEM BIOPH RES CO, V203, P1175, DOI 10.1006/bbrc.1994.2306; Matsushima H, 1998, J LAB CLIN MED, V131, P518, DOI 10.1016/S0022-2143(98)90060-9; McDonald MC, 1999, FREE RADICAL BIO MED, V27, P493, DOI 10.1016/S0891-5849(99)00100-8; Metz JM, 2004, CLIN CANCER RES, V10, P6411, DOI 10.1158/1078-0432.CCR-04-0658; Mora LD, 2003, PHARMACOL RES, V47, P517, DOI 10.1016/S1043-6618(03)00040-9; Mukhopadhyay P, 2010, FREE RADICAL BIO MED, V48, P457, DOI 10.1016/j.freeradbiomed.2009.11.022; Naghibi B, 2007, TOXICOLOGY, V232, P192, DOI 10.1016/j.tox.2007.01.005; Nassar T, 2002, EUR J PHARMACOL, V436, P111, DOI 10.1016/S0014-2999(01)01566-7; Okuda M, 2000, BIOCHEM PHARMACOL, V59, P195, DOI 10.1016/S0006-2952(99)00303-2; OSMAN AEM, 1993, TUMORI, V79, P268, DOI 10.1177/030089169307900408; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Qian W, 2005, AM J PHYSIOL-CELL PH, V289, pC1466, DOI 10.1152/ajpcell.00265.2005; Ramachandran L, 2012, IRAN J RADIAT RES, V10, P1; RIES F, 1986, AM J KIDNEY DIS, V8, P368, DOI 10.1016/S0272-6386(86)80112-3; SAFIRSTEIN R, 1986, AM J KIDNEY DIS, V8, P356, DOI 10.1016/S0272-6386(86)80111-1; Sahni V, 2009, NAT REV NEPHROL, V5, P450, DOI 10.1038/nrneph.2009.97; Samai M, 2007, FREE RADICAL BIO MED, V43, P528, DOI 10.1016/j.freeradbiomed.2007.05.014; Santos NAG, 2008, CANCER CHEMOTH PHARM, V61, P145, DOI 10.1007/s00280-007-0459-y; Schubert R, 2004, HUM MOL GENET, V13, P1793, DOI 10.1093/hmg/ddh189; Shah SV, 2007, J AM SOC NEPHROL, V18, P16, DOI 10.1681/ASN.2006050500; Sharman EH, 2001, NEUROBIOL AGING, V22, P629, DOI 10.1016/S0197-4580(01)00226-3; Shiraishi F, 2000, AM J PHYSIOL-RENAL, V278, pF726, DOI 10.1152/ajprenal.2000.278.5.F726; Silva CR, 2001, PHARMACOL RES, V43, P561, DOI 10.1006/phrs.2001.0822; Somani SM, 2000, PHARMACOL TOXICOL, V86, P234, DOI 10.1034/j.1600-0773.2000.d01-41.x; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Sun MS, 2000, J AM SOC NEPHROL, V11, P291, DOI 10.1681/ASN.V112291; Tanabe K, 2012, AM J PHYSIOL-RENAL, V303, pF1264, DOI 10.1152/ajprenal.00227.2012; Tengan CH, 2012, INT J MOL SCI, V13, P17160, DOI 10.3390/ijms131217160; Terada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080850; Wilcox CS, 2008, PHARMACOL REV, V60, P418, DOI 10.1124/pr.108.000240; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Yang C, 2008, CELL DEATH DIFFER, V15, P530, DOI 10.1038/sj.cdd.4402287; Yao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e; ZHANG JG, 1994, BIOCHEM PHARMACOL, V47, P1127, DOI 10.1016/0006-2952(94)90383-2; Zhang L, 2006, BIOCHEMISTRY-US, V45, P8959, DOI 10.1021/bi060027g; Zsengeller ZK, 2012, J HISTOCHEM CYTOCHEM, V60, P521, DOI 10.1369/0022155412446227	74	57	60	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108889	10.1371/journal.pone.0108889	http://dx.doi.org/10.1371/journal.pone.0108889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271439	gold, Green Published, Green Submitted			2022-12-27	WOS:000343729600076
J	Martinez-Torres, F; Nochi, T; Wahl, A; Garcia, JV; Denton, PW				Martinez-Torres, Francisco; Nochi, Tomonori; Wahl, Angela; Garcia, J. Victor; Denton, Paul W.			Hypogammaglobulinemia in BLT Humanized Mice - An Animal Model of Primary Antibody Deficiency	PLOS ONE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; MEMORY B-CELLS; HUMAN IMMUNE-SYSTEM; BONE-MARROW; MOUSE MODEL; VAGINAL TRANSMISSION; HIV-1 REPLICATION; T-CELLS; INFECTION; DIFFERENTIATION	Primary antibody deficiencies present clinically as reduced or absent plasma antibodies without another identified disorder that could explain the low immunoglobulin levels. Bone marrow-liver-thymus (BLT) humanized mice also exhibit primary antibody deficiency or hypogammaglobulinemia. Comprehensive characterization of B cell development and differentiation in BLT mice revealed other key parallels with primary immunodeficiency patients. We found that B cell ontogeny was normal in the bone marrow of BLT mice but observed an absence of switched memory B cells in the periphery. PC-KLH immunizations led to the presence of switched memory B cells in immunized BLT mice although plasma cells producing PC- or KLH- specific IgG were not detected in tissues. Overall, we have identified the following parallels between the humoral immune systems of primary antibody deficiency patients and those in BLT mice that make this in vivo model a robust and translational experimental platform for gaining a greater understanding of this heterogeneous array of humoral immunodeficiency disorders in humans: (i) hypogammaglobulinemia; (ii) normal B cell ontogeny in bone marrow; and (iii) poor antigen-specific IgG response to immunization. Furthermore, the development of strategies to overcome these humoral immune aberrations in BLT mice may in turn provide insights into the pathogenesis of some primary antibody deficiency patients which could lead to novel clinical interventions for improved humoral immune function.	[Martinez-Torres, Francisco; Nochi, Tomonori; Wahl, Angela; Garcia, J. Victor; Denton, Paul W.] Univ N Carolina, Chapel Hill Sch Med, UNC Ctr AIDS, Div Infect Dis,Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Garcia, JV (corresponding author), Univ N Carolina, Chapel Hill Sch Med, UNC Ctr AIDS, Div Infect Dis,Dept Med, Chapel Hill, NC 27599 USA.	victor_garcia@med.unc.edu; pauden@rm.dk	Nochi, Tomonori/U-2533-2019	Nochi, Tomonori/0000-0003-1800-6972; Denton, Paul/0000-0003-2458-8147	National Institutes of Health [AI073146, AI096113]; University of North Carolina Center for AIDS Research [P30 AI50410]; Japan Society for the Promotion of Science Research Fellowship; Young Researcher Overseas Visits Program for Vitalizing Brain Circulation; amfAR Mathilde Krim Fellowship in Basic Biomedical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096113, P30AI050410, R01AI073146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina Center for AIDS Research; Japan Society for the Promotion of Science Research Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Young Researcher Overseas Visits Program for Vitalizing Brain Circulation; amfAR Mathilde Krim Fellowship in Basic Biomedical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grants AI073146 and AI096113 (JVG), the University of North Carolina Center for AIDS Research Grant P30 AI50410, the Japan Society for the Promotion of Science Research Fellowship and Young Researcher Overseas Visits Program for Vitalizing Brain Circulation (T.N.)and by an amfAR Mathilde Krim Fellowship in Basic Biomedical Research (A.W). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	An DS, 2007, CLIN VACCINE IMMUNOL, V14, P391, DOI 10.1128/CVI.00403-06; Ayieko C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067230; Biswas S, 2011, IMMUNOLOGY; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Buckley RH, 2011, IMMUNOL RES, V49, P25, DOI 10.1007/s12026-010-8191-9; Chang H, 2012, GENES IMMUN, V13, P399, DOI 10.1038/gene.2012.16; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Chateau M, 2013, J VIROL, V87, P1274, DOI 10.1128/JVI.01777-12; Chateau ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060024; Choi B, 2011, J CLIN IMMUNOL, V31, P253, DOI 10.1007/s10875-010-9478-2; Conley ME, 1999, CLIN IMMUNOL, V93, P190, DOI 10.1006/clim.1999.4799; Cunningham-Rundles C, 2012, IMMUNOL RES, V54, P227, DOI 10.1007/s12026-012-8318-2; Denton PW, 2012, MUCOSAL IMMUNOL, V5, P555, DOI 10.1038/mi.2012.31; Denton PW, 2011, AIDS REV, V13, P135; Denton PW, 2011, J VIROL, V85, P7582, DOI 10.1128/JVI.00537-11; Denton PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008829; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; DESIDERIO SV, 1984, NATURE, V311, P752, DOI 10.1038/311752a0; Dudek TE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003984; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Garraud O, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-63; Goldacker S, 2007, CLIN IMMUNOL, V124, P294, DOI 10.1016/j.clim.2007.04.011; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; HERMANS PE, 1976, AM J MED, V61, P221, DOI 10.1016/0002-9343(76)90173-X; HERMASZEWSKI RA, 1993, Q J MED, V86, P31; Honeycutt JB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-121; Houghton PJ, 2002, CLIN CANCER RES, V8, P3646; JOLLIFF CR, 1982, CLIN CHEM, V28, P126; Kalscheuer H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003481; Ko J, 2005, CLIN IMMUNOL, V116, P37, DOI 10.1016/j.clim.2005.03.019; Krisko JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003242; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Lang JL, 2013, J IMMUNOL, V190, P2090, DOI 10.4049/jimmunol.1202810; LEE W, 1974, NATURE, V247, P55, DOI 10.1038/247055a0; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Matsumura B, 2003, EXP HEMATOL, V31, P789, DOI 10.1016/S0301-472X(03)00193-0; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Nochi T, 2013, CELL REP, V3, P1874, DOI 10.1016/j.celrep.2013.05.037; Noordzij JG, 2002, BLOOD, V100, P2145; Notarangelo LD, 2010, J ALLERGY CLIN IMMUN, V125, pS182, DOI 10.1016/j.jaci.2009.07.053; Ochtrop MLG, 2011, BLOOD, V118, P309, DOI 10.1182/blood-2010-11-321695; Pessach IM, 2011, CURR OPIN ALLERGY CL, V11, P505, DOI 10.1097/ACI.0b013e32834cb943; Rachid R, 2006, CURR ALLERGY ASTHM R, V6, P357, DOI 10.1007/s11882-996-0004-9; Rajesh D, 2010, HUM IMMUNOL, V71, P551, DOI 10.1016/j.humimm.2010.02.019; Reynaud CA, 2012, CELL MOL LIFE SCI, V69, P1625, DOI 10.1007/s00018-012-0971-z; Salzer U, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4032; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Scharenberg AM, 1993, GENEREVIEWS R; Schuh W, 2003, J IMMUNOL, V171, P3343, DOI 10.4049/jimmunol.171.7.3343; Seung E, 2013, J INFECT DIS, V208, pS155, DOI 10.1093/infdis/jit448; Smith M, 1998, J CLIN ONCOL, V16, P966, DOI 10.1200/JCO.1998.16.3.966; Smith M, 1998, J CLIN ONCOL, V24, P209; SNELLER MC, 1993, ANN INTERN MED, V118, P720, DOI 10.7326/0003-4819-118-9-199305010-00011; SPICKETT GP, 1991, LANCET, V337, P281, DOI 10.1016/0140-6736(91)90882-P; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Takemori T, 2014, EUR J IMMUNOL, V44, P1258, DOI 10.1002/eji.201343716; Tonomura N, 2008, BLOOD, V111, P4293, DOI 10.1182/blood-2007-11-121319; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; van Lochem EG, 2004, CYTOM PART B-CLIN CY, V60B, P1, DOI 10.1002/cyto.b.20008; Wahl A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002732; Warnatz K, 2006, BLOOD, V107, P3045, DOI 10.1182/blood-2005-07-2955; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; Watkins RL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-125; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744; Wood PM, 2010, CURR OPIN HEMATOL, V17, P356, DOI 10.1097/MOH.0b013e328338f69e; Yajima M, 2008, J INFECT DIS, V198, P673, DOI 10.1086/590502; Zou W, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-44	67	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108663	10.1371/journal.pone.0108663	http://dx.doi.org/10.1371/journal.pone.0108663			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271886	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600055
J	Tsuji, Y				Tsuji, Yamato			Inter-Annual Variation in Characteristics of Endozoochory by Wild Japanese Macaques	PLOS ONE			English	Article							BEAR URSUS-THIBETANUS; SEED DISPERSAL; SEASONAL-VARIATION; MAST PRODUCTION; FOOD-HABITS; FOREST; FRUIT; BEHAVIOR; OUTCOMES	Endozoochory is important to the dynamics and regeneration of forest ecosystems. Despite the universality of inter-annual variation in fruit production, few studies have addressed the sign (seed predation versus seed dispersal) and strength (frequency and quantity) of fruit-frugivore interaction and the effectiveness of endozoochory in response to the long-term temporal context. In this study I evaluated the characteristics of endozoochorous dispersal by wild Japanese macaques Macaca fuscata inhabiting deciduous forest in northern Japan for five different years. I collected 378 fecal samples from the macaques in fall (September to November) and quantified the proportion of feces containing seeds, number of seeds per fecal sample, ratio of intact seeds, and seed diversity. The proportion of feces containing seeds of any species (five-year mean: 85.9%, range: 78-97%) did not show significant inter-annual variation, while species-level proportions did. The intact ratio of seeds (mean: 83%, range: 61-98%) varied significantly both between years and between months, and this varied among dominant plant species. The number of seeds per fecal sample (mean: 78, range: 32-102) varied monthly but did not between years, and the seed diversity (mean: 0.66, range: 0.57-0.81) did not show significant inter-annual variation, both of which were attributed to longer duration of macaques' gastro-intestinal passage time of seeds exceed their feeding bouts. This study demonstrated that frequency and success of seed dispersal over seed predation of macaque endozoochory showed inter-annual variation, indicating low specificity across the seed-macaque network. The temporal variability in the quality of seed dispersal may provide evidence of high resilience in response to fluctuating environmental conditions in the temperate forests.	Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan	Kyoto University	Tsuji, Y (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.	ytsuji1002@gmail.com	Tsuji, Yamato/N-4794-2018	Tsuji, Yamato/0000-0003-3948-3807	Japan Society for the Promotion of Science [23780160]; Corporative Research Fund of the Primate Research Institute, Kyoto University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Corporative Research Fund of the Primate Research Institute, Kyoto University	This study was supported by a Grant-in-Aid from the Japan Society for the Promotion of Science (No. 23780160) and the Corporative Research Fund of the Primate Research Institute, Kyoto University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto I, 2011, MAMM STUDY, V36, P199, DOI 10.3106/041.036.0403; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; Corlett RT, 1998, BIOL REV, V73, P413, DOI 10.1017/S0006323198005234; Dennis A.J., 2007, SEED DISPERSAL THEOR; Go M, 2010, PRIMATES, V51, P149, DOI 10.1007/s10329-009-0179-5; Hanya G, 2013, PRIMATES, V54, P101, DOI 10.1007/s10329-012-0341-3; Hickey JR, 1999, OIKOS, V87, P499, DOI 10.2307/3546814; HILL DA, 1995, AM J PRIMATOL, V35, P241, DOI 10.1002/ajp.1350350307; Hill DA, 1997, AM J PRIMATOL, V43, P305; Holland JN, 2009, ECOL LETT, V12, P1357, DOI 10.1111/j.1461-0248.2009.01390.x; Izawa K., 2009, RES WILD JAPANESE MA; Kaplin BA, 1998, AM J PRIMATOL, V45, P83, DOI 10.1002/(SICI)1098-2345(1998)45:1<83::AID-AJP7>3.0.CO;2-S; KELLY D, 1994, TRENDS ECOL EVOL, V9, P465, DOI 10.1016/0169-5347(94)90310-7; Koike S, 2011, OIKOS, V120, P280, DOI 10.1111/j.1600-0706.2010.18626.x; Koike S, 2010, MAMM BIOL, V75, P17, DOI 10.1016/j.mambio.2009.03.008; Komiyama A., 1991, Research Bulletin of the Faculty of Agriculture Gifu University, P165; Kozakai C, 2011, J WILDLIFE MANAGE, V75, P867, DOI 10.1002/jwmg.122; Kunz BK, 2008, J TROP ECOL, V24, P235, DOI 10.1017/S0266467408005014; Leavey DJ, 2002, SEED DISPERSAL FRUGI; Maruhashi T, 1998, PRIMATES, V39, P291, DOI 10.1007/BF02573078; Masaki T, 2012, J PLANT RES, V125, P103, DOI 10.1007/s10265-011-0423-0; MATTSON DJ, 1992, J WILDLIFE MANAGE, V56, P432, DOI 10.2307/3808855; Nakanishi H, 1996, VEGETATIO, V123, P207, DOI 10.1007/BF00118272; Nakayama S., 2000, SEEDS WILD PLANTS JA; Otani T, 2000, ECOL RES, V15, P133, DOI 10.1046/j.1440-1703.2000.00330.x; Perea R, 2013, OIKOS, V122, P943, DOI 10.1111/j.1600-0706.2012.20940.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Sawada A, 2011, INT J PRIMATOL, V32, P390, DOI 10.1007/s10764-010-9476-5; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; Shibata M, 1998, ECOLOGY, V79, P54, DOI 10.1890/0012-9658(1998)079[0054:CACOMS]2.0.CO;2; Sun IF, 2007, J ECOL, V95, P818, DOI 10.1111/j.1365-2745.2007.01235.x; Suzuki W, 2005, FOREST ECOL MANAG, V205, P105, DOI 10.1016/j.foreco.2004.10.050; Takahashi K, 2008, ECOL RES, V23, P471, DOI 10.1007/s11284-007-0382-z; Takita M, 1998, B HOKKAIDO FOR RES I, V35, P31; Terakawa M., 2008, Japanese Journal of Conservation Ecology, V13, P161; Terakawa M, 2009, ECOL RES, V24, P663, DOI 10.1007/s11284-008-0537-6; Traveset A., 2007, Seed dispersal: theory and its application in a changing world, P78, DOI 10.1079/9781845931650.0078; Tsuji Y, 2010, J ZOOL, V280, P171, DOI 10.1111/j.1469-7998.2009.00650.x; Tsuji Y, 2006, AM J PRIMATOL, V68, P1068, DOI 10.1002/ajp.20307; Tsuji Y, 2012, INT J PRIMATOL, V33, P489, DOI 10.1007/s10764-012-9589-0; Tsuji Y, 2011, MAMM BIOL, V76, P525, DOI 10.1016/j.mambio.2011.01.001; Tsuji Y, 2009, INT J PRIMATOL, V30, P169, DOI 10.1007/s10764-009-9336-3; WILLSON MF, 1993, OIKOS, V67, P159, DOI 10.2307/3545106	43	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108155	10.1371/journal.pone.0108155	http://dx.doi.org/10.1371/journal.pone.0108155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272286	gold, Green Published, Green Submitted			2022-12-27	WOS:000343729600027
J	Werner, E; Wang, HC; Doetsch, PW				Werner, Erica; Wang, Huichen; Doetsch, Paul W.			Opposite Roles for p38MAPK-Driven Responses and Reactive Oxygen Species in the Persistence and Resolution of Radiation-Induced Genomic Instability	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; CHRONIC OXIDATIVE STRESS; NORMAL HUMAN FIBROBLASTS; LOW-DOSE RADIATION; LOW-LET RADIATION; P38 MAP KINASE; IONIZING-RADIATION; HUMAN-CELLS; GENETIC INSTABILITY	We report the functional and temporal relationship between cellular phenotypes such as oxidative stress, p38MAPK-dependent responses and genomic instability persisting in the progeny of cells exposed to sparsely ionizing low-Linear Energy Transfer (LET) radiation such as X-rays or high-charge and high-energy (HZE) particle high-LET radiation such as Fe-56 ions. We found that exposure to low and high-LET radiation increased reactive oxygen species (ROS) levels as a threshold-like response induced independently of radiation quality and dose. This response was sustained for two weeks, which is the period of time when genomic instability is evidenced by increased micronucleus formation frequency and DNA damage associated foci. Indicators for another persisting response sharing phenotypes with stress-induced senescence, including beta galactosidase induction, increased nuclear size, p38MAPK activation and IL-8 production, were induced in the absence of cell proliferation arrest during the first, but not the second week following exposure to high-LET radiation. This response was driven by a p38MAPK-dependent mechanism and was affected by radiation quality and dose. This stress response and elevation of ROS affected genomic instability by distinct pathways. Through interference with p38MAPK activity, we show that radiation-induced stress phenotypes promote genomic instability. In contrast, exposure to physiologically relevant doses of hydrogen peroxide or increasing endogenous ROS levels with a catalase inhibitor reduced the level of genomic instability. Our results implicate persistently elevated ROS following exposure to radiation as a factor contributing to genome stabilization.	[Werner, Erica; Doetsch, Paul W.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Wang, Huichen; Doetsch, Paul W.] Emory Univ, Sch Med, Dept Radiat Oncol, Winship Canc Inst, Atlanta, GA USA; [Doetsch, Paul W.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA USA	Emory University; Emory University; Emory University	Werner, E (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	ewerner@emory.edu; medpwd@emory.edu		Werner, Erica/0000-0002-8183-1601	National Aeronautics and Space Administration (NASA) [NNX11AC3OG]; NATIONAL CANCER INSTITUTE [P30CA138292] Funding Source: NIH RePORTER	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by a National Aeronautics and Space Administration (NASA) Grant NNX11AC3OG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Anderson JA, 2010, RADIAT RES, V174, P195, DOI 10.1667/RR2071.1; Asaithamby A, 2008, RADIAT RES, V169, P437, DOI 10.1667/RR1165.1; Barascu A, 2012, EMBO J, V31, P1080, DOI 10.1038/emboj.2011.492; Barcellos-Hoff MH, 1998, RADIAT RES, V150, pS109, DOI 10.2307/3579813; Bartkova J, 2010, ONCOGENE, V29, P5095, DOI 10.1038/onc.2010.249; Benveniste MFK, 2013, CLIN RADIOL, V68, pE275, DOI 10.1016/j.crad.2013.01.013; Bhogal N, 2010, RADIAT RES, V173, P1, DOI 10.1667/RR1851.1; Bonassi S, 2011, MUTAGENESIS, V26, P93, DOI 10.1093/mutage/geq075; Brooks AL, 2001, RADIAT RES, V155, P353, DOI 10.1667/0033-7587(2001)155[0353:REOHIP]2.0.CO;2; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Costes SV, 2010, MUTAT RES-REV MUTAT, V704, P78, DOI 10.1016/j.mrrev.2009.12.006; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Cucinotta FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074988; Cucinotta FA, 2012, HEALTH PHYS, V103, P643, DOI 10.1097/HP.0b013e318267b3ad; Datta K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042224; Davis T, 2005, J GERONTOL A-BIOL, V60, P1386, DOI 10.1093/gerona/60.11.1386; Davis T, 2013, AGE, V35, P1767, DOI 10.1007/s11357-012-9476-9; Dayal D, 2008, BIOCHEM J, V413, P185, DOI 10.1042/BJ20071643; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; Desai N, 2005, RADIAT RES, V164, P518, DOI 10.1667/RR3431.1; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Falk M, 2010, MUTAT RES-REV MUTAT, V704, P88, DOI 10.1016/j.mrrev.2010.01.013; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fournier C, 2007, RADIOTHER ONCOL, V83, P277, DOI 10.1016/j.radonc.2007.04.022; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Gisselsson D, 2001, AM J PATHOL, V158, P199, DOI 10.1016/S0002-9440(10)63958-2; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Groesser T, 2007, RADIAT RES, V168, P675, DOI 10.1667/RR0967.1; Groesser T, 2011, INT J RADIAT BIOL, V87, P696, DOI 10.3109/09553002.2010.549535; Grosovsky AJ, 1996, MOL CELL BIOL, V16, P6252; Grudzenski S, 2010, P NATL ACAD SCI USA, V107, P14205, DOI 10.1073/pnas.1002213107; Harper K, 1997, EXP HEMATOL, V25, P263; Hayashi MT, 2013, ONCOGENE, V32, P4593, DOI 10.1038/onc.2012.615; HOLMBERG K, 1993, MUTAT RES, V286, P321, DOI 10.1016/0027-5107(93)90197-N; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Kadhim MA, 2006, RADIAT PROT DOSIM, V122, P221, DOI 10.1093/rpd/ncl445; KADHIM MA, 1992, NATURE, V355, P738, DOI 10.1038/355738a0; Kadhim M, 2013, MUTAT RES-REV MUTAT, V752, P84, DOI 10.1016/j.mrrev.2012.12.001; Kim GJ, 2006, MUTAGENESIS, V21, P361, DOI 10.1093/mutage/gel048; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lenarczyk M, 2009, RADIAT RES, V171, P164, DOI 10.1667/RR1454.1; Limoli CL, 2000, ADV SPACE RES, V25, P2107, DOI 10.1016/S0273-1177(99)01062-5; Limoli CL, 2003, CANCER RES, V63, P3107; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Lorimore SA, 2003, ONCOGENE, V22, P7058, DOI 10.1038/sj.onc.1207044; Marks LB, 2003, SEMIN RADIAT ONCOL, V13, P333, DOI 10.1016/S1053-4296(03)00034-1; Miller RC, 1999, P NATL ACAD SCI USA, V96, P19, DOI 10.1073/pnas.96.1.19; Mondello C, 2010, MUTAT RES-REV MUTAT, V704, P29, DOI 10.1016/j.mrrev.2010.01.008; National Academy of Sciences/National Research Council, 2006, HLTH RISK EXP LOW LE, V2; Navarro CL, 2006, HUM MOL GENET, V15, pR151, DOI 10.1093/hmg/ddl214; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108; NICHOLLS P, 1962, BIOCHIM BIOPHYS ACTA, V59, P414, DOI 10.1016/0006-3002(62)90191-9; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; PRISE KM, 1994, INT J RADIAT BIOL, V66, P537, DOI 10.1080/09553009414551581; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Richards SA, 2011, HUM MOL GENET, V20, P3997, DOI 10.1093/hmg/ddr327; Robbins MEC, 2004, INT J RADIAT BIOL, V80, P251, DOI 10.1080/09553000410001692726; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rowe LA, 2008, FREE RADICAL BIO MED, V45, P1167, DOI 10.1016/j.freeradbiomed.2008.07.018; Rowe LA, 2012, MECH AGEING DEV, V133, P147, DOI 10.1016/j.mad.2012.03.009; Rugo RE, 2004, RADIAT RES, V162, P416, DOI 10.1667/RR3238; Rugo RE, 2002, RADIAT RES, V158, P210, DOI 10.1667/0033-7587(2002)158[0210:XRCAPI]2.0.CO;2; Rydberg B, 2005, RADIAT RES, V163, P526, DOI 10.1667/RR3346; Samet JM, 2009, CLIN CANCER RES, V15, P5626, DOI 10.1158/1078-0432.CCR-09-0376; Schanz S, 2012, DNA REPAIR, V11, P823, DOI 10.1016/j.dnarep.2012.07.005; Shimizu N, 1998, J CELL BIOL, V140, P1307, DOI 10.1083/jcb.140.6.1307; Smith LE, 2003, HEALTH PHYS, V85, P23, DOI 10.1097/00004032-200307000-00006; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Sutherland BM, 2000, P NATL ACAD SCI USA, V97, P103, DOI 10.1073/pnas.97.1.103; Suzuki K, 2009, MUTAT RES-FUND MOL M, V671, P33, DOI 10.1016/j.mrfmmm.2009.08.010; Syljuasen RG, 2006, CANCER RES, V66, P10253, DOI 10.1158/0008-5472.CAN-06-2144; Tang FR, 2014, INT J RADIAT BIOL, P1, DOI [10.3109/09553002.2013.836617, DOI 10.3109/09553002.2013.836617]; TEST ST, 1984, J BIOL CHEM, V259, P399; Tivey HSE, 2013, J GERONTOL A-BIOL, V68, P1001, DOI 10.1093/gerona/gls336; Tominaga H, 2004, J RADIAT RES, V45, P181, DOI 10.1269/jrr.45.181; Winterbourn CC, 2014, BBA-GEN SUBJECTS, V1840, P730, DOI 10.1016/j.bbagen.2013.05.004; Yegorov YE, 1998, EXP CELL RES, V243, P207, DOI 10.1006/excr.1998.4169; Yu T, 2006, DNA REPAIR, V5, P935, DOI 10.1016/j.dnarep.2006.05.040; Zahnreich S, 2010, MUTAT RES-GEN TOX EN, V701, P60, DOI 10.1016/j.mrgentox.2010.03.010; Zolzer F, 2012, CYTOGENET GENOME RES, V136, P288, DOI 10.1159/000338084	89	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108234	10.1371/journal.pone.0108234	http://dx.doi.org/10.1371/journal.pone.0108234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271419	Green Submitted, Green Published, gold			2022-12-27	WOS:000343729600036
J	Wu, WM; Hong, XF; Fu, LL; Liu, SL; You, L; Zhou, L; Zhao, YP				Wu, Wenming; Hong, Xiafei; Fu, Lilan; Liu, Shanglong; You, Lei; Zhou, Li; Zhao, Yupei			The Effect of Pylorus Removal on Delayed Gastric Emptying after Pancreaticoduodenectomy: A Meta-Analysis of 2,599 Patients	PLOS ONE			English	Article							STOMACH-PRESERVING PANCREATICODUODENECTOMY; WHIPPLE RESECTION; PANCREATIC-CANCER; PRESERVATION; HEAD; ADENOCARCINOMA; SURVIVAL; IMPACT; CARCINOMA; SURGERY	Background: Delayed gastric emptying is a serious complication of pancreaticoduodenectomy. The effect of pylorus removal on delayed gastric emptying has not been well evaluated. Study Design: We searched five databases (PubMed, EMBASE and the Cochrane Central Register of Controlled Trials, Scopus and Web of Science) up to July 2014. The meta-regression analysis was performed to evaluate any factors accountable for the heterogeneity. Publication bias was assessed by Egger's test, and corrected by Duval's trim and fill method. Subgroup analyses were conducted for different surgical techniques of pyloric removal. Other intraoperative and postoperative parameters were compared between two groups. Results: We included 27 studies involving 2,599 patients, with a moderate-high heterogeneity for primary outcome (I-2 = 63%). Meta-regression analysis showed that four variables primarily contributed to the heterogeneity, namely nasogastric tube intubation time, solid food start time, preoperative diabetes percentage and the number of patients in pylorus-preserving group. After excluding four studies, the remaining twenty-three studies showed reduced heterogeneity (I-2 = 51%). Then we used Duval's trim and fill method to correct publication bias. The corrected MH odds ratio was 0.78 (95% CI: 0.52-1.17). A subgroup analysis showed that pylorus removal tends to reduce delayed gastric emptying incidence for subtotal stomach-preserving pancreaticoduodenectomy or pylorus-resecting pancreaticoduodenectomy, compared with pylorus-preserving group. However, standard Whipple procedure failed to show any significant reduction of DGE compared with pylorus-removal group. No significant differences were observed in terms of length of hospital stay, infection and pancreatic fistula; however, pylorus removal resulted in longer operation time, more blood loss and higher mortality. Conclusion: The pylorus removal does not significantly reduce the overall incidence of delayed gastric emptying. Subtotal stomach-preserving pancreaticoduodenectomy or pylorus-resecting pancreaticoduodenectomy tends to reduce delayed gastric emptying incidence, but needs further validation.	[Zhao, Yupei] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhao, YP (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China.	zhao8028@263.net						Akizuki E, 2008, J GASTROINTEST SURG, V12, P1185, DOI 10.1007/s11605-008-0513-z; Balzano G, 2008, BRIT J SURG, V95, P1387, DOI 10.1002/bjs.6324; Di Carlo V, 1999, WORLD J SURG, V23, P920; Diener Markus K, 2011, PYLORUS PRESERVING P; Duffy JP, 2003, ARCH SURG-CHICAGO, V138, P941, DOI 10.1001/archsurg.138.9.941; Fischer CP, 2006, J GASTROINTEST SURG, V10, P215, DOI 10.1016/j.gassur.2005.07.017; Fujii T, 2012, ANN SURG ONCOL, V19, P176, DOI 10.1245/s10434-011-1901-2; Gao Hong-Qiao, 2007, Zhonghua Wai Ke Za Zhi, V45, P1048; Gauvin JM, 2003, ARCH SURG-CHICAGO, V138, P1261, DOI 10.1001/archsurg.138.11.1261; Hackert T, 2013, AM J SURG, V206, P296, DOI 10.1016/j.amjsurg.2012.10.042; Hayashibe A, 2007, J SURG ONCOL, V95, P106, DOI 10.1002/jso.20608; Henegouwen MIV, 1997, J AM COLL SURGEONS, V185, P373, DOI 10.1016/S1072-7515(01)00944-9; Hoem D, 2012, EJSO-EUR J SURG ONC, V38, P245, DOI 10.1016/j.ejso.2011.12.010; Horstmann O, 2004, PANCREAS, V28, P69, DOI 10.1097/00006676-200401000-00011; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Iqbal N, 2008, EJSO-EUR J SURG ONC, V34, P1237, DOI 10.1016/j.ejso.2007.12.004; Jimenez RE, 2000, ANN SURG, V231, P293, DOI 10.1097/00000658-200003000-00001; Karanicolas PJ, 2007, ANN SURG ONCOL, V14, P1825, DOI 10.1245/s10434-006-9330-3; Kawai M, 2011, ANN SURG, V253, P495, DOI 10.1097/SLA.0b013e31820d98f1; Kim DK, 2005, ANN SURG ONCOL, V12, P222, DOI 10.1245/ASO.2005.03.078; Kurahara H, 2010, J SURG ONCOL, V102, P615, DOI 10.1002/jso.21687; Kurosaki I, 2005, J GASTROINTEST SURG, V9, P846, DOI 10.1016/j.gassur.2005.02.009; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; LIBERSKI SM, 1990, GASTROENTEROLOGY, V99, P252, DOI 10.1016/0016-5085(90)91255-5; Lin PW, 2005, HEPATO-GASTROENTEROL, V52, P1601; Makhija Rohit, 2002, J Hepatobiliary Pancreat Surg, V9, P614, DOI 10.1007/s005340200083; Matsumoto I, 2014, J SURG ONCOL, V109, P690, DOI 10.1002/jso.23566; Mosca F, 1997, SURGERY, V122, P553, DOI 10.1016/S0039-6060(97)90128-8; Nanashima A, 2013, HEPATO-GASTROENTEROL, V60, P1182, DOI 10.5754/hge11045; Ohwada S, 2001, ANN SURG, V234, P668, DOI 10.1097/00000658-200111000-00013; Paquet KJ, 1998, CHIR GASTROENTEROL, V14, P54, DOI 10.1159/000012471; PATEL AG, 1995, ARCH SURG-CHICAGO, V130, P838; Pirro N, 2002, ANN CHIR, V127, P95, DOI 10.1016/S0003-3944(01)00706-4; Qu H, 2013, EJSO-EUR J SURG ONC, V39, P213, DOI 10.1016/j.ejso.2012.12.010; RODER JD, 1992, BRIT J SURG, V79, P152, DOI 10.1002/bjs.1800790219; Sato G, 2014, WORLD J SURG, V38, P968, DOI 10.1007/s00268-013-2288-y; Schafer M, 2002, ANN SURG, V236, P137, DOI 10.1097/01.SLA.0000022024.90584.E9; Seiler CA, 2005, BRIT J SURG, V92, P547, DOI 10.1002/bjs.4881; Srinarmwong Chatchai, 2008, Journal of the Medical Association of Thailand, V91, P693; Takahashi S, 1999, JPN J GASTROENTEROL, V32, P2427; Tani M, 2009, SURG TODAY, V39, P219, DOI 10.1007/s00595-008-3847-y; Tran KTC, 2004, ANN SURG, V240, P738, DOI 10.1097/01.sla.0000143248.71964.29; TRAVERSO LW, 1978, SURG GYNECOL OBSTET, V146, P959; Watson K, 1944, BRIT J SURG, V31, P368, DOI 10.1002/bjs.18003112406; Wells G, 2000, NEWCASTLE OTTAWA SCA; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005; Yang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090316; Yin Z, 2013, ANN SURG ONCOL, V20, P1203, DOI 10.1245/s10434-012-2705-8	48	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108380	10.1371/journal.pone.0108380	http://dx.doi.org/10.1371/journal.pone.0108380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272034	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600042
J	Yan, QR; Du, F; Huang, XF; Fu, Q; Chen, S; Dai, D; Bao, CD				Yan, Qingran; Du, Fang; Huang, Xinfang; Fu, Qiong; Chen, Sheng; Dai, Dai; Bao, Chunde			Prevention of Immune Nephritis by the Small Molecular Weight Immunomodulator Iguratimod in MRL/lpr Mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACTIVE RHEUMATOID-ARTHRITIS; T-CELL SUBSETS; B-CELLS; THERAPEUTIC TARGETS; ANTIRHEUMATIC DRUG; DOUBLE-BLIND; T-614; GENE; LPR	Objective: This study was performed to investigate the therapeutic effects of iguratimod in a lupus mouse model. Methods: Female MRL/lpr mice were treated with iguratimod, vehicle solution or cyclophosphamide. Proteinuria was monitored and kidney injury was blindly scored by a renal pathologist. Serum anti-double-stranded DNA antibodies were monitored by radioimmunoassay. Kidney IgG and CD20 were stained by immunohistochemistry. Splenic lymphocyte phenotypes were analyzed by flow cytometry. BAFF, IL-17A, IL-6, and IL-21 levels in serum and splenic lymphocytes were detected by ELISA or quantitative PCR. Results: Compared with the vehicle-treated controls, MRL/lpr mice treated with iguratimod showed less protenuria, less acute pathological lesions and no chronic changes in the kidneys. There were significant differences in glomerular injury and vasculitis scores, as well as in the semi-quantitave analysis of immune complex deposition between the two groups. Disease activity markers in sera (anti-dsDNA antibodies and immunoglobulin levels) were reduced and hypocomplementemia was attenuated. Lymphocyte expression of BAFF, IL-6, IL-17A and IL-21 was decreased. The abnormal splenic B220+ T cell and plasma cell populations in MRL/lpr mice were reduced by iguratimod treatment, with recovery of the total B cell population and inhibition of B cell infiltration of the kidney tissue. The dosage of iguratimod used in this study showed no significant cytotoxic effects in vivo and no overt side-effects were observed. Conclusion: Iguratimod ameliorates immune nephritis in MRL/lpr mice via a non-antiproliferative mechanism. Our data suggest a potential therapeutic role of iguratimod in lupus.	[Yan, Qingran; Du, Fang; Huang, Xinfang; Fu, Qiong; Chen, Sheng; Bao, Chunde] Shanghai Jiao Tong Univ, Shanghai Inst Rheumatol, Sch Med, Dept Rheumatol,Renji Hosp, Shanghai 200030, Peoples R China; [Dai, Dai] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Dai, Dai] Shanghai Jiao Tong Univ, Sch Med, Lab Mol Rheumatol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Bao, CD (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Rheumatol, Sch Med, Dept Rheumatol,Renji Hosp, Shanghai 200030, Peoples R China.	baochunde_1678@126.com	Yan, Qingran/AAH-4402-2020		National Natural Science Foundation of China [81373207]; Doctoral Innovation Fund of Shanghai Jiao Tong University School of Medicine [bxj201221]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Innovation Fund of Shanghai Jiao Tong University School of Medicine	This work was supported by grants from National Natural Science Foundation of China (grant no. 81373207) and Doctoral Innovation Fund of Shanghai Jiao Tong University School of Medicine (grant no. bxj201221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Y, 1998, J NEUROIMMUNOL, V89, P35, DOI 10.1016/S0165-5728(98)00056-3; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Cunnane G, 2004, ARTHRITIS RHEUM-US, V50, P1539, DOI 10.1002/art.20147; Du F, 2012, INT IMMUNOPHARMACOL, V13, P54, DOI 10.1016/j.intimp.2012.03.003; Du F, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2554; Espeli M, 2011, J AM SOC NEPHROL, V22, P296, DOI 10.1681/ASN.2010050515; GIESE T, 1992, J IMMUNOL, V149, P3097; Hara Masako, 2007, Mod Rheumatol, V17, P10; Hara Masako, 2007, Mod Rheumatol, V17, P1, DOI 10.1007/s10165-006-0542-y; HUNSICKER LG, 1972, NEW ENGL J MED, V287, P835, DOI 10.1056/NEJM197210262871701; Jiang C, 2011, J IMMUNOL, V186, P6136, DOI 10.4049/jimmunol.1001931; KAWANO MM, 1995, BLOOD, V85, P487; Kohno M, 2001, J RHEUMATOL, V28, P2591; Kyttaris VC, 2010, J IMMUNOL, V184, P4605, DOI 10.4049/jimmunol.0903595; Lacotte S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058140; Lee HT, 2010, J RHEUMATOL, V37, P45, DOI 10.3899/jrheum.090450; Lu LJ, 2008, CHINESE MED J-PEKING, V121, P615, DOI 10.1097/00029330-200804010-00008; Lu LJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P979, DOI 10.1002/art.24643; Luo Q, 2013, J IMMUNOL, V191, P4969, DOI 10.4049/jimmunol.1300832; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Martin JC, 2014, CLIN IMMUNOL, V154, P1, DOI 10.1016/j.clim.2014.05.004; MORSE HC, 1982, J IMMUNOL, V129, P2612; MURRAY LJ, 1990, EUR J IMMUNOL, V20, P163, DOI 10.1002/eji.1830200124; Nijnik A, 2006, INT IMMUNOL, V18, P1127, DOI 10.1093/intimm/dxl047; Rankin AL, 2012, J IMMUNOL, V188, P1656, DOI 10.4049/jimmunol.1003871; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Ronnblom L, 2010, NAT REV RHEUMATOL, V6, P339, DOI 10.1038/nrrheum.2010.64; Sanz I, 2010, NAT REV RHEUMATOL, V6, P326, DOI 10.1038/nrrheum.2010.68; Sawada T, 2000, IMMUNOPHARMACOLOGY, V49, P285, DOI 10.1016/S0162-3109(00)00242-3; Schiffer L, 2003, J IMMUNOL, V171, P489, DOI 10.4049/jimmunol.171.1.489; SMITH HR, 1984, CLIN IMMUNOL IMMUNOP, V30, P51, DOI 10.1016/0090-1229(84)90006-0; Sun C-Y, 2013, INT J RHEUMATOLOGY, V2013, P9; Tanaka K, 2003, RHEUMATOLOGY, V42, P1365, DOI 10.1093/rheumatology/keg381; WATSON ML, 1992, J EXP MED, V176, P1645, DOI 10.1084/jem.176.6.1645; Wong HK, 1999, J IMMUNOL, V163, P1682; Zhou X, 2014, INT REV IMMUNOLOGY	37	25	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108273	10.1371/journal.pone.0108273	http://dx.doi.org/10.1371/journal.pone.0108273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271634	Green Submitted, gold, Green Published			2022-12-27	WOS:000343729600037
J	Chan, SK; Kitajima-Ihara, T; Fujii, R; Gotoh, T; Murakami, M; Ihara, K; Kouyama, T				Chan, Siu Kit; Kitajima-Ihara, Tomomi; Fujii, Ryudoh; Gotoh, Toshiaki; Murakami, Midori; Ihara, Kunio; Kouyama, Tsutomu			Crystal Structure of Cruxrhodopsin-3 from Haloarcula vallismortis	PLOS ONE			English	Article							PROTEIN CONFORMATIONAL-CHANGES; DRIVEN PROTON PUMP; MILLISECOND-TIMESCALE; MEMBRANE-PROTEIN; OPTICAL CONTROL; N INTERMEDIATE; BACTERIORHODOPSIN; PHOTOREACTION; RHODOPSINS; PH	Cruxrhodopsin-3 (cR3), a retinylidene protein found in the claret membrane of Haloarcula vallismortis, functions as a light-driven proton pump. In this study, the membrane fusion method was applied to crystallize cR3 into a crystal belonging to space group P321. Diffraction data at 2.1 angstrom resolution show that cR3 forms a trimeric assembly with bacterioruberin bound to the crevice between neighboring subunits. Although the structure of the proton-release pathway is conserved among proton-pumping archaeal rhodopsins, cR3 possesses the following peculiar structural features: 1) The DE loop is long enough to interact with a neighboring subunit, strengthening the trimeric assembly; 2) Three positive charges are distributed at the cytoplasmic end of helix F, affecting the higher order structure of cR3; 3) The cytoplasmic vicinity of retinal is more rigid in cR3 than in bacteriorhodopsin, affecting the early reaction step in the proton-pumping cycle; 4) the cytoplasmic part of helix E is greatly bent, influencing the proton uptake process. Meanwhile, it was observed that the photobleaching of retinal, which scarcely occurred in the membrane state, became significant when the trimeric assembly of cR3 was dissociated into monomers in the presence of an excess amount of detergent. On the basis of these observations, we discuss structural factors affecting the photostabilities of ion-pumping rhodopsins.	[Chan, Siu Kit; Kitajima-Ihara, Tomomi; Fujii, Ryudoh; Gotoh, Toshiaki; Murakami, Midori; Kouyama, Tsutomu] Nagoya Univ, Dept Phys, Grad Sch Sci, Nagoya, Aichi 464, Japan; [Ihara, Kunio] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 464, Japan; [Kouyama, Tsutomu] RIKEN Harima Inst SPring 8, Sayo, Hyogo, Japan	Nagoya University; Nagoya University; RIKEN	Kouyama, T (corresponding author), Nagoya Univ, Dept Phys, Grad Sch Sci, Nagoya, Aichi 464, Japan.	kouyama@bio.phys.nagoya-u.ac.jp	murakami, midori/AAL-1023-2021; IHARA, Kunio/D-1952-2011		Ministry of Education, Science, and Culture of Japan	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid from the Ministry of Education, Science, and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Betancourt FMH, 2000, BBA-BIOENERGETICS, V1460, P106, DOI 10.1016/S0005-2728(00)00133-X; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chizhov I, 1996, BIOPHYS J, V71, P2329, DOI 10.1016/S0006-3495(96)79475-4; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; CLINE SW, 1989, J BACTERIOL, V171, P4987, DOI 10.1128/jb.171.9.4987-4991.1989; DENCHER NA, 1979, FEBS LETT, V108, P307, DOI 10.1016/0014-5793(79)80552-9; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Enamil N, 2006, J MOL BIOL, V358, P675, DOI 10.1016/j.jmb.2006.02.032; Essen LO, 1998, P NATL ACAD SCI USA, V95, P11673, DOI 10.1073/pnas.95.20.11673; Faham S, 2002, J MOL BIOL, V316, P1, DOI 10.1006/jmbi.2001.5295; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hayakawa N, 2008, J MOL BIOL, V384, P812, DOI 10.1016/j.jmb.2008.09.075; Hempelmann F, 2011, J AM CHEM SOC, V133, P4645, DOI 10.1021/ja111116a; Hino T, 2004, ACTA CRYSTALLOGR D, V60, P803, DOI 10.1107/S0907444904003233; Hirai T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005769; Ihara K, 1999, J MOL BIOL, V285, P163, DOI 10.1006/jmbi.1998.2286; Kamikubo H, 1996, P NATL ACAD SCI USA, V93, P1386, DOI 10.1073/pnas.93.4.1386; Kitajima T, 1996, BIOCHEM BIOPH RES CO, V220, P341, DOI 10.1006/bbrc.1996.0407; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kouyama T, 2004, J MOL BIOL, V335, P531, DOI 10.1016/j.jmb.2003.10.068; KOUYAMA T, 1985, BIOPHYS J, V48, P201, DOI 10.1016/S0006-3495(85)83773-5; KOUYAMA T, 1988, BIOCHEMISTRY-US, V27, P5855, DOI 10.1021/bi00416a006; KOUYAMA T, 1994, J MOL BIOL, V236, P990, DOI 10.1016/0022-2836(94)90005-1; Kouyama T, 2010, PHOTOCH PHOTOBIO SCI, V9, P1458, DOI 10.1039/c0pp00236d; Kouyama T, 2010, J MOL BIOL, V396, P564, DOI 10.1016/j.jmb.2009.11.061; LOZIER RH, 1992, P NATL ACAD SCI USA, V89, P3610, DOI 10.1073/pnas.89.8.3610; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; Matsui Y, 2002, J MOL BIOL, V324, P469, DOI 10.1016/S0022-2836(02)01110-5; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; Mukai Y, 1999, PROTEIN ENG, V12, P755, DOI 10.1093/protein/12.9.755; Nakanishi T, 2013, BIOPHYS J, V104, P377, DOI 10.1016/j.bpj.2012.12.018; NASUDAKOUYAMA A, 1990, BIOCHEMISTRY-US, V29, P6778, DOI 10.1021/bi00481a005; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Okumura H, 2005, J MOL BIOL, V351, P481, DOI 10.1016/j.jmb.2005.06.026; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Peck RF, 2000, MOL MICROBIOL, V35, P667, DOI 10.1046/j.1365-2958.2000.01739.x; Phatak P, 2008, P NATL ACAD SCI USA, V105, P19672, DOI 10.1073/pnas.0810712105; Ran TT, 2013, ACTA CRYSTALLOGR D, V69, P1965, DOI 10.1107/S0907444913017575; Sakai K, 2002, J APPL CRYSTALLOGR, V35, P270, DOI 10.1107/S0021889801021331; Sasaki T, 2012, BIOCHEMISTRY-US, V51, P2875; Sato H, 1999, ACTA CRYSTALLOGR D, V55, P1251, DOI 10.1107/S090744499900503X; Steller I, 1997, J APPL CRYSTALLOGR, V30, P1036, DOI 10.1107/S0021889897008777; Subramaniam S, 1999, J MOL BIOL, V287, P145, DOI 10.1006/jmbi.1999.2589; SUGIYAMA Y, 1994, BBA-BIOENERGETICS, V1188, P287, DOI 10.1016/0005-2728(94)90047-7; Swamy M., 2006, SCI STKE, V2006, pl4, DOI DOI 10.1126/STKE.3452006PL4.PMID:16868305; Takeda K, 2004, J MOL BIOL, V341, P1023, DOI 10.1016/j.jmb.2004.06.080; Takeda K, 1998, J MOL BIOL, V283, P463, DOI 10.1006/jmbi.1998.2103; TATENO M, 1994, ARCH BIOCHEM BIOPHYS, V315, P127, DOI 10.1006/abbi.1994.1480; Tsukamoto T, 2013, FEBS LETT, V587, P322, DOI 10.1016/j.febslet.2012.12.022; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vonck J, 2000, EMBO J, V19, P2152, DOI 10.1093/emboj/19.10.2152; Wada T, 2011, J MOL BIOL, V411, P986, DOI 10.1016/j.jmb.2011.06.028; Yamamoto M, 2009, J MOL BIOL, V393, P559, DOI 10.1016/j.jmb.2009.08.047; Yoshimura K, 2008, J MOL BIOL, V375, P1267, DOI 10.1016/j.jmb.2007.11.039; Zhang J, 2013, PROTEINS, V81, P1585, DOI 10.1002/prot.24316	60	9	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108362	10.1371/journal.pone.0108362	http://dx.doi.org/10.1371/journal.pone.0108362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268964	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700086
J	Fonseca, NA; Marioni, J; Brazma, A				Fonseca, Nuno A.; Marioni, John; Brazma, Alvis			RNA-Seq Gene Profiling - A Systematic Empirical Comparison	PLOS ONE			English	Article							BURROWS-WHEELER TRANSFORM; READ ALIGNMENT; DIFFERENTIAL EXPRESSION; ACCURATE ALIGNMENT; QUANTIFICATION; TRANSCRIPTOMES; TOPHAT; TOOL	Accurately quantifying gene expression levels is a key goal of experiments using RNA-sequencing to assay the transcriptome. This typically requires aligning the short reads generated to the genome or transcriptome before quantifying expression of pre-defined sets of genes. Differences in the alignment/quantification tools can have a major effect upon the expression levels found with important consequences for biological interpretation. Here we address two main issues: do different analysis pipelines affect the gene expression levels inferred from RNA-seq data? And, how close are the expression levels inferred to the "true" expression levels? We evaluate fifty gene profiling pipelines in experimental and simulated data sets with different characteristics (e. g, read length and sequencing depth). In the absence of knowledge of the 'ground truth' in real RNAseq data sets, we used simulated data to assess the differences between the "true" expression and those reconstructed by the analysis pipelines. Even though this approach does not take into account all known biases present in RNAseq data, it still allows to estimate the accuracy of the gene expression values inferred by different analysis pipelines. The results show that i) overall there is a high correlation between the expression levels inferred by the best pipelines and the true quantification values; ii) the error in the estimated gene expression values can vary considerably across genes; and iii) a small set of genes have expression estimates with consistently high error (across data sets and methods). Finally, although the mapping software is important, the quantification method makes a greater difference to the results.	[Fonseca, Nuno A.; Marioni, John; Brazma, Alvis] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England	European Molecular Biology Laboratory (EMBL)	Fonseca, NA (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Hinxton, England.	nf@ebi.ac.uk; marioni@ebi.ac.uk; brazma@ebi.ac.uk	Fonseca, Nuno A./B-7801-2009	Fonseca, Nuno A./0000-0003-4832-578X; Marioni, John/0000-0001-9092-0852; Brazma, Alvis/0000-0001-5988-7409	European Community's FP7 HEALTH grants CAGEKID [241669]	European Community's FP7 HEALTH grants CAGEKID	This work was supported by European Community's FP7 HEALTH grants CAGEKID (grant agreement 241669). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DUJ, 2012, PLOS ONE, V0007; ELDER GH, 1978, NEW ENGL J MED, V299, P274, DOI 10.1056/NEJM197808102990603; Elsheikh SE, 2008, BRIT J CANCER, V99, P327, DOI 10.1038/sj.bjc.6604463; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Fonseca NA, 2014, IRAP INTEGRATED RNA; Fonseca NA, 2012, BIOINFORMATICS, V28, P3169, DOI 10.1093/bioinformatics/bts605; Griebel T, 2012, NUCLEIC ACIDS RES, V40, P10073, DOI 10.1093/nar/gks666; Hu J, 2012, BIOINFORMATICS, V28, P1933, DOI 10.1093/bioinformatics/bts294; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-305; Kvam VM, 2012, AM J BOT, V99, P248, DOI 10.3732/ajb.1100340; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ma XY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-220; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nariai N, 2013, BIOINFORMATICS; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Rivera J, 2010, J CELL BIOCHEM, V111, P1464, DOI 10.1002/jcb.22874; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	32	55	55	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107026	10.1371/journal.pone.0107026	http://dx.doi.org/10.1371/journal.pone.0107026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268973	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700026
J	Freeman, ED; Sharp, TR; Larsen, RT; Knight, RN; Slater, SJ; McMillan, BR				Freeman, Eric D.; Sharp, Tiffanny R.; Larsen, Randy T.; Knight, Robert N.; Slater, Steven J.; McMillan, Brock R.			Negative Effects of an Exotic Grass Invasion on Small-Mammal Communities	PLOS ONE			English	Article							BROMUS-TECTORUM CHEATGRASS; BIOLOGICAL INVASIONS; GREAT-BASIN; DESERT; FIRE; ECOSYSTEM; RODENTS; PLANTS; CONSEQUENCES; COMPETITION	Exotic invasive species can directly and indirectly influence natural ecological communities. Cheatgrass (Bromus tectorum) is non-native to the western United States and has invaded large areas of the Great Basin. Changes to the structure and composition of plant communities invaded by cheatgrass likely have effects at higher trophic levels. As a keystone guild in North American deserts, granivorous small mammals drive and maintain plant diversity. Our objective was to assess potential effects of invasion by cheatgrass on small-mammal communities. We sampled small-mammal and plant communities at 70 sites (Great Basin, Utah). We assessed abundance and diversity of the small-mammal community, diversity of the plant community, and the percentage of cheatgrass cover and shrub species. Abundance and diversity of the small-mammal community decreased with increasing abundance of cheatgrass. Similarly, cover of cheatgrass remained a significant predictor of small-mammal abundance even after accounting for the loss of the shrub layer and plant diversity, suggesting that there are direct and indirect effects of cheatgrass. The change in the small-mammal communities associated with invasion of cheatgrass likely has effects through higher and lower trophic levels and has the potential to cause major changes in ecosystem structure and function.	[Freeman, Eric D.; Sharp, Tiffanny R.; Larsen, Randy T.; McMillan, Brock R.] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA; [Larsen, Randy T.] Monte L Bean Life Sci Museum, Provo, UT USA; [Knight, Robert N.] US Army Dugway Proving Ground, Environm Programs, Dugway, UT USA; [Slater, Steven J.] HawkWatch Int, Salt Lake City, UT USA	Brigham Young University	Freeman, ED (corresponding author), Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA.	edfreeman1@gmail.com			US Army Dugway Proving Grounds [R0202329]	US Army Dugway Proving Grounds	Support was provided by US Army Dugway Proving Grounds Grant #R0202329. Robert N. Knight of Dugway Proving Ground, a coauthor of this manuscript, was key in gaining access to military lands, facilitating interaction between authors and the military, took part in concept development, and participated in writing the manuscript.	Balch JK, 2013, GLOBAL CHANGE BIOL, V19, P173, DOI 10.1111/gcb.12046; BLAIR C L, 1982, Wilson Bulletin, V94, P46; Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2; BROWN JH, 1973, ECOLOGY, V54, P788, DOI 10.2307/1935673; BROWN JH, 1990, SCIENCE, V250, P1705, DOI 10.1126/science.250.4988.1705; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; Cuddington K, 2004, ECOL MODEL, V178, P335, DOI 10.1016/j.ecolmodel.2004.03.010; D'Antonio C, 2002, RESTOR ECOL, V10, P703, DOI 10.1046/j.1526-100X.2002.01051.x; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Dukes JS, 2004, REV CHIL HIST NAT, V77, P411; Fitch Henry S., 1946, CONDOR, V48, P205, DOI 10.2307/1363939; Gano K, 1982, NW SCI, V56; GUO QF, 1995, OIKOS, V73, P251, DOI 10.2307/3545915; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Hiebert RD, 1997, PRIORITIZING INVASIV, P195; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Humphrey LD, 2004, J ARID ENVIRON, V58, P405, DOI 10.1016/j.jaridenv.2003.11.008; KELRICK MI, 1986, OECOLOGIA, V68, P327, DOI 10.1007/BF01036734; Kerley GIH, 2009, J ARID ENVIRON, V73, P651, DOI 10.1016/j.jaridenv.2009.01.001; Kindt R., 2005, WORLD; Knapp PA, 1996, GLOBAL ENVIRON CHANG, V6, P37, DOI 10.1016/0959-3780(95)00112-3; Mack RN, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P253; MELGOZA G, 1990, OECOLOGIA, V83, P7, DOI 10.1007/BF00324626; Novak SJ, 2001, BIOSCIENCE, V51, P114, DOI 10.1641/0006-3568(2001)051[0114:TPIASG]2.0.CO;2; Oksanen J., 2016, R PACKAG; Ostoja SM, 2009, DIVERS DISTRIB, V15, P863, DOI 10.1111/j.1472-4642.2009.00593.x; PARMENTER RR, 1983, OECOLOGIA, V59, P145, DOI 10.1007/BF00378831; Pearson DE, 2009, OECOLOGIA, V159, P549, DOI 10.1007/s00442-008-1241-5; PRICE MV, 1978, ECOLOGY, V59, P910, DOI 10.2307/1938543; PRICE MV, 1983, GREAT BASIN NAT MEM, V7, P117; R Core Team, 2018, R LANG ENV STAT COMP; REICHMAN OJ, 1975, J MAMMAL, V56, P503, DOI 10.2307/1379375; Rieder JP, 2010, BIOL INVASIONS, V12, P2429, DOI 10.1007/s10530-009-9653-7; Ripley R., 2011, MASS SUPPORT FUNCTIO; SCHMUTZ JK, 1989, CAN J ZOOL, V67, P2596, DOI 10.1139/z89-366; SIEG CH, 1986, NORTHWEST SCI, V60, P81; Slater SJ, 2012, GREAT BASIN AVIAN SP; STEWART G, 1949, ECOLOGY, V30, P58, DOI 10.2307/1932277; VANDERWALL SB, 1992, ECOLOGY, V73, P614, DOI 10.2307/1940767; Walker L.R., 1997, ASSESSMENT MANAGEMEN, P69, DOI [10.1007/978-1-4612-1926-2_7, DOI 10.1007/978-1-4612-1926-2_7]; Weidenhamer JD, 2010, J CHEM ECOL, V36, P59, DOI 10.1007/s10886-009-9735-0; WHISENANT SG, 1990, USDA INTERM, V276, P4; White GC, 1996, ECOLOGY, V77, P2549, DOI 10.2307/2265753; Young J.A., 2009, CHEATGRASS FIRE FORA; YOUNG JA, 1973, J RANGE MANAGE, V26, P410, DOI 10.2307/3896974; Zouhar K., 2003, BROMUS TECTORUM FIRE	46	36	37	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108843	10.1371/journal.pone.0108843	http://dx.doi.org/10.1371/journal.pone.0108843			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25269073	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700177
J	Huang, LJ; Zhang, T; Li, S; Duan, JT; Ye, F; Li, HX; She, ZG; Gao, GQ; Yang, X				Huang, Lijun; Zhang, Ting; Li, Shuai; Duan, Junting; Ye, Fang; Li, Hanxiang; She, Zhigang; Gao, Guoquan; Yang, Xia			Anthraquinone G503 Induces Apoptosis in Gastric Cancer Cells through the Mitochondrial Pathway	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; NF-KAPPA-B; OXIDATIVE STRESS; PERMEABILITY TRANSITION; MARINE ANTHRAQUINONE; ANTICANCER ACTIVITY; DNA FRAGMENTATION; MELANOMA-CELLS; DEATH RECEPTOR; ACTIVATION	G503 is an anthraquinone compound isolated from the secondary metabolites of a mangrove endophytic fungus from the South China Sea. The present study elucidates the anti-tumor activity and the underlying mechanism of G503. Cell viability assay performed in nine cancer cell lines and two normal cell lines demonstrated that the gastric cancer cell line SGC7901 is the most G503-sensitive cancer cells. G503 induced SGC7901 cell death via apoptosis. G503 exposure activated caspases-3, 8 and -9. Pretreatment with the pan-caspase inhibitor Z-VAD-FMK and caspase-9 inhibitor Z-LEHD-FMK, but not caspase-8 inbibitor Z-IETD-FMK, attenuated the effect of G503. These results suggested that the intrinsic mitochondrial apoptosis pathway, rather than the extrinsic pathway, was involved in G503-induced apoptosis. Furthermore, G503 increased the ratio of Bax to Bcl-2 in the mitochondria and decreased the ratio in the cytosol. G503 treatment resulted in mitochondrial depolarization, cytochrome c release and the subsequent cleavage of caspase -9 and -3. Moreover, it is reported that the endoplasmic reticulum apoptosis pathway may also be activated by G503 by inducing capase-4 cleavage. In consideration of the lower 50% inhibitory concentration for gastric cancer cells, G503 may serve as a promising candidate for gastric cancer chemotherapy.	[Huang, Lijun; Zhang, Ting; Li, Shuai; Gao, Guoquan; Yang, Xia] Sun Yat Sen Univ, Dept Biochem, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Li, Hanxiang; She, Zhigang; Yang, Xia] Sun Yat Sen Univ, Dept Educ Guangdong Prov, Key Lab Funct Mol Marine Microorganisms, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Guoquan] Sun Yat Sen Univ, Minist Educ, China Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Gao, GQ (corresponding author), Sun Yat Sen Univ, Dept Biochem, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China.	gaogq@mail.sysu.edu.cn; yangxia@mail.sysu.edu.cn	Li, Hanxiang/ABF-4049-2020		National Nature Science Foundation of China [30973449, 81172163, 81272515, 81272338, 81200706]; National Key Sci-Tech Special Project of China [2009ZX09103-642, 2013ZX09102053]; Program for Doctoral Station in University [20120171110053, 20130171110053]; Key Project of Nature Science Foundation of Guangdong Province, China [10251008901000009]; Key Sci-tech Research Project of Guangdong Province, China [2011B031200006]; Guandong Natural Science Fund [S2012010009250, S2012040006986]; Key Sci-tech Research Project of Guangzhou Municipality, China [2011Y1-00017-8, 12A52061519]; Program for Young Teacher in University [10YKPY28]; Changjiang Scholars and Innovative Research Team in University [985, PCSIRT 0947]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Special Project of China; Program for Doctoral Station in University; Key Project of Nature Science Foundation of Guangdong Province, China; Key Sci-tech Research Project of Guangdong Province, China; Guandong Natural Science Fund; Key Sci-tech Research Project of Guangzhou Municipality, China; Program for Young Teacher in University; Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This study was supported by National Nature Science Foundation of China, Grant Number: 30973449, 81172163, 81272515, 81272338, 81200706; National Key Sci-Tech Special Project of China, Grant Number: 2009ZX09103-642, 2013ZX09102053; Program for Doctoral Station in University, Grant Number: 20120171110053, 20130171110053; Key Project of Nature Science Foundation of Guangdong Province, China, Grant Number: 10251008901000009; Key Sci-tech Research Project of Guangdong Province, China, Grant Number: 2011B031200006; Guandong Natural Science Fund, Grant Number: S2012010009250, S2012040006986; Key Sci-tech Research Project of Guangzhou Municipality, China, Grant Number: 2011Y1-00017-8, 12A52061519; Program for Young Teacher in University, Grant Number: 10YKPY28; Changjiang Scholars and Innovative Research Team in University, number: 985 project PCSIRT 0947. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleo E, 2006, CANCER RES, V66, P9235, DOI 10.1158/0008-5472.CAN-06-0702; Banerjee S, 2008, J NAT PROD, V71, P492, DOI 10.1021/np0705716; Bian ZM, 2009, INVEST OPHTH VIS SCI, V50, P6006, DOI 10.1167/iovs.09-3628; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Bratton SB, 2000, EXP CELL RES, V256, P27, DOI 10.1006/excr.2000.4835; Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; Chowdhury I, 2006, CELL MOL BIOL LETT, V11, P506, DOI 10.2478/s11658-006-0041-3; Clementi ME, 2003, ANTICANCER RES, V23, P2445; Cooper EL, 2004, EVID-BASED COMPL ALT, V1, P215, DOI 10.1093/ecam/neh032; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Feng D, 2010, INFLAMM RES, V59, P115, DOI 10.1007/s00011-009-0077-8; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gu XQ, 2011, APOPTOSIS, V16, P846, DOI 10.1007/s10495-011-0618-9; Gupta S, 2003, INT J ONCOL, V22, P15; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Huang Q, 2007, MED RES REV, V27, P609, DOI 10.1002/med.20094; Hyman BT, 2012, NAT REV NEUROSCI, V13, P395, DOI 10.1038/nrn3228; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kang YH, 2008, ONCOL REP, V20, P637, DOI 10.3892/or_00000053; Laurent G, 2001, BLOOD, V98, P913, DOI 10.1182/blood.V98.4.913; Li R, 2013, ONCOL LETT, V5, P877, DOI 10.3892/ol.2013.1103; Liu WL, 2002, ACTA PHARMACOL SIN, V23, P45; Liu WL, 2000, ACTA PHARMACOL SIN, V21, P991; Martin D, 2002, J BIOL CHEM, V277, P42943, DOI 10.1074/jbc.M201070200; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Mates JM, 2008, ARCH TOXICOL, V82, P273, DOI 10.1007/s00204-008-0304-z; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Nakase I, 2009, CANCER LETT, V274, P290, DOI 10.1016/j.canlet.2008.09.023; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Nicolau-Galmes F, 2011, APOPTOSIS, V16, P1253, DOI 10.1007/s10495-011-0640-y; Pan X., 2012, P NATL ACAD SCI USA, V109, pE23, DOI DOI 10.1073/pnas.1116932108; Pastorino JG, 1999, J BIOL CHEM, V274, P31734, DOI 10.1074/jbc.274.44.31734; Perchellet EM, 2004, BIOCHEM PHARMACOL, V67, P523, DOI 10.1016/j.bcp.2003.09.012; Perchellet EM, 2001, ANTI-CANCER DRUG, V12, P401, DOI 10.1097/00001813-200106000-00002; PharmD CW, 2007, PLANTS CHEMOTHERAPY, P155; Rupinder SK, 2007, VASC PHARMACOL, V46, P383, DOI 10.1016/j.vph.2007.01.006; Saify ZS, 1999, PARK J PHARM SCI, V12, P21; Selimovic D, 2008, CELL SIGNAL, V20, P311, DOI 10.1016/j.cellsig.2007.10.015; She ZG, 2008, Chinese Patent Application, Patent No. [200510037139.4, 2005100371394]; Stennicke HR, 1998, BBA-PROTEIN STRUCT M, V1387, P17, DOI 10.1016/S0167-4838(98)00133-2; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Teiten MH, 2013, BIOORGAN MED CHEM, V21, P3850, DOI 10.1016/j.bmc.2013.04.024; Wang DJ, 2013, ONCOL REP, V29, P2341, DOI 10.3892/or.2013.2376; Wang RQ, 2011, J IMMUNOL, V187, P5964, DOI 10.4049/jimmunol.1101205; Wang XH, 2006, P NATL ACAD SCI USA, V103, P3604, DOI 10.1073/pnas.0510962103; Wang ZL, 2009, INFLAMM RES, V58, P649, DOI 10.1007/s00011-009-0030-x; WEISS RB, 1992, SEMIN ONCOL, V19, P670; Xie G, 2010, BRIT J PHARMACOL, V159, P689, DOI 10.1111/j.1476-5381.2009.00577.x; Yamamuro A, 2011, J PHARMACOL SCI, V115, P239, DOI 10.1254/jphs.10217SC; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zhu X, 2012, MAR DRUGS, V10, P694, DOI 10.3390/md10040694	60	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108286	10.1371/journal.pone.0108286	http://dx.doi.org/10.1371/journal.pone.0108286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268882	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700075
J	Sorouri, M; Fitzsimmons, SP; Aydanian, AG; Bennett, S; Shapiro, MA				Sorouri, Mahsa; Fitzsimmons, Sean P.; Aydanian, Antonina G.; Bennett, Sonita; Shapiro, Marjorie A.			Diversity of the Antibody Response to Tetanus Toxoid: Comparison of Hybridoma Library to Phage Display Library	PLOS ONE			English	Article							IMMUNE-RESPONSE; GENE FAMILIES; AFFINITY; REPERTOIRE; GENERATION; SELECTION; EXPRESSION; STRATEGIES; ANTIGENS; SEQUENCE	Monoclonal antibodies are important tools in research and since the 1990s have been an important therapeutic class targeting a wide variety of diseases. Earlier methods of mAb production relied exclusively on the lengthy process of making hybridomas. The advent of phage display technology introduced an alternative approach for mAb production. A potential concern with this approach is its complete dependence on an in vitro selection process, which may result in selection of V-H-V-L pairs normally eliminated during the in vivo selection process. The diversity of V-H-V-L pairs selected from phage display libraries relative to an endogenous response is unknown. To address these questions, we constructed a panel of hybridomas and a phage display library using the spleen of a single tetanus toxoid-immunized mouse and compared the diversity of the immune response generated using each technique. Surprisingly, the tetanus toxoid-specific antibodies produced by the hybridoma library exhibited a higher degree of V-H-V-L genetic diversity than their phage display-derived counterparts. Furthermore, the overlap among the V-genes from each library was very limited. Consistent with the notion that accumulation of many small DNA changes lead to increased antigen specificity and affinity, the phage clones displayed substantial micro-heterogeneity. Contrary to previous reports, we found that antigen specificity against tetanus toxoid is encoded by both V kappa and V-H genes. Finally, the phage-derived tetanus-specific clones had a lower binding affinity than the hybridomas, a phenomenon thought to be the result of random pairing of the V-genes.	[Sorouri, Mahsa; Fitzsimmons, Sean P.; Aydanian, Antonina G.; Bennett, Sonita; Shapiro, Marjorie A.] US FDA, Lab Mol & Dev Immunol, Div Monoclonal Antibodies, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	Shapiro, MA (corresponding author), US FDA, Lab Mol & Dev Immunol, Div Monoclonal Antibodies, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA.	marjorie.shapiro@fda.hhs.gov			FDA funds	FDA funds	The source of support is internal FDA funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amersdorfer P, 1997, INFECT IMMUN, V65, P3743, DOI 10.1128/IAI.65.9.3743-3752.1997; Baird CL, 2010, CANCER BIOMARK, V6, P271, DOI 10.3233/CBM-2009-0144; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Brekke KM, 2004, IMMUNOGENETICS, V56, P490, DOI 10.1007/s00251-004-0659-0; Carmen Sara, 2002, Briefings in Functional Genomics & Proteomics, V1, P189, DOI 10.1093/bfgp/1.2.189; de Haard HJ, 1999, J BIOL CHEM, V274, P18218, DOI 10.1074/jbc.274.26.18218; de Kruif J, 2009, J MOL BIOL, V387, P548, DOI 10.1016/j.jmb.2009.02.009; Derda R, 2011, MOLECULES, V16, P1776, DOI 10.3390/molecules16021776; Galanis M, 1999, CURRENT PROTOCOLS IM; Griffiths AD, 1998, CURR OPIN BIOTECH, V9, P102, DOI 10.1016/S0958-1669(98)80092-X; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; Hoogenboom HR, 1998, IMMUNOTECHNOLOGY, V4, P1, DOI 10.1016/S1380-2933(98)00007-4; Kaushik A, 1996, RES IMMUNOL, V147, P9, DOI 10.1016/0923-2494(96)81545-8; KETTLEBOROUGH CA, 1993, EUR J IMMUNOL, V23, P206, DOI 10.1002/eji.1830230132; Kramer RA, 2005, EUR J IMMUNOL, V35, P2131, DOI 10.1002/eji.200526134; Lefranc Marie-Paule, 2004, In Silico Biology, V4, P17; Lewiecki EM, 2013, EXPERT OPIN BIOL TH, V13, P183, DOI 10.1517/14712598.2012.740006; Lloyd C, 2009, PROTEIN ENG DES SEL, V22, P159, DOI 10.1093/protein/gzn058; Lou JL, 2001, J IMMUNOL METHODS, V253, P233, DOI 10.1016/S0022-1759(01)00385-4; Lucas AH, 2001, INFECT IMMUN, V69, P853, DOI 10.1128/IAI.69.2.853-864.2001; Mainville CA, 1996, J IMMUNOL, V156, P1038; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Meijer PJ, 2006, J MOL BIOL, V358, P764, DOI 10.1016/j.jmb.2006.02.040; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Ohlin M, 1996, MOL IMMUNOL, V33, P47, DOI 10.1016/0161-5890(95)00123-9; Pansri P, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-6; Popi AF, 2009, IMMUNOLOGY, V126, P114, DOI 10.1111/j.1365-2567.2008.02883.x; Poulsen TR, 2007, J IMMUNOL, V179, P3841, DOI 10.4049/jimmunol.179.6.3841; Rogosch T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00176; Saggy I, 2012, PROTEIN ENG DES SEL, V25, P539, DOI 10.1093/protein/gzs060; Sahebkar A, 2013, CLIN THER, V35, P1082, DOI 10.1016/j.clinthera.2013.06.019; Schable KF, 1999, EUR J IMMUNOL, V29, P2082, DOI 10.1002/(SICI)1521-4141(199907)29:07&lt;2082::AID-IMMU2082&gt;3.0.CO;2-C; Thiebe R, 1999, EUR J IMMUNOL, V29, P2072, DOI 10.1002/(SICI)1521-4141(199907)29:07&lt;2072::AID-IMMU2072&gt;3.0.CO;2-E; Tohidkia MR, 2012, J DRUG TARGET, V20, P195, DOI 10.3109/1061186X.2011.611517; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Welschof M, 1998, METH MOLEC MED, V13, P593, DOI 10.1385/0-89603-485-2:593; Willats WGT, 2002, PLANT MOL BIOL, V50, P837, DOI 10.1023/A:1021215516430; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382	40	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e106699	10.1371/journal.pone.0106699	http://dx.doi.org/10.1371/journal.pone.0106699			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268771	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700014
J	Zhuo, C; Zhao, QY; Xiao, SN				Zhuo, Chao; Zhao, Qian-yu; Xiao, Shu-nian			The Impact of spgM, rpfF, rmlA Gene Distribution on Biofilm Formation in Stenotrophomonas maltophilia	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; CYSTIC-FIBROSIS PATIENTS; ANTIBIOTIC-RESISTANCE; VIRULENCE; PATHOGEN; MOTILITY; FLAGELLA; GENOME; MUCUS	Background: Stenotrophomonas maltophilia is emerging as one of the most frequently found bacteria in chronic pulmonary infection. Biofilm is increasingly recognized as a contributing factor to disease pathogenesis. In the present study, a total of 37 isolates of S. maltophilia obtained from chronic pulmonary infection patients were evaluated to the relationship between biofilm production and the relative genes expression. Methods: The clonal relatedness of isolates was determined by pulse-field gel electrophoresis. Biofilm formation assays were performed by crystal violet assay, and confirmed by Electron microscopy analysis and CLSM analysis. PCR was employed to learn gene distribution and expression. Results: Twenty-four pulsotypes were designated for 37 S. maltophilia isolates, and these 24 pulsotypes exhibited various levels of biofilm production, 8 strong biofilm-producing S. maltophilia strains with OD492 value above 0.6, 14 middle biofilm-producing strains with OD492 average value of 0.4 and 2 weak biofilm-producing strains with OD492 average value of 0.19. CLSM analysis showed that the isolates from the early stage of chronic infection enable to form more highly structured and multilayered biofim than those in the late stage. The prevalence of spgM, rmlA, and rpfF genes was 83.3%, 87.5%, and 50.0% in 24 S. maltophilia strains, respectively, and the presence of rmlA, spgM or rpfF had a close relationship with biofilm formation but did not significantly affect the mean amount of biofilm. Significant mutations of spgM and rmlA were found in both strong and weak biofilm-producing strains. Conclusion: Mutations in spgM and rmlA may be relevant to biofilm formation in the clinical isolates of S. maltophilia.	[Zhuo, Chao; Zhao, Qian-yu; Xiao, Shu-nian] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Zhuo, C (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	chao_sheep@263.net			Natural Science Foundation of China [30971318]; Key Foundation of Guangdong province Bureau of Science and Technology [2009A030301011]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Foundation of Guangdong province Bureau of Science and Technology	The work was supported by a grant from the Natural Science Foundation of China (no. 30971318) and a grant (no. 2009A030301011) from the Key Foundation of Guangdong province Bureau of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Bridier A, 2010, J MICROBIOL METH, V82, P64, DOI 10.1016/j.mimet.2010.04.006; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; de Oliveira-Garcia D, 2002, EMERG INFECT DIS, V8, P918, DOI 10.3201/eid0809.010535; Di Bonaventura G, 2004, ANTIMICROB AGENTS CH, V48, P151, DOI 10.1128/AAC.48.1.151-160.2004; Di Bonaventura G, 2010, INFECT IMMUN, V78, P2466, DOI 10.1128/IAI.01391-09; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Figueiredo PMS, 2006, LETT APPL MICROBIOL, V43, P443, DOI 10.1111/j.1472-765X.2006.01965.x; Fouhy Y, 2007, J BACTERIOL, V189, P4964, DOI 10.1128/JB.00310-07; Goss CH, 2002, AM J RESP CRIT CARE, V166, P356, DOI 10.1164/rccm.2109078; Huang TP, 2006, J BACTERIOL, V188, P3116, DOI 10.1128/JB.188.8.3116-3120.2006; KARPATI F, 1994, INFECTION, V22, P258, DOI 10.1007/BF01739911; Lee B, 2005, J CLIN MICROBIOL, V43, P5247, DOI 10.1128/JCM.43.10.5247-5255.2005; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Mahenthiralingam E, 1996, J CLIN MICROBIOL, V34, P1129, DOI 10.1128/JCM.34.5.1129-1135.1996; McKay GA, 2003, INFECT IMMUN, V71, P3068, DOI 10.1128/IAI.71.6.3068-3075.2003; Pompilio A, 2008, FEMS MICROBIOL LETT, V287, P41, DOI 10.1111/j.1574-6968.2008.01292.x; Pompilio A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-159; Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837; SEIFERT H, 1995, J CLIN MICROBIOL, V33, P1402, DOI 10.1128/JCM.33.5.1402-1407.1995; Shi ZY, 1996, J CLIN MICROBIOL, V34, P2784, DOI 10.1128/JCM.34.11.2784-2790.1996; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Zgair AK, 2011, J MED MICROBIOL, V60, P1032, DOI 10.1099/jmm.0.026377-0	26	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108409	10.1371/journal.pone.0108409	http://dx.doi.org/10.1371/journal.pone.0108409			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285537	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700019
J	Lou, BH; Chen, M; Luo, XJ; Dai, YM				Lou, Baohui; Chen, Min; Luo, Xiaojie; Dai, Yongming			Reduced Right Frontal Fractional Anisotropy Correlated with Early Elevated Plasma LDL Levels in Obese Young Adults	PLOS ONE			English	Article							BODY-MASS INDEX; BRAIN; CHOLESTEROL; RISK; ABNORMALITIES; VOLUMES; MEMORY; GRAY	Objective: To investigate the underlying physiological mechanisms of the structural differences in gray matter (GM) and white matter (WM) associated with obesity in young Chinese adults. Materials and Methods: A total of 49 right-handed obese or overweight (n = 22, mean age 31.72 +/- 8.04 years) and normal weight (n = 27, mean age 29.04 +/- 7.32 years) Han Chinese individuals were recruited. All participants underwent voxel-based morphometry analysis of T1-weighted MRI and tract-based spatial statistics analysis of diffusion tensor imaging. Partial correlation analysis was performed between the physiological data obtained and the abnormal structural alterations. Results: In the OO group, GM atrophy occurred in the left prefrontal cortex, bilateral cingulate gyrus, and the right temporal lobe, while enlargement was observed in the bilateral putamen. WM atrophy was observed predominantly in the regions that regulate food intake, such as the bilateral basal ganglia, the right amygdala, and the left insula. The OO group exhibited lower fractional anisotropy (FA) in bilateral frontal corticospinal tracts and the right brainstem. Significant negative correlations were observed between FA values of those three clusters and BMI, and waist circumference, while the volume of bilateral putamen positively correlated with both BMI and waist circumference. High plasma LDL levels were correlated with low FA values in the right frontal corticospinal tract. Interestingly, the negative correlation was limited to male participants. Conclusions: Obesity-related alterations of GM and WM volumes were observed predominantly in food reward circuit, which may motivate abnormal dietary intake. Further, early elevated plasma LDL might contribute to low right frontal FA values of male adults, which requires further demonstration by larger-scale and longitudinal studies.	[Lou, Baohui; Chen, Min] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Lou, Baohui] Beijing Hosp, Beijing Inst Geriatr, Beijing, Peoples R China; [Chen, Min; Luo, Xiaojie] Beijing Hosp, Dept Radiol, Beijing, Peoples R China; [Dai, Yongming] Philips Healthcare, Shanghai, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Hospital; Beijing Hospital; Philips; Philips Healthcare	Chen, M (corresponding author), Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China.	cjr.chenmin@vip.163.com			National Natural Science Foundation of China [81271555]; Philips Healthcare	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Philips Healthcare	This work was supported by a grant from the National Natural Science Foundation of China (No. 81271555; http://www.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Yongming Dai is employed by Philips Healthcare. Philips Healthcare provided support in the form of salary for author YD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Aung Wint Yan, 2013, Imaging Med, V5, P427; Bobb JF, 2012, HUM BRAIN MAPP; Brodtmann A, 2009, BRAIN RES, V1259, P17, DOI 10.1016/j.brainres.2008.12.044; Cohen JI, 2011, NEURORADIOL J, V24, P854, DOI 10.1177/197140091102400604; Ehrlich D, 2012, J NEUROL SCI, V322, P92, DOI 10.1016/j.jns.2012.07.002; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Geliebter A, 2013, APPETITE; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Haley AP, 2013, OBESITY; Haltia LT, 2007, J CLIN ENDOCR METAB, V92, P3278, DOI 10.1210/jc.2006-2495; He Q, 2013, BRAIN STRUCTURE FUNC; Herrero MJ, 2003, GEN HOSP PSYCHIAT, V25, P277, DOI 10.1016/S0163-8343(03)00043-4; Hou XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057319; Hui L, 2012, LIFE SCI, V91, P1159, DOI 10.1016/j.lfs.2012.04.039; Hung YH, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00111; Karlsson HK, 2013, OBESITY; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Li Xiao-yan, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P683; Marks BL, 2011, BRIT J SPORT MED, V45, P1208, DOI 10.1136/bjsm.2009.068114; Nummenmaa L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031089; Pannacciulli N, 2006, NEUROIMAGE, V31, P1419, DOI 10.1016/j.neuroimage.2006.01.047; Peri A, 2011, NEUROSCIENCE, V191, P107, DOI 10.1016/j.neuroscience.2011.03.011; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shepardson NE, 2011, ARCH NEUROL-CHICAGO, V68, P1239, DOI 10.1001/archneurol.2011.203; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stanek KM, 2011, OBESITY, V19, P500, DOI 10.1038/oby.2010.312; Stice E, 2013, NEUROSCI BIOBEHAV R, V37, P2047, DOI 10.1016/j.neubiorev.2012.12.001; Taki Y, 2008, OBESITY, V16, P119, DOI 10.1038/oby.2007.4; Umeda T, 2012, LIFE SCI, V91, P1169, DOI 10.1016/j.lfs.2011.12.022; Vance JE, 2012, DIS MODEL MECH, V5, P746, DOI 10.1242/dmm.010124; Verstynen TD, 2012, PSYCHOSOM MED, V74, P682, DOI 10.1097/PSY.0b013e318261909c; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Walther K, 2010, HUM BRAIN MAPP, V31, P1052, DOI 10.1002/hbm.20916; Wang H, 2007, INT J OBESITY, V31, P272, DOI 10.1038/sj.ijo.0803416; Wang H, 2013, OBES REV, V14, P134, DOI 10.1111/obr.12106; Wang Wenjuan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P16; Weygandt M, 2013, NEUROIMAGE, V83, P669, DOI 10.1016/j.neuroimage.2013.07.028; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Widya RL, 2011, AM J CLIN NUTR, V93, P1190, DOI 10.3945/ajcn.110.006304; Yokum S, 2012, INT J OBESITY, V36, P656, DOI 10.1038/ijo.2011.175	45	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108180	10.1371/journal.pone.0108180	http://dx.doi.org/10.1371/journal.pone.0108180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279729	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800012
J	Spanbauer, TL; Allen, CR; Angeler, DG; Eason, T; Fritz, SC; Garmestani, AS; Nash, KL; Stone, JR				Spanbauer, Trisha L.; Allen, Craig R.; Angeler, David G.; Eason, Tarsha; Fritz, Sherilyn C.; Garmestani, Ahjond S.; Nash, Kirsty L.; Stone, Jeffery R.			Prolonged Instability Prior to a Regime Shift	PLOS ONE			English	Article							EARLY-WARNING SIGNALS; FISHER INFORMATION; ECOLOGICAL-SYSTEMS; MULTIDECADAL DROUGHT; CRITICAL TRANSITIONS; ROCKY-MOUNTAINS; CLIMATE-CHANGE; ECOSYSTEM; TIME; RESILIENCE	Regime shifts are generally defined as the point of 'abrupt' change in the state of a system. However, a seemingly abrupt transition can be the product of a system reorganization that has been ongoing much longer than is evident in statistical analysis of a single component of the system. Using both univariate and multivariate statistical methods, we tested a long-term high-resolution paleoecological dataset with a known change in species assemblage for a regime shift. Analysis of this dataset with Fisher Information and multivariate time series modeling showed that there was a, 2000 year period of instability prior to the regime shift. This period of instability and the subsequent regime shift coincide with regional climate change, indicating that the system is undergoing extrinsic forcing. Paleoecological records offer a unique opportunity to test tools for the detection of thresholds and stable-states, and thus to examine the long-term stability of ecosystems over periods of multiple millennia.	[Spanbauer, Trisha L.; Fritz, Sherilyn C.] Univ Nebraska, Dept Earth & Atmospher Sci, Lincoln, NE 68588 USA; [Spanbauer, Trisha L.; Fritz, Sherilyn C.] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Allen, Craig R.] Univ Nebraska, Sch Nat Resources, Nebraska Cooperat Fish & Wildlife Res Unit, US Geol Survey, Lincoln, NE USA; [Angeler, David G.] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden; [Eason, Tarsha; Garmestani, Ahjond S.] US Environm Protect Agcy, Natl Risk Management Res Lab, Off Res & Dev, Cincinnati, OH USA; [Nash, Kirsty L.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Stone, Jeffery R.] Indiana State Univ, Dept Earth & Environm Syst, Terre Haute, IN 47809 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; United States Department of the Interior; United States Geological Survey; University of Nebraska System; University of Nebraska Lincoln; Swedish University of Agricultural Sciences; United States Environmental Protection Agency; James Cook University; Indiana State University	Spanbauer, TL (corresponding author), Univ Nebraska, Dept Earth & Atmospher Sci, Lincoln, NE 68588 USA.	tspanbauer@unl.edu	Nash, Kirsty L/B-5456-2015; Garmestani, Ahjond/AAJ-3695-2020; Spanbauer, Trisha/P-6916-2019	Nash, Kirsty L/0000-0003-0976-3197; Garmestani, Ahjond/0000-0001-5678-7293; Eason, Tarsha/0000-0001-9881-3293; Stone, Jeffery/0000-0002-1313-0643	U.S. Geological Survey; Nebraska Game and Parks Commission; University of Nebraska-Lincoln; United States Fish and Wildlife Service; Wildlife Management Institute; August T. Larsson Foundation of the Swedish University of Agricultural Sciences; NSF's Integrative Graduate Education and Research Traineeship (IGERT) program (NSF) [0903469]; Sedimentary Geology & Paleobiology program (NSF) [1251678]; Directorate For Geosciences [1251678] Funding Source: National Science Foundation; Division Of Earth Sciences [1251581] Funding Source: National Science Foundation	U.S. Geological Survey(United States Geological Survey); Nebraska Game and Parks Commission; University of Nebraska-Lincoln; United States Fish and Wildlife Service(US Fish & Wildlife Service); Wildlife Management Institute; August T. Larsson Foundation of the Swedish University of Agricultural Sciences; NSF's Integrative Graduate Education and Research Traineeship (IGERT) program (NSF); Sedimentary Geology & Paleobiology program (NSF); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The Nebraska Cooperative Fish and Wildlife Research Unit is jointly supported by a cooperative agreement between the U.S. Geological Survey, the Nebraska Game and Parks Commission, the University of Nebraska-Lincoln, the United States Fish and Wildlife Service, and the Wildlife Management Institute. This work was supported in part by the August T. Larsson Foundation of the Swedish University of Agricultural Sciences and the NSF's Integrative Graduate Education and Research Traineeship (IGERT) program (NSF #0903469) and the Sedimentary Geology & Paleobiology program (NSF #1251678). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeler DG, 2009, ECOLOGY, V90, P3245, DOI 10.1890/07-0391.1; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Booth RK, 2005, HOLOCENE, V15, P321, DOI 10.1191/0959683605hl825ft; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Bracht-Flyr B, 2012, QUATERNARY RES, V77, P456, DOI 10.1016/j.yqres.2011.12.005; Brock WA, 2006, ECOL SOC, V11; Cabezas H, 2005, J CLEAN PROD, V13, P455, DOI 10.1016/j.jclepro.2003.09.011; Cabezas H., 2010, SAN LUIS BASIN SUSTA, P163; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Dai L, 2012, SCIENCE, V336, P1175, DOI 10.1126/science.1219805; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Eason T, 2012, REV DEV, P55; Eason T, 2014, CLEAN TECHNOL ENVIR, V16, P773, DOI 10.1007/s10098-013-0687-2; Eason T, 2012, J ENVIRON MANAGE, V94, P41, DOI 10.1016/j.jenvman.2011.08.003; Fath BD, 2004, ECOL MODEL, V174, P25, DOI 10.1016/j.ecolmodel.2003.12.045; Fath BD, 2003, J THEOR BIOL, V222, P517, DOI 10.1016/S0022-5193(03)00067-5; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Frank KT, 2011, NATURE, V477, P86, DOI 10.1038/nature10285; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Hughes TP, 2013, TRENDS ECOL EVOL, V28, P149, DOI 10.1016/j.tree.2012.08.022; Karunanithi AT, 2008, ECOL SOC, V13; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Mayer A. L., 2007, EXPLORATORY DATA ANA, DOI [10.1007/978-1-84628-777-0_7, DOI 10.1007/978-1-84628-777-0{_}]; Mayer AL, 2006, ECOL MODEL, V195, P72, DOI 10.1016/j.ecolmodel.2005.11.011; McCabe GJ, 2004, P NATL ACAD SCI USA, V101, P4136, DOI 10.1073/pnas.0306738101; Menendez R, 2006, P ROY SOC B-BIOL SCI, V273, P1465, DOI 10.1098/rspb.2006.3484; Pederson GT, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019770; Rico-Ramirez V, 2010, IND ENG CHEM RES, V49, P1812, DOI 10.1021/ie901220w; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Shastri Y, 2008, ENVIRON SCI TECHNOL, V42, P6710, DOI 10.1021/es800661x; Stevens LR, 2006, QUATERNARY RES, V65, P264, DOI 10.1016/j.yqres.2005.08.024; Stone JR, 2006, GEOLOGY, V34, P409, DOI 10.1130/G22225.1; Stone JR, 2004, LIMNOL OCEANOGR, V49, P1540; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Williams JW, 2011, J ECOL, V99, P664, DOI 10.1111/j.1365-2745.2011.01810.x	42	47	48	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108936	10.1371/journal.pone.0108936	http://dx.doi.org/10.1371/journal.pone.0108936			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25280010	Green Accepted, Green Published, gold			2022-12-27	WOS:000342670800040
J	Tang, XY; Nick, TG; Cleves, MA; Erickson, SW; Li, M; Li, JY; MacLeod, SL; Hobbs, CA				Tang, Xinyu; Nick, Todd G.; Cleves, Mario A.; Erickson, Stephen W.; Li, Ming; Li, Jingyun; MacLeod, Stewart L.; Hobbs, Charlotte A.			Maternal Obesity and Tobacco Use Modify the Impact of Genetic Variants on the Occurrence of Conotruncal Heart Defects	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE-POLYMORPHISMS; CARDIOVASCULAR-DISEASE; HOMOCYSTEINE LEVELS; BIRTH-DEFECTS; SCIENTIFIC STATEMENT; CURRENT KNOWLEDGE; CANCER RISK; SMOKING; ASSOCIATION; GLUTATHIONE	Conotruncal heart defects (CTDs) are among the most severe birth defects worldwide. Studies of CTDs indicate both lifestyle behaviors and genetic variation contribute to the risk of CTDs. Based on a hybrid design using data from 616 case-parental and 1645 control-parental triads recruited for the National Birth Defects Prevention Study between 1997 and 2008, we investigated whether the occurrence of CTDs is associated with interactions between 921 maternal and/or fetal single nucleotide polymorphisms (SNPs) and maternal obesity and tobacco use. The maternal genotypes of the variants in the glutamate-cysteine ligase, catalytic subunit (GCLC) gene and the fetal genotypes of the variants in the glutathione S-transferase alpha 3 (GSTA3) gene were associated with an elevated risk of CTDs among obese mothers. The risk of delivering infants with CTDs among obese mothers carrying AC genotype for a variant in the GCLC gene (rs6458939) was 2.00 times the risk among those carrying CC genotype (95% confidence interval: 1.41, 2.38). The maternal genotypes of several variants in the glutathione-S-transferase (GST) family of genes and the fetal genotypes of the variants in the GCLC gene interacted with tobacco exposures to increase the risk of CTDs. Our study suggests that the genetic basis underlying susceptibility of the developing heart to the adverse effects of maternal obesity and tobacco use involve both maternal and embryonic genetic variants. These results may provide insights into the underlying pathophysiology of CTDs, and ultimately lead to novel prevention strategies.	[Tang, Xinyu; Nick, Todd G.; Li, Ming; Li, Jingyun] Univ Arkansas Med Sci, Coll Med, Dept Pediat, Biostat Program, Little Rock, AR 72205 USA; [Cleves, Mario A.; MacLeod, Stewart L.; Hobbs, Charlotte A.] Univ Arkansas Med Sci, Coll Med, Dept Pediat, Div Birth Defects Res, Little Rock, AR 72205 USA; [Erickson, Stephen W.] Univ Arkansas Med Sci, Coll Publ Hlth, Dept Biostat, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Hobbs, CA (corresponding author), Univ Arkansas Med Sci, Coll Med, Dept Pediat, Div Birth Defects Res, Little Rock, AR 72205 USA.	HobbsCharlotte@uams.edu			National Institute of Child Health and Human Development (NICHD) [5R01HD039054-12]; National Center on Birth Defects and Developmental Disabilities (NCBDDD) [5U01DD000491-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD039054] Funding Source: NIH RePORTER; National Center on Birth Defects and Developmental Disabilities [U01DD000491] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center on Birth Defects and Developmental Disabilities (NCBDDD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center on Birth Defects and Developmental Disabilities(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work is supported by the National Institute of Child Health and Human Development (NICHD) under award number 5R01HD039054-12 and the National Center on Birth Defects and Developmental Disabilities (NCBDDD) under award number 5U01DD000491-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirkhizi F, 2014, OBES RES CLIN PRACT, V8, pE26, DOI 10.1016/j.orcp.2012.07.004; Barrett Jeffrey C, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.ip71; Botto LD, 2000, AM J EPIDEMIOL, V151, P878, DOI 10.1093/oxfordjournals.aje.a010291; Botto LD, 1996, PEDIATRICS, V98, P911; Botto LD, 2007, BIRTH DEFECTS RES A, V79, P714, DOI 10.1002/bdra.20403; Chitty KM, 2014, J PSYCHIATR RES, V55, P59, DOI 10.1016/j.jpsychires.2014.03.024; Chowdhury S, 2012, MOL GENET METAB, V107, P596, DOI 10.1016/j.ymgme.2012.09.022; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Cogswell ME, 2009, AM J EPIDEMIOL, V170, P975, DOI 10.1093/aje/kwp226; Danileviciute A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-161; Davis W, 2014, METAB BRAIN DIS, V29, P409, DOI 10.1007/s11011-014-9486-7; Delpisheh A, 2008, ANN HUM BIOL, V35, P573, DOI 10.1080/03014460802375596; Delpisheh A, 2009, EUR J OBSTET GYN R B, V143, P38, DOI 10.1016/j.ejogrb.2008.11.006; Ermis B, 2004, ANN CLIN LAB SCI, V34, P405; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Finnell RH, 2004, TOXICOL APPL PHARM, V198, P75, DOI 10.1016/j.taap.2003.09.031; Fisher-Wellman KH, 2014, DIABETES, V63, P132, DOI 10.2337/db13-0940; Fratta Pasini A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030291; Gelb B, 2013, CIRC RES, V112, P698, DOI 10.1161/CIRCRESAHA.111.300297; Gilboa SM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.005; Goldmuntz E, 2008, CIRC-CARDIOVASC GENE, V1, P126, DOI 10.1161/CIRCGENETICS.108.796342; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; Hobbs CA, 2005, AM J CLIN NUTR, V82, P598, DOI 10.1093/ajcn/82.3.598; Hobbs CA, 2014, BIRTH DEFECTS RES A, V100, P116, DOI 10.1002/bdra.23225; Hobbs CA, 2011, BIRTH DEFECTS RES A, V91, P195, DOI 10.1002/bdra.20784; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Inoue T, 2003, NAT STRUCT BIOL, V10, P291, DOI 10.1038/nsb907; Institute of M, 2009, WEIGHT GAIN DUR PREG; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Lee CJJ, 2011, FASEB J, V25, P2468, DOI 10.1096/fj.10-178814; Linnebank M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053322; Liu YH, 2010, J CLIN ONCOL, V28, P2467, DOI 10.1200/JCO.2009.26.6213; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Lupo PJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/630940; Madsen NL, 2013, CONGENIT HEART DIS, V8, P131, DOI 10.1111/j.1747-0803.2012.00714.x; Malik S, 2008, PEDIATRICS, V121, pE810, DOI 10.1542/peds.2007-1519; Oddy WH, 2009, AUST NZ J OBSTET GYN, V49, P11, DOI 10.1111/j.1479-828X.2008.00934.x; Oguma Tsuyoshi, 2008, Allergol Int, V57, P307, DOI 10.2332/allergolint.08-RAI-0033; Oh SS, 2010, INT J CANCER, V127, P2169, DOI 10.1002/ijc.25214; Park SL, 2010, CARCINOGENESIS, V31, P1264, DOI 10.1093/carcin/bgq096; Pfeiffer CM, 2013, J NUTR, V143, p957S, DOI 10.3945/jn.112.173021; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Pinzar E, 2000, J BIOL CHEM, V275, P31239, DOI 10.1074/jbc.M000750200; Radulescu L, 2013, J Med Life, V6, P292; Romero P, 2005, GENOME BIOL, V6; Sanchez-Margalet V, 2002, J NUTR BIOCHEM, V13, P75, DOI 10.1016/S0955-2863(01)00197-8; Sen S, 2014, J PERINATOL, V34, P105, DOI 10.1038/jp.2013.153; Shaw GM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-49; Shaw GM, 2005, AM J MED GENET A, V138A, P21, DOI 10.1002/ajmg.a.30924; SHAW GM, 1995, AM J MED GENET, V59, P536, DOI 10.1002/ajmg.1320590428; Spitz MR, 2012, CANCER EPIDEM BIOMAR, V21, P1213, DOI 10.1158/1055-9965.EPI-12-0352-T; Stark KD, 2007, AM J CLIN NUTR, V85, P796, DOI 10.1093/ajcn/85.3.796; URADE Y, 2006, FUNCTIONAL STRUCTURA, P135; van Beynum IM, 2007, QJM-INT J MED, V100, P743, DOI 10.1093/qjmed/hcm094; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Vaya A, 2012, CLIN HEMORHEOL MICRO, V52, P49, DOI 10.3233/CH-2012-1544; Vermunt JK, 1997, LEM GEN PROGRAM ANAL; Vogel C, 2000, CURR DRUG METAB, V1, P391, DOI 10.2174/1389200003338884; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Wang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065120, 10.1371/journal.pone.0068807]; Wang T, 2011, ARCH GYNECOL OBSTET, V284, P813, DOI 10.1007/s00404-010-1740-6; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058041; Weinberg CR, 2005, AM J HUM GENET, V77, P627, DOI 10.1086/496900; Wlodarczyk BJ, 2011, AM J MED GENET C, V157C, P215, DOI 10.1002/ajmg.c.30314; Yong E, 2013, GENETIC TEST AUTISM; Yoon PW, 2001, PUBLIC HEALTH REP, V116, P32, DOI 10.1093/phr/116.S1.32; Zienolddiny S, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3445	67	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108903	10.1371/journal.pone.0108903	http://dx.doi.org/10.1371/journal.pone.0108903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275547	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500037
J	Thompson, KR; Sanchez, DJ; Wesley, AH; Reber, PJ				Thompson, Kelsey R.; Sanchez, Daniel J.; Wesley, Abigail H.; Reber, Paul J.			Ego Depletion Impairs Implicit Learning	PLOS ONE			English	Article							DUAL-TASK CONDITIONS; WORKING-MEMORY CAPACITY; PARKINSONS-DISEASE; LIMITED RESOURCE; SELF-CONTROL; DOPAMINE; PERFORMANCE; SET	Implicit skill learning occurs incidentally and without conscious awareness of what is learned. However, the rate and effectiveness of learning may still be affected by decreased availability of central processing resources. Dual-task experiments have generally found impairments in implicit learning, however, these studies have also shown that certain characteristics of the secondary task (e.g., timing) can complicate the interpretation of these results. To avoid this problem, the current experiments used a novel method to impose resource constraints prior to engaging in skill learning. Ego depletion theory states that humans possess a limited store of cognitive resources that, when depleted, results in deficits in self-regulation and cognitive control. In a first experiment, we used a standard ego depletion manipulation prior to performance of the Serial Interception Sequence Learning (SISL) task. Depleted participants exhibited poorer test performance than did non-depleted controls, indicating that reducing available executive resources may adversely affect implicit sequence learning, expression of sequence knowledge, or both. In a second experiment, depletion was administered either prior to or after training. Participants who reported higher levels of depletion before or after training again showed less sequence-specific knowledge on the post-training assessment. However, the results did not allow for clear separation of ego depletion effects on learning versus subsequent sequence-specific performance. These results indicate that performance on an implicitly learned sequence can be impaired by a reduction in executive resources, in spite of learning taking place outside of awareness and without conscious intent.	[Thompson, Kelsey R.; Wesley, Abigail H.; Reber, Paul J.] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; [Sanchez, Daniel J.] SRI Int, Comp Sci Lab, Menlo Pk, CA 94025 USA	Northwestern University; SRI International	Reber, PJ (corresponding author), Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA.	preber@northwestern.edu			NSF grant [CNS-1228357]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS047987] Funding Source: NIH RePORTER; Division Of Computer and Network Systems [1228357] Funding Source: National Science Foundation	NSF grant(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The research reported was supported by NSF grant CNS-1228357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badgaiyan RD, 2007, NEUROIMAGE, V38, P549, DOI 10.1016/j.neuroimage.2007.07.052; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; Braver TS, 2002, NEUROSCI BIOBEHAV R, V26, P809, DOI 10.1016/S0149-7634(02)00067-2; Cools R, 2008, J NEUROSCI, V28, P1208, DOI 10.1523/JNEUROSCI.4475-07.2008; Filoteo JV, 2010, PSYCHOL SCI, V21, P415, DOI 10.1177/0956797610362646; Frensch PA, 2003, CURR DIR PSYCHOL SCI, V12, P13, DOI 10.1111/1467-8721.01213; FRENSCH PA, 1994, J EXP PSYCHOL LEARN, V20, P567, DOI 10.1037/0278-7393.20.3.567; Frensch PA, 1998, PSYCHOL RES-PSYCH FO, V61, P83, DOI 10.1007/s004260050015; Gaschler R, 2012, J EXP PSYCHOL LEARN, V38, P1389, DOI 10.1037/a0028071; Gobel EW, 2013, NEUROPSYCHOLOGY, V27, P314, DOI 10.1037/a0032305; Halvorson KM, 2013, PSYCHON B REV, V20, P1005, DOI 10.3758/s13423-013-0409-0; Hsiao AT, 2001, PSYCHON B REV, V8, P336, DOI 10.3758/BF03196170; Jimenez L, 2005, PSYCHOL RES-PSYCH FO, V69, P352, DOI 10.1007/s00426-004-0210-9; Kaufman SB, 2010, COGNITION, V116, P321, DOI 10.1016/j.cognition.2010.05.011; Moors A, 2006, PSYCHOL BULL, V132, P297, DOI 10.1037/0033-2909.132.2.297; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Nagano-Saito A, 2008, J NEUROSCI, V28, P3697, DOI 10.1523/JNEUROSCI.3921-07.2008; Reber PJ, 2013, NEUROPSYCHOLOGIA, V51, P2026, DOI 10.1016/j.neuropsychologia.2013.06.019; Reber PJ, 1997, J EXP PSYCHOL GEN, V126, P178, DOI 10.1037/0096-3445.126.2.178; REED J, 1994, J EXP PSYCHOL LEARN, V20, P585, DOI 10.1037/0278-7393.20.3.585; Sanchez DJ, 2013, COGNITION, V126, P341, DOI 10.1016/j.cognition.2012.11.006; Sanchez DJ, 2010, PSYCHON B REV, V17, P790, DOI 10.3758/PBR.17.6.790; Schmeichel BJ, 2003, J PERS SOC PSYCHOL, V85, P33, DOI 10.1037/0022-3514.85.1.33; Schumacher EH, 2009, J EXP PSYCHOL GEN, V138, P270, DOI 10.1037/a0015378; Shohamy D, 2005, BEHAV BRAIN RES, V156, P191, DOI 10.1016/j.bbr.2004.05.023; Siegert RJ, 2006, NEUROPSYCHOLOGY, V20, P490, DOI 10.1037/0894-4105.20.4.490; STADLER MA, 1995, J EXP PSYCHOL LEARN, V21, P674, DOI 10.1037/0278-7393.21.3.674; Taatgen NA, 2008, J EXP PSYCHOL GEN, V137, P548, DOI 10.1037/0096-3445.137.3.548; Tice DM, 2007, J EXP SOC PSYCHOL, V43, P379, DOI 10.1016/j.jesp.2006.05.007	30	3	3	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109370	10.1371/journal.pone.0109370	http://dx.doi.org/10.1371/journal.pone.0109370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ2BX	25275517	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500099
J	Walsh, SK; Hector, EE; Andreasson, AC; Jonsson-Rylander, AC; Wainwright, CL				Walsh, Sarah K.; Hector, Emma E.; Andreasson, Anne-Christine; Jonsson-Rylander, Ann-Cathrine; Wainwright, Cherry L.			GPR55 Deletion in Mice Leads to Age-Related Ventricular Dysfunction and Impaired Adrenoceptor-Mediated Inotropic Responses	PLOS ONE			English	Article							CANNABINOID RECEPTOR GPR55; CARDIAC-FUNCTION; MESENTERIC VASODILATION; ACTIVATION; LYSOPHOSPHATIDYLINOSITOL; REVEALS; MOUSE; CB1; HETERODIMERIZATION; ENDOCANNABINOIDS	G protein coupled receptor 55 (GPR55) is expressed throughout the body, and although its exact physiological function is unknown, studies have suggested a role in the cardiovascular system. In particular, GPR55 has been proposed as mediating the haemodynamic effects of a number of atypical cannabinoid ligands; however this data is conflicting. Thus, given the incongruous nature of our understanding of the GPR55 receptor and the relative paucity of literature regarding its role in cardiovascular physiology, this study was carried out to examine the influence of GPR55 on cardiac function. Cardiac function was assessed via pressure volume loop analysis, and cardiac morphology/composition assessed via histological staining, in both wild-type (WT) and GPR55 knockout (GPR55(-/-)) mice. Pressure volume loop analysis revealed that basal cardiac function was similar in young WT and GPR55(-/-) mice. In contrast, mature GPR55(-/-) mice were characterised by both significant ventricular remodelling (reduced left ventricular wall thickness and increased collagen deposition) and systolic dysfunction when compared to age-matched WT mice. In particular, the load-dependent parameter, ejection fraction, and the load-independent indices, end-systolic pressure-volume relationship (ESPVR) and E-max, were all significantly (P<0.05) attenuated in mature GPR55(-/-) mice. Furthermore, GPR55(-/-) mice at all ages were characterised by a reduced contractile reserve. Our findings demonstrate that mice deficient in GPR55 exhibit maladaptive adrenergic signalling, as evidenced by the reduced contractile reserve. Furthermore, with age these mice are characterised by both significant adverse ventricular remodelling and systolic dysfunction. Taken together, this may suggest a role for GPR55 in the control of adrenergic signalling in the heart and potentially a role for this receptor in the pathogenesis of heart failure.	[Walsh, Sarah K.; Hector, Emma E.; Wainwright, Cherry L.] Robert Gordon Univ, Inst Hlth & Wellbeing Res, Aberdeen AB9 1FR, Scotland; [Andreasson, Anne-Christine; Jonsson-Rylander, Ann-Cathrine] AstraZeneca R&D, IMED CVGI, Bioscience, Molndal, Sweden	Robert Gordon University; AstraZeneca	Wainwright, CL (corresponding author), Robert Gordon Univ, Inst Hlth & Wellbeing Res, Aberdeen AB9 1FR, Scotland.	c.wainwright@rgu.ac.uk	Walsh, Sarah/ABF-2490-2020	Wainwright, Cherry/0000-0003-1404-965X; Walsh, Sarah K/0000-0002-9936-5303; Hector, Emma/0000-0002-4531-1166	Institute for Health & Wellbeing Research; Robert Gordon University	Institute for Health & Wellbeing Research; Robert Gordon University	This study was funded by a pump-priming grant from the Institute for Health & Wellbeing Research, the Robert Gordon University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker D, 2006, TRENDS PHARMACOL SCI, V27, P1, DOI 10.1016/j.tips.2005.11.003; Balenga NAB, 2011, CELL RES, V21, P1452, DOI 10.1038/cr.2011.60; Bondarenko A, 2010, BRIT J PHARMACOL, V161, P308, DOI 10.1111/j.1476-5381.2010.00744.x; BRISTOW MR, 1988, J PHARMACOL EXP THER, V247, P1039; Cannavo A, 2013, FRONT PHYSIOL, V4, P1; Cantarella G, 2011, BIOCHEM PHARMACOL, V82, P380, DOI 10.1016/j.bcp.2011.05.004; Chaulet H, 2006, J MOL CELL CARDIOL, V40, P540, DOI 10.1016/j.yjmcc.2006.01.015; Copik AJ, 2009, MOL PHARMACOL, V75, P713, DOI 10.1124/mol.108.050765; Daly CJ, 2010, BRIT J PHARMACOL, V159, P787, DOI 10.1111/j.1476-5381.2009.00608.x; Du XJ, 2006, CARDIOVASC RES, V71, P735, DOI 10.1016/j.cardiores.2006.06.015; Dzimiri N, 1999, PHARMACOL REV, V51, P465; Hata JA, 2004, J MOL CELL CARDIOL, V37, P11, DOI 10.1016/j.yjmcc.2004.03.014; Henstridge CM, 2011, MOL ENDOCRINOL, V25, P1835, DOI 10.1210/me.2011-1197; Henstridge CM, 2010, BRIT J PHARMACOL, V160, P604, DOI 10.1111/j.1476-5381.2009.00625.x; Heubach UF, 2002, BRIT J PHARMACOL, V136, P217, DOI 10.1038/sj.bjp.0704700; HONG SL, 1981, J BIOL CHEM, V256, P5215; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; Jensen BC, 2009, CIRC-HEART FAIL, V2, P654, DOI 10.1161/CIRCHEARTFAILURE.108.846212; Johns DG, 2007, BRIT J PHARMACOL, V152, P825, DOI 10.1038/sj.bjp.0707419; Kapur A, 2009, J BIOL CHEM, V284, P29817, DOI 10.1074/jbc.M109.050187; Kargl J, 2012, J BIOL CHEM, V287, P44234, DOI 10.1074/jbc.M112.364109; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Komatsu S, 2012, J CELL PHYSIOL, V227, P3201, DOI 10.1002/jcp.24008; Krum H, 2009, LANCET, V373, P941, DOI 10.1016/S0140-6736(09)60236-1; Kunos G, 2000, CHEM PHYS LIPIDS, V108, P159, DOI 10.1016/S0009-3084(00)00194-8; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Lin G, 2001, CIRC RES, V89, P343, DOI 10.1161/hh1601.095912; Liu J, 2011, J MOL CELL CARDIOL, V51, P730, DOI 10.1016/j.yjmcc.2011.07.028; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Mohl MC, 2011, CARDIOVASC RES, V91, P310, DOI 10.1093/cvr/cvr081; Mukhopadhyay P, 2010, CARDIOVASC RES, V85, P773, DOI 10.1093/cvr/cvp369; Pacher P, 2005, HANDB EXP PHARMACOL, V168, P599; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Pertwee RG, 2007, BRIT J PHARMACOL, V152, P984, DOI 10.1038/sj.bjp.0707464; Romero-Zerbo SY, 2011, J ENDOCRINOL, V211, P177, DOI 10.1530/JOE-11-0166; RUFFOLO RR, 1985, J PHARMACOL EXP THER, V235, P558; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sawzdargo M, 1999, MOL BRAIN RES, V64, P193, DOI 10.1016/S0169-328X(98)00277-0; Shah AS, 2001, CIRCULATION, V103, P1311; STEINFATH M, 1992, BRIT J PHARMACOL, V107, P185, DOI 10.1111/j.1476-5381.1992.tb14484.x; Sylantyev S, 2013, P NATL ACAD SCI USA, V110, P5193, DOI 10.1073/pnas.1211204110; Uberti MA, 2005, J PHARMACOL EXP THER, V313, P16, DOI 10.1124/jpet.104.079541; Ufer C, 2009, BRIT J PHARMACOL, V158, P300, DOI 10.1111/j.1476-5381.2009.00328.x; Wagner JA, 1999, HYPERTENSION, V33, P429, DOI 10.1161/01.HYP.33.1.429; Waldeck-Weiermair M, 2008, J CELL SCI, V121, P1704, DOI 10.1242/jcs.020958; White DC, 2000, P NATL ACAD SCI USA, V97, P5428, DOI 10.1073/pnas.090091197; White R, 1997, BRIT J PHARMACOL, V122, P1573, DOI 10.1038/sj.bjp.0701546; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Yang B, 1999, AM J PHYSIOL-HEART C, V277, pH1906, DOI 10.1152/ajpheart.1999.277.5.H1906; Yu J, 2013, J BIOL CHEM, V288, P22481, DOI 10.1074/jbc.M113.456178; Zhu WZ, 2005, CIRC RES, V97, P244, DOI 10.1161/01.RES.0000176764.38934.86	51	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108999	10.1371/journal.pone.0108999	http://dx.doi.org/10.1371/journal.pone.0108999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275556	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500044
J	White, WT; Last, PR; Dharmadi; Faizah, R; Chodrijah, U; Buckworth, RC; Dichmont, CM				White, William T.; Last, Peter R.; Dharmadi; Faizah, Ria; Chodrijah, Umi; Buckworth, Rik C.; Dichmont, Catherine M.			Rapid Fishery Assessment by Market Survey (RFAMS) - An Improved Rapid-Assessment Approach to Characterising Fish Landings in Developing Countries	PLOS ONE			English	Article							STOCKS; AREAS; NEEDS	The complex multi-gear, multi-species tropical fisheries in developing countries are poorly understood and characterising the landings from these fisheries is often impossible using conventional approaches. A rapid assessment method for characterising landings at fish markets, using an index of abundance and estimated weight within taxonomic groups, is described. This approach was developed for contexts where there are no detailed data collection protocols, and where consistent data collection across a wide range of fisheries types and geographic areas is required, regardless of the size of the site and scale of the landings. This methodology, which was demonstrated at seven fish landing sites/fish markets in southern Indonesia between July 2008 and January 2011, provides a rapid assessment of the abundance and diversity in the wild catch over a wide variety of taxonomic groups. The approach has wider application for species-rich fisheries in developing countries where there is an urgent need for better data collection protocols, monitoring future changes in market demographics, and evaluating health of fisheries.	[White, William T.; Last, Peter R.] CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia; [Dharmadi; Faizah, Ria; Chodrijah, Umi] Minist Marine Affairs & Fisheries, Agcy Marine & Fisheries Res & Dev, Res Ctr Fisheries Management & Conservat, Jakarta, Indonesia; [Buckworth, Rik C.; Dichmont, Catherine M.] CSIRO, Oceans & Atmosphere Flagship, Dutton Pk, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Ministry of Marine Affairs and Fisheries; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	White, WT (corresponding author), CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia.	william.white@csiro.au	White, William T/B-9748-2009; Dichmont, Catherine M/A-9528-2008	White, William T/0000-0001-9705-2453; Chodrijah, Umi/0000-0002-2895-0177; Buckworth, Rik/0000-0003-3422-7847	Australian Centre for Agricultural Research (ACIAR); Wealth from Oceans Flagship [FIS2006\142]	Australian Centre for Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res); Wealth from Oceans Flagship	This project was funded by the Australian Centre for Agricultural Research (ACIAR, website: aciar.gov.au) and the Wealth from Oceans Flagship (website: www.csiro.au/Organisation-Structure/Flagships/Wealth-from-Oceans-Flagship.aspx), project number FIS2006\142. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunu C., 2005, FAO FISHERIES CIRCUL; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; DUDLEY R G, 1987, Aquaculture and Fisheries Management, V18, P365, DOI 10.1111/j.1365-2109.1987.tb00325.x; FAO, 2013, FIGIS FISHSTAT DATAB; FAO, 2012, THE STATE OF WORLD F; FAO, 2004, FAO FISHERIES AND AQ; Gorley C.K., 2006, GETTING STARTED PRIM; HARRIS AN, 1991, MAR BIOL, V111, P503, DOI 10.1007/BF01319424; Houk P, 2012, CORAL REEFS, V31, P13, DOI 10.1007/s00338-011-0826-3; Jennings S., 2001, MARINE FISHERIES ECO; Mahon R, 1997, CAN J FISH AQUAT SCI, V54, P2207, DOI 10.1139/cjfas-54-9-2207; Mous PJ, 2005, FISHERIES MANAG ECOL, V12, P259, DOI 10.1111/j.1365-2400.2005.00448.x; PCI, 2001, STUDY ON FISHERIES D; Pet-Soede C, 1999, FISH RES, V42, P41, DOI 10.1016/S0165-7836(99)00034-X; Somerfield PJ, 1997, MAR ENVIRON RES, V43, P145, DOI 10.1016/0141-1136(96)00083-9; THRESHER RE, 1986, COPEIA, P876; Tokeshi M, 2013, PAC SCI, V67, P1, DOI 10.2984/67.1.1; Venema SC, 1996, REPORT ON THE INDONE; White William T., 2013, P11; White WT., 2006, ECONOMICALLY IMPORTA; Zeller D, 2007, FISH B-NOAA, V105, P266	21	2	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109182	10.1371/journal.pone.0109182	http://dx.doi.org/10.1371/journal.pone.0109182			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275308	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500071
J	Boussau, B; Walton, Z; Delgado, JA; Collantes, F; Beani, L; Stewart, IJ; Cameron, SA; Whitfield, JB; Johnston, JS; Holland, PWH; Bachtrog, D; Kathirithamby, J; Huelsenbeck, JP				Boussau, Bastien; Walton, Zaak; Delgado, Juan A.; Collantes, Francisco; Beani, Laura; Stewart, Isaac J.; Cameron, Sydney A.; Whitfield, James B.; Johnston, J. Spencer; Holland, Peter W. H.; Bachtrog, Doris; Kathirithamby, Jeyaraney; Huelsenbeck, John P.			Strepsiptera, Phylogenomics and the Long Branch Attraction Problem	PLOS ONE			English	Article							PHYLOGENETIC METHODS; MAXIMUM-LIKELIHOOD; MODEL; EVOLUTION; SEQUENCE; GENES; 18S; PERFORMANCE; PARSIMONY; SELECTION	Insect phylogeny has recently been the focus of renewed interest as advances in sequencing techniques make it possible to rapidly generate large amounts of genomic or transcriptomic data for a species of interest. However, large numbers of markers are not sufficient to guarantee accurate phylogenetic reconstruction, and the choice of the model of sequence evolution as well as adequate taxonomic sampling are as important for phylogenomic studies as they are for single-gene phylogenies. Recently, the sequence of the genome of a strepsipteran has been published and used to place Strepsiptera as sister group to Coleoptera. However, this conclusion relied on a data set that did not include representatives of Neuropterida or of coleopteran lineages formerly proposed to be related to Strepsiptera. Furthermore, it did not use models that are robust against the long branch attraction artifact. Here we have sequenced the transcriptomes of seven key species to complete a data set comprising 36 species to study the higher level phylogeny of insects, with a particular focus on Neuropteroidea (Coleoptera, Strepsiptera, Neuropterida), especially on coleopteran taxa considered as potential close relatives of Strepsiptera. Using models robust against the long branch attraction artifact we find a highly resolved phylogeny that confirms the position of Strepsiptera as a sister group to Coleoptera, rather than as an internal clade of Coleoptera, and sheds new light onto the phylogeny of Neuropteroidea.	[Boussau, Bastien; Walton, Zaak; Bachtrog, Doris; Huelsenbeck, John P.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Boussau, Bastien] Univ Lyon 1, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Delgado, Juan A.; Collantes, Francisco] Univ Murcia, Fac Biol, Dept Zool & Antropol Fis, Murcia, Spain; [Beani, Laura] Univ Florence, Dipartimento Biol, Florence, Italy; [Stewart, Isaac J.] Fisher High Sch, Fisher, IL USA; [Stewart, Isaac J.; Cameron, Sydney A.; Whitfield, James B.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Johnston, J. Spencer] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Holland, Peter W. H.; Kathirithamby, Jeyaraney] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Huelsenbeck, John P.] King Abdulaziz Univ, Dept Biol Sci, Jeddah 21413, Saudi Arabia	University of California System; University of California Berkeley; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; University of Murcia; University of Florence; University of Illinois System; University of Illinois Urbana-Champaign; Texas A&M University System; Texas A&M University College Station; University of Oxford; King Abdulaziz University	Boussau, B (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	bastien.boussau@univ-lyon1.fr	Collantes, Francisco/M-4798-2017; Collantes, Francisco/L-5937-2019	Collantes, Francisco/0000-0002-8085-6399; Collantes, Francisco/0000-0002-8085-6399; Holland, Peter/0000-0003-1533-9376; Boussau, Bastien/0000-0003-0776-4460	NSF [DEB-0445453]; NIH [GM-069801, GM076007, GM093182]; Packard Fellowship; Human Frontier Science Program; CNRS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076007, R01GM093182, R01GM069801] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellowship(The David & Lucile Packard Foundation); Human Frontier Science Program(Human Frontier Science Program); CNRS(Centre National de la Recherche Scientifique (CNRS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the NSF (DEB-0445453) and NIH (GM-069801) awarded to J.P.H. and NIH (GM076007 and GM093182), and a Packard Fellowship awarded to D.B.B.B. was supported by a Human Frontier Science Program post-doctoral fellowship and the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Alfaro ME, 2006, SYST BIOL, V55, P89, DOI 10.1080/10635150500433565; Anderson FE, 2004, MOL PHYLOGENET EVOL, V33, P440, DOI 10.1016/j.ympev.2004.06.015; Arnett RH, 1963, BEETLES US; Beani L, 2005, J MORPHOL, V265, P291, DOI 10.1002/jmor.10359; Bollback JP, 2002, MOL BIOL EVOL, V19, P1171, DOI 10.1093/oxfordjournals.molbev.a004175; Boussau B, 2010, TRENDS ECOL EVOL, V25, P224, DOI 10.1016/j.tree.2009.09.007; CARMEAN D, 1995, NATURE, V373, P666, DOI 10.1038/373666b0; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cox CJ, 2008, P NATL ACAD SCI USA, V105, P20356, DOI 10.1073/pnas.0810647105; CROWSON RA, 1960, ANNU REV ENTOMOL, V5, P111, DOI 10.1146/annurev.en.05.010160.000551; Crowson RA, 1981, BIOL COLEOPTERA; de Vienne DM, 2012, MOL BIOL EVOL, V29, P1587, DOI 10.1093/molbev/msr317; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Gillespie JJ, 2005, INSECT MOL BIOL, V14, P625, DOI 10.1111/j.1365-2583.2005.00591.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRAYBEAL A, 1994, SYST BIOL, V43, P174, DOI 10.2307/2413460; HENDY MD, 1989, SYST ZOOL, V38, P297, DOI 10.2307/2992396; Hrabar M, 2014, NEW FINDINGS LIFE HI, P1; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Huelsenbeck JP, 2011, SYST BIOL, V60, P225, DOI 10.1093/sysbio/syq089; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; HUELSENBECK JP, 1995, MOL BIOL EVOL, V12, P843; Huelsenbeck JP, 2003, SYST BIOL, V52, P641, DOI 10.1080/10635150390235467; HUELSENBECK JP, 1993, SYST BIOL, V42, P247, DOI 10.2307/2992463; HUELSENBECK JP, 1995, SYST BIOL, V44, P17, DOI 10.2307/2413481; Huelsenbeck JP, 1997, SYST BIOL, V46, P69, DOI 10.2307/2413636; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Ishiwata K, 2010, MOL PHYLOGENET EVOL, V58, P1; Johnston JS, 2004, INSECT MOL BIOL, V13, P581, DOI 10.1111/j.0962-1075.2004.00514.x; Jurine M, 1816, MEM ACCAD SCI TORINO, V23, P1; KATHIRITHAMBY J, 1989, SYST ENTOMOL, V14, P41, DOI 10.1111/j.1365-3113.1989.tb00265.x; Kathirithamby J, 2009, ANNU REV ENTOMOL, V54, P227, DOI 10.1146/annurev.ento.54.110807.090525; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kinzelbach RK, 1978, TIERWELT DEUTSCHLAND, V65; Kinzelbach RK, 1971, ZOOLOGICA, V119, P129; Kristensen N.P., 1991, P125; KRISTENSEN NP, 1981, ANNU REV ENTOMOL, V26, P135, DOI 10.1146/annurev.en.26.010181.001031; Lamarck J. B, 1816, HIST NATURELLE ANIMA, V3; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Latreille P.A., 1809, GENERA CRUSTACEORUM, V4; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Longhorn SJ, 2010, MOL PHYLOGENET EVOL, V55, P846, DOI 10.1016/j.ympev.2010.03.024; McKenna DD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011887; McMahon DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021206; Miele V, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-116; Niehuis O, 2012, CURR BIOL, V22, P1309, DOI 10.1016/j.cub.2012.05.018; Peters RS, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-52; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Pohl H, 2005, CLADISTICS, V21, P328, DOI 10.1111/j.1096-0031.2005.00074.x; Pohl H, 2008, ZOOLOGY, V111, P318, DOI 10.1016/j.zool.2007.06.008; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rossi P, 1793, B SOC PHILOMATHIQUE, V1, P49; Rota-Stabelli O, 2013, SYST BIOL, V62, P121, DOI 10.1093/sysbio/sys077; Schmid-Hempel P., 1998, Parasites in social insects.; Sheffield NC, 2009, SYST BIOL, V58, P381, DOI 10.1093/sysbio/syp037; Swofford DL, 2001, SYST BIOL, V50, P525, DOI 10.1080/106351501750435086; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thomarat F, 2004, J MOL EVOL, V59, P780, DOI 10.1007/s00239-004-2673-0; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1111/j.1096-0031.2001.tb00115.x, 10.1006/clad.2000.0147]; WHITING MF, 1994, NATURE, V368, P696, DOI 10.1038/368696a0; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; Zhen Y, 2012, SCIENCE, V337, P1634, DOI 10.1126/science.1226630	70	44	44	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e107709	10.1371/journal.pone.0107709	http://dx.doi.org/10.1371/journal.pone.0107709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272037	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000343729600018
J	Caiello, I; Minnone, G; Holzinger, D; Vogl, T; Prencipe, G; Manzo, A; De Benedetti, F; Strippoli, R				Caiello, Ivan; Minnone, Gaetana; Holzinger, Dirk; Vogl, Thomas; Prencipe, Giusi; Manzo, Antonio; De Benedetti, Fabrizio; Strippoli, Raffaele			IL-6 Amplifies TLR Mediated Cytokine and Chemokine Production: Implications for the Pathogenesis of Rheumatic Inflammatory Diseases	PLOS ONE			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; TOLL-LIKE RECEPTOR; NF-KAPPA-B; RANDOMIZED-TRIAL; HUMAN-MONOCYTES; INTERLEUKIN-6; CELLS; PROTEIN; MICE; AUTOIMMUNITY	The role of Interleukin(IL)-6 in the pathogenesis of joint and systemic inflammation in rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis (s-JIA) has been clearly demonstrated. However, the mechanisms by which IL-6 contributes to the pathogenesis are not completely understood. This study investigates whether IL-6 affects, alone or upon toll like receptor (TLR) ligand stimulation, the production of inflammatory cytokines and chemokines in human peripheral blood mononuclear cells (PBMCs), synovial fluid mononuclear cells from JIA patients (SFMCs) and fibroblast-like synoviocytes from rheumatoid arthritis patients (RA synoviocytes) and signalling pathways involved. PBMCs were pre-treated with IL-6 and soluble IL-6 Receptor (sIL-6R). SFMCs and RA synoviocytes were pre-treated with IL-6/sIL-6R or sIL-6R, alone or in combination with Tocilizumab (TCZ). Cells were stimulated with LPS, S100A8-9, poly(I-C), CpG, Pam2CSK4, MDP, IL-1 beta. Treatment of PBMCs with IL-6 induced production of TNF-alpha, CXCL8, and CCL2, but not IL-1 beta. Addition of IL-6 to the same cells after stimulation with poly(I-C), CpG, Pam2CSK4, and MDP induced a significant increase in IL-1 beta and CXCL8, but not TNF-alpha production compared with TLR ligands alone. This enhanced production of IL-1b and CXCL8 paralleled increased p65 NF-kappa B activation. In contrast, addition of IL-6 to PBMCs stimulated with LPS or S100A8-9 (TLR-4 ligands) led to reduction of IL-1 beta, TNF-alpha and CXCL8 with reduced p65 NF-kappa B activation. IL-6/IL-1 beta co-stimulation increased CXCL8, CCL2 and IL-6 production. Addition of IL-6 to SFMCs stimulated with LPS or S100A8 increased CXCL8, CCL2 and IL-1 beta production. Treatment of RA synoviocytes with sIL-6R increased IL-6, CXCL8 and CCL2 production, with increased STAT3 and p65 NF-kappa B phosphorylation. Our results suggest that IL-6 amplifies TLR-induced inflammatory response. This effect may be relevant in the presence of high IL-6 and sIL-6R levels, such as in arthritic joints in the context of stimulation by endogenous TLR ligands.	[Caiello, Ivan; Minnone, Gaetana; Prencipe, Giusi; De Benedetti, Fabrizio; Strippoli, Raffaele] Bambino Gesu Pediat Hosp, Div Rheumatol, Rome, Italy; [Holzinger, Dirk; Vogl, Thomas] Univ Childrens Hosp Muenster, Dept Paediat Rheumatol & Immunol, Munster, Germany; [Holzinger, Dirk] Univ Hosp Muenster, Inst Immunol, Munster, Germany; [Manzo, Antonio] Univ Pavia, IRCCS Policlin S Matteo Fdn, Div Rheumatol, Rheumatol & Translat Immunol Res Labs LaRIT, I-27100 Pavia, Italy; [Strippoli, Raffaele] Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, I-00185 Rome, Italy	IRCCS Bambino Gesu; University of Munster; University of Munster; IRCCS Fondazione San Matteo; University of Pavia; Sapienza University Rome	De Benedetti, F (corresponding author), Bambino Gesu Pediat Hosp, Div Rheumatol, Rome, Italy.	fabrizio.debenedetti@opbg.net; rafstrippoli@libero.it	prencipe, giusi/K-5829-2016; Caiello, Ivan/K-8023-2016; Strippoli, Raffaele/J-2129-2018; de benedetti, fabrizio/J-9577-2018; Manzo, Antonio/K-5511-2018; Minnone, Gaetana/J-8735-2018	prencipe, giusi/0000-0003-1152-9041; Caiello, Ivan/0000-0001-8791-6748; Strippoli, Raffaele/0000-0003-3483-8381; de benedetti, fabrizio/0000-0001-8749-8232; Manzo, Antonio/0000-0002-9743-6008; Minnone, Gaetana/0000-0002-6068-6919; Holzinger, Dirk/0000-0002-8062-8820	IRCCS Bambino Gesu Children's Hospital "Ricerca Corrente"	IRCCS Bambino Gesu Children's Hospital "Ricerca Corrente"	This study was supported by research funding from the IRCCS Bambino Gesu Children's Hospital "Ricerca Corrente" to FDB. IRCCS Bambino Gesu Hospital "Ricerca Corrente" had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADERKA D, 1989, J IMMUNOL, V143, P3517; Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; Asensi V, 2004, INFECT IMMUN, V72, P3823, DOI 10.1128/IAI.72.7.3823-3828.2004; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Brown KD, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2457; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113; De Benedetti F, 2012, NEW ENGL J MED, V367, P2385, DOI 10.1056/NEJMoa1112802; DeBenedetti F, 1997, J RHEUMATOL, V24, P1403; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; FATTORI E, 1994, J EXP MED, V180, P1243, DOI 10.1084/jem.180.4.1243; Gerss J, 2012, ANN RHEUM DIS, V71, P1991, DOI 10.1136/annrheumdis-2012-201329; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Holzinger D, 2012, ANN RHEUM DIS, V71, P974, DOI 10.1136/annrheumdis-2011-200598; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Nishimoto N, 2000, INT IMMUNOL, V12, P187, DOI 10.1093/intimm/12.2.187; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Prencipe G, 2014, J IMMUNOL, V192, P3345, DOI 10.4049/jimmunol.1300825; Ruperto N, 2012, NEW ENGL J MED, V367, P2396, DOI 10.1056/NEJMoa1205099; Samson M, 2012, ARTHRITIS RHEUM-US, V64, P2499, DOI 10.1002/art.34477; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; SCHINDLER R, 1990, BLOOD, V75, P40; Scire CA, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2302; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Sokolove J, 2011, ARTHRITIS RHEUM-US, V63, P53, DOI 10.1002/art.30081; Stein N, 2012, FAMILIAL MEDITERRANE; Strippoli R, 2012, ARTHRITIS RHEUM-US, V64, P1680, DOI 10.1002/art.33496; Strippoli R, 2010, J CELL SCI, V123, P4321, DOI 10.1242/jcs.071647; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Wang LX, 2003, J IMMUNOL, V171, P3194, DOI 10.4049/jimmunol.171.6.3194; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yoshida Y, 2004, J BIOL CHEM, V279, P1768, DOI 10.1074/jbc.M311498200; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	36	44	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e107886	10.1371/journal.pone.0107886	http://dx.doi.org/10.1371/journal.pone.0107886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271853	gold, Green Published, Green Submitted			2022-12-27	WOS:000343729600023
J	Chen, XL; Thomson, H; Cooke, J; Scott, J; Hossain, P; Lotery, A				Chen, Xiaoli; Thomson, Heather; Cooke, Jessica; Scott, Jennifer; Hossain, Parwez; Lotery, Andrew			Adult Limbal Neurosphere Cells: A Potential Autologous Cell Resource for Retinal Cell Generation	PLOS ONE			English	Article							NEURAL STEM-CELLS; CILIARY EPITHELIAL-CELLS; MARROW STROMAL CELLS; PHOTORECEPTOR PRECURSORS; SONIC HEDGEHOG; MOUSE RETINA; MULLER GLIA; OPTIC-CUP; ROD; TRANSPLANTATION	The Corneal limbus is a readily accessible region at the front of the eye, separating the cornea and sclera. Neural colonies (neurospheres) can be generated from adult corneal limbus in vitro. We have previously shown that these neurospheres originate from neural crest stem/progenitor cells and that they can differentiate into functional neurons in vitro. The aim of this study was to investigate whether mouse and human limbal neurosphere cells (LNS) could differentiate towards a retinal lineage both in vivo and in vitro following exposure to a developing retinal microenvironment. In this article we show that LNS can be generated from adult mice and aged humans (up to 97 years) using a serum free culture assay. Following culture with developing mouse retinal cells, we detected retinal progenitor cell markers, mature retinal/neuronal markers and sensory cilia in the majority of mouse LNS experiments. After transplantation into the sub-retinal space of neonatal mice, mouse LNS cells expressed photoreceptor specific markers, but no incorporation into host retinal tissue was seen. Human LNS cells also expressed retinal progenitor markers at the transcription level but mature retinal markers were not observed in vitro or in vivo. This data highlights that mouse corneal limbal stromal progenitor cells can transdifferentiate towards a retinal lineage. Complete differentiation is likely to require more comprehensive regulation; however, the accessibility and plasticity of LNS makes them an attractive cell resource for future study and ultimately therapeutic application.	[Chen, Xiaoli; Thomson, Heather; Scott, Jennifer; Hossain, Parwez; Lotery, Andrew] Univ Southampton, Southampton Gen Hosp, Fac Med, Southampton, Hants, England; [Hossain, Parwez; Lotery, Andrew] Univ Hosp Southampton NHS Fdn Trust, Eye Unit, Southampton, Hants, England; [Cooke, Jessica] Univ Bristol, Bristol Eye Hosp, Sch Clin Sci, Bristol, Avon, England	University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Bristol Eye Hospital; University of Bristol	Lotery, A (corresponding author), Univ Southampton, Southampton Gen Hosp, Fac Med, Southampton, Hants, England.	a.j.lotery@soton.ac.uk	Hossain, Parwez/AAB-6065-2022	Hossain, Parwez/0000-0002-3131-2395; Lotery, Andrew/0000-0001-5541-4305	National Eye Research Centre; T.F.C. Frost Charity, Rosetrees Trust; Gift of Sight Appeal; Brian Mercer Charitable Trust; Rosetrees Trust [M124-F1] Funding Source: researchfish	National Eye Research Centre; T.F.C. Frost Charity, Rosetrees Trust; Gift of Sight Appeal; Brian Mercer Charitable Trust; Rosetrees Trust(Rosetrees Trust)	This work was supported by the National Eye Research Centre (http://www.nerc-charity.org.uk/), T.F.C. Frost Charity, Rosetrees Trust (http://www.rosetreestrust.co.uk/), the Gift of Sight Appeal (http://www.giftofsight.org.uk/), and the Brian Mercer Charitable Trust (http://www.brianmercercharitabletrust.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2005, INVEST OPHTH VIS SCI, V46, P3411, DOI 10.1167/iovs.04-1112; Akita J, 2002, BRAIN RES, V954, P286, DOI 10.1016/S0006-8993(02)03356-5; ALTSHULER D, 1992, DEVELOPMENT, V114, P947; Amato MA, 2004, CELL MOL LIFE SCI, V61, P899, DOI 10.1007/s00018-003-3370-7; Bhatia B, 2011, EXP EYE RES, V93, P852, DOI 10.1016/j.exer.2011.09.015; Brandl C, 2009, EXP EYE RES, V89, P209, DOI 10.1016/j.exer.2009.03.009; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Canola K, 2007, INVEST OPHTH VIS SCI, V48, P446, DOI 10.1167/iovs.06-0190; Carr AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008152; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; Chen XL, 2012, BRIT J OPHTHALMOL, V96, P1431, DOI 10.1136/bjophthalmol-2012-301546; Cicero SA, 2009, P NATL ACAD SCI USA, V106, P6685, DOI 10.1073/pnas.0901596106; Comyn O, 2010, CURR OPIN NEUROL, V23, P4, DOI 10.1097/WCO.0b013e3283352f96; Dravida S, 2005, DEV BRAIN RES, V160, P239, DOI 10.1016/j.devbrainres.2005.09.008; Du YD, 2005, STEM CELLS, V23, P1266, DOI 10.1634/stemcells.2004-0256; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Giannelli SG, 2011, STEM CELLS, V29, P344, DOI 10.1002/stem.579; Gonzalez-Cordero A, 2013, NAT BIOTECHNOL, V31, P741, DOI 10.1038/nbt.2643; Gualdoni S, 2010, STEM CELLS, V28, P1048, DOI 10.1002/stem.423; Hendrickson A, 2008, EXP EYE RES, V87, P415, DOI 10.1016/j.exer.2008.07.016; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hermann A, 2006, J NEUROSCI RES, V83, P1502, DOI 10.1002/jnr.20840; Joly S, 2011, GLIA, V59, P1033, DOI 10.1002/glia.21174; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kobayashi T, 2010, DEV GROWTH DIFFER, V52, P351, DOI 10.1111/j.1440-169X.2010.01170.x; Leveillard T, 2007, M S-MED SCI, V23, P240, DOI 10.1051/medsci/2007233240; Lotery A, 2007, BRIT J OPHTHALMOL, V91, P1303, DOI 10.1136/bjo.2007.116939; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Mansergh FC, 2010, EXP EYE RES, V91, P500, DOI 10.1016/j.exer.2010.07.003; Morgans CW, 1996, J NEUROSCI, V16, P6713; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Singh MS, 2013, P NATL ACAD SCI USA, V110, P1101, DOI 10.1073/pnas.1119416110; Sun GW, 2006, DEV BIOL, V289, P243, DOI 10.1016/j.ydbio.2005.10.035; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Tucker BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018992; Uchida S, 2005, INVEST OPHTH VIS SCI, V46, P1620, DOI 10.1167/iovs.04-0288; Wang YP, 2005, DEVELOPMENT, V132, P5103, DOI 10.1242/dev.02096; WATANABE T, 1992, DEVELOPMENT, V114, P899; West EL, 2010, STEM CELLS, V28, P1997, DOI 10.1002/stem.520; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156; Zhao LY, 2010, MECH DEVELOP, V127, P62, DOI 10.1016/j.mod.2009.10.006; Zhao X, 2008, STEM CELLS, V26, P939, DOI 10.1634/stemcells.2007-0727	46	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108418	10.1371/journal.pone.0108418	http://dx.doi.org/10.1371/journal.pone.0108418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271851	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000343729600047
J	Weiden, MD; Hoshino, S; Levy, DN; Li, YH; Kumar, R; Burke, SA; Dawson, R; Hioe, CE; Borkowsky, W; Rom, WN; Hoshino, Y				Weiden, Michael D.; Hoshino, Satomi; Levy, David N.; Li, Yonghua; Kumar, Rajnish; Burke, Sean A.; Dawson, Rodney; Hioe, Catarina E.; Borkowsky, William; Rom, William N.; Hoshino, Yoshihiko			Adenosine Deaminase Acting on RNA-1 (ADAR1) Inhibits HIV-1 Replication in Human Alveolar Macrophages	PLOS ONE			English	Article							VIRUS TYPE-1 INFECTION; DOUBLE-STRANDED-RNA; LONG-TERM SURVIVORS; INTERFERON-GAMMA; PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; OPPORTUNISTIC INFECTIONS; VIRAL BURDEN; IFN-GAMMA; EXPRESSION	While exploring the effects of aerosol IFN-gamma treatment in HIV-1/tuberculosis co-infected patients, we observed A to G mutations in HIV-1 envelope sequences derived from bronchoalveolar lavage (BAL) of aerosol IFN-gamma-treated patients and induction of adenosine deaminase acting on RNA 1 (ADAR1) in the BAL cells. IFN-gamma induced ADAR1 expression in monocyte-derived macrophages (MDM) but not T cells. ADAR1 siRNA knockdown induced HIV-1 expression in BAL cells of four HIV-1 infected patients on antiretroviral therapy. Similar results were obtained in MDM that were HIV-1 infected in vitro. Over-expression of ADAR1 in transformed macrophages inhibited HIV-1 viral replication but not viral transcription measured by nuclear run-on, suggesting that ADAR1 acts post-transcriptionally. The A to G hyper-mutation pattern observed in ADAR1 over-expressing cells in vitro was similar to that found in the lungs of HIV-1 infected patients treated with aerosol IFN-gamma suggesting the model accurately represented alveolar macrophages. Together, these results indicate that ADAR1 restricts HIV-1 replication post-transcriptionally in macrophages harboring HIV-1 provirus. ADAR1 may therefore contribute to viral latency in macrophages.	[Weiden, Michael D.; Hoshino, Satomi; Rom, William N.; Hoshino, Yoshihiko] NYU, Sch Med, Div Pulm & Crit Care Med, Dept Med, New York, NY 10012 USA; [Weiden, Michael D.; Hoshino, Satomi; Rom, William N.; Hoshino, Yoshihiko] NYU, Sch Med, Dept Environm Med, New York, NY USA; [Kumar, Rajnish; Hioe, Catarina E.] NYU, Sch Med, Dept Pathol, New York, NY USA; [Li, Yonghua; Borkowsky, William] NYU, Sch Med, Dept Pediat, New York, NY USA; [Levy, David N.; Burke, Sean A.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY USA; [Kumar, Rajnish; Hioe, Catarina E.] VA New York Harbor Healthcare Syst, New York, NY USA; [Dawson, Rodney] Univ Cape Town, Dept Med, Lung Inst, ZA-7925 Cape Town, South Africa	New York University; New York University; New York University; New York University; New York University; University of Cape Town	Hoshino, Y (corresponding author), NYU, Sch Med, Div Pulm & Crit Care Med, Dept Med, New York, NY 10012 USA.	yhoshino@nih.go.jp	Hoshino, Yoshihiko/B-5159-2019; Kumar, Rajnish/D-8259-2015	Hoshino, Yoshihiko/0000-0002-3132-0715; Rom, William/0000-0002-8793-7028	National Institutes of Health [DA22612, HL57879, AI80298, AI58876, AI48371, AI27742, HL59832, HL93016]; Uehara Memorial Foundation; HIV/AIDS-Related Pilot Project grants from the New York University Center for AIDS Research; VA Merit Review; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059832, R01HL057879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078783, R01AI058876, K24AI080298, P30AI027742, R01AI048371] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25461178] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); HIV/AIDS-Related Pilot Project grants from the New York University Center for AIDS Research; VA Merit Review(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by National Institutes of Health grants DA22612 (to Y.H.), HL57879 (to M.W.), AI80298 (to M.W.), AI58876 (to D.L.), AI48371 (to C.H.), AI27742 (to W.B.), HL59832 (to W.R.), and HL93016 (to W.R.). Y.H. is the recipient of grants of Uehara Memorial Foundation, and Y.H. and D.L. were each recipients of HIV/AIDS-Related Pilot Project grants from the New York University Center for AIDS Research. C.H. is the recipient of VA Merit Review. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, WHO GLOB TUB REP; BASS BL, 1989, CELL, V56, P331, DOI 10.1016/0092-8674(89)90234-1; BESANSKY NJ, 1991, J VIROL, V65, P2695, DOI 10.1128/JVI.65.5.2695-2698.1991; Biswas N, 2012, VIROLOGY, V422, P265, DOI 10.1016/j.virol.2011.10.024; Bovolenta C, 1999, J IMMUNOL, V162, P323; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Clerzius G, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-96; Condos R, 1997, LANCET, V349, P1513, DOI 10.1016/S0140-6736(96)12273-X; Condos R, 2004, CHEST, V125, P2146, DOI 10.1378/chest.125.6.2146; Condos R, 2003, INFECT IMMUN, V71, P2058, DOI 10.1128/IAI.71.4.2058-2064.2003; CONNOR RI, 1993, J VIROL, V67, P1772, DOI 10.1128/JVI.67.4.1772-1777.1993; Dawson R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006984; Doria M, 2009, NUCLEIC ACIDS RES, V37, P5848, DOI 10.1093/nar/gkp604; Dorman SE, 2004, LANCET, V364, P2113, DOI 10.1016/S0140-6736(04)17552-1; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; HAJJAR AM, 1995, J VIROL, V69, P5878, DOI 10.1128/JVI.69.9.5878-5882.1995; Hoshino Y, 2004, J IMMUNOL, V172, P6251, DOI 10.4049/jimmunol.172.10.6251; Hoshino Y, 2002, J EXP MED, V195, P495, DOI 10.1084/jem.20011614; Huang YX, 1998, VIROLOGY, V240, P36, DOI 10.1006/viro.1997.8913; KAMIJO R, 1993, J EXP MED, V178, P1435, DOI 10.1084/jem.178.4.1435; KOYANAGI Y, 1988, SCIENCE, V241, P1673, DOI 10.1126/science.3047875; Kumar M, 1997, P NATL ACAD SCI USA, V94, P3542, DOI 10.1073/pnas.94.8.3542; MURPHY DG, 1991, VIROLOGY, V181, P760, DOI 10.1016/0042-6822(91)90913-V; Nakata K, 1997, AM J RESP CRIT CARE, V155, P996, DOI 10.1164/ajrccm.155.3.9117038; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; Raju B, 2004, INFECT IMMUN, V72, P1275, DOI 10.1128/IAI.72.3.1275-1283.2004; Riddell LA, 2001, AIDS RES HUM RETROV, V17, P789, DOI 10.1089/088922201750251981; RUEDA P, 1994, VIROLOGY, V198, P653, DOI 10.1006/viro.1994.1077; Scadden ADJ, 2001, EMBO J, V20, P4243, DOI 10.1093/emboj/20.15.4243; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Twigg HL, 2008, J INFECT DIS, V197, P109, DOI 10.1086/523766; Valente L, 2005, PROG NUCLEIC ACID RE, V79, P299, DOI 10.1016/S0079-6603(04)79006-6; Whalen CC, 2000, AIDS, V14, P1219, DOI 10.1097/00002030-200006160-00020; Wong SK, 2002, P NATL ACAD SCI USA, V99, P15118, DOI 10.1073/pnas.232416799; Zaitseva M, 2000, BLOOD, V96, P3109, DOI 10.1182/blood.V96.9.3109.h8003109_3109_3117; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang LQ, 1997, J VIROL, V71, P5608, DOI 10.1128/JVI.71.7.5608-5613.1997	43	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108476	10.1371/journal.pone.0108476	http://dx.doi.org/10.1371/journal.pone.0108476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272020	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600049
J	Arasaradnam, RP; McFarlane, MJ; Ryan-Fisher, C; Westenbrink, E; Hodges, P; Thomas, MG; Chambers, S; O'Connell, N; Bailey, C; Harmston, C; Nwokolo, CU; Bardhan, KD; Covington, JA				Arasaradnam, Ramesh P.; McFarlane, Michael J.; Ryan-Fisher, Courtenay; Westenbrink, Erik; Hodges, Paula; Thomas, Matthew G.; Chambers, Samantha; O'Connell, Nicola; Bailey, Catherine; Harmston, Christopher; Nwokolo, Chuka U.; Bardhan, Karna D.; Covington, James A.			Detection of Colorectal Cancer (CRC) by Urinary Volatile Organic Compound Analysis	PLOS ONE			English	Article							ELECTRONIC E-NOSE; PERFORMANCE; DISEASE; FERMENTONOMICS; SPECTROMETRY; BIOMARKERS; DIAGNOSIS; INSIGHTS; TESTS; PILOT	Colorectal cancer (CRC) is a leading cause of cancer related death in Europe and the USA. There is no universally accepted effective non-invasive screening test for CRC. Guaiac based faecal occult blood (gFOB) testing has largely been superseded by Faecal Immunochemical testing (FIT), but sensitivity still remains poor. The uptake of population based FOBt testing in the UK is also low at around 50%. The detection of volatile organic compounds (VOCs) signature(s) for many cancer subtypes is receiving increasing interest using a variety of gas phase analytical instruments. One such example is FAIMS (Field Asymmetric Ion Mobility Spectrometer). FAIMS is able to identify Inflammatory Bowel disease (IBD) patients by analysing shifts in VOCs patterns in both urine and faeces. This study extends this concept to determine whether CRC patients can be identified through non-invasive analysis of urine, using FAIMS. 133 patients were recruited; 83 CRC patients and 50 healthy controls. Urine was collected at the time of CRC diagnosis and headspace analysis undertaken using a FAIMS instrument (Owlstone, Lonestar, UK). Data was processed using Fisher Discriminant Analysis (FDA) after feature extraction from the raw data. FAIMS analyses demonstrated that the VOC profiles of CRC patients were tightly clustered and could be distinguished from healthy controls. Sensitivity and specificity for CRC detection with FAIMS were 88% and 60% respectively. This study suggests that VOC signatures emanating from urine can be detected in patients with CRC using ion mobility spectroscopy technology (FAIMS) with potential as a novel screening tool.	[Arasaradnam, Ramesh P.; Bardhan, Karna D.] Univ Warwick, Clin Sci Res Inst, Coventry CV4 7AL, Warwick, England; [Westenbrink, Erik; Thomas, Matthew G.; Covington, James A.] Univ Warwick, Sch Engn, Coventry CV4 7AL, Warwick, England; [Arasaradnam, Ramesh P.; McFarlane, Michael J.; Ryan-Fisher, Courtenay; Hodges, Paula; Chambers, Samantha; O'Connell, Nicola; Bailey, Catherine] Univ Hosp Coventry & Warwickshire, Dept Gastroenterol, Coventry, Warwick, England; [Bardhan, Karna D.] Rotherham Gen Hosp, Dept Gastroenterol, Rotherham, Yorks, England; [Harmston, Christopher] Univ Hosp Coventry & Warwickshire, Dept Surg, Coventry, Warwick, England; [Thomas, Matthew G.] Univ Warwick, MOAC Doctoral Training Ctr, Coventry CV4 7AL, Warwick, England	University of Warwick; University of Warwick; University of Warwick; University of Warwick; University of Warwick	Arasaradnam, RP (corresponding author), Univ Warwick, Clin Sci Res Inst, Coventry CV4 7AL, Warwick, England.	r.arasaradnam@warwick.ac.uk	Covington, James A./Q-1934-2018; Thomas, Matthew/D-6786-2013	Covington, James A./0000-0003-1307-6488; Harmston, Christopher/0000-0001-5045-5191; Arasaradnam, Ramesh/0000-0002-2231-3062; Thomas, Matthew/0000-0001-8093-4919; Hodges, Phoebe/0000-0002-7231-0804	Bardhan Research and Education Charity (BRET) charity, Warwickshire Private Hospital charity, Eveson trust; Engineering and Physical Sciences Research Council [981795] Funding Source: researchfish	Bardhan Research and Education Charity (BRET) charity, Warwickshire Private Hospital charity, Eveson trust; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was supported by Bardhan Research and Education Charity (BRET) charity, Warwickshire Private Hospital charity, Eveson trust - provided funding for materials. BRET was established by Professor Bardhan but he had no input into the funding decision made by the grant awarding committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DF, 2013, BRIT J SURG, V100, P144, DOI 10.1002/bjs.8942; Arasaradnam RP, 2014, ALIMENT PHARM THER, V39, P780, DOI 10.1111/apt.12657; Arasaradnam R. P., 2012, Journal of Medical Engineering & Technology, V36, P333, DOI 10.3109/03091902.2012.690015; Arasaradnam RP, 2011, GUT, V60, P1768, DOI 10.1136/gut.2011.241216; Arasaradnam R. P., 2011, Journal of Medical Engineering & Technology, V35, P87, DOI 10.3109/03091902.2010.539770; Arasaradnam RP, 2009, MED HYPOTHESES, V73, P753, DOI 10.1016/j.mehy.2009.04.027; Arasaradnam R.P., 2014, PLOS ONE IN PRESS; Arasaradnam RP, 2013, INFLAMM BOWEL DIS, V19, P999, DOI 10.1097/MIB.0b013e3182802b26; Arasaradnam RP, 2010, BIOACTIVE FOODS EXTR; Bernabei M, 2008, SENSOR ACTUAT B-CHEM, V131, P1, DOI 10.1016/j.snb.2007.12.030; Brenner H, 2013, EUR J CANCER, V49, P3049, DOI 10.1016/j.ejca.2013.04.023; Buszewski B, 2007, BIOMED CHROMATOGR, V21, P553, DOI 10.1002/bmc.835; Covington JA, 2013, SENSORS-BASEL, V13, P11899, DOI 10.3390/s130911899; Covington JA, 2012, SENSORS-BASEL, V12, P13002, DOI 10.3390/s121013002; de Meij TG, 2014, INT J CANCER, V134, P1132, DOI 10.1002/ijc.28446; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; Imperiale TF, 2012, DIGEST DIS, V30, P16, DOI 10.1159/000341884; Khalid T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069602; Lidgard GP, 2013, CLIN GASTROENTEROL H, V11, P1313, DOI 10.1016/j.cgh.2013.04.023; Lippi G, 2012, CLIN CHEM LAB MED, V50, P435, DOI 10.1515/CCLM.2011.672; Moss SM, 2012, GUT, V61, P101, DOI 10.1136/gut.2010.236430; Pagnini C, 2011, J CLIN GASTROENTEROL, V45, P602, DOI 10.1097/MCG.0b013e31820abf29; Peng G, 2010, BRIT J CANCER, V103, P542, DOI 10.1038/sj.bjc.6605810; Phillips Michael, 2003, Breast J, V9, P184, DOI 10.1046/j.1524-4741.2003.09309.x; Probert CSJ, 2009, J GASTROINTEST LIVER, V18, P337; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Silva CL, 2011, BRIT J CANCER, V105, P1894, DOI 10.1038/bjc.2011.437; Sonoda H, 2011, GUT, V60, P814, DOI 10.1136/gut.2010.218305; Westhoff M, 2010, INT J ION MOBIL SPEC, V13, P131, DOI 10.1007/s12127-010-0049-2	30	100	102	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108750	10.1371/journal.pone.0108750	http://dx.doi.org/10.1371/journal.pone.0108750			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268885	Green Published, gold			2022-12-27	WOS:000343671700155
J	Ghadhanfar, E; Al-Bader, M; Turcani, M				Ghadhanfar, Elham; Al-Bader, Maie; Turcani, Marian			Wistar Rats Resistant to the Hypertensive Effects of Ouabain Exhibit Enhanced Cardiac Vagal Activity and Elevated Plasma Levels of Calcitonin Gene-Related Peptide	PLOS ONE			English	Article							POWER SPECTRAL-ANALYSIS; NA+-K+-ATPASE; BLOOD-PRESSURE; BAROREFLEX SENSITIVITY; ACETYLCHOLINE-RELEASE; CARDIOTONIC STEROIDS; ENDOGENOUS OUABAIN; OXIDATIVE STRESS; SMOOTH-MUSCLE; SODIUM-IONS	Ouabain is a cardiac glycoside produced in the adrenal glands and hypothalamus. It affects the function of all cells by binding to Na+/K+-ATPase. Several lines of evidence suggest that endogenous ouabain could be involved in the pathogenesis of essential (particularly, salt-sensitive) hypertension. However, information regarding the postulated hypertensive effect of the long-term administration of low-dose exogenous ouabain is inconsistent. This study was designed to help settle this controversy through the use of telemetric monitoring of arterial blood pressure and to elucidate the ouabain-induced alterations that could either promote or prevent hypertension. Ouabain (63 and 324 mu g/kg/day) was administered subcutaneously to male Wistar rats. Radiotelemetry was used to monitor blood pressure, heart rate and measures of cardiovascular variability and baroreflex sensitivity. The continuous administration of ouabain for 3 months did not elevate arterial blood pressure. The low-frequency power of systolic pressure variability, urinary excretion of catecholamines, and cardiovascular response to restraint stress and a high-salt diet as well as the responsiveness to alpha 1-adrenergic stimulation were all unaltered by ouabain administration, suggesting that the activity of the sympathetic nervous system was not increased. However, surrogate indices of cardiac vagal nerve activity based on heart rate variability were elevated. Molecular remodeling in mesenteric arteries that could support the development of hypertension (increased expression of the genes for the Na+/Ca2+ exchanger and Na+/K+-ATPase alpha 2 isoform) was not evident. Instead, the plasma level of vasodilatory calcitonin gene-related peptide (CGRP) significantly rose from 55 (11, SD) in the control group to 89 (20, SD) pg/ml in the ouabain-treated rats (P-Tukey's = 18.10(-5)). These data show that long-term administration of exogenous ouabain does not necessarily cause hypertension in rodents. The augmented parasympathetic activity and elevated plasma level of CGRP could be linked to the missing hypertensive effect of ouabain administration.	[Ghadhanfar, Elham; Al-Bader, Maie; Turcani, Marian] Kuwait Univ, Fac Med, Dept Physiol, Kuwait, Kuwait	Kuwait University	Turcani, M (corresponding author), Kuwait Univ, Fac Med, Dept Physiol, Kuwait, Kuwait.	mturcani@gmail.com		Al-Bader, Maie/0000-0002-1235-5437	Kuwait University Research grant [YM02/09]; Kuwait University General facility projects [GM01/01, GM01/05]; College of Graduate Studies Kuwait University	Kuwait University Research grant; Kuwait University General facility projects; College of Graduate Studies Kuwait University	This work was supported by Kuwait University Research grant No. YM02/09 (MT, EG), Kuwait University General facility projects No. GM01/01, GM01/05, and College of Graduate Studies Kuwait University (EG) (https://www.ovpr.kuniv.edu/research/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu GR, 1998, CLIN EXP HYPERTENS, V20, P85, DOI 10.3109/10641969809053208; ANDERSEN SLV, 1993, AM J PHYSIOL, V264, pC419, DOI 10.1152/ajpcell.1993.264.2.C419; Baecher S, 2014, CLIN CHIM ACTA, V431, P87, DOI 10.1016/j.cca.2014.01.038; Blaustein MP, 2012, AM J PHYSIOL-HEART C, V302, pH1031, DOI 10.1152/ajpheart.00899.2011; BLAUSTEIN MP, 1977, AM J PHYSIOL, V232, pC165, DOI 10.1152/ajpcell.1977.232.5.C165; BRAIN SD, 1985, NATURE, V313, P54, DOI 10.1038/313054a0; Cao CH, 2009, AM J PHYSIOL-RENAL, V296, pF98, DOI 10.1152/ajprenal.90429.2008; Dostanic I, 2005, AM J PHYSIOL-HEART C, V288, pH477, DOI 10.1152/ajpheart.00083.2004; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Fedorova OV, 2010, BBA-MOL BASIS DIS, V1802, P1230, DOI 10.1016/j.bbadis.2010.03.011; Gabor A, 2012, J APPL PHYSIOL, V113, P1294, DOI 10.1152/japplphysiol.00553.2012; Gomez RS, 1996, J NEUROCHEM, V66, P1440; Hamlyn JM, 2013, CURR OPIN NEPHROL HY, V22, P51, DOI 10.1097/MNH.0b013e32835b36ec; HOLZER P, 1992, REV PHYSIOL BIOCH P, V121, P49, DOI 10.1007/BFb0033194; Huang BS, 1999, HYPERTENSION, V34, P733, DOI 10.1161/01.HYP.34.4.733; Jacobs BE, 2012, AM J PHYSIOL-HEART C, V302, pH1317, DOI 10.1152/ajpheart.00532.2011; Kawada T, 2001, AM J PHYSIOL-HEART C, V281, pH139, DOI 10.1152/ajpheart.2001.281.1.H139; Kurtz TW, 2005, ARTERIOSCL THROM VAS, V25, pE22, DOI 10.1161/01.ATV.0000158419.98675.d7; Manunta P, 1999, HYPERTENSION, V34, P450, DOI 10.1161/01.HYP.34.3.450; MANUNTA P, 1994, J HYPERTENS, V12, P549; Manunta P, 2000, HYPERTENS RES, V23, pS77, DOI 10.1291/hypres.23.Supplement_S77; MCRITCHIE RJ, 1976, CIRC RES, V38, P321, DOI 10.1161/01.RES.38.4.321; Padilha AS, 2008, EUR J PHARMACOL, V600, P110, DOI 10.1016/j.ejphar.2008.10.023; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Piccirillo G, 2001, CLIN SCI, V100, P267, DOI 10.1042/CS20000222; PIDGEON GB, 1994, CLIN SCI, V86, P391, DOI 10.1042/cs0860391; Pritchard TJ, 2007, AM J PHYSIOL-HEART C, V293, pH1172, DOI 10.1152/ajpheart.00279.2007; Pulgar VM, 2013, J CARDIOVASC PHARM, V62, P174, DOI 10.1097/FJC.0b013e3182955d33; Pulina MV, 2010, AM J PHYSIOL-HEART C, V298, pH263, DOI 10.1152/ajpheart.00784.2009; Rindler TN, 2011, AM J PHYSIOL-HEART C, V301, pH1396, DOI 10.1152/ajpheart.00121.2011; Rossoni LV, 2002, BRIT J PHARMACOL, V135, P771, DOI 10.1038/sj.bjp.0704501; Rossoni LV, 2002, AM J PHYSIOL-HEART C, V283, pH2110, DOI 10.1152/ajpheart.00454.2002; Sabharwal R, 2010, HYPERTENSION, V55, P627, DOI 10.1161/HYPERTENSIONAHA.109.148171; Salmon AM, 2001, NAT NEUROSCI, V4, P357, DOI 10.1038/86001; SCHIEBINGER RJ, 1993, CIRC RES, V72, P1035, DOI 10.1161/01.RES.72.5.1035; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Shields Robert W Jr, 2009, Cleve Clin J Med, V76 Suppl 2, pS37, DOI 10.3949/ccjm.76.s2.08; Silva E, 2011, LIFE SCI, V88, P719, DOI 10.1016/j.lfs.2011.02.012; Sjogren B, 2012, MOL PHARMACOL, V82, P500, DOI 10.1124/mol.112.079293; Smillie SJ, 2014, HYPERTENSION, V63, P1056, DOI 10.1161/HYPERTENSIONAHA.113.02517; Smillie SJ, 2011, NEUROPEPTIDES, V45, P93, DOI 10.1016/j.npep.2010.12.002; Staessen JA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-13; Stauss HM, 2007, CLIN EXP PHARMACOL P, V34, P362, DOI 10.1111/j.1440-1681.2007.04588.x; Takahashi H, 2011, HYPERTENS RES, V34, P1147, DOI 10.1038/hr.2011.105; TAMURA M, 1994, J BIOL CHEM, V269, P11972; Tian G, 2001, HYPERTENS RES, V24, P729, DOI 10.1291/hypres.24.729; Voss A, 2009, PHILOS T R SOC A, V367, P277, DOI 10.1098/rsta.2008.0232; WALLICK DW, 1988, AM J PHYSIOL, V254, pH313, DOI 10.1152/ajpheart.1988.254.2.H313; WANG W, 1994, HYPERTENSION, V24, P571, DOI 10.1161/01.HYP.24.5.571; Wenceslau CF, 2011, J VASC RES, V48, P316, DOI 10.1159/000322576; Xavier FE, 2009, J HYPERTENS, V27, P1233, DOI 10.1097/HJH.0b013e32832a391f; Xavier FE, 2004, J HYPERTENS, V22, P949, DOI 10.1097/00004872-200405000-00017; Yamazaki T, 2007, ACTA PHYSIOL, V191, P275, DOI 10.1111/j.1748-1716.2007.01749.x; Zhang J, 2005, J PHYSIOL-LONDON, V569, P243, DOI 10.1113/jphysiol.2005.091801	54	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108909	10.1371/journal.pone.0108909	http://dx.doi.org/10.1371/journal.pone.0108909			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279791	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800037
J	Ishikawa, T; Tomatsu, S; Tsunoda, Y; Lee, J; Hoffman, DS; Kakei, S				Ishikawa, Takahiro; Tomatsu, Saeka; Tsunoda, Yoshiaki; Lee, Jongho; Hoffman, Donna S.; Kakei, Shinji			Releasing Dentate Nucleus Cells from Purkinje Cell Inhibition Generates Output from the Cerebrocerebellum	PLOS ONE			English	Article							SIMPLE-SPIKE ACTIVITY; PRIMARY MOTOR CORTEX; MOLECULAR LAYER INTERNEURONS; WRIST TRACKING MOVEMENT; 2 MAINTAINED POSTURES; CEREBELLAR NUCLEI; ARM MOVEMENTS; PREMOTOR CORTEX; VENTRAL PARAFLOCCULUS; OCULOMOTOR VERMIS	The cerebellum generates its vast amount of output to the cerebral cortex through the dentate nucleus (DN) that is essential for precise limb movements in primates. Nuclear cells in DN generate burst activity prior to limb movement, and inactivation of DN results in cerebellar ataxia. The question is how DN cells become active under intensive inhibitory drive from Purkinje cells (PCs). There are two excitatory inputs to DN, mossy fiber and climbing fiber collaterals, but neither of them appears to have sufficient strength for generation of burst activity in DN. Therefore, we can assume two possible mechanisms: post-inhibitory rebound excitation and disinhibition. If rebound excitation works, phasic excitation of PCs and a concomitant inhibition of DN cells should precede the excitation of DN cells. On the other hand, if disinhibition plays a primary role, phasic suppression of PCs and activation of DN cells should be observed at the same timing. To examine these two hypotheses, we compared the activity patterns of PCs in the cerebrocerebellum and DN cells during step-tracking wrist movements in three Japanese monkeys. As a result, we found that the majority of wrist-movement-related PCs were suppressed prior to movement onset and the majority of wrist-movement-related DN cells showed concurrent burst activity without prior suppression. In a minority of PCs and DN cells, movement-related increases and decreases in activity, respectively, developed later. These activity patterns suggest that the initial burst activity in DN cells is generated by reduced inhibition from PCs, i.e., by disinhibition. Our results indicate that suppression of PCs, which has been considered secondary to facilitation, plays the primary role in generating outputs from DN. Our findings provide a new perspective on the mechanisms used by PCs to influence limb motor control and on the plastic changes that underlie motor learning in the cerebrocerebellum.	[Ishikawa, Takahiro; Lee, Jongho; Kakei, Shinji] Tokyo Metropolitan Inst Med Sci, Motor Disorders Project, Setagaya Ku, Tokyo 113, Japan; [Tsunoda, Yoshiaki] Tokyo Metropolitan Inst Med Sci, Frontal Lobe Funct Project, Setagaya Ku, Tokyo 113, Japan; [Tomatsu, Saeka] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neurophysiol, Kodaira, Tokyo 187, Japan; [Hoffman, Donna S.] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA USA; [Hoffman, Donna S.] Univ Pittsburgh, Sch Med, Ctr Neural Basis Cognit, Pittsburgh, PA USA	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; National Center for Neurology & Psychiatry - Japan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kakei, S (corresponding author), Tokyo Metropolitan Inst Med Sci, Motor Disorders Project, Setagaya Ku, Tokyo 113, Japan.	kakei-sj@igakuken.or.jp		Kakei, Shinji/0000-0001-5111-5789; hu song, cai hua/0000-0001-6542-980X	Tokyo Metropolitan Institute of Medical Science; Japan Science and Technology Agency (PRESTO); Ministry of Education, Culture, Sports, Science and Technology in Japan [14580784, 15016008, 16015212, 20033029, 21500319, 24650224, 18700492, 20700478]; NBRP "Japanese Monkeys'' through the National BioResource Project of the MEXT Japan; Grants-in-Aid for Scientific Research [25560276] Funding Source: KAKEN	Tokyo Metropolitan Institute of Medical Science; Japan Science and Technology Agency (PRESTO)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NBRP "Japanese Monkeys'' through the National BioResource Project of the MEXT Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Tokyo Metropolitan Institute of Medical Science and grants-in-aid from the Japan Science and Technology Agency (PRESTO) to SK (http://www.jst.go.jp/) and from the Ministry of Education, Culture, Sports, Science and Technology in Japan (http://www.mext.go.jp/) (No. 14580784, No. 15016008, No. 16015212, No. 20033029, No. 21500319) to SK and (No. 24650224) to TI and (No. 18700492, No. 20700478) to ST. This project was also supported by NBRP "Japanese Monkeys'' through the National BioResource Project of the MEXT Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ALLEN GI, 1974, PHYSIOL REV, V54, P957, DOI 10.1152/physrev.1974.54.4.957; Alvina K, 2008, NAT NEUROSCI, V11, P1256, DOI 10.1038/nn.2195; Bengtsson F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084616; Bengtsson F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018822; Blot A, 2014, NAT NEUROSCI, V17, P289, DOI 10.1038/nn.3624; BRODAL P, 1992, NEUROSCI RES, V13, P83, DOI 10.1016/0168-0102(92)90092-Q; Cajal S. R., 1911, HISTOLOGIE SYSTEME N, V2; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Casabona A, 2008, NEUROSCIENCE, V157, P271, DOI 10.1016/j.neuroscience.2008.09.006; Catz N, 2008, P NATL ACAD SCI USA, V105, P7309, DOI 10.1073/pnas.0706032105; Chan-Palay V, 1977, CEREBELLAR DENTATE N; CHAPMAN CE, 1986, J NEUROPHYSIOL, V55, P203, DOI 10.1152/jn.1986.55.2.203; Coltz JD, 1999, J NEUROSCI, V19, P1782; Crammond DJ, 1996, EXP BRAIN RES, V108, P45; Dean P, 2010, NAT REV NEUROSCI, V11, P30, DOI 10.1038/nrn2756; DIETRICHS E, 1983, BRAIN RES, V259, P127, DOI 10.1016/0006-8993(83)91074-0; ECCLES JC, 1966, EXP BRAIN RES, V1, P161; Eccles JC, 1967, CEREBELLUM NEURONAL; ESPINOZA E, 1990, J NEUROPHYSIOL, V64, P698, DOI 10.1152/jn.1990.64.3.698; FORTIER PA, 1989, J NEUROPHYSIOL, V62, P198, DOI 10.1152/jn.1989.62.1.198; Gao WC, 2006, J NEUROSCI, V26, P8377, DOI 10.1523/JNEUROSCI.2434-06.2006; Gauck V, 2000, J NEUROSCI, V20, P3006; Glickstein M, 1997, PROG BRAIN RES, V114, P251; Goodkin HP, 2003, J NEUROPHYSIOL, V89, P896, DOI 10.1152/jn.00115.2002; HARVEY RJ, 1977, J PHYSIOL-LONDON, V271, P515, DOI 10.1113/jphysiol.1977.sp012012; Hashimoto M, 2010, EUR J NEUROSCI, V31, P1402, DOI 10.1111/j.1460-9568.2010.07151.x; Heiney SA, 2014, J NEUROSCI, V34, P2321, DOI 10.1523/JNEUROSCI.4547-13.2014; Hoebeek FE, 2010, P NATL ACAD SCI USA, V107, P8410, DOI 10.1073/pnas.0907118107; Holdefer RN, 2005, J NEUROPHYSIOL, V93, P35, DOI 10.1152/jn.00603.2004; Ishikawa T, 2014, NEUROSCI RES, V87, P84, DOI 10.1016/j.neures.2014.07.006; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Jorntell H, 2010, TRENDS NEUROSCI, V33, P524, DOI 10.1016/j.tins.2010.08.004; Kakei S, 2001, NAT NEUROSCI, V4, P1020, DOI 10.1038/nn726; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kitazawa S, 1998, NATURE, V392, P494, DOI 10.1038/33141; Kobayashi Y, 1998, J NEUROPHYSIOL, V80, P832, DOI 10.1152/jn.1998.80.2.832; KORN H, 1980, P NATL ACAD SCI-BIOL, V77, P6244, DOI 10.1073/pnas.77.10.6244; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; Lu XF, 2007, EUR J NEUROSCI, V25, P2374, DOI 10.1111/j.1460-9568.2007.05482.x; MANO N, 1980, J NEUROPHYSIOL, V43, P713, DOI 10.1152/jn.1980.43.3.713; Mano N, 1984, SHINKEI KENKYU NO SH, V28, P87; MANO NI, 1986, J NEUROPHYSIOL, V56, P137, DOI 10.1152/jn.1986.56.1.137; Matsushita M, 2001, J COMP NEUROL, V432, P101, DOI 10.1002/cne.1091; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; MIYASHITA Y, 1984, J PHYSIOL-LONDON, V351, P251, DOI 10.1113/jphysiol.1984.sp015243; NAGAO S, 1992, NEUROREPORT, V3, P13, DOI 10.1097/00001756-199201000-00003; OHTSUKA K, 1995, J NEUROPHYSIOL, V74, P1828, DOI 10.1152/jn.1995.74.5.1828; OJAKANGAS CL, 1992, J NEUROPHYSIOL, V68, P2222, DOI 10.1152/jn.1992.68.6.2222; Person AL, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00097; Person AL, 2012, NATURE, V481, P502, DOI 10.1038/nature10732; Rancillac A, 2004, J PHYSIOL-LONDON, V554, P707, DOI 10.1113/jphysiol.2003.055871; Roitman AV, 2005, J NEUROSCI, V25, P9244, DOI 10.1523/JNEUROSCI.1886-05.2005; Shinoda Y, 1997, PROG BRAIN RES, V114, P193; SHINODA Y, 1992, J NEUROPHYSIOL, V67, P547, DOI 10.1152/jn.1992.67.3.547; Shinoda Y, 2012, HDB CEREBELLUM CEREB; Smith SL, 2005, P NATL ACAD SCI USA, V102, P14901, DOI 10.1073/pnas.0505028102; Soetedjo R, 2006, J NEUROSCI, V26, P7741, DOI 10.1523/JNEUROSCI.4658-05.2006; STONE LS, 1990, J NEUROPHYSIOL, V63, P1241, DOI 10.1152/jn.1990.63.5.1241; STRICK PL, 1983, J NEUROSCI, V3, P2007; Szapiro G, 2007, NAT NEUROSCI, V10, P735, DOI 10.1038/nn1907; Tadayonnejad R, 2010, CEREBELLUM, V9, P352, DOI 10.1007/s12311-010-0168-7; THACH WT, 1970, J NEUROPHYSIOL, V33, P527, DOI 10.1152/jn.1970.33.4.527; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; THACH WT, 1970, J NEUROPHYSIOL, V33, P537, DOI 10.1152/jn.1970.33.4.537; Thach WT, 1982, CEREBELLUM NEW VISTA, P440; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P57, DOI 10.1152/jn.1993.69.1.57; VILIS T, 1977, J NEUROPHYSIOL, V40, P1214, DOI 10.1152/jn.1977.40.5.1214; WALSH JV, 1974, J NEUROPHYSIOL, V37, P30, DOI 10.1152/jn.1974.37.1.30; WETTS R, 1985, J NEUROPHYSIOL, V54, P231, DOI 10.1152/jn.1985.54.2.231; Witter L, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00133; Wu HS, 1999, J COMP NEUROL, V411, P97, DOI 10.1002/(SICI)1096-9861(19990816)411:1<97::AID-CNE8>3.0.CO;2-O; Yamamoto K, 2007, J NEUROPHYSIOL, V97, P1588, DOI 10.1152/jn.00206.2006; Yang Y, 2013, ELIFE, V2, DOI 10.7554/eLife.01574	77	52	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108774	10.1371/journal.pone.0108774	http://dx.doi.org/10.1371/journal.pone.0108774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279763	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000342670800028
J	Neuner, I; Kawohl, W; Arrubla, J; Warbrick, T; Hitz, K; Wyss, C; Boers, F; Shah, NJ				Neuner, Irene; Kawohl, Wolfram; Arrubla, Jorge; Warbrick, Tracy; Hitz, Konrad; Wyss, Christine; Boers, Frank; Shah, N. Jon			Cortical Response Variation with Different Sound Pressure Levels: A Combined Event-Related Potentials and fMRI Study	PLOS ONE			English	Article							AUDITORY-EVOKED-POTENTIALS; DIPOLE SOURCE ACTIVITY; CENTRAL SEROTONERGIC NEUROTRANSMISSION; SIMULTANEOUS EEG-FMRI; HYBRID MR-PET; INTENSITY DEPENDENCE; LOUDNESS DEPENDENCE; AFFECTIVE-DISORDERS; CLINICAL-RESPONSE; NEURONAL-ACTIVITY	Introduction: Simultaneous recording of electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) provides high spatial and temporal resolution. In this study we combined EEG and fMRI to investigate the structures involved in the processing of different sound pressure levels (SPLs). Methods: EEG data were recorded simultaneously with fMRI from 16 healthy volunteers using MR compatible devices at 3 T. Tones with different SPLs were delivered to the volunteers and the N1/P2 amplitudes were included as covariates in the fMRI data analysis in order to compare the structures activated with high and low SPLs. Analysis of variance (ANOVA) and ROI analysis were also performed. Additionally, source localisation analysis was performed on the EEG data. Results: The integration of averaged ERP parameters into the fMRI analysis showed an extended map of areas exhibiting covariation with the BOLD signal related to the auditory stimuli. The ANOVA and ROI analyses also revealed additional brain areas other than the primary auditory cortex (PAC) which were active with the auditory stimulation at different SPLs. The source localisation analyses showed additional sources apart from the PAC which were active with the high SPLs. Discussion: The PAC and the insula play an important role in the processing of different SPLs. In the fMRI analysis, additional activation was found in the anterior cingulate cortex, opercular and orbito-frontal cortices with high SPLs. A strong response of the visual cortex was also found with the high SPLs, suggesting the presence of cross-modal effects.	[Neuner, Irene; Arrubla, Jorge; Warbrick, Tracy; Boers, Frank; Shah, N. Jon] Forschungszentrum Julich, INM 4, Julich, Germany; [Neuner, Irene; Arrubla, Jorge] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Neuner, Irene; Shah, N. Jon] Rhein Westfal TH Aachen, JARA BRAIN Translat Med, Aachen, Germany; [Kawohl, Wolfram; Hitz, Konrad; Wyss, Christine] Univ Hosp Psychiat, Ctr Social Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland; [Shah, N. Jon] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University	Neuner, I (corresponding author), Forschungszentrum Julich, INM 4, Julich, Germany.	i.neuner@fz-juelich.de	Shah, N. Jon/H-5849-2013	Shah, N. Jon/0000-0002-8151-6169; Neuner, Irene/0000-0002-5164-8873; Wyss, Christine/0000-0003-2088-9794	Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association	Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association	N. Jon Shah was funded in part by the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Angrilli A, 2008, NEUROPSYCHOLOGIA, V46, P1179, DOI 10.1016/j.neuropsychologia.2007.10.018; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bamiou DE, 2003, BRAIN RES REV, V42, P143, DOI 10.1016/S0165-0173(03)00172-3; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Blinowska K., 2009, COMPUT INTELL NEUROS, DOI DOI 10.1155/2009/813607; Brocke B, 2000, NEUROPSYCHOBIOLOGY, V41, P24, DOI 10.1159/000026629; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Da Costa S, 2011, J NEUROSCI, V31, P14067, DOI 10.1523/JNEUROSCI.2000-11.2011; Debener S, 2008, INT J PSYCHOPHYSIOL, V67, P159, DOI 10.1016/j.ijpsycho.2007.07.001; Debener S, 2006, TRENDS COGN SCI, V10, P558, DOI 10.1016/j.tics.2006.09.010; Debener S, 2011, CLIN NEUROPHYSIOL, V122, P217, DOI 10.1016/j.clinph.2010.07.008; Dierks T, 1999, PSYCHOPHARMACOLOGY, V146, P101, DOI 10.1007/s002130051094; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Engelien A, 1995, BRAIN, V118, P1395, DOI 10.1093/brain/118.6.1395; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; GALLINAT J, 1994, PHARMACOPSYCHIATRY, V27, P52, DOI 10.1055/s-2007-1014275; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Hagenmuller F, 2011, HUM PSYCHOPHARM CLIN, V26, P147, DOI 10.1002/hup.1186; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; HEGERL U, 1994, INT J PSYCHOPHYSIOL, V17, P1, DOI 10.1016/0167-8760(94)90050-7; HEGERL U, 1993, BIOL PSYCHIAT, V33, P173, DOI 10.1016/0006-3223(93)90137-3; Hegerl U, 2001, J AFFECT DISORDERS, V62, P93, DOI 10.1016/S0165-0327(00)00353-0; HEGERL U, 1994, PHARMACOPSYCHIATRY, V27, P75, DOI 10.1055/s-2007-1014283; HEGERL U, 1992, PSYCHIAT RES, V44, P181, DOI 10.1016/0165-1781(92)90022-U; Hegerl U, 2000, IDEN TIFYING PSYCHIA, P112; Hensch T, 2008, CLIN NEUROPHYSIOL, V119, P224, DOI 10.1016/j.clinph.2007.09.127; Huster RJ, 2012, J NEUROSCI, V32, P6053, DOI 10.1523/JNEUROSCI.0447-12.2012; Jancke L, 1999, NEUROSCI LETT, V266, P125, DOI 10.1016/S0304-3940(99)00288-8; Jancke L, 1998, NEUROPSYCHOLOGIA, V36, P875, DOI 10.1016/S0028-3932(98)00019-0; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Juckel G, 2012, NEUROIMAGE, V60, P2027, DOI 10.1016/j.neuroimage.2012.02.019; Juckel G, 1996, EVOKED POTENTIAL, V100, P527, DOI 10.1016/S0168-5597(96)95534-3; Juckel G, 2008, HUM PSYCHOPHARM CLIN, V23, P115, DOI 10.1002/hup.906; Kawohl W, 2008, NEUROPSYCHIATRIE, V22, P23; Kawohl W, 2008, INT J NEUROPSYCHOPH, V11, P477, DOI 10.1017/S1461145708008420; Kiehl KA, 2001, PSYCHOPHYSIOLOGY, V38, P133, DOI 10.1111/1469-8986.3810133; Koike T, 2011, NEUROSCI RES, V69, P322, DOI 10.1016/j.neures.2010.12.018; Lauritzen M, 2003, J NEUROSCI, V23, P3972; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Lee TW, 2005, J PSYCHIATR NEUROSCI, V30, P202; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Malonek D, 1997, P NATL ACAD SCI USA, V94, P14826, DOI 10.1073/pnas.94.26.14826; Mayhew SD, 2010, NEUROIMAGE, V49, P849, DOI 10.1016/j.neuroimage.2009.06.080; MITZDORF U, 1994, PHARMACOPSYCHIATRY, V27, P49, DOI 10.1055/s-2007-1014274; Mulert C, 2005, NEUROIMAGE, V28, P49, DOI 10.1016/j.neuroimage.2005.05.041; Mullinger KJ, 2014, NEUROIMAGE, V94, P263, DOI 10.1016/j.neuroimage.2014.02.029; Neuner I, 2013, NUCL INSTRUM METH A, V702, P37, DOI 10.1016/j.nima.2012.08.022; Niazy RK, 2005, NEUROIMAGE, V28, P720, DOI 10.1016/j.neuroimage.2005.06.067; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Norra C, 2008, HUM PSYCHOPHARM CLIN, V23, P31, DOI 10.1002/hup.880; Novitski N, 2001, NEUROIMAGE, V14, P244, DOI 10.1006/nimg.2001.0797; O'Neill BV, 2008, HUM PSYCHOPHARM CLIN, V23, P355, DOI 10.1002/hup.940; O'Neill BV, 2008, HUM PSYCHOPHARM CLIN, V23, P301, DOI 10.1002/hup.926; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Ostwald D, 2010, NEUROIMAGE, V49, P498, DOI 10.1016/j.neuroimage.2009.07.038; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pissiota A, 2003, EUR J NEUROSCI, V18, P1325, DOI 10.1046/j.1460-9568.2003.02855.x; RAPIN I, 1966, ELECTROEN CLIN NEURO, V21, P335, DOI 10.1016/0013-4694(66)90039-3; Scarff CJ, 2004, NEUROIMAGE, V23, P1129, DOI 10.1016/j.neuroimage.2004.07.035; SCHERG M, 1986, ELECTROEN CLIN NEURO, V65, P344, DOI 10.1016/0168-5597(86)90014-6; Scherg M, 1989, J Cogn Neurosci, V1, P336, DOI 10.1162/jocn.1989.1.4.336; Shah NJ, 2013, J MAGN RESON, V229, P101, DOI 10.1016/j.jmr.2012.11.027; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; Uppenkamp S, 2014, HEARING RES, V307, P65, DOI 10.1016/j.heares.2013.08.005; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Wyss C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068650	74	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109216	10.1371/journal.pone.0109216	http://dx.doi.org/10.1371/journal.pone.0109216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279457	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000342670800065
J	Andersson, E; Lindborg, R				Andersson, Erik; Lindborg, Regina			Species Richness and Assemblages in Landscapes of Different Farming Intensity - Time to Revise Conservation Strategies?	PLOS ONE			English	Article							FARMLAND BIODIVERSITY; ECOSYSTEM SERVICES; DIVERSITY; HABITAT; FRAGMENTATION; HETEROGENEITY; MATRIX; BIRDS	Worldwide conservation goals to protect biodiversity emphasize the need to rethink which objectives are most suitable for different landscapes. Comparing two different Swedish farming landscapes, we used survey data on birds and vascular plants to test whether landscapes with large, intensively managed farms had lower richness and diversity of the two taxa than landscapes with less intensively managed small farms, and if they differed in species composition. Landscapes with large intensively managed farms did not have lower richness than smaller low intensively managed farms. The landscape types were also similar in that they had few red listed species, normally targeted in conservation. Differences in species composition demonstrate that by having both types of agricultural landscapes regional diversity is increased, which is seldom captured in the objectives for agro-environmental policies. Thus we argue that focus on species richness or red listed species would miss the actual diversity found in the two landscape types. Biodiversity conservation, especially in production landscapes, would therefore benefit from a hierarchy of local to regional objectives with explicit targets in terms of which aspects of biodiversity to focus on.	[Andersson, Erik] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Lindborg, Regina] Stockholm Univ, Dept Phys Geog & Quaternary Geol, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Andersson, E (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden.	erik.andersson@su.se	Andersson, Erik/AAE-9771-2019	Andersson, Erik/0000-0003-2716-5502	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas)	The study was financially supported by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) to Ekoklim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Baldi A, 2011, BIRD STUDY, V58, P365, DOI 10.1080/00063657.2011.588685; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bengtsson J, 2003, AMBIO, V32, P389, DOI 10.1639/0044-7447(2003)032[0389:RRADL]2.0.CO;2; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Blitzer EJ, 2012, AGR ECOSYST ENVIRON, V146, P34, DOI 10.1016/j.agee.2011.09.005; Bommarco R, 2013, TRENDS ECOL EVOL, V28, P230, DOI 10.1016/j.tree.2012.10.012; Butler SJ, 2007, SCIENCE, V315, P381, DOI 10.1126/science.1136607; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Clarke K. R., 1988, P 14 INT BIOM C NAM, P131, DOI DOI 10.1111/J.1442-9993.1993.TB00438.X; Cousins SAO, 2009, BIOL CONSERV, V142, P2752, DOI 10.1016/j.biocon.2009.07.001; Cramp S., 1977, HDB BIRDS EUROPE MID; Debinski DM, 2006, J BIOGEOGR, V33, P1791, DOI 10.1111/j.1365-2699.2006.01596.x; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Eriksson O, 2002, J VEG SCI, V13, P743, DOI 10.1111/j.1654-1103.2002.tb02102.x; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Firmino A, 1999, LANDSCAPE URBAN PLAN, V46, P83, DOI 10.1016/S0169-2046(99)00049-3; Gardenfors U, 2010, RODLISTADE ARTER SVE; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Gonthier DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1358; Gorley RN, 2006, PRIMER V6; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Lindborg R, 2014, BIOL CONSERV, V169, P206, DOI 10.1016/j.biocon.2013.11.015; Lindborg R, 2008, AGR ECOSYST ENVIRON, V125, P213, DOI 10.1016/j.agee.2008.01.006; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; MANTEL N, 1967, CANCER RES, V27, P209; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Plue J, 2013, BIOL CONSERV, V160, P250, DOI 10.1016/j.biocon.2013.02.010; Prevedello JA, 2010, BIODIVERS CONSERV, V19, P1205, DOI 10.1007/s10531-009-9750-z; Pykala J, 2005, AGR ECOSYST ENVIRON, V108, P109, DOI 10.1016/j.agee.2005.01.012; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Strijker D, 2005, BASIC APPL ECOL, V6, P99, DOI 10.1016/j.baae.2005.01.001; Sutherland WJ, 2002, TRENDS ECOL EVOL, V17, P148, DOI 10.1016/S0169-5347(01)02421-1; Sutherland WJ, 2000, CONSERVATION HDB; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x	44	8	8	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109816	10.1371/journal.pone.0109816	http://dx.doi.org/10.1371/journal.pone.0109816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275484	Green Submitted, gold, Green Published			2022-12-27	WOS:000342591500114
J	Hu, PP; Shen, HC; Wang, GH; Zhang, P; Liu, Q; Du, JJ				Hu, Pingping; Shen, Hongchang; Wang, Guanghui; Zhang, Ping; Liu, Qi; Du, Jiajun			Prognostic Significance of Systemic Inflammation-Based Lymphocyte- Monocyte Ratio in Patients with Lung Cancer: Based on a Large Cohort Study	PLOS ONE			English	Article							B-CELL LYMPHOMA; PREOPERATIVE LYMPHOCYTE; NEUTROPHIL-LYMPHOCYTE; PREDICTING SURVIVAL; ABSOLUTE LYMPHOCYTE; COUNT; MACROPHAGES; DIAGNOSIS; RESECTION; ORIGIN	Increasing evidence indicates cancer-related inflammatory biomarkers show great promise for predicting the outcome of cancer patients. The lymphocyte- monocyte ratio (LMR) was demonstrated to be independent prognostic factor mainly in hematologic tumor. The aim of the present study was to investigate the prognostic value of LMR in operable lung cancer. We retrospectively enrolled a large cohort of patients with primary lung cancer who underwent complete resection at our institution from 2006 to 2011. Inflammatory biomarkers including lymphocyte count and monocyte count were collected from routinely performed preoperative blood tests and the LMR was calculated. Survival analyses were calculated for overall survival (OS) and disease-free survival (DFS). A total of 1453 patients were enrolled in the study. The LMR was significantly associated with OS and DFS in multivariate analyses of the whole cohort (HR = 1.522, 95% CI: 1.275-1.816 for OS, and HR = 1.338, 95% CI: 1.152-1.556 for DFS). Univariate subgroup analyses disclosed that the prognostic value was limited to patients with non-small-cell lung cancer (NSCLC) (HR: 1.824, 95% CI: 1.520-2.190), in contrast to patients with small cell lung cancer (HR: 1.718, 95% CI: 0.946-3.122). Multivariate analyses demonstrated that LMR was still an independent prognostic factor in NSCLC. LMR can be considered as a useful independent prognostic marker in patients with NSCLC after complete resection. This will provide a reliable and convenient biomarker to stratify high risk of death in patients with operable NSCLC.	[Hu, Pingping; Zhang, Ping; Liu, Qi; Du, Jiajun] Shandong Univ, Inst Oncol, Shandong Prov Hosp, Jinan 250100, Peoples R China; [Shen, Hongchang] Shandong Univ, Dept Oncol, Shandong Prov Hosp, Jinan 250100, Peoples R China; [Wang, Guanghui; Du, Jiajun] Shandong Univ, Dept Thorac Surg, Shandong Prov Hosp, Jinan 250100, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Liu, Q (corresponding author), Shandong Univ, Inst Oncol, Shandong Prov Hosp, Jinan 250100, Peoples R China.	liuqi66@sdu.edu.cn; dujiajun@sdu.edu.cn			National Natural Science Foundation of China [81301728]; Provincial Natural Science Foundation of Shandong [ZR2013HZ001]; Provincial Science and Technology Development Plan of Shandong [2012G0021836]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province); Provincial Science and Technology Development Plan of Shandong	The work was supported by National Natural Science Foundation of China (81301728), Provincial Natural Science Foundation of Shandong (ZR2013HZ001), and Provincial Science and Technology Development Plan of Shandong (2012G0021836). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2013, ACTA HAEMATOL-BASEL, V130, P242, DOI 10.1159/000350484; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bishara S, 2008, EUR J OBSTET GYN R B, V138, P71, DOI 10.1016/j.ejogrb.2007.05.012; Botta C, 2013, CANCER BIOL THER, V14, P469, DOI 10.4161/cbt.24425; Cihan YB, 2014, ASIAN PAC J CANCER P, V15, P2061, DOI 10.7314/APJCP.2014.15.5.2061; Clarke S, 2011, CLIN PHARM THERAPEUT, P90; Clear AJ, 2010, BLOOD, V115, P5053, DOI 10.1182/blood-2009-11-253260; Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001; Dou X, 2013, ASIAN PAC J CANCER P, V14, P3881, DOI 10.7314/APJCP.2013.14.6.3881; Galdiero MR, 2013, J CELL PHYSIOL, V228, P1404, DOI 10.1002/jcp.24260; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haruki K, 2012, J SURG ONCOL, V106, P31, DOI 10.1002/jso.23033; Kobayashi N, 2012, LUNG CANCER, V75, P223, DOI 10.1016/j.lungcan.2011.06.009; Koh YW, 2012, ONCOLOGIST, V17, P871, DOI 10.1634/theoncologist.2012-0034; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Lee YY, 2012, GYNECOL ONCOL, V124, P92, DOI 10.1016/j.ygyno.2011.09.034; Li JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054839; Li YL, 2014, ANN HEMATOL, V93, P617, DOI 10.1007/s00277-013-1916-9; Li ZM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041658, 10.1371/journal.pone.0053176]; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Liu Y, 2014, CELL MOL IMMUNOL, V11, P49, DOI [10.1038/cmi.2013.40, 10.1038/cmi.2014.83]; McMillan DC, 2003, BRIT J SURG, V90, P215, DOI 10.1002/bjs.4038; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Porrata LF, 2012, LEUKEMIA LYMPHOMA, V53, P2159, DOI 10.3109/10428194.2012.690605; Porrata LF, 2012, BRIT J HAEMATOL, V157, P321, DOI 10.1111/j.1365-2141.2012.09067.x; Roxburgh CSD, 2010, FUTURE ONCOL, V6, P149, DOI 10.2217/FON.09.136; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Stotz M, 2014, BRIT J CANCER, V110, P435, DOI 10.1038/bjc.2013.785; Szkandera J, 2013, INT J CANC; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Zhang J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0352-3	33	113	118	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108062	10.1371/journal.pone.0108062	http://dx.doi.org/10.1371/journal.pone.0108062			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275631	Green Submitted, gold, Green Published			2022-12-27	WOS:000342591500014
J	Liu, M; Liu, JB; Wang, LM; Wu, HY; Zhou, CC; Zhu, HX; Xu, NZ; Xie, YF				Liu, Mei; Liu, Jibing; Wang, Liming; Wu, Huiyong; Zhou, Changchun; Zhu, Hongxia; Xu, Ningzhi; Xie, Yinfa			Association of Serum MicroRNA Expression in Hepatocellular Carcinomas Treated with Transarterial Chemoembolization and Patient Survival	PLOS ONE			English	Article							CIRCULATING MICRORNAS; ALPHA-FETOPROTEIN; CANCER; MIR-122; MARKERS; MIR-21	Background and Aim: Hepatocellular carcinoma (HCC) is one of the most deadly tumors. Transarterial chemoembolization (TACE) is effective for unresectable HCC. In recent years, miRNAs have been proposed as novel diagnostic and prognostic tools for HCC. This study aimed to identify whether microRNAs (miRNAs) can serve as biomarkers to reliably predict outcome before HCC patients are treated with TACE. Methods: Eleven miRNAs (miR-, miR-19a, miR-101-3p, miR-199a-5p, miR-200a, miR-21, miR-214, miR-221, miR-222, miR-223 and miR-, -5p) were quantified by quantitative real-time PCR (qRT-PCR) in 136 HCC patients' serum before they received TACE therapy. Univariate and multivariate analysis were used to identify the prognostic value of clinical parameters and miRNAs. Area under the receiver operating characteristic curve (AUC) was used to evaluate the prediction potency. Results: The levels of some miRNAs were dramatically associated with clinicopathologic features regarding Child-Puge class, AFP, tumor size and satellite nodules. Univariate analysis revealed that miR-200a, miR-21, miR-122 and miR-224-5p were significantly associated with patients' survival. Multivariate analysis demonstrated that AFP, satellite nodules and miR-200a were the independent prognostic factors associated with survival in this cohort (p = 0.000, 0.001, 0.000, respectively). The probability of the prognostic accuracy of miR-200a was 81.64% (74.47% specificity and 88.76% sensitivity), which was higher than the classifier established by combination of AFP and satellite nodules (76.87% probability, 70.21% specificity and 69.66% sensitivity). Furthermore, the combination of AFP, satellite nodules and miR-200a demonstrated as a classifier for HCC prognosis, yielding a ROC curve area of 88.19% (93.62% specificity and 68.54% sensitivity). Conclusions: Our study indicated that serum miR-200a may prognosticate disease outcome in HCC patients with TACE therapy. Therefore, miR-200a can potentially guide individualized treatment for HCC patients with a high risk of TACE treatment failures.	[Liu, Mei; Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Lab Cell & Mol Biol, Beijing 100730, Peoples R China; [Liu, Mei; Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Liu, Mei; Wang, Liming; Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China; [Liu, Mei; Wang, Liming; Zhu, Hongxia; Xu, Ningzhi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Jibing; Wu, Huiyong; Xie, Yinfa] Shandong Acad Med Sci, Canc Hosp Shandong Prov, Dept Intervent Surg Oncol, Jinan, Shandong, Peoples R China; [Wang, Liming] Chinese Acad Med Sci, Inst Canc, Dept Abdominal Surg, Beijing 100021, Peoples R China; [Zhou, Changchun] Shandong Acad Med Sci, Canc Hosp Shandong Prov, Clin Lab, Jinan, Shandong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Chinese Academy of Medical Sciences - Peking Union Medical College; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Xu, NZ (corresponding author), Chinese Acad Med Sci, Lab Cell & Mol Biol, Beijing 100730, Peoples R China.	xningzhi@public.bta.net.cn; Laoxie6996@163.com	Wang, Liming/AAD-7697-2020; , CC. Zhou/AGI-1229-2022		State Key Laboratory of Molecular Oncology program [SKL-2013-14]; Development projects of Shandong province science and technology [2012GSF11837]; Beijing Hope Run Special Fund, PR China [LC2012B19]	State Key Laboratory of Molecular Oncology program; Development projects of Shandong province science and technology; Beijing Hope Run Special Fund, PR China	This work was supported by State Key Laboratory of Molecular Oncology program (SKL-2013-14), Development projects of Shandong province science and technology (2012GSF11837) and Beijing Hope Run Special Fund (LC2012B19), PR China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au V, 2014, BIOSCI TRENDS, V8, P101, DOI 10.5582/bst.8.101; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371; Callegari Elisa, 2013, Onco Targets Ther, V6, P1167, DOI 10.2147/OTT.S36161; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Dhayat SA, 2014, J SURG ONCOL, V110, P430, DOI 10.1002/jso.23668; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Farinati F, 2006, AM J GASTROENTEROL, V101, P524, DOI 10.1111/j.1572-0241.2006.00443.x; Ferracin M, 2010, EXPERT REV MOL DIAGN, V10, P297, DOI 10.1586/ERM.10.11; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Gramantieri L, 2009, CLIN CANCER RES, V15, P5073, DOI 10.1158/1078-0432.CCR-09-0092; Han ZB, 2012, MOL ONCOL, V6, P445, DOI 10.1016/j.molonc.2012.04.001; Hung CS, 2013, ANN SURG ONCOL, V20, pS360, DOI 10.1245/s10434-012-2482-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Kojima K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1345; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Li Q, 2013, J GASTROENTEROL HEPA; Li Q, 2010, J GASTROEN HEPATOL, V25, P164, DOI 10.1111/j.1440-1746.2009.05971.x; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Minguez B, 2011, DIS MARKERS, V31, P181, DOI [10.1155/2011/310675, 10.3233/DMA-2011-0841]; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Negrini M, 2011, ANTI-CANCER AGENT ME, V11, P500, DOI 10.2174/187152011796011037; Park JK, 2011, CANCER RES, V71, P7608, DOI 10.1158/0008-5472.CAN-11-1144; Petrelli A, 2014, HEPATOLOGY, V59, P228, DOI 10.1002/hep.26616; Riaz A, 2009, J CLIN ONCOL, V27, P5734, DOI 10.1200/JCO.2009.23.1282; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang Y, 2012, ANN SURG ONCOL, V19, P3540, DOI 10.1245/s10434-012-2368-5; Wang Y, 2014, GENE, V533, P389, DOI 10.1016/j.gene.2013.09.038; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	35	56	57	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109347	10.1371/journal.pone.0109347	http://dx.doi.org/10.1371/journal.pone.0109347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275448	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500097
J	Tsangaras, K; Wales, N; Sicheritz-Ponten, T; Rasmussen, S; Michaux, J; Ishida, Y; Morand, S; Kampmann, ML; Gilbert, MTP; Greenwood, AD				Tsangaras, Kyriakos; Wales, Nathan; Sicheritz-Ponten, Thomas; Rasmussen, Simon; Michaux, Johan; Ishida, Yasuko; Morand, Serge; Kampmann, Marie-Louise; Gilbert, M. Thomas P.; Greenwood, Alex D.			Hybridization Capture Using Short PCR Products Enriches Small Genomes by Capturing Flanking Sequences (CapFlank)	PLOS ONE			English	Article							MITOCHONDRIAL; EFFICIENT; MUS; DNA; EVOLUTION	Solution hybridization capture methods utilize biotinylated oligonucleotides as baits to enrich homologous sequences from next generation sequencing (NGS) libraries. Coupled with NGS, the method generates kilo to gigabases of high confidence consensus targeted sequence. However, in many experiments, a non-negligible fraction of the resulting sequence reads are not homologous to the bait. We demonstrate that during capture, the bait-hybridized library molecules add additional flanking library sequences iteratively, such that baits limited to targeting relatively short regions (e.g. few hundred nucleotides) can result in enrichment across entire mitochondrial and bacterial genomes. Our findings suggest that some of the off-target sequences derived in capture experiments are non-randomly enriched, and that CapFlank will facilitate targeted enrichment of large contiguous sequences with minimal prior target sequence information.	[Tsangaras, Kyriakos; Kampmann, Marie-Louise; Greenwood, Alex D.] Leibniz Inst Zoo & Wildlife Res, Dept Wildlife Dis, Berlin, Germany; [Wales, Nathan; Gilbert, M. Thomas P.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Sicheritz-Ponten, Thomas; Rasmussen, Simon] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Michaux, Johan] Univ Liege, Inst Bot, Conservat Genet Unit, Liege, Belgium; [Ishida, Yasuko] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Morand, Serge] Univ Montpellier 2, Inst Sci Evolut, Montpellier 5, France	Leibniz Institut fur Zoo und Wildtierforschung; University of Copenhagen; Technical University of Denmark; University of Liege; University of Illinois System; University of Illinois Urbana-Champaign; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Greenwood, AD (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Wildlife Dis, Berlin, Germany.	greenwood@izw-berlin.de	Wales, Nathan/B-4263-2015; Morand, Serge/M-5433-2018; Greenwood, Alex/GWU-8292-2022; Rasmussen, Simon/AAA-2308-2020; Rasmussen, Simon/G-6258-2016; Gilbert, Marcus TP/A-8936-2013; Sicheritz-Ponten, Thomas/A-4325-2017	Wales, Nathan/0000-0003-0359-8450; Morand, Serge/0000-0003-3986-7659; Rasmussen, Simon/0000-0001-6323-9041; Rasmussen, Simon/0000-0001-6323-9041; Gilbert, Marcus TP/0000-0002-5805-7195; Sicheritz-Ponten, Thomas/0000-0001-6615-1141	French ANR BiodivHealthSEA [ANR 11CPEL 002]; ANR CERoPath; program APEGE of INEE-CNRS; National Institute of General Medical Sciences (NIGMS) [R01GM092706]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092706] Funding Source: NIH RePORTER	French ANR BiodivHealthSEA(French National Research Agency (ANR)); ANR CERoPath(French National Research Agency (ANR)); program APEGE of INEE-CNRS; National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JM and SM were supported by the French ANR BiodivHealthSEA (grant number ANR 11CPEL 002) and ANR CERoPath. SM was additionally supported by the program APEGE of INEE-CNRS for the project NcRNARAt. YI and ADG were supported by Grant Number R01GM092706 from the National Institute of General Medical Sciences (NIGMS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIGMS or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila-Arcos MC, 2013, MOL BIOL EVOL, V30, P299, DOI 10.1093/molbev/mss223; Avila-Arcos MC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00074; Burbano HA, 2010, SCIENCE, V328, P723, DOI 10.1126/science.1188046; Cappellini E, 2010, NATURWISSENSCHAFTEN, V97, P205, DOI 10.1007/s00114-009-0629-3; Castiglia R, 2005, BIOL J LINN SOC, V84, P395, DOI 10.1111/j.1095-8312.2005.00442.x; Duncavage EJ, 2011, J MOL DIAGN, V13, P325, DOI 10.1016/j.jmoldx.2011.01.006; Guo Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-194; Hasman H, 2014, J CLIN MICROBIOL, V52, P139, DOI 10.1128/JCM.02452-13; Herman DS, 2009, NAT METHODS, V6, P507, DOI 10.1038/nmeth.1343; Japelaghi RH, 2011, MOL BIOTECHNOL, V49, P129, DOI 10.1007/s12033-011-9384-8; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Li H., 2013, ARXIV PREPRINT; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao GJW, 2011, CLIN CHEM, V57, P92, DOI 10.1373/clinchem.2010.154336; Lundrigan BL, 2002, SYST BIOL, V51, P410, DOI 10.1080/10635150290069878; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mason VC, 2011, GENOME RES, V21, P1695, DOI 10.1101/gr.120196.111; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Suzuki H, 2004, MOL PHYLOGENET EVOL, V33, P626, DOI 10.1016/j.ympev.2004.08.003; Tsangaras K, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-92; Winkelmann I, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0273	25	17	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109101	10.1371/journal.pone.0109101	http://dx.doi.org/10.1371/journal.pone.0109101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275614	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500060
J	Jung, H; Roser, JF; Yoon, M				Jung, Heejun; Roser, Janet F.; Yoon, Minjung			UTF1, a Putative Marker for Spermatogonial Stem Cells in Stallions	PLOS ONE			English	Article							I IGF-I; RHESUS MACAQUES; LEYDIG-CELLS; RAT TESTIS; EXPRESSION; DAZL; GENE; PLURIPOTENCY; TRANSPLANTATION; LOCALIZATION	Spermatogonial stem cells (SSCs) continuously undergo self-renewal and differentiation to sustain spermatogenesis throughout adulthood in males. In stallions, SSCs may be used for the production of progeny from geldings after cryopreservation and therapy for infertile and subfertile stallions. Undifferentiated cell transcription factor 1 (UTF1) is a putative marker for undifferentiated spermatogonia in humans and rats. The main purposes of this study are to determine the following: 1) changes in the expression pattern of UTF1 at various reproductive stages of stallions, 2) subpopulations of spermatogonia that express UTF1. Testicular samples were collected and categorized based on the age of the horses as follows: pre-pubertal (<1 yr), pubertal (1-1.5 yr), post-pubertal (2-3 yr), and adult (4-8 yr). Western blot analysis was utilized to determine the cross-activity of the UTF1 antibody to horse testes tissues. Immunohistochemistry was conducted to investigate the UTF1 expression pattern in germ cells at different reproductive stages. Whole mount staining was applied to determine the subpopulation of UTF1-positive spermatogonia. Immunohistological analysis showed that most germ cells in the pre-pubertal and pubertal stages were immunolabeled with UTF1, whereas only a few germ cells in the basal compartment of the seminiferous tubule cross-sections of post-pubertal and adult tissues were UTF1-positive. No staining was observed in the Sertoli or Leydig cells at any reproductive stages. Whole mount staining showed that A(s), A(pr), and chains of 4, 8, 16 A(al) spermatogonia were immunolabeled with UTF1 in the post-pubertal stallion tubule. Isolated single germ cells were also immunolabeled with UTF1. In conclusion, UTF1 is expressed in undifferentiated spermatogonia, and its antibody can be used as a putative marker for SSCs in stallions.	[Jung, Heejun; Yoon, Minjung] Kyungpook Natl Univ, Dept Anim & Biotechnol, Sangju, South Korea; [Yoon, Minjung] Kyungpook Natl Univ, Dept Horse Compan & Wild Anim Sci, Sangju, South Korea; [Roser, Janet F.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA	Kyungpook National University; Kyungpook National University; University of California System; University of California Davis	Yoon, M (corresponding author), Kyungpook Natl Univ, Dept Anim & Biotechnol, Sangju, South Korea.	mjyoon@knu.ac.kr			National Research Foundation of Korea (NRF) of the Ministry of Education, Science, and Technology [2012R1A1A1039495]	National Research Foundation of Korea (NRF) of the Ministry of Education, Science, and Technology(National Research Foundation of Korea)	Funding provided by National Research Foundation of Korea (NRF) of the Ministry of Education, Science, and Technology (2012R1A1A1039495). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Costa GMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044091; De Rooij DG, 2000, J ANDROL, V21, P776; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Dobrinski I, 2000, MOL REPROD DEV, V57, P270, DOI 10.1002/1098-2795(200011)57:3&lt;270::AID-MRD9&gt;3.0.CO;2-Z; Gassei K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053976; Hermann BP, 2007, STEM CELLS, V25, P2330, DOI 10.1634/stemcells.2007-0143; Hermann BP, 2009, HUM REPROD, V24, P1704, DOI 10.1093/humrep/dep073; Jia JL, 2012, CELL, V151, P576, DOI 10.1016/j.cell.2012.09.023; JOHNSON L, 1981, BIOL REPROD, V24, P703, DOI 10.1095/biolreprod24.3.703; JOHNSON L, 1991, BIOL REPROD, V44, P284, DOI 10.1095/biolreprod44.2.284; Jung HJ, 2014, ANIM REPROD SCI, V147, P32, DOI 10.1016/j.anireprosci.2014.03.011; Kooistra SM, 2010, STEM CELLS, V28, P1703, DOI 10.1002/stem.497; Kristensen DM, 2008, HUM REPROD, V23, P775, DOI 10.1093/humrep/den010; Lin YM, 2001, MOL HUM REPROD, V7, P1015, DOI 10.1093/molehr/7.11.1015; Luo JP, 2010, MOL REPROD DEV, V77, P348, DOI 10.1002/mrd.21153; Nishimoto M, 2005, MOL CELL BIOL, V25, P5084, DOI 10.1128/MCB.25.12.5084-5094.2005; Reijo RA, 2000, BIOL REPROD, V63, P1490, DOI 10.1095/biolreprod63.5.1490; Rocchietti-March M, 2000, INT J ANDROL, V23, P51, DOI 10.1046/j.1365-2605.2000.00207.x; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Schrans-Stassen BHGJ, 2001, BIOL REPROD, V65, P771, DOI 10.1095/biolreprod65.3.771; van Bragt MPA, 2008, REPRODUCTION, V136, P33, DOI 10.1530/REP-07-0536; van den Boom V, 2007, J CELL BIOL, V178, P913, DOI 10.1083/jcb.200702058; Yoon MJ, 2011, ANIM REPROD SCI, V126, P195, DOI 10.1016/j.anireprosci.2011.05.008; Yoon MJ, 2011, REPROD DOMEST ANIM, V46, P221, DOI 10.1111/j.1439-0531.2010.01643.x; Yoon MJ, 2010, ANIM REPROD SCI, V122, P353, DOI 10.1016/j.anireprosci.2010.10.001; Zhang QB, 2008, PROG NAT SCI-MATER, V18, P1209, DOI 10.1016/j.pnsc.2008.02.012	28	20	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108825	10.1371/journal.pone.0108825	http://dx.doi.org/10.1371/journal.pone.0108825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272017	gold, Green Published, Green Submitted			2022-12-27	WOS:000343729600065
J	Nemeth, CL; Glasper, ER; Harrell, CS; Malviya, SA; Otis, JS; Neigh, GN				Nemeth, Christina L.; Glasper, Erica R.; Harrell, Constance S.; Malviya, Sanjana A.; Otis, Jeffrey S.; Neigh, Gretchen N.			Meloxicam Blocks Neuroinflammation, but Not Depressive-Like Behaviors, in HIV-1 Transgenic Female Rats	PLOS ONE			English	Article							MAJOR DEPRESSION; HIPPOCAMPAL NEUROGENESIS; ANTIDEPRESSANT TREATMENT; MODEL; ADHERENCE; CYTOKINES; BRAIN; DYSFUNCTION; SYMPTOMS; AIDS	Adolescents living with human immunodeficiency virus (HIV) comprise approximately 12% of the HIV-positive population worldwide. HIV-positive adolescents experience a higher rate of clinical depression, a greater risk of sexual and drug abuse behaviors, and a decreased adherence to highly active antiretroviral therapies (HAART). Using adolescent HIV-1 transgenic rats (HIV-1 tg) that display related immune response alterations and pathologies, this study tested the hypothesis that developmental expression of HIV-1-related proteins induces a depressive-like phenotype that parallels a decrease in hippocampal cell proliferation and an increase in pro-inflammatory cytokine expression in the hippocampus. Consistent with this hypothesis, adolescent HIV-1 tg rats demonstrated a depressive-like behavioral phenotype, had decreased levels of cell proliferation, and exhibited elevated expression of monocyte chemotactic protein-1 (Mcp-1) in the hippocampus relative to controls. Subsequently, we tested the ability of meloxicam, a selective COX-2 inhibitor, to attenuate behavioral deficits via inflammatory mechanisms. Daily meloxicam treatments did not alter the behavioral profile despite effectively reducing hippocampal inflammatory gene expression. Together, these data support a biological basis for the co-morbid manifestation of depression in HIV-positive patients as early as in adolescence and suggest that modifications in behavior manifest independent of inflammatory activity in the hippocampus.	[Nemeth, Christina L.; Harrell, Constance S.; Neigh, Gretchen N.] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Nemeth, Christina L.; Harrell, Constance S.; Malviya, Sanjana A.; Neigh, Gretchen N.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA; [Neigh, Gretchen N.] Emory Univ, Ctr Behav Neurosci, Atlanta, GA 30322 USA; [Otis, Jeffrey S.] Emory Univ, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA; [Glasper, Erica R.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA	Emory University; Emory University; Emory University; Emory University; University System of Maryland; University of Maryland College Park	Neigh, GN (corresponding author), Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.	gretchen.neigh@emory.edu	GLASPER, ERICA/GOK-0082-2022; Neigh, Gretchen/AAW-5691-2020	GLASPER, ERICA/0000-0003-1938-2144; Neigh, Gretchen/0000-0003-0955-9161; Harrell Shreckengost, Constance S./0000-0001-5229-0140	Department of Physiology, Emory University, Atlanta, GA; Creative and Novel Ideas in HIV Research Program (CNIHR) [P30 AI027767-24]; Office of AIDS Research; National Institutes of Allergies and Infectious Diseases; International AIDS Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169, T32GM008605] Funding Source: NIH RePORTER	Department of Physiology, Emory University, Atlanta, GA; Creative and Novel Ideas in HIV Research Program (CNIHR); Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Allergies and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International AIDS Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to acknowledge the financial support of The Department of Physiology, Emory University, Atlanta, GA. Additionally, this research was supported by the Creative and Novel Ideas in HIV Research Program (CNIHR) through a supplement to the University of Alabama at Birmingham (UAB) Center For AIDS Research funding (P30 AI027767-24). This funding was made possible by collaborative efforts of the Office of AIDS Research, the National Institutes of Allergies and Infectious Diseases, and the International AIDS Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Mansoor, 2005, Expert Opin Drug Metab Toxicol, V1, P739, DOI 10.1517/17425255.1.4.739; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Bourque SL, 2010, J AM ASSOC LAB ANIM, V49, P617; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; Braganca M, 2011, AIDS BEHAV, V15, P1879, DOI 10.1007/s10461-011-9973-3; Byakika-Tusiime J, 2009, AIDS BEHAV, V13, pS82, DOI 10.1007/s10461-009-9546-x; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Carroll BJ, 2004, AM J PSYCHIAT, V161, P1309, DOI 10.1176/appi.ajp.161.7.1309-a; Chaudoir SR, 2012, AIDS BEHAV, V16, P2382, DOI 10.1007/s10461-011-0039-3; Derntl B, 2011, SOC NEUROSCI-UK, V6, P482, DOI 10.1080/17470919.2011.579800; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; Duman RS, 2001, NEUROPSYCHOPHARMACOL, V25, P836, DOI 10.1016/S0893-133X(01)00358-X; Engelhardt G, 1996, BRIT J RHEUMATOL, V35, P4; FILE SE, 1978, BRIT J PHARMACOL, V62, P19, DOI 10.1111/j.1476-5381.1978.tb07001.x; Fischer CW, 2012, BEHAV BRAIN RES, V230, P85, DOI 10.1016/j.bbr.2012.01.050; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Goncalves MB, 2010, BRIT J PHARMACOL, V159, P1118, DOI 10.1111/j.1476-5381.2009.00618.x; Heine VM, 2004, EUR J NEUROSCI, V19, P131, DOI 10.1046/j.1460-9568.2003.03100.x; Hinkin CH, 2002, NEUROLOGY, V59, P1944, DOI 10.1212/01.WNL.0000038347.48137.67; Jung KH, 2006, NEUROBIOL DIS, V23, P237, DOI 10.1016/j.nbd.2006.02.016; Kacanek D, 2010, JAIDS-J ACQ IMM DEF, V53, P266, DOI 10.1097/QAI.0b013e3181b720e7; Kempermann G, 2003, BIOL PSYCHIAT, V54, P499, DOI 10.1016/S0006-3223(03)00319-6; Kipnis J, 2008, TRENDS IMMUNOL, V29, P455, DOI 10.1016/j.it.2008.07.007; Koenig LJ, 2011, CURR OPIN OBSTET GYN, V23, P321, DOI 10.1097/GCO.0b013e32834a581b; Korenov M, 2009, J NEUROSCI METH, V177, P108, DOI 10.1016/j.jneumeth.2008.09.027; Lashomb AL, 2009, J NEUROVIROL, V15, P14, DOI 10.1080/13550280802232996; Lawson MA, 2011, BRAIN BEHAV IMMUN, V25, P1569, DOI 10.1016/j.bbi.2011.05.006; Lopes M, 2012, J CLIN PSYCHIAT, V73, P384, DOI 10.4088/JCP.10m06304; Mellins CA, 2011, AIDS PATIENT CARE ST, V25, P413, DOI 10.1089/apc.2011.0025; MERRILL JE, 1991, FASEB J, V5, P2391, DOI 10.1096/fasebj.5.10.2065887; Miller AH, 2010, BRAIN BEHAV IMMUN, V24, P1, DOI 10.1016/j.bbi.2009.09.009; Moran LM, 2013, EXP NEUROL, V239, P139, DOI 10.1016/j.expneurol.2012.10.008; Moran LM, 2012, CURR HIV RES, V10, P415, DOI 10.2174/157016212802138788; National Survey on Drug Use and Health, 2012, DEPR TRIPL AG 12 15; Neigh GN, 2009, J CEREBR BLOOD F MET, V29, P1673, DOI 10.1038/jcbfm.2009.85; Paramesparan Y, 2010, J ACQ IMMUN DEF SYND, V55, P132; Peng JS, 2010, J NEUROIMMUNOL, V218, P94, DOI 10.1016/j.jneuroim.2009.09.014; Piletz JE, 2009, WORLD J BIOL PSYCHIA, V10, P313, DOI 10.3109/15622970802573246; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Rao JS, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-101; Ray PE, 2003, KIDNEY INT, V63, P2242, DOI 10.1046/j.1523-1755.2003.00028.x; Reid W, 2004, VIROLOGY, V321, P111, DOI 10.1016/j.virol.2003.12.010; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; Royal W, 2012, J NEUROIMMUNOL, V247, P16, DOI 10.1016/j.jneuroim.2012.03.015; Russo I, 2011, CELL CYCLE, V10, P2568, DOI 10.4161/cc.10.15.15946; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Stockmeier CA, 2004, BIOL PSYCHIAT, V56, P640, DOI 10.1016/j.biopsych.2004.08.022; Suarez EC, 2003, PSYCHOSOM MED, V65, P362, DOI 10.1097/01.PSY.0000035719.79068.2B; Sung YH, 2010, NEUROSCI LETT, V470, P86, DOI 10.1016/j.neulet.2009.12.063; Taupin Philippe, 2008, Int J Med Sci, V5, P127; Urbach YK, 2010, METHODS MOL BIOL, V597, P333, DOI 10.1007/978-1-60327-389-3_24; Vigorito M, 2007, J NEUROIMMUNE PHARM, V2, P319, DOI 10.1007/s11481-007-9078-y; Walkup J, 2008, PSYCHIAT QUART, V79, P43, DOI 10.1007/s11126-007-9055-x; Williams PL, 2010, AIDS BEHAV, V14, P1072, DOI 10.1007/s10461-010-9782-0; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Zanin V, 2012, J NEUROVIROL, V18, P416, DOI 10.1007/s13365-012-0109-y	59	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108399	10.1371/journal.pone.0108399	http://dx.doi.org/10.1371/journal.pone.0108399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271421	Green Submitted, gold, Green Published			2022-12-27	WOS:000343729600044
J	Ryan, BJ; Wachsmuth, NB; Schmidt, WF; Byrnes, WC; Julian, CG; Lovering, AT; Subudhi, AW; Roach, RC				Ryan, Benjamin J.; Wachsmuth, Nadine B.; Schmidt, Walter F.; Byrnes, William C.; Julian, Colleen G.; Lovering, Andrew T.; Subudhi, Andrew W.; Roach, Robert C.			AltitudeOmics: Rapid Hemoglobin Mass Alterations with Early Acclimatization to and De-Acclimatization from 5260 m in Healthy Humans	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; MONOXIDE REBREATHING METHOD; PEAK OXYGEN-UPTAKE; PLASMA-VOLUME; BLOOD-VOLUME; ERYTHROCYTE INFUSION; IRON-METABOLISM; CELL MASS; HYPOXIA; NEOCYTOLYSIS	It is classically thought that increases in hemoglobin mass (Hbmass) take several weeks to develop upon ascent to high altitude and are lost gradually following descent. However, the early time course of these erythropoietic adaptations has not been thoroughly investigated and data are lacking at elevations greater than 5000 m, where the hypoxic stimulus is dramatically increased. As part of the AltitudeOmics project, we examined Hbmass in healthy men and women at sea level (SL) and 5260 m following 1, 7, and 16 days of high altitude exposure (ALT1/ALT7/ALT16). Subjects were also studied upon return to 5260 m following descent to 1525 m for either 7 or 21 days. Compared to SL, absolute Hbmass was not different at ALT1 but increased by 3.7 +/- 5.8% (mean +/- SD; n = 20; p<0.01) at ALT7 and 7.6 +/- 6.6% (n = 21; p<0.001) at ALT16. Following descent to 1525 m, Hbmass was reduced compared to ALT16 (-6.0 +/- 3.7%; n = 20; p = 0.001) and not different compared to SL, with no difference in the loss in Hbmass between groups that descended for 7 (-6.3 +/- 3.0%; n = 13) versus 21 days (-5.7 +/- 5.0; n = 7). The loss in Hbmass following 7 days at 1525 m was correlated with an increase in serum ferritin (r = -0.64; n = 13; p<0.05), suggesting increased red blood cell destruction. Our novel findings demonstrate that Hbmass increases within 7 days of ascent to 5260 m but that the altitude-induced Hbmass adaptation is lost within 7 days of descent to 1525 m. The rapid time course of these adaptations contrasts with the classical dogma, suggesting the need to further examine mechanisms responsible for Hbmass adaptations in response to severe hypoxia.	[Ryan, Benjamin J.; Byrnes, William C.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Wachsmuth, Nadine B.; Schmidt, Walter F.] Univ Bayreuth, Dept Sports Med Sports Physiol, Bayreuth, Germany; [Julian, Colleen G.; Subudhi, Andrew W.; Roach, Robert C.] Univ Colorado, Dept Emergency Med, Altitude Res Ctr, Aurora, CO USA; [Lovering, Andrew T.] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA; [Subudhi, Andrew W.] Univ Colorado, Dept Biol, Colorado Springs, CO 80907 USA	University of Colorado System; University of Colorado Boulder; University of Bayreuth; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Oregon; University of Colorado System; University of Colorado at Colorado Springs	Ryan, BJ (corresponding author), Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA.	benjamin.ryan@colorado.edu	Lovering, Andrew/AAV-4419-2021; Roach, Robert/F-4729-2011	Lovering, Andrew/0000-0001-7826-4290; Ryan, Benjamin/0000-0001-5848-6988; Roach, Robert/0000-0002-7998-8976; Schmidt, Walter/0000-0002-9766-5564; Wachsmuth, Nadine B./0000-0002-6321-3594; Subudhi, Andrew/0000-0001-9719-7660	U.S. Department of Defense [W81XWH-11-2-0040 TATRC, W81XWH-10-2-0114]; Cardiopulmonary & Respiratory Physiology Laboratory, University of Oregon; Altitude Research Center; Charles S. Houston Endowed Professorship, Department of Emergency Medicine, School of Medicine, University of Colorado Denver; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD057022] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER	U.S. Department of Defense(United States Department of Defense); Cardiopulmonary & Respiratory Physiology Laboratory, University of Oregon; Altitude Research Center; Charles S. Houston Endowed Professorship, Department of Emergency Medicine, School of Medicine, University of Colorado Denver; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The overall AltitudeOmics study was funded, in part, by grants from the U.S. Department of Defense (W81XWH-11-2-0040 TATRC to RCR, and W81XWH-10-2-0114 to ATL); the Cardiopulmonary & Respiratory Physiology Laboratory, University of Oregon; the Altitude Research Center and the Charles S. Houston Endowed Professorship, Department of Emergency Medicine, School of Medicine, University of Colorado Denver. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBRECHT PH, 1972, J APPL PHYSIOL, V32, P54, DOI 10.1152/jappl.1972.32.1.54; Alfrey CP, 1997, LANCET, V349, P1389, DOI 10.1016/S0140-6736(96)09208-2; Alfrey CP, 1996, J APPL PHYSIOL, V81, P98, DOI 10.1152/jappl.1996.81.1.98; Boning D, 2004, INT J SPORTS MED, V25, P561, DOI 10.1055/s-2004-820963; Boning D, 2001, INT J SPORTS MED, V22, P572, DOI 10.1055/s-2001-18530; Boning D, 1997, INT J SPORTS MED, V18, P179, DOI 10.1055/s-2007-972616; Calbet JAL, 2002, J PHYSIOL-LONDON, V545, P715, DOI 10.1113/jphysiol.2002.029108; CHAPLIN H, 1953, J CLIN INVEST, V32, P1309, DOI 10.1172/JCI102859; Cristancho E, 2007, HIGH ALT MED BIOL, V8, P296, DOI 10.1089/ham.2007.8406; Durussel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056151; Eastwood A, 2012, INT J SPORTS MED, V33, P253, DOI 10.1055/s-0031-1291184; Eastwood A, 2008, J APPL PHYSIOL, V104, P982, DOI 10.1152/japplphysiol.00719.2007; ECKARDT KU, 1989, J APPL PHYSIOL, V66, P1785, DOI 10.1152/jappl.1989.66.4.1785; FINCH CA, 1977, BLOOD, V50, P699; Garvican L, 2012, SCAND J MED SCI SPOR, V22, P95, DOI 10.1111/j.1600-0838.2010.01145.x; Goetze O, 2013, HEPATOLOGY, V58, P2153, DOI 10.1002/hep.26581; Gore CJ, 2013, BRIT J SPORT MED, V47, P31, DOI 10.1136/bjsports-2013-092840; Gore CJ, 2005, J APPL PHYSIOL, V99, P1745, DOI 10.1152/japplphysiol.00505.2005; Gough CE, 2011, SCAND J MED SCI SPOR, V21, pE365, DOI 10.1111/j.1600-0838.2011.01316.x; Grover RF, 1998, EUR J APPL PHYSIOL, V77, P264, DOI 10.1007/s004210050331; Grover RF, 2001, HIGH ALTITUDE EXPLOR; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hutler M, 2001, SCAND J CLIN LAB INV, V61, P83; Imoberdorf R, 2001, J APPL PHYSIOL, V90, P528, DOI 10.1152/jappl.2001.90.2.528; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Leon-Velarde F, 2005, HIGH ALT MED BIOL, V6, P147, DOI 10.1089/ham.2005.6.147; Loeppky JA, 2005, HIGH ALT MED BIOL, V6, P60, DOI 10.1089/ham.2005.6.60; Lundby C, 2008, J APPL PHYSIOL, V105, P417, DOI 10.1152/japplphysiol.90529.2008; MAIRBAURL H, 1990, J APPL PHYSIOL, V68, P1186, DOI 10.1152/jappl.1990.68.3.1186; MILLEDGE JS, 1985, J APPL PHYSIOL, V59, P360, DOI 10.1152/jappl.1985.59.2.360; MILLER ME, 1982, BRIT J HAEMATOL, V52, P545, DOI 10.1111/j.1365-2141.1982.tb03929.x; Olsen NV, 2011, J PHYSIOL-LONDON, V589, P1273, DOI 10.1113/jphysiol.2010.194241; Pandolf KB, 1998, EUR J APPL PHYSIOL O, V79, P1, DOI 10.1007/s004210050465; Pottgiesser T, 2008, TRANSFUSION, V48, P1390, DOI 10.1111/j.1537-2995.2008.01719.x; Poulsen TD, 1998, EUR J APPL PHYSIOL O, V77, P457, DOI 10.1007/s004210050360; Prommer N, 2007, EUR J APPL PHYSIOL, V100, P383, DOI 10.1007/s00421-007-0439-2; Prommer N, 2008, MED SCI SPORT EXER, V40, P2112, DOI 10.1249/MSS.0b013e3181820942; PUGH LGC, 1964, J PHYSIOL-LONDON, V170, P344, DOI 10.1113/jphysiol.1964.sp007335; Rasmussen P, 2013, MED SCI SPORT EXER, V45, P1767, DOI 10.1249/MSS.0b013e31829047e5; Reeves JT, 2001, J APPL PHYSIOL, V91, P2579, DOI 10.1152/jappl.2001.91.6.2579; Reljic D, 2013, J ATHL TRAINING, V48, P109, DOI 10.4085/1062-6050-48.1.05; REYNAFARJE C, 1959, BLOOD, V14, P433, DOI 10.1182/blood.V14.4.433.433; Rice L, 2005, CELL PHYSIOL BIOCHEM, V15, P245, DOI 10.1159/000087234; Rice L, 2001, ANN INTERN MED, V134, P652, DOI 10.7326/0003-4819-134-8-200104170-00010; RICHALET JP, 1994, AM J PHYSIOL, V266, pR756, DOI 10.1152/ajpregu.1994.266.3.R756; Risso A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00054; Robach P, 2004, MED SCI SPORT EXER, V36, P1493, DOI 10.1249/01.MSS.0000139889.56481.E0; Robach P, 2002, PFLUG ARCH EUR J PHY, V444, P821, DOI 10.1007/s00424-002-0894-x; Robach P, 2000, J APPL PHYSIOL, V89, P29; Robach P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002996; Robach P, 2007, BLOOD, V109, P4724, DOI 10.1182/blood-2006-08-040006; Robach P, 2009, BLOOD, V113, P6707, DOI 10.1182/blood-2008-09-178095; Ryan BJ, 2011, SCAND J CLIN LAB INV, V71, P523, DOI 10.3109/00365513.2011.589008; Sawka MN, 1996, J APPL PHYSIOL, V81, P636, DOI 10.1152/jappl.1996.81.2.636; Sawka MN, 2000, MED SCI SPORT EXER, V32, P332, DOI 10.1097/00005768-200002000-00012; Schmidt W, 2005, EUR J APPL PHYSIOL, V95, P486, DOI 10.1007/s00421-005-0050-3; Schumacher YO, 2008, J SPORT MED PHYS FIT, V48, P509; Smith TG, 2008, BRIT J HAEMATOL, V141, P325, DOI 10.1111/j.1365-2141.2008.07029.x; STRAY-GUNDERSEN J, 1992, Medicine and Science in Sports and Exercise, V24, pS90, DOI 10.1249/00005768-199205001-00541; Subudhi AW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092191; Talbot NP, 2011, HIGH ALT MED BIOL, V12, P265, DOI 10.1089/ham.2011.1005; Wachsmuth NB, 2013, EUR J APPL PHYSIOL, V113, P1199, DOI 10.1007/s00421-012-2536-0; Wachsmuth N, 2013, BRIT J SPORT MED, V47, P93, DOI 10.1136/bjsports-2013-092761; WOLFEL EE, 1991, J APPL PHYSIOL, V70, P1129, DOI 10.1152/jappl.1991.70.3.1129; Young AJ, 1996, J APPL PHYSIOL, V81, P252, DOI 10.1152/jappl.1996.81.1.252	66	47	48	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108788	10.1371/journal.pone.0108788	http://dx.doi.org/10.1371/journal.pone.0108788			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271637	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600061
J	Yuan, Y; Brown, S				Yuan, Ye; Brown, Steven			The Neural Basis of Mark Making: A Functional MRI Study of Drawing	PLOS ONE			English	Article							MOTION; FMRI; PERCEPTION; ACTIVATION; SULCUS	Compared to most other forms of visually-guided motor activity, drawing is unique in that it "leaves a trail behind" in the form of the emanating image. We took advantage of an MRI-compatible drawing tablet in order to examine both the motor production and perceptual emanation of images. Subjects participated in a series of mark making tasks in which they were cued to draw geometric patterns on the tablet's surface. The critical comparison was between when visual feedback was displayed (image generation) versus when it was not (no image generation). This contrast revealed an occipito-parietal stream involved in motion-based perception of the emerging image, including areas V5/MT+, LO, V3A, and the posterior part of the intraparietal sulcus. Interestingly, when subjects passively viewed animations of visual patterns emerging on the projected surface, all of the sensorimotor network involved in drawing was strongly activated, with the exception of the primary motor cortex. These results argue that the origin of the human capacity to draw and write involves not only motor skills for tool use but also motor-sensory links between drawing movements and the visual images that emanate from them in real time.	[Yuan, Ye; Brown, Steven] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada	McMaster University	Brown, S (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada.	stebro@mcmaster.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada (SB). (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong D. F., 1995, GESTURE NATURE LANGU; Arnoldussen DM, 2011, P NATL ACAD SCI USA, V108, P11668, DOI 10.1073/pnas.1102984108; Backus BT, 2001, J NEUROPHYSIOL, V86, P2054, DOI 10.1152/jn.2001.86.4.2054; Beauchamp MS, 2002, NEURON, V34, P149, DOI 10.1016/S0896-6273(02)00642-6; Cardin V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047685; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Coraballis MC, 2003, HAND MOUTH ORIGINS L; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; Diciotti S, 2010, CONCEPT MAGN RESON A, V36A, P139, DOI 10.1002/cmr.a.20158; Dick AS, 2012, DEVELOPMENTAL SCI, V15, P165, DOI 10.1111/j.1467-7687.2011.01100.x; EKMAN P., 1969, SEMIOTICA, V1, P49, DOI DOI 10.1515/SEMI.1969.1.1.49; ELKINS, 1999, DOMAIN IMAGES; Ellamil M, 2012, NEUROIMAGE, V59, P1783, DOI 10.1016/j.neuroimage.2011.08.008; Ferber S, 2007, NEUROREPORT, V18, P1089, DOI 10.1097/WNR.0b013e3281ac2143; Fischer E, 2012, NEURON, V73, P1228, DOI 10.1016/j.neuron.2012.01.022; Frutiger SA, 2000, NEUROIMAGE, V12, P515, DOI 10.1006/nimg.2000.0644; Gallagher HL, 2004, NEUROPSYCHOLOGIA, V42, P1725, DOI 10.1016/j.neuropsychologia.2004.05.006; Galletti C, 2003, NEUROPSYCHOLOGIA, V41, P1717, DOI 10.1016/S0028-3932(03)00174-X; Georgieva S, 2009, J NEUROSCI, V29, P727, DOI 10.1523/JNEUROSCI.4753-08.2009; Gowen E, 2007, NEUROIMAGE, V36, P396, DOI 10.1016/j.neuroimage.2007.03.005; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Harrington GS, 2007, HUM BRAIN MAPP, V28, P450, DOI 10.1002/hbm.20286; Harrington GS, 2009, CORTEX, V45, P386, DOI 10.1016/j.cortex.2007.10.015; Hein G, 2008, J COGNITIVE NEUROSCI, V20, P2125, DOI 10.1162/jocn.2008.20148; Ino T, 2003, NEUROSCI RES, V45, P71, DOI 10.1016/S0168-0102(02)00194-3; Katanoda K, 2001, HUM BRAIN MAPP, V13, P34, DOI 10.1002/hbm.1023; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kawashima R, 2000, NEUROIMAGE, V12, P698, DOI 10.1006/nimg.2000.0643; Lerner A, 2004, NEUROIMAGE, V21, P904, DOI 10.1016/j.neuroimage.2003.10.019; Livingstone M., 2002, VISION ART BIOL SEEI; Makuuchi M, 2003, COGNITIVE BRAIN RES, V16, P338, DOI 10.1016/S0926-6410(02)00302-6; Miall RC, 2009, CORTEX, V45, P394, DOI 10.1016/j.cortex.2007.10.013; Niemeier M, 2005, CEREB CORTEX, V15, P325, DOI 10.1093/cercor/bhh134; Ogawa K, 2007, CORTEX, V43, P289, DOI 10.1016/S0010-9452(08)70455-6; Ogawa K, 2009, NEUROPSYCHOLOGIA, V47, P1013, DOI 10.1016/j.neuropsychologia.2008.10.022; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Omura K, 2004, NEUROREPORT, V15, P949, DOI 10.1097/00001756-200404290-00004; Schaer K, 2012, BEHAV BRAIN RES, V233, P209, DOI 10.1016/j.bbr.2012.05.009; Schmahmann J.D., 2000, MRI ATLAS HUMAN CERE; Suchan B, 2002, BEHAV BRAIN RES, V131, P163, DOI 10.1016/S0166-4328(01)00373-4; Sugihara G, 2006, NEUROIMAGE, V32, P1837, DOI 10.1016/j.neuroimage.2006.05.035; Swisher JD, 2007, J NEUROSCI, V27, P5326, DOI 10.1523/JNEUROSCI.0991-07.2007; Talairach J., 1988, COPLANAR STEREOTAXIC; Tam F, 2011, HUM BRAIN MAPP, V32, P240, DOI 10.1002/hbm.21013; Thaler L, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00092	46	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108628	10.1371/journal.pone.0108628	http://dx.doi.org/10.1371/journal.pone.0108628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271440	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600052
J	Khairullah, A; Klein, LC; Ingle, SM; May, MT; Whetzel, CA; Susman, EJ; Paus, T				Khairullah, Ammar; Klein, Laura Cousino; Ingle, Suzanne M.; May, Margaret T.; Whetzel, Courtney A.; Susman, Elizabeth J.; Paus, Tomas			Testosterone Trajectories and Reference Ranges in a Large Longitudinal Sample of Male Adolescents	PLOS ONE			English	Article							CIRCADIAN VARIATION; BOUND TESTOSTERONE; ANDROGEN RECEPTOR; PUBERTY; YOUNG; BOYS; MEN; SERUM; ANDROSTENEDIONE; SYMPTOMS	Purpose: Pubertal dynamics plays an important role in physical and psychological development of children and adolescents. We aim to provide reference ranges of plasma testosterone in a large longitudinal sample. Furthermore, we describe a measure of testosterone trajectories during adolescence that can be used in future investigations of development. Methods: We carried out longitudinal measurements of plasma testosterone in 2,216 samples obtained from 513 males (9 to 17 years of age) from the Avon Longitudinal Study of Parents and Children. We used integration of a model fitted to each participant's testosterone trajectory to calculate a measure of average exposure to testosterone over adolescence. We pooled these data with corresponding values reported in the literature to provide a reference range of testosterone levels in males between the ages of 6 and 19 years. Results: The average values of total testosterone in the ALSPAC sample range from 0.82 nmol/L (Standard Deviation [SD]: 0.09) at 9 years of age to 16.5 (SD: 2.65) nmol/L at 17 years of age; these values are congruent with other reports in the literature. The average exposure to testosterone is associated with different features of testosterone trajectories such as Peak Testosterone Change, Age at Peak Testosterone Change, and Testosterone at 17 years of age as well as the timing of the growth spurt during puberty. Conclusions: The average exposure to testosterone is a useful measure for future investigations using testosterone trajectories to examine pubertal dynamics.	[Khairullah, Ammar; Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON, Canada; [Khairullah, Ammar; Paus, Tomas] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Klein, Laura Cousino; Whetzel, Courtney A.; Susman, Elizabeth J.] Penn State Univ, Dept Biobehav Hlth, State Coll, PA USA; [Klein, Laura Cousino] Penn State Univ, Penn State Inst Neurosci, State Coll, PA USA; [Ingle, Suzanne M.; May, Margaret T.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Whetzel, Courtney A.] Penn State Univ, Ctr Hlth Aging, State Coll, PA USA	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Bristol; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Paus, T (corresponding author), Univ Toronto, Rotman Res Inst, Toronto, ON, Canada.	tpaus@research.baycrest.org			Ontario Graduate Scholarship; Max and Ruth Wiseman Graduate Student Fellowship; NIH [5R01MH085772]; Medical Research Council [MC_PC_15018] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085772] Funding Source: NIH RePORTER	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Max and Ruth Wiseman Graduate Student Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	AK received student financial support from the Ontario Graduate Scholarship and the Max and Ruth Wiseman Graduate Student Fellowship. TP is the Tanenbaum Chair in Population Neuroscience at the Rotman Research Institute, University of Toronto. This research was funded by NIH, 5R01MH085772 (to TP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borenstein M, 2009, INTRO META ANAL; Boyd A, 2012, INT J EPIDEMIOL; COOKE RR, 1993, CLIN ENDOCRINOL, V39, P163, DOI 10.1111/j.1365-2265.1993.tb01769.x; ELLIS L, 1992, STEROIDS, V57, P72, DOI 10.1016/0039-128X(92)90032-5; Elmlinger MW, 2005, CLIN LAB, V51, P625; Grumbach MM, 2002, HORM RES, V57, P2, DOI 10.1159/000058094; Hansen L, 1999, J APPL PHYSIOL, V87, P1141, DOI 10.1152/jappl.1999.87.3.1141; Hero M, 2005, J PEDIATR-US, V146, P245, DOI 10.1016/j.jpeds.2004.09.002; Hiort O, 2002, BEST PRACT RES CL EN, V16, P31, DOI 10.1053/beem.2002.0178; Huang B, 2012, J RES ADOLESCENCE, V22, P381, DOI 10.1111/j.1532-7795.2011.00773.x; Khairullah Ammar, 2013, Int J Dev Sci, V7, P105; Kindblom JM, 2006, DIABETES, V55, P3047, DOI 10.2337/db06-0192; LEE PA, 1974, J CLIN ENDOCR METAB, V39, P664, DOI 10.1210/jcem-39-4-664; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Mendle J, 2010, DEV PSYCHOL, V46, P1341, DOI 10.1037/a0020205; Palmert MR, 2001, J CLIN ENDOCR METAB, V86, P2364, DOI 10.1210/jc.86.6.2364; Patton GC, 2007, LANCET, V369, P1130, DOI 10.1016/S0140-6736(07)60366-3; Peper JS, 2009, PSYCHONEUROENDOCRINO, V34, P332, DOI 10.1016/j.psyneuen.2008.09.012; Perrin JS, 2008, J NEUROSCI, V28, P9519, DOI 10.1523/JNEUROSCI.1212-08.2008; PLYMATE SR, 1989, J ANDROL, V10, P366; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Pudar Hozo S, 2005, BMC MED RES METHODOL, V5; Sankar JS, 2012, GENDER MED, V9, P232, DOI 10.1016/j.genm.2012.05.001; SCHNAKENBURG KV, 1980, EUR J PEDIATR, V133, P259, DOI 10.1007/BF00496086; SHARMA M, 1989, BIOL PSYCHIAT, V25, P305, DOI 10.1016/0006-3223(89)90178-9; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; SODERGARD R, 1982, J STEROID BIOCHEM, V16, P801, DOI 10.1016/0022-4731(82)90038-3; STANHOPE R, 1988, CLIN ENDOCRINOL, V28, P83, DOI 10.1111/j.1365-2265.1988.tb01207.x; Starka L, 2008, NEUROENDOCRINOL LETT, V29, P201; van Rijn S, 2011, PSYCHOL MED, V41, P1815, DOI 10.1017/S0033291710002576; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Young AF, 2006, AUST NZ J PUBL HEAL, V30, P353, DOI 10.1111/j.1467-842X.2006.tb00849.x	33	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108838	10.1371/journal.pone.0108838	http://dx.doi.org/10.1371/journal.pone.0108838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268961	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700176
J	Park, YK; Lee, J; Hong, VS; Choi, JS; Lee, TY; Jang, BC				Park, Yu-Kyoung; Lee, Jinho; Hong, Victor Sukbong; Choi, Jong-Soon; Lee, Tae-Yoon; Jang, Byeong-Churl			Identification of KMU-3, a Novel Derivative of Gallic Acid, as an Inhibitor of Adipogenesis	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; ADIPOCYTE DIFFERENTIATION; ADIPOSE-TISSUE; C/EBP-ALPHA; 3T3-L1 PREADIPOCYTES; INSULIN SENSITIVITY; GENE-EXPRESSION; PPAR-GAMMA; PROTEIN; BINDING	Differentiation of preadipocyte, also called adipogenesis, leads to the phenotype of mature adipocyte. Excessive adipogenesis, however, is largely linked to the development of obesity. Herein we investigated a library of 53 novel chemicals, generated from a number of polyphenolic natural compounds, on adipogenesis. Strikingly, among the chemicals tested, KMU-3, a derivative of gallic acid, strongly suppressed lipid accumulation during the differentiation of 3T3-L1 preadipocytes into adipocytes. On mechanistic levels, KMU-3 inhibited expressions of CCAAT/enhancer-binding protein-alpha (C/EBP-alpha), peroxisome proliferator-activated receptor-gamma (PPAR-gamma), and fatty acid synthase (FAS) during adipocyte differentiation. Moreover, KMU-3 reduced expressions of adipokines, including retinol binding protein-4 (RBP-4), leptin, and regulated on activation, normal T cell expressed and secreted (RANTES) during adipocyte differentiation. Of further note, KMU-3 rapidly blocked the phosphorylation of signal transducer and activator of transcription-3 (STAT-3) during the early stage of adipogenesis. Importantly, pharmacological inhibition studies revealed that AG490, a JAK-2/STAT-3 inhibitor suppressed adipogenesis and STAT-3 phosphorylation, implying that early blockage of STAT-3 activity is crucial for the KMU-3- mediated anti-adipogenesis. These findings demonstrate firstly that KMU-3 inhibits adipogenesis by down-regulating STAT-3, PPAR-gamma, C/EBP-alpha, and FAS. This work shows that KMU-3 is an inhibitor of adipogenesis and thus may have therapeutic potential against obesity.	[Park, Yu-Kyoung; Jang, Byeong-Churl] Keimyung Univ, Coll Med, Dept Mol Med, Taegu, South Korea; [Lee, Jinho; Hong, Victor Sukbong] Keimyung Univ, Coll Nat Sci, Dept Chem, Taegu, South Korea; [Choi, Jong-Soon] Korea Basic Sci Inst, Div Life Sci, Taejon, South Korea; [Choi, Jong-Soon] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Taejon, South Korea; [Lee, Tae-Yoon] Yeungnam Univ, Dept Microbiol, Coll Med, Taegu, South Korea	Keimyung University; Keimyung University; Korea Basic Science Institute (KBSI); Chungnam National University; Yeungnam University	Jang, BC (corresponding author), Keimyung Univ, Coll Med, Dept Mol Med, Taegu, South Korea.	jangbc123@gw.kmu.ac.kr			National Research Foundation of Korea (NRF) - Korea Government (MSIP) [2014R1A5A2010008]; Korea Basic Science Institute [D34403]	National Research Foundation of Korea (NRF) - Korea Government (MSIP); Korea Basic Science Institute	This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korea Government (MSIP) (No. 2014R1A5A2010008), and also in part by the Korea Basic Science Institute grants (D34403 and 2013-University-Institute Cooperation Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Bays HE, 2009, AM J MED, V122, pS26, DOI 10.1016/j.amjmed.2008.10.015; Behloul N, 2013, EUR J PHARMACOL, V698, P31, DOI 10.1016/j.ejphar.2012.11.013; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Cai GW, 2008, CYTOKINE, V44, P242, DOI 10.1016/j.cyto.2008.08.006; Cao YH, 2010, NAT REV DRUG DISCOV, V9, P107, DOI 10.1038/nrd3055; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Coe NR, 1998, BBA-LIPID LIPID MET, V1391, P287, DOI 10.1016/S0005-2760(97)00205-1; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Deo DD, 2002, J BIOL CHEM, V277, P21237, DOI 10.1074/jbc.M110955200; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Feve B, 2005, BEST PRACT RES CL EN, V19, P483, DOI 10.1016/j.beem.2005.07.007; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Gustafson B, 2003, BIOCHEM BIOPH RES CO, V308, P933, DOI 10.1016/S0006-291X(03)01518-3; Havel PJ, 2002, CURR OPIN LIPIDOL, V13, P51, DOI 10.1097/00041433-200202000-00008; Hsu CL, 2007, J AGR FOOD CHEM, V55, P7359, DOI 10.1021/jf071223c; Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882; Hwang CS, 1997, ANNU REV CELL DEV BI, V13, P231, DOI 10.1146/annurev.cellbio.13.1.231; Koh EH, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2010.08.005; Konishi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2317, DOI 10.1271/bbb.67.2317; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; LAKSHMAN.MR, 1972, P NATL ACAD SCI USA, V69, P3516, DOI 10.1073/pnas.69.12.3516; Lee JH, 2014, CANCER LETT, V345, P140, DOI 10.1016/j.canlet.2013.12.008; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; Martini CN, 2009, MOL CELL ENDOCRINOL, V298, P42, DOI 10.1016/j.mce.2008.10.023; Matsuda M, 2013, OBES RES CLIN PRACT, V7, pE330, DOI 10.1016/j.orcp.2013.05.004; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Melnikova I, 2006, NAT REV DRUG DISCOV, V5, P369, DOI 10.1038/nrd2037; Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Rayalam S, 2008, PHYTOTHER RES, V22, P1367, DOI 10.1002/ptr.2503; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Sale EM, 1997, MOL CELL BIOL, V17, P6068; Satoh H, 2005, DIABETES, V54, P1304, DOI 10.2337/diabetes.54.5.1304; Shang CA, 2003, MOL ENDOCRINOL, V17, P2494, DOI 10.1210/me.2003-0139; Song NJ, 2013, J LIPID RES, V54, P1385, DOI 10.1194/jlr.M035576; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stephens JM, 1996, J BIOL CHEM, V271, P10441, DOI 10.1074/jbc.271.18.10441; Stewart WC, 1999, BBA-MOL CELL RES, V1452, P188, DOI 10.1016/S0167-4889(99)00129-9; Tammela P, 2004, ARCH BIOCHEM BIOPHYS, V425, P193, DOI 10.1016/j.abb.2004.03.023; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x; Wang DM, 2010, BIOL CELL, V102, P1, DOI 10.1042/BC20090070; Wang SN, 2010, J FORMOS MED ASSOC, V109, P422, DOI 10.1016/S0929-6646(10)60073-3; Xu HF, 2008, BREAST CANCER RES TR, V107, P63, DOI 10.1007/s10549-007-9536-5; Yadav A, 2013, CLIN CHIM ACTA, V417, P80, DOI 10.1016/j.cca.2012.12.007; Zhang KM, 2011, J CELL BIOCHEM, V112, P488, DOI 10.1002/jcb.22936; Zhou YR, 2006, INT J BIOCHEM CELL B, V38, P2151, DOI 10.1016/j.biocel.2006.06.009	57	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109344	10.1371/journal.pone.0109344	http://dx.doi.org/10.1371/journal.pone.0109344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285517	Green Submitted, Green Published, gold			2022-12-27	WOS:000345743700059
J	Bharaj, P; Chahar, HS; Alozie, OK; Rodarte, L; Bansal, A; Goepfert, PA; Dwivedi, A; Manjunath, N; Shankar, P				Bharaj, Preeti; Chahar, Harendra Singh; Alozie, Ogechika K.; Rodarte, Lizette; Bansal, Anju; Goepfert, Paul A.; Dwivedi, Alok; Manjunath, N.; Shankar, Premlata			Characterization of Programmed Death-1 Homologue-1 (PD-1H) Expression and Function in Normal and HIV Infected Individuals	PLOS ONE			English	Article							PD-1/PD-L1 PATHWAY; IMMUNE REGULATION; DISEASE; COSTIMULATION; CONSEQUENCES; TOLERANCE; RECEPTOR; MOUSE; CELLS	Chronic immune activation that persists despite anti-retroviral therapy (ART) is the strongest predictor of disease progression in HIV infection. Monocyte/macrophages in HIV-infected individuals are known to spontaneously secrete cytokines, although neither the mechanism nor the molecules involved are known. Here we show that overexpression of the newly described co-stimulatory molecule, PD1 homologue (PD-1H) in human monocyte/macrophages is sufficient to induce spontaneous secretion of multiple cytokines. The process requires signaling via PD-1H as cytokine secretion could be abrogated by deletion of the cytoplasmic domain. Such overexpression of PD-1H, associated with spontaneous cytokine expression is seen in monocytes from chronically HIV-infected individuals and this correlates with immune activation and CD4 depletion, but not viral load. Moreover, antigen presentation by PD-1H-overexpressing monocytes results in enhanced cytokine secretion by HIV-specific T cells. These results suggest that PD-1H might play a crucial role in modulating immune activation and immune response in HIV infection.	[Bharaj, Preeti; Chahar, Harendra Singh; Rodarte, Lizette; Manjunath, N.; Shankar, Premlata] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci,Ctr Excellence Infect Dis, El Paso, TX 79409 USA; [Alozie, Ogechika K.] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Internal Med, El Paso, TX USA; [Bansal, Anju; Goepfert, Paul A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Dwivedi, Alok] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci,Div Biostat & Epidemiol, El Paso, TX USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; University of Alabama System; University of Alabama Birmingham; Texas Tech University System; Texas Tech University	Shankar, P (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci,Ctr Excellence Infect Dis, El Paso, TX 79409 USA.	manjunath.swamy@ttuhsc.edu; premlata.shankar@ttuhsc.edu	Bharaj, Preeti/AAX-7394-2020	Bharaj, Preeti/0000-0002-9411-9373	NIH [R01AI084795, R21AI108259]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI108259, R01AI084795] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant R01AI084795 to PS and R21AI108259 to MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirayan-Chevillard N, 2000, CLIN EXP IMMUNOL, V120, P107, DOI 10.1046/j.1365-2249.2000.01201.x; Ariffin JK, 2013, CURR OPIN MICROBIOL, V16, P303, DOI 10.1016/j.mib.2013.03.002; Ceeraz S, 2013, TRENDS IMMUNOL, V34, P556, DOI 10.1016/j.it.2013.07.003; Chahroudi A, 2012, SCIENCE, V335, P1188, DOI 10.1126/science.1217550; Cohen OJ, 1997, IMMUNOL REV, V159, P31, DOI 10.1111/j.1600-065X.1997.tb01005.x; Dong C, 2003, IMMUNOL RES, V28, P39, DOI 10.1385/IR:28:1:39; Flajnik MF, 2012, IMMUNOGENETICS, V64, P571, DOI 10.1007/s00251-012-0616-2; Flies DB, 2014, J CLIN INVEST, V124, P1966, DOI 10.1172/JCI74589; Flies DB, 2011, J IMMUNOL, V187, P1537, DOI 10.4049/jimmunol.1100660; Gianchecchi E, 2013, AUTOIMMUN REV, V12, P1091, DOI 10.1016/j.autrev.2013.05.003; Greenfield EA, 1998, CRIT REV IMMUNOL, V18, P389, DOI 10.1615/CritRevImmunol.v18.i5.10; Hunt Peter W, 2007, Curr HIV/AIDS Rep, V4, P42, DOI 10.1007/s11904-007-0007-8; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Le Mercier I, 2014, CANCER RES, V74, P1933, DOI 10.1158/0008-5472.CAN-13-1506; Nurieva RI, 2009, IMMUNOL REV, V229, P88, DOI 10.1111/j.1600-065X.2009.00769.x; Sakr MA, 2010, CANCER SCI, V101, P2368, DOI 10.1111/j.1349-7006.2010.01675.x; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Saresella M, 2012, CURR MOL MED, V12, P259, DOI 10.2174/156652412799218903; Szkaradkiewicz Andrzej, 1993, Archivum Immunologiae et Therapiae Experimentalis, V41, P147; Tippett E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019968; Vaidya SV, 2006, IMMUNOL LETT, V105, P180, DOI 10.1016/j.imlet.2006.02.006; Wang L, 2011, J EXP MED, V208, P577, DOI 10.1084/jem.20100619; Yoshida A, 2001, INVEST OPHTH VIS SCI, V42, P1631; Zhu YW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3043	24	43	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109103	10.1371/journal.pone.0109103	http://dx.doi.org/10.1371/journal.pone.0109103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279955	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800055
J	Gonzalez-Mateo, GT; Fernandez-Millara, V; Bellon, T; Liappas, G; Ruiz-Ortega, M; Lopez-Cabrera, M; Selgas, R; Aroeira, LS				Gonzalez-Mateo, Guadalupe T.; Fernandez-Millara, Vanessa; Bellon, Teresa; Liappas, Georgios; Ruiz-Ortega, Marta; Lopez-Cabrera, Manuel; Selgas, Rafael; Aroeira, Luiz S.			Paricalcitol Reduces Peritoneal Fibrosis in Mice through the Activation of Regulatory T Cells and Reduction in IL-17 Production	PLOS ONE			English	Article							VITAMIN-D; 1,25-DIHYDROXYVITAMIN D-3; MURINE MODEL; ALTERNATIVE ACTIVATION; DIALYSIS; INFLAMMATION; RECEPTOR; DIFFERENTIATION; CYTOKINES; SOLUTE	Fibrosis is a significant health problem associated with a chronic inflammatory reaction. The precise mechanisms involved in the fibrotic process are still poorly understood. However, given that inflammation is a major causative factor, immunomodulation is a possible therapeutic approach to reduce fibrosis. The vitamin D receptor (VDR) that is present in all hematopoietic cells has been associated with immunomodulation. We investigated whether the intraperitoneal administration of paricalcitol, a specific activator of the VDR, modulates peritoneal dialysis fluid (PDF)-induced peritoneal fibrosis. We characterized the inflammatory process in the peritoneal cavity of mice treated or not treated with paricalcitol and analyzed the ensuing fibrosis. The treatment reduced peritoneal IL-17 levels, which strongly correlated with a significantly lower peritoneal fibrotic response. In vitro studies demonstrate that both CD4(+) and CD8(+) regulatory T cells appear to impact the regulation of IL-17. Paricalcitol treatment resulted in a significantly increased frequency of CD8(+) T cells showing a regulatory phenotype. The frequency of CD4(+) Tregs tends to be increased, but it did not achieve statistical significance. However, paricalcitol treatment increased the number of CD4(+) and CD8(+) Treg cells in vivo. In conclusion, the activation of immunological regulatory mechanisms by VDR signaling could prevent or reduce fibrosis, as shown in peritoneal fibrosis induced by PDF exposure in mice.	[Gonzalez-Mateo, Guadalupe T.; Fernandez-Millara, Vanessa; Bellon, Teresa; Selgas, Rafael] Hosp La Paz, Inst Invest Sanitaria Hosp Univ La Paz IdiPA, Res Dept, Madrid, Spain; [Gonzalez-Mateo, Guadalupe T.; Liappas, Georgios; Lopez-Cabrera, Manuel] CSIC UAM, Mol Biol Ctr Severo Ochoa, Madrid, Spain; [Ruiz-Ortega, Marta] Autonomous Univ Madrid, IIS Fdn Jimenez Daiz, Cellular Biol Renal Dis Lab, E-28049 Madrid, Spain; [Selgas, Rafael] Hosp Univ La Paz, Dept Nephrol, Madrid, Spain; [Selgas, Rafael] Red Invest Renal REDinREN, Madrid, Spain; [Selgas, Rafael] IRSIN, Madrid, Spain; [Aroeira, Luiz S.] Univ Vigo, Ctr Invest Biomed CINBIO, Inst Invest Biomed Vigo IBIV, Dept Immunol, Vigo 36310, Spain	Hospital Universitario La Paz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Fundacion Jimenez Diaz; Hospital Universitario La Paz; Universidade de Vigo; CINBIO	Aroeira, LS (corresponding author), Univ Vigo, Ctr Invest Biomed CINBIO, Inst Invest Biomed Vigo IBIV, Dept Immunol, Vigo 36310, Spain.	lstark@uvigo.es	González-Mateo, Guadalupe Tirma/AAS-5509-2021; Ortega, Marta Ruiz/AAN-2136-2020; Ruiz-Ortega, Marta/D-3584-2012; Cabrera, Manuel López/AAA-5463-2019; Bellón, Teresa/ABF-4916-2020; Aroeira, Luiz Stark/D-7558-2014; González-Mateo, Guadalupe T/G-2551-2016; ruiz-ortega, marta/D-3584-2012	González-Mateo, Guadalupe Tirma/0000-0002-8144-904X; Ortega, Marta Ruiz/0000-0002-1495-6535; Ruiz-Ortega, Marta/0000-0002-1495-6535; Bellón, Teresa/0000-0002-0138-6879; Aroeira, Luiz Stark/0000-0001-9391-1409; González-Mateo, Guadalupe T/0000-0002-8144-904X; Lopez Cabrera, Manuel/0000-0002-0976-9719; ruiz-ortega, marta/0000-0002-1403-2690	European Union Seventh Framework Programme [FP7/REGPOT-2012-2013.1, 316265]; Fondo de Investigaciones Sanitarias (Health Research Fund) [RETICS 06/0016, FIS PI 09/0064]; Ministerio de Economia y competitividad [SAF 2013-47611-R, SAF 2010-21249, SAF 2007-61201]; Comunidad Autonoma de Madrid [RETICS 12/0021, S2012DMD2321]; Fondo Investigaciones Sanitarias [PI 11/01854]; Renal Foundation Inigo Alvarez de Toledo, FIBHULP; Severo Ochoa Foundation; EuTRiPD program (European Training and Research in Peritoneal Dialysis) [ITN-2011-287813]; AbbVie Spain	European Union Seventh Framework Programme(European Commission); Fondo de Investigaciones Sanitarias (Health Research Fund)(Instituto de Salud Carlos III); Ministerio de Economia y competitividad(Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); Fondo Investigaciones Sanitarias(Instituto de Salud Carlos III); Renal Foundation Inigo Alvarez de Toledo, FIBHULP; Severo Ochoa Foundation; EuTRiPD program (European Training and Research in Peritoneal Dialysis); AbbVie Spain(AbbVie)	LSA is funded by the European Union Seventh Framework Programme [FP7/REGPOT-2012-2013.1] under grant agreement no 316265, BIOCAPS. This study was supported by RETICS 06/0016 (VFM, RS) and FIS PI 09/0064 (RS) from the Fondo de Investigaciones Sanitarias (Health Research Fund). MLC was funded by SAF 2013-47611-R, SAF 2010-21249, and SAF 2007-61201 from the Ministerio de Economia y competitividad. MRO was supported by RETICS 12/0021, S2012DMD2321 from the Comunidad Autonoma de Madrid, PI 11/01854 from Fondo Investigaciones Sanitarias. GTGM was supported by Renal Foundation Inigo Alvarez de Toledo, FIBHULP, and by Severo Ochoa Foundation. GL is funded from the EuTRiPD program (European Training and Research in Peritoneal Dialysis, ITN-2011-287813). The research was also partially sponsored by AbbVie Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroeira LS, 2009, J AM SOC NEPHROL; Artaza JN, 2009, J ENDOCRINOL, V200, P207, DOI 10.1677/JOE-08-0241; Bellon T, 2011, NEPHROL DIAL TRANSPL, V26, P2995, DOI 10.1093/ndt/gfq771; Bikle Daniel D, 2009, Curr Osteoporos Rep, V7, P58; Cantorna MT, 1998, J IMMUNOL, V160, P5314; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Daniels MD, 2008, AUTOIMMUNITY, V41, P490, DOI 10.1080/08916930802167902; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; Deluca HF, 2001, FASEB J, V15, P2579, DOI 10.1096/fj.01-0433rev; Doucet C, 2008, AM J PHYSIOL-RENAL, V295, pF179, DOI 10.1152/ajprenal.00252.2007; Faust WC, 2009, J UROLOGY, V181, P290, DOI 10.1016/j.juro.2008.09.039; Ghoreishi M, 2009, J IMMUNOL, V182, P6071, DOI 10.4049/jimmunol.0804064; Ginanjar Eka, 2007, Acta Med Indones, V39, P133; Gonzalez-Mateo GT, 2009, PERITON DIALYSIS INT, V29, P227; Hirata H, 2008, RESPIROLOGY, V13, P788, DOI 10.1111/j.1440-1843.2008.01361.x; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Krediet RT, 2000, ADV RENAL REPLACE TH, V7, P271, DOI 10.1053/jarr.2000.16269; Lee JW, 2014, BIOCHEM BIOPH RES CO, V444, P121, DOI 10.1016/j.bbrc.2014.01.005; Li YJ, 2005, KIDNEY INT, V68, P1500, DOI 10.1111/j.1523-1755.2005.00562.x; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Marra F, 2009, SEMIN IMMUNOPATHOL, V31, P345, DOI 10.1007/s00281-009-0169-0; Martin JG, 2006, PULM PHARMACOL THER, V19, P377, DOI 10.1016/j.pupt.2005.10.005; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Meems LMG, 2012, J STEROID BIOCHEM, V132, P282, DOI 10.1016/j.jsbmb.2012.06.004; Mortier S, 2003, J AM SOC NEPHROL, V14, P1296, DOI 10.1097/01.ASN.0000060681.91079.30; Musi B, 1998, PERITON DIALYSIS INT, V18, P303; Nevado J, 2005, BRIT J PHARMACOL, V146, P268, DOI 10.1038/sj.bjp.0706309; Pecoits-Filho R, 2004, PERITON DIALYSIS INT, V24, P327; Pecoits-Filho R, 2002, NEPHROL DIAL TRANSPL, V17, P1480, DOI 10.1093/ndt/17.8.1480; Pomie C, 2008, HUM IMMUNOL, V69, P708, DOI 10.1016/j.humimm.2008.08.288; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Roberts GW, 2009, J AM SOC NEPHROL, V20, P1895, DOI 10.1681/ASN.2008101127; Rodrigues-Diez R, 2014, KIDNEY INT; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Simonian PL, 2009, J IMMUNOL, V182, P657, DOI 10.4049/jimmunol.182.1.657; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Theiss AL, 2005, GASTROENTEROLOGY, V129, P204, DOI 10.1053/j.gastro.2005.05.019; Tzianabos AO, 2008, J IMMUNOL, V180, P6970, DOI 10.4049/jimmunol.180.10.6970; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yokoyama T, 2001, NEPHRON, V89, P215, DOI 10.1159/000046070; Zamauskaite A, 1999, NEPHROL DIAL TRANSPL, V14, P49, DOI 10.1093/ndt/14.1.49; Zhang LN, 2010, INVEST OPHTH VIS SCI, V51, P2109, DOI 10.1167/iovs.09-3993; Zhang QZ, 2009, PLOS ONE, V4, pA192, DOI 10.1371/journal.pone.0007798; Zhang Y, 2010, J AM SOC NEPHROL, V21, P966, DOI 10.1681/ASN.2009080872	44	45	47	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108477	10.1371/journal.pone.0108477	http://dx.doi.org/10.1371/journal.pone.0108477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279459	Green Published, gold			2022-12-27	WOS:000342670800017
J	Li, TY; Hsieh, JS; Lee, KT; Hou, MF; Wu, CL; Kao, HY; Shi, HY				Li, Tsai-Yun; Hsieh, Jan-Sing; Lee, King-Teh; Hou, Ming-Feng; Wu, Chia-Ling; Kao, Hao-Yun; Shi, Hon-Yi			Cost Trend Analysis of Initial Cancer Treatment in Taiwan	PLOS ONE			English	Article							CELL LUNG-CANCER; HOSPITAL RESOURCE UTILIZATION; PROSTATE-CANCER; SINGLE-AGENT; CARE; CHEMOTHERAPY; PACLITAXEL; BREAST	Background: Despite the high cost of initial cancer care, that is, care in the first year after diagnosis, limited information is available for specific categories of cancer-related costs, especially costs for specific services. This study purposed to identify causes of change in cancer treatment costs over time and to perform trend analyses of the percentage of cancer patients who had received a specific treatment type and the mean cost of care for patients who had received that treatment. Methodology/Principal Findings: The analysis of trends in initial treatment costs focused on cancer-related surgery, chemotherapy, radiation therapy, and treatments other than active treatments. For each cancer-specific trend, slopes were calculated for regression models with 95% confidence intervals. Analyses of patients diagnosed in 2007 showed that the National Health Insurance (NHI) system paid, on average, $10,780 for initial care of a gastric cancer patient and $10,681 for initial care of a lung cancer patient, which were inflation-adjusted increases of $6,234 and $5,522, respectively, over the 1996 care costs. During the same interval, the mean NHI payment for initial care for the five specific cancers increased significantly (p<0.05). Hospitalization costs comprised the largest portion of payments for all cancers. During 1996-2007, the use of chemotherapy and radiation therapy significantly increased in all cancer types (p<0.05). In 2007, NHI payments for initial care for these five cancers exceeded $12 billion, and gastric and lung cancers accounted for the largest share. Conclusions/Significance: In addition to the growing number of NHI beneficiaries with cancer, treatment costs and the percentage of patients who undergo treatment are growing. Therefore, the NHI must accurately predict the economic burden of new chemotherapy agents and radiation therapies and may need to develop programs for stratifying patients according to their potential benefit from these expensive treatments.	[Li, Tsai-Yun] Kaohsiung Med Univ Hosp, Dept Gen Affairs, Kaohsiung, Taiwan; [Li, Tsai-Yun; Lee, King-Teh; Kao, Hao-Yun; Shi, Hon-Yi] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Hsieh, Jan-Sing] Kaohsiung Med Univ Hosp, Dept Surg, Div Gastrointestinal & Gen Surg, Kaohsiung, Taiwan; [Lee, King-Teh] Kaohsiung Med Univ Hosp, Dept Surg, Div Hepatobiliary Surg, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Municipal Tatung Hosp, Kaohsiung, Taiwan; [Hou, Ming-Feng] Natl Sun Yat Sen Univ, Kaohsiung Med Univ, Joint Res Ctr, Kaohsiung 80424, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Inst Clin Med, Kaohsiung, Taiwan; [Wu, Chia-Ling] Chimei Med Ctr, Dept Neurosurg, Yongkang, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University	Shi, HY (corresponding author), Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan.	hshi@kmu.edu.tw	Kao, Hao-Yun/AAZ-5597-2021; Hao-Yun, Kao/AGD-6394-2022	Kao, Hao-Yun/0000-0002-9390-9314; Hou, Ming-Feng/0000-0001-6030-9702	Kaohsiung Medical University Hospital [KMUH101-1M91]; National Science Council [NSC 102-2314-B-037-043, NSYSUKMU103-P030]	Kaohsiung Medical University Hospital; National Science Council(Ministry of Science and Technology, Taiwan)	This study was financially supported by Kaohsiung Medical University Hospital Program Grant KMUH101-1M91, National Science Council Program Grant NSC 102-2314-B-037-043 and Grant NSYSUKMU103-P030. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER MS, 1991, MED CARE, V29, P40, DOI 10.1097/00005650-199101000-00004; Chang GM, 2011, MED CARE, V49, P1054, DOI 10.1097/MLR.0b013e318235382b; Chiang CJ, 2010, JPN J CLIN ONCOL, V40, P897, DOI 10.1093/jjco/hyq057; Dasbach EJ, 2008, ASIAN PAC J CANCER P, V9, P459; Dinan MA, 2012, INT J RADIAT ONCOL, V82, pE781, DOI 10.1016/j.ijrobp.2011.11.024; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Ettinger DS, 2005, J CLIN ONCOL, V23, P4991, DOI 10.1200/JCO.2005.00.414; Friedman B, 2006, MED CARE RES REV, V63, P327, DOI 10.1177/1077558706287042; Friedman Bernard, 2002, J Health Care Finance, V29, P1; Goldberg DS, 2013, PHARMACOEPIDEM DR S, V22, P103, DOI 10.1002/pds.3367; Haug U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088407; Hou YY, 2012, OTOL NEUROTOL, V33, P400, DOI 10.1097/MAO.0b013e318248ea56; Hung TC, 2013, RESP CARE, V58, P669, DOI 10.4187/respcare.01519; John-Baptiste AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062614; Kubota K, 2008, LANCET ONCOL, V9, P1135, DOI 10.1016/S1470-2045(08)70261-4; Li CY, 2013, SUPPORT CARE CANCER, V21, P3461, DOI 10.1007/s00520-013-1931-3; Lopes G, 2013, BREAST CANCER RES TR, V137, P187, DOI 10.1007/s10549-012-2326-8; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039187; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Ministry of Health and Welfare, 2013, CANC REG ANN REP TAI; Mundle S, 2009, CANCER-AM CANCER SOC, V115, P706, DOI 10.1002/cncr.24090; Shi HY, 2013, SURG ENDOSC, V27, P3139, DOI 10.1007/s00464-013-2867-x; Spigel DR, 2012, CURR TREAT OPTION ON, V13, P505, DOI 10.1007/s11864-012-0212-6; Stump TK, 2013, J ONCOL PRACT, V9, P251, DOI 10.1200/JOP.2013.000929; Warren JL, 2008, J NATL CANCER I, V100, P888, DOI 10.1093/jnci/djn175; Wu GHM, 2006, BMC CANCER, V6, P1, DOI 10.1186/1471-2407-6-136; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Yabroff KR, 2007, NAT CLIN PRACT ONCOL, V4, P643, DOI 10.1038/ncponc0978	28	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108432	10.1371/journal.pone.0108432	http://dx.doi.org/10.1371/journal.pone.0108432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279947	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800015
J	Matsubara, C; Murakami, H; Imai, K; Mizoue, T; Akashi, H; Miyoshi, C; Nakasa, T				Matsubara, Chieko; Murakami, Hitoshi; Imai, Koubun; Mizoue, Tetsuya; Akashi, Hidechika; Miyoshi, Chiaki; Nakasa, Tamotsu			Prevalence and Risk Factors for Depressive Reaction among Resident Survivors after the Tsunami following the Great East Japan Earthquake, March 11, 2011	PLOS ONE			English	Article							MENTAL-HEALTH; POSTTRAUMATIC STRESS; ELDERLY-PEOPLE; SYMPTOMS; PHQ-2; DISORDERS; TRAUMA; ADULTS; IMPACT	Objectives: The Great East Japan Earthquake caused a gigantic tsunami which devastated coastal areas of northern Japan on 11 March 2011. Despite the large number of 'resident survivors' who continued to reside in their damaged houses on the second or upper floors, research on the mental health of these individuals has been limited. This study explored the prevalence of depressive reaction and risk factors for depressive reaction among these resident survivors. Methods: A cross-sectional household health support needs screening was conducted for resident survivors in Higashi-Matsushima city, Miyagi prefecture, two to four months after the tsunami. The health interview that was conducted including mental status, assessed by the Patient Health Questionnaire-2 (PHQ-2). Results: Of 5,454 respondents, 8.1% had depressive reaction. After adjustment by the number of weeks from the tsunami and the mortality rate at each respondent's place of residence, depressive reaction was significantly associated with house flooding below or above the ground floor (odds ratios of 1.92, 2.36, respectively), the unavailability of gas supply (odds ratio, 1.67), being female (odds ratio, 1.47), middle aged or elderly (odds ratios of 2.41, 2.42, respectively), regular intake of psychotropic medicine(s) since before the tsunami (odds ratio, 2.53) and the presence of one to five or more than six cohabiters (odds ratios of 0.61, 0.52, respectively). Conclusions: The results suggest a considerable psychological burden (depressive reaction) following the tsunami among resident survivors. Special supports for families with psychiatric problems need to be considered among resident survivors. Restoration of lifeline utilities and the strengthening of social ties of persons living alone may help prevent depressive reaction among resident survivors after a tsunami.	[Matsubara, Chieko; Murakami, Hitoshi; Akashi, Hidechika; Miyoshi, Chiaki; Nakasa, Tamotsu] Natl Ctr Global Hlth & Med, Bur Int Med Cooperat, Shinjuku Ku, Tokyo, Japan; [Imai, Koubun] Natl Ctr Global Hlth & Med, Dept Psychiat, Shinjuku Ku, Tokyo, Japan; [Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Shinjuku Ku, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Matsubara, C (corresponding author), Natl Ctr Global Hlth & Med, Bur Int Med Cooperat, Shinjuku Ku, Tokyo, Japan.	c-matsubara@it.ncgm.go.jp		Imai, Koubun/0000-0002-4216-2791	Ministry of Health, Labor and Welfare, Japan [H23-6]; National Center for Global Health and Medicine [26A-201]	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This study was funded by Research Grant for International Health, H23-6, by the Ministry of Health, Labor and Welfare, Japan (http://www.ncgm.go.jp/kaihatsu/). This work was also supported in part by Grants-in-Aid for Research from the National Center for Global Health and Medicine (26A-201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Richard E, 2011, Int J Emerg Ment Health, V13, P69; Akiyama T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-337; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Cabinet Office Government of Japan, 2011, WHIT PAP DIS MAN 201; Chen YL, 2011, INT PSYCHOGERIATR, V23, P1686, DOI 10.1017/S1041610211000986; Cluver L, 2009, J TRAUMA STRESS, V22, P106, DOI 10.1002/jts.20396; Fan F, 2011, J TRAUMA STRESS, V24, P44, DOI 10.1002/jts.20599; Frankenberg E, 2008, AM J PUBLIC HEALTH, V98, P1671, DOI 10.2105/AJPH.2007.120915; Fullerton CS, 1999, AVIAT SPACE ENVIR MD, V70, P902; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Goenjian AK, 2001, AM J PSYCHIAT, V158, P788, DOI 10.1176/appi.ajp.158.5.788; Higashi-Matsushima city, 2013, OV TOG GREAT E JAP E; Inagaki M, 2013, GEN HOSP PSYCHIAT, V35, P592, DOI 10.1016/j.genhosppsych.2013.08.001; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Kristensen P, 2009, DEPRESS ANXIETY, V26, P1127, DOI 10.1002/da.20625; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Malhotra R, 2010, INT PSYCHOGERIATR, V22, P227, DOI 10.1017/S1041610209990871; Mizuho Information & Research Institute, 2012, STUD STABL SUPPL LP; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Nakagawa H, 2011, CURRENT SITUATION, V61, p[29, 49]; Nakagawa H, 2011, CURRENT SITUATION, V61, P29; Nishi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035248; Rosendal S, 2011, COMPR PSYCHIAT, V52, P630, DOI 10.1016/j.comppsych.2010.12.004; Schoen R, 1997, POPUL DEV REV, V23, P333, DOI 10.2307/2137548; Schweitzer R, 2006, AUST NZ J PSYCHIAT, V40, P179, DOI 10.1111/j.1440-1614.2006.01766.x; Seplaki CL, 2006, SOC SCI MED, V62, P3121, DOI 10.1016/j.socscimed.2005.11.059; Sicotte M, 2008, AGING MENT HEALTH, V12, P193, DOI 10.1080/13607860701616358; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tani K, 2012, DISTRIBUTION NUMBER, V32, P1; Tayama J, 2012, PSYCHOSOMATICS, V53, P196, DOI 10.1016/j.psym.2011.11.005; Thavichachart N, 2009, CLIN PRACT EPIDEMIOL, V5, DOI DOI 10.1186/1745-0179-5-11; The Japan Research Institute, 2011, IMP EMPL CAT COUNT 2; The National Police Agency, 2013, POL MEAS DAM SIT TOH; Udomratn P, 2009, ASIAN J PSYCHIATR, V2, P124, DOI 10.1016/j.ajp.2009.10.008; van Griensven F, 2006, JAMA-J AM MED ASSOC, V296, P537, DOI 10.1001/jama.296.5.537; Viswanath B, 2012, AM J GERIAT PSYCHIAT, V20, P402, DOI 10.1097/JGP.0b013e318246b7e9; WHO, 2013, DEF OLD ELD PERS; Yu XN, 2011, J AFFECT DISORDERS, V134, P444, DOI 10.1016/j.jad.2011.05.007; Zhang YL, 2013, ASIA PAC PSYCHIAT	40	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109240	10.1371/journal.pone.0109240	http://dx.doi.org/10.1371/journal.pone.0109240			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3DZ	25279563	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800066
J	Zunhammer, M; Eichhammer, P; Busch, V				Zunhammer, Matthias; Eichhammer, Peter; Busch, Volker			Sleep Quality during Exam Stress: The Role of Alcohol, Caffeine and Nicotine	PLOS ONE			English	Article							ACADEMIC-PERFORMANCE; SELF-CONTROL; INSOMNIA; INDEX; CONSUMPTION; VALIDATION; COLLEGE; SMOKING	Academic exam stress is known to compromise sleep quality and alter drug consumption in university students. Here we evaluated if sleeping problems and changes in legal drug consumption during exam stress are interrelated. We used the Pittsburgh Sleep Quality Index (PSQI) to survey sleep quality before, during, and after an academic exam period in 150 university students in a longitudinal questionnaire study. Self-reports of alcohol, caffeine, and nicotine consumption were obtained. The Perceived Stress Questionnaire (PSQ-20) was used as a measure of stress. Sleep quality and alcohol consumption significantly decreased, while perceived stress and caffeine consumption significantly increased during the exam period. No significant change in nicotine consumption was observed. In particular, students shortened their time in bed and showed symptoms of insomnia. Mixed model analysis indicated that sex, age, health status, as well as the amounts of alcohol and caffeine consumed had no significant influence on global sleep quality. The amount of nicotine consumed and perceived stress were identified as significant predictors of diminished sleep quality. Nicotine consumption had a small-to-very-small effect on sleep quality; perceived stress had a small-to-moderate effect. In conclusion, diminished sleep quality during exam periods was mainly predicted by perceived stress, while legal drug consumption played a minor role. Exam periods may pose an interesting model for the study of stress-induced sleeping problems and their mechanisms.	[Zunhammer, Matthias] Univ Regensburg, Dept Expt Psychol, D-93053 Regensburg, Germany; [Zunhammer, Matthias; Eichhammer, Peter; Busch, Volker] Univ Regensburg, Clin Psychiat & Psychotherapy, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg	Zunhammer, M (corresponding author), Univ Regensburg, Dept Expt Psychol, D-93053 Regensburg, Germany.	matthias.zunhammer@klinik.uni-regensburg.de			German National Merit Foundation	German National Merit Foundation	Author MZ was supported by a scholarship of the German National Merit Foundation (http://www.studienstiftung.de/). This research received no other specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrberg K, 2012, J PSYCHIATR RES, V46, P1618, DOI 10.1016/j.jpsychires.2012.09.008; Akerstedt T, 2002, J PSYCHOSOM RES, V53, P741, DOI 10.1016/S0022-3999(02)00333-1; Astill RG, 2013, J SLEEP RES, V22, P373, DOI 10.1111/jsr.12032; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Bayerisches Landesamt fur Statistik und Datenverarbeitung, 2011, ZENS 2011 BEV HAUSH; Buckley TM, 2005, J CLIN ENDOCR METAB, V90, P3106, DOI 10.1210/jc.2004-1056; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohrs S, 2014, ADDICT BIOL, V19, P486, DOI 10.1111/j.1369-1600.2012.00487.x; Cronlein T, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-65; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Drake C, 2013, J CLIN SLEEP MED, V9, P1195, DOI 10.5664/jcsm.3170; Ebrahim IO, 2013, ALCOHOL CLIN EXP RES, V37, DOI 10.1111/acer.12006; Feige B, 2006, ALCOHOL CLIN EXP RES, V30, P1527, DOI 10.1111/j.1530-0277.2006.00184.x; Fliege H, 2005, PSYCHOSOM MED, V67, P78, DOI 10.1097/01.psy.0000151491.80178.78; Genzel L, 2013, CHRONOBIOL INT, V30, P766, DOI 10.3109/07420528.2012.763132; Gunn HE, 2014, J PSYCHOSOM RES, V76, P242, DOI 10.1016/j.jpsychores.2013.11.010; Hall M, 2004, PSYCHOSOM MED, V66, P56, DOI 10.1097/01.PSY.0000106884.58744.09; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Oaten M, 2006, BASIC APPL SOC PSYCH, V28, P1, DOI 10.1207/s15324834basp2801_1; Oaten M, 2005, J SOC CLIN PSYCHOL, V24, P254, DOI 10.1521/jscp.24.2.254.62276; Onyper SV, 2012, CHRONOBIOL INT, V29, P318, DOI 10.3109/07420528.2012.655868; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; Singleton RA, 2009, J STUD ALCOHOL DRUGS, V70, P355, DOI 10.15288/jsad.2009.70.355; Steptoe A, 1996, J PSYCHOSOM RES, V41, P171, DOI 10.1016/0022-3999(96)00095-5; WEST R, 1992, PSYCHOPHARMACOLOGY, V108, P456, DOI 10.1007/BF02247421; Zunhammer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084911	29	41	43	3	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109490	10.1371/journal.pone.0109490	http://dx.doi.org/10.1371/journal.pone.0109490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3DZ	25279939	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800087
J	Gonzalez-Magaldi, M; Martin-Acebes, MA; Kremer, L; Sobrino, F				Gonzalez-Magaldi, Monica; Martin-Acebes, Miguel A.; Kremer, Leonor; Sobrino, Francisco			Membrane Topology and Cellular Dynamics of Foot-and-Mouth Disease Virus 3A Protein	PLOS ONE			English	Article							POLIOVIRUS REPLICATION COMPLEX; ENDOPLASMIC-RETICULUM; NONSTRUCTURAL PROTEINS; SUBCELLULAR-LOCALIZATION; PLASMA-MEMBRANE; LIVING CELLS; LIPID RAFTS; GUINEA-PIG; HOST; ASSOCIATION	Foot-and-mouth disease virus non-structural protein 3A plays important roles in virus replication, virulence and host-range; nevertheless little is known on the interactions that this protein can establish with different cell components. In this work, we have performed in vivo dynamic studies from cells transiently expressing the green fluorescent protein (GFP) fused to the complete 3A (GFP3A) and versions including different 3A mutations. The results revealed the presence of a mobile fraction of GFP3A, which was found increased in most of the mutants analyzed, and the location of 3A in a continuous compartment in the cytoplasm. A dual behavior was also observed for GFP3A upon cell fractionation, being the protein equally recovered from the cytosolic and membrane fractions, a ratio that was also observed when the insoluble fraction was further fractioned, even in the presence of detergent. Similar results were observed in the fractionation of GFP3ABBB, a 3A protein precursor required for initiating RNA replication. A nonintegral membrane protein topology of FMDV 3A was supported by the lack of glycosylation of versions of 3A in which each of the protein termini was fused to a glycosylation acceptor tag, as well as by their accessibility to degradation by proteases. According to this model 3A would interact with membranes through its central hydrophobic region exposing its N- and C- termini to the cytosol, where interactions between viral and cellular proteins required for virus replication are expected to occur.	[Gonzalez-Magaldi, Monica; Martin-Acebes, Miguel A.; Sobrino, Francisco] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Kremer, Leonor] CSIC, Ctr Nacl Biotecnol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Sobrino, F (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	fsobrino@cbm.csic.es	Kremer, Leonor/L-5445-2015; Martin-Acebes, Miguel A./L-2258-2014	Kremer, Leonor/0000-0002-2235-2010; Martin-Acebes, Miguel A./0000-0001-6015-3613; Gonzalez-Magaldi, Monica/0000-0001-9022-4590; Sobrino, Francisco/0000-0003-4968-8291	Spanish grant [BIO2011-24351]; Fundacion Ramon Areces; Spanish Ministry of Science and Innovation; Instituto de Salud Carlos III grant [PI10/00594]; CSIC grant from the Spanish Ministerio de Economia y Competitividad [201120E007]; JAE-Doc fellowship from CSIC	Spanish grant(Spanish Government); Fundacion Ramon Areces; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III grant(Instituto de Salud Carlos III); CSIC grant from the Spanish Ministerio de Economia y Competitividad; JAE-Doc fellowship from CSIC	Work at the F.S. laboratory was supported by Spanish grant BIO2011-24351, by an institutional grant from Fundacion Ramon Areces, and by the ICTS program from the Spanish Ministry of Science and Innovation. Work at the L. Kremer laboratory was supported by The Instituto de Salud Carlos III grant PI10/00594 and the CSIC grant 201120E007 from the Spanish Ministerio de Economia y Competitividad. MAMA is recipient of a JAE-Doc fellowship from CSIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armer H, 2008, J VIROL, V82, P10556, DOI 10.1128/JVI.00907-08; Beard CW, 2000, J VIROL, V74, P987, DOI 10.1128/JVI.74.2.987-991.2000; Belov GA, 2012, J VIROL, V86, P302, DOI 10.1128/JVI.05937-11; Belsham GJ, 2005, CURR TOP MICROBIOL, V288, P43; Bhattacharya B, 2010, VIRUSES-BASEL, V2, P1218, DOI 10.3390/v2051218; BIENZ K, 1992, J VIROL, V66, P2740, DOI 10.1128/JVI.66.5.2740-2747.1992; BIENZ K, 1983, VIROLOGY, V131, P39, DOI 10.1016/0042-6822(83)90531-7; BIENZ K, 1994, ARCH VIROL, P147; Bohm K J, 2003, Tsitol Genet, V37, P11; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Carrillo C, 2005, J VIROL, V79, P6487, DOI 10.1128/JVI.79.10.6487-6504.2005; Choe SS, 2004, J VIROL, V78, P5973, DOI 10.1128/JVI.78.11.5973-5982.2004; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; DATTA U, 1994, J VIROL, V68, P4468, DOI 10.1128/JVI.68.7.4468-4477.1994; DE CASTRO M. P., 1964, ARQ INST BIOL [SAO PAULO], V31, P63; Doedens JR, 1997, J VIROL, V71, P9054, DOI 10.1128/JVI.71.12.9054-9064.1997; Domingo E, 2002, COMP IMMUNOL MICROB, V25, P297, DOI 10.1016/S0147-9571(02)00027-9; Dundr M, 2003, CURR PROTOC CELL BIO; FALK MM, 1992, J VIROL, V66, P2251, DOI 10.1128/JVI.66.4.2251-2260.1992; FORSS S, 1982, NUCLEIC ACIDS RES, V10, P6441, DOI 10.1093/nar/10.20.6441; FORSS S, 1984, NUCLEIC ACIDS RES, V12, P6587, DOI 10.1093/nar/12.16.6587; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Fujita K, 2007, BIOCHEMISTRY-US, V46, P5185, DOI 10.1021/bi6024758; Garcia-Briones M, 2006, VIROLOGY, V349, P409, DOI 10.1016/j.virol.2006.02.042; GILMORE R, 1985, CELL, V42, P497, DOI 10.1016/0092-8674(85)90107-2; Gladue DP, 2014, J VIROL, V88, P2737, DOI 10.1128/JVI.03059-13; Gonzalez-Magaldi M, 2012, J VIROL; Hogue IB, 2011, J VIROL, V85, P9749, DOI 10.1128/JVI.00743-11; Knox C, 2005, J GEN VIROL, V86, P687, DOI 10.1099/vir.0.80208-0; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Liu J, 2004, VIROLOGY, V321, P297, DOI 10.1016/j.virol.2004.01.011; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Lu YN, 2008, BIOCHEM BIOPH RES CO, V369, P344, DOI 10.1016/j.bbrc.2008.02.023; Martin-Acebes MA, 2010, VIROLOGY, V403, P47, DOI 10.1016/j.virol.2010.04.005; MARTINEZSALAS E, 1993, J VIROL, V67, P3748; Matto M, 2004, J VIROL, V78, P12047, DOI 10.1128/JVI.78.21.12047-12053.2004; Midgley R, 2013, J GEN VIROL, V94, P2636, DOI 10.1099/vir.0.055442-0; Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200; Moffat K, 2005, J VIROL, V79, P4382, DOI 10.1128/JVI.79.7.4382-4395.2005; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Nunez JI, 2001, J VIROL, V75, P3977, DOI 10.1128/JVI.75.8.3977-3983.2001; Nunez JI, 2007, J VIROL, V81, P8497, DOI 10.1128/JVI.00340-07; O'Donnell VK, 2001, VIROLOGY, V287, P151, DOI 10.1006/viro.2001.1035; Pacheco JM, 2003, J VIROL, V77, P13017, DOI 10.1128/JVI.77.24.13017-13027.2003; Pacheco JM, 2010, VIROLOGY, V405, P149, DOI 10.1016/j.virol.2010.05.036; Pereira HG, 1981, VIRUS DISEASE OF FOO, P333; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; Snapp EL, 2009, TRENDS CELL BIOL, V19, P649, DOI 10.1016/j.tcb.2009.08.002; SOBRINO F, 1983, VIROLOGY, V128, P310, DOI 10.1016/0042-6822(83)90258-1; Sobrino F, 2001, VET RES, V32, P1, DOI 10.1051/vetres:2001106; Sobrino F, 2004, FOOT AND MOUTH DISEA; Strauss DM, 2003, J MOL BIOL, V330, P225, DOI 10.1016/S0022-2836(03)00577-1; Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000; TERSHAK DR, 1984, J VIROL, V52, P777, DOI 10.1128/JVI.52.3.777-783.1984; Teterina NL, 2011, J VIROL, V85, P4284, DOI 10.1128/JVI.02398-10; Toja M, 1997, THESIS; Towner JS, 1996, J BIOL CHEM, V271, P26810, DOI 10.1074/jbc.271.43.26810; van Geest M, 2000, MICROBIOL MOL BIOL R, V64, P13, DOI 10.1128/MMBR.64.1.13-33.2000; Verkman AS, 2002, TRENDS BIOCHEM SCI, V27, P27, DOI 10.1016/S0968-0004(01)02003-5; Virtanen SS, 2010, CELL BIOL INT, V34, P815, DOI 10.1042/CBI20090288; White J, 1999, TRENDS CELL BIOL, V9, P61, DOI 10.1016/S0962-8924(98)01433-0; WIMMER E, 1982, CELL, V28, P199, DOI 10.1016/0092-8674(82)90335-X; Wolk B, 2008, J VIROL, V82, P10519, DOI 10.1128/JVI.00640-08; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1	68	27	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e106685	10.1371/journal.pone.0106685	http://dx.doi.org/10.1371/journal.pone.0106685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275544	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500004
J	Lu, YH; He, MD; Zhang, Y; Xu, SC; Zhang, L; He, Y; Chen, CH; Liu, C; Pi, HF; Yu, ZP; Zhou, Z				Lu, Yonghui; He, Mindi; Zhang, Yang; Xu, Shangcheng; Zhang, Lei; He, Yue; Chen, Chunhai; Liu, Chuan; Pi, Huifeng; Yu, Zhengping; Zhou, Zhou			Differential Pro-Inflammatory Responses of Astrocytes and Microglia Involve STAT3 Activation in Response to 1800 MHz Radiofrequency Fields	PLOS ONE			English	Article							NITRIC-OXIDE; RADIATION-EXPOSURE; PHONE USE; CELL; EXPRESSION; BRAIN; GENES; ALPHA; INDUCTION; APOPTOSIS	Microglia and astrocytes play important role in maintaining the homeostasis of central nervous system (CNS). Several CNS impacts have been postulated to be associated with radiofrequency (RF) electromagnetic fields exposure. Given the important role of inflammation in neural physiopathologic processes, we investigated the pro-inflammatory responses of microglia and astrocytes and the involved mechanism in response to RF fields. Microglial N9 and astroglial C8-D1A cells were exposed to 1800 MHz RF for different time with or without pretreatment with STAT3 inhibitor. Microglia and astrocytes were activated by RF exposure indicated by up-regulated CD11b and glial fibrillary acidic protein (GFAP). However, RF exposure induced differential pro-inflammatory responses in astrocytes and microglia, characterized by different expression and release profiles of IL-1 beta, TNF-alpha, IL-6, PGE2, nitric oxide (NO), inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2). Moreover, the RF exposure activated STAT3 in microglia but not in astrocytes. Furthermore, the STAT3 inhibitor Stattic ameliorated the RF-induced release of pro-inflammatory cytokines in microglia but not in astrocytes. Our results demonstrated that RF exposure differentially induced pro-inflammatory responses in microglia and astrocytes, which involved differential activation of STAT3 in microglia and astrocytes. Our data provide novel insights into the potential mechanisms of the reported CNS impacts associated with mobile phone use and present STAT3 as a promising target to protect humans against increasing RF exposure.	[Lu, Yonghui; He, Mindi; Xu, Shangcheng; Zhang, Lei; Chen, Chunhai; Liu, Chuan; Pi, Huifeng; Yu, Zhengping; Zhou, Zhou] Third Mil Med Univ, Dept Occupat Hlth, Key Lab Med Protect Electromagnet Radiat, Minist Educ China, Chongqing, Peoples R China; [Zhang, Yang] Third Mil Med Univ, Southwest Hosp, Dept Lab Med, Chongqing, Peoples R China; [He, Yue] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Neurosurg, Wuhan 430074, Peoples R China	Army Medical University; Ministry of Education, China; Army Medical University; Huazhong University of Science & Technology	Lu, YH (corresponding author), Third Mil Med Univ, Dept Occupat Hlth, Key Lab Med Protect Electromagnet Radiat, Minist Educ China, Chongqing, Peoples R China.	lunazhou00@163.com	Zhang, Yang/AAQ-5411-2021	zhang, yang/0000-0002-4061-4408; Chen, Chunhai/0000-0002-7549-213X	National Basic Research Program of China (973 Program) [2011CB503700]; National Natural Science Foundation of China [31200627, 31170800]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program)(2011CB503700) and the National Natural Science Foundation of China (31200627, 31170800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arafah K, 2013, GLIA, V61, P636, DOI 10.1002/glia.22462; Baan R, 2011, LANCET ONCOL, V12, P624, DOI 10.1016/S1470-2045(11)70147-4; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Bouji M, 2012, EXP GERONTOL, V47, P444, DOI 10.1016/j.exger.2012.03.015; Brillaud E, 2007, TOXICOLOGY, V238, P23, DOI 10.1016/j.tox.2007.05.019; Caito SW, 2014, NEUROTOXICOLOGY, V42, P1, DOI 10.1016/j.neuro.2014.02.006; Campisi A, 2010, NEUROSCI LETT, V473, P52, DOI 10.1016/j.neulet.2010.02.018; Daniels WMU, 2009, METAB BRAIN DIS, V24, P629, DOI 10.1007/s11011-009-9164-3; Finnie JW, 2010, PATHOLOGY, V42, P151, DOI 10.3109/00313020903494086; Fujimoto Y, 2006, EUR SPINE J, V15, P223, DOI 10.1007/s00586-005-0933-3; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Grinshpun J, 2008, EUR J PHARMACOL, V584, P312, DOI 10.1016/j.ejphar.2008.02.025; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hardell L, 2008, INT J ONCOL, V32, P1097; Heinrich S, 2011, ENVIRON INT, V37, P26, DOI 10.1016/j.envint.2010.06.008; Hietanen M, 2006, SCAND J WORK ENV HEA, V32, P169, DOI 10.5271/sjweh.994; Hirose H, 2010, BIOELECTROMAGNETICS, V31, P104, DOI 10.1002/bem.20532; Ivancsits S, 2003, INT ARCH OCC ENV HEA, V76, P431, DOI 10.1007/s00420-003-0446-5; Joubert V, 2008, RADIAT RES, V169, P38, DOI 10.1667/RR1077.1; Joubert V, 2007, BIOELECTROMAGNETICS, V28, P115, DOI 10.1002/bem.20274; Journiac N, 2009, P NATL ACAD SCI USA, V106, P21365, DOI 10.1073/pnas.0911782106; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Kim BW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055792; Kim JA, 2014, NEUROPHARMACOLOGY, V79, P476, DOI 10.1016/j.neuropharm.2013.06.032; Kim KC, 2011, BIOCHEM BIOPH RES CO, V409, P687, DOI 10.1016/j.bbrc.2011.05.065; Koyama Y, 1999, J NEUROCHEM, V73, P1004, DOI 10.1046/j.1471-4159.1999.0731004.x; Kudo M., 2007, J TOKYO MED U, V65, P29; Kumnok J, 2008, J NEUROVIROL, V14, P205, DOI 10.1080/13550280802008305; Kyrkanides S, 1999, J NEUROIMMUNOL, V95, P95, DOI 10.1016/S0165-5728(98)00270-7; Le Dreau G, 2010, GLIA, V58, P1510, DOI 10.1002/glia.21025; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Makar VR, 2006, BIOELECTROMAGNETICS, V27, P458, DOI 10.1002/bem.20230; Maskey D, 2012, NEUROSCI LETT, V506, P292, DOI 10.1016/j.neulet.2011.11.025; McCormack D, 2012, J SURG RES, V178, P28, DOI 10.1016/j.jss.2012.08.004; McQuade JMS, 2009, RADIAT RES, V171, P615, DOI 10.1667/RR1507.1; Medeiros R, 2013, EXP NEUROL, V239, P133, DOI 10.1016/j.expneurol.2012.10.007; Morgan TE, 1997, FREE RADICAL BIO MED, V23, P524, DOI 10.1016/S0891-5849(97)00120-2; Nittby H, 2008, BIOELECTROMAGNETICS, V29, P219, DOI 10.1002/bem.20386; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Patruno A, 2010, BRIT J DERMATOL, V162, P258, DOI 10.1111/j.1365-2133.2009.09527.x; Przanowski P, 2014, J MOL MED, V92, P239, DOI 10.1007/s00109-013-1090-5; Qin HW, 2012, P NATL ACAD SCI USA, V109, P5004, DOI 10.1073/pnas.1117218109; Quan Y, 2013, J BIOL CHEM, V288, P9293, DOI 10.1074/jbc.M113.455816; Reale M, 2006, NITRIC OXIDE-BIOL CH, V15, P50, DOI 10.1016/j.niox.2005.11.010; Redmayne M, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-90; RIGHI M, 1989, EUR J IMMUNOL, V19, P1443, DOI 10.1002/eji.1830190815; Roy A, 2008, FREE RADICAL BIO MED, V45, P686, DOI 10.1016/j.freeradbiomed.2008.05.026; Schuderer J, 2004, IEEE T MICROW THEORY, V52, P2057, DOI 10.1109/TMTT.2004.832009; Sirav B, 2011, ELECTROMAGN BIOL MED, V30, P253, DOI 10.3109/15368378.2011.600167; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stansley B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-115; Straccia M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-156; Tanabe K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-16; Testylier G, 2002, BIOELECTROMAGNETICS, V23, P249, DOI 10.1002/bem.10008; Thorlin T, 2006, RADIAT RES, V166, P409, DOI 10.1667/RR3584.1; Tribouillard-Tanvier D, 2012, J BIOL CHEM, V287, P4628, DOI 10.1074/jbc.M111.269480; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P808, DOI 10.1001/jama.2011.186; Watilliaux A, 2011, NEUROTOX RES, V20, P109, DOI 10.1007/s12640-010-9225-8; Woiciechowsky C, 2004, MED SCI MONITOR, V10, pBR325; Yabe T, 2005, GLIA, V50, P223, DOI 10.1002/glia.20171; Yahata Y, 2003, J BIOL CHEM, V278, P40026, DOI 10.1074/jbc.M301866200; Yang XS, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-54; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhao TY, 2007, NEUROSCI LETT, V412, P34, DOI 10.1016/j.neulet.2006.09.092	65	34	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108318	10.1371/journal.pone.0108318	http://dx.doi.org/10.1371/journal.pone.0108318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275372	gold, Green Submitted, Green Published			2022-12-27	WOS:000342591500016
J	Boyle, GM; D'Souza, MMA; Pierce, CJ; Adams, RA; Cantor, AS; Johns, JP; Maslovskaya, L; Gordon, VA; Reddell, PW; Parsons, PG				Boyle, Glen M.; D'Souza, Marjorie M. A.; Pierce, Carly J.; Adams, Ryan A.; Cantor, Aaron S.; Johns, Jenny P.; Maslovskaya, Lidia; Gordon, Victoria A.; Reddell, Paul W.; Parsons, Peter G.			Intra-Lesional Injection of the Novel PKC Activator EBC-46 Rapidly Ablates Tumors in Mouse Models	PLOS ONE			English	Article							PROTEIN-KINASE-C; INGENOL MEBUTATE GEL; CANCER-THERAPY; MICE; CHEMOTHERAPY; ENZASTAURIN; NEUTROPHILS; INHIBITOR; TOXICITY; EFFICACY	Intra-lesional chemotherapy for treatment of cutaneous malignancies has been used for many decades, allowing higher local drug concentrations and less toxicity than systemic agents. Here we describe a novel diterpene ester, EBC-46, and provide preclinical data supporting its use as an intra-lesional treatment. A single injection of EBC-46 caused rapid inflammation and influx of blood, followed by eschar formation and rapid tumor ablation in a range of syngeneic and xenograft models. EBC-46 induced oxidative burst from purified human polymorphonuclear cells, which was prevented by the Protein Kinase C inhibitor bisindolylmaleimide-1. EBC-46 activated a more specific subset of PKC isoforms (PKC-beta I, -beta II, -alpha and -gamma) compared to the structurally related phorbol 12-myristate 13-acetate (PMA). Although EBC-46 showed threefold less potency for inhibiting cell growth than PMA in vitro, it was more effective for cure of tumors in vivo. No viable tumor cells were evident four hours after injection by ex vivo culture. Pharmacokinetic profiles from treated mice indicated that EBC-46 was retained preferentially within the tumor, and resulted in significantly greater local responses (erythema, oedema) following intra-lesional injection compared with injection into normal skin. The efficacy of EBC-46 was reduced by co-injection with bisindolylmaleimide-1. Loss of vascular integrity following treatment was demonstrated by an increased permeability of endothelial cell monolayers in vitro and by CD31 immunostaining of treated tumors in vivo. Our results demonstrate that a single intra-lesional injection of EBC-46 causes PKC-dependent hemorrhagic necrosis, rapid tumor cell death and ultimate cure of solid tumors in pre-clinical models of cancer.	[Boyle, Glen M.; D'Souza, Marjorie M. A.; Pierce, Carly J.; Adams, Ryan A.; Cantor, Aaron S.; Johns, Jenny P.; Maslovskaya, Lidia; Parsons, Peter G.] QIMR Berghofer Med Res Inst, Drug Discovery Canc Drug Mech Grp, Brisbane, Qld, Australia; [D'Souza, Marjorie M. A.; Adams, Ryan A.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Adams, Ryan A.] Princess Alexandra Hosp, Dept Otolaryngol Head & Neck Surg, Brisbane, Qld 4102, Australia; [Gordon, Victoria A.; Reddell, Paul W.] QBiotics Ltd, Yungaburra, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland	Boyle, GM (corresponding author), QIMR Berghofer Med Res Inst, Drug Discovery Canc Drug Mech Grp, Brisbane, Qld, Australia.	Glen.Boyle@qimrberghofer.edu.au	Boyle, Glen/G-1347-2013; Parsons, Peter G/H-8163-2015	Boyle, Glen/0000-0002-1385-529X; Parsons, Peter G/0000-0002-0473-3346; de Souza, Maria Anna Marjorie A./0000-0003-4452-5784; Reddell, Paul/0000-0002-0993-8957	National Health and Medical Research Council of Australia [APP1017676]; University of Queensland International Research Tuition Award (UQIRTA); University of Queensland Research Scholarship (UQIRS); Queensland Government; Wilson Fellowship for Skin Cancer Research	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland International Research Tuition Award (UQIRTA); University of Queensland Research Scholarship (UQIRS); Queensland Government; Wilson Fellowship for Skin Cancer Research	This work was supported by the National Health and Medical Research Council of Australia Development Grant, Number APP1017676 (PGP, GMB, PWR). MMAD was supported by the University of Queensland International Research Tuition Award (UQIRTA) and a University of Queensland Research Scholarship (UQIRS). GMB was supported by a Smart Futures Researcher-in-Residence fellowship from the Queensland Government, and is currently supported by the Wilson Fellowship for Skin Cancer Research administered by the Perpetual Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AS, 2009, CANCER TREAT REV, V35, P1, DOI 10.1016/j.ctrv.2008.07.006; Breitkreutz D, 2007, J CANCER RES CLIN, V133, P793, DOI 10.1007/s00432-007-0280-3; Castro DJ, 2003, HEAD NECK-J SCI SPEC, V25, P717, DOI 10.1002/hed.10261; Challacombe JM, 2006, J IMMUNOL, V177, P8123, DOI 10.4049/jimmunol.177.11.8123; CHEN TR, 1977, EXP CELL RES, V104, P255, DOI 10.1016/0014-4827(77)90089-1; CORBETT TH, 1975, CANCER RES, V35, P2434; Cozzi SJ, 2013, ARCH DERMATOL RES, V305, P79, DOI 10.1007/s00403-012-1270-0; Cozzi SJ, 2012, J INVEST DERMATOL, V132, P1263, DOI 10.1038/jid.2011.418; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Good LM, 2011, J AM ACAD DERMATOL, V64, P413, DOI 10.1016/j.jaad.2009.12.013; Gras J, 2013, DRUG TODAY, V49, P15, DOI 10.1358/dot.2013.49.1.1910723; Han ZT, 1998, P NATL ACAD SCI USA, V95, P5357, DOI 10.1073/pnas.95.9.5357; Han ZT, 1998, P NATL ACAD SCI USA, V95, P5362, DOI 10.1073/pnas.95.9.5362; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; KEISARI Y, 1984, INT J CANCER, V34, P845, DOI 10.1002/ijc.2910340616; LAFRENIERE R, 1986, J NATL CANCER I, V76, P309; Li LW, 2010, CANCER RES, V70, P4509, DOI 10.1158/0008-5472.CAN-09-4303; LUM H, 1994, AM J PHYSIOL, V267, pL223, DOI 10.1152/ajplung.1994.267.3.L223; Martin G, 2013, J AM ACAD DERMATOL, V68, pS39, DOI 10.1016/j.jaad.2012.09.050; Mason SA, 2010, INVEST NEW DRUG, V28, P575, DOI 10.1007/s10637-009-9292-y; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Nagpala PG, 1996, J CELL PHYSIOL, V166, P249, DOI 10.1002/(SICI)1097-4652(199602)166:2<249::AID-JCP2>3.0.CO;2-P; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; OCHI T, 1985, JPN J EXP MED, V55, P245; Ogbourne SM, 2004, CANCER RES, V64, P2833, DOI 10.1158/0008-5472.CAN-03-2837; Oh Y, 2008, J CLIN ONCOL, V26, P1135, DOI 10.1200/JCO.2007.14.3685; Pavey S, 2004, ONCOGENE, V23, P4060, DOI 10.1038/sj.onc.1207563; Podar K, 2007, EXPERT OPIN INV DRUG, V16, P1693, DOI 10.1517/13543784.16.10.1693; Rimessi A, 2007, CELL STRESS CHAPERON, V12, P291, DOI 10.1379/CSC-211.1; Robertson MJ, 2007, J CLIN ONCOL, V25, P1741, DOI 10.1200/JCO.2006.09.3146; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Song XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072331; van Herpen CML, 2008, INT J CANCER, V123, P2354, DOI 10.1002/ijc.23756; Weinberg BD, 2008, J PHARM SCI-US, V97, P1681, DOI 10.1002/jps.21038	34	51	55	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108887	10.1371/journal.pone.0108887	http://dx.doi.org/10.1371/journal.pone.0108887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272271	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600075
J	Petruzzelli, R; Christensen, DR; Parry, KL; Sanchez-Elsner, T; Houghton, FD				Petruzzelli, Raffaella; Christensen, David R.; Parry, Kate L.; Sanchez-Elsner, Tilman; Houghton, Franchesca D.			HIF-2 alpha Regulates NANOG Expression in Human Embryonic Stem Cells following Hypoxia and Reoxygenation through the Interaction with an Oct-Sox Cis Regulatory Element	PLOS ONE			English	Article							INDUCIBLE FACTORS; HISTONE H3; OXYGEN; DIFFERENTIATION; PLURIPOTENCY; BINDING; DERIVATION; TENSIONS; REVEALS; LINES	Low O-2 tension is beneficial for human embryonic stem cell (hESC) maintenance but the mechanism of regulation is unknown. HIF-2 alpha was found to bind directly to predicted hypoxic response elements (HREs) in the proximal promoter of OCT4, NANOG and SOX2 only in hESCs cultured under hypoxia (5% O-2). This binding induced an array of histone modifications associated with gene transcription while a heterochromatic state existed at atmospheric O-2. Interestingly, an enhanced euchromatic state was found when hESCs were exposed to hypoxia followed by 72 hours reoxygenation. This was sustained by HIF-2 alpha which enhanced stemness by binding to an oct-sox cis-regulatory element in the NANOG promoter. Thus, these data have uncovered a novel role of HIF-2 alpha as a direct regulator of key transcription factors controlling self-renewal in hESCs but also in the induction of epigenetic modifications ensuring a euchromatic conformation which enhances the regenerative potential of these cells.	[Petruzzelli, Raffaella; Christensen, David R.; Parry, Kate L.; Sanchez-Elsner, Tilman; Houghton, Franchesca D.] Univ Southampton, Fac Med, Ctr Human Dev Stem Cells & Regenerat, Southampton SO9 5NH, Hants, England	University of Southampton	Houghton, FD (corresponding author), Univ Southampton, Fac Med, Ctr Human Dev Stem Cells & Regenerat, Southampton SO9 5NH, Hants, England.	F.D.Houghton@soton.ac.uk	Petruzzelli, Raffaella/ABH-7049-2020	Petruzzelli, Raffaella/0000-0003-2868-4486; Christensen, David/0000-0003-4018-3537; Houghton, Franchesca/0000-0002-5167-1694; Sanchez-Elsner, Tilman/0000-0003-1915-2410	Gerald Kerkut Charitable Trust; UK Medical Research Council [G0701153, G1000406]; MRC [G0701153] Funding Source: UKRI; Medical Research Council [G0701153, 974249] Funding Source: researchfish	Gerald Kerkut Charitable Trust; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Gerald Kerkut Charitable Trust, http://www.southampton.ac.uk/similar to gktrust/, FDH & TS, and the UK Medical Research Council (G0701153 and G1000406), http://www.mrc.ac.uk, FDH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Das B, 2012, STEM CELLS, V30, P1685, DOI 10.1002/stem.1142; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Forristal CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062507; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Keith B, 2001, P NATL ACAD SCI USA, V98, P6692, DOI 10.1073/pnas.121494298; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Menendez P, 2006, CYTOTHERAPY, V8, P530, DOI 10.1080/14653240601026654; Millman JR, 2009, CURR OPIN ORGAN TRAN, V14, P694, DOI 10.1097/MOT.0b013e3283329d53; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Scaffidi P, 2001, J BIOL CHEM, V276, P47296, DOI 10.1074/jbc.M107619200; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; WANG GL, 1993, J BIOL CHEM, V268, P21513; Westfall SD, 2008, STEM CELLS DEV, V17, P869, DOI 10.1089/scd.2007.0240; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Zhang X, 2009, J CELL BIOL, V184, P67, DOI 10.1083/jcb.200801009	29	49	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108309	10.1371/journal.pone.0108309	http://dx.doi.org/10.1371/journal.pone.0108309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271810	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000343729600039
J	Roth-Walter, F; Moskovskich, A; Gomez-Casado, C; Diaz-Perales, A; Oida, K; Singer, J; Kinaciyan, T; Fuchs, HC; Jensen-Jarolim, E				Roth-Walter, Franziska; Moskovskich, Anna; Gomez-Casado, Cristina; Diaz-Perales, Araceli; Oida, Kumiko; Singer, Josef; Kinaciyan, Tamar; Fuchs, Heidemarie C.; Jensen-Jarolim, Erika			Immune Suppressive Effect of Cinnamaldehyde Due to Inhibition of Proliferation and Induction of Apoptosis in Immune Cells: Implications in Cancer	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; CINNAMIC ALDEHYDE; CYCLE PROGRESSION; PROSTATE-CANCER; T-CELLS; ACTIVATION; ENHANCEMENT; CARCINOMAS; EXPRESSION	Background: Besides its anti-inflammatory effects, cinnamaldehyde has been reported to have anti-carcinogenic activity. Here, we investigated its impact on immune cells. Methods: Activation of nuclear factor-kappa B by cinnamaldehyde (0-10 mu g/ml) alone or in combination with lipopolysaccharide was assessed in THP1XBlue human monocytic cell line and in human peripheral blood mononuclear cells (PBMCs). Proliferation and secretion of cytokines (IL10 and TNF alpha) was determined in primary immune cells and the human cell lines (THP1, Jurkat E6-1 and Raji cell lines) stimulated with cinnamaldehyde alone or in conjunction with lipopolysaccharide. Nitric oxide was determined in mouse RAW264.7 cells. Moreover, different treated PBMCs were stained for CD3, CD20 and AnnexinV. Results: Low concentrations (up to 1 mu g/ml) of cinnamaldehyde resulted in a slight increase in nuclar factor-kB activation, whereas higher concentrations led to a dose-dependent decrease of nuclear factor-kB activation (up to 50%) in lipopolysachharide-stimulated THP1 cells and PBMCs. Accordingly, nitric oxide, interleukin 10 secretion as well as cell proliferation were reduced in lipopolysachharide-stimulated RAW264.7 cells, PBMCs and THP1, Raji and Jurkat-E6 immune cells in the presence of cinnamaldehyde in a concentration-dependent manner. Flow cytometric analysis of PBMCs revealed that CD3+ were more affected than CD20+ cells to apopotosis by cinnamaldehyde. Conclusion: We attribute the anti-inflammatory properties of cinnamaldehyde to its ability to block nuclear factor-kappa B activation in immune cells. Treatment with cinnamaldehyde led to inhibition of cell viability, proliferation and induced apoptosis in a dose-dependent manner in primary and immortalized immune cells. Therefore, despite its described anti-carcinogenic property, treatment with cinnamaldehyde in cancer patients might be contraindicated due to its ability to inhibit immune cell activation.	[Roth-Walter, Franziska; Moskovskich, Anna; Oida, Kumiko; Jensen-Jarolim, Erika] Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria; [Roth-Walter, Franziska; Moskovskich, Anna; Oida, Kumiko; Jensen-Jarolim, Erika] Univ Vienna, Vienna, Austria; [Gomez-Casado, Cristina; Diaz-Perales, Araceli] Tech Univ Madrid, Ctr Plant Biotechnol & Genom, Dept Biotechnol, Madrid, Spain; [Oida, Kumiko] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Tokyo, Japan; [Singer, Josef; Jensen-Jarolim, Erika] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Pathophysiol & Allergy Res, Vienna, Austria; [Kinaciyan, Tamar] Med Univ Vienna, Div Immunol Allergy & Infect Dis, Dept Dermatol, Vienna, Austria; [Fuchs, Heidemarie C.] Univ Appl Sci Technikum Wien, Dept Biochem Engn, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; Universidad Politecnica de Madrid; Centro de Investigacion en Biotecnologia Genomica de Plantas (CBGP); Tokyo University of Agriculture & Technology; Medical University of Vienna; Medical University of Vienna	Jensen-Jarolim, E (corresponding author), Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria.	Erika.jensen-jarolim@meduniwien.ac.at	Díaz-Perales, Araceli/D-8433-2016; Jensen-Jarolim, Erika/C-5120-2018; Roth-Walter, Franziska/V-4651-2017; Gomez-Casado, Cristina/AAE-4826-2021; Gomez-Casado, Cristina/K-4031-2016	Díaz-Perales, Araceli/0000-0002-1093-3627; Jensen-Jarolim, Erika/0000-0003-4019-5765; Roth-Walter, Franziska/0000-0001-5005-9228; Kinaciyan, Tamar/0000-0002-8238-2561; Gomez-Casado, Cristina/0000-0002-7707-6367	Austrian Science Fund (FWF) [P 23398-B11, W1205-B09]; Spanish Government (FPI programme, MICINN-MINECO)	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Spanish Government (FPI programme, MICINN-MINECO)	The study was supported by the Austrian Science Fund (FWF) grant P 23398-B11, and grant W1205-B09 to JS. CGC was supported by a training grant from the Spanish Government (FPI programme, MICINN-MINECO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SM, 2005, ANN CLIN MICROBIOLOG, V4; Anand P, 2008, PHARM RES-DORDR, V25, P2097, DOI 10.1007/s11095-008-9661-9; [Anonymous], 2006, HIGH DAILY INTAKES C; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Cabello CM, 2009, FREE RADICAL BIO MED, V46, P220, DOI 10.1016/j.freeradbiomed.2008.10.025; Cao HP, 2010, PHYTOMEDICINE, V17, P1027, DOI 10.1016/j.phymed.2010.03.023; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; consortium TA, 2006, REVISED TEST PLAN CI; del Campo AB, 2012, TISSUE ANTIGENS, V79, P147, DOI 10.1111/j.1399-0039.2011.01831.x; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; DESILVA HV, 1987, MUTAT RES, V187, P11, DOI 10.1016/0165-1218(87)90071-1; Dhuley J. N., 1999, Indian Journal of Experimental Biology, V37, P238; Dietl J, 2007, INT J GYNECOL CANCER, V17, P764, DOI 10.1111/j.1525-1438.2006.00861.x; DORNISH JM, 1989, CANCER RES, V49, P3917; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gupta S, 2011, ONCOTARGETS THER, V4, P79, DOI 10.2147/OTT.S14107; Hanada T, 2006, J EXP MED, V203, P1391, DOI 10.1084/jem.20060436; Heimdal JH, 1999, ACTA OTO-LARYNGOL, V119, P281; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Imai T, 2002, CANCER LETT, V175, P9, DOI 10.1016/S0304-3835(01)00706-6; Jeong HW, 2003, BIOCHEM PHARMACOL, V65, P1343, DOI 10.1016/S0006-2952(03)00038-8; Karagiannis P, 2009, CANCER IMMUNOL IMMUN, V58, P915, DOI 10.1007/s00262-008-0607-1; Kegley SE, 2010, PAN PESTIDICE DATABA; Khan A, 2003, DIABETES CARE, V26, P3215, DOI 10.2337/diacare.26.12.3215; Koh WS, 1998, INT J IMMUNOPHARMACO, V20, P643, DOI 10.1016/S0192-0561(98)00064-2; Koppikar SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-210; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Kwek SS, 2012, NAT REV CANCER, V12, P289, DOI 10.1038/nrc3223; Kwon BM, 1998, ARCH PHARM RES, V21, P147, DOI 10.1007/BF02974019; Kwon HK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-392; Kwon HK, 2009, CANCER LETT, V278, P174, DOI 10.1016/j.canlet.2009.01.015; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lee CW, 2007, J PHARMACOL SCI, V104, P19, DOI 10.1254/jphs.FP0061204; Liao BC, 2008, TOXICOL APPL PHARM, V229, P161, DOI 10.1016/j.taap.2008.01.021; Liao JC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/429320; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MERETO E, 1994, MUTAT RES, V322, P1, DOI 10.1016/0165-1218(94)90027-2; MOLEYAR V, 1992, INT J FOOD MICROBIOL, V16, P337, DOI 10.1016/0168-1605(92)90035-2; MOON KH, 1983, DRUG CHEM TOXICOL, V6, P521, DOI 10.3109/01480548309017807; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Motz GT, 2013, IMMUNITY, V39, P61, DOI 10.1016/j.immuni.2013.07.005; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Oida K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04057; Olsen RV, 2014, EUR J PAIN; Pages F, 2011, SEMIN IMMUNOPATHOL, V33, P317, DOI 10.1007/s00281-011-0278-4; Parkman R, 2006, BIOL BLOOD MARROW TR, V12, P919, DOI 10.1016/j.bbmt.2006.05.008; Pawelec G, 2010, CRIT REV ONCOL HEMAT, V75, P165, DOI 10.1016/j.critrevonc.2010.06.012; PETERS MMCG, 1994, FOOD CHEM TOXICOL, V32, P869, DOI 10.1016/0278-6915(94)90084-1; Reddy AM, 2004, PLANTA MED, V70, P823, DOI 10.1055/s-2004-827230; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Roth-Walter F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104803; Roth-Walter F, 2014, J BIOL CHEM, V289, P17416, DOI 10.1074/jbc.M114.567875; Roussel AM, 2009, J AM COLL NUTR, V28, P16, DOI 10.1080/07315724.2009.10719756; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Westra WH, 1998, HEAD NECK-J SCI SPEC, V20, P430, DOI 10.1002/(SICI)1097-0347(199808)20:5<430::AID-HED12>3.0.CO;2-K; Wu SJ, 2007, FOOD CHEM TOXICOL, V45, P2446, DOI 10.1016/j.fct.2007.05.032; Wu SJ, 2005, LIFE SCI, V77, P938, DOI 10.1016/j.lfs.2005.02.005; Yeh HF, 2013, J AGR FOOD CHEM, V61, P6293, DOI 10.1021/jf401536y; Youn HS, 2008, BIOCHEM PHARMACOL, V75, P494, DOI 10.1016/j.bcp.2007.08.033; YUAN JH, 1992, FOOD CHEM TOXICOL, V30, P997, DOI 10.1016/0278-6915(92)90109-X; YUAN JH, 1993, FUND APPL TOXICOL, V20, P83, DOI 10.1006/faat.1993.1010; Zhao H, 2014, J PHARMACEUT BIOMED, V89, P150, DOI 10.1016/j.jpba.2013.10.044	64	29	31	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108402	10.1371/journal.pone.0108402	http://dx.doi.org/10.1371/journal.pone.0108402			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271635	Green Submitted, Green Published, gold			2022-12-27	WOS:000343729600045
J	Hosoya, T; Sakai, F; Yamashita, M; Shiozaki, T; Endo, T; Ukibe, K; Uenishi, H; Kadooka, Y; Moriya, T; Nakagawa, H; Nakayama, Y; Miyazaki, T				Hosoya, Tomohiro; Sakai, Fumihiko; Yamashita, Maya; Shiozaki, Takuya; Endo, Tsutomu; Ukibe, Ken; Uenishi, Hiroshi; Kadooka, Yukio; Moriya, Tomohiro; Nakagawa, Hisako; Nakayama, Yosuke; Miyazaki, Tadaaki			Lactobacillus helveticus SBT2171 Inhibits Lymphocyte Proliferation by Regulation of the JNK Signaling Pathway	PLOS ONE			English	Article							SURVIVAL; CELLS	Lactobacillus helveticus SBT2171 (LH2171) is a lactic acid bacterium with high protease activity and used in starter cultures in the manufacture of cheese. We recently reported that consumption of cheese manufactured using LH2171 alleviated symptoms of dextran sodium sulfate (DSS)-induced colitis in mice. In this study, we have examined whether LH2171 itself exerts an inhibitory effect on the excessive proliferation of lymphocytes. We found that LH2171 inhibited the proliferation of LPS-stimulated mouse T and B cells, and the human lymphoma cell lines, Jurkat and BJAB. Cell cycle analysis showed an accumulation of LH2171-treated BJAB cells in the G2/M phase. Further, phosphorylation of c-Jun N-terminal kinase (JNK) and c-Jun was reduced by LH2171 in BJAB cells. Subsequently, expression of cell division cycle 2 (CDC2), regulated by the JNK signaling pathway and essential for G2/M phase progression, was inhibited by LH2171. It was also demonstrated that intraperitoneal administration of LH2171 strongly alleviated symptoms of collagen-induced arthritis (CIA) in mice. These findings suggest that LH2171 inhibits the proliferation of lymphocytes through a suppression of the JNK signaling pathway and exerts an immunosuppressive effect in vivo.	[Hosoya, Tomohiro; Sakai, Fumihiko; Yamashita, Maya; Ukibe, Ken; Uenishi, Hiroshi; Kadooka, Yukio; Moriya, Tomohiro] Megmilk Snow Brand Co LTD, Milk Sci Res Inst, Saitama, Japan; [Shiozaki, Takuya; Nakagawa, Hisako; Nakayama, Yosuke; Miyazaki, Tadaaki] Hokkaido Univ, Inst Med Genet, Dept Probiot Immunol, Sapporo, Hokkaido 060, Japan; [Endo, Tsutomu] Hokkaido Univ, Inst Med Genet, Div Mol Immunol, Sapporo, Hokkaido 060, Japan	Hokkaido University; Hokkaido University	Miyazaki, T (corresponding author), Hokkaido Univ, Inst Med Genet, Dept Probiot Immunol, Sapporo, Hokkaido 060, Japan.	miyazaki@pop.med.hokudai.ac.jp			Megmilk Snow Brand Co., Ltd.	Megmilk Snow Brand Co., Ltd.	The research fund is from Megmilk Snow Brand Co., Ltd. The funder provided support in the form of salaries for authors (Tomohiro Hosoya, Fumihiko Sakai, Maya Yamashita, Ken Ukibe, Hiroshi Uenishi, Yukio Kadooka, and Tomohiro Moriya), but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Gerondakis S, 2007, IMMUNOL CELL BIOL, V85, P471, DOI 10.1038/sj.icb.7100097; Gururajan M, 2005, BLOOD, V106, P1382, DOI 10.1182/blood-2004-10-3819; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Hosoya T, 2012, J DAIRY SCI, V95, P2810, DOI 10.3168/jds.2011-4763; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kanayama M, 2011, J IMMUNOL, V187, P5851, DOI 10.4049/jimmunol.1101524; Khiem D, 2008, P NATL ACAD SCI USA, V105, P17067, DOI 10.1073/pnas.0804868105; Li CY, 2011, INT ARCH ALLERGY IMM, V156, P128, DOI 10.1159/000322350; Melino M, 2008, J IMMUNOL, V181, P7300, DOI 10.4049/jimmunol.181.10.7300; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Peluso I, 2007, INFECT IMMUN, V75, P1730, DOI 10.1128/IAI.01172-06; SASAKI M, 1995, J DAIRY RES, V62, P601, DOI 10.1017/S0022029900031332; Sasaki M, 1996, MICROBIOL-UK, V142, P799, DOI 10.1099/00221287-142-4-799; TAN PST, 1995, APPL ENVIRON MICROB, V61, P3430, DOI 10.1128/AEM.61.9.3430-3435.1995; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; THNG JPH, 1990, CELL, V63, P313, DOI 10.1016/0092-8674(90)90164-A; van Baarlen P, 2013, TRENDS IMMUNOL, V34, P208, DOI 10.1016/j.it.2013.01.005; van Gent M, 2011, J IMMUNOL, V186, P1694, DOI 10.4049/jimmunol.0903120; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Yamashita M, 2014, J DAIRY SCI, V97, P4772, DOI 10.3168/jds.2014-8041; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; Yoshida A, 2011, IMMUNOLOGY, V133, P442, DOI 10.1111/j.1365-2567.2011.03455.x	26	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108360	10.1371/journal.pone.0108360	http://dx.doi.org/10.1371/journal.pone.0108360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268890	gold, Green Published			2022-12-27	WOS:000343671700085
J	Schulz, TR; McBryde, ES; Leder, K; Biggs, BA				Schulz, Thomas R.; McBryde, Emma S.; Leder, Karin; Biggs, Beverley-Ann			Using Stool Antigen to Screen for Helicobacter pylori in Immigrants and Refugees from High Prevalence Countries Is Relatively Cost Effective in Reducing the Burden of Gastric Cancer and Peptic Ulceration	PLOS ONE			English	Article							UNITED-STATES; INFECTION; METAANALYSIS; MANAGEMENT; DIAGNOSIS; ERADICATION; STRATEGIES; DYSPEPSIA; DISEASE; RISK	Objectives: Refugees and immigrants from developing countries settling in industrialised countries have a high prevalence of Helicobacter pylori (H. pylori). Screening these groups for H. pylori and use of eradication therapy to reduce the future burden of gastric cancer and peptic ulcer disease is not currently recommended in most countries. We investigated whether a screening and eradication approach would be cost effective in high prevalence populations. Methods: Nine different screening and follow-up strategies for asymptomatic immigrants from high H. pylori prevalence areas were compared with the current approach of no screening. Cost effectiveness comparisons assumed population prevalence's of H. pylori of 25%, 50% or 75%. The main outcome measure was the net cost for each cancer prevented for each strategy. Total costs of each strategy and net costs including savings from reductions in ulcers and gastric cancer were also calculated. Results: Stool antigen testing with repeat testing after treatment was the most cost effective approach relative to others, for each prevalence value. The net cost per cancer prevented with this strategy was US 111,800 (assuming 75% prevalence), $132,300 (50%) and $193,900 (25%). A test and treat strategy using stool antigen remained relatively cost effective, even when the prevalence was 25%. Conclusions: H. pylori screening and eradication can be an effective strategy for reducing rates of gastric cancer and peptic ulcers in high prevalence populations and our data suggest that use of stool antigen testing is the most cost effective approach.	[Schulz, Thomas R.; McBryde, Emma S.; Leder, Karin; Biggs, Beverley-Ann] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia; [Schulz, Thomas R.; McBryde, Emma S.; Biggs, Beverley-Ann] Univ Melbourne, Dept Med, Doherty Inst, Melbourne, Vic, Australia; [Leder, Karin] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Clayton, Vic 3800, Australia; [McBryde, Emma S.] Burnet Inst Prahran, Ctr Populat Hlth, Melbourne, Vic, Australia	Royal Melbourne Hospital; University of Melbourne; Monash University	Biggs, BA (corresponding author), Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia.	babiggs@unimelb.edu.au	Leder, Karin/AAD-2388-2019; Leder, Karin/H-4979-2014; McBryde, Emma/D-2220-2018	Leder, Karin/0000-0003-1368-1039; Biggs, Beverley-Ann/0000-0002-2961-9793; McBryde, Emma/0000-0002-9570-9172; Schulz, Thomas/0000-0002-1185-0030				[Anonymous], 2013, SEER CANC STAT REV 1; Areia M, 2013, HELICOBACTER, V18, P325, DOI 10.1111/hel.12050; Bai Y, GUT, V59, P722; Barkun A, 2010, AM J MED, V123, P358, DOI 10.1016/j.amjmed.2009.09.031; Barton PM, 2008, MED DECIS MAKING, V28, P44, DOI 10.1177/0272989X07309644; Blaser MJ, 2008, GUT, V57, P561, DOI 10.1136/gut.2007.133462; CDC, 2012, DOM INT PAR GUID; CDC, 2012, TUB FACT SHEET; Cherian S, 2008, MED J AUSTRALIA, V189, P438, DOI 10.5694/j.1326-5377.2008.tb02116.x; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; De Vries AC, 2008, SCAND J GASTROENTERO, V43, P403, DOI 10.1080/00365520701814077; Eckman MH, 2011, CLIN INFECT DIS, V52, P1294, DOI 10.1093/cid/cir199; Fischbach LA, 2004, ALIMENT PHARM THER, V20, P1071, DOI 10.1111/j.1365-2036.2004.02248.x; Fock KM, 2009, J GASTROEN HEPATOL, V24, P1587, DOI 10.1111/j.1440-1746.2009.05982.x; Ford AC, 2011, ERADICATION THERAPY; Gisbert JR, 2006, AM J GASTROENTEROL, V101, P1921, DOI 10.1111/j.1572-0241.2006.00668.x; Globocan, 2008, STOM CANC INC MORT P; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; Holmes KP, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-344; [IFHP of IF Plans H], 2010, 2010 COMP PRICE REPO; Ito M, 2009, J GASTROENTEROL, V44, P365, DOI 10.1007/s00535-009-0036-8; Jafri NS, 2008, ANN INTERN MED, V148, P923, DOI 10.7326/0003-4819-148-12-200806170-00226; Laheij RJF, 1998, J CLIN MICROBIOL, V36, P2803, DOI 10.1128/JCM.36.10.2803-2809.1998; Lane JA, 2011, ALIMENT PHARM THER, V33, P922, DOI 10.1111/j.1365-2036.2011.04610.x; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Malfertheiner P, 2011, LANCET IN PRESS; McColl KEL, 2010, NEW ENGL J MED, V362, P1597, DOI 10.1056/NEJMcp1001110; [MPI Institute MP], 2010, 2010 AM COMM SURV CE; Muennig P, 1999, NEW ENGL J MED, V340, P773, DOI 10.1056/NEJM199903113401006; Naja F, 2007, CAN J GASTROENTEROL, V21, P501, DOI 10.1155/2007/462804; Nordenstedt H, 2011, SCAND J GASTROENTERO, V46, P597, DOI 10.3109/00365521.2011.551890; Pareek M, 2011, LANCET INFECT DIS, V11, P435, DOI 10.1016/S1473-3099(11)70069-X; Sonnenberg A, 2010, GASTROENTEROLOGY, V139, P1894, DOI 10.1053/j.gastro.2010.08.018; Sung JJY, 2009, ALIMENT PHARM THER, V29, P938, DOI 10.1111/j.1365-2036.2009.03960.x; Torres J, 2005, CANCER EPIDEM BIOMAR, V14, P1874, DOI 10.1158/1055-9965.EPI-05-0113; Vaira D, 1999, LANCET, V354, P1732, DOI 10.1016/S0140-6736(05)76722-2; Xie Feng, 2009, J Am Coll Radiol, V6, P317, DOI 10.1016/j.jacr.2009.01.022; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Yaghoobi M, 2010, AM J GASTROENTEROL, V105, P1007, DOI 10.1038/ajg.2009.734; Yamaoka Y, 2008, INTERNAL MED, V47, P1077, DOI 10.2169/internalmedicine.47.0975; Yeh JM, 2009, INT J CANCER, V124, P157, DOI 10.1002/ijc.23864	42	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108610	10.1371/journal.pone.0108610	http://dx.doi.org/10.1371/journal.pone.0108610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268809	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000343671700124
J	Wani, KD; Kadu, BS; Mansara, P; Gupta, P; Deore, AV; Chikate, RC; Poddar, P; Dhole, SD; Kaul-Ghanekar, R				Wani, Kirtee D.; Kadu, Brijesh S.; Mansara, Prakash; Gupta, Preeti; Deore, Avinash V.; Chikate, Rajeev C.; Poddar, Pankaj; Dhole, Sanjay D.; Kaul-Ghanekar, Ruchika			Synthesis, Characterization and In Vitro Study of Biocompatible Cinnamaldehyde Functionalized Magnetite Nanoparticles (CPGF Nps) For Hyperthermia and Drug Delivery Applications in Breast Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IRON-OXIDE NANOPARTICLES; ESTROGEN-RECEPTOR STATUS; FE3O4 NANOPARTICLES; CHEMOTHERAPY; CELLS; CYTOTOXICITY; EXPRESSION; CARCINOMA	Cinnamaldehyde, the bioactive component of the spice cinnamon, and its derivatives have been shown to possess anticancer activity against various cancer cell lines. However, its hydrophobic nature invites attention for efficient drug delivery systems that would enhance the bioavailability of cinnamaldehyde without affecting its bioactivity. Here, we report the synthesis of stable aqueous suspension of cinnamaldehyde tagged Fe3O4 nanoparticles capped with glycine and pluronic polymer (CPGF NPs) for their potential application in drug delivery and hyperthermia in breast cancer. The monodispersed superparamagnetic NPs had an average particulate size of similar to 20 nm. TGA data revealed the drug payload of similar to 18%. Compared to the free cinnamaldehyde, CPGF NPs reduced the viability of breast cancer cell lines, MCF7 and MDAMB231, at lower doses of cinnamaldehyde suggesting its increased bioavailability and in turn its therapeutic efficacy in the cells. Interestingly, the NPs were non-toxic to the non-cancerous HEK293 and MCF10A cell lines compared to the free cinnamaldehyde. The novelty of CPGF nanoparticulate system was that it could induce cytotoxicity in both ER/PRpositive/Her2 negative (MCF7) and ER/PRnegative/Her2 negative (MDAMB231) breast cancer cells, the latter being insensitive to most of the chemotherapeutic drugs. The NPs decreased the growth of the breast cancer cells in a dose-dependent manner and altered their migration through reduction in MMP-2 expression. CPGF NPs also decreased the expression of VEGF, an important oncomarker of tumor angiogenesis. They induced apoptosis in breast cancer cells through loss of mitochondrial membrane potential and activation of caspase-3. Interestingly, upon exposure to the radiofrequency waves, the NPs heated up to 41.6 degrees C within 1 min, suggesting their promise as a magnetic hyperthermia agent. All these findings indicate that CPGF NPs prove to be potential nano-chemotherapeutic agents in breast cancer.	[Wani, Kirtee D.; Mansara, Prakash; Kaul-Ghanekar, Ruchika] Interact Res Sch Hlth Affairs, Cell & Translat Res Lab, Pune, Maharashtra, India; [Kadu, Brijesh S.; Chikate, Rajeev C.] MES Abasaheb Garware Coll, Postgrad & Res Ctr, Dept Chem, Nanosci Grp, Pune, Maharashtra, India; [Gupta, Preeti; Poddar, Pankaj] CSIR, Natl Chem Lab, Phys & Mat Chem Div, Pune, Maharashtra, India; [Deore, Avinash V.; Dhole, Sanjay D.] Univ Pune, Dept Phys, Pune, Maharashtra, India	Bharati Vidyapeeth Deemed University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Savitribai Phule Pune University	Kaul-Ghanekar, R (corresponding author), Interact Res Sch Hlth Affairs, Cell & Translat Res Lab, Bharati Vidyapeeth Univ Med Coll Campus, Pune, Maharashtra, India.	ruchika.kaulghanekar@gmail.com	Chikate, Rajeev/AAJ-9613-2020	Chikate, Rajeev/0000-0002-6312-0582; Chikate, Rajeev/0000-0003-3777-9196; MANSARA, PRAKASH/0000-0002-2851-448X; Deore, Avinash/0000-0003-2412-4617	Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth University	Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth University	This work was supported by the Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, EXP BIOL MED, V234, P825, DOI 10.3181/0902-MR-78; Ahmed M, 2013, OPEN ACCESS SCI REPO, V2, P641, DOI DOI 10.2174/1381612826666200515132218; Akbarzadeh A, 2012, NANOTECHNOL SCI APPL, V5, P13, DOI 10.2147/NSA.S24328; Aljarrah K, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-62; Asin L, 2012, PHARM RES-DORDR, V29, P1319, DOI 10.1007/s11095-012-0710-z; Bentzon N, 2008, INT J CANCER, V122, P1089, DOI 10.1002/ijc.22892; Berry CC, 2003, J PHYS D APPL PHYS, V36, pR198, DOI 10.1088/0022-3727/36/13/203; Bhadoriya S. S., 2011, J CURR PHARM RES, V8, P1; Bhattaram VA, 2002, PHYTOMEDICINE, V9, P1; Binkley JM, 2012, CANCER-AM CANCER SOC, V118, P2207, DOI 10.1002/cncr.27469; Choudhari AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070127; CLARK GM, 1983, NEW ENGL J MED, V309, P1343, DOI 10.1056/NEJM198312013092240; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dent R, 2009, BREAST CANCER RES TR, V115, P423, DOI 10.1007/s10549-008-0086-2; Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017; Gonzales M, 2007, J MAGN MAGN MATER, V311, P59, DOI 10.1016/j.jmmm.2006.10.1150; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Hasany SF, 2012, J NANOSCI NANOTECHNO, V2, P148, DOI DOI 10.5923/J.NN.20120206.01; Hilger I, 2012, NANOMEDICINE-UK, V7, P1443, DOI 10.2217/NNM.12.112; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Ismail IA, 2012, BIOL PHARM BULL, V35, P895; Jain TK, 2005, MOL PHARMACEUT, V2, P194, DOI 10.1021/mp0500014; Kale SN, 2012, NANOMED-NANOTECHNOL, V8, P452, DOI 10.1016/j.nano.2011.07.010; Kareparamban J. A., 2012, International Journal of Research in Pharmacy and Chemistry, V2, P299; Kikumori T, 2009, BREAST CANCER RES TR, V113, P435, DOI 10.1007/s10549-008-9948-x; Kong G, 2000, CANCER RES, V60, P4440; Koppikar SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-210; Kwon BM, 1998, ARCH PHARM RES, V21, P147, DOI 10.1007/BF02974019; Liao GS, 2013, EVID-BASED COMPL ALT, V2013, P1; Mauri FA, 1999, INT J ONCOL, V15, P1137; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; PAONE JF, 1981, SURG GYNECOL OBSTET, V152, P70; Patnaik JL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2901; Petri-Fink A, 2008, EUR J PHARM BIOPHARM, V68, P129, DOI 10.1016/j.ejpb.2007.02.024; Poddar P, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.060403; Quaranta M, 2007, ANTICANCER RES, V27, P3593; Ren YY, 2012, INT J NANOMED, V7, P2261, DOI 10.2147/IJN.S29357; Rose DP, 2009, EXPERT REV ANTICANC, V9, P1091, DOI 10.1586/ERA.09.71; Sadeghi-Aliabadi Hojjat, 2013, Avicenna Journal of Medical Biotechnology, V5, P96; Schott AF, 2012, J CLIN ONCOL, V30, P1747, DOI 10.1200/JCO.2011.41.3161; Shafi KVPM, 2002, CHEM MATER, V14, P1778, DOI [10.1021/cm011535+, 10.1021/cm011535]; Shieh DB, 2006, NANOTECHNOLOGY, V17, P4174, DOI 10.1088/0957-4484/17/16/030; Singh R, 2009, PHARM BIOL, V47, P1174, DOI 10.3109/13880200903019242; SONG CW, 1984, CANCER RES, V44, P4721; Stammati A, 1999, FOOD CHEM TOXICOL, V37, P813, DOI 10.1016/S0278-6915(99)00075-7; UNEMORI EN, 1992, J CELL PHYSIOL, V153, P557, DOI 10.1002/jcp.1041530317; VERONESI U, 1995, J NATL CANCER I, V87, P19, DOI 10.1093/jnci/87.1.19; Wani K. D., 2011, Journal of Bionanoscience, V5, P59, DOI 10.1166/jbns.2011.1041; WILLIAMS CH, 1988, BIOCHEM J, V256, P911, DOI 10.1042/bj2560911; Yin SY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/302426	50	51	52	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107315	10.1371/journal.pone.0107315	http://dx.doi.org/10.1371/journal.pone.0107315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268975	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700036
J	Alberti, L; Renaud, S; Losi, L; Leyvraz, S; Benhattar, J				Alberti, Loredana; Renaud, Stephanie; Losi, Lorena; Leyvraz, Serge; Benhattar, Jean			High Expression of hTERT and Stemness Genes in BORIS/CTCFL Positive Cells Isolated from Embryonic Cancer Cells	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE EXPRESSION; CELLULAR SENESCENCE; TELOMERASE ACTIVITY; MOLECULAR BEACONS; MESSENGER-RNA; FACTOR BORIS; TESTIS GENE; TUMOR; CTCF; QUANTIFICATION	BORIS/CTCFL is a member of cancer testis antigen family normally expressed in germ cells. In tumors, it is aberrantly expressed although its functions are not completely well-defined. To better understand the functions of BORIS in cancer, we selected the embryonic cancer cells as a model. Using a molecular beacon, which specifically targets BORIS mRNA, we demonstrated that BORIS positive cells are a small subpopulation of tumor cells (3-5% of total). The BORIS-positive cells isolated using BORIS-molecular beacon, expressed higher telomerase hTERT, stem cell (NANOG, OCT4, SOX2) and cancer stem cell marker genes (CD44 and ALDH1) compared to the BORIS-negative tumor cells. In order to define the functional role of BORIS, stable BORIS-depleted embryonic cancer cells were generated. BORIS silencing strongly down-regulated the expression of hTERT, stem cell and cancer stem cell marker genes. Moreover, the BORIS knockdown increased cellular senescence in embryonic cancer cells, revealing a putative role of BORIS in the senescence biological program. Our data indicate an association of BORIS expressing cells subpopulation with the expression of stemness genes, highlighting the critical role played by BORIS in embryonic neoplastic disease.	[Alberti, Loredana; Benhattar, Jean] Univ Lausanne Hosp, Inst Pathol, Lausanne, Switzerland; [Renaud, Stephanie] Univ Lausanne, Inst Biotechnol, Lausanne, Switzerland; [Losi, Lorena] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Leyvraz, Serge] Univ Lausanne Hosp, Dept Oncol, Lausanne, Switzerland; [Benhattar, Jean] Biopath Lab, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Universita di Modena e Reggio Emilia; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Benhattar, J (corresponding author), Univ Lausanne Hosp, Inst Pathol, Lausanne, Switzerland.	jean.benhattar@gmail.com	Losi, Lorena/B-2583-2012	Losi, Lorena/0000-0002-8483-3936	Swiss National Science Foundation [31003A-113505]; Emma Muschamp Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Emma Muschamp Foundation	This research was supported by the Swiss National Science Foundation (grant number: 31003A-113505; www.snf.ch); and Emma Muschamp Foundation (www.s-a-v.org/-Fondations-associees-.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden-Jacob J, 2001, SPECTROCHIM ACTA A, V57, P2271, DOI 10.1016/S1386-1425(01)00476-0; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; de Necochea-Campion R, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-213; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Domomt J, 2005, J CLIN ONCOL, V23, P3086, DOI 10.1200/JCO.2005.06.944; Dunn KL, 2003, BIOCHEM CELL BIOL, V81, P161, DOI 10.1139/o03-052; Gertler R, 2004, J CLIN ONCOL, V22, P1807, DOI 10.1200/JCO.2004.09.160; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herold M, 2012, DEVELOPMENT, V139, P1045, DOI 10.1242/dev.065268; Hiyama E, 2007, BRIT J CANCER, V96, P1020, DOI 10.1038/sj.bjc.6603671; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; John T, 2008, CLIN CANCER RES, V14, P3291, DOI 10.1158/1078-0432.CCR-07-1322; Kholmanskikh O, 2008, INT J CANCER, V122, P777, DOI 10.1002/ijc.23140; Kim H, 2013, J HEPATOL, V59, P746, DOI 10.1016/j.jhep.2013.05.011; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; King FW, 2011, STEM CELLS DEV, V20, P475, DOI 10.1089/scd.2010.0219; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; Kouprina N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000359; Li YS, 2008, BIOCHEM BIOPH RES CO, V373, P457, DOI 10.1016/j.bbrc.2008.05.038; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Marian CO, 2010, INT J CANCER, V127, P321, DOI 10.1002/ijc.25043; Marian CO, 2010, CLIN CANCER RES, V16, P154, DOI 10.1158/1078-0432.CCR-09-2850; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Monk M, 2008, MOL HUM REPROD, V14, P347, DOI 10.1093/molehr/gan025; Monroy-Contreras R, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/741723; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Noutsias M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-3; Paranjape AN, 2012, ONCOGENE, V31, P1896, DOI 10.1038/onc.2011.378; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Przyborski SA, 2004, STEM CELLS DEV, V13, P400, DOI 10.1089/1547328041797507; Pugacheva EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013872; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Renaud S, 2011, NUCLEIC ACIDS RES, V39, P862, DOI 10.1093/nar/gkq827; Rhee WJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn039; SAGER R, 1991, ENVIRON HEALTH PERSP, V93, P59, DOI 10.2307/3431170; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Tabori U, 2006, J CLIN ONCOL, V24, P1522, DOI 10.1200/JCO.2005.04.2127; Terrin L, 2008, CLIN CANCER RES, V14, P7444, DOI 10.1158/1078-0432.CCR-08-0478; TESHIMA S, 1988, LAB INVEST, V59, P328; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Vicente-Duenas C, 2012, ONCOTARGET, V3, P261, DOI 10.18632/oncotarget.461; Wege H, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng003; Woloszynska-Read Anna, 2010, Cancer Immun, V10, P6; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388	51	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109921	10.1371/journal.pone.0109921	http://dx.doi.org/10.1371/journal.pone.0109921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279549	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800106
J	Ismadi, MZ; Gupta, P; Fouras, A; Verma, P; Jadhav, S; Bellare, J; Hourigan, K				Ismadi, Mohd-Zulhilmi; Gupta, Priyanka; Fouras, Andreas; Verma, Paul; Jadhav, Sameer; Bellare, Jayesh; Hourigan, Kerry			Flow Characterization of a Spinner Flask for Induced Pluripotent Stem Cell Culture Application	PLOS ONE			English	Article							LARGE-SCALE EXPANSION; BIOREACTOR; BONE; DIFFERENTIATION; HYDRODYNAMICS; DESIGN	We present detailed quantitative measurement analyses for flow in a spinner flask with spinning rates between 20 to 45 RPM, utilizing the optical velocimetry measurement technique of Particle Image Velocimetry (PIV). A partial section of the impeller was immersed in the working fluid to reduce the shear forces induced on the cells cultured on microcarriers. Higher rotational speeds improved the mixing effect in the medium at the expense of a higher shear environment. It was found that the mouse induced pluripotent stem (iPS) cells achieved the optimum number of cells over 7 days in 25 RPM suspension culture. This condition translates to 0.0984 Pa of maximum shear stress caused by the interaction of the fluid flow with the bottom surface. However, inverse cell growth was obtained at 28 RPM culture condition. Such a narrow margin demonstrated that mouse iPS cells cultured on microcarriers are very sensitive to mechanical forces. This study provides insight to biomechanical parameters, specifically the shear stress distribution, for a commercially available spinner flask over a wide range of Reynolds number.	[Ismadi, Mohd-Zulhilmi; Gupta, Priyanka; Fouras, Andreas; Verma, Paul; Hourigan, Kerry] Monash Univ, Div Biol Engn, Melbourne, Vic 3004, Australia; [Ismadi, Mohd-Zulhilmi; Fouras, Andreas; Hourigan, Kerry] Monash Univ, Dept Mech & Aerosp Engn, Melbourne, Vic 3004, Australia; [Gupta, Priyanka] Monash Univ, Dept Chem Engn, Melbourne, Vic 3004, Australia; [Gupta, Priyanka; Jadhav, Sameer; Bellare, Jayesh] Indian Inst Technol, Dept Chem Engn, Mumbai 400076, Maharashtra, India; [Verma, Paul] South Australian Res & Dev Inst, Rosedale, SA, Australia	Monash University; Monash University; Monash University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; South Australian Research & Development Institute (SARDI)	Ismadi, MZ (corresponding author), Monash Univ, Div Biol Engn, Melbourne, Vic 3004, Australia.	zac.ismadi@monash.edu	Verma, Paul/AAQ-4657-2021; Bellare, Jayesh/AAO-8713-2020; Ismadi, Mohd-Zulhilmi/H-9022-2016; Hourigan, Kerry/B-7999-2009	Bellare, Jayesh/0000-0002-6792-8327; Ismadi, Mohd-Zulhilmi/0000-0002-7724-114X; Hourigan, Kerry/0000-0002-8995-1851; Gupta, Priyanka/0000-0003-2726-9766	Australia India Strategic Research Fund [BF050038]; Australian Research Council [DP110100434]	Australia India Strategic Research Fund(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Research Council(Australian Research Council)	This research was supported from the Australia India Strategic Research Fund BF050038 and under Australian Research Council's Discovery Projects funding scheme (project number DP110100434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches E, 2007, BIOTECHNOL BIOENG, V96, P1211, DOI 10.1002/bit.21191; [Anonymous], 2012, 9 INT C CFD MIN PROC; Bancroft GN, 2003, TISSUE ENG, V9, P549, DOI 10.1089/107632703322066723; Cabrita GJM, 2003, TRENDS BIOTECHNOL, V21, P233, DOI 10.1016/S0167-7799(03)00076-3; Cameron CM, 2006, BIOTECHNOL BIOENG, V94, P938, DOI 10.1002/bit.20919; Dusting J, 2006, BIOTECHNOL BIOENG, V94, P1196, DOI 10.1002/bit.20960; Fernandes AM, 2007, J BIOTECHNOL, V132, P227, DOI 10.1016/j.jbiotec.2007.05.031; Fok EYL, 2005, STEM CELLS, V23, P1333, DOI 10.1634/stemcells.2005-0112; Fouras A, 2008, EXP FLUIDS, V44, P317, DOI 10.1007/s00348-007-0404-1; Fouras A, 2009, EXP FLUIDS, V47, P569, DOI 10.1007/s00348-009-0616-7; FREED L, 2000, TISSUE ENG BIOREACTO; Freed LE, 1997, IN VITRO CELL DEV-AN, V33, P381; Gerecht-Nir S, 2004, TRANSPL IMMUNOL, V12, P203, DOI 10.1016/j.trim.2003.12.013; GOODWIN TJ, 1993, P SOC EXP BIOL MED, V202, P181; Gupta P, 2014, CYTOTECHNOLOGY; Gupta P, 2014, THESIS MONASH RES AC; HU WS, 1985, BIOTECHNOL BIOENG, V27, P1466, DOI 10.1002/bit.260271011; Ismadi MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065714; Kaiser SC, 2013, CHEM-ING-TECH, V85, P95, DOI 10.1002/cite.201200180; Kallos MS, 2003, MED BIOL ENG COMPUT, V41, P271, DOI 10.1007/BF02348431; Kehoe DE, 2010, TISSUE ENG PT A, V16, P405, DOI [10.1089/ten.tea.2009.0454, 10.1089/ten.TEA.2009.0454]; KOLLER MR, 1993, BLOOD, V82, P378; KURIYAMA S, 1992, OPHTHALMOLOGICA, V205, P89, DOI 10.1159/000310319; Lock LT, 2009, TISSUE ENG PT A, V15, P2051, DOI 10.1089/ten.tea.2008.0455; Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001; Niebruegge S, 2008, TISSUE ENG PT A, V14, P1591, DOI 10.1089/ten.tea.2007.0247; PALSSON BO, 1993, BIO-TECHNOL, V11, P368, DOI 10.1038/nbt0393-368; Schroeder M, 2005, BIOTECHNOL BIOENG, V92, P920, DOI 10.1002/bit.20668; Sen A, 2001, IND ENG CHEM RES, V40, P5350, DOI 10.1021/ie001107y; Shachar M, 2003, HEART FAIL REV, V8, P271, DOI 10.1023/A:1024729919743; Singh H, 2005, J BIOTECHNOL, V119, P181, DOI 10.1016/j.jbiotec.2005.03.021; Sucosky P, 2004, BIOTECHNOL BIOENG, V85, P34, DOI 10.1002/bit.10788; Tat PA, 2010, CELL TRANSPLANT, V19, P525, DOI 10.3727/096368910X491374; Thouas GA, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/32754; Venkat RV, 1996, BIOTECHNOL BIOENG, V49, P456, DOI 10.1002/(SICI)1097-0290(19960220)49:4<456::AID-BIT13>3.0.CO;2-8; Zandstra PW, 2003, TISSUE ENG, V9, P767, DOI 10.1089/107632703768247449; Zhang ZY, 2009, BIOMATERIALS, V30, P2694, DOI 10.1016/j.biomaterials.2009.01.028	37	55	57	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e106493	10.1371/journal.pone.0106493	http://dx.doi.org/10.1371/journal.pone.0106493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279733	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800004
J	Bolkhovskaya, OV; Zorin, DY; Ivanchenko, MV				Bolkhovskaya, Olesya V.; Zorin, Daniil Yu.; Ivanchenko, Mikhail V.			Assessing T Cell Clonal Size Distribution: A Non-Parametric Approach	PLOS ONE			English	Article							REPERTOIRE DIVERSITY; CROSS-REACTIVITY; MAINTENANCE	Clonal structure of the human peripheral T-cell repertoire is shaped by a number of homeostatic mechanisms, including antigen presentation, cytokine and cell regulation. Its accurate tuning leads to a remarkable ability to combat pathogens in all their variety, while systemic failures may lead to severe consequences like autoimmune diseases. Here we develop and make use of a non-parametric statistical approach to assess T cell clonal size distributions from recent next generation sequencing data. For 41 healthy individuals and a patient with ankylosing spondylitis, who undergone treatment, we invariably find power law scaling over several decades and for the first time calculate quantitatively meaningful values of decay exponent. It has proved to be much the same among healthy donors, significantly different for an autoimmune patient before the therapy, and converging towards a typical value afterwards. We discuss implications of the findings for theoretical understanding and mathematical modeling of adaptive immunity.	[Bolkhovskaya, Olesya V.] NI Lobachevskii State Univ, Dept Stat, Fac Radiophys, Nizhnii Novgorod, Russia; [Zorin, Daniil Yu.; Ivanchenko, Mikhail V.] NI Lobachevskii State Univ, Dept Bioinformat, Fac Computat Math & Cybernet, Nizhnii Novgorod, Russia	Lobachevsky State University of Nizhni Novgorod; Lobachevsky State University of Nizhni Novgorod	Ivanchenko, MV (corresponding author), NI Lobachevskii State Univ, Dept Bioinformat, Fac Computat Math & Cybernet, Nizhnii Novgorod, Russia.	ivanchenko.mv@gmail.com	Ivanchenko, Mikhail V/J-7045-2013; Ivanchenko, Mikhail/AGE-5444-2022; Bolkhovskaya, Olesya/AAQ-4264-2020	Ivanchenko, Mikhail V/0000-0002-1903-7423; Bolkhovskaya, Olesya/0000-0002-6679-9295				Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Baker BM, 2012, IMMUNOL REV, V250, P10, DOI 10.1111/j.1600-065X.2012.01165.x; Baum PD, 2012, EUR J IMMUNOL, V42, P2834, DOI 10.1002/eji.201242999; Bolotin DA, 2012, EUR J IMMUNOL, V42, P3073, DOI 10.1002/eji.201242517; Britanova OV, 2012, BONE MARROW TRANSPL, V47, P1479, DOI 10.1038/bmt.2012.44; Britanova OV, 2014, J IMMUNOL, V192, P2689, DOI 10.4049/jimmunol.1302064; Callard RE, 2003, TRENDS IMMUNOL, V24, P370, DOI 10.1016/S1471-4906(03)00164-9; DeBoer RJ, 1997, INT IMMUNOL, V9, P779, DOI 10.1093/intimm/9.5.779; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Grimmett G. R., 2001, PROBABILITY RANDOM P; Ivanchenko MV, 2011, JETP LETT+, V93, P35, DOI 10.1134/S0021364011010048; Janeway CA, 2001, IMMUNOBIOLOGY; Kedzierska K, 2006, J IMMUNOL, V177, P6705, DOI 10.4049/jimmunol.177.10.6705; Khor B, 2002, CURR OPIN IMMUNOL, V14, P230, DOI 10.1016/S0952-7915(02)00326-6; Mamedov IZ, 2011, EMBO MOL MED, V3, P201, DOI 10.1002/emmm.201100129; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Meier J, 2013, BIOL BLOOD MARROW TR, V19, P366, DOI 10.1016/j.bbmt.2012.12.004; Naumov YN, 2003, J IMMUNOL, V170, P3994, DOI 10.4049/jimmunol.170.8.3994; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Rempala GA, 2011, J THEOR BIOL, V269, P1, DOI 10.1016/j.jtbi.2010.10.001; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; ROSENBLATT M, 1956, ANN MATH STAT, V27, P832, DOI 10.1214/aoms/1177728190; Sepulveda N, 2010, J IMMUNOL METHODS, V353, P124, DOI 10.1016/j.jim.2009.11.009; Stirk ER, 2008, J THEOR BIOL, V255, P237, DOI 10.1016/j.jtbi.2008.07.017; Stirk ER, 2010, J THEOR BIOL, V265, P396, DOI 10.1016/j.jtbi.2010.05.004; Stirk ER, 2010, MATH BIOSCI, V224, P74, DOI 10.1016/j.mbs.2009.12.004; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; van Heijst JWJ, 2013, NAT MED, V19, P372, DOI 10.1038/nm.3100; Warren RL, 2011, GENOME RES, V21, P790, DOI 10.1101/gr.115428.110	33	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108658	10.1371/journal.pone.0108658	http://dx.doi.org/10.1371/journal.pone.0108658			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275470	Green Submitted, gold, Green Published			2022-12-27	WOS:000342591500025
J	Chen, MQ; Zhou, M; Ye, ZY; Zhou, Y; Tan, WS				Chen, Maiqin; Zhou, Min; Ye, Zhaoyang; Zhou, Yan; Tan, Wen-Song			Ectopic Osteogenesis of Macroscopic Tissue Constructs Assembled from Human Mesenchymal Stem Cell-Laden Microcarriers through In Vitro Perfusion Culture	PLOS ONE			English	Article							CULTIVATION SYSTEM; ENGINEERED BONE; VIVO; VASCULARIZATION; AGGREGATION; FABRICATION; EXPANSION	We had previously demonstrated the feasibility of preparing a centimeter-sized bone tissue construct by following a modular approach. In the present study, the objectives were to evaluate osteogenesis and tissue formation of human amniotic mesenchymal stem cells-laden CultiSpher S microcarriers during in vitro perfusion culture and after subcutaneous implantation. Microtissues were prepared in dynamic culture using spinner flasks in 28 days. In comparison with 1-week perfusion culture, microtissues became more obviously fused, demonstrating significantly higher cellularity, metabolic activity, ALP activity and calcium content while maintaining cell viability after 2-week perfusion. After subcutaneous implantation in nude mice for 6 and 12 weeks, all explants showed tight contexture, suggesting profound tissue remodeling in vivo. In addition, 12-week implantation resulted in slightly better tissue properties. However, in vitro perfusion culture time exerted great influence on the properties of corresponding explants. Degradation of microcarriers was more pronounced in the explants of 2-week perfused macrotissues compared to those of 1-week perfusion and directly implanted microtissues. Moreover, more blood vessel infiltration and bone matrix deposition with homogeneous spatial distribution were found in the explants of 2-week perfused macrotissues. Taken together, in vitro perfusion culture time is critical in engineering bone tissue replacements using such a modular approach, which holds great promise for bone regeneration.	[Chen, Maiqin; Zhou, Min; Ye, Zhaoyang; Zhou, Yan; Tan, Wen-Song] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Sch Bioengn, Shanghai 200237, Peoples R China	East China University of Science & Technology	Ye, ZY (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Sch Bioengn, Shanghai 200237, Peoples R China.	zhaoyangye@ecust.edu.cn; zhouyan@ecust.edu.cn; wstan@ecust.edu.cn	yan, zhou/AEX-8535-2022	yan, zhou/0000-0002-9205-9936	Basic Research Project of Shanghai Science and Technology Commission [12JC1403101]; SRF for ROCS (SEM); National Special Fund for State Key Laboratory of Bioreactor Engineering [2060204]; National Natural Science Foundation of China [31170951]	Basic Research Project of Shanghai Science and Technology Commission; SRF for ROCS (SEM)(Scientific Research Foundation for the Returned Overseas Chinese Scholars); National Special Fund for State Key Laboratory of Bioreactor Engineering; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Basic Research Project of Shanghai Science and Technology Commission (12JC1403101), SRF for ROCS (SEM), National Special Fund for State Key Laboratory of Bioreactor Engineering (2060204) and National Natural Science Foundation of China (31170951). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botchwey EA, 2003, J BIOMED MATER RES A, V67A, P357, DOI 10.1002/jbm.a.10111; Carrier RL, 2002, TISSUE ENG, V8, P175, DOI 10.1089/107632702753724950; Chen MQ, 2011, BIOMATERIALS, V32, P7532, DOI 10.1016/j.biomaterials.2011.06.054; Chung HJ, 2009, TISSUE ENG PT A, V15, P1391, DOI 10.1089/ten.tea.2008.0344; David B, 2011, TISSUE ENG PART C-ME, V17, P505, DOI [10.1089/ten.tec.2010.0468, 10.1089/ten.TEC.2010.0468]; Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105; Du YA, 2011, BIOTECHNOL BIOENG, V108, P1693, DOI 10.1002/bit.23102; Fernandez JG, 2010, ADV MATER, V22, P2538, DOI 10.1002/adma.200903893; Frauenschuh S, 2007, BIOTECHNOL PROGR, V23, P187, DOI 10.1021/bp060155w; Frohlich M, 2010, TISSUE ENG PT A, V16, P179, DOI [10.1089/ten.tea.2009.0164, 10.1089/ten.TEA.2009.0164]; Gardel LS, 2013, J BIOMED MATER RES B, V101, P1377, DOI 10.1002/jbm.b.32955; Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G; Huss FRM, 2007, J PLAST RECONSTR AES, V60, P543, DOI 10.1016/j.bjps.2005.10.031; Huss FRM, 2010, J PLAST RECONSTR AES, V63, P848, DOI 10.1016/j.bjps.2009.01.068; Imparato G, 2013, BIOMATERIALS, V34, P7851, DOI 10.1016/j.biomaterials.2013.06.062; Ishaug SL, 1997, J BIOMED MATER RES, V36, P17; Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0; Jager M, 2007, J BONE MINER RES, V22, P1224, DOI 10.1359/JBMR.070414; Janssen FW, 2006, BIOMATERIALS, V27, P315, DOI 10.1016/j.biomaterials.2005.07.044; Khan OF, 2010, BIOMATERIALS, V31, P8254, DOI 10.1016/j.biomaterials.2010.07.041; Kim KI, 2014, BIOMATERIALS, V35, P4792, DOI 10.1016/j.biomaterials.2014.02.048; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Luo HY, 2014, J TISSUE ENG REGEN M, V8, P493, DOI 10.1002/term.1554; Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001; Matsunaga YT, 2011, ADV MATER, V23, pH90, DOI 10.1002/adma.201004375; McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103; Mei Y, 2010, J BIOTECHNOL, V150, P438, DOI 10.1016/j.jbiotec.2010.09.953; Mercier NR, 2004, ANN BIOMED ENG, V32, P418, DOI 10.1023/B:ABME.0000017547.84146.fd; Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084; Muhitch JW, 2000, CYTOTECHNOLOGY, V32, P253, DOI 10.1023/A:1008117410827; Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029; Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h; Palmiero C, 2010, ACTA BIOMATER, V6, P2548, DOI 10.1016/j.actbio.2010.01.026; Raynaud CM, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/658356; Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107; Scherberich A, 2007, STEM CELLS, V25, P1823, DOI 10.1634/stemcells.2007-0124; Schop D, 2008, J TISSUE ENG REGEN M, V2, P126, DOI 10.1002/term.73; Twal WO, 2014, ANN BIOMED ENG, V42, P1470, DOI 10.1007/s10439-013-0883-6; Yang J, 2009, ADV MATER, V21, P3404, DOI 10.1002/adma.200801990; Zhang ZY, 2010, BIOMATERIALS, V31, P608, DOI 10.1016/j.biomaterials.2009.09.078	40	150	158	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109214	10.1371/journal.pone.0109214	http://dx.doi.org/10.1371/journal.pone.0109214			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275528	gold, Green Submitted, Green Published			2022-12-27	WOS:000342591500076
J	Martinsen, S; Flodin, P; Berrebi, J; Lofgren, M; Bileviciute-Ljungar, I; Ingvar, M; Fransson, P; Kosek, E				Martinsen, Sofia; Flodin, Par; Berrebi, Jonathan; Lofgren, Monika; Bileviciute-Ljungar, Indre; Ingvar, Martin; Fransson, Peter; Kosek, Eva			Fibromyalgia Patients Had Normal Distraction Related Pain Inhibition but Cognitive Impairment Reflected in Caudate Nucleus and Hippocampus during the Stroop Color Word Test	PLOS ONE			English	Article							CEREBRAL BLOOD-FLOW; PROCESSING SPEED; HEALTHY CONTROLS; MODULATION; ACTIVATION; ATTENTION; SPECTROSCOPY; CONNECTIVITY; STIMULATION; DYSFUNCTION	The mechanisms causing cognitive problems in chronic pain patients are not well understood. We used the Stroop color word task (SCWT) to investigate distraction-induced analgesia, cognitive performance, and cerebral activation patterns in 29 fibromyalgia (FM) patients (mean age 49.8 years, range 25-64 years) and 31 healthy controls (HC) (mean age 46.3 years, range 20-63 years). In the first study, SCWT was used to investigate distraction-induced analgesia in FM patients. Two versions of the task were applied, one with only congruent color-word images and one with incongruent images. Pressure pain thresholds were assessed using a pressure algometer before, during, and following SCWT. In the second study, reaction times (RTs) were assessed and functional magnetic resonance imaging (fMRI) was used to investigate cerebral activation patterns in FM patients and HC during the SCWT. An event-related task mixing incongruent and congruent images was used. In study one, we found reduced pressure pain sensitivity during SCWT in both groups alike and no statistically significant differences were seen between the incongruent and congruent conditions. The study two revealed longer RTs during the incongruent compared to the congruent condition in both groups. FM patients had longer RTs than HC in both conditions. Furthermore, we found a significant interaction between group and congruency; that is, the group differences in RTs were more pronounced during the incongruent condition. This was reflected in a reduced activation of the caudate nucleus, lingual gyrus, temporal areas, and the hippocampus in FM patients compared to HC. In conclusion, we found normal pain inhibition during SWTC in FM patients. The cognitive difficulties seen in FM patients, reflected in longer RTs, were related to reduced activation of the caudate nucleus and hippocampus during incongruent SCWT, which most likely affected the mechanisms of cognitive learning in FM patients.	[Martinsen, Sofia; Flodin, Par; Berrebi, Jonathan; Ingvar, Martin; Fransson, Peter; Kosek, Eva] Karolinska Inst, Dept Clin Neurosci, Osher Ctr Integrat Med, Stockholm, Sweden; [Lofgren, Monika; Bileviciute-Ljungar, Indre] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, S-18288 Danderyd, Sweden	Karolinska Institutet; Danderyds Hospital; Karolinska Institutet	Martinsen, S (corresponding author), Karolinska Inst, Dept Clin Neurosci, Osher Ctr Integrat Med, Stockholm, Sweden.	sofia.martinsen@ki.se	; Fransson, Peter/M-5679-2014	Ingvar, Martin/0000-0002-9041-5714; Fransson, Peter/0000-0002-1305-9875; Lofgren, Monika/0000-0002-8701-0206; Kosek, Eva/0000-0003-0488-8177	Swedish Rheumatism Association; Stockholm County Council; Swedish Foundation for Strategic Research; Swedish Research Council [K2013-52X-22199-01-3]; Karolinska Institute Foundation	Swedish Rheumatism Association; Stockholm County Council(Stockholm County Council); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institute Foundation(Karolinska Institutet)	This study was supported by grants from the Swedish Rheumatism Association, the Stockholm County Council, the Swedish Foundation for Strategic Research, the Swedish Research Council K2013-52X-22199-01-3, and Karolinska Institute Foundation. No financial interests reported. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantick SJ, 2002, BRAIN, V125, P310, DOI 10.1093/brain/awf022; Baudic S, 2013, J PSYCHIATR RES, V47, P72, DOI 10.1016/j.jpsychires.2012.09.003; Bennett R, 2005, CLIN EXP RHEUMATOL, V23, pS154; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Cherry BJ, 2014, J GERONTOL B-PSYCHOL, V69, P199, DOI 10.1093/geronb/gbs122; Cherry BJ, 2009, ARCH PHYS MED REHAB, V90, P2066, DOI 10.1016/j.apmr.2009.07.011; Contopoulos-Ioannidis DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3006; Djamshidian A, 2011, PARKINSONISM RELAT D, V17, P212, DOI 10.1016/j.parkreldis.2010.12.014; Emad Y, 2008, J RHEUMATOL, V35, P1371; Fayed N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3072; Fechir M, 2012, EUR J PAIN, V16, P82, DOI 10.1016/j.ejpain.2011.06.009; Bertolucci PHF, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0344-9; Floden D, 2011, J COGNITIVE NEUROSCI, V23, P867, DOI 10.1162/jocn.2010.21492; Glass JM, 2011, J PAIN, V12, P1219, DOI 10.1016/j.jpain.2011.06.007; Glass JM, 2009, RHEUM DIS CLIN N AM, V35, P299, DOI 10.1016/j.rdc.2009.06.002; Gonzalez JL, 2010, J PSYCHOSOM RES, V69, P279, DOI 10.1016/j.jpsychores.2010.05.002; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Grisart JM, 1999, EUR J PAIN-LONDON, V3, P325, DOI 10.1016/S1090-3801(99)90014-9; Gur A, 2002, Clin Exp Rheumatol, V20, P753; Holman AJ, 2005, ARTHRITIS RHEUM-US, V52, P2495, DOI 10.1002/art.21191; Hsieh YH, 2008, KAOHSIUNG J MED SCI, V24, P197, DOI 10.1016/S1607-551X(08)70117-7; Jensen KB, 2013, ARTHRITIS RHEUM-US, V65, P3293, DOI 10.1002/art.38170; Jensen KB, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-32; Jensen KB, 2009, PAIN, V144, P95, DOI 10.1016/j.pain.2009.03.018; Kosek E, 1997, PAIN, V70, P41, DOI 10.1016/S0304-3959(96)03295-2; Kosek E, 1996, PAIN, V64, P415, DOI 10.1016/0304-3959(95)00112-3; Krause KH, 1998, J MUSCULOSKELET PAIN, V6, P111, DOI 10.1300/J094v06n04_10; Kwiatek R, 2000, ARTHRITIS RHEUM-US, V43, P2823, DOI 10.1002/1529-0131(200012)43:12<2823::AID-ANR24>3.0.CO;2-E; Lannersten L, 2010, PAIN, V151, P77, DOI 10.1016/j.pain.2010.06.021; Lautenbacher S, 1997, CLIN J PAIN, V13, P189, DOI 10.1097/00002508-199709000-00003; Leavitt F, 2008, JCR-J CLIN RHEUMATOL, V14, P214, DOI 10.1097/RHU.0b013e31817a2472; Legangneux E, 2001, RHEUMATOLOGY, V40, P290, DOI 10.1093/rheumatology/40.3.290; MOUNTZ JM, 1995, ARTHRITIS RHEUM, V38, P926, DOI 10.1002/art.1780380708; Oliveira PJ, 2013, J AUTOMIMMUNE DIS RH, V1, P11; Petrovic P, 2002, PAIN, V95, P1, DOI 10.1016/S0304-3959(01)00467-5; Petrovic P, 2000, PAIN, V85, P19, DOI 10.1016/S0304-3959(99)00232-8; Reyero F, 2011, EUR PSYCHIAT, V26, P482, DOI 10.1016/j.eurpsy.2010.03.012; del Paso GAR, 2012, EUR J PAIN, V16, P421, DOI 10.1002/j.1532-2149.2011.00032.x; Seminowicz DA, 2004, PAIN, V112, P48, DOI 10.1016/j.pain.2004.07.027; Seminowicz DA, 2007, CEREB CORTEX, V17, P1412, DOI 10.1093/cercor/bhl052; Staud R, 2005, PAIN, V118, P176, DOI 10.1016/j.pain.2005.08.007; Stray LL, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-18; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tracey I, 2002, J NEUROSCI, V22, P2748, DOI 10.1523/JNEUROSCI.22-07-02748.2002; Treister R, 2015, PAIN PRACT, V15, P4, DOI 10.1111/papr.12129; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Veldhuijzen DS, 2012, J PAIN, V13, P507, DOI 10.1016/j.jpain.2012.02.011; Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1084, DOI 10.1001/jama.2009.1308; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wood PB, 2007, EUR J NEUROSCI, V25, P3576, DOI 10.1111/j.1460-9568.2007.05623.x; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	51	26	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108637	10.1371/journal.pone.0108637	http://dx.doi.org/10.1371/journal.pone.0108637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ2BX	25275449	Green Submitted, Green Published, gold			2022-12-27	WOS:000342591500024
J	Rainford, JL; Hofreiter, M; Nicholson, DB; Mayhew, PJ				Rainford, James L.; Hofreiter, Michael; Nicholson, David B.; Mayhew, Peter J.			Phylogenetic Distribution of Extant Richness Suggests Metamorphosis Is a Key Innovation Driving Diversification in Insects	PLOS ONE			English	Article							INSIGHTS; CONSEQUENCES; RADIATIONS; SHIFTS; LAND; TREE; COLONIZATION; ARTHROPOD; DIVERSITY; INFERENCE	Insects and their six-legged relatives (Hexapoda) comprise more than half of all described species and dominate terrestrial and freshwater ecosystems. Understanding the macroevolutionary processes generating this richness requires a historical perspective, but the fossil record of hexapods is patchy and incomplete. Dated molecular phylogenies provide an alternative perspective on divergence times and have been combined with birth-death models to infer patterns of diversification across a range of taxonomic groups. Here we generate a dated phylogeny of hexapod families, based on previously published sequence data and literature derived constraints, in order to identify the broad pattern of macroevolutionary changes responsible for the composition of the extant hexapod fauna. The most prominent increase in diversification identified is associated with the origin of complete metamorphosis, confirming this as a key innovation in promoting insect diversity. Subsequent reductions are recovered for several groups previously identified as having a higher fossil diversity during the Mesozoic. In addition, a number of recently derived taxa are found to have radiated following the development of flowering plant (angiosperm) floras during the mid-Cretaceous. These results reveal that the composition of the modern hexapod fauna is a product of a key developmental innovation, combined with multiple and varied evolutionary responses to environmental changes from the mid Cretaceous floral transition onward.	[Rainford, James L.; Hofreiter, Michael; Nicholson, David B.; Mayhew, Peter J.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Hofreiter, Michael] Univ Potsdam, Inst Biochem & Biol, Fac Math & Nat Sci, Potsdam, Germany; [Nicholson, David B.] Natl Museums Scotland, Dept Nat Sci, Edinburgh, Midlothian, Scotland; [Nicholson, David B.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	University of York - UK; University of Potsdam; Natural History Museum London	Rainford, JL (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	jlr516@york.ac.uk	Mayhew, Peter J/I-6363-2012; Hofreiter, Michael/A-3996-2017	Mayhew, Peter J/0000-0002-7346-6560; Hofreiter, Michael/0000-0003-0441-4705; Nicholson, David/0000-0002-1296-5673	NERC [NE/J500197/1]; National Museums of Scotland; Natural History Museum, London; Natural Environment Research Council [1107606] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Museums of Scotland; Natural History Museum, London; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was primarily funded by NERC (http://www.nerc.ac.uk) grant NE/J500197/1. Contributions were also made by the National Museums of Scotland and The Natural History Museum, London in funding for DN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Blagoderov V, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)509[1:HTFFFD]2.0.CO;2; Brown J.W., 2012, MEDUSA MODELING EVOL; CARPENTER F. M., 1953, AMER SCIENTIST, V41, P256; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cho S, 2011, SYST BIOL, V60, P782, DOI 10.1093/sysbio/syr079; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; Davis RB, 2009, J EVOLUTION BIOL, V22, P1750, DOI 10.1111/j.1420-9101.2009.01789.x; Davis RB, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-252; Davis RB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-109; Davis RB, 2010, P ROY SOC B-BIOL SCI, V277, P1597, DOI 10.1098/rspb.2009.2299; de Queiroz A, 1998, SYST BIOL, V47, P710, DOI 10.1080/106351598260699; Dudley R, 2002, BIOMECHANICS INSECT; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Fiz-Palacios O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-341; GASTON KJ, 1991, CONSERV BIOL, V5, P283, DOI 10.1111/j.1523-1739.1991.tb00140.x; Gomez-Zurita J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000360; Grimaldi David, 2005, pi; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Heikkila M, 2012, P ROY SOC B-BIOL SCI, V279, P1093, DOI 10.1098/rspb.2011.1430; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kenrick P, 2012, PHILOS T R SOC B, V367, P519, DOI 10.1098/rstb.2011.0271; Labandeir CC, 2011, ENTOMOL AM-NY, V117, P9, DOI 10.1664/10-RA-011.1; Labandeira CC, 1998, ANNU REV EARTH PL SC, V26, P329, DOI 10.1146/annurev.earth.26.1.329; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; Labandeira Conrad C., 2005, American Entomologist, V51, P14; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Mayhew PJ, 2007, BIOL REV, V82, P425, DOI 10.1111/j.1469-185X.2007.00018.x; Mayhew PJ, 2002, P ROY SOC B-BIOL SCI, V269, P969, DOI 10.1098/rspb.2002.1957; Mayhew PJ, 2003, BIOL J LINN SOC, V80, P23, DOI 10.1046/j.1095-8312.2003.00217.x; Miller M.A., 2010, P GAT COMP ENV WORKS; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; Nel A, 2013, NATURE, V503, P257, DOI 10.1038/nature12629; Nicholson DB, 2014, P R SOC IN PRESS B; Nyman T, 2010, BIOL REV, V85, P393, DOI 10.1111/j.1469-185X.2009.00109.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Regier JC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058568, 10.1371/journal.pone.0072678]; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ross Andrew J., 2000, P288, DOI 10.1017/CBO9780511535505.020; Rota-Stabelli O, 2013, CURR BIOL, V23, P392, DOI 10.1016/j.cub.2013.01.026; SOHN JC, 2012, ZOOTAXA, P1; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; Wheat CW, 2013, SYST BIOL, V62, P93, DOI 10.1093/sysbio/sys074; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; WIEGMANN BM, 1993, AM NAT, V142, P737, DOI 10.1086/285570; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Wills MA, 2001, GEOL J, V36, P187, DOI 10.1002/gj.882; Yang AS, 2001, EVOL DEV, V3, P59, DOI 10.1046/j.1525-142x.2001.003002059.x; Yeates DK, 2012, AUST J ENTOMOL, V51, P79, DOI 10.1111/j.1440-6055.2012.00857.x; Yoshizawa K, 2010, MOL PHYLOGENET EVOL, V55, P939, DOI 10.1016/j.ympev.2010.02.026	58	90	94	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109085	10.1371/journal.pone.0109085	http://dx.doi.org/10.1371/journal.pone.0109085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275450	gold, Green Published, Green Accepted			2022-12-27	WOS:000342591500056
J	Xu, Y; Ito, T; Fushimi, S; Takahashi, S; Itakura, J; Kimura, R; Sato, M; Mino, M; Yoshimura, A; Matsukawa, A				Xu, Yang; Ito, Toshihiro; Fushimi, Soichiro; Takahashi, Sakuma; Itakura, Junya; Kimura, Ryojiro; Sato, Miwa; Mino, Megumi; Yoshimura, Akihiko; Matsukawa, Akihiro			Spred-2 Deficiency Exacerbates Lipopolysaccharide-Induced Acute Lung Inflammation in Mice	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; ALVEOLAR MACROPHAGES; SIGNALING PATHWAYS; EPITHELIAL-CELLS; GENE-EXPRESSION; MAP KINASE; CROSS-TALK; INJURY	Background: Acute respiratory distress syndrome (ARDS) is a severe and life-threatening acute lung injury (ALI) that is caused by noxious stimuli and pathogens. ALI is characterized by marked acute inflammation with elevated alveolar cytokine levels. Mitogen-activated protein kinase (MAPK) pathways are involved in cytokine production, but the mechanisms that regulate these pathways remain poorly characterized. Here, we focused on the role of Sprouty-related EVH1-domain-containing protein (Spred)-2, a negative regulator of the Ras-Raf-extracellular signal-regulated kinase (ERK)-MAPK pathway, in lipopolysaccharide (LPS)-induced acute lung inflammation. Methods: Wild-type (WT) mice and Spred-2(-/-) mice were exposed to intratracheal LPS (50 mu g in 50 mu L PBS) to induce pulmonary inflammation. After LPS-injection, the lungs were harvested to assess leukocyte infiltration, cytokine and chemokine production, ERK-MAPK activation and immunopathology. For ex vivo experiments, alveolar macrophages were harvested from untreated WT and Spred-2(-/-) mice and stimulated with LPS. In in vitro experiments, specific knock down of Spred-2 by siRNA or overexpression of Spred-2 by transfection with a plasmid encoding the Spred-2 sense sequence was introduced into murine RAW264.7 macrophage cells or MLE-12 lung epithelial cells. Results: LPS- induced acute lung inflammation was significantly exacerbated in Spred-2(-/-) mice compared with WT mice, as indicated by the numbers of infiltrating leukocytes, levels of alveolar TNF-alpha, CXCL2 and CCL2 in a later phase, and lung pathology. U0126, a selective MEK/ERK inhibitor, reduced the augmented LPS-induced inflammation in Spred-2(-/-) mice. Specific knock down of Spred-2 augmented LPS-induced cytokine and chemokine responses in RAW264.7 cells and MLE-12 cells, whereas Spred-2 overexpression decreased this response in RAW264.7 cells. Conclusions: The ERK-MAPK pathway is involved in LPS-induced acute lung inflammation. Spred-2 controls the development of LPS-induced lung inflammation by negatively regulating the ERK-MAPK pathway. Thus, Spred-2 may represent a therapeutic target for the treatment of ALI.	[Xu, Yang; Ito, Toshihiro; Fushimi, Soichiro; Takahashi, Sakuma; Itakura, Junya; Kimura, Ryojiro; Sato, Miwa; Mino, Megumi; Matsukawa, Akihiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol & Expt Med, Okayama, Japan; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan	Okayama University; Keio University	Matsukawa, A (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol & Expt Med, Okayama, Japan.	amatsu@md.okayama-u.ac.jp	Yoshimura, Akihiko/K-5515-2013	Matsukawa, Akihiro/0000-0002-5081-6089	Ministry of Education, Culture, Sports, Science and Technology of Japan;  [25293095]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a Grant-in-Aid for Scientific Research (B) (25293095). There were no further internal or external sources of funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aga M, 2004, AM J PHYSIOL-CELL PH, V286, pC923, DOI 10.1152/ajpcell.00417.2003; Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Asti C, 2000, PULM PHARMACOL THER, V13, P61, DOI 10.1006/pupt.2000.0231; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; Carter AB, 1998, AM J RESP CELL MOL, V18, P384, DOI 10.1165/ajrcmb.18.3.2972; Engelhardt CM, 2004, HISTOCHEM CELL BIOL, V122, P527, DOI 10.1007/s00418-004-0725-6; Fang WF, 2007, AM J PHYSIOL-LUNG C, V293, pL336, DOI 10.1152/ajplung.00011.2007; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fey D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00355; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Jarrar D, 2002, AM J PHYSIOL-LUNG C, V283, pL799, DOI 10.1152/ajplung.00465.2001; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kato R, 2003, BIOCHEM BIOPH RES CO, V302, P767, DOI 10.1016/S0006-291X(03)00259-6; Lee HS, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-23; Li XY, 2010, CYTOKINE, V49, P1, DOI 10.1016/j.cyto.2009.08.010; LOHMANNMATTHES ML, 1994, EUR RESPIR J, V7, P1678; Matsukawa A, 2005, J IMMUNOL, V175, P3354, DOI 10.4049/jimmunol.175.5.3354; Matsukawa A, 2001, J EXP MED, V193, P679, DOI 10.1084/jem.193.6.679; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Maus UA, 2002, AM J PHYSIOL-LUNG C, V282, pL1245, DOI 10.1152/ajplung.00453.2001; MEDURI GU, 1995, CHEST, V107, P1062, DOI 10.1378/chest.107.4.1062; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Menges CW, 2008, ONCOGENE, V27, P2934, DOI 10.1038/sj.onc.1210957; Musah S, 2012, TOXICOLOGY, V299, P125, DOI 10.1016/j.tox.2012.05.014; Nick JA, 2002, J IMMUNOL, V169, P5260, DOI 10.4049/jimmunol.169.9.5260; Nobuhisa I, 2004, J EXP MED, V199, P737, DOI 10.1084/jem.20030830; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Ryu JH, 2010, MOL CELLS, V30, P173, DOI 10.1007/s10059-010-0146-4; Schuh K, 2009, BIOCHEM PHARMACOL, V77, P1827, DOI 10.1016/j.bcp.2009.03.012; Sharma AK, 2007, AM J PHYSIOL-LUNG C, V293, pL105, DOI 10.1152/ajplung.00470.2006; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Taniguchi K, 2007, MOL CELL BIOL, V27, P4541, DOI 10.1128/MCB.01600-06; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wang LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055311	38	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108914	10.1371/journal.pone.0108914	http://dx.doi.org/10.1371/journal.pone.0108914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275324	gold, Green Submitted, Green Published			2022-12-27	WOS:000342591500039
J	Bode, S; Bennett, D; Stahl, J; Murawski, C				Bode, Stefan; Bennett, Daniel; Stahl, Jutta; Murawski, Carsten			Distributed Patterns of Event-Related Potentials Predict Subsequent Ratings of Abstract Stimulus Attributes	PLOS ONE			English	Article							NEURAL MECHANISMS; DECISION-MAKING; ATTENTION; FUTURE; P300; CLASSIFICATION; COMPONENT; DYNAMICS; PICTURES; EMOTION	Exposure to pleasant and rewarding visual stimuli can bias people's choices towards either immediate or delayed gratification. We hypothesised that this phenomenon might be based on carry-over effects from a fast, unconscious assessment of the abstract 'time reference' of a stimuli, i.e. how the stimulus relates to one's personal understanding and connotation of time. Here we investigated whether participants' post-experiment ratings of task-irrelevant, positive background visual stimuli for the dimensions 'arousal' (used as a control condition) and 'time reference' were related to differences in single-channel event-related potentials (ERPs) and whether they could be predicted from spatio-temporal patterns of ERPs. Participants performed a demanding foreground choice-reaction task while on each trial one task-irrelevant image (depicting objects, people and scenes) was presented in the background. Conventional ERP analyses as well as multivariate support vector regression (SVR) analyses were conducted to predict participants' subsequent ratings. We found that only SVR allowed both 'arousal' and 'time reference' ratings to be predicted during the first 200 ms post-stimulus. This demonstrates an early, automatic semantic stimulus analysis, which might be related to the high relevance of 'time reference' to everyday decision-making and preference formation.	[Bode, Stefan; Bennett, Daniel; Stahl, Jutta] Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3052, Australia; [Bennett, Daniel; Murawski, Carsten] Univ Melbourne, Dept Finance, Parkville, Vic 3052, Australia; [Stahl, Jutta] Univ Cologne, Dept Psychol, D-50931 Cologne, Germany	University of Melbourne; University of Melbourne; University of Cologne	Bode, S (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3052, Australia.	sbode@unimelb.edu.au		Murawski, Carsten/0000-0002-1237-9535; Stahl, Jutta/0000-0002-3252-180X; Bennett, Daniel/0000-0001-6608-9026; Bode, Stefan/0000-0002-0258-7795	Early Career Researcher (ECR) Grant from the University of Melbourne; Department of Finance Initiative Project Grant from the University of Melbourne; Australian Research Council [DE 140100350]	Early Career Researcher (ECR) Grant from the University of Melbourne; Department of Finance Initiative Project Grant from the University of Melbourne; Australian Research Council(Australian Research Council)	This work was supported by an Early Career Researcher (ECR) Grant from the University of Melbourne to S.B., a Department of Finance Initiative Project Grant from the University of Melbourne to C.M. and S.B., and an Australian Research Council Discovery Early Career Researcher Award (DE 140100350) to S.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai O, 2007, CLIN NEUROPHYSIOL, V118, P2637, DOI 10.1016/j.clinph.2007.08.025; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; BODDY J, 1981, BIOL PSYCHOL, V12, P43, DOI 10.1016/0301-0511(81)90019-3; Bode S, 2012, J NEUROSCI, V32, P12488, DOI 10.1523/JNEUROSCI.1708-12.2012; Bogler C, 2011, CURR BIOL, V21, P1667, DOI 10.1016/j.cub.2011.08.039; Bradley M. M., 2007, HDB EMOTION ELICITAT, P29; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheng YY, 2012, BRIT J PSYCHOL, V103, P129, DOI 10.1111/j.2044-8295.2011.02067.x; Cohen HL, 2002, ALCOHOL CLIN EXP RES, V26, P303, DOI 10.1111/j.1530-0277.2002.tb02539.x; Colas JT, 2014, HUM BRAIN MAPP, V35, P2924, DOI 10.1002/hbm.22374; Creswell JD, 2013, SOC COGN AFFECT NEUR, V8, P863, DOI 10.1093/scan/nst004; Custers R, 2010, SCIENCE, V329, P47, DOI 10.1126/science.1188595; Das K, 2010, NEUROIMAGE, V51, P1425, DOI 10.1016/j.neuroimage.2010.03.030; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dijksterhuis A, 2006, SCIENCE, V311, P1005, DOI 10.1126/science.1121629; Dijksterhuis A, 2010, ANNU REV PSYCHOL, V61, P467, DOI 10.1146/annurev.psych.093008.100445; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Feng CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029668; Gaeta H, 2003, PSYCHOPHYSIOLOGY, V40, P198, DOI 10.1111/1469-8986.00022; Garcia JO, 2013, CURR BIOL, V23, P515, DOI 10.1016/j.cub.2013.02.013; GEVINS A, 1989, Brain Topography, V2, P37, DOI 10.1007/BF01128842; Haufe S, 2014, NEUROIMAGE, V87, P96, DOI 10.1016/j.neuroimage.2013.10.067; Hillyard SA, 1998, CURR OPIN NEUROBIOL, V8, P202, DOI 10.1016/S0959-4388(98)80141-4; Kaspar K, 2011, J VIS, V11, pe13; Kim BK, 2013, J EXP PSYCHOL GEN, V142, P328, DOI 10.1037/a0028954; Kim H, 2007, P NATL ACAD SCI USA, V104, P18253, DOI 10.1073/pnas.0703101104; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kovalenko AA, 2010, NEUROPHYSIOLOGY+, V42, P70, DOI 10.1007/s11062-010-9133-9; Lang P.J., 2008, INT AFFECTIVE PICTUR; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lang PJ, 1998, PSYCHOPHYSIOLOGY, V35, P199, DOI 10.1017/S0048577298001991; Lin Z, PSYCH SCI IN PRESS; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Luck SJ, 2012, OXFORD HDB EVENT REL; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Murawski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034155; Naber M, 2012, J VIS, V12, pe1; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Oppermann F, 2012, J COGNITIVE NEUROSCI, V24, P521, DOI 10.1162/jocn_a_00100; Peelen MV, 2009, NATURE, V460, P94, DOI 10.1038/nature08103; PERNIER J, 1988, ELECTROEN CLIN NEURO, V69, P385, DOI 10.1016/0013-4694(88)90009-0; PERRIN F, 1987, IEEE T BIO-MED ENG, V34, P283, DOI 10.1109/TBME.1987.326089; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Peters J, 2011, TRENDS COGN SCI, V15, P227, DOI 10.1016/j.tics.2011.03.002; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Philiastides MG, 2006, CEREB CORTEX, V16, P509, DOI 10.1093/cercor/bhi130; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Sabatinelli D, 2007, CEREB CORTEX, V17, P1085, DOI 10.1093/cercor/bhl017; Schupp HT, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-16; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; Tusche A, 2013, NEUROIMAGE, V72, P174, DOI 10.1016/j.neuroimage.2013.01.020; Tusche A, 2010, J NEUROSCI, V30, P8024, DOI 10.1523/JNEUROSCI.0064-10.2010; Van den Bergh B, 2008, J CONSUM RES, V35, P85, DOI 10.1086/525505; Van der Laan LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041738; VERLEGER R, 1988, BEHAV BRAIN SCI, V11, P343, DOI 10.1017/S0140525X00058015; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Wijers AA, 1996, BRAIN  POTENTIAL ALA; Wilson M, 2004, P ROY SOC B-BIOL SCI, V271, pS177, DOI 10.1098/rsbl.2003.0134; Woelbert E, 2013, NEUROSCI NEUROECON, V2, P11, DOI DOI 10.2147/NAN.S24226; Zhong CB, 2010, PSYCHOL SCI, V21, P619, DOI 10.1177/0956797610366090	66	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109070	10.1371/journal.pone.0109070	http://dx.doi.org/10.1371/journal.pone.0109070			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZM	25271850	gold, Green Published			2022-12-27	WOS:000343729600095
J	Chor, JSY; Lam, HCY; Chan, A; Lee, HM; Fok, E; Griffiths, S; Cheung, P				Chor, Josette Sin Yee; Lam, Holly Ching Yu; Chan, Amy; Lee, Hang Mei; Fok, Eliza; Griffiths, Sian; Cheung, Polly			Socioeconomic Disparity in Breast Cancer Detection in Hong Kong - A High Income City: Retrospective Epidemiological Study Using the Breast Cancer Registry	PLOS ONE			English	Article							UNITED-STATES; DIAGNOSIS; STAGE; SURVIVAL	Background: It is not known whether socioeconomic disparities affect the detection of breast cancer in Asian countries where the incidence of breast cancer is a rising trend. In this study, we explore the socioeconomic profiles of women and the stage of the disease at the time of diagnosis in breast cancer patients aged 40 or over in Hong Kong. Method: During the period 2008 to 2011, 5393 breast cancer patients registered with the Hong Kong Breast Cancer Registry. Participants and their clinicians were asked to complete standardised questionnaires including patient socio-demographics, health history and risk factors, the course of the disease, post-treatment physical discomfort and psychosocial impact, follow-up recurrence and survival status. Results: Monthly household incomes, educational levels and the practice of regular screening are independently associated with the stage of the disease at diagnosis. Higher socioeconomic status and a higher educational level were associated with an earlier stage of the disease at the time of diagnosis. Yearly clinical examinations, ultrasound and mammographic screening every 2 to 3 years were significantly associated with the earlier detection of breast cancer. Conclusion: There were socioeconomic disparities among Hong Kong women who were found to have breast cancer. Population-based screening policies, including raising awareness among women at risk, should be implemented.	[Chor, Josette Sin Yee; Lam, Holly Ching Yu; Griffiths, Sian] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China; [Chan, Amy; Lee, Hang Mei; Fok, Eliza; Cheung, Polly] Hong Kong Breast Canc Fdn, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Chor, JSY (corresponding author), Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China.	josette@cuhk.edu.hk			Professor Richard Yu Charity Photo Exhibition; WKK; Astra-Zeneca; Genomic Health; Glaxo-Smith-Kline; Novartis; Pfizer; Roche; Sanofi-Aventis	Professor Richard Yu Charity Photo Exhibition; WKK; Astra-Zeneca(AstraZeneca); Genomic Health; Glaxo-Smith-Kline(GlaxoSmithKline); Novartis(Novartis); Pfizer(Pfizer); Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis)	The financial support is from Professor Richard Yu Charity Photo Exhibition, WKK, Astra-Zeneca, Genomic Health, Glaxo-Smith-Kline, Novartis, Pfizer, Roche and Sanofi-Aventis and individual and anonymous donors who have supported the maintenance of HKBCR database. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell RT, 2009, HEALTH PLACE, V15, P870, DOI 10.1016/j.healthplace.2009.02.007; Chan L K, 1998, Australas Radiol, V42, P6, DOI 10.1111/j.1440-1673.1998.tb00554.x; Chatterjee N, 2011, J GEN INTERN MED, V26, pS24; Clegg LX, 2009, CANCER CAUSE CONTROL, V20, P417, DOI 10.1007/s10552-008-9256-0; Cuthbertson SA, 2009, J PUBLIC HEALTH-UK, V31, P398, DOI 10.1093/pubmed/fdp042; DeSantis C, 2010, CANCER CAUSE CONTROL, V21, P1445, DOI 10.1007/s10552-010-9572-z; Gorey KM, 2009, ANN EPIDEMIOL, V19, P121, DOI 10.1016/j.annepidem.2008.10.010; Howlader N, 2011, SEER CANC STAT REV 1; Keller D, 2011, AM SURGEON, V77, P933; Lui C. Y., 2007, Hong Kong Medical Journal, V13, P106; Maskarinec G, 2011, WOMENS HEALTH, V7, P677, DOI [10.2217/WHE.11.67, 10.2217/whe.11.67]; Northington L, 2010, INTEGRATED COMMUNITY, V15, P387; Ooi SL, 2011, BREAST CANCER RES TR, V127, P729, DOI 10.1007/s10549-010-1191-6; Rauscher GH, 2012, J WOMENS HEALTH, V21, P154, DOI 10.1089/jwh.2010.2415; Rauscher GH, 2011, AACR INT C SCI CANC, pB48; Sprague BL, 2011, CANCER-AM CANCER SOC, V117, P1542, DOI 10.1002/cncr.25589; Yu XQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-364	17	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e107630	10.1371/journal.pone.0107630	http://dx.doi.org/10.1371/journal.pone.0107630			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271739	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600014
J	Legras, JL; Erny, C; Charpentier, C				Legras, Jean-Luc; Erny, Claude; Charpentier, Claudine			Population Structure and Comparative Genome Hybridization of European Flor Yeast Reveal a Unique Group of Saccharomyces cerevisiae Strains with Few Gene Duplications in Their Genome	PLOS ONE			English	Article							ADAPTIVE EVOLUTION; MOLECULAR CHARACTERIZATION; BIOFILM FORMATION; CLONAL INTERFERENCE; SHERRY WINES; ADAPTATION; EXPRESSION; GENOTYPE; REARRANGEMENTS; FERMENTATION	Wine biological aging is a wine making process used to produce specific beverages in several countries in Europe, including Spain, Italy, France, and Hungary. This process involves the formation of a velum at the surface of the wine. Here, we present the first large scale comparison of all European flor strains involved in this process. We inferred the population structure of these European flor strains from their microsatellite genotype diversity and analyzed their ploidy. We show that almost all of these flor strains belong to the same cluster and are diploid, except for a few Spanish strains. Comparison of the array hybridization profile of six flor strains originating from these four countries, with that of three wine strains did not reveal any large segmental amplification. Nonetheless, some genes, including YKL221W/MCH2 and YKL222C, were amplified in the genome of four out of six flor strains. Finally, we correlated ICR1 ncRNA and FLO11 polymorphisms with flor yeast population structure, and associate the presence of wild type ICR1 and a long Flo11p with thin velum formation in a cluster of Jura strains. These results provide new insight into the diversity of flor yeast and show that combinations of different adaptive changes can lead to an increase of hydrophobicity and affect velum formation.	[Legras, Jean-Luc] INRA, Sci OEnol UMR1083, F-34060 Montpellier, France; [Legras, Jean-Luc] Montpellier SupAgro, Sci OEnol UMR1083, Montpellier, France; [Legras, Jean-Luc] Univ Montpellier I, Sci OEnol UMR1083, Montpellier, France; [Erny, Claude] Univ Haute Alsace, Lab Vigne Biotechnol & Environm, Colmar, France; [Charpentier, Claudine] Univ Bourgogne, Inst Univ Vigne & Vin, Dijon, France	INRAE; Universite de Montpellier; Institut Agro; Montpellier SupAgro; Universite de Montpellier; Universite de Montpellier; Universites de Strasbourg Etablissements Associes; Universite de Haute-Alsace (UHA); Universite de Bourgogne	Legras, JL (corresponding author), INRA, Sci OEnol UMR1083, F-34060 Montpellier, France.	jean-luc.legras@supagro.inra.fr	Legras, Jean-Luc/A-7589-2008	Legras, Jean-Luc/0000-0002-4006-4389				ADAMS J, 1992, CURR GENET, V22, P13, DOI 10.1007/BF00351736; Alexandre H, 2013, INT J FOOD MICROBIOL, V167, P269, DOI 10.1016/j.ijfoodmicro.2013.08.021; Ames RM, 2010, GENOME BIOL EVOL, V2, P591, DOI 10.1093/gbe/evq043; Pozo-Bayon MA, 2011, ADV FOOD NUTR RES, V63, P17, DOI 10.1016/B978-0-12-384927-4.00002-6; Arlt H, 2011, TRAFFIC, V12, P1592, DOI 10.1111/j.1600-0854.2011.01252.x; Borneman AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001287; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; Brion C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-681; Budroni M, 2000, J APPL MICROBIOL, V89, P657, DOI 10.1046/j.1365-2672.2000.01163.x; Bumgarner SL, 2009, P NATL ACAD SCI USA, V106, P18321, DOI 10.1073/pnas.0909641106; Capece A, 2013, FOOD MICROBIOL, V36, P447, DOI 10.1016/j.fm.2013.07.008; Carreto L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-524; Chang SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003232; Charpentier C, 2009, ANTON LEEUW INT J G, V95, P263, DOI 10.1007/s10482-009-9309-8; Collin S, 2012, J AGR FOOD CHEM, V60, P380, DOI 10.1021/jf203832c; Cortes MB, 1998, J AGR FOOD CHEM, V46, P2389, DOI 10.1021/jf970903k; Cubillos FA, 2011, MOL ECOL, V20, P1401, DOI 10.1111/j.1365-294X.2011.05005.x; Cubillos FA, 2009, FEMS MICROBIOL ECOL, V67, P162, DOI 10.1111/j.1574-6941.2008.00600.x; Delobel P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084645; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Dunn B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-53; Dunn B, 2012, GENOME RES, V22, P908, DOI 10.1101/gr.130310.111; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erny C, 2012, APPL ENVIRON MICROB, V78, P3256, DOI 10.1128/AEM.06752-11; Esteve-Zarzoso B, 2004, ANTON LEEUW INT J G, V85, P151, DOI 10.1023/B:ANTO.0000020282.83717.bd; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Fidalgo M, 2006, P NATL ACAD SCI USA, V103, P11228, DOI 10.1073/pnas.0601713103; Fornachon JC, 1953, STUDIES SHERRY FLOR; Galeote V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017872; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Goddard MR, 2010, ENVIRON MICROBIOL, V12, P63, DOI 10.1111/j.1462-2920.2009.02035.x; Gresham D, 2010, P NATL ACAD SCI USA, V107, P18551, DOI 10.1073/pnas.1014023107; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Guijo S, 1997, YEAST, V13, P101, DOI 10.1002/(SICI)1097-0061(199702)13:2<101::AID-YEA66>3.0.CO;2-H; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ibanez C, 2014, INT J FOOD MICROBIOL, V171, P129, DOI [10.1016/j.ijfoodmicro.2013.10.023, 10.1016]; Infante JJ, 2003, GENETICS, V165, P1745; Ishigami M, 2004, FEMS MICROBIOL LETT, V237, P425, DOI 10.1016/j.femsle.2004.07.012; Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Legras JL, 2003, FEMS MICROBIOL LETT, V221, P249, DOI 10.1016/S0378-1097(03)00205-2; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Makuc J, 2001, YEAST, V18, P1131, DOI 10.1002/yea.763; MARTINEZ P, 1995, YEAST, V11, P1399, DOI 10.1002/yea.320111408; Mesa JJ, 1999, FOOD SCI TECHNOL-LEB, V32, P114; Naumova ES, 2005, APPL BIOCHEM MICRO+, V41, P578, DOI 10.1007/s10438-005-0105-6; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Novo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074086; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; Perez-Ortin JE, 2002, GENOME RES, V12, P1533, DOI 10.1101/gr.436602; PHAM TT, 1995, J AGR FOOD CHEM, V43, P2616; Pritchard JK, 2000, GENETICS, V155, P945; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SANCHO ED, 1986, APPL ENVIRON MICROB, V51, P395, DOI 10.1128/AEM.51.2.395-397.1986; Stefanini I, 2012, P NATL ACAD SCI USA, V109, P13398, DOI 10.1073/pnas.1208362109; Takezaki N, 1996, GENETICS, V144, P389; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Zara G, 2009, MICROBIOL-SGM, V155, P3838, DOI 10.1099/mic.0.028738-0; Zara S, 2005, APPL ENVIRON MICROB, V71, P2934, DOI 10.1128/AEM.71.6.2934-2939.2005; Zara S, 2002, YEAST, V19, P269, DOI 10.1002/yea.831; Zara S, 2010, APPL ENVIRON MICROB, V76, P4089, DOI 10.1128/AEM.00111-10; Zimmer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086298	67	36	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108089	10.1371/journal.pone.0108089	http://dx.doi.org/10.1371/journal.pone.0108089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272156	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600026
J	Panovska-Griffiths, J; Vassall, A; Prudden, HJ; Lepine, A; Boily, MC; Chandrashekar, S; Mitchell, KM; Beattie, TS; Alary, M; Martin, NK; Vickerman, P				Panovska-Griffiths, Jasmina; Vassall, Anna; Prudden, Holly J.; Lepine, Aurelia; Boily, Marie-Claude; Chandrashekar, Sudha; Mitchell, Kate M.; Beattie, Tara S.; Alary, Michel; Martin, Natasha K.; Vickerman, Peter			Optimal Allocation of Resources in Female Sex Worker Targeted HIV Prevention Interventions: Model Insights from Avahan in South India	PLOS ONE			English	Article							COST-EFFECTIVENESS; INFECTION; EPIDEMIC; PROGRAM; HEALTH; MEN	Background: The Avahan programme has provided HIV prevention activities, including condom promotion, to female sex workers (FSWs) in southern India since 2004. Evidence suggests Avahan averted 202,000 HIV infections over 4 years. For replicating this intervention elsewhere, it is essential to understand how the intervention's impact could have been optimised for different budget levels. Methods: Behavioural data were used to determine how condom use varied for FSWs with different levels of intervention intensity. Cost data from 64 Avahan districts quantified how district-level costs related to intervention scale and intensity. A deterministic model for HIV transmission amongst FSWs and clients projected the impact and cost of intervention strategies for different scale and intensity, and identified the optimal strategies that maximise impact for different budget levels. Results: As budget levels increase, the optimal intervention strategy is to first increase intervention intensity which achieves little impact, then scale-up coverage to high levels for large increases in impact, and lastly increase intensity further for small additional gains. The cost-effectiveness of these optimal strategies generally improves with increasing resources, while straying from these strategies can triple costs for the same impact. Projections suggest Avahan was close to being optimal, and moderate budget reductions (>= 20%) would have reduced impact considerably (>40%). Discussion: Our analysis suggests that tailoring the design of HIV prevention programmes for FSWs can improve impact, and that a certain level of resources are required to achieve demonstrable impact. These insights are critical for optimising the use of limited resources for preventing HIV.	[Panovska-Griffiths, Jasmina; Vassall, Anna; Prudden, Holly J.; Lepine, Aurelia; Chandrashekar, Sudha; Mitchell, Kate M.; Beattie, Tara S.; Vickerman, Peter] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Social & Math Epidemiol Grp, London WC1, England; [Panovska-Griffiths, Jasmina] UCL, Dept Math, London, England; [Martin, Natasha K.; Vickerman, Peter] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Boily, Marie-Claude] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Boily, Marie-Claude; Alary, Michel] CHU Quebec, Ctr Rech, Quebec City, PQ, Canada; [Alary, Michel] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Chandrashekar, Sudha] St Johns Res Inst, Bangalore, Karnataka, India	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of Bristol; Imperial College London; Laval University; Laval University; St. John's National Academy of Health Sciences; St. John's Research Institute	Panovska-Griffiths, J (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Social & Math Epidemiol Grp, London WC1, England.	jasmina.panovska-griffiths@lshtm.ac.uk	Mitchell, Kate/ABE-5796-2020	Vickerman, Peter/0000-0002-8291-5890; Boily, Marie-Claude/0000-0003-3919-006X; Beattie, Tara/0000-0001-9156-7341; Panovska-Griffiths, Jasmina/0000-0002-7720-1121; Vassall, Anna/0000-0002-2911-1375; Martin, Natasha/0000-0001-8344-1810; Lepine, Aurelia/0000-0002-9237-2914	World Bank grant; National Institute for Health Research [PDF-2011-04-049] Funding Source: researchfish	World Bank grant; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by a World Bank grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alary M, 2013, AIDS, V27, P1369, DOI 10.1097/QAD.0b013e32835fd7bd; [Anonymous], 2011, IND INT BEH BIOL ASS; [Anonymous], JOINT UN PROGR HIV A; Arora P, 2004, CAN MED ASSOC J, V171, P1337, DOI 10.1503/cmaj.045032; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Beyrer C, 2010, LANCET, V376, P551, DOI 10.1016/S0140-6736(10)60928-2; Bill & Melinda Gates Foundation, 2010, AV IND AIDS IN COMM; Bill & Melinda Gates Foundation, 2008, AV IND AIDS IN BUS H, P40; Boily MC, 2013, AIDS, V27, P1449, DOI 10.1097/QAD.0b013e32835fba81; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Bradley J, 2010, SEX TRANSM INFECT, V86, pI44, DOI 10.1136/sti.2009.038398; Brandeau Margaret L, 2005, Health Care Manag Sci, V8, P19, DOI 10.1007/s10729-005-5213-6; Chandrashkar S, 2011, SEX TRANSM INFECT, V87, pA9, DOI 10.1136/sextrans-2011-050102.30; Deering KN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S8; Galarraga O, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S5; Hira SK, 2003, NATL MED J INDIA, V16, P126; IHME, 2012, FIN GLOB HLTH 2012 E; Indian Council of Medical Research and Family Health International, 2009, IND INT BEH BIOL ASS; Leach-Kemon K, 2012, HEALTH AFFAIR, V31, P228, DOI 10.1377/hlthaff.2011.1154; Menzies NA, 2012, PLOS ONE, V8; Menzies NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048726; Meyer-Rath G, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001247; Mishra S, 2014, SEX TRANSM INFECT, V90, P19, DOI 10.1136/sextrans-2013-051250; Mitchell KM, 2014, J THEOR BIOL, V355, P140, DOI 10.1016/j.jtbi.2014.04.005; Murray CJL, 2011, LANCET, V378, P8, DOI 10.1016/S0140-6736(10)62356-2; NACO, 2007, TARG INT NACP 3 OP G, V1; Pickles M, 2013, LANCET GLOB HEALTH, V1, pE289, DOI 10.1016/S2214-109X(13)70083-4; Pickles M, 2010, SEX TRANSM INFECT, V86, pI33, DOI 10.1136/sti.2009.038950; Pinkerton S D, 1998, J Assoc Nurses AIDS Care, V9, P88, DOI 10.1016/S1055-3290(98)80012-5; Ramesh BA, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000343762.54831.5c; Siapka M, 2014, B WHO IN PRESS; Sweeney S, 2012, SEX TRANSM INFECT, V88, P85, DOI 10.1136/sextrans-2011-050199; The International Labour Organization (ILO) National AIDS Control Organization, 2007, TARG INT HIGH RISK G; UNAIDS, 2011, UNAIDS 2011 2015 STR; United Nations General Assembly (UNGASS) Geneva, 2006, UN ACCESS ASS JOINT, P1; Vickerman P, 2010, AIDS, V24, P2554, DOI 10.1097/QAD.0b013e32833e8663; Williams JR, 2006, SEX TRANSM INFECT, V82, P372, DOI 10.1136/sti.2006.020875	39	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e107066	10.1371/journal.pone.0107066	http://dx.doi.org/10.1371/journal.pone.0107066			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271808	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000343729600007
J	Rodero, MP; Licata, F; Poupel, L; Hamon, P; Khosrotehrani, K; Combadiere, C; Boissonnas, A				Rodero, Mathieu P.; Licata, Fabrice; Poupel, Lucie; Hamon, Pauline; Khosrotehrani, Kiarash; Combadiere, Christophe; Boissonnas, Alexandre			In Vivo Imaging Reveals a Pioneer Wave of Monocyte Recruitment into Mouse Skin Wounds	PLOS ONE			English	Article							NEUTROPHILS; EXTRAVASATION; MACROPHAGES; POPULATION; EXPRESSION; MICROSCOPY; PHENOTYPE; INFECTION; MIGRATION; DYNAMICS	The cells of the mononuclear phagocyte system are essential for the correct healing of adult skin wounds, but their specific functions remain ill-defined. The absence of granulation tissue immediately after skin injury makes it challenging to study the role of mononuclear phagocytes at the initiation of this inflammatory stage. To study their recruitment and migratory behavior within the wound bed, we developed a new model for real-time in vivo imaging of the wound, using transgenic mice that express green and cyan fluorescent proteins and specifically target monocytes. Within hours after the scalp injury, monocytes invaded the wound bed. The complete abrogation of this infiltration in monocyte-deficient CCR2(-/-) mice argues for the involvement of classical monocytes in this process. Monocyte infiltration unexpectedly occurred as early as neutrophil recruitment did and resulted from active release from the bloodstream toward the matrix through microhemorrhages rather than transendothelial migration. Monocytes randomly scouted around the wound bed, progressively slowed down, and stopped. Our approach identified and characterized a rapid and earlier than expected wave of monocyte infiltration and provides a novel framework for investigating the role of these cells during early stages of wound healing.	[Rodero, Mathieu P.; Licata, Fabrice; Poupel, Lucie; Hamon, Pauline; Combadiere, Christophe; Boissonnas, Alexandre] Sorbonne Univ, Univ Paris 06, Ctr Immunol & Malad Infect, CR7, F-75230 Paris 05, France; [Rodero, Mathieu P.; Licata, Fabrice; Poupel, Lucie; Hamon, Pauline; Combadiere, Christophe; Boissonnas, Alexandre] INSERM, U1135, CIMI, Paris, France; [Khosrotehrani, Kiarash] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Khosrotehrani, Kiarash] Univ Queensland, UQ Diamantina Inst, Translat Res Inst, Woolloongabba, Qld, Australia; [Rodero, Mathieu P.; Licata, Fabrice; Poupel, Lucie; Hamon, Pauline; Combadiere, Christophe; Boissonnas, Alexandre] CNRS, ERL, CIMI, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Queensland; University of Queensland; Centre National de la Recherche Scientifique (CNRS)	Rodero, MP (corresponding author), Sorbonne Univ, Univ Paris 06, Ctr Immunol & Malad Infect, CR7, 91 Bd Hop, F-75230 Paris 05, France.	mathieu.rodero@institutimagine.org; alexandre.boissonnas@upmc.fr	rodero, mathieu/C-8083-2011; Boissonnas, Alexandre/A-2801-2016; Khosrotehrani, Kiarash/M-8025-2015; Combadiere, Christophe/I-5639-2013	rodero, mathieu/0000-0002-1300-0187; Boissonnas, Alexandre/0000-0002-7770-7210; Khosrotehrani, Kiarash/0000-0002-6406-4076; Combadiere, Christophe/0000-0002-1755-4531; Hamon, Pauline/0000-0002-6776-1635; Poupel, Lucie/0000-0001-7015-8450	ANR Emergence "I-CKAIRE'' [ANR-12-EMMA-0050]; NHMRC; Inserm; UPMC emergence; European Grant ENDOSTEM (FP7) [241440]	ANR Emergence "I-CKAIRE''(French National Research Agency (ANR)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UPMC emergence; European Grant ENDOSTEM (FP7)	This work was supported by grants from Inserm, UPMC emergence, European Grant ENDOSTEM (FP7 #241440), ANR Emergence "I-CKAIRE'' (ANR-12-EMMA-0050). KK is supported by an NHMRC career development fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abtin A, 2014, NAT IMMUNOL, V15, P45, DOI 10.1038/ni.2769; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Jacquelin S, 2013, BLOOD, V122, P674, DOI 10.1182/blood-2013-01-480749; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kim MH, 2008, J INVEST DERMATOL, V128, P1812, DOI 10.1038/sj.jid.5701223; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; Li L, 2012, J BIOL CHEM, V287, P25353, DOI 10.1074/jbc.M112.349126; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; MacDonald KPA, 2005, J IMMUNOL, V175, P1399, DOI 10.4049/jimmunol.175.3.1399; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mirza RE, 2013, DIABETES; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mirza RE, 2013, DIABETES, V62, P2579, DOI 10.2337/db12-1450; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; Ovchinnikov DA, 2008, J LEUKOCYTE BIOL, V83, P430, DOI 10.1189/jlb.0807585; Rodero MP, 2013, J INVEST DERMATOL, V133, P783, DOI 10.1038/jid.2012.368; Rodero MP, 2013, EXP DERMATOL, V22, P143, DOI 10.1111/exd.12068; Rodero MP, 2010, INT J CLIN EXP PATHO, V3, P643; Sarris M, 2012, CURR BIOL, V22, P2375, DOI 10.1016/j.cub.2012.11.018; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Soehnlein O, 2009, THROMB HAEMOSTASIS, V102, P198, DOI 10.1160/TH08-11-0720; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Wang BM, 2012, CELL IMMUNOL, V278, P103, DOI 10.1016/j.cellimm.2012.07.005; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386	35	34	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108212	10.1371/journal.pone.0108212	http://dx.doi.org/10.1371/journal.pone.0108212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272047	Green Submitted, gold, Green Published			2022-12-27	WOS:000343729600033
J	Chuang, TH; Lai, CY; Tseng, PH; Yuan, CJ; Hsu, LC				Chuang, Tsung-Hsien; Lai, Chao-Yang; Tseng, Ping-Hui; Yuan, Chiun-Jye; Hsu, Li-Chung			Development of CpG-Oligodeoxynucleotides for Effective Activation of Rabbit TLR9 Mediated Immune Responses	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; BACTERIAL-DNA; STRUCTURAL BIOLOGY; ADJUVANTS; AGONISTS; IDENTIFICATION; RECOGNITION; MECHANISMS; GENERATION; MOTIFS	CpG-oligodeoxynucleotides (CpG-ODN) are potent immune stimuli being developed for use as adjuvants in different species. Toll-like receptor 9 (TLR9) is the cellular receptor for CpG-ODN in mammalian cells. The CpG-ODN with 18-24 deoxynucleotides that are in current use for human and mouse cells, however, have low activity with rabbit TLR9. Using a cell-based activation assay, we developed a type of CpG-ODN containing a GACGTT or AACGTT motif in 12 phosphorothioate-modified deoxynucleotides with potent stimulatory activity for rabbit TLR9. The developed CpG-ODN have higher activities than other developed CpG-ODN in eliciting antigen-nonspecific immune responses in rabbit splenocytes. When mixed with an NJ85 peptide derived from rabbit hemorrhagic disease virus, they had potent activities to boost an antigen-specific T cell activation and antibody production in rabbits. Compared to Freund's adjuvant, the developed CpG-ODN are capable of boosting a potent and less toxic antibody response. The results of this study suggest that both the choice of CpG-motif and its length are important factors for CpG-ODN to effectively activate rabbit TLR9 mediated immune responses.	[Chuang, Tsung-Hsien; Lai, Chao-Yang] Natl Hlth Res Inst, Immunol Res Ctr, Miaoli, Taiwan; [Chuang, Tsung-Hsien] Kaohsiung Med Univ, Program Environm & Occupat Med, Kaohsiung, Taiwan; [Tseng, Ping-Hui] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Yuan, Chiun-Jye] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Hsu, Li-Chung] Natl Taiwan Univ, Inst Mol Med, Taipei 10764, Taiwan	National Health Research Institutes - Taiwan; Kaohsiung Medical University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University	Chuang, TH (corresponding author), Natl Hlth Res Inst, Immunol Res Ctr, Miaoli, Taiwan.	thchuang@nhri.org.tw	Chuang, Tsung-Hsien/F-9679-2010	Hsu, Li-Chung/0000-0001-7206-5231	National Health Research Institutes, Taiwan [IM-102-PP-02]; National Science Council of Taiwan [NSC102-2320-B-400-009-MY3, NSC102-2325-B-002-06]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants from the National Health Research Institutes, Taiwan to THC (IM-102-PP-02), and from the National Science Council of Taiwan to THC (NSC102-2320-B-400-009-MY3) and LCH (NSC102-2325-B-002-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes J, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-12; Agrawal S, 2007, BIOCHEM SOC T, V35, P1461, DOI 10.1042/BST0351461; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Carrington AC, 2006, VET IMMUNOL IMMUNOP, V112, P87, DOI 10.1016/j.vetimm.2006.03.015; Chaung HC, 2006, INT IMMUNOPHARMACOL, V6, P1586, DOI 10.1016/j.intimp.2006.06.001; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Chuang TH, 2002, J LEUKOCYTE BIOL, V71, P538; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Chuang TH, 2001, BBA-GENE STRUCT EXPR, V1518, P157, DOI 10.1016/S0167-4781(00)00289-X; Coll RC, 2010, J INNATE IMMUN, V2, P406, DOI 10.1159/000315469; De Gregorio E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00214; Gosu V, 2012, MOLECULES, V17, P13503, DOI 10.3390/molecules171113503; Govindaraj RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025118; Heegaard PMH, 2011, ARCH VIROL, V156, P183, DOI 10.1007/s00705-010-0863-1; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Imler JL, 2001, TRENDS CELL BIOL, V11, P304, DOI 10.1016/S0962-8924(01)02004-9; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kerr Peter J., 2013, Veterinary Clinics of North America Exotic Animal Practice, V16, P437, DOI 10.1016/j.cvex.2013.02.002; Klinman DM, 2009, ADV DRUG DELIVER REV, V61, P248, DOI 10.1016/j.addr.2008.12.012; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 2012, NUCLEIC ACID THER, V22, P77, DOI 10.1089/nat.2012.0340; Liu J, 2012, COMP IMMUNOL MICROB, V35, P443, DOI 10.1016/j.cimid.2012.03.008; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; Mutwiri G, 2012, VET IMMUNOL IMMUNOP, V148, P85, DOI 10.1016/j.vetimm.2011.05.032; Pan XC, 2012, J BIOL CHEM, V287, P30596, DOI 10.1074/jbc.M112.396432; Pisetsky DS, 2000, SPRINGER SEMIN IMMUN, V22, P21, DOI 10.1007/s002810000021; Rader C, 2000, J BIOL CHEM, V275, P13668, DOI 10.1074/jbc.275.18.13668; Rader C, 2009, METHOD MOL BIOL, V525, pxiv; Rader Christoph, 2009, V525, P101, DOI 10.1007/978-1-59745-554-1_5; Rankin R, 2001, ANTISENSE NUCLEIC A, V11, P333, DOI 10.1089/108729001753231713; Salem AK, 2009, ADV DRUG DELIVER REV, V61, P193, DOI 10.1016/j.addr.2008.12.003; Sato Y, 1996, SCIENCE, V273, P352, DOI 10.1126/science.273.5273.352; Severa M, 2007, CURR TOP MICROBIOL, V316, P167; SPIEKERPOLET H, 1995, P NATL ACAD SCI USA, V92, P9348, DOI 10.1073/pnas.92.20.9348; Stills HF, 2005, ILAR J, V46, P280, DOI 10.1093/ilar.46.3.280; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Wagner H, 1999, ADV IMMUNOL, V73, P329, DOI 10.1016/S0065-2776(08)60790-7; Wagner H, 2009, ADV DRUG DELIVER REV, V61, P243, DOI 10.1016/j.addr.2008.12.010; Wang X, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003132; Weeratna RD, 2000, VACCINE, V18, P1755, DOI 10.1016/S0264-410X(99)00526-5; Yamamoto S, 2000, SPRINGER SEMIN IMMUN, V22, P11, DOI 10.1007/s002810000019; Zhou W, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-18	47	14	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108808	10.1371/journal.pone.0108808	http://dx.doi.org/10.1371/journal.pone.0108808			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25269083	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700167
J	Crescenzo-Chaigne, B; Barbezange, C; Frigard, V; Poulain, D; van der Werf, S				Crescenzo-Chaigne, Bernadette; Barbezange, Cyril; Frigard, Vianney; Poulain, Damien; van der Werf, Sylvie			Chimeric NP Non Coding Regions between Type A and C Influenza Viruses Reveal Their Role in Translation Regulation	PLOS ONE			English	Article							3' UNTRANSLATED REGION; MESSENGER-RNA; VIRAL-RNA; NUCLEOTIDE-SEQUENCES; POLYMERASE COMPLEXES; VIRION RNA; BINDING; TRANSCRIPTION; REPLICATION; SEGMENTS	Exchange of the non coding regions of the NP segment between type A and C influenza viruses was used to demonstrate the importance not only of the proximal panhandle, but also of the initial distal panhandle strength in type specificity. Both elements were found to be compulsory to rescue infectious virus by reverse genetics systems. Interestingly, in type A influenza virus infectious context, the length of the NP segment 5' NC region once transcribed into mRNA was found to impact its translation, and the level of produced NP protein consequently affected the level of viral genome replication.	[Crescenzo-Chaigne, Bernadette; Barbezange, Cyril; Frigard, Vianney; Poulain, Damien; van der Werf, Sylvie] Inst Pasteur, Unite Genet Mol Virus ARN, Paris, France; [Crescenzo-Chaigne, Bernadette; Barbezange, Cyril; Frigard, Vianney; Poulain, Damien; van der Werf, Sylvie] CNRS, Unite Mixte Rech 3569, Paris, France; [van der Werf, Sylvie] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	van der Werf, S (corresponding author), Inst Pasteur, Unite Genet Mol Virus ARN, Paris, France.	sylvie.van-der-werf@pasteur.fr	Barbezange, Cyril/W-5133-2019	Barbezange, Cyril/0000-0001-9606-2983; van der WERF, Sylvie/0000-0002-1148-4456	Institut Pasteur; Centre National de la Recherche Scientifique; University Paris Diderot, Sorbonne Paris Cite , Paris, France	Institut Pasteur(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Paris Diderot, Sorbonne Paris Cite , Paris, France	This work was supported by institutional funds from the Institut Pasteur, the Centre National de la Recherche Scientifique and the University Paris Diderot, Sorbonne Paris Cite , Paris, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y., 2013, NUCL ACIDS RES; Bergmann M, 1996, VIRUS RES, V44, P23, DOI 10.1016/0168-1702(96)01335-4; Cheong HK, 1999, NUCLEIC ACIDS RES, V27, P1392, DOI 10.1093/nar/27.5.1392; COOPER PD, 1967, BRIT MED BULL, V23, P155, DOI 10.1093/oxfordjournals.bmb.a070537; Crescenzo-Chaigne B, 2002, VIROLOGY, V303, P240, DOI 10.1006/viro.2002.1637; Crescenzo-Chaigne B, 1999, VIROLOGY, V265, P342, DOI 10.1006/viro.1999.0059; Crescenzo-Chaigne B, 2001, J GEN VIROL, V82, P1075, DOI 10.1099/0022-1317-82-5-1075; Crescenzo-Chaigne B, 2007, J VIROL, V81, P11282, DOI 10.1128/JVI.00910-07; Crescenzo-Chaigne B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081550; Crescenzo-Chaigne B, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-132; Crow M, 2004, J VIROL, V78, P6263, DOI 10.1128/JVI.78.12.6263-6270.2004; Dassi E, 2013, NUCLEIC ACIDS RES, V41, P3201, DOI 10.1093/nar/gkt017; DESSELBERGER U, 1980, GENE, V8, P315, DOI 10.1016/0378-1119(80)90007-4; Flick R, 1996, RNA, V2, P1046; FODOR E, 1995, J VIROL, V69, P4012, DOI 10.1128/JVI.69.7.4012-4019.1995; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; FODOR E, 1994, J VIROL, V68, P4092, DOI 10.1128/JVI.68.6.4092-4096.1994; Gerber M, 2014, TRENDS MICROBIOL; Goto H, 2013, J VIROL, V87, P11316, DOI 10.1128/JVI.01301-13; Hause BM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003176; Holden KL, 2004, VIROLOGY, V329, P119, DOI 10.1016/j.virol.2004.08.004; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; Jia J, 2013, CURR OPIN GENET DEV, V23, P29, DOI 10.1016/j.gde.2012.12.004; LUYTJES W, 1989, CELL, V59, P1107, DOI 10.1016/0092-8674(89)90766-6; Marklund JK, 2012, J VIROL, V86, P7292, DOI 10.1128/JVI.00014-12; Marsh GA, 2007, J VIROL, V81, P9727, DOI 10.1128/JVI.01144-07; Matsuzaki Y, 2006, J INFECT DIS, V193, P1229, DOI 10.1086/502973; Matsuzaki Y, 2012, J CLIN VIROL, V54, P130, DOI 10.1016/j.jcv.2012.02.012; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Newcomb LL, 2009, J VIROL, V83, P29, DOI 10.1128/JVI.02293-07; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; PANNEERSELVAM M, 1986, J IMMUNOL, V136, P2534; Pleschka S, 1996, J VIROL, V70, P4188, DOI 10.1128/JVI.70.6.4188-4192.1996; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; PRITLOVE DC, 1995, J GEN VIROL, V76, P2205, DOI 10.1099/0022-1317-76-9-2205; Pritlove DC, 1999, J VIROL, V73, P2109, DOI 10.1128/JVI.73.3.2109-2114.1999; Resa-Infante P, 2011, RNA BIOL, V8, P207, DOI 10.4161/rna.8.2.14513; ROBERTSON JS, 1979, NUCLEIC ACIDS RES, V6, P3745, DOI 10.1093/nar/6.12.3745; ROGERS GN, 1986, J BIOL CHEM, V261, P5947; STOECKLE MY, 1987, P NATL ACAD SCI USA, V84, P2703, DOI 10.1073/pnas.84.9.2703; TILEY LS, 1994, J VIROL, V68, P5108, DOI 10.1128/JVI.68.8.5108-5116.1994; Vendeix FAP, 2009, RNA, V15, P2278, DOI 10.1261/rna.1734309; Verma B, 2010, J GEN VIROL, V91, P1245, DOI 10.1099/vir.0.018507-0; Vignuzzi M, 2001, J GEN VIROL, V82, P1737, DOI 10.1099/0022-1317-82-7-1737; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; Wei Y, 2009, AM J TROP MED HYG, V81, P817, DOI 10.4269/ajtmh.2009.08-0595; Wong SCC, 2005, J CLIN PATHOL, V58, P276, DOI 10.1136/jcp.2004.016592; YAMASHITA M, 1989, VIROLOGY, V171, P458, DOI 10.1016/0042-6822(89)90615-6; Zeenko VV, 2002, J VIROL, V76, P5678, DOI 10.1128/JVI.76.11.5678-5691.2002	51	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e109046	10.1371/journal.pone.0109046	http://dx.doi.org/10.1371/journal.pone.0109046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268971	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700216
J	Elosegui-Artola, A; Jorge-Penas, A; Moreno-Arotzena, O; Oregi, A; Lasa, M; Garcia-Aznar, JM; De Juan-Pardo, EM; Aldabe, R				Elosegui-Artola, Alberto; Jorge-Penas, Alvaro; Moreno-Arotzena, Oihana; Oregi, Amaia; Lasa, Marta; Manuel Garcia-Aznar, Jose; De Juan-Pardo, Elena M.; Aldabe, Rafael			Image Analysis for the Quantitative Comparison of Stress Fibers and Focal Adhesions	PLOS ONE			English	Article							MATRIX-RIGIDITY; MYOSIN IIB; CELL-SHAPE; FORCE; POLARIZATION; STRETCH; GROWTH; INTEGRINS; FREQUENCY; MIGRATION	Actin stress fibers (SFs) detect and transmit forces to the extracellular matrix through focal adhesions (FAs), and molecules in this pathway determine cellular behavior. Here, we designed two different computational tools to quantify actin SFs and the distribution of actin cytoskeletal proteins within a normalized cellular morphology. Moreover, a systematic cell response comparison between the control cells and those with impaired actin cytoskeleton polymerization was performed to demonstrate the reliability of the tools. Indeed, a variety of proteins that were present within the string beginning at the focal adhesions (vinculin) up to the actin SFs contraction (non-muscle myosin II (NMMII)) were analyzed. Finally, the software used allows for the quantification of the SFs based on the relative positions of FAs. Therefore, it provides a better insight into the cell mechanics and broadens the knowledge of the nature of SFs.	[Elosegui-Artola, Alberto; Jorge-Penas, Alvaro; Oregi, Amaia; De Juan-Pardo, Elena M.] Univ Navarra, Ctr Estudios & Invest Tecn, Tissue Engn & Biomat Unit, San Sebastian, Spain; [Elosegui-Artola, Alberto; Jorge-Penas, Alvaro; Oregi, Amaia; De Juan-Pardo, Elena M.] Univ Navarra, Tecnun, San Sebastian, Spain; [Moreno-Arotzena, Oihana; Manuel Garcia-Aznar, Jose] Univ Zaragoza, Aragon Inst Engn Res, Zaragoza, Spain; [Lasa, Marta; Aldabe, Rafael] Univ Navarra, Ctr Appl Med Res CIMA, Gene Therapy & Hepatol Area, E-31080 Pamplona, Spain	University of Navarra; University of Navarra; University of Zaragoza; University of Navarra	De Juan-Pardo, EM (corresponding author), Queensland Univ Technol, Fac Sci & Engn, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia.	elena.juanpardo@qut.edu.au; raldabe@unav.es	Aldabe, Rafael/F-3112-2015; De-Juan-Pardo, Elena M./I-5871-2016; Garcia-Aznar, Jose Manuel/F-8256-2010; Moreno-Arotzena, Oihana/AAA-1845-2019; Lasa, Marta/AFU-6812-2022; Elosegui-Artola, Alberto/G-2691-2016	Aldabe, Rafael/0000-0002-9461-020X; De-Juan-Pardo, Elena M./0000-0001-9005-7497; Garcia-Aznar, Jose Manuel/0000-0002-9864-7683; Lasa, Marta/0000-0002-2981-162X; Elosegui-Artola, Alberto/0000-0003-0644-3294	ISCIII a Consolidation Program grant; UTE project CIMA; Spanish Ministry of Science and Innovation, ISCIII [PS09/00393]; European Research Council (ERC) [ERC-2012-StG 306751]; Spanish Ministry of Economy and Competitiveness [DPI2012-38090-C03-01]	ISCIII a Consolidation Program grant; UTE project CIMA; Spanish Ministry of Science and Innovation, ISCIII; European Research Council (ERC)(European Research Council (ERC)European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government)	R.A. is recipient of ISCIII a Consolidation Program grant. This work was supported by the UTE project CIMA (to R.A.), the Spanish Ministry of Science and Innovation, ISCIII (project PS09/00393) (to R.A.) and the European Research Council (ERC) through project ERC-2012-StG 306751 and the Spanish Ministry of Economy and Competitiveness (DPI2012-38090-C03-01) (J.M.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Biggs MJP, 2008, J MICROSC-OXFORD, V231, P28, DOI 10.1111/j.1365-2818.2008.02013.x; Biggs MJP, 2007, J ORTHOP RES, V25, P273, DOI 10.1002/jor.20319; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Cai YF, 2010, J CELL SCI, V123, P413, DOI 10.1242/jcs.058297; Colombelli J, 2009, J CELL SCI, V122, P1665, DOI 10.1242/jcs.042986; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hsu HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004853; Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kaunas R, 2006, CELL SIGNAL, V18, P1924, DOI 10.1016/j.cellsig.2006.02.008; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mohl C, 2012, J CELL SCI, V125, P155, DOI 10.1242/jcs.090746; Paran Y, 2007, J STRUCT BIOL, V158, P233, DOI 10.1016/j.jsb.2006.12.013; Peterson LJ, 2004, MOL BIOL CELL, V15, P3497, DOI 10.1091/mbc.E03-09-0696; Pollard TD, 2003, CELL, V113, P549, DOI 10.1016/S0092-8674(03)00357-X; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Rivolta I, 2011, BIOPHYS CHEM, V158, P134, DOI 10.1016/j.bpc.2011.06.009; Roca-Cusachs P, 2008, BIOPHYS J, V94, P4984, DOI 10.1529/biophysj.107.116863; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; Schwarz US, 2003, MAT SCI ENG C-BIO S, V23, P387, DOI 10.1016/S0928-4931(02)00309-0; Stricker J, 2011, BIOPHYS J, V100, P2883, DOI 10.1016/j.bpj.2011.05.023; SURRALLES J, 1994, MUTAGENESIS, V9, P347, DOI 10.1093/mutage/9.4.347; Tanner K, 2010, BIOPHYS J, V99, P2775, DOI 10.1016/j.bpj.2010.08.071; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Uhlirova R, 2010, J CELL BIOCHEM, V109, P915, DOI 10.1002/jcb.22466; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Van Damme P, 2012, P NATL ACAD SCI USA, V109, P12449, DOI 10.1073/pnas.1210303109; Weichsel J, 2010, CYTOM PART A, V77A, P52, DOI 10.1002/cyto.a.20818; Wong RPC, 2007, MOL CANCER THER, V6, P1692, DOI 10.1158/1535-7163.MCT-07-0134; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613; Zhao L, 2011, J BIOMECH, V44, P2388, DOI 10.1016/j.jbiomech.2011.06.033	44	21	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107393	10.1371/journal.pone.0107393	http://dx.doi.org/10.1371/journal.pone.0107393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25269086	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700037
J	Henkel, SG; Ter Beek, A; Steinsiek, S; Stagge, S; Bettenbrock, K; de Mattos, MJT; Sauter, T; Sawodny, O; Ederer, M				Henkel, Sebastian G.; Ter Beek, Alexander; Steinsiek, Sonja; Stagge, Stefan; Bettenbrock, Katja; de Mattos, M. Joost Teixeira; Sauter, Thomas; Sawodny, Oliver; Ederer, Michael			Basic Regulatory Principles of Escherichia coli's Electron Transport Chain for Varying Oxygen Conditions	PLOS ONE			English	Article							ARCB SENSOR KINASE; SUCCINATE-DEHYDROGENASE; RESPIRATORY-CHAIN; TRANSCRIPTIONAL REGULATION; CATABOLITE REPRESSION; 2-COMPONENT SYSTEM; FUMARATE REDUCTASE; AEROBIC CONDITIONS; GROWTH-CONDITIONS; REDOX REGULATION	For adaptation between anaerobic, micro-aerobic and aerobic conditions Escherichia coli's metabolism and in particular its electron transport chain (ETC) is highly regulated. Although it is known that the global transcriptional regulators FNR and ArcA are involved in oxygen response it is unclear how they interplay in the regulation of ETC enzymes under micro-aerobic chemostat conditions. Also, there are diverse results which and how quinones (oxidised/reduced, ubiquinone/other quinones) are controlling the ArcBA two-component system. In the following a mathematical model of the E. coli ETC linked to basic modules for substrate uptake, fermentation product excretion and biomass formation is introduced. The kinetic modelling focusses on regulatory principles of the ETC for varying oxygen conditions in glucose-limited continuous cultures. The model is based on the balance of electron donation (glucose) and acceptance (oxygen or other acceptors). Also, it is able to account for different chemostat conditions due to changed substrate concentrations and dilution rates. The parameter identification process is divided into an estimation and a validation step based on previously published and new experimental data. The model shows that experimentally observed, qualitatively different behaviour of the ubiquinone redox state and the ArcA activity profile in the micro-aerobic range for different experimental conditions can emerge from a single network structure. The network structure features a strong feed-forward effect from the FNR regulatory system to the ArcBA regulatory system via a common control of the dehydrogenases of the ETC. The model supports the hypothesis that ubiquinone but not ubiquinol plays a key role in determining the activity of ArcBA in a glucose-limited chemostat at micro-aerobic conditions.	[Henkel, Sebastian G.; Sawodny, Oliver; Ederer, Michael] Univ Stuttgart, Inst Syst Dynam, D-70174 Stuttgart, Germany; [Ter Beek, Alexander; de Mattos, M. Joost Teixeira] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Steinsiek, Sonja; Stagge, Stefan; Bettenbrock, Katja] Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany; [Sauter, Thomas] Univ Luxembourg, Life Sci Res Unit, Luxembourg, Luxembourg	University of Stuttgart; University of Amsterdam; Max Planck Society; University of Luxembourg	Ederer, M (corresponding author), Univ Stuttgart, Inst Syst Dynam, D-70174 Stuttgart, Germany.	michael.ederer@isys.uni-stuttgart.de	Bettenbrock, Katja/AAN-5812-2020	Sauter, Thomas/0000-0001-8225-2954; Stagge, Stefan/0000-0003-4908-0913	German Federal Ministry of Education and Research (BMBF); Netherlands Organisation for Scientific Research (NWO) within the SysMO initiative Systems Biology of Microorganisms	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Netherlands Organisation for Scientific Research (NWO) within the SysMO initiative Systems Biology of Microorganisms	This work was supported and funded by the German Federal Ministry of Education and Research (BMBF) and the Netherlands Organisation for Scientific Research (NWO) within the SysMO initiative Systems Biology of Microorganisms, (www.sysmo.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeeva S, 2002, J BACTERIOL, V184, P1402, DOI 10.1128/JB.184.5.1402-1406.2002; Alexeeva S, 2003, J BACTERIOL, V185, P204, DOI 10.1128/JB.185.1.204-209.2003; Alexeeva S, 2000, J BACTERIOL, V182, P4934, DOI 10.1128/JB.182.17.4934-4940.2000; Alexeeva S, 2000, THESIS U AMSTERDAM; Alvarez AF, 2013, J BACTERIOL, V195, P3054, DOI 10.1128/JB.00406-13; Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036; Bekker M, 2007, MICROBIOL-SGM, V153, P1974, DOI 10.1099/mic.0.2007/006098-0; Bekker M, 2009, J BACTERIOL, V191, P5510, DOI 10.1128/JB.00562-09; Bekker M, 2010, J BACTERIOL, V192, P746, DOI 10.1128/JB.01156-09; Bettenbrock K, 2006, J BIOL CHEM, V281, P2578, DOI 10.1074/jbc.M508090200; Bettenbrock K, 2014, ADV MICROB PHYSIOL, V64, P65, DOI 10.1016/B978-0-12-800143-1.00002-6; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BONGAERTS J, 1995, MOL MICROBIOL, V16, P521, DOI 10.1111/j.1365-2958.1995.tb02416.x; Brondsted L, 1996, J BACTERIOL, V178, P1556, DOI 10.1128/jb.178.6.1556-1564.1996; Bueno E, 2012, ANTIOXID REDOX SIGN, V16, P819, DOI 10.1089/ars.2011.4051; Carius L, 2013, BIOTECHNOL BIOENG, V110, P573, DOI 10.1002/bit.24734; COTTER PA, 1992, FEMS MICROBIOL LETT, V91, P31; DASSA J, 1991, MOL GEN GENET, V229, P341, DOI 10.1007/BF00267454; DMELLO R, 1995, J BACTERIOL, V177, P867, DOI 10.1128/jb.177.3.867-870.1995; Ederer M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00124; Forbes NS, 2010, NAT REV CANCER, V10, P784, DOI 10.1038/nrc2934; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Green J, 1996, BIOCHEM J, V316, P887, DOI 10.1042/bj3160887; GREEN J, 1994, MOL MICROBIOL, V12, P433, DOI 10.1111/j.1365-2958.1994.tb01032.x; Green J, 2009, CURR OPIN MICROBIOL, V12, P145, DOI 10.1016/j.mib.2009.01.008; GUEST JR, 1981, J GEN MICROBIOL, V122, P171; HAYASHI M, 1989, BIOCHIM BIOPHYS ACTA, V977, P62, DOI 10.1016/S0005-2728(89)80009-X; HIRSCH CA, 1963, J BIOL CHEM, V238, P3770; INGLEDEW WJ, 1984, MICROBIOL REV, V48, P222, DOI 10.1128/MMBR.48.3.222-271.1984; IUCHI S, 1993, J BIOL CHEM, V268, P23972; Jahreis K, 2008, FEMS MICROBIOL REV, V32, P891, DOI 10.1111/j.1574-6976.2008.00125.x; Jordan PA, 1997, FEBS LETT, V416, P349, DOI 10.1016/S0014-5793(97)01219-2; JUNEMANN S, 1995, BIOCHEMISTRY-US, V34, P14861; Klamt S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100191; LAMBDEN PR, 1976, J GEN MICROBIOL, V97, P145, DOI 10.1099/00221287-97-2-145; Lara AR, 2006, BIOTECHNOL BIOENG, V93, P372, DOI 10.1002/bit.20704; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; MILLER MJ, 1985, J BIOL CHEM, V260, P4003; PARK SJ, 1995, MOL MICROBIOL, V15, P473, DOI 10.1111/j.1365-2958.1995.tb02261.x; Partridge JD, 2007, J BIOL CHEM, V282, P11230, DOI 10.1074/jbc.M700728200; Peercy BE, 2006, J THEOR BIOL, V242, P547, DOI 10.1016/j.jtbi.2006.04.006; Pouvreau LAM, 2008, METHOD ENZYMOL, V436, P97, DOI 10.1016/S0076-6879(08)36006-6; PUUSTINEN A, 1989, FEBS LETT, V249, P163, DOI 10.1016/0014-5793(89)80616-7; RICE CW, 1978, J BACTERIOL, V134, P115, DOI 10.1128/JB.134.1.115-124.1978; Rodriguez C, 2004, J BACTERIOL, V186, P2085, DOI 10.1128/JB.186.7.2085-2090.2004; Rolfe MD, 2011, J BIOL CHEM, V286, P10147, DOI 10.1074/jbc.M110.211144; Sawers RG, 2005, J BACTERIOL, V187, P2609, DOI 10.1128/JB.187.8.2609-2617.2005; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Shan Yue, 2012, Subcell Biochem, V64, P159, DOI 10.1007/978-94-007-5055-5_8; Sharma P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075412; Soupene E, 2003, J BACTERIOL, V185, P5611, DOI 10.1128/JB.185.18.5611-5626.2003; SPIRO S, 1989, MOL MICROBIOL, V3, P601, DOI 10.1111/j.1365-2958.1989.tb00207.x; Steinsiek S, 2011, J BIOTECHNOL, V154, P35, DOI 10.1016/j.jbiotec.2011.03.015; Steinsiek S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087307; Tseng CP, 1996, J BACTERIOL, V178, P1094, DOI 10.1128/jb.178.4.1094-1098.1996; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; UNDEN G, 1995, ARCH MICROBIOL, V164, P81; Valgepea K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-166; van der Star WRL, 2007, WATER RES, V41, P4149, DOI 10.1016/j.watres.2007.03.044; Vaz AIF, 2007, J GLOBAL OPTIM, V39, P197, DOI 10.1007/s10898-007-9133-5; YOUNG IG, 1976, BIOCHIM BIOPHYS ACTA, V449, P376, DOI 10.1016/0005-2728(76)90149-3	62	6	7	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107640	10.1371/journal.pone.0107640	http://dx.doi.org/10.1371/journal.pone.0107640			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268772	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700044
J	Zhong, JH; Li, H; Xiao, N; Ye, XP; Ke, Y; Wang, YY; Ma, L; Chen, J; You, XM; Zhang, ZY; Lu, SD; Li, LQ				Zhong, Jian-Hong; Li, Hang; Xiao, Nan; Ye, Xin-Ping; Ke, Yang; Wang, Yan-Yan; Ma, Liang; Chen, Jie; You, Xue-Mei; Zhang, Zhi-Yuan; Lu, Shi-Dong; Li, Le-Qun			Hepatic Resection Is Safe and Effective for Patients with Hepatocellular Carcinoma and Portal Hypertension	PLOS ONE			English	Article							VENOUS-PRESSURE GRADIENT; LIVER RESECTION; CIRRHOTIC-PATIENTS; SURGICAL-TREATMENT; THERAPY OPTIONS; CHILD-PUGH; CONSENSUS; TERM; MANAGEMENT; CONTRAINDICATION	Background & Aims: Official guidelines do not recommend hepatic resection (HR) for patients with hepatocellular carcinoma (HCC) and portal hypertension (PHT). This study aims to investigate the safety and efficacy of HR for patients with HCC and PHT. Methods: Mortality and survival after HR were analyzed retrospectively in a consecutive sample of 1738 HCC patients with PHT (n = 386) or without it (n = 1352). To assess the robustness of findings, we repeated the analysis using propensity scorematched analysis. We also comprehensively searched the PubMed database for studies evaluating the efficacy and safety of HR for patients with HCC and PHT. Results: The 90-day mortality rate was 6.7% among those with PHT and 2.1% among those without it (P<.001). Patients without PHT had a survival benefit over those with PHT at 1, 3, and 5 years (96% vs 90%, 75% vs 67%, 54% vs 45%, respectively; P = .001). In contrast, PHT was not associated with worse short- or long-term survival when only propensity score-matched pairs of patients and those with early-stage HCC or those who underwent minor hepatectomy were included in the analysis (all P>.05). Moreover, the recurrence rates were similar between the two groups. Consistent with our findings, all 9 studies identified in our literature search reported HR to be safe and effective for patients with HCC and PHT. Conclusions: HR is safe and effective in HCC patients with PHT and preserved liver function. This is especially true for patients who have early-stage HCC or who undergo minor hepatectomy.	[Zhong, Jian-Hong; Ke, Yang; Wang, Yan-Yan; Ma, Liang; Chen, Jie; You, Xue-Mei; Zhang, Zhi-Yuan; Lu, Shi-Dong; Li, Le-Qun] Guangxi Med Univ, Hepatobiliary Surg Dept, Affiliated Tumor Hosp, Nanning, Peoples R China; [Li, Hang] Guangxi Med Univ, Dept Ultrasound, Affiliated Tumor Hosp, Nanning, Peoples R China; [Xiao, Nan] Guangxi Med Univ, Dept Gen Surg Educ, Nanning, Peoples R China; [Ye, Xin-Ping] Guangxi Med Univ, Affiliated Hosp 1, Hepatobiliary Surg Dept, Nanning, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Li, LQ (corresponding author), Guangxi Med Univ, Hepatobiliary Surg Dept, Affiliated Tumor Hosp, Nanning, Peoples R China.	zhongjianhong66@163.com	LI, LI QING/GRR-8855-2022; Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022; Wang, Yanbo/HFZ-8018-2022; Zhong, Jian-Hong/D-6641-2018; zhang, zhiyuan/GRS-2141-2022; li, li/HII-4157-2022; wang, yan/GSE-6489-2022	Zhong, Jian-Hong/0000-0002-1494-6396; 	Self-raised Scientific Research Fund of the Ministry of Health of Guangxi Province [Z2012345, Z2014241]; Youth Science Foundation of Guangxi Medical University [GXMUYSF201302]; Guangxi Natural Science Foundation [2011GXNSFD018032]; HCC Bridge Study [CA182023]	Self-raised Scientific Research Fund of the Ministry of Health of Guangxi Province; Youth Science Foundation of Guangxi Medical University; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); HCC Bridge Study	This work was supported by the Self-raised Scientific Research Fund of the Ministry of Health of Guangxi Province (no. Z2012345 and Z2014241) and Youth Science Foundation of Guangxi Medical University (no. GXMUYSF201302) to JHZ; and Guangxi Natural Science Foundation (no. 2011GXNSFD018032) and the HCC Bridge Study (no. CA182023) to LQL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alswat KA, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.7612; Boleslawski E, 2012, BRIT J SURG, V99, P855, DOI 10.1002/bjs.8753; Bruix J, 1996, GASTROENTEROLOGY, V111, P1018, DOI 10.1016/S0016-5085(96)70070-7; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Capussotti L, 2006, WORLD J SURG, V30, P992, DOI 10.1007/s00268-005-0524-9; Chen X, 2012, BRIT J SURG, V99, P1701, DOI 10.1002/bjs.8951; Chen XP, 2006, BRIT J SURG, V93, P600, DOI 10.1002/bjs.5335; Choi GH, 2011, LIVER INT, V31, P485, DOI 10.1111/j.1478-3231.2010.02436.x; Cucchetti A, 2009, ANN SURG, V250, P922, DOI 10.1097/SLA.0b013e3181b977a5; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; de Franchis R, 2005, J HEPATOL, V43, P167, DOI 10.1016/j.jhep.2005.05.009; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; Figueras J, 2005, ANN SURG, V241, P582, DOI 10.1097/01.sla.0000157168.26021.b8; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Giannini EG, 2013, LIVER INT, V33, P1594, DOI 10.1111/liv.12199; Hasegawa K, 2013, J HEPATOL, V58, P724, DOI 10.1016/j.jhep.2012.11.009; Hidaka M, 2012, BRIT J SURG, V99, P1284, DOI 10.1002/bjs.8861; Hsieh CB, 2011, EJSO-EUR J SURG ONC, V37, P497, DOI 10.1016/j.ejso.2011.03.004; Imamura H, 2003, ARCH SURG-CHICAGO, V138, P1198, DOI 10.1001/archsurg.138.11.1198; Ishizawa T, 2008, GASTROENTEROLOGY, V134, P1908, DOI 10.1053/j.gastro.2008.02.091; Jamagin WR, 2002, ANN SURG, V236, P397, DOI 10.1097/01.SLA.0000029003.66466.B3; Jarnagin W, 2010, HPB, V12, P302, DOI 10.1111/j.1477-2574.2010.00182.x; Kawano Y, 2008, ANN SURG ONCOL, V15, P1670, DOI 10.1245/s10434-008-9880-7; Ke Yang, 2013, Cancer Biology Medicine, V10, P158, DOI 10.7497/j.issn.2095-3941.2013.03.006; Kikuchi LOO, 2009, J CLIN GASTROENTEROL, V43, P191, DOI 10.1097/MCG.0b013e31817ff199; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Li C, 2014, J GASTROINTEST SURG, V18, P1469, DOI 10.1007/s11605-014-2550-0; Llovet JM, 1999, HEPATOLOGY, V30, P1434, DOI 10.1002/hep.510300629; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Maithel SK, 2011, J AM COLL SURGEONS, V212, P638, DOI 10.1016/j.jamcollsurg.2011.01.004; Margarit C, 2005, LIVER TRANSPLANT, V11, P1242, DOI 10.1002/lt.20398; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Pang YY, 2002, HPB, V4, P99, DOI [DOI 10.1080/136518202760378489, 10.1016/S1365-182X(17)30755-4, DOI 10.1016/S1365-182X(17)30755-4]; Poon RT, 2004, ANN SURG, V240, P698, DOI 10.1097/01.sla.0000141195.66155.0c; de Lope CR, 2012, J HEPATOL, V56, pS75, DOI 10.1016/S0168-8278(12)60009-9; Ruzzenente A, 2011, WORLD J GASTROENTERO, V17, P5083, DOI 10.3748/wjg.v17.i46.5083; Santambrogio R, 2013, HPB, V15, P78, DOI 10.1111/j.1477-2574.2012.00594.x; Stremitzer S, 2011, BRIT J SURG, V98, P1752, DOI 10.1002/bjs.7672; Torzilli G, 2013, ANN SURG, V257, P929, DOI 10.1097/SLA.0b013e31828329b8; Wu JC, 2009, J HEPATOL, V51, P890, DOI 10.1016/j.jhep.2009.07.009; Zhong JH, 2012, EJSO-EUR J SURG ONC, V38, P286, DOI 10.1016/j.ejso.2012.01.006; Zhong JH, 2012, INT J CLIN PRACT, V66, P21, DOI 10.1111/j.1742-1241.2011.02814.x; Zhong JH, 2014, SCAND J GASTROENTERO, V49, P649, DOI 10.3109/00365521.2014.905626; Zhong JH, 2014, ANN SURG, V260, P329, DOI 10.1097/SLA.0000000000000236; Zhong JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068193; Zhou XD, 2003, J CANCER RES CLIN, V129, P543, DOI 10.1007/s00432-003-0446-6	47	35	40	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108755	10.1371/journal.pone.0108755	http://dx.doi.org/10.1371/journal.pone.0108755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268959	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700156
J	Panhwar, QA; Naher, UA; Jusop, S; Othman, R; Latif, MA; Ismail, MR				Panhwar, Qurban Ali; Naher, Umme Aminun; Jusop, Shamshuddin; Othman, Radziah; Latif, Md Abdul; Ismail, Mohd Razi			Biochemical and Molecular Characterization of Potential Phosphate-Solubilizing Bacteria in Acid Sulfate Soils and Their Beneficial Effects on Rice Growth	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; ORGANIC-ACIDS; OIL PALM; RHIZOSPHERE; ALUMINUM; POLYSACCHARIDES; IDENTIFICATION; DIAZOTROPHS; MECHANISMS; TOXICITY	A study was conducted to determine the total microbial population, the occurrence of growth promoting bacteria and their beneficial traits in acid sulfate soils. The mechanisms by which the bacteria enhance rice seedlings grown under high Al and low pH stress were investigated. Soils and rice root samples were randomly collected from four sites in the study area (Kelantan, Malaysia). The topsoil pH and exchangeable Al ranged from 3.3 to 4.7 and 1.24 to 4.25 cmol(c) kg(-1), respectively, which are considered unsuitable for rice production. Total bacterial and actinomycetes population in the acidic soils were found to be higher than fungal populations. A total of 21 phosphate-solubilizing bacteria (PSB) including 19 N-2-fixing strains were isolated from the acid sulfate soil. Using 16S rRNA gene sequence analysis, three potential PSB strains based on their beneficial characteristics were identified (Burkholderia thailandensis, Sphingomonas pituitosa and Burkholderia seminalis). The isolated strains were capable of producing indoleacetic acid (IAA) and organic acids that were able to reduce Al availability via a chelation process. These PSB isolates solubilized P (43.65%) existing in the growth media within 72 hours of incubation. Seedling of rice variety, MR 219, grown at pH 4, and with different concentrations of Al (0, 50 and 100 mu M) was inoculated with these PSB strains. Results showed that the bacteria increased the pH with a concomitant reduction in Al concentration, which translated into better rice growth. The improved root volume and seedling dry weight of the inoculated plants indicated the potential of these isolates to be used in a bio-fertilizer formulation for rice cultivation on acid sulfate soils.	[Panhwar, Qurban Ali; Jusop, Shamshuddin; Othman, Radziah] Univ Putra Malaysia, Dept Land Management, Fac Agr, Serdang 43400, Selangor, Malaysia; [Naher, Umme Aminun; Othman, Radziah; Latif, Md Abdul; Ismail, Mohd Razi] Univ Putra Malaysia, Inst Trop Agr, Serdang 43400, Selangor, Malaysia; [Naher, Umme Aminun; Latif, Md Abdul] Bangladesh Rice Res Inst, Gazipur, Bangladesh	Universiti Putra Malaysia; Universiti Putra Malaysia; Bangladesh Rice Research Institute (BRRI)	Jusop, S (corresponding author), Univ Putra Malaysia, Dept Land Management, Fac Agr, Serdang 43400, Selangor, Malaysia.	shamshud@upm.edu.my		Latif, Mohammad Abdul/0000-0002-4289-575X; Ismail, M.R./0000-0001-5670-9279	Universiti Putra Malaysia; Ministry of Education, Malaysia	Universiti Putra Malaysia; Ministry of Education, Malaysia(Ministry of Education, Malaysia)	The authors acknowledge the financial and technical support given by Universiti Putra Malaysia and the Ministry of Education, Malaysia under the Long-term Research Grant Scheme (LRGS) fund for Food Security. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias ME, 2005, INT MICROBIOL, V8, P13; Azlin CO, 2005, MALAYS J MICROBIOL, V1, P31; Benton J., 2001, LAB GUIDE CONDUCTING; Bremner JM, 1982, AGRONOMY, P595, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C31; Bueno SM, 2006, BRAZ J MICROBIOL, V37, P296, DOI 10.1590/S1517-83822006000300018; Caballero-Mellado J, 2007, APPL ENVIRON MICROB, V73, P5308, DOI 10.1128/AEM.00324-07; Caiola MG, 1996, EUR J PHYCOL, V31, P97, DOI 10.1080/09670269600651251; Chakraborty B. N., 2010, World Journal of Agricultural Sciences, V6, P195; Chen YP, 2006, APPL SOIL ECOL, V34, P33, DOI 10.1016/j.apsoil.2005.12.002; Chung H, 2005, SOIL BIOL BIOCHEM, V37, P1970, DOI 10.1016/j.soilbio.2005.02.025; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; El Zemrany H, 2007, PLANT SOIL, V291, P109, DOI 10.1007/s11104-006-9178-0; Glick BR, 2005, FEMS MICROBIOL LETT, V251, P1, DOI 10.1016/j.femsle.2005.07.030; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; GRAHAM PH, 1994, CAN J MICROBIOL, V40, P198, DOI 10.1139/m94-033; Gyaneshwar P, 2001, J BACTERIOL, V183, P2634, DOI 10.1128/JB.183.8.2634-2645.2001; Haynes RJ, 2001, NUTR CYCL AGROECOSYS, V59, P47, DOI 10.1023/A:1009823600950; HUE NV, 1986, SOIL SCI SOC AM J, V50, P28, DOI 10.2136/sssaj1986.03615995005000010006x; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jusop Shamshuddin, 2013, Australian Journal of Crop Science, V7, P314; KAPLAN D, 1987, APPL ENVIRON MICROB, V53, P2953, DOI 10.1128/AEM.53.12.2953-2956.1987; KATZNELSON H, 1959, CAN J MICROBIOL, V5, P79, DOI 10.1139/m59-010; Khiari L, 2005, CAN J SOIL SCI, V85, P75, DOI 10.4141/S03-049; Klugh KR, 2007, TREE PHYSIOL, V27, P1103, DOI 10.1093/treephys/27.8.1103; Kumar A, 2010, AFR J MICROBIOL RES, V4, P820; Ludwig W, 1998, PLANT SOIL, V204, P1, DOI 10.1023/A:1004350708767; Ma JF, 2000, PLANT CELL PHYSIOL, V41, P383, DOI 10.1093/pcp/41.4.383; MARSCHNER H, 1991, PLANT SOIL, V134, P1, DOI 10.1007/BF00010712; Mathew EK, 2001, AGR WATER MANAGE, V47, P191, DOI 10.1016/S0378-3774(00)00110-4; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nahas E, 1996, WORLD J MICROB BIOT, V12, P567, DOI 10.1007/BF00327716; Naher UA, 2009, INT J AGRIC BIOL, V11, P547; Naher UA, 2013, INT J MOL SCI, V14, P17812, DOI 10.3390/ijms140917812; Naher UA, 2011, AUST J CROP SCI, V5, P1210; Nautiyal CS, 1999, FEMS MICROBIOL LETT, V170, P265, DOI 10.1111/j.1574-6968.1999.tb13383.x; NGUYEN C, 1992, PLANT SOIL, V143, P193, DOI 10.1007/BF00007873; Parasanna A, 2011, INT J SOIL SCI, V6, P134, DOI DOI 10.3923/IJSS.2011.134.141; Pawar S. T., 2013, Journal of Microbiology and Biotechnology Research, V3, P24; Pradhan N, 2006, AFR J BIOTECHNOL, V5, P850; Qurban Ali Panhwar, 2012, African Journal of Biotechnology, V11, P2711, DOI 10.5897/AJB10.2218; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; Shamshuddin J, 2014, ADV AGRON, V124, P91, DOI 10.1016/B978-0-12-800138-7.00003-6; Shamshuddin J, 2004, COMMUN SOIL SCI PLAN, V35, P117, DOI 10.1081/CSS-120027638; Shamshuddin J, 2010, MALAY J SOIL SCI, V14, P1; Singh S, 2011, WORLD J MICROB BIOT, V27, P1971, DOI 10.1007/s11274-011-0657-y; Somasegaran P, 1985, METHODS LEGUME RHIZO, P39; Suarez-Moreno ZR, 2008, MICROBIOL-SGM, V154, P2048, DOI 10.1099/mic.0.2008/017780-0; Sullivan S, 2004, AUST J SOIL RES, V42, P595; Takeuchi M, 2001, INT J SYST EVOL MICR, V51, P1405, DOI 10.1099/00207713-51-4-1405; Teh SC, 2006, SOIL PHYS ANAL, V1; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Woo SM, 2010, 19 WORLD C SOIL SCI; Zhang JY, 2010, INT J SYST EVOL MICR, V60, P790, DOI 10.1099/ijs.0.011486-0	53	55	59	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e97241	10.1371/journal.pone.0097241	http://dx.doi.org/10.1371/journal.pone.0097241			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285745	gold, Green Published, Green Submitted			2022-12-27	WOS:000345743700001
J	Schalekamp, S; van Ginneken, B; van den Berk, IAH; Hartmann, IJC; Snoeren, MM; Odink, AE; van Lankeren, W; Pegge, SAH; Schijf, LJ; Karssemeijer, N; Schaefer-Prokop, CM				Schalekamp, Steven; van Ginneken, Bram; van den Berk, Inge A. H.; Hartmann, Ieneke J. C.; Snoeren, Miranda M.; Odink, Arlette E.; van Lankeren, Winnifred; Pegge, Sjoert A. H.; Schijf, Laura J.; Karssemeijer, Nico; Schaefer-Prokop, Cornelia M.			Bone Suppression Increases the Visibility of Invasive Pulmonary Aspergillosis in Chest Radiographs	PLOS ONE			English	Article							FEBRILE NEUTROPENIC PATIENTS; CRITICALLY-ILL PATIENTS; FUNGAL-INFECTIONS; ATTRIBUTABLE MORTALITY; MOLD DISEASE; FEVER; CHILDREN; CANCER; RECIPIENTS; PNEUMONIA	Objective: Chest radiographs (CXR) are an important diagnostic tool for the detection of invasive pulmonary aspergillosis (IPA) in critically ill patients, but their diagnostic value is limited by a poor sensitivity. By using advanced image processing, the aim of this study was to increase the value of chest radiographs in the diagnostic work up of neutropenic patients who are suspected of IPA. Methods: The frontal CXRs of 105 suspected cases of IPA were collected from four institutions. Radiographs could contain single or multiple sites of infection. CT was used as reference standard. Five radiologists and two residents participated in an observer study for the detection of IPA on CXRs with and without bone suppressed images (ClearRead BSI 3.2; Riverain Technologies). The evaluation was performed separately for the right and left lung, resulting in 78 diseased cases (or lungs) and 132 normal cases (or lungs). For each image, observers scored the likelihood of focal infectious lesions being present on a continuous scale (0-100). The area under the receiver operating characteristics curve (AUC) served as the performance measure. Sensitivity and specificity were calculated by considering only the lungs with a suspiciousness score of greater than 50 to be positive. Results: The average AUC for only CXRs was 0.815. Performance significantly increased, to 0.853, when evaluation was aided with BSI (p = 0.01). Sensitivity increased from 49% to 66% with BSI, while specificity decreased from 95% to 90%. Conclusion: The detection of IPA in CXRs can be improved when their evaluation is aided by bone suppressed images. BSI improved the sensitivity of the CXR examination, outweighing a small loss in specificity.	[Schalekamp, Steven; van Ginneken, Bram; Snoeren, Miranda M.; Karssemeijer, Nico; Schaefer-Prokop, Cornelia M.] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands; [Pegge, Sjoert A. H.; Schaefer-Prokop, Cornelia M.] Meander Med Ctr, Dept Radiol, Amersfoort, Netherlands; [van den Berk, Inge A. H.; Schijf, Laura J.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Hartmann, Ieneke J. C.] Maasstad Hosp, Dept Radiol, Rotterdam, Netherlands; [Odink, Arlette E.; van Lankeren, Winnifred] Erasmus MC, Dept Radiol, Rotterdam, Netherlands	Radboud University Nijmegen; Meander Medisch Centrum; University of Amsterdam; Academic Medical Center Amsterdam; Maasstad Hospital; Erasmus University Rotterdam; Erasmus MC	Schalekamp, S (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands.	steven.schalekamp@gmail.com	Snoeren, Miranda/Q-7623-2019; van Ginneken, Bram/A-3728-2012; Schalekamp, Steven/Y-2572-2018; Snoeren, M.M./L-4656-2015; Karssemeijer, N./H-8058-2014	Snoeren, Miranda/0000-0002-7613-5433; van Ginneken, Bram/0000-0003-2028-8972; Schalekamp, Steven/0000-0002-3984-3596; 	Riverain Technologies	Riverain Technologies	Riverain Technologies provided a research grant to N. Karssemeijer. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blot SI, 2012, AM J RESP CRIT CARE, V186, P56, DOI 10.1164/rccm.201111-1978OC; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; DONOWITZ GR, 1991, ARCH INTERN MED, V151, P701, DOI 10.1001/archinte.151.4.701; DORFMAN DD, 1992, INVEST RADIOL, V27, P723, DOI 10.1097/00004424-199209000-00015; FEUSNER J, 1988, J CLIN ONCOL, V6, P1699, DOI 10.1200/JCO.1988.6.11.1699; Freedman MT, 2011, RADIOLOGY, V260, P265, DOI 10.1148/radiol.11100153; Freemantle N, 2011, J ANTIMICROB CHEMOTH, V66, pi25, DOI 10.1093/jac/dkq439; Greene RE, 2007, CLIN INFECT DIS, V44, P373, DOI 10.1086/509917; Heitkamp DE, 2012, J AM COLL RADIOL, V9, P164, DOI 10.1016/j.jacr.2011.12.005; Heussel CP, 1999, J CLIN ONCOL, V17, P796, DOI 10.1200/JCO.1999.17.3.796; Hillis SL, 2008, ACAD RADIOL, V15, P647, DOI 10.1016/j.acra.2007.12.015; HUBBELL FA, 1985, NEW ENGL J MED, V312, P209, DOI 10.1056/NEJM198501243120404; JOCHELSON MS, 1986, ANN INTERN MED, V105, P708, DOI 10.7326/0003-4819-105-5-708; KATZ JA, 1991, CANCER, V68, P940, DOI 10.1002/1097-0142(19910901)68:5<940::AID-CNCR2820680505>3.0.CO;2-V; Korones DN, 1997, CANCER, V80, P1160; Li F, 2012, EUR RADIOL, V22, P2729, DOI 10.1007/s00330-012-2550-y; Maertens J, 2011, J ANTIMICROB CHEMOTH, V66, pi37, DOI 10.1093/jac/dkq440; Morrell M, 2005, ANTIMICROB AGENTS CH, V49, P3640, DOI 10.1128/AAC.49.9.3640-3645.2005; Nijhuis CSMO, 2003, EUR J CANCER, V39, P2495, DOI 10.1016/j.ejca.2003.06.002; Ninin E, 2001, CLIN INFECT DIS, V33, P41, DOI 10.1086/320871; Nivoix Y, 2008, CLIN INFECT DIS, V47, P1176, DOI 10.1086/592255; O'Grady NP, 2008, CRIT CARE MED, V36, P1330, DOI 10.1097/CCM.0b013e318169eda9; Pagano L, 2007, CLIN INFECT DIS, V45, P1161, DOI 10.1086/522189; Renoult E, 2004, PEDIATR BLOOD CANCER, V43, P224, DOI 10.1002/pbc.20127; Roberts SD, 2012, SUPPORT CARE CANCER, V20, P2589, DOI 10.1007/s00520-011-1366-7; Roe CA, 1997, ACAD RADIOL, V4, P587, DOI 10.1016/S1076-6332(97)80210-3; Ruhnke M, 2012, ANN ONCOL, V23, P823, DOI 10.1093/annonc/mdr407; Schalekamp S, 2013, EUR J RADIOL, V82, P2399, DOI 10.1016/j.ejrad.2013.09.016; Upton A, 2007, CLIN INFECT DIS, V44, P531, DOI 10.1086/510592; Vandewoude KH, 2004, J HOSP INFECT, V56, P269, DOI 10.1016/j.jhin.2004.01.006; VONEIFF M, 1995, RESPIRATION, V62, P341, DOI 10.1159/000196477	31	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108551	10.1371/journal.pone.0108551	http://dx.doi.org/10.1371/journal.pone.0108551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279774	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800021
J	Tsumoto, K; Ashihara, T; Haraguchi, R; Nakazawa, K; Kurachi, Y				Tsumoto, Kunichika; Ashihara, Takashi; Haraguchi, Ryo; Nakazawa, Kazuo; Kurachi, Yoshihisa			Ischemia-Related Subcellular Redistribution of Sodium Channels Enhances the Proarrhythmic Effect of Class I Antiarrhythmic Drugs: A Simulation Study	PLOS ONE			English	Article							EPICARDIAL BORDER ZONE; HEALING CANINE INFARCTS; CARDIAC MYOCYTES; REDUCED EXCITABILITY; REENTRANT CIRCUITS; NA+ CHANNELS; CURRENTS; HEART; MECHANISM; MODEL	Background: Cardiomyocytes located at the ischemic border zone of infarcted ventricle are accompanied by redistribution of gap junctions, which mediate electrical transmission between cardiomyocytes. This ischemic border zone provides an arrhythmogenic substrate. It was also shown that sodium (Na+) channels are redistributed within myocytes located in the ischemic border zone. However, the roles of the subcellular redistribution of Na+ channels in the arrhythmogenicity under ischemia remain unclear. Methods: Computer simulations of excitation conduction were performed in a myofiber model incorporating both subcellular Na+ channel redistribution and the electric field mechanism, taking into account the intercellular cleft potentials. Results: We found in the myofiber model that the subcellular redistribution of the Na+ channels under myocardial ischemia, decreasing in Na+ channel expression of the lateral cell membrane of each myocyte, decreased the tissue excitability, resulting in conduction slowing even without any ischemia-related electrophysiological change. The conventional model (i.e., without the electric field mechanism) did not reproduce the conduction slowing caused by the subcellular Na+ channel redistribution. Furthermore, Na+ channel blockade with the coexistence of a non-ischemic zone with an ischemic border zone expanded the vulnerable period for reentrant tachyarrhythmias compared to the model without the ischemic border zone. Na+ channel blockade tended to cause unidirectional conduction block at sites near the ischemic border zone. Thus, such a unidirectional conduction block induced by a premature stimulus at sites near the ischemic border zone is associated with the initiation of reentrant tachyarrhythmias. Conclusions: Proarrhythmia of Na+ channel blockade in patients with old myocardial infarction might be partly attributable to the ischemia-related subcellular Na+ channel redistribution.	[Tsumoto, Kunichika; Kurachi, Yoshihisa] Osaka Univ, Grad Sch Med, Dept Pharmacol, Suita, Osaka, Japan; [Ashihara, Takashi] Shiga Univ Med Sci, Dept Cardiovasc Med, Otsu, Shiga 52021, Japan; [Haraguchi, Ryo] Natl Cerebral & Cardiovasc Ctr, Dept Med Informat, Suita, Osaka, Japan; [Nakazawa, Kazuo] Natl Cerebral & Cardiovasc Ctr, Res Inst, Lab Biomed Sci & Informat Management, Suita, Osaka, Japan; [Kurachi, Yoshihisa] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka, Japan	Osaka University; Shiga University of Medical Science; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; Osaka University	Tsumoto, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Pharmacol, Suita, Osaka, Japan.	tsumoto@pharma2.med.osaka-u.ac.jp; ykurachi@pharma2.med.osaka-u.ac.jp	Haraguchi, Ryo/AAS-6426-2021	Tsumoto, Kunichika/0000-0001-7457-3125; Haraguchi, Ryo/0000-0002-2433-2793	Ministry of Education, Culture, Sports, Science and Technology [22136002]; Japan Society for the Promotion of Science, Japan [24790214]; Grants-in-Aid for Scientific Research [22136002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas [22136002] from the Ministry of Education, Culture, Sports, Science and Technology, and for Young Scientists (B) [24790214] from Japan Society for the Promotion of Science, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL R, 1995, CIRC RES, V77, P1180, DOI 10.1161/01.RES.77.6.1180; [Anonymous], 1989, NEW ENGL J MED, V321, P406; Arevalo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068872; Baba S, 2005, CIRCULATION, V112, P2386, DOI 10.1161/CIRCULATIONAHA.105.534784; Bernus O, 2005, EUROPACE, V7, pS93, DOI 10.1016/j.eupc.2005.03.018; Cabo C, 2006, CARDIOVASC RES, V72, P241, DOI 10.1016/j.cardiores.2006.07.005; Coromilas J, 2002, CIRCULATION, V105, P2309, DOI 10.1161/01.CIR.0000016292.14390.16; DAVIDENKO J, 1985, J CARDIOVASC PHARM, V7, P341, DOI 10.1097/00005344-198503000-00021; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Faber GM, 2000, BIOPHYS J, V78, P2392, DOI 10.1016/S0006-3495(00)76783-X; Findlay I, 2008, PROG BIOPHYS MOL BIO, V96, P482, DOI 10.1016/j.pbiomolbio.2007.07.002; GERDES AM, 1995, J MOL CELL CARDIOL, V27, P849, DOI 10.1016/0022-2828(95)90000-4; Haufe V, 2005, J PHYSIOL-LONDON, V564, P683, DOI 10.1113/jphysiol.2004.079681; Jiang M, 2000, CARDIOVASC RES, V48, P34, DOI 10.1016/S0008-6363(00)00159-0; Katz B., 1966, NERVE MUSCLE SYNAPSE; KLEBER AG, 1987, CIRC RES, V61, P271, DOI 10.1161/01.RES.61.2.271; Kucera JP, 2002, CIRC RES, V91, P1176, DOI 10.1161/01.RES.0000046237.54156.0A; Lin XM, 2011, HEART RHYTHM, V8, P1923, DOI 10.1016/j.hrthm.2011.07.016; LUE WM, 1992, CIRCULATION, V85, P1175, DOI 10.1161/01.CIR.85.3.1175; Lukas A, 1996, CARDIOVASC RES, V32, P593, DOI 10.1016/0008-6363(96)00115-0; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Maier SKG, 2002, P NATL ACAD SCI USA, V99, P4073, DOI 10.1073/pnas.261705699; Mori Y, 2008, P NATL ACAD SCI USA, V105, P6463, DOI 10.1073/pnas.0801089105; Peters NS, 1998, CIRCULATION, V97, P1746, DOI 10.1161/01.CIR.97.17.1746; Peters NS, 1997, CIRCULATION, V95, P988; Petitprez S, 2011, CIRC RES, V108, P294, DOI 10.1161/CIRCRESAHA.110.228312; Pinto JMB, 1999, CARDIOVASC RES, V42, P284, DOI 10.1016/S0008-6363(99)00013-9; Pu JL, 1997, CIRC RES, V81, P110, DOI 10.1161/01.RES.81.1.110; Qiu DY, 1996, CIRC RES, V79, P461, DOI 10.1161/01.RES.79.3.461; Satoh H, 1996, BIOPHYS J, V70, P1494, DOI 10.1016/S0006-3495(96)79711-4; Shaw RM, 1997, CIRC RES, V81, P727; Spach MS, 2000, CIRC RES, V86, P302, DOI 10.1161/01.RES.86.3.302; SPERELAKIS N, 1977, J THEOR BIOL, V64, P71, DOI 10.1016/0022-5193(77)90114-X; Suzuki S, 2008, PROG BIOPHYS MOL BIO, V98, P52, DOI 10.1016/j.pbiomolbio.2008.05.003; Tsumoto K, 2011, BIOPHYS J, V100, P554, DOI 10.1016/j.bpj.2010.12.3716; Verkerk AO, 2008, EUROPACE, V10, P257, DOI 10.1093/europace/eum267; Verkerk AO, 2007, EUROPACE, V9, P571, DOI 10.1093/europace/eum121; Vreeker A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094722; Yao JA, 2003, CIRC RES, V92, P437, DOI 10.1161/01.RES.0000059301.81035.06	39	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109271	10.1371/journal.pone.0109271	http://dx.doi.org/10.1371/journal.pone.0109271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279776	gold, Green Published, Green Submitted			2022-12-27	WOS:000342670800069
J	Cotton, TEA; Dumbrell, AJ; Helgason, T				Cotton, T. E. Anne; Dumbrell, Alex J.; Helgason, Thorunn			What Goes in Must Come out: Testing for Biases in Molecular Analysis of Arbuscular Mycorrhizal Fungal Communities	PLOS ONE			English	Article							POLYMORPHISM T-RFLP; BACTERIAL COMMUNITY; DIVERSITY; GENES; SPECIFICITY; PRIMERS; NUMBER	Arbuscular mycorrhizal (AM) fungi are widely distributed microbes that form obligate symbioses with the majority of terrestrial plants, altering nutrient transfers between soils and plants, thereby profoundly affecting plant growth and ecosystem properties. Molecular methods are commonly used in the study of AM fungal communities. However, the biases associated with PCR amplification of these organisms and their ability to be utilized quantitatively has never been fully tested. We used Terminal Restriction Fragment Length Polymorphism (TRFLP) analysis to characterise artificial community templates containing known quantities of defined AM fungal genotypes. This was compared to a parallel in silico analysis that predicted the results of this experiment in the absence of bias. The data suggest that when used quantitatively the TRFLP protocol tested is a powerful, repeatable method for AM fungal community analysis. However, we suggest some limitations to its use for population-level analyses. We found no evidence of PCR bias, supporting the quantitative use of other PCR-based methods for the study of AM fungi such as next generation amplicon sequencing. This finding greatly improves our confidence in methods that quantitatively examine AM fungal communities, providing a greater understanding of the ecology of these important fungi.	[Cotton, T. E. Anne; Helgason, Thorunn] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Cotton, T. E. Anne; Dumbrell, Alex J.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England	University of York - UK; University of Essex	Cotton, TEA (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	anne.cotton@sheffield.ac.uk	Helgason, Thorunn/P-6435-2019	Helgason, Thorunn/0000-0003-3639-1499	Biotechnology and Biological Sciences Research Council; Natural Environment Research Council [NE/D01090X/1]; NERC [NE/D01090X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by a Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) Ph. D. studentship (TEAC) and the Natural Environment Research Council (www.nerc.ac.uk) grant NE/D01090X/1 (AJD, TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alguacil MM, 2008, ECOL APPL, V18, P527, DOI 10.1890/07-0521.1; Berry D, 2011, APPL ENVIRON MICROB, V77, P7846, DOI 10.1128/AEM.05220-11; Brachmann A, 2006, PLOS BIOL, V4, P1111, DOI 10.1371/journal.pbio.0040239; Cheng L, 2012, SCIENCE, V337, P1084, DOI 10.1126/science.1224304; Chessel D., 2004, R NEWS, V4, P5; Clapp JP, 2002, ECOL STU AN, V157, P201; Corradi N, 2007, APPL ENVIRON MICROB, V73, P366, DOI 10.1128/AEM.01574-06; Cotton TEA, 2010, THESIS U YORK UK; Dickie IA, 2007, MYCORRHIZA, V17, P259, DOI 10.1007/s00572-007-0129-2; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Dumbrell AJ, 2010, J ECOL, V98, P419, DOI 10.1111/j.1365-2745.2009.01622.x; Egert M, 2003, APPL ENVIRON MICROB, V69, P2555, DOI 10.1128/AEM.69.5.2555-2562.2003; Fitter AH, 1996, PHILOS T R SOC B, V351, P1367, DOI 10.1098/rstb.1996.0120; Fonseca VG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks002; Gosling P, 2013, NEW PHYTOL, V198, P546, DOI 10.1111/nph.12169; Hausmann NT, 2009, NEW PHYTOL, V183, P1188, DOI 10.1111/j.1469-8137.2009.02882.x; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Helgason T, 2007, J ECOL, V95, P623, DOI 10.1111/j.1365-2745.2007.01239.x; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; Jansa J, 2008, NEW PHYTOL, V177, P779, DOI 10.1111/j.1469-8137.2007.02294.x; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Kitts C L, 2001, Curr Issues Intest Microbiol, V2, P17; Klironomos JN, 2000, ECOL LETT, V3, P137, DOI 10.1046/j.1461-0248.2000.00131.x; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Nuccio EE, 2013, ENVIRON MICROBIOL, V15, P1870, DOI 10.1111/1462-2920.12081; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; PETRANOVIC M, 1990, NUCLEIC ACIDS RES, V18, P2159, DOI 10.1093/nar/18.8.2159; R Development Core Team, 2007, R LANG ENV STAT COMP; Roberts DM, 2012, METHODS ECOL EVOL, V3, P24, DOI 10.1111/j.2041-210X.2011.00139.x; Rosendahl S, 2008, NEW PHYTOL, V178, P253, DOI 10.1111/j.1469-8137.2008.02378.x; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Siddiky MRK, 2012, SOIL BIOL BIOCHEM, V50, P33, DOI 10.1016/j.soilbio.2012.03.001; SIMON L, 1992, APPL ENVIRON MICROB, V58, P291, DOI 10.1128/AEM.58.1.291-295.1992; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Smith DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090234; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vandenkoornhuyse P, 2003, MOL ECOL, V12, P3085, DOI 10.1046/j.1365-294X.2003.01967.x; Vogelsang KM, 2006, NEW PHYTOL, V172, P554, DOI 10.1111/j.1469-8137.2006.01854.x; Wagg C, 2011, ECOLOGY, V92, P1303, DOI 10.1890/10-1915.1	46	12	13	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109234	10.1371/journal.pone.0109234	http://dx.doi.org/10.1371/journal.pone.0109234			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275629	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500078
J	Cumbo, F; Paci, P; Santoni, D; Di Paola, L; Giuliani, A				Cumbo, Fabio; Paci, Paola; Santoni, Daniele; Di Paola, Luisa; Giuliani, Alessandro			GIANT: A Cytoscape Plugin for Modular Networks	PLOS ONE			English	Article							GRAPH-THEORY; PROTEIN; HEMOGLOBIN; CENTRALITY; PARADIGM	Network analysis provides deep insight into real complex systems. Revealing the link between topological and functional role of network elements can be crucial to understand the mechanisms underlying the system. Here we propose a Cytoscape plugin (GIANT) to perform network clustering and characterize nodes at the light of a modified Guimera-Amaral cartography. This approach results into a vivid picture of the a topological/functional relationship at both local and global level. The plugin has been already approved and uploaded on the Cytoscape APP store.	[Cumbo, Fabio; Paci, Paola; Santoni, Daniele] CNR, Inst Syst Anal & Comp Sci Antonio Ruberti, Rome, Italy; [Paci, Paola] SysBio Ctr Syst Biol, Milan, Italy; [Paci, Paola] SysBio Ctr Syst Biol, Rome, Italy; [Di Paola, Luisa] Univ CAMPUS BioMed, Fac Engn, Rome, Italy; [Giuliani, Alessandro] Ist Super Sanita, Environm & Hlth Dept, I-00161 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); University Campus Bio-Medico - Rome Italy; Istituto Superiore di Sanita (ISS)	Di Paola, L (corresponding author), Univ CAMPUS BioMed, Fac Engn, Rome, Italy.	l.dipaola@unicampus.it	Cumbo, Fabio/AAG-7079-2019; Giuliani, Alessandro/K-7589-2016; Giuliani, Alessandro/AAF-1740-2020	Cumbo, Fabio/0000-0003-2920-5838; Giuliani, Alessandro/0000-0002-4640-804X; Giuliani, Alessandro/0000-0002-4640-804X; Di Paola, Luisa/0000-0001-5329-8689; SANTONI, DANIELE/0000-0003-1898-5285	SysBioNet; Italian Roadmap Research Infrastructures; Epigenomics Flagship Project (Progetto Bandiera Epigenomica) EPIGEN - Italian Ministry of Education, University and Research (MIUR); National Research Council of Italy (CNR)	SysBioNet; Italian Roadmap Research Infrastructures; Epigenomics Flagship Project (Progetto Bandiera Epigenomica) EPIGEN - Italian Ministry of Education, University and Research (MIUR); National Research Council of Italy (CNR)(Consiglio Nazionale delle Ricerche (CNR))	The manuscript has been produced thanks to the financial support from SysBioNet, Italian Roadmap Research Infrastructures 2012 and from The Epigenomics Flagship Project (Progetto Bandiera Epigenomica) EPIGEN funded by Italian Ministry of Education, University and Research (MIUR) and the National Research Council of Italy (CNR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Bollobas B, 1985, CAMBRIDGE STUDIES AD; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; De Ruvo M, 2012, BIOPHYS CHEM, V165, P21, DOI 10.1016/j.bpc.2012.03.001; Di Paola L, 2013, CHEM REV, V113, P1598, DOI 10.1021/cr3002356; Dongen SV, 1997, THESIS U UTRECHT NET; Fasoli M, 2012, PLANT CELL, V24, P3489, DOI 10.1105/tpc.112.100230; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hardison RC, 2002, HUM MUTAT, V19, P225, DOI 10.1002/humu.10044; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Krishnan A, 2008, CURR PROTEIN PEPT SC, V9, P28; Meila M, 2001, ADV NEUR IN, V13, P873; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Oliva G, 2013, PROCEEDINGS OF THE 2013 IEEE 2ND INTERNATIONAL NETWORK SCIENCE WORKSHOP (NSW), P131, DOI 10.1109/NSW.2013.6609209; Paci P, 2012, CURR PROTEOMICS, V9, P160, DOI 10.2174/157016412803251815; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tasdighian S, 2014, J CHEM INF MODEL, V54, P159, DOI 10.1021/ci400218v	25	31	31	6	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e105001	10.1371/journal.pone.0105001	http://dx.doi.org/10.1371/journal.pone.0105001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275465	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500002
J	Hayat, T; Hussain, T; Shehzad, SA; Alsaedi, A				Hayat, T.; Hussain, Tariq; Shehzad, S. A.; Alsaedi, A.			Thermal and Concentration Stratifications Effect s in Radiative Flow of Jeffrey Fluid over a Stretching Sheet	PLOS ONE			English	Article							HOMOTOPY ANALYSIS METHOD; CONVECTIVE BOUNDARY-CONDITION; MHD 3-DIMENSIONAL FLOW; STAGNATION POINT FLOW; MIXED-CONVECTION; HEAT-TRANSFER; ENTROPY GENERATION; JEFFERY FLUID; POROUS-MEDIUM; NANOFLUID	In this article we investigate the heat and mass transfer analysis in mixed convective radiative flow of Jeffrey fluid over a moving surface. The effects of thermal and concentration stratifications are also taken into consideration. Rosseland's approximations are utilized for thermal radiation. The nonlinear boundary layer partial differential equations are converted into nonlinear ordinary differential equations via suitable dimensionless variables. The solutions of nonlinear ordinary differential equations are developed by homotopic procedure. Convergence of homotopic solutions is examined graphically and numerically. Graphical results of dimensionless velocity, temperature and concentration are presented and discussed in detail. Values of the skin-friction coefficient, the local Nusselt and the local Sherwood numbers are analyzed numerically. Temperature and concentration profiles are decreased when the values of thermal and concentration stratifications parameters increase. Larger values of radiation parameter lead to the higher temperature and thicker thermal boundary layer thickness.	[Hayat, T.] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, T.; Alsaedi, A.] King Abdulaziz Univ, Fac Sci, Dept Math, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah, Saudi Arabia; [Hussain, Tariq] Mohammad Ali Jinnah Univ, Fac Comp, Dept Math, Islamabad, Pakistan; [Shehzad, S. A.] Comsats Inst Informat Technol, Dept Math, Sahiwal, Pakistan	Quaid I Azam University; King Abdulaziz University; Mohammad Ali Jinnah University; COMSATS University Islamabad (CUI)	Shehzad, SA (corresponding author), Comsats Inst Informat Technol, Dept Math, Sahiwal, Pakistan.	s.a.shehzad@hotmail.com	Hussain, Muhammad/AAD-2380-2022; Alsaedi, Ahmed/A-2094-2013; Shehzad, Sabir Ali/J-3885-2014; Hayat, Tasawar/E-9449-2015; Hayat, Tasawar/A-3853-2013; Hayat, Tasawar/Y-2524-2019	Alsaedi, Ahmed/0000-0003-3452-8922; Hussain, Tariq/0000-0002-1332-2418	Deanship of Scientific Research (DSR) King Abdulaziz University, Jeddah, Saudi Arabia [78-130-35-HiCi]	Deanship of Scientific Research (DSR) King Abdulaziz University, Jeddah, Saudi Arabia	This project is funded by the Deanship of Scientific Research (DSR) King Abdulaziz University, Jeddah, Saudi Arabia under grant no. 78-130-35-HiCi. The authors, therefore, acknowledge with thanks DSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasbandy S, 2014, INT J NUMER METHOD H, V24, P390, DOI 10.1108/HFF-05-2012-0096; Abbasbandy S, 2013, QUAEST MATH, V36, P93, DOI 10.2989/16073606.2013.780336; Alsaadi FE, 2013, J MECH, V29, P623, DOI 10.1017/jmech.2013.44; [Anonymous], 2013, J EGYPTIAN MATH SOC, DOI DOI 10.1016/j.joems.2013.02.006; Hayat T, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13158-1; Hayat T, 2013, J MECH, V29, P403, DOI 10.1017/jmech.2013.6; Hayat T, 2013, J BRAZ SOC MECH SCI, V35, P381, DOI 10.1007/s40430-013-0036-8; Hayat T, 2013, APPL MATH MECH-ENGL, V34, P823, DOI 10.1007/s10483-013-1710-7; Hayat T, 2012, NUCL ENG DES, V243, P15, DOI 10.1016/j.nucengdes.2011.11.005; Hayat T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103214; Hayat T, 2014, J HYDROL HYDROMECH, V62, P117, DOI 10.2478/johh-2014-0016; Hayat T, 2014, INT J NUMER METHOD H, V24, P342, DOI 10.1108/HFF-03-2012-0065; Ibrahim W, 2013, COMPUT FLUIDS, V86, P433, DOI 10.1016/j.compfluid.2013.07.029; Kothandapani M, 2008, INT J NONLIN MECH, V43, P915, DOI 10.1016/j.ijnonlinmec.2008.06.009; Liao SJ, 2009, COMMUN NONLINEAR SCI, V14, P983, DOI 10.1016/j.cnsns.2008.04.013; Makinde OD, 2013, INT J HEAT MASS TRAN, V62, P526, DOI 10.1016/j.ijheatmasstransfer.2013.03.049; Moradi A, 2013, INT J THERM SCI, V64, P129, DOI 10.1016/j.ijthermalsci.2012.08.014; Ramzan M, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13049-5; Rashidi MM, 2013, ENERGY, V55, P497, DOI 10.1016/j.energy.2013.01.036; Rashidi MM, 2013, INT J HEAT MASS TRAN, V62, P515, DOI 10.1016/j.ijheatmasstransfer.2013.03.004; Shehzad SA, 2013, BRAZ J CHEM ENG, V30, P897, DOI 10.1590/S0104-66322013000400021; Shehzad SA, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13056-6; Shehzad SA, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13007-3; Shehzad SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078240; Shehzad SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068139; Sheikholeslami M, 2013, ENERGY, V60, P501, DOI 10.1016/j.energy.2013.07.070; Sheikholeslami M, 2012, J APPL MATH, DOI 10.1155/2012/421320; Srinivasacharya D, 2014, INT J ENG MATH, V2014; [特里帕蒂D Tripathi D], 2011, [应用数学和力学, Applied Mathematics and Mechanics], V32, P1148; Turkyilmazoglu M, 2013, INT J MECH SCI, V77, P263, DOI 10.1016/j.ijmecsci.2013.10.011; Turkyilmazoglu M, 2013, INT J HEAT MASS TRAN, V59, P167, DOI 10.1016/j.ijheatmasstransfer.2012.12.009; Turkyilmazoglu M, 2013, INT J HEAT MASS TRAN, V57, P82, DOI 10.1016/j.ijheatmasstransfer.2012.10.006; Turkyilmazoglu M, 2012, COMMUN NONLINEAR SCI, V17, P4097, DOI 10.1016/j.cnsns.2012.01.030; Turkyilmazoglu M, 2010, APPL MATH LETT, V23, P1226, DOI 10.1016/j.aml.2010.06.003; Zhang W, 2012, ACTA MECH, V223, P2537, DOI 10.1007/s00707-012-0725-x	35	44	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e107858	10.1371/journal.pone.0107858	http://dx.doi.org/10.1371/journal.pone.0107858			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275441	Green Submitted, Green Published, gold			2022-12-27	WOS:000342591500009
J	Hevia, D; Mayo, JC; Tan, DX; Rodriguez-Garcia, A; Sainz, RM				Hevia, David; Mayo, Juan C.; Tan, Dun-Xian; Rodriguez-Garcia, Aida; Sainz, Rosa M.			Melatonin Enhances Photo-Oxidation of 2 ',7 '-Dichlorodihydrofluorescein by an Antioxidant Reaction That Renders N1-Acetyl-N2-Formyl-5-Methoxykynuramine (AFMK)	PLOS ONE			English	Article							FLUORESCENT DYE 2'-7'-DICHLOROFLUORESCEIN; OXIDATIVE STRESS MEASUREMENTS; PROSTATE-CANCER CELLS; DICHLOROFLUORESCEIN ASSAY; FLUOROMETRIC ANALYSIS; SUPEROXIDE-DISMUTASE; PROOXIDANT ACTIVITY; HYDROGEN-PEROXIDE; SPECIES FORMATION; OXYGEN	The indolamine melatonin (MEL) is described as an antioxidant and a free radical scavenger. However occasionally, the indoleamine has been reported to increase free radicals with insufficient mechanistic explanation. In an attempt to find a reason for those controversial results, a potential mechanism that explains MEL prooxidant activity is investigated. The current controversy about redox detection methods has prompted us to search a possible interaction between MEL and dichlorodihydrofluorescein (DCFH2), perhaps the most widely fluorescence probe employed for free radicals detection in cellular models. Here, it is demonstrated that melatonin potentiates the photooxidation of DCFH2 in a cell-free system, increasing the production of its fluorescent metabolite. Indeed, MEL works as an antioxidant scavenging hydroxyl radicals in this system. Thus, this reaction between MEL and DCFH2 produces N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK), a biogenic amine with antioxidant properties too. This reaction is O-2 and light dependent and it is prevented by antioxidants such as N-acetylcysteine or ascorbic acid. Furthermore, when DCFH2 has been employed to evaluate antioxidant or prooxidant activities of MEL in cellular models it is confirmed that it works as an antioxidant but these results can be modulated by light misleading to a prooxidant conclusion. In conclusion, here is demonstrated that DCFH2, light and melatonin interact and results obtained using these fluorescence probes in studies with melatonin have to be carefully interpreted.	[Hevia, David; Mayo, Juan C.; Rodriguez-Garcia, Aida; Sainz, Rosa M.] Univ Oviedo, Dept Morfol & Biol Celular, Sch Med, E-33006 Oviedo, Spain; [Hevia, David; Mayo, Juan C.; Rodriguez-Garcia, Aida; Sainz, Rosa M.] Inst Univ Oncol Principado Asturias, Oviedo, Spain; [Tan, Dun-Xian] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Oviedo; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Texas System; University of Texas Health San Antonio	Sainz, RM (corresponding author), Univ Oviedo, Dept Morfol & Biol Celular, Sch Med, E-33006 Oviedo, Spain.	sainzrosa@uniovi.es	Hevia, David/B-4193-2017; Sainz, Rosa M./N-5885-2014; Rodriguez-Garcia, Aida/AAG-7264-2020; Mayo, Juan Carlos/H-3435-2011; Rodriguez-Garcia, Aida/E-9376-2013	Hevia, David/0000-0002-1421-6262; Sainz, Rosa M./0000-0003-3048-5582; Rodriguez-Garcia, Aida/0000-0001-6309-2035; Mayo, Juan Carlos/0000-0002-0882-2047; Rodriguez-Garcia, Aida/0000-0002-0299-4753; Rodriguez Garcia, Aida/0000-0002-9147-0897	ISCIII grant [FISS-09-PS09/02204]; "Severo Ochoa'' fellowship program (FICYT); Instituto Universitario Oncologico del Principado de Asturias (IUOPA)	ISCIII grant; "Severo Ochoa'' fellowship program (FICYT); Instituto Universitario Oncologico del Principado de Asturias (IUOPA)	This work has been supported by an ISCIII (FISS-09-PS09/02204) grant. ARG acknowledges support from the "Severo Ochoa'' fellowship program (FICYT). DH and JCM acknowledge sponsorship from Instituto Universitario Oncologico del Principado de Asturias (IUOPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal M, 2003, BIOCHEM BIOPH RES CO, V304, P619, DOI 10.1016/S0006-291X(03)00641-7; Albertini MC, 2006, ANN NY ACAD SCI, V1091, P10, DOI 10.1196/annals.1378.050; Allegra M, 2003, J PINEAL RES, V34, P1, DOI 10.1034/j.1600-079X.2003.02112.x; BASS DA, 1983, J IMMUNOL, V130, P1910; Behrends A, 2007, J ENVIRON SCI HEAL B, V42, P599, DOI 10.1080/03601230701465437; Bejarano I, 2011, BASIC CLIN PHARMACOL, V108, P14, DOI 10.1111/j.1742-7843.2010.00619.x; Bilski P, 2002, FREE RADICAL BIO MED, V33, P938, DOI 10.1016/S0891-5849(02)00982-6; Blask DE, 2011, J PINEAL RES, V51, P259, DOI 10.1111/j.1600-079X.2011.00888.x; Blask David E., 2002, Current Topics in Medicinal Chemistry, V2, P113, DOI 10.2174/1568026023394407; BRANDT R, 1965, ANAL BIOCHEM, V11, P6, DOI 10.1016/0003-2697(65)90035-7; Buyukavci M, 2006, FUND CLIN PHARMACOL, V20, P73, DOI 10.1111/j.1472-8206.2005.00389.x; CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1; Chignell CF, 2003, FREE RADICAL BIO MED, V34, P1029, DOI 10.1016/S0891-5849(03)00022-4; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Fischer TW, 2012, J PINEAL RES; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; GYLLENHAMMAR H, 1987, J IMMUNOL METHODS, V97, P209, DOI 10.1016/0022-1759(87)90461-3; Hafer K, 2008, RADIAT RES, V169, P460, DOI 10.1667/RR1212.1; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; HARDELAND R, 1993, NEUROSCI BIOBEHAV R, V17, P347, DOI 10.1016/S0149-7634(05)80016-8; HARDELAND R, 1995, J PINEAL RES, V18, P104, DOI 10.1111/j.1600-079X.1995.tb00147.x; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Hevia D, 2010, ANAL BIOANAL CHEM, V397, P1235, DOI 10.1007/s00216-010-3653-4; Hevia D, 2010, J CHROMATOGR A, V1217, P1368, DOI 10.1016/j.chroma.2009.12.070; Hevia D, 2008, J PINEAL RES, V45, P247, DOI 10.1111/j.1600-079X.2008.00581.x; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; KESTON AS, 1965, ANAL BIOCHEM, V11, P1, DOI 10.1016/0003-2697(65)90034-5; Kim YM, 2006, MOL CELLS, V21, P161; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lemoine P, 2012, EXPERT OPIN PHARMACO, V13, P895, DOI 10.1517/14656566.2012.667076; Liochev SI, 2001, J BIOL CHEM, V276, P35253, DOI 10.1074/jbc.M104237200; Marchesi E, 1999, FREE RADICAL BIO MED, V26, P148, DOI 10.1016/S0891-5849(98)00174-9; Mayo JC, 2002, CELL MOL LIFE SCI, V59, P1706, DOI 10.1007/PL00012498; Mediavilla MD, 2010, CURR MED CHEM, V17, P4462, DOI 10.2174/092986710794183015; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Nourooz-Zadeh J, 1999, REDOX REP, V4, P17, DOI 10.1179/135100099101534693; Osseni RA, 2000, LIFE SCI, V68, P387, DOI 10.1016/S0024-3205(00)00955-3; POEGGELER B, 1994, J PINEAL RES, V17, P1, DOI 10.1111/j.1600-079X.1994.tb00106.x; Possel H, 1997, FEBS LETT, V416, P175, DOI 10.1016/S0014-5793(97)01197-6; Quiros I, 2009, INT J CANCER, V125, P1497, DOI 10.1002/ijc.24501; REITER RJ, 1991, MOL CELL ENDOCRINOL, V79, pC153, DOI 10.1016/0303-7207(91)90087-9; Reiter RJ, 2009, BIOL REPROD, V81, P445, DOI 10.1095/biolreprod.108.075655; Rota C, 1999, FREE RADICAL BIO MED, V27, P873, DOI 10.1016/S0891-5849(99)00137-9; Sainz RM, 2003, BIOCHEM BIOPH RES CO, V302, P625, DOI 10.1016/S0006-291X(03)00230-4; Sanchez-Sanchez AM, 2011, FREE RADICAL RES, V45, P1333, DOI 10.3109/10715762.2011.623700; Stehle JH, 2011, J PINEAL RES, V51, P17, DOI 10.1111/j.1600-079X.2011.00856.x; Tan Dun-Xian, 2002, Current Topics in Medicinal Chemistry, V2, P181, DOI 10.2174/1568026023394443; Tan DX, 2010, BIOL REV, V85, P607, DOI 10.1111/j.1469-185X.2009.00118.x; Tan DX, 2000, FREE RADICAL BIO MED, V29, P1177, DOI 10.1016/S0891-5849(00)00435-4; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Wolfler A, 2001, FEBS LETT, V502, P127, DOI 10.1016/S0014-5793(01)02680-1; Wrona M, 2005, FREE RADICAL BIO MED, V38, P262, DOI 10.1016/j.freeradbiomed.2004.10.022; Wrona M, 2008, FREE RADICAL BIO MED, V44, P56, DOI 10.1016/j.freeradbiomed.2007.09.005; Wrona M, 2006, FREE RADICAL BIO MED, V41, P657, DOI 10.1016/j.freeradbiomed.2006.05.006; Zhang HM, 2011, J PINEAL RES, V50, P78, DOI 10.1111/j.1600-079X.2010.00815.x	57	9	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109257	10.1371/journal.pone.0109257	http://dx.doi.org/10.1371/journal.pone.0109257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275380	gold, Green Published, Green Submitted			2022-12-27	WOS:000342591500088
J	Rao, GD; Sui, JK; Zeng, YF; He, CY; Duan, AG; Zhang, JG				Rao, Guodong; Sui, Jinkai; Zeng, Yanfei; He, Caiyun; Duan, Aiguo; Zhang, Jianguo			De Novo Transcriptome and Small RNA Analysis of Two Chinese Willow Cultivars Reveals Stress Response Genes in Salix matsudana	PLOS ONE			English	Article							PLANT-PATHOGEN INTERACTIONS; ATOMIC LAYER DEPOSITION; ABSCISIC-ACID; OXIDATIVE STRESS; REACTIVE OXYGEN; CAPSICUM-ANNUUM; POTATO PLANTS; WRKY GENE; TOLERANCE; ARABIDOPSIS	Salix matsudana Koidz. is a deciduous, rapidly growing, and drought resistant tree and is one of the most widely distributed and commonly cultivated willow species in China. Currently little transcriptomic and small RNAomic data are available to reveal the genes involve in the stress resistant in S. matsudana. Here, we report the RNA-seq analysis results of both transcriptome and small RNAome data using Illumina deep sequencing of shoot tips from two willow variants(Salix. matsudana and Salix matsudana Koidz. cultivar 'Tortuosa'). De novo gene assembly was used to generate the consensus transcriptome and small RNAome, which contained 106,403 unique transcripts with an average length of 944 bp and a total length of 100.45 MB, and 166 known miRNAs representing 35 miRNA families. Comparison of transcriptomes and small RNAomes combined with quantitative real-time PCR from the two Salix libraries revealed a total of 292 different expressed genes(DEGs) and 36 different expressed miRNAs (DEMs). Among the DEGs and DEMs, 196 genes and 24 miRNAs were up regulated, 96 genes and 12 miRNA were down regulated in S. matsudana. Functional analysis of DEGs and miRNA targets showed that many genes were involved in stress resistance in S. matsudana. Our global gene expression profiling presents a comprehensive view of the transcriptome and small RNAome which provide valuable information and sequence resources for uncovering the stress response genes in S. matsudana. Moreover the transcriptome and small RNAome data provide a basis for future study of genetic resistance in Salix.	[Zeng, Yanfei; He, Caiyun; Duan, Aiguo; Zhang, Jianguo] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Rao, Guodong; Sui, Jinkai; Zeng, Yanfei; He, Caiyun; Duan, Aiguo; Zhang, Jianguo] Chinese Acad Forestry, Res Inst Forestry, State Forestry Adm, Key Lab Tree Breeding & Cultivat, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Chinese Academy of Forestry; Research Institute of Forestry, CAF	Zhang, JG (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	raoguodong02@163.com	Guodong, Rao/AAG-8821-2019		National Natural Science Foundation of China [31400569]; Fundamental Research Funds for the Central Non-profit Research Institution of CAF [RIF2013-11]; Beijing Co-building Plan for Scientific Research and Postgraduate Education [2013K0140, 2013K0141, 2014K0151, 2014K0152]; Collaborative Innovation Plan of Jiangsu Higher Education	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Non-profit Research Institution of CAF; Beijing Co-building Plan for Scientific Research and Postgraduate Education; Collaborative Innovation Plan of Jiangsu Higher Education	The research was sponsored by grants from the National Natural Science Foundation of China (31400569), the Fundamental Research Funds for the Central Non-profit Research Institution of CAF (RIF2013-11), Beijing Co-building Plan for Scientific Research and Postgraduate Education (2013K0140, 2013K0141, 2014K0151, 2014K0152), and Collaborative Innovation Plan of Jiangsu Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Almeida R, 2005, BIODIVERS CONSERV, V14, P1059, DOI 10.1007/s10531-004-8413-3; Argueso CT, 2009, PLANT CELL ENVIRON, V32, P1147, DOI 10.1111/j.1365-3040.2009.01940.x; Bottino MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059423; Broin M, 2000, FEBS LETT, V467, P245, DOI 10.1016/S0014-5793(00)01165-0; Brunskill EW, 2012, DEV BIOL, V368, P4, DOI 10.1016/j.ydbio.2012.05.030; Chang CH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-491; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dang FF, 2014, PHYSIOL PLANTARUM, V150, P397, DOI 10.1111/ppl.12093; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Ding SJ, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-80; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Fan J, 2009, PLANT PHYSIOL, V150, P1750, DOI 10.1104/pp.109.137943; Figueiredo DD, 2012, J EXP BOT, V63, P3643, DOI 10.1093/jxb/ers035; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greger M, 1999, INT J PHYTOREMEDIAT, V1, P115, DOI 10.1080/15226519908500010; He CY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-119; Hjalten J, 1998, OECOLOGIA, V117, P127, DOI 10.1007/s004420050640; Ivanova D, 2014, PLANT PHYSIOL BIOCH, V74, P276, DOI 10.1016/j.plaphy.2013.11.019; Jaillais Y, 2010, NAT STRUCT MOL BIOL, V17, P642, DOI 10.1038/nsmb0610-642; Jiang SS, 2013, PLANT PHYSIOL BIOCH, V71, P112, DOI 10.1016/j.plaphy.2013.07.004; Karp A, 2011, J INTEGR PLANT BIOL, V53, P151, DOI 10.1111/j.1744-7909.2010.01015.x; Kim MD, 2010, PHYSIOL PLANTARUM, V140, P153, DOI 10.1111/j.1399-3054.2010.01392.x; Kim SH, 2004, PLANT MOL BIOL, V55, P883, DOI 10.1007/s11103-005-2151-0; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Li Q, 2012, J GENET GENOMICS, V39, P351, DOI 10.1016/j.jgg.2012.04.008; Liu ZX, 2013, PLANT CELL REP, V32, P227, DOI 10.1007/s00299-012-1357-2; Lv XM, 2009, J BIOTECHNOL, V141, P104, DOI 10.1016/j.jbiotec.2009.03.009; Markakis MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082596; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Morgan T, 1998, HYPERTENSION, V32, P683, DOI 10.1161/01.HYP.32.4.683; Muoki RC, 2012, MOL BIOTECHNOL, V52, P82, DOI 10.1007/s12033-011-9476-5; Oide S, 2013, NEW PHYTOL, V200, P1187, DOI 10.1111/nph.12436; Punshon T, 1997, NEW PHYTOL, V137, P303, DOI 10.1046/j.1469-8137.1997.00802.x; Rao GD, 2012, MOL BIOL REP, V39, P6887, DOI 10.1007/s11033-012-1515-1; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; Roxas VP, 2000, PLANT CELL PHYSIOL, V41, P1229, DOI 10.1093/pcp/pcd051; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Shi WN, 2014, PLANT CELL REP, V33, P483, DOI 10.1007/s00299-013-1548-5; Suzuki S, 2006, PLANT PHYSIOL, V142, P1233, DOI 10.1104/pp.106.086678; Tsarouhas V, 2004, THEOR APPL GENET, V108, P1335, DOI 10.1007/s00122-003-1544-1; Van Houtte H, 2013, PLANT PHYSIOL, V161, P1158, DOI 10.1104/pp.112.211391; Wang JY, 2008, J INTEGR PLANT BIOL, V50, P56, DOI 10.1111/j.1744-7909.2007.00590.x; Watanabe S, 2014, PLANT CELL ENVIRON, V37, P1022, DOI 10.1111/pce.12218; Wong MML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-342; Yang JL, 2013, TREE PHYSIOL, V33, P628, DOI 10.1093/treephys/tpt038; Ye ZY, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-108; Zhang CQ, 2012, PLANT MOL BIOL, V80, P169, DOI 10.1007/s11103-012-9937-7; Zhang DX, 2013, FUNGAL GENET BIOL, V61, P1, DOI 10.1016/j.fgb.2013.08.013; Zhang SW, 2009, PLANT PHYSIOL, V151, P1889, DOI 10.1104/pp.109.146803; Zheng L, 2013, PLANT MOL BIOL, V82, P303, DOI 10.1007/s11103-013-0063-y; Zheng S, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-116	56	21	25	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109122	10.1371/journal.pone.0109122	http://dx.doi.org/10.1371/journal.pone.0109122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275458	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500065
J	Takarada, Y; Nozaki, D				Takarada, Yudai; Nozaki, Daichi			Maximal Voluntary Force Strengthened by the Enhancement of Motor System State through Barely Visible Priming Words with Reward	PLOS ONE			English	Article							UNCONSCIOUS ACTIVATION; INHIBITION; PURSUIT; BRAIN; WILL	The topic of unconscious influences on behaviour has long been explored as a means of understanding human performance and the neurobiological correlates of intention, motivation, and action. However, what is relatively unknown is whether subconsciously delivered priming stimuli, with or without rewards, can affect individuals' maximum level of force produced with their best effort. We demonstrated using transcranial magnetic stimulation that barely visible priming of an action concept, when combined with a reward in the form of a consciously visible positive stimulus, could alter the state of the motor system. In accordance with this neurophysiological alteration, the prime-plus-reward stimuli significantly increased the hand-grip force level of maximum voluntary contraction with little conscious awareness. This is the first objective evidence that the barely conscious presence of a behavioral goal can influence the state of the motor system and arouse latent ability for human force exertion.	[Takarada, Yudai] Waseda Univ, Fac Sports Sci, Tokorozawa, Saitama, Japan; [Nozaki, Daichi] Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo 113, Japan	Waseda University; University of Tokyo	Takarada, Y (corresponding author), Waseda Univ, Fac Sports Sci, Tokorozawa, Saitama, Japan.	takarada@waseda.jp						Aarts H, 2008, SCIENCE, V319, P1639, DOI 10.1126/science.1150432; Aron AR, 2003, BRAIN, V126, P713, DOI 10.1093/brain/awg067; Bargh JA, 2001, J PERS SOC PSYCHOL, V81, P1014, DOI 10.1037//0022-3514.81.6.1014; BELANGER AY, 1981, J APPL PHYSIOL, V51, P1131, DOI 10.1152/jappl.1981.51.5.1131; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Custers R, 2010, SCIENCE, V329, P47, DOI 10.1126/science.1188595; D'Ostilio K, 2012, EUR J NEUROSCI, V35, P332, DOI 10.1111/j.1460-9568.2011.07941.x; D'Ostilio K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016613; Househam E, 2004, MUSCLE NERVE, V29, P401, DOI 10.1002/mus.10564; IKAI M, 1961, J APPL PHYSIOL, V16, P157, DOI 10.1152/jappl.1961.16.1.157; James William, 1950, PRINCIPLES PSYCHOL, V2; Lau HC, 2007, J NEUROSCI, V27, P5805, DOI 10.1523/JNEUROSCI.4335-06.2007; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Sumner P, 2007, NEURON, V54, P697, DOI 10.1016/j.neuron.2007.05.016; van Gaal S, 2010, J NEUROSCI, V30, P4143, DOI 10.1523/JNEUROSCI.2992-09.2010	17	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109422	10.1371/journal.pone.0109422	http://dx.doi.org/10.1371/journal.pone.0109422			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275612	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500101
J	Wang, IN; Hu, CC; Lee, CW; Yen, SM; Yeh, WB; Hsu, YH; Lin, NS				Wang, Ing-Nang; Hu, Chung-Chi; Lee, Ching-Wei; Yen, Sih-Min; Yeh, Wen-Bing; Hsu, Yau-Heiu; Lin, Na-Sheng			Genetic Diversity and Evolution of Satellite RNAs Associated with the Bamboo Mosaic Virus	PLOS ONE			English	Article							NATURAL-POPULATIONS; DOWN-REGULATION; REPLICATION; POTEXVIRUS; SEQUENCE; RESISTANCE; RECOMBINATION; REQUIRES; REGION; GENERATION	Satellite RNAs (satRNAs) are subviral agents that depend on cognate helper viruses for genome replication and encapsidation. Their negative impacts on helper viruses have been exploited to control plant viral diseases. SatBaMV is a commonly found satRNA associated with Bamboo mosaic virus (BaMV) that infects diverse bamboo species in the field. To investigate the genetic diversity and evolution of satRNAs, we examined seven satBaMV populations derived from five bamboo species and cultivars from Taiwan, China, and India and one from the greenhouse. We found 3 distinct clades among the seven populations. Clade I is consisted of all satBaMV isolates, except for those from Dendrocalamus latiflorus in Taiwan and Bambusa vulgaris in India, which belong to Clades II and III, respectively. Interestingly, nucleotide diversity was lower for Clade I than II and III. However, the nucleotide diversity did not seem to depend on bamboo species or geographic location. Our population genetic analyses revealed the presence of excessive low-frequency polymorphic sites, which suggests that the satBaMV population was under purifying selection and/or population expansion. Further analysis of P20, the only satBaMV gene that encodes a non-structural protein involved in the long-distance movement of satBaMV, showed evidence of purifying selection. Taken together, our results suggest that purifying selection against defective P20 protein is responsible at least in part for the evolution of the satBaMV genome.	[Wang, Ing-Nang; Lin, Na-Sheng] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Wang, Ing-Nang] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; [Hu, Chung-Chi; Lee, Ching-Wei; Yen, Sih-Min; Hsu, Yau-Heiu] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Yeh, Wen-Bing] Natl Chung Hsin Univ, Dept Entomol, Taichung, Taiwan	Academia Sinica - Taiwan; State University of New York (SUNY) System; State University of New York (SUNY) Albany; National Chung Hsing University; National Chung Hsing University	Lin, NS (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan.	nslin@sinica.edu.tw			Institute of Plant and Microbial Biology (IPMB), Academia Sinica, Taiwan; National Science Council, Taiwan (NSC) [101-2811-B-001-024]	Institute of Plant and Microbial Biology (IPMB), Academia Sinica, Taiwan; National Science Council, Taiwan (NSC)(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the Institute of Plant and Microbial Biology (IPMB), Academia Sinica, Taiwan, to NSL. INW received funding from the National Science Council, Taiwan (NSC 101-2811-B-001-024), IPMB, and Academia Sinica during his sabbatical visit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Prados JL, 1998, PHYTOPATHOLOGY, V88, P520, DOI 10.1094/PHYTO.1998.88.6.520; ARANDA MA, 1993, J VIROL, V67, P5896, DOI 10.1128/JVI.67.10.5896-5901.1993; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bracho MA, 1998, J GEN VIROL, V79, P2921, DOI 10.1099/0022-1317-79-12-2921; Chen HC, 2007, VIROLOGY, V365, P271, DOI 10.1016/j.virol.2007.03.050; Chen HC, 2012, NUCLEIC ACIDS RES, V40, P4641, DOI 10.1093/nar/gks030; Chen SC, 2010, J GEN VIROL, V91, P782, DOI 10.1099/vir.0.015941-0; COLLMER CW, 1992, ANNU REV PHYTOPATHOL, V30, P419, DOI 10.1146/annurev.py.30.090192.002223; den Boon JA, 2010, ANNU REV MICROBIOL, V64, P241, DOI 10.1146/annurev.micro.112408.134012; Domingo-Calap P, 2009, J VIROL METHODS, V161, P136, DOI 10.1016/j.jviromet.2009.06.003; FU YX, 1993, GENETICS, V133, P693; Garcia-Arenal F, 2000, VIRUS RES, V71, P1, DOI 10.1016/S0168-1702(00)00183-0; GERLACH WL, 1987, NATURE, V328, P802, DOI 10.1038/328802a0; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; HANS F, 1993, BIOCHIMIE, V75, P597, DOI 10.1016/0300-9084(93)90066-2; HARRISON BD, 1987, NATURE, V328, P799, DOI 10.1038/328799a0; HEMMER O, 1993, VIROLOGY, V194, P800, DOI 10.1006/viro.1993.1321; Hsu YH, 2006, J VIROL, V80, P2566, DOI 10.1128/JVI.80.5.2566-2574.2006; Hsu YH, 1998, MOL PLANT MICROBE IN, V11, P1207, DOI 10.1094/MPMI.1998.11.12.1207; Hu CC, 2009, VIRUSES-BASEL, V1, P1325, DOI 10.3390/v1031325; Huang YW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002726; Huang YW, 2009, VIROLOGY, V386, P139, DOI 10.1016/j.virol.2009.01.019; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Kong QZ, 1997, PLANT CELL, V9, P2051, DOI 10.1105/tpc.9.11.2051; KURATH G, 1989, VIROLOGY, V173, P231, DOI 10.1016/0042-6822(89)90239-0; Lin KY, 2013, MOL PLANT PATHOL, V14, P693, DOI 10.1111/mpp.12040; Lin MK, 2004, J GEN VIROL, V85, P251, DOI 10.1099/vir.0.19442-0; LIN MT, 1977, PHYTOPATHOLOGY, V67, P1439, DOI 10.1094/Phyto-67-1439; LIN NS, 1992, PHYTOPATHOLOGY, V82, P731, DOI 10.1094/Phyto-82-731; LIN NS, 1994, VIROLOGY, V202, P707, DOI 10.1006/viro.1994.1392; Lin NS, 1996, P NATL ACAD SCI USA, V93, P3138, DOI 10.1073/pnas.93.7.3138; LIN NS, 1993, PLANT DIS, V77, P448, DOI 10.1094/PD-77-0448; LIN NS, 1994, J GEN VIROL, V75, P2513, DOI 10.1099/0022-1317-75-9-2513; LIU JS, 1995, ARCH VIROL, V140, P1511, DOI 10.1007/BF01322678; Liu JS, 1997, J MOL EVOL, V44, P207, DOI 10.1007/PL00006137; LIU YY, 1993, J GEN VIROL, V74, P1471, DOI 10.1099/0022-1317-74-7-1471; Mader RM, 2001, J LAB CLIN MED, V137, P422, DOI 10.1067/mlc.2001.115452; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; MURANT AF, 1982, ANNU REV PHYTOPATHOL, V20, P49, DOI 10.1146/annurev.py.20.090182.000405; Nee S, 2000, PHILOS T R SOC B, V355, P1607, DOI 10.1098/rstb.2000.0722; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Palani PV, 2006, MOL PLANT MICROBE IN, V19, P758, DOI 10.1094/MPMI-19-0758; Pita JS, 2007, J VIROL, V81, P9072, DOI 10.1128/JVI.00587-07; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Rambaut A, 2009, FIGTREE V1 3 1 TREE; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roossinck MJ, 2001, MOL PLANT PATHOL, V2, P59, DOI 10.1046/j.1364-3703.2001.00058.x; ROOSSINCK MJ, 1992, MICROBIOL REV, V56, P265, DOI 10.1128/MMBR.56.2.265-279.1992; Shi BJ, 1997, J GEN VIROL, V78, P1181, DOI 10.1099/0022-1317-78-5-1181; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simon AE, 2004, ANNU REV PHYTOPATHOL, V42, P415, DOI 10.1146/annurev.phyto.42.040803.140402; SLEAT DE, 1990, P NATL ACAD SCI USA, V87, P2946, DOI 10.1073/pnas.87.8.2946; SMITH JM, 1992, J MOL EVOL, V34, P126; Sokal RR., 2011, BIOMETRY; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TIEN P, 1991, ADV VIRUS RES, V39, P321; Tsai MS, 1999, J VIROL, V73, P3032, DOI 10.1128/JVI.73.4.3032-3039.1999; Verchot-Lubicz J, 2007, J GEN VIROL, V88, P1643, DOI 10.1099/vir.0.82667-0; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Vijayapalani P, 2012, NUCLEIC ACIDS RES, V40, P638, DOI 10.1093/nar/gkr705; Yeh WB, 2004, VIROLOGY, V330, P105, DOI 10.1016/j.virol.2004.09.025	65	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108015	10.1371/journal.pone.0108015	http://dx.doi.org/10.1371/journal.pone.0108015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275532	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500012
J	Anwar, S; Dikhit, MR; Singh, KP; Kar, RK; Zaidi, A; Sahoo, GC; Roy, AK; Nozaki, T; Das, P; Ali, V				Anwar, Shadab; Dikhit, Manas Ranjan; Singh, Krishn Pratap; Kar, Rajiv Kumar; Zaidi, Amir; Sahoo, Ganesh Chandra; Roy, Awadh Kishore; Nozaki, Tomoyoshi; Das, Pradeep; Ali, Vahab			Interaction between Nbp35 and Cfd1 Proteins of Cytosolic Fe-S Cluster Assembly Reveals a Stable Complex Formation in Entamoeba histolytica	PLOS ONE			English	Article							IRON-SULFUR CLUSTERS; CFD1-NBP35 COMPLEX; PARASITIC PROTIST; BIOGENESIS; MITOCHONDRIAL; MATURATION; METABOLISM; EVOLUTION; NFS1P; DEHYDROGENASE	Iron-Sulfur (Fe-S) proteins are involved in many biological functions such as electron transport, photosynthesis, regulation of gene expression and enzymatic activities. Biosynthesis and transfer of Fe-S clusters depend on Fe-S clusters assembly processes such as ISC, SUF, NIF, and CIA systems. Unlike other eukaryotes which possess ISC and CIA systems, amitochondriate Entamoeba histolytica has retained NIF & CIA systems for Fe-S cluster assembly in the cytosol. In the present study, we have elucidated interaction between two proteins of E. histolytica CIA system, Cytosolic Fe-S cluster deficient 1 (Cfd1) protein and Nucleotide binding protein 35 (Nbp35). In-silico analysis showed that structural regions ranging from amino acid residues (P33-K35, G131-V135 and I147-E151) of Nbp35 and (G5-V6, M34-D39 and G46-A52) of Cfd1 are involved in the formation of protein-protein complex. Furthermore, Molecular dynamic (MD) simulations study suggested that hydrophobic forces surpass over hydrophilic forces between Nbp35 and Cfd1 and Van-der-Waal interaction plays crucial role in the formation of stable complex. Both proteins were separately cloned, expressed as recombinant fusion proteins in E. coli and purified to homogeneity by affinity column chromatography. Physical interaction between Nbp35 and Cfd1 proteins was confirmed in vitro by co-purification of recombinant Nbp35 with thrombin digested Cfd1 and in vivo by pull down assay and immunoprecipitation. The insilico, in vitro as well as in vivo results prove a stable interaction between these two proteins, supporting the possibility of its involvement in Fe-S cluster transfer to target apo-proteins through CIA machinery in E. histolytica. Our study indicates that initial synthesis of a Fe-S precursor in mitochondria is not necessary for the formation of Cfd1-Nbp35 complex. Thus, Cfd1 and Nbp35 with the help of cytosolic NifS and NifU proteins can participate in the maturation of non-mitosomal Fe-S proteins without any apparent assistance of mitosomes.	[Anwar, Shadab; Singh, Krishn Pratap; Zaidi, Amir; Ali, Vahab] Rajendra Mem Res Inst Med Sci, Dept Biochem, Lab Mol Biochem & Cell Biol, Patna, Bihar, India; [Dikhit, Manas Ranjan; Kar, Rajiv Kumar; Sahoo, Ganesh Chandra] Rajendra Mem Res Inst Med Sci, Dept Biomed Informat Ctr, Patna, Bihar, India; [Roy, Awadh Kishore] TM Bhagalpur Univ, Dept Bot, Bhagalpur, India; [Nozaki, Tomoyoshi] Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan; [Das, Pradeep] Rajendra Mem Res Inst Med Sci, Dept Mol Biol, Patna, Bihar, India	Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI); Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI); National Institute of Infectious Diseases (NIID); Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI)	Ali, V (corresponding author), Rajendra Mem Res Inst Med Sci, Dept Biochem, Lab Mol Biochem & Cell Biol, Patna, Bihar, India.	vahab_ali@yahoo.com	; Dikhit, Manas/F-1293-2015	Zaidi, Amir/0000-0001-5029-4180; Dikhit, Manas/0000-0002-9131-8975	Indian Council of Medical Research (ICMR), Ministry of Health and Family Welfare, and Department of Science & Technology, New Delhi, India [DST/INT/JSPSP-117]	Indian Council of Medical Research (ICMR), Ministry of Health and Family Welfare, and Department of Science & Technology, New Delhi, India	This work was supported by a grant from Indian Council of Medical Research (ICMR), Ministry of Health and Family Welfare, and Department of Science & Technology (DST/INT/JSPSP-117), New Delhi, India. The funder had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Ali V, 2004, EUR J BIOCHEM, V271, P2670, DOI 10.1111/j.1432-1033.2004.04195.x; Ali V, 2004, J BIOL CHEM, V279, P16863, DOI 10.1074/jbc.M313314200; Ali V, 2003, BIOCHEM J, V375, P729, DOI 10.1042/BJ20030630; Ali V, 2013, ADV PARASIT, V83, P1, DOI 10.1016/B978-0-12-407705-8.00001-X; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Balk J, 2011, TRENDS PLANT SCI, V16, P218, DOI 10.1016/j.tplants.2010.12.006; Basu S, 2013, EUKARYOT CELL, V12, P343, DOI 10.1128/EC.00304-12; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Broderick JB, 2007, NAT CHEM BIOL, V3, P243, DOI 10.1038/nchembio0507-243; Bych K, 2008, J BIOL CHEM, V283, P35797, DOI 10.1074/jbc.M807303200; Changmai P, 2013, MOL MICROBIOL, V89, P135, DOI 10.1111/mmi.12264; CLARK CG, 1995, P NATL ACAD SCI USA, V92, P6518, DOI 10.1073/pnas.92.14.6518; Craig EA, 1999, BIOL CHEM, V380, P1167, DOI 10.1515/BC.1999.148; DEAN DR, 1993, J BACTERIOL, V175, P6737, DOI 10.1128/jb.175.21.6737-6744.1993; DIAMOND LS, 1995, J EUKARYOT MICROBIOL, V42, P277, DOI 10.1111/j.1550-7408.1995.tb01579.x; Dolezal P, 2005, P NATL ACAD SCI USA, V102, P10924, DOI 10.1073/pnas.0500349102; Eramian D, 2006, PROTEIN SCI, V15, P1653, DOI 10.1110/ps.062095806; Ewald PP, 1921, ANN PHYS-BERLIN, V64, P253; Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664; Gill EE, 2007, MOL MICROBIOL, V66, P1306, DOI 10.1111/j.1365-2958.2007.05979.x; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Kumar B, 2011, INT J PARASITOL, V41, P991, DOI 10.1016/j.ijpara.2011.05.006; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muhlenhoff U, 2000, BBA-BIOENERGETICS, V1459, P370, DOI 10.1016/S0005-2728(00)00174-2; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; Nakai Y, 2004, J BIOL CHEM, V279, P12363, DOI 10.1074/jbc.M312448200; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Netz DJA, 2012, J BIOL CHEM, V287, P12365, DOI 10.1074/jbc.M111.328914; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Nyvltova E, 2013, P NATL ACAD SCI USA, V110, P7371, DOI 10.1073/pnas.1219590110; Olson JW, 2000, BIOCHEMISTRY-US, V39, P16213, DOI 10.1021/bi001744s; Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sambrook J., 2001, MOL CLONING LAB MANU; Seeber F, 2002, INT J PARASITOL, V32, P1207, DOI 10.1016/S0020-7519(02)00022-X; Sharma A, 2010, BIOINFORMATION, V5, P136, DOI 10.6026/97320630005136; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Srinivasan K, 2012, SPECTROCHIM ACTA A, V94, P89, DOI 10.1016/j.saa.2012.03.066; Stehling O, 2013, CELL METAB, V18, P187, DOI 10.1016/j.cmet.2013.06.015; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Subramaniam S, 2009, J BIOMOL STRUCT DYN, V26, P473, DOI 10.1080/07391102.2009.10507262; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tovar J, 1999, MOL MICROBIOL, V32, P1013, DOI 10.1046/j.1365-2958.1999.01414.x; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Tsaousis AD, 2012, P NATL ACAD SCI USA, V109, P10426, DOI 10.1073/pnas.1116067109; van Wietmarschen N, 2012, J BIOL CHEM, V287, P43351, DOI 10.1074/jbc.M112.431270; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	59	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108971	10.1371/journal.pone.0108971	http://dx.doi.org/10.1371/journal.pone.0108971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271645	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600085
J	Cashdan, E				Cashdan, Elizabeth			Biogeography of Human Infectious Diseases: A Global Historical Analysis	PLOS ONE			English	Article							PARASITE SPECIES RICHNESS; LATITUDINAL GRADIENTS; GEOGRAPHICAL RANGE; PATTERNS; ENERGY; DETERMINANTS; DIVERSITY; CLIMATE; BIODIVERSITY; PREVALENCE	Objectives: Human pathogen richness and prevalence vary widely across the globe, yet we know little about whether global patterns found in other taxa also predict diversity in this important group of organisms. This study (a) assesses the relative importance of temperature, precipitation, habitat diversity, and population density on the global distributions of human pathogens and (b) evaluates the species-area predictions of island biogeography for human pathogen distributions on oceanic islands. Methods: Historical data were used in order to minimize the influence of differential access to modern health care on pathogen prevalence. The database includes coded data (pathogen, environmental and cultural) for a worldwide sample of 186 non-industrial cultures, including 37 on islands. Prevalence levels for 10 pathogens were combined into a pathogen prevalence index, and OLS regression was used to model the environmental determinants of the prevalence index and number of pathogens. Results: Pathogens (number and prevalence index) showed the expected latitudinal gradient, but predictors varied by latitude. Pathogens increased with temperature in high-latitude zones, while mean annual precipitation was a more important predictor in low-latitude zones. Other environmental factors associated with more pathogens included seasonal dry extremes, frost-free climates, and human population density outside the tropics. Islands showed the expected species-area relationship for all but the smallest islands, and the relationship was not mediated by habitat diversity. Although geographic distributions of free-living and parasitic taxa typically have different determinants, these data show that variables that influence the distribution of free-living organisms also shape the global distribution of human pathogens. Understanding the cause of these distributions is potentially important, since geographical variation in human pathogens has an important influence on global disparities in human welfare.	Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Cashdan, E (corresponding author), Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA.	cashdan@anthro.utah.edu		Cashdan, Elizabeth/0000-0001-7300-1539				Acuna-Soto R, 2007, AGU SPRING M ABSTR, V1; Barrett R, 1998, ANNU REV ANTHROPOL, V27, P247, DOI 10.1146/annurev.anthro.27.1.247; BLACK FL, 1975, SCIENCE, V187, P515, DOI 10.1126/science.163483; Bordes F, 2011, OIKOS, V120, P1889, DOI 10.1111/j.1600-0706.2011.19314.x; Cashdan E, 2001, AM ANTHROPOL, V103, P968, DOI 10.1525/aa.2001.103.4.968; Cashdan E, 2003, WORLD CULTURES, V13; Cashdan E, 2013, HUM NATURE-INT BIOS, V24, P59, DOI 10.1007/s12110-012-9159-3; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; COHEN MN, 1984, PALEOPATHOLOGY ORIGI; Crosby A.W., 1986, ECOLOGICAL IMPERIALI, DOI DOI 10.1017/CBO9780511805554; Curtin Philip D., 1989, DEATH MIGRATION EURO; Dunn RR, 2010, P ROY SOC B-BIOL SCI, V277, P2587, DOI 10.1098/rspb.2010.0340; Eshed V, 2010, AM J PHYS ANTHROPOL, V143, P121, DOI 10.1002/ajpa.21301; Eyre S.R., 1968, VEGETATION SOILS WOR; Faust EC, 1964, CRAIG FAUSTS CLIN PA; Fincher CL, 2008, P ROY SOC B-BIOL SCI, V275, P2587, DOI 10.1098/rspb.2008.0688; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Kamiya T, 2014, ECOGRAPHY, V37, P689, DOI 10.1111/j.1600-0587.2013.00571.x; Kamiya T, 2014, BIOL REV, V89, P123, DOI 10.1111/brv.12046; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Lindenfors P, 2007, GLOBAL ECOL BIOGEOGR, V16, P496, DOI 10.1111/j.1466-8238.2006.00301.x; Lomolino MV, 2000, GLOBAL ECOL BIOGEOGR, V9, P1, DOI 10.1046/j.1365-2699.2000.00185.x; Lomolino MV, 2001, J BIOGEOGR, V28, P431, DOI 10.1046/j.1365-2699.2001.00550.x; Lomolino MV, 2000, J BIOGEOGR, V27, P17, DOI 10.1046/j.1365-2699.2000.00377.x; LOW BS, 1990, AM ZOOL, V30, P325; Low BS, 1994, WORLD CULTURES, V8, P24; MAC ARTHUR ROBERT H., 1967; McNeill W.H., 1976, PLAGUES PEOPLES, V1st ed.; Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015; MURDOCK GP, 1970, ETHNOLOGY, V9, P302, DOI 10.2307/3773028; MURDOCK GP, 1972, ETHNOLOGY, V11, P254, DOI 10.2307/3773219; MURDOCK GP, 1969, ETHNOLOGY, V8, P329, DOI 10.2307/3772907; Murray DR, 2010, J CROSS CULT PSYCHOL, V41, P99, DOI 10.1177/0022022109349510; Nunn CL, 2005, DIVERS DISTRIB, V11, P249, DOI 10.1111/j.1366-9516.2005.00160.x; Nunn CL, 2003, AM NAT, V162, P597, DOI 10.1086/378721; Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217; Poulin R, 2014, INT J PARASITOL, V44, P581, DOI 10.1016/j.ijpara.2014.02.003; Robar N, 2010, OIKOS, V119, P1273, DOI 10.1111/j.1600-0706.2009.18292.x; RODENWALDT E, 1961, WORLD ATLAS EPIDEMIC; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Simmons JS., 1944, GLOBAL EPIDEMIOLOGY; Smith KF, 2007, ECOLOGY, V88, P1903, DOI 10.1890/06-1052.1; Spurgin LG, 2012, OECOLOGIA, V168, P691, DOI 10.1007/s00442-011-2149-z; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Thompson RA, 2002, AM J TROP MED HYG, V67, P648, DOI 10.4269/ajtmh.2002.67.648; Whiting JWM, 1989, WORLD CULTURES, V1, P179; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x; Whittaker RJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P76, DOI 10.1111/j.1466-8238.2006.00268.x; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032	50	16	18	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e106752	10.1371/journal.pone.0106752	http://dx.doi.org/10.1371/journal.pone.0106752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZM	25271730	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600006
J	Kernot, J; Olds, T; Lewis, LK; Maher, C				Kernot, Jocelyn; Olds, Tim; Lewis, Lucy K.; Maher, Carol			Usability Testing and Piloting of the Mums Step It Up Program - A Team-Based Social Networking Physical Activity Intervention for Women with Young Children	PLOS ONE			English	Article							ACTIVITY PATTERNS; ADULTS; HEALTH	Background: Women's physical activity levels decline during their transition to parenthood. Facebook is widely used by Australian mothers and provides the opportunity to target social networks in order to maintain and increase physical activity. Method: This mixed method study aimed to pilot and assess the usability of the Mums Step It Up Facebook app, a new team-based physical activity intervention for mothers with young children. A purposive sample of five "Captain'' women with young children, were recruited through personal contacts. These women used the app to recruit 3-7 Facebook friends (with children under 5) to join their respective teams (total n = 25). The app encourages women to take 10,000 steps a day measured by a pedometer. Women used the app for 28 days to log steps, interact with team mates and monitor progress. Physical activity was assessed at two time points (baseline and final week) using the Active Australia Survey. Usability testing with the five "Captain'' women took place over two one hour face-to-face sessions. A questionnaire seeking feedback on the app was completed at time point two. Results: Participants' total physical activity increased by an average of 177 minutes per week (p = 0.01). The complexity of the team forming process and issues using the Facebook environment, where a variety of devices and software platforms are used, was highlighted. Discussion: A team-based Facebook app shows considerable promise for the recruitment and retention of participants to a social network-based physical activity intervention. A randomised controlled trial to further evaluate the effectiveness of the intervention is warranted.	[Kernot, Jocelyn; Olds, Tim; Lewis, Lucy K.; Maher, Carol] Univ S Australia, Hlth & Use Time HUT Grp, Sansom Inst Hlth Res, Sch Hlth Sci, Adelaide, SA 5001, Australia	University of South Australia	Kernot, J (corresponding author), Univ S Australia, Hlth & Use Time HUT Grp, Sansom Inst Hlth Res, Sch Hlth Sci, Adelaide, SA 5001, Australia.	Jocelyn.Kernot@unisa.edu.au	Maher, Carol/C-8169-2009; Olds, Tim/A-1223-2008; Kernot, Jocelyn/F-4116-2013	Maher, Carol/0000-0002-8676-0224; Olds, Tim/0000-0001-6894-5519; Kernot, Jocelyn/0000-0001-8702-7705; Lewis, Lucy/0000-0001-9579-9991	Division of Health Sciences at the University of South Australia; Australian Postgraduate Award Scholarship; Australian Research Council Australian Postdoctoral Fellowship	Division of Health Sciences at the University of South Australia; Australian Postgraduate Award Scholarship; Australian Research Council Australian Postdoctoral Fellowship(Australian Research Council)	The software development for the Mums Step it Up Facebook app was funded by a research development grant from the Division of Health Sciences at the University of South Australia (http://www.unisa.edu.au). JK is supported by an Australian Postgraduate Award Scholarship. CM is supported by an Australian Research Council Australian Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1987, ADV EXP SOC PSYCHOL, V20, P1, DOI 10.1016/S0065-2601(08)60411-6; Ajzen I., 1985, ACTION CONTROL, P11, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; [Anonymous], 2012, FAC REL STARTS MUMS; Australian Institute of Health and Wellfare (AIHW), 2003, ACT AUSTR SURV GUID; Bartholomew MK, 2012, FAM RELAT, V61, P455, DOI 10.1111/j.1741-3729.2012.00708.x; Blum JW, 2004, MATERN CHILD HEALT J, V8, P163, DOI 10.1023/B:MACI.0000037649.24025.2c; Brown WJ, 2008, AUST NZ J PUBL HEAL, V32, P535, DOI 10.1111/j.1753-6405.2008.00305.x; Brown WJ, 2003, AM J PREV MED, V25, P140, DOI 10.1016/S0749-3797(03)00119-3; Campaign Brief, 2013, FAC AUSTR CEL 12 MIL; Cavallo DN, 2012, AM J PREV MED, V43, P527, DOI 10.1016/j.amepre.2012.07.019; Chou WYS, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1249; Cowling, 2014, SOCIAL MEDIA STAT AU; Foster D., 2010, P 14 INT ACAD MINDTR, P111, DOI [10.1145/1930488.1930510, DOI 10.1145/1930488.1930510]; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Larson-Meyer DE, 2002, OBES RES, V10, P841, DOI 10.1038/oby.2002.114; Leahey TM, 2012, OBESITY, V20, P1413, DOI 10.1038/oby.2012.18; Leahey TM, 2010, PREV MED, V51, P45, DOI 10.1016/j.ypmed.2010.04.004; Maher CA, 2013, J MED INTER IN PRESS; Napolitano MA, 2012, USING FACEBOOK TEXT; Pereira MA, 2007, AM J PREV MED, V32, P312, DOI 10.1016/j.amepre.2006.12.017; Public Relations Institute of Australia, 2012, 13 MILL AUSTR SPEND; Statistics Brain, 2013, FAC STAT; Turner-McGrievy G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1841; Valle CG, 2013, J CANCER SURVIV, V7, P355, DOI 10.1007/s11764-013-0279-5; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; Vandelanotte C, 2007, AM J PREV MED, V33, P54, DOI 10.1016/j.amepre.2007.02.041; Volkswagen, 2009, FUN THEOR; W. K. Kellogg Foundation, 2004, LOG MOD DEV GUID; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organisation, 2012, 10 FACTS PHYS ACT	31	30	30	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108842	10.1371/journal.pone.0108842	http://dx.doi.org/10.1371/journal.pone.0108842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272039	gold, Green Published, Green Submitted			2022-12-27	WOS:000343729600066
J	Pedro, SA; Abelman, S; Ndjomatchoua, FT; Sang, R; Tonnang, HEZ				Pedro, Sansao A.; Abelman, Shirley; Ndjomatchoua, Frank T.; Sang, Rosemary; Tonnang, Henri E. Z.			Stability, Bifurcation and Chaos Analysis of Vector-Borne Disease Model with Application to Rift Valley Fever	PLOS ONE			English	Article							POPULATION-DYNAMICS; VIRUS; DIPTERA; TRANSMISSION; LIVESTOCK; EPIDEMIC; BUNYAVIRIDAE; PHLEBOVIRUS; TEMPERATURE; KENYA	This paper investigates a RVF epidemic model by qualitative analysis and numerical simulations. Qualitative analysis have been used to explore the stability dynamics of the equilibrium points while visualization techniques such as bifurcation diagrams, Poincare maps, maxima return maps and largest Lyapunov exponents are numerically computed to confirm further complexity of these dynamics induced by the seasonal forcing on the mosquitoes oviposition rates. The obtained results show that ordinary differential equation models with external forcing can have rich dynamic behaviour, ranging from bifurcation to strange attractors which may explain the observed fluctuations found in RVF empiric outbreak data, as well as the non deterministic nature of RVF inter-epidemic activities. Furthermore, the coexistence of the endemic equilibrium is subjected to existence of certain number of infected Aedes mosquitoes, suggesting that Aedes have potential to initiate RVF epidemics through transovarial transmission and to sustain low levels of the disease during post epidemic periods. Therefore we argue that locations that may serve as RVF virus reservoirs should be eliminated or kept under control to prevent multi-periodic outbreaks and consequent chains of infections. The epidemiological significance of this study is: (1) low levels of birth rate (in both Aedes and Culex) can trigger unpredictable outbreaks; (2) Aedes mosquitoes are more likely capable of inducing unpredictable behaviour compared to the Culex; (3) higher oviposition rates on mosquitoes do not in general imply manifestation of irregular behaviour on the dynamics of the disease. Finally, our model with external seasonal forcing on vector oviposition rates is able to mimic the linear increase in livestock seroprevalence during inter-epidemic period showing a constant exposure and presence of active transmission foci. This suggests that RVF outbreaks partly build upon RVF inter-epidemic activities. Therefore, active RVF surveillance in livestock is recommended.	[Pedro, Sansao A.; Abelman, Shirley] Univ Witwatersrand, Sch Computat & Appl Math, Johannesburg, South Africa; [Pedro, Sansao A.; Ndjomatchoua, Frank T.; Sang, Rosemary; Tonnang, Henri E. Z.] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya; [Pedro, Sansao A.] Univ Eduardo Mondlane, Dept Matemat & Informat, Maputo, Mozambique; [Ndjomatchoua, Frank T.] Univ Yaounde I, Dept Phys, Yaounde, Cameroon	University of Witwatersrand; International Centre of Insect Physiology & Ecology (ICIPE); Eduardo Mondlane University; University of Yaounde I	Pedro, SA (corresponding author), Univ Witwatersrand, Sch Computat & Appl Math, Johannesburg, South Africa.	spedro@icipe.org	Ndjomatchoua, Frank/K-1178-2019; TONNANG, Henri/AAQ-2206-2021	Ndjomatchoua, Frank/0000-0001-8435-6167; TONNANG, Henri/0000-0002-9424-9186; Pedro, Sansao/0000-0003-0190-3765	German Academy Exchange Service (DAAD) under International Center of Insect Physiology and Ecology (ICIPE) ARPPIS programme	German Academy Exchange Service (DAAD) under International Center of Insect Physiology and Ecology (ICIPE) ARPPIS programme	The lead author (SAP) received a personal PhD scholarship from German Academy Exchange Service (DAAD) under International Center of Insect Physiology and Ecology (ICIPE) ARPPIS programme. The funder had no role in study design and analysis, decision to publish or preparation of the manuscript.	Aguilar-Stoen M, 2014, EPIDEMIOL INFECT, P1; Alligood K. T., 1996, CHAOS INTRO DYNAMICA; Ba Y, 2005, J MED ENTOMOL, V42, P739, DOI 10.1603/0022-2585(2005)042[0739:AOBOTR]2.0.CO;2; Bacaer N, 2007, B MATH BIOL, V69, P1067, DOI 10.1007/s11538-006-9166-9; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Castillo-Chavez C, 2002, J MATH BIOL, V36, P227; Chevalier V, 2004, REV SCI TECH OIE, V23, P535, DOI 10.20506/rst.23.2.1505; Chitnis N, 2013, J BIOL DYNAM, V7, P11, DOI 10.1080/17513758.2012.733427; DAVIES FG, 1985, B WORLD HEALTH ORGAN, V63, P941; DAVIES FG, 1992, EPIDEMIOL INFECT, V108, P185, DOI 10.1017/S0950268800049633; DIEKMANN O, 1990, J MATH BIOL, V28, P365; FAO, 2012, RIFT VALL FEV VIG NE, V27; Freund JA, 2006, ECOL COMPLEX, V3, P129, DOI 10.1016/j.ecocom.2005.11.001; Fuchs B.A., 1961, FUNCTIONS COMPLEX VA, VII; GAFF H, 2011, INT J ARTIFICIAL LIF, V2, P1, DOI DOI 10.4018/JALR.2011040101; Gaff HD, 2007, ELECTRON J DIFFER EQ; Geering WA., 2002, PREPARATION RIFT VAL; Glyn Davies F., 2003, RECOGNIZING RIFT VAL; Gould H., 1996, INTRO COMPUTER SIMUL; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; Greenhalgh D, 2009, J MATH BIOL, V59, P1, DOI 10.1007/s00285-008-0206-y; Greenman J, 2004, PHYSICA D, V190, P136, DOI 10.1016/j.physd.2003.08.008; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Ireland JM, 2004, J THEOR BIOL, V231, P229, DOI 10.1016/j.jtbi.2004.06.017; Kasari TR, 2008, JAVMA-J AM VET MED A, V232, P514, DOI 10.2460/javma.232.4.514; Korobeinikov A, 2007, B MATH BIOL, V69, P1871, DOI 10.1007/s11538-007-9196-y; LaSalle J.P., 1976, CBMS NSF REGIONAL C, V25; Li Jing, 2011, Comput Math Methods Med, V2011, P527610, DOI 10.1155/2011/527610; LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; LIPSITCH M, 1995, P ROY SOC B-BIOL SCI, V260, P321, DOI 10.1098/rspb.1995.0099; LOGAN TM, 1991, J MED ENTOMOL, V28, P293, DOI 10.1093/jmedent/28.2.293; Meegan J. M., 1989, The arboviruses: epidemiology and ecology. Volume IV., P51; Mpeshe SC, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/627586; Mpeshe SC, 2011, ACTA BIOTHEOR, V59, P231, DOI 10.1007/s10441-011-9132-2; Munyua P, 2010, AM J TROP MED HYG, V83, P58, DOI 10.4269/ajtmh.2010.09-0292; Nchu F., 2013, African Journal of Microbiology Research, V7, P3891; PARKER BM, 1986, ANN ENTOMOL SOC AM, V79, P925, DOI 10.1093/aesa/79.6.925; Parker TS, 1983, PRACTICALS NUMERICAL; Pedro SA, 2010, J THEOR BIOL, V267, P471, DOI 10.1016/j.jtbi.2010.09.019; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Perron O, 1930, MATH Z, V32, P703, DOI 10.1007/BF01194662; PRESS WH, 1986, NUMERICAL RECIPES AR; Romoser WS, 2011, RES REP TROP MED, V2, P121, DOI 10.2147/RRTM.S13947; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Sang R, 2010, AM J TROP MED HYG, V83, P28, DOI 10.4269/ajtmh.2010.09-0319; Spickler A. R., 2006, RIFT VALLEY FEVER IN; Sumaye RD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002356; Turell MJ, 2008, J MED ENTOMOL, V45, P102, DOI 10.1603/0022-2585(2008)45[102:VCOSAM]2.0.CO;2; TURELL MJ, 1985, AM J TROP MED HYG, V34, P1211, DOI 10.4269/ajtmh.1985.34.1211; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6	52	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108172	10.1371/journal.pone.0108172	http://dx.doi.org/10.1371/journal.pone.0108172			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271641	gold, Green Submitted, Green Published			2022-12-27	WOS:000343729600029
J	Sfar, N; Mangalam, M; Kaumanns, W; Singh, M				Sfar, Nasibah; Mangalam, Madhur; Kaumanns, Werner; Singh, Mewa			A Comparative Assessment of Hand Preference in Captive Red Howler Monkeys, Alouatta seniculus and Yellow-Breasted Capuchin Monkeys, Sapajus xanthosternos	PLOS ONE			English	Article							COORDINATED-BIMANUAL TASKS; MANUAL LATERALITY; CEBUS-APELLA; NONHUMAN-PRIMATES; HANDEDNESS; POSTURE; SPECIALIZATION; METAANALYSIS; EVOLUTION; MACAQUES	There are two major theories that attempt to explain hand preference in non-human primates-the 'task complexity' theory and the 'postural origins' theory. In the present study, we proposed a third hypothesis to explain the evolutionary origin of hand preference in non-human primates, stating that it could have evolved owing to structural and functional adaptations to feeding, which we refer to as the 'niche structure' hypothesis. We attempted to explore this hypothesis by comparing hand preference across species that differ in the feeding ecology and niche structure: red howler monkeys, Alouatta seniculus and yellow-breasted capuchin monkeys, Sapajus xanthosternos. The red howler monkeys used the mouth to obtain food more frequently than the yellow-breasted capuchin monkeys. The red howler monkeys almost never reached for food presented on the opposite side of a wire mesh or inside a portable container, whereas the yellow-breasted capuchin monkeys reached for food presented in all four spatial arrangements (scattered, on the opposite side of a wire mesh, inside a suspended container, and inside a portable container). In contrast to the red howler monkeys that almost never acquired bipedal and clinging posture, the yellow-breasted capuchin monkeys acquired all five body postures (sitting, bipedal, tripedal, clinging, and hanging). Although there was no difference between the proportion of the red howler monkeys and the yellow-breasted capuchin monkeys that preferentially used one hand, the yellow-breasted capuchin monkeys exhibited an overall weaker hand preference than the red howler monkeys. Differences in hand preference diminished with the increasing complexity of the reaching-for-food tasks, i.e., the relatively more complex tasks were perceived as equally complex by both the red howler monkeys and the yellow-breasted capuchin monkeys. These findings suggest that species-specific differences in feeding ecology and niche structure can influence the perception of the complexity of the task and, consequently, hand preference.	[Sfar, Nasibah] Univ Cologne, Dept Biol, D-50931 Cologne, Germany; [Mangalam, Madhur; Singh, Mewa] Univ Mysore, Biopsychol Lab, Mysore, Karnataka, India; [Mangalam, Madhur; Singh, Mewa] Univ Mysore, Inst Excellence, Mysore, Karnataka, India; [Kaumanns, Werner] LTM Res & Conservat, Gleichen, Germany; [Singh, Mewa] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, Bangalore 560012, Karnataka, India	University of Cologne; University of Mysore; University of Mysore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Singh, M (corresponding author), Univ Mysore, Biopsychol Lab, Mysore, Karnataka, India.	mewasinghltm@gmail.com						Alfaro JWL, 2012, J BIOGEOGR, V39, P272, DOI 10.1111/j.1365-2699.2011.02609.x; Blois-Heulin C, 2006, AM J PRIMATOL, V68, P429, DOI 10.1002/ajp.20239; Bradshaw JL., 1993, EVOLUTION LATERAL AS; Chapelain A, 2006, BEHAV BRAIN RES, V173, P237, DOI 10.1016/j.bbr.2006.06.028; DODSON DL, 1992, AM J PRIMATOL, V26, P191, DOI 10.1002/ajp.1350260305; FAGOT J, 1991, PSYCHOL BULL, V109, P76, DOI 10.1037/0033-2909.109.1.76; FAGOT J, 1988, BRAIN BEHAV EVOLUT, V32, P89, DOI 10.1159/000116536; Fitch WT, 2013, ANN NY ACAD SCI, V1288, P70, DOI 10.1111/nyas.12071; FORSYTHE C, 1988, J COMP PSYCHOL, V102, P248, DOI 10.1037/0735-7036.102.3.248; Giraldo P, 2007, NEWTROP PRIMATES, V14, P2, DOI [10.1896/044.014.0102, DOI 10.1896/044.014.0102]; Harrison KE, 2000, J COMP PSYCHOL, V114, P13, DOI 10.1037/0735-7036.114.1.13; Helene M, 2007, AM J PRIMATOL, V69, P1064, DOI [10.1002/ajp.20437, DOI 10.1002/AJP.20437]; Hopkins W D, 1997, Laterality, V2, P267, DOI 10.1080/135765097397486; HOPKINS WD, 1993, J COMP PSYCHOL, V107, P162, DOI 10.1037/0735-7036.107.2.162; Hopkins WD, 2011, J HUM EVOL, V60, P605, DOI 10.1016/j.jhevol.2010.12.008; Jalles-Filho E., 2008, INT J COMP PSYCHOL, V21, P12; JULLIOT C, 1993, INT J PRIMATOL, V14, P527, DOI 10.1007/BF02215446; LARSON CF, 1989, BRAIN BEHAV EVOLUT, V33, P261, DOI 10.1159/000115934; Lernould J. -M., 2012, International Zoo Yearbook, V46, P71, DOI 10.1111/j.1748-1090.2012.00169.x; Lilak AL, 2008, AM J PRIMATOL, V70, P254, DOI 10.1002/ajp.20485; MacLean EL, 2014, P NATL ACAD SCI USA, V111, pE2140, DOI 10.1073/pnas.1323533111; MACNEILAGE PF, 1987, BEHAV BRAIN SCI, V10, P247, DOI 10.1017/S0140525X00047695; Mangalam M, 2014, AM J PRIMATOL, V76, P576, DOI 10.1002/ajp.22250; MARTIN P, 1988, MEASURING BEHAV; McGrew WC, 1997, YEARB PHYS ANTHROPOL, V40, P201; Milliken GW, 2005, J COMP PSYCHOL, V119, P430, DOI 10.1037/0735-7036.119.4.430; Papademetriou E, 2005, J COMP PSYCHOL, V119, P33, DOI 10.1037/0735-7036.119.1.33; PARKER ST, 1977, J HUM EVOL, V6, P623, DOI 10.1016/S0047-2484(77)80135-8; Pullwitt S, 2005, THESIS U COLOGNE; Scheumann M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-52; Sfar N, 2012, THESIS U COLOGNE; Spinozzi G, 1998, J COMP PSYCHOL, V112, P183, DOI 10.1037/0735-7036.112.2.183; Stevens JR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0499; Trouillard E, 2005, LATERALITY, V10, P7, DOI 10.1080/13576500342000275; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Vauclair J, 2005, COGNITIVE BRAIN RES, V25, P210, DOI 10.1016/j.cogbrainres.2005.05.012; Vleeschouwer KD, 1995, J COMP PSYCHOL, V109, P203, DOI [10.1037/0735-7036.109.2.203, DOI 10.1037/0735-7036.109.2.203]; Westergaard G C, 1997, Laterality, V2, P65, DOI 10.1080/135765097397657; WESTERGAARD GC, 1993, PRIMATES, V34, P295, DOI 10.1007/BF02382624; Westergaard GC, 1996, J COMP PSYCHOL, V110, P406, DOI 10.1037/0735-7036.110.4.406; Westergaard GC, 1998, J COMP PSYCHOL, V112, P55, DOI 10.1037//0735-7036.112.1.55; Zhao DP, 2010, BEHAV BRAIN RES, V208, P85, DOI 10.1016/j.bbr.2009.11.011	42	3	3	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e107838	10.1371/journal.pone.0107838	http://dx.doi.org/10.1371/journal.pone.0107838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZM	25271639	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000343729600021
J	Gant, Z; Gant, L; Song, RG; Willis, L; Johnson, AS				Gant, Zanetta; Gant, Larry; Song, Ruiguang; Willis, Leigh; Johnson, Anna Satcher			A Census Tract-Level Examination of Social Determinants of Health among Black/African American Men with Diagnosed HIV Infection, 2005-2009-17 US Areas	PLOS ONE			English	Article							RISK BEHAVIORS; BLACK-MEN; UNITED-STATES; SEX; HIV/AIDS; EPIDEMIOLOGY; TRANSMISSION; METAANALYSIS; INVOLVEMENT; DISPARITIES	Background: HIV disproportionately affects black men in the United States: most diagnoses are for black gay, bisexual, and other men who have sex with men (collectively referred to as MSM). A better understanding of the social conditions in which black men live and work may better explain why HIV incidence and diagnosis rates are higher than expected in this population. Methods: Using data from the National HIV Surveillance System and the US Census Bureau's American Community Survey, we examined the relationships of HIV diagnosis rates and 5 census tract-level social determinants of health variables for 21,948 black MSM and non-MSM aged >= 15 years residing in 17 areas in the United States. We examined federal poverty status, marital status, education level, employment status, and vacancy status and computed rate ratios (RRs) and prevalence odds ratios (PORs), using logistic regression with zero-inflated negative binomial modeling. Results: Among black MSM, HIV diagnosis rates decreased as poverty increased (RR: 0.54). At the time of HIV diagnosis, black MSM were less likely than black non-MSM to live in census tracts with a higher proportion below the poverty level (POR: 0.81) and with a higher proportion of vacant houses (POR: 0.86). In comparison, housing vacancy was positively associated with HIV diagnosis rates among black non-MSM (RR: 1.65). HIV diagnosis rates were higher for black MSM (RR: 2.75) and non-MSM (RR: 4.90) whose educational level was low. Rates were significantly lower for black MSM (RR: 0.06) and non-MSM (RR: 0.26) as the proportion unemployed and the proportion married increased. Conclusions: This exploratory study found differences in the patterns of HIV diagnosis rates for black MSM and non-MSM and provides insight into the transmission of HIV infection in areas that reflect substantial disadvantage in education, housing, employment, and income.	[Gant, Zanetta; Song, Ruiguang; Willis, Leigh; Johnson, Anna Satcher] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA; [Gant, Larry] Univ Michigan, Sch Social Work, Ann Arbor, MI 48109 USA	Centers for Disease Control & Prevention - USA; University of Michigan System; University of Michigan	Gant, Z (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA.	zgant@cdc.gov	Gant, Larry/AAZ-3067-2021	Gant, Larry/0000-0001-9770-7480; Satcher Johnson, Anna/0000-0002-8915-6903	Centers for Disease Control and Prevention (CDC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The Centers for Disease Control and Prevention (CDC) provides funding to state and local health departments to conduct surveillance of HIV disease in accordance with their own disease reporting regulations. CDC provides technical guidance for the collection of data by the state and local health departments and data are sent to CDC for national-level analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2002, EPIDEMIOLOGY, V13, P707, DOI 10.1097/00001648-200211000-00016; Adimora AA, 2009, AM J PREV MED, V37, P468, DOI 10.1016/j.amepre.2009.06.020; Auerbach JD, 2011, GLOB PUBLIC HEALTH, V6, pS293, DOI 10.1080/17441692.2011.594451; Bowleg L, 2011, DIRECTOR, V202, P6176; Bowleg L, 2011, CULT HEALTH SEX, V13, P545, DOI 10.1080/13691058.2011.556201; Centers for Disease Control and Prevention, 2013, SOC DET HLTH AD DA S; Centers for Disease Control and Prevention, 2013, HIV SURV RAC ETHN SL; Centers for Disease Control and Prevention (CDC), 2013, HIV SURV REP 2011; Cohen D, 2000, AM J PUBLIC HEALTH, V90, P230, DOI 10.2105/AJPH.90.2.230; Denning P, 2010, INT AIDS C; Diez-Roux AV, 1998, AM J PUBLIC HEALTH, V88, P216, DOI 10.2105/AJPH.88.2.216; Fitzpatrick K, 2010, UNHELATHY CITIES POV; Hall HI, 2008, JAIDS-J ACQ IMM DEF, V49, P294, DOI 10.1097/QAI.0b013e3181893f17; Harrison KM, 2008, PUBLIC HEALTH REP, V123, P618, DOI 10.1177/003335490812300512; Mayer KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087298; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Millett GA, 2012, LANCET, V380, P411, DOI 10.1016/S0140-6736(12)60722-3; National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (U.S.), 2010, EST HOL FRAM RED IN; O'Leary A, 2007, AIDS BEHAV, V11, P706, DOI 10.1007/s10461-006-9205-4; Oparanozie A, 2012, J BLACK PSYCHOL, V38, P32, DOI 10.1177/0095798410397542; Paz-Bailey G, 2013, MMWR-MORBID MORTAL W, V62, P958; Peterman TA, 2005, J INFECT DIS, V191, pS123, DOI 10.1086/425284; Poundstone KE, 2004, EPIDEMIOL REV, V26, P22, DOI 10.1093/epirev/mxh005; Prejean J, 2011, PLOS ONE, P6; Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098; Raj A, 2008, AM J MENS HEALTH, V2, P291, DOI 10.1177/1557988308320269; Raj A, 2008, JAIDS-J ACQ IMM DEF, V47, P131, DOI 10.1097/QAI.0b013e31815a5731; Raj A, 2012, AM J MENS HEALTH, V6, P178, DOI 10.1177/1557988311416496; Ramirez-Valles J, 2002, HEALTH EDUC RES, V17, P389, DOI 10.1093/her/17.4.389; SAVINWILLIAMS RC, 1994, J CONSULT CLIN PSYCH, V62, P261, DOI 10.1037/0022-006X.62.2.261; Scribner RA, 2008, SUBST USE MISUSE, V43, P203, DOI 10.1080/10826080701690607; Siddiqi A, 2010, J EPIDEMIOL COMMUN H, V64, P29, DOI 10.1136/jech.2008.085068; Stein JA, 2007, AIDS BEHAV, V11, P87, DOI 10.1007/s10461-005-9058-2; Varjas K., 2008, J SCH VIOLENCE, V7, P59, DOI [https://doi.org/10.1300/J202v07n02_05, DOI 10.1300/J202V07N02_05]; Waldron I, 1996, SOC SCI MED, V43, P113, DOI 10.1016/0277-9536(95)00347-9; Warner L, 2009, J INFECT DIS, V199, P59, DOI 10.1086/595569; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOS GAP GEN HLTH EQ; Wilton L, 2009, HIV/AIDS IN U.S. COMMUNITIES OF COLOR, P179, DOI 10.1007/978-0-387-98152-9_10; Yau KKW, 2003, BIOMETRICAL J, V45, P437, DOI 10.1002/bimj.200390024; Z Gant, 2012, Open AIDS J, V6, P1, DOI 10.2174/1874613601206010001	42	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107701	10.1371/journal.pone.0107701	http://dx.doi.org/10.1371/journal.pone.0107701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268831	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700045
J	Jere, KC; O'Neill, HG; Potgieter, AC; van Dijk, AA				Jere, Khuzwayo C.; O'Neill, Hester G.; Potgieter, A. Christiaan; van Dijk, Alberdina A.			Chimaeric Virus-Like Particles Derived from Consensus Genome Sequences of Human Rotavirus Strains Co-Circulating in Africa	PLOS ONE			English	Article							SECRETING CELL RESPONSES; HEAT-LABILE TOXIN; GROUP-A; INDEPENDENT AMPLIFICATION; PROTECTIVE IMMUNITY; STRUCTURAL PROTEINS; BREAST-MILK; EXPRESSION; VACCINE; SAFETY	Rotavirus virus-like particles (RV-VLPs) are potential alternative non-live vaccine candidates due to their high immunogenicity. They mimic the natural conformation of native viral proteins but cannot replicate because they do not contain genomic material which makes them safe. To date, most RV-VLPs have been derived from cell culture adapted strains or common G1 and G3 rotaviruses that have been circulating in communities for some time. In this study, chimaeric RV-VLPs were generated from the consensus sequences of African rotaviruses (G2, G8, G9 or G12 strains associated with either P[4], P[6] or P[8] genotypes) characterised directly from human stool samples without prior adaptation of the wild type strains to cell culture. Codon-optimised sequences for insect cell expression of genome segments 2 (VP2), 4 (VP4), 6 (VP6) and 9 (VP7) were cloned into a modified pFASTBAC vector, which allowed simultaneous expression of up to four genes using the Bac-to-Bac Baculovirus Expression System (BEVS; Invitrogen). Several combinations of the genome segments originating from different field strains were cloned to produce double-layered RV-VLPs (dRV-VLP; VP2/6), triple-layered RV-VLPs (tRV-VLP; VP2/6/7 or VP2/6/7/4) and chimaeric tRV-VLPs. The RV-VLPs were produced by infecting Spodoptera frugiperda 9 and Trichoplusia ni cells with recombinant baculoviruses using multi-cistronic, dual co-infection and stepwise-infection expression strategies. The size and morphology of the RV-VLPs, as determined by transmission electron microscopy, revealed successful production of RV-VLPs. The novel approach of producing tRV-VLPs, by using the consensus insect cell codon-optimised nucleotide sequence derived from dsRNA extracted directly from clinical specimens, should speed-up vaccine research and development by by-passing the need to adapt rotaviruses to cell culture. Other problems associated with cell culture adaptation, such as possible changes in epitopes, can also be circumvented. Thus, it is now possible to generate tRV-VLPs for evaluation as non-live vaccine candidates for any human or animal field rotavirus strain.	[Jere, Khuzwayo C.; O'Neill, Hester G.; Potgieter, A. Christiaan; van Dijk, Alberdina A.] North West Univ, Ctr Human Metabon, Potchefstroom, South Africa; [Jere, Khuzwayo C.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [O'Neill, Hester G.] Univ Free State, Dept Microbiol Biochem & Food Biotechnol, Bloemfontein, South Africa; [Potgieter, A. Christiaan] Deltamune Pty Ltd, Lyttelton, Centurion, South Africa	North West University - South Africa; University of Liverpool; University of the Free State	van Dijk, AA (corresponding author), North West Univ, Ctr Human Metabon, Potchefstroom, South Africa.	Albie.VanDijk@nwu.ac.za	O'Neill, Hester G/G-1607-2014	O'Neill, Hester G/0000-0002-5044-6081; Jere, Khuzwayo/0000-0003-3376-8529	South African Department of Science and Technology; North-West University; Canon Collins Trust; Poliomyelitis Research Foundation	South African Department of Science and Technology; North-West University; Canon Collins Trust; Poliomyelitis Research Foundation	The study was partially funded by the South African Department of Science and Technology. KCJ received PhD funding from the North-West University, Poliomyelitis Research Foundation and the Canon Collins Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, Wkly Epidemiol Rec, V88, P49; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Arnold Michelle, 2009, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15c03s15; Bernstein DI, 1998, VACCINE, V16, P381, DOI 10.1016/S0264-410X(97)00210-7; BRUSSOW H, 1990, J VIROL, V64, P3635; Bucardo F, 2012, INFECT GENET EVOL, V12, P1282, DOI 10.1016/j.meegid.2012.03.007; Bundy BC, 2008, BIOTECHNOL BIOENG, V100, P28, DOI 10.1002/bit.21716; Castro-Acosta RM, 2010, ELECTROPHORESIS, V31, P1376, DOI 10.1002/elps.200900558; Charpilienne A, 2002, J VIROL, V76, P7822, DOI 10.1128/JVI.76.15.7822-7831.2002; Ciarlet M, 1999, J GEN VIROL, V80, P943, DOI 10.1099/0022-1317-80-4-943; Ciarlet M, 1998, J VIROL, V72, P9233, DOI 10.1128/JVI.72.11.9233-9246.1998; Cortes-Perez NG, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/317545; CRAWFORD SE, 1994, J VIROL, V68, P5945, DOI 10.1128/JVI.68.9.5945-5952.1994; Desselberger U, 2011, J INFECT DIS, V203, P188, DOI 10.1093/infdis/jiq031; Dormitzer PR, 2004, NATURE, V430, P1053, DOI 10.1038/nature02836; Estes MK, 2007, FIELDS VIROLOGY, P1917; Gao JP, 2013, J VET SCI, V14, P441, DOI 10.4142/jvs.2013.14.4.441; GAVILANES F, 1982, J BIOL CHEM, V257, P7770; Glass RI, 2006, ADV EXP MED BIOL, V582, P45; Glass RI, 2014, J INFECTION, V68, pS9, DOI 10.1016/j.jinf.2013.09.010; Gouvea Vera, 1995, Trends in Microbiology, V3, P159, DOI 10.1016/S0966-842X(00)88908-8; Grgacic EVL, 2006, METHODS, V40, P60, DOI 10.1016/j.ymeth.2006.07.018; Gurgel RQ, 2007, EMERG INFECT DIS, V13, P1571, DOI 10.3201/eid1310.070412; Heaton PM, 2005, J INFECT DIS, V192, pS17, DOI 10.1086/431500; Hu LY, 2012, NATURE, V485, P256, DOI 10.1038/nature10996; Istrate C, 2008, VACCINE, V26, P4594, DOI 10.1016/j.vaccine.2008.05.089; Jere KC, 2011, INFECT GENET EVOL, V11, P2072, DOI 10.1016/j.meegid.2011.09.023; Jere KC, 2011, J MED VIROL, V83, P2018, DOI 10.1002/jmv.22207; Jiang BM, 1998, BIOTECHNOL BIOENG, V60, P369, DOI 10.1002/(SICI)1097-0290(19981105)60:3<369::AID-BIT14>3.0.CO;2-H; Kaba SA, 2004, J VIROL METHODS, V122, P113, DOI 10.1016/j.jviromet.2004.07.006; Kim Y, 2002, VIROLOGY, V302, P1, DOI 10.1006/viro.2002.1610; Kirkwood CD, 2011, PEDIATR INFECT DIS J, V30, pS48, DOI 10.1097/INF.0b013e3181fefd90; Kost TA, 2010, CURR GENE THER, V10, P168; LABBE M, 1991, J VIROL, V65, P2946; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Matic S, 2012, PLANT BIOTECHNOL J, V10, P410, DOI 10.1111/j.1467-7652.2011.00671.x; Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Mena JA, 2006, J BIOTECHNOL, V122, P443, DOI 10.1016/j.jbiotec.2005.10.005; Mena JA, 2005, J CHROMATOGR B, V824, P267, DOI 10.1016/j.jchromb.2005.07.034; Mena JA, 2003, BIOTECHNIQUES, V34, P260, DOI 10.2144/03342bm05; Moon SS, 2013, PEDIATR INFECT DIS J, V32, P863, DOI 10.1097/INF.0b013e318290646d; Moon SS, 2010, PEDIATR INFECT DIS J, V29, P919, DOI 10.1097/INF.0b013e3181e232ea; Mwenda JM, 2010, J INFECT DIS, V202, pS5, DOI 10.1086/653557; Nelson EAS, 2009, VACCINE, V27, pF1, DOI 10.1016/j.vaccine.2009.09.001; Page N, 2010, J INFECT DIS, V202, pS55, DOI 10.1086/653551; Palomares LA, 2009, BIOCHEM ENG J, V45, P158, DOI 10.1016/j.bej.2009.02.006; Parashar U, 2013, EXPERT REV VACCINES, V12, P113, DOI [10.1586/erv.12.148, 10.1586/ERV.12.148]; Patient R, 2009, NEW BIOTECHNOL, V25, P226, DOI 10.1016/j.nbt.2009.01.001; Peixoto C, 2007, J BIOTECHNOL, V127, P452, DOI 10.1016/j.jbiotec.2006.08.002; Pesavento JB, 2003, J VIROL, V77, P3291, DOI 10.1128/JVI.77.5.3291-3296.2003; Potgieter AC, 2009, J GEN VIROL, V90, P1423, DOI 10.1099/vir.0.009381-0; PRASAD BVV, 1988, J MOL BIOL, V199, P269, DOI 10.1016/0022-2836(88)90313-0; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Settembre EC, 2011, EMBO J, V30, P408, DOI 10.1038/emboj.2010.322; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Trask SD, 2006, J VIROL, V80, P11293, DOI 10.1128/JVI.01346-06; Trask SD, 2012, NAT REV MICROBIOL, V10, P165, DOI 10.1038/nrmicro2673; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vieira HLA, 2005, J BIOTECHNOL, V120, P72, DOI 10.1016/j.jbiotec.2005.03.026; WARD RL, 1991, J CLIN MICROBIOL, V29, P1915, DOI 10.1128/JCM.29.9.1915-1923.1991; WARD RL, 1984, J CLIN MICROBIOL, V19, P748, DOI 10.1128/JCM.19.6.748-753.1984; WARD RL, 1988, J VIROL, V62, P4358, DOI 10.1128/JVI.62.11.4358-4361.1988; Yao LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032510; Yuan LJ, 2001, J VIROL, V75, P9229, DOI 10.1128/JVI.75.19.9229-9238.2001; Yuan LJ, 2000, J VIROL, V74, P8843, DOI 10.1128/JVI.74.19.8843-8853.2000; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6; Zhou HL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-3	72	2	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e105167	10.1371/journal.pone.0105167	http://dx.doi.org/10.1371/journal.pone.0105167			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268783	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700004
J	Qin, T; Sun, YY; Bai, WW; Wang, B; Xing, YF; Liu, Y; Yang, RX; Zhao, YX; Li, JM				Qin, Tao; Sun, Yuan-Yuan; Bai, Wen-Wu; Wang, Bo; Xing, Yi-Fan; Liu, Yan; Yang, Rui-Xue; Zhao, Yu-Xia; Li, Jian-Min			Period2 Deficiency Blunts Hypoxia-Induced Mobilization and Function of Endothelial Progenitor Cells	PLOS ONE			English	Article							BONE-MARROW; MYOCARDIAL-INFARCTION; INDUCED NEOVASCULARIZATION; GROWTH; MATRIX-METALLOPROTEINASE-9; VASCULOGENESIS; DYSFUNCTION; RECRUITMENT; EXPRESSION; PROMOTES	Background: In the clinic, variations in circadian rhythm are evident in patients with cardiovascular disease, and the risk of cardiovascular events increases when rhythms are disrupted. In this study, we focused on the role of the circadian gene period2 (per2) in mobilization and function of endothelial progenitor cells (EPCs) in vitro and in vivo after myocardial infarction (MI) in mice. Methods and Results: MI was produced by surgical ligation of the left anterior descending coronary artery in mice with and without per2 deficiency. Trans-thoracic echocardiography was used to evaluate cardiac function in mice. Per2(-/-) mice with MI showed decreased cardiac function and increased infarct size. The number of CD34+ cells and capillary density were decreased in the myocardium of per2(-/-) mice on immunohistochemistry. Flow cytometry revealed decreased number of circulating EPCs in per2(-/-) mice after MI. In vitro, per2(-/-) EPCs showed decreased migration and tube formation capacity under hypoxia. Western blot analysis revealed inhibited activation of extracellular signal-regulated kinase and Akt signaling in the bone marrow of per2(-/-) mice and inhibited PI3K/Akt expression in per2(-/-) EPCs under hypoxia. Conclusions: Per2 modulates EPC mobilization and function after MI, which is important to recovery after MI in mice.	[Sun, Yuan-Yuan; Liu, Yan; Yang, Rui-Xue] Shandong Univ, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China; [Sun, Yuan-Yuan; Liu, Yan; Yang, Rui-Xue] Shandong Univ, Chinese Minist Hlth, Jinan 250100, Shandong, Peoples R China; [Sun, Yuan-Yuan; Bai, Wen-Wu; Wang, Bo; Xing, Yi-Fan; Zhao, Yu-Xia] Shandong Univ, Qilu Hosp, Dept Tradit Chinese Med, Jinan 250100, Shandong, Peoples R China; [Qin, Tao] Shandong Univ, Qilu Hosp, Dept Emergency Surg, Jinan 250100, Shandong, Peoples R China; [Li, Jian-Min] Shandong Univ, Qilu Hosp, Dept Orthoped, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Zhao, YX (corresponding author), Shandong Univ, Qilu Hosp, Dept Tradit Chinese Med, Jinan 250100, Shandong, Peoples R China.	yxzhao@sdu.edu.cn; lijianmin@163.com			National 973 Basic Research Program of China [2012CB518603]; National Natural Science Foundation of China [30873325, 81100103, 81173251, 81302939]; Natural Science Foundation of Shandong Province [ZR2011HQ020, ZR2009CM049]; postdoctoral special foundation for innovative projects of Shandong Province [201103049]; promotive research fund for excellent young and middle-aged scientists of Shandong Province [BS2013YY015]	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); postdoctoral special foundation for innovative projects of Shandong Province; promotive research fund for excellent young and middle-aged scientists of Shandong Province	This study was supported by the National 973 Basic Research Program of China (no. 2012CB518603), National Natural Science Foundation of China (no's. 30873325, 81100103, 81173251, 81302939), Natural Science Foundation of Shandong Province (no's. ZR2011HQ020, ZR2009CM049), postdoctoral special foundation for innovative projects of Shandong Province (No. 201103049) and promotive research fund for excellent young and middle-aged scientists of Shandong Province (BS2013YY015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonio N, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-101; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Brenner W, 2004, J NUCL MED, V45, P512; Chironi G, 2007, ATHEROSCLEROSIS, V191, P115, DOI 10.1016/j.atherosclerosis.2006.02.041; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Eckle T, 2012, NAT MED, V18, P774, DOI 10.1038/nm.2728; Eirin A, 2013, HYPERTENSION, V62, P585, DOI 10.1161/HYPERTENSIONAHA.113.01621; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Hansen Johnni, 2014, Ugeskr Laeger, V176, P146; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hoffmann BR, 2013, PHYSIOL GENOMICS, V45, P1021, DOI 10.1152/physiolgenomics.00070.2013; Huang PH, 2009, ARTERIOSCL THROM VAS, V29, P1179, DOI 10.1161/ATVBAHA.109.189175; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Kanzler I, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0310-4; Kido M, 2005, J AM COLL CARDIOL, V46, P2116, DOI 10.1016/j.jacc.2005.08.045; Kissel CK, 2007, J AM COLL CARDIOL, V49, P2341, DOI 10.1016/j.jacc.2007.01.095; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Krishnamurthy P, 2011, CIRC RES, V109, P1280, DOI 10.1161/CIRCRESAHA.111.248369; Kuliczkowski W, 2012, AM J THER, V19, P44, DOI 10.1097/MJT.0b013e3181e0cab3; Lamont EW, 2007, SLEEP MED, V8, P547, DOI 10.1016/j.sleep.2006.11.002; Leone AM, 2005, EUR HEART J, V26, P1196, DOI 10.1093/eurheartj/ehi164; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Llevadot J, 2001, J CLIN INVEST, V108, P399, DOI 10.1172/JCI200113131; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Maemura Koji, 2013, Nihon Rinsho, V71, P2124; Massot A, 2013, CEREBROVASC DIS, V35, P81, DOI 10.1159/000346097; Moon SK, 2004, J CELL PHYSIOL, V198, P417, DOI 10.1002/jcp.10435; Muller JE, 1999, AM HEART J, V137, pS1, DOI 10.1016/S0002-8703(99)70390-X; Murayama T, 2002, EXP HEMATOL, V30, P967, DOI 10.1016/S0301-472X(02)00867-6; Nakajima M, 2006, CELL BIOL INT, V30, P239, DOI 10.1016/j.cellbi.2005.11.003; Pan XY, 2013, CIRCULATION, V128, P1758, DOI 10.1161/CIRCULATIONAHA.113.002885; Porto I, 2013, AM J CARDIOL, V112, P782, DOI 10.1016/j.amjcard.2013.04.056; Prasad A, 2005, J AM COLL CARDIOL, V45, P508, DOI 10.1016/j.jacc.2004.10.054; Riegersperger M, 2013, TRANSPLANTATION, V95, P1338, DOI 10.1097/TP.0b013e31828fabb3; Sato M, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00409; Shantsila E, 2007, J AM COLL CARDIOL, V49, P741, DOI 10.1016/j.jacc.2006.09.050; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Sun YY, 2014, J CELL MOL MED, V18, P907, DOI 10.1111/jcmm.12241; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tanimura S, 2003, BIOCHEM BIOPH RES CO, V304, P801, DOI 10.1016/S0006-291X(03)00670-3; Wang CY, 2008, CIRCULATION, V118, P2166, DOI 10.1161/CIRCULATIONAHA.108.790469; Yao YY, 2012, HUM GENE THER, V23, P859, DOI 10.1089/hum.2011.123; Yue X, 2013, EXP THER MED, V6, P341, DOI 10.3892/etm.2013.1154; Zhou JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063126	47	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108806	10.1371/journal.pone.0108806	http://dx.doi.org/10.1371/journal.pone.0108806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268972	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700166
J	Wei, HY; Yasar, H; Funk, NW; Giese, M; Baz, ES; Stengl, M				Wei, Hongying; Yasar, Hanzey; Funk, Nico W.; Giese, Maria; Baz, El-Sayed; Stengl, Monika			Signaling of Pigment-Dispersing Factor (PDF) in the Madeira Cockroach Rhyparobia maderae	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; CIRCADIAN CLOCK CELLS; ACCESSORY MEDULLA; SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; NEURONS; DROSOPHILA; PACEMAKER; NEUROPEPTIDE; RHYTHMS	The insect neuropeptide pigment-dispersing factor (PDF) is a functional ortholog of vasoactive intestinal polypeptide, the coupling factor of the mammalian circadian pacemaker. Despite of PDF's importance for synchronized circadian locomotor activity rhythms its signaling is not well understood. We studied PDF signaling in primary cell cultures of the accessory medulla, the circadian pacemaker of the Madeira cockroach. In Ca2+ imaging studies four types of PDF-responses were distinguished. In regularly bursting type 1 pacemakers PDF application resulted in dose-dependent long-lasting increases in Ca2+ baseline concentration and frequency of oscillating Ca2+ transients. Adenylyl cyclase antagonists prevented PDF-responses in type 1 cells, indicating that PDF signaled via elevation of intracellular cAMP levels. In contrast, in type 2 pacemakers PDF transiently raised intracellular Ca2+ levels even after blocking adenylyl cyclase activity. In patch clamp experiments the previously characterized types 1-4 could not be identified. Instead, PDF-responses were categorized according to ion channels affected. Application of PDF inhibited outward potassium or inward sodium currents, sometimes in the same neuron. In a comparison of Ca2+ imaging and patch clamp experiments we hypothesized that in type 1 cells PDF-dependent rises in cAMP concentrations block primarily outward K+ currents. Possibly, this PDF-dependent depolarization underlies PDF-dependent phase advances of pacemakers. Finally, we propose that PDF-dependent concomitant modulation of K+ and Na+ channels in coupled pacemakers causes ultradian membrane potential oscillations as prerequisite to efficient synchronization via resonance.	[Wei, Hongying; Yasar, Hanzey; Funk, Nico W.; Giese, Maria; Baz, El-Sayed; Stengl, Monika] Univ Kassel, FB 10, D-34125 Kassel, Germany	Universitat Kassel	Stengl, M (corresponding author), Univ Kassel, FB 10, D-34125 Kassel, Germany.	stengl@uni-kassel.de		Baz, El-Sayed/0000-0003-1382-6090	DFG [STE531/18-1, STE531/18-2, STE 531/21-1]; Egyptian Ministry of Higher Education (MoHE); DAAD (Deutsche Akademischer Austauschdienst)	DFG(German Research Foundation (DFG)); Egyptian Ministry of Higher Education (MoHE)(Ministry of Higher Education & Scientific Research (MHESR)); DAAD (Deutsche Akademischer Austauschdienst)(Deutscher Akademischer Austausch Dienst (DAAD))	This study was supported by DFG grants STE531/18-1,2 and STE 531/21-1 to MS. In addition, ESB is supported by a Ph.D. scholarship awarded by the Egyptian Ministry of Higher Education (MoHE) and the DAAD (Deutsche Akademischer Austauschdienst). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003849; An SW, 2011, J NEUROPHYSIOL, V105, P2289, DOI 10.1152/jn.00966.2010; Atkinson SE, 2011, J BIOL RHYTHM, V26, P210, DOI 10.1177/0748730411402810; Brancaccio M, 2013, NEURON, V78, P714, DOI 10.1016/j.neuron.2013.03.011; Cantrell AR, 1997, J NEUROSCI, V17, P7330; Choi C, 2012, CELL REP, V2, P332, DOI 10.1016/j.celrep.2012.06.021; Choi C, 2009, CURR BIOL, V19, P1167, DOI 10.1016/j.cub.2009.06.029; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; DeHaven W, 2004, J BIOL CHEM, V279, P40609, DOI 10.1074/jbc.M404743200; Depetris-Chauvin A, 2011, CURR BIOL, V21, P1783, DOI 10.1016/j.cub.2011.09.027; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Duvall LB, 2013, J BIOL RHYTHM, V28, P239, DOI 10.1177/0748730413497179; Duvall LB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001337; Emery P, 2004, NEURON, V43, P443, DOI 10.1016/j.neuron.2004.08.009; Ganetzky B, 1999, ANN NY ACAD SCI, V868, P356, DOI 10.1111/j.1749-6632.1999.tb11297.x; Granados-Fuentes D, 2012, J NEUROSCI, V32, P10045, DOI 10.1523/JNEUROSCI.0174-12.2012; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hamasaka Y, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.43; Harmar AJ, 2003, J NEUROENDOCRINOL, V15, P335, DOI 10.1046/j.1365-2826.2003.01005.x; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hastings MH, 2014, J NEUROENDOCRINOL, V26, P2, DOI 10.1111/jne.12125; Hastings MH, 2008, CURR BIOL, V18, pR805, DOI 10.1016/j.cub.2008.07.021; Helfrich-Forster C, 2014, J NEUROGENET, V28, P329, DOI 10.3109/01677063.2014.905556; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; Helfrich-Forster C, 2004, J COMP PHYSIOL A, V190, P601, DOI 10.1007/s00359-004-0527-2; Helfrich-Forster C, 1998, CHRONOBIOL INT, V15, P567, DOI 10.3109/07420529808993195; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; HOMBERG U, 1991, CELL TISSUE RES, V266, P343, DOI 10.1007/BF00318190; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Im SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018974; Im SH, 2010, J COMP NEUROL, V518, P1925, DOI 10.1002/cne.22311; Itri JN, 2010, J NEUROPHYSIOL, V103, P632, DOI 10.1152/jn.00670.2009; Itri JN, 2005, NAT NEUROSCI, V8, P650, DOI 10.1038/nn1448; Kudo T, 2013, J NEUROPHYSIOL, V110, P1097, DOI 10.1152/jn.00114.2013; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Lear BC, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000154; Li Y, 2014, P NATL ACAD SCI USA, V111, pE1284, DOI 10.1073/pnas.1402562111; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Loesel R, 1998, NATURWISSENSCHAFTEN, V85, P238, DOI 10.1007/s001140050490; Loesel R, 2001, J COMP NEUROL, V439, P193, DOI 10.1002/cne.1342; Maywood ES, 2011, P NATL ACAD SCI USA, V108, P14306, DOI 10.1073/pnas.1101767108; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Meelkop E, 2011, PROG NEUROBIOL, V93, P125, DOI 10.1016/j.pneurobio.2010.10.004; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Meyer-Spasche A, 2004, NEUROSCI LETT, V358, P91, DOI 10.1016/j.neulet.2003.12.114; Mizrak D, 2012, CURR BIOL, V22, P1871, DOI 10.1016/j.cub.2012.07.070; Mohawk JA, 2011, TRENDS NEUROSCI, V34, P349, DOI 10.1016/j.tins.2011.05.003; Muraro NI, 2013, NEUROSCIENCE, V247, P280, DOI 10.1016/j.neuroscience.2013.05.036; Nielsen HS, 2002, EUR J NEUROSCI, V15, P570, DOI 10.1046/j.0953-816x.2001.01882.x; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Pakhotin P, 2006, PFLUG ARCH EUR J PHY, V452, P7, DOI 10.1007/s00424-005-0003-z; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Petri B, 1997, J NEUROSCI, V17, P4087; Rao K R, 1988, Peptides, V9 Suppl 1, P153, DOI 10.1016/0196-9781(88)90239-2; Reischig T, 2003, J EXP BIOL, V206, P1877, DOI 10.1242/jeb.00373; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ruben M, 2012, J BIOL RHYTHM, V27, P353, DOI 10.1177/0748730412455918; Schneider NL, 2007, J COMP PHYSIOL A, V193, P35, DOI 10.1007/s00359-006-0169-7; Schneider NL, 2006, J NEUROPHYSIOL, V95, P1996, DOI 10.1152/jn.00835.2005; Schneider NL, 2005, J NEUROSCI, V25, P5138, DOI 10.1523/JNEUROSCI.5138-A-04.2005; Seluzicki A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001810; Shafer OT, 2008, NEURON, V58, P223, DOI 10.1016/j.neuron.2008.02.018; Shafer OT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008298; Taghert PH, 2012, NEURON, V76, P82, DOI 10.1016/j.neuron.2012.08.035; Takahashi JS, 2008, SCIENCE, V322, P909, DOI 10.1126/science.1158822; Talsma AD, 2012, P NATL ACAD SCI USA, V109, P12177, DOI 10.1073/pnas.1200247109; Vansteensel MJ, 2008, BRAIN RES REV, V58, P18, DOI 10.1016/j.brainresrev.2007.10.009; Vosko AM, 2007, GEN COMP ENDOCR, V152, P165, DOI 10.1016/j.ygcen.2007.04.018; Wei HY, 2012, EUR J NEUROSCI, V36, P3021, DOI 10.1111/j.1460-9568.2012.08227.x; Wu Y, 2008, J BIOL RHYTHM, V23, P117, DOI 10.1177/0748730407312984; Wulbeck C, 2008, J BIOL RHYTHM, V23, P409, DOI 10.1177/0748730408322699; Yoshii T, 2009, J NEUROSCI, V29, P2597, DOI 10.1523/JNEUROSCI.5439-08.2009	74	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108757	10.1371/journal.pone.0108757	http://dx.doi.org/10.1371/journal.pone.0108757			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25269074	Green Published, gold			2022-12-27	WOS:000343671700157
J	Chae, Y; Lee, IS; Jung, WM; Chang, DS; Napadow, V; Lee, H; Park, HJ; Wallraven, C				Chae, Younbyoung; Lee, In-Seon; Jung, Won-Mo; Chang, Dong-Seon; Napadow, Vitaly; Lee, Hyejung; Park, Hi-Joon; Wallraven, Christian			Decreased Peripheral and Central Responses to Acupuncture Stimulation following Modification of Body Ownership	PLOS ONE			English	Article							SHAM ACUPUNCTURE; PREMOTOR CORTEX; RUBBER HAND; BRAIN; NEEDLE; PAIN; SENSATION; FEEL; FMRI; INTEROCEPTION	Acupuncture stimulation increases local blood flow around the site of stimulation and induces signal changes in brain regions related to the body matrix. The rubber hand illusion (RHI) is an experimental paradigm that manipulates important aspects of bodily self-awareness. The present study aimed to investigate how modifications of body ownership using the RHI affect local blood flow and cerebral responses during acupuncture needle stimulation. During the RHI, acupuncture needle stimulation was applied to the real left hand while measuring blood microcirculation with a LASER Doppler imager (Experiment 1, N = 28) and concurrent brain signal changes using functional magnetic resonance imaging (fMRI; Experiment 2, N = 17). When the body ownership of participants was altered by the RHI, acupuncture stimulation resulted in a significantly lower increase in local blood flow (Experiment 1), and significantly less brain activation was detected in the right insula (Experiment 2). This study found changes in both local blood flow and brain responses during acupuncture needle stimulation following modification of body ownership. These findings suggest that physiological responses during acupuncture stimulation can be influenced by the modification of body ownership.	[Chae, Younbyoung; Jung, Won-Mo; Wallraven, Christian] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Chae, Younbyoung; Lee, In-Seon; Lee, Hyejung; Park, Hi-Joon] Kyung Hee Univ, Acupuncture & Meridian Sci Res Ctr, Coll Korean Med, Seoul, South Korea; [Chang, Dong-Seon] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, D-72076 Tubingen, Germany; [Napadow, Vitaly] Harvard Univ, Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Sch Med, Charlestown, MA USA; [Napadow, Vitaly] Kyung Hee Univ, Dept Biomed Engn, Yongin, South Korea	Korea University; Kyung Hee University; Max Planck Society; Harvard University; Massachusetts General Hospital; Kyung Hee University	Chae, Y (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea.	ybchae@khu.ac.kr; wallraven@korea.ac.kr	Lee, In-Seon/AAM-1252-2020; Chae, Younbyoung/AAM-1243-2020; Park, Hi-Joon/AAG-1196-2021	Lee, In-Seon/0000-0001-9275-3111; Park, Hi-Joon/0000-0002-0538-2664; Wallraven, Christian/0000-0002-2604-9115; Napadow, Vitaly/0000-0003-1941-1750; Chae, Younbyoung/0000-0001-6787-2215; Chang, Dong-Seon/0000-0003-4562-1321	NCCIH NIH HHS [P01-AT006663,, R01-AT007550, P01 AT006663, R01 AT005280, R01-AT005280, R01 AT007550] Funding Source: Medline; NIAMS NIH HHS [R01-AR064367, R01 AR064367] Funding Source: Medline; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT005280] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT007550, P01AT006663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064367] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Asghar AU, 2010, BRAIN RES, V1315, P111, DOI 10.1016/j.brainres.2009.12.019; Barnsley N, 2011, CURR BIOL, V21, pR945, DOI 10.1016/j.cub.2011.10.039; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Chae Y, 2013, J PAIN, V14, P215, DOI 10.1016/j.jpain.2012.11.011; Chae Y, 2009, MOVEMENT DISORD, V24, P1794, DOI 10.1002/mds.22673; Chae Y, 2009, NEUROSCI LETT, V450, P80, DOI 10.1016/j.neulet.2008.11.048; Chang DS, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/849602; Choi YJ, 2013, COMPLEMENT THER MED, V21, P207, DOI 10.1016/j.ctim.2012.12.009; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Davis RT, 2012, ACUPUNCT MED, V30, P113, DOI 10.1136/acupmed-2011-010111; Dhond RP, 2007, J ALTERN COMPLEM MED, V13, P603, DOI 10.1089/acm.2007.7040; Dincer F, 2003, COMPLEMENT THER MED, V11, P235, DOI 10.1016/S0965-2299(03)00124-9; Dougherty DD, 2008, BEHAV BRAIN RES, V193, P63, DOI 10.1016/j.bbr.2008.04.020; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Fang JL, 2009, HUM BRAIN MAPP, V30, P1196, DOI 10.1002/hbm.20583; Folegatti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006920; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Harris RE, 2009, NEUROIMAGE, V47, P1077, DOI 10.1016/j.neuroimage.2009.05.083; Herbert BM, 2012, TOP COGN SCI, V4, P692, DOI 10.1111/j.1756-8765.2012.01189.x; Hsiu H, 2011, EVID-BASED COMPL ALT, V2011, P435928, DOI [10.1093/ecam/neq.073, DOI 10.1093/ECAM/NEQ.073]; Huang WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032960; Hui KKS, 2010, AUTON NEUROSCI-BASIC, V157, P81, DOI 10.1016/j.autneu.2010.03.022; Hui Kathleen K S, 2007, BMC Complement Altern Med, V7, P33, DOI 10.1186/1472-6882-7-33; Kang OS, 2011, AUTON NEUROSCI-BASIC, V159, P127, DOI 10.1016/j.autneu.2010.07.027; Kong J, 2009, NEUROIMAGE, V47, P1066, DOI 10.1016/j.neuroimage.2009.05.087; Kong J, 2009, NEUROIMAGE, V45, P940, DOI 10.1016/j.neuroimage.2008.12.025; Kong J, 2009, HUM BRAIN MAPP, V30, P38, DOI 10.1002/hbm.20481; Langevin HM, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/180805; Lee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104582; Liu H, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/932581; Liu T, 2009, EVID-BASED COMPL ALT, V6, P185, DOI 10.1093/ecam/nen002; Lopez C, 2008, NEUROPHYSIOL CLIN, V38, P149, DOI 10.1016/j.neucli.2007.12.006; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mehling WE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005614; Mohan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052400; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Moseley GL, 2012, NEUROSCI BIOBEHAV R, V36, P34, DOI 10.1016/j.neubiorev.2011.03.013; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Napadow V, 2009, NEUROIMAGE, V47, P1055, DOI 10.1016/j.neuroimage.2009.05.079; Newport R, 2010, EXP BRAIN RES, V204, P385, DOI 10.1007/s00221-009-2104-y; Pariente J, 2005, NEUROIMAGE, V25, P1161, DOI 10.1016/j.neuroimage.2005.01.016; Park H, 2002, AM J CHINESE MED, V30, P45, DOI 10.1142/S0192415X02000053; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Tsukayama H, 2006, CLIN J PAIN, V22, P346, DOI 10.1097/01.ajp.0000176359.94644.mL; Uchida S, 2008, EVID-BASED COMPL ALT, V5, P145, DOI 10.1093/ecam/nem051; Zeller D, 2011, J NEUROSCI, V31, P4852, DOI 10.1523/JNEUROSCI.5154-10.2011; Zhang WT, 2003, NEUROREPORT, V14, P1591, DOI 10.1097/00001756-200308260-00010	51	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109489	10.1371/journal.pone.0109489	http://dx.doi.org/10.1371/journal.pone.0109489			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285620	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700069
J	Khalid, U; Gislason, GH; Hansen, PR				Khalid, Usman; Gislason, Gunnar Hilmar; Hansen, Peter Riis			Sarcoidosis in Patients with Psoriasis: A Population-Based Cohort Study	PLOS ONE			English	Article							MEDICAL COMORBIDITY; EPIDEMIOLOGY; ASSOCIATION; DISEASE	Purpose: Psoriasis is a chronic inflammatory disease characterized by a systemic immunological response which is mainly driven by activated T helper (Th) 1 and Th17 lymphocytes. Like psoriasis, sarcoidosis is a chronic inflammatory disorder with Th1/Th17-driven inflammation. Therefore, we investigated the risk of sarcoidosis in patients with psoriasis compared to the background population in a nationwide cohort. Methods: The study included the entire Danish population aged >= 10 years followed from 1(st) January 1997 until diagnosis of sarcoidosis, death or 31st December 2011. Patients with a history of psoriasis and/or sarcoidosis at baseline were excluded. Information on comorbidity and concomitant medication was identified by individual-level linkage of administrative registers. Incidence rates of sarcoidosis were calculated and adjusted hazard ratios (HRs) were estimated by multivariable Cox regression models adjusted for age, gender, comorbidity, medications and socioeconomic status. Results: A total of 6,043,518 subjects were eligible for analysis. In the study period 70,125 patients with new-onset psoriasis, including 11,834 patients with severe psoriasis, were identified. The overall incidence rates of sarcoidosis were 1.18, 2.22, and 4.06 per 10,000 person-years for the reference population (9,717 cases), mild psoriasis (78 cases) and severe psoriasis (22 cases), respectively. Compared to the reference population, the age-and gender-adjusted HRs for sarcoidosis were increased in patients with psoriasis with HR 1.49 (95% confidence interval [CI] 1.18-1.87) and HR 2.51 (CI 1.64-3.85) for those with mild and severe disease, respectively. Conclusion: In this nationwide cohort, psoriasis was associated with a disease severity-dependent increased risk of sarcoidosis.	[Khalid, Usman; Gislason, Gunnar Hilmar; Hansen, Peter Riis] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hellerup, Denmark; [Gislason, Gunnar Hilmar; Hansen, Peter Riis] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Gislason, Gunnar Hilmar] Univ Southren Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Khalid, U (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hellerup, Denmark.	usman.khalid@regionh.dk	Hansen, Peter Riis/AAR-7659-2020; Gislason, Gunnar/B-7561-2009	Gislason, Gunnar/0000-0002-0548-402X; Hansen, Peter Riis/0000-0002-9056-535X	LEO foundation	LEO foundation(LEO Pharma)	The study was financially supported by unrestricted grants from the LEO foundation. The sponsors had no influence on data collection, no access to the data, and no influence on the decision to submit.	Adrianto I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043907; Ahlehoff O, 2011, J INTERN MED, V270, P147, DOI 10.1111/j.1365-2796.2010.02310.x; Ahlehoff O, 2012, EUR HEART J, V33, P2054, DOI 10.1093/eurheartj/ehr285; [Anonymous], 1999, Am J Respir Crit Care Med, V160, P736; Cathcart S, 2012, J DRUGS DERMATOL, V11, P609; Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103; Farley E, 2011, GIORN ITAL DERMAT V, V146, P9; Gaist D, 1997, DAN MED BULL, V44, P445; Gerke AK, 2008, CLIN CHEST MED, V29, P379, DOI 10.1016/j.ccm.2008.03.014; Hassler A, 2013, RHEUMATOL INT, V33, P2955, DOI 10.1007/s00296-012-2523-0; HILLERDAL G, 1984, AM REV RESPIR DIS, V130, P29; Judson MA, 2003, CHEST, V123, P406, DOI 10.1378/chest.123.2.406; Kim HS, 2011, DIS MARKERS, V31, P17, DOI [10.1155/2011/185106, 10.3233/DMA-2011-0796]; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nayak-Rao S, 2013, Indian J Nephrol, V23, P375, DOI 10.4103/0971-4065.116325; Nikolopoulou Melita, 2006, BMC Pulm Med, V6, P26, DOI 10.1186/1471-2466-6-26; Nuttall M, 2006, J CLIN EPIDEMIOL, V59, P265, DOI 10.1016/j.jclinepi.2005.07.015; Samarasekera EJ, 2013, J INVEST DERMATOL, V133, P2340, DOI 10.1038/jid.2013.149; Schafer T, 2006, DERMATOLOGY, V212, P327, DOI 10.1159/000092283; ten Berge B, 2012, RHEUMATOLOGY, V51, P37, DOI 10.1093/rheumatology/ker316; Usuki K, 2001, J DERMATOL, V28, P86, DOI 10.1111/j.1346-8138.2001.tb00095.x; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wanat KA, 2013, JAMA DERMATOL, V149, P848, DOI 10.1001/jamadermatol.2013.4256; Wendling D, 2014, EXPERT REV CLIN IMMU, V10, P159, DOI 10.1586/1744666X.2014.866038; Wu JJ, 2012, J AM ACAD DERMATOL, V67, P924, DOI 10.1016/j.jaad.2012.04.039; Yang YW, 2011, BRIT J DERMATOL, V165, P1037, DOI 10.1111/j.1365-2133.2011.10494.x; Yeung H, 2013, JAMA DERMATOL, V149, P1173, DOI 10.1001/jamadermatol.2013.5015	28	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109632	10.1371/journal.pone.0109632	http://dx.doi.org/10.1371/journal.pone.0109632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285443	gold, Green Submitted, Green Published			2022-12-27	WOS:000345743700077
J	Bell, ET; Suchodolski, JS; Isaiah, A; Fleeman, LM; Cook, AK; Steiner, JM; Mansfield, CS				Bell, Erin T.; Suchodolski, Jan S.; Isaiah, Anitha; Fleeman, Linda M.; Cook, Audrey K.; Steiner, Joerg M.; Mansfield, Caroline S.			Faecal Microbiota of Cats with Insulin-Treated Diabetes Mellitus	PLOS ONE			English	Article							RNA GENE ANALYSIS; GUT MICROBIOTA; INTESTINAL MICROBIOTA; BACTERIAL MICROBIOTA; HEALTHY DOGS; WEIGHT-LOSS; OBESITY; DIET; PH; METABOLISM	Microorganisms within the gastrointestinal tract significantly influence metabolic processes within their mammalian host, and recently several groups have sought to characterise the gastrointestinal microbiota of individuals affected by metabolic disease. Differences in the composition of the gastrointestinal microbiota have been reported in mouse models of type 2 diabetes mellitus, as well as in human patients. Diabetes mellitus in cats has many similarities to type 2 diabetes in humans. No studies of the gastrointestinal microbiota of diabetic cats have been previously published. The objectives of this study were to compare the composition of the faecal microbiota of diabetic and non-diabetic cats, and secondarily to determine if host signalment and dietary factors influence the composition of the faecal microbiota in cats. Faecal samples were collected from insulin-treated diabetic and non-diabetic cats, and Illumina sequencing of the 16S rRNA gene and quantitative PCR were performed on each sample. ANOSIM based on the unweighted UniFrac distance metric identified no difference in the composition of the faecal microbiota between diabetic and non-diabetic cats, and no significant differences in the proportions of dominant bacteria by phylum, class, order, family or genus as determined by 16S rRNA gene sequencing were identified between diabetic and non-diabetic cats. qPCR identified a decrease in Faecalibacterium spp. in cats aged over ten years. Cat breed or gender, dietary carbohydrate, protein or fat content, and dietary formulation (wet versus dry food) did not affect the composition of the faecal microbiota. In conclusion, the composition of the faecal microbiota was not altered by the presence of diabetes mellitus in cats. Additional studies that compare the functional products of the microbiota in diabetic and non-diabetic cats are warranted to further investigate the potential impact of the gastrointestinal microbiota on metabolic diseases such as diabetes mellitus in cats.	[Bell, Erin T.; Mansfield, Caroline S.] Univ Melbourne, Fac Vet Sci, TRACTS Grp, Melbourne, Vic, Australia; [Suchodolski, Jan S.; Isaiah, Anitha; Steiner, Joerg M.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Gastrointestinal Lab, College Stn, TX USA; [Fleeman, Linda M.] Anim Diabet Australia, Melbourne, Vic, Australia; [Cook, Audrey K.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX USA	University of Melbourne; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Bell, ET (corresponding author), Univ Melbourne, Fac Vet Sci, TRACTS Grp, Melbourne, Vic, Australia.	belle@unimelb.edu.au	Mansfield, Caroline/GZA-5920-2022	Cook, Audrey/0000-0002-2840-6497; Isaiah, Anitha/0000-0001-7118-4124	Hills Pet Nutrition	Hills Pet Nutrition	This work was supported by a grant from Hills Pet Nutrition, www.hillspet.com.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abecia L., 2010, International Journal of Probiotics and Prebiotics, V5, P61; Baral R., 2003, J VET INTERN MED, V17, P433; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Brosey BP, 2000, AM J VET RES, V61, P359, DOI 10.2460/ajvr.2000.61.359; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; Desai AR, 2009, VET MICROBIOL, V137, P120, DOI 10.1016/j.vetmic.2008.12.019; Devillard E, 2007, J BACTERIOL, V189, P2566, DOI 10.1128/JB.01359-06; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elia M, 2007, EUR J CLIN NUTR, V61, pS40, DOI 10.1038/sj.ejcn.1602938; Endesfelder D, 2014, DIABETES, V63, P2006, DOI 10.2337/db13-1676; Feitoza AB, 2009, NUTR HOSP, V24, P422; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Garcia-Mazcorro JF, 2012, FEMS MICROBIOL ECOL, V80, P624, DOI 10.1111/j.1574-6941.2012.01331.x; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Hewitt KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054703; Hopkins MJ, 2002, DIGEST LIVER DIS, V34, pS12, DOI 10.1016/S1590-8658(02)80157-8; Jia J, 2011, LETT APPL MICROBIOL, V53, P288, DOI 10.1111/j.1472-765X.2011.03105.x; Jia J, 2011, FEMS MICROBIOL ECOL, V78, P395, DOI 10.1111/j.1574-6941.2011.01172.x; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lubbs DC, 2009, J ANIM PHYSIOL AN N, V93, P113, DOI 10.1111/j.1439-0396.2007.00788.x; LUPTON JR, 1985, AM J PHYSIOL, V249, pG382, DOI 10.1152/ajpgi.1985.249.3.G382; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Minamoto Yasushi, 2012, Animal Health Research Reviews, V13, P64, DOI 10.1017/S1466252312000060; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Ott SJ, 2004, DIAGN MICR INFEC DIS, V50, P237, DOI 10.1016/j.diagmicrobio.2004.08.012; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Ritchie LE, 2008, FEMS MICROBIOL ECOL, V66, P590, DOI 10.1111/j.1574-6941.2008.00609.x; Ritchie LE, 2010, VET MICROBIOL, V144, P140, DOI 10.1016/j.vetmic.2009.12.045; Scheen AJ, 2003, ACTA CLIN BELG, V58, P335, DOI 10.1179/acb.2003.58.6.001; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012; Suchodolski JS, 2008, FEMS MICROBIOL ECOL, V66, P567, DOI 10.1111/j.1574-6941.2008.00521.x; Suchodolski JS, 2011, VET CLIN N AM-SMALL, V41, P261, DOI 10.1016/j.cvsm.2010.12.006; Tiihonen K, 2010, AGEING RES REV, V9, P107, DOI 10.1016/j.arr.2009.10.004; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; van Tongeren SP, 2005, APPL ENVIRON MICROB, V71, P6438, DOI 10.1128/AEM.71.10.6438-6442.2005; Woodmansey EJ, 2004, APPL ENVIRON MICROB, V70, P6113, DOI 10.1128/AEM.70.10.6113-6122.2004; Wu XK, 2010, CURR MICROBIOL, V61, P69, DOI 10.1007/s00284-010-9582-9	48	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108729	10.1371/journal.pone.0108729	http://dx.doi.org/10.1371/journal.pone.0108729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279695	Green Published, gold			2022-12-27	WOS:000342670800027
J	Bruun, TH; Muhlbauer, K; Benen, T; Kliche, A; Wagner, R				Bruun, Tim-Henrik; Muehlbauer, Katharina; Benen, Thomas; Kliche, Alexander; Wagner, Ralf			A Mammalian Cell Based FACS-Panning Platform for the Selection of HIV-1 Envelopes for Vaccine Development	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; NEUTRALIZING ANTIBODIES; IN-VIVO; DISPLAY; GENE; EFFICACY; VECTOR; BROAD; PROTECTION	An increasing number of broadly neutralizing monoclonal antibodies (bnMAb) against the HIV-1 envelope (Env) protein has been discovered recently. Despite this progress, vaccination efforts with the aim to re-elicit bnMAbs that provide protective immunity have failed so far. Herein, we describe the development of a mammalian cell based FACS-panning method in which bnMAbs are used as tools to select surface-exposed envelope variants according to their binding affinity. For that purpose, an HIV-1 derived lentiviral vector was developed to infect HEK293T cells at low multiplicity of infection (MOI) in order to link Env phenotype and genotype. For proof of principle, a gp145 Env model-library was established in which the complete V3 domain was substituted by five strain specific V3 loop sequences with known binding affinities to nMAb 447-52D, respectively. Env genes were recovered from selected cells by PCR, subcloned into a lentiviral vector (i) to determine and quantify the enrichment nMAb binders and (ii) to generate a new batch of transduction competent particles. After 2 selection cycles the Env variant with highest affinity was enriched 20-fold and represented 80% of the remaining Env population. Exploiting the recently described bnMAbs, this procedure might prove useful in selecting Env proteins from large Env libraries with the potential to elicit bnMAbs when used as vaccine candidates.	[Bruun, Tim-Henrik; Muehlbauer, Katharina; Benen, Thomas; Kliche, Alexander; Wagner, Ralf] Univ Regensburg, Inst Med Microbiol & Hyg, D-93053 Regensburg, Germany	University of Regensburg	Wagner, R (corresponding author), Univ Regensburg, Inst Med Microbiol & Hyg, D-93053 Regensburg, Germany.	ralf.wagner@klinik.uni-regensburg.de			Bill and Melinda Gates Foundation [38637/VDC]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill and Melinda Gates Foundation to RW (Grant No. 38637/VDC, PI Robin Weiss, https://www.cavd.org/ProtectiveAbs/Pages/weiss.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addgene, 2011, ADDG PWPXLD PLASM DA; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; BERNARD P, 1994, GENE, V148, P71, DOI 10.1016/0378-1119(94)90235-6; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; BREITLING F, 1991, GENE, V104, P147, DOI 10.1016/0378-1119(91)90244-6; Burton DR, 2010, SCIENCE, V329, P770, DOI 10.1126/science.1194693; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Ching L, 2010, J VIROL, V84, P9932, DOI 10.1128/JVI.00868-10; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; Dhillon AK, 2008, ACTA CRYSTALLOGR D, V64, P792, DOI 10.1107/S0907444908013978; Du SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020927; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Fleiss J.L., 2013, STAT METHODS RATES P; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; Garrity RR, 1997, J IMMUNOL, V159, P279; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; GORNY MK, 1993, J IMMUNOL, V150, P635; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Haynes BF, 2006, EXPERT REV VACCINES, V5, P578; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Heyndrickx L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036438; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Ho M, 2006, P NATL ACAD SCI USA, V103, P9637, DOI 10.1073/pnas.0603653103; Hoot S, 2013, PLOS PATHOG, V9, DOI [10.1371/annotation/ed7c0148-97eb-4416-824d-6e6d1aaeceef, DOI 10.1371/ANNOTATION/ED7C0148-97EB-4416-824D-6E6D1AAECEEF]; Hoxie JA, 2010, ANNU REV MED, V61, P135, DOI 10.1146/annurev.med.60.042507.164323; HUANG MTF, 1990, NUCLEIC ACIDS RES, V18, P937, DOI 10.1093/nar/18.4.937; Hust M, 2011, J BIOTECHNOL, V152, P159, DOI 10.1016/j.jbiotec.2010.09.945; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Joyce MG, 2013, J VIROL, V87, P2294, DOI 10.1128/JVI.02717-12; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Khare PD, 2003, VIROLOGY, V315, P313, DOI 10.1016/S0042-6822(03)00530-0; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kulp DW, 2013, CURR OPIN VIROL, V3, P322, DOI 10.1016/j.coviro.2013.05.010; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Matrai J, 2010, MOL THER, V18, P477, DOI 10.1038/mt.2009.319; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; McKinnon LR, 2010, AIDS REV, V12, P209; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moscoso CG, 2011, P NATL ACAD SCI USA, V108, P6091, DOI 10.1073/pnas.1016113108; Munier CML, 2011, DRUGS, V71, P387, DOI 10.2165/11585400-000000000-00000; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; Ross AL, 2010, LANCET INFECT DIS, V10, P305, DOI 10.1016/S1473-3099(10)70069-4; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schiffner T, 2013, J VIROL, V87, P10163, DOI 10.1128/JVI.01161-13; Selvarajah S, 2008, AIDS RES HUM RETROV, V24, P301, DOI 10.1089/aid.2007.0158; Shapiro H.M., 2005, PRACTICAL FLOW CYTOM, V736, DOI [10.1002/0471722731.fmatter, DOI 10.1002/0471722731.FMATTER]; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; VanAntwerp JJ, 2000, BIOTECHNOL PROGR, V16, P31, DOI 10.1021/bp990133s; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wu XL, 2011, J VIROL, V85, P4578, DOI 10.1128/JVI.02585-10; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zolla-Pazner S, 2004, AIDS RES HUM RETROV, V20, P1254, DOI 10.1089/aid.2004.20.1254; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	72	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109196	10.1371/journal.pone.0109196	http://dx.doi.org/10.1371/journal.pone.0109196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279768	gold, Green Published, Green Submitted			2022-12-27	WOS:000342670800061
J	Chen, DQ; Huang, JY; Feng, B; Pan, BZ; De, W; Wang, R; Chen, LB				Chen, Dong-Qin; Huang, Jia-Yuan; Feng, Bing; Pan, Ban-Zhou; De, Wei; Wang, Rui; Chen, Long-Bang			Histone Deacetylase 1/Sp1/MicroRNA-200b Signaling Accounts for Maintenance of Cancer Stem-Like Cells in Human Lung Adenocarcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; REPRESSIVE COMPLEX 2; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; PROSTATE-CANCER; SELF-RENEWAL; C-KIT; METASTASIS; CHEMORESISTANCE; TUMORIGENICITY	The presence of cancer stem-like cells (CSCs) is one of the mechanisms responsible for chemoresistance that has been a major hindrance towards lung adenocarcinoma (LAD) treatment. Recently, we have identified microRNA (miR)-200b as a key regulator of chemoresistance in human docetaxel-resistant LAD cells. However, whether miR-200b has effects on regulating CSCs remains largely unclear and needs to be further elucidated. Here, we showed that miR-200b was significantly downregulated in CD133(+)/CD326(+) cells that exhibited properties of CSCs derived from docetaxel-resistant LAD cells. Also, restoration of miR-200b could inhibit maintenance and reverse chemoresistance of CSCs. Furthermore, suppressor of zeste-12 (Suz-12) was identified as a direct and functional target of miR-200b, and silencing of Suz-12 phenocopied the effects of miR-200b on CSCs. Additionally, overexpression of histone deacetylase (HDAC) 1 was identified as a pivotal mechanism responsible for miR-200b repression in CSCs through a specificity protein (Sp) 1-dependent mechanism, and restoration of miR-200b by HDAC1 repression significantly suppressed CSCs formation and reversed chemoresistance of CSCs by regulating Suz-12-E-cadherin signaling. Also, downregulation of HDAC1 or upregulation of miR-200b reduced the in vivo tumorigenicity of CSCs. Finally, Suz-12 was inversely correlated with miR-200b, positively correlated with HDAC1 and upregulated in docetaxel-resistant LAD tissues compared with docetaxel-sensitive tissues. Taken together, the HDAC1/miR-200b/Suz-12-E-cadherin signaling might account for maintenance of CSCs and formation of chemoresistant phenotype in docetaxel-resistant LAD cells.	[Chen, Dong-Qin; Huang, Jia-Yuan; Feng, Bing; Pan, Ban-Zhou; Wang, Rui; Chen, Long-Bang] Nanjing Univ, Jinling Hosp, Sch Med, Dept Med Oncol, Nanjing 210008, Jiangsu, Peoples R China; [De, Wei] Nanjing Med Univ, Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University	Wang, R (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Med Oncol, Nanjing 210008, Jiangsu, Peoples R China.	wangrui1977218@163.com; dr.chenlb@163.com			National Natural Science Foundation of China [81272474, 81301914]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (LBC No. 81272474, BF No. 81301914). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou A, 2013, CELL CYCLE, V12, P3743, DOI 10.4161/cc.27305; Asiedu MK, 2014, ONCOGENE, V33, P1316, DOI 10.1038/onc.2013.57; Bao B, 2011, CANCER LETT, V307, P26, DOI 10.1016/j.canlet.2011.03.012; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Bitarte N, 2011, STEM CELLS, V29, P1661, DOI 10.1002/stem.741; Bu PC, 2013, CELL STEM CELL, V12, P602, DOI 10.1016/j.stem.2013.03.002; Buurman R, 2012, GASTROENTEROLOGY, V143, P811, DOI 10.1053/j.gastro.2012.05.033; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Crea F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-40; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Emlet DR, 2014, CANCER RES, V74, P1238, DOI 10.1158/0008-5472.CAN-13-1407; Fan Y, 2014, CLIN CANCER RES, V20, P1531, DOI 10.1158/1078-0432.CCR-13-1455; Feng B, 2012, CANCER-AM CANCER SOC, V118, P3365, DOI 10.1002/cncr.26560; Gerger A, 2011, CLIN CANCER RES, V17, P6934, DOI 10.1158/1078-0432.CCR-11-1180; Giudice FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058672; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Kim IG, 2014, ONCOGENE, V33, P3908, DOI 10.1038/onc.2013.373; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Labisso WL, 2012, CELL CYCLE, V11, P1593, DOI 10.4161/cc.20008; Levina V, 2010, CANCER RES, V70, P338, DOI 10.1158/0008-5472.CAN-09-1102; Okuda H, 2013, CANCER RES, V73, P1434, DOI 10.1158/0008-5472.CAN-12-2037; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Sahlberg SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094621; Sarvi S, 2014, CANCER RES, V74, P1554, DOI 10.1158/0008-5472.CAN-13-1541; Scaffidi P, 2011, NAT CELL BIOL, V13, P1051, DOI 10.1038/ncb2308; Shi J, 2013, ONCOGENE, V32, P930, DOI 10.1038/onc.2012.110; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siemens H, 2013, ONCOTARGET, V4, P1399, DOI 10.18632/oncotarget.1202; Sun L, 2012, ONCOGENE, V31, P432, DOI 10.1038/onc.2011.263; Van den Broeck A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073968; Vazquez-Martin A, 2013, CELL CYCLE, V12, P3471, DOI 10.4161/cc.26692; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Wee EJH, 2012, ONCOGENE, V31, P4182, DOI 10.1038/onc.2011.584; White RA, 2013, J CLIN INVEST, V123, P4390, DOI 10.1172/JCI65856; Yamashita T, 2013, HEPATOLOGY, V57, P1484, DOI 10.1002/hep.26168; Yang J, 2013, STEM CELLS, V31, P248, DOI 10.1002/stem.1281; You JS, 2008, ONCOGENE, V27, P1376, DOI 10.1038/sj.onc.1210776; Yuan JH, 2011, HEPATOLOGY, V54, P2025, DOI 10.1002/hep.24606; Yuan W, 2012, SCIENCE, V337, P971, DOI 10.1126/science.1225237; Zeng SS, 2014, J HEPATOL, V60, P127, DOI 10.1016/j.jhep.2013.08.024; Zhang X, 2012, ONCOGENE, V31, P3002, DOI 10.1038/onc.2011.470; Zhao J, 2013, CLIN CANCER RES, V19, P3567, DOI 10.1158/1078-0432.CCR-12-3478; Zhao SJ, 2003, CANCER RES, V63, P2624	47	23	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109578	10.1371/journal.pone.0109578	http://dx.doi.org/10.1371/journal.pone.0109578			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279705	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800091
J	Podesta, MF; Yam, P; Codagnone, MG; Uccelli, NA; Colman, D; Reines, A				Fernanda Podesta, Maria; Yam, Patricia; Gabriel Codagnone, Martin; Alejandra Uccelli, Nonthue; Colman, David; Reines, Analia			Distinctive PSA-NCAM and NCAM Hallmarks in Glutamate-Induced Dendritic Atrophy and Synaptic Disassembly	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; VERTEBRATE NERVOUS-SYSTEM; HIPPOCAMPAL CA3C NEURONS; STRESS-INDUCED ATROPHY; POLYSIALIC ACID; STRUCTURAL PLASTICITY; PYRAMIDAL NEURONS; APICAL DENDRITES; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE	Dendritic and synapse remodeling are forms of structural plasticity that play a critical role in normal hippocampal function. Neural cell adhesion molecule (NCAM) and its polysialylated form (PSA-NCAM) participate in neurite outgrowth and synapse formation and plasticity. However, it remains unclear whether they contribute to dendritic retraction and synaptic disassembly. Cultured hippocampal neurons exposed to glutamate (5 mu M) showed a reduced MAP-2 (+) area in the absence of neuronal death 24 h after the insult. Concomitantly, synapse loss, revealed by decreased synaptophysin and postsynaptic density-95 cluster number and area, together with changes in NCAM and PSA-NCAM levels were found. Dendritic atrophy and PSA-NCAM reduction proved NMDA-receptor dependent. Live-imaging experiments evidenced dendritic atrophy 4 h after the insult; this effect was preceded by smaller NCAM clusters (1 h) and decreased surface and total PSA-NCAM levels (3 h). Simultaneously, total NCAM cluster number and area remained unchanged. The subsequent synapse disassembly (6 h) was accompanied by reductions in total NCAM cluster number and area. A PSA mimetic peptide prevented both the dendritic atrophy and the subsequent synaptic changes (6 h) but had no effect on the earliest synaptic remodeling (3 h). Thus, NCAM-synaptic reorganization and PSA-NCAM level decrease precede glutamate-induced dendritic atrophy, whereas the NCAM level reduction is a delayed event related to synapse loss. Consequently, distinctive stages in PSA-NCAM/NCAM balance seem to accompany glutamate-induced dendritic atrophy and synapse loss.	[Fernanda Podesta, Maria; Gabriel Codagnone, Martin; Alejandra Uccelli, Nonthue; Reines, Analia] CONICET UBA, Inst Invest Farmacol, ININFA, Buenos Aires, DF, Argentina; [Fernanda Podesta, Maria; Gabriel Codagnone, Martin; Alejandra Uccelli, Nonthue; Reines, Analia] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Farmacol, RA-1113 Buenos Aires, DF, Argentina; [Yam, Patricia; Colman, David] McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada; [Fernanda Podesta, Maria; Gabriel Codagnone, Martin; Alejandra Uccelli, Nonthue; Reines, Analia] Inst Biol Celular & Neurociencias Prof E De Rober, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; McGill University	Reines, A (corresponding author), CONICET UBA, Inst Invest Farmacol, ININFA, Buenos Aires, DF, Argentina.	areines@ffyb.uba.ar		Codagnone, Martin/0000-0001-8266-940X; Yam, Patricia/0000-0002-3631-3151	CONICET [PIP 2010-0937]; Agencia National de Promocion Cientifica y Tecnica (ANPCYT) [PICT 2010-2739]; Universidad de Buenos Aires (UBACYT), Argentina	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia National de Promocion Cientifica y Tecnica (ANPCYT); Universidad de Buenos Aires (UBACYT), Argentina(University of Buenos Aires)	This work was supported by grants to AR from CONICET (PIP 2010-0937), Agencia National de Promocion Cientifica y Tecnica (ANPCYT) PICT 2010-2739 and Universidad de Buenos Aires (UBACYT 2010 and 2012), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova LG, 2006, ARCH NEUROL-CHICAGO, V63, P693, DOI 10.1001/archneur.63.5.693; Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9; Bisaz R, 2011, HIPPOCAMPUS, V21, P56, DOI 10.1002/hipo.20723; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Christian KM, 2011, NEUROSCIENCE, V174, P26, DOI 10.1016/j.neuroscience.2010.11.033; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; Cremer H, 1997, MOL CELL NEUROSCI, V8, P323, DOI 10.1006/mcne.1996.0588; Czeh B, 2007, EUR ARCH PSY CLIN N, V257, P250, DOI 10.1007/s00406-007-0728-0; Diestel S, 2007, J CELL SCI, V120, P4035, DOI 10.1242/jcs.019729; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Fuchs E, 2004, EUR NEUROPSYCHOPHARM, V14, pS481, DOI 10.1016/j.euroneuro.2004.09.002; Fux CM, 2003, MOL CELL NEUROSCI, V24, P939, DOI 10.1016/j.mcn.2003.07.001; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Geuze E, 2005, MOL PSYCHIATR, V10, P160, DOI 10.1038/sj.mp.4001579; Gilabert-Juan J, 2011, EXP NEUROL, V232, P33, DOI 10.1016/j.expneurol.2011.07.009; Gould E., 2007, HIPPOCAMPUS BOOK, P321; Guirado R, 2014, CEREB CORTEX, V24, P3014, DOI 10.1093/cercor/bht156; Hammond MSL, 2006, J BIOL CHEM, V281, P34859, DOI 10.1074/jbc.M602568200; Heckers S, 2001, HIPPOCAMPUS, V11, P520, DOI 10.1002/hipo.1068; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kiss JZ, 2001, BRAIN RES REV, V36, P175, DOI 10.1016/S0165-0173(01)00093-5; Kochlamazashvili G, 2010, J NEUROSCI, V30, P4171, DOI 10.1523/JNEUROSCI.5806-09.2010; Leuner B, 2010, ANNU REV PSYCHOL, V61, P111, DOI 10.1146/annurev.psych.093008.100359; Leuner K, 2012, MOL NEUROBIOL, V46, P194, DOI 10.1007/s12035-012-8300-y; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; Magarinos AM, 1996, J NEUROSCI, V16, P3534; MATTSON MP, 1988, J NEUROSCI, V8, P2087; McEwen BS, 2002, EUR PSYCHIAT, V17, p318S; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mehanna A, 2010, MOL THER, V18, P34, DOI 10.1038/mt.2009.235; Mehanna A, 2009, BRAIN, V132, P1449, DOI 10.1093/brain/awp128; Minana R, 2001, EUR J NEUROSCI, V13, P749, DOI 10.1046/j.0953-816x.2000.01439.x; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Monzo HJ, 2013, J NEUROCHEM, V126, P758, DOI 10.1111/jnc.12363; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Muller T, 1999, J BIOL CHEM, V274, P10173, DOI 10.1074/jbc.274.15.10173; Nguyen L, 2003, CURR MED CHEM, V10, P2185, DOI 10.2174/0929867033456774; Pham K, 2003, EUR J NEUROSCI, V17, P879, DOI 10.1046/j.1460-9568.2003.02513.x; Polo-Parada L, 2004, J NEUROSCI, V24, P1852, DOI 10.1523/JNEUROSCI.4406-03.2004; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Poltorak M, 1996, J NEUROCHEM, V66, P1532; Reines A, 2012, J NEUROSCI, V32, P6323, DOI 10.1523/JNEUROSCI.0916-12.2012; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Ryan TA, 2001, NEURON, V32, P759, DOI 10.1016/S0896-6273(01)00527-X; Sandi C, 2004, NAT REV NEUROSCI, V5, P917, DOI 10.1038/nrn1555; Sandi C, 2001, NEUROSCIENCE, V102, P329, DOI 10.1016/S0306-4522(00)00484-X; Sandi C, 2007, NEUROENDOCRINOLOGY, V85, P158, DOI 10.1159/000101535; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Seidenfaden R, 2006, NEUROCHEM INT, V49, P1, DOI 10.1016/j.neuint.2005.12.011; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Shin MH, 2002, EXP MOL MED, V34, P401, DOI 10.1038/emm.2002.57; Sytnyk V, 2002, J CELL BIOL, V159, P649, DOI 10.1083/jcb.200205098; Tereshchenko Y, 2011, J COMP NEUROL, V519, P2475, DOI 10.1002/cne.22636; Theodosis DT, 1999, J NEUROSCI, V19, P10228; Thompson PM, 2012, PROG MOL BIOL TRANSL, V107, P1, DOI 10.1016/B978-0-12-385883-2.00009-6; Torregrossa P, 2004, J BIOL CHEM, V279, P30707, DOI 10.1074/jbc.M403935200; van der Borght K, 2007, EXP NEUROL, V204, P473, DOI 10.1016/j.expneurol.2006.10.014; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; Venero C, 2002, NEUROSCIENCE, V115, P1211, DOI 10.1016/S0306-4522(02)00543-2; Wainwright SR, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/805497; Wakabayashi Y, 2008, PROG NEURO-PSYCHOPH, V32, P1199, DOI 10.1016/j.pnpbp.2008.03.005; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Wielgat P, 2012, ADV MED SCI-POLAND, V57, P23, DOI 10.2478/v10039-012-0011-0; Wilson MT, 1998, J NEUROSCI RES, V52, P599, DOI 10.1002/(SICI)1097-4547(19980601)52:5<599::AID-JNR12>3.3.CO;2-X; Xu XH, 2011, J NEUROCHEM, V119, P100, DOI 10.1111/j.1471-4159.2011.07416.x; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yoshimi K, 2005, ANN NEUROL, V58, P31, DOI 10.1002/ana.20506; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001	73	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108921	10.1371/journal.pone.0108921	http://dx.doi.org/10.1371/journal.pone.0108921			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279838	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800038
J	Rizkallah, J; Jack, M; Saeed, M; Shafer, LA; Vo, M; Tam, J				Rizkallah, Jacques; Jack, Megan; Saeed, Mahwash; Shafer, Leigh Anne; Vo, Minh; Tam, James			Non-Invasive Bedside Assessment of Central Venous Pressure: Scanning into the Future	PLOS ONE			English	Article							INFERIOR VENA-CAVA; RIGHT ATRIAL PRESSURE; VOLUME STATUS; ECHOCARDIOGRAPHIC-ASSESSMENT; VALVE INCOMPETENCE; DIAMETER; COMPLICATIONS; ASSOCIATION; ULTRASOUND; GUIDELINES	Background: Noninvasive evaluation of central venous pressure (CVP) can be achieved by assessing the Jugular Venous Pressure (JVP), Peripheral Venous Collapse (PVC), and ultrasound visualization of the inferior vena cava. The relative accuracy of these techniques compared to one another and their application by trainees of varying experience remains uncertain. We compare the application and utility of the JVP, PVC, and handheld Mini Echo amongst trainees of varying experience including a medical student, internal medicine resident, and cardiology fellow. We also introduce and validate a new physical exam technique to assess central venous pressures, the Anthem sign. Methods: Patients presenting for their regularly scheduled echocardiograms at the hospital echo department had clinical evaluations of their CVP using these non-invasive bedside techniques. The examiners were blinded to the echo results, each other's assessments, and patient history; their CVP estimates were compared to the gold standard level 3 echocardiographer's estimates at the completion of the study. Results: 325 patients combined were examined (mean age 65, s.d. 16 years). When compared to the gold standard of central venous pressure by a level 3 echocardiographer, the JVP was the most sensitive at 86%, improving with clinical experience (p<0.01). The classic PVC technique and Anthem sign had better specificity compared to the JVP. Mini Echo estimates were comparable to physical exam assessments. Conclusions: JVP evaluation is the most sensitive physical examination technique in CVP assessments. The PVC techniques along with the newly described Anthem sign may be of value for the early learner who still has not mastered the art of JVP assessment and in obese patients in whom JVP evaluation is problematic. Mini Echo estimates of CVPs are comparable to physical examination by trained clinicians and require less instruction. The use of Mini Echo in medical training should be further evaluated and encouraged.	[Rizkallah, Jacques; Saeed, Mahwash; Vo, Minh; Tam, James] Univ Manitoba, Dept Med, Cardiol Sect, Winnipeg, MB, Canada; [Jack, Megan] Univ Manitoba, Sch Med, Winnipeg, MB, Canada; [Shafer, Leigh Anne] Univ Manitoba, Hlth Sci Ctr, Dept Med, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Tam, J (corresponding author), Univ Manitoba, Dept Med, Cardiol Sect, Winnipeg, MB, Canada.	JTAM@sbgh.mb.ca						Abdullah MH, 2011, EXP CLIN TRANSPLANT, V9, P393; Akkawi NM, 2002, J ULTRAS MED, V21, P747, DOI 10.7863/jum.2002.21.7.747; Alexandrou E, 2014, CRIT CARE MED, V42, P536, DOI 10.1097/CCM.0b013e3182a667f0; [Anonymous], 2007, EVIDENCE BASED PHYS; Arbo JE, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2013.08.008; Bahcebasi S, 2011, HEMODIAL INT, V15, P284, DOI 10.1111/j.1542-4758.2010.00525.x; Blair JE, 2009, AM J CARDIOL, V103, P246, DOI 10.1016/j.amjcard.2008.08.061; Brennan JM, 2007, J AM SOC ECHOCARDIOG, V20, P857, DOI 10.1016/j.echo.2007.01.005; Calvache JA, 2014, J INTENSIVE CARE MED; Chiaco JMSC, 2013, CLEV CLIN J MED, V80, P638, DOI 10.3949/ccjm.80a.13039; Cook DJ, 1996, JAMA-J AM MED ASSOC, V275, P630, DOI 10.1001/jama.275.8.630; Dabrowski W, 2007, MED SCI MONITOR, V13, pCR548; DeCara J M, 2003, Eur J Echocardiogr, V4, P141, DOI 10.1053/euje.2002.0617; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dipti A, 2012, AM J EMERG MED, V30, P1414, DOI 10.1016/j.ajem.2011.10.017; DRESSER LP, 1987, AM J SURG, V154, P220, DOI 10.1016/0002-9610(87)90185-1; Ferrada P, 2012, AM SURGEON, V78, P468; Gerotziafas GT, 2004, INT ANGIOL, V23, P195; Guilbert MC, 2008, J VASC SURG, V48, P918, DOI 10.1016/j.jvs.2008.04.046; Gunst M, 2008, J TRAUMA, V65, P509, DOI 10.1097/TA.0b013e3181825bc5; Huff L, 2009, COMPR CHILD ADOLES N, V32, P65, DOI 10.1080/01460860902737418; Journeycake JM, 2003, CURR OPIN HEMATOL, V10, P369, DOI 10.1097/00062752-200309000-00008; Jue J, 1992, J Am Soc Echocardiogr, V5, P613; Kimura BJ, 2002, AM J CARDIOL, V90, P1038, DOI 10.1016/S0002-9149(02)02699-1; Koster M, 2013, CLIN HEMORHEOL MICRO, V54, P325, DOI 10.3233/CH-131737; Kotlinska-Hasiec E, 2014, MINERVA ANESTESIOL, V80, P785; Laudenbach N, 2014, J PEDIATR NURS, V29, P348, DOI 10.1016/j.pedn.2014.02.002; LeBlond R. F., 2009, DEGOWINS DIAGNOSTIC; Leonard AD, 2008, BRIT J ANAESTH, V101, P166, DOI 10.1093/bja/aen125; Leroyer C, 2013, MED MALADIES INFECT, V43, P350, DOI 10.1016/j.medmal.2013.06.013; Lewis T, 1930, BRIT MED J, V1930, P849, DOI 10.1136/bmj.1.3618.849; Mandelbaum A, 1996, NEPHROL DIAL TRANSPL, V11, P24; Marik PE, 2008, CHEST, V134, P172, DOI 10.1378/chest.07-2331; McGee SR, 1998, AM HEART J, V136, P10, DOI 10.1016/S0002-8703(98)70175-9; Miguelena Dayra, 2013, Rev. salud pública, V15, P886; MORENO FL, 1984, AM J CARDIOL, V53, P579, DOI 10.1016/0002-9149(84)90034-1; Nagueh SF, 1996, CIRCULATION, V93, P1160, DOI 10.1161/01.CIR.93.6.1160; Ommen SR, 2000, MAYO CLIN PROC, V75, P24, DOI 10.4065/75.1.24; Pasalioglu KB, 2014, PAK J MED SCI, V30, P725; Patel AR, 2011, JACC-CARDIOVASC IMAG, V4, P938, DOI 10.1016/j.jcmg.2011.05.006; Perloff J, 2009, PHYS EXAMINATION HEA, P124; Rao NM, 2012, NEUROLOGIST, V18, P391, DOI 10.1097/NRL.0b013e31826a9954; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Schefold JC, 2010, J EMERG MED, V38, P632, DOI 10.1016/j.jemermed.2007.11.027; Schlant RC, 1994, HURSTS HEART 8 EDITI; Schonenberger M, 2011, SWISS MED WEEKLY, V141, P13294; Schreiber SJ, 2005, J NEUROL NEUROSUR PS, V76, P509, DOI 10.1136/jnnp.2004.043844; Seth R, 2002, J GEN INTERN MED, V17, P861, DOI 10.1046/j.1525-1497.2002.20101.x; Stawicki SP, 2009, J AM COLL SURGEONS, V209, P55, DOI 10.1016/j.jamcollsurg.2009.02.062; Stawicki SPA, 2014, J TRAUMA ACUTE CARE, V76, P956, DOI 10.1097/TA.0000000000000152; Thalhammer C, 2007, J AM COLL CARDIOL, V50, P1584, DOI 10.1016/j.jacc.2007.07.022; Thanakitcharu Prasert, 2013, Journal of the Medical Association of Thailand, V96, pS14; ur Rehman H, 2013, NEW ENGL J MED, V369, P27; Uthoff H, 2012, ULTRASCHALL MED, V33, P256; Wiwatworapan Weerapan, 2012, Journal of the Medical Association of Thailand, V95, P320; Yildirimturk O, 2011, J CLIN ULTRASOUND, V39, P337, DOI 10.1002/jcu.20837	56	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109215	10.1371/journal.pone.0109215	http://dx.doi.org/10.1371/journal.pone.0109215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279995	Green Submitted, gold, Green Published			2022-12-27	WOS:000342670800064
J	Gladykowska-Rzeczycka, JJ; Nowakowski, D				Gladykowska-Rzeczycka, Judyta J.; Nowakowski, Dariusz			A Biological Stone from a Medieval Cemetery in Poland	PLOS ONE			English	Article							BLADDER STONE; DIFFERENTIAL-DIAGNOSIS; CALCIFIED OBJECT; URINARY STONES; NORWICH; DISEASE; JORDAN	A review of the literature shows that origination of biological stones as well as their pathogenesis mostly depend on the environmental factors. As a result, the structural spectrum of such calculi and their chemical composition are highly diversified. It is well known that biological stones are formed mostly in the digestive and urinary tracts. However, it has been demonstrated that this kind of stony structure can be also, though rarely, found in circulatory and reproductive systems, skin, mucosa, and tear ducts. Although in palaeopathology, the list of biological stones is enriched by stony tumours and/or discharges, it is very difficult to uncover the small size deposits in excavation material. In the literature such findings, originating from different countries and centuries, are few. The described stone was found among the bones of an adult individual in the medieval cemetery of Gdansk (Poland). The SEM, X-ray spectrometer and chemical evaluation revealed that it was a bladder calculus.	[Nowakowski, Dariusz] Wroclaw Univ Environm & Life Sci, Dept Anthropol, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences	Nowakowski, D (corresponding author), Wroclaw Univ Environm & Life Sci, Dept Anthropol, Wroclaw, Poland.	darekn@hot.pl	Nowakowski, Dariusz/B-4004-2017	Nowakowski, Dariusz/0000-0002-8301-7662				Abboud IA, 2008, ENVIRON GEOCHEM HLTH, V30, P445, DOI 10.1007/s10653-007-9128-7; Agarwal R, 2000, Eur J Ultrasound, V11, P143, DOI 10.1016/S0929-8266(99)00078-6; ANDERSEN D A, 1962, Br J Urol, V34, P160; Anderson T, 2003, INT J OSTEOARCHAEOL, V13, P165, DOI 10.1002/oa.641; Anderson T, 2001, BJU INT, V88, P351, DOI 10.1046/j.1464-410X.2001.02298.x; Armentano N, 2012, INT J PALEOPATHOL, V2, P236, DOI 10.1016/j.ijpp.2012.11.003; Aufderheide AC, 1998, THE CAMBRIDGE ENCYCL, P247; Baud C.A., 1991, HUMAN PALEOPATHOLOGY, P257; Boryslawski K, 2010, MORPHOLOGY AND SYSTE, P3; Brothwell D., 2000, CANNINGTON CEMETERY; Brothwell DR., 1967, DIS ANTIQUITY, P349; Cook DC, 2014, INT J OSTEOARCHAEOL, V24, P123, DOI 10.1002/oa.1302; D'Alessio A, 2005, ARCHAEOMETRY, V47, P127, DOI 10.1111/j.1475-4754.2005.00192.x; Ece A, 2000, INT J UROL, V7, P330, DOI 10.1046/j.1442-2042.2000.00207.x; GARTNER J, 1990, CLIN ORTHOP RELAT R, P111; Giuffra V, 2008, UROLOGY, V72, P780, DOI 10.1016/j.urology.2008.04.031; Gladykowska-Rzeczycka J., 1991, HUMAN PALEOPATHOLOGY, P251; Gladykowska-Rzeczycka J.J., 2003, J PALEOPATHOLOGY, V15, P47; Gladykowska-Rzeczycka JJ, 2003, JOURNAL OF PALEOPATH, V15, P111; Gladykowska-Rzeczycka JJ, 2009, METODY ZRODLA DOKUME, P82; Gladykowska-Rzeczyska JJ, 2006, PALEOPATHOLOGY NEWSL, P19; Hesse A, 1997, WORLD J UROL, V15, P165, DOI 10.1007/BF02201853; Iliadelis E, 1999, EUR J OPHTHALMOL, V9, P266, DOI 10.1177/112067219900900402; Kamoun A, 1999, BRITISH JOURNAL OF R, V72, P1213; Komar D, 2003, INT J OSTEOARCHAEOL, V13, P157, DOI 10.1002/oa.670; KRAMAR C, 1983, ARCH PATHOL LAB MED, V107, P91; Kramar CH, 1984, TWO PLEURAL PLAQUES, P199; Krzywdzinski R, 2006, ARCHEOLOGIA GDANSKA, V2, P7; Lonsdale K, 1968, Br J Urol, V40, P33; LONSDALE K, 1968, SCIENCE, V159, P1199, DOI 10.1126/science.159.3820.1199; Mauer C, 1976, UROLOGE B, V16, P226; Maurice-Estepa L, 1999, SCAND J UROL NEPHROL, V33, P299, DOI 10.1080/003655999750017365; Ortner D., 2003, IDENTIFICATION PATHO; Perry M, 2008, INT J OSTEOARCHAEOL, V18, P507, DOI 10.1002/oa.960; Quintelier K, 2009, INT J OSTEOARCHAEOL, V19, P436, DOI 10.1002/oa.971; ROBERTSON WG, 1978, BRIT J UROL, V50, P449, DOI 10.1111/j.1464-410X.1978.tb06189.x; Steinbock RT, 1989, JOURNAL OF PALEOPATH, V3, P34; Steinbock RT, 1989, J PALEOPATHOL, V3, P39; STREITZ JM, 1981, J UROLOGY, V126, P452, DOI 10.1016/S0022-5347(17)54571-1; Strouhal E, 1977, MITTEILUNGEN ANTHR G, V107, P215; SUTOR DJ, 1974, BRIT J UROL, V46, P393, DOI 10.1111/j.1464-410X.1974.tb10177.x; SZALAI F, 1987, International Urology and Nephrology, V19, P151, DOI 10.1007/BF02550466; Trinchieri A, 1996, Arch Ital Urol Androl, V68, P203; Wells C., 1981, E ANGLIAN ARCHAEOLOG E ANGLIAN ARCHAEOLOG, V9, P247	44	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109096	10.1371/journal.pone.0109096	http://dx.doi.org/10.1371/journal.pone.0109096			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275551	gold, Green Published, Green Submitted			2022-12-27	WOS:000342591500059
J	Watts, SD; Torres-Salazar, D; Divito, CB; Amara, SG				Watts, Spencer D.; Torres-Salazar, Delany; Divito, Christopher B.; Amara, Susan G.			Cysteine Transport through Excitatory Amino Acid Transporter 3 (EAAT3)	PLOS ONE			English	Article							NEURONAL GLUTAMATE TRANSPORTER; SUBSTRATE TRANSPORT; ANION CONDUCTANCE; MEDIATED RELEASE; HIGH-AFFINITY; CARRIER 1; FAMILY; EAAC1; NEUROTRANSMITTERS; SELENOCYSTEINE	Excitatory amino acid transporters (EAATs) limit glutamatergic signaling and maintain extracellular glutamate concentrations below neurotoxic levels. Of the five known EAAT isoforms (EAATs 1-5), only the neuronal isoform, EAAT3 (EAAC1), can efficiently transport the uncharged amino acid L-cysteine. EAAT3-mediated cysteine transport has been proposed to be a primary mechanism used by neurons to obtain cysteine for the synthesis of glutathione, a key molecule in preventing oxidative stress and neuronal toxicity. The molecular mechanisms underlying the selective transport of cysteine by EAAT3 have not been elucidated. Here we propose that the transport of cysteine through EAAT3 requires formation of the thiolate form of cysteine in the binding site. Using Xenopus oocytes and HEK293 cells expressing EAAT2 and EAAT3, we assessed the transport kinetics of different substrates and measured transporter-associated currents electrophysiologically. Our results show that L-selenocysteine, a cysteine analog that forms a negatively-charged selenolate ion at physiological pH, is efficiently transported by EAATs 1-3 and has a much higher apparent affinity for transport when compared to cysteine. Using a membrane tethered GFP variant to monitor intracellular pH changes associated with transport activity, we observed that transport of either L-glutamate or L-selenocysteine by EAAT3 decreased intracellular pH, whereas transport of cysteine resulted in cytoplasmic alkalinization. No change in pH was observed when cysteine was applied to cells expressing EAAT2, which displays negligible transport of cysteine. Under conditions that favor release of intracellular substrates through EAAT3 we observed release of labeled intracellular glutamate but did not detect cysteine release. Our results support a model whereby cysteine transport through EAAT3 is facilitated through cysteine de-protonation and that once inside, the thiolate is rapidly re-protonated. Moreover, these findings suggest that cysteine transport is predominantly unidirectional and that reverse transport does not contribute to depletion of intracellular cysteine pools.	[Watts, Spencer D.; Divito, Christopher B.; Amara, Susan G.] Univ Pittsburgh, Ctr Neurosci, Dept Neurobiol, Pittsburgh, PA 15260 USA; [Torres-Salazar, Delany; Amara, Susan G.] NIMH, Lab Cellular & Mol Neurobiol, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Amara, SG (corresponding author), Univ Pittsburgh, Ctr Neurosci, Dept Neurobiol, Pittsburgh, PA 15260 USA.	susan.amara@nih.gov		Amara, Susan/0000-0001-8914-1106; Torres-Salazar, Delany/0000-0002-6789-9810	National Institutes of Health [MH080726]; American Heart Association postdoctoral fellowship [09POST2010115]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported by National Institutes of Health Grant MH080726 to SGA and the American Heart Association postdoctoral fellowship (#09POST2010115) to DT-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Aoyama K, 2013, AMINO ACIDS, V45, P133, DOI 10.1007/s00726-013-1481-5; ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Berman AE, 2011, ANN NEUROL, V69, P509, DOI 10.1002/ana.22162; Billups B, 1996, J NEUROSCI, V16, P6722; Chen YM, 2003, J NEUROCHEM, V84, P1332, DOI 10.1046/j.1471-4159.2003.01630.x; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Elsliger MA, 1999, BIOCHEMISTRY-US, V38, P5296, DOI 10.1021/bi9902182; ERECINSKA M, 1986, FEBS LETT, V199, P95, DOI 10.1016/0014-5793(86)81231-5; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; Grewer C, 2008, IUBMB LIFE, V60, P609, DOI 10.1002/iub.98; Hawkes WC, 2010, BIOL TRACE ELEM RES, V134, P235, DOI 10.1007/s12011-010-8656-7; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; Koch HP, 1999, MOL PHARMACOL, V56, P1095, DOI 10.1124/mol.56.6.1095; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lacourciere GM, 2001, BIOFACTORS, V14, P69, DOI 10.1002/biof.5520140110; LEVI G, 1993, TRENDS NEUROSCI, V16, P415, DOI 10.1016/0166-2236(93)90010-J; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; Nothmann D, 2011, J BIOL CHEM, V286, P3935, DOI 10.1074/jbc.M110.187492; Poitry-Yamate CL, 2002, J NEUROCHEM, V82, P987, DOI 10.1046/j.1471-4159.2002.01075.x; RENNER EL, 1989, AM J PHYSIOL, V256, pG44, DOI 10.1152/ajpgi.1989.256.1.G44; Scopelliti AJ, 2013, J BIOL CHEM, V288, P8250, DOI 10.1074/jbc.M112.441022; Seal RP, 1999, ANNU REV PHARMACOL, V39, P431, DOI 10.1146/annurev.pharmtox.39.1.431; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watts SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035373; Watzke N, 2000, J GEN PHYSIOL, V116, P609, DOI 10.1085/jgp.116.5.609; Zerangue N, 1996, J BIOL CHEM, V271, P27991, DOI 10.1074/jbc.271.45.27991; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zerangue N, 1996, J PHYSIOL-LONDON, V493, P419, DOI 10.1113/jphysiol.1996.sp021393; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104	40	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109245	10.1371/journal.pone.0109245	http://dx.doi.org/10.1371/journal.pone.0109245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275463	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000342591500082
J	Pinto, JM; Wroblewski, KE; Kern, DW; Schumm, LP; McClintock, MK				Pinto, Jayant M.; Wroblewski, Kristen E.; Kern, David W.; Schumm, L. Philip; McClintock, Martha K.			Olfactory Dysfunction Predicts 5-Year Mortality in Older Adults	PLOS ONE			English	Article							NATIONAL SOCIAL-LIFE; BODY-MASS INDEX; AGING PROJECT; ALZHEIMERS-DISEASE; VECTOR HYPOTHESIS; AIR-POLLUTION; UNITED-STATES; HEALTH; BIOMARKERS; BRAIN	Prediction of mortality has focused on disease and frailty, although antecedent biomarkers may herald broad physiological decline. Olfaction, an ancestral chemical system, is a strong candidate biomarker because it is linked to diverse physiological processes. We sought to determine if olfactory dysfunction is a harbinger of 5-year mortality in the National Social Life, Health and Aging Project [NSHAP], a nationally representative sample of older U.S. adults. 3,005 community-dwelling adults aged 57-85 were studied in 2005-6 (Wave 1) and their mortality determined in 2010-11 (Wave 2). Olfactory dysfunction, determined objectively at Wave 1, was used to estimate the odds of 5-year, all cause mortality via logistic regression, controlling for demographics and health factors. Mortality for anosmic older adults was four times that of normosmic individuals while hyposmic individuals had intermediate mortality (p < 0.001), a "dose-dependent" effect present across the age range. In a comprehensive model that included potential confounding factors, anosmic older adults had over three times the odds of death compared to normosmic individuals (OR, 3.37 [95% CI 2.04, 5.57]), higher than and independent of known leading causes of death, and did not result from the following mechanisms: nutrition, cognitive function, mental health, smoking and alcohol abuse or frailty. Olfactory function is thus one of the strongest predictors of 5-year mortality and may serve as a bellwether for slowed cellular regeneration or as a marker of cumulative toxic environmental exposures. This finding provides clues for pinpointing an underlying mechanism related to a fundamental component of the aging process.	[Pinto, Jayant M.] Univ Chicago, Dept Surg, Sect Otolaryngol Head & Neck Surg, Chicago, IL 60637 USA; [Wroblewski, Kristen E.; Schumm, L. Philip] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Kern, David W.; McClintock, Martha K.] Univ Chicago, Dept Comparat Human Dev, Chicago, IL 60637 USA; [Kern, David W.; McClintock, Martha K.] Univ Chicago, Inst Mind & Biol, Chicago, IL 60637 USA; [Kern, David W.; McClintock, Martha K.] Univ Chicago, Natl Opin Res Ctr, Ctr Demog & Econ Aging, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Pinto, JM (corresponding author), Univ Chicago, Dept Surg, Sect Otolaryngol Head & Neck Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jpinto@surgery.bsd.uchicago.edu		Schumm, Phil/0000-0002-3050-2429	National Institutes of Health; National Institute on Aging; Office of Women's Health Research; Office of AIDS Research; Office of Behavioral and Social Sciences Research [AG021487, AG033903-01, AG030481]; National Institute on Aging [AG029795, AG036762, T32000243]; McHugh Otolaryngology Research Fund; American Geriatrics Society; Center on the Demography and Economics of Aging; Mellon Foundation Social Sciences Dissertation-Year Fellowship; Institute of Translational Medicine at The University of Chicago [KL2RR025000, UL1RR024999]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025000, UL1RR024999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021487, K23AG036762, T35AG029795, R01AG033903, R37AG030481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Office of Women's Health Research; Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Behavioral and Social Sciences Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); McHugh Otolaryngology Research Fund; American Geriatrics Society; Center on the Demography and Economics of Aging; Mellon Foundation Social Sciences Dissertation-Year Fellowship; Institute of Translational Medicine at The University of Chicago; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The National Institutes of Health, including the National Institute on Aging, the Office of Women's Health Research, the Office of AIDS Research, and the Office of Behavioral and Social Sciences Research (AG021487, AG033903-01, and AG030481). Support was also provided by the National Institute on Aging (AG029795, AG036762, and T32000243), the McHugh Otolaryngology Research Fund, the American Geriatrics Society, The Center on the Demography and Economics of Aging, a Mellon Foundation Social Sciences Dissertation-Year Fellowship, and the Institute of Translational Medicine at The University of Chicago (KL2RR025000 and UL1RR024999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; Burton SD, 2012, J NEUROPHYSIOL, V108, P2115, DOI 10.1152/jn.00362.2012; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Canter for Disease Control, 2013, MORT TABL; Cao S, 2014, J EPIDEMIOL COMMUN H, V68, P683, DOI 10.1136/jech-2013-203439; CORTI MC, 1994, JAMA-J AM MED ASSOC, V272, P1036, DOI 10.1001/jama.272.13.1036; de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083; Doty RL, 2008, ANN NEUROL, V63, P7, DOI 10.1002/ana.21327; Doucet S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007579; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Gan WQ, 2013, AM J RESP CRIT CARE, V187, P721, DOI 10.1164/rccm.201211-2004OC; Garcia-Esparcia P, 2013, J NEUROPATH EXP NEUR, V72, P524, DOI 10.1097/NEN.0b013e318294fd76; Goldman N, 2006, J GERONTOL A-BIOL, V61, P1070, DOI 10.1093/gerona/61.10.1070; Hays NP, 2006, PHYSIOL BEHAV, V88, P257, DOI 10.1016/j.physbeh.2006.05.029; Jacob S, 2002, HORM BEHAV, V42, P274, DOI 10.1006/hbeh.2002.1826; Jacob S, 2002, NAT GENET, V30, P175, DOI 10.1038/ng830; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Keller A, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-122; Kern DW, FIELD METHO IN PRESS; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Locher JL, 2007, J GERONTOL A-BIOL, V62, P1389, DOI 10.1093/gerona/62.12.1389; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88; Mueller C, 2006, AM J RHINOL, V20, P113, DOI 10.1177/194589240602000121; Mullol J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001256; Niimura Yoshihito, 2009, Human Genomics, V4, P107; O'Muircheartaigh C, 2009, J GERONTOL B-PSYCHOL, V64, pI12, DOI 10.1093/geronb/gbp045; Pagano SF, 2000, STEM CELLS, V18, P295, DOI 10.1634/stemcells.18-4-295; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Pinto JM, 2013, J GERONTOL A; Prediger RDS, 2012, NEUROTOX RES, V21, P90, DOI 10.1007/s12640-011-9281-8; Qato DM, 2010, PHARMACOEPIDEM DR S, V19, P834, DOI 10.1002/pds.1974; Reuben DB, 2002, J AM GERIATR SOC, V50, P638, DOI 10.1046/j.1532-5415.2002.50157.x; Rosero-Bixby L, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-11; Roy NS, 2000, NAT MED, V6, P271; Schumm LP, 2009, J GERONTOL B-PSYCHOL, V64, pI76, DOI 10.1093/geronb/gbp048; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; Stamps JJ, 2013, J NEUROL SCI, V333, P19, DOI 10.1016/j.jns.2013.06.033; Suzman R, 2009, J GERONTOL B-PSYCHOL, V64, pI5, DOI 10.1093/geronb/gbp078; Waite LJ, 2009, J GERONTOL B-PSYCHOL, V64, pI56, DOI 10.1093/geronb/gbp038; Watabe-Rudolph M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027801; Welge-Lussen A, 2009, B-ENT, P129; Williams SR, 2009, J GERONTOL B-PSYCHOL, V64, pI67, DOI 10.1093/geronb/gbn015; Wilson RS, 2008, EXP AGING RES, V34, P173, DOI 10.1080/03610730802070001; Wilson RS, 2009, ANN NY ACAD SCI, V1170, P730, DOI 10.1111/j.1749-6632.2009.04013.x; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	50	189	194	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e107541	10.1371/journal.pone.0107541	http://dx.doi.org/10.1371/journal.pone.0107541			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271633	Green Published, gold			2022-12-27	WOS:000343729600013
J	Wang, H; Stefanovic, B				Wang, Hao; Stefanovic, Branko			Role of LARP6 and Nonmuscle Myosin in Partitioning of Collagen mRNAs to the ER Membrane	PLOS ONE			English	Article							HEPATIC STELLATE-CELLS; OIM MOUSE-TISSUES; ENDOPLASMIC-RETICULUM; I COLLAGEN; OSTEOGENESIS IMPERFECTA; SMOOTH-MUSCLE; PROTEIN-SYNTHESIS; TERMINAL PROPEPTIDE; KINASE INHIBITORS; TRIPLE-HELIX	Type I collagen is extracellular matrix protein composed of two alpha 1(I) and one alpha 2(I) polypeptides that fold into triple helix. Collagen polypeptides are translated in coordination to synchronize the rate of triple helix folding to the rate of posttranslational modifications of individual polypeptides. This is especially important in conditions of high collagen production, like fibrosis. It has been assumed that collagen mRNAs are targeted to the membrane of the endoplasmic reticulum (ER) after translation of the signal peptide and by signal peptide recognition particle (SRP). Here we show that collagen mRNAs associate with the ER membrane even when translation is inhibited. Knock down of LARP6, an RNA binding protein which binds 5' stem-loop of collagen mRNAs, releases a small amount of collagen mRNAs from the membrane. Depolimerization of nonmuscle myosin filaments has a similar, but stronger effect. In the absence of LARP6 or nonmuscle myosin filaments collagen polypeptides become hypermodified, are poorly secreted and accumulate in the cytosol. This indicates lack of coordination of their synthesis and retro-translocation due to hypermodifications and misfolding. Depolimerization of nonmuscle myosin does not alter the secretory pathway through ER and Golgi, suggesting that the role of nonmuscle myosin is primarily to partition collagen mRNAs to the ER membrane. We postulate that collagen mRNAs directly partition to the ER membrane prior to synthesis of the signal peptide and that LARP6 and nonmuscle myosin filaments mediate this process. This allows coordinated initiation of translation on the membrane bound collagen alpha 1(I) and alpha 2(I) mRNAs, a necessary step for proper synthesis of type I collagen.	[Wang, Hao; Stefanovic, Branko] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Stefanovic, B (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	branko.stefanovic@med.fsu.edu			NIH grant [R01 DK059466-07A2]; College of Medicine, Florida State University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059466] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Medicine, Florida State University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The full funding for this manuscript came in part from the NIH grant R01 DK059466-07A2 to B. S. and in part from the College of Medicine, Florida State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Bachmann A, 2005, P NATL ACAD SCI USA, V102, P13897, DOI 10.1073/pnas.0505141102; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bascom RA, 1999, J BIOL CHEM, V274, P2953, DOI 10.1074/jbc.274.5.2953; BATEMAN JF, 1987, J BIOL CHEM, V262, P4445; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Bordeleau ME, 2006, CHEM BIOL, V13, P1287, DOI 10.1016/j.chembiol.2006.10.005; Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439; Bregendahl K, 2008, J NUTR, V138, P1976, DOI 10.1093/jn/138.10.1976; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Cai L, 2010, J MOL BIOL, V401, P564, DOI 10.1016/j.jmb.2010.06.057; Cai Le, 2009, Expert Rev Gastroenterol Hepatol, V3, P1, DOI 10.1586/17474124.3.1.1; Cai L, 2010, J MOL BIOL, V395, P309, DOI 10.1016/j.jmb.2009.11.020; Challa AA, 2011, MOL CELL BIOL, V31, P3773, DOI 10.1128/MCB.05263-11; Chen AYY, 2010, J DRUGS DERMATOL, V9, P829; Connell LE, 2006, J CELL SCI, V119, P2269, DOI 10.1242/jcs.02926; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Cui XYA, 2013, J BIOL CHEM, V288, P29633, DOI 10.1074/jbc.M113.482505; Cui XYA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001336; Dang YJ, 2009, J BIOL CHEM, V284, P23613, DOI 10.1074/jbc.M109.009985; Duran JM, 2003, MOL BIOL CELL, V14, P445, DOI 10.1091/mbc.E02-04-0214; El-Harake WA, 1998, AM J PHYSIOL-ENDOC M, V274, pE586, DOI 10.1152/ajpendo.1998.274.4.E586; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Fitzgerald J, 1999, J BIOL CHEM, V274, P27392, DOI 10.1074/jbc.274.39.27392; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; HAUKIPURO K, 1991, ANN SURG, V213, P75, DOI 10.1097/00000658-199101000-00013; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Hermesh O, 2013, BBA-MOL CELL RES, V1833, P2519, DOI 10.1016/j.bbamcr.2013.01.013; Hu BA, 2013, CURR OPIN RHEUMATOL, V25, P71, DOI 10.1097/BOR.0b013e32835b1352; ISEMURA M, 1991, CELL BIOL INT REP, V15, P965, DOI 10.1016/0309-1651(91)90146-A; Jiang F, 2006, J HEPATOL, V45, P401, DOI 10.1016/j.jhep.2006.03.016; Jin YJ, 2001, J BIOL CHEM, V276, P30342, DOI 10.1074/jbc.M102404200; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Kalson NS, 2013, P NATL ACAD SCI USA, V110, pE4743, DOI 10.1073/pnas.1314348110; Kelley CA, 1997, COMP BIOCHEM PHYS B, V117, P39, DOI 10.1016/S0305-0491(96)00313-6; Kivirikko KI, 1998, MATRIX BIOL, V16, P355, DOI 10.1016/S0945-053X(98)90008-7; Koide T, 1999, J BIOL CHEM, V274, P34523, DOI 10.1074/jbc.274.49.34523; Kraut-Cohen J, 2013, MOL BIOL CELL, V24, P3069, DOI 10.1091/mbc.E13-01-0038; LAMANDE SR, 1995, J BIOL CHEM, V270, P8642, DOI 10.1074/jbc.270.15.8642; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; Lerner RS, 2003, RNA, V9, P1123, DOI 10.1261/rna.5610403; Li Xuhang, 2008, V440, P97, DOI 10.1007/978-1-59745-178-9_8; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Liu ZN, 2011, J HEPATOL, V54, P132, DOI 10.1016/j.jhep.2010.06.020; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Locke D, 2006, FASEB J, V20, P1221, DOI 10.1096/fj.05-5309fje; Lofgren M, 2003, J GEN PHYSIOL, V121, P301, DOI 10.1085/jgp.200208720; Ma XF, 2012, FRONT BIOSCI-LANDMRK, V17, P545, DOI 10.2741/3942; Malfait F, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.038224; Mandon E. C., 2013, COLD SPRING HARB PER, V5; Manojlovic Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065897; Manojlovic Z, 2012, RNA, V18, P321, DOI 10.1261/rna.030288.111; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; Miles CA, 2002, J MOL BIOL, V321, P797, DOI 10.1016/S0022-2836(02)00703-9; Moore CC, 2011, WORLD J HEPATOL, V3, P184, DOI 10.4254/wjh.v3.i7.184; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nagata K, 1996, TRENDS BIOCHEM SCI, V21, P23, DOI 10.1016/0968-0004(96)80881-4; Nicchitta CV, 2005, BIOCHEM CELL BIOL, V83, P687, DOI 10.1139/O05-147; Nicchitta CV, 2002, CURR OPIN CELL BIOL, V14, P412, DOI 10.1016/S0955-0674(02)00353-8; Ogut O, 2007, J MUSCLE RES CELL M, V28, P409, DOI 10.1007/s10974-008-9132-2; Oliver JE, 1996, HUM MUTAT, V7, P318, DOI 10.1002/(SICI)1098-1004(1996)7:4<318::AID-HUMU5>3.3.CO;2-S; Pace JM, 2008, J BIOL CHEM, V283, P16061, DOI 10.1074/jbc.M801982200; Pandya K, 2006, P NATL ACAD SCI USA, V103, P16864, DOI 10.1073/pnas.0607700103; Pinzani M, 2010, EXPERT REV GASTROENT, V4, P459, DOI [10.1586/egh.10.47, 10.1586/EGH.10.47]; POPE FM, 1986, J MED GENET, V23, P377, DOI 10.1136/jmg.23.4.377; Pyhtila B, 2008, RNA, V14, P445, DOI 10.1261/rna.721108; Shahbaz AU, 2010, J HYPERTENS, V28, pS25, DOI 10.1097/01.hjh.0000388491.35836.d2; Shi J, 2007, BRIT J PHARMACOL, V152, P122, DOI 10.1038/sj.bjp.0707368; Simerly C, 1998, MOL BIOL CELL, V9, P2509, DOI 10.1091/mbc.9.9.2509; Sims TJ, 2003, CONNECT TISSUE RES, V44, P202, DOI 10.1080/03008200390181663; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Stefanovic B, 2004, MOL CELL BIOL, V24, P1758, DOI 10.1128/MCB.24.4.1758-1768.2004; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; Stefanovic L, 2005, EXP BIOL MED, V230, P573, DOI 10.1177/153537020523000809; Stephens Samuel B., 2008, V419, P197, DOI 10.1007/978-1-59745-033-1_14; Stephens SB, 2005, MOL BIOL CELL, V16, P5819, DOI 10.1091/mbc.E05-07-0685; Tajima Shingo, 1994, Journal of Dermatology (Tokyo), V21, P219; Tangkijvanich P, 2001, HEPATOLOGY, V33, P74, DOI 10.1053/jhep.2001.20677; Thalacker-Mercer AE, 2008, NUTR REV, V66, P91, DOI 10.1111/j.1753-4887.2007.00012.x; Ueno T, 2012, NUCLEIC ACIDS RES, V40, P3006, DOI 10.1093/nar/gkr1197; Ueno T, 2010, EXP CELL RES, V316, P329, DOI 10.1016/j.yexcr.2009.11.009; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; VILLA P, 1992, IN VITRO CELL DEV-AN, V28A, P157; Vukmirovic M, 2013, MOL CELL BIOL, V33, P3893, DOI 10.1128/MCB.00195-13; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Yamada NA, 2003, MUTAGENESIS, V18, P277, DOI 10.1093/mutage/18.3.277; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	90	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108870	10.1371/journal.pone.0108870	http://dx.doi.org/10.1371/journal.pone.0108870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271881	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600071
J	Allken, V; Chepkoech, JL; Einevoll, GT; Halnes, G				Allken, Vaneeda; Chepkoech, Joy-Loi; Einevoll, Gaute T.; Halnes, Geir			The Subcellular Distribution of T-Type Ca2+ Channels in Interneurons of the Lateral Geniculate Nucleus	PLOS ONE			English	Article							CALCIUM-CHANNEL; ION CHANNELS; DENDRITIC OUTPUTS; ACTION-POTENTIALS; APICAL DENDRITES; RELAY CELLS; IN-VITRO; NEURONS; BURST; BACKPROPAGATION	Inhibitory interneurons (INs) in the lateral geniculate nucleus (LGN) provide both axonal and dendritic GABA output to thalamocortical relay cells (TCs). Distal parts of the IN dendrites often enter into complex arrangements known as triadic synapses, where the IN dendrite plays a dual role as postsynaptic to retinal input and presynaptic to TC dendrites. Dendritic GABA release can be triggered by retinal input, in a highly localized process that is functionally isolated from the soma, but can also be triggered by somatically elicited Ca2+-spikes and possibly by backpropagating action potentials. Ca2+ -spikes in INs are predominantly mediated by T-type Ca2+-channels (T-channels). Due to the complex nature of the dendritic signalling, the function of the IN is likely to depend critically on how T-channels are distributed over the somatodendritic membrane (T-distribution). To study the relationship between the T-distribution and several IN response properties, we here run a series of simulations where we vary the T-distribution in a multicompartmental IN model with a realistic morphology. We find that the somatic response to somatic current injection is facilitated by a high T-channel density in the soma-region. Conversely, a high T-channel density in the distal dendritic region is found to facilitate dendritic signalling in both the outward direction (increases the response in distal dendrites to somatic input) and the inward direction (the soma responds stronger to distal synaptic input). The real T-distribution is likely to reflect a compromise between several neural functions, involving somatic response patterns and dendritic signalling.	[Allken, Vaneeda; Chepkoech, Joy-Loi; Einevoll, Gaute T.; Halnes, Geir] Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway; [Chepkoech, Joy-Loi] Univ Oslo, Dept Psychol, Oslo, Norway; [Einevoll, Gaute T.] Univ Oslo, Dept Phys, Oslo, Norway	Norwegian University of Life Sciences; University of Oslo; University of Oslo	Halnes, G (corresponding author), Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway.	geir.halnes@nmbu.no	Halnes, Geir/AAT-5319-2021		Research Council of Norway (ISP-Fysikk) [216699, 178892]; FP7 EU project (BrainScaleS); Norwegian Labour and Welfare Administration	Research Council of Norway (ISP-Fysikk)(Research Council of Norway); FP7 EU project (BrainScaleS); Norwegian Labour and Welfare Administration	The project was supported by the Research Council of Norway (ISP-Fysikk, project number 216699; eVITA program, project number 178892), an FP7 EU project (BrainScaleS), and the Norwegian Labour and Welfare Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Goycolea C, 2008, NEURON, V57, P420, DOI 10.1016/j.neuron.2007.12.022; AKAIKE N, 1991, COMP BIOCHEM PHYS C, V98, P31; Antal M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000348; Augustinaite S, 2011, J PHYSIOL-LONDON, V589, P2963, DOI 10.1113/jphysiol.2011.205542; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; BLOOMFIELD SA, 1989, P NATL ACAD SCI USA, V86, P3911, DOI 10.1073/pnas.86.10.3911; Briska AM, 2003, EUR J NEUROSCI, V17, P1531, DOI 10.1046/j.1460-9568.2003.02579.x; Broicher T, 2007, MOL CELL NEUROSCI, V36, P132, DOI 10.1016/j.mcn.2007.05.013; Carbone E, 2006, CELL CALCIUM, V40, P147, DOI 10.1016/j.ceca.2006.04.019; Casale AE, 2011, J NEUROSCI, V31, P18289, DOI 10.1523/JNEUROSCI.4417-11.2011; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Cheong E, 2013, PHYSIOL REV, V93, P961, DOI 10.1152/physrev.00010.2012; Cox CL, 1998, NATURE, V394, P478, DOI 10.1038/28855; Cox CL, 2000, NEURON, V27, P597, DOI 10.1016/S0896-6273(00)00069-6; Crandall SR, 2013, J NEUROPHYSIOL, V110, P470, DOI 10.1152/jn.00559.2012; Crandall SR, 2010, J NEUROSCI, V30, P15419, DOI 10.1523/JNEUROSCI.3636-10.2010; Destexhe A, 1996, J NEUROSCI, V16, P169; Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998; Egger V, 2005, J NEUROSCI, V25, P3521, DOI 10.1523/JNEUROSCI.4746-04.2005; Errington AC, 2011, J NEUROSCI, V31, P8669, DOI 10.1523/JNEUROSCI.0317-11.2011; Fanselow EE, 2001, P NATL ACAD SCI USA, V98, P15330, DOI 10.1073/pnas.261273898; Gillessen T, 1997, J NEUROPHYSIOL, V77, P1639, DOI 10.1152/jn.1997.77.3.1639; Gittis AH, 2010, J NEUROPHYSIOL, V104, P1625, DOI 10.1152/jn.00378.2010; Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144; Halnes G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002160; HAMOS JE, 1985, NATURE, V317, P618, DOI 10.1038/317618a0; Hines Michael L, 2009, Front Neuroinform, V3, P1, DOI 10.3389/neuro.11.001.2009; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Isomura Y, 2002, J NEUROPHYSIOL, V87, P1169, DOI 10.1152/jn.00536.2001; KOCH C, 1985, PROC R SOC SER B-BIO, V225, P365, DOI 10.1098/rspb.1985.0067; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185; MARKRAM H, 1994, P NATL ACAD SCI USA, V91, P5207, DOI 10.1073/pnas.91.11.5207; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Migliore M, 2004, J COMPUT NEUROSCI, V16, P5, DOI 10.1023/B:JCNS.0000004837.81595.b0; Migliore M, 1999, J COMPUT NEUROSCI, V7, P5, DOI 10.1023/A:1008906225285; Munsch T, 1997, NEUROREPORT, V8, P2411, DOI 10.1097/00001756-199707280-00001; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Nusser Z, 2009, TRENDS NEUROSCI, V32, P267, DOI 10.1016/j.tins.2009.01.003; Pape HC, 2004, PFLUG ARCH EUR J PHY, V448, P131, DOI 10.1007/s00424-003-1234-5; PAPE HC, 1994, J PHYSIOL-LONDON, V478, P403, DOI 10.1113/jphysiol.1994.sp020261; PAPE HC, 1995, NEUROSCIENCE, V68, P1105, DOI 10.1016/0306-4522(95)00205-W; Parajuli LK, 2010, J COMP NEUROL, V518, P4362, DOI 10.1002/cne.22461; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Pressler RT, 2013, J NEUROSCI, V33, P2494, DOI 10.1523/JNEUROSCI.3458-12.2013; Remme MWH, 2011, J COMPUT NEUROSCI, V31, P13, DOI 10.1007/s10827-010-0295-7; Sejnowski TJ, 2009, FRONT NEUROSCI-SWITZ, V3, P332, DOI 10.3389/neuro.01.038.2009; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; Sherman SM, 2004, TRENDS NEUROSCI, V27, P670, DOI 10.1016/j.tins.2004.08.003; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; SHERMAN SM, 1986, EXP BRAIN RES, V63, P1; SPERELAKIS N, 1990, MOL CELL BIOCHEM, V99, P97; Steriade M, 2002, J PHYSL, V546, P1; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Wei HY, 2011, J NEUROSCI, V31, P17287, DOI 10.1523/JNEUROSCI.6431-10.2011; Weiss N., 2012, BIOCHIM BIOPHYS ACTA, V1828, P1579; Williams SR, 1996, J PHYSIOL-LONDON, V490, P129, DOI 10.1113/jphysiol.1996.sp021131; Williams SR, 2000, J NEUROSCI, V20, P1307; Wolfart J, 2002, J NEUROSCI, V22, P3404; Zhang Y, 2012, BIOCHIM BIOPHYS ACTA, V1828, P1550; Zhelay TI, 2005, NEUROPHYSIOLOGY+, V37, P1, DOI 10.1007/s11062-005-0037-z; Zhou Q, 1997, J NEUROPHYSIOL, V77, P2816, DOI 10.1152/jn.1997.77.5.2816; Zhu JJ, 1999, NEUROSCIENCE, V91, P1445, DOI 10.1016/S0306-4522(98)00665-4; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P702, DOI 10.1152/jn.1999.81.2.702; Zhu JJ, 2001, J NEUROSCI, V21, P1148; Zhu JJ, 1999, NEUROSCIENCE, V92, P445, DOI 10.1016/S0306-4522(98)00759-3; Zomorrodi R, 2008, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.005.2008	72	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107780	10.1371/journal.pone.0107780	http://dx.doi.org/10.1371/journal.pone.0107780			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268996	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700047
J	Kwon, O; Kim, TJ; Lee, IJ; Byun, SS; Lee, SE; Hong, SK				Kwon, Ohseong; Kim, Tae Jin; Lee, In Jae; Byun, Seok-Soo; Lee, Sang Eun; Hong, Sung Kyu			Can Contemporary Patients with Biopsy Gleason Score 3+4 Be Eligible for Active Surveillance?	PLOS ONE			English	Article							LOCALIZED PROSTATE-CANCER; LOW-RISK; RADICAL PROSTATECTOMY; UNFAVORABLE DISEASE; MEN; OUTCOMES; CORES; PROGRESSION; VALIDATION; PREDICTORS	Introduction: We analyzed whether expansion of existing active surveillance (AS) protocols to include men with biopsy Gleason score (GS) 3+4 prostate cancer (PCa) would significantly alter pathologic and biochemical outcomes of potential candidates of AS. Methods: Among patients who underwent radical prostatectomy at our center between 2006 and 2013, we identified 577 patients (group A) who preoperatively fulfilled at least one of 6 different AS criteria. Also, we identified 217 patients (group B) with biopsy GS 3+4 but fulfilled non-GS criteria from at least one of 6 AS criteria. Designating group C as expanded group incorporating all patients in group A and B, we compared risk of unfavorable disease (pathologic GS >= 4+3 and/or pathologic T stage >= pT3a) and biochemical recurrence (BCR)-free survival between groups. Results: Rates of unfavorable disease were not significantly different between patients of group A and C who met AS criteria from 5 institutions (all p>0.05), not including University of Toronto (p<0.001). Also BCR-free survivals were not significantly different between patients in group A and C meeting each of 6 AS criteria (all p>0.05). Among group B, PSAD>0.15 ng/mL/cm(3) (p = 0.011) and tumor length of biopsy GS 3+4 core>4 mm (p = 0.007) were significant predictors of unfavorable disease. When these two criteria were newly applied in defining group B, rates of unfavorable disease in group A and B was 15.6% and 14.7%, respectively (p = 0.886). Conclusion: Overall rate of pathologically aggressive PCa harbored by potential candidates for AS may not be increased significantly with expansion of criteria to biopsy GS 3+4 under most contemporary AS protocols. PSAD and tumor length of biopsy GS 3+4 core may be useful predictors of more aggressive disease among potential candidates for AS with biopsy GS 3+4.	[Kwon, Ohseong; Kim, Tae Jin; Lee, In Jae; Byun, Seok-Soo; Lee, Sang Eun; Hong, Sung Kyu] Seoul Natl Univ, Dept Urol, Bundang Hosp, Songnam, South Korea	Seoul National University (SNU)	Hong, SK (corresponding author), Seoul Natl Univ, Dept Urol, Bundang Hosp, Songnam, South Korea.	hsk823@chol.com	Kwon, OhSeong/DBV-0709-2022; Kwon, Ohseong/W-8318-2019	Kwon, Ohseong/0000-0002-8933-6656				Berglund RK, 2008, J UROLOGY, V180, P1964, DOI 10.1016/j.juro.2008.07.051; Bul M, 2013, EUR UROL, V63, P597, DOI 10.1016/j.eururo.2012.11.005; Bul M, 2012, BJU INT, V110, P1672, DOI 10.1111/j.1464-410X.2012.11434.x; Cooperberg MR, 2013, J CLIN ONCOL, V31, P1428, DOI 10.1200/JCO.2012.46.4396; Cooperberg MR, 2011, J CLIN ONCOL, V29, P228, DOI 10.1200/JCO.2010.31.4252; Davies JD, 2011, J UROLOGY, V186, P2221, DOI 10.1016/j.juro.2011.07.104; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Epstein JI, 2012, EUR UROL, V61, P1019, DOI 10.1016/j.eururo.2012.01.050; Freedland SJ, 2003, UROLOGY, V61, P742, DOI 10.1016/S0090-4295(02)02525-6; Haffner J, 2011, BJU INT, V108, pE171, DOI 10.1111/j.1464-410X.2011.10112.x; Hardie C, 2005, BJU INT, V95, P956, DOI 10.1111/j.1464-410X.2005.05446.x; Iremashvili V, 2012, EUR UROL, V62, P462, DOI 10.1016/j.eururo.2012.03.011; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Lin DW, 2013, CLIN CANCER RES, V19, P2442, DOI 10.1158/1078-0432.CCR-12-3283; Magheli A, 2010, J UROLOGY, V183, P126, DOI 10.1016/j.juro.2009.08.139; Moore CM, 2014, CURR OPIN UROL, V24, P280, DOI 10.1097/MOU.0000000000000040; Patel MI, 2004, J UROLOGY, V171, P1520, DOI 10.1097/01.ju.0000118224.54949.78; Roemeling S, 2007, EUR UROL, V51, P1244, DOI 10.1016/j.eururo.2006.11.053; Russo GI, 2014, UROL ONCOL-SEMIN ORI, V32, P291, DOI 10.1016/j.urolonc.2013.07.004; Selvadurai ED, 2013, EUR UROL, V64, P981, DOI 10.1016/j.eururo.2013.02.020; Shore N, 2014, CURR MED RES OPIN, V30, P547, DOI 10.1185/03007995.2013.873398; Soloway MS, 2010, EUR UROL, V58, P831, DOI 10.1016/j.eururo.2010.08.027; Song SH, 2014, J UROLOGY, V192, P402, DOI 10.1016/j.juro.2014.02.2568; Steyerberg EW, 2007, J UROLOGY, V177, P107, DOI 10.1016/j.juro.2006.08.068; Tosoian JJ, 2011, J CLIN ONCOL, V29, P2185, DOI 10.1200/JCO.2010.32.8112; Turley RS, 2008, BJU INT, V102, P1074, DOI 10.1111/j.1464-410X.2008.08015.x; Vargas HA, 2012, J UROLOGY, V188, P1732, DOI 10.1016/j.juro.2012.07.024; Whitson JM, 2011, J UROLOGY, V185, P1656, DOI 10.1016/j.juro.2010.12.042; Yashi M, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-43	29	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e109031	10.1371/journal.pone.0109031	http://dx.doi.org/10.1371/journal.pone.0109031			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268898	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700215
J	Lima, A; Seabra, V; Bernardes, M; Azevedo, R; Sousa, H; Medeiros, R				Lima, Aurea; Seabra, Vitor; Bernardes, Miguel; Azevedo, Rita; Sousa, Hugo; Medeiros, Rui			Role of Key TYMS Polymorphisms on Methotrexate Therapeutic Outcome in Portuguese Rheumatoid Arthritis Patients	PLOS ONE			English	Article							THYMIDYLATE-SYNTHASE GENE; SINGLE NUCLEOTIDE POLYMORPHISM; COMMON POLYMORPHISMS; REDUCTASE GENES; TOXICITY; FOLATE; EFFICACY; ASSOCIATION; REGION; PHARMACOGENETICS	Background: Therapeutic outcome of rheumatoid arthritis (RA) patients treated with methotrexate (MTX) can be modulated by thymidylate synthase (TS) levels, which may be altered by genetic polymorphisms in TS gene (TYMS). This study aims to elucidate the influence of TYMS polymorphisms in MTX therapeutic outcome (regarding both clinical response and toxicity) in Portuguese RA patients. Methods: Clinicopathological data from 233 Caucasian RA patients treated with MTX were collected, outcomes were defined and patients were genotyped for the following TYMS polymorphisms: 1) 28 base pairs (bp) variable number tandem repeat (rs34743033); 2) single nucleotide polymorphism C>G (rs2853542); and 3) 6 bp sequence deletion (1494del6, rs34489327). Chi-square and binary logistic regression analyses were performed, using genotype and haplotype-based approaches. Results: Considering TYMS genotypes, 3R3R (p = 0.005, OR = 2.34), 3RC3RG (p = 0.016, OR = 3.52) and 6bp- carriers (p = 0.011, OR = 1.96) were associated with non-response to MTX. Multivariate analysis confirmed the increased risk for non-response to MTX in 6bp- carriers (p = 0.016, OR = 2.74). Data demonstrated that TYMS polymorphisms were in linkage disequilibrium (p<0.00001). Haplotype multivariate analysis revealed that haplotypes harboring both 3R and 6bp-alleles were associated with non-response to MTX. Regarding MTX-related toxicity, no statistically significant differences were observed in relation to TYMS genotypes and haplotypes. Conclusion: Our study reveals that TYMS polymorphisms could be important to help predicting clinical response to MTX in RA patients. Despite the potential of these findings, translation into clinical practice needs larger studies to confirm these evidences.	[Lima, Aurea; Seabra, Vitor] CESPU, Inst Res & Adv Training Hlth Sci & Technol, Higher Inst Hlth Sci North ISCS N, Dept Pharmaceut Sci, Gandra PRD, Portugal; [Lima, Aurea; Azevedo, Rita; Sousa, Hugo; Medeiros, Rui] Portuguese Inst Oncol Porto IPO Porto, Mol Oncol Grp CI, Oporto, Portugal; [Lima, Aurea; Medeiros, Rui] Univ Porto, Abel Salazar Inst Biomed Sci ICBAS, P-4100 Oporto, Portugal; [Bernardes, Miguel; Azevedo, Rita; Sousa, Hugo] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Bernardes, Miguel] Sao Joao Hosp Ctr, Dept Rheumatol, Oporto, Portugal; [Sousa, Hugo; Medeiros, Rui] Portuguese Inst Oncol Porto IPO Porto, Virol Serv, Oporto, Portugal; [Medeiros, Rui] Portuguese League Canc LPCC NRNorte, Res Dept, Oporto, Portugal	Universidade do Porto; Universidade do Porto; Sao Joao Hospital	Lima, A (corresponding author), CESPU, Inst Res & Adv Training Hlth Sci & Technol, Higher Inst Hlth Sci North ISCS N, Dept Pharmaceut Sci, Gandra PRD, Portugal.	aurea.lima@iscsn.cespu.pt	Sousa, Hugo/B-7714-2011; Azevedo, Rita/AAQ-1888-2020; Seabra, Vítor/AAR-6607-2021; Medeiros, Rui/C-7938-2009; Seabra, Vitor/AAS-9537-2020	Sousa, Hugo/0000-0001-5795-2131; Azevedo, Rita/0000-0002-3015-9675; Seabra, Vítor/0000-0002-8704-5775; Medeiros, Rui/0000-0003-3010-8373; Lima, Aurea/0000-0002-9779-0584	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/64441/2009]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	Funding support from a Doctoral Grant (SFRH/BD/64441/2009) for Aurea Lima - Fundacao para a Ciencia e Tecnologia (FCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Benucci M, 2011, INT J RHEUMATOL, V2011, DOI 10.1155/2011/845496; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Campalani E, 2007, J INVEST DERMATOL, V127, P1860, DOI 10.1038/sj.jid.5700808; Chan ESL, 2002, ARTHRITIS RES, V4, P266, DOI 10.1186/ar419; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; Dervieux T, 2004, ARTHRITIS RHEUM-US, V50, P2766, DOI 10.1002/art.20460; Dotor E, 2006, J CLIN ONCOL, V24, P1603, DOI 10.1200/JCO.2005.03.5253; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Finckh A, 2006, ARTHRIT RHEUM-ARTHR, V55, P864, DOI 10.1002/art.22353; Ghodke Y, 2008, CLIN RHEUMATOL, V27, P787, DOI 10.1007/s10067-008-0852-x; Gibofsky Allan, 2012, Am J Manag Care, V18, pS295; Grabar PB, 2008, EUR J CLIN PHARMACOL, V64, P1057, DOI 10.1007/s00228-008-0521-7; Inoue S, 2009, YAKUGAKU ZASSHI, V129, P843, DOI 10.1248/yakushi.129.843; James HM, 2008, J RHEUMATOL, V35, P562; Jekic B, 2013, EUR J CLIN PHARMACOL, V69, P377, DOI 10.1007/s00228-012-1341-3; Kawakami K, 2003, CANCER RES, V63, P6004; Krajinovic M, 2005, PHARMACOGENOMICS J, V5, P374, DOI 10.1038/sj.tpj.6500332; Krajinovic M, 2002, LANCET, V359, P1033, DOI 10.1016/S0140-6736(02)08065-0; Kremer JM, 2004, ARTHRITIS RHEUM-US, V50, P1370, DOI 10.1002/art.20278; Kumagai K, 2003, INT J MOL MED, V11, P593; Lima A, 2014, MOL BIOL REP; Lima A., 2013, PHARMACOGENOMICS; Lima A. B., 2014, MOL BIOL REP, P1; Lima A, 2013, PHARMACOGENOMICS, V14, P1337, DOI 10.2217/pgs.13.118; Lurje G, 2008, PHARMACOGENET GENOM, V18, P161, DOI 10.1097/FPC.0b013e3282f4aea6; Mandola MV, 2004, PHARMACOGENETICS, V14, P319, DOI 10.1097/00008571-200405000-00007; Mandola MV, 2003, CANCER RES, V63, P2898; Marsh S, 2005, INVEST NEW DRUG, V23, P533, DOI 10.1007/s10637-005-4021-7; Marsh S, 2001, INT J ONCOL, V19, P383; Mikuls TR, 2000, ARTHRITIS RHEUM, V43, P464, DOI 10.1002/1529-0131(200002)43:2<464::AID-ANR30>3.0.CO;2-U; O'Dell JR, 2004, NEW ENGL J MED, V350, P2591, DOI 10.1056/NEJMra040226; Ortiz Z, 1998, J RHEUMATOL, V25, P36; Ortiz Z, 2000, COCHRANE DB SYST REV; Owen SA, 2013, PHARMACOGENOMICS J, V13, P227, DOI 10.1038/tpj.2012.7; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Pullmann R, 2006, J BIOL CHEM, V281, P23456, DOI 10.1074/jbc.M600282200; Ranganathan P, 2008, J RHEUMATOL, V35, P572; Ranganathan P, 2006, ARTHRITIS RHEUM-US, V54, P1366, DOI 10.1002/art.21762; Rindfleisch JA, 2005, AM FAM PHYSICIAN, V72, P1037; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Sullivan KM, 2009, PUBLIC HEALTH REP, V124, P471, DOI 10.1177/003335490912400320; Swierkot J, 2006, PHARMACOL REP, V58, P473; Takatori R, 2006, CLIN EXP RHEUMATOL, V24, P546; Touroutoglou N, 1996, CLIN CANCER RES, V2, P227; US Department Of Health nd Human Services National Institutes of Health National Cancer Institute, 2010, COMM TERM CRIT ADV E; Weisman MH, 2006, ARTHRITIS RHEUM-US, V54, P607, DOI 10.1002/art.21573; Zhang ZD, 2004, CLIN CANCER RES, V10, P7903, DOI 10.1158/1078-0432.CCR-04-0923; Zhu H, 2014, PHARMACOGENOMICS, V15, P551, DOI [10.2217/PGS.14.25, 10.2217/pgs.14.25]	51	40	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108165	10.1371/journal.pone.0108165	http://dx.doi.org/10.1371/journal.pone.0108165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279663	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800011
J	Murakami, T; Oakes, M; Ogura, M; Tovar, V; Yamamoto, C; Mitsuhashi, M				Murakami, Taku; Oakes, Melanie; Ogura, Mieko; Tovar, Vivian; Yamamoto, Cindy; Mitsuhashi, Masato			Development of Glomerulus-, Tubule-, and Collecting Duct-Specific mRNA Assay in Human Urinary Exosomes and Microvesicles	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; BIOMARKERS	Urinary exosomes and microvesicles (EMV) are promising biomarkers for renal diseases. Although the density of EMV is very low in urine, large quantity of urine can be easily obtained. In order to analyze urinary EMV mRNA, a unique filter device to adsorb urinary EMV from 10 mL urine was developed, which is far more convenient than the standard ultracentrifugation protocol. The filter part of the device is detachable and aligned to a 96-well microplate format, therefore multiple samples can be processed simultaneously in a high throughput manner following the isolation step. For EMV mRNA quantification, the EMV on the filter is lysed directly by adding lysis buffer and transferred to an oligo(dT)-immobilized microplate for mRNA isolation followed by cDNA synthesis and real-time PCR. Under the optimized assay condition, our method provided comparable or even superior results to the standard ultracentrifugation method in terms of mRNA assay sensitivity, linearity, intra-assay reproducibility, and ease of use. The assay system was applied to quantification of kidney-specific mRNAs such as NPHN and PDCN (glomerular filtration), SLC12A1 (tubular absorption), UMOD and ALB (tubular secretion), and AQP2 (collecting duct water absorption). 12-hour urine samples were collected from four healthy subjects for two weeks, and day-to-day and individual-to-individual variations were investigated. Kidney-specific genes as well as control genes (GAPDH, ACTB, etc.) were successfully detected and confirmed their stable expressions through the two-week study period. In conclusion, this method is readily available to clinical studies of kidney diseases.	[Murakami, Taku; Oakes, Melanie; Ogura, Mieko; Tovar, Vivian; Yamamoto, Cindy; Mitsuhashi, Masato] Hitachi Chem Res Ctr Inc, Irvine, CA 92617 USA; [Oakes, Melanie] Univ Calif Irvine, Genom High Throughput Facil, Irvine, CA USA; [Mitsuhashi, Masato] NanoSomiX Inc, Irvine, CA USA	Hitachi Limited; University of California System; University of California Irvine	Mitsuhashi, M (corresponding author), Hitachi Chem Res Ctr Inc, Irvine, CA 92617 USA.	mitsuhashiconsultant@HCRcenter.com			Hitachi Chemical Research Center, Inc (HCR); NanoSomiX, Inc.	Hitachi Chemical Research Center, Inc (HCR); NanoSomiX, Inc.	All the study was funded by Hitachi Chemical Research Center, Inc (HCR). TM, M Oakes, M Ogura, VT and CY are employees of HCR, Inc. and MM is a consultant of HCR and a founder and CTO of NanoSomiX, Inc. Hitachi Chemical Research Center, Inc (HCR) provided support in the form of salaries for authors, TM, M Oakes, M Ogura, VT, CT and MM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Co-author MM is a founder and CTO of NanoSomiX, Inc. NanoSomiX, Inc. provided support in the form of salary for author MM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	Alvarez ML, 2012, KIDNEY INT, V82, P1024, DOI 10.1038/ki.2012.256; Aoki J, 2014, CLIN CHEM, V60, P675, DOI 10.1373/clinchem.2013.213850; Bonventre JV, 2010, NAT BIOTECHNOL, V28, P436, DOI 10.1038/nbt0510-436; Cheruvanky A, 2007, AM J PHYSIOL-RENAL, V292, pF1657, DOI 10.1152/ajprenal.00434.2006; Fang DYP, 2013, NEPHROLOGY, V18, P1, DOI 10.1111/nep.12005; Fassett RG, 2011, KIDNEY INT, V80, P806, DOI 10.1038/ki.2011.198; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; Mitsuhashi M, 2006, CLIN CHEM, V52, P634, DOI 10.1373/clinchem.2005.048983; Mitsuhashi M, 2013, FASEB J, V27, P5141, DOI 10.1096/fj.13-238980; *OFF HUM RES PROT, 2004, HUM SUBJ REG DEC CHA; Rood IM, 2010, KIDNEY INT, V78, P810, DOI 10.1038/ki.2010.262; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thomas R, 2008, PRIMARY CARE, V35, P329, DOI 10.1016/j.pop.2008.01.008; Zeringer Emily, 2013, World J Methodol, V3, P11, DOI 10.5662/wjm.v3.i1.11	16	23	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109074	10.1371/journal.pone.0109074	http://dx.doi.org/10.1371/journal.pone.0109074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275511	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500052
J	Park, HM; Shon, JC; Lee, MY; Liu, KH; Kim, JK; Lee, SJ; Lee, CH				Park, Hye Min; Shon, Jong Cheol; Lee, Mee Youn; Liu, Kwang-Hyeon; Kim, Jeong Kee; Lee, Sang Jun; Lee, Choong Hwan			Mass Spectrometry-Based Metabolite Profiling in the Mouse Liver following Exposure to Ultraviolet B Radiation	PLOS ONE			English	Article							INFLAMMATORY CYTOKINE PRODUCTION; HEPATIC TAURINE CONCENTRATION; POLYUNSATURATED FATTY-ACIDS; BILE-ACIDS; GLUTAMATE METABOLISM; LIPID-ACCUMULATION; OXIDATIVE STRESS; DISEASE; SKIN; LYSOPHOSPHATIDYLCHOLINE	Although many studies have been performed on the effects of ultraviolet (UV) radiation on the skin, only a limited number of reports have investigated these effects on non-skin tissue. This study aimed to describe the metabolite changes in the liver of hairless mice following chronic exposure to UVB radiation. We did not observe significant macroscopic changes or alterations in hepatic cholesterol and triglyceride levels in the liver of UVB-irradiated mice, compared with those for normal mice. In this study, we detected hepatic metabolite changes by UVB exposure and identified several amino acids, fatty acids, nucleosides, carbohydrates, phospholipids, lysophospholipids, and taurine-conjugated cholic acids as candidate biomarkers in response to UVB radiation in the mouse liver by using various mass spectrometry (MS)-based metabolite profiling including ultra-performance liquid chromatography-quadrupole time-of-flight (TOF)-MS, gas chromatography-TOF-MS and nanomate LTQ-MS. Glutamine exhibited the most dramatic change with a 5-fold increase in quantity. The results from altering several types of metabolites suggest that chronic UVB irradiation may impact significantly on major hepatic metabolism processes, despite the fact that the liver is not directly exposed to UVB radiation. MS-based metabolomic approach for determining regulatory hepatic metabolites following UV irradiation will provide a better understanding of the relationship between internal organs and UV light.	[Park, Hye Min; Lee, Mee Youn; Lee, Choong Hwan] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Shon, Jong Cheol; Liu, Kwang-Hyeon] Kyungpook Natl Univ, Coll Pharm, Taegu, South Korea; [Shon, Jong Cheol; Liu, Kwang-Hyeon] Kyungpook Natl Univ, Pharmaceut Sci Res Inst, Taegu, South Korea; [Kim, Jeong Kee; Lee, Sang Jun] AmorePacific Corp R&D Ctr, Food Res Inst, Yongin, Gyeonggi Do, South Korea	Konkuk University; Kyungpook National University; Kyungpook National University; Korea Food Research Institute (KFRI)	Lee, CH (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea.	chlee123@konkuk.ac.kr		Shon, Jong Cheol/0000-0002-1994-9465	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HN10C0017, HN13C0076]	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (Grant No. HN10C0017 and HN13C0076). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; BISHOP SC, 1979, BRIT J DERMATOL, V101, P399, DOI 10.1111/j.1365-2133.1979.tb00017.x; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; Brosnan ME, 2009, AM J CLIN NUTR, V90, p857S, DOI 10.3945/ajcn.2009.27462Z; Brosnan ME, 2007, TXB HEPATOLOGY BASIC, P142; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Chavez-Tapia NC, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-20; Das J, 2012, FOOD FUNCT, V3, P1251, DOI 10.1039/c2fo30117b; El-Zawahry BM, 2012, PHOTODERMATOL PHOTO, V28, P84, DOI 10.1111/j.1600-0781.2011.00643.x; Garrod S, 2001, MAGNET RESON MED, V45, P781, DOI 10.1002/mrm.1106; HARDISON WGM, 1977, AM J PHYSIOL, V232, pE75, DOI 10.1152/ajpendo.1977.232.1.E75; HARDISON WGM, 1978, GASTROENTEROLOGY, V75, P71; Hasko G, 2000, J IMMUNOL, V164, P1013, DOI 10.4049/jimmunol.164.2.1013; Haussinger D, 2004, ANAT REC PART A, V280A, P893, DOI 10.1002/ar.a.20094; Hofmann AF, 1999, ARCH INTERN MED, V159, P2647, DOI 10.1001/archinte.159.22.2647; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Kim J, 2013, MOL NUTR FOOD RES, V57, P1886, DOI 10.1002/mnfr.201200700; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Le TT, 2013, J LIPID RES, V54, P1044, DOI 10.1194/jlr.M034249; Leamy AK, 2013, PROG LIPID RES, V52, P165, DOI 10.1016/j.plipres.2012.10.004; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Liaudet L, 2001, AM J RESP CRIT CARE, V164, P1213, DOI 10.1164/ajrccm.164.7.2101013; Mas MR, 2004, HEPATOL RES, V28, P207, DOI 10.1016/j.herpes.2003.11.012; Masson P, 2010, ANAL CHEM, V82, P7779, DOI 10.1021/ac101722e; MIDELFART K, 1985, DERMATOLOGICA, V171, P95, DOI 10.1159/000249399; MURPHY GM, 1974, GUT, V15, P151, DOI 10.1136/gut.15.2.151; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Hung ND, 2012, INFLAMM RES, V61, P473, DOI 10.1007/s00011-012-0434-x; Nguyen P, 2008, J ANIM PHYSIOL AN N, V92, P272, DOI 10.1111/j.1439-0396.2007.00752.x; Olofsson KE, 2008, BIOCHEM BIOPH RES CO, V370, P348, DOI 10.1016/j.bbrc.2008.03.087; Park HM, 2013, METABOLOMIC IN PRESS, DOI [10.1007/s11306-013-0594-x, DOI 10.1007/S11306-013-0594-X]; Perrin-Cocon L, 2006, VACCINE, V24, P1254, DOI 10.1016/j.vaccine.2005.09.036; PILTINGSRUD HV, 1976, AM IND HYG ASSOC J, V37, P437, DOI 10.1080/0002889768507489; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; SHAMBAUGH GE, 1977, AM J CLIN NUTR, V30, P2083, DOI 10.1093/ajcn/30.12.2083; SHERWIN RS, 1980, DIABETES CARE, V3, P261, DOI 10.2337/diacare.3.2.261; Staels B, 2009, DIABETES CARE, V32, pS237, DOI 10.2337/dc09-S355; Svobodova Alena, 2006, Biomedical Papers (Olomouc), V150, P25; Svobodova AR, 2011, BIOL PHARM BULL, V34, P471; Trautinger F, 2001, CLIN EXP DERMATOL, V26, P573, DOI 10.1046/j.1365-2230.2001.00893.x; Verschooten L, 2006, PHOTOCHEM PHOTOBIOL, V82, P1016, DOI 10.1562/2006-04-27-IR-884.1; VESSEY DA, 1978, BIOCHEM J, V174, P621, DOI 10.1042/bj1740621; Vinayavekhin N, 2010, ACS CHEM BIOL, V5, P91, DOI 10.1021/cb900271r; Watford M, 2002, NUTRITION, V18, P301, DOI 10.1016/S0899-9007(02)00739-6; Watford M, 2000, J NUTR, V130, p983S, DOI 10.1093/jn/130.4.983S; Yang DW, 2000, J NUTR, V130, p991S, DOI 10.1093/jn/130.4.991S	48	53	54	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109479	10.1371/journal.pone.0109479	http://dx.doi.org/10.1371/journal.pone.0109479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275468	gold, Green Published, Green Submitted			2022-12-27	WOS:000342591500106
J	Wilson, T; Omelchenko, I; Foster, S; Zhang, Y; Shi, XR; Nuttall, AL				Wilson, Teresa; Omelchenko, Irina; Foster, Sarah; Zhang, Yuan; Shi, Xiaorui; Nuttall, Alfred L.			JAK2/STAT3 Inhibition Attenuates Noise-Induced Hearing Loss	PLOS ONE			English	Article							FACTOR-KAPPA-B; NADPH OXIDASE; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; SIGNAL TRANSDUCER; INDUCED APOPTOSIS; STAT3; EXPRESSION; ACTIVATION; PROTECTS	Signal transducers and activators of transcription 3 (STAT3) is a stress responsive transcription factor that plays a key role in oxidative stress-mediated tissue injury. As reactive oxygen species (ROS) are a known source of damage to tissues of the inner ear following loud sound exposure, we examined the role of the Janus kinase 2 (JAK2)/STAT3 signaling pathway in noise induce hearing loss using the pathway specific inhibitor, JSI-124. Mice were exposed to a moderately damaging level of loud sound revealing the phosphorylation of STAT3 tyrosine 705 residues and nuclear localization in many cell types in the inner ear including the marginal cells of the stria vascularis, type II, III, and IV fibrocytes, spiral ganglion cells, and in the inner hair cells. Treatment of the mice with the JAK2/STAT3 inhibitor before noise exposure reduced levels of phosphorylated STAT3 Y705. We performed auditory brain stem response and distortion product otoacoustic emission measurements and found increased recovery of hearing sensitivity at two weeks after noise exposure with JAK2/STAT3 inhibition. Performance of cytocochleograms revealed improved outer hair cell survival in JSI-124 treated mice relative to control. Finally, JAK2/STAT3 inhibition reduced levels of ROS detected in outer hair cells at two hours post noise exposure. Together, these findings demonstrate that inhibiting the JAK2/STAT3 signaling pathway is protective against noise-induced cochlear tissue damage and loss of hearing sensitivity.	[Wilson, Teresa; Foster, Sarah; Zhang, Yuan; Shi, Xiaorui; Nuttall, Alfred L.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Omelchenko, Irina] Univ Washington, Virginia Merrill Bloedel Hearing Res Ctr, Seattle, WA 98195 USA; [Nuttall, Alfred L.] Univ Michigan, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA	Oregon Health & Science University; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan	Nuttall, AL (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	nuttall@ohsu.edu			National Institutes of Health (NIH) [R01 DC000105, NIH P30 DC005983, NIH R01 DC010844, NIH P30 NS061800]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010844, R01DC000105, P30DC005983] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by National Institutes of Health (NIH) R01 DC000105 (Nuttall, PI), NIH P30 DC005983 (Gillespie, PI), NIH R01 DC010844 (Shi, PI) and NIH P30 NS061800 (Aicher, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2009, NEUROSCIENCE, V160, P530, DOI 10.1016/j.neuroscience.2009.02.073; Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bourgeais Jerome, 2013, JAKSTAT, V2, pe25764, DOI 10.4161/jkst.25764; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Chen FQ, 2012, J NEUROSCI, V32, P12421, DOI 10.1523/JNEUROSCI.6381-11.2012; Cimica V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020188; Duan WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057941; Evans P, 1999, ANN NY ACAD SCI, V884, P19, DOI 10.1111/j.1749-6632.1999.tb08633.x; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Fujioka M, 2006, J NEUROSCI RES, V83, P575, DOI 10.1002/jnr.20764; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Hertzano R, 2004, HUM MOL GENET, V13, P2143, DOI 10.1093/hmg/ddh218; Huang WL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-309; Jiang HY, 2005, J NEUROSCI RES, V79, P644, DOI 10.1002/jnr.20392; Kim HJ, 2010, J NEUROSCI, V30, P3933, DOI 10.1523/JNEUROSCI.6054-09.2010; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Lamm K, 1996, Audiol Neurootol, V1, P148; Leaman DW, 1996, FASEB J, V10, P1578, DOI 10.1096/fasebj.10.14.9002549; Li L, 2010, CANCER RES, V70, P8222, DOI 10.1158/0008-5472.CAN-10-0894; Manea A, 2010, ARTERIOSCL THROM VAS, V30, P105, DOI 10.1161/ATVBAHA.109.193896; Masuda M, 2006, BRAIN RES, V1068, P237, DOI 10.1016/j.brainres.2005.11.020; Mattagajasingh SN, 2012, BBA-MOL CELL RES, V1823, P997, DOI 10.1016/j.bbamcr.2012.02.008; Mei S, 2012, J PATHOL, V226, P519, DOI 10.1002/path.3006; Mukherjea D, 2010, ANTIOXID REDOX SIGN, V13, P589, DOI 10.1089/ars.2010.3110; Nishi T, 2002, J BIOL CHEM, V277, P44548, DOI 10.1074/jbc.M202970200; Nkansah E, 2013, FEBS LETT, V587, P833, DOI 10.1016/j.febslet.2013.01.065; Nuttall Alfred L., 1999, Noise Health, V2, P17; Ohinata Y, 2000, BRAIN RES, V878, P163, DOI 10.1016/S0006-8993(00)02733-5; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P229, DOI 10.1159/000013846; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P219, DOI 10.1159/000013845; Ponnusamy M, 2009, AM J PHYSIOL-RENAL, V297, pF1361, DOI 10.1152/ajprenal.00251.2009; Ramkumar V, 2004, HEARING RES, V188, P47, DOI 10.1016/S0378-5955(03)00344-7; Reich Nancy C, 2013, JAKSTAT, V2, pe27080, DOI 10.4161/jkst.27080; Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018; Sandberg EM, 2004, J BIOL CHEM, V279, P34547, DOI 10.1074/jbc.M405045200; Shi XR, 2003, BRAIN RES, V967, P1, DOI 10.1016/S0006-8993(02)04090-8; Shim K, 2011, JOVE-J VIS EXP, DOI 10.3791/2793; Simon AR, 2000, SCIENCE, V290, P144, DOI 10.1126/science.290.5489.144; Tabuchi K, 2011, CURR MED CHEM, V18, P4866, DOI 10.2174/092986711797535254; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tawfik A, 2005, VASC PHARMACOL, V43, P320, DOI 10.1016/j.vph.2005.08.018; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; Tornabene SV, 2006, HEARING RES, V222, P115, DOI 10.1016/j.heares.2006.09.004; Vlajkovic SM, 2013, HEARING RES, V304, P145, DOI 10.1016/j.heares.2013.07.012; Wakabayashi K, 2010, NEUROSCI RES, V66, P345, DOI 10.1016/j.neures.2009.12.008; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028; YAMANE H, 1995, ACTA OTO-LARYNGOL, P87; Yamasoba T, 1998, BRAIN RES, V784, P82, DOI 10.1016/S0006-8993(97)01156-6; Yu HM, 2006, APOPTOSIS, V11, P931, DOI 10.1007/s10495-006-6578-9; Zouein Fouad A, 2013, JAKSTAT, V2, pe24352, DOI 10.4161/jkst.24352	53	23	27	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108276	10.1371/journal.pone.0108276	http://dx.doi.org/10.1371/journal.pone.0108276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275304	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500015
J	Dankert, D; Demond, H; Trapphoff, T; Heiligentag, M; Rademacher, K; Eichenlaub-Ritter, U; Horsthemke, B; Grummer, R				Dankert, Debora; Demond, Hannah; Trapphoff, Tom; Heiligentag, Martyna; Rademacher, Katrin; Eichenlaub-Ritter, Ursula; Horsthemke, Bernhard; Gruemmer, Ruth			Pre- and Postovulatory Aging of Murine Oocytes Affect the Transcript Level and Poly(A) Tail Length of Maternal Effect Genes	PLOS ONE			English	Article							EARLY EMBRYONIC-DEVELOPMENT; MOUSE OOCYTES; MESSENGER-RNA; CYTOPLASMIC POLYADENYLATION; DELAYED FERTILIZATION; TRANSLATIONAL CONTROL; DNA METHYLATION; IN-VITRO; MATURATION; GROWTH	Maternal effect genes code for oocyte proteins that are important for early embryogenesis. Transcription in oocytes does not take place from the onset of meiotic progression until zygotic genome activation. During this period, protein levels are regulated posttranscriptionally, for example by poly(A) tail length. Posttranscriptional regulation may be impaired in preovulatory and postovulatory aged oocytes, caused by delayed ovulation or delayed fertilization, respectively, and may lead to developmental defects. We investigated transcript levels and poly(A) tail length of ten maternal effect genes in in vivo-and in vitro- (follicle culture) grown oocytes after pre- and postovulatory aging. Quantitative RT-PCR was performed using random hexamer-primed cDNA to determine total transcript levels and oligo(dT)(16)-primed cDNA to analyze poly(A) tail length. Transcript levels of in vivo preovulatory-aged oocytes remained stable except for decreases in Brg1 and Tet3. Most genes investigated showed a tendency towards increased poly(A) content. Polyadenylation of in vitro preovulatory-aged oocytes was also increased, along with transcript level declines of Trim28, Nlrp2, Nlrp14 and Zar1. In contrast to preovulatory aging, postovulatory aging of in vivo-and in vitro-grown oocytes led to a shortening of poly(A) tails. Postovulatory aging of in vivo-grown oocytes resulted in deadenylation of Nlrp5 after 12 h, and deadenylation of 4 further genes (Tet3, Trim28, Dnmt1, Oct4) after 24 h. Similarly, transcripts of in vitro-grown oocytes were deadenylated after 12 h of postovulatory aging (Tet3, Trim28, Zfp57, Dnmt1, Nlrp5, Zar1). This impact of aging on poly(A) tail length may affect the timed translation of maternal effect gene transcripts and thereby contribute to developmental defects.	[Dankert, Debora; Gruemmer, Ruth] Univ Duisburg Essen, Univ Hosp Essen, Inst Anat, Essen, Germany; [Demond, Hannah; Rademacher, Katrin; Horsthemke, Bernhard] Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Essen, Germany; [Trapphoff, Tom; Heiligentag, Martyna; Eichenlaub-Ritter, Ursula] Univ Bielefeld, Inst Gene Technol Microbiol, D-33615 Bielefeld, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Bielefeld	Grummer, R (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Anat, Essen, Germany.	ruth.gruemmer@uk-essen.de		Demond, Hannah/0000-0003-4706-4792	Deutsche Forschungsgemeinschaft [GR 1138/12-1, HO 949/21-1, EI 199/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding was provided by Deutsche Forschungsgemeinschaft (www.dfg.de): GR 1138/12-1, HO 949/21-1, and EI 199/7-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anckaert E, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111641; BACHVAROVA R, 1980, DEV BIOL, V74, P1, DOI 10.1016/0012-1606(80)90048-2; Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; Bittner AK, 2011, FERTIL STERIL, V95, P2390, DOI 10.1016/j.fertnstert.2011.03.022; Blandau RJ, 1939, AM J ANAT, V64, P303, DOI 10.1002/aja.1000640204; Blandau RJ, 1941, AM J ANAT, V68, P275, DOI 10.1002/aja.1000680206; BROWER PT, 1981, DEV BIOL, V86, P373, DOI 10.1016/0012-1606(81)90195-0; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; CHANG MC, 1952, FERTIL STERIL, V3, P251; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; CHI MMY, 1988, BIOL REPROD, V39, P295, DOI 10.1095/biolreprod39.2.295; Clarke HJ, 2012, POSTTRANSCRIPTIONAL; Dailey T, 1996, AM J HUM GENET, V59, P176; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; Demant M, 2012, HUM REPROD, V27, P1096, DOI 10.1093/humrep/der453; Fernandes R, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093583; GEBAUER F, 1994, EMBO J, V13, P5712, DOI 10.1002/j.1460-2075.1994.tb06909.x; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Hu Y, 2001, HUM REPROD, V16, P737, DOI 10.1093/humrep/16.4.737; Janicke A, 2012, RNA, V18, P1289, DOI 10.1261/rna.031898.111; Jones G, 2013, BIOL PATHOLOGY OOCYT; Jukic AMZ, 2011, HUM REPROD, V26, P920, DOI 10.1093/humrep/der009; Kang MK, 2011, BMB REP, V44, P147, DOI 10.5483/BMBRep.2011.44.3.147; Kim B, 2014, DEV BIOL, V386, P331, DOI 10.1016/j.ydbio.2013.12.025; Kosubek A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013532; LEIBFRIEDRUTLEDGE ML, 1987, BIOL REPROD, V36, P376, DOI 10.1095/biolreprod36.2.376; Leon V De, 1983, DEV BIOL; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Liang XW, 2008, BIOCHEM BIOPH RES CO, V371, P16, DOI 10.1016/j.bbrc.2008.03.105; Liu N, 2009, REPRODUCTION, V138, P223, DOI 10.1530/REP-09-0122; Ma WG, 2003, P NATL ACAD SCI USA, V100, P2963, DOI 10.1073/pnas.0530162100; MARSTON JH, 1964, J EXP ZOOL, V155, P237, DOI 10.1002/jez.1401550211; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Meyer E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000423; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Miao YL, 2005, BIOL REPROD, V73, P1025, DOI 10.1095/biolreprod.105.043703; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; PAYNTON BV, 1994, MOL REPROD DEV, V37, P172, DOI 10.1002/mrd.1080370208; PAYNTON BV, 1988, DEV BIOL, V129, P304, DOI 10.1016/0012-1606(88)90377-6; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Peng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030344; Pfluger E, 1882, ARCH GESAMMTE PHYSL; Qiao TW, 2008, MOL REPROD DEV, V75, P521, DOI 10.1002/mrd.20779; Sanchez F, 2009, MOL HUM REPROD, V15, P539, DOI 10.1093/molehr/gap051; Segers I, 2010, FERTIL STERIL, V93, P2695, DOI 10.1016/j.fertnstert.2009.11.035; SMITS LJ, 1995, MED HYPOTHESES, V45, P441, DOI 10.1016/0306-9877(95)90218-X; Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008; Tarin JJ, 1999, BIOL REPROD, V61, P1347, DOI 10.1095/biolreprod61.5.1347; Tarin JJ, 2002, BIOL REPROD, V66, P495, DOI 10.1095/biolreprod66.2.495; Tay J, 2003, GENE DEV, V17, P1457, DOI 10.1101/gad.1071403; Thelie A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-125; Tian X, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-202; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Trapphoff T, 2013, FERTIL STERIL, V100, P1758, DOI 10.1016/j.fertnstert.2013.08.021; Trapphoff T, 2010, HUM REPROD, V25, P3025, DOI 10.1093/humrep/deq278; Weill L, 2012, NAT STRUCT MOL BIOL, V19, P577, DOI 10.1038/nsmb.2311; Wigglesworth K, 2013, P NATL ACAD SCI USA, V110, pE3723, DOI 10.1073/pnas.1314829110; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; Young WC, 1936, SCIENCE, V84, P270; Zhang N, 2011, MOL REPROD DEV, V78, P684, DOI 10.1002/mrd.21366	65	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108907	10.1371/journal.pone.0108907	http://dx.doi.org/10.1371/journal.pone.0108907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271735	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600078
J	de Polo, A; Margiotta-Casaluci, L; Lockyer, AE; Scrimshaw, MD				de Polo, Anna; Margiotta-Casaluci, Luigi; Lockyer, Anne E.; Scrimshaw, Mark D.			A New Role for Carbonic Anhydrase 2 in the Response of Fish to Copper and Osmotic Stress: Implications for Multi-Stressor Studies	PLOS ONE			English	Article							RAINBOW-TROUT; IONIC REGULATION; SALMO-GAIRDNERI; CLIMATE-CHANGE; GULF TOADFISH; NA+/K+-ATPASE; TOXICITY; SALINITY; ACCUMULATION; GILLS	The majority of ecotoxicological studies are performed under stable and optimal conditions, whereas in reality the complexity of the natural environment faces organisms with multiple stressors of different type and origin, which can activate pathways of response often difficult to interpret. In particular, aquatic organisms living in estuarine zones already impacted by metal contamination can be exposed to more severe salinity variations under a forecasted scenario of global change. In this context, the present study aimed to investigate the effect of copper exposure on the response of fish to osmotic stress by mimicking in laboratory conditions the salinity changes occurring in natural estuaries. We hypothesized that copper-exposed individuals are more sensitive to osmotic stresses, as copper affects their osmoregulatory system by acting on a number of osmotic effector proteins, among which the isoform two of the enzyme carbonic anhydrase (CA2) was identified as a novel factor linking the physiological responses to both copper and osmotic stress. To test this hypothesis, two in vivo studies were performed using the euryhaline fish sheepshead minnow (Cyprinodon variegatus) as test species and applying different rates of salinity transition as a controlled way of dosing osmotic stress. Measured endpoints included plasma ions concentrations and gene expression of CA2 and the a1a-subunit of the enzyme Na+/K+ ATPase. Results showed that plasma ions concentrations changed after the salinity transition, but notably the magnitude of change was greater in the copper-exposed groups, suggesting a sensitizing effect of copper on the responses to osmotic stress. Gene expression results demonstrated that CA2 is affected by copper at the transcriptional level and that this enzyme might play a role in the observed combined effects of copper and osmotic stress on ion homeostasis.	[de Polo, Anna; Margiotta-Casaluci, Luigi; Lockyer, Anne E.; Scrimshaw, Mark D.] Brunel Univ, Inst Environm, London, England; [Margiotta-Casaluci, Luigi] AstraZeneca, Global Hlth Safety & Environm, Freshwater Quarry, Brixham, Devon, England	Brunel University; AstraZeneca	de Polo, A (corresponding author), Brunel Univ, Inst Environm, London, England.	annadp84@gmail.com	Lockyer, Anne/AAO-4327-2021; Margiotta-Casaluci, Luigi/A-5402-2011; Scrimshaw, Mark/A-2785-2015	Margiotta-Casaluci, Luigi/0000-0001-6938-0396; de Polo, Anna/0000-0002-5607-8048; Scrimshaw, Mark/0000-0001-9965-786X; Lockyer, Anne/0000-0002-3498-2423	Isambard Scholarship grant	Isambard Scholarship grant	The first author was the recipient of an Isambard Scholarship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemi JA, 2012, AQUAT TOXICOL, V109, P111, DOI 10.1016/j.aquatox.2011.12.005; Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; Arnold WR, 2010, ARCH ENVIRON CON TOX, V59, P225, DOI 10.1007/s00244-010-9467-8; Atkinson MJ, 1998, J AQUARICULTURE AQUA, V8, P39; Atli G, 2011, ECOTOXICOLOGY, V20, P1861, DOI 10.1007/s10646-011-0724-z; Blanchard J, 2005, ENVIRON TOXICOL CHEM, V24, P1403, DOI 10.1897/04-373R.1; Brooks Steven J., 2009, P413, DOI 10.1007/978-4-431-85709-9_24; Caldwell D, 2014, CHEMOSPHERE IN PRESS; de Polo A, 2012, ENVIRON TOXICOL CHEM, V31, P230, DOI 10.1002/etc.1705; Evans TG, 2010, J FISH BIOL, V76, P1903, DOI 10.1111/j.1095-8649.2010.02590.x; Grosell M, 2007, AQUAT TOXICOL, V84, P162, DOI 10.1016/j.aquatox.2007.03.026; Grosell M, 2004, AQUAT TOXICOL, V68, P263, DOI 10.1016/j.aquatox.2004.03.007; Grosell M, 2007, AM J PHYSIOL-REG I, V293, pR2099, DOI 10.1152/ajpregu.00156.2007; Grosell M, 2012, FISH PHYSIOL, V31A, P53, DOI 10.1016/S1546-5098(11)31002-3; Harrison MD, 1999, J BIOCHEM MOL TOXIC, V13, P93, DOI 10.1002/(SICI)1099-0461(1999)13:2<93::AID-JBT5>3.0.CO;2-3; Henry RP, 1996, ANNU REV PHYSIOL, V58, P523, DOI 10.1146/annurev.ph.58.030196.002515; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; Hooper MJ, 2013, ENVIRON TOXICOL CHEM, V32, P32, DOI 10.1002/etc.2043; IPPC, 2007, CLIM CHANG IMP AD VU; KTH Department of Sustainable Development Environmental Science and Engineering, 2010, VIS MINTEQ FREE EQ S; KULTZ D, 1992, COMP BIOCHEM PHYS B, V102, P293, DOI 10.1016/0305-0491(92)90125-B; LAUREN DJ, 1985, J COMP PHYSIOL B, V155, P635, DOI 10.1007/BF00694455; LAUREN DJ, 1987, CAN J FISH AQUAT SCI, V44, P105; Lee JA, 2010, AQUAT TOXICOL, V99, P65, DOI 10.1016/j.aquatox.2010.04.006; Leitao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068702; Lionetto MG, 2012, INT J ENV RES PUB HE, V9, P3965, DOI 10.3390/ijerph9113965; Lokke H, 2010, SCI TOTAL ENVIRON, V408, P3719, DOI 10.1016/j.scitotenv.2010.05.009; Lopes I, 2005, CHEMOSPHERE, V61, P1189, DOI 10.1016/j.chemosphere.2005.02.072; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; MILLER TG, 1980, WATER RES, V14, P129, DOI 10.1016/0043-1354(80)90228-6; Muller PY, 2002, PROCESSING GENE EXPR; Noyes PD, 2009, ENVIRON INT, V35, P971, DOI 10.1016/j.envint.2009.02.006; Richards JG, 2003, INTEGR COMP BIOL, V42, P1300; Rider CV, 2014, TOXICOL SCI, V137, P3, DOI 10.1093/toxsci/kft228; Sattin G, 2010, COMP BIOCHEM PHYS A, V156, P169, DOI 10.1016/j.cbpa.2010.01.018; Schiedek D, 2007, MAR POLLUT BULL, V54, P1845, DOI 10.1016/j.marpolbul.2007.09.020; Scott GR, 2005, J EXP BIOL, V208, P2719, DOI 10.1242/jeb.01688; Sheahan D, 2013, MCCIP SCI REV, V4, P1; Skaggs HS, 2002, COMP BIOCHEM PHYS C, V133, P605, DOI 10.1016/S1532-0456(02)00175-8; Soyut H, 2008, BIOL TRACE ELEM RES, V123, P179, DOI 10.1007/s12011-008-8108-9; STAGG RM, 1982, J COMP PHYSIOL, V149, P83, DOI 10.1007/BF00735718; Supuran CT, 2007, BIOORGAN MED CHEM, V15, P4336, DOI 10.1016/j.bmc.2007.04.020; Vitale AM, 1999, COMP BIOCHEM PHYS C, V122, P121, DOI 10.1016/S0742-8413(98)10094-4; Yeo R, 2013, ANAEST INTENS CARE M, V14, P296, DOI 10.1016/j.mpaic.2013.04.009	44	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e107707	10.1371/journal.pone.0107707	http://dx.doi.org/10.1371/journal.pone.0107707			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272015	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600017
J	Ryu, YK; Kang, JH; Moon, EY				Ryu, Yun-Kyoung; Kang, Joo-Hyun; Moon, Eun-Yi			The Actin-Sequestering Protein Thymosin Beta-4 Is a Novel Target of Hypoxia-Inducible Nitric Oxide and HIF-1 alpha Regulation	PLOS ONE			English	Article							CERVICAL TUMOR-CELLS; COLON-CANCER CELLS; PACLITAXEL-RESISTANCE; SYNTHASE GENE; CHROMOSOMAL LOCALIZATION; COLORECTAL-CARCINOMA; ACTIVATION; VEGF; ERK; OVEREXPRESSION	The actin-sequestering protein thymosin beta-4 (T beta 4) is involved in various cellular and physiological processes such as proliferation, motility, growth and metastasis. Nitric oxide (NO) promotes tumor invasiveness and metastasis by activating various enzymes. Herein, we investigated whether hypoxia-inducible NO regulates T beta 4 expression and cancer cell migration using HeLa cervical cancer cells. NO production and T beta 4 expression were increased in a hypoxic condition. The treatment with N-(beta-D-Glucopyranosyl)-N2-acetyl-S-nitroso-D, L-penicillaminamide (SNAP-1), to generate NO, enhanced the transcription of T beta 4 and cancer cell migration. SNAP-1-induced cell migration was decreased by the inhibition of T beta 4 with small interference (si) RNA. In a hypoxic condition, treatment with N-G-monomethyl-L-arginine (L-NMMA), nitric oxide synthase (NOS) inhibitor, reduced T beta 4 transcriptional activity, and hypoxia-inducible factor (HIF)-1 alpha. Hypoxia-induced cancer cell migration was also decreased by L-NMMA treatment. In a normoxic condition, T beta 4 transcriptional activity was decreased in the cells incubated in the presence of L-NMMA after co-transfection with T beta 4 promoter and GST-conjugated HIF-1 alpha. Collectively, these results suggest that NO could regulate the expression of T beta 4 by direct or indirect effect of HIF-1 alpha on T beta 4 promoter.	[Ryu, Yun-Kyoung; Moon, Eun-Yi] Sejong Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Kang, Joo-Hyun] Korea Inst Radiol & Med Sci, Mol Imaging Res Ctr, Seoul, South Korea	Sejong University; Korea Institute of Radiological & Medical Sciences	Moon, EY (corresponding author), Sejong Univ, Dept Biosci & Biotechnol, Seoul, South Korea.	eunyimoon@sejong.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST) [2013M2B2A9A03051296, 2010-0018545, 2012-R1A2A2A01005449]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported by Grants from Mid-career Researcher Program (#2012-R1A2A2A01005449), and Nuclear R&D Program (#2013M2B2A9A03051296 and 2010-0018545) through National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babykutty S, 2012, CLIN EXP METASTAS, V29, P471, DOI 10.1007/s10585-012-9464-6; Brakebusch C, 2005, CANCER METAST REV, V24, P403, DOI 10.1007/s10555-005-5132-5; Cha HJ, 2003, J NATL CANCER I, V95, P1674, DOI 10.1093/jnci/djg100; CHARTRAIN NA, 1994, J BIOL CHEM, V269, P6765; Gao N, 2004, MOL CELL BIOCHEM, V255, P33, DOI 10.1023/B:MCBI.0000007259.65742.16; GELLER DA, 1993, P NATL ACAD SCI USA, V90, P522, DOI 10.1073/pnas.90.2.522; GRILLON C, 1990, FEBS LETT, V274, P30, DOI 10.1016/0014-5793(90)81322-F; HALL AV, 1994, J BIOL CHEM, V269, P33082; Huang HC, 2007, ONCOGENE, V26, P2781, DOI 10.1038/sj.onc.1210078; Huff T, 2001, INT J BIOCHEM CELL B, V33, P205, DOI 10.1016/S1357-2725(00)00087-X; Hussain SP, 2008, CANCER RES, V68, P7130, DOI 10.1158/0008-5472.CAN-08-0410; Ido Y, 2001, MICROCIRCULATION, V8, P251, DOI 10.1038/sj.mn.7800079; Ignarro J. L. E., 2000, NITRIC OXIDE BIOL PA; Im YS, 2012, BIOMOL THER, V20, P165, DOI 10.4062/biomolther.2012.20.2.165; Kavya R, 2006, NITRIC OXIDE-BIOL CH, V15, P280, DOI 10.1016/j.niox.2006.07.003; Kosmidou I, 2001, AM J PHYSIOL-LUNG C, V280, pL585, DOI 10.1152/ajplung.2001.280.4.L585; LOW TLK, 1981, P NATL ACAD SCI-BIOL, V78, P1162, DOI 10.1073/pnas.78.2.1162; MARSDEN PA, 1993, J BIOL CHEM, V268, P17478; Maulik N, 2002, FREE RADICAL BIO MED, V33, P1047, DOI 10.1016/S0891-5849(02)01005-5; Michiels C, 2001, IUBMB LIFE, V52, P49, DOI 10.1080/15216540252774766; Minet E, 2001, FREE RADICAL BIO MED, V31, P847, DOI 10.1016/S0891-5849(01)00657-8; Moncada S, 2006, BRIT J PHARMACOL, V147, pS193, DOI 10.1038/sj.bjp.0706458; Moon EY, 2007, ONCOL RES, V16, P507, DOI 10.3727/096504007783438349; Moon EY, 2011, J IMMUNOTOXICOL, V8, P56, DOI 10.3109/1547691X.2010.543995; Moon EY, 2010, CLIN EXP METASTAS, V27, P601, DOI 10.1007/s10585-010-9350-z; Mottet D, 2003, J CELL PHYSIOL, V194, P30, DOI 10.1002/jcp.10176; Oh JM, 2008, CANCER LETT, V264, P29, DOI 10.1016/j.canlet.2008.01.004; Oh JM, 2010, LIFE SCI, V87, P286, DOI 10.1016/j.lfs.2010.07.002; Oh JM, 2010, BIOMOL THER, V18, P145, DOI 10.4062/biomolther.2010.18.2.145; Oh SY, 2006, EXP CELL RES, V312, P1651, DOI 10.1016/j.yexcr.2006.01.030; Oliveira CJR, 2003, FREE RADICAL BIO MED, V35, P381, DOI 10.1016/S0891-5849(03)00311-3; RIEGER KJ, 1993, BIOCHEM J, V296, P373, DOI 10.1042/bj2960373; Ryu YK, 2012, INT J CANCER, V131, P2067, DOI 10.1002/ijc.27490; SAFER D, 1991, J BIOL CHEM, V266, P4029; Sanuphan A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/186972; Sosne G, 2004, INVEST OPHTH VIS SCI, V45, P1095, DOI 10.1167/iovs.03-1002; Tejedo JR, 2004, ENDOCRINOLOGY, V145, P2319, DOI 10.1210/en.2003-1489; Wang WS, 2004, ONCOGENE, V23, P6666, DOI 10.1038/sj.onc.1207888; Wang WS, 2003, ONCOGENE, V22, P3297, DOI 10.1038/sj.onc.1206404; Wink DA, 1998, CARCINOGENESIS, V19, P711, DOI 10.1093/carcin/19.5.711; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133; Yasuda H, 2008, NITRIC OXIDE-BIOL CH, V19, P205, DOI 10.1016/j.niox.2008.04.026; Zhou Q, 2007, CARCINOGENESIS, V28, P28, DOI 10.1093/carcin/bgl085	44	0	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e106532	10.1371/journal.pone.0106532	http://dx.doi.org/10.1371/journal.pone.0106532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271630	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600005
J	Zhang, XY; Tang, GL; Xu, XY; Nong, XH; Qi, SH				Zhang, Xiao-yong; Tang, Gui-ling; Xu, Xin-ya; Nong, Xu-hua; Qi, Shu-Hua			Insights into Deep-Sea Sediment Fungal Communities from the East Indian Ocean Using Targeted Environmental Sequencing Combined with Traditional Cultivation	PLOS ONE			English	Article							CULTURABLE FUNGI; PHYLOGENETIC DIVERSITY; FILAMENTOUS FUNGI; GENE-EXPRESSION; YEASTS; ECTOMYCORRHIZAL; REVISION; REGIONS	The fungal diversity in deep-sea environments has recently gained an increasing amount attention. Our knowledge and understanding of the true fungal diversity and the role it plays in deep-sea environments, however, is still limited. We investigated the fungal community structure in five sediments from a depth of,4000 m in the East India Ocean using a combination of targeted environmental sequencing and traditional cultivation. This approach resulted in the recovery of a total of 45 fungal operational taxonomic units (OTUs) and 20 culturable fungal phylotypes. This finding indicates that there is a great amount of fungal diversity in the deep-sea sediments collected in the East Indian Ocean. Three fungal OTUs and one culturable phylotype demonstrated high divergence (89%-97%) from the existing sequences in the GenBank. Moreover, 44.4% fungal OTUs and 30% culturable fungal phylotypes are new reports for deep-sea sediments. These results suggest that the deep-sea sediments from the East India Ocean can serve as habitats for new fungal communities compared with other deep-sea environments. In addition, different fungal community could be detected when using targeted environmental sequencing compared with traditional cultivation in this study, which suggests that a combination of targeted environmental sequencing and traditional cultivation will generate a more diverse fungal community in deep-sea environments than using either targeted environmental sequencing or traditional cultivation alone. This study is the first to report new insights into the fungal communities in deep-sea sediments from the East Indian Ocean, which increases our knowledge and understanding of the fungal diversity in deep-sea environments.	[Zhang, Xiao-yong; Tang, Gui-ling; Xu, Xin-ya; Nong, Xu-hua; Qi, Shu-Hua] Chinese Acad Sci, South China Sea Inst Oceanol, Guangdong Key Lab Marine Mat Med, Key Lab Trop Marine Bioresources & Ecol,RNAM Ctr, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Qi, SH (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Guangdong Key Lab Marine Mat Med, Key Lab Trop Marine Bioresources & Ecol,RNAM Ctr, Guangzhou, Guangdong, Peoples R China.	shuhuaqi@scsio.ac.cn			National Basic Research Program of China [2010CB833803]; National High Technology Research and Development Program of China (863 Program) [2012AA092104]; Natural Science Foundation of China [41206139, 41376160]; regional innovation demonstration project of Guangdong Province marine economic development [GD2012-D01-002]; National Marine Public Welfare Research Project of China [201305017]; National Key Technologies RD Program [2011BAE06B04-03]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); regional innovation demonstration project of Guangdong Province marine economic development; National Marine Public Welfare Research Project of China; National Key Technologies RD Program(National Key Technology R&D Program)	The authors are grateful for the financial support provided by the National Basic Research Program of China (2010CB833803), National High Technology Research and Development Program of China (863 Program, 2012AA092104), Natural Science Foundation of China (41206139, 41376160), regional innovation demonstration project of Guangdong Province marine economic development (GD2012-D01-002), National Marine Public Welfare Research Project of China (201305017) and National Key Technologies R&D Program (2011BAE06B04-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2010, SOIL BIOL BIOCHEM, V42, P1872, DOI 10.1016/j.soilbio.2010.07.011; Anderson IC, 2004, ENVIRON MICROBIOL, V6, P769, DOI 10.1111/j.1462-2920.2004.00675.x; BAROSS JA, 1975, APPL MICROBIOL, V30, P309, DOI 10.1128/AEM.30.2.309-318.1975; Bass D, 2007, P ROY SOC B-BIOL SCI, V274, P3069, DOI 10.1098/rspb.2007.1067; Bates ST, 2009, ENVIRON MICROBIOL, V11, P56, DOI 10.1111/j.1462-2920.2008.01738.x; Bhadury P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026445; BILLS GF, 1994, MYCOLOGIA, V86, P187, DOI 10.2307/3760635; Buchan A, 2002, MICROB ECOL, V43, P329, DOI 10.1007/s00248-001-1062-0; Burgaud G, 2010, FEMS MICROBIOL ECOL, V73, P121, DOI 10.1111/j.1574-6941.2010.00881.x; Burgaud G, 2009, ENVIRON MICROBIOL, V11, P1588, DOI 10.1111/j.1462-2920.2009.01886.x; Damare S, 2006, DEEP-SEA RES PT I, V53, P14, DOI 10.1016/j.dsr.2005.09.005; Damare S, 2008, MICROB ECOL, V56, P168, DOI 10.1007/s00248-007-9334-y; DEARAUJO FV, 1995, ANTON LEEUW INT J G, V68, P91, DOI 10.1007/BF00873096; DeLong EE, 2001, SYST BIOL, V50, P470, DOI 10.1080/106351501750435040; Edgcomb VP, 2011, ENVIRON MICROBIOL, V13, P172, DOI 10.1111/j.1462-2920.2010.02318.x; Gadanho M, 2005, MICROB ECOL, V50, P408, DOI 10.1007/s00248-005-0195-y; Gorfer M, 2011, ISME J, V5, P1771, DOI 10.1038/ismej.2011.53; Green LE, 2008, J ECOL, V96, P1076, DOI 10.1111/j.1365-2745.2008.01388.x; Jebaraj CS, 2010, FEMS MICROBIOL ECOL, V71, P399, DOI 10.1111/j.1574-6941.2009.00804.x; Jones MD, 2012, APPL SOIL ECOL, V60, P29, DOI 10.1016/j.apsoil.2012.01.010; Lai XT, 2007, ISME J, V1, P756, DOI 10.1038/ismej.2007.51; Lara E, 2010, PROTIST, V161, P116, DOI 10.1016/j.protis.2009.06.005; Le Calvez T, 2009, APPL ENVIRON MICROB, V75, P6415, DOI 10.1128/AEM.00653-09; Lee SH, 2011, MICROB ECOL, V61, P646, DOI 10.1007/s00248-010-9776-5; Liu T, 2011, NAT PROD RES, V25, P1596, DOI 10.1080/14786419.2010.490916; Liu WC, 2010, FUNGAL DIVERS, V42, P1, DOI 10.1007/s13225-010-0022-8; Luna GM, 2009, CURR MICROBIOL, V59, P356, DOI 10.1007/s00284-009-9445-4; Nagahama T, 2001, ANTON LEEUW INT J G, V80, P101, DOI 10.1023/A:1012270503751; Nagahama Takahiko, 2012, Prog Mol Subcell Biol, V53, P173, DOI 10.1007/978-3-642-23342-5_9; Nagahama T, 2011, ENVIRON MICROBIOL, V13, P2359, DOI 10.1111/j.1462-2920.2011.02507.x; Nagano Y, 2012, FUNGAL ECOL, V5, P463, DOI 10.1016/j.funeco.2012.01.004; Nagano Y, 2010, FUNGAL ECOL, V3, P316, DOI 10.1016/j.funeco.2010.01.002; Orsi W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056335; Orsi WD, 2013, NATURE, V499, P205, DOI 10.1038/nature12230; Pang KL, 2005, BOT MAR, V48, P332, DOI 10.1515/BOT.2005.046; Pivkin MV, 2000, BIOL BULL-US, V198, P101, DOI 10.2307/1542808; Raghlukumar C, 2004, DEEP-SEA RES PT I, V51, P1759, DOI 10.1016/j.dsr.2004.08.002; Raghukumar C, 1998, AQUAT MICROB ECOL, V15, P153, DOI 10.3354/ame015153; Rao S, 2013, CURR MICROBIOL, V66, P185, DOI 10.1007/s00284-012-0256-7; ROTH F. J., 1964, CANADIAN JOUR BOT, V42, P375; Sakayaroj J, 2010, FUNGAL DIVERS, V42, P27, DOI 10.1007/s13225-009-0013-9; Singh P, 2012, WORLD J MICROB BIOT, V28, P659, DOI 10.1007/s11274-011-0859-3; Singh P, 2011, MICROB ECOL, V61, P507, DOI 10.1007/s00248-010-9765-8; Singh P, 2010, FUNGAL DIVERS, V40, P89, DOI 10.1007/s13225-009-0009-5; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P5656, DOI 10.1128/AEM.69.9.5656-5663.2003; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P2657, DOI 10.1128/AEM.69.5.2657-2663.2003; Takami H, 1997, FEMS MICROBIOL LETT, V152, P279, DOI 10.1016/S0378-1097(97)00211-5; Takishita K, 2006, EXTREMOPHILES, V10, P165, DOI 10.1007/s00792-005-0495-7; Thaler AD, 2012, FUNGAL ECOL, V5, P270, DOI 10.1016/j.funeco.2011.07.002; Toledo-Hernandez C, 2008, CORAL REEFS, V27, P707, DOI 10.1007/s00338-008-0387-2; Urban A, 2008, MYCORRHIZA, V18, P339, DOI 10.1007/s00572-008-0189-y; Waldrop MP, 2006, ECOL LETT, V9, P1127, DOI 10.1111/j.1461-0248.2006.00965.x; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019039; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zare R, 2001, NOVA HEDWIGIA, V73, P1; Zare R, 2008, MYCOL RES, V112, P811, DOI 10.1016/j.mycres.2008.01.019; Zhang XY, 2014, J IND MICROBIOL BIOT, V41, P741, DOI 10.1007/s10295-014-1412-9; Zhang XY, 2013, CURR MICROBIOL, V67, P525, DOI 10.1007/s00284-013-0394-6; Zhao D, 2013, BIOCONTROL SCI TECHN, V23, P980, DOI 10.1080/09583157.2013.809514	61	69	73	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109118	10.1371/journal.pone.0109118	http://dx.doi.org/10.1371/journal.pone.0109118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272044	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600098
J	Wei, JN; Hansen, A; Zhang, Y; Li, H; Liu, QY; Sun, YH; Xue, SL; Zhao, SF; Bi, P				Wei, Junni; Hansen, Alana; Zhang, Ying; Li, Hong; Liu, Qiyong; Sun, Yehuan; Xue, Shulian; Zhao, Shufang; Bi, Peng			The Impact of Climate Change on Infectious Disease Transmission: Perceptions of CDC Health Professionals in Shanxi Province, China	PLOS ONE			English	Article							MORTALITY; VULNERABILITIES; ADAPTATION; RISKS	There have been increasing concerns about the challenge of emerging and re-emerging infectious diseases due to climate change, especially in developing countries including China. Health professionals play a significant role in the battle to control and prevent infectious diseases. This study therefore aims to investigate the perceptions and attitudes of health professionals at the Centers for Disease Control and Prevention (CDC) in different levels in China, and to consider adaptation measures to deal with the challenge of climate change. In 2013, a cross-sectional questionnaire survey was undertaken among 314 staff in CDCs in Shanxi Province, China, whose routine work involves disease control and prevention. Data were analyzed using descriptive methods and logistic regression. A majority of the CDC staff were aware of the health risks from climate change, especially its impacts on infectious disease transmission in their jurisdictions, and believed climate change might bring about both temporal and spatial change in transmission patterns. It was thought that adaptation measures should be established including: strengthening/improving currently existing disease surveillance systems and vector monitoring; building CDC capacity in terms of infrastructure and in-house health professional training; development and refinement of relevant legislation, policies and guidelines; better coordination among various government departments; the involvement of the community in infectious disease interventions; and collaborative research with other institutions. This study provides a snapshot of the understanding of CDC staff regarding climate change risks relevant to infectious diseases and adaptation in China. Results may help inform future efforts to develop adaptation measures to minimize infectious disease risks due to climate change.	[Wei, Junni; Xue, Shulian; Zhao, Shufang] Shanxi Med Univ, Dept Epidemiol, Sch Publ Hlth, Taiyuan, Shanxi, Peoples R China; [Hansen, Alana; Bi, Peng] Univ Adelaide, Discipline Publ Hlth, Sch Populat Hlth, Adelaide, SA, Australia; [Zhang, Ying] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Li, Hong] Shanxi Ctr Dis Control & Prevent, Taiyuan, Shanxi, Peoples R China; [Liu, Qiyong] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Liu, Qiyong] Shandong Univ, Climate Change & Hlth Ctr, Jinan, Shandong, Peoples R China; [Sun, Yehuan] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China	Shanxi Medical University; University of Adelaide; University of Sydney; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Shandong University; Anhui Medical University	Wei, JN (corresponding author), Shanxi Med Univ, Dept Epidemiol, Sch Publ Hlth, Taiyuan, Shanxi, Peoples R China.	junxinni@163.com; peng.bi@adelaide.edu.au	Zhang, Ying/ABE-2275-2021	Zhang, Ying/0000-0001-6214-2440; Bi, Peng/0000-0002-3238-3427				Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; Bai L, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-10; Balbus JM, 2009, J OCCUP ENVIRON MED, V51, P33, DOI 10.1097/JOM.0b013e318193e12e; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Bernstein AS, 2011, CURR OPIN PEDIATR, V23, P221, DOI 10.1097/MOP.0b013e3283444c89; Bowen KJ, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.21820; Cubasch U., 2013, CLIMATE CHANGE 2013; Ebi KL, 2013, CLIMATIC CHANGE, V118, P355, DOI 10.1007/s10584-012-0648-5; Forsberg B, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-S1-S4; Guo YM, 2013, HEART, V99, P195, DOI 10.1136/heartjnl-2012-302518; IPCC, 2012, MAN RISKS EXTR EV DI; IPCC, 2014, HUM HLTH IMP AD COB; Iyer Veena, 2014, Emerg Health Threats J, V7, P22838, DOI 10.3402/ehtj.v7.22838; Khanjani N, 2013, IRAN J ENVIRON HEALT, V10, DOI 10.1186/1735-2746-10-11; Luber G, 2008, AM J PREV MED, V35, P429, DOI 10.1016/j.amepre.2008.08.021; Mathee A, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5612; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Moors E, 2013, SCI TOTAL ENV; NDRC, 2007, NAT DEV REF COMM CHI; NDRC, 2013, NAT DEV REF COMM CHI; NDRC, 2012, NAT DEV REF COMM CHI; Panic M, 2013, INT J ENV RES PUB HE, V10, P7083, DOI 10.3390/ijerph10127083; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Rosenthal JK, 2007, ANN ACAD MED SINGAP, V36, P834; Semenza JC, 2012, ENVIRON HEALTH PERSP, V120, P385, DOI 10.1289/ehp.1103805; Sheffield PE, 2011, ENVIRON HEALTH PERSP, V119, P291, DOI 10.1289/ehp.1002233; Shuman EK, 2011, INT J OCCUP ENV MED, V2, P11; Suk JE, 2014, INT J ENV RES PUB HE, V11, P2218, DOI 10.3390/ijerph110202218; Suk JE, 2011, AM J PUBLIC HEALTH, V101, P2068, DOI 10.2105/AJPH.2011.300181; Wiley LF, 2010, J LAW MED ETHICS, V38, P629, DOI 10.1111/j.1748-720X.2010.00516.x; Wu F, 2011, VECTOR-BORNE ZOONOT, V11, P1181, DOI 10.1089/vbz.2010.0032; Xu WS, 2013, ENVIRON POLLUT, V178, P288, DOI 10.1016/j.envpol.2013.03.020; Zhang Y, 2010, ENVIRON INT, V36, P439, DOI 10.1016/j.envint.2010.03.005	33	19	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109476	10.1371/journal.pone.0109476	http://dx.doi.org/10.1371/journal.pone.0109476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285440	gold, Green Published, Green Submitted			2022-12-27	WOS:000345743700067
J	Lee, YL; Hu, HY; Yang, NP; Chou, P; Chu, DC				Lee, Ya-Ling; Hu, Hsiao-Yun; Yang, Nan-Ping; Chou, Pesus; Chu, Dachen			Dental Prophylaxis Decreases the Risk of Esophageal Cancer in Males; A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; OF-THE-LITERATURE; PERIODONTAL-DISEASE; CARDIOVASCULAR-DISEASE; TOOTH LOSS; EUROPEAN WORKSHOP; GASTRIC CANCERS; ORAL-HEALTH; INFLAMMATION; COHORT	Background: Periodontal disease (PD) is one of the most common chronic inflammatory diseases. Esophageal cancer (EC) is also a common cause of death due to cancer among males. Systemic inflammatory processes have been shown to increase the risk of cancer. We conducted a retrospective cohort study to investigate the association between PD and EC. Methods: A total of 718,409 subjects were recruited from the Taiwan National Health Insurance Research Database (NHIRD) and followed from January 1, 2000 to December 31, 2010. Of these, 519,831 subjects were diagnosed with PD and were grouped according to the most advanced treatment they received: dental prophylaxis, intensive treatment, or no treatment. The IRs of EC were compared among groups. Results: A total of 682 patients developed EC, resulting in an overall IR of 0.11 case-number per 1000 person-years (parts per thousand/y). The dental prophylaxis group had a significantly lower IR of EC (0.06 parts per thousand/y) than other groups (p < 0.001). Multivariable Cox regression analysis further revealed that male subjects [hazard ratio (HR) = 10.04, 95% confidence interval (CI) = 7.58-13.30], as well as a history of esophageal ulcers (HR = 7.10, 95% CI = 5.03-10.01), alcohol abuse (HR = 5.46, 95% CI = 2.26-13.18), or esophageal reflux (HR = 1.86, 95% CI = 1.02-3.52), were factors associated with a higher risk of EC. And the dental prophylaxis group showed a significantly lower risk for EC (HR = 0.53, 95% CI = 0.44-0.65). Further subgroup analysis showed that the dental prophylaxis group among males had a significant lower risk (HR = 0.54, 95% CI = 0.44-0.66) for EC, while that of the females did not has statistically significant difference. Conclusion: For this cohort, subjects received dental prophylaxis reduced the risk of EC compared to all PD and no PD groups among males.	[Lee, Ya-Ling] Taipei City Hosp, Dept Dent, Taipei, Taiwan; [Lee, Ya-Ling; Hu, Hsiao-Yun; Yang, Nan-Ping; Chou, Pesus; Chu, Dachen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Ya-Ling; Hu, Hsiao-Yun; Yang, Nan-Ping; Chou, Pesus; Chu, Dachen] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Chu, Dachen] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan; [Chu, Dachen] Taipei City Hosp, Dept Neurosurg, Taipei, Taiwan; [Hu, Hsiao-Yun] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Yang, Nan-Ping] Keelung Hosp, Dept Educ & Res, Minist Hlth & Welf, Keelung, Taiwan	Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taipei University of Nursing & Health Science (NTUNHS); Taipei City Hospital; Taipei City Hospital	Chu, DC (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	DAD57@tpech.gov.tw						Abdel-Latif MMM, 2009, CURR OPIN PHARMACOL, V9, P396, DOI 10.1016/j.coph.2009.06.010; Abnet CC, 2005, SCAND J GASTROENTERO, V40, P681, DOI 10.1080/00365520510015430; Abnet CC, 2001, CANCER CAUSE CONTROL, V12, P847, DOI 10.1023/A:1012290009545; Abnet CC, 2008, CANCER EPIDEM BIOMAR, V17, P3062, DOI 10.1158/1055-9965.EPI-08-0558; Albandar JM, 2011, J PERIODONTOL, V82, P337, DOI 10.1902/jop.2011.100638; Albandar JM, 2002, PERIODONTOL 2000, V29, P7, DOI 10.1034/j.1600-0757.2002.290101.x; Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; Baan R, 2007, LANCET ONCOL, V8, P292, DOI 10.1016/S1470-2045(07)70099-2; Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; Becker C, 2013, CANCER CAUSE CONTROL, V24, P1763, DOI 10.1007/s10552-013-0253-6; Cheng KC, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-177; Chung CS, 2010, J FORMOS MED ASSOC, V109, P408, DOI 10.1016/S0929-6646(10)60072-1; D'Aiuto F, 2004, J DENT RES, V83, P156, DOI 10.1177/154405910408300214; de Oliveira C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2451; Dietrich T, 2008, CIRCULATION, V117, P1668, DOI 10.1161/CIRCULATIONAHA.107.711507; Dye B.A., 2007, VITAL HLTH STAT, V11, P1; Fitzpatrick SG, 2010, J DENT, V38, P83, DOI 10.1016/j.jdent.2009.10.007; Guha N, 2007, AM J EPIDEMIOL, V166, P1159, DOI 10.1093/aje/kwm193; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Ishiguro S, 2009, CANCER LETT, V275, P240, DOI 10.1016/j.canlet.2008.10.020; Islami F, 2009, EUR J CANCER, V45, P3156, DOI 10.1016/j.ejca.2009.09.018; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Joshipura KJ, 2004, J DENT RES, V83, P151, DOI 10.1177/154405910408300213; Kinane D, 2008, J CLIN PERIODONTOL, V35, P333, DOI 10.1111/j.1600-051X.2008.01278.x; Klein JP, 2003, SURVIVAL ANAL TECHNI, P329; Lambert R, 2007, BEST PRACT RES CL GA, V21, P921, DOI 10.1016/j.bpg.2007.10.001; Lee YL, 2013, STROKE, V44, P1026, DOI 10.1161/STROKEAHA.111.000076; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Loos BG, 2005, J PERIODONTOL, V76, P2106, DOI 10.1902/jop.2005.76.11-S.2106; Lowe G D, 2001, Ann Periodontol, V6, P1, DOI 10.1902/annals.2001.6.1.1; Mao WM, 2011, ASIAN PAC J CANCER P, V12, P2461; Michaud DS, 2008, LANCET ONCOL, V9, P550, DOI 10.1016/S1470-2045(08)70106-2; National Department of Health, 1972, CANC REG ANN REP; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Petersen PE, 2005, J PERIODONTOL, V76, P2187, DOI 10.1902/jop.2005.76.12.2187; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pischon N, 2007, J PERIODONTOL, V78, P683, DOI 10.1902/jop.2007.060286; Poehlmann A, 2012, PATHOL RES PRACT, V208, P269, DOI 10.1016/j.prp.2012.03.007; Sanz M, 2010, EUR HEART J SUPPL, V12, pB3, DOI 10.1093/eurheartj/suq003; Sepehr A, 2005, ANTICANCER RES, V25, P543; Stata Corporation, 2011, STAT SURV AN EP TABL, P64; Tezal M, 2007, ARCH OTOLARYNGOL, V133, P450, DOI 10.1001/archotol.133.5.450; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Ward SG, 2009, CURR OPIN PHARMACOL, V9, P677, DOI 10.1016/j.coph.2009.10.005	46	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109444	10.1371/journal.pone.0109444	http://dx.doi.org/10.1371/journal.pone.0109444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279666	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800083
J	Rai, S; Tanaka, H; Suzuki, M; Ogoh, H; Taniguchi, Y; Morita, Y; Shimada, T; Tanimura, A; Matsui, K; Yokota, T; Oritani, K; Tanabe, K; Watanabe, T; Kanakura, Y; Matsumura, I				Rai, Shinya; Tanaka, Hirokazu; Suzuki, Mai; Ogoh, Honami; Taniguchi, Yasuhiro; Morita, Yasuyoshi; Shimada, Takahiro; Tanimura, Akira; Matsui, Keiko; Yokota, Takafumi; Oritani, Kenji; Tanabe, Kenji; Watanabe, Toshio; Kanakura, Yuzuru; Matsumura, Itaru			Clathrin Assembly Protein CALM Plays a Critical Role in KIT Signaling by Regulating Its Cellular Transport from Early to Late Endosomes in Hematopoietic Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; RECEPTOR TYROSINE KINASES; C-KIT; MEDIATED ENDOCYTOSIS; COATED PITS; STEM-CELL; SPATIAL REGULATION; MICE; INTERNALIZATION; MUTATIONS	CALM is implicated in the formation of clathrin-coated vesicles, which mediate endocytosis and intracellular trafficking of growth factor receptors and nutrients. We previously found that CALM-deficient mice suffer from severe anemia due to the impaired clathrin-mediated endocytosis of transferrin receptor in immature erythroblast. However, CALM has been supposed to regulate the growth and survival of hematopoietic stem/progenitor cells. So, in this study, we focused on the function of CALM in these cells. We here show that the number of Linage(-)Sca-1(+)KIT(+) (LSK) cells decreased in the fetal liver of CALM(-/-) mice. Also, colony forming activity was impaired in CALM(-/-) LSK cells. In addition, SCF, FLT3, and TPO-dependent growth was severely impaired in CALM(-/-) LSK cells, while they can normally proliferate in response to IL-3 and IL-6. We also examined the intracellular trafficking of KIT using CALM(-/-) murine embryonic fibroblasts (MEFs) engineered to express KIT. At first, we confirmed that endocytosis of SCF-bound KIT was not impaired in CALM(-/-) MEFs by the internalization assay. However, SCF-induced KIT trafficking from early to late endosome was severely impaired in CALM(-/-) MEFs. As a result, although intracellular KIT disappeared 30 min after SCF stimulation in wild-type (WT) MEFs, it was retained in CALM(-/-) MEFs. Furthermore, SCF-induced phosphorylation of cytosolic KIT was enhanced and prolonged in CALM(-/-) MEFs compared with that in WT MEFs, leading to the excessive activation of Akt. Similar hyperactivation of Akt was observed in CALM(-/-) KIT+ cells. These results indicate that CALM is essential for the intracellular trafficking of KIT and its normal functions. Also, our data demonstrate that KIT located in the early endosome can activate downstream molecules as a signaling endosome. Because KIT activation is involved in the pathogenesis of some malignancies, the manipulation of CALM function would be an attractive therapeutic strategy.	[Rai, Shinya; Tanaka, Hirokazu; Taniguchi, Yasuhiro; Morita, Yasuyoshi; Shimada, Takahiro; Matsumura, Itaru] Kinki Univ, Fac Med, Dept Hematol & Rheumatol, Osaka, Japan; [Suzuki, Mai] Natl Canc Ctr, Div Hematol Malignancy, Tokyo, Japan; [Tanimura, Akira; Matsui, Keiko; Yokota, Takafumi; Oritani, Kenji; Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Osaka, Japan; [Tanabe, Kenji] Tokyo Womens Med Univ, Med Res Inst, Tokyo, Japan; [Suzuki, Mai; Ogoh, Honami; Watanabe, Toshio] Nara Womens Univ, Grad Sch Humanities & Sci, Dept Biol Sci, Nara 630, Japan	Kindai University (Kinki University); National Cancer Center - Japan; Osaka University; Tokyo Women's Medical University; Nara Womens University	Tanaka, H (corresponding author), Kinki Univ, Fac Med, Dept Hematol & Rheumatol, Osaka, Japan.	htanaka@med.kindai.ac.jp		Tanabe, Kenji/0000-0003-2645-9429; Tanimura, Akira/0000-0002-2039-5543; taniguchi, yasuhiro/0000-0003-0754-7415	Japan Society for the Promotion of Science [25461439, 25130712]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid for Scientific Research (C) (25461439) and Grant-in-Aid for Scientific Research on Innovative Areas (25130712) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (http://kaken.nii.ac.jp/).	Al-Mawali Adhra, 2013, Oman Med J, V28, P432, DOI 10.5001/omj.2013.121; Buitenhuis M, 2009, CELL CYCLE, V8, P560, DOI 10.4161/cc.8.4.7654; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Caudell D, 2008, LEUKEMIA, V22, P678, DOI 10.1038/sj.leu.2405074; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Dobrowolski R, 2012, NAT REV MOL CELL BIO, V13, P53, DOI 10.1038/nrm3244; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Essers MAG, 2010, MOL ONCOL, V4, P443, DOI 10.1016/j.molonc.2010.06.001; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gillooly DJ, 2001, SCIENCE, V291, P993, DOI 10.1126/science.291.5506.993; Godlee C, 2013, J CELL BIOL, V203, P717, DOI 10.1083/jcb.201307100; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Gommerman JL, 1997, J BIOL CHEM, V272, P30519, DOI 10.1074/jbc.272.48.30519; Graveel CR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009209; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Hom RA, 2007, J MOL BIOL, V373, P412, DOI 10.1016/j.jmb.2007.08.016; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Jahn T, 2002, ONCOGENE, V21, P4508, DOI 10.1038/sj.onc.1205559; Jahn T, 2007, BLOOD, V110, P1739, DOI 10.1182/blood-2006-05-020925; Jordan CT, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000914; Kandachar V, 2012, CURR OPIN CELL BIOL, V24, P534, DOI 10.1016/j.ceb.2012.06.006; Kazazic M, 2009, TRAFFIC, V10, P235, DOI 10.1111/j.1600-0854.2008.00858.x; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Kiyoi H, 2006, INT J HEMATOL, V83, P301, DOI 10.1532/IJH97.06071; Klebig ML, 2003, P NATL ACAD SCI USA, V100, P8360, DOI 10.1073/pnas.1432634100; Kon S, 2013, J CLIN INVEST, V123, P1123, DOI 10.1172/JCI63711; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Legendre-Guillemin V, 2004, J CELL SCI, V117, P9, DOI 10.1242/jcs.00928; Martelli AM, 2011, LEUKEMIA, V25, P1064, DOI 10.1038/leu.2011.46; Matsumura I, 2008, CANCER SCI, V99, P479, DOI 10.1111/j.1349-7006.2007.00717.x; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Miaczynska M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009035; Miller SE, 2011, CELL, V147, P1118, DOI 10.1016/j.cell.2011.10.038; Nakayama M, 2013, NAT CELL BIOL, V15, P249, DOI 10.1038/ncb2679; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Okada Y, 2006, NAT CELL BIOL, V8, P1017, DOI 10.1038/ncb1464; Paschka P, 2008, SEMIN ONCOL, V35, P410, DOI 10.1053/j.seminoncol.2008.04.011; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Polak R, 2012, BLOOD, V119, P911, DOI 10.1182/blood-2011-07-366203; Potter MD, 1997, BLOOD, V90, P1850, DOI 10.1182/blood.V90.5.1850; Pratcorona M, 2013, BLOOD, V121, P2734, DOI 10.1182/blood-2012-06-431122; Rengarajan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086373; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schnittger S, 2006, BLOOD, V107, P1791, DOI 10.1182/blood-2005-04-1466; Shimizu YJ, 1996, J IMMUNOL, V156, P3443; Sun J, 2007, EXP CELL RES, V313, P3935, DOI 10.1016/j.yexcr.2007.08.021; Suzuki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031854; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Wang YY, 2011, P NATL ACAD SCI USA, V108, P2450, DOI 10.1073/pnas.1019625108; Windler SL, 2010, CURR BIOL, V20, P538, DOI 10.1016/j.cub.2010.01.049; Xiang ZF, 2007, MOL CELL BIOL, V27, P267, DOI 10.1128/MCB.01153-06; Zhao L, 2012, BLOOD, V119, P1511, DOI 10.1182/blood-2011-02-338210	58	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109441	10.1371/journal.pone.0109441	http://dx.doi.org/10.1371/journal.pone.0109441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279552	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800082
J	Del-Monte, J; Raffard, S; Capdevielle, D; Salesse, RN; Schmidt, RC; Varlet, M; Bardy, BG; Boulenger, JP; Gely-Nargeot, MC; Marin, L				Del-Monte, Jonathan; Raffard, Stephane; Capdevielle, Delphine; Salesse, Robin N.; Schmidt, Richard C.; Varlet, Manuel; Bardy, Benoit G.; Boulenger, Jean-Philippe; Gely-Nargeot, Marie-Christine; Marin, Ludovic			Social Priming Increases Nonverbal Expressive Behaviors in Schizophrenia	PLOS ONE			English	Article							COGNITIVE REMEDIATION THERAPY; NEGATIVE SYMPTOMS; SCALE	Semantic priming tasks are classically used to influence and implicitly promote target behaviors. Recently, several studies have demonstrated that prosocial semantic priming modulated feelings of social affiliation. The main aim of this study was to determine whether inducing feelings of social affiliation using priming tasks could modulate nonverbal social behaviors in schizophrenia. We used the Scrambled Sentence Task to prime schizophrenia patients according to three priming group conditions: pro-social, non-social or anti-social. Forty-five schizophrenia patients, diagnosed according to DSM-IV-TR, were randomly assigned to one of the three priming groups of 15 participants. We evaluated nonverbal social behaviors using the Motor-Affective subscale of the Motor-Affective-Social-Scale. Results showed that schizophrenia patients with pro-social priming had significantly more nonverbal behaviors than schizophrenia patients with anti-social and non-social priming conditions. Schizophrenia patient behaviors are affected by social priming. Our results have several clinical implications for the rehabilitation of social skills impairments frequently encountered among individuals with schizophrenia.	[Del-Monte, Jonathan; Salesse, Robin N.; Varlet, Manuel; Bardy, Benoit G.; Marin, Ludovic] Univ Montpellier I, Movement Hlth Lab, Montpellier, France; [Del-Monte, Jonathan; Raffard, Stephane; Capdevielle, Delphine; Boulenger, Jean-Philippe] Univ Montpellier I, CHU Montpellier, Hop Colombiere, Univ Dept Adult Psychiat, Montpellier, France; [Del-Monte, Jonathan; Raffard, Stephane; Gely-Nargeot, Marie-Christine] Univ Montpellier, Dept Sport Sci Psychol & Med, Lab Dynam Human Abil & Hlth Behav, Epsylon, F-34059 Montpellier, France; [Schmidt, Richard C.] Coll Holy Cross, Dept Psychol, Worcester, MA 01610 USA; [Capdevielle, Delphine; Boulenger, Jean-Philippe] INSERM, U1061, Montpellier, France; [Bardy, Benoit G.] Inst Univ France, Paris, France; [Varlet, Manuel] Univ Western Sydney, MARCS Inst, Sydney, NSW, Australia	Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; College of the Holy Cross; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut Universitaire de France; Western Sydney University	Del-Monte, J (corresponding author), Univ Montpellier I, Movement Hlth Lab, Montpellier, France.	delmontejonathan@gmail.com	Raffard, Stéphane/K-9822-2013; Del-Monte, Jonathan/P-3664-2019; Bardy, Benoît/AAU-3078-2021; Raffard, Stephane/M-3926-2019	Del-Monte, Jonathan/0000-0002-3393-2360; Raffard, Stephane/0000-0001-5563-0323; Marin, Ludovic/0000-0002-9040-8012; Bardy, Benoit/0000-0001-9272-1734; Capdevielle, Delphine/0000-0002-7146-8554	AlterEgo; European Union FP7 [600610]	AlterEgo; European Union FP7(European Commission)	This research was supported by AlterEgo, a project funded by the European Union FP7 (grant #600610). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J.R., 1983, ARCHITECTURE COGNITI; Baran X., 2008, AM PSYCH ASS M WASH; BARGH J A, 1989, P3; Bargh J. A., 1990, HDB MOTIVATION COGNI, V2, P93; Bargh JA, 2001, J PERS SOC PSYCHOL, V81, P1014, DOI 10.1037//0022-3514.81.6.1014; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Brune M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-6; Del-Monte J, 2013, PSYCHIAT RES, V210, P29, DOI 10.1016/j.psychres.2013.05.034; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; First M.B., 2014, STRUCTURED CLIN INTE; Fiszdon JM, 2005, ACTA PSYCHIAT SCAND, V112, P187, DOI 10.1111/j.1600-0447.2005.00565.x; Goldin-Meadow S, 1999, TRENDS COGN SCI, V3, P419, DOI 10.1016/S1364-6613(99)01397-2; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Krebs MO, 2000, SCHIZOPHR RES, V45, P245, DOI 10.1016/S0920-9964(99)00206-6; Kupper Z, 2010, SCHIZOPHR RES, V121, P90, DOI 10.1016/j.schres.2010.03.032; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Lavelle M, 2014, J NERV MENT DIS, V202, P47, DOI 10.1097/NMD.0000000000000031; Lavelle M, 2013, SCHIZOPHRENIA BULL, V39, P1150, DOI 10.1093/schbul/sbs091; Leighton J, 2010, J EXP SOC PSYCHOL, V46, P905, DOI 10.1016/j.jesp.2010.07.001; Liebowitz M R, 1987, Mod Probl Pharmacopsychiatry, V22, P141; Mackinnon A, 2005, ENCEPHALE, V31, P31; Minzenberg MJ, 2002, J INT NEUROPSYCH SOC, V8, P699, DOI 10.1017/S1355617702801357; Over H, 2009, PSYCHOL SCI, V20, P1189, DOI 10.1111/j.1467-9280.2009.02419.x; Penades R, 2006, SCHIZOPHR RES, V87, P323, DOI 10.1016/j.schres.2006.04.019; Pilling S, 2002, PSYCHOL MED, V32, P783, DOI 10.1017/S0033291702005640; Pomarol-Clotet E, 2008, BRIT J PSYCHIAT, V192, P92, DOI 10.1192/bjp.bp.106.032102; Rossell SL, 2006, SCHIZOPHR RES, V82, P121, DOI 10.1016/j.schres.2005.11.001; Schroder T, 2013, PSYCHOL REV, V120, P255, DOI 10.1037/a0030972; Shanks DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056515; Sidlova M, 2011, BIOMED PAP, V155, P173, DOI 10.5507/bp.2011.010; SMITH ER, 1994, HDB SOCIAL COGNITION, V1, P99; SRULL TK, 1979, J PERS SOC PSYCHOL, V37, P1660, DOI 10.1037/0022-3514.37.10.1660; Tremeau F, 2005, AM J PSYCHIAT, V162, P92, DOI 10.1176/appi.ajp.162.1.92; Tremeau F, 2008, PSYCHIAT RES, V160, P346, DOI 10.1016/j.psychres.2007.06.021; VERA AH, 1993, COGNITIVE SCI, V17, P7, DOI 10.1207/s15516709cog1701_2; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060249; Wegner D. M., 1998, HDB SOCIAL PSYCHOL, P446; Wykes T, 2003, SCHIZOPHR RES, V61, P163, DOI 10.1016/S0920-9964(02)00239-6; Wykes T, 2011, AM J PSYCHIAT, V168, P472, DOI 10.1176/appi.ajp.2010.10060855	39	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109139	10.1371/journal.pone.0109139	http://dx.doi.org/10.1371/journal.pone.0109139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ2BX	25275522	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500067
J	Linneman, J; Paulus, D; Lim-Fong, G; Lopanik, NB				Linneman, Jonathan; Paulus, Darcy; Lim-Fong, Grace; Lopanik, Nicole B.			Latitudinal Variation of a Defensive Symbiosis in the Bugula neritina (Bryozoa) Sibling Species Complex	PLOS ONE			English	Article							CANDIDATUS-ENDOBUGULA-SERTULA; BACTERIAL SYMBIONT; MICROBIAL SYMBIONT; CHEMICAL DEFENSE; BRYOSTATINS; POPULATIONS; IDENTIFICATION; DISPERSAL; LARVAE; BIOSYNTHESIS	Mutualistic relationships are beneficial for both partners and are often studied within a single environment. However, when the range of the partners is large, geographical differences in selective pressure may shift the relationship outcome from positive to negative. The marine bryozoan Bugula neritina is a colonial invertebrate common in temperate waters worldwide. It is the source of bioactive polyketide metabolites, the bryostatins. Evidence suggests that an uncultured vertically transmitted symbiont, "Candidatus Endobugula sertula'', hosted by B. neritina produces the bryostatins, which protect the vulnerable larvae from predation. Studies of B. neritina along the North American Atlantic coast revealed a complex of two morphologically similar sibling species separated by an apparent biogeographic barrier: the Type S sibling species was found below Cape Hatteras, North Carolina, while Type N was found above. Interestingly, the Type N colonies lack "Ca. Endobugula sertula'' and, subsequently, defensive bryostatins; their documented northern distribution was consistent with traditional biogeographical paradigms of latitudinal variation in predation pressure. Upon further sampling of B. neritina populations, we found that both host types occur in wider distribution, with Type N colonies living south of Cape Hatteras, and Type S to the north. Distribution of the symbiont, however, was not restricted to Type S hosts. Genetic and microscopic evidence demonstrates the presence of the symbiont in some Type N colonies, and larvae from these colonies are endowed with defensive bryostatins and contain "Ca. Endobugula sertula''. Molecular analysis of the symbiont from Type N colonies suggests an evolutionarily recent acquisition, which is remarkable for a symbiont thought to be transmitted only vertically. Furthermore, most Type S colonies found at higher latitudes lack the symbiont, suggesting that this host-symbiont relationship is more flexible than previously thought. Our data suggest that the symbiont, but not the host, is restricted by biogeographical boundaries.	[Linneman, Jonathan; Lopanik, Nicole B.] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA; [Paulus, Darcy; Lim-Fong, Grace] Randolph Macon Coll, Dept Biol, Ashland, VA 23005 USA	University System of Georgia; Georgia State University	Lopanik, NB (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA.	nlopanik@gsu.edu			Georgia State University Research Foundation; Randolph-Macon College Chenery Grant	Georgia State University Research Foundation; Randolph-Macon College Chenery Grant	This work was funded in part by the Georgia State University Research Foundation and the Randolph-Macon College Chenery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; Anderson CM, 2007, APPL ENVIRON MICROB, V73, P303, DOI 10.1128/AEM.00604-06; BRIGGS J C, 1974, P475; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; CARLTON JT, 1995, MAR BIOL, V121, P721, DOI 10.1007/BF00349308; CARY SC, 1993, P NATL ACAD SCI USA, V90, P5695, DOI 10.1073/pnas.90.12.5695; Cheney KL, 2005, BIOL LETTERS, V1, P162, DOI 10.1098/rsbl.2004.0288; Clay K, 2014, FUNCT ECOL, V28, P293, DOI 10.1111/1365-2435.12258; Cockburn SN, 2013, ECOL LETT, V16, P609, DOI 10.1111/ele.12087; Davidson SK, 2001, APPL ENVIRON MICROB, V67, P4531, DOI 10.1128/AEM.67.10.4531-4537.2001; Davidson SK, 1999, BIOL BULL, V196, P273, DOI 10.2307/1542952; Diaz-Ferguson E, 2010, ESTUAR COAST, V33, P828, DOI 10.1007/s12237-009-9220-6; Erwin PM, 2006, INTEGR COMP BIOL, V46, pE40; Fehlauer-Ale KH, 2014, ZOOL SCR, V43, P193, DOI 10.1111/zsc.12042; Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P340, DOI 10.1128/AEM.62.2.340-346.1996; Floerl O, 2004, ECOL APPL, V14, P1724, DOI 10.1890/03-5399; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Garcia-Martinez J, 1999, J MICROBIOL METH, V36, P55, DOI 10.1016/S0167-7012(99)00011-1; Gordon Dennis P., 1992, New Zealand Oceanographic Institute Miscellaneous Publication, V107, P1; Haygood MG, 1997, APPL ENVIRON MICROB, V63, P4612, DOI 10.1128/AEM.63.11.4612-4616.1997; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hewitt Chad L., 2002, Pacific Science, V56, P213, DOI 10.1353/psc.2002.0016; Jaenike J, 2010, SCIENCE, V329, P212, DOI 10.1126/science.1188235; Kellner RLL, 1996, OECOLOGIA, V107, P293, DOI 10.1007/BF00328445; Kellner RLL, 2002, INSECT BIOCHEM MOLEC, V32, P389, DOI 10.1016/S0965-1748(01)00115-1; KEOUGH MJ, 1989, MAR ECOL PROG SER, V57, P163, DOI 10.3354/meps057163; KEOUGH MJ, 1987, ECOLOGY, V68, P199, DOI 10.2307/1938820; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lim GE, 2004, APPL ENVIRON MICROB, V70, P4921, DOI 10.1128/AEM.70.8.4921-4929.2004; Lim-Fong GE, 2008, APPL ENVIRON MICROB, V74, P3605, DOI 10.1128/AEM.02798-07; Lindquist N, 1996, MAR BIOL, V126, P745, DOI 10.1007/BF00351341; Lindquist N, 1996, ECOL MONOGR, V66, P431, DOI 10.2307/2963489; Lopanik N, 2004, OECOLOGIA, V139, P131, DOI 10.1007/s00442-004-1487-5; Lopanik NB, 2006, MAR ECOL PROG SER, V327, P183, DOI 10.3354/meps327183; Lopanik NB, 2014, FUNCT ECOL, V28, P328, DOI 10.1111/1365-2435.12160; Mackie JA, 2006, MAR BIOL, V149, P285, DOI 10.1007/s00227-005-0196-x; Mackie JA, 2012, SCI REPORTS, V2, P10; Manyak-Davis A, 2013, AM NAT, V182, P347, DOI 10.1086/671170; Mathew M, 2014, BIOL BULL, V226, P125; McCartney MA, 2013, J BIOGEOGR, V40, P1386, DOI 10.1111/jbi.12103; McGovern TM, 2003, MOL ECOL, V12, P1207, DOI 10.1046/j.1365-294X.2003.01758.x; Moran NA, 2006, P NATL ACAD SCI USA, V103, P12803, DOI 10.1073/pnas.0605772103; Oliver KM, 2008, P R SOC B, V275, P293, DOI 10.1098/rspb.2007.1192; Pennings SC, 2005, ECOLOGY, V86, P2310, DOI 10.1890/04-1022; Polin S, 2014, ECOL EVOL, V4, P826, DOI 10.1002/ece3.991; Ryland JS, 2011, AQUAT INVASIONS, V6, P17, DOI 10.3391/ai.2011.6.1.03; Sachs JL, 2006, TRENDS ECOL EVOL, V21, P585, DOI 10.1016/j.tree.2006.06.018; Sanders JG, 2011, BIOL BULL-US, V220, P199, DOI 10.1086/BBLv220n3p199; Sharp KH, 2007, ISME J, V1, P693, DOI 10.1038/ismej.2007.78; Sudek S, 2007, J NAT PROD, V70, P67, DOI 10.1021/np060361d; Tamburri MN, 1996, LIMNOL OCEANOGR, V41, P1188, DOI 10.4319/lo.1996.41.6.1188; Thomas MJ, 2013, FRESHW SCI, V32, P1358, DOI 10.1899/12-187.1; Trindade-Silva AE, 2010, CURR OPIN BIOTECH, V21, P834, DOI 10.1016/j.copbio.2010.09.018; Vermeij G.J., 1978, BIOGEOGRAPHY ADAPTAT; Vorburger C, 2011, J EVOLUTION BIOL, V24, P1611, DOI 10.1111/j.1420-9101.2011.02292.x; Wares JP, 2002, MOL ECOL, V11, P1131, DOI 10.1046/j.1365-294X.2002.01510.x; Wilkinson TL, 2003, ARTHROPOD STRUCT DEV, V32, P241, DOI 10.1016/S1467-8039(03)00036-7; WOOLLACOTT RM, 1981, MAR BIOL, V65, P155, DOI 10.1007/BF00397080; WOOLLACOTT RM, 1975, J MORPHOL, V147, P355, DOI 10.1002/jmor.1051470308; Yule KM, 2013, OIKOS, V122, P1512, DOI 10.1111/j.1600-0706.2012.00229.x	60	20	20	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108783	10.1371/journal.pone.0108783	http://dx.doi.org/10.1371/journal.pone.0108783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275632	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500030
J	Zhang, LH; Chen, HW; Li, YL; Li, YN; Wang, SJ; Su, JP; Liu, XJ; Chen, DF; Chen, XW				Zhang, Luhua; Chen, Haiwei; Li, Yanlan; Li, Yanan; Wang, Shengjun; Su, Jinping; Liu, Xuejun; Chen, Defu; Chen, Xiwen			Evaluation of the Agronomic Performance of Atrazine-Tolerant Transgenic japonica Rice Parental Lines for Utilization in Hybrid Seed Production	PLOS ONE			English	Article							HERBICIDE RESISTANCE; CHLOROHYDROLASE; DEGRADATION; GENE	Currently, the purity of hybrid seed is a crucial limiting factor when developing hybrid japonica rice (Oryza sativa L.). To chemically control hybrid seed purity, we transferred an improved atrazine chlorohydrolase gene (atzA) from Pseudomonas ADP into hybrid japonica parental lines (two maintainers, one restorer), and Nipponbare, by using Agrobacterium-mediated transformation. We subsequently selected several transgenic lines from each genotype by using PCR, RT-PCR, and germination analysis. In the presence of the investigated atrazine concentrations, particularly 150 mu M atrazine, almost all of the transgenic lines produced significantly larger seedlings, with similar or higher germination percentages, than did the respective controls. Although the seedlings of transgenic lines were taller and gained more root biomass compared to the respective control plants, their growth was nevertheless inhibited by atrazine treatment compared to that without treatment. When grown in soil containing 2 mg/kg or 5 mg/kg atrazine, the transgenic lines were taller, and had higher total chlorophyll contents than did the respective controls; moreover, three of the strongest transgenic lines completely recovered after 45 days of growth. After treatment with 2 mg/kg or 5 mg/kg of atrazine, the atrazine residue remaining in the soil was 2.9-7.0% or 0.8-8.7% respectively, for transgenic lines, and 44.0-59.2% or 28.1-30.8%, respectively, for control plants. Spraying plants at the vegetative growth stage with 0.15% atrazine effectively killed control plants, but not transgenic lines. Our results indicate that transgenic atzA rice plants show tolerance to atrazine, and may be used as parental lines in future hybrid seed production.	[Zhang, Luhua; Chen, Haiwei; Li, Yanlan; Li, Yanan; Chen, Defu; Chen, Xiwen] Nankai Univ, Coll Life Sci, Mol Genet Lab, Tianjin 300071, Peoples R China; [Wang, Shengjun; Su, Jinping; Liu, Xuejun] Tianjin Crop Res Inst, Tianjin, Peoples R China	Nankai University	Chen, DF (corresponding author), Nankai Univ, Coll Life Sci, Mol Genet Lab, Tianjin 300071, Peoples R China.	chendefu@nankai.edu.cn; xiwenchen@nankai.edu.cn			Key Project of Tianjin Science and Technology Support Program [11ZCGYNC01000]; Key Program of the Natural Science Foundation of Tianjin [12YFJZJC01700, 14JCZDJC34100]; Natural Science Foundation of China [31070273, 31070717]; 111 Project [B08011]	Key Project of Tianjin Science and Technology Support Program; Key Program of the Natural Science Foundation of Tianjin; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the Key Project of Tianjin Science and Technology Support Program (11ZCGYNC01000), the Key Program of the Natural Science Foundation of Tianjin (12YFJZJC01700, 14JCZDJC34100), the grant of Natural Science Foundation of China (No. 31070273, 31070717) and the 111 Project (No. B08011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai B, 2003, LETT APPL MICROBIOL, V36, P272, DOI 10.1046/j.1472-765X.2003.01307.x; Chen DF, 2014, PLANTA, V239, P1351, DOI 10.1007/s00425-014-2064-8; deSouza ML, 1996, J BACTERIOL, V178, P4894, DOI 10.1128/jb.178.16.4894-4900.1996; ERICKSON LE, 1989, CRIT REV ENV CONTR, V19, P1, DOI 10.1080/10643388909388356; HOFGEN R, 1988, NUCLEIC ACIDS RES, V16, P9877, DOI 10.1093/nar/16.20.9877; Hu GuoCheng, 2000, Chinese Journal of Applied and Environmental Biology, V6, P511; Kawahigashi H, 2007, BIOTECHNOL ADV, V25, P75, DOI 10.1016/j.biotechadv.2006.10.002; Li SQ, 2007, J INTEGR PLANT BIOL, V49, P791, DOI 10.1111/j.1744-7909.2007.00513.x; Li Y, 2000, HYBRID RICE, V15, P9; Loh JP, 1999, ANN BOT-LONDON, V84, P155, DOI 10.1006/anbo.1999.0903; MA JF, 1990, PLANT SOIL, V126, P115, DOI 10.1007/BF00041376; Peng C, 2013, AGR OUTLOOK, P4; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Ramesh S, 2004, J BIOTECHNOL, V111, P131, DOI 10.1016/j.jbiotec.2004.04.004; Rhine ED, 2003, MICROB ECOL, V46, P145, DOI 10.1007/s00248-002-1048-6; Rutherford AW, 2001, TRENDS BIOCHEM SCI, V26, P648, DOI 10.1016/S0968-0004(01)01953-3; Shi KB, 2004, HYBRID RICE, V19, P76; Tang Shu-zhu, 2010, Zhongguo Shuidao Kexue, V24, P116, DOI 10.3969/j.issn.1001-7216.2010.02.03; Udikovic-Kolic N, 2012, APPL MICROBIOL BIOT, V96, P1175, DOI 10.1007/s00253-012-4495-0; Wang HZ, 2010, PLANT CELL REP, V29, P1391, DOI 10.1007/s00299-010-0924-7; Wang L, 2005, PLANT BIOTECHNOL J, V3, P475, DOI 10.1111/j.1467-7652.2005.00138.x; Wang Y, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1104, DOI 10.1134/S0006297913100040; [吴发强 Wu Faqiang], 2006, [分子植物育种, Molecular Plant Breeding], V4, P846; Xiao GY, 2009, RICE SCI, V16, P235, DOI 10.1016/S1672-6308(08)60084-0; Xiao GY, 2007, MOL BREEDING, V20, P287, DOI 10.1007/s11032-007-9091-0; [熊绪让 Xiong Xurang], 2004, [杂交水稻, Hybrid Rice], V19, P41; Xue S, 2001, J ZHEJIANG AGR SCI, P181; Yan W, 2000, US Patent, Patent No. 6066779	28	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108569	10.1371/journal.pone.0108569	http://dx.doi.org/10.1371/journal.pone.0108569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275554	gold, Green Published, Green Submitted			2022-12-27	WOS:000342591500021
J	Zhang, MM; Qiu, XY; Zhang, H; Yang, XT; Hong, N; Yang, YH; Chen, H; Yu, CG				Zhang, Mingming; Qiu, Xinyun; Zhang, Hao; Yang, Xiaotong; Hong, Na; Yang, Yonghua; Chen, Hui; Yu, Chenggong			Faecalibacterium prausnitzii Inhibits Interleukin-17 to Ameliorate Colorectal Colitis in Rats	PLOS ONE			English	Article							DENDRITIC CELLS; IL-17; BUTYRATE; IL-23; DISEASE	Background and Aims: It has been shown that Faecalibacterium prausnitzii (F. prausnitzii), one of the dominant intestinal bacterial flora, may protect colonic mucosa against the development of inflammation and subsequent inflammatory bowel disease (IBD), with the underlying mechanisms being unclear. Methods: The impacts of F. prausnitzii and its metabolites on IL-23/Th17/IL-17 pathway markers were determined in human monocytes and a rat model of colitis induced by 2,4,6-trinitrobenzene sulfonic acid. F. prausnitzii and its culture medium (containing complete metabolites) were used to treat the rats in vivo, as well as rat splenocytes and human monocytes in vitro. Inflammatory cytokines were measured in colon tissue, plasma and cell culture medium. Results: The culture supernatant of F. prausnitzii increased plasma anti-Th17 cytokines (IL-10 and IL-12) and suppressed IL-17 levels in both plasma and colonic mucosa, with ameliorated colonic colitis lesions. This inhibition of IL-17 release has also been observed in both rat splenocytes and human venous monocytes in vitro. The culture supernatant of F. prausnitzii also suppressed Th17 cell differentiation induced by cytokines (TGF-beta and IL-6) and bone marrow-derived dendritic cells (BMDCs) in vitro. The metabolites of F. prausnitzii in the culture supernatant exert a stronger anti-inflammatory effect than the bacterium itself. F. prausnitzii protected the colon mucosa against the development of IBD by its metabolites, suggesting a promising potential for the use of F. prausnitzii and its metabolic products in the treatment of IBD.	[Zhang, Mingming; Qiu, Xinyun; Yang, Xiaotong; Hong, Na; Yu, Chenggong] Nanjing Univ, Sch Med, Affiliated Hosp, Dept Gastroenterol,Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Mingming] Fudan Univ, Huashan Hosp, Dept Digest Dis, Shanghai 200433, Peoples R China; [Zhang, Hao; Yang, Yonghua] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Chen, Hui] Univ Technol Sydney, Fac Sci, Ctr Hlth Technol, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia	Nanjing University; Fudan University; Nanjing University; University of Technology Sydney	Yang, YH (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	yangyh@nju.edu.cn; chenggong_yu@nju.edu.cn	Chen, Hui/R-6137-2019; Chen, Hui/D-2005-2014	Chen, Hui/0000-0001-6883-3752; Chen, Hui/0000-0001-6883-3752	National Natural Science Foundation of China [81170359]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study has been supported by a research grant from National Natural Science Foundation of China (No. 81170359). The authors thank the Research Center of Sine Pharmaceutical (Shanghai Sine Pharmaceutical Co., Ltd., Shanghai, China) for the generous gift of Bifidobacterium longum, and the advice provided by Ms Hongjing Yu and Mr Lichuan Guo. The authors thank Professor Changhong Liu for the technique assistance. The authors thank Dr Shaun Sandow (Physiology, University of New South Wales) for his assistance English and grammar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baroja ML, 2007, CLIN EXP IMMUNOL, V149, P470, DOI 10.1111/j.1365-2249.2007.03434.x; Breuer RI, 1997, GUT, V40, P485, DOI 10.1136/gut.40.4.485; BROWN RS, 1993, CANCER, V72, P2979, DOI 10.1002/1097-0142(19931115)72:10<2979::AID-CNCR2820721020>3.0.CO;2-X; Cao Y, 2014, GASTROENTEROLOGY RES; CATO EP, 1974, INT J SYST BACTERIOL, V24, P256, DOI 10.1099/00207713-24-2-256; Di Sabatino A, 2005, ALIMENT PHARM THER, V22, P789, DOI 10.1111/j.1365-2036.2005.02639.x; Foligne B, 2006, DIGEST DIS SCI, V51, P390, DOI 10.1007/s10620-006-3143-x; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Fuss IJ, 2006, INFLAMM BOWEL DIS, V12, P9, DOI 10.1097/01.MIB.0000194183.92671.b6; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hoeve MA, 2006, EUR J IMMUNOL, V36, P661, DOI 10.1002/eji.200535239; Holtta V, 2008, INFLAMM BOWEL DIS, V14, P1175, DOI 10.1002/ibd.20475; Hundorfean G, 2012, INFLAMM BOWEL DIS, V18, P180, DOI 10.1002/ibd.21677; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jing H, 2003, J LEUKOCYTE BIOL, V74, P868, DOI 10.1189/jlb.0303116; Loos M, 2009, SCAND J IMMUNOL, V69, P130, DOI 10.1111/j.1365-3083.2008.02206.x; Lopez P, 2010, INT J FOOD MICROBIOL, V138, P157, DOI 10.1016/j.ijfoodmicro.2009.12.023; Machiels Kathleen, 2014, Gut, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin R, 2014, INFLAMM BOWEL DIS, V20, P417, DOI 10.1097/01.MIB.0000440815.76627.64; Mathur AN, 2006, BLOOD, V108, P1595, DOI 10.1182/blood-2006-04-015016; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Nielsen OH, 2003, SCAND J GASTROENTERO, V38, P180, DOI 10.1080/00365520310000672; Qiu XY, 2013, J CROHNS COLITIS, V7, pE558, DOI 10.1016/j.crohns.2013.04.002; Sarrabayrouse G, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001833; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Suau A, 2001, SYST APPL MICROBIOL, V24, P139, DOI 10.1078/0723-2020-00015; Tanabe S, 2008, INT J MOL MED, V22, P181, DOI 10.3892/ijmm_00000006; Wallace TC, 2011, NUTR REV, V69, P392, DOI 10.1111/j.1753-4887.2011.00402.x; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yin L, 2001, J BIOL CHEM, V276, P44641, DOI 10.1074/jbc.M105170200; Zhang Z, 2006, INFLAMM BOWEL DIS, V12, P382, DOI 10.1097/01.MIB.0000218764.06959.91	34	62	69	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109146	10.1371/journal.pone.0109146	http://dx.doi.org/10.1371/journal.pone.0109146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275569	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500068
J	Ataka, M; Kominami, Y; Yoshimura, K; Miyama, T; Jomura, M; Tani, M				Ataka, Mioko; Kominami, Yuji; Yoshimura, Kenichi; Miyama, Takafumi; Jomura, Mayuko; Tani, Makoto			In Situ CO2 Efflux from Leaf Litter Layer Showed Large Temporal Variation Induced by Rapid Wetting and Drying Cycle	PLOS ONE			English	Article							SOIL RESPIRATION; MICROBIAL CONTRIBUTIONS; FOREST; MOISTURE; FLUXES; BUDGET	We performed continuous and manual in situ measurements of CO2 efflux from the leaf litter layer (R-LL) and water content of the leaf litter layer (LWC) in conjunction with measurements of soil respiration (R-S) and soil water content (SWC) in a temperate forest; our objectives were to evaluate the response of R-LL to rainfall events and to assess temporal variation in its contribution to R-S. We measured R-LL in a treatment area from which all potential sources of CO2 except for the leaf litter layer were removed. Capacitance sensors were used to measure LWC. R-LL increased immediately after wetting of the leaf litter layer; peak R-LL values were observed during or one day after rainfall events and were up to 8.6-fold larger than R-LL prior to rainfall. R-LL declined to pre-wetting levels within 2-4 day after rainfall events and corresponded to decreasing LWC, indicating that annual R-LL is strongly influenced by precipitation. Temporal variation in the observed contribution of R-LL to R-S varied from nearly zero to 51%. Continuous in situ measurements of LWC and CO2 efflux from leaf litter only, combined with measurements of R-S, can provide robust data to clarify the response of R-LL to rainfall events and its contribution to total R-S.	[Ataka, Mioko; Tani, Makoto] Kyoto Univ, Grad Sch Agr, Div Environm Sci & Technol, Lab Forest Hydrol, Kyoto, Japan; [Kominami, Yuji; Yoshimura, Kenichi; Miyama, Takafumi] Forestry & Forest Prod Res Inst, Kansai Res Ctr, Kyoto, Japan; [Jomura, Mayuko] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan	Kyoto University; Forestry & Forest Products Research Institute - Japan; Nihon University	Ataka, M (corresponding author), Kyoto Univ, Grad Sch Agr, Div Environm Sci & Technol, Lab Forest Hydrol, Kyoto, Japan.	teshimamioko@yahoo.co.jp	MIYAMA, Takafumi/AAB-5656-2022	MIYAMA, Takafumi/0000-0003-1842-0073; Jomura, Mayuko/0000-0002-9858-3771; Tani, Makoto/0000-0001-8458-8638	Japan Society for the Promotion of Science (JSPS) [25-2482, 20380182]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding was provided by the Japan Society for the Promotion of Science (JSPS; grant number 25-2482 (http://www.jsps.go.jp/english/index.html)) Grant-in-Aid for Scientific Research (B) (20380182 (http://www.jsps.go.jp/english/index.html)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2004, SOIL BIOL BIOCHEM, V36, P1527, DOI 10.1016/j.soilbio.2004.07.018; Ataka M., 2014, Applied and Environmental Soil Science, V2014, P627129; Ataka M, 2014, J FOREST RES-JPN, V19, P295, DOI 10.1007/s10310-013-0422-1; BIRCH H. F., 1958, Plant and Soil, V10, P9, DOI 10.1007/BF01343734; Borken W, 2003, SOIL SCI SOC AM J, V67, P1888, DOI 10.2136/sssaj2003.1888; Borken W, 2009, GLOBAL CHANGE BIOL, V15, P808, DOI 10.1111/j.1365-2486.2008.01681.x; Carbone MS, 2011, OECOLOGIA, V167, P265, DOI 10.1007/s00442-011-1975-3; Cisneros-Dozal LM, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000197; Curtis PS, 2002, AGR FOREST METEOROL, V113, P3, DOI 10.1016/S0168-1923(02)00099-0; Dannoura M, 2006, TELLUS B, V58, P502, DOI 10.1111/j.1600-0889.2006.00216.x; DeForest JL, 2009, INT J BIOMETEOROL, V53, P1432; Fierer N, 2003, MICROB ECOL, V45, P63, DOI 10.1007/s00248-002-1007-2; Goto Y., 2003, Bulletin of the Forestry and Forest Products Research Institute, Ibaraki, P115; Goulden ML, 2004, ECOL APPL, V14, pS42, DOI 10.1890/02-6008; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Jomura M, 2007, TELLUS B, V59, P211, DOI 10.1111/j.1600-0889.2006.00234.x; Jomura M., 2005, Journal of the Japanese Forest Society, V87, P138; Kaneko S, 2007, J FOREST RES-JPN, V12, P38, DOI 10.1007/s10310-006-0248-1; Keith H, 2009, AGR FOREST METEOROL, V149, P535, DOI 10.1016/j.agrformet.2008.10.002; Kirschbaum MUF, 2013, SOIL BIOL BIOCHEM, V57, P568, DOI 10.1016/j.soilbio.2012.10.012; Kominami Y, 2008, AGR FOREST METEOROL, V148, P723, DOI 10.1016/j.agrformet.2008.01.017; Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P425, DOI 10.1016/j.soilbio.2005.08.020; Lee X, 2004, GLOBAL CHANGE BIOL, V10, P1017, DOI 10.1111/j.1529-8817.2003.00787.x; Loescher HW, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006932; Matsumoto A., 2010, Journal of the Japanese Forest Society, V92, P269, DOI 10.4005/jjfs.92.269; Moyano FE, 2008, AGR FOREST METEOROL, V148, P135, DOI 10.1016/j.agrformet.2007.09.006; Ngao J, 2005, GLOBAL CHANGE BIOL, V11, P1768, DOI 10.1111/j.1365-2486.2004.01014.x; ORCHARD VA, 1983, SOIL BIOL BIOCHEM, V15, P447, DOI 10.1016/0038-0717(83)90010-X; SCHNURER J, 1986, MICROBIAL ECOL, V12, P217, DOI 10.1007/BF02011206; Subke JA, 2003, SOIL BIOL BIOCHEM, V35, P1467, DOI 10.1016/S0038-0717(03)00241-4; Suseela V, 2012, GLOBAL CHANGE BIOL, V18, P336, DOI 10.1111/j.1365-2486.2011.02516.x; Tamai K., 1994, Journal of the Japanese Forestry Society, V76, P233; TEWARY CK, 1982, PLANT SOIL, V65, P233, DOI 10.1007/BF02374653; Wilson TB, 2014, AGR FOREST METEOROL, V192, P42, DOI 10.1016/j.agrformet.2014.02.005; Yuste JC, 2005, TREE PHYSIOL, V25, P609, DOI 10.1093/treephys/25.5.609; [No title captured]	36	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108404	10.1371/journal.pone.0108404	http://dx.doi.org/10.1371/journal.pone.0108404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271761	gold, Green Published, Green Submitted			2022-12-27	WOS:000343729600046
J	Idoine, AD; Boulouis, A; Rupprecht, J; Bock, R				Idoine, Adam D.; Boulouis, Alix; Rupprecht, Jens; Bock, Ralph			The Diurnal Logic of the Expression of the Chloroplast Genome in Chlamydomonas reinhardtii	PLOS ONE			English	Article							GENE-EXPRESSION; ENDOGENOUS FLUCTUATIONS; H-2 PRODUCTION; CELL-CYCLE; TRANSCRIPTION; REVEALS; PERSPECTIVES; PROMOTERS; TUFA	Chloroplasts are derived from cyanobacteria and have retained a bacterial-type genome and gene expression machinery. The chloroplast genome encodes many of the core components of the photosynthetic apparatus in the thylakoid membranes. To avoid photooxidative damage and production of harmful reactive oxygen species (ROS) by incompletely assembled thylakoid protein complexes, chloroplast gene expression must be tightly regulated and co-ordinated with gene expression in the nucleus. Little is known about the control of chloroplast gene expression at the genome-wide level in response to internal rhythms and external cues. To obtain a comprehensive picture of organelle transcript levels in the unicellular model alga Chlamydomonas reinhardtii in diurnal conditions, a qRT-PCR platform was developed and used to quantify 68 chloroplast, 21 mitochondrial as well as 71 nuclear transcripts in cells grown in highly controlled 12 h light/12 h dark cycles. Interestingly, in anticipation of dusk, chloroplast transcripts from genes involved in transcription reached peak levels first, followed by transcripts from genes involved in translation, and finally photosynthesis gene transcripts. This pattern matches perfectly the theoretical demands of a cell "waking up'' from the night. A similar trend was observed in the nuclear transcripts. These results suggest a striking internal logic in the expression of the chloroplast genome and a previously unappreciated complexity in the regulation of chloroplast genes.	[Idoine, Adam D.; Boulouis, Alix; Rupprecht, Jens; Bock, Ralph] Max Planck Inst Mol Pflanzenphysiol, D-14476 Golm, Germany	Max Planck Society	Bock, R (corresponding author), Max Planck Inst Mol Pflanzenphysiol, D-14476 Golm, Germany.	rbock@mpimp-golm.mpg.de	Bock, Ralph/B-4352-2009	Bock, Ralph/0000-0001-7502-6940; Boulouis, Alix/0000-0002-2552-3938	BMBF (Systems Biology Initiative FORSYS: GoFORSYS); Deutsche Forschungsgemeinschaft [FOR2092, BO 1482/17-1]	BMBF (Systems Biology Initiative FORSYS: GoFORSYS)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the BMBF (Systems Biology Initiative FORSYS: GoFORSYS) and the Deutsche Forschungsgemeinschaft (FOR2092, BO 1482/17-1) to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDAUF SL, 1990, P NATL ACAD SCI USA, V87, P5317, DOI 10.1073/pnas.87.14.5317; Beer LL, 2009, CURR OPIN BIOTECH, V20, P264, DOI 10.1016/j.copbio.2009.06.002; Berry JO, 2013, PHOTOSYNTH RES, V117, P91, DOI 10.1007/s11120-013-9880-8; BLOWERS AD, 1990, PLANT CELL, V2, P1059; Bohne AV, 2006, CURR GENET, V49, P333, DOI 10.1007/s00294-006-0060-7; Braeutigam Katharina, 2007, V19, P409, DOI 10.1007/4735_2007_0243; Carter ML, 2004, PHOTOSYNTH RES, V82, P339, DOI 10.1007/s11120-004-4213-6; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Day A, 2011, PLANT BIOTECHNOL J, V9, P540, DOI 10.1111/j.1467-7652.2011.00604.x; Eberhard S, 2002, PLANT J, V31, P149, DOI 10.1046/j.1365-313X.2002.01340.x; Erickson B, 2005, PLANT PHYSIOL, V137, P534, DOI 10.1104/pp.104.053256; Esquivel MG, 2011, TRENDS BIOTECHNOL, V29, P595, DOI 10.1016/j.tibtech.2011.06.008; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; HERRIN DL, 1986, J CELL BIOL, V103, P1837, DOI 10.1083/jcb.103.5.1837; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Hwang S, 1996, P NATL ACAD SCI USA, V93, P996, DOI 10.1073/pnas.93.3.996; Jarvis P, 2013, NAT REV MOL CELL BIO, V14, P787, DOI 10.1038/nrm3702; Kawazoe R, 2012, MOL BIOL REP, V39, P10565, DOI 10.1007/s11033-012-1942-z; KLEIN U, 1992, P NATL ACAD SCI USA, V89, P3453, DOI 10.1073/pnas.89.8.3453; KLEIN U, 1994, P NATL ACAD SCI USA, V91, P10819, DOI 10.1073/pnas.91.23.10819; LEU S, 1990, BIOCHIM BIOPHYS ACTA, V1049, P311, DOI 10.1016/0167-4781(90)90103-9; Liere Karsten, 2007, V19, P121, DOI 10.1007/4735_2007_0232; Matsuo T, 2006, MOL CELL BIOL, V26, P863, DOI 10.1128/MCB.26.3.863-870.2006; Matsuo T, 2008, GENE DEV, V22, P918, DOI 10.1101/gad.1650408; Maul JE, 2002, PLANT CELL, V14, P2659, DOI 10.1105/tpc.006155; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mettler T, 2014, PLANT CELL, V26, P2310, DOI 10.1105/tpc.114.124537; Ramundo S, 2013, PLANT CELL, V25, P167, DOI 10.1105/tpc.112.103051; Rochaix JD, 2001, PLANT PHYSIOL, V127, P1394, DOI 10.1104/pp.010628; Rupprecht J, 2006, APPL MICROBIOL BIOT, V72, P442, DOI 10.1007/s00253-006-0528-x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salvador ML, 1998, MOL CELL BIOL, V18, P7235, DOI 10.1128/MCB.18.12.7235; Salvador ML, 1999, PLANT PHYSIOL, V121, P1367, DOI 10.1104/pp.121.4.1367; SALVADOR ML, 1993, PLANT J, V3, P213, DOI 10.1046/j.1365-313X.1993.t01-13-00999.x; Shiina T, 2005, INT REV CYTOL, V244, P1, DOI 10.1016/S0074-7696(05)44001-2; SHIMADA H, 1991, NUCLEIC ACIDS RES, V19, P983, DOI 10.1093/nar/19.5.983; Terashima M, 2011, CURR GENET, V57, P151, DOI 10.1007/s00294-011-0339-1	38	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108760	10.1371/journal.pone.0108760	http://dx.doi.org/10.1371/journal.pone.0108760			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272288	gold, Green Submitted, Green Published			2022-12-27	WOS:000343729600059
J	Joliot, V; Ait-Mohamed, O; Battisti, V; Pontis, J; Philipot, O; Robin, P; Ito, H; Ait-Si-Ali, S				Joliot, Veronique; Ait-Mohamed, Ouardia; Battisti, Valentine; Pontis, Julien; Philipot, Ophelie; Robin, Philippe; Ito, Hidenori; Ait-Si-Ali, Slimane			The SWI/SNF Subunit/Tumor Suppressor BAF47/INI1 Is Essential in Cell Cycle Arrest upon Skeletal Muscle Terminal Differentiation	PLOS ONE			English	Article							CHROMATIN-REMODELING COMPLEX; ACTIN-RELATED PROTEINS; TUMOR-SUPPRESSOR; BAF COMPLEX; N-COR; BRG1; MYOGENIN; BINDING; MYOD; SNF5	Myogenic terminal differentiation is a well-orchestrated process starting with permanent cell cycle exit followed by muscle-specific genetic program activation. Individual SWI/SNF components have been involved in muscle differentiation. Here, we show that the master myogenic differentiation factor MyoD interacts with more than one SWI/SNF subunit, including the catalytic subunit BRG1, BAF53a and the tumor suppressor BAF47/INI1. Downregulation of each of these SWI/SNF subunits inhibits skeletal muscle terminal differentiation but, interestingly, at different differentiation steps and extents. BAF53a downregulation inhibits myotube formation but not the expression of early muscle-specific genes. BRG1 or BAF47 downregulation disrupt both proliferation and differentiation genetic programs expression. Interestingly, BRG1 and BAF47 are part of the SWI/SNF remodeling complex as well as the N-CoR-1 repressor complex in proliferating myoblasts. However, our data show that, upon myogenic differentiation, BAF47 shifts in favor of N-CoR-1 complex. Finally, BRG1 and BAF47 are well-known tumor suppressors but, strikingly, only BAF47 seems essential in the myoblasts irreversible cell cycle exit. Together, our data unravel differential roles for SWI/SNF subunits in muscle differentiation, with BAF47 playing a dual role both in the permanent cell cycle exit and in the regulation of muscle-specific genes.	[Joliot, Veronique; Ait-Mohamed, Ouardia; Battisti, Valentine; Pontis, Julien; Philipot, Ophelie; Robin, Philippe; Ait-Si-Ali, Slimane] Univ Paris Diderot, Sorbonne Paris Cite, Ctr Epigenet & Destin Cellulaire, UMR7216,CNRS, Paris, France; [Ito, Hidenori] Aichi Human Serv Ctr, Inst Dev Res, Dept Mol Neurobiol, Kasugai, Aichi, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Joliot, V (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Ctr Epigenet & Destin Cellulaire, UMR7216,CNRS, Paris, France.	veronique.joliot@univ-paris-diderot.fr; slimane.aitsiali@univ-paris-diderot.fr		Ito, Hidenori/0000-0002-6527-477X	Association Francaise contre les Myopathies Telethon [16557]; Agence Nationale de la Recherche; Fondation Bettencourt- Schueller; Fondation Association pour la Recherche sur le Cancer (Fondation ARC) [SFI20121205835]; Groupement des Entreprises Francaises pour la Lutte contre le Cancer (GEFLUC); Institut National du Cancer (INCa) [INCa_5879]; CNRS; Universite Paris Diderot (Appel d'Offre Projets Puridisciplinaires Paris Diderot); "Who Am I?" Laboratory of Excellence - French Government [ANR-11-LABX-0071]; ANR [ANR-11-IDEX-0005-01]; Univ Paris Diderot fellowship; DIM Stem-Pole fellowship; Ministere de la Recherche PhD fellowship; Fondation ARC fellowship; FRM fellowship	Association Francaise contre les Myopathies Telethon; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Bettencourt- Schueller; Fondation Association pour la Recherche sur le Cancer (Fondation ARC); Groupement des Entreprises Francaises pour la Lutte contre le Cancer (GEFLUC); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Diderot (Appel d'Offre Projets Puridisciplinaires Paris Diderot); "Who Am I?" Laboratory of Excellence - French Government; ANR(French National Research Agency (ANR)); Univ Paris Diderot fellowship; DIM Stem-Pole fellowship; Ministere de la Recherche PhD fellowship; Fondation ARC fellowship; FRM fellowship(Fondation pour la Recherche Medicale)	This work was supported by the: Association Francaise contre les Myopathies Telethon (Grant No 16557, http://www.afm-telethon.fr/association); Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/), Fondation Bettencourt- Schueller (Grant 2006; http://www.fondationbs.org/); Fondation Association pour la Recherche sur le Cancer (Fondation ARC, Grant No SFI20121205835; http://www.fondation-arc.org/); Groupement des Entreprises Francaises pour la Lutte contre le Cancer (GEFLUC, Grant 2011; http://www.gefluc.org/); Institut National du Cancer (INCa; grant No INCa_5879); CNRS; Universite Paris Diderot (Appel d'Offre Projets Puridisciplinaires Paris Diderot 2011-2012) and the "Who Am I?" Laboratory of Excellence #ANR-11-LABX-0071 funded by the French Government through its "Investments for the Future" program operated by the ANR under grant #ANR-11-IDEX-0005-01. OA was recipient of a Univ Paris Diderot and DIM Stem-Pole fellowships, VB was recipient of the Ministere de la Recherche PhD fellowship, Fondation ARC and FRM fellowships and JP was recipient of the Ministere de la Recherche PhD fellowship and Fondation ARC fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors do not have any conflict of interest regarding the manuscript.	Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; Albini S, 2013, CELL REP, V3, P661, DOI 10.1016/j.celrep.2013.02.012; Albini S, 2010, EXP CELL RES, V316, P3073, DOI 10.1016/j.yexcr.2010.05.023; Bailey P, 1999, MOL ENDOCRINOL, V13, P1155, DOI 10.1210/me.13.7.1155; Bao XM, 2013, CELL STEM CELL, V12, P193, DOI 10.1016/j.stem.2012.12.014; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Caramel J, 2008, ONCOGENE, V27, P2035, DOI 10.1038/sj.onc.1210847; Chai JJ, 2005, CANCER RES, V65, P10192, DOI 10.1158/0008-5472.CAN-05-1896; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; Euskirchen G, 2012, J BIOL CHEM, V287, P30897, DOI 10.1074/jbc.R111.309302; Faralli H, 2011, J BIOL CHEM, V286, P23498, DOI 10.1074/jbc.M110.206003; Forcales SV, 2012, EMBO J, V31, P301, DOI 10.1038/emboj.2011.391; Gresh L, 2005, EMBO J, V24, P3313, DOI 10.1038/sj.emboj.7600802; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hughes SM, 2001, CURR BIOL, V11, pR237, DOI 10.1016/S0960-9822(01)00114-2; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; Isakoff MS, 2005, P NATL ACAD SCI USA, V102, P17745, DOI 10.1073/pnas.0509014102; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Klochendler-Yeivin A, 2002, CURR OPIN GENET DEV, V12, P73, DOI 10.1016/S0959-437X(01)00267-2; Krasteva V, 2012, BLOOD, V120, P4720, DOI 10.1182/blood-2012-04-427047; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; Ohkawa Y, 2007, J BIOL CHEM, V282, P6564, DOI 10.1074/jbc.M608898200; Oma Y, 2011, NUCLEUS-PHILA, V2, P38, DOI 10.4161/nucl.2.1.14510; Philipot O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009425; Puri PL, 2012, GENE DEV, V26, P2673, DOI 10.1101/gad.207415.112; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Rando OJ, 2002, P NATL ACAD SCI USA, V99, P2824, DOI 10.1073/pnas.032662899; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Romero OA, 2013, ONCOGENE, P1; Sansam CG, 2006, CELL CYCLE, V5, P621, DOI 10.4161/cc.5.6.2579; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Sevenet N, 1999, AM J HUM GENET, V65, P1342, DOI 10.1086/302639; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Stojanova A, 2009, BIOCHEM CELL BIOL, V87, P163, DOI 10.1139/O08-113; Takeuchi JK, 2011, NAT COMMUN, V2, P1; Taulli R, 2013, ONCOGENE, P1; Trotter K., 2008, NUCL RECEPT SIGNAL, V6, P1, DOI DOI 10.1621/NRS.06004; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; Versteege I, 2002, ONCOGENE, V21, P6403, DOI 10.1038/sj.onc.1205841; Vradii D, 2006, J CELL PHYSIOL, V206, P112, DOI 10.1002/jcp.20432; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wei Q, 2001, FEBS LETT, V490, P171, DOI 10.1016/S0014-5793(01)02120-2; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Yahi H, 2008, J BIOL CHEM, V283, P23692, DOI 10.1074/jbc.M802647200; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; You JS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003459; Zhang ZK, 2002, MOL CELL BIOL, V22, P5975, DOI 10.1128/MCB.22.16.5975-5988.2002; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	58	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108858	10.1371/journal.pone.0108858	http://dx.doi.org/10.1371/journal.pone.0108858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271443	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600068
J	Kapoor, A; Travesset, A				Kapoor, Abhijeet; Travesset, Alex			Mechanism of the Exchange Reaction in HRAS from Multiscale Modeling	PLOS ONE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; RAS P21; SIGNAL-TRANSDUCTION; PROTEINS; SWITCH; ACTIVATION; SOS; GTP	HRAS regulates cell growth promoting signaling processes by cycling between active (GTP-bound) and inactive (GDP-bound) states. Understanding the transition mechanism is central for the design of small molecules to inhibit the formation of RAS-driven tumors. Using a multiscale approach involving coarse-grained (CG) simulations, all-atom classical molecular dynamics (CMD; total of 3.02 mu s), and steered molecular dynamics (SMD) in combination with Principal Component Analysis (PCA), we identified the structural features that determine the nucleotide (GDP) exchange reaction. We show that weakening the coupling between the SwitchI (residues 25-40) and SwitchII (residues 59-75) accelerates the opening of SwitchI; however, an open conformation of SwitchI is unstable in the absence of guanine nucleotide exchange factors (GEFs) and rises up towards the bound nucleotide to close the nucleotide pocket. Both I21 and Y32, play a crucial role in SwitchI transition. We show that an open SwitchI conformation is not necessary for GDP destabilization but is required for GDP/Mg escape from the HRAS. Further, we present the first simulation study showing displacement of GDP/Mg away from the nucleotide pocket. Both SwitchI and SwitchII, delays the escape of displaced GDP/Mg in the absence of GEF. Based on these results, a model for the mechanism of GEF in accelerating the exchange process is hypothesized.	[Kapoor, Abhijeet; Travesset, Alex] Iowa State Univ, Ames, IA 50011 USA	Iowa State University	Kapoor, A (corresponding author), Iowa State Univ, Ames, IA 50011 USA.	akapoor@iastate.edu	Kapoor, Abhijeet/V-3284-2019	Kapoor, Abhijeet/0000-0002-3606-3463	National Science Foundation through CAREER [DMR-0748475]; Division Of Materials Research [0748475] Funding Source: National Science Foundation	National Science Foundation through CAREER; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work is supported by National Science Foundation through the grant CAREER DMR-0748475. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JA, 2008, J COMPUT PHYS, V227, P5342, DOI 10.1016/j.jcp.2008.01.047; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Buhrman G, 2007, STRUCTURE, V15, P1618, DOI 10.1016/j.str.2007.10.011; Buhrman G, 2011, J MOL BIOL, V413, P773, DOI 10.1016/j.jmb.2011.09.011; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Cool RH, 1999, MOL CELL BIOL, V19, P6297; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Ford B, 2006, STRUCTURE, V14, P427, DOI 10.1016/j.str.2005.12.010; Gorfe AA, 2008, STRUCTURE, V16, P885, DOI 10.1016/j.str.2008.03.009; Grant BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025711; Grant BJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000325; Hall BE, 2002, P NATL ACAD SCI USA, V99, P12138, DOI 10.1073/pnas.192453199; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; Hocker HJ, 2013, P NATL ACAD SCI USA, V110, P10201, DOI 10.1073/pnas.1300016110; Holzapfel G, 2012, BIOCHEMISTRY-US, V51, P6114, DOI 10.1021/bi300509j; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kapoor A, 2014, PROTEINS, V82, P505, DOI 10.1002/prot.24416; Kapoor A, 2013, PROTEINS, V81, P1200, DOI 10.1002/prot.24269; Kobayashi C, 2010, BIOPHYS J, V99, P3726, DOI 10.1016/j.bpj.2010.09.063; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Ma JP, 1997, P NATL ACAD SCI USA, V94, P11905, DOI 10.1073/pnas.94.22.11905; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; MISTOU MY, 1992, EMBO J, V11, P2391, DOI 10.1002/j.1460-2075.1992.tb05303.x; Mori K, 2005, J AM CHEM SOC, V127, P15127, DOI 10.1021/ja0467972; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sharma N, 2014, EUR BIOPHYS J BIOPHY, V43, P81, DOI 10.1007/s00249-014-0942-4; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; SUNG YJ, 1995, BIOCHEMISTRY-US, V34, P3470, DOI 10.1021/bi00010a040; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3	34	4	4	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108846	10.1371/journal.pone.0108846	http://dx.doi.org/10.1371/journal.pone.0108846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272152	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600067
J	Ousaid, AM; Millet, G; Haliyo, S; Regnier, S; Hayward, V				Ousaid, Abdenbi Mohand; Millet, Guillaume; Haliyo, Sinan; Regnier, Stephane; Hayward, Vincent			Feeling What an Insect Feels	PLOS ONE			English	Article							FORCE; BEHAVIOR; SENSOR	We describe a manually operated, bilateral mechanical scaling instrument that simultaneously magnifies microscopic forces and reduces displacements with quasi-perfect transparency. In contrast with existing micro-teleoperation designs, the system is unconditionally stable for any scaling gains and interaction curves. In the present realization, the work done by the hand is more than a million times that done by a microscopic probe so that one can feel complete interaction cycles with water and compare them to what is felt when an insect leg interacts with a wet surface.	[Ousaid, Abdenbi Mohand; Millet, Guillaume; Haliyo, Sinan; Regnier, Stephane; Hayward, Vincent] Univ Paris 06, Sorbonne Univ, UMR 7222, ISIR Inst Syst Intelligents & Robot, Paris, France; [Hayward, Vincent] CNRS, UMR 7222, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Ousaid, AM (corresponding author), Univ Paris 06, Sorbonne Univ, UMR 7222, ISIR Inst Syst Intelligents & Robot, Paris, France.	mohand_ousaid@isir.upmc.fr	Hayward, Vincent/A-4646-2010; Haliyo, Sinan/ABG-7378-2020; Mohand-Ousaid, Abdenbi/ABC-9635-2021; Régnier, Stéphane/P-2533-2014	Hayward, Vincent/0000-0002-2102-1965; Haliyo, Sinan/0000-0003-4587-381X; Mohand-Ousaid, Abdenbi/0000-0002-5213-4874; 	European Research Council (FP7) ERC Advanced Grant (patch) [247300]; French National Agency of Research	European Research Council (FP7) ERC Advanced Grant (patch); French National Agency of Research(French National Research Agency (ANR))	The work is supported by the European Research Council (FP7) ERC Advanced Grant (patch) to VH (No. 247300) and the French National Agency of Research, through the PACMAN project to SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Adams RJ, 1999, IEEE T ROBOTIC AUTOM, V15, P465, DOI 10.1109/70.768179; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Daniel RW, 1998, INT J ROBOT RES, V17, P811, DOI 10.1177/027836499801700801; Federle W, 2004, ARTHROPOD STRUCT DEV, V33, P67, DOI 10.1016/j.asd.2003.11.001; Gosline AHC, 2008, IEEE-ASME T MECH, V13, P669, DOI 10.1109/TMECH.2008.2004623; HANNAFORD B, 1989, IEEE T ROBOTIC AUTOM, V5, P426, DOI 10.1109/70.88057; Hannaford B, 1990, ADV CONTROL DYNAMIC, P1; Hatamura Y., 1990, Proceedings. IEEE Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robots (Cat. No.90CH2832-4), P203, DOI 10.1109/MEMSYS.1990.110277; Hollis R. L., 1990, Proceedings. IEEE Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robots (Cat. No.90CH2832-4), P115, DOI 10.1109/MEMSYS.1990.110261; Hoole S., 1800, SELECT WORKS ANTONY; Hunter IW, 1990, IEEE CONTR SYST MAG, V10, P3, DOI 10.1109/37.45787; LLEWELLYN FB, 1952, P IRE, V40, P271, DOI 10.1109/JRPROC.1952.273783; Mohand-Ousaid A, 2012, INT J ROBOT RES, V31, P319, DOI 10.1177/0278364911430421; Ousaid AM, 2014, IEEE INT CONF ROBOT, P5946, DOI 10.1109/ICRA.2014.6907735; Ousaid AM, 2013, IEEE ASME INT C ADV, P612, DOI 10.1109/AIM.2013.6584160; Sidobre D, 2004, MEAS SCI TECHNOL, V15, P451, DOI 10.1088/0957-0233/15/2/020; Sitti M, 1998, 1998 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS - PROCEEDINGS, VOLS 1-3, P1739, DOI 10.1109/IROS.1998.724849; Sun Y, 2005, J MICROELECTROMECH S, V14, P4, DOI 10.1109/JMEMS.2004.839028	18	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108895	10.1371/journal.pone.0108895	http://dx.doi.org/10.1371/journal.pone.0108895			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271636	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600077
J	Zhang, HY; Chen, WX; Jiao, Y; Xu, Y; Zhang, XR; Wu, JT				Zhang, Hong-Ying; Chen, Wen-Xin; Jiao, Yun; Xu, Yao; Zhang, Xiang-Rong; Wu, Jing-Tao			Selective Vulnerability Related to Aging in Large-Scale Resting Brain Networks	PLOS ONE			English	Article							AGE-RELATED-CHANGES; INTRINSIC FUNCTIONAL CONNECTIVITY; TEST-RETEST RELIABILITY; DEFAULT-MODE NETWORK; ALZHEIMERS-DISEASE; WORKING-MEMORY; OLDER-ADULTS; FRONTOTEMPORAL DEMENTIA; HEMISPHERIC-ASYMMETRY; EPISODIC RETRIEVAL	Normal aging is associated with cognitive decline. Evidence indicates that large-scale brain networks are affected by aging; however, it has not been established whether aging has equivalent effects on specific large-scale networks. In the present study, 40 healthy subjects including 22 older (aged 60-80 years) and 18 younger (aged 22-33 years) adults underwent resting-state functional MRI scanning. Four canonical resting-state networks, including the default mode network (DMN), executive control network (ECN), dorsal attention network (DAN) and salience network, were extracted, and the functional connectivities in these canonical networks were compared between the younger and older groups. We found distinct, disruptive alterations present in the large-scale aging-related resting brain networks: the ECN was affected the most, followed by the DAN. However, the DMN and salience networks showed limited functional connectivity disruption. The visual network served as a control and was similarly preserved in both groups. Our findings suggest that the aged brain is characterized by selective vulnerability in large-scale brain networks. These results could help improve our understanding of the mechanism of degeneration in the aging brain. Additional work is warranted to determine whether selective alterations in the intrinsic networks are related to impairments in behavioral performance.	[Zhang, Hong-Ying; Chen, Wen-Xin; Wu, Jing-Tao] Yangzhou Univ, Subei Peoples Hosp Jiangsu Prov, Dept Radiol, Yangzhou, Peoples R China; [Jiao, Yun] Southeast Univ, Jiangsu Key Lab Mol & Funct Imaging, Nanjing, Jiangsu, Peoples R China; [Xu, Yao] Yangzhou Univ, Subei Peoples Hosp Jiangsu Prov, Dept Neurol, Yangzhou, Peoples R China; [Zhang, Xiang-Rong] Southeast Univ, Zhongda Hosp, Dept Psychiat, Nanjing, Jiangsu, Peoples R China	Yangzhou University; Southeast University - China; Yangzhou University; Southeast University - China	Wu, JT (corresponding author), Yangzhou Univ, Subei Peoples Hosp Jiangsu Prov, Dept Radiol, Yangzhou, Peoples R China.	wujingtaodoctor@126.com	Wu, Jing/GZK-5063-2022		Social Development and Scientific and Technology Project of Yangzhou [YZ2011087]; National Natural Science Foundation of China [81471642, 30870704, 81271739, 91132727]; National Program on Key Basic Research Project of China [2013CB733800, 2013CB733803, 2010CB529602]; Jiangsu Province Natural Science Foundation of China [BK2012747]	Social Development and Scientific and Technology Project of Yangzhou; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key Basic Research Project of China(National Basic Research Program of China); Jiangsu Province Natural Science Foundation of China(Natural Science Foundation of Jiangsu Province)	This work was supported in part by grant YZ2011087 from the Social Development and Scientific and Technology Project of Yangzhou; grants 81471642, 30870704, 81271739, and 91132727 from the National Natural Science Foundation of China; grants 2013CB733800, 2013CB733803, and 2010CB529602 from the National Program on Key Basic Research Project of China; and grant BK2012747 from Jiangsu Province Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Ansado J, 2012, BRAIN RES; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Braver TS, 2002, NEUROSCI BIOBEHAV R, V26, P809, DOI 10.1016/S0149-7634(02)00067-2; Bressler SL, 2001, TRENDS COGN SCI, V5, P26, DOI 10.1016/S1364-6613(00)01564-3; Bryan J, 2000, J CLIN EXP NEUROPSYC, V22, P40, DOI 10.1076/1380-3395(200002)22:1;1-8;FT040; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cao M, 2014, DEV COGN NEUROS-NETH, V7, P76, DOI 10.1016/j.dcn.2013.11.004; Clapp WC, 2011, P NATL ACAD SCI USA, V108, P7212, DOI 10.1073/pnas.1015297108; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Diamond A, 2004, AM J PSYCHIAT, V161, P125, DOI 10.1176/appi.ajp.161.1.125; Dolcos F, 2002, NEUROSCI BIOBEHAV R, V26, P819, DOI 10.1016/S0149-7634(02)00068-4; Ferreira LK, 2013, NEUROSCI BIOBEHAV R, V37, P384, DOI 10.1016/j.neubiorev.2013.01.017; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Geerligs L, 2014, CEREB CORTEX; Gianaros PJ, 2009, BIOL PSYCHIAT, V65, P943, DOI 10.1016/j.biopsych.2008.10.007; Gotz J, 2009, J ALZHEIMERS DIS, V18, P243, DOI 10.3233/JAD-2009-1143; Goh JO, 2009, RESTOR NEUROL NEUROS, V27, P391, DOI 10.3233/RNN-2009-0493; Goh JOS, 2011, AGING DIS, V2, P30; Grady CL, 2010, CEREB CORTEX, V20, P1432, DOI 10.1093/cercor/bhp207; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guo CC, 2012, NEUROIMAGE, V61, P1471, DOI 10.1016/j.neuroimage.2012.03.027; Gutchess AH, 2005, J COGNITIVE NEUROSCI, V17, P84, DOI 10.1162/0898929052880048; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hayasaka S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00880; Hedden T, 2005, CURR OPIN NEUROL, V18, P740, DOI 10.1097/01.wco.0000189875.29852.48; Koch W, 2010, NEUROIMAGE, V51, P280, DOI 10.1016/j.neuroimage.2009.12.008; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; Kukolja J, 2009, NEUROBIOL AGING, V30, P630, DOI 10.1016/j.neurobiolaging.2007.08.015; la Fougere C, 2011, NEUROIMAGE, V56, P951, DOI 10.1016/j.neuroimage.2010.11.015; Li SJ, 2000, MAGNET RESON MED, V43, P45, DOI 10.1002/(SICI)1522-2594(200001)43:1<45::AID-MRM6>3.0.CO;2-0; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Madden DJ, 2004, CEREB CORTEX, V14, P143, DOI 10.1093/cercor/bhg113; Mather M, 2012, ANN NY ACAD SCI, V1251, P33, DOI 10.1111/j.1749-6632.2012.06471.x; Meindl T, 2010, HUM BRAIN MAPP, V31, P237, DOI 10.1002/hbm.20860; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Morrison JH, 2002, PROG BRAIN RES, V136, P467; Morrison JH, 2007, INT REV NEUROBIOL, V81, P41, DOI 10.1016/S0074-7742(06)81004-4; Nashiro K, 2012, GERONTOLOGY, V58, P156, DOI 10.1159/000328465; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Onoda K, 2012, J COGNITIVE NEUROSCI, V24, P2186, DOI 10.1162/jocn_a_00269; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Persson J, 2006, PROG BRAIN RES, V157, P45, DOI 10.1016/S0079-6123(06)57004-9; Reuter-Lorenz PA, 2010, J GERONTOL B-PSYCHOL, V65, P405, DOI 10.1093/geronb/gbq035; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Seeley WW, 2008, CURR OPIN NEUROL, V21, P701, DOI 10.1097/WCO.0b013e3283168e2d; Silver H, 2009, DEMENT GERIATR COGN, V27, P292, DOI 10.1159/000204916; Smith EE, 2001, P NATL ACAD SCI USA, V98, P2095, DOI 10.1073/pnas.98.4.2095; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Wang L, 2010, NEUROIMAGE, V51, P910, DOI 10.1016/j.neuroimage.2010.02.046; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Wang X, 2013, NEUROSCIENCE, V254, P404, DOI 10.1016/j.neuroscience.2013.09.009; Wang XK, 2010, CURR GENOMICS, V11, P618, DOI 10.2174/138920210793360943; Washington SD, 2014, HUM BRAIN MAPP, V35, P1284, DOI 10.1002/hbm.22252; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010; Wu JT, 2011, NEUROSCI LETT, V504, P62, DOI 10.1016/j.neulet.2011.08.059; Wu T, 2007, NEUROSCI LETT, V422, P164, DOI 10.1016/j.neulet.2007.06.011; ZEZULA J, 1988, NEUROSCIENCE, V25, P771, DOI 10.1016/0306-4522(88)90036-X; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075; Zhou SS, 2011, BRAIN COGNITION, V75, P205, DOI 10.1016/j.bandc.2010.12.003; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	81	32	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108807	10.1371/journal.pone.0108807	http://dx.doi.org/10.1371/journal.pone.0108807			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271846	gold, Green Submitted, Green Published			2022-12-27	WOS:000343729600063
J	Wakasugi, M; Kazama, JJ; Narita, I; Iseki, K; Moriyama, T; Yamagata, K; Fujimoto, S; Tsuruya, K; Asahi, K; Konta, T; Kimura, K; Kondo, M; Kurahashi, I; Ohashi, Y; Watanabe, T				Wakasugi, Minako; Kazama, Junichiro James; Narita, Ichiei; Iseki, Kunitoshi; Moriyama, Toshiki; Yamagata, Kunihiro; Fujimoto, Shouichi; Tsuruya, Kazuhiko; Asahi, Koichi; Konta, Tsuneo; Kimura, Kenjiro; Kondo, Masahide; Kurahashi, Issei; Ohashi, Yasuo; Watanabe, Tsuyoshi			Association between Combined Lifestyle Factors and Non-Restorative Sleep in Japan: A Cross-Sectional Study Based on a Japanese Health Database	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; NONRESTORATIVE SLEEP; CIGARETTE-SMOKING; RISK-FACTOR; ALCOHOL-CONSUMPTION; PRIMARY PREVENTION; COMBINED IMPACT	Background: Although lifestyle factors such as cigarette smoking, excessive drinking, obesity, low or no exercise, and unhealthy dietary habits have each been associated with inadequate sleep, little is known about their combined effect. The aim of this study was to quantify the overall impact of lifestyle-related factors on non-restorative sleep in the general Japanese population. Methods and Findings: A cross-sectional study of 243,767 participants (men, 39.8%) was performed using the Specific Health Check and Guidance System in Japan. A healthy lifestyle score was calculated by adding up the number of low-risk lifestyle factors for each participant. Low risk was defined as (1) not smoking, (2) body mass index,<25 kg/m(2), (3) moderate or less alcohol consumption, (4) regular exercise, and (5) better eating patterns. Logistic regression analysis was used to examine the relationship between the score and the prevalence of non-restorative sleep, which was determined from questionnaire responses. Among 97,062 men (mean age, 63.9 years) and 146,705 women (mean age, 63.7 years), 18,678 (19.2%) and 38,539 (26.3%) reported non-restorative sleep, respectively. The prevalence of non-restorative sleep decreased with age for both sexes. Compared to participants with a healthy lifestyle score of 5 (most healthy), those with a score of 0 (least healthy) had a higher prevalence of non-restorative sleep (odds ratio, 1.59 [95% confidence interval, 1.29-1.97] for men and 2.88 [1.74-4.76] for women), independently of hypertension, hypercholesterolemia, diabetes, and chronic kidney disease. The main limitation of the study was the cross-sectional design, which limited causal inferences for the identified associations. Conclusions: A combination of several unhealthy lifestyle factors was associated with non-restorative sleep among the general Japanese population. Further studies are needed to establish whether general lifestyle modification improves restorative sleep.	[Wakasugi, Minako] Niigata Univ, Grad Sch Med & Dent Sci, Ctr Interorgan Commun Res, Niigata, Japan; [Kazama, Junichiro James] Niigata Univ, Grad Sch Med & Dent Sci, Dept Clin Nephrol & Rheumatol, Niigata, Japan; [Narita, Ichiei; Iseki, Kunitoshi; Moriyama, Toshiki; Yamagata, Kunihiro; Fujimoto, Shouichi; Tsuruya, Kazuhiko; Asahi, Koichi; Konta, Tsuneo; Kimura, Kenjiro; Kondo, Masahide; Watanabe, Tsuyoshi] Steering Comm Design Comprehens Hlth Care Syst Ch, Fukushima, Japan; [Kurahashi, Issei] iAnalysis LLC, Tokyo, Japan; [Ohashi, Yasuo] Chuo Univ, Dept Integrated Sci & Engn Sustainable Soc, Tokyo 112, Japan	Niigata University; Niigata University; Chuo University	Wakasugi, M (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Ctr Interorgan Commun Res, Niigata, Japan.	minakowa@med.niigata-u.ac.jp	Wakasugi, Minako/D-6814-2018; Narita, Ichiei/G-5204-2017; Konta, Tsuneo/AAO-9286-2021	Wakasugi, Minako/0000-0003-1555-7736; Narita, Ichiei/0000-0001-7692-3096; 	Ministry of Health, Labor, and Welfare of Japan [H24-intractible(renal)-ippan-006]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a Health and Labor Sciences Research Grant for "Design of a comprehensive health care system for chronic kidney disease (CKD) based on individual risk assessment by Specific Health Checkups'' (H24-intractible(renal)-ippan-006) from the Ministry of Health, Labor, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MA, 2003, CIRCULATION, V107, P443, DOI 10.1161/01.CIR.0000045669.16499.EC; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Averina M, 2006, ATHEROSCLEROSIS, V188, P309, DOI 10.1016/j.atherosclerosis.2005.11.007; Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Bazzano LA, 2003, ANN INTERN MED, V138, P891, DOI 10.7326/0003-4819-138-11-200306030-00010; Brand S, 2010, J ADOLESCENT HEALTH, V46, P133, DOI 10.1016/j.jadohealth.2009.06.018; Brower KJ, 2003, SLEEP MED REV, V7, P523, DOI 10.1016/S1087-0792(03)90005-0; Chandola T, 2010, SLEEP, V33, P739, DOI 10.1093/sleep/33.6.739; Chang ET, 2009, ARCH INTERN MED, V169, P717, DOI 10.1001/archinternmed.2009.29; Chaput JP, 2008, SLEEP, V31, P517, DOI 10.1093/sleep/31.4.517; Chiuve SE, 2006, CIRCULATION, V114, P160, DOI 10.1161/CIRCULATIONAHA.106.621417; Chiuve SE, 2011, JAMA-J AM MED ASSOC, V306, P62, DOI 10.1001/jama.2011.907; Choi J, 2013, OBES REV, V14, P232, DOI 10.1111/obr.12003; Davies HTO, 1998, BRIT MED J, V316, P989, DOI 10.1136/bmj.316.7136.989; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Gangwisch JE, 2007, SLEEP, V30, P1667, DOI 10.1093/sleep/30.12.1667; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Gangwisch JE, 2005, SLEEP, V28, P1289, DOI 10.1093/sleep/28.10.1289; Grandner MA, 2014, J SLEEP RES, V23, P22, DOI 10.1111/jsr.12084; Grandner MA, 2013, J CLIN SLEEP MED, V9, P897, DOI 10.5664/jcsm.2990; HARRISON NA, 1989, BRIT J UROL, V63, P202, DOI 10.1111/j.1464-410X.1989.tb05166.x; Hasler G, 2004, SLEEP, V27, P661, DOI 10.1093/sleep/27.4.661; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Jiao L, 2009, ARCH INTERN MED, V169, P764, DOI 10.1001/archinternmed.2009.46; Johnson TV, 2013, MOL DIAGN THER, V17, P147, DOI 10.1007/s40291-013-0026-7; Kaneita Y, 2008, SLEEP, V31, P645, DOI 10.1093/sleep/31.5.645; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Kim BS, 2012, SOC PSYCH PSYCH EPID, V47, P2019, DOI 10.1007/s00127-012-0502-0; Kim K, 2000, SLEEP, V23, P41; Kim S, 2011, PUBLIC HEALTH NUTR, V14, P889, DOI 10.1017/S136898001000296X; Kohro T, 2008, INT HEART J, V49, P193, DOI 10.1536/ihj.49.193; Leger D, 2010, SLEEP MED, V11, P987, DOI 10.1016/j.sleep.2010.04.019; Liu K, 2012, CIRCULATION, V125, P996, DOI 10.1161/CIRCULATIONAHA.111.060681; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Morgan K, 2003, J SLEEP RES, V12, P231, DOI 10.1046/j.1365-2869.2003.00355.x; Ohayon MM, 2005, ARCH INTERN MED, V165, P35, DOI 10.1001/archinte.165.1.35; Ohayon MM, 2002, J PSYCHOSOM RES, V53, P593, DOI 10.1016/S0022-3999(02)00449-X; Patel SR, 2006, AM J EPIDEMIOL, V164, P947, DOI 10.1093/aje/kwj280; Peuhkuri K, 2012, NUTR RES, V32, P309, DOI 10.1016/j.nutres.2012.03.009; PHILLIPS BA, 1995, ARCH INTERN MED, V155, P734, DOI 10.1001/archinte.155.7.734; Phillips B, 2005, J CLIN SLEEP MED, V1, P277; Platz EA, 2000, CANCER CAUSE CONTROL, V11, P579, DOI 10.1023/A:1008999232442; Qin LQ, 2003, LIFE SCI, V73, P2467, DOI 10.1016/S0024-3205(03)00628-3; Roth T, 2010, SLEEP, V33, P449, DOI 10.1093/sleep/33.4.449; Sasazuki S, 2012, PREV MED, V54, P112, DOI 10.1016/j.ypmed.2011.11.003; Seino Y., 2010, Journal of the Japan Diabetes Society, V53, P450, DOI 10.1111/j.2040-1124.2010.00074.x; Shochat T, 2012, NAT SCI SLEEP, V4, P19, DOI 10.2147/NSS.S18891; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; The Office for Lifestyle-Related Diseases Control GAD Health Service Bureau Ministry of Health Labour and Welfare of Japan, 2006, EX PHYS ACT GUID HLT; Tsuruya K, 2014, ATHEROSCLEROSIS, V233, P260, DOI 10.1016/j.atherosclerosis.2013.12.037; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; van Leeuwen WMA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004589; Vernon MK, 2010, SLEEP MED REV, V14, P205, DOI 10.1016/j.smrv.2009.10.002; Wakasugi M, 2013, HYPERTENS RES, V36, P328, DOI 10.1038/hr.2012.186; WETTER DW, 1994, PREV MED, V23, P328, DOI 10.1006/pmed.1994.1046; Yamamoto R, 2012, AM J KIDNEY DIS, V59, P343, DOI 10.1053/j.ajkd.2011.08.032; Zhang JH, 2013, SLEEP, V36, P671, DOI 10.5665/sleep.2624	60	37	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108718	10.1371/journal.pone.0108718	http://dx.doi.org/10.1371/journal.pone.0108718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268956	gold, Green Published			2022-12-27	WOS:000343671700146
J	Wang, Y; Sun, HY; Du, W; Blanzieri, E; Viero, G; Xu, Y; Liang, YC				Wang, Yan; Sun, Huiyan; Du, Wei; Blanzieri, Enrico; Viero, Gabriella; Xu, Ying; Liang, Yanchun			Identification of Essential Proteins Based on Ranking Edge-Weights in Protein-Protein Interaction Networks	PLOS ONE			English	Article							CENTRALITY; TRANSLATION; COMPLEX; COMMUNITIES; INTEGRATION; EXPRESSION; MATURATION; DISCOVERY; DATABASE; FAMILY	Essential proteins are those that are indispensable to cellular survival and development. Existing methods for essential protein identification generally rely on knock-out experiments and/or the relative density of their interactions (edges) with other proteins in a Protein-Protein Interaction (PPI) network. Here, we present a computational method, called EW, to first rank protein-protein interactions in terms of their Edge Weights, and then identify sub-PPI-networks consisting of only the highly-ranked edges and predict their proteins as essential proteins. We have applied this method to publicly-available PPI data on Saccharomyces cerevisiae (Yeast) and Escherichia coli (E. coli) for essential protein identification, and demonstrated that EW achieves better performance than the state-of-the-art methods in terms of the precision-recall and Jackknife measures. The highly-ranked protein-protein interactions by our prediction tend to be biologically significant in both the Yeast and E. coli PPI networks. Further analyses on systematically perturbed Yeast and E. coli PPI networks through randomly deleting edges demonstrate that the proposed method is robust and the top-ranked edges tend to be more associated with known essential proteins than the lowly-ranked edges.	[Wang, Yan; Sun, Huiyan; Du, Wei; Xu, Ying; Liang, Yanchun] Jilin Univ, Coll Comp Sci & Technol, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun 130023, Peoples R China; [Wang, Yan; Blanzieri, Enrico] Univ Trento, Dept Informat & Commun Technol, Povo, Italy; [Viero, Gabriella] Univ Trento, Natl Res Council, Inst Biophys, Povo, Italy; [Wang, Yan; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; [Wang, Yan; Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	Jilin University; University of Trento; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Trento; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Liang, YC (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun 130023, Peoples R China.	blanzier@disi.unitn.it; ycliang@jlu.edu.cn	Sun, Huiyan/Y-4461-2018; Viero, Gabriella/G-2096-2012; Du, Wei/J-9804-2015	Sun, Huiyan/0000-0002-4664-7147; Viero, Gabriella/0000-0002-6755-285X; Du, Wei/0000-0001-9872-4821; Blanzieri, Enrico/0000-0001-6524-0601	Natural Science Foundation of China [61272207, 61402194, 61472159]; Jilin Innovation Team Project [20122805]; Science-Technology Development Project from Jilin Province [20140101180JC]; Erasmus Nundus Programme, Action 2, ONE MORE STEP	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Innovation Team Project; Science-Technology Development Project from Jilin Province; Erasmus Nundus Programme, Action 2, ONE MORE STEP	This work was supported by the Natural Science Foundation of China [61272207, 61402194, 61472159], http://www.nsfc.gov.cn; Jilin Innovation Team Project [20122805], http://kjt.jl.gov.cn/kjt/4/tindex.shtml; Science-Technology Development Project from Jilin Province [20140101180JC], http://kjt.jl.gov.cn/kjt/4/tindex.shtml; Erasmus Nundus Programme, Action 2, ONE MORE STEP, http://www.one-more-step.eu/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Chen WH, 2012, NUCLEIC ACIDS RES, V40, pD901, DOI 10.1093/nar/gkr986; Cohen-Or I, 2010, RES MICROBIOL, V161, P694, DOI [10.1016/j.resmic.2010.06.009, 10.1016/J.resmic.2010.06.009]; Cullen LM, 2005, IMMUNOL CELL BIOL, V83, P217, DOI 10.1111/j.1440-1711.2005.01332.x; Du YCN, 2002, CELL, V109, P835, DOI 10.1016/S0092-8674(02)00773-0; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Holman AG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-243; Hong B, 1997, MOL CELL BIOL, V17, P378, DOI 10.1128/MCB.17.1.378; Horsey EW, 2004, RNA, V10, P813, DOI 10.1261/rna.5255804; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Jukes TH, 1969, EVOLUTION PROTEIN MO; Kearse MG, 2011, NUCLEIC ACIDS RES, V39, P2701, DOI 10.1093/nar/gkq1218; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lebreton A, 2006, J BIOL CHEM, V281, P27099, DOI 10.1074/jbc.M602199200; Li M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-15; Li M, 2010, LECT N BIOINFORMAT, V6053, P89; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; LINDAHL L, 1983, CELL, V33, P241, DOI 10.1016/0092-8674(83)90353-7; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; Miles TD, 2005, MOL CELL BIOL, V25, P10419, DOI 10.1128/MCB.25.23.10419-10432.2005; Moll I, 2002, MOL MICROBIOL, V44, P1387, DOI 10.1046/j.1365-2958.2002.02971.x; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Peng W, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-87; Pereira-Leal JB, 2005, MOL BIOL EVOL, V22, P421, DOI 10.1093/molbev/msi024; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Reigstad CS, 2007, J BIOL CHEM, V282, P21259, DOI 10.1074/jbc.M611502200; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Saleh A, 1998, J BIOL CHEM, V273, P26559, DOI 10.1074/jbc.273.41.26559; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; STEPHENSON K, 1989, SOC NETWORKS, V11, P1, DOI 10.1016/0378-8733(89)90016-6; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wang JX, 2012, IEEE ACM T COMPUT BI, V9, P1070, DOI 10.1109/TCBB.2011.147; Wuchty S, 2003, J THEOR BIOL, V223, P45, DOI 10.1016/S0022-5193(03)00071-7; Wuchty S, 2002, PROTEOMICS, V2, P1715, DOI 10.1002/1615-9861(200212)2:12<1715::AID-PROT1715>3.0.CO;2-O; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; YU H, 2004, RNA, V71, P817; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zaki Nazar, 2008, Engineering Letters, V16, P505	56	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108716	10.1371/journal.pone.0108716	http://dx.doi.org/10.1371/journal.pone.0108716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268881	gold, Green Published			2022-12-27	WOS:000343671700145
J	Yang, Y; Zhang, J; Yan, H				Yang, Ye; Zhang, Jie; Yan, Hong			Comparison of Combined and Sequential Surgery for Proliferative Diabetic Retinopathy: A Single Surgeon Study	PLOS ONE			English	Article							INTRAOCULAR-LENS IMPLANTATION; PARS-PLANA VITRECTOMY; EXTRACAPSULAR CATARACT-EXTRACTION; ENDOTHELIAL GROWTH-FACTOR; NEOVASCULAR GLAUCOMA; PHACOEMULSIFICATION; COMPLICATIONS; PROGRESSION; EYES	Purpose: To compare the results of combined and consecutive surgeries to treat proliferative diabetic retinopathy and cataract. Methods: Retrospective comparative study. Forty-one patients with proliferative diabetic retinopathy (PDR) were enrolled. Twenty-nine eyes for the combined surgery group and twelve eyes for the sequential group were included. All surgeries were performed by one surgeon. Phacoemulsification was performed using a clear cornea incision. The vitrectomy was performed using a 20-gauge vitreous cutter. Results: The best corrected visual acuity (BCVA) and intra- and post-operative complications were the main outcome measures. In the combined surgery group, the BCVA increased in 18 (62.1%) eyes, while eight (27.6%) eyes remained stable and three (10.3%) eyes decreased. Postoperative complications included fibrinous exudation in nine eyes, macular edema in three eyes and vitreous hemorrhage in three eyes. In the sequential surgery group, the BCVA increased in seven (58.3%) eyes, remained the same in four (33.3%) eyes and was reduced in one (8.3%) eye. Postoperative complications included macular edema in two eyes, neovascular glaucoma in two eyes and vitreous hemorrhage in one eye. Conclusions: Both combined and sequential surgeries are safe and effective for treating PDR and cataracts. The combined surgery had a higher incidence of fibrinous exudation.	[Yang, Ye; Zhang, Jie; Yan, Hong] Fourth Mil Med Univ, Dept Ophthalmol, Tangdu Hosp, Xian 710032, Peoples R China; [Yang, Ye] Chinese Peoples Liberat Army 451 Hosp, Xian, Shaanxi, Peoples R China	Air Force Military Medical University	Yan, H (corresponding author), Fourth Mil Med Univ, Dept Ophthalmol, Tangdu Hosp, Xian 710032, Peoples R China.	yhongb@fmmu.edu.cn						ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; BLANKENSHIP GW, 1980, ARCH OPHTHALMOL-CHIC, V98, P2196, DOI 10.1001/archopht.1980.01020041048008; Canan H, 2013, CLIN OPHTHALMOL, V7, P1597, DOI 10.2147/OPTH.S47780; Chang MA, 2002, OPHTHALMOLOGY, V109, P948, DOI 10.1016/S0161-6420(01)01010-7; Demetriades AM, 2003, AM J OPHTHALMOL, V135, P291, DOI 10.1016/S0002-9394(02)01972-4; Douglas MJ, 2003, OPHTHALMIC SUR LA IM, V34, P270; Funatsu H, 2004, BRIT J OPHTHALMOL, V88, P1064, DOI 10.1136/bjo.2003.032656; Herrmann WA, 2010, OPHTHALMOLOGE, V107, P975, DOI 10.1007/s00347-010-2236-2; Honjo M, 1998, OPHTHALMIC SURG LAS, V29, P99; Kadonosono K, 2001, OPHTHALMIC SURG LAS, V32, P19; Lahey JM, 2003, OPHTHALMOLOGY, V110, P1335, DOI 10.1016/S0161-6420(03)00454-8; Muselier A, 2010, AM J OPHTHALMOL, V150, P387, DOI 10.1016/j.ajo.2010.04.008; PAVESE T, 1987, J CATARACT REFR SURG, V13, P197, DOI 10.1016/S0886-3350(87)80135-9; POLINER LS, 1985, AM J OPHTHALMOL, V100, P637, DOI 10.1016/0002-9394(85)90617-8; Rivas-Aguiño P., 2009, Arch Soc Esp Oftalmol, V84, P31; Sadiq SA, 1995, EYE, V9, P728, DOI 10.1038/eye.1995.185; Schiff WM, 2007, OPHTHALMOLOGY, V114, P544, DOI 10.1016/j.ophtha.2006.08.017; Smiddy WE, 2004, RETINA-J RET VIT DIS, V24, P574, DOI 10.1097/00006982-200408000-00011; THOMPSON JT, 1995, AM J OPHTHALMOL, V119, P48, DOI 10.1016/S0002-9394(14)73812-7; Treumer F, 2006, GRAEF ARCH CLIN EXP, V244, P808, DOI 10.1007/s00417-005-0146-9; Tseng HY, 2007, KAOHSIUNG J MED SCI, V23, P339, DOI 10.1016/S1607-551X(09)70419-X; Vatavuk Z, 2005, COLLEGIUM ANTROPOL, V29, P13	22	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108933	10.1371/journal.pone.0108933	http://dx.doi.org/10.1371/journal.pone.0108933			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268829	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700195
J	Rey, MD; Prieto, P				Rey, Maria-Dolores; Prieto, Pilar			Dynamics of DNA Replication during Premeiosis and Early Meiosis in Wheat	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; FLOW CYTOMETRIC DETERMINATION; PLANT-CELL CYCLE; MEIOTIC S-PHASE; TRITICUM-AESTIVUM; PH1 LOCUS; HORDEUM-CHILENSE; COMMON WHEAT; PHOSPHORYLATION; CHROMOSOMES	Meiosis is a specialised cell division that involves chromosome replication, two rounds of chromosome segregation and results in the formation of the gametes. Meiotic DNA replication generally precedes chromosome pairing, recombination and synapsis in sexually developing eukaryotes. In this work, replication has been studied during premeiosis and early meiosis in wheat using flow cytometry, which has allowed the quantification of the amount of DNA in wheat anther in each phase of the cell cycle during premeiosis and each stage of early meiosis. Flow cytometry has been revealed as a suitable and user-friendly tool to detect and quantify DNA replication during early meiosis in wheat. Chromosome replication was detected in wheat during premeiosis and early meiosis until the stage of pachytene, when chromosomes are associated in pairs to further recombine and correctly segregate in the gametes. In addition, the effect of the Ph1 locus, which controls chromosome pairing and affects replication in wheat, was also studied by flow cytometry. Here we showed that the Ph1 locus plays an important role on the length of meiotic DNA replication in wheat, particularly affecting the rate of replication during early meiosis in wheat.	[Rey, Maria-Dolores; Prieto, Pilar] Agencia Estatal Consejo Super Invest Cient CSIC, Dept Plant Breeding, Inst Sustainable Agr, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Prieto, P (corresponding author), Agencia Estatal Consejo Super Invest Cient CSIC, Dept Plant Breeding, Inst Sustainable Agr, Cordoba, Spain.	pilar.prieto@ias.csic.es	Rey, María-Dolores/I-3931-2018; Prieto, Pilar/N-6394-2014	Rey, María-Dolores/0000-0002-6967-8536; Prieto, Pilar/0000-0002-8160-808X	FP7 [ERC-StG-243118]; The European Regional Development Fund (FEDER) from the European Union	FP7; The European Regional Development Fund (FEDER) from the European Union	This research was supported by grant ERC-StG-243118 from the FP7 and The European Regional Development Fund (FEDER) from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kaff N, 2008, ANN BOT-LONDON, V101, P863, DOI 10.1093/aob/mcm252; Alexandrow MG, 2005, J CELL BIOL, V168, P875, DOI 10.1083/jcb.200409055; AragonAlcaide L, 1996, CHROMOSOMA, V105, P261, DOI 10.1007/BF02524643; BENNETT MD, 1972, PROC R SOC SER B-BIO, V181, P81, DOI 10.1098/rspb.1972.0041; BINO RJ, 1993, ANN BOT-LONDON, V72, P181, DOI 10.1006/anbo.1993.1097; BINO RJ, 1992, ANN BOT-LONDON, V69, P231, DOI 10.1093/oxfordjournals.aob.a088335; Brito G, 2010, TREES-STRUCT FUNCT, V24, P723, DOI 10.1007/s00468-010-0442-9; Cha RS, 2000, GENE DEV, V14, P493; Colas I, 2008, P NATL ACAD SCI USA, V105, P6075, DOI 10.1073/pnas.0801521105; COLLINS I, 1994, MOL CELL BIOL, V14, P3524, DOI 10.1128/MCB.14.5.3524; COX AV, 1993, ANN BOT-LONDON, V72, P239, DOI 10.1006/anbo.1993.1104; Dolezel J, 2005, ANN BOT-LONDON, V95, P99, DOI 10.1093/aob/mci005; Dolezel J, 1998, CURRENT TOPICS IN PLANT CYTOGENETICS RELATED TO PLANT IMPROVEMENT, P80; DROUIN R, 1991, CYTOGENET CELL GENET, V57, P91, DOI 10.1159/000133121; Forsburg SL, 2000, NAT GENET, V25, P263, DOI 10.1038/77015; Forsburg SL, 2002, MOL CELL, V9, P703, DOI 10.1016/S1097-2765(02)00508-7; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; GRALLERT B, 1991, CURR GENET, V20, P199, DOI 10.1007/BF00326233; Greer E, 2012, PLANT CELL, V24, P152, DOI 10.1105/tpc.111.094771; Griffiths S, 2006, NATURE, V439, P749, DOI 10.1038/nature04434; Gutierrez C, 1998, CURR OPIN PLANT BIOL, V1, P492, DOI 10.1016/S1369-5266(98)80041-1; Harper JW, 2001, CHEM REV, V101, P2511, DOI 10.1021/cr0001030; Hernandez P, 2001, THEOR APPL GENET, V102, P1259, DOI 10.1007/s001220000514; HOLM PB, 1977, CARLSBERG RES COMMUN, V42, P249, DOI 10.1007/BF02910453; HOTTA Y, 1961, J BIOPHYS BIOCHEM CY, V11, P311, DOI 10.1083/jcb.11.2.311; Huntley RP, 1999, CURR OPIN PLANT BIOL, V2, P440, DOI 10.1016/S1369-5266(99)00027-8; Jasencakova Z, 2001, CHROMOSOMA, V110, P83, DOI 10.1007/s004120100132; Jordan P, 2006, BIOCHEM SOC T, V34, P545, DOI 10.1042/BST0340545; Kotogany E, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-5; Leus L, 2009, ACTA HORTIC, V836, P221, DOI 10.17660/ActaHortic.2009.836.31; LIMA-DE-FARIA A, 1968, Hereditas (Lund), V60, P249; LIMADEFARIA A, 1966, HEREDITAS-GENETISK A, V56, P398; Mironov V, 1999, PLANT CELL, V11, P509; MUKHERJEE AB, 1968, NATURE, V219, P489, DOI 10.1038/219489a0; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; OKAMOTO M., 1957, Wheat Information Service, pp; ORMEROD MG, 1987, CYTOMETRY, V8, P637, DOI 10.1002/cyto.990080617; Prieto P, 2004, HEREDITAS, V141, P122, DOI 10.1111/j.1601-5223.2004.01825.x; Prieto P, 2004, NAT CELL BIOL, V6, P906, DOI 10.1038/ncb1168; RILEY R, 1958, NATURE, V182, P713, DOI 10.1038/182713a0; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sears E. R., 1958, Proceedings of the X International Congress of Genetics, McGill University, Montreal, Canada, August 20-27, 1958., V2, P258; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SIMCHEN G, 1974, GENETICS, V76, P745; Smith KN, 2001, CURR BIOL, V11, P88, DOI 10.1016/S0960-9822(01)00026-4; Stillman B, 1996, DNA REPLICATION IN E; Strich R, 2004, CURR TOP DEV BIOL, V61, P29, DOI 10.1016/S0070-2153(04)61002-7; Thomson AM, 2010, J CELL BIOL, V188, P209, DOI 10.1083/jcb.200911037; Vrana J, 2000, GENETICS, V156, P2033; Wang XW, 2002, CROP SCI, V42, P1365, DOI 10.2135/cropsci2002.1365; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; WIMBER DE, 1963, GENETICS, V48, P1731; Yousafzai FK, 2010, FUNCT INTEGR GENOMIC, V10, P147, DOI 10.1007/s10142-010-0171-6; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	55	3	3	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e107714	10.1371/journal.pone.0107714	http://dx.doi.org/10.1371/journal.pone.0107714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275307	gold, Green Submitted, Green Published			2022-12-27	WOS:000342591500007
J	Rimmele, TS; Chatton, JY				Rimmele, Theresa S.; Chatton, Jean-Yves			A Novel Optical Intracellular Imaging Approach for Potassium Dynamics in Astrocytes	PLOS ONE			English	Article							MOUSE CORTICAL ASTROCYTES; CENTRAL-NERVOUS-SYSTEM; GLUTAMATE UPTAKE; EXTRACELLULAR POTASSIUM; IN-SITU; ENERGY-METABOLISM; GLIAL-CELLS; GUINEA-PIG; SODIUM; RAT	Astrocytes fulfill a central role in regulating K+ and glutamate, both released by neurons into the extracellular space during activity. Glial glutamate uptake is a secondary active process that involves the influx of three Na+ ions and one proton and the efflux of one K+ ion. Thus, intracellular K+ concentration ([K+](i)) is potentially influenced both by extracellular K+ concentration ([K+](o)) fluctuations and glutamate transport in astrocytes. We evaluated the impact of these K+ ion movements on [K+] i in primary mouse astrocytes by microspectrofluorimetry. We established a new noninvasive and reliable approach to monitor and quantify [K+](i) using the recently developed K+ sensitive fluorescent indicator Asante Potassium Green-1 (APG-1). An in situ calibration procedure enabled us to estimate the resting [K+](i) at 13361 mM. We first investigated the dependency of [K+](i) levels on [K+](o). We found that [K+](i) followed [K+](o) changes nearly proportionally in the range 310 mM, which is consistent with previously reported microelectrode measurements of intracellular K+ concentration changes in astrocytes. We then found that glutamate superfusion caused a reversible drop of [K+](i) that depended on the glutamate concentration with an apparent EC50 of 11.1 +/- 1.4 mu M, corresponding to the affinity of astrocyte glutamate transporters. The amplitude of the [K+](i) drop was found to be 2.3 +/- 0.1 mu M for 200 mM glutamate applications. Overall, this study shows that the fluorescent K+ indicator APG-1 is a powerful new tool for addressing important questions regarding fine [K+](i) regulation with excellent spatial resolution.	[Rimmele, Theresa S.; Chatton, Jean-Yves] Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland; [Chatton, Jean-Yves] Univ Lausanne, Cellular Imaging Facil, Lausanne, Switzerland	University of Lausanne; University of Lausanne	Chatton, JY (corresponding author), Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland.	jean-yves.chatton@unil.ch		Chatton, Jean-Yves/0000-0002-8911-0315	Swiss National Science Foundation [31003A-135720]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work is supported by grant #31003A-135720 from the Swiss National Science Foundation to JY Chatton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedee T, 1997, GLIA, V21, P46, DOI 10.1002/(SICI)1098-1136(199709)21:1<46::AID-GLIA5>3.0.CO;2-#; Amzica F, 2002, J PHYSIOL-PARIS, V96, P209, DOI 10.1016/S0928-4257(02)00008-6; Anderson CM, 2000, GLIA, V32, P1; Azarias G, 2011, J NEUROSCI, V31, P3550, DOI 10.1523/JNEUROSCI.4378-10.2011; BALLANYI K, 1987, J PHYSIOL-LONDON, V382, P159, DOI 10.1113/jphysiol.1987.sp016361; Bernardinelli Y, 2004, P NATL ACAD SCI USA, V101, P14937, DOI 10.1073/pnas.0405315101; Bernardinelli Y, 2006, GLIA, V54, P460, DOI 10.1002/glia.20387; Chatton JY, 2000, EUR J NEUROSCI, V12, P3843, DOI 10.1046/j.1460-9568.2000.00269.x; Cholet N, 2002, CEREB CORTEX, V12, P515, DOI 10.1093/cercor/12.5.515; COLES JA, 1983, J PHYSIOL-LONDON, V340, P157, DOI 10.1113/jphysiol.1983.sp014756; COLES JA, 1989, GLIA, V2, P213, DOI 10.1002/glia.440020402; D'Ambrosio R, 2002, J NEUROPHYSIOL, V87, P87, DOI 10.1152/jn.00240.2001; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dufour S, 2011, J NEUROSCI METH, V194, P206, DOI 10.1016/j.jneumeth.2010.10.004; Dzubay JA, 1999, J NEUROSCI, V19, P5265; GARDNERMEDWIN AR, 1983, J PHYSIOL-LONDON, V335, P375, DOI 10.1113/jphysiol.1983.sp014540; HEINEMANN U, 1975, BRAIN RES, V93, P63, DOI 10.1016/0006-8993(75)90286-3; Hertz L, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00114; HOUNSGAARD J, 1983, J PHYSIOL-LONDON, V340, P359, DOI 10.1113/jphysiol.1983.sp014767; KASNER SE, 1992, AM J PHYSIOL, V262, pF462, DOI 10.1152/ajprenal.1992.262.3.F462; KETTENMANN H, 1983, J NEUROSCI, V3, P500; Kiedrowski L, 1999, MOL PHARMACOL, V56, P619, DOI 10.1124/mol.56.3.619; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Kozoriz MG, 2010, J BIOL CHEM; Lalo U, 2006, J NEUROSCI, V26, P2673, DOI 10.1523/JNEUROSCI.4689-05.2006; Lamy CM, 2011, NEUROIMAGE, V58, P572, DOI 10.1016/j.neuroimage.2011.06.074; Langer J, 2012, GLIA, V60, P239, DOI 10.1002/glia.21259; Langer J, 2009, J PHYSIOL-LONDON, V587, P5859, DOI 10.1113/jphysiol.2009.182279; Larsen BR, 2014, GLIA, V62, P608, DOI 10.1002/glia.22629; Leis JA, 2005, GLIA, V50, P407, DOI 10.1002/glia.20145; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Matos M, 2013, J NEUROSCI, V33, P18492, DOI 10.1523/JNEUROSCI.1828-13.2013; MEISINGSET KK, 1981, CYTOMETRY, V1, P272, DOI 10.1002/cyto.990010406; MINTA A, 1989, J BIOL CHEM, V264, P19449; Olsen M, 2012, METHODS MOL BIOL, V814, P265, DOI 10.1007/978-1-61779-452-0_18; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Rose CR, 2013, GLIA; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; SORG O, 1992, J NEUROSCI, V12, P4923; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; WUTTKE WA, 1990, J NEUROPHYSIOL, V63, P1089, DOI 10.1152/jn.1990.63.5.1089; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhou M, 2009, J NEUROSCI, V29, P8551, DOI 10.1523/JNEUROSCI.5784-08.2009	45	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109243	10.1371/journal.pone.0109243	http://dx.doi.org/10.1371/journal.pone.0109243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275375	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500080
J	Brown, JG				Brown, Jeffrey G.			Jaw Function in Smilodon fatalis: A Reevaluation of the Canine Shear-Bite and a Proposal for a New Forelimb-Powered Class 1 Lever Model	PLOS ONE			English	Article							PREDATORY BEHAVIOR; LATE MIOCENE; EVOLUTION; FORCE; CATS; PLEISTOCENE; MORPHOLOGY; CARNIVORA; ANATOMY; FELIDAE	The jaw function of Smilodon fatalis has long been a source of debate. Although modern-day lions subdue large prey through the use of a suffocating throat bite, the dramatically elongated maxillary canines of S. fatalis suggest an alternative bite mechanism. The current literature favors a "canine shear-bite,'' in which the depression of the cranium by the ventral neck flexors assists the mandibular adductors in closing the jaws. Although the model makes intuitive sense and appears to be supported by scientific data, the mechanical feasibility of "neck-powered'' biting has not been experimentally demonstrated. In the present study, the computer-assisted manipulation of digitized images of a high-quality replica of an S. fatalis neck and skull shows that a rotation of the cranium by the ventral neck flexors will not result in jaw closure. Instead, the cranium and mandible rotate ventrally together (at the atlantooccipital joint), and the jaws remain in an open configuration. The only manner by which rotation of the cranium can simultaneously result in jaw closure is by an anterior rotation at the temporomandibular joint. Based on this finding, the author proposes a new Class 1 lever mechanism for S. fatalis jaw function. In this model, the mandible is immobilized against the neck of the prey and a dorsally directed force from the extension of the forelimbs rotates the cranium anteriorly at the temporomandibular joint. The maxillary canines pierce the prey's neck and assist in clamping the ventral neck structures. The model is based on a maximum gape angle of approximately 90 degrees and incorporates a secondary virtual point of rotation located slightly anteroventral to the temporomandibular joint. The Class 1 Lever Model is mechanically feasible, consistent with current data on S. fatalis anatomy and ecology, and may provide a basis for similar studies on other fossil taxa.				brown.jeffreyg@gmail.com			STFC [ST/J001465/1] Funding Source: UKRI	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Abolhassani N, 2007, MED ENG PHYS, V29, P413, DOI 10.1016/j.medengphy.2006.07.003; Akersten WA., 1985, CANINE FUNCTION SMIL; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Andersson K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024971; Anton M, 2005, QUATERNARY SCI REV, V24, P1287, DOI 10.1016/j.quascirev.2004.09.008; Anton M, 2004, J VERTEBR PALEONTOL, V24, P957, DOI 10.1671/0272-4634(2004)024[0957:FKCSOT]2.0.CO;2; Anton M, 2004, ZOOL J LINN SOC-LOND, V140, P207, DOI 10.1111/j.1096-3642.2003.00093.x; Anton M, 1999, J VERTEBR PALEONTOL, V19, P771, DOI 10.1080/02724634.1999.10011190; Anyonge W, 1996, J MAMMAL, V77, P1059, DOI 10.2307/1382786; Atkins T, 2009, SCI ENG CUTTING; Biknevicius AR, 1996, J VERTEBR PALEONTOL, V16, P510, DOI 10.1080/02724634.1996.10011336; Biknevicius Audrone R., 1996, P393; Bourke J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002200; Brakefield T, 1996, BIG CATS KINGDOM MIG; Bryant Harold N., 1996, P283; Budras KD, 2003, ANATOMY HORSE; Christiansen P, 2008, J MAMM EVOL, V15, P155, DOI 10.1007/s10914-007-9069-z; Christiansen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002807; Christiansen P, 2007, ZOOL J LINN SOC-LOND, V151, P423, DOI 10.1111/j.1096-3642.2007.00321.x; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; Christiansen P, 2011, ZOOL J LINN SOC-LOND, V162, P220, DOI 10.1111/j.1096-3642.2010.00675.x; Coltrain JB, 2004, PALAEOGEOGR PALAEOCL, V205, P199, DOI 10.1016/j.palaeo.2003.12.008; Dumont ER, 2003, J EXP BIOL, V206, P2117, DOI 10.1242/jeb.00375; Elster P, 2009, ANATOMICAL ATLAS EQU; EMERSON SB, 1980, PALEOBIOLOGY, V6, P295, DOI 10.1017/S0094837300006813; Ewer, 1998, CARNIVORES; Figueirido B, 2011, PALEOBIOLOGY, V37, P490, DOI 10.1666/09062.1; Freeman PW, 2007, J ZOOL, V273, P273, DOI 10.1111/j.1469-7998.2007.00325.x; Freeman PW, 2006, J ZOOL, V269, P51, DOI 10.1111/j.1469-7998.2006.00049.x; Hamill J, 2009, BIOMECHANICAL BASIS; Harris C, 2004, STRENGTH COND J, V26, P8, DOI 10.1519/1533-4295(2004)026<0008:SWAACM>2.0.CO;2; Hudson LC, 2010, ATLAS FELINE ANATOMY; IWASAKI Y, 1989, J NEUROL SCI, V90, P155, DOI 10.1016/0022-510X(89)90098-1; Jackson RC, 2012, IEEE INT CONF ROBOT, P4675, DOI 10.1109/ICRA.2012.6224756; Kreighbaum E., 1996, BIOMECHANICS QUALITA; Kurten B, 1952, CHINESE HIPPARION FA; Lapchak PA, 2012, SPR SER TRANSL STROK, P1, DOI 10.1007/978-1-4419-9530-8; Lawn BR, 2013, J THEOR BIOL, V338, P59, DOI 10.1016/j.jtbi.2013.08.029; MAI YW, 1989, J PHYS D APPL PHYS, V22, P48, DOI 10.1088/0022-3727/22/1/007; MARTIN L D, 1980, Transactions of the Nebraska Academy of Sciences, V8, P141; Martin LD, 2011, OTHER SABER TOOTHS S, P3; Matthew W. D., 1901, Memoirs American Museum, Vi, P355; Matthew WD, 1910, B AM MUS NAT HIST, V28, P289; McGowan C., 1999, PRACTICAL GUIDE VERT; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Meachen-Samuels JA, 2012, PALEOBIOLOGY, V38, P1, DOI 10.1666/10036.1; Meachen-Samuels JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011412; Merriam J. C., 1932, FELIDAE RANCHO LA BR; Meyers C, 2006, WINNING TECHNIQUES S; NOLTE J, 2009, HUMAN BRAIN INTRO IT; PARRY BW, 1984, EQUINE VET J, V16, P53, DOI 10.1111/j.2042-3306.1984.tb01853.x; Pieknik R, 2006, SUTURE SURG HEMOSTAS; Piras P, 2013, SYST BIOL, V62, P878, DOI 10.1093/sysbio/syt053; PURSLOW PP, 1983, J MATER SCI, V18, P3591, DOI 10.1007/BF00540731; Rothschild Bruce M., 2011, P35; Sakamoto M, 2010, J EVOLUTION BIOL, V23, P463, DOI 10.1111/j.1420-9101.2009.01922.x; Salesa MJ, 2010, J ANAT, V216, P381, DOI 10.1111/j.1469-7580.2009.01178.x; Salesa MJ, 2005, ZOOL J LINN SOC-LOND, V144, P363, DOI 10.1111/j.1096-3642.2005.00174.x; SCHALLER G B, 1972, P480; Sherris DA., 2004, ESSENTIAL SURG SKILL; Simon RP, 2003, CECIL TXB MED, P2268; Simpson G. G., 1941, AM MUS NOVIT, V1120; Slater GJ, 2008, PALEOBIOLOGY, V34, P403, DOI 10.1666/07061.1; Smith W, 2008, HARRISONS PRINCIPLES, P2513; Therrien F, 2005, ZOOL J LINN SOC-LOND, V145, P393, DOI 10.1111/j.1096-3642.2005.00194.x; Turnbull WD, 1970, MAMMALIAN MASTICATOR, P149; Turner A, 2011, ESTUD GEOL-MADRID, V67, P255, DOI 10.3989/egeol.40590.188; uzkaya N., 2012, FUNDAMENTALS BIOMECH; Van Valkenburgh B, 2007, INTEGR COMP BIOL, V47, P147, DOI 10.1093/icb/icm016; VANVALKENBURGH B, 1987, J ZOOL, V212, P379; VANVALKENBURGH B, 1990, J ZOOL, V222, P319; Walker WF, 1994, FUNCTIONAL ANATOMY V; Wallace SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056173; Wheeler H. Todd, 2011, P19; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 1999, AUST J ZOOL, V47, P489, DOI 10.1071/ZO99006; Wroe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066888	77	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e107456	10.1371/journal.pone.0107456	http://dx.doi.org/10.1371/journal.pone.0107456			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272032	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600010
J	Chandran, JS; Kazanis, I; Clapcote, SJ; Ogawa, F; Millar, JK; Porteous, DJ; Ffrench-Constant, C				Chandran, Jayanth S.; Kazanis, Ilias; Clapcote, Steven J.; Ogawa, Fumiaki; Millar, J. Kirsty; Porteous, David J.; Ffrench-Constant, Charles			Disc1 Variation Leads to Specific Alterations in Adult Neurogenesis	PLOS ONE			English	Article							NEURAL STEM-CELLS; HIPPOCAMPAL NEUROGENESIS; SCHIZOPHRENIA; DISRUPTION; LIS1; DOUBLECORTIN; EXPRESSION; MATURATION; PLASTICITY; PHENOTYPES	Disrupted in schizophrenia 1 (DISC1) is a risk factor for a spectrum of neuropsychiatric illnesses including schizophrenia, bipolar disorder, and major depressive disorder. Here we use two missense Disc1 mouse mutants, described previously with distinct behavioural phenotypes, to demonstrate that Disc1 variation exerts differing effects on the formation of newly generated neurons in the adult hippocampus. Disc1 mice carrying a homozygous Q31L mutation, and displaying depressive-like phenotypes, have fewer proliferating cells while Disc1 mice with a homozygous L100P mutation that induces schizophrenia-like phenotypes, show changes in the generation, placement and maturation of newly generated neurons in the hippocampal dentate gyrus. Our results demonstrate Disc1 allele specific effects in the adult hippocampus, and suggest that the divergence in behavioural phenotypes may in part stem from changes in specific cell populations in the brain.	[Chandran, Jayanth S.; Ffrench-Constant, Charles] Univ Edinburgh, MRC, Ctr Regenerat Med, Ctr Multiple Sclerosis Res, Edinburgh, Midlothian, Scotland; [Kazanis, Ilias] Univ Cambridge, Dept Vet Med, Cambridge, England; [Clapcote, Steven J.] Univ Leeds, Inst Membrane & Syst Biol, Leeds, W Yorkshire, England; [Ogawa, Fumiaki; Millar, J. Kirsty; Porteous, David J.] Univ Edinburgh, Inst Genet & Mol Med, Mol Med Ctr, Med Genet Sect, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Cambridge; University of Leeds; University of Edinburgh	Chandran, JS (corresponding author), Univ Edinburgh, MRC, Ctr Regenerat Med, Ctr Multiple Sclerosis Res, Edinburgh, Midlothian, Scotland.	j.chandran@shef.ac.uk	Kazanis, Ilias/B-5198-2011; Porteous, David/AAA-3446-2021	Kazanis, Ilias/0000-0003-1035-0584; Porteous, David/0000-0003-1249-6106	Wellcome Trust; Medical research council [G0701518]; BBSRC [BB/E021190/1, BB/L00402X/1] Funding Source: UKRI; MRC [G0100266, G0902166, G0701518] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C007425/1, BB/L00402X/1, BB/E021190/1] Funding Source: researchfish; Medical Research Council [G0902166, G0701518, G0100266, MR/K026992/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical research council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	CFFC is supported by a grant from the Wellcome Trust, which also provides strategic support (ISSF) for DP. JSC, CFFC - Medical research council (www.mrc.ac.uk), grant code number: G0701518. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradshaw NJ, 2011, J NEUROSCI, V31, P9043, DOI 10.1523/JNEUROSCI.5410-10.2011; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Gebara E, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00145; Hippenmeyer S, 2010, NEURON, V68, P695, DOI 10.1016/j.neuron.2010.09.027; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jhaveri DJ, 2010, J NEUROSCI, V30, P2795, DOI 10.1523/JNEUROSCI.3780-09.2010; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; Kuroda K, 2011, HUM MOL GENET, V20, P4666, DOI 10.1093/hmg/ddr400; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Kvajo M, 2011, P NATL ACAD SCI USA, V108, pE1349, DOI 10.1073/pnas.1114113108; Lavado A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000460; Lee FHF, 2011, J NEUROSCI, V31, P3197, DOI 10.1523/JNEUROSCI.4219-10.2011; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; Lipina TV, 2012, NEUROPHARMACOLOGY, V62, P1252, DOI 10.1016/j.neuropharm.2011.02.020; Lipina TV, 2011, SYNAPSE, V65, P234, DOI 10.1002/syn.20839; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Pieper AA, 2005, P NATL ACAD SCI USA, V102, P14052, DOI 10.1073/pnas.0506713102; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Porteous DJ, 2011, TRENDS MOL MED; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; SHOLL DA, 1953, J ANAT, V87, P387; Singh KK, 2011, NEURON, V72, P545, DOI 10.1016/j.neuron.2011.09.030; Soares DC, 2011, ACS CHEM NEUROSCI, V2, P609, DOI 10.1021/cn200062k; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Youn YH, 2009, J NEUROSCI, V29, P15520, DOI 10.1523/JNEUROSCI.4630-09.2009	37	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108088	10.1371/journal.pone.0108088	http://dx.doi.org/10.1371/journal.pone.0108088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272038	Green Published, gold			2022-12-27	WOS:000343729600025
J	Donaldson-Matasci, M; Dornhaus, A				Donaldson-Matasci, Matina; Dornhaus, Anna			Dance Communication Affects Consistency, but Not Breadth, of Resource Use in Pollen-Foraging Honey Bees	PLOS ONE			English	Article							COLLECTIVE DECISION-MAKING; APIS-MELLIFERA; COLONIES; INFORMATION; FORAGERS; BENEFITS; RECRUITMENT; BEHAVIOR; QUALITY; ANTS	In groups of cooperatively foraging individuals, communication may improve the group's performance by directing foraging effort to where it is most useful. Honey bees (Apis mellifera) use a specialized dance to communicate the location of floral resources. Because honey bees dance longer for more rewarding resources, communication may shift the colony's foraging effort towards higher quality resources, and thus narrow the spectrum of resource types used. To test the hypothesis that dance communication changes how much honey bee colonies specialize on particular resources, we manipulated their ability to communicate location, and assessed the relative abundance of different pollen taxa they collected. This was repeated across five natural habitats that differed in floral species richness and spatial distribution. Contrary to expectation, impairing communication did not change the number or diversity of pollen (resource) types used by individual colonies per day. However, colonies with intact dance communication were more consistent in their resource use, while those with impaired communication were more likely to collect rare, novel pollen types. This suggests that communication plays an important role in shaping how much colonies invest in exploring new resources versus exploiting known ones. Furthermore, colonies that did more exploration also tended to collect less pollen overall, but only in environments with greater floral abundance per patch. In such environments, the ability to effectively exploit highly rewarding resources may be especially important-and dance communication may help colonies do just that. This could help explain how communication benefits honey bee colonies, and also why it does so only under certain environmental conditions.	[Donaldson-Matasci, Matina] Harvey Mudd Coll, Dept Biol, Claremont, CA 91711 USA; [Donaldson-Matasci, Matina; Dornhaus, Anna] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	Claremont Colleges; Harvey Mudd College; University of Arizona	Donaldson-Matasci, M (corresponding author), Harvey Mudd Coll, Dept Biol, Claremont, CA 91711 USA.	mdonaldsonmatasci@g.hmc.edu			University of Arizona's Center for Insect Science through NIH Training Grant [1K12GM000708]; NSF [IOS-0921280, IOS-0841756]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	University of Arizona's Center for Insect Science through NIH Training Grant; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.C.D. was funded by the University of Arizona's Center for Insect Science through NIH Training Grant #1K12GM000708 and by NSF grant #IOS-0921280. A.D. was funded by NSF grants #IOS-0921280 and #IOS-0841756. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. See relevant websites: (PERT) http://cis.arl.arizona.edu/PERT/index.htm; (NIH-Training) http://www.nigms.nih.gov/Training/; and (NSF-IOS) http://www.nsf.gov/div/index.jsp?div=ios.	BARTHOLDI JJ, 1993, J THEOR BIOL, V160, P23, DOI 10.1006/jtbi.1993.1002; Bates D., 2011, IME4 LINEAR MIXED EF; Beekman M, 2004, FUNCT ECOL, V18, P829, DOI 10.1111/j.0269-8463.2004.00924.x; Beekman M, 2008, BEHAV ECOL, V19, P255, DOI 10.1093/beheco/arm117; Beekman M, 2007, BEHAV ECOL SOCIOBIOL, V61, P985, DOI 10.1007/s00265-006-0331-9; Biesmeijer JC, 2001, BEHAV ECOL SOCIOBIOL, V49, P89, DOI 10.1007/s002650000289; CAMAZINE S, 1991, J THEOR BIOL, V149, P547, DOI 10.1016/S0022-5193(05)80098-0; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; CLARK CW, 1984, AM NAT, V123, P626, DOI 10.1086/284228; Cook SM, 2003, ECOL ENTOMOL, V28, P622, DOI 10.1046/j.1365-2311.2003.00548.x; Czaczkes TJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1009; Davis O.K., 2000, RO KAPPS POLLEN SPOR; Dechaume-Moncharmont FX, 2005, P ROY SOC B-BIOL SCI, V272, P1689, DOI 10.1098/rspb.2005.3137; Detrain C, 2008, ADV INSECT PHYSIOL, V35, P123, DOI 10.1016/S0065-2806(08)00002-7; Diggle PJ, 1983, STAT ANAL SPATIAL PO; Donaldson-Matasci MC, 2013, ANIM BEHAV, V85, P585, DOI 10.1016/j.anbehav.2012.12.020; Donaldson-Matasci MC, 2012, BEHAV ECOL SOCIOBIOL, V66, P583, DOI 10.1007/s00265-011-1306-z; Dornhaus A, 2004, BEHAV ECOL SOCIOBIOL, V55, P395, DOI 10.1007/s00265-003-0726-9; Dornhaus A, 2002, ENTOMOL GEN, V26, P93; Dornhaus A, 2006, BEHAV ECOL, V17, P336, DOI 10.1093/beheco/arj036; Eckholm BJ, 2011, BEHAV ECOL SOCIOBIOL, V65, P1037, DOI 10.1007/s00265-010-1108-8; Granovskiy B, 2012, BEHAV ECOL, V23, P588, DOI 10.1093/beheco/ars002; Guilhaumon F, 2011, MMSAR MMSAR R PACKAG; Kirchner WH, 1998, J INSECT BEHAV, V11, P169, DOI 10.1023/A:1021098405564; Lanan MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047976; Mattila HR, 2008, P ROY SOC B-BIOL SCI, V275, P809, DOI 10.1098/rspb.2007.1620; MCNAMARA JM, 1985, J THEOR BIOL, V117, P231, DOI 10.1016/S0022-5193(85)80219-8; MONOD J, 1950, ANN I PASTEUR PARIS, V79, P390; Oksanen J., 2016, R PACKAG; Pernal SF, 2001, BEHAV ECOL SOCIOBIOL, V51, P53, DOI 10.1007/s002650100412; Pernal SF, 2002, ANIM BEHAV, V63, P369, DOI 10.1006/anbe.2001.1904; PIELOU E C, 1969, P286; R Core Team, 2020, R LANG ENV STAT COMP; Schmickl T, 2004, ADAPT BEHAV, V12, P263, DOI 10.1177/105971230401200311; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1988, BEHAV ECOL SOCIOBIOL, V22, P229, DOI 10.1007/BF00299837; SEELEY TD, 1986, BEHAV ECOL SOCIOBIOL, V19, P343, DOI 10.1007/BF00295707; SEELEY TD, 1983, BEHAV ECOL SOCIOBIOL, V12, P253, DOI 10.1007/BF00290778; SEELEY TD, 1992, BEHAV ECOL SOCIOBIOL, V30, P59, DOI 10.1007/BF00168595; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Shaffer Z, 2013, ANIM BEHAV, V86, P967, DOI 10.1016/j.anbehav.2013.08.014; Sherman G, 2002, NATURE, V419, P920, DOI 10.1038/nature01127; Sumpter DJT, 2003, ANIM BEHAV, V66, P273, DOI 10.1006/anbe.2003.2224; Thom C, 2003, J EXP BIOL, V206, P2111, DOI 10.1242/jeb.00398; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Waddington KD, 1998, ANIM BEHAV, V56, P35, DOI 10.1006/anbe.1998.0736; WADDINGTON KD, 1994, BEHAV ECOL SOCIOBIOL, V35, P423, DOI 10.1007/BF00165845; ZIMMERMAN D, 1991, BIOMETRIKA, V78, P287	49	10	10	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e107527	10.1371/journal.pone.0107527	http://dx.doi.org/10.1371/journal.pone.0107527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271418	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600012
J	Moon, SJ; Kim, CJ; Lee, YJ; Hong, M; Han, J; Bahn, GH				Moon, Su Jin; Kim, Chang Ju; Lee, Yeon Jung; Hong, Minha; Han, Juhee; Bahn, Geon Ho			Effect of Atomoxetine on Hyperactivity in an Animal Model of Attention-Deficit/Hyperactivity Disorder (ADHD)	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; DOPAMINE; NOREPINEPHRINE; SCHIZOPHRENIA; EXPRESSION; SHR	Background: Hyperactivity related behaviors as well as inattention and impulsivity are regarded as the nuclear symptoms of attention-deficit/hyperactivity disorder (ADHD). Purpose: To investigate the therapeutic effects of atomoxetine on the motor activity in relation to the expression of the dopamine (DA) D2 receptor based on the hypothesis that DA system hypofunction causes ADHD symptoms, which would correlate with extensive D2 receptor overproduction and a lack of DA synthesis in specific brain regions: prefrontal cortex (PFC), striatum, and hypothalamus. Methods: Young male spontaneously hypertensive rats (SHR), animal models of ADHD, were randomly divided into four groups according to the daily dosage of atomoxetine and treated for 21 consecutive days. The animals were assessed using an open-field test, and the DA D2 receptor expression was examined. Results: The motor activity improved continuously in the group treated with atomoxetine at a dose of 1 mg/Kg/day than in the groups treated with atomoxetine at a dose of 0.25 mg/Kg/day or 0.5 mg/Kg/day. With respect to DA D-2 receptor immunohistochemistry, we observed significantly increased DA D-2 receptor expression in the PFC, striatum, and hypothalamus of the SHRs as compared to the WKY rats. Treatment with atomoxetine significantly decreased DA D-2 expression in the PFC, striatum, and hypothalamus of the SHRs, in a dose-dependent manner. Conclusion: Hyperactivity in young SHRs can be improved by treatment with atomoxetine via the DA D2 pathway.	[Moon, Su Jin] Daedong Hosp, Dept Psychiat, Taegu, South Korea; [Kim, Chang Ju] Kyung Hee Univ, Sch Med, Dept Physiol, Seoul, South Korea; [Lee, Yeon Jung; Han, Juhee; Bahn, Geon Ho] Kyung Hee Univ, Sch Med, Dept Psychiat, Seoul, South Korea; [Hong, Minha] Dankook Univ, Coll Med, Dept Psychiat, Cheonan, South Korea	Kyung Hee University; Kyung Hee University; Dankook University	Bahn, GH (corresponding author), Kyung Hee Univ, Sch Med, Dept Psychiat, Seoul, South Korea.	mompeian@hanmail.net	Kim, Chang Ju/M-4216-2017; Bahn, Geon Ho/Q-4424-2019; bahn, geon ho/AAT-3577-2021; Lee, Yeon Jung/B-5140-2019; Hong, Minha/V-7086-2019	Kim, Chang Ju/0000-0003-4749-5795; bahn, geon ho/0000-0002-3550-0422; Hong, Minha/0000-0003-4924-1107				[Anonymous], LEWIS CHILD ADOLESCE; Bowton E, 2010, J NEUROSCI, V30, P6048, DOI 10.1523/JNEUROSCI.5094-09.2010; Brown RT, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e43; Bymaster FP, 2002, NEUROPSYCHOPHARMACOL, V27, P699, DOI 10.1016/S0893-133X(02)00346-9; Davids E, 2003, BRAIN RES REV, V42, P1, DOI 10.1016/S0165-0173(02)00274-6; Del'Guidice T, 2014, PSYCHOPHARMACOLOGY, V231, P109, DOI 10.1007/s00213-013-3212-8; Dopheide JA, 2009, PHARMACOTHERAPY, V29, P656, DOI 10.1592/phco.29.6.656; Durand M, 1999, NEUROPHARMACOLOGY, V38, P893, DOI 10.1016/S0028-3908(99)00009-X; Durston S, 2003, NEUROIMAGE, V20, P2135, DOI 10.1016/j.neuroimage.2003.08.004; Fernando ABP, 2012, PSYCHOPHARMACOLOGY, V219, P341, DOI 10.1007/s00213-011-2408-z; Genro JP, 2010, EXPERT REV NEUROTHER, V10, P587, DOI [10.1586/ern.10.17, 10.1586/ERN.10.17]; Grunder G, 2010, CURR OPIN INVEST DR, V11, P823; LEVY F, 1991, AUST NZ J PSYCHIAT, V25, P277, DOI 10.3109/00048679109077746; Levy F, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-12; Levy F, 2009, AUST NZ J PSYCHIAT, V43, P101, DOI 10.1080/00048670802607238; Marcil J, 1997, J MOL CELL CARDIOL, V29, P1009, DOI 10.1006/jmcc.1996.0343; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moreno M, 2013, PSYCHOPHARMACOLOGY, V228, P19, DOI 10.1007/s00213-013-3010-3; Prediger RDS, 2005, INT J NEUROPSYCHOPH, V8, P583, DOI 10.1017/S1461145705005341; Stahl SM, 2003, J CLIN PSYCHIAT, V64, P110, DOI 10.4088/JCP.v64n0201; Ueno K, 2002, BEHAV PHARMACOL, V13, P1, DOI 10.1097/00008877-200202000-00001; Wang M, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-25; Wu LH, 2010, BRAIN PATHOL, V20, P1042, DOI 10.1111/j.1750-3639.2010.00410.x	23	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108918	10.1371/journal.pone.0108918	http://dx.doi.org/10.1371/journal.pone.0108918			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271814	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600079
J	Barriga, A; Lorente, E; Johnstone, C; Mir, C; del Val, M; Lopez, D				Barriga, Alejandro; Lorente, Elena; Johnstone, Carolina; Mir, Carmen; del Val, Margarita; Lopez, Daniel			A Common Minimal Motif for the Ligands of HLA-B*27 Class I Molecules	PLOS ONE			English	Article							HLA-B27 SUBTYPES; NATURAL LIGANDS; PEPTIDE LIGANDS; CTL EPITOPES; ANTIGEN; B-ASTERISK-2705; BINDING; IDENTIFICATION; POLYMORPHISM; RECOGNITION	CD8(+) T cells identify and kill infected cells through the specific recognition of short viral antigens bound to human major histocompatibility complex (HLA) class I molecules. The colossal number of polymorphisms in HLA molecules makes it essential to characterize the antigen-presenting properties common to large HLA families or supertypes. In this context, the HLA-B*27 family comprising at least 100 different alleles, some of them widely distributed in the human population, is involved in the cellular immune response against pathogens and also associated to autoimmune spondyloarthritis being thus a relevant target of study. To this end, HLA binding assays performed using nine HLA-B*2705-restricted ligands endogenously processed and presented in virus-infected cells revealed a common minimal peptide motif for efficient binding to the HLA-B*27 family. The motif was independently confirmed using four unrelated peptides. This experimental approach, which could be easily transferred to other HLA class I families and supertypes, has implications for the validation of new bioinformatics tools in the functional clustering of HLA molecules, for the identification of antiviral cytotoxic T lymphocyte responses, and for future vaccine development.	[Barriga, Alejandro; Lorente, Elena; Johnstone, Carolina; Mir, Carmen; Lopez, Daniel] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [del Val, Margarita] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Lopez, D (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain.	dlopez@isciii.es	Lorente, Elena/B-1219-2019; López, Daniel/I-2632-2014; Del Val, Margarita/E-4769-2010; Johnstone, Carolina/K-9907-2014	Lorente, Elena/0000-0002-2246-6851; López, Daniel/0000-0003-0268-5878; Del Val, Margarita/0000-0001-6769-4279; Johnstone, Carolina/0000-0002-4966-6212; Barriga, Alejandro/0000-0001-6357-1917	Spanish "Ministerio de Economia y Competitividad''	Spanish "Ministerio de Economia y Competitividad''	This work was supported by grants to D. L. from the Spanish "Ministerio de Economia y Competitividad''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Dror L, 2010, ARTHRITIS RHEUM-US, V62, P420, DOI 10.1002/art.27257; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Boisgerault F, 1996, J CLIN INVEST, V98, P2764, DOI 10.1172/JCI119102; Crotzer VL, 2000, J IMMUNOL, V164, P6120, DOI 10.4049/jimmunol.164.12.6120; de Castro JAL, 2004, TISSUE ANTIGENS, V63, P424, DOI 10.1111/j.0001-2815.2004.00220.x; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; Fiorillo MT, 1998, EUR J IMMUNOL, V28, P2508, DOI 10.1002/(SICI)1521-4141(199808)28:08<2508::AID-IMMU2508>3.0.CO;2-1; Galocha B, 1996, TISSUE ANTIGENS, V48, P509, DOI 10.1111/j.1399-0039.1996.tb02664.x; Garcia F, 1997, TISSUE ANTIGENS, V49, P580, DOI 10.1111/j.1399-0039.1997.tb02805.x; Garcia F, 1997, TISSUE ANTIGENS, V49, P215, DOI 10.1111/j.1399-0039.1997.tb02741.x; Garcia-Peydro M, 1999, J IMMUNOL, V163, P2299; Herberts CA, 2001, J GEN VIROL, V82, P2131, DOI 10.1099/0022-1317-82-9-2131; Infantes S, 2010, MOL CELL PROTEOMICS, V9, P1533, DOI 10.1074/mcp.M900508-MCP200; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; Kondo E, 2004, BLOOD, V103, P630, DOI 10.1182/blood-2003-03-0824; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; LOPEZ D, 1994, J IMMUNOL, V152, P5557; LOPEZ D, 1992, J IMMUNOL, V148, P996; Marti M, 2001, TISSUE ANTIGENS, V58, P351, DOI 10.1034/j.1399-0039.2001.580603.x; Montserrat V, 2003, J IMMUNOL, V170, P5778, DOI 10.4049/jimmunol.170.11.5778; Paradela A, 1998, J IMMUNOL, V161, P5481; PARKER KC, 1994, J IMMUNOL, V152, P163; PAZMANY L, 1992, J EXP MED, V175, P361, DOI 10.1084/jem.175.2.361; Raghavan M, 1996, PROTEIN SCI, V5, P2080, DOI 10.1002/pro.5560051014; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Roberts CGP, 1996, AIDS RES HUM RETROV, V12, P593, DOI 10.1089/aid.1996.12.593; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Samino Y, 2006, J BIOL CHEM, V281, P6358, DOI 10.1074/jbc.M512263200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terajima M, 2008, J VIROL, V82, P9283, DOI 10.1128/JVI.01047-08; Thomsen M, 2013, IMMUNOGENETICS, V65, P655, DOI 10.1007/s00251-013-0714-9; Vazquez MN, 2005, ARTHRITIS RHEUM-US, V52, P3290, DOI 10.1002/art.21284; VILLADANGOS JA, 1994, J IMMUNOL, V152, P2317; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; York IA, 1999, IMMUNOL REV, V172, P49, DOI 10.1111/j.1600-065X.1999.tb01355.x	37	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e106772	10.1371/journal.pone.0106772	http://dx.doi.org/10.1371/journal.pone.0106772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268942	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700016
J	Davies, GR; Mills, GM; Lawrence, M; Battle, C; Morris, K; Hawkins, K; Williams, PR; Davidson, S; Thomas, D; Evans, PA				Davies, Gareth R.; Mills, Gavin M.; Lawrence, Matthew; Battle, Ceri; Morris, Keith; Hawkins, Karl; Williams, Phylip Rhodri; Davidson, Simon; Thomas, Dafydd; Evans, Phillip Adrian			The Role of Whole Blood Impedance Aggregometry and Its Utilisation in the Diagnosis and Prognosis of Patients with Systemic Inflammatory Response Syndrome and Sepsis in Acute Critical Illness	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; PLATELET-AGGREGATION; ANTIPLATELET DRUGS; ORGAN FAILURE; SEPTIC SHOCK; THROMBOCYTOPENIA; EPIDEMIOLOGY; DEFINITIONS; PATHWAY; IMPACT	Objective: To assess the prognostic and diagnostic value of whole blood impedance aggregometry in patients with sepsis and SIRS and to compare with whole blood parameters (platelet count, haemoglobin, haematocrit and white cell count). Methods: We performed an observational, prospective study in the acute setting. Platelet function was determined using whole blood impedance aggregometry (multiplate) on admission to the Emergency Department or Intensive Care Unit and at 6 and 24 hours post admission. Platelet count, haemoglobin, haematocrit and white cell count were also determined. Results: 106 adult patients that met SIRS and sepsis criteria were included. Platelet aggregation was significantly reduced in patients with severe sepsis/septic shock when compared to SIRS/uncomplicated sepsis (ADP: 90.7 +/- 37.6 vs 61.4 +/- 40.6; p<0.001, Arachadonic Acid 99.9 +/- 48.3 vs 66.3 +/- 50.2; p = 0.001, Collagen 102.6 +/- 33.0 vs 79.1 +/- 38.8; p = 0.001; SD +/- mean)). Furthermore platelet aggregation was significantly reduced in the 28 day mortality group when compared with the survival group (Arachadonic Acid 58.8 +/- 47.7 vs 91.1 +/- 50.9; p<0.05, Collagen 36.6 +/- 36.6 vs 98.0 +/- 35.1; p = 0.001; SD +/- mean)). However haemoglobin, haematocrit and platelet count were more effective at distinguishing between subgroups and were equally effective indicators of prognosis. Significant positive correlations were observed between whole blood impedance aggregometry and platelet count (ADP 0.588 p<0.0001, Arachadonic Acid 0.611 p<0.0001, Collagen 0.599 p<0.0001 (Pearson correlation)). Conclusions: Reduced platelet aggregometry responses were not only significantly associated with morbidity and mortality in sepsis and SIRS patients, but also correlated with the different pathological groups. Whole blood aggregometry significantly correlated with platelet count, however, when we adjust for the different groups we investigated, the effect of platelet count appears to be non-significant.	[Mills, Gavin M.; Lawrence, Matthew; Battle, Ceri; Morris, Keith; Hawkins, Karl; Thomas, Dafydd; Evans, Phillip Adrian] Morriston Hosp, NISCHR, Haemostasis Biomed Res Unit, Swansea, W Glam, Wales; [Davies, Gareth R.; Lawrence, Matthew; Hawkins, Karl; Evans, Phillip Adrian] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales; [Battle, Ceri] Abertawe Bro Morgannwg Univ, Hlth Board, Intens Therapy Unit, Swansea, W Glam, Wales; [Morris, Keith] Univ Wales Coll Cardiff, Inst Cardiff, Sch Appl Sci, Cardiff CF1 3NS, S Glam, Wales; [Williams, Phylip Rhodri] Swansea Univ, Coll Engn, Swansea, W Glam, Wales; [Davidson, Simon] Royal Brompton & Harefield NHS Fdn Trust, Dept Haematol, London, England; [Thomas, Dafydd] Abertawe Bro Morgannwg Univ, Hlth Board, Cardiac Intens Care Unit, Swansea, W Glam, Wales	Morriston Hospital; Swansea University; Cardiff University; Swansea University; Royal Brompton & Harefield NHS Foundation Trust	Evans, PA (corresponding author), Morriston Hosp, NISCHR, Haemostasis Biomed Res Unit, Swansea, W Glam, Wales.	Phillip.A.Evans@wales.nhs.uk	Battle, Ceri/AAK-5856-2021; Davidson, Simon/AGX-8916-2022	Battle, Ceri/0000-0002-7503-1931; Davies, Gareth Richard/0000-0002-0863-9234; Lawrence, Matthew/0000-0001-7344-2836; Hawkins, Karl/0000-0003-0174-4151; Evans, Phillip Adrian/0000-0002-0814-5162	European Social Fund (ESF) through the European Union	European Social Fund (ESF) through the European Union	This work is part-funded by the European Social Fund (ESF) through the European Union's Convergence programme administered by the Welsh Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamzik M, 2012, CRIT CARE, V16, DOI 10.1186/cc11816; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; Baurand A, 2000, THROMB HAEMOSTASIS, V84, P484; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brenner T, 2012, ACTA ANAESTH SCAND, V56, P1277, DOI 10.1111/j.1399-6576.2012.02750.x; Brun-Buisson C, 2000, INTENS CARE MED, V26, pS64, DOI 10.1007/s001340051121; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Chiarla C, 2010, RESP PHYSIOL NEUROBI, V172, P32, DOI 10.1016/j.resp.2010.04.012; Dempfle CE, 2004, THROMB HAEMOSTASIS, V91, P213, DOI 10.1160/TH03-03-0182; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Gafter-Gvili A, 2011, MAYO CLIN PROC, V86, P389, DOI 10.4065/mcp.2010.0705; Gando S, 1998, CRIT CARE MED, V26, P2005, DOI 10.1097/00003246-199812000-00030; Garraud O, 2013, CRIT CARE, V17, DOI 10.1186/cc12716; Hanke AA, 2010, EUR J MED RES, V15, P214; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Kempe DS, 2007, J MOL MED-JMM, V85, P269, DOI 10.1007/s00109-006-0123-8; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lundahl TH, 1998, PLATELETS, V9, P223, DOI 10.1080/09537109876735; Mavrommatis AC, 2000, CRIT CARE MED, V28, P451, DOI 10.1097/00003246-200002000-00027; Reggiori G, 2009, CRIT CARE MED, V37, P3041, DOI 10.1097/CCM.0b013e3181b02b3f; Salat A, 1999, THROMB RES, V93, P145, DOI 10.1016/S0049-3848(98)00179-0; Sharron M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041549; Stissing T, 2011, CLIN APPL THROMB-HEM, V17, pE211, DOI 10.1177/1076029610397183; ter Avest E, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-9; Thiolliere F, 2013, INTENS CARE MED, V39, P1460, DOI 10.1007/s00134-013-2963-3; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Winning J, 2010, CRIT CARE MED, V38, P32, DOI 10.1097/CCM.0b013e3181b4275c; Winning J, 2009, PLATELETS, V20, P50, DOI 10.1080/09537100802503368; Woth G, 2011, J THROMB THROMBOLYS, V31, P6, DOI 10.1007/s11239-010-0486-0; Wurtz M, 2012, THROMB RES, V129, P56, DOI 10.1016/j.thromres.2011.08.019; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884	33	23	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108589	10.1371/journal.pone.0108589	http://dx.doi.org/10.1371/journal.pone.0108589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25269018	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700117
J	Klibansky, LKJ; McCartney, MA				Klibansky, Lara K. J.; McCartney, Michael A.			Conspecific Sperm Precedence Is a Reproductive Barrier between Free-Spawning Marine Mussels in the Northwest Atlantic Mytilus Hybrid Zone	PLOS ONE			English	Article							URCHIN STRONGYLOCENTROTUS-FRANCISCANUS; FERTILIZATION SUCCESS; GAMETE COMPATIBILITY; BLUE MUSSELS; VITELLINE COAT; SEA-URCHINS; EDULIS; HYBRIDIZATION; SPECIATION; TROSSULUS	Reproductive isolation at the gamete stage has become a focus of speciation research because of its potential to evolve rapidly between closely related species. Conspecific sperm precedence (CSP), a type of gametic isolation, has been demonstrated in a number of taxa, both marine and terrestrial, with the potential to play an important role in speciation. Free-spawning marine invertebrates are ideal subjects for the study of CSP because of a likely central role for gametic barriers in reproductive isolation. The western Atlantic Mytilus blue mussel hybrid zone, ranging from the Atlantic Canada to eastern Maine, exhibits characteristics conducive to the study of CSP. Previous studies have shown that gametic incompatibility is incomplete, variable in strength and the genotype distribution is bimodal-dominated by the parental species, with a low frequency of hybrids. We conducted gamete crossing experiments using M. trossuius and M. edulis individuals collected from natural populations during the spring spawning season in order to detect the presence or absence of CSP within this hybrid zone. We detected CSP, defined here as a reduction in heterospecific offspring from competitive fertilizations in vitro compared to that seen in non-competitive fertilizations, in five of the twelve crosses in which conspecific crosses were detectable. This is the first finding of CSP in a naturally hybridizing population of a free-spawning marine invertebrate. Our findings support earlier predictions that CSP can promote assortative fertilization in bimodal hybrid zones, further advancing their hypothesized progression towards full speciation. Despite strong CSP numerous heterospecific fertilizations remain, reinforcing the hypothesis that compatible females are a source of hybrid offspring in mixed natural spawns.	[Klibansky, Lara K. J.; McCartney, Michael A.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA	University of North Carolina; University of North Carolina Wilmington	Klibansky, LKJ (corresponding author), North Carolina Div Marine Fisheries, Morehead City, NC USA.	lara.klibansky@gmail.com			Sigma Xi; John Colucci, Jr. Memorial Scholarship, University of North Carolina Wilmington; National Science Foundation Biological Oceanography Standard Grant [0961157]; Division Of Ocean Sciences [0961325] Funding Source: National Science Foundation	Sigma Xi; John Colucci, Jr. Memorial Scholarship, University of North Carolina Wilmington; National Science Foundation Biological Oceanography Standard Grant; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by Sigma Xi Grant-in-Aid of Research, http://www.sigmaxi.org/ (LKJK); The John Colucci, Jr. Memorial Scholarship, University of North Carolina Wilmington, http://catalogue.uncw.edu/content.php?catoid=16&navoid=982 (LKJK); and National Science Foundation Biological Oceanography Standard Grant Number 0961157, http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=11696&org=OCE&from=home (Philip Yund, Charles Tilburg, MAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierne N, 2002, EVOLUTION, V56, P292, DOI 10.1111/j.0014-3820.2002.tb01339.x; Coyne J.A., 2004, SPECIATION; DAN JC, 1962, BIOL BULL, V123, P531, DOI 10.2307/1539574; FOCARELLI R, 1991, MOL REPROD DEV, V28, P143, DOI 10.1002/mrd.1080280207; Geyer LB, 2005, EVOLUTION, V59, P97; Gosling E., 1992, The mussel Mytilus: ecology, physiology, genetics and culture., P309; Harper FM, 2005, BIOL BULL-US, V209, P113, DOI 10.2307/3593129; Harrison R.G., 1990, Oxford Surveys in Evolutionary Biology, V7, P69; Heath DD, 1995, CAN J FISH AQUAT SCI, V52, P2621, DOI 10.1139/f95-851; Howard DJ, 1998, EVOLUTION, V52, P511, DOI 10.1111/j.1558-5646.1998.tb01650.x; Howard DJ, 1999, ANNU REV ECOL SYST, V30, P109, DOI 10.1146/annurev.ecolsys.30.1.109; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; LEIGHTON DL, 1982, INT J INVER REP DEV, V5, P273; Lessios HA, 2011, INTEGR COMP BIOL, V51, P456, DOI 10.1093/icb/icr039; Levitan DR, 2000, P ROY SOC B-BIOL SCI, V267, P531, DOI 10.1098/rspb.2000.1032; LEVITAN DR, 1992, ECOLOGY, V73, P248, DOI 10.2307/1938736; Levitan DR, 2004, AM NAT, V164, P298, DOI 10.1086/423150; Lima TG, 2013, MOL BIOL EVOL, V30, P2688, DOI 10.1093/molbev/mst165; LUTZ RA, 1992, MUSSEL MYTILUS ECOLO, P53; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Maloy AP, 2003, J SHELLFISH RES, V22, P119; McCartney MA, 2002, BIOL BULL-US, V202, P166, DOI 10.2307/1543653; Miller PE, 2000, J PHYCOL, V36, P238, DOI 10.1046/j.1529-8817.2000.99041.x; Miranda MBB, 2010, BIOL BULL-US, V218, P266, DOI 10.1086/BBLv218n3p266; MORSE DE, 1977, SCIENCE, V196, P298, DOI 10.1126/science.403609; NIIJIMA L, 1965, J CELL BIOL, V25, P249, DOI 10.1083/jcb.25.2.249; Rawson PD, 1996, GENETICS, V144, P241; Rawson PD, 2003, MAR BIOL, V143, P317, DOI 10.1007/s00227-003-1084-x; Riginos C, 2005, MOL ECOL, V14, P381, DOI 10.1111/j.1365-294X.2004.02379.x; Riginos C, 2003, MOL BIOL EVOL, V20, P200, DOI 10.1093/molbev/msg021; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; SEUTIN G, 1993, AUK, V110, P117; Simpson RJ, 1999, BIOTECHNIQUES, V26, P1050, DOI 10.2144/99266bm08; Slaughter C, 2008, BIOL BULL-US, V214, P57, DOI 10.2307/25066660; TAKAGI T, 1994, J BIOCHEM-TOKYO, V116, P598, DOI 10.1093/oxfordjournals.jbchem.a124566; Toro JE, 2006, AQUAC RES, V37, P1703, DOI 10.1111/j.1365-2109.2006.01610.x; Vacquier V. D., 2011, COLD SPRING HARBOR P, V3, P1; VACQUIER VD, 1990, P NATL ACAD SCI USA, V87, P5792, DOI 10.1073/pnas.87.15.5792; WILLIAMS DA, 1976, BIOMETRIKA, V63, P33, DOI 10.2307/2335081; YUND PO, 1994, ECOLOGY, V75, P2151, DOI 10.2307/1940874; Zar JH, 1999, BIOSTATISTICAL ANAL; Zigler KS, 2005, EVOLUTION, V59, P2399	42	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108433	10.1371/journal.pone.0108433	http://dx.doi.org/10.1371/journal.pone.0108433			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268856	gold, Green Submitted, Green Published			2022-12-27	WOS:000343671700095
J	Remue, J; Hughes, S; De Houwer, J; De Raedt, R				Remue, Jonathan; Hughes, Sean; De Houwer, Jan; De Raedt, Rudi			To Be or Want to Be: Disentangling the Role of Actual versus Ideal Self in Implicit Self-Esteem	PLOS ONE			English	Article							RELATIONAL ASSESSMENT PROCEDURE; ASSOCIATION TEST; DEPRESSED-PATIENTS; DISCREPANCIES	A growing body of work suggests that both depressed and non-depressed individuals display implicit positivity towards the self. In the current study, we examined whether this positivity can be underpinned by two qualitatively distinct propositions related to actual ('I am good') or ideal ('I want to be good') self-esteem. Dysphoric and non-dysphoric participants completed a self-esteem Implicit Association Test (IAT) as well an Implicit Relational Assessment Procedure (IRAP) targeting their actual self-esteem and an IRAP targeting ideal self-esteem. Both groups demonstrated similar and positive IAT effects. A more complex picture emerged with regard to the IRAP effects. Whereas non-dysphorics did not differ in their actual and ideal self-esteem, their dysphoric counterparts demonstrated lower actual than ideal self-esteem. Our results suggest that closer attention to the role of propositional processes in implicit measures may unlock novel insight into the relationship between implicit self-esteem and depression.	[Remue, Jonathan; Hughes, Sean; De Houwer, Jan; De Raedt, Rudi] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Hughes, Sean] Natl Univ Ireland Maynooth, Dept Psychol, Maynooth, Kildare, Ireland	Ghent University; Maynooth University	Remue, J (corresponding author), Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium.	Jonathan.Remue@Ugent.be	De Raedt, Rudi/A-3269-2012; Remue, Jonathan/A-8112-2013; De Raedt, Rudi/AAL-4093-2021; De Houwer, Jan/ABF-6866-2021	De Raedt, Rudi/0000-0001-6781-4808; Remue, Jonathan/0000-0001-7012-6221; De Raedt, Rudi/0000-0001-6781-4808; De Houwer, Jan/0000-0003-0488-5224; Hughes, Sean/0000-0001-7689-4272	Concerted Research Action of Ghent University [BOF10/GOA/014]; Ghent University [BOF09/01M00209]; Government of Ireland Research Fellowship	Concerted Research Action of Ghent University; Ghent University(Ghent University); Government of Ireland Research Fellowship	Preparation of this paper was supported by Grant BOF10/GOA/014 for a Concerted Research Action of Ghent University, awarded to RDR, Grant BOF09/01M00209 of Ghent University to JDH as well as a Government of Ireland Research Fellowship (http://www.research.ie/scheme/government-ireland-postgraduate-scholarship-scheme-2014) to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, OX MED PUBL; Barnes-Holmes D., 2006, IRISH PSYCHOL, V7, P169, DOI [10.1007/BF03395684, DOI 10.1007/S10508-012-9920-Z]; Barnes-Holmes D, 2010, PSYCHOL REC, V60, P527, DOI 10.1007/BF03395726; Barnes-Holmes Y., 2001, THESIS NATL U IRELAN; Baumeister R. F., 1999, SELF SOCIAL PSYCHOL; Beck A, 1979, COGNITIVE THERAPY DE; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Buhrmester MD, 2011, J PERS SOC PSYCHOL, V100, P365, DOI 10.1037/a0021341; Clark D.A., 1999, SCI FDN COGNITIVE TH; Crocker J, 2004, PSYCHOL BULL, V130, P392, DOI 10.1037/0033-2909.130.3.392; De Houwer J, 2001, J EXP SOC PSYCHOL, V37, P443, DOI 10.1006/jesp.2000.1464; De Houwer J, 2009, PSYCHOL BULL, V135, P347, DOI 10.1037/a0014211; De Raedt R, 2006, BEHAV RES THER, V44, P1017, DOI 10.1016/j.brat.2005.08.003; Franck E, 2008, COGNITION EMOTION, V22, P1588, DOI 10.1080/02699930801921271; Franck E, 2008, PSYCHOL BELG, V48, P25, DOI 10.5334/pb-48-1-25; Gawronski B, 2014, HANDBOOK OF RESEARCH METHODS IN SOCIAL AND PERSONALITY PSYCHOLOGY, SECOND EDITION, P283; Gemar MC, 2001, J ABNORM PSYCHOL, V110, P282, DOI 10.1037/0021-843X.110.2.282; Golijani-Moghaddam N, 2013, J CONTEXT BEHAV SCI, V2, P105, DOI 10.1016/j.jcbs.2013.05.002; Greenwald AG, 2002, PSYCHOL REV, V109, P3, DOI 10.1037/0033-295X.109.1.3; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Hayes SC, 2012, J CONTEXT BEHAV SCI, V1, P1, DOI 10.1016/j.jcbs.2012.09.004; HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037/0033-295X.94.3.319; Hughes S., 2013, ADV RELATIONAL FRAME; Hughes S, 2012, J CONTEXT BEHAV SCI, V1, P17, DOI 10.1016/j.jcbs.2012.09.003; Hughes S, 2011, PSYCHOL REC, V61, P465, DOI 10.1007/BF03395772; Ingram RE, 1998, CLIN PSYCHOL PSYCHOT, V6, P69, DOI [10.1002/(sici)1099-0879(199902)6:1<69::aid-cpp177>3.0.co;2-w, DOI 10.1002/(SICI)1099-0879(199902)6:1<69::AID-CPP177>3.0.CO;2-W]; Lagnado D.A., 2007, CAUSAL LEARNING PSYC, P154, DOI DOI 10.1093/ACPROF:OSO/9780195176803.003.0011; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Moretti M, 1999, REV GEN PSYCHOL, V3, P188, DOI DOI 10.1037/1089-2680.3.3.188; Nicholson E, J CONTEXTUAL BEHAV S; Pyszczynski T, 2004, PSYCHOL BULL, V130, P483, DOI 10.1037/0033-2909.130.3.483; Remue J, 2013, COGNITION EMOTION, V27, P1441, DOI 10.1080/02699931.2013.786681; Risch AK, 2010, J BEHAV THER EXP PSY, V41, P199, DOI 10.1016/j.jbtep.2010.01.003; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Stevens EN, 2014, COGNITION EMOTION, V28, P707, DOI 10.1080/02699931.2013.845082; Tangney JP, 1998, J PERS SOC PSYCHOL, V75, P256, DOI 10.1037/0022-3514.75.1.256; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Van der Does A.J.W, 2002, MANUAL DUTCH VERSION; Yamaguchi S, 2007, PSYCHOL SCI, V18, P498, DOI 10.1111/j.1467-9280.2007.01928.x; Young J. E. S., 1994, COGNITIVE THERAPY PE	40	30	31	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108837	10.1371/journal.pone.0108837	http://dx.doi.org/10.1371/journal.pone.0108837			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268889	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700175
J	Apitz, T; Bunzeck, N				Apitz, Thore; Bunzeck, Nico			Early Effects of Reward Anticipation Are Modulated by Dopaminergic Stimulation	PLOS ONE			English	Article							PRIMATE PREFRONTAL NEURONS; MESOLIMBIC SYSTEM; NEURAL DYNAMICS; WORKING-MEMORY; VISUAL-CORTEX; HUMAN BRAIN; SIGNALS; REPRESENTATIONS; OSCILLATIONS; EXPECTATION	The abilities to predict future rewards and assess the value of reward delivery are crucial aspects of adaptive behavior. While the mesolimbic system, including dopaminergic midbrain, ventral striatum and prefrontal cortex have long been associated with reward processing, recent studies also indicate a prominent role of early visual brain regions. However, the precise underlying neural mechanisms still remain unclear. To address this issue, we presented participants with visual cues predicting rewards of high and low magnitudes and probability (2x2 factorial design), while neural activity was scanned using magnetoencephalography. Importantly, one group of participants received 150 mg of the dopamine precursor levodopa prior to the experiment, while another group received a placebo. For the placebo group, neural signals of reward probability (but not magnitude) emerged at similar to 100 ms after cue presentation at occipital sensors in the event-related magnetic fields. Importantly, these probability signals were absent in the levodopa group indicating a close link. Moreover, levodopa administration reduced oscillatory power in the high (20-30 Hz) and low (13-20 Hz) beta band during both reward anticipation and delivery. Taken together, our findings indicate that visual brain regions are involved in coding prospective reward probability but not magnitude and that these effects are modulated by dopamine.	[Apitz, Thore; Bunzeck, Nico] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Bunzeck, Nico] Univ Lubeck, Dept Psychol, Lubeck, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck	Bunzeck, N (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.	nico.bunzeck@ipsy.uni-luebeck.de		Bunzeck, Nico/0000-0001-8834-450X	Hamburg state	Hamburg state	This work was supported by Hamburg state cluster of excellence (neurodapt!), (http://www.neurodapt.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apitz T, 2013, NEUROPSYCHOPHARMACOL, V38, P2409, DOI 10.1038/npp.2013.141; Beierholm U, 2013, NEUROPSYCHOPHARMACOL, V38, P1495, DOI 10.1038/npp.2013.48; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Bhattacharyya S, 2012, ARCH GEN PSYCHIAT, V69, P27, DOI 10.1001/archgenpsychiatry.2011.161; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Bunzeck N, 2014, CEREB CORTEX, V24, P1351, DOI 10.1093/cercor/bhs420; Bunzeck N, 2012, HUM BRAIN MAPP, V33, P1309, DOI 10.1002/hbm.21288; Bunzeck N, 2011, J NEUROSCI, V31, P12816, DOI 10.1523/JNEUROSCI.0461-11.2011; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cohen MX, 2008, COGN AFFECT BEHAV NE, V8, P113, DOI 10.3758/CABN.8.2.113; Cohen MX, 2007, NEUROIMAGE, V35, P968, DOI 10.1016/j.neuroimage.2006.11.056; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Dillon DG, 2008, PSYCHOPHYSIOLOGY, V45, P36, DOI 10.1111/j.1469-8986.2007.00594.x; Donamayor N, 2012, NEUROIMAGE, V62, P17, DOI 10.1016/j.neuroimage.2012.04.038; Donamayor N, 2011, HUM BRAIN MAPP, V32, P2228, DOI 10.1002/hbm.21184; Eckart C, 2013, NEUROIMAGE, V66, P293, DOI 10.1016/j.neuroimage.2012.11.001; Engelmann JB, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.004.2009; Ernst M, 2004, NEUROPSYCHOLOGIA, V42, P1585, DOI 10.1016/j.neuropsychologia.2004.05.011; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Galvan A, 2005, J NEUROSCI, V25, P8650, DOI 10.1523/JNEUROSCI.2431-05.2005; Goldman-Rakic PS, 2000, BRAIN RES REV, V31, P295, DOI 10.1016/S0165-0173(99)00045-4; Gruber MJ, 2010, J NEUROSCI, V30, P9793, DOI 10.1523/JNEUROSCI.0915-10.2010; Guitart-Masip M, 2012, P NATL ACAD SCI USA, V109, P7511, DOI 10.1073/pnas.1202229109; Guitart-Masip M, 2010, J NEUROSCI, V30, P1721, DOI 10.1523/JNEUROSCI.5331-09.2010; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; HajiHosseini A, 2012, NEUROIMAGE, V60, P1678, DOI 10.1016/j.neuroimage.2012.01.125; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Hsieh LT, 2011, J NEUROSCI, V31, P10803, DOI 10.1523/JNEUROSCI.0828-11.2011; Jacob SN, 2013, J NEUROSCI, V33, P13724, DOI 10.1523/JNEUROSCI.0210-13.2013; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kawasaki M, 2013, SOC COGN AFFECT NEUR, V8, P523, DOI 10.1093/scan/nss027; Khader PH, 2010, NEUROSCI LETT, V468, P339, DOI 10.1016/j.neulet.2009.11.028; Kilner JM, 2010, ANN APPL STAT, V4, P1272, DOI 10.1214/10-AOAS337; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Litvak V, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/852961; Lodge DJ, 2007, J NEUROSCI, V27, P11424, DOI 10.1523/JNEUROSCI.2847-07.2007; Marco-Pallares J, 2008, NEUROPSYCHOLOGIA, V46, P241, DOI 10.1016/j.neuropsychologia.2007.07.016; Marco-Pallares J, 2009, BIOL PSYCHIAT, V66, P154, DOI 10.1016/j.biopsych.2009.01.006; Nieuwenhuis S, 2004, CEREB CORTEX, V14, P741, DOI 10.1093/cercor/bhh034; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Nyholm D, 2012, CLIN NEUROPHARMACOL, V35, P111, DOI 10.1097/WNF.0b013e31825645d1; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Peters J, 2009, J NEUROSCI, V29, P15727, DOI 10.1523/JNEUROSCI.3489-09.2009; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Schultz W, 2004, CURR OPIN NEUROBIOL, V14, P139, DOI 10.1016/j.conb.2004.03.017; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Thomas J, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00214; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Weil RS, 2010, J NEUROPHYSIOL, V104, P1746, DOI 10.1152/jn.00870.2009; Worsley KJ, 2004, NEUROIMAGE, V23, pS189, DOI 10.1016/j.neuroimage.2004.07.026; Wu K, 2012, BRAIN, V135, P2449, DOI 10.1093/brain/aws157; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006; Yu RJ, 2006, NEUROREPORT, V17, P1649, DOI 10.1097/01.wnr.0000236866.39328.1d	62	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108886	10.1371/journal.pone.0108886	http://dx.doi.org/10.1371/journal.pone.0108886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285436	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700038
J	Menezes, AMB; Perez-Padilla, R; Wehrmeister, FC; Lopez-Varela, MV; Muino, A; Valdivia, G; Lisboa, C; Jardim, JRB; de Oca, MM; Talamo, C; Bielemann, R; Gazzotti, M; Laurenti, R; Celli, B; Victora, CG				Menezes, Ana Maria B.; Perez-Padilla, Rogelio; Wehrmeister, Fernando Cesar; Lopez-Varela, Maria Victorina; Muino, Adriana; Valdivia, Gonzalo; Lisboa, Carmen; Jardim, Jose Roberto B.; de Oca, Maria Montes; Talamo, Carlos; Bielemann, Renata; Gazzotti, Mariana; Laurenti, Ruy; Celli, Bartolome; Victora, Cesar G.		PLATINO Team	FEV1 Is a Better Predictor of Mortality than FVC: The PLATINO Cohort Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LATIN-AMERICAN CITIES; FORCED VITAL CAPACITY; LUNG-FUNCTION DECLINE; GENETIC-STRUCTURE; ALL-CAUSE; GENERAL-POPULATION; FOLLOW-UP; RISK; OUTCOMES	Objective: To determine whether the presence of chronic obstructive lung disease (COPD) and reduction of lung function parameters were predictors of mortality in a cohort. Materials/Patients and Methods: Population based cohorts were followed in Montevideo, Santiago and Sao Paulo during 5, 6 and 9 years, respectively. Outcomes included all-cause, cardiovascular, respiratory and cancer mortality; exposures were COPD, forced expiratory volume in one second (FEV1) and forced vital capacity (FVC). Cox regression was used for analyses. Sensitivity, specificity, positive and negative predictive values, receiver operator characteristics curves and Youden's index were calculated. Results: Main causes of death were cardiovascular, respiratory and cancer. Baseline COPD was associated with overall mortality (HR = 1.43 for FEV1/FVC<LLN; 2.01 for GOLD 2-4; 1.46 for GOLD 1-4; 1.50 for FEV1/FEV6 <LLN). For cardiovascular mortality, significant associations were found with GOLD 2-4 (HR = 2.68) and with GOLD 1-4 (HR = 1.78) for both genders together (not among women). Low FEV1 was risk for overall and respiratory mortality (both genders combined). FVC was not associated with overall mortality. For most COPD criteria sensitivity was low and specificity high. The area under the curve for FEV1 was greater than for FVC for overall and cardiovascular mortality. Answer to the Question: COPD and low FEV1 are important predictors for overall and cardiovascular mortality in Latin America.	[Menezes, Ana Maria B.; Wehrmeister, Fernando Cesar; Bielemann, Renata; Victora, Cesar G.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil; [Perez-Padilla, Rogelio] Natl Inst Resp Dis Sleep Clin & Pulm Physiol, Mexico City, DF, Mexico; [Lopez-Varela, Maria Victorina] Univ Republica, Fac Med, Montevideo, Uruguay; [Muino, Adriana] Ctr Hosp Pereira Rossell, Montevideo, Uruguay; [Valdivia, Gonzalo; Lisboa, Carmen] Pontificia Univ Catolica Chile, Santiago, Chile; [Jardim, Jose Roberto B.; Gazzotti, Mariana] Univ Fed Sao Paulo, Sao Paulo, Brazil; [de Oca, Maria Montes; Talamo, Carlos] Cent Univ Venezuela, Fac Med, Caracas, Venezuela; [Laurenti, Ruy] Univ Sao Paulo, Sao Paulo, Brazil; [Celli, Bartolome] St Elizabeths Med Ctr, Boston, MA USA	Universidade Federal de Pelotas; Universidad de la Republica, Uruguay; Pontificia Universidad Catolica de Chile; Universidade Federal de Sao Paulo (UNIFESP); University of Central Venezuela; Universidade de Sao Paulo; St. Elizabeth's Medical Center	Menezes, AMB (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil.	anamene@terra.com.br	Wehrmeister, Fernando/A-3006-2014; Menezes, Ana MB/G-7266-2012; Nascimento, Oliver A./B-3039-2011; Jardim, Jose R/E-3205-2016; Victora, Cesar Gomes/Y-2455-2019; de, Maria Montes/AAP-7687-2021	Wehrmeister, Fernando/0000-0001-7137-1747; Menezes, Ana MB/0000-0002-2996-9427; Nascimento, Oliver A./0000-0003-3138-2219; Victora, Cesar Gomes/0000-0002-2465-2180; Valdivia, Gonzalo/0000-0001-5368-6745	The Asociacion Latinoamericana de Torax (ALAT); Boehringer Ingelheim GmbH; GlaxoSmithKline; Novartis	The Asociacion Latinoamericana de Torax (ALAT); Boehringer Ingelheim GmbH(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis)	The PLATINO study has been sponsored by The Asociacion Latinoamericana de Torax (ALAT), Boehringer Ingelheim GmbH, GlaxoSmithKline and Novartis for the collection of the data during the field work. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON HR, 1988, INT J EPIDEMIOL, V17, P56, DOI 10.1093/ije/17.1.56; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 2001, GPE DISCUSSION PAPER; Baughman P, 2012, EUR J EPIDEMIOL, V27, P933, DOI 10.1007/s10654-012-9750-2; BEATY TH, 1982, AM J EPIDEMIOL, V116, P102, DOI 10.1093/oxfordjournals.aje.a113385; Burney PGJ, 2011, THORAX, V66, P49, DOI 10.1136/thx.2010.147041; Duong M, 2013, LANCET RESP MED, V1, P599, DOI 10.1016/S2213-2600(13)70164-4; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Hebert JR, 2010, INT J EPIDEMIOL, V39, P1619, DOI 10.1093/ije/dyq157; Hole DJ, 1996, BRIT MED J, V313, P711; Kumar R, 2010, NEW ENGL J MED, V363, P321, DOI 10.1056/NEJMoa0907897; Lee HM, 2010, EUR RESPIR J, V36, P1002, DOI 10.1183/09031936.00042410; Mannino DM, 2006, THORAX, V61, P472, DOI 10.1136/thx.2005.052449; Mannino DM, 2006, AM J RESP CRIT CARE, V173, P985, DOI 10.1164/rccm.200508-1344OC; Mannino DM, 2003, THORAX, V58, P388, DOI 10.1136/thorax.58.5.388; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Menezes Ana M B, 2004, BMC Med Res Methodol, V4, P15, DOI 10.1186/1471-2288-4-15; Menezes AMB, 2014, ARCH BRONCONEUMOL, V50, P10, DOI 10.1016/j.arbres.2013.07.014; OLOFSON J, 1987, EUR J RESPIR DIS, V71, P69; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Perez-Padilla Rogelio, 2007, COPD, V4, P113, DOI 10.1080/15412550701341012; Perez-Padilla R, 2006, ARCH BRONCONEUMOL, V42, P317, DOI 10.1157/13090581; Probst-Hensch NM, 2010, THORAX, V65, P150, DOI 10.1136/thx.2009.115063; Puddu PE, 2011, EUR J EPIDEMIOL, V26, P595, DOI 10.1007/s10654-011-9600-7; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; World Health Organization, 2011, GLOB STAT REP ALC HL	34	45	45	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109732	10.1371/journal.pone.0109732	http://dx.doi.org/10.1371/journal.pone.0109732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285441	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700087
J	Kessner, S; Forkmann, K; Ritter, C; Wiech, K; Ploner, M; Bingel, U				Kessner, Simon; Forkmann, Katarina; Ritter, Christoph; Wiech, Katja; Ploner, Markus; Bingel, Ulrike			The Effect of Treatment History on Therapeutic Outcome: Psychological and Neurobiological Underpinnings	PLOS ONE			English	Article							PLACEBO ANALGESIA; NEURAL MECHANISMS; PAIN PERCEPTION; BRAIN; FMRI; EXPERIENCE; HUMANS; NOCEBO; LOCUS	It is increasingly recognized that the efficacy of medical treatments is determined in critical part by the therapeutic context in which it is delivered. An important characteristic of that context is treatment history. We recently reported first evidence for a carry-over of treatment experience to subsequent treatment response across different treatment approaches. Here we expand on these findings by exploring the psychological and neurobiological underpinnings of the effect of treatment experience on future treatment response in an experimental model of placebo analgesia with a conditioning procedure. In a combined behavioral and neuroimaging study we experimentally induced positive or negative experiences with an analgesic treatment in two groups of healthy human subjects. Subsequently we compared responses to a second, different analgesic treatment between both groups. We found that participants with an experimentally induced negative experience with the first treatment showed a substantially reduced response to a second analgesic treatment. Intriguingly, several psychological trait variables including anxiety, depression and locus of control modulate the susceptibility for the effects of prior treatment experiences on future treatment outcome. These behavioral effects were supported by neuroimaging data which showed significant differences in brain regions encoding pain and analgesia between groups. These differences in activation patterns were present not only during the pain phase, but also already prior to painful stimulation and scaled with the individual treatment response. Our data provide behavioral and neurobiological evidence showing that the influence of treatment history transfers over time and over therapeutic approaches. Our experimental findings emphasize the careful consideration of treatment history and a strictly systematic treatment approach to avoid negative carry-over effects.	[Kessner, Simon; Ritter, Christoph; Bingel, Ulrike] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Forkmann, Katarina; Ritter, Christoph; Bingel, Ulrike] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, Essen, Germany; [Wiech, Katja] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Wiech, Katja] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford Ctr Funct Magnet Resonance Imaging Brain, Oxford OX3 9DU, England; [Ploner, Markus] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Duisburg Essen; University of Oxford; University of Oxford; Technical University of Munich	Bingel, U (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.	ulrike.bingel@uk-essen.de	Ploner, Markus/C-3281-2013	Ploner, Markus/0000-0002-7767-7170; Kessner, Simon Stephan/0000-0002-2051-8531; Ritter, Christoph/0000-0001-8899-6444	German Research Foundation [BI 789/2-1]; Federal Ministry of Education and Research [01GQ0808]; Medical Research Council [MR/L011719/1] Funding Source: researchfish; MRC [MR/L011719/1] Funding Source: UKRI	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the German Research Foundation (BI 789/2-1, www.dfg.de) and the Federal Ministry of Education and Research (01GQ0808, www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre-Obadia N, 2011, PAIN, V152, P1233, DOI 10.1016/j.pain.2010.12.027; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; BATTERMAN RC, 1968, CURR THER RES CLIN E, V10, P136; Bingel U, 2004, CEREB CORTEX, V14, P1340, DOI 10.1093/cercor/bhh094; Bingel U, 2002, PAIN, V99, P313, DOI 10.1016/S0304-3959(02)00157-4; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Bingel U, 2008, PHYSIOLOGY, V23, P371, DOI 10.1152/physiol.00024.2008; Colloca L, 2008, PAIN, V136, P211, DOI 10.1016/j.pain.2008.02.006; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; Colloca L, 2011, PAIN, V152, P1215, DOI 10.1016/j.pain.2011.02.043; Doering BK, 2012, TRENDS PHARMACOL SCI, V33, P165, DOI 10.1016/j.tips.2011.12.001; Eickhoff SB, 2006, CEREB CORTEX, V16, P268, DOI 10.1093/cercor/bhi106; Eippert F, 2009, NEURON, V63, P533, DOI 10.1016/j.neuron.2009.07.014; Faymonville ME, 2000, ANESTHESIOLOGY, V92, P1257, DOI 10.1097/00000542-200005000-00013; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; FRUHSTORFER H, 1976, J NEUROL NEUROSUR PS, V39, P1071, DOI 10.1136/jnnp.39.11.1071; Hautzinger M., 1993, ADS ALLGEMEINE DEPRE; Kessner S, 2013, JAMA INTERN MED, V173, P1468, DOI 10.1001/jamainternmed.2013.6705; Kong J, 2008, J NEUROSCI, V28, P13354, DOI 10.1523/JNEUROSCI.2944-08.2008; KRAMPEN G, 1979, Z EXP ANGEW PSYCHOL, V26, P573; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Laux L., 1981, STATE TRAIT ANXIETY; LEVENSON H, 1973, J CONSULT CLIN PSYCH, V41, P397, DOI 10.1037/h0035357; Levenson H, 1972, P 80 ANN CONV AM PSY, V7, P259; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Montgomery GH, 1997, PAIN, V72, P107, DOI 10.1016/S0304-3959(97)00016-X; Organization WH, 1986, CANC PAIN REL; Petrides M, 1999, EUR J NEUROSCI, V11, P1011, DOI 10.1046/j.1460-9568.1999.00518.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Spielberger C. D., 1973, MANUAL STATE TRAIT I; SUCHMAN AL, 1992, CLIN PHARMACOL THER, V52, P372, DOI 10.1038/clpt.1992.157; Tracey I, 2011, NAT REV NEUROL, V7, P173, DOI 10.1038/nrneurol.2011.4; Volkow ND, 2003, J NEUROSCI, V23, P11461; VOUDOURIS NJ, 1990, PAIN, V43, P121, DOI 10.1016/0304-3959(90)90057-K; VOUDOURIS NJ, 1985, J PERS SOC PSYCHOL, V48, P47, DOI 10.1037/0022-3514.48.1.47; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Whalley B, 2008, J PSYCHOSOM RES, V64, P537, DOI 10.1016/j.jpsychores.2007.11.007; Wiech K, 2008, TRENDS COGN SCI, V12, P306, DOI 10.1016/j.tics.2008.05.005; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	41	35	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109014	10.1371/journal.pone.0109014	http://dx.doi.org/10.1371/journal.pone.0109014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ2BX	25275613	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500045
J	Rahmati, M; Petitbarat, M; Dubanchet, S; Bensussan, A; Chaouat, G; Ledee, N				Rahmati, Mona; Petitbarat, Marie; Dubanchet, Sylvie; Bensussan, Armand; Chaouat, Gerard; Ledee, Nathalie			Granulocyte-Colony Stimulating Factor Related Pathways Tested on an Endometrial Ex-Vivo Model	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR UPA; HUMAN-PLACENTA; RECURRENT MISCARRIAGE; IMPLANTATION FAILURE; EMBRYO IMPLANTATION; ADHESION MOLECULES; PREGNANCY RATES; EXPRESSION; CELLS; PREECLAMPSIA	Introduction: Recombinant human Granulocyte-Colony Stimulating Factor (rhG-CSF) supplementation seems to be a promising innovative therapy in reproductive medicine, used in case of recurrent miscarriage, embryo implantation failure or thin endometrium, although its mechanisms of action remain unknown. Our aim was to identify possible endometrial pathways influenced by rhG-CSF. Materials and Methods: Hypothetical molecular interactions regulated by G-CSF were designed through a previous large scale endometrial microarray study. The variation of endometrial expression of selected target genes was confirmed in control and infertile patients. G-CSF supplementation influence on these targets was tested on an endometrial ex-vivo culture. Middle luteal phase endometrial biopsies were cultured on collagen sponge with or without rhG-CSF supplementation during 3 consecutive days. Variations of endometrial mRNA expression for the selected targets were studied by RT-PCR. Results: At the highest dose of rhG-CSF stimulation, the mRNA expression of these selected target genes was significantly increased if compared with their expression without addition of rhG-CSF. The selected targets were G-CSF Receptor (G-CSFR), Integrin alpha-V/beta-3 (ITGB3) implicated in cell migration and embryo implantation, Plasminogen Activator Urokinase Receptor (PLAUR) described as interacting with integrins and implicated in cell migration, Thymidine Phosphorylase (TYMP) implicated in local angiogenesis, CD40 and its ligand CD40L involved in cell proliferation control. Conclusion: RhG-CSF seems able to influence endometrial expressions crucial for implantation process involving endometrial vascular remodelling, local immune modulation and cellular adhesion pathways. These variations observed in an ex-vivo model should be tested in-vivo. The strict indications or counter indication of rhG-CSF supplementation in reproductive field are not yet established, while the safety of its administration in early pregnancy on early embryogenesis still needs to be demonstrated. Nevertheless, rhG-CSF appears as a promising therapy in some difficult and unsolved cases of reproductive failure. Indications of pre-conceptual rhG-CSF supplementation may derive from a diagnosed lack of endometrial expression of some target genes.	[Rahmati, Mona; Petitbarat, Marie; Dubanchet, Sylvie; Bensussan, Armand; Chaouat, Gerard; Ledee, Nathalie] Univ Paris Diderot, Hop St Louis, INSERM,UMRS 976, Equipe Implantat & Dialogue Cytokin Mere Conceptu, Paris, France; [Rahmati, Mona; Ledee, Nathalie] Hop Pierre Rouques Les Bluets, Serv Assistance Med Procreat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Rahmati, M (corresponding author), Univ Paris Diderot, Hop St Louis, INSERM,UMRS 976, Equipe Implantat & Dialogue Cytokin Mere Conceptu, Paris, France.	mona.rahmati@gmail.com	Bensussan, Armand/E-5434-2017; LEDEE, nathalie/AAE-8303-2019	Bensussan, Armand/0000-0002-0409-2497; LEDEE, nathalie/0000-0002-3166-2643	Fertility Innovation; Merck Serono	Fertility Innovation; Merck Serono(Merck & Company)	This work is supported by Grant for Fertility Innovation, 2010, Merck Serono, http://www.grantforfertilityinnovation.com/en/gfi2010/winners/dr_nathalie_ledee.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barad DH, 2014, FERTIL STERIL, V101, P710, DOI 10.1016/j.fertnstert.2013.12.016; BONILLA MA, 1989, NEW ENGL J MED, V320, P1574, DOI 10.1056/NEJM198906153202402; Burghardt RC, 2009, REPRODUCTION, V137, P567, DOI 10.1530/REP-08-0304; Deves C, 2014, MOL BIOSYST, V10, P592, DOI 10.1039/c3mb70453j; GIANNI AM, 1989, LANCET, V2, P580; Gleicher N, 2013, HUM REPROD, V28, P172, DOI 10.1093/humrep/des370; Gleicher N, 2011, FERTIL STERIL, V95; Goddard KAB, 2007, HUM HERED, V63, P1, DOI 10.1159/000097926; Hassan SB, 2014, IMMUNOPHARM IMMUNOT, V36, P96, DOI 10.3109/08923973.2014.890626; Kunicki M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/913235; Lala PK, 2003, PLACENTA, V24, P575, DOI 10.1016/S0143-4004(03)00063-8; Larsen EC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-154; Laudanski P, 2014, EUR J OBSTET GYN R B, V172, P85, DOI 10.1016/j.ejogrb.2013.10.007; Ledee N, 2011, J PATHOL, V225, P554, DOI 10.1002/path.2948; Massuto DA, 2010, REPRODUCTION, V139, P465, DOI 10.1530/REP-09-0447; McCracken S, 1996, J ENDOCRINOL, V149, P249, DOI 10.1677/joe.0.1490249; McCracken SA, 1999, BIOL REPROD, V60, P790, DOI 10.1095/biolreprod60.4.790; Miyama Masato, 1998, Osaka City Medical Journal, V44, P85; MORSTYN G, 1988, LANCET, V1, P667, DOI 10.1016/S0140-6736(88)91475-4; Naruse K, 2009, PLACENTA, V30, P398, DOI 10.1016/j.placenta.2009.02.002; Nordengren J, 2004, MOL HUM REPROD, V10, P655, DOI 10.1093/molehr/gah081; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; Petitbarat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014497; Polanski LT, 2014, REPROD BIOMED ONLINE, V28, P409, DOI 10.1016/j.rbmo.2013.12.006; Pula G, 2010, ARTERIOSCL THROM VAS, V30, P2631, DOI 10.1161/ATVBAHA.110.215855; Renaud SJ, 2007, BIOL REPROD, V76, P448, DOI 10.1095/biolreprod.106.055376; Sakurai T, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100180; Santjohanser C, 2013, ARCH IMMUNOL THER EX, V61, P159, DOI 10.1007/s00005-012-0212-z; Scarpellini F, 2009, HUM REPROD, V24, P2703, DOI 10.1093/humrep/dep240; Singh H, 2009, J ANAT, V215, P3, DOI 10.1111/j.1469-7580.2008.01034.x; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Smith KA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00029; Su LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087867; Uszynski M, 2011, SEMIN THROMB HEMOST, V37, P165, DOI 10.1055/s-0030-1270345; UZUMAKI H, 1989, P NATL ACAD SCI USA, V86, P9323, DOI 10.1073/pnas.86.23.9323; Wurfel W, 2010, HUM REPROD, V25, P2151, DOI 10.1093/humrep/deq106; Yamakoshi S, 2012, REPRODUCTION, V143, P377, DOI 10.1530/REP-11-0364; Zhao YL, 2010, FERTIL STERIL, V94, P2264, DOI 10.1016/j.fertnstert.2010.01.068; Zhu LH, 2013, J CLIN ENDOCR METAB, V98, P4417, DOI 10.1210/jc.2013-1429	39	37	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e102286	10.1371/journal.pone.0102286	http://dx.doi.org/10.1371/journal.pone.0102286			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275446	Green Submitted, Green Published, gold			2022-12-27	WOS:000342591500001
J	Yu, W; Zeng, L				Yu, Wei; Zeng, Li			A Novel Weighted Total Difference Based Image Reconstruction Algorithm for Few-View Computed Tomography	PLOS ONE			English	Article							LINEAR INVERSE PROBLEMS; THRESHOLDING ALGORITHM	In practical applications of computed tomography (CT) imaging, due to the risk of high radiation dose imposed on the patients, it is desired that high quality CT images can be accurately reconstructed from limited projection data. While with limited projections, the images reconstructed often suffer severe artifacts and the edges of the objects are blurred. In recent years, the compressed sensing based reconstruction algorithm has attracted major attention for CT reconstruction from a limited number of projections. In this paper, to eliminate the streak artifacts and preserve the edge structure information of the object, we present a novel iterative reconstruction algorithm based on weighted total difference (WTD) minimization, and demonstrate the superior performance of this algorithm. The WTD measure enforces both the sparsity and the directional continuity in the gradient domain, while the conventional total difference (TD) measure simply enforces the gradient sparsity horizontally and vertically. To solve our WTD-based few-view CT reconstruction model, we use the soft-threshold filtering approach. Numerical experiments are performed to validate the efficiency and the feasibility of our algorithm. For a typical slice of FORBILD head phantom, using 40 projections in the experiments, our algorithm outperforms the TD-based algorithm with more than 60% gains in terms of the root-mean-square error (RMSE), normalized root mean square distance (NRMSD) and normalized mean absolute distance (NMAD) measures and with more than 10% gains in terms of the peak signal-to-noise ratio (PSNR) measure. While for the experiments of noisy projections, our algorithm outperforms the TD-based algorithm with more than 15% gains in terms of the RMSE, NRMSD and NMAD measures and with more than 4% gains in terms of the PSNR measure. The experimental results indicate that our algorithm achieves better performance in terms of suppressing streak artifacts and preserving the edge structure information of the object.	[Yu, Wei; Zeng, Li] Chongqing Univ, Educ Minist China, Key Lab Optoelect Technol & Syst, Chongqing 630044, Peoples R China; [Zeng, Li] Chongqing Univ, Coll Math & Stat, Chongqing 630044, Peoples R China; [Yu, Wei] Chongqing Univ, Educ Minist China, Engn Res Ctr Ind Computed Tomog Nondestruct Testi, Chongqing 630044, Peoples R China	Chongqing University; Chongqing University; Chongqing University	Zeng, L (corresponding author), Chongqing Univ, Educ Minist China, Key Lab Optoelect Technol & Syst, Chongqing 630044, Peoples R China.	drlizeng@cqu.edu.cn			National Natural Science Foundation of China [61271313]; National Instrumentation Program of China [2013YQ030629]; Chongqing science and technology research plan project [cstc2012ggyyjs70016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Instrumentation Program of China; Chongqing science and technology research plan project	This work is supported by the National Natural Science Foundation of China under grant (61271313) (http://www.nsfc.gov.cn), National Instrumentation Program of China (2013YQ030629) (http://www.most.gov.cn), and Chongqing science and technology research plan project (cstc2012ggyyjs70016) (http://www.ctin.ac.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN AH, 1984, ULTRASONIC IMAGING, V6, P81, DOI 10.1016/0161-7346(84)90008-7; Armitage P., 2002, STAT METHODS MED RES; Bajpai M, 2013, RES NONDESTRUCT EVAL, V24, P211, DOI 10.1080/09349847.2013.795635; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Beister M, 2012, PHYS MEDICA, V28, P94, DOI 10.1016/j.ejmp.2012.01.003; Bian JG, 2010, PHYS MED BIOL, V55, P6575, DOI 10.1088/0031-9155/55/22/001; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes EJ, 2006, COMMUN PUR APPL MATH, V59, P1207, DOI 10.1002/cpa.20124; Chang M, 2013, J X-RAY SCI TECHNOL, V21, P161, DOI 10.3233/XST-130370; Chen GH, 2008, MED PHYS, V35, P660, DOI 10.1118/1.2836423; Daubechies I, 2004, COMMUN PUR APPL MATH, V57, P1413, DOI 10.1002/cpa.20042; Daubechies I, 2008, J FOURIER ANAL APPL, V14, P764, DOI 10.1007/s00041-008-9039-8; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Flores LA, 2014, RADIAT PHYS CHEM, V95, P247, DOI 10.1016/j.radphyschem.2013.03.011; Frush DP, 2003, PEDIATRICS, V112, P951, DOI 10.1542/peds.112.4.951; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Han X, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/16/5245; Han XA, 2011, IEEE T MED IMAGING, V30, P606, DOI 10.1109/TMI.2010.2089695; Herman GT, 2009, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84628-723-7; Jin SO, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-44; Kak A.V., 1988, PRINCIPLES COMPUTERI, DOI DOI 10.1137/1.9780898719277.CH7; Kambara K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090040; Karonis NT, 2013, J PARALLEL DISTR COM, V73, P1605, DOI 10.1016/j.jpdc.2013.07.016; Li YY, 1996, IEEE T IMAGE PROCESS, V5, P987, DOI 10.1109/83.503914; Liu BD, 2011, PHYS MED BIOL, V56, P6337, DOI 10.1088/0031-9155/56/19/012; Lu Y, 2012, PHYS MED BIOL, V57, P173, DOI 10.1088/0031-9155/57/1/173; Pan XC, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/12/123009; Ritschl L, 2011, PHYS MED BIOL, V56, P1545, DOI 10.1088/0031-9155/56/6/003; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Shu XB, 2010, LECT NOTES COMPUT SC, V6316, P393; Sidky EY, 2006, J X-RAY SCI TECHNOL, V14, P119; Takx RAP, 2014, PLOS ONE, P9; Vandeghinste B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068449; Wright SJ, 2009, IEEE T SIGNAL PROCES, V57, P2479, DOI 10.1109/TSP.2009.2016892; Yu HY, 2010, PHYS MED BIOL, V55, P3905, DOI 10.1088/0031-9155/55/13/022; Zhao X, 2013, J X-RAY SCI TECHNOL, V21, P53, DOI 10.3233/XST-130366	36	18	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109345	10.1371/journal.pone.0109345	http://dx.doi.org/10.1371/journal.pone.0109345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275385	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500096
J	Zhang, QZ; Yao, DZ; Yang, JW; Zhou, YQ				Zhang, Quanzhi; Yao, Dazhi; Yang, Jinwei; Zhou, Yuqiu			Factors Influencing Sleep Disturbances among Spouse Caregivers of Cancer Patients in Northeast China	PLOS ONE			English	Article							QUALITY-OF-LIFE; FAMILY CAREGIVERS; BREAST-CANCER; COPING STRATEGIES; STEM-CELL; DISTRESS; ADJUSTMENT; FATIGUE; HEALTH; PREDICTORS	Background: In China, spouse caregivers of cancer patients (SCCPs) are involved in all aspects of patient care and experience psychological distress which could result in sleep disturbance and fatigue. However, few studies have explored the differences between SCCPs and the general population, or what factors affect SCCPs' sleep. This study aims to (1) Compare the differences in sleep disturbances and fatigue severity between SCCPs and the age-and gender-matched general population, and (2) Identify selected personal characteristics, including coping style that affect sleep disturbances in SCCPs. Methodology/Principal Findings: The Stress and Coping Model was used to guide this study. Participants were recruited from the northeast part of China and included 600 people from the general population and 300 SCCPs. Participants completed a socio-demographic form, Fatigue Scale-14, trait Coping Style Questionnaire, and Symptom Checklist-90. Results: The majority of the participants were middle age, most of whom (78.7%) spent more than 8 hours each day taking care of their spouses. Compared to the general population, the SCCPs experienced significant sleep disturbances with a mean of 7.30 (SD = 1.27), and fatigue severity with a mean of 8.11 (SD = 3.25). Among the selected SCCPs' personal characteristics, current poor health status (beta = 0.14, P<0.001), having a spouse under mixed treatment (beta = 0.13, p<0.001), and financial burden (beta = 0.14, P<0.001) are the significant predictors for sleep disturbances. Positive coping is the predictor for fewer sleep disturbances (beta = 0.27, P<0.001). Those who reported sleep disturbances also experienced higher physical and mental fatigue severity (P<0.001). Conclusion: Intervention to improve coping style in SCCPs is needed. Further research is also needed to explore the other mediators and moderators that regulate sleep disturbance and health outcomes in the SCCPs.	[Zhang, Quanzhi; Yao, Dazhi; Yang, Jinwei; Zhou, Yuqiu] Harbin Med Univ, Sch Nursing, Daqing, Peoples R China	Harbin Medical University	Zhou, YQ (corresponding author), Harbin Med Univ, Sch Nursing, Daqing Campus, Daqing, Peoples R China.	hlxzyq@126.com			Seed Fund of Harbin Medical University (Daqing) [DQ2013-06]; Heilongjiang Provincial Health Bureau [2013-118, 2009-260]	Seed Fund of Harbin Medical University (Daqing); Heilongjiang Provincial Health Bureau	This research was supported by the Seed Fund of Harbin Medical University (Daqing, Grant No. DQ2013-06) and Heilongjiang Provincial Health Bureau (Grant No. 2013-118 and No. 2009-260). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie S, 2011, PSYCHO-ONCOLOGY, V20, P1137, DOI 10.1002/pon.1962; Berger AM, 2009, ONCOL NURS FORUM, V36, P401, DOI 10.1188/09.ONF.E165-E177; Blum Kay, 2010, Semin Oncol Nurs, V26, P243, DOI 10.1016/j.soncn.2010.08.005; Bradley SE, 2009, J NEURO-ONCOL, V93, P333, DOI 10.1007/s11060-008-9778-z; Carney S, 2011, J CLIN ONCOL, V29, P1001, DOI 10.1200/JCO.2010.30.9104; Carter PA, 2006, CANCER NURS, V29, P95, DOI 10.1097/00002820-200603000-00003; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Delgado-Guay MO, 2013, AM J HOSP PALLIAT ME, V30, P455, DOI 10.1177/1049909112458030; Derogatis L R, 1974, Mod Probl Pharmacopsychiatry, V7, P79; Dhruva A, 2012, CANCER NURS, V35, P70, DOI 10.1097/NCC.0b013e3182194a25; Fitzell A, 2010, PSYCHO-ONCOLOGY, V19, P1171, DOI 10.1002/pon.1666; Fletcher BAS, 2008, ONCOL NURS FORUM, V35, P187, DOI 10.1188/08.ONF.E23-E44; Funk L, 2010, PALLIATIVE MED, V24, P594, DOI 10.1177/0269216310371411; Gibbins J, 2009, J PAIN SYMPTOM MANAG, V38, P860, DOI 10.1016/j.jpainsymman.2009.04.025; Gough K, 2009, J PAIN SYMPTOM MANAG, V37, P797, DOI 10.1016/j.jpainsymman.2008.04.012; Hebert RS, 2009, J PAIN SYMPTOM MANAG, V37, P3, DOI 10.1016/j.jpainsymman.2007.12.010; Hodges LJ, 2005, SOC SCI MED, V60, P1, DOI 10.1016/j.socscimed.2004.04.018; Jiang Q, 1996, CHINESE MENTAL HLTH, V10, P180; Kershaw T, 2004, PSYCHOL HEALTH, V19, P139, DOI 10.1080/08870440310001652687; Kim Y, 2006, PSYCHO-ONCOLOGY, V15, P795, DOI 10.1002/pon.1013; Kim Y, 2010, PSYCHO-ONCOLOGY, V19, P431, DOI 10.1002/pon.1576; Kurtz ME, 2004, MED SCI MONITOR, V10, pCR447; Lau DT, 2010, J PALLIAT MED, V13, P1085, DOI 10.1089/jpm.2010.0082; Lazarus R.S., 1984, EMOTION ADAPTATION; Leslie MB, 2002, J SOC PERS RELAT, V19, P45, DOI 10.1177/0265407502191003; McCorkle R, 2007, UROL NURS, V27, P78; McCorkle Ruth, 2007, Urol Nurs, V27, P65; McCurry SM, 2008, SLEEP, V31, P741, DOI 10.1093/sleep/31.5.741; Miaskowski C, 2011, CANCER NURS, V34, P255, DOI 10.1097/NCC.0b013e3181f65d9b; Murray SA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2581; Northouse L, 2001, J BEHAV MED, V24, P115, DOI 10.1023/A:1010772913717; Park SM, 2010, SUPPORT CARE CANCER, V18, P699, DOI 10.1007/s00520-009-0668-5; Phipps S, 2005, J PEDIATR PSYCHOL, V30, P139, DOI 10.1093/jpepsy/jsi002; PTACEK JT, 1994, J PSYCHOSOC ONCOL, V12, P47, DOI 10.1300/J077V12N03_04; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Stajduhar KI, 2010, PALLIATIVE MED, V24, P573, DOI 10.1177/0269216310371412; Steele R G, 1996, Oncol Nurs Forum, V23, P823; Tanner Christine A, 2007, Commun Nurs Res, V40, P3; Van Houtven CH, 2010, ONCOLOGIST, V15, P883, DOI 10.1634/theoncologist.2010-0005; Wiedebusch S, 2010, PEDIATR NEPHROL, V25, P1477, DOI 10.1007/s00467-010-1540-z; Wielgus KK, 2009, ONCOL NURS FORUM, V36, P38, DOI 10.1188/09.ONF.38-48; [徐朝艳 Xu Chaoyan], 2006, [中华护理杂志, Chinese Journal of Nursing], V41, P530	42	12	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108614	10.1371/journal.pone.0108614	http://dx.doi.org/10.1371/journal.pone.0108614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ2BX	25275619	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500022
J	Bonilla, IM; Long, VP; Vargas-Pinto, P; Wright, P; Belevych, A; Lou, Q; Mowrey, K; Yoo, J; Binkley, PF; Fedorov, VV; Gyorke, S; Janssen, PML; Kilic, A; Mohler, PJ; Carnes, CA				Bonilla, Ingrid M.; Long, Victor P., III; Vargas-Pinto, Pedro; Wright, Patrick; Belevych, Andriy; Lou, Qing; Mowrey, Kent; Yoo, Jae; Binkley, Philip F.; Fedorov, Vadim V.; Gyoerke, Sandor; Janssen, Paulus M. L.; Kilic, Ahmet; Mohler, Peter J.; Carnes, Cynthia A.			Calcium-Activated Potassium Current Modulates Ventricular Repolarization in Chronic Heart Failure	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ACTION-POTENTIAL PROLONGATION; TORSADES-DE-POINTES; TO-BEAT VARIABILITY; ATRIAL-FIBRILLATION; MYOCYTES; CARDIOMYOPATHY; APAMIN; MODEL; SK2	The role of I-KCa in cardiac repolarization remains controversial and varies across species. The relevance of the current as a therapeutic target is therefore undefined. We examined the cellular electrophysiologic effects of I-KCa blockade in controls, chronic heart failure (HF) and HF with sustained atrial fibrillation. We used perforated patch action potential recordings to maintain intrinsic calcium cycling. The I-KCa blocker (apamin 100 nM) was used to examine the role of the current in atrial and ventricular myocytes. A canine tachypacing induced model of HF (1 and 4 months, n = 5 per group) was used, and compared to a group of 4 month HF with 6 weeks of superimposed atrial fibrillation (n = 7). A group of age-matched canine controls were used (n = 8). Human atrial and ventricular myocytes were isolated from explanted end-stage failing hearts which were obtained from transplant recipients, and studied in parallel. Atrial myocyte action potentials were unchanged by I-KCa blockade in all of the groups studied. I-KCa blockade did not affect ventricular myocyte repolarization in controls. HF caused prolongation of ventricular myocyte action potential repolarization. I-KCa blockade caused further prolongation of ventricular repolarization in HF and also caused repolarization instability and early afterdepolarizations. SK2 and SK3 expression in the atria and SK3 in the ventricle were increased in canine heart failure. We conclude that during HF, I-KCa blockade in ventricular myocytes results in cellular arrhythmias. Furthermore, our data suggest an important role for I-KCa in the maintenance of ventricular repolarization stability during chronic heart failure. Our findings suggest that novel antiarrhythmic therapies should have safety and efficacy evaluated in both atria and ventricles.	[Bonilla, Ingrid M.; Long, Victor P., III; Yoo, Jae; Carnes, Cynthia A.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Bonilla, Ingrid M.; Long, Victor P., III; Wright, Patrick; Belevych, Andriy; Lou, Qing; Binkley, Philip F.; Fedorov, Vadim V.; Gyoerke, Sandor; Janssen, Paulus M. L.; Kilic, Ahmet; Mohler, Peter J.] Ohio State Univ, Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Vargas-Pinto, Pedro; Carnes, Cynthia A.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA; [Mowrey, Kent] St Jude Med, Sylmar, CA USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Carnes, CA (corresponding author), Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA.	carnes.4@osu.edu	Fedorov, Vadim/N-4462-2013; Long, Victor/AAF-6038-2021; Carnes, Cynthia/C-9540-2012	Vargas-Pinto, Pedro/0000-0001-5729-1628; Belevych, Andriy/0000-0002-1272-5784; Janssen, Paul/0000-0002-9682-3014; Carnes, Cynthia/0000-0003-0420-6973	NIH [R01-HL115580, R01-HL089836, HL074045, HL084583, HL083422, HL114383]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074045, R01HL114383, R01HL115580, R01HL083422, R01HL084583, R01HL089836] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Pacemakers and leads provided by St. Jude Medical, Sylmar, CA as an in-kind donation (Carnes). Research supported in part by NIH grants (R01-HL115580 to CAC and VVF; R01-HL089836 to CAC; HL074045 to SG; HL084583, HL083422, HL114383 to PJM) and the American Heart Association (PJM). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Belevych AE, 2011, CARDIOVASC RES, V90, P493, DOI 10.1093/cvr/cvr025; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; BKAILY G, 1992, AM J PHYSIOL, V262, pH463, DOI 10.1152/ajpheart.1992.262.2.H463; Bonilla IM, 2014, J CARDIOVASC ELECTR, V25, P299, DOI 10.1111/jce.12327; Bonilla IM, 2013, J CARDIOVASC PHARM, V61, P401, DOI 10.1097/FJC.0b013e31828748ca; Bonilla IM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00105; BRILLANTES AMB, 1994, CIRC RES, V75, P503, DOI 10.1161/01.RES.75.3.503; Chang PC, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004713; Chang SH, 2012, CIRC J, V76, P184, DOI 10.1253/circj.CJ-11-0525; Chua SK, 2011, CIRC RES, V108, P971, DOI 10.1161/CIRCRESAHA.110.238386; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Glukhov AV, 2012, CIRCULATION, V125, P1835, DOI 10.1161/CIRCULATIONAHA.111.047274; Grunnet M, 2001, NEUROPHARMACOLOGY, V40, P879, DOI 10.1016/S0028-3908(01)00028-4; Grunnet M, 2001, PFLUG ARCH EUR J PHY, V441, P544, DOI 10.1007/s004240000447; Gui L, 2013, AM J PHYSIOL-HEART C, V304, pH118, DOI 10.1152/ajpheart.00820.2011; Hsueh CH, 2013, HEART RHYTHM, V10, P891, DOI 10.1016/j.hrthm.2013.01.033; Kaab S, 1996, CIRC RES, V78, P262, DOI 10.1161/01.RES.78.2.262; Kannel WB, 1998, AM J CARDIOL, V82, p2N, DOI 10.1016/S0002-9149(98)00583-9; Kubalova Z, 2005, P NATL ACAD SCI USA, V102, P14104, DOI 10.1073/pnas.0504298102; Li N, 2009, J PHYSIOL-LONDON, V587, P1087, DOI 10.1113/jphysiol.2008.167718; Nattel S, 2009, J PHYSIOL-LONDON, V587, P1385, DOI 10.1113/jphysiol.2009.170621; Nishijima Y, 2005, J CARD FAIL, V11, P638, DOI 10.1016/j.cardfail.2005.05.006; Nishijima Y, 2007, LIFE SCI, V81, P1152, DOI 10.1016/j.lfs.2007.08.022; PARK Y, 1994, J PHYSIOL-LONDON, V481, P555, DOI 10.1113/jphysiol.1994.sp020463; Qi XY, 2014, CIRCULATION, V129, P430, DOI 10.1161/CIRCULATIONAHA.113.003019; Ro S, 2001, AM J PHYSIOL-GASTR L, V281, pG964, DOI 10.1152/ajpgi.2001.281.4.G964; Roden DM, 1998, PACE, V21, P1029, DOI 10.1111/j.1540-8159.1998.tb00148.x; Schreieck J, 2000, J CARDIOVASC ELECTR, V11, P180, DOI 10.1111/j.1540-8167.2000.tb00318.x; Sridhar A, 2009, CARDIOVASC RES, V84, P227, DOI 10.1093/cvr/cvp216; Terentyev D, 2014, AM J PHYSIOL-HEART C, V306, pH738, DOI 10.1152/ajpheart.00621.2013; Terentyev D, 2008, CIRC RES, V103, P1466, DOI 10.1161/CIRCRESAHA.108.184457; Thomsen MB, 2007, CARDIOVASC RES, V73, P521, DOI 10.1016/j.cardiores.2006.11.025; Thomsen MB, 2006, J AM COLL CARDIOL, V48, P1268, DOI 10.1016/j.jacc.2006.05.048; Tuteja D, 2005, AM J PHYSIOL-HEART C, V289, pH2714, DOI 10.1152/ajpheart.00534.2005; Van Wagoner DR, 1999, CIRC RES, V85, P428, DOI 10.1161/01.RES.85.5.428; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Weatherall KL, 2011, P NATL ACAD SCI USA, V108, P18494, DOI 10.1073/pnas.1110724108; Weatherall KL, 2010, PROG NEUROBIOL, V91, P242, DOI 10.1016/j.pneurobio.2010.03.002; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Winslow RL, 1999, CIRC RES, V84, P571, DOI 10.1161/01.RES.84.5.571; Workman AJ, 2009, HEART RHYTHM, V6, P445, DOI 10.1016/j.hrthm.2008.12.028; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Xu YF, 2003, J BIOL CHEM, V278, P49085, DOI 10.1074/jbc.M307508200; Yu CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096691; Yu T, 2012, LIFE SCI, V90, P219, DOI 10.1016/j.lfs.2011.11.008	46	44	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108824	10.1371/journal.pone.0108824	http://dx.doi.org/10.1371/journal.pone.0108824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271970	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600064
J	Cui, BY; Zhang, LF; Song, YH; Wei, JS; Li, CF; Wang, TT; Wang, Y; Zhao, TY; Shen, XH				Cui, Boyu; Zhang, Lifeng; Song, Yunhong; Wei, Jinsong; Li, Changfu; Wang, Tietao; Wang, Yao; Zhao, Tianyong; Shen, Xihui			Engineering an Enhanced, Thermostable, Monomeric Bacterial Luciferase Gene As a Reporter in Plant Protoplasts	PLOS ONE			English	Article							DIRECTED EVOLUTION; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; MOLECULAR EVOLUTION; LUMINESCENCE DECAY; RANDOM MUTAGENESIS; LUX GENES; IN-VIVO; EXPRESSION; PROTEIN	The application of the luxCDABE operon of the bioluminescent bacterium Photorhabdus luminescens as a reporter has been published for bacteria, yeast and mammalian cells. We report here the optimization of fused luxAB (the bacterial luciferase heterodimeric enzyme) expression, quantum yield and its application as a reporter gene in plant protoplasts. The fused luxAB gene was mutated by error prone PCR or chemical mutagenesis and screened for enhanced luciferase activity utilizing decanal as substrate. Positive luxAB mutants with superior quantum yield were subsequently shuffled by DNase I digestion and PCR assembly for generation of recombinants with additional increases in luciferase activity in bacteria. The coding sequence of the best recombinant, called eluxAB, was then optimized further to conform to Arabidopsis (Arabidopsis thaliana) codon usage. A plant expression vector of the final, optimized eluxAB gene (opt-eluxAB) was constructed and transformed into protoplasts of Arabidopsis and maize (Zea mays). Luciferase activity was dramatically increased for opt-eluxAB compared to the original luxAB in Arabidopsis and maize cells. The opt-eluxAB driven by two copies of the 35S promoter expresses significantly higher than that driven by a single copy. These results indicate that the eluxAB gene can be used as a reporter in plant protoplasts. To our knowledge, this is the first report to engineer the bacterium Photorhabdus luminescens luciferase luxAB as a reporter by directed evolution which paved the way for further improving the luxAB reporter in the future.	[Cui, Boyu; Zhang, Lifeng; Song, Yunhong; Wei, Jinsong; Li, Changfu; Wang, Tietao; Wang, Yao; Zhao, Tianyong; Shen, Xihui] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Cui, Boyu; Zhang, Lifeng; Song, Yunhong; Wei, Jinsong; Li, Changfu; Wang, Tietao; Wang, Yao; Zhao, Tianyong; Shen, Xihui] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Cui, Boyu; Song, Yunhong; Wang, Tietao; Shen, Xihui] Northwest A&F Univ, Dept Microbiol, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Zhang, Lifeng; Wei, Jinsong; Li, Changfu; Wang, Yao; Zhao, Tianyong] Northwest A&F Univ, Coll Life Sci, Dept Biochem & Mol Biol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Zhao, TY (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	tzhao2@nwsuaf.edu.cn; xihuishen@nwsuaf.edu.cn		Wang, Tietao/0000-0001-8540-436X	National Natural Science Foundation of China [31170121, 31170100, 31370150]; Ministry of Agriculture in China [2014ZX0800920B]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture in China(Ministry of Agriculture & Rural Affairs)	This work was supported by the National Natural Science Foundation of China 31170121 (to XS), 31170100 and 31370150 (to YW), and the Special fund for transgenic research by Ministry of Agriculture in China 2014ZX0800920B (to TZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMASHANU S, 1990, J BIOLUM CHEMILUM, V5, P89, DOI 10.1002/bio.1170050204; Bessler C, 2003, PROTEIN SCI, V12, P2141, DOI 10.1110/ps.0384403; BOYLAN M, 1989, J BIOL CHEM, V264, P1915; Chen KC, 2008, CHEM BIOL, V15, P1277, DOI 10.1016/j.chembiol.2008.10.008; Cirino Patrick C, 2003, Methods Mol Biol, V231, P3; Close D, 2012, SENSORS-BASEL, V12, P732, DOI 10.3390/s120100732; Close DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012441; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; DiGrazia P M, 1991, Biodegradation, V2, P81, DOI 10.1007/BF00114598; ESCHER A, 1989, P NATL ACAD SCI USA, V86, P6528, DOI 10.1073/pnas.86.17.6528; Fisher AJ, 1996, J BIOL CHEM, V271, P21956, DOI 10.1074/jbc.271.36.21956; Gu L, 2013, PLANT SCI, V213, P38, DOI 10.1016/j.plantsci.2013.09.002; Gupta RK, 2003, FEMS YEAST RES, V4, P305, DOI 10.1016/S1567-1356(03)00174-0; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hosseinkhani S, 2005, BIOCHEM J, V385, P575, DOI 10.1042/BJ20040863; Kadurugamuwa JL, 2003, ANTIMICROB AGENTS CH, V47, P3130, DOI 10.1128/AAC.47.10.3130-3137.2003; Kaur J, 2006, CRIT REV BIOTECHNOL, V26, P165, DOI 10.1080/07388550600851423; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; KIRCHNER G, 1989, GENE, V81, P349, DOI 10.1016/0378-1119(89)90195-9; KONCZ C, 1987, P NATL ACAD SCI USA, V84, P131, DOI 10.1073/pnas.84.1.131; KONCZ C, 1990, DEV GENET, V11, P224, DOI 10.1002/dvg.1020110308; Kuklin NA, 2003, ANTIMICROB AGENTS CH, V47, P2740, DOI 10.1128/AAC.47.9.2740-2748.2003; Lei BF, 1998, BIOCHEMISTRY-US, V37, P14623, DOI 10.1021/bi981841+; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; Miller J.H., 1993, TRENDS BIOCHEM SCI L, V18, P193; Monshausen GB, 2012, CURR OPIN PLANT BIOL, V15, P677, DOI 10.1016/j.pbi.2012.09.014; Niladevi KN, 2008, PROCESS BIOCHEM, V43, P654, DOI 10.1016/j.procbio.2008.02.002; Patterson SS, 2005, J IND MICROBIOL BIOT, V32, P115, DOI 10.1007/s10295-005-0211-8; Rasila TS, 2009, ANAL BIOCHEM, V388, P71, DOI 10.1016/j.ab.2009.02.008; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHEEN J, 1991, PLANT CELL, V3, P225, DOI 10.1105/tpc.3.3.225; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; SZITTNER R, 1990, J BIOL CHEM, V265, P16581; Taghva A, 2010, WORLD NEUROSURG, V73, P307, DOI 10.1016/j.wneu.2010.01.020; Tinikul R, 2012, J BIOTECHNOL, V162, P346, DOI 10.1016/j.jbiotec.2012.08.018; Turner NJ, 2003, TRENDS BIOTECHNOL, V21, P474, DOI 10.1016/j.tibtech.2003.09.001; Valkova N, 1999, BIOCHEMISTRY-US, V38, P13820, DOI 10.1021/bi991407n; Xiong AS, 2012, CRIT REV BIOTECHNOL, V32, P133, DOI 10.3109/07388551.2011.593503; Xu S, 2013, ENVIRON MICROBIOL, V16, P1090; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang WP, 2013, ENVIRON MICROBIOL, V15, P557, DOI 10.1111/1462-2920.12005; Zuo ZY, 2007, ENZYME MICROB TECH, V40, P569, DOI 10.1016/j.enzmictec.2006.05.018	43	9	10	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e107885	10.1371/journal.pone.0107885	http://dx.doi.org/10.1371/journal.pone.0107885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271765	gold, Green Submitted, Green Published			2022-12-27	WOS:000343729600022
J	Duran-Prado, M; Frontinan, J; Santiago-Mora, R; Peinado, JR; Parrado-Fernandez, C; Gomez-Almagro, MV; Moreno, M; Lopez-Dominguez, JA; Villalba, JM; Alcain, FJ				Duran-Prado, Mario; Frontinan, Javier; Santiago-Mora, Raquel; Ramon Peinado, Juan; Parrado-Fernandez, Cristina; Victoria Gomez-Almagro, Maria; Moreno, Maria; Alberto Lopez-Dominguez, Jose; Manuel Villalba, Jose; Alcain, Francisco J.			Coenzyme Q(10) Protects Human Endothelial Cells from beta-Amyloid Uptake and Oxidative Stress-Induced Injury	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; PEPTIDE; DISEASE; PERMEABILITY; DYSFUNCTION; CHANNEL; MITOCHONDRIA; INFLAMMATION; BETA(1-42); MECHANISM	Neuropathological symptoms of Alzheimer's disease appear in advances stages, once neuronal damage arises. Nevertheless, recent studies demonstrate that in early asymptomatic stages, beta-amyloid peptide damages the cerebral microvasculature through mechanisms that involve an increase in reactive oxygen species and calcium, which induces necrosis and apoptosis of endothelial cells, leading to cerebrovascular dysfunction. The goal of our work is to study the potential preventive effect of the lipophilic antioxidant coenzyme Q (CoQ) against beta-amyloid-induced damage on human endothelial cells. We analyzed the protective effect of CoQ against A beta-induced injury in human umbilical vein endothelial cells (HUVECs) using fluorescence and confocal microscopy, biochemical techniques and RMN-based metabolomics. Our results show that CoQ pretreatment of HUVECs delayed A beta incorporation into the plasma membrane and mitochondria. Moreover, CoQ reduced the influx of extracellular Ca2+, and Ca2+ release from mitochondria due to opening the mitochondrial transition pore after beta-amyloid administration, in addition to decreasing O-2(center dot-) and H2O2 levels. Pretreatment with CoQ also prevented beta-amyloid-induced HUVECs necrosis and apoptosis, restored their ability to proliferate, migrate and form tube-like structures in vitro, which is mirrored by a restoration of the cell metabolic profile to control levels. CoQ protected endothelial cells from A beta-induced injury at physiological concentrations in human plasma after oral CoQ supplementation and thus could be a promising molecule to protect endothelial cells against amyloid angiopathy.	[Duran-Prado, Mario; Frontinan, Javier; Santiago-Mora, Raquel; Ramon Peinado, Juan; Parrado-Fernandez, Cristina; Alcain, Francisco J.] Univ Castilla La Mancha, Fac Med, Dept Med Sci, E-13071 Ciudad Real, Spain; [Duran-Prado, Mario; Frontinan, Javier; Ramon Peinado, Juan; Parrado-Fernandez, Cristina; Alcain, Francisco J.] Reg Ctr Biomed Res, Oxidat Stress & Neurodegenerat Grp, Ciudad Real, Spain; [Victoria Gomez-Almagro, Maria; Moreno, Maria] Univ Castilla La Mancha, Fac Chem Sci & Technol, Dept Organ Chem, E-13071 Ciudad Real, Spain; [Victoria Gomez-Almagro, Maria; Moreno, Maria] Univ Castilla La Mancha, Inst Reg Invest Cient Aplicada, Dept Organ Chem, E-13071 Ciudad Real, Spain; [Victoria Gomez-Almagro, Maria] Fdn Parque Cient & Tecnol Albacete, Albacete, Spain; [Alberto Lopez-Dominguez, Jose; Manuel Villalba, Jose] Univ Cordoba, Fac Sci, Dept Cell Biol Physiol & Immunol, Agrifood Campus Int Excellence ceiA3, E-14004 Cordoba, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de Cordoba	Duran-Prado, M (corresponding author), Univ Castilla La Mancha, Fac Med, Dept Med Sci, E-13071 Ciudad Real, Spain.	mario.duran@uclm.es; franciscoj.alcain@uclm.es	Gomez, M. Victoria/AAR-1362-2020; duran-prado, mario/M-6545-2014; López-Domínguez, José Alberto/AAA-9275-2020; Gomez, M. Victoria/D-2455-2013; Frontiñan, Javier/AAS-4103-2020; Alcain, Francisco J./N-7503-2016; Peinado, Juan R/A-3450-2011; Frontiñán Rubio, Javier/R-2845-2017	Gomez, M. Victoria/0000-0002-3183-0504; duran-prado, mario/0000-0001-9652-5765; López-Domínguez, José Alberto/0000-0001-8733-3294; Gomez, M. Victoria/0000-0002-3183-0504; Frontiñan, Javier/0000-0002-5587-953X; Alcain, Francisco J./0000-0002-6833-7940; Peinado, Juan R/0000-0002-0004-7963; Frontiñán Rubio, Javier/0000-0002-5587-953X; PARRADO-FERNANDEZ, CRISTINA/0000-0003-2771-3206	Universidad de Castilla-La Mancha [GE20112221]	Universidad de Castilla-La Mancha	The authors' work is supported by Grants: Universidad de Castilla-La Mancha GE20112221. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1992, NEUROSCI LETT, V146, P152, DOI 10.1016/0304-3940(92)90065-F; Anantharaman M, 2006, AM J PATHOL, V168, P1608, DOI 10.2353/ajpath.2006.051223; Arroyo A, 2000, J BIOENERG BIOMEMBR, V32, P199, DOI 10.1023/A:1005568132027; Barth BM, 2012, J NEUROSCI RES, V90, P229, DOI 10.1002/jnr.22748; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Belliere J, 2012, J BIOENERG BIOMEMBR, V44, P207, DOI 10.1007/s10863-012-9406-7; Bello RI, 2005, EXP GERONTOL, V40, P694, DOI 10.1016/j.exger.2005.07.003; Bhatia R, 2000, FASEB J, V14, P1233, DOI 10.1096/fasebj.14.9.1233; Biron KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023789; Blanc EM, 1997, J NEUROCHEM, V68, P1870; Burklen TS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/35936; Cha MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034929; Dai YL, 2011, ATHEROSCLEROSIS, V216, P395, DOI 10.1016/j.atherosclerosis.2011.02.013; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Fernandez-Ayala DJM, 2005, BBA-BIOMEMBRANES, V1713, P129, DOI 10.1016/j.bbamem.2005.05.010; Folin M, 2005, INT J MOL MED, V15, P929; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; Gao LG, 2012, ATHEROSCLEROSIS, V221, P311, DOI 10.1016/j.atherosclerosis.2011.10.027; Genova ML, 2011, BIOFACTORS, V37, P330, DOI 10.1002/biof.168; Grammas P, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-26; Hamilton SJ, 2009, DIABETES CARE, V32, P810, DOI 10.2337/dc08-1736; Hsu MJ, 2007, J NEUROSCI, V27, P5719, DOI 10.1523/JNEUROSCI.1874-06.2007; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kandimalla KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004627; Kawahara M, 2010, CURR PHARM DESIGN, V16, P2779, DOI 10.2174/138161210793176545; Lal R, 2007, BBA-BIOMEMBRANES, V1768, P1966, DOI 10.1016/j.bbamem.2007.04.021; Langsjoen PH, 2000, J AM COLL CARDIOL, V35, P816, DOI 10.1016/S0735-1097(99)00617-8; Li G, 2005, BIOFACTORS, V25, P97, DOI 10.1002/biof.5520250111; Lim SC, 2008, ATHEROSCLEROSIS, V196, P966, DOI 10.1016/j.atherosclerosis.2007.11.012; Lupo G, 2001, NEUROSCI LETT, V303, P185, DOI 10.1016/S0304-3940(01)01749-9; Marchesi VT, 2011, FASEB J, V25, P5, DOI 10.1096/fj.11-0102ufm; Mason RP, 1996, BIOCHEM BIOPH RES CO, V222, P78, DOI 10.1006/bbrc.1996.0699; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mugoni V, 2013, CELL, V152, P504, DOI 10.1016/j.cell.2013.01.013; Naderi J, 2006, APOPTOSIS, V11, P1359, DOI 10.1007/s10495-006-8417-4; Park L, 2005, J NEUROSCI, V25, P1769, DOI 10.1523/JNEUROSCI.5207-04.2005; Park L, 2004, J CEREBR BLOOD F MET, V24, P334, DOI 10.1097/01.WCB.0000105800.49957.1E; Patel NS, 2008, AMYLOID, V15, P5, DOI 10.1080/13506120701814723; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Rizzo MT, 2010, MOL NEUROBIOL, V42, P52, DOI 10.1007/s12035-010-8132-6; Simakova O, 2011, INT J ALZHEIMERS DIS, V2011; Suo ZM, 1997, BRAIN RES, V762, P144, DOI 10.1016/S0006-8993(97)00383-1; Tiano L, 2007, EUR HEART J, V28, P2249, DOI 10.1093/eurheartj/ehm267; Trushina E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032737; Tsai KL, 2012, J NUTR BIOCHEM, V23, P458, DOI 10.1016/j.jnutbio.2011.01.011; Tsai KL, 2011, MOL NUTR FOOD RES, V55, pS227, DOI 10.1002/mnfr.201100147; Tsuneki H, 2007, EUR J PHARMACOL, V566, P1, DOI 10.1016/j.ejphar.2007.03.006; Tsuneki H, 2013, EUR J PHARMACOL, V701, P218, DOI 10.1016/j.ejphar.2012.12.027; Villalba JM, 2010, EXPERT OPIN INV DRUG, V19, P535, DOI 10.1517/13543781003727495; WONG MKK, 1984, LAB INVEST, V51, P75; Xu J, 2001, J CEREBR BLOOD F MET, V21, P702, DOI 10.1097/00004647-200106000-00008	51	33	35	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109223	10.1371/journal.pone.0109223	http://dx.doi.org/10.1371/journal.pone.0109223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272163	gold, Green Submitted, Green Published			2022-12-27	WOS:000343729600107
J	Olano-Marin, J; Plis, K; Sonnichsen, L; Borowik, T; Niedzialkowska, M; Jedrzejewska, B				Olano-Marin, Juanita; Plis, Kamila; Soennichsen, Leif; Borowik, Tomasz; Niedzialkowska, Magdalena; Jedrzejewska, Bogumila			Weak Population Structure in European Roe Deer (Capreolus capreolus) and Evidence of Introgressive Hybridization with Siberian Roe Deer (C. pygargus) in Northeastern Poland	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; GENETIC-STRUCTURE; CONTROL REGION; CYTOCHROME-B; R-PACKAGE; MITOCHONDRIAL; DNA; PHYLOGEOGRAPHY; DIFFERENTIATION; VARIABILITY	We investigated contemporary and historical influences on the pattern of genetic diversity of European roe deer (Capreolus capreolus). The study was conducted in northeastern Poland, a zone where vast areas of primeval forests are conserved and where the European roe deer was never driven to extinction. A total of 319 unique samples collected in three sampling areas were genotyped at 16 microsatellites and one fragment (610 bp) of mitochondrial DNA (mtDNA) control region. Genetic diversity was high, and a low degree of genetic differentiation among sampling areas was observed with both microsatellites and mtDNA. No evidence of genetic differentiation between roe deer inhabiting open fields and forested areas was found, indicating that the ability of the species to exploit these contrasting environments might be the result of its phenotypic plasticity. Half of the studied individuals carried an mtDNA haplotype that did not belong to C. capreolus, but to a related species that does not occur naturally in the area, the Siberian roe deer (C. pygargus). No differentiation between individuals with Siberian and European mtDNA haplotypes was detected at microsatellite loci. Introgression of mtDNA of Siberian roe deer into the genome of European roe deer has recently been detected in eastern Europe. Such introgression might be caused by human-mediated translocations of Siberian roe deer within the range of European roe deer or by natural hybridization between these species in the past.	[Olano-Marin, Juanita; Plis, Kamila; Soennichsen, Leif; Borowik, Tomasz; Niedzialkowska, Magdalena; Jedrzejewska, Bogumila] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Soennichsen, Leif] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany	Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Leibniz Institut fur Zoo und Wildtierforschung	Olano-Marin, J (corresponding author), Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland.	jolano@ibs.bialowieza.pl	Plis, Kamila/G-3216-2013; Plis, Kamila/AAB-4843-2022; Borowik, Tomasz/W-4008-2018	Plis, Kamila/0000-0002-7462-5324; Borowik, Tomasz/0000-0003-0321-8200; Jedrzejewska, Bogumila/0000-0002-9652-0953; Niedzialkowska, Magdalena/0000-0002-7746-4116	Polish Ministry of Sciences and Higher Education [N N304 172536]; Mammal Research Institute PAS in Bialowieza; Leibniz Institute for Zoo and Wildlife Research in Berlin; project Research Potential in Conservation and Sustainable Management of Biodiversity-BIOCONSUS [245737]	Polish Ministry of Sciences and Higher Education(Ministry of Science and Higher Education, Poland); Mammal Research Institute PAS in Bialowieza; Leibniz Institute for Zoo and Wildlife Research in Berlin; project Research Potential in Conservation and Sustainable Management of Biodiversity-BIOCONSUS	The project was financed by the Polish Ministry of Sciences and Higher Education (grant no. N N304 172536), and the budget of the Mammal Research Institute PAS in Bialowieza and of the Leibniz Institute for Zoo and Wildlife Research in Berlin. JOM and LS were supported by the project Research Potential in Conservation and Sustainable Management of Biodiversity-BIOCONSUS in the 7th Framework Programme (contract no. 245737). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R., 1998, EUROPEAN ROE DEER BI; [Anonymous], 1993, WHITEHEAD ENCY DEER; Baker KH, 2013, ECOL EVOL, V3, P89, DOI 10.1002/ece3.430; Balkenhol N, 2009, MOL ECOL, V18, P4151, DOI 10.1111/j.1365-294X.2009.04322.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnot N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014436; Coulon A, 2006, P ROY SOC B-BIOL SCI, V273, P341, DOI 10.1098/rspb.2005.3329; Coulon A, 2006, MOL ECOL, V15, P1669, DOI 10.1111/j.1365-294X.2006.02861.x; Danilkin A, 1995, BEHAV ECOLOGY SIBERI; Danilkin Aleksey A., 1995, Mammalian Species, V512, P1; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FRUZINSKI B, 1982, ACTA THERIOL, V27, P479, DOI 10.4098/AT.arch.82-42; Galpern P, 2012, MOL ECOL RESOUR, V12, P771, DOI 10.1111/j.1755-0998.2012.03137.x; Gentile G, 2009, ITAL J ZOOL, V76, P16, DOI 10.1080/11250000802018725; Guillot G, 2008, BIOINFORMATICS, V24, P2222, DOI 10.1093/bioinformatics/btn419; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harris RB, 2002, WILDLIFE SOC B, V30, P634; Hepenstrick D, 2012, BASIC APPL ECOL, V13, P631, DOI 10.1016/j.baae.2012.08.009; Hewison AJM, 2001, CAN J ZOOL, V79, P679, DOI 10.1139/cjz-79-4-679; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; HOFMANN RR, 1988, ACTA THERIOL, V33, P103, DOI 10.4098/AT.arch.88-9; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jedrzejewska B, 1997, ACTA THERIOL, V42, P399; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalwzinski J., 1974, Acta Theriologica, V19, P291; Karcov G., 1903, BELOVEZHSKAYA PUSHCH; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Koh HS, 2013, J BIOL RES-THESSALON, V19, P46; KURT F, 1993, ACTA THERIOL, V38, P187, DOI 10.4098/AT.arch.93-52; Lane N, 2009, NATURE, V462, P272, DOI 10.1038/462272a; LEDIG FT, 1992, OIKOS, V63, P87, DOI 10.2307/3545518; Linnell JDC, 2011, UNGULATE MANAGEMENT; Lorenzini R, 2006, BIOL J LINN SOC, V88, P85, DOI 10.1111/j.1095-8312.2006.00606.x; Lorenzini R, 2014, ZOOL J LINN SOC-LOND, V170, P209, DOI 10.1111/zoj12091; MAJEWSKA B, 1982, ACTA THERIOL, V27, P471, DOI 10.4098/AT.arch.82-41; Matosiuk M, 2014, MOL ECOL, V23, P2559, DOI 10.1111/mec.12745; Niedzialkowska M, 2012, J WILDLIFE MANAGE, V76, P1264, DOI 10.1002/jwmg.367; Nies G, 2005, MAMM BIOL, V70, P130, DOI 10.1016/j.mambio.2004.05.001; OKARMA H, 1995, ACTA THERIOL, V40, P197, DOI 10.4098/AT.arch.95-20; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2012, R LANG ENV STAT COMP; Randi E, 1998, HEREDITY, V80, P429, DOI 10.1038/sj.hdy.6883180; Randi E, 2005, VET RES COMMUN, V29, P71, DOI 10.1007/s11259-005-0025-1; Randi E, 2004, MOL ECOL, V13, P3071, DOI 10.1111/j.1365-294X.2004.02279.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sonnichsen L, 2012, THESIS FREIE U BERLI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Upton GJG, 1985, SPATIAL DATA ANAL EX; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vernesi C, 2002, MOL ECOL, V11, P1285, DOI 10.1046/j.1365-294X.2002.01534.x; Vorobieva NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024045; Wiehler J, 1998, ACTA THERIOL, P187; Xiao CT, 2007, BIOCHEM GENET, V45, P93, DOI 10.1007/s10528-006-9052-z; Zachos FE, 2006, J ZOOL SYST EVOL RES, V44, P167, DOI 10.1111/j.1439-0469.2006.00350.x; Zvychainaya EY, 2011, BIOL BULL+, V38, P434, DOI 10.1134/S1062359011050189; Zvychainaya E.Yu., 2011, VESTN OKHOTOVEDENIYA, V8, P168	64	22	22	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109147	10.1371/journal.pone.0109147	http://dx.doi.org/10.1371/journal.pone.0109147			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271423	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600100
J	Shi, YL; Dadhwal, P; Li, X; Liang, FT				Shi, Yanlin; Dadhwal, Poonam; Li, Xin; Liang, Fang Ting			BosR Functions as a Repressor of the ospAB Operon in Borrelia burgdorferi	PLOS ONE			English	Article							OUTER-SURFACE-PROTEIN; MAMMALIAN INFECTION; EXPRESSION; TICKS; HOST; RPOS; VIRULENCE; GENES; LIPOPROTEINS; SPIROCHETE	The Lyme disease spirochete, Borrelia burgdorferi, must abundantly produce outer surface lipoprotein A (OspA) in the tick vector but downregulate OspA in mammals in order to evade the immune system and maintain its natural enzootic cycle. Here, we show that BosR binds two regulatory elements of the ospAB operon and that increasing BosR expression leads to downregulation of OspA. Both regulatory sequences, cisI and cisII, showed strong BosR-binding and cisII bound much tighter than cisI. A promoterless bosR gene fused with an inducible promoter was introduced into an rpoS mutant and a wild-type strain to assess RpoS-independent and -dependent downregulation of OspA by BosR. With the induction of BosR expression, OspA expression was reduced more significantly in the RpoS-deficient than wild-type background, but not completely repressed. In the presence of constitutive expression of OspC, DbpA and DbpB, increasing BosR production resulted in complete repression of OspA in the RpoS mutant. Taken together, the study clearly demonstrated BosR serves as a repressor that binds both regulatory elements of the ospAB operon and shuts off expression.	[Shi, Yanlin; Dadhwal, Poonam; Liang, Fang Ting] Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Li, Xin] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA	Louisiana State University System; Louisiana State University; University System of Ohio; Ohio State University	Liang, FT (corresponding author), Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	fliang@vetmed.lsu.edu		Li, Xin/0000-0002-7270-3480	National Institutes of Health [R01 AI077733]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by R01 AI077733 from the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins DR, 1998, J CLIN INVEST, V101, P2240, DOI 10.1172/JCI2325; BARTHOLD SW, 1995, INFECT IMMUN, V63, P2255, DOI 10.1128/IAI.63.6.2255-2261.1995; Chen LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083276; de Silva AM, 1999, INFECT IMMUN, V67, P30, DOI 10.1128/IAI.67.1.30-35.1999; deSilva AM, 1996, J EXP MED, V183, P271, DOI 10.1084/jem.183.1.271; DeSilva AM, 1997, INFECT IMMUN, V65, P3146, DOI 10.1128/IAI.65.8.3146-3150.1997; Eggers CH, 2004, J BACTERIOL, V186, P7390, DOI 10.1128/JB.186.21.7390-7402.2004; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; HOWE TR, 1986, INFECT IMMUN, V54, P207, DOI 10.1128/IAI.54.1.207-212.1986; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Hyde JA, 2009, MOL MICROBIOL, V74, P1344, DOI 10.1111/j.1365-2958.2009.06951.x; Liang FT, 2004, INFECT IMMUN, V72, P5759, DOI 10.1128/IAI.72.10.5759-5767.2004; Liang FT, 2004, MICROB PATHOGENESIS, V37, P35, DOI 10.1016/j.micpath.2004.02.007; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Miller CL, 2013, MOL MICROBIOL, V88, P105, DOI 10.1111/mmi.12171; Ohnishi J, 2001, P NATL ACAD SCI USA, V98, P670, DOI 10.1073/pnas.98.2.670; Ouyang ZM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001272; Ouyang ZM, 2009, MOL MICROBIOL, V74, P1331, DOI 10.1111/j.1365-2958.2009.06945.x; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Shi YL, 2008, INFECT IMMUN, V76, P1239, DOI 10.1128/IAI.00897-07; Sohaskey CD, 1999, MOL MICROBIOL, V33, P41, DOI 10.1046/j.1365-2958.1999.01443.x; Stewart PE, 2006, INFECT IMMUN, V74, P3547, DOI 10.1128/IAI.00158-06; Strother KO, 2007, INFECT IMMUN, V75, P2786, DOI 10.1128/IAI.01307-06; Wang P, 2013, MOL MICROBIOL, V89, P1140, DOI 10.1111/mmi.12337; WEIS JJ, 1994, INFECT IMMUN, V62, P4632, DOI 10.1128/IAI.62.10.4632-4636.1994; Xu QL, 2008, MOL MICROBIOL, V69, P15, DOI 10.1111/j.1365-2958.2008.06264.x; Xu QL, 2007, MOL MICROBIOL, V64, P220, DOI 10.1111/j.1365-2958.2007.05636.x; Xu QL, 2006, INFECT IMMUN, V74, P5177, DOI 10.1128/IAI.00713-06; Xu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053212; Xu QL, 2010, MICROBIOL-SGM, V156, P2194, DOI 10.1099/mic.0.036608-0; Xu Q, 2008, MICROBIOL-SGM, V154, P3420, DOI 10.1099/mic.0.2008/019737-0; Xu QL, 2005, INFECT IMMUN, V73, P7208, DOI 10.1128/IAI.73.11.7208-7215.2005	36	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109307	10.1371/journal.pone.0109307	http://dx.doi.org/10.1371/journal.pone.0109307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271631	gold, Green Published, Green Submitted			2022-12-27	WOS:000343729600109
J	Wang, Y; Fu, J; Jiang, MM; Zhang, XA; Cheng, L; Xu, XJ; Fan, ZY; Zhang, J; Ye, QN; Song, HF				Wang, Yu; Fu, Jie; Jiang, Mengmeng; Zhang, Xiaoai; Cheng, Long; Xu, Xiaojie; Fan, Zhongyi; Zhang, Jing; Ye, Qinong; Song, Haifeng			MiR-410 Is Overexpressed in Liver and Colorectal Tumors and Enhances Tumor Cell Growth by Silencing FHL1 via a Direct/Indirect Mechanism	PLOS ONE			English	Article							SUPPRESSOR GENE; CANCER; METHYLATION; CARCINOMA; EXPRESSION; HYPERMETHYLATION; CONTRIBUTES; SIGNATURES; MICRORNAS; MIGRATION	FHL1 is an important tumor-suppressor that is downregulated in multiple tumors by unknown mechanisms. We demonstrated that miR-410 specifically targets the 3'UTR of FHL1. Furthermore, using DNA bisulfite modification and sequencing experiments, we demonstrated that the FHL1 promoter is hypermethylated in cancer cells. FHL1 methylation is increased upon miR-410 expression, suggesting that the regulation of FHL1 by miR-410 occurs by a dual mechanism. Using chromatin immunoprecipitation assays, we observed that miR-410 overexpression results in the increased binding of DNMT3A at the FHL1 promoter, which could explain how miR-410 regulates FHL1 methylation. Importantly, in vitro and in vivo results suggest that miR-410 may have oncogenic properties. Furthermore, both miR-410 and DNMT3A are upregulated in clinical human liver and colorectal tumors cancers. Our results suggest that miR-410 may function as an oncomiR and are consistent with its key function in regulating FHL1 in certain digestive system cancers.	[Wang, Yu; Fu, Jie; Jiang, Mengmeng; Zhang, Jing; Song, Haifeng] Beijing Inst Radiat Med, Dept Pharmacol & Toxicol, Beijing, Peoples R China; [Wang, Yu] SDU Sch Life Sci, Jinan, Peoples R China; [Zhang, Xiaoai] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Cheng, Long; Xu, Xiaojie; Fan, Zhongyi; Ye, Qinong] Beijing Inst Biotechnol, Dept Med Mol Biol, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Beijing Institute of Microbiology & Epidemiology	Ye, QN (corresponding author), Beijing Inst Biotechnol, Dept Med Mol Biol, Beijing, Peoples R China.	yeqn66@yahoo.com; bapklab@yahoo.com		Liu, Wei/0000-0002-9302-8170	Postdoctoral Science Foundation [201150M1523]; National Natural Science Foundation [81301941, 81272701]	Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by Postdoctoral Science Foundation (201150M1523) and National Natural Science Foundation (81301941 and 81272701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada K, 2013, ONCOGENE, V32, P2140, DOI 10.1038/onc.2012.228; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen LC, 2012, INT J BIOCHEM CELL B, V44, P1711, DOI 10.1016/j.biocel.2012.06.027; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Gattolliat CH, 2011, BRIT J CANCER, V105, P1352, DOI 10.1038/bjc.2011.388; Kondo Y, 2000, HEPATOLOGY, V32, P970, DOI 10.1053/jhep.2000.19797; Li X, 2008, CANCER SCI, V99, P1326, DOI 10.1111/j.1349-7006.2008.00816.x; Liu SC, 2013, ONCOL LETT, V6, P1045, DOI 10.3892/ol.2013.1472; Lu QJ, 2005, ACTA PHARMACOL SIN, V26, P1259, DOI 10.1111/j.1745-7254.2005.00177.x; Matsumoto M, 2010, INT J MOL MED, V26, P241, DOI 10.3892/ijmm_00000458; Milosevic J, 2012, AM J RESP CELL MOL, V47, P879, DOI 10.1165/rcmb.2011-0377OC; Niu C, 2012, INT J CANCER, V130, P2549, DOI 10.1002/ijc.26259; Richardson K, 2013, AM J HUM GENET, V92, P5, DOI 10.1016/j.ajhg.2012.10.020; Sakashita K, 2008, ANN SURG ONCOL; Shen YQ, 2006, CANCER RES, V66, P1543, DOI 10.1158/0008-5472.CAN-05-3152; Snyder CM, 2013, DEVELOPMENT, V140, P31, DOI 10.1242/dev.081851; Starlard-Davenport Athena, 2013, J Carcinog, V12, P15, DOI 10.4103/1477-3163.115720; Torres A, 2013, INT J CANCER, V132, P1633, DOI 10.1002/ijc.27840; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Xu XJ, 2013, J CLIN INVEST, V123, P630, DOI 10.1172/JCI64265; Yan PS, 2006, CLIN CANCER RES, V12, P6626, DOI 10.1158/1078-0432.CCR-06-0467; Yang Y, 2012, BIOCHEM GENET, V50, P122, DOI 10.1007/s10528-011-9478-9; Zhang JX, 2013, CANCER LETT, V329, P91, DOI 10.1016/j.canlet.2012.10.033	28	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108708	10.1371/journal.pone.0108708	http://dx.doi.org/10.1371/journal.pone.0108708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272045	gold, Green Published, Green Submitted			2022-12-27	WOS:000343729600057
J	Chikenji, T; Gingery, A; Zhao, CF; Vanhees, M; Moriya, T; Reisdorf, R; An, KN; Amadio, PC				Chikenji, Takako; Gingery, Anne; Zhao, Chunfeng; Vanhees, Matthias; Moriya, Tamami; Reisdorf, Ramona; An, Kai-Nan; Amadio, Peter C.			Transforming Growth Factor-beta (TGF-beta) Expression Is Increased in the Subsynovial Connective Tissue in a Rabbit Model of Carpal Tunnel Syndrome	PLOS ONE			English	Article							GENE-EXPRESSION; LOAD FACTORS; FIBROSIS; ANTIBODY	Carpal tunnel syndrome (CTS) is an idiopathic disease that results from increased fibrosis of the subsynovial connective tissue (SSCT). A recent study found overexpression of both transforming growth factor-beta (TGF-beta) and connective tissue growth factor (CTGF) in the SSCT of CTS patients. This study investigated TGF-beta and CTGF expression in a rabbit model of CTS, in which SSCT fibrosis is induced by a surgical injury. Levels of TGF-beta 1 and CTGF at 6, 12, 24 weeks after injury were determined by immunohistochemistry A significant increase in TGF-beta 1 and a concomitant significant increase in CTGF were found at 6 weeks, in addition to higher cell density compared to normal (all p<0.05), Interestingly, CTGF expression was reduced at 12 and 24 weeks, suggesting that an initial insult results in a time limited response. We conclude that this rabbit model mimics the fibrosis found in human CTS, and may be useful to study pathogenetic mechanisms of CTS in vivo.	[Chikenji, Takako; Zhao, Chunfeng; Vanhees, Matthias; Moriya, Tamami; Reisdorf, Ramona; An, Kai-Nan; Amadio, Peter C.] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA; [Gingery, Anne] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Amadio, PC (corresponding author), Mayo Clin, Dept Orthoped Surg, Rochester, MN USA.	pamadio@mayo.edu	Takako, Chikenji/AAT-8342-2021; Vanhees, Matthias/AAU-5541-2021	Takako, Chikenji/0000-0003-2832-3656; Vanhees, Matthias/0000-0001-6905-9092; Gingery, Anne/0000-0002-1690-7382	NIH/NIAMS [AR49823]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049823] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25860144] Funding Source: KAKEN	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by a grant from NIH/NIAMS (AR49823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Shady M, 2000, LIVER, V20, P296, DOI 10.1034/j.1600-0676.2000.020004296.x; Ask K, 2008, INT J BIOCHEM CELL B, V40, P484, DOI 10.1016/j.biocel.2007.08.016; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Buscemi L, 2011, CURR BIOL, V21, P2046, DOI 10.1016/j.cub.2011.11.037; Chikenji T, 2014, J ORTHOP RES, V32, P116, DOI 10.1002/jor.22485; Chujo S, 2005, J CELL PHYSIOL, V203, P447, DOI 10.1002/jcp.20251; CROMACK DT, 1987, J SURG RES, V42, P622, DOI 10.1016/0022-4804(87)90005-9; Denton CP, 2007, ARTHRITIS RHEUM-US, V56, P323, DOI 10.1002/art.22289; Donato G, 2009, CLIN NEUROPATHOL, V28, P129; Gerritsen AAM, 2001, BRIT J SURG, V88, P1285, DOI 10.1046/j.0007-1323.2001.01858.x; Grehn F, 2007, OPHTHALMOLOGY, V114, P1831, DOI 10.1016/j.ophtha.2007.06.028; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Ihn H, 2002, ARCH IMMUNOL THER EX, V50, P325; Jaschinski F, 2011, CURR PHARM BIOTECHNO, V12, P2203, DOI 10.2174/138920111798808266; Kawelke N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028181; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Le M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048040; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; Miyake Y, 2011, BIOCHEM BIOPH RES CO, V409, P247, DOI 10.1016/j.bbrc.2011.04.138; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Moriya Tamami, 2011, Hand (N Y), V6, P399, DOI 10.1007/s11552-011-9356-2; Morris JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090353; Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X; Schild C, 2004, BBA-MOL CELL RES, V1691, P33, DOI 10.1016/j.bbamcr.2003.12.001; Schild C, 2002, EXP CELL RES, V274, P83, DOI 10.1006/excr.2001.5458; SCHUIND F, 1990, J HAND SURG-AM, V15A, P497, DOI 10.1016/0363-5023(90)90070-8; SHAH M, 1995, J CELL SCI, V108, P985; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Shiri R, 2009, OCCUP ENVIRON MED, V66, P368, DOI 10.1136/oem.2008.039719; Sun YL, 2012, J ORTHOP RES, V30, P649, DOI 10.1002/jor.21565; Vanhees Matthias, 2013, Hand (N Y), V8, P54, DOI 10.1007/s11552-012-9469-2; Viikari-Juntura E, 1999, SCAND J WORK ENV HEA, V25, P163, DOI 10.5271/sjweh.423; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100	39	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108312	10.1371/journal.pone.0108312	http://dx.doi.org/10.1371/journal.pone.0108312			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25269071	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700077
J	Khan, AE; Scheelbeek, PFD; Shilpi, AB; Chan, Q; Mojumder, SK; Rahman, A; Haines, A; Vineis, P				Khan, Aneire Ehmar; Scheelbeek, Pauline Franka Denise; Shilpi, Asma Begum; Chan, Queenie; Mojumder, Sontosh Kumar; Rahman, Atiq; Haines, Andy; Vineis, Paolo			Salinity in Drinking Water and the Risk of (Pre)Eclampsia and Gestational Hypertension in Coastal Bangladesh: A Case-Control Study	PLOS ONE			English	Article							BLOOD-PRESSURE; OXIDATIVE STRESS; SODIUM-EXCRETION; URINARY SODIUM; PREECLAMPSIA; SALT; HEALTH; ALDOSTERONE; PREVENTION; INTERSALT	Background: Hypertensive disorders in pregnancy are among the leading causes of maternal and perinatal death in low-income countries, but the aetiology remains unclear. We investigated the relationship between salinity in drinking water and the risk of (pre)eclampsia and gestational hypertension in a coastal community. Methods: A population-based case-control study was conducted in Dacope, Bangladesh among 202 pregnant women with (pre) eclampsia or gestational hypertension, enrolled from the community served by the Upazilla Health Complex, Dacope and 1,006 matched controls from the same area. Epidemiological and clinical data were obtained from all participants. Urinary sodium and sodium levels in drinking water were measured. Logistic regression was used to calculate odds ratios, and 95% confidence intervals. Findings: Drinking water sources had exceptionally high sodium levels (mean 516.6 mg/L, S.D 524.2). Women consuming tube-well (groundwater) were at a higher disease risk than rainwater users (p<0.001). Adjusted risks for (pre) eclampsia and gestational hypertension considered together increased in a dose-response manner for increasing sodium concentrations (300.01-600 mg/L, 600.1-900 mg/L, >900.01 mg/L, compared to <300 mg/L) in drinking water (ORs 3.30 [95% CI 2.00-5.51], 4.40 [2.70-7.25] and 5.48 [3.30-9.11] (p-trend<0.001). Significant associations were seen for both (pre) eclampsia and gestational hypertension separately. Interpretation: Salinity in drinking water is associated with increased risk of (pre) eclampsia and gestational hypertension in this population. Given that coastal populations in countries such as Bangladesh are confronted with high salinity exposure, which is predicted to further increase as a result of sea level rise and other environmental influences, it is imperative to develop and evaluate affordable approaches to providing water with low salt content.	[Khan, Aneire Ehmar; Scheelbeek, Pauline Franka Denise; Chan, Queenie; Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC HPA Ctr Environm & Hlth, London, England; [Khan, Aneire Ehmar; Scheelbeek, Pauline Franka Denise; Chan, Queenie; Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Khan, Aneire Ehmar; Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, Grantham Inst Climate Change, London, England; [Shilpi, Asma Begum] Dhaka Childrens Hosp, Dhaka, Bangladesh; [Mojumder, Sontosh Kumar] Upazilla Hlth Complex Dacope, Khulna, Bangladesh; [Rahman, Atiq] Bangladesh Ctr Adv Studies, Dhaka, Bangladesh; [Haines, Andy] London Sch Hyg & Trop Med, London WC1, England	Imperial College London; Imperial College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Khan, AE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC HPA Ctr Environm & Hlth, London, England.	aneire.khan@imperial.ac.uk	Chan, Queenie/C-5017-2011	Chan, Queenie/0000-0001-9278-230X; Haines, Andy/0000-0002-8053-4605	Grantham Institute for Climate Change, Imperial College London	Grantham Institute for Climate Change, Imperial College London	The research study was funded by the Grantham Institute for Climate Change, Imperial College London (https://www3.imperial.ac.uk/climatechange). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2012, J HEALTH POPUL NUTR, V30, P1; Ahsan H, 2006, J EXPO SCI ENV EPID, V16, P191, DOI 10.1038/sj.jea.7500449; Al-Solaiman Y, 2009, J HUM HYPERTENS, V23, P826, DOI 10.1038/jhh.2009.32; Brown IJ, 2013, AM J EPIDEMIOL, V177, P1180, DOI 10.1093/aje/kwt066; CALABRESE EJ, 1981, SCI TOTAL ENVIRON, V18, P117, DOI 10.1016/S0048-9697(81)80054-X; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Duley L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005548; Dutta D.C., 2004, TXB OBSTET INCLUDING; El-Moselhy EA, 2011, J AM SCI, V7; ELLIOTT P, 1988, BRIT MED J, V297, P319; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; Escher G, 2007, MOL ASPECTS MED, V28, P245, DOI 10.1016/j.mam.2007.03.002; Firoz T, 2011, BEST PRACT RES CL OB, V25, P537, DOI 10.1016/j.bpobgyn.2011.04.002; HALLENBECK WH, 1981, AM J EPIDEMIOL, V114, P817, DOI 10.1093/oxfordjournals.aje.a113252; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; Hubel CA, 1999, P SOC EXP BIOL MED, V222, P222, DOI 10.1046/j.1525-1373.1999.d01-139.x; Karim MF, 2008, GLOBAL ENVIRON CHANG, V18, P490, DOI 10.1016/j.gloenvcha.2008.05.002; Khan A, 2008, LANCET, V371, P385, DOI 10.1016/S0140-6736(08)60197-X; Khan AE, 2011, ENVIRON HEALTH PERSP, V119, P1328, DOI 10.1289/ehp.1002804; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kopkan L, 2010, AM J PHYSIOL-RENAL, V299, pF656, DOI 10.1152/ajprenal.00047.2010; Koutsoyiannis D, 2009, HYDROLOG SCI J, V54, P3, DOI 10.1623/hysj.54.1.3; Lauro V, 1997, Acta Biomed Ateneo Parmense, V68 Suppl 1, P95; Macdonald-Wallis C, 2011, J HYPERTENS, V29, P1703, DOI 10.1097/HJH.0b013e328349eec6; Ministry of Environment and Forest B, 2006, IMP SEA LEV RIS LANC; Moran P, 2004, SEMIN NEPHROL, V24, P588, DOI 10.1016/S0270-9295(04)00130-5; Nishida C, 2004, PUBLIC HEALTH NUTR, V7, P245, DOI 10.1079/PHN2003592; Rahman A.A., 2003, GROUNDWATER RESOURCE; Reyes L, 2012, J OBSTET GYNAECOL RE, V38, P498, DOI 10.1111/j.1447-0756.2011.01763.x; Sibai BM, 2002, OBSTET GYNECOL, V100, P369, DOI 10.1016/S0029-7844(02)02128-2; USEPA, 2003, DRINK WAT ADV CONS A; WEIR RJ, 1973, LANCET, V1, P291; WELTY TK, 1986, JAMA-J AM MED ASSOC, V255, P622, DOI 10.1001/jama.255.5.622	33	93	94	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108715	10.1371/journal.pone.0108715	http://dx.doi.org/10.1371/journal.pone.0108715			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268785	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000343671700144
J	Nagano, T; Edamatsu, H; Kobayashi, K; Takenaka, N; Yamamoto, M; Sasaki, N; Nishimura, Y; Kataoka, T				Nagano, Tatsuya; Edamatsu, Hironori; Kobayashi, Kazuyuki; Takenaka, Nobuyuki; Yamamoto, Masatsugu; Sasaki, Naoto; Nishimura, Yoshihiro; Kataoka, Tohru			Phospholipase C epsilon, an Effector of Ras and Rap Small GTPases, Is Required for Airway Inflammatory Response in a Mouse Model of Bronchial Asthma	PLOS ONE			English	Article							NF-KAPPA-B; SKIN INFLAMMATION; CRUCIAL ROLE; ALLERGIC INFLAMMATION; EPITHELIAL-CELLS; PLC-EPSILON; T-CELL; EXPRESSION; ACTIVATION; MICE	Background: Phospholipase C epsilon (PLC epsilon) is an effector of Ras and Rap small GTPases and expressed in non-immune cells. It is well established that PLC epsilon plays an important role in skin inflammation, such as that elicited by phorbol ester painting or ultraviolet irradiation and contact dermatitis that is mediated by T helper (Th) 1 cells, through upregulating inflammatory cytokine production by keratinocytes and dermal fibroblasts. However, little is known about whether PLC epsilon is involved in regulation of inflammation in the respiratory system, such as Th2-cells-mediated allergic asthma. Methods: We prepared a mouse model of allergic asthma using PLC epsilon(+/+) mice and PLC epsilon(Delta X/Delta X) mutant mice in which PLC epsilon was catalytically-inactive. Mice with different PLC epsilon genotypes were immunized with ovalbumin (OVA) followed by the challenge with an OVA-containing aerosol to induce asthmatic response, which was assessed by analyzing airway hyperresponsiveness, bronchoalveolar lavage fluids, inflammatory cytokine levels, and OVA-specific immunoglobulin (Ig) levels. Effects of PLC epsilon genotype on cytokine production were also examined with primary-cultured bronchial epithelial cells. Results: After OVA challenge, the OVA-immunized PLC epsilon(Delta X/Delta X) mice exhibited substantially attenuated airway hyperresponsiveness and broncial inflammation, which were accompanied by reduced Th2 cytokine content in the bronchoalveolar lavage fluids. In contrast, the serum levels of OVA-specific IgGs and IgE were not affected by the PLC epsilon genotype, suggesting that sensitization was PLC epsilon-independent. In the challenged mice, PLCe deficiency reduced proinflammatory cytokine production in the bronchial epithelial cells. Primary-cultured bronchial epithelial cells prepared from PLC epsilon(Delta X/Delta X) mice showed attenuated pro-inflammatory cytokine production when stimulated with tumor necrosis factor-alpha, suggesting that reduced cytokine production in PLC epsilon(Delta X/Delta X) mice was due to cell-autonomous effect of PLC epsilon deficiency. Conclusions: PLCe plays an important role in the pathogenesis of bronchial asthma through upregulating inflammatory cytokine production by the bronchial epithelial cells.	[Nagano, Tatsuya; Edamatsu, Hironori; Takenaka, Nobuyuki; Kataoka, Tohru] Kobe Univ, Grad Sch Med, Dept Biochem & Mol & Biol, Div Mol Biol, Kobe, Hyogo 657, Japan; [Nagano, Tatsuya; Kobayashi, Kazuyuki; Yamamoto, Masatsugu; Nishimura, Yoshihiro] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Resp Med, Kobe, Hyogo 657, Japan; [Sasaki, Naoto] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 657, Japan	Kobe University; Kobe University; Kobe University	Kataoka, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol & Biol, Div Mol Biol, Kobe, Hyogo 657, Japan.	kataoka@people.kobe-u.ac.jp	Yamamoto, Masatsugu/AAH-7093-2020	Yamamoto, Masatsugu/0000-0003-0596-555X; Edamatsu, Hironori/0000-0002-1335-4217	JSPS KAKENHI [23390071, 24790810, 22790290, 24590379]; MEXT Global COE Program [A08]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT Global COE Program	This work was supported by JSPS KAKENHI 23390071 and MEXT Global COE Program A08 to T.K., JSPS KAKENHI 24790810 to T.N., and JSPS KAKENHI 22790290 and 24590379 to H.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchard JC, 2013, CLIN EXP IMMUNOL, V172, P203, DOI 10.1111/cei.12048; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Chappaz S, 2007, BLOOD, V110, P3862, DOI 10.1182/blood-2007-02-074245; DEJONG PM, 1993, IN VITRO CELL DEV-AN, V29A, P379, DOI 10.1007/BF02633985; Dusaban SS, 2013, P NATL ACAD SCI USA, V110, P3609, DOI 10.1073/pnas.1217355110; Edamatsu H, 2011, INFLAMM REGEN, V31, P370; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157; Harada Y, 2011, BIOCHEM BIOPH RES CO, V414, P106, DOI 10.1016/j.bbrc.2011.09.032; Hazlett LD, 2010, INVEST OPHTH VIS SCI, V51, P1524, DOI 10.1167/iovs.09-3983; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Hu LZ, 2010, J IMMUNOL, V184, P993, DOI 10.4049/jimmunol.0901816; Huang WG, 2013, J BIOL CHEM, V288, P5840, DOI 10.1074/jbc.M112.422501; Ichinohe M, 2007, BIOCHEM BIOPH RES CO, V356, P912, DOI 10.1016/j.bbrc.2007.03.082; Ikeda K, 2003, BLOOD, V101, P3594, DOI 10.1182/blood-2002-09-2817; Ikuta S, 2008, CANCER RES, V68, P64, DOI 10.1158/0008-5472.CAN-07-3245; Jang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056433; Jin SLC, 2010, J ALLERGY CLIN IMMUN, V126, P1252, DOI 10.1016/j.jaci.2010.08.014; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Li MZ, 2009, CARCINOGENESIS, V30, P1424, DOI 10.1093/carcin/bgp125; Lotzer K, 2010, ARTERIOSCL THROM VAS, V30, P395, DOI 10.1161/ATVBAHA.109.191395; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Mionnet C, 2010, NAT MED, V16, P1305, DOI 10.1038/nm.2253; Nakamura Y, 2008, FASEB J, V22, P841, DOI 10.1096/fj.07-9239com; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Oka M, 2011, LAB INVEST, V91, P711, DOI 10.1038/labinvest.2011.10; Ryan MR, 2005, P NATL ACAD SCI USA, V102, P16735, DOI 10.1073/pnas.0505168102; Saperstein S, 2009, J INTERF CYTOK RES, V29, P273, DOI 10.1089/jir.2008.0076; Schneider D, 2013, AM J PHYSIOL-LUNG C, V304, pL162, DOI 10.1152/ajplung.00182.2012; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Song CH, 2002, ONCOGENE, V21, P8105, DOI 10.1038/sj.onc.1206003; Stordeur P, 2002, J IMMUNOL METHODS, V259, P55, DOI 10.1016/S0022-1759(01)00489-6; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Tadano M, 2005, MOL CELL BIOL, V25, P2191, DOI 10.1128/MCB.25.6.2191-2199.2005; Takahashi M, 2009, CLIN EXP METASTAS, V26, P817, DOI 10.1007/s10585-009-9281-8; Takenaka N, 2011, EUR J IMMUNOL, V41, P202, DOI 10.1002/eji.201040675; UEDA A, 1994, J IMMUNOL, V153, P2052; WIDMER U, 1993, J IMMUNOL, V150, P4996; Wu DM, 2003, EUR J NEUROSCI, V17, P1571, DOI 10.1046/j.1460-9568.2003.02591.x; Yamamoto M, 2010, CLIN EXP IMMUNOL, V162, P315, DOI 10.1111/j.1365-2249.2010.04243.x	44	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108373	10.1371/journal.pone.0108373	http://dx.doi.org/10.1371/journal.pone.0108373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25269075	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700087
J	Johnston, JE; Valentiner, E; Maxson, P; Miranda, ML; Fry, RC				Johnston, Jill E.; Valentiner, Ellis; Maxson, Pamela; Miranda, Marie Lynn; Fry, Rebecca C.			Maternal Cadmium Levels during Pregnancy Associated with Lower Birth Weight in Infants in a North Carolina Cohort	PLOS ONE			English	Article							FETAL-GROWTH RESTRICTION; HUMAN PLACENTA; TOBACCO-SMOKE; EXPOSURE; BLOOD; METALS; HEALTH; CARCINOGENESIS; POPULATION; COTININE	Cadmium (Cd) is a ubiquitous environmental contaminant, a known carcinogen, and understudied as a developmental toxicant. In the present study, we examined the relationships between Cd levels during pregnancy and infant birth outcomes in a prospective pregnancy cohort in Durham, North Carolina. The study participants (n = 1027) had a mean Cd level of 0.46 mg/L with a range of <0.08 to 2.52 mu g/L. Multivariable models were used to establish relationships between blood Cd tertiles and fetal growth parameters, namely birth weight, low birth weight, birth weight percentile by gestational age, small for gestational age, pre-term birth, length, and head circumference. In multivariable models, high maternal blood Cd levels (>= 0.50 mu g/L) during pregnancy were inversely associated with birth weight percentile by gestational age (p = 0.007) and associated with increased odds of infants being born small for gestational age (p<0.001). These observed effects were independent of cotinine-defined smoking status. The results from this study provide further evidence of health risks associated with early life exposure to Cd among a large pregnancy cohort.	[Fry, Rebecca C.] Univ N Carolina, Dept Environm Sci & Engn, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA; [Johnston, Jill E.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Valentiner, Ellis; Maxson, Pamela; Miranda, Marie Lynn] Univ Michigan, Sch Nat Resources, Ann Arbor, MI 48109 USA; [Miranda, Marie Lynn] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Miranda, Marie Lynn] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fry, RC (corresponding author), Univ N Carolina, Dept Environm Sci & Engn, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA.	rfry@unc.edu		Miranda, Marie Lynn/0000-0002-5670-0837; Fry, Rebecca/0000-0003-0899-9018	U.S. Environmental Protection Agency [RD-83329301]; National Institute of Environmental Health Sciences [ES005948, ES010126, ES019315, ES007018]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, R01ES019315, P42ES005948] Funding Source: NIH RePORTER	U.S. Environmental Protection Agency(United States Environmental Protection Agency); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the U.S. Environmental Protection Agency (RD-83329301) and in part by the National Institute of Environmental Health Sciences (ES005948, ES010126, ES019315, and ES007018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SV, 2011, SCI TOTAL ENVIRON, V409, P1632, DOI 10.1016/j.scitotenv.2011.01.037; Arita A, 2009, METALLOMICS, V1, P222, DOI 10.1039/b903049b; Burgette LF, 2012, J AM STAT ASSOC, V107, P439, DOI 10.1080/01621459.2011.643713; CDC, 2013, 4 CDC USDHHS; Egan SK, 2007, J EXPO SCI ENV EPID, V17, P573, DOI 10.1038/sj.jes.7500554; GaliciaGarcia V, 1997, TOXICOL LETT, V91, P57, DOI 10.1016/S0378-4274(97)03869-1; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Iyengar GV, 2001, SCI TOTAL ENVIRON, V280, P221, DOI 10.1016/S0048-9697(01)00827-0; JAMESON S, 1993, ANN NY ACAD SCI, V678, P178; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; JARVIS MJ, 1988, AM J PUBLIC HEALTH, V78, P696, DOI 10.2105/AJPH.78.6.696; Kippler M, 2012, ENVIRON HEALTH PERSP, V120, P284, DOI 10.1289/ehp.1103711; Kippler M, 2010, TOXICOL LETT, V192, P162, DOI 10.1016/j.toxlet.2009.10.018; Klebanoff MA, 1998, AM J EPIDEMIOL, V148, P259; Lin CM, 2011, OCCUP ENVIRON MED, V68, P641, DOI 10.1136/oem.2010.059758; Liu S, 2013, ENVIRON HEALTH PERSP, V121, P705, DOI 10.1289/ehp.1205518; Llanos MN, 2009, REPROD TOXICOL, V27, P88, DOI 10.1016/j.reprotox.2008.11.057; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Menai M, 2012, REPROD TOXICOL, V34, P622, DOI 10.1016/j.reprotox.2012.09.002; Miranda ML, 2011, INT J ENV RES PUB HE, V8, P698, DOI 10.3390/ijerph8030698; Miranda ML, 2010, INT J ENV RES PUB HE, V7, P1508, DOI 10.3390/ijerph7041508; Nishijo M, 2002, OCCUP ENVIRON MED, V59, P394, DOI 10.1136/oem.59.6.394; Olsson IM, 2002, ENVIRON HEALTH PERSP, V110, P1185, DOI 10.1289/ehp.021101185; Pirkle JL, 1996, JAMA-J AM MED ASSOC, V275, P1233, DOI 10.1001/jama.275.16.1233; Ronco AM, 2005, BIOMETALS, V18, P233, DOI 10.1007/s10534-005-0583-2; Salpietro CD, 2002, J PERINAT MED, V30, P395, DOI 10.1515/JPM.2002.061; Sanders AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031354; Sanders AP, 2013, EPIGENETICS, V9, P0; Satarug S, 2003, TOXICOL LETT, V137, P65, DOI 10.1016/S0378-4274(02)00381-8; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; Selvin S, 1996, PAEDIATR PERINAT EP, V10, P220, DOI 10.1111/j.1365-3016.1996.tb00045.x; Shirai S, 2010, J ENVIRON SCI HEAL A, V45, P1468, DOI 10.1080/10934529.2010.500942; Thompson J, 2008, REPROD TOXICOL, V25, P304, DOI 10.1016/j.reprotox.2008.02.001; Waalkes MP, 2000, J INORG BIOCHEM, V79, P241, DOI 10.1016/S0162-0134(00)00009-X; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; Woodruff TJ, 2011, ENVIRON HEALTH PERSP, V119, P878, DOI 10.1289/ehp.1002727; Yang KP, 2006, AM J PHYSIOL-ENDOC M, V290, pE135, DOI 10.1152/ajpendo.00356.2005; Zhang YL, 2004, J ENVIRON SCI HEAL A, V39, P2507, DOI [10.1081/ESE-200026331, 10.1081/lesa-200026331]	39	84	86	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109661	10.1371/journal.pone.0109661	http://dx.doi.org/10.1371/journal.pone.0109661			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285731	gold, Green Submitted, Green Published			2022-12-27	WOS:000345743700079
J	Garg, A; Stein, A; Zhao, W; Dwivedi, A; Frutos, R; Cornillot, E; Ben Mamoun, C				Garg, Aprajita; Stein, Anna; Zhao, William; Dwivedi, Ankit; Frutos, Roger; Cornillot, Emmanuel; Ben Mamoun, Choukri			Sequence and Annotation of the Apicoplast Genome of the Human Pathogen Babesia microti	PLOS ONE			English	Article							APICOMPLEXAN; VISUALIZATION; ARTEMIS	The apicomplexan intraerythrocytic parasite Babesia microti is an emerging human pathogen and the primary cause of human babesiosis, a malaria-like illness endemic in the United States. The pathogen is transmitted to humans by the tick vector, Ixodes scapularis, and by transfusion of blood from asymptomatic B. microti-infected donors. Whereas the nuclear and mitochondrial genomes of this parasite have been sequenced, assembled and annotated, its apicoplast genome remained incomplete, mainly due to its low representation and high A+T content. Here we report the complete sequence and annotation of the apicoplast genome of the B. microti R1 isolate. The genome consists of a 28.7 kb circular molecule encoding primarily functions important for maintenance of the apicoplast DNA, transcription, translation and maturation of organellar proteins. Genome analysis and annotation revealed a unique gene structure and organization of the B. microti apicoplast genome and suggest that all metabolic and non-housekeeping functions in this organelle are nuclear-encoded. B. microti apicoplast functions are significantly different from those of the host, suggesting that they might be useful as targets for development of potent and safe therapies for the treatment of human babesiosis.	[Garg, Aprajita; Stein, Anna; Zhao, William; Ben Mamoun, Choukri] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA; [Dwivedi, Ankit; Frutos, Roger; Cornillot, Emmanuel] Ctr Etude Agents Pathogenes & Biotechnol Sante, Inst Biol Computationnelle, UMR 5236, Montpellier, France; [Frutos, Roger] CIRAD, Ird, UMR 17, Montpellier, France	Yale University; CIRAD; Institut de Recherche pour le Developpement (IRD)	Ben Mamoun, C (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.	choukri.benmamoun@yale.edu	Cornillot, Emmanuel/P-9656-2017	Cornillot, Emmanuel/0000-0002-1202-1162	National Institutes of Health [AI097218]; Bill and Melinda Gates Foundation [OPP1069779, OPP1086229]; ANR program Investissement d'avenir [ANR-11-BINF-0002]; French ministry of research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097218] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); ANR program Investissement d'avenir(French National Research Agency (ANR)); French ministry of research(Ministry of Research, FranceEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partly supported by the National Institutes of Health [AI097218 to CBM], and the Bill and Melinda Gates Foundation (Awards OPP1069779 and OPP1086229 to CBM), the ANR program Investissement d'avenir (ANR-11-BINF-0002 to EC) and the French ministry of research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouLaila M, 2012, ANTIMICROB AGENTS CH, V56, P3196, DOI 10.1128/AAC.05488-11; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; CDC, 2011, NAT NOT INF COND US; Cornillot E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072657; Cornillot E, 2012, NUCLEIC ACIDS RES, V40, P9102, DOI 10.1093/nar/gks700; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Fleige T, 2010, MICROBES INFECT, V12, P253, DOI 10.1016/j.micinf.2009.12.010; Herwaldt BL, 2011, ANN INTERN MED, V155, P509, DOI 10.7326/0003-4819-155-8-201110180-00362; Hikosaka K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-622; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Institute of Medicine of the National Academies, 2011, CRIT NEEDS GAPS UND; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Kjemtrup AM, 2000, INT J PARASITOL, V30, P1323, DOI 10.1016/S0020-7519(00)00137-5; Krause PJ, 2000, NEW ENGL J MED, V343, P1454, DOI 10.1056/NEJM200011163432004; Krause PJ, 1998, NEW ENGL J MED, V339, P160, DOI 10.1056/NEJM199807163390304; Leiby DA, 2011, CLIN MICROBIOL REV, V24, P14, DOI 10.1128/CMR.00022-10; Magalhaes PJ, 1998, MOL BIOL CELL, V9, P2375, DOI 10.1091/mbc.9.9.2375; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; van Dooren GG, 2013, ANNU REV MICROBIOL, V67, P271, DOI 10.1146/annurev-micro-092412-155741; Vannier E, 2008, INFECT DIS CLIN N AM, V22, P469, DOI 10.1016/j.idc.2008.03.010; Vannier E, 2012, NEW ENGL J MED, V366, P2397, DOI 10.1056/NEJMra1202018; YOSHIONARI S, 1994, FEBS LETT, V338, P137, DOI 10.1016/0014-5793(94)80351-X; Young C, 2012, TRANSFUSION, V52, P1523, DOI 10.1111/j.1537-2995.2012.03612.x	28	19	22	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e107939	10.1371/journal.pone.0107939	http://dx.doi.org/10.1371/journal.pone.0107939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25280009	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800008
J	Li, BY; Yao, Q; Zhu, HH				Li, Baiyuan; Yao, Qing; Zhu, Honghui			Approach to Analyze the Diversity of Myxobacteria in Soil by Semi-Nested PCR-Denaturing Gradient Gel Electrophoresis (DGGE) Based on Taxon-Specific Gene	PLOS ONE			English	Article							SP NOV.; BIOLOGY	The genotypic diversity of insoluble macromolecules degraded myxobacteria, provided an opportunity to discover new bacterial resources and find new ecological functions. In this study, we developed a semi-nested-PCR-denaturing gradient gel electrophoresis (DGGE) strategy to determine the presence and genotypic diversity of myxobacteria in soil. After two rounds of PCR with myxobacteria-specific primers, an 194 bp fragment of mglA, a key gene involved in gliding motility, suitable for DGGE was obtained. A large number of bands were observed in DGGE patterns, indicating diverse myxobacteria inhabiting in soils. Furthermore, sequencing and BLAST revealed that most of the bands belonged to the myxobacteria-group, and only three of the twenty-eight bands belonged to other group, i.e., Deinococcus maricopensis. The results verified that myxobacterial strains with discrepant sequence compositions of gene mglA could be discriminated by DGGE with myxobacteria-specific primers. Collectively, the developed semi-nested-PCR-DGGE strategy is a useful tool for studying the diversity of myxobacteria.	[Li, Baiyuan; Zhu, Honghui] Guangdong Prov Key Lab Microbial Culture Collect, State Key Lab Appl Microbiol Southern China, Guangdong Inst Microbiol, Guangzhou, Guangdong, Peoples R China; [Li, Baiyuan] Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China; [Li, Baiyuan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yao, Qing] South China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; South China Agricultural University	Zhu, HH (corresponding author), Guangdong Prov Key Lab Microbial Culture Collect, State Key Lab Appl Microbiol Southern China, Guangdong Inst Microbiol, Guangzhou, Guangdong, Peoples R China.	zhuhh@gdim.cn	Zhu, Honghui/N-2251-2015; YAO, Qing/B-3206-2009	YAO, Qing/0000-0003-3449-6166; ZHU, Honghui/0000-0001-6854-8417	Natural Science Foundation of China [31170009]; Open Foundation of Tarim University [BRZD1004]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation of Tarim University	Financial support provided by Natural Science Foundation of China (Project no. 31170009) and by the Open Foundation of Tarim University (Project no. BRZD1004) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACKHART BD, 1985, P NATL ACAD SCI USA, V82, P8767, DOI 10.1073/pnas.82.24.8767; BROCKMAN ER, 1963, J BACTERIOL, V86, P605, DOI 10.1128/JB.86.3.605-606.1963; BROSIUS J, 1981, J MOL BIOL, V148, P107, DOI 10.1016/0022-2836(81)90508-8; Dar SA, 2005, APPL ENVIRON MICROB, V71, P2325, DOI 10.1128/AEM.71.5.2325-2330.2005; Dworkin M, 1996, MICROBIOL REV, V60, P70, DOI 10.1128/MMBR.60.1.70-102.1996; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garcia R, 2010, MOL PHYLOGENET EVOL, V57, P878, DOI 10.1016/j.ympev.2010.08.028; Garcia RO, 2009, INT J SYST EVOL MICR, V59, P1524, DOI 10.1099/ijs.0.003814-0; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; HARTZELL P, 1991, J BACTERIOL, V173, P7615, DOI 10.1128/jb.173.23.7615-7624.1991; Iizuka T, 2013, INT J SYST EVOL MICR, V63, P1360, DOI 10.1099/ijs.0.040501-0; Mignot T, 2007, SCIENCE, V315, P853, DOI 10.1126/science.1137223; Miyata M, 2010, ANNU REV MICROBIOL, V64, P519, DOI 10.1146/annurev.micro.112408.134116; Mohr KI, 2012, INT J SYST EVOL MICR, V62, P1191, DOI 10.1099/ijs.0.033696-0; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Reichenbach H, 1999, ENVIRON MICROBIOL, V1, P15, DOI 10.1046/j.1462-2920.1999.00016.x; Reichenbach H., 1992, PROKARYOTES, P3416; Reichenbach H, 1993, MYXOBACTERIA; ROSENBERG E, 1984, BIO-TECHNOL, V2, P796, DOI 10.1038/nbt0984-796; Salles JF, 2002, APPL ENVIRON MICROB, V68, P1595, DOI 10.1128/AEM.68.4.1595-1603.2002; Shimkets L.J., 2006, PROKARYOTES, P31, DOI [10.1007/0-387-30747-8_3, DOI 10.1007/0-387-30747-8_3]; Singh VK, 1998, BIOTECHNIQUES, V24, P318, DOI 10.2144/98242pf02; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wu ZH, 2006, ENVIRON MICROBIOL, V8, P370, DOI 10.1111/j.1462-2920.2005.00952.x; Yeates C, 1998, LETT APPL MICROBIOL, V27, P49, DOI 10.1046/j.1472-765X.1998.00383.x; Yergeau E, 2005, J MICROBIOL METH, V60, P143, DOI 10.1016/j.mimet.2004.09.006	29	7	13	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108877	10.1371/journal.pone.0108877	http://dx.doi.org/10.1371/journal.pone.0108877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25280065	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800032
J	Li, SS; Wu, J; Chen, LG; Du, H; Xu, YJ; Wang, LJ; Zhang, HJ; Zheng, XC; Wang, LS				Li, Shan-Shan; Wu, Jie; Chen, Li-Guang; Du, Hui; Xu, Yan-Jun; Wang, Li-Jing; Zhang, Hui-Jin; Zheng, Xu-Chen; Wang, Liang-Sheng			Biogenesis of C-Glycosyl Flavones and Profiling of Flavonoid Glycosides in Lotus (Nelumbo nucifera)	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; LENS ALDOSE REDUCTASE; ELECTROSPRAY-IONIZATION; IDENTIFICATION; LEAVES; QUERCETIN	Flavonoids in nine tissues of Nelumbo nucifera Gaertner were identified and quantified by high-performance liquid chromatography with diode array detector (HPLC-DAD) and HPLC-electrospray ionization-mass spectrometry (HPLC-ESI-MSn). Thirty-eight flavonoids were identified; eleven C-glycosides and five O-glycosides were discovered for the first time in N. nucifera. Most importantly, the C-glycosyl apigenin or luteolin detected in lotus plumules proved valuable for deep elucidation of flavonoid composition in lotus tissues and for further utilization as functional tea and medicine materials. Lotus leaves possessed the significantly highest amount of flavonoids (2.06E3 +/- 0.08 mg 100 g(-1) FW) and separating and purifying the bioactive compound, quercetin 3-O-glucuronide, from leaves showed great potential. In contrast, flavonoids in flower stalks, seed coats and kernels were extremely low. Simultaneously, the optimal picking time was confirmed by comparing the compound contents in five developmental phases. Finally, we proposed the putative flavonoid biosynthesis pathway in N. nucifera.	[Li, Shan-Shan; Wu, Jie; Du, Hui; Wang, Li-Jing; Zhang, Hui-Jin; Zheng, Xu-Chen; Wang, Liang-Sheng] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources & Beijing Bot Garden, Beijing, Peoples R China; [Li, Shan-Shan; Wu, Jie; Du, Hui; Wang, Li-Jing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Li-Guang] Chinese Acad Forestry, Inst Forest Protect, Beijing, Peoples R China; [Xu, Yan-Jun] China Agr Univ, Coll Sci, Beijing 100094, Peoples R China; [Zheng, Xu-Chen] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; China Agricultural University; Nanjing Agricultural University	Xu, YJ (corresponding author), China Agr Univ, Coll Sci, Beijing 100094, Peoples R China.	xyj-323@163.com; wanglsh@ibcas.ac.cn			National Natural Science Foundation of China [31071824, 31270376]; International Science & Technology Cooperation Program of China [2011DFA30560]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China	This study was financially supported by the National Natural Science Foundation of China (Grant No. 31071824 and 31270376), and International Science & Technology Cooperation Program of China (Grant No. 2011DFA30560). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Garcia B, 2009, J MASS SPECTROM, V44, P1017, DOI 10.1002/jms.1573; Abad-Garcia B, 2008, RAPID COMMUN MASS SP, V22, P1834, DOI 10.1002/rcm.3560; Abad-Garcia B, 2009, J CHROMATOGR A, V1216, P5398, DOI 10.1016/j.chroma.2009.05.039; Ablajan K, 2006, J MASS SPECTROM, V41, P352, DOI 10.1002/jms.995; BUTTERY BR, 1975, CAN J BOT, V53, P219, DOI 10.1139/b75-026; Castillo-Munoz N, 2009, J AGR FOOD CHEM, V57, P209, DOI 10.1021/jf802863g; Chen S, 2012, ANAL CHIM ACTA, V724, P127, DOI 10.1016/j.aca.2012.02.051; Chen S, 2012, J CHROMATOGR A, V1227, P145, DOI 10.1016/j.chroma.2011.12.098; Chen X, 2014, PHARM BIOL, V52, P655, DOI 10.3109/13880209.2013.853809; Cummins I, 2006, PHYTOCHEMISTRY, V67, P1722, DOI 10.1016/j.phytochem.2006.01.012; CW Man, 2009, CHINA FLOWERS HORTIC, V18, P38; Ferreres F, 2003, PHYTOCHEM ANALYSIS, V14, P352, DOI 10.1002/pca.727; Georgiev V, 2014, NUTRIENTS, V6, P391, DOI 10.3390/nu6010391; Goo HR, 2009, ARCH PHARM RES, V32, P201, DOI 10.1007/s12272-009-1136-y; H Li, 2011, THESIS CHINESE ACAD, P18; Huang B, 2010, J AGR FOOD CHEM, V58, P441, DOI 10.1021/jf902643e; Iwashina T, 2000, J PLANT RES, V113, P287, DOI 10.1007/PL00013940; Jung HA, 2008, FOOD CHEM TOXICOL, V46, P3818, DOI 10.1016/j.fct.2008.10.004; Juranic Z, 2005, BIOFACTORS, V23, P207, DOI 10.1002/biof.5520230405; KITTA K, 1992, J AGR FOOD CHEM, V40, P1843, DOI 10.1021/jf00022a023; Koerner JL, 2009, J CHROMATOGR A, V1216, P1403, DOI 10.1016/j.chroma.2008.12.086; Lim SS, 2006, PHYTOTHER RES, V20, P825, DOI 10.1002/ptr.1847; Lin LZ, 2010, FOOD CHEM, V120, P319, DOI 10.1016/j.foodchem.2009.09.083; Mabry T.J., 1970, SYSTEMATIC IDENTIFIC, P41, DOI 10.1007/978-3-642-88458-0; MARKHAM KR, 1982, TECHNIQUES FLAVONOID, P5; Moon JH, 2001, FREE RADICAL BIO MED, V30, P1274, DOI 10.1016/S0891-5849(01)00522-6; Mukherjee PK, 2009, J PHARM PHARMACOL, V61, P407, DOI 10.1211/jpp/61.04.0001; RAMARATHNAM N, 1989, J AGR FOOD CHEM, V37, P316, DOI 10.1021/jf00086a009; Sareedenchai V, 2010, BIOCHEM SYST ECOL, V38, P935, DOI 10.1016/j.bse.2009.09.006; Shan SB, 2012, STRAIT PHARM J, V24, P42; Tao WW, 2011, PHYTOCHEM ANALYSIS, V22, P455, DOI 10.1002/pca.1302; Vukics V, 2009, THESIS SEMMELWEIS U, P55; Yang RZ, 2009, J CHROMATOGR A, V1216, P106, DOI 10.1016/j.chroma.2008.11.046; Zhu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034335	34	41	48	11	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108860	10.1371/journal.pone.0108860	http://dx.doi.org/10.1371/journal.pone.0108860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279809	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800029
J	Singh, B; Shamsnia, A; Raythatha, MR; Milligan, RD; Cady, AM; Madan, S; Lucci, A				Singh, Balraj; Shamsnia, Anna; Raythatha, Milan R.; Milligan, Ryan D.; Cady, Amanda M.; Madan, Simran; Lucci, Anthony			Highly Adaptable Triple-Negative Breast Cancer Cells as a Functional Model for Testing Anticancer Agents	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; FTO GENE; METASTASIS; OBESITY; GROWTH; EVOLUTION; TUMOR; IDENTIFICATION; ITRACONAZOLE	A major obstacle in developing effective therapies against solid tumors stems from an inability to adequately model the rare subpopulation of panresistant cancer cells that may often drive the disease. We describe a strategy for optimally modeling highly abnormal and highly adaptable human triple-negative breast cancer cells, and evaluating therapies for their ability to eradicate such cells. To overcome the shortcomings often associated with cell culture models, we incorporated several features in our model including a selection of highly adaptable cancer cells based on their ability to survive a metabolic challenge. We have previously shown that metabolically adaptable cancer cells efficiently metastasize to multiple organs in nude mice. Here we show that the cancer cells modeled in our system feature an embryo-like gene expression and amplification of the fat mass and obesity associated gene FTO. We also provide evidence of upregulation of ZEB1 and downregulation of GRHL2 indicating increased epithelial to mesenchymal transition in metabolically adaptable cancer cells. Our results obtained with a variety of anticancer agents support the validity of the model of realistic panresistance and suggest that it could be used for developing anticancer agents that would overcome panresistance.	[Lucci, Anthony] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Lucci, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.	alucci@mdanderson.org	Singh, Balraj/AHD-5938-2022	Lucci, Anthony/0000-0003-4039-174X	State of Texas Rare and Aggressive Breast Cancer Research Program Grant; Breast Cancer Metastasis Research Program at MD Anderson Cancer Center; National Institutes of Health [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	State of Texas Rare and Aggressive Breast Cancer Research Program Grant; Breast Cancer Metastasis Research Program at MD Anderson Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a State of Texas Rare and Aggressive Breast Cancer Research Program Grant, Breast Cancer Metastasis Research Program at MD Anderson Cancer Center, and CA16672 (Core) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barnabas N, 2013, INT J BREAST CANCER, V2013, DOI 10.1155/2013/872743; Berulava T, 2013, EUR J HUM GENET, V21, P317, DOI 10.1038/ejhg.2012.168; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chao HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051719; Cieply B, 2013, CANCER RES, V73, P6299, DOI 10.1158/0008-5472.CAN-12-4082; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gulati P, 2013, P NATL ACAD SCI USA, V110, P2557, DOI 10.1073/pnas.1222796110; Guo LX, 2011, AM J PATHOL, V178, P2357, DOI 10.1016/j.ajpath.2011.01.047; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Jain R, 2013, J MAMMARY GLAND BIOL, V18, P257, DOI 10.1007/s10911-013-9307-3; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Masuda H, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3579; McKnight SL, 2010, SCIENCE, V330, P1338, DOI 10.1126/science.1199908; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pan QT, 2003, MOL CANCER RES, V1, P701; Raghav KP, 2012, CLIN CANCER RES, V18, P2269, DOI 10.1158/1078-0432.CCR-11-2830; Reid MA, 2013, MOL CELL, V50, P200, DOI 10.1016/j.molcel.2013.02.008; Rudin CM, 2013, J THORAC ONCOL, V8, P619, DOI 10.1097/JTO.0b013e31828c3950; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Singh B, 2007, ONCOGENE, V26, P3789, DOI 10.1038/sj.onc.1210154; Singh B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036510; Singh B, 2010, CLIN EXP METASTAS, V27, P233, DOI 10.1007/s10585-010-9321-4; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; TALMADGE JE, 1982, SCIENCE, V217, P361, DOI 10.1126/science.6953592; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Van Laere SJ, 2013, CLIN CANCER RES, V19, P4685, DOI 10.1158/1078-0432.CCR-12-2549; Wang Y, 2014, NATURE          0730, DOI [10.1038/nature13600, DOI 10.1038/NATURE13600]; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Zhang DW, 2009, CLIN CANCER RES, V15, P6639, DOI 10.1158/1078-0432.CCR-09-0951; Zhang QM, 2007, MUTAGENESIS, V22, P329, DOI 10.1093/mutage/gem021	42	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109487	10.1371/journal.pone.0109487	http://dx.doi.org/10.1371/journal.pone.0109487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279830	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800086
J	Svensson, F; Norberg, J; Snoeijs, P				Svensson, Filip; Norberg, Jon; Snoeijs, Pauline			Diatom Cell Size, Coloniality and Motility: Trade-Offs between Temperature, Salinity and Nutrient Supply with Climate Change	PLOS ONE			English	Article							TRAITS-ENVIRONMENT RELATIONSHIPS; COOLING-WATER DISCHARGE; COMMUNITY STRUCTURE; MARINE; PHYTOPLANKTON; LIGHT; BIOGEOGRAPHY; ASSEMBLAGES; RESPONSES; DYNAMICS	Reduction in body size has been proposed as a universal response of organisms, both to warming and to decreased salinity. However, it is still controversial if size reduction is caused by temperature or salinity on their own, or if other factors interfere as well. We used natural benthic diatom communities to explore how "body size'' (cells and colonies) and motility change along temperature (2-26 degrees C) and salinity (0.5-7.8) gradients in the brackish Baltic Sea. Fourth-corner analysis confirmed that small cell and colony sizes were associated with high temperature in summer. Average community cell volume decreased linearly with 2.2% per degrees C. However, cells were larger with artificial warming when nutrient concentrations were high in the cold season. Average community cell volume increased by 5.2% per degrees C of artificial warming from 0 to 8.5 degrees C and simultaneously there was a selection for motility, which probably helped to optimize growth rates by trade-offs between nutrient supply and irradiation. Along the Baltic Sea salinity gradient cell size decreased with decreasing salinity, apparently mediated by nutrient stoichiometry. Altogether, our results suggest that climate change in this century may polarize seasonality by creating two new niches, with elevated temperature at high nutrient concentrations in the cold season (increasing cell size) and elevated temperature at low nutrient concentrations in the warm season (decreasing cell size). Higher temperature in summer and lower salinity by increased land-runoff are expected to decrease the average cell size of primary producers, which is likely to affect the transfer of energy to higher trophic levels.	[Svensson, Filip; Snoeijs, Pauline] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Norberg, Jon] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Svensson, F (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	filip.svensson@su.se		Norberg, Jon/0000-0003-1861-5030	Swedish Environmental protection Agency; Swedish Research Council	Swedish Environmental protection Agency; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded by grants from the Swedish Environmental protection Agency (temperature data set) and the Swedish Research Council (salinity data set) to Pauline Snoeijs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GL, 2013, GLOBAL CHANGE BIOL, V19, P3540, DOI 10.1111/gcb.12285; [Anonymous], 2012, DEV ENV MODELLING; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Atkinson D, 2003, P ROY SOC B-BIOL SCI, V270, P2605, DOI 10.1098/rspb.2003.2538; Barton AD, 2013, ECOL LETT, V16, P522, DOI 10.1111/ele.12063; Blanchet FG, 2008, ECOL MODEL, V215, P325, DOI 10.1016/j.ecolmodel.2008.04.001; Blanchet FG, 2011, OECOLOGIA, V166, P357, DOI 10.1007/s00442-010-1867-y; Blomqvist S, 2004, LIMNOL OCEANOGR, V49, P2236, DOI 10.4319/lo.2004.49.6.2236; Cartaxana P, 2008, LIMNOL OCEANOGR-METH, V6, P466, DOI 10.4319/lom.2008.6.466; Cohn SA, 1996, J PHYCOL, V32, P928, DOI 10.1111/j.0022-3646.1996.00928.x; de Mazancourt C, 2008, ECOL LETT, V11, P380, DOI 10.1111/j.1461-0248.2008.01152.x; Doscher R, 2004, AMBIO, V33, P242, DOI 10.1639/0044-7447(2004)033[0242:SSSTAH]2.0.CO;2; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Dray S, 2008, ECOLOGY, V89, P3400, DOI 10.1890/08-0349.1; Falkowski PG, 2007, NAT REV MICROBIOL, V5, P813, DOI 10.1038/nrmicro1751; Finkel ZV, 2009, P ROY SOC B-BIOL SCI, V276, P1627, DOI 10.1098/rspb.2008.1610; Finkel ZV, 2001, LIMNOL OCEANOGR, V46, P86, DOI 10.4319/lo.2001.46.1.0086; Fonselius S, 2003, J SEA RES, V49, P229, DOI 10.1016/S1385-1101(03)00035-2; Forster J, 2013, ISME J, V7, P28, DOI 10.1038/ismej.2012.76; GEIDER RJ, 1986, MAR ECOL PROG SER, V30, P93, DOI 10.3354/meps030093; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; GROVER JP, 1991, AM NAT, V138, P811, DOI 10.1086/285254; Hillebrand H, 2010, GLOBAL CHANGE BIOL, V16, P1181, DOI 10.1111/j.1365-2486.2009.02045.x; HOAGLAND KD, 1982, AM J BOT, V69, P188, DOI 10.2307/2443006; HOPE AB, 1988, NEW PHYTOL, V110, P441; JORGENSEN EG, 1968, PHYSIOL PLANTARUM, V21, P423, DOI 10.1111/j.1399-3054.1968.tb07266.x; Key T, 2010, ENVIRON MICROBIOL, V12, P95, DOI 10.1111/j.1462-2920.2009.02046.x; Lange K, 2011, FRESHWATER BIOL, V56, P264, DOI 10.1111/j.1365-2427.2010.02492.x; Legendre P, 1997, ECOLOGY, V78, P547; Legendre P, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2728; Lepparanta M., 2009, PHYS OCEANOGRAPHY BA; Lewandowska A, 2010, MAR ECOL PROG SER, V405, P101, DOI 10.3354/meps08520; Litchman E, 2009, P NATL ACAD SCI USA, V106, P2665, DOI 10.1073/pnas.0810891106; Litchman E, 2010, HYDROBIOLOGIA, V653, P15, DOI 10.1007/s10750-010-0341-5; Mackenzie BR, 2007, GLOBAL CHANGE BIOL, V13, P1335, DOI 10.1111/j.1365-2486.2007.01360.x; MARGALEF R., 1954, HYDROBIOLOGIA, V6, P83, DOI 10.1007/BF00039412; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Moran XAG, 2010, GLOBAL CHANGE BIOL, V16, P1137, DOI 10.1111/j.1365-2486.2009.01960.x; Neumann T, 2010, J MARINE SYST, V81, P213, DOI 10.1016/j.jmarsys.2009.12.001; Norris RD, 2013, SCIENCE, V341, P492, DOI 10.1126/science.1240543; Passy SI, 2007, AQUAT BOT, V86, P171, DOI 10.1016/j.aquabot.2006.09.018; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Peter KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071528; Potapova M, 1997, J PHYCOL, V33, P924, DOI 10.1111/j.0022-3646.1997.00924.x; Raven JA, 1998, FUNCT ECOL, V12, P503, DOI 10.1046/j.1365-2435.1998.00233.x; Rodriguez J, 2001, NATURE, V410, P360, DOI 10.1038/35066560; Round FE, 1990, DIATOMS BIOL MORPHOL; Shurin JB, 2006, P ROY SOC B-BIOL SCI, V273, P1, DOI 10.1098/rspb.2005.3377; Snoeijs P, 1995, ECOSCIENCE, V2, P382, DOI 10.1080/11956860.1995.11682307; Snoeijs P, 2002, J PHYCOL, V38, P265, DOI 10.1046/j.1529-8817.2002.01105.x; Snoeijs P, 1995, INTERCALIBRATION DIS, V3, P125; Snoeijs P, 1998, INTERCALIBRATION DIS, V5, P141; Snoeijs P, 1994, 4374 SWED ENV PROT A, P70; Snoeijs P, 1996, INTERCALIBRATION DIS, V4, P125; Snoeijs P., 1994, INTERCALIBRATION DIS, V2, P125; Snoeijs P., 1993, OPULUS PRESS UPPSALA, V1, P129; SNOEIJS P J M, 1989, Diatom Research, V4, P373; Snoeijs Pauli, 1992, Diatom Research, V7, P313; SNOEIJS PJM, 1989, J APPL ECOL, V26, P935, DOI 10.2307/2403703; SNOEIJS PJM, 1990, J VEG SCI, V1, P599, DOI 10.2307/3235565; SNOEIJS PJM, 1989, HYDROBIOLOGIA, V184, P99, DOI 10.1007/BF00014306; Sommer U, 2002, HYDROBIOLOGIA, V484, P11, DOI 10.1023/A:1021340601986; STEINMAN AD, 1987, CAN J FISH AQUAT SCI, V44, P1640, DOI 10.1139/f87-199; Takabayashi M, 2006, J PLANKTON RES, V28, P831, DOI 10.1093/plankt/fbl018; Tall L, 2006, LIMNOL OCEANOGR, V51, P1211, DOI 10.4319/lo.2006.51.2.1211; ter Braak CJF, 2012, ECOLOGY, V93, P1525, DOI 10.1890/12-0126.1; Ulanova A, 2009, J PHYCOL, V45, P54, DOI 10.1111/j.1529-8817.2008.00628.x; WATRAS CJ, 1982, J EXP MAR BIOL ECOL, V62, P25, DOI 10.1016/0022-0981(82)90214-3; Winder M, 2009, P ROYAL SOC B, V276; Winder M, 2008, OECOLOGIA, V156, P179, DOI 10.1007/s00442-008-0964-7; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yvon-Durocher G, 2011, GLOBAL CHANGE BIOL, V17, P1681, DOI 10.1111/j.1365-2486.2010.02321.x	72	36	37	1	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109993	10.1371/journal.pone.0109993	http://dx.doi.org/10.1371/journal.pone.0109993			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279720	gold, Green Submitted, Green Published			2022-12-27	WOS:000342670800108
J	Barnes, SL; Quarles, CC; Yankeelov, TE				Barnes, Stephanie L.; Quarles, C. Chad; Yankeelov, Thomas E.			Modeling the Effect of Intra-Voxel Diffusion of Contrast Agent on the Quantitative Analysis of Dynamic Contrast Enhanced Magnetic Resonance Imaging	PLOS ONE			English	Article							GADOLINIUM-DTPA; MRI; PERMEABILITY; DIFFERENTIATION; ZD6474; HETEROGENEITY; PARAMETERS; INHIBITOR; AZD2171; POTENT	Quantitative dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) provides estimates of physiologically relevant parameters related to tissue blood flow, vascular permeability, and tissue volume fractions which can then be used for prognostic and diagnostic reasons. However, standard techniques for DCE-MRI analysis ignore intra-voxel diffusion, which may play an important role in contrast agent distribution and voxel signal intensity and, thus, will affect quantification of the aforementioned parameters. To investigate the effect of intra-voxel diffusion on quantitative DCE-MRI, we developed a finite element model of contrast enhancement at the voxel level. For diffusion in the range of that expected for gadolinium chelates in tissue (i.e., 1 x 10(-4) to 4 x 10(-4) mm(2)/s), parameterization errors range from -58% to 12% for K-trans, -9% to 8% for v(e), and -60% to 213% for v(p) over the range of K-trans, v(e), v(p), and temporal resolutions investigated. Thus the results show that diffusion has a significant effect on parameterization using standard techniques.	[Barnes, Stephanie L.; Quarles, C. Chad; Yankeelov, Thomas E.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37235 USA; [Barnes, Stephanie L.; Quarles, C. Chad; Yankeelov, Thomas E.] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN USA; [Quarles, C. Chad; Yankeelov, Thomas E.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Quarles, C. Chad; Yankeelov, Thomas E.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; [Quarles, C. Chad; Yankeelov, Thomas E.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA; [Quarles, C. Chad; Yankeelov, Thomas E.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37235 USA; [Quarles, C. Chad; Yankeelov, Thomas E.] Vanderbilt Univ, Program Chem & Phys Biol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Yankeelov, TE (corresponding author), Vanderbilt Univ, Inst Imaging Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	thomas.yankeelov@vanderbilt.edu	Quarles, Chad/V-1168-2019	Yankeelov, Thomas/0000-0001-6201-3913	National Cancer Institute [R01CA138599, R01CA158079, R25CA092043, P30CA68485, P50CA098131, U01CA174706]; NATIONAL CANCER INSTITUTE [R01CA158079, R01CA138599, R25CA092043, P30CA068485, P50CA098131, U01CA174706] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the National Cancer Institute through R01CA138599, R01CA158079, R25CA092043, P30CA68485, P50CA098131, and U01CA174706. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley DP, 2008, NMR BIOMED, V21, P42, DOI 10.1002/nbm.1161; BRIX G, 1991, J COMPUT ASSIST TOMO, V15, P621, DOI 10.1097/00004728-199107000-00018; Checkley D, 2003, BRIT J CANCER, V89, P1889, DOI 10.1038/sj.bjc.6601386; CRANK J, 1947, P CAMB PHILOS SOC, V43, P50, DOI 10.1007/BF02127704; Daldrup H, 1998, AM J ROENTGENOL, V171, P941, DOI 10.2214/ajr.171.4.9762973; de Lussanet QG, 2004, EUR J CANCER, V40, P1262, DOI 10.1016/j.ejca.2004.01.020; Delaney GW, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/34002; Donahue MJ, 2008, MAGN RESON MED, V59, P336, DOI 10.1002/mrm.21467; Ferrier MC, 2007, NEOPLASIA, V9, P546, DOI 10.1593/neo.07289; Fluckiger JU, 2013, PHYS MED BIOL, V58, P1983, DOI 10.1088/0031-9155/58/6/1983; Gordon MJ, 1999, BIOTECHNOL BIOENG, V65, P459, DOI 10.1002/(SICI)1097-0290(19991120)65:4<459::AID-BIT10>3.0.CO;2-O; Guo JY, 2012, CANCER-AM CANCER SOC, V118, P3776, DOI 10.1002/cncr.26701; Haris M, 2008, CLIN RADIOL, V63, P562, DOI 10.1016/j.crad.2007.11.002; Haris M, 2008, NEURORADIOLOGY, V50, P531, DOI 10.1007/s00234-008-0378-6; Hennequin LF, 2002, J MED CHEM, V45, P1300, DOI 10.1021/jm011022e; Hirashima Y, 2012, INT J CANCER, V130, P2359, DOI 10.1002/ijc.26282; Jia G, 2008, RADIOLOGY, V248, P901, DOI 10.1148/radiol.2491071936; KETY SS, 1951, PHARMACOL REV, V3, P1; Koh TS, 2013, MAGN RESON MED, V69, P269, DOI 10.1002/mrm.24246; Koo HR, 2012, J MAGN RESON IMAGING, V36, P145, DOI 10.1002/jmri.23635; Lagrange J, 1877, OEUVRES LAGRANGE, P183; LARSSON HBW, 1990, MAGNET RESON MED, V16, P117, DOI 10.1002/mrm.1910160111; Loveless ME, 2012, MAGN RESON MED, V67, P226, DOI 10.1002/mrm.22988; Lynch D. R., 2005, NUMERICAL PARTIAL DI; Maxwell RJ, 2002, NMR BIOMED, V15, P89, DOI 10.1002/nbm.754; MUSSURAKIS S, 1995, INVEST RADIOL, V30, P650, DOI 10.1097/00004424-199511000-00005; Mussurakis S, 1997, CLIN RADIOL, V52, P516, DOI 10.1016/S0009-9260(97)80328-5; Pannetier NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057636; Pellerin M, 2007, MAGN RESON MED, V58, P1124, DOI 10.1002/mrm.21400; Radjenovic A, 2008, BRIT J RADIOL, V81, P120, DOI 10.1259/bjr/98435332; Semmineh NB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084764; Sourbron S, 2014, IEEE T MED IMAGING; TOFTS PS, 1994, MAGN RESON IMAGING, V12, P81, DOI 10.1016/0730-725X(94)92355-8; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Wedge SR, 2005, CANCER RES, V65, P4389, DOI 10.1158/0008-5472.CAN-04-4409; Wedge SR, 2002, CANCER RES, V62, P4645; Yang S, 2003, AM J NEURORADIOL, V24, P1554; Yankeelov TE, 2007, CURR MED IMAGING REV, V3, P91, DOI 10.2174/157340507780619179	38	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108726	10.1371/journal.pone.0108726	http://dx.doi.org/10.1371/journal.pone.0108726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275536	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500028
J	Bergman, JM; Wrande, M; Hughes, D				Bergman, Jessica M.; Wrande, Marie; Hughes, Diarmaid			Acetate Availability and Utilization Supports the Growth of Mutant Sub-Populations on Aging Bacterial Colonies	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; ENCODES ACETYL-COENZYME; ESCHERICHIA-COLI; SALMONELLA-ENTERICA; PROTEIN ACETYLATION; STATIONARY-PHASE; COA SYNTHETASE; A SYNTHETASE; CULTURES; LYSINE	When bacterial colonies age most cells enter a stationary phase, but sub-populations of mutant bacteria can continue to grow and accumulate. These sub-populations include bacteria with mutations in rpoB (RNA polymerase beta-subunit) or rpoS (RNA polymerase stress-response sigma factor). Here we have identified acetate as a nutrient present in the aging colonies that is utilized by these mutant subpopulations to support their continued growth. Proteome analysis of aging colonies showed that several proteins involved in acetate conversion and utilization were upregulated during aging. Acetate is known to be excreted during the exponential growth phase but can be imported later during the transition to stationary phase and converted to acetyl-CoA. Acetyl-CoA is used in multiple processes, including feeding into the TCA cycle, generating ATP via the glyoxylate shunt, as a source of acetyl groups for protein modification, and to support fatty acid biosynthesis. We showed that deletion of acs (encodes acetyl-CoA synthetase; converts acetate into acetyl-CoA) significantly reduced the accumulation of rpoB and rpoS mutant subpopulations on aging colonies. Measurement of radioactive acetate uptake showed that the rate of conversion decreased in aging wild-type colonies, was maintained at a constant level in the rpoB mutant, and significantly increased in the aging rpoS mutant. Finally, we showed that the growth of subpopulations on aging colonies was greatly enhanced if the aging colony itself was unable to utilize acetate, leaving more acetate available for mutant subpopulations to use. Accordingly, the data show that the accumulation of subpopulations of rpoB and rpoS mutants on aging colonies is supported by the availability in the aging colony of acetate, and by the ability of the subpopulation cells to convert the acetate to acetyl-CoA.	[Bergman, Jessica M.; Wrande, Marie; Hughes, Diarmaid] Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, Uppsala, Sweden	Uppsala University	Hughes, D (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, Uppsala, Sweden.	diarmaid.hughes@imbim.uu.se	Hughes, Diarmaid/A-9487-2014	Hughes, Diarmaid/0000-0002-7456-9182	Swedish Science Research Council; Knut and Alice Wallenberg Foundation (RiboCore Project); SSF (Swedish Foundation for Strategic Research); Vinnova (Swedish Innovation Agency); Science for Life Mass Spectrometry Technology Platform in Uppsala, Sweden	Swedish Science Research Council; Knut and Alice Wallenberg Foundation (RiboCore Project); SSF (Swedish Foundation for Strategic Research)(Swedish Foundation for Strategic Research); Vinnova (Swedish Innovation Agency)(Vinnova); Science for Life Mass Spectrometry Technology Platform in Uppsala, Sweden	Diarmaid Hughes acknowledges support from The Swedish Science Research Council (Vetenskapsradet), the Knut and Alice Wallenberg Foundation (RiboCore Project), SSF (Swedish Foundation for Strategic Research) and Vinnova (Swedish Innovation Agency). This work was supported by the Science for Life Mass Spectrometry Technology Platform in Uppsala, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank Svenja N. Reinders, Eva Garcia Barreales, and Shanjun Gao, who each contributed to parts of this project as Masters students.	Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; ELMANSI EMT, 1989, J GEN MICROBIOL, V135, P2875; Farmer WR, 1997, APPL ENVIRON MICROB, V63, P3205, DOI 10.1128/AEM.63.8.3205-3210.1997; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Gardner JG, 2006, J BACTERIOL, V188, P5460, DOI 10.1128/JB.00215-06; HOLMS WH, 1986, CURR TOP CELL REGUL, V28, P69; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Jones JD, 2011, PROTEOMICS, V11, P3012, DOI 10.1002/pmic.201000812; KIHARA M, 1981, J BACTERIOL, V145, P1209, DOI 10.1128/JB.145.3.1209-1221.1981; Kiyonami R, 2011, QUANTIFYING PEPTIDES; KORNBERG HL, 1966, BIOCHEM J, V99, P1; KUMARI S, 1995, J BACTERIOL, V177, P2878, DOI 10.1128/jb.177.10.2878-2886.1995; Kumari S, 2000, J BACTERIOL, V182, P551, DOI 10.1128/JB.182.2.551-554.2000; Lima BP, 2011, MOL MICROBIOL, V81, P1190, DOI 10.1111/j.1365-2958.2011.07742.x; MAJEWSKI RA, 1990, BIOTECHNOL BIOENG, V35, P732, DOI 10.1002/bit.260350711; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Marcusson LL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000541; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Notley-McRobb L, 2002, J BACTERIOL, V184, P806, DOI 10.1128/JB.184.3.806-811.2002; PRUSS BM, 1994, J BACTERIOL, V176, P2143; REPASKE DR, 1981, J BACTERIOL, V145, P1196, DOI 10.1128/JB.145.3.1196-1208.1981; Saint-Ruf C, 2004, GENETICS, V168, P541, DOI 10.1534/genetics.104.028704; Saint-Ruf C, 2014, J BACTERIOL, V196, P3059, DOI 10.1128/JB.01421-13; SALMOND CV, 1984, J GEN MICROBIOL, V130, P2845; SCHMIEGER H, 1973, MOL GEN GENET, V120, P181, DOI 10.1007/BF00267246; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Sutton A, 2000, J BACTERIOL, V182, P4375, DOI 10.1128/JB.182.16.4375-4379.2000; Taddei F, 1997, MOL GEN GENET, V256, P277, DOI 10.1007/s004380050570; TADDEI F, 1995, P NATL ACAD SCI USA, V92, P11736, DOI 10.1073/pnas.92.25.11736; Thao S, 2011, CURR OPIN MICROBIOL, V14, P200, DOI 10.1016/j.mib.2010.12.013; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wrande M, 2008, P NATL ACAD SCI USA, V105, P11863, DOI 10.1073/pnas.0804739105; Yu BJ, 2008, J MICROBIOL BIOTECHN, V18, P1529; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	42	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109255	10.1371/journal.pone.0109255	http://dx.doi.org/10.1371/journal.pone.0109255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275605	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500086
J	Wu, J; Wang, LF; Li, L; Wang, SM				Wu, Jing; Wang, Lanfen; Li, Long; Wang, Shumin			De Novo Assembly of the Common Bean Transcriptome Using Short Reads for the Discovery of Drought-Responsive Genes	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; PHASEOLUS-VULGARIS; ABIOTIC STRESSES; ENHANCES TOLERANCE; GENOME SEQUENCE; ABSCISIC-ACID; SSR MARKERS; RESISTANCE; SALT; EXPRESSION	The common bean (Phaseolus vulgaris L.) is one of the most important food legumes, far ahead of other legumes. The average grain yield of the common bean worldwide is much lower than its potential yields, primarily due to drought in the field. However, the gene network that mediates plant responses to drought stress remains largely unknown in this species. The major goals of our study are to identify a large scale of genes involved in drought stress using RNA-seq. First, we assembled 270 million high-quality trimmed reads into a non-redundant set of 62,828 unigenes, representing approximately 49 Mb of unique transcriptome sequences. Of these unigenes, 26,501 (42.2%) common bean unigenes had significant similarity with unigenes/predicted proteins from other legumes or sequenced plants. All unigenes were functionally annotated within the GO, COG and KEGG pathways. The strategy for de novo assembly of transcriptome data generated here will be useful in other legume plant transcriptome studies. Second, we identified 10,482 SSRs and 4,099 SNPs in transcripts. The large number of genetic markers provides a resource for gene discovery and development of functional molecular markers. Finally, we found differential expression genes (DEGs) between terminal drought and optimal irrigation treatments and between the two different genotypes Long 22-0579 (drought tolerant) and Naihua (drought sensitive). DEGs were confirmed by quantitative real-time PCR assays, which indicated that these genes are functionally associated with the drought-stress response. These resources will be helpful for basic and applied research for genome analysis and crop drought resistance improvement in the common bean.	[Wang, Shumin] Minist Agr, Key Lab Crop Germplasm Resources & Utilizat, Beijing, Peoples R China; Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China	Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Wang, SM (corresponding author), Minist Agr, Key Lab Crop Germplasm Resources & Utilizat, Beijing, Peoples R China.	wangshumin@caas.cn			Ministry of Agriculture of China (China Agriculture Research System) [CARS-09]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2013BAD01B03-18a]; Agricultural Science and Technology Innovation Program (ASTIP) of CAAS	Ministry of Agriculture of China (China Agriculture Research System); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Agricultural Science and Technology Innovation Program (ASTIP) of CAAS	This work was supported by grants from the Ministry of Agriculture of China (the earmarked fund for China Agriculture Research System [CARS-09]), National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2013BAD01B03-18a) and the Agricultural Science and Technology Innovation Program (ASTIP) of CAAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar R, 2010, PLANT PHYSIOL BIOCH, V48, P547, DOI 10.1016/j.plaphy.2010.02.002; Alet AI, 2011, PLANT SIGNAL BEHAV, V6, P278, DOI 10.4161/psb.6.2.14702; Asfaw A, 2012, MOL BREEDING, V30, P681, DOI 10.1007/s11032-011-9654-y; Asfaw A, 2012, G3-GENES GENOM GENET, V2, P579, DOI 10.1534/g3.112.002303; Blair MW, 2012, MOL BREEDING, V29, P71, DOI 10.1007/s11032-010-9527-9; Blair MW, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-50; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Cannon SB, 2009, PLANT PHYSIOL, V151, P970, DOI 10.1104/pp.109.144659; Carels N, 2000, GENETICS, V154, P1819; Chen JB, 2010, THEOR APPL GENET, V120, P1393, DOI 10.1007/s00122-010-1263-3; Chen M, 2007, BIOCHEM BIOPH RES CO, V353, P299, DOI 10.1016/j.bbrc.2006.12.027; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Choudhary NL, 2005, INDIAN J BIOCHEM BIO, V42, P366; Cichy KA, 2009, CROP SCI, V49, P1742, DOI 10.2135/cropsci2008.10.0605; De Ronde JA, 2004, J PLANT PHYSIOL, V161, P1211, DOI 10.1016/j.jplph.2004.01.014; Degenkolbe T, 2009, PLANT MOL BIOL, V69, P133, DOI 10.1007/s11103-008-9412-7; Gaitan-Solis E, 2008, PLANT GENOME-US, V1, P125, DOI 10.3835/plantgenome2008.04.0204; Galeano CH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-629; Garcia RAV, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-41; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gong PJ, 2010, J EXP BOT, V61, P3563, DOI 10.1093/jxb/erq167; Goretti D, 2014, MOL BREEDING, V33, P531, DOI 10.1007/s11032-013-9970-5; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Henry A, 2010, FIELD CROP RES, V117, P209, DOI 10.1016/j.fcr.2010.03.004; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Huang JZ, 2012, DNA RES, V19, P195, DOI 10.1093/dnares/dss004; Kasukabe Y, 2004, PLANT CELL PHYSIOL, V45, P712, DOI 10.1093/pcp/pch083; Li HW, 2011, PLANTA, V234, P1007, DOI 10.1007/s00425-011-1458-0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JH, 2012, J EXP BOT, V63, P6407, DOI 10.1093/jxb/ers295; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Liu SX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003790; Lopez CG, 2003, CROP SCI, V43, P577, DOI 10.2135/cropsci2003.0577; Luo X, 2012, PLANTA, V235, P1141, DOI 10.1007/s00425-011-1563-0; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Marshall A, 2012, PLANT CELL, V24, P2262, DOI 10.1105/tpc.112.096677; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; Miklas PN, 2006, EUPHYTICA, V147, P105, DOI 10.1007/s10681-006-4600-5; Mittal A, 2014, PLANT BIOTECHNOL J, V12, P578, DOI 10.1111/pbi.12162; Nielsen DC, 1998, CROP SCI, V38, P422, DOI 10.2135/cropsci1998.0011183X003800020025x; Nir I, 2014, PLANT CELL ENVIRON, V37, P113, DOI 10.1111/pce.12135; Oono Y, 2003, PLANT J, V34, P868, DOI 10.1046/j.1365-313X.2003.01774.x; Prophete E, 2014, J PLANT REGIST, V8, P49, DOI 10.3198/jpr2013.08.0046crg; Ramirez-Vallejo P, 1998, EUPHYTICA, V99, P127, DOI 10.1023/A:1018353200015; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Rodriguez-Uribe L, 2006, J EXP BOT, V57, P1391, DOI 10.1093/jxb/erj118; Rosales MA, 2012, PLANT PHYSIOL BIOCH, V56, P24, DOI 10.1016/j.plaphy.2012.04.007; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schneider KA, 1997, CROP SCI, V37, P51, DOI 10.2135/cropsci1997.0011183X003700010008x; Schneider KA, 1997, CROP SCI, V37, P43, DOI 10.2135/cropsci1997.0011183X003700010007x; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Singh SP, 2001, CROP SCI, V41, P276, DOI 10.2135/cropsci2001.411276x; Souza TLPO, 2012, MOL BREEDING, V30, P419, DOI 10.1007/s11032-011-9632-4; Teran H, 2002, CROP SCI, V42, P64, DOI 10.2135/cropsci2002.0064; Utsumi Y, 2012, DNA RES, V19, P335, DOI 10.1093/dnares/dss016; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Wu XianShan, 2008, Journal of Triticeae Crops, V28, P626; Xia JH, 2013, DNA RES, V20, P449, DOI 10.1093/dnares/dst022; Xu ZS, 2008, BOTANY, V86, P969, DOI 10.1139/B08-041; Yamada M, 2005, J EXP BOT, V56, P1975, DOI 10.1093/jxb/eri195; Yao LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058108; Zeeman SC, 2004, PLANT PHYSIOL, V135, P849, DOI 10.1104/pp.103.032631; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266	69	40	44	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109262	10.1371/journal.pone.0109262	http://dx.doi.org/10.1371/journal.pone.0109262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275443	Green Submitted, Green Published, gold			2022-12-27	WOS:000342591500089
J	Silveira, CM; Siu, ER; Anthony, JC; Saito, LP; de Andrade, AG; Kutschenko, A; Viana, MC; Wang, YP; Martins, SS; Andrade, LH				Silveira, Camila Magalhaes; Siu, Erica Rosanna; Anthony, James C.; Saito, Luis Paulo; de Andrade, Arthur Guerra; Kutschenko, Andressa; Viana, Maria Carmen; Wang, Yuan-Pang; Martins, Silvia S.; Andrade, Laura Helena			Drinking Patterns and Alcohol Use Disorders in Sao Paulo, Brazil: The Role of Neighborhood Social Deprivation and Socioeconomic Status	PLOS ONE			English	Article							MENTAL-HEALTH-SURVEY; COMPARATIVE RISK-ASSESSMENT; GLOBAL BURDEN; GENDER-DIFFERENCES; BINGE DRINKING; CONSUMPTION; POPULATION; INEQUALITY; DISEASE; ASSOCIATION	Background: Research conducted in high-income countries has investigated influences of socioeconomic inequalities on drinking outcomes such as alcohol use disorders (AUD), however, associations between area-level neighborhood social deprivation (NSD) and individual socioeconomic status with these outcomes have not been explored in Brazil. Thus, we investigated the role of these factors on drink-related outcomes in a Brazilian population, attending to male-female variations. Methods: A multi-stage area probability sample of adult household residents in the Sao Paulo Metropolitan Area was assessed using the WHO Composite International Diagnostic Interview (WMH-CIDI) (n = 5,037). Estimation focused on prevalence and correlates of past-year alcohol disturbances [heavy drinking of lower frequency (HDLF), heavy drinking of higher frequency (HDHF), abuse, dependence, and DMS-5 AUD] among regular users (RU); odds ratio (OR) were obtained. Results: Higher NSD, measured as an area-level variable with individual level variables held constant, showed an excess odds for most alcohol disturbances analyzed. Prevalence estimates for HDLF and HDHF among RU were 9% and 20%, respectively, with excess odds in higher NSD areas; schooling (inverse association) and low income were associated with male HDLF. The only individual-level association with female HDLF involved employment status. Prevalence estimates for abuse, dependence, and DSM-5 AUD among RU were 8%, 4%, and 8%, respectively, with excess odds of: dependence in higher NSD areas for males; abuse and AUD for females. Among RU, AUD was associated with unemployment, and low education with dependence and AUD. Conclusions: Regular alcohol users with alcohol-related disturbances are more likely to be found where area-level neighborhood characteristics reflect social disadvantage. Although we cannot draw inferences about causal influence, the associations are strong enough to warrant future longitudinal alcohol studies to explore causal mechanisms related to the heterogeneous patterns of association and male-female variations observed herein. Hopefully, these findings may help guide future directions for public health.	[Silveira, Camila Magalhaes; Siu, Erica Rosanna; Saito, Luis Paulo; Kutschenko, Andressa; Viana, Maria Carmen; Wang, Yuan-Pang; Andrade, Laura Helena] Univ Sao Paulo, Sch Med, Inst Psychiat, Sect Psychiat Epidemiol LIM 23, Sao Paulo, Brazil; [Silveira, Camila Magalhaes; de Andrade, Arthur Guerra] Univ Sao Paulo, Sch Med, Dept & Inst Psychiat, Program Interdisciplinary Grp Studies Alcohol & D, Sao Paulo, Brazil; [Anthony, James C.] Michigan State Univ, Dept Epidemiol & Stat, E Lansing, MI 48824 USA; [Martins, Silvia S.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Michigan State University; Columbia University	Silveira, CM (corresponding author), Univ Sao Paulo, Sch Med, Inst Psychiat, Sect Psychiat Epidemiol LIM 23, Sao Paulo, Brazil.	camilams@usp.br	Siu, Erica R/J-9116-2012; Martins, Silvia Saboia/C-9405-2014; de Andrade, Arthur Guerra/AAC-5288-2019; Wang, Yuan-Pang/A-4863-2008; Silveira, Camila M/C-6467-2015; Andrade, Arthur G/O-1964-2015; Andrade, Laura Helena S. G./F-3023-2010; Anthony, Jim/H-3637-2011	Siu, Erica R/0000-0001-7492-7579; Martins, Silvia Saboia/0000-0003-3059-9993; de Andrade, Arthur Guerra/0000-0002-6856-8212; Wang, Yuan-Pang/0000-0001-7076-8312; Silveira, Camila M/0000-0002-1598-4896; Andrade, Arthur G/0000-0002-6856-8212; Andrade, Laura Helena S. G./0000-0002-2362-3521; Anthony, Jim/0000-0001-7176-0929	State of Sao Paulo Research Foundation, Brazil (FAPESP) [03/00204-3, 2011/50517-4]; National Council for Scientific and Technological Development (CNPq) [313675/2009-0]; Foundation for Science and Technology of Vitoria, Espirito Santo, Brazil (Fundo de Apoio a Ciencia e Tecnologia do Municipio de Vitoria) [FACITEC 002/2003]; National Institute on Drug Abuse (NIDA) [DA020667, DA023434, R01DA016558, K05DA015799]; National Institute of Child and Human Development (NICHD) [HD060072]; United States National Institutes of Mental Health [R01MH070884]; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]; Fogarty International Center [FIRCA R03-TW006481]; Pan American Health Organization; Eli Lilly and Company Foundation; Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline; Bristol-Myers Squibb; Shire; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060072] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW006481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R13MH066849, R01MH069864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016558, K05DA015799] Funding Source: NIH RePORTER	State of Sao Paulo Research Foundation, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Science and Technology of Vitoria, Espirito Santo, Brazil (Fundo de Apoio a Ciencia e Tecnologia do Municipio de Vitoria); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Child and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); United States National Institutes of Mental Health; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Pan American Health Organization; Eli Lilly and Company Foundation(Eli Lilly); Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline(GlaxoSmithKline); Bristol-Myers Squibb(Bristol-Myers Squibb); Shire; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The Sao Paulo Megacity Mental Health Survey was funded by the State of Sao Paulo Research Foundation, Brazil (FAPESP Grants 03/00204-3 and 2011/50517-4, URL: http://www.fapesp.br/materia/176/projeto-tematico/projeto-tematico.htm), National Council for Scientific and Technological Development (CNPq - grant 313675/2009-0). Instrument development was supported by the Foundation for Science and Technology of Vitoria, Espirito Santo, Brazil (Fundo de Apoio a Ciencia e Tecnologia do Municipio de Vitoria - FACITEC 002/2003). Dr. Martins received research support from National Institute on Drug Abuse (NIDA) grants DA020667 and DA023434 and from National Institute of Child and Human Development (NICHD) grant HD060072, USA while working on this manuscript. Dr. Anthony also had NIDA grants to support his work: R01DA016558, and K05DA015799. The Sao Paulo Megacity Mental Health Survey is carried out in conjunction with the World Health Organization World Mental Health (WMH) Survey Initiative. The authors thank the WMH staff for assistance with instrumentation, fieldwork, and data analysis. The main coordination center activities, at Harvard University, were supported by the United States National Institutes of Mental Health (R01MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, the Eli Lilly and Company Foundation, Ortho-McNeil Pharmaceutical, Inc., GlaxoSmithKline, Bristol-Myers Squibb, and Shire. The authors declare that the funders of the SPMHS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors also declare that the commercial funders of the Harvard coordination center had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank the SPMHS staff members, Beatriz Margarita Adler, Marlene Galativicis Teixeira, Indaiade Santana Bassani, and Fidel Beraldi. Thanks also are due to the WMH staff for assistance with instrumentation, fieldwork, and data analysis. A complete list of WMH publications can be found at http://www.hcp.med.harvard.edu/wmh/.	Abdin E, 2014, ALCOHOL ALCOHOLISM, V49, P103, DOI 10.1093/alcalc/agt126; Agrawal A, 2011, ADDICTION, V106, P1935, DOI 10.1111/j.1360-0443.2011.03517.x; Almeida N, 2005, SOC PSYCH PSYCH EPID, V40, P214, DOI 10.1007/s00127-005-0883-4; Almeida-Filho N, 2004, REV SAUDE PUBL, V38, P45, DOI 10.1590/S0034-89102004000100007; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; ANTHONY JC, 1985, ARCH GEN PSYCHIAT, V42, P667; Bloomfield K, 2006, ALCOHOL ALCOHOLISM, V41, pI26, DOI 10.1093/alcalc/agl073; Bloomfield Kim, 2000, Subst Abus, V21, P223, DOI 10.1023/A:1007849106375; Bromet EJ, 2005, SOC PSYCH PSYCH EPID, V40, P681, DOI 10.1007/s00127-005-0927-9; Caetano R, 2012, ADDICTION, V107, P60, DOI 10.1111/j.1360-0443.2011.03567.x; Castro DS, 2012, DRUG ALCOHOL DEPEN, V126, P272, DOI 10.1016/j.drugalcdep.2012.05.017; Chuang YC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-151; Barros MBD, 2007, REV SAUDE PUBL, V41, P502, DOI 10.1590/S0034-89102006005000032; Degenhardt L, 2007, INT J METH PSYCH RES, V16, P111, DOI 10.1002/mpr.220; Degenhardt L, 2008, PLOS MED, V5, P1053, DOI 10.1371/journal.pmed.0050141; DOHRENWEND BP, 1992, SCIENCE, V255, P946, DOI 10.1126/science.1546291; Dzurova D, 2010, HEALTH PLACE, V16, P590, DOI 10.1016/j.healthplace.2010.01.004; Elliott M, 2000, HEALTH PLACE, V6, P287, DOI 10.1016/S1353-8292(00)00010-1; Esan O, 2013, ALCOHOL, V47, P249, DOI 10.1016/j.alcohol.2012.12.011; Fonseca AM, 2010, CIENC SAUDE COLETIVA, V15, P663, DOI 10.1590/S1413-81232010000300008; Galduroz JCF, 2007, BRAZ J MED BIOL RES, V40, P367, DOI 10.1590/S0100-879X2007000300012; Galea S, 2007, DRUG ALCOHOL DEPEN, V90, pS4, DOI 10.1016/j.drugalcdep.2006.11.008; Galea S, 2007, AM J PREV MED, V32, pS195, DOI 10.1016/j.amepre.2007.04.003; Greenfield TK, 2000, AM J PUBLIC HEALTH, V90, P47, DOI 10.2105/AJPH.90.1.47; Grittner U, 2013, EUR J PUBLIC HEALTH, V23, P332, DOI 10.1093/eurpub/cks044; Gruenewald PJ, 2007, ADDICTION, V102, P870, DOI 10.1111/j.1360-0443.2007.01856.x; Guimarães Vanessa Valente, 2010, Rev. bras. epidemiol., V13, P314, DOI 10.1590/S1415-790X2010000200013; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Harrel F.E., 2001, REGRESSION MODELING; Heeringa SG, 2010, APPL SURVEY DATA ANA, P91; Hemmingsson T, 1998, SOC SCI MED, V47, P1399, DOI 10.1016/S0277-9536(98)00258-5; Holmila M, 2005, ADDICTION, V100, P1763, DOI 10.1111/j.1360-0443.2005.01249.x; Hosseinpoor AR, 2012, BMC PUBLIC HEALTH, V12, DOI [10.1186/1471-2458-12-198, 10.1186/1471-2458-12-912]; IBGE, 2001, CENS DEM POP ANO 200; Johnson JG, 1999, J ABNORM PSYCHOL, V108, P490, DOI 10.1037/0021-843X.108.3.490; JonesWebb R, 1997, J STUD ALCOHOL, V58, P539, DOI 10.15288/jsa.1997.58.539; Karriker-Jaffe KJ, 2012, J STUD ALCOHOL DRUGS, V73, P865, DOI 10.15288/jsad.2012.73.865; Kerr-Correa F., 2005, Alcohol, gender and drinking problems: perspectives from low and middle income countries, P49; Kerr-Correa F, 2008, REV BRAS PSIQUIATR, V30, P235, DOI 10.1590/S1516-44462008000300010; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kim JH, 2008, ALCOHOL ALCOHOLISM, V43, P360, DOI 10.1093/alcalc/agm181; KISH L, 1970, J AM STAT ASSOC, V65, P1071, DOI 10.2307/2284276; Laranjeira R, 2010, REV BRAS PSIQUIATR, V32, P231, DOI 10.1590/S1516-44462009005000012; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lima Maria Cristina Pereira, 2013, Rev. bras. epidemiol., V16, P49, DOI 10.1590/S1415-790X2013000100005; Lima MC, 2007, CONTEMP DRUG PROBL, V34, P427; Luo Z, 2013, STAT MED; Mair C, 2013, J STUD ALCOHOL DRUGS, V74, P50, DOI 10.15288/jsad.2013.74.50; Malyutina S, 2004, ALCOHOL ALCOHOLISM, V39, P64, DOI 10.1093/alcalc/agh022; Marmot M, 1997, ADDICTION, V92, pS13, DOI 10.1111/j.1360-0443.1997.tb03391.x; Matheson FI, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.112441; Mendoza-Sassi RA, 2003, ADDICTION, V98, P799, DOI 10.1046/j.1360-0443.2003.00411.x; Mewton L, 2011, ADDICTION, V106, P941, DOI 10.1111/j.1360-0443.2010.03340.x; MIDANIK LT, 1994, AM J PUBLIC HEALTH, V84, P1218, DOI 10.2105/AJPH.84.8.1218; Moreira LB, 1996, J STUD ALCOHOL, V57, P253, DOI 10.15288/jsa.1996.57.253; Mulia N, 2012, ALCOHOL ALCOHOLISM, V47, P178, DOI 10.1093/alcalc/agr168; Neve RJM, 1996, ADDICTION, V91, P357, DOI 10.1111/j.1360-0443.1996.tb02286.x; Pollack CE, 2005, INT J EPIDEMIOL, V34, P772, DOI 10.1093/ije/dyi026; Primo Newton Luiz Numa Peixoto, 2004, Rev. psiquiatr. Rio Gd. Sul, V26, P280, DOI 10.1590/S0101-81082004000300005; Rehm J, 2005, REV PANAM SALUD PUBL, V18, P241, DOI 10.1590/S1020-49892005000900003; Rehm J, 2004, COMP QUANTIFICATION, P959; Rehm J, 2007, INT J METH PSYCH RES, V16, P66, DOI 10.1002/mpr.204; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Romley JA, 2007, J STUD ALCOHOL DRUGS, V68, P48, DOI 10.15288/jsad.2007.68.48; Room R, 2005, DRUG ALCOHOL REV, V24, P143, DOI 10.1080/09595230500102434; Sanchez ZM, 2013, J PEDIATR-US, V163, P363, DOI 10.1016/j.jpeds.2013.01.029; Shield KD, 2013, ADDICTION, V108, P912, DOI 10.1111/add.12112; Silveira CM, 2007, J STUD ALCOHOL DRUGS, V68, P18, DOI 10.15288/jsad.2007.68.18; Silveira CM, 2012, CLINICS, V67, P205, DOI 10.6061/clinics/2012(03)01; Silveira CM, 2011, ALCOHOL ALCOHOLISM, V46, P324, DOI 10.1093/alcalc/agr007; Stimpson JP, 2007, AM J HEALTH BEHAV, V31, P215, DOI 10.5993/AJHB.31.2.10; Toomey TL, 2012, ALCOHOL CLIN EXP RES, V36, P1468, DOI 10.1111/j.1530-0277.2012.01753.x; Tuithof M, 2012, DRUG ALCOHOL DEPEN, V123, P115, DOI 10.1016/j.drugalcdep.2011.10.030; United Nations, 2011, REPORT SECRETARY GEN; Viana MC, 2009, REV BRAS PSIQUIATR, V31, P375, DOI 10.1590/S1516-44462009000400016; Wilsnack SC, 2005, ADDICTION, V100, P1760, DOI 10.1111/j.1360-0443.2005.01251.x; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; Wolter K. M., 1985, INTRO VARIANCE ESTIM; World Health Organization, 2011, GLOB STAT REP ALC HL; World Health Organization, 2010, GLOB STRAT RED HARM; World Health Organization (WHO), 2005, ALC GEND DRINK PROBL	82	20	21	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108355	10.1371/journal.pone.0108355	http://dx.doi.org/10.1371/journal.pone.0108355			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZM	25272008	Green Published, gold			2022-12-27	WOS:000343729600041
J	Taube, R; Alhadeff, R; Assa, D; Krugliak, M; Arkin, IT				Taube, Robert; Alhadeff, Raphael; Assa, Dror; Krugliak, Miriam; Arkin, Isaiah T.			Bacteria-Based Analysis of HIV-1 Vpu Channel Activity	PLOS ONE			English	Article							INFLUENZA M2 CHANNEL; ION-CHANNEL; TRANSMEMBRANE DOMAIN; VIRUS; PROTEIN; RELEASE; CD4; MEMBRANE; IDENTIFICATION; SUBSTITUTION	HIV-1 Vpu is a small, single-span membrane protein with two attributed functions that increase the virus' pathogenicity: degradation of CD4 and inactivation of BST-2. Vpu has also been shown to posses ion channel activity, yet no correlation has been found between this attribute and Vpu's role in viral release. In order to gain further insight into the channel activity of Vpu we devised two bacteria-based assays that can examine this function in detail. In the first assay Vpu was over-expressed, such that it was deleterious to bacterial growth due to membrane permeabilization. In the second and more sensitive assay, the channel was expressed at low levels in K+ transport deficient bacteria. Consequently, Vpu expression enabled the bacteria to grow at otherwise non permissive low K+ concentrations. Hence, Vpu had the opposite impact on bacterial growth in the two assays: detrimental in the former and beneficial in the latter. Furthermore, we show that channel blockers also behave reciprocally in the two assays, promoting growth in the first assay and hindering it in the second assay. Taken together, we investigated Vpu's channel activity in a rapid and quantitative approach that is amenable to high-throughput screening, in search of novel blockers.	[Taube, Robert; Alhadeff, Raphael; Assa, Dror; Krugliak, Miriam; Arkin, Isaiah T.] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Taube, Robert] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany	Hebrew University of Jerusalem; Humboldt University of Berlin	Arkin, IT (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Edmund J Safra Campus, IL-91904 Jerusalem, Israel.	arkin@huji.ac.il	Arkin, Isaiah/GQA-4328-2022	Arkin, Isaiah/0000-0002-7659-1746	Israeli Science Foundation [175/13]; GIF [1086-13.11/2010]; Rudin Fellowship Trust	Israeli Science Foundation(Israel Science Foundation); GIF(German-Israeli Foundation for Scientific Research and Development); Rudin Fellowship Trust	Israeli Science Foundation: 175/13, GIF: 1086-13.11/2010, The Rudin Fellowship Trust, ITA is the Arthur Lejwa Professor of Structural Biochemistry at the Hebrew University of Jerusalem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhadeff R, 2014, BBA-BIOMEMBRANES, V1838, P1068, DOI 10.1016/j.bbamem.2013.07.033; Astrahan P, 2011, BBA-BIOMEMBRANES, V1808, P394, DOI 10.1016/j.bbamem.2010.08.021; Balannik V, 2010, PFLUG ARCH EUR J PHY, V459, P593, DOI 10.1007/s00424-009-0760-1; Bolduan S, 2011, VIROLOGY, V416, P75, DOI 10.1016/j.virol.2011.04.009; Bour S, 2001, J BIOL CHEM, V276, P15920, DOI 10.1074/jbc.M010533200; BOUR S, 1991, J VIROL, V65, P6387, DOI 10.1128/JVI.65.12.6387-6396.1991; BUONOCORE L, 1990, NATURE, V345, P625, DOI 10.1038/345625a0; Casella CR, 1999, J VIROL, V73, P92, DOI 10.1128/JVI.73.1.92-100.1999; CLOYD MW, 1990, VIROLOGY, V174, P103, DOI 10.1016/0042-6822(90)90059-Z; CRISE B, 1990, J VIROL, V64, P5585, DOI 10.1128/JVI.64.11.5585-5593.1990; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Ewart GD, 1996, J VIROL, V70, P7108, DOI 10.1128/JVI.70.10.7108-7115.1996; Ewart GD, 2002, EUR BIOPHYS J BIOPHY, V31, P26, DOI 10.1007/s002490100177; Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4; Herrero L, 2013, BIOCHEMISTRY-US, V52, P171, DOI 10.1021/bi3011175; Hout DR, 2006, VIROLOGY, V348, P449, DOI 10.1016/j.virol.2005.12.025; Hout DR, 2006, VIROLOGY, V344, P541, DOI 10.1016/j.virol.2005.08.022; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; Khoury G, 2010, ANTIMICROB AGENTS CH, V54, P835, DOI 10.1128/AAC.01308-09; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Kuhl BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027660; KURTZ S, 1995, ANTIMICROB AGENTS CH, V39, P2204, DOI 10.1128/AAC.39.10.2204; Leonov H, 2011, J AM CHEM SOC, V133, P9903, DOI 10.1021/ja202288m; Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820; MALDARELLI F, 1993, J VIROL, V67, P5056, DOI 10.1128/JVI.67.8.5056-5061.1993; Maniatis T., 1982, MOL CLONING; Mao LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054070; Marassi FM, 1999, P NATL ACAD SCI USA, V96, P14336, DOI 10.1073/pnas.96.25.14336; Mehnert T, 2008, PROTEINS, V70, P1488, DOI 10.1002/prot.21642; Mehnert T, 2007, J BIOMOL STRUCT DYN, V24, P589, DOI 10.1080/07391102.2007.10507148; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Schubert U, 1996, FEBS LETT, V398, P12, DOI 10.1016/S0014-5793(96)01146-5; Skasko M, 2011, VIROLOGY, V411, P65, DOI 10.1016/j.virol.2010.12.038; STREBEL K, 1988, SCIENCE, V241, P1221, DOI 10.1126/science.3261888; Stumpe S, 1997, ARCH MICROBIOL, V167, P126, DOI 10.1007/s002030050425; TERWILLIGER EF, 1989, P NATL ACAD SCI USA, V86, P5163, DOI 10.1073/pnas.86.13.5163; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Velicelebi G, 1999, Methods Enzymol, V294, P20; WILLEY RL, 1992, J VIROL, V66, P226, DOI 10.1128/JVI.66.1.226-234.1992; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992	44	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e105387	10.1371/journal.pone.0105387	http://dx.doi.org/10.1371/journal.pone.0105387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272035	gold, Green Published, Green Submitted			2022-12-27	WOS:000343729600002
J	Van Wassenbergh, S; Dries, B; Herrel, A				Van Wassenbergh, Sam; Dries, Billy; Herrel, Anthony			New Insights into Muscle Function during Pivot Feeding in Seahorses	PLOS ONE			English	Article							PREY CAPTURE KINEMATICS; ELASTIC ENERGY-STORAGE; SNOUT LENGTH; POWER OUTPUT; FAST SUCTION; PERFORMANCE; MECHANICS; TONGUE; STRIKE; FORCE	Seahorses, pipefish and their syngnathiform relatives are considered unique amongst fishes in using elastic recoil of post-cranial tendons to pivot the head extremely quickly towards small crustacean prey. It is known that pipefish activate the epaxial muscles for a considerable time before striking, at which rotations of the head and the hyoid are temporarily prevented to allow energy storage in the epaxial tendons. Here, we studied the motor control of this system in seahorses using electromyographic recordings of the epaxial muscles and the sternohyoideus-hypaxial muscles with simultaneous high-speed video recordings of prey capture. In addition we present the results from a stimulation experiment including the muscle hypothesised to be responsible for the locking and triggering of pivot feeding in seahorses (m. adductor arcus palatini). Our data confirmed that the epaxial pre-activation pattern observed previously for pipefish also occurs in seahorses. Similar to the epaxials, the sternohyoideus-hypaxial muscle complex shows prolonged anticipatory activity. Although a considerable variation in displacements of the mouth via head rotation could be observed, it could not be demonstrated that seahorses have control over strike distance. In addition, we could not identify the source of the kinematic variability in the activation patterns of the associated muscles. Finally, the stimulation experiment supported the previously hypothesized role of the m. adductor arcus palatini as the trigger in this elastic recoil system. Our results show that pre-stressing of both the head elevators and the hyoid retractors is taking place. As pre-activation of the main muscles involved in pivot feeding has now been demonstrated for both seahorses and pipefish, this is probably a generalized trait of Syngnathidae.	[Van Wassenbergh, Sam; Dries, Billy; Herrel, Anthony] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Van Wassenbergh, Sam; Herrel, Anthony] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; [Dries, Billy] Univ Ghent, Dept Vet Med Imaging & Small Anim Orthopaed, Merelbeke, Belgium; [Herrel, Anthony] Museum Natl Hist Nat, CNRS, Dept Ecol & Gest Biodivers, Paris, France	University of Antwerp; Ghent University; Ghent University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN)	Van Wassenbergh, S (corresponding author), Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium.	sam.vanwassenbergh@ugent.be	Herrel, Anthony/C-3712-2013	Herrel, Anthony/0000-0003-0991-4434; Van Wassenbergh, Sam/0000-0001-5746-4621	Fund for Scientific Research Flanders [G053907]	Fund for Scientific Research Flanders(FWO)	This work was supported by a grant from the Fund for Scientific Research Flanders (G053907; www.fwo.be) and a Fund for Scientific Research Flanders Postdoctoral Fellowship to SVW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS P, 1990, J ZOOL, V220, P653, DOI 10.1111/j.1469-7998.1990.tb04741.x; AERTS P, 1993, J EXP BIOL, V177, P129; Anderson CV, 2012, J EXP BIOL, V215, P4345, DOI 10.1242/jeb.078881; Askew GN, 2001, J EXP BIOL, V204, P3587; Astley HC, 2012, BIOL LETTERS, V8, P386, DOI 10.1098/rsbl.2011.0982; BIEWENER AA, 1995, J EXP BIOL, V198, P1829; Coughlin DJ, 2006, COMP BIOCHEM PHYS A, V145, P533, DOI 10.1016/j.cbpa.2006.08.026; Curtin NA, 2005, P ROY SOC B-BIOL SCI, V272, P581, DOI 10.1098/rspb.2004.2982; de Groot JH, 2004, P ROY SOC B-BIOL SCI, V271, P761, DOI 10.1098/rspb.2003.2637; de Lussanet MHE, 2007, J R SOC INTERFACE, V4, P561, DOI 10.1098/rsif.2006.0201; Deban SM, 2007, J EXP BIOL, V210, P655, DOI 10.1242/jeb.02664; Eaton R.C., 1984, P213; Flammang BE, 2009, ZOOLOGY, V112, P86, DOI 10.1016/j.zool.2008.04.003; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Herrel A, 2000, J EXP BIOL, V203, P3255; Higham TE, 2006, J EXP BIOL, V209, P2713, DOI 10.1242/jeb.02315; HYLANDER WL, 1989, ARCH ORAL BIOL, V34, P713, DOI 10.1016/0003-9969(89)90078-2; Konow N, 2008, INTEGR COMP BIOL, V48, P246, DOI 10.1093/icb/icn045; Lappin AK, 2006, J EXP BIOL, V209, P2535, DOI 10.1242/jeb.02276; Leysen H, 2011, J MORPHOL, V272, P1259, DOI 10.1002/jmor.10982; McHenry MJ, 2012, J EXP BIOL, V215, P1231, DOI 10.1242/jeb.061465; MULLER M, 1987, J THEOR BIOL, V126, P343, DOI 10.1016/S0022-5193(87)80241-2; Ottenhoff FAM, 1996, J ORAL REHABIL, V23, P270, DOI 10.1111/j.1365-2842.1996.tb00852.x; Patek SN, 2007, J EXP BIOL, V210, P3677, DOI 10.1242/jeb.006486; Poppinga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045735; Roos G, 2010, THESIS U ANTWERPEN; Roos G, 2009, J EXP BIOL, V212, P3490, DOI 10.1242/jeb.033050; Roos G, 2009, PHYSIOL BIOCHEM ZOOL, V82, P7, DOI 10.1086/589838; Singh AK, 2011, BIOL LETTERS, V7, P547, DOI 10.1098/rsbl.2011.0057; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Van Wassenbergh S, 2006, J EXP ZOOL PART A, V305A, P559, DOI 10.1002/jez.a.293; Van Wassenbergh S, 2008, J R SOC INTERFACE, V5, P285, DOI 10.1098/rsif.2007.1124; Van Wassenbergh S, 2007, J EXP BIOL, V210, P1183, DOI 10.1242/jeb.000109; Van Wassenbergh S, 2013, J EXP BIOL, V216, P407, DOI 10.1242/jeb.074658; Van Wassenbergh S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1168; Van Wassenbergh S, 2011, ZOOLOGY, V114, P46, DOI 10.1016/j.zool.2010.10.001; Van Wassenbergh S, 2009, BIOL LETTERS, V5, P200, DOI 10.1098/rsbl.2008.0765	37	17	17	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109068	10.1371/journal.pone.0109068	http://dx.doi.org/10.1371/journal.pone.0109068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271759	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600094
J	Beirne, C; Delahay, R; Hares, M; Young, A				Beirne, Christopher; Delahay, Richard; Hares, Michelle; Young, Andrew			Age-Related Declines and Disease-Associated Variation in Immune Cell Telomere Length in a Wild Mammal	PLOS ONE			English	Article							BADGERS MELES-MELES; INFECTION; DYNAMICS; SYSTEM; SELECTION; ECOLOGY; BIOLOGY; TESTS	Immunosenescence, the deterioration of immune system capability with age, may play a key role in mediating age-related declines in whole-organism performance, but the mechanisms that underpin immunosenescence are poorly understood. Biomedical research on humans and laboratory models has documented age and disease related declines in the telomere lengths of leukocytes ('immune cells'), stimulating interest their having a potentially general role in the emergence of immunosenescent phenotypes. However, it is unknown whether such observations generalise to the immune cell populations of wild vertebrates living under ecologically realistic conditions. Here we examine longitudinal changes in the mean telomere lengths of immune cells in wild European badgers (Meles meles). Our findings provide the first evidence of within-individual age-related declines in immune cell telomere lengths in a wild vertebrate. That the rate of age-related decline in telomere length appears to be steeper within individuals than at the overall population level raises the possibility that individuals with short immune cell telomeres and/or higher rates of immune cell telomere attrition may be selectively lost from this population. We also report evidence suggestive of associations between immune cell telomere length and bovine tuberculosis infection status, with individuals detected at the most advanced stage of infection tending to have shorter immune cell telomeres than disease positive individuals. While male European badgers are larger and show higher rates of annual mortality than females, we found no evidence of a sex difference in either mean telomere length or the average rate of within-individual telomere attrition with age. Our findings lend support to the view that age-related declines in the telomere lengths of immune cells may provide one potentially general mechanism underpinning age-related declines in immunocompetence in natural populations.	[Beirne, Christopher; Hares, Michelle; Young, Andrew] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Exeter, Cornwall, England; [Delahay, Richard] Anim Hlth & Vet Labs Agcy, Natl Wildlife Management Ctr, Nympsfield, Glos, England	University of Exeter	Young, A (corresponding author), Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn Campus, Exeter, Cornwall, England.	a.j.young@exeter.ac.uk	Delahay, Richard/J-2261-2014; Delahay, Richard/GSI-4663-2022; Beirne, Christopher/S-9430-2019	Beirne, Christopher/0000-0003-3988-2031	University of Exeter; Food and Environment Research Agency (FERA); BBSRC David Phillips fellowship; Biotechnology and Biological Sciences Research Council [BB/H022716/1] Funding Source: researchfish; BBSRC [BB/H022716/1] Funding Source: UKRI	University of Exeter; Food and Environment Research Agency (FERA); BBSRC David Phillips fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by the University of Exeter and the Food and Environment Research Agency (FERA). AY was supported by a BBSRC David Phillips fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter BP, 2012, HAEMATOL-HEMATOL J, V97, P353, DOI 10.3324/haematol.2011.055269; Angelier F, 2013, FUNCT ECOL, V27, P342, DOI 10.1111/1365-2435.12041; Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Aubert G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002696; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Baerlocher GM, 2003, J LEUKOCYTE BIOL, V73, P289, DOI 10.1189/jlb.0702361; Barrett ELB, 2013, MOL ECOL, V22, P249, DOI 10.1111/mec.12110; Barrett ELB, 2012, J AVIAN BIOL, V43, P571, DOI 10.1111/j.1600-048X.2012.05787.x; Barrett ELB, 2011, AGING CELL, V10, P913, DOI 10.1111/j.1474-9726.2011.00741.x; Barton K, 2014, PACKAGE MUMIN; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caprioli M, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0340; Chambers MA, 2002, VET MICROBIOL, V86, P183, DOI 10.1016/S0378-1135(02)00012-3; Chambers MA, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-42; Delahay RJ, 2013, EPIDEMIOL INFECT, V141, P1445, DOI 10.1017/S0950268813000721; Dugdale HL, 2011, MOL ECOL, V20, P3261, DOI 10.1111/j.1365-294X.2011.05167.x; Effros RB, 2011, EXP GERONTOL, V46, P135, DOI 10.1016/j.exger.2010.08.027; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Foote CG, 2013, MOL ECOL RESOUR, V13, P417, DOI 10.1111/1755-0998.12079; Fossel M, 2012, CURR GERIATR REP, V1, P121, DOI 10.1007/s13670-012-0013-6; Geiger S, 2012, MOL ECOL, V21, P1500, DOI 10.1111/j.1365-294X.2011.05331.x; Goronzy JJ, 2006, EXP GERONTOL, V41, P246, DOI 10.1016/j.exger.2005.12.002; Graham J, 2013, EPIDEMIOL INFECT, P1; Haussmann MF, 2003, P ROY SOC B-BIOL SCI, V270, P1387, DOI 10.1098/rspb.2003.2385; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Horn T, 2010, HEREDITY, V105, P497, DOI 10.1038/hdy.2010.113; Ilmonen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002143; Johnson DDP, 2001, J ZOOL, V255, P199, DOI 10.1017/S0952836901001273; Larbi A, 2008, PHYSIOLOGY, V23, P64, DOI 10.1152/physiol.00040.2007; Lin TT, 2014, BRIT J HAEMATOL, P1; Monaghan P, 2006, TRENDS ECOL EVOL, V21, P47, DOI 10.1016/j.tree.2005.11.007; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nettle D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083617; Nussey DH, 2014, METHODS ECOL EVOL, V5, P299, DOI 10.1111/2041-210X.12161; Nussey DH, 2012, AGING CELL, V11, P178, DOI 10.1111/j.1474-9726.2011.00771.x; Palacios MG, 2011, ECOLOGY, V92, P952, DOI 10.1890/10-0662.1; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Salomons HM, 2009, P ROY SOC B-BIOL SCI, V276, P3157, DOI 10.1098/rspb.2009.0517; Stier A, 2014, FUNCT ECOL, V28, P601, DOI 10.1111/1365-2435.12204; Tomlinson AJ, 2013, LIFE HIST CORRELATES; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; Vera E, 2012, CELL REP, V2, P732, DOI 10.1016/j.celrep.2012.08.023; Weng NP, 2012, CURR OPIN IMMUNOL, V24, P470, DOI 10.1016/j.coi.2012.05.001; Weng NP, 1997, P NATL ACAD SCI USA, V94, P10827, DOI 10.1073/pnas.94.20.10827; Yang CT, 1999, LIFE SCI, V64, P1383, DOI 10.1016/S0024-3205(99)00072-7	49	36	36	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108964	10.1371/journal.pone.0108964	http://dx.doi.org/10.1371/journal.pone.0108964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268841	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700205
J	Hashjin, AA; Kringos, DS; Manoochehri, J; Ravaghi, H; Klazinga, NS				Hashjin, Asgar Aghaei; Kringos, Dionne S.; Manoochehri, Jila; Ravaghi, Hamid; Klazinga, Niek S.			Implementation of Patient Safety and Patient-Centeredness Strategies in Iranian Hospitals	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; EPIDEMIOLOGY; CULTURE; CARE	Objective: To examine the extent of implementation for patient safety (PS) and patient-centeredness (PC) strategies and their association with hospital characteristics (type, ownership, teaching status, annual evaluation grade) in Iran. Methods: A cross-sectional study through an adapted version of the MARQuIS questionnaire, eliciting information from hospital and nursing managers in 84 Iranian hospitals on the implementation of PS and PC strategies in 2009-2010. Results: The majority of hospitals reported to have implemented 84% of the PS and 72% of the PC strategies. In general, implementation of PS strategies was unrelated to the type of hospital, with the exception of health promotion reports, which were more common in the Social Security Organization (SSO), and MRSA testing, which was reported more often in nonprofit hospitals. MRSA testing was also more common among teaching hospitals compared to non-teaching hospitals. The higher grade hospitals reported PS strategies significantly more frequently than lower grade hospitals. Overall, there was no significant difference in the reported implementation of PC strategies across general and specialized hospitals; except for the provision of information in different languages and recording of patient's diet which were reported significantly more often by general than specialized hospitals. Moreover, patient hotel services were more common in private compared to public hospitals. Conclusions: Despite substantial reporting of PS and PC strategies, there is still room for strengthening standard setting on safety, patient services and patient-centered information strategies in Iranian hospitals. To assure effective implementation of PS and PC strategies, enforcing standards, creating a PS and PC culture, increasing organizational responsiveness, and partnering with patients and their families need more attention.	[Hashjin, Asgar Aghaei; Kringos, Dionne S.; Klazinga, Niek S.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [Hashjin, Asgar Aghaei; Ravaghi, Hamid] Iran Univ Med Sci, Sch Hlth Serv Management & Informat Sci, Dept Hlth Serv Management, Tehran, Iran; [Manoochehri, Jila] Univ Tehran Med Sci, Tehran Heart Ctr Hosp, Dept Qual Improvement, Tehran, Iran	University of Amsterdam; Academic Medical Center Amsterdam; Iran University of Medical Sciences; Tehran University of Medical Sciences	Hashjin, AA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.aghaeihashjin@amc.uva.nl	Ravaghi, Hamid/AAA-3867-2022; Kringos, Dionne/ABE-2290-2020; Ravaghi, Hamid/GOH-0893-2022	Ravaghi, Hamid/0000-0003-2717-920X; Kringos, Dionne/0000-0003-2711-4713; 				Aghaei Hashjin A, 2014, IMPLEMENTATION OF HO; [Anonymous], 2006, ASSESSING OF THE EFF; Askari E, 2012, IRAN J BASIC MED SCI, V15, P1010; Australian Commission on Safety and Quality in Health Care (ACSQHC), 2010, DISCUSSION PAPER DRA; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Griese BR, 2011, PATIENT IDENTIFICATI; Groene O, 2009, BMJ JOURNAL OF QUALI, V18, pi44, DOI 10.1136; Groene O, 2014, INT J QUAL HEALTH C, V26, P81, DOI 10.1093/intqhc/mzu022; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Hashjin AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086014; Hrisos S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080759; Iranian Ministry of Health and Medical Education (MOHME), 2011, HOSPITAL ACCREDITATI; James JT, 2013, J PATIENT SAF, V9, P122, DOI 10.1097/PTS.0b013e3182948a69; Joolaee S, 2012, NURS ETHICS, V19, P45, DOI 10.1177/0969733011412100; Lombarts MJ, 2009, BMJ JOURNAL OF QUALI, V18; Longo DR, 2007, J HEALTHC MANAG, V52, P188, DOI 10.1097/00115514-200705000-00009; Pollack Andrew, 2010, NEW YORK TIMES; Sheikhtaheri A, 2013, ASIAN BIOMED, V7, P365, DOI 10.5372/1905-7415.0703.188; Verbeek-Van Noord I, 2014, INT J QUAL HEALTH C, V26, P64, DOI 10.1093/intqhc/mzt087; Wagner C, 2013, INT J QUAL HEALTH C, V25, P213, DOI 10.1093/intqhc/mzt024; WHO, 2013, PATIENT SAFETY; WHO, 2007, PATIENT SAFETY SOLUT, V1; Wong J, 2004, STRATEGIES FOR HOSPI; World Health Organization (WHO), 2013, 10 FACTS ON PATIENT; World Health Organization (WHO), 2013, PATIENT SAFETY FRIEN; World Health Organization (WHO), 2013, PATIENT SAFETY ASSES; Zahraei SM, 2012, ARCH IRAN MED, V15, P764, DOI 0121512/AIM.009; Zargarzadeh AH, 2013, J PHARM CARE, V1, P125	28	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108831	10.1371/journal.pone.0108831	http://dx.doi.org/10.1371/journal.pone.0108831			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268797	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700174
J	Hojman, P; Fjelbye, J; Zerahn, B; Christensen, JF; Dethlefsen, C; Lonkvist, CK; Brandt, C; Gissel, H; Pedersen, BK; Gehl, J				Hojman, Pernille; Fjelbye, Jonas; Zerahn, Bo; Christensen, Jesper F.; Dethlefsen, Christine; Lonkvist, Camilla K.; Brandt, Claus; Gissel, Hanne; Pedersen, Bente Klarlund; Gehl, Julie			Voluntary Exercise Prevents Cisplatin-Induced Muscle Wasting during Chemotherapy in Mice	PLOS ONE			English	Article							LUNG-CANCER PATIENTS; PHYSICAL-ACTIVITY; RESISTANCE EXERCISE; SKELETAL-MUSCLE; INTERVENTION; MODEL	Loss of muscle mass related to anti-cancer therapy is a major concern in cancer patients, being associated with important clinical endpoints including survival, treatment toxicity and patient-related outcomes. We investigated effects of voluntary exercise during cisplatin treatment on body weight, food intake as well as muscle mass, strength and signalling. Mice were treated weekly with 4 mg/kg cisplatin or saline for 6 weeks, and randomized to voluntary wheel running or not. Cisplatin treatment induced loss of body weight (29.8%, P<0.001), lean body mass (20.6%, P = 0.001), as well as anorexia, impaired muscle strength (22.5% decrease, P<0.001) and decreased glucose tolerance. In addition, cisplatin impaired Akt-signalling, induced genes related to protein degradation and inflammation, and reduced muscle glycogen content. Voluntary wheel running during treatment attenuated body weight loss by 50% (P<0.001), maintained lean body mass (P<0.001) and muscle strength (P<0.001), reversed anorexia and impairments in Akt and protein degradation signalling. Cisplatin-induced muscular inflammation was not prevented by voluntary wheel running, nor was glucose tolerance improved. Exercise training may preserve muscle mass in cancer patients receiving cisplatin treatment, potentially improving physical capacity, quality of life and overall survival.	[Hojman, Pernille; Fjelbye, Jonas; Dethlefsen, Christine; Brandt, Claus; Pedersen, Bente Klarlund] Univ Copenhagen, Rigshosp, Ctr Inflammat & Metab, DK-2100 Copenhagen, Denmark; [Hojman, Pernille; Fjelbye, Jonas; Dethlefsen, Christine; Brandt, Claus; Pedersen, Bente Klarlund] Univ Copenhagen, Rigshosp, Ctr Phys Activ Res, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Zerahn, Bo] Copenhagen Univ Hosp Herlev, Dept Clin Physiol & Nucl Med, Herlev, Denmark; [Christensen, Jesper F.] Copenhagen Univ Hosp, Univ Hosp Ctr Hlth Care Res UCSF, Copenhagen, Denmark; [Lonkvist, Camilla K.; Gehl, Julie] Copenhagen Univ Hosp Herlev, Dept Oncol, Herlev, Denmark; [Gissel, Hanne] Univ Aarhus, Inst Biomed, Aarhus C, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Aarhus University	Hojman, P (corresponding author), Univ Copenhagen, Rigshosp, Ctr Inflammat & Metab, DK-2100 Copenhagen, Denmark.	phojman@inflammation-metabolism.dk; Julie.Gehl@regionh.dk	Brandt, Claus/AAB-2695-2020; Pedersen, Bente Klarlund/AGR-3217-2022	Brandt, Claus/0000-0002-7871-7437; Pedersen, Bente Klarlund/0000-0001-6508-6288; Zerahn, Bo/0000-0002-3457-6249; Gehl, Julie/0000-0003-3829-0210	Danish National Research Foundation [DNRF55]; Trygfonden; Danish Council for Independent Research; Novo Nordic Foundation; Lundbeck Foundation; Fabrikant Einar Willumsens legat; Acta Oncologica Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond); Trygfonden; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordic Foundation(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Fabrikant Einar Willumsens legat; Acta Oncologica Foundation	CIM is supported by a grant from the Danish National Research Foundation (DNRF55). CFAS is supported by a grant from Trygfonden. This study was further supported by grants from the Danish Council for Independent Research and by grants from the Novo Nordic Foundation, Lundbeck Foundation, and Fabrikant Einar Willumsens legat. JG is a Royal Swedish Academy of Sciences Research Fellow supported by a grant from the Acta Oncologica Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard-Barbash R, 2012, JNCI-J NATL CANCER I, V104, P815, DOI 10.1093/jnci/djs207; Brown JC, 2012, COMPR PHYSIOL, V2, P2775, DOI 10.1002/cphy.c120005; Christensen JF, 2014, ANN ONCOL, V25, P947, DOI 10.1093/annonc/mdt551; Christensen JF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-326; Courneya KS, 2007, J CLIN ONCOL, V25, P4396, DOI 10.1200/JCO.2006.08.2024; Damrauer J.S., 2008, BASIC APPL MYOL, V18, P139, DOI [10.4081/ejtm.2018.7590, DOI 10.4081/EJTM.2018.7590, DOI 10.4081/ejtm.2018.7590]; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Fanzani A, 2011, TOXICOL APPL PHARM, V250, P312, DOI 10.1016/j.taap.2010.11.003; Feldman DR, 2008, JAMA-J AM MED ASSOC, V299, P672, DOI 10.1001/jama.299.6.672; Gissel H, 2010, AM J PHYSIOL-REG I, V298, pR918, DOI 10.1152/ajpregu.00692.2009; Green JA, 2001, LANCET, V358, P781, DOI 10.1016/S0140-6736(01)05965-7; dos Santos NAG, 2012, ARCH TOXICOL, V86, P1233, DOI 10.1007/s00204-012-0821-7; Hojman P, 2011, AM J PHYSIOL-ENDOC M, V301, pE504, DOI 10.1152/ajpendo.00520.2010; Jones LW, 2012, J APPL PHYSIOL, V113, P263, DOI 10.1152/japplphysiol.01575.2011; Jones LW, 2010, J APPL PHYSIOL, V108, P343, DOI 10.1152/japplphysiol.00424.2009; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Pedersen BK, 2013, COMPR PHYSIOL, V3, P1337, DOI 10.1002/cphy.c120033; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Plomgaard P, 2008, J CLIN ENDOCR METAB, V93, P543, DOI 10.1210/jc.2007-1761; Quist M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-477; Quist M, 2012, LUNG CANCER, V75, P203, DOI 10.1016/j.lungcan.2011.07.006; Reveiz L, 2012, COCHRANE DB SYST REV, V6, pCD007464; Samuel SR, 2013, INDIAN J MED RES, V137, P515; Scatchard K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006469.pub2; Segal RJ, 2003, J CLIN ONCOL, V21, P1653, DOI 10.1200/JCO.2003.09.534; Smuder AJ, 2011, J APPL PHYSIOL, V110, P935, DOI 10.1152/japplphysiol.00677.2010; van Putten M., 2011, USE HANGING WIRE TES	28	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e109030	10.1371/journal.pone.0109030	http://dx.doi.org/10.1371/journal.pone.0109030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268807	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700214
J	Malhotra, AK; Goldberg, SR; Mclay, L; Martin, NR; Wolfe, LG; Levy, MM; Khiatani, V; Borchers, TC; Duane, TM; Aboutanos, MB; Ivatury, RR				Malhotra, Ajai K.; Goldberg, Stephanie R.; McLay, Laura; Martin, Nancy R.; Wolfe, Luke G.; Levy, Mark M.; Khiatani, Vishal; Borchers, Todd C.; Duane, Therese M.; Aboutanos, Michel B.; Ivatury, Rao R.			DVT Surveillance Program in the ICU: Analysis of Cost-Effectiveness	PLOS ONE			English	Article							DEEP VENOUS THROMBOSIS; VEIN THROMBOSIS; PULMONARY-EMBOLISM; TRAUMA PATIENTS; INTENSIVE-CARE; SCREENING PROTOCOL; THROMBOEMBOLISM; PROPHYLAXIS; PREVENTION; HEPARIN	Background: Venous Thrombo-embolism (VTE - Deep venous thrombosis (DVT) and/or pulmonary embolism (PE) - in traumatized patients causes significant morbidity and mortality. The current study evaluates the effectiveness of DVT surveillance in reducing PE, and performs a cost-effectiveness analysis. Methods: All traumatized patients admitted to the adult ICU underwent twice weekly DVT surveillance by bilateral lower extremity venous Duplex examination (48-month surveillance period - SP). The rates of DVT and PE were recorded and compared to the rates observed in the 36-month pre-surveillance period (PSP). All patients in both periods received mechanical and pharmacologic prophylaxis unless contraindicated. Total costs - diagnostic, therapeutic and surveillance for both periods were recorded and the incremental cost for each Quality Adjusted Life Year (QALY) gained was calculated. Results: 4234 patients were eligible (PSP - 1422 and SP - 2812). Rate of DVT in SP (2.8%) was significantly higher than in PSP (1.3%) - p<0.05, and rate of PE in SP (0.7%) was significantly lower than that in PSP (1.5%) - p<0.05. Logistic regression demonstrated that surveillance was an independent predictor of increased DVT detection (OR: 2.53 - CI: 1.462-4.378) and decreased PE incidence (OR: 0.487 - CI: 0.262-0.904). The incremental cost was $509,091/life saved in the base case, translating to $29,102/QALY gained. A sensitivity analysis over four of the parameters used in the model indicated that the incremental cost ranged from $18,661 to $48,821/QALY gained. Conclusions: Surveillance of traumatized ICU patients increases DVT detection and reduces PE incidence. Costs in terms of QALY gained compares favorably with other interventions accepted by society.	[Malhotra, Ajai K.; Goldberg, Stephanie R.; Martin, Nancy R.; Wolfe, Luke G.; Levy, Mark M.; Khiatani, Vishal; Borchers, Todd C.; Duane, Therese M.; Aboutanos, Michel B.; Ivatury, Rao R.] Virginia Commonwealth Univ, Dept Surg, Richmond, VA 23298 USA; [McLay, Laura] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University	Malhotra, AK (corresponding author), Virginia Commonwealth Univ, Dept Surg, Richmond, VA 23298 USA.	akmalhot@vcu.edu	Ivatury, Rao R./H-2922-2019	Albert, Laura/0000-0001-7079-4473				Adams RC, 2008, J TRAUMA, V65, P300, DOI 10.1097/TA.0b013e31817cf744; Angus DC, 2003, CRIT CARE MED, V31, P1, DOI 10.1097/00003246-200301000-00001; Arias E, 2011, NATL VITAL STAT REPO, V59; BOYLE MH, 1983, NEW ENGL J MED, V308, P1330, DOI 10.1056/NEJM198306023082206; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; BURNS GA, 1993, J TRAUMA, V35, P405, DOI 10.1097/00005373-199309000-00012; Cipolle MD, 2002, J TRAUMA, V52, P453, DOI 10.1097/00005373-200203000-00007; DENNIS JW, 1993, J TRAUMA, V35, P132, DOI 10.1097/00005373-199307000-00021; Dhankhar P, 2008, VACCINE, V26, P4251, DOI 10.1016/j.vaccine.2008.05.048; Doyle NM, 2004, AM J OBSTET GYNECOL, V191, P1019, DOI 10.1016/j.ajog.2004.06.048; GAGE BF, 1995, JAMA-J AM MED ASSOC, V274, P1839, DOI 10.1001/jama.274.23.1839; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Gould MK, 1999, ANN INTERN MED, V130, P789, DOI 10.7326/0003-4819-130-10-199905180-00002; Graham JD, 1997, JAMA-J AM MED ASSOC, V278, P1418, DOI 10.1001/jama.278.17.1418; Grigorakos L, 2008, HEPATO-GASTROENTEROL, V55, P887; Kahane CJ, 2004, 809835 DOT HS; KALISH SC, 1995, J GEN INTERN MED, V10, P321, DOI 10.1007/BF02599951; KNUDSON MM, 1994, J TRAUMA, V37, P480, DOI 10.1097/00005373-199409000-00025; KNUDSON MM, 1992, J TRAUMA, V32, P2, DOI 10.1097/00005373-199201000-00002; KUDSK KA, 1989, AM J SURG, V158, P515, DOI 10.1016/0002-9610(89)90182-7; Lee KH, 1996, CRIT CARE MED, V24, P2046, DOI 10.1097/00003246-199612000-00019; Major KM, 2003, AM SURGEON, V69, P857; Merli G, 2003, J TRAUMA, V54, P1116, DOI 10.1097/01.TA.0000066385.10596.71; MEYER CS, 1995, ANN VASC SURG, V9, P109, DOI 10.1007/BF02015324; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P1, DOI 10.1016/S0003-9993(96)90210-5; MOSER KM, 1981, ANN INTERN MED, V94, P439, DOI 10.7326/0003-4819-94-4-439; NAPOLITANO LM, 1995, J TRAUMA, V39, P651, DOI 10.1097/00005373-199510000-00006; Owens DK, 1997, ANN INTERN MED, V126, P1, DOI 10.7326/0003-4819-126-1-199701010-00001; Perlroth DJ, 2007, ARCH INTERN MED, V167, P74, DOI 10.1001/archinte.167.1.74; Piotrowski JJ, 1996, AM J SURG, V172, P210, DOI 10.1016/S0002-9610(96)00154-7; RAMSEY SD, 1995, CHEST, V108, P1594, DOI 10.1378/chest.108.6.1594; Raskob GE, 2010, AM J PREV MED, V38, pS502, DOI 10.1016/j.amepre.2010.01.010; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Satiani B, 1997, ANN VASC SURG, V11, P626, DOI 10.1007/s100169900101; Schwarcz TH, 2001, J VASC SURG, V34, P447, DOI 10.1067/mva.2001.117146; SHACKFORD SR, 1990, AM J SURG, V159, P365, DOI 10.1016/S0002-9610(05)81272-3; Sharma OP, 2007, AM SURGEON, V73, P1173; Spain DA, 1997, J TRAUMA, V42, P463, DOI 10.1097/00005373-199703000-00014; Stinett AA, 1996, COST EFFECTIVENESS H, P349; WEINSTEIN MC, 1982, CIRCULATION, V66, P56	42	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e106793	10.1371/journal.pone.0106793	http://dx.doi.org/10.1371/journal.pone.0106793			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25269021	gold, Green Submitted, Green Published			2022-12-27	WOS:000343671700017
J	Yu, H; Soler, M; Mila, I; Clemente, HS; Savelli, B; Dunand, C; Paiva, JAP; Myburg, AA; Bouzayen, M; Grima-Pettenati, J; Cassan-Wang, H				Yu, Hong; Soler, Marcal; Mila, Isabelle; Clemente, Helene San; Savelli, Bruno; Dunand, Christophe; Paiva, Jorge A. P.; Myburg, Alexander A.; Bouzayen, Mondher; Grima-Pettenati, Jacqueline; Cassan-Wang, Hua			Genome-Wide Characterization and Expression Profiling of the AUXIN RESPONSE FACTOR (ARF) Gene Family in Eucalyptus grandis	PLOS ONE			English	Article							TENSION WOOD; FUNCTIONAL-ANALYSIS; CAMBIAL MERISTEM; ARABIDOPSIS; IDENTIFICATION; TRANSCRIPTION; AUX/IAA; REPRESSION; DIVERGENCE; MODULATION	Auxin is a central hormone involved in a wide range of developmental processes including the specification of vascular stem cells. Auxin Response Factors (ARF) are important actors of the auxin signalling pathway, regulating the transcription of auxin-responsive genes through direct binding to their promoters. The recent availability of the Eucalyptus grandis genome sequence allowed us to examine the characteristics and evolutionary history of this gene family in a woody plant of high economic importance. With 17 members, the E. grandis ARF gene family is slightly contracted, as compared to those of most angiosperms studied hitherto, lacking traces of duplication events. In silico analysis of alternative transcripts and gene truncation suggested that these two mechanisms were preeminent in shaping the functional diversity of the ARF family in Eucalyptus. Comparative phylogenetic analyses with genomes of other taxonomic lineages revealed the presence of a new ARF clade found preferentially in woody and/or perennial plants. High-throughput expression profiling among different organs and tissues and in response to environmental cues highlighted genes expressed in vascular cambium and/or developing xylem, responding dynamically to various environmental stimuli. Finally, this study allowed identification of three ARF candidates potentially involved in the auxin-regulated transcriptional program underlying wood formation.	[Yu, Hong; Soler, Marcal; Clemente, Helene San; Savelli, Bruno; Dunand, Christophe; Grima-Pettenati, Jacqueline; Cassan-Wang, Hua] Univ Toulouse 3, UMR5546, CNRS, LRSV Lab Rech Sci Vegetales, Castanet Tolosan, France; [Mila, Isabelle; Bouzayen, Mondher] Univ Toulouse, Inst Natl Polytech, Ecole Natl Super Agron Toulouse, Lab Genom & Biotechnol Fruits, Castanet Tolosan, France; [Paiva, Jorge A. P.] Inst Invest Cientif & Trop IICT MCTES, Lisbon, Portugal; [Paiva, Jorge A. P.] Inst Biol Expt & Tecnol, Oeiras, Portugal; [Myburg, Alexander A.] Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst, Genom Res Inst, ZA-0002 Pretoria, South Africa	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; University of Pretoria	Grima-Pettenati, J (corresponding author), Univ Toulouse 3, UMR5546, CNRS, LRSV Lab Rech Sci Vegetales, Castanet Tolosan, France.	yu@lrsv.ups-tlse.fr	Bouzayen, Mondher/AFQ-0802-2022; Soler, Marçal/G-3522-2016; Paiva, Jorge A P/C-2858-2008; Wang, Hua Cassan/AAF-5966-2021; Myburg, Alexander A/C-5426-2008; Dunand, Christophe/I-6424-2012	Soler, Marçal/0000-0002-9138-9394; Paiva, Jorge A P/0000-0003-3162-4396; Wang, Hua Cassan/0000-0002-7395-9285; Myburg, Alexander A/0000-0003-0644-5003; Dunand, Christophe/0000-0003-1637-4042; Isabelle, Mila/0000-0002-8878-0018	Centre National pour la Recherche Scientifique (CNRS); University Paul Sabatier Toulouse III (UPS); French Laboratory of Excellence project "TULIP'' [ANR-10-LABX-41, ANR-11-IDEX-0002-02]; Plant KBBE TreeForJoules project [ANR-2010-KBBE-007-01, PKBBE/AGR_GPL/0001/2010]; China Scholarship council; Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya; Programa Ciencia; POPH (QREN)	Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Paul Sabatier Toulouse III (UPS); French Laboratory of Excellence project "TULIP''; Plant KBBE TreeForJoules project; China Scholarship council(China Scholarship Council); Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya; Programa Ciencia(Spanish Government); POPH (QREN)	This work was supported by the Centre National pour la Recherche Scientifique (CNRS), the University Paul Sabatier Toulouse III (UPS), the French Laboratory of Excellence project "TULIP'' (ANR-10-LABX-41; ANR-11-IDEX-0002-02) and the Plant KBBE TreeForJoules project (ANR-2010-KBBE-007-01 (FR) and PKBBE/AGR_GPL/0001/2010 (FCT, PT)). HY was supported by PhD grants from the China Scholarship council. MS was supported by a Postdoc fellowship "Beatriu de Pinos'' thanks to the Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya. JAPP acknowledges Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) and his research contract funded by Programa Ciencia 2008 and POPH (QREN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson-Gunneras S, 2006, PLANT J, V45, P144, DOI 10.1111/j.1365-313X.2005.02584.x; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Audran-Delalande C, 2012, PLANT CELL PHYSIOL, V53, P659, DOI 10.1093/pcp/pcs022; Baba K, 2011, P NATL ACAD SCI USA, V108, P3418, DOI 10.1073/pnas.1011506108; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cassan-Wang H, 2012, PLANT CELL PHYSIOL, V53, P2101, DOI 10.1093/pcp/pcs152; Ha CV, 2013, DNA RES, V20, P511, DOI 10.1093/dnares/dst027; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Finet C, 2013, MOL BIOL EVOL, V30, P45, DOI 10.1093/molbev/mss220; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Gutierrez L, 2012, PLANT CELL, V24, P2515, DOI 10.1105/tpc.112.099119; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Jin H, 2011, PLANTA, V234, P959, DOI 10.1007/s00425-011-1449-1; Kalluri UC, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-59; Kumar R, 2011, MOL GENET GENOMICS, V285, P245, DOI 10.1007/s00438-011-0602-7; Liu N, 2014, J EXP BOT, V65, P2507, DOI 10.1093/jxb/eru141; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Love J, 2009, P NATL ACAD SCI USA, V106, P5984, DOI 10.1073/pnas.0811660106; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Miyashima S, 2013, EMBO J, V32, P178, DOI 10.1038/emboj.2012.301; Mun JH, 2012, MOL GENET GENOMICS, V287, P765, DOI 10.1007/s00438-012-0718-4; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Nilsson J, 2008, PLANT CELL, V20, P843, DOI 10.1105/tpc.107.055798; Okushima Y, 2005, PLANT J, V43, P29, DOI 10.1111/j.1365-313X.2005.02426.x; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Paponov IA, 2008, MOL PLANT, V1, P321, DOI 10.1093/mp/ssm021; Paux E, 2005, NEW PHYTOL, V167, P89, DOI 10.1111/j.1469-8137.2005.01396.x; Pekker I, 2005, PLANT CELL, V17, P2899, DOI 10.1105/tpc.105.034876; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilate G, 2004, NEW PHYTOL, V164, P63, DOI 10.1111/j.1469-8137.2004.01176.x; Pitre FE, 2007, J AGR FOOD CHEM, V55, P10306, DOI 10.1021/jf071611e; Pitre FE, 2010, TREE PHYSIOL, V30, P1273, DOI 10.1093/treephys/tpq073; Pufky John, 2003, Functional & Integrative Genomics, V3, P135, DOI 10.1007/s10142-003-0093-7; Remington DL, 2004, PLANT PHYSIOL, V135, P1738, DOI 10.1104/pp.104.039669; Sessions A, 1997, DEVELOPMENT, V124, P4481; Shen CJ, 2010, J EXP BOT, V61, P3971, DOI 10.1093/jxb/erq208; Sorce C, 2013, PLANT CELL REP, V32, P885, DOI 10.1007/s00299-013-1431-4; Sundberg B, 2000, EXPTL BIOL REV, P169; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; TIMELL TE, 1969, SVEN PAPPERSTIDN, V72, P173; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Tuominen H, 1997, PLANT PHYSIOL, V115, P577, DOI 10.1104/pp.115.2.577; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Uggla C, 1996, P NATL ACAD SCI USA, V93, P9282, DOI 10.1073/pnas.93.17.9282; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wan SB, 2014, PLANT CELL REP, V33, P1365, DOI 10.1007/s00299-014-1622-7; Wang DK, 2007, GENE, V394, P13, DOI 10.1016/j.gene.2007.01.006; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Williams L, 2005, P NATL ACAD SCI USA, V102, P9703, DOI 10.1073/pnas.0504029102; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Wu J, 2011, PLANT CELL REP, V30, P2059, DOI 10.1007/s00299-011-1113-z; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xing HY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-178; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zouine M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084203	65	31	36	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108906	10.1371/journal.pone.0108906	http://dx.doi.org/10.1371/journal.pone.0108906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25269088	Green Submitted, gold, Green Published			2022-12-27	WOS:000343671700187
J	Wang, Q; Liu, L; Li, H; McCullough, LE; Qi, YN; Li, JY; Zhang, J; Miller, E; Yang, CX; Smith, JS				Wang, Qiong; Liu, Li; Li, Hui; McCullough, Lauren E.; Qi, Ya-na; Li, Jia-yuan; Zhang, Jing; Miller, Erline; Yang, Chun-xia; Smith, Jennifer S.			Genetic and Dietary Determinants of Insulin-Like Growth Factor (IGF)-1 and IGF Binding Protein (BP)-3 Levels among Chinese Women	PLOS ONE			English	Article							BREAST-CANCER RISK; EPITHELIAL OVARIAN-CANCER; FACTOR-I; CIRCULATING LEVELS; COLORECTAL-CANCER; PREMENOPAUSAL WOMEN; SIGNALING PATHWAY; SOY ISOFLAVONES; POLYMORPHISMS; IGFBP-3	Background: Higher insulin-like growth factor (IGF)-1 and lower IGF binding protein (BP)-3 levels have been associated with higher commoncancer risk, including breast cancer. Dietary factors, genetic polymorphisms, and the combination of both may influence circulating IGF-1 and IGFBP-3 serum concentrations. Methods: From September 2011 to July 2012, we collected demographic, reproductive and dietary data on 143 women (>= 40 years). We genotyped IGF-1 rs1520220 and IGFBP-3 rs2854744 and measured circulating IGF-1 and IGFBP-3 levels in serum. Covariance analyses were used to estimate the associations of serum levels of IGF-1 and IGFBP-3, and the molar ratio of IGF-1to IGFBP-3 with IGF-1 rs1520220 and IGFBP-3 rs2854744 genotypes. We subsequently assessed the combined influence of genetics and diet (daily intake of protein, fat and soy isoflavones) on IGF-1 and IGFBP-3 levels. Results: Among women aged less than 50 years, circulating IGF-1 serum levels were significantly lower for those with CC genotype for IGF-1 rs1520220 than levels for those with the GC or GG genotypes (in recessive model: P = 0.007). In gene-diet analyses among these women, we found carrying CC genotype for IGF-1 rs1520220 and high soy isoflavone intake tend to be associated with lower circulating IGF-1 levels synthetically (P = 0.002). Women with GG or GC genotypes for IGF-1 rs1520220 and with low intake of soy isoflavones had the highest levels of circulating IGF-1 (geometric mean [95% CI]: 195 [37, 1021] mu g/L). Comparatively, women with both the CC genotype and high soy intake had the lowest levels of circulating IGF-1 (geometric mean [95% CI]: 120 [38,378] mu g/L). Conclusions: IGF-1 serum levels are significantly lower among women with the CC genotype for IGF-1-rs1520220. High soy isoflavone intake may interact with carrying CC genotype for IGF-1-rs1520220 to lower women's serum IGF-1 levels more.	[Wang, Qiong; Li, Hui; Qi, Ya-na; Li, Jia-yuan; Yang, Chun-xia] Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol & Biostat, Chengdu 610064, Peoples R China; [Liu, Li; Zhang, Jing] Chengdu Womens & Childrens Cent Hosp, Comprehens Guidance Ctr Womens Hlth, Chengdu, Peoples R China; [McCullough, Lauren E.; Li, Jia-yuan; Miller, Erline; Smith, Jennifer S.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Smith, Jennifer S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wang, Qiong] Sun Yat Sen Univ, Dept Hlth Serv Management, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China	Sichuan University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Sun Yat Sen University	Li, JY (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol & Biostat, Chengdu 610064, Peoples R China.	lijiayuan@scu.edu.cn	li, jia/GVT-7587-2022		Ministry of Education Fundamental Research Foundation for Central Universities, P.R. China [2010SCU21001]	Ministry of Education Fundamental Research Foundation for Central Universities, P.R. China	This work was funded by the Ministry of Education Fundamental Research Foundation for Central Universities, P.R. China (grant no. 2010SCU21001). The URL of funder's website is http://st.scu.edu.cn/index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zahrani A, 2006, HUM MOL GENET, V15, P1, DOI 10.1093/hmg/ddi398; Allen NE, 2002, CANCER EPIDEM BIOMAR, V11, P1441; Bao PP, 2012, NUTR CANCER, V64, P806, DOI 10.1080/01635581.2012.707277; Canzian F, 2006, BRIT J CANCER, V94, P299, DOI 10.1038/sj.bjc.6602936; Cao H, 2013, MOL MED REP, V7, P1361, DOI 10.3892/mmr.2013.1339; Chen C, 2006, CANCER EPIDEM BIOMAR, V15, P2461, DOI 10.1158/1055-9965.EPI-06-0541; Chen WF, 2004, J CLIN ENDOCR METAB, V89, P2351, DOI 10.1210/jc.2003-032065; Deal C, 2001, J CLIN ENDOCR METAB, V86, P1274, DOI 10.1210/jc.86.3.1274; DiGiovanni J, 2000, P NATL ACAD SCI USA, V97, P3455, DOI 10.1073/pnas.97.7.3455; Dong JY, 2011, BREAST CANCER RES TR, V125, P315, DOI 10.1007/s10549-010-1270-8; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Fletcher O, 2005, CANCER EPIDEM BIOMAR, V14, P2; Gann PH, 2005, INT J CANCER, V116, P297, DOI 10.1002/ijc.21042; Giovannucci E, 2000, CANCER EPIDEM BIOMAR, V9, P345; Giovannucci E, 2003, CANCER EPIDEM BIOMAR, V12, P84; Gu F, 2010, CANCER EPIDEM BIOMAR, V19, P77; Harrela M, 1996, J CLIN INVEST, V98, P2612, DOI 10.1172/JCI119081; Heald AH, 2003, PUBLIC HEALTH NUTR, V6, P175, DOI 10.1079/PHN2002414; Holmes MD, 2002, CANCER EPIDEM BIOMAR, V11, P852; Hong YL, 1996, J CLIN ENDOCR METAB, V81, P1791, DOI 10.1210/jc.81.5.1791; Jernstrom H, 2001, CANCER EPIDEM BIOMAR, V10, P377; Jiang B, 2014, WORLD J GASTROENTERO, V20, P1608, DOI 10.3748/wjg.v20.i6.1608; Jiang Bo, 2009, Zhonghua Wei Chang Wai Ke Za Zhi, V12, P264; Kaaks R, 2002, CANCER CAUSE CONTROL, V13, P307, DOI 10.1023/A:1015270324325; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Khandwala HM, 2000, ENDOCR REV, V21, P215, DOI 10.1210/er.21.3.215; Krajcik RA, 2002, CANCER EPIDEM BIOMAR, V11, P1566; Lagiou P, 2009, BRIT J CANCER, V100, P1794, DOI 10.1038/sj.bjc.6605074; Lau MT, 2012, CANCER LETT, V326, P191, DOI 10.1016/j.canlet.2012.08.016; Lu LG, 2013, CARCINOGENESIS, V34, P2024, DOI 10.1093/carcin/bgt168; Lu LG, 2012, CARCINOGENESIS, V33, P2119, DOI 10.1093/carcin/bgs243; Malin A, 2005, CANCER EPIDEM BIOMAR, V14, P1496, DOI 10.1158/1055-9965.EPI-04-0880; Patel AV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002578; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Price AJ, 2012, CANCER EPIDEM BIOMAR, V21, P1531, DOI 10.1158/1055-9965.EPI-12-0481-T; Qian BY, 2011, BREAST CANCER RES TR, V130, P217, DOI 10.1007/s10549-011-1552-9; Ren ZF, 2004, CANCER EPIDEM BIOMAR, V13, P1290; Renehan AG, 2006, ENDOCR-RELAT CANCER, V13, P273, DOI 10.1677/erc.1.01219; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Rinaldi S, 2006, ENDOCR-RELAT CANCER, V13, P593, DOI 10.1677/erc.1.01150; Roddam AW, 2008, ANN INTERN MED, V149, P461, DOI 10.7326/0003-4819-149-7-200810070-00006; Sax AT, 2014, CANCER EPIDEMIOL, V38, P455, DOI 10.1016/j.canep.2014.05.011; Stattin P, 2004, J CLIN ONCOL, V22, P3104, DOI 10.1200/JCO.2004.10.105; Tas F, 2014, TUMOR BIOL, V35, P3125, DOI 10.1007/s13277-013-1405-8; Vrieling A, 2004, CANCER CAUSE CONTROL, V15, P787, DOI 10.1023/B:CACO.0000043429.51915.c6; Wang Q, 2011, DNA CELL BIOL, V30, P585, DOI 10.1089/dna.2010.1195; Wang Qiong, 2010, Chin J Cancer, V29, P683; Wangen KE, 2000, J CLIN ENDOCR METAB, V85, P3043, DOI 10.1210/jc.85.9.3043; Wu YP, 2003, CANCER RES, V63, P4384; Yu H, 2002, CANCER EPIDEM BIOMAR, V11, P705; Zhu ZJ, 2003, CARCINOGENESIS, V24, P1225, DOI 10.1093/carcin/bgg077	51	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108934	10.1371/journal.pone.0108934	http://dx.doi.org/10.1371/journal.pone.0108934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285521	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700039
J	Brown-Schmidt, S; Horton, WS				Brown-Schmidt, Sarah; Horton, William S.			The Influence of Partner-Specific Memory Associations on Picture Naming: A Failure to Replicate Horton (2007)	PLOS ONE			English	Article							CONTEXT-DEPENDENT MEMORY; ENVIRONMENTAL CONTEXT; LANGUAGE PRODUCTION; AUDIENCE DESIGN; EXPERIENCE; PRECEDENTS; RETRIEVAL; COMMUNICATION; RECOGNITION; AMNESIA	The results of two experiments by Horton (2007) show that speakers name a pictured object faster when in the presence of another person with whom the speaker has previously associated that object name. The first of those two experiments (Horton, 2007, Experiment 1) is the focus of the present research. This paper presents the results of three experiments designed to replicate and extend Horton's (2007) Experiment 1. The original findings were not replicated. These findings do not support the hypothesis that partner-specific memory associations facilitate object naming.	[Brown-Schmidt, Sarah] Univ Illinois, Dept Psychol, Champaign, IL 61820 USA; [Brown-Schmidt, Sarah] Univ Illinois, Beckman Inst Adv Sci & Technol, Champaign, IL USA; [Horton, William S.] Northwestern Univ, Dept Psychol, Evanston, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University	Brown-Schmidt, S (corresponding author), Univ Illinois, Dept Psychol, Champaign, IL 61820 USA.	sarahbrownschmidt@gmail.com	Horton, William S./H-4906-2019		National Science Foundation [12-57029]; Division Of Behavioral and Cognitive Sci [1257029] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This material is based upon work supported by the National Science Foundation under Grant No. 12-57029 to S. Brown-Schmidt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard E. G., 2004, APPROACHES STUDYING, P173; Barr DJ, 2014, J EXP PSYCHOL GEN, V143, P404, DOI 10.1037/a0031813; Barr DJ, 2002, J MEM LANG, V46, P391, DOI 10.1006/jmla.2001.2815; BJORK RA, 1989, CURRENT ISSUES IN COGNITIVE PROCESSES, P313; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brennan SE, 2009, TOP COGN SCI, V1, P274, DOI 10.1111/j.1756-8765.2009.01019.x; Brown-Schmidt S, 2012, LANG COGNITIVE PROC, V27, P62, DOI 10.1080/01690965.2010.543363; Brown-Schmidt S, 2009, J MEM LANG, V61, P171, DOI 10.1016/j.jml.2009.04.003; Clark H.H., 1978, THEORETICAL ISSUES N, P57, DOI DOI 10.3115/980262.980272; Clark H.H., 1992, ARENAS LANGUAGE USE; Clark H.H., 1996, USING LANGUAGE; Clark HerbertH., 1981, ELEMENTS DISCOURSE U, P10; Creel SC, 2008, COGNITION, V106, P633, DOI 10.1016/j.cognition.2007.03.013; Duff MC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00069; Eich E, 1985, J EXP PSYCHOL LEARN, V8, P157; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; FERNANDEZ A, 1985, MEM COGNITION, V13, P333, DOI 10.3758/BF03202501; Galati A, 2010, J MEM LANG, V62, P35, DOI 10.1016/j.jml.2009.09.002; Gerrig RJ, 1998, DISCOURSE PROCESS, V26, P67, DOI 10.1080/01638539809545039; Gerrig RJ, 2001, PSYCHOL SCI, V12, P81, DOI 10.1111/1467-9280.00314; GILLUND G, 1984, PSYCHOL REV, V91, P1, DOI 10.1037/0033-295X.91.1.1; GODDEN D, 1980, BRIT J PSYCHOL, V71, P99, DOI 10.1111/j.2044-8295.1980.tb02735.x; GODDEN DR, 1975, BRIT J PSYCHOL, V66, P325, DOI 10.1111/j.2044-8295.1975.tb01468.x; Gorman KS, 2013, J EXP PSYCHOL LEARN, V39, P843, DOI 10.1037/a0029467; Heller D., 2012, CIT U NEW YORK C HUM; Horton WS, 2007, LANG COGNITIVE PROC, V22, P1114, DOI 10.1080/01690960701402933; Horton WS, 2007, PSYCHOL AGING, V22, P281, DOI 10.1037/0882-7974.22.2.281; Horton WS, 2012, MEM COGNITION, V40, P113, DOI 10.3758/s13421-011-0135-7; Horton WS, 2005, COGNITION, V96, P127, DOI 10.1016/j.cognition.2004.07.001; Horton WS, 2005, DISCOURSE PROCESS, V40, P1, DOI 10.1207/s15326950dp4001_1; Horton WS, 2002, J MEM LANG, V47, P589, DOI 10.1016/S0749-596X(02)00019-0; JACOBY LL, 1982, CAN J PSYCHOL, V36, P300, DOI 10.1037/h0080638; JACOBY LL, 1981, J EXP PSYCHOL GEN, V110, P306, DOI 10.1037/0096-3445.110.3.306; JACOBY LL, 1983, J EXP PSYCHOL LEARN, V9, P21, DOI 10.1037/0278-7393.9.1.21; Knutsen D, 2012, J MEM LANG, V67, P326, DOI 10.1016/j.jml.2012.06.001; Kronmuller E, 2007, J MEM LANG, V56, P436, DOI 10.1016/j.jml.2006.05.002; Kurczek J, 2013, J EXP PSYCHOL GEN, V142, P1346, DOI 10.1037/a0034026; Matthews D, 2010, DEV PSYCHOL, V46, P749, DOI 10.1037/a0019657; Myers JL, 1998, DISCOURSE PROCESS, V26, P131, DOI 10.1080/01638539809545042; Parker A, 1999, EUR J COGN PSYCHOL, V11, P555, DOI 10.1080/095414499382291; Parker A, 2007, MEMORY, V15, P423, DOI 10.1080/09658210701309834; RATCLIFF R, 1988, PSYCHOL REV, V95, P385, DOI 10.1037/0033-295X.95.3.385; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Rubin RD, 2011, PSYCHOL SCI, V22, P1574, DOI 10.1177/0956797611418245; Shintel H, 2007, J EXP PSYCHOL LEARN, V33, P357, DOI 10.1037/0278-7393.33.2.357; Smith SM, 2001, PSYCHON B REV, V8, P203, DOI 10.3758/BF03196157; SMITH SM, 1979, J EXP PSYCHOL-HUM L, V5, P460, DOI 10.1037/0278-7393.5.5.460; Trude AM, 2014, CORTEX, V54, P117, DOI 10.1016/j.cortex.2014.01.015; Van Overschelde JP, 2004, J MEM LANG, V50, P289, DOI 10.1016/j.jml.2003.10.003; Weenink D., 2003, PRAAT DOING PHONETIC	50	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109035	10.1371/journal.pone.0109035	http://dx.doi.org/10.1371/journal.pone.0109035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3DZ	25279672	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800051
J	Chen, H; Chen, CC; Acosta, C; Wu, SY; Sun, T; Konofagou, EE				Chen, Hong; Chen, Cherry C.; Acosta, Camilo; Wu, Shih-Ying; Sun, Tao; Konofagou, Elisa E.			A New Brain Drug Delivery Strategy: Focused Ultrasound-Enhanced Intranasal Drug Delivery	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BARRIER DISRUPTION; IN-VIVO; MICROBUBBLES; MICE; ACTIVATION; MECHANISMS; DEPENDENCE; PRESSURE; DISEASE	Central nervous system (CNS) diseases are difficult to treat because of the blood-brain barrier (BBB), which prevents most drugs from entering into the brain. Intranasal (IN) administration is a promising approach for drug delivery to the brain, bypassing the BBB; however, its application has been restricted to particularly potent substances and it does not offer localized delivery to specific brain sites. Focused ultrasound (FUS) in combination with microbubbles can deliver drugs to the brain at targeted locations. The present study proposed to combine these two different platform techniques (FUS+IN) for enhancing the delivery efficiency of intranasally administered drugs at a targeted location. After IN administration of 40 kDa fluorescently-labeled dextran as the model drug, FUS targeted at one region within the caudate putamen of mouse brains was applied in the presence of systemically administered microbubbles. To compare with the conventional FUS technique, in which intravenous (IV) drug injection is employed, FUS was also applied after IV injection of the same amount of dextran in another group of mice. Dextran delivery outcomes were evaluated using fluorescence imaging of brain slices. The results showed that FUS+IN enhanced drug delivery within the targeted region compared with that achieved by IN only. Despite the fact that the IN route has limited drug absorption across the nasal mucosa, the delivery efficiency of FUS+IN was not significantly different from that of FUS+IV. As a new drug delivery platform, the FUS+IN technique is potentially useful for treating CNS diseases.	[Chen, Hong; Chen, Cherry C.; Acosta, Camilo; Wu, Shih-Ying; Sun, Tao; Konofagou, Elisa E.] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Konofagou, Elisa E.] Columbia Univ, Dept Radiol, New York, NY USA	Columbia University; Columbia University	Konofagou, EE (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.	ek2191@columbia.edu	Sun, Tao/S-1310-2019; Chen, Hong/J-2863-2014	Sun, Tao/0000-0002-3853-971X; Chen, Hong/0000-0002-9271-4697; Chen, Hong/0000-0003-1904-0857	National Institutes of Health [RO1 EB009041, RO1 AG038961]; Kinetics Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038961] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kinetics Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health grants RO1 EB009041 and RO1 AG038961 and the Kinetics Foundation. The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baseri B, 2012, PHYS MED BIOL, V57, pN65, DOI 10.1088/0031-9155/57/7/N65; Baseri B, 2010, ULTRASOUND MED BIOL, V36, P1445, DOI 10.1016/j.ultrasmedbio.2010.06.005; Burgess A, 2013, ACS CHEM NEUROSCI, V8588, P1; Burgess A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027877; Chapman CD, 2013, PHARM RES-DORDR, V30, P2475, DOI 10.1007/s11095-012-0915-1; Chen CC, 2013, J CONTROL RELEASE, V172, P795, DOI 10.1016/j.jconrel.2013.09.025; Chen H, 2014, J CEREBR BLOOD F MET, V34, P1197, DOI 10.1038/jcbfm.2014.71; Chen H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.034301; Choi JJ, 2007, PHYS MED BIOL, V52, P5509, DOI 10.1088/0031-9155/52/18/004; Choi JJ, 2010, IEEE T BIO-MED ENG, V57, P145, DOI 10.1109/TBME.2009.2034533; Costantino HR, 2007, INT J PHARMACEUT, V337, P1, DOI 10.1016/j.ijpharm.2007.03.025; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Ferrara K, 2007, ANNU REV BIOMED ENG, V9, P415, DOI 10.1146/annurev.bioeng.8.061505.095852; Freiherr J, 2013, CNS DRUGS, V27, P505, DOI 10.1007/s40263-013-0076-8; Gabathuler R, 2010, NEUROBIOL DIS, V37, P48, DOI 10.1016/j.nbd.2009.07.028; Hadaczek P, 2006, MOL THER, V14, P69, DOI 10.1016/j.ymthe.2006.02.018; Hanson LR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S5; Huang Q, 2012, EXP NEUROL, V233, P350, DOI 10.1016/j.expneurol.2011.10.027; Illum L, 2004, J PHARM PHARMACOL, V56, P3, DOI 10.1211/0022357022539; Jordao JF, 2013, EXP NEUROL, V248, P16, DOI 10.1016/j.expneurol.2013.05.008; Konofagou EE, 2012, CURR PHARM BIOTECHNO, V13, P1332; Lai CY, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00204; Lochhead JJ, 2012, ADV DRUG DELIVER REV, V64, P614, DOI 10.1016/j.addr.2011.11.002; Marquet F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084310; McDannold N, 2005, ULTRASOUND MED BIOL, V31, P1527, DOI 10.1016/j.ultrasmedbio.2005.07.010; McDannold N, 2012, CANCER RES, V72, P3652, DOI 10.1158/0008-5472.CAN-12-0128; Mitragotri S, 2005, NAT REV DRUG DISCOV, V4, P255, DOI 10.1038/nrd1662; Pardridge William M, 2005, NeuroRx, V2, P3; Pires A, 2009, J PHARM PHARM SCI, V12, P288, DOI 10.18433/J3NC79; QUON CY, 1988, J CARDIOTHORAC AN S1, V2, P13; Samiotaki G, 2013, IEEE T ULTRASON FERR, V60, P2257, DOI 10.1109/TUFFC.2013.6644731; Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010; Treat LH, 2012, ULTRASOUND MED BIOL, V38, P1716, DOI 10.1016/j.ultrasmedbio.2012.04.015; Tung YS, 2011, J ACOUST SOC AM, V130, P3059, DOI 10.1121/1.3646905; Tung YS, 2010, PHYS MED BIOL, V55, P6141, DOI 10.1088/0031-9155/55/20/007; Workman P, 2001, CURR CANCER DRUG TAR, V1, P33, DOI 10.2174/1568009013334269; Wu SY, 2014, IEEE T ULTRASON FERR, V61, P966, DOI 10.1109/TUFFC.2014.2992	38	37	38	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108880	10.1371/journal.pone.0108880	http://dx.doi.org/10.1371/journal.pone.0108880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279463	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800033
J	Eckhard, LH; Sol, A; Abtew, E; Shai, Y; Domb, AJ; Bachrach, G; Beyth, N				Eckhard, Lea H.; Sol, Asaf; Abtew, Ester; Shai, Yechiel; Domb, Abraham J.; Bachrach, Gilad; Beyth, Nurit			Biohybrid Polymer-Antimicrobial Peptide Medium against Enterococcus faecalis	PLOS ONE			English	Article							ACID) BIODEGRADABLE CARRIER; RICINOLEIC ACID; IN-VIVO; ANTIBACTERIAL; PACLITAXEL; DEFENSINS; BACTERIA; EFFICACY	Antimicrobial peptides (AMPs) are conserved evolutionary components of the innate immune system that are being tested as alternatives to antibiotics. Slow release of AMPs using biodegradable polymers can be advantageous in maintaining high peptide levels for topical treatment, especially in the oral environment in which dosage retention is challenged by drug dilution with saliva flow and by drug inactivation by salivary enzymatic activity. Enterococcus faecalis is a multidrug resistant nosocomial pathogen and a persistent pathogen in root canal infections. In this study, four ultra-short lipopeptides (C16-KGGK, C16-KLLK, C16-KAAK and C16-KKK) and an amphipathic a-helical antimicrobial peptide (Amp-1D) were tested against E. faecalis. The antibacterial effect was determined against planktonic bacteria and bacteria grown in biofilm. Of the five tested AMPs, C16-KGGK was the most effective. Next C16-KGGK was formulated with one of two polymers poly (lactic acid co castor oil) (DLLA) or ricinoleic acid-based poly (ester-anhydride) P(SA-RA). Peptide-synthetic polymer conjugates, also referred to as biohybrid mediums were tested for antibacterial activity against E. faecalis grown in suspension and in biofilms. The new formulations exhibited strong and improved anti- E. faecalis activity.	[Eckhard, Lea H.; Beyth, Nurit] Hebrew Univ Jerusalem, Fac Med Dent, Dept Prosthodont, Jerusalem, Israel; [Sol, Asaf; Bachrach, Gilad] Hebrew Univ Jerusalem, Fac Med Dent, Inst Dent Sci, Jerusalem, Israel; [Abtew, Ester; Domb, Abraham J.] Hebrew Univ Jerusalem, Fac Med, Sch Pharmacol, Inst Drug Res, Jerusalem, Israel; [Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Weizmann Institute of Science	Beyth, N (corresponding author), Hebrew Univ Jerusalem, Fac Med Dent, Dept Prosthodont, Jerusalem, Israel.	nuritb@ekmd.huji.ac.il		Domb, Abraham J./0000-0002-2241-7726; Bachrach, Gilad/0000-0003-1350-2280; Sol, Asaf/0000-0002-8731-2490	Legacy Heritage Clinical Research Initiative of the Israel Science Foundation [1764/11]	Legacy Heritage Clinical Research Initiative of the Israel Science Foundation	This research was supported by The Legacy Heritage Clinical Research Initiative of the Israel Science Foundation (grant No. 1764/11) (NB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tahami Khaled, 2007, Recent Pat Drug Deliv Formul, V1, P65, DOI 10.2174/187221107779814113; Beyth N, 2010, P NATL ACAD SCI USA, V107, P22038, DOI 10.1073/pnas.1010341107; Blondelle SE, 1996, ANTIMICROB AGENTS CH, V40, P1067, DOI 10.1128/AAC.40.5.1067; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Devine DA, 1999, MICROBIOL-UK, V145, P965, DOI 10.1099/13500872-145-4-965; Jain JP, 2008, POLYM REV, V48, P156, DOI 10.1080/15583720701834232; Joly S, 2004, J CLIN MICROBIOL, V42, P1024, DOI 10.1128/JCM.42.3.1024-1029.2004; Krasko MY, 2003, J POLYM SCI POL CHEM, V41, P1059, DOI 10.1002/pola.10651; Krishna OD, 2010, BIOPOLYMERS, V94, P32, DOI 10.1002/bip.21333; Lee JK, 2013, INT ENDOD J, V46, P406, DOI 10.1111/iej.12002; Lee JK, 2013, J ENDODONT, V39, P1625, DOI 10.1016/j.joen.2013.07.035; Lee SH, 2012, J ENDODONT, V38, P351, DOI 10.1016/j.joen.2011.12.026; Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Papo N, 2002, J BIOL CHEM, V277, P33913, DOI 10.1074/jbc.M204928200; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005; Shelton CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002360; Shikanov A, 2006, BIOMACROMOLECULES, V7, P288, DOI 10.1021/bm050648+; Shikanov A, 2005, J CONTROL RELEASE, V105, P52, DOI 10.1016/j.jconrel.2005.02.018; Shikanov A, 2004, J BIOMED MATER RES A, V69A, P47, DOI 10.1002/jbm.a.20101; Slager J, 2009, PHARM RES-DORD, V26, P1838, DOI 10.1007/s11095-009-9893-3; SOREN L, 1995, J ANTIMICROB CHEMOTH, V35, P669, DOI 10.1093/jac/35.5.669; Stuart CH, 2006, J ENDODONT, V32, P93, DOI 10.1016/j.joen.2005.10.049; SWENSON JM, 1995, J CLIN MICROBIOL, V33, P3019, DOI 10.1128/JCM.33.11.3019-3021.1995; Vaisman B, 2010, J BIOMED MATER RES A, V92A, P419, DOI 10.1002/jbm.a.32342	27	20	21	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109413	10.1371/journal.pone.0109413	http://dx.doi.org/10.1371/journal.pone.0109413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279943	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800079
J	Fu, C; Ao, J; Dettmann, A; Seiler, S; Free, SJ				Fu, Ci; Ao, Jie; Dettmann, Anne; Seiler, Stephan; Free, Stephen J.			Characterization of the Neurospora crassa Cell Fusion Proteins, HAM-6, HAM-7, HAM-8, HAM-9, HAM-10, AMPH-1 and WHI-2	PLOS ONE			English	Article							CONIDIAL ANASTOMOSIS TUBES; HYPHAL FUSION; KINASE PATHWAY; FILAMENTOUS GROWTH; SEXUAL DEVELOPMENT; DOMAIN; YEAST; BEHAVIOR; COMPLEX; ORGANIZATION	Intercellular communication of vegetative cells and their subsequent cell fusion is vital for different aspects of growth, fitness, and differentiation of filamentous fungi. Cell fusion between germinating spores is important for early colony establishment, while hyphal fusion in the mature colony facilitates the movement of resources and organelles throughout an established colony. Approximately 50 proteins have been shown to be important for somatic cell-cell communication and fusion in the model filamentous fungus Neurospora crassa. Genetic, biochemical, and microscopic techniques were used to characterize the functions of seven previously poorly characterized cell fusion proteins. HAM-6, HAM-7 and HAM-8 share functional characteristics and are proposed to function in the same signaling network. Our data suggest that these proteins may form a sensor complex at the cell wall/plasma membrane for the MAK-1 cell wall integrity mitogen-activated protein kinase (MAPK) pathway. We also demonstrate that HAM-9, HAM-10, AMPH-1 and WHI-2 have more general functions and are required for normal growth and development. The activation status of the MAK-1 and MAK-2 MAPK pathways are altered in mutants lacking these proteins. We propose that these proteins may function to coordinate the activities of the two MAPK modules with other signaling pathways during cell fusion.	[Fu, Ci; Ao, Jie; Free, Stephen J.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Dettmann, Anne; Seiler, Stephan] Univ Freiburg, Inst Biol 2, D-79106 Freiburg, Germany; [Seiler, Stephan] Univ Freiburg, Freiburg Inst Adv Studies FRIAS, D-79106 Freiburg, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Freiburg; University of Freiburg	Free, SJ (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	free@buffalo.edu			National Institutes of Health [R01GM078589, 3R01GM078589-04S1]; Deutsche Forschungsgemeinschaft [SE1054/4-2, SE1054/6-1]; UB Foundation; UB Graduate Student Association Mark Dimond Research Fund [SU-12-08]; National Science Foundation [DBI0923133];  [PO1 GM068087]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078589, P01GM068087] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); UB Foundation; UB Graduate Student Association Mark Dimond Research Fund; National Science Foundation(National Science Foundation (NSF)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this study was provided by grants R01GM078589 and 3R01GM078589-04S1 from National Institutes of Health to SF, by grants SE1054/4-2 and SE1054/6-1 from the Deutsche Forschungsgemeinschaft to SS, funds from UB Foundation, and grant SU-12-08 from UB Graduate Student Association Mark Dimond Research Fund to CF. Funding for the confocal microscope was by grant DBI0923133 from National Science Foundation to SUNY University at Buffalo. Funding for the creation of the single gene deletion library was provided by the grant PO1 GM068087. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldabbous MS, 2010, MICROBIOL-SGM, V156, P2621, DOI 10.1099/mic.0.040147-0; Berepiki A, 2010, EUKARYOT CELL, V9, P547, DOI 10.1128/EC.00253-09; Bloemendal S, 2012, MOL MICROBIOL, V84, P310, DOI 10.1111/j.1365-2958.2012.08024.x; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Bowman BJ, 2009, EUKARYOT CELL, V8, P1845, DOI 10.1128/EC.00174-09; Cano-Dominguez N, 2008, EUKARYOT CELL, V7, P1352, DOI 10.1128/EC.00137-08; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Dettmann A, 2013, MOL MICROBIOL, V90, P796, DOI 10.1111/mmi.12399; Dettmann A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002950; Fleissner A, 2005, EUKARYOT CELL, V4, P920, DOI 10.1128/EC.4.5.920-930.2005; Fleissner A, 2009, P NATL ACAD SCI USA, V106, P19393, DOI 10.1073/pnas.0907039106; Fleissner Andre, 2008, V475, P21, DOI 10.1007/978-1-59745-250-2_2; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Freitag M, 2005, FUNGAL GENET NEWSLET, V52, P14; Fu C, 2011, EUKARYOT CELL, V10, P1100, DOI 10.1128/EC.05003-11; Glass NL, 2004, TRENDS MICROBIOL, V12, P135, DOI 10.1016/j.tim.2004.01.007; Glass NL, 2000, ANNU REV GENET, V34, P165, DOI 10.1146/annurev.genet.34.1.165; Goryachev AB, 2012, BIOESSAYS, V34, P259, DOI 10.1002/bies.201100135; Greenwald CJ, 2010, GENETICS, V186, P1217, DOI 10.1534/genetics.110.121780; Grimshaw SJ, 2004, J BIOL CHEM, V279, P2192, DOI 10.1074/jbc.M305605200; Hickey PC, 2005, METHOD MICROBIOL, V34, P63, DOI 10.1016/S0580-8517(04)3403-1; Hickey PC, 2002, FUNGAL GENET BIOL, V37, P109, DOI 10.1016/S1087-1845(02)00035-X; Honda S, 2009, GENETICS, V182, P11, DOI 10.1534/genetics.108.098707; Kaida D, 2002, GENES CELLS, V7, P543, DOI 10.1046/j.1365-2443.2002.00538.x; Kawabata T, 2007, FUNGAL GENET NEWSL, V54, P5, DOI [10.4148/1941-4765.1096, DOI 10.4148/1941-4765.1096]; Khatun R, 2011, FUNGAL GENET BIOL, V48, P465, DOI 10.1016/j.fgb.2010.11.002; Kothe GO, 1998, GENETICS, V149, P117; Leadsham JE, 2009, J CELL SCI, V122, P706, DOI 10.1242/jcs.042424; Leeder AC, 2013, GENETICS, V195, P883, DOI 10.1534/genetics.113.156984; Li D, 2005, GENETICS, V170, P1091, DOI 10.1534/genetics.104.036772; Lichius A, 2010, DISTINGUISH CONIDIAL, P1; Lichius A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042565; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Maddi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042374; Mahs A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051454; Maerz S, 2008, GENETICS, V179, P1313, DOI 10.1534/genetics.108.089425; Maerz S, 2009, MOL MICROBIOL, V74, P707, DOI 10.1111/j.1365-2958.2009.06896.x; Maniatis T., 1982, MOL CLONING; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; MCNALLY MT, 1988, CURR GENET, V14, P545, DOI 10.1007/BF00434079; Mendl N, 2011, J CELL SCI, V124, P1339, DOI 10.1242/jcs.076406; Palma-Guerrero J, 2013, 27 FUNG GEN C AS CA; Pandey A, 2004, EUKARYOT CELL, V3, P348, DOI 10.1128/EC.3.2.348-358.2004; Park G, 2008, EUKARYOT CELL, V7, P2113, DOI 10.1128/EC.00466-07; Radcliffe PA, 1997, MICROBIOL-UK, V143, P1867, DOI 10.1099/00221287-143-6-1867; Read Nick D., 2012, Fungal Biology Reviews, V26, P1, DOI 10.1016/j.fbr.2012.02.003; Read ND, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P260; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Richard F, 2012, BIOL LETTERS, V8, P419, DOI 10.1098/rsbl.2011.1141; Richthammer C, 2012, MOL MICROBIOL, V85, P716, DOI 10.1111/j.1365-2958.2012.08133.x; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Roca MG, 2010, EUKARYOT CELL, V9, P1171, DOI 10.1128/EC.00329-09; Roca MG, 2005, FEMS MICROBIOL LETT, V249, P191, DOI 10.1016/j.femsle.2005.06.048; Roca MG, 2005, EUKARYOT CELL, V4, P911, DOI 10.1128/EC.4.5.911-919.2005; Roca MG, 2010, ANAL QUANTIFY CONIDI; Saito H, 2010, CURR OPIN MICROBIOL, V13, P677, DOI 10.1016/j.mib.2010.09.001; Schurg T, 2012, MOL MICROBIOL, V86, P349, DOI 10.1111/j.1365-2958.2012.08197.x; Seiler S, 2000, NAT CELL BIOL, V2, P333, DOI 10.1038/35014022; Simonin A, 2012, EUKARYOT CELL, V11, P1345, DOI 10.1128/EC.00213-12; Simonin AR, 2010, FUNGAL GENET BIOL, V47, P855, DOI 10.1016/j.fgb.2010.06.010; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tinsley JH, 1996, MOL BIOL CELL, V7, P731, DOI 10.1091/mbc.7.5.731; Vogt N, 2008, MOL BIOL CELL, V19, P4554, DOI 10.1091/mbc.E07-12-1266; Xiang QJ, 2002, GENETICS, V160, P169; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181	67	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e107773	10.1371/journal.pone.0107773	http://dx.doi.org/10.1371/journal.pone.0107773			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279949	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800007
J	Jongen, JLM; Smits, H; Pederzani, T; Bechakra, M; Hossaini, M; Koekkoek, SK; Huygen, FJPM; De Zeeuw, CI; Holstege, JC; Joosten, EAJ				Jongen, Joost L. M.; Smits, Helwin; Pederzani, Tiziana; Bechakra, Malik; Hossaini, Mehdi; Koekkoek, Sebastiaan K.; Huygen, Frank J. P. M.; De Zeeuw, Chris I.; Holstege, Jan C.; Joosten, Elbert A. J.			Spinal Autofluorescent Flavoprotein Imaging in a Rat Model of Nerve Injury-Induced Pain and the Effect of Spinal Cord Stimulation	PLOS ONE			English	Article							REFLEX SYMPATHETIC DYSTROPHY; CORTEX IN-VIVO; NEUROPATHIC PAIN; DORSAL-HORN; C-FOS; CENTRAL SENSITIZATION; NOCICEPTIVE ACTIVITY; CORTICAL ACTIVITY; INDUCED ANALGESIA; PLASTICITY	Nerve injury may cause neuropathic pain, which involves hyperexcitability of spinal dorsal horn neurons. The mechanisms of action of spinal cord stimulation (SCS), an established treatment for intractable neuropathic pain, are only partially understood. We used Autofluorescent Flavoprotein Imaging (AFI) to study changes in spinal dorsal horn metabolic activity. In the Seltzer model of nerve-injury induced pain, hypersensitivity was confirmed using the von Frey and hotplate test. 14 Days after nerve-injury, rats were anesthetized, a bipolar electrode was placed around the affected sciatic nerve and the spinal cord was exposed by a laminectomy at T13. AFI recordings were obtained in neuropathic rats and a control group of naive rats following 10 seconds of electrical stimulation of the sciatic nerve at C-fiber strength, or following non-noxious palpation. Neuropathic rats were then treated with 30 minutes of SCS or sham stimulation and AFI recordings were obtained for up to 60 minutes after cessation of SCS/sham. Although AFI responses to noxious electrical stimulation were similar in neuropathic and naive rats, only neuropathic rats demonstrated an AFI-response to palpation. Secondly, an immediate, short-lasting, but strong reduction in AFI intensity and area of excitation occurred following SCS, but not following sham stimulation. Our data confirm that AFI can be used to directly visualize changes in spinal metabolic activity following nerve injury and they imply that SCS acts through rapid modulation of nociceptive processing at the spinal level.	[Jongen, Joost L. M.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Smits, Helwin; Joosten, Elbert A. J.] UMC, Pain Management & Res Ctr, Maastricht, Netherlands; [Pederzani, Tiziana; Bechakra, Malik; Hossaini, Mehdi; Koekkoek, Sebastiaan K.; De Zeeuw, Chris I.; Holstege, Jan C.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Huygen, Frank J. P. M.] Erasmus MC, Dept Pain Med, Rotterdam, Netherlands; [De Zeeuw, Chris I.] Royal Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Maastricht University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Jongen, JLM (corresponding author), Erasmus MC, Dept Neurol, Rotterdam, Netherlands.	j.jongen@erasmusmc.nl			Pain Knowledge Center Rotterdam/Dutch Ministry of Health; TREND consortium; BSIK program from the Dutch government; Dutch Organization for Medical Sciences; Life Sciences; Senter (Neuro-Basic); Prinses Beatrix Fonds; European Union	Pain Knowledge Center Rotterdam/Dutch Ministry of Health; TREND consortium; BSIK program from the Dutch government; Dutch Organization for Medical Sciences; Life Sciences(European Commission); Senter (Neuro-Basic); Prinses Beatrix Fonds; European Union(European Commission)	The development of this manuscript was supported by research grants from the Pain Knowledge Center Rotterdam/Dutch Ministry of Health (JJ), the TREND consortium (HS), the BSIK program from the Dutch government (HS), the Dutch Organization for Medical Sciences (CDZ), Life Sciences (CDZ), Senter (Neuro-Basic; CDZ), the Prinses Beatrix Fonds (CDZ), and the European Union (CDZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barchini J, 2012, NEUROSCIENCE, V215, P196, DOI 10.1016/j.neuroscience.2012.04.057; Barnes JA, 2011, J NEUROSCI, V31, P12778, DOI 10.1523/JNEUROSCI.2579-11.2011; Bennett DLH, 1998, EUR J NEUROSCI, V10, P1282, DOI 10.1046/j.1460-9568.1998.00139.x; Catheline G, 1999, PAIN, V80, P347, DOI 10.1016/S0304-3959(98)00234-6; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Craig AD, 2004, J NEUROPHYSIOL, V92, P2604, DOI 10.1152/jn.00385.2004; Cruccu G, 2007, EUR J NEUROL, V14, P952, DOI 10.1111/j.1468-1331.2007.01916.x; Cui JG, 1997, PAIN, V73, P87, DOI 10.1016/S0304-3959(97)00077-8; de Vos CC, 2009, J DIABETES COMPLICAT, V23, P40, DOI 10.1016/j.jdiacomp.2007.08.002; Doth AH, 2010, PAIN, V149, P338, DOI 10.1016/j.pain.2010.02.034; Geurts JW, 2013, NEUROMODULATION, V16, P523, DOI 10.1111/ner.12024; Guan Y, 2010, ANESTHESIOLOGY, V113, P1392, DOI 10.1097/ALN.0b013e3181fcd95c; Hossaini M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035293; Hossaini M, 2010, PAIN, V151, P356, DOI 10.1016/j.pain.2010.07.023; Husson TR, 2007, J NEUROSCI, V27, P8665, DOI 10.1523/JNEUROSCI.2156-07.2007; Janssen SP, 2012, NEUROCHEM INT, V60, P21, DOI 10.1016/j.neuint.2011.11.006; Jongen JLM, 2012, NEUROSCIENTIST, V18, P8, DOI 10.1177/1073858410391813; Jongen JLM, 2010, J NEUROSCI, V30, P4081, DOI 10.1523/JNEUROSCI.0011-10.2010; Kemler MA, 2000, NEW ENGL J MED, V343, P618, DOI 10.1056/NEJM200008313430904; Kemler MA, 2006, NEW ENGL J MED, V354, P2394, DOI 10.1056/NEJMc055504; Komagata S, 2011, J NEUROSCI, V31, P4896, DOI 10.1523/JNEUROSCI.6753-10.2011; Kubota Y, 2008, NEUROSCI RES, V60, P422, DOI 10.1016/j.neures.2007.12.013; LaCroix-Fralish ML, 2005, SPINE, V30, P1821, DOI 10.1097/01.brs.0000174122.63291.38; Latremoliere A, 2010, J PAIN, V11, P801, DOI 10.1016/j.jpain.2010.06.006; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Maeda Y, 2009, BRAIN RES, V1259, P40, DOI 10.1016/j.brainres.2008.12.060; Moayedi M, 2013, J NEUROPHYSIOL, V109, P5, DOI 10.1152/jn.00457.2012; Mogil JS, 1999, P NATL ACAD SCI USA, V96, P7744, DOI 10.1073/pnas.96.14.7744; Murakami H, 2004, EUR J NEUROSCI, V19, P1352, DOI 10.1111/j.1460-9568.2004.03237.x; Oaklander AL, 2006, PAIN, V120, P235, DOI 10.1016/j.pain.2005.09.036; OCHOA JL, 1993, ANN NEUROL, V33, P465, DOI 10.1002/ana.410330509; Pluijms WA, 2012, BRIT J ANAESTH, V109, P623, DOI 10.1093/bja/aes251; Reinert KC, 2004, J NEUROPHYSIOL, V92, P199, DOI 10.1152/jn.01275.2003; Reinert KC, 2007, J NEUROSCI RES, V85, P3221, DOI 10.1002/jnr.21348; Rowbotham MC, 1996, BRAIN, V119, P347, DOI 10.1093/brain/119.2.347; Sasaki S, 2002, NEUROIMAGE, V17, P1240, DOI 10.1006/nimg.2002.1286; Schechtmann G, 2008, PAIN, V139, P136, DOI 10.1016/j.pain.2008.03.023; Schoffnegger D, 2008, PAIN, V135, P300, DOI 10.1016/j.pain.2007.12.016; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Shechter R, 2013, ANESTHESIOLOGY, V119, P422, DOI 10.1097/ALN.0b013e31829bd9e2; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; SHIR Y, 1991, PAIN, V45, P309, DOI 10.1016/0304-3959(91)90056-4; Smits H, 2006, NEUROSCIENCE, V143, P541, DOI 10.1016/j.neuroscience.2006.08.007; Smits H, 2012, PAIN, V153, P177, DOI 10.1016/j.pain.2011.10.015; Smits H, 2009, NEUROSCI LETT, V450, P70, DOI 10.1016/j.neulet.2008.11.013; Song ZY, 2011, PAIN, V152, P1666, DOI 10.1016/j.pain.2011.03.012; Takahashi K, 2006, EUR J NEUROSCI, V23, P1365, DOI 10.1111/j.1460-9568.2006.04662.x; Tohmi M, 2009, J NEUROCHEM, V109, P3, DOI 10.1111/j.1471-4159.2009.05926.x; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Wang XM, 2011, J NEUROPHYSIOL, V105, P1732, DOI 10.1152/jn.00717.2010; Weber B, 2004, EUR J NEUROSCI, V20, P2664, DOI 10.1111/j.1460-9568.2004.03735.x; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Yamashita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035676	55	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109029	10.1371/journal.pone.0109029	http://dx.doi.org/10.1371/journal.pone.0109029			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279562	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800050
J	Kersbergen, KJ; Benders, MJNL; Groenendaal, F; Koopman-Esseboom, C; Nievelstein, RAJ; van Haastert, IC; de Vries, LS				Kersbergen, Karina J.; Benders, Manon J. N. L.; Groenendaal, Floris; Koopman-Esseboom, Corine; Nievelstein, Rutger A. J.; van Haastert, Ingrid C.; de Vries, Linda S.			Different Patterns of Punctate White Matter Lesions in Serially Scanned Preterm Infants	PLOS ONE			English	Article							BRAIN IMAGING FINDINGS; PREMATURE NEWBORNS; INJURY; ULTRASONOGRAPHY; ULTRASOUND; DIAGNOSIS; MRI	Background and Purpose: With the increased use of MRI in preterm infants, punctate white matter lesions (PWML) are more often recognized. The aim of this study was to describe the incidence and characteristics of these lesions as well as short-term outcome in a cohort of serially scanned preterm infants, using both conventional imaging, diffusion (DWI) and susceptibility (SWI) weighted imaging. Materials and Methods: 112 preterm infants with 2 MRIs in the neonatal period, with evidence of punctate white matter lesions, were included. Appearance, lesion load, location, and abnormalities on DWI and SWI were scored and outcome data were collected. Results: Different patterns of punctate white matter lesions did appear: a linear appearance associated with signal loss on SWI, and a cluster appearance associated with restricted diffusion on DWI on the first MRI. Cluster and mixed lesions on the first scan changed in appearance in over 50% on the second scan, whereas linear lesions generally kept their appearance. Lesions were only visible on the early scan in 33%, and were only seen at term equivalent age in 20%. Nine infants developed cerebral palsy, due to additional overt white matter lesions in six. Conclusion: Two patterns of punctate white matter lesions were identified: one with loss of signal on SWI in a linear appearance, and the other with DWI lesions with restricted diffusion in a cluster appearance. These different patterns are suggestive of a difference in underlying pathophysiology. To reliably classify PWML in the preterm infant in either pattern, an early MRI with DWI and SWI sequences is required.	[Kersbergen, Karina J.; Benders, Manon J. N. L.; Groenendaal, Floris; Koopman-Esseboom, Corine; van Haastert, Ingrid C.; de Vries, Linda S.] Wilhelmina Childrens Hosp, Dept Perinatol, Utrecht, Netherlands; [Kersbergen, Karina J.; Benders, Manon J. N. L.; Groenendaal, Floris; Koopman-Esseboom, Corine; van Haastert, Ingrid C.; de Vries, Linda S.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Nievelstein, Rutger A. J.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	de Vries, LS (corresponding author), Wilhelmina Childrens Hosp, Dept Perinatol, Utrecht, Netherlands.	L.S.deVries@umcutrecht.nl	de Vries, Linda S/AAB-6454-2021; Groenendaal, Floris/P-6872-2019	Groenendaal, Floris/0000-0002-9284-1637	Wilhelmina Research Fund [OZF2008-19]	Wilhelmina Research Fund	This study includes infants from a study funded by the Wilhelmina Research Fund, OZF2008-19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2001, AM J PERINAT, V18, P79, DOI 10.1055/s-2001-13633; Bassi L, 2011, PEDIATR RES, V69, P561, DOI 10.1203/PDR.0b013e3182182836; Bayley N., 2019, BAYLEY SCALES INFANT; Benders MJNL, 2014, CLIN PERINATOL, V41, P69, DOI 10.1016/j.clp.2013.09.005; Cornette LG, 2002, ARCH DIS CHILD-FETAL, V86, P171, DOI 10.1136/fn.86.3.F171; de Bruine FT, 2014, PEDIATR RADIOL, V44, P305, DOI 10.1007/s00247-013-2803-1; de Bruine FT, 2011, RADIOLOGY, V261, P899, DOI 10.1148/radiol.11110797; Debillon T, 2003, ARCH DIS CHILD-FETAL, V88, P275, DOI 10.1136/fn.88.4.F275; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; GOMORI JM, 1985, RADIOLOGY, V157, P87, DOI 10.1148/radiology.157.1.4034983; Griffiths R, 1984, ABILITIES YOUNG CHIL; Leijser LM, 2009, EARLY HUM DEV, V85, P111, DOI 10.1016/j.earlhumdev.2008.11.012; Leijser LM, 2009, EARLY HUM DEV, V85, P101, DOI 10.1016/j.earlhumdev.2008.11.010; Maalouf EF, 2001, PEDIATRICS, V107, P719, DOI 10.1542/peds.107.4.719; McCrea HL, 2008, CLIN PERINATOL, V35, P777, DOI 10.1016/j.clp.2008.07.014; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Miller SP, 2003, AM J NEURORADIOL, V24, P1661; Miller SP, 2002, J MAGN RESON IMAGING, V16, P621, DOI 10.1002/jmri.10205; Niwa T, 2011, NEURORADIOLOGY, V53, P669, DOI 10.1007/s00234-011-0872-0; Raybaud C, 2013, NEURORADIOLOGY, V55, P23, DOI 10.1007/s00234-013-1231-0; Rutherford MA, 2010, NEURORADIOLOGY, V52, P505, DOI 10.1007/s00234-010-0700-y; Sie LTL, 2005, NEUROPEDIATRICS, V36, P78, DOI 10.1055/s-2005-837574; Verboon-Maciolek MA, 2008, PEDIATR INFECT DIS J, V27, P241, DOI 10.1097/INF.0b013e31815c1b07	23	47	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108904	10.1371/journal.pone.0108904	http://dx.doi.org/10.1371/journal.pone.0108904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279755	Green Submitted, gold, Green Published			2022-12-27	WOS:000342670800036
J	Krag, A; Bendtsen, F; Dahl, EK; Kjaer, A; Petersen, CL; Moller, S				Krag, Aleksander; Bendtsen, Flemming; Dahl, Emilie Kristine; Kjaer, Andreas; Petersen, Claus Leth; Moller, Soren			Cardiac Function in Patients with Early Cirrhosis during Maximal Beta-Adrenergic Drive: A Dobutamine Stress Study	PLOS ONE			English	Article							SYSTEMIC HEMODYNAMICS; LIVER-CIRRHOSIS; BLOOD-VOLUME; DYSFUNCTION; EXERCISE; ECHOCARDIOGRAPHY; CARDIOMYOPATHY; COMPLICATIONS; PATHOGENESIS; CONTRIBUTES	Background and aim: Cardiac dysfunction in patients with early cirrhosis is debated. We investigated potential cardiac dysfunction by assessing left ventricular systolic performance during a dobutamine stress test in patients with early cirrhosis. Patients and methods: Nineteen patients with Child A and B cirrhosis (9 with non-alcoholic cirrhosis) and 7 matched controls were included. We used cardiac magnetic resonance imaging to assess left ventricular volumes and cardiac output (CO) at rest and during maximal heart rate induced by increasing dosages of dobutamine and atropine. Results: Patients with cirrhosis and controls had an equal stress response, the heart rate and ejection fraction increased similarly and maximal heart rate was reached in all. At rest CO was higher in Child B patients than controls. During maximal stress, Child B patients had higher CO (10.6 +/- 2.7 vs. 8.0 +/- 1.8 L/min), left ventricle end diastolic volume (90 +/- 25 vs. 67 +/- 16 mL), left ventricular end diastolic volume (10 +/- 4 vs. 6 +/- 2 mL) and stroke volume (80 +/- 23 vs. 61 +/- 15 mL) than Child A patients. The systemic vascular resistance was lower in Child B than Child A patients (670 +/- 279 vs. 911 +/- 274 dyne*s*cm(-5)). The left ventricle mass increased by 5.6 gram per model for end stage liver disease (MELD) point. MELD score correlated with the end diastolic and systolic volume, CO, and stroke volume at rest and at stress (all p < 0.05). Conclusion: In patients with early cirrhosis the chronotropoic and inotropic response to pharmacological stress induced by dobutamine is normal. With progression of the disease, the mass of the heart increases along with increase in cardiac volumes.	[Krag, Aleksander; Dahl, Emilie Kristine] Odense Univ Hosp, Dept Gastroenterol, DK-5000 Odense, Denmark; [Krag, Aleksander; Bendtsen, Flemming] Univ Copenhagen, Hvidovre Hosp, Div Med, Gastro Unit, Copenhagen, Denmark; [Kjaer, Andreas] Univ Copenhagen, Rigshosp, Hvidovre Hosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Petersen, Claus Leth; Moller, Soren] Univ Copenhagen, Hvidovre Hosp, Ctr Funct Imaging & Res, Dept Clin Physiol & Nucl Med, Copenhagen, Denmark	University of Southern Denmark; Odense University Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Krag, A (corresponding author), Odense Univ Hosp, Dept Gastroenterol, DK-5000 Odense, Denmark.	Aleksander.Krag@rsyd.dk	Krag, Aleksander/ABH-9649-2020; Kjaer, Andreas/E-8932-2015	Krag, Aleksander/0000-0002-9598-4932; Kjaer, Andreas/0000-0002-2706-5547; Moller, Soren/0000-0001-9684-7764; Dahl, Emilie Kristine/0000-0002-1383-5619	Lundbeck Foundation; Hvidovre Hospital Foundation for Liver Disease; Novo Nordic Foundation; University of Copenhagen; Capital Region of Denmark, Foundation for Health Research; Novo Nordisk Fonden [NNF11OC1014467, NNF11OC1015075, NNF13OC0006329] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Hvidovre Hospital Foundation for Liver Disease; Novo Nordic Foundation(Novo Nordisk Foundation); University of Copenhagen; Capital Region of Denmark, Foundation for Health Research; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by grants from the Lundbeck Foundation, Hvidovre Hospital Foundation for Liver Disease, and The Novo Nordic Foundation. Aleksander Krag received a grant from University of Copenhagen and The Capital Region of Denmark, Foundation for Health Research. Department of Radiology, Frederiksberg Hospital is thanked for the CMRI investigations. The author(s) received no specific funding for this work.	Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; BERNARDI M, 1991, J HEPATOL, V12, P207, DOI 10.1016/0168-8278(91)90940-D; Cazzaniga M, 2007, GUT, V56, P869, DOI 10.1136/gut.2006.102467; Ceolotto G, 2008, HEPATOLOGY, V48, P1913, DOI 10.1002/hep.22533; Dahl EK, 2014, SCAND J GASTROENTERO, V49, P362, DOI 10.3109/00365521.2013.867359; DeMinicis S, 2014, HEPATOLOGY, V59, P1738, DOI 10.1002/hep.26695; DELISSIO M, 1991, J APPL PHYSIOL, V70, P210, DOI 10.1152/jappl.1991.70.1.210; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; GROSE RD, 1995, J HEPATOL, V22, P326, DOI 10.1016/0168-8278(95)80286-X; Hachamovitch R, 1998, CIRCULATION, V97, P535; Hunter JD, 2010, BRIT J ANAESTH, V104, P3, DOI 10.1093/bja/aep339; Iwakiri Y, 2006, HEPATOLOGY, V43, pS121, DOI 10.1002/hep.20993; Kim Moon Young, 2010, Korean J Hepatol, V16, P376, DOI 10.3350/kjhep.2010.16.4.376; Krag A, 2010, GUT, V59, P105, DOI 10.1136/gut.2009.180570; Krag A, 2012, MED HYPOTHESES, V79, P53, DOI 10.1016/j.mehy.2012.03.032; Krag A, 2010, EUR J GASTROEN HEPAT, V22, P1085, DOI 10.1097/MEG.0b013e32833a4822; Laffi G, 1996, HEPATOLOGY, V24, P1063; LEE SS, 1990, HEPATOLOGY, V12, P481, DOI 10.1002/hep.1840120306; Lemyze M, 2013, DIGEST LIVER DIS, V45, P362, DOI 10.1016/j.dld.2012.09.022; Lenstrup M, 2006, SCAND J CLIN LAB INV, V66, P647, DOI 10.1080/00365510600892233; Ma ZH, 1996, GASTROENTEROLOGY, V110, P1191, DOI 10.1053/gast.1996.v110.pm8613009; Moller S, 2008, GUT, V57, P268, DOI 10.1136/gut.2006.112177; MOLLER S, 1995, GASTROENTEROLOGY, V109, P1917, DOI 10.1016/0016-5085(95)90759-9; MOLLER S, 1995, HEPATOLOGY, V22, P472, DOI 10.1002/hep.1840220216; Moller S, 2007, SCAND J GASTROENTERO, V42, P419, DOI 10.1080/00365520601151695; Moller S, 2013, INT J CARDIOL, V167, P1101, DOI 10.1016/j.ijcard.2012.09.089; Moller S, 2009, LIVER INT, V29, P1528, DOI 10.1111/j.1478-3231.2009.02103.x; Nazar A, 2013, J HEPATOL, V58, P51, DOI 10.1016/j.jhep.2012.08.027; Rabie RN, 2009, AM J GASTROENTEROL, V104, P2458, DOI 10.1038/ajg.2009.321; Ruiz-del-Arbol L, 2005, HEPATOLOGY, V42, P439, DOI 10.1002/hep.20766; Ruiz-del-Arbol L, 2013, HEPATOLOGY, V58, P1732, DOI 10.1002/hep.26509; Ruiz-del-Arbol W, 2003, HEPATOLOGY, V38, P1210, DOI 10.1053/jhep.2003.50447; RuizdelArbol L, 1997, GASTROENTEROLOGY, V113, P579, DOI 10.1053/gast.1997.v113.pm9247479; Schrier RW, 2001, MT SINAI J MED, V68, P350; SELBERG O, 1993, J CLIN INVEST, V91, P1897, DOI 10.1172/JCI116407; Shujaat A, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/761051; Stahl W, 2010, CRIT CARE, V14, DOI 10.1186/cc9261; Theocharidou E, 2012, LIVER INT, V32, P1327, DOI 10.1111/j.1478-3231.2011.02751.x; Timoh T, 2011, TRANSPL P, V43, P1649, DOI 10.1016/j.transproceed.2011.01.188; Wong F, 2001, GUT, V49, P268, DOI 10.1136/gut.49.2.268	40	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109179	10.1371/journal.pone.0109179	http://dx.doi.org/10.1371/journal.pone.0109179			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279659	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800059
J	Sivapalan, N; Wattie, J; Inman, MD; Sehmi, R				Sivapalan, Nirooya; Wattie, Jennifer; Inman, Mark D.; Sehmi, Roma			Lung-Homing of Endothelial Progenitor Cells and Airway Vascularization Is Only Partially Dependant on Eosinophils in a House Dust Mite-Exposed Mouse Model of Allergic Asthma	PLOS ONE			English	Article							ANGIOGENIC SWITCH; HYPERRESPONSIVENESS; INFLAMMATION; EXPRESSION; CONTRIBUTES; IL-25; CD34; MICE; LINK	Background: Asthmatic responses involve a systemic component where activation of the bone marrow leads to mobilization and lung-homing of progenitor cells. This traffic may be driven by stromal cell derived factor-1 (SDF-1), a potent progenitor chemoattractant. We have previously shown that airway angiogenesis, an early remodeling event, can be inhibited by preventing the migration of endothelial progenitor cells (EPC) to the lungs. Given intranasally, AMD3100, a CXCR4 antagonist that inhibits SDF-1 mediated effects, attenuated allergen-induced lung-homing of EPC, vascularization of pulmonary tissue, airway eosinophilia and development of airway hyperresponsiveness. Since SDF-1 is also an eosinophil chemoattractant, we investigated, using a transgenic eosinophil deficient mouse strain (PHIL) whether EPC lung accumulation and lung vascularization in allergic airway responses is dependent on eosinophilic inflammation. Methods: Wild-type (WT) BALB/c and eosinophil deficient (PHIL) mice were sensitized to house dust mite (HDM) using a chronic exposure protocol and treated with AMD3100 to modulate SDF-1 stimulated progenitor traffic. Following HDM challenge, lung-extracted EPCs were enumerated along with airway inflammation, microvessel density (MVD) and airway methacholine responsiveness (AHR). Results: Following Ag sensitization, both WT and PHIL mice exhibited HDM-induced increase in airway inflammation, EPC lung-accumulation, lung angiogenesis and AHR. Treatment with AMD3100 significantly attenuated outcome measures in both groups of mice. Significantly lower levels of EPC and a trend for lower vascularization were detected in PHIL versus WT mice. Conclusions: This study shows that while allergen-induced lung-homing of endothelial progenitor cells, increased tissue vascularization and development lung dysfunction can occur in the absence of eosinophils, the presence of these cells worsens the pathology of the allergic response.	[Sivapalan, Nirooya; Wattie, Jennifer; Inman, Mark D.; Sehmi, Roma] McMaster Univ, St Josephs Healthcare, Firestone Inst Resp Hlth, Asthma Res Grp, Hamilton, ON, Canada	McMaster University	Sehmi, R (corresponding author), McMaster Univ, St Josephs Healthcare, Firestone Inst Resp Hlth, Asthma Res Grp, Hamilton, ON, Canada.	sehmir@mcmaster.ca			Canadian Lung Association	Canadian Lung Association	This work was supported by a grant-in-aid from the Canadian Lung Association. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Asosingh K, 2007, J IMMUNOL, V178, P6482, DOI 10.4049/jimmunol.178.10.6482; Asosingh K, 2013, J IMMUNOL, V190, P3458, DOI 10.4049/jimmunol.1202095; Asosingh K, 2010, J ALLERGY CLIN IMMUN, V125, P918, DOI 10.1016/j.jaci.2010.01.017; Asosingh K, 2009, BIOCHEM SOC T, V37, P805, DOI 10.1042/BST0370805; Chetta Alfredo, 2007, Inflammation & Allergy Drug Targets, V6, P41, DOI 10.2174/187152807780077273; Corrigan CJ, 2011, P NATL ACAD SCI USA, V108, P1579, DOI 10.1073/pnas.1014241108; DiGiovanni FA, 2009, DIS MODEL MECH, V2, P275, DOI 10.1242/dmm.001859; Doyle TM, 2011, EUR RESPIR J, V38, P679, DOI 10.1183/09031936.00133210; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gauvreau Gail M., 2009, P433, DOI 10.1007/978-4-431-88315-9_26; Gregory LG, 2013, THORAX, V68, P82, DOI 10.1136/thoraxjnl-2012-202003; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; HOGG JC, 1987, AM REV RESPIR DIS, V135, pS54; Imaoka H, 2011, AM J RESP CRIT CARE, V184, P771, DOI 10.1164/rccm.201102-0272OC; Inman MD, 1999, AM J RESP CELL MOL, V21, P473, DOI 10.1165/ajrcmb.21.4.3622; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Jones CP, 2009, STEM CELLS, P1; Kawanami O, 2000, PATHOL INT, V50, P136, DOI 10.1046/j.1440-1827.2000.01006.x; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Larrivee B, 2005, J IMMUNOL, V175, P2890, DOI 10.4049/jimmunol.175.5.2890; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Luttun A, 2007, BLOOD, V109, P1795, DOI 10.1182/blood-2006-12-062257; Manuyakorn W, 2013, ASIAN PAC J ALLERGY, V31, P3; MCFADDEN ER, 1990, LANCET, V335, P880, DOI 10.1016/0140-6736(90)90478-N; MOROOSE R, 1986, ANNU REV MED, V37, P157; Muller AM, 2002, EXP MOL PATHOL, V72, P221, DOI 10.1006/exmp.2002.2424; Nagase H, 2000, J IMMUNOL, V164, P5935, DOI 10.4049/jimmunol.164.11.5935; Pandya NM, 2006, VASC PHARMACOL, V44, P265, DOI 10.1016/j.vph.2006.01.005; Paredi P, 2009, THORAX, V64, P444, DOI 10.1136/thx.2008.100032; Pascual RM, 2005, J ALLERGY CLIN IMMUN, V116, P477, DOI 10.1016/j.jaci.2005.07.011; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Puxeddu A, 2005, INT J BIOCHEM CELL B, V37, P628, DOI 10.1016/j.biocel.2004.09.001; Puxeddu I, 2005, J ALLERGY CLIN IMMUN, V116, P531, DOI 10.1016/j.jaci.2005.06.007; Puxeddu I, 2009, ALLERGY, V64, P368, DOI 10.1111/j.1398-9995.2008.01822.x; Southam DS, 2007, J ALLERGY CLIN IMMUN, V119, P848, DOI 10.1016/j.jaci.2006.12.623; Townley RG, 2003, CLIN REV ALLERG IMMU, V24, P85, DOI 10.1385/CRIAI:24:1:85; Wilson JW, 2006, CURR OPIN ALLERGY CL, V6, P51, DOI 10.1097/01.all.0000200505.54425.47; Wilson JW, 2003, CURR ALLERGY ASTHM R, V3, P153, DOI 10.1007/s11882-003-0028-3; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoder MC, 2010, ARTERIOSCL THROM VAS, V30, P1094, DOI 10.1161/ATVBAHA.109.191635; Yoder MI, 2009, CURR OPIN HEMATOL, V16, P269, DOI 10.1097/MOH.0b013e32832bbcab	42	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109991	10.1371/journal.pone.0109991	http://dx.doi.org/10.1371/journal.pone.0109991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279605	Green Submitted, gold, Green Published			2022-12-27	WOS:000342670800107
J	Abdel-Mohsen, M; Deng, XT; Danesh, A; Liegler, T; Jacobs, ES; Rauch, A; Ledergerber, B; Norris, PJ; Gunthard, HF; Wong, JK; Pillai, SK				Abdel-Mohsen, Mohamed; Deng, Xutao; Danesh, Ali; Liegler, Teri; Jacobs, Evan S.; Rauch, Andri; Ledergerber, Bruno; Norris, Philip J.; Guenthard, Huldrych F.; Wong, Joseph K.; Pillai, Satish K.			Role of MicroRNA Modulation in the Interferon-alpha/Ribavirin Suppression of HIV-1 In Vivo	PLOS ONE			English	Article							PERSISTENT LCMV INFECTION; C VIRUS; ANTIRETROVIRAL ACTIVITY; PEGINTERFERON ALPHA-2A; RESTRICTION FACTORS; CELLULAR MICRORNAS; ELITE SUPPRESSORS; GENE-EXPRESSION; CELLS; APOPTOSIS	Background: Interferon-alpha (IFN-alpha) treatment suppresses HIV-1 viremia and reduces the size of the HIV-1 latent reservoir. Therefore, investigation of the molecular and immunologic effects of IFN-alpha may provide insights that contribute to the development of novel prophylactic, therapeutic and curative strategies for HIV-1 infection. In this study, we hypothesized that microRNAs (miRNAs) contribute to the IFN-alpha-mediated suppression of HIV-1. To inform the development of novel miRNA-based antiretroviral strategies, we investigated the effects of exogenous IFN-alpha treatment on global miRNA expression profile, HIV-1 viremia, and potential regulatory networks between miRNAs and cell-intrinsic anti-HIV-1 host factors in vivo. Methods: Global miRNA expression was examined in longitudinal PBMC samples obtained from seven HIV/HCV-coinfected, antiretroviral therapy-naive individuals before, during, and after pegylated interferon-alpha/ribavirin therapy (IFN-alpha/RBV). We implemented novel hybrid computational-empirical approaches to characterize regulatory networks between miRNAs and anti-HIV-1 host restriction factors. Results: miR-422a was the only miRNA significantly modulated by IFN-alpha/RBV in vivo (p < 0.0001, paired t test; FDR < 0.037). Our interactome mapping revealed extensive regulatory involvement of miR-422a in p53-dependent apoptotic and pyroptotic pathways. Based on sequence homology and inverse expression relationships, 29 unique miRNAs may regulate anti-HIV-1 restriction factor expression in vivo. Conclusions: The specific reduction of miR-422a is associated with exogenous IFN-alpha treatment, and likely contributes to the IFN-alpha suppression of HIV-1 through the enhancement of anti-HIV-1 restriction factor expression and regulation of genes involved in programmed cell death. Moreover, our regulatory network analysis presents additional candidate miRNAs that may be targeted to enhance anti-HIV-1 restriction factor expression in vivo.	[Abdel-Mohsen, Mohamed; Liegler, Teri; Norris, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Abdel-Mohsen, Mohamed; Deng, Xutao; Danesh, Ali; Jacobs, Evan S.; Norris, Philip J.; Pillai, Satish K.] Blood Syst Res Inst, San Francisco, CA 94118 USA; [Rauch, Andri] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland; [Rauch, Andri] Univ Bern, Bern, Switzerland; [Ledergerber, Bruno; Guenthard, Huldrych F.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Norris, Philip J.; Pillai, Satish K.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Wong, Joseph K.] San Francisco VA Med Ctr, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute; University of Bern; University Hospital of Bern; University of Bern; University of Zurich; University Zurich Hospital; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Pillai, SK (corresponding author), Blood Syst Res Inst, San Francisco, CA 94118 USA.	satish.pillai@ucsf.edu	Ledergerber, Bruno/B-5656-2009; Rauch, Andri/E-9948-2017; gunthard, huldrych f/F-1724-2011	Ledergerber, Bruno/0000-0002-6881-4401; Rauch, Andri/0000-0001-5297-6062; gunthard, huldrych f/0000-0002-1142-6723; Abdel-Mohsen, Mohamed/0000-0002-9945-4314	National Institutes of Health [1K01DA024654]; University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research [P30 AI027763]; Swiss HIV Cohort Study Project [594]; Swiss National Science Foundation [324730-130865, 33CS30-134277]; Swiss HIV Cohort Study Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI091573, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA024654] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research(University of California System); Swiss HIV Cohort Study Project; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss HIV Cohort Study Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by grants from the National Institutes of Health 1K01DA024654, and the University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (grant number P30 AI027763). Additional support was provided by Swiss HIV Cohort Study Project 594 and Swiss National Science Foundation Grant 324730-130865. The Swiss HIV Cohort Study is supported by Swiss National Science Foundation Grant 33CS30-134277 and the Swiss HIV Cohort Study Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mohsen M, 2014, J VIROL, V88, P763, DOI 10.1128/JVI.02687-13; Abdel-Mohsen M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-106; Ahluwalia JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-117; Althaus CF, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-27; Asmuth DM, 2010, J INFECT DIS, V201, P1686, DOI 10.1086/652420; Azzoni L, 2013, J INFECT DIS, V207, P213, DOI 10.1093/infdis/jis663; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; Doitsh G, 2013, NATURE; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; Hayes AM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-36; Holland B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058586; Houzet L, 2012, NUCLEIC ACIDS RES, V40, P11684, DOI 10.1093/nar/gks912; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Hubbard JJ, 2012, J INFECT DIS, V205, P1443, DOI 10.1093/infdis/jis211; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Mallery DL, 2010, P NATL ACAD SCI USA, V107, P19985, DOI 10.1073/pnas.1014074107; Mao GG, 2012, CELL RES, V22, P973, DOI 10.1038/cr.2012.18; Marucco DA, 2007, J ANTIMICROB CHEMOTH, V59, P565, DOI 10.1093/jac/dkl497; McEwan WA, 2012, J VIROL, V86, P8482, DOI 10.1128/JVI.00728-12; McEwan WA, 2013, NAT IMMUNOL, V14, P327, DOI 10.1038/ni.2548; McNamara LA, 2013, J INFECT DIS, V207, P201, DOI 10.1093/infdis/jis667; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mishra R, 2013, J NEUROSCI, V33, P5992, DOI 10.1523/JNEUROSCI.4796-12.2013; Monroe KM, 2013, SCIENCE; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Pillai S, INTERFERON TRE UNPUB; Pillai SK, 2012, P NATL ACAD SCI USA, V109, P3035, DOI 10.1073/pnas.1111573109; Porta C, 2005, ONCOGENE, V24, P605, DOI 10.1038/sj.onc.1208204; Portales P, 2003, AIDS, V17, P495, DOI 10.1097/00002030-200303070-00004; Poy MN, 2007, DIABETES OBES METAB, V9, P67, DOI 10.1111/j.1463-1326.2007.00775.x; Rempel H, 2010, AIDS, V24, P1415, DOI 10.1097/QAD.0b013e32833ac623; RONALD PJM, 1994, AIDS, V8, P339, DOI 10.1097/00002030-199403000-00007; Rotger M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000781; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Song KH, 2010, J LIPID RES, V51, P2223, DOI 10.1194/jlr.M004531; Specter S, 1994, J Fla Med Assoc, V81, P485; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Sun H, 2013, J INFECT DIS; Swaminathan S, 2012, J IMMUNOL, V188, P6238, DOI 10.4049/jimmunol.1101196; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang X, 2011, AM J PATHOL, V178, P41, DOI 10.1016/j.ajpath.2010.11.042; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Wang YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031167; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Witwer KW, 2012, BLOOD, V119, P6395, DOI 10.1182/blood-2012-02-412742; Witwer KW, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-5; Yanamadala S, 2003, MOL CANCER RES, V1, P747; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yeung ML, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-81; Zhang H, 1999, CANCER RES, V59, P3021; Zhang ZN, 2013, CLIN CHEM, V59, P1175, DOI 10.1373/clinchem.2012.197335	63	5	5	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109220	10.1371/journal.pone.0109220	http://dx.doi.org/10.1371/journal.pone.0109220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275557	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000342591500077
J	Reinhard, MA; Regen, W; Baglioni, C; Nissen, C; Feige, B; Hennig, J; Riemann, D; Spiegelhalder, K				Reinhard, Matthias A.; Regen, Wolfram; Baglioni, Chiara; Nissen, Christoph; Feige, Bernd; Hennig, Juergen; Riemann, Dieter; Spiegelhalder, Kai			The Relationship between Brain Morphology and Polysomnography in Healthy Good Sleepers	PLOS ONE			English	Article							RESTLESS LEGS SYNDROME; VOXEL-BASED MORPHOMETRY; HUMAN CEREBRAL-CORTEX; SLOW-WAVE ACTIVITY; REM-SLEEP; MOVEMENTS; INSOMNIA	Background: Normal sleep continuity and architecture show remarkable inter-individual variability. Previous studies suggest that brain morphology may explain inter-individual differences in sleep variables. Method: Thirty-eight healthy subjects spent two consecutive nights at the sleep laboratory with polysomnographic monitoring. Furthermore, high-resolution T1-weighted MRI datasets were acquired in all participants. EEG sleep recordings were analyzed using standard sleep staging criteria and power spectral analysis. Using the FreeSurfer software for automated segmentation, 174 variables were determined representing the volume and thickness of cortical segments and the volume of subcortical brain areas. Regression analyses were performed to examine the relationship with polysomnographic and spectral EEG power variables. Results: The analysis did not provide any support for the a-priori formulated hypotheses of an association between brain morphology and polysomnographic variables. Exploratory analyses revealed that the thickness of the left caudal anterior cingulate cortex was positively associated with EEG beta2 power (24-32 Hz) during REM sleep. The volume of the left postcentral gyrus was positively associated with periodic leg movements during sleep (PLMS). Conclusions: The function of the anterior cingulate cortex as well as EEG beta power during REM sleep have been related to dreaming and sleep-related memory consolidation, which may explain the observed correlation. Increased volumes of the postcentral gyrus may be the result of increased sensory input associated with PLMS. However, due to the exploratory nature of the corresponding analyses, these results have to be replicated before drawing firm conclusions.	[Reinhard, Matthias A.; Regen, Wolfram; Baglioni, Chiara; Nissen, Christoph; Feige, Bernd; Riemann, Dieter; Spiegelhalder, Kai] Univ Med Ctr Freiburg, Dept Psychiat & Psychotherapy, Freiburg, Germany; [Hennig, Juergen] Univ Med Ctr Freiburg, Dept Diagnost Radiol, Freiburg, Germany	University of Freiburg; University of Freiburg	Spiegelhalder, K (corresponding author), Univ Med Ctr Freiburg, Dept Psychiat & Psychotherapy, Freiburg, Germany.	Kai.Spiegelhalder@uniklinik-freiburg.de	Baglioni, Chiara/ABC-3423-2020; Nissen, Christoph/C-7642-2015; Feige, Bernd/C-6690-2012; Baglioni, Chiara/AAC-2605-2019; Spiegelhalder, Kai/B-7861-2019; Riemann, Dieter/R-4013-2019; Hennig, Jürgen/F-2424-2010	Nissen, Christoph/0000-0001-9809-0275; Feige, Bernd/0000-0002-9436-1258; Hennig, Jürgen/0000-0002-2273-3497; Riemann, Dieter/0000-0002-1968-6220	Else Kroener-Fresenius-Stiftung [2011_A208]; European Community's Seventh Framework Programme (People, Marie Curie Actions, Intra-European Fellowship, FP7-PEOPLE-IEF) [235321]	Else Kroener-Fresenius-Stiftung; European Community's Seventh Framework Programme (People, Marie Curie Actions, Intra-European Fellowship, FP7-PEOPLE-IEF)	KS and DR have received funding by the Else Kroener-Fresenius-Stiftung (2011_A208; http://www.ekfs.de/). CB and DR have received funding from the European Community's Seventh Framework Programme (People, Marie Curie Actions, Intra-European Fellowship, FP7-PEOPLE-IEF-2008; http://cordis.europa.eu/fp7/home_en.html) under grant agreement n. 235321. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHERMANN P, 1993, BRAIN RES BULL, V31, P97, DOI 10.1016/0361-9230(93)90016-5; American Academy of Sleep Medicine, 2007, AASM MANUAL SCORING; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buchmann A, 2011, J SLEEP RES, V20, P506, DOI 10.1111/j.1365-2869.2011.00916.x; De Gennaro L, 2005, NEUROIMAGE, V26, P114, DOI 10.1016/j.neuroimage.2005.01.020; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Feige B, 2008, J SLEEP RES, V17, P180, DOI 10.1111/j.1365-2869.2008.00651.x; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Hening W, 2004, CLIN NEUROPHYSIOL, V115, P1965, DOI 10.1016/j.clinph.2004.03.032; Hobson JA, 2009, NAT REV NEUROSCI, V10, P803, DOI 10.1038/nrn2716; Hornyak M, 2005, SLEEP, V28, P331; Le Van Quyen M, 2010, J NEUROSCI, V30, P7770, DOI 10.1523/JNEUROSCI.5049-09.2010; Lewandowski A, 2013, J PSYCHOPHYSIOL, V27, P105, DOI 10.1027/0269-8803/a000092; LLINAS R, 1993, P NATL ACAD SCI USA, V90, P2078, DOI 10.1073/pnas.90.5.2078; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Margariti PN, 2012, AM J NEURORADIOL, V33, P667, DOI 10.3174/ajnr.A2829; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perlis ML, 2001, SLEEP MED REV, V5, P365, DOI 10.1053/smrv.2001.0151; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Rizzo G, 2012, EUR J NEUROL, V19, P1045, DOI 10.1111/j.1468-1331.2011.03604.x; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Saletin JM, 2013, NEUROIMAGE, V83, P658, DOI 10.1016/j.neuroimage.2013.06.021; Spiegelhalder K, 2014, HUM BRAIN MAPP, V35, P3431, DOI 10.1002/hbm.22412; Spiegelhalder K, 2013, SLEEP, V36, P731, DOI 10.5665/sleep.2638; Spiegelhalder K, 2012, BIOL PSYCHOL, V91, P329, DOI 10.1016/j.biopsycho.2012.08.009; Taki Y, 2012, NEUROIMAGE, V60, P471, DOI 10.1016/j.neuroimage.2011.11.072; Tucker AM, 2007, J SLEEP RES, V16, P170, DOI 10.1111/j.1365-2869.2007.00594.x; Werth E, 1997, ELECTROEN CLIN NEURO, V103, P535, DOI 10.1016/S0013-4694(97)00070-9; Winkelman JW, 2013, SLEEP, V36, P991, DOI 10.5665/sleep.2794	36	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109336	10.1371/journal.pone.0109336	http://dx.doi.org/10.1371/journal.pone.0109336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275322	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500095
J	Religa, AA; Ramesar, J; Janse, CJ; Scherf, A; Waters, AP				Religa, Agnieszka A.; Ramesar, Jai; Janse, Chris J.; Scherf, Artur; Waters, Andrew P.			P. berghei Telomerase Subunit TERT is Essential for Parasite Survival	PLOS ONE			English	Article							CHROMOSOME SIZE POLYMORPHISM; PLASMODIUM-FALCIPARUM; MALARIA PARASITE; TETRAHYMENA-TELOMERASE; REVERSE-TRANSCRIPTASE; DYSKERATOSIS-CONGENITA; IDENTIFICATION; SEQUENCES; DNA; TRANSFECTION	Telomeres define the ends of chromosomes protecting eukaryotic cells from chromosome instability and eventual cell death. The complex regulation of telomeres involves various proteins including telomerase, which is a specialized ribonucleoprotein responsible for telomere maintenance. Telomeres of chromosomes of malaria parasites are kept at a constant length during blood stage proliferation. The 7-bp telomere repeat sequence is universal across different Plasmodium species (GGGTTT/CA), though the average telomere length varies. The catalytic subunit of telomerase, telomerase reverse transcriptase (TERT), is present in all sequenced Plasmodium species and is approximately three times larger than other eukaryotic TERTs. The Plasmodium RNA component of TERT has recently been identified in silico. A strategy to delete the gene encoding TERT via double cross-over (DXO) homologous recombination was undertaken to study the telomerase function in P. berghei. Expression of both TERT and the RNA component (TR) in P. berghei blood stages was analysed by Western blotting and Northern analysis. Average telomere length was measured in several Plasmodium species using Telomere Restriction Fragment (TRF) analysis. TERT and TR were detected in blood stages and an average telomere length of similar to 950 bp established. Deletion of the tert gene was performed using standard transfection methodologies and we show the presence of tert(-) mutants in the transfected parasite populations. Cloning of tertmutants has been attempted multiple times without success. Thorough analysis of the transfected parasite populations and the parasite obtained from extensive parasite cloning from these populations provide evidence for a so called delayed death phenotype as observed in different organisms lacking TERT. The findings indicate that TERT is essential for P. berghei cell survival. The study extends our current knowledge on telomere biology in malaria parasites and validates further investigations to identify telomerase inhibitors to induce parasite cell death.	[Religa, Agnieszka A.; Waters, Andrew P.] Univ Glasgow, Inst Infect Immun & Inflammat, Wellcome Trust Ctr Mol Parasitol, Glasgow, Lanark, Scotland; [Ramesar, Jai; Janse, Chris J.] Leiden Univ, Med Ctr, Leiden Malaria Res Grp, Leiden, Netherlands; [Scherf, Artur] Inst Pasteur, Biol Host Parasite Interact Unit, Paris, France	University of Glasgow; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Waters, AP (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Wellcome Trust Ctr Mol Parasitol, Glasgow, Lanark, Scotland.	Andy.Waters@glasgow.ac.uk		Janse, Chris J/0000-0002-6410-6205; Scherf, Artur/0000-0003-2411-3328	European Commission [242095]; FP6 Marie Curie Action [MEST-CT-2005-020492]	European Commission(European CommissionEuropean Commission Joint Research Centre); FP6 Marie Curie Action	This work was also supported by Evimalar (Ref: 242095) a grant of the European Commission under FP7. APW is a Wellcome Trust Principal Research Fellow (REF: 083811/Z/07/Z); AAR was a MalParTraining PhD fellowship holder within FP6 Marie Curie Action under contract No. MEST-CT-2005-020492. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306; Amiard S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086220; Baran N, 2002, NUCLEIC ACIDS RES, V30, P5570, DOI 10.1093/nar/gkf676; Blackburn E., 2005, TELOMERES; BLACKBURN EH, 1978, J MOL BIOL, V120, P33, DOI 10.1016/0022-2836(78)90294-2; BLACKBURN EH, 1982, COLD SPRING HARB SYM, V47, P1195, DOI 10.1101/SQB.1983.047.01.135; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bottius E, 1998, MOL CELL BIOL, V18, P919, DOI 10.1128/MCB.18.2.919; Chakrabarti K, 2007, RNA, V13, P1923, DOI 10.1261/rna.751807; Chiang YJ, 2004, MOL CELL BIOL, V24, P7024, DOI 10.1128/MCB.24.16.7024-7031.2004; COLLINS K, 1993, GENE DEV, V7, P1364, DOI 10.1101/gad.7.7b.1364; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Dokal I, 2001, LANCET, pS27; DORE E, 1990, MOL CELL BIOL, V10, P2423, DOI 10.1128/MCB.10.5.2423; DORE E, 1994, MOL BIOL REP, V20, P27, DOI 10.1007/BF00999852; DORE E, 1986, MOL BIOCHEM PARASIT, V21, P121, DOI 10.1016/0166-6851(86)90015-0; Figueiredo LM, 2000, MOL BIOCHEM PARASIT, V106, P169, DOI 10.1016/S0166-6851(99)00199-1; Figueiredo LM, 2005, NUCLEIC ACIDS RES, V33, P1111, DOI 10.1093/nar/gki260; Figueiredo LM, 2002, EMBO J, V21, P815, DOI 10.1093/emboj/21.4.815; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Frias C, 2012, FRONT BIOSCI-LANDMRK, V17, P2181, DOI 10.2741/4044; GREIDER CW, 1991, MOL CELL BIOL, V11, P4572, DOI 10.1128/MCB.11.9.4572; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Kirwan M, 2009, BBA-MOL BASIS DIS, V1792, P371, DOI 10.1016/j.bbadis.2009.01.010; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lue NF, 1997, NUCLEIC ACIDS RES, V25, P4331, DOI 10.1093/nar/25.21.4331; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Mahmoudi N, 2008, ANTIMICROB AGENTS CH, V52, P1215, DOI 10.1128/AAC.01043-07; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Martin-Ruiz C, 2004, J BIOL CHEM, V279, P17826, DOI 10.1074/jbc.M311980200; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; MATTEI D, 1994, MUTAT RES, V324, P115, DOI 10.1016/0165-7992(94)90055-8; McCarthy JS, 2010, HUM VACCINES, V6, P114, DOI 10.4161/hv.6.1.10394; MELEK M, 1994, MOL CELL BIOL, V14, P7827, DOI 10.1128/MCB.14.12.7827; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Nelson ND, 2012, MUTAT RES-FUND MOL M, V730, P43, DOI 10.1016/j.mrfmmm.2011.06.008; PACE T, 1990, MOL CELL BIOL, V10, P6759, DOI 10.1128/MCB.10.12.6759; PACE T, 1987, MOL BIOCHEM PARASIT, V24, P193, DOI 10.1016/0166-6851(87)90106-X; PONZI M, 1985, EMBO J, V4, P2991, DOI 10.1002/j.1460-2075.1985.tb04034.x; PONZI M, 1992, NUCLEIC ACIDS RES, V20, P4491, DOI 10.1093/nar/20.17.4491; PONZI M, 1990, MOL BIOCHEM PARASIT, V41, P73, DOI 10.1016/0166-6851(90)90098-7; Shay JW, 2010, FEBS LETT, V584, P3819, DOI 10.1016/j.febslet.2010.05.026; Stanisic DI, 2013, TRENDS PARASITOL, V29, P612, DOI 10.1016/j.pt.2013.10.001; Stoppler H, 1997, J BIOL CHEM, V272, P13332, DOI 10.1074/jbc.272.20.13332; Ujike-Asai A, 2007, J LEUKOCYTE BIOL, V82, P429, DOI 10.1189/jlb.1006638; van Spaendonk RML, 2001, J BIOL CHEM, V276, P22638, DOI 10.1074/jbc.M101234200; VANDIJK MR, 1995, SCIENCE, V268, P1358, DOI 10.1126/science.7761856; Vulliamy TJ, 2001, BLOOD CELL MOL DIS, V27, P353, DOI 10.1006/bcmd.2001.0389; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0; Yuan XM, 1999, GENES CELLS, V4, P563, DOI 10.1046/j.1365-2443.1999.00284.x	56	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108930	10.1371/journal.pone.0108930	http://dx.doi.org/10.1371/journal.pone.0108930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275500	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000342591500042
J	Yang, XD; Zhang, XN; Lv, GH; Ali, A				Yang, Xiao-Dong; Zhang, Xue-Ni; Lv, Guang-Hui; Ali, Arshad			Linking Populus euphratica Hydraulic Redistribution to Diversity Assembly in the Arid Desert Zone of Xinjiang, China	PLOS ONE			English	Article							WATER-UPTAKE; SOIL-WATER; ARTEMISIA-TRIDENTATA; PLANT INTERACTIONS; ROOT DISTRIBUTION; LIFT; SAVANNA; SHRUB; TREES; ISLANDS	The hydraulic redistribution (HR) of deep-rooted plants significantly improves the survival of shallow-rooted shrubs and herbs in arid deserts, which subsequently maintain species diversity. This study was conducted in the Ebinur desert located in the western margin of the Gurbantonggut Desert. Isotope tracing, community investigation and comparison analysis were employed to validate the HR of Populus euphratica and to explore its effects on species richness and abundance. The results showed that, P. euphratica has HR. Shrubs and herbs that grew under the P. euphratica canopy (under community: UC) showed better growth than the ones growing outside (Outside community: OC), exhibiting significantly higher species richness and abundance in UC than OC (p<0.05) along the plant growing season. Species richness and abundance were significantly logarithmically correlated with the P. euphratica crown area in UC (R-2 = 0.51 and 0.84, p<0.001). In conclusion, P. euphratica HR significantly ameliorates the water conditions of the shallow soil, which then influences the diversity assembly in arid desert communities.	[Yang, Xiao-Dong; Ali, Arshad] E China Normal Univ, Coll Ecol & Environm Sci, Shanghai 200062, Peoples R China; [Yang, Xiao-Dong; Ali, Arshad] Chinese Natl Ecosyst Observat & Res Network, Tiantong Natl Forest Ecosyst Observat & Res Stn, Ningbo, Peoples R China; [Zhang, Xue-Ni; Lv, Guang-Hui] Xinjiang Univ, Inst Resources & Environm Sci, Urumqi, Peoples R China; [Zhang, Xue-Ni; Lv, Guang-Hui] Minist Educ, Xinjiang Key Lab Oasis Ecol, Urumqi, Peoples R China	East China Normal University; Xinjiang University	Lv, GH (corresponding author), Xinjiang Univ, Inst Resources & Environm Sci, Urumqi, Peoples R China.	ler@xju.edu.cn	Ali, Arshad/G-3988-2014	Ali, Arshad/0000-0001-9966-2917	National Natural Science Foundation of China [31060061]; Doctoral Program Foundation of Institutions of Higher Education of China [20106501110001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (Grant No. 31060061), and Doctoral Program Foundation of Institutions of Higher Education of China (Grant No. 20106501110001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON GB, 1983, J HYDROL, V64, P377, DOI 10.1016/0022-1694(83)90078-1; ALLISON GB, 1983, J HYDROL, V60, P157, DOI 10.1016/0022-1694(83)90019-7; Armas C, 2005, J ECOL, V93, P978, DOI 10.1111/j.1365-2745.2005.01033.x; Armas C, 2010, OECOLOGIA, V162, P11, DOI 10.1007/s00442-009-1447-1; Barchuk AH, 2005, AUSTRAL ECOL, V30, P695, DOI 10.1111/j.1442-9993.2005.01511.x; BELSKY AJ, 1994, ECOLOGY, V75, P922, DOI 10.2307/1939416; BELSKY AJ, 1989, J APPL ECOL, V26, P1005, DOI 10.2307/2403708; Burgess SSO, 1998, OECOLOGIA, V115, P306, DOI 10.1007/s004420050521; Caldwell MM, 1998, OECOLOGIA, V113, P151, DOI 10.1007/s004420050363; CALLAWAY RM, 1992, ECOLOGY, V73, P2118, DOI 10.2307/1941460; David TS, 2013, FOREST ECOL MANAG, V307, P136, DOI 10.1016/j.foreco.2013.07.012; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; DAWSON TE, 1993, OECOLOGIA, V95, P565, DOI 10.1007/BF00317442; EHLERINGER JR, 1992, PLANT CELL ENVIRON, V15, P1073, DOI 10.1111/j.1365-3040.1992.tb01657.x; Ellsworth PZ, 2007, PLANT SOIL, V291, P93, DOI 10.1007/s11104-006-9177-1; Filella I, 2003, BIOL PLANTARUM, V47, P209, DOI 10.1023/B:BIOP.0000022253.08474.fd; FRANCO AC, 1989, J ECOL, V77, P870, DOI 10.2307/2260991; FRANCO AC, 1990, OECOLOGIA, V82, P151, DOI 10.1007/BF00323528; Haase P, 1996, J HYDROL, V177, P23, DOI 10.1016/0022-1694(95)02794-7; HACKER SD, 1995, ECOLOGY, V76, P2165, DOI 10.2307/1941690; HAMBLIN AP, 1985, ADV AGRON, V38, P95, DOI 10.1016/S0065-2113(08)60674-4; Hao XM, 2013, ECOL RES, V28, P653, DOI 10.1007/s11284-013-1058-5; Horton JL, 1998, TRENDS ECOL EVOL, V13, P232, DOI 10.1016/S0169-5347(98)01328-7; Huxman TE, 2004, OECOLOGIA, V141, P254, DOI 10.1007/s00442-004-1682-4; JACKSON LE, 1990, AGR ECOSYST ENVIRON, V32, P89, DOI 10.1016/0167-8809(90)90126-X; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Kim K, 2011, J HYDROL, V399, P364, DOI 10.1016/j.jhydrol.2011.01.008; King DA, 1996, J TROP ECOL, V12, P25, DOI 10.1017/S0266467400009299; Kurz-Besson C, 2006, PLANT SOIL, V282, P361, DOI 10.1007/s11104-006-0005-4; Lee JE, 2005, P NATL ACAD SCI USA, V102, P17576, DOI 10.1073/pnas.0508785102; Lehto T, 2011, MYCORRHIZA, V21, P71, DOI 10.1007/s00572-010-0348-9; Li XR, 2009, SCI CHINA SER D, V52, P669, DOI 10.1007/s11430-009-0054-7; Maestre FT, 2003, ECOLOGY, V84, P3186, DOI 10.1890/02-0635; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; Neumann RB, 2012, NEW PHYTOL, V194, P337, DOI 10.1111/j.1469-8137.2012.04088.x; Numata M, 1979, METHODS ECOLOGICAL S; Poorter L, 2003, ECOLOGY, V84, P602, DOI 10.1890/0012-9658(2003)084[0602:AORFTS]2.0.CO;2; Prieto I, 2010, OECOLOGIA, V163, P855, DOI 10.1007/s00442-010-1615-3; Raz-Yaseef N, 2010, AGR FOREST METEOROL, V150, P454, DOI 10.1016/j.agrformet.2010.01.010; Reynolds JF, 1999, ECOL MONOGR, V69, P69, DOI 10.1890/0012-9615(1999)069[0069:IODODS]2.0.CO;2; RICHARDS JH, 1987, OECOLOGIA, V73, P486, DOI 10.1007/BF00379405; Rousset O, 1999, J VEG SCI, V10, P493, DOI 10.2307/3237184; Ryel RJ, 2002, OECOLOGIA, V130, P173, DOI 10.1007/s004420100794; Sardans J, 2014, ECOHYDROLOGY, V7, P1, DOI 10.1002/eco.1459; Schade JD, 2005, BIOGEOCHEMISTRY, V73, P541, DOI 10.1007/s10533-004-1718-1; Segoli M, 2012, ARID LAND RES MANAG, V26, P344, DOI 10.1080/15324982.2012.694397; Shumway SW, 2000, OECOLOGIA, V124, P138, DOI 10.1007/s004420050033; VETTERLEIN D, 1993, PLANT SOIL, V149, P275, DOI 10.1007/BF00016618; Walker LR, 2001, WEST N AM NATURALIST, V61, P25; Warren JM, 2011, OECOLOGIA, V166, P899, DOI 10.1007/s00442-011-1953-9; WELTZIN JF, 1990, J VEG SCI, V1, P325, DOI 10.2307/3235707; Williams DG, 2000, ECOL MONOGR, V70, P517, DOI 10.1890/0012-9615(2000)070[0517:IAIVFS]2.0.CO;2; Xia Y, 2010, J ARID ENVIRON, V74, P378, DOI 10.1016/j.jaridenv.2009.08.016; Yang Xiao-Dong, 2011, Chinese Journal of Plant Ecology, V35, P816, DOI 10.3724/SP.J.1258.2011.00816; Yu TF, 2013, PLANT SOIL, V372, P297, DOI 10.1007/s11104-013-1727-8; Zhang JT, 2004, QUANTITIVE ECOLOGY; Zhao F, 2011, J ARID LAND RESOURCE, V8, P156; [赵良菊 ZHAO Liangju], 2008, [地球学报, Acta Geoscientia Sinica], V29, P709; Zou CB, 2005, OECOLOGIA, V145, P32, DOI 10.1007/s00442-005-0110-8	59	14	22	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109071	10.1371/journal.pone.0109071	http://dx.doi.org/10.1371/journal.pone.0109071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275494	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500051
J	Cai, XZ; Qiao, Y; Diao, C; Xu, XX; Chen, Y; Du, SY; Liu, XD; Liu, N; Yu, S; Chen, D; Jiang, Y				Cai, Xinze; Qiao, Ying; Diao, Cheng; Xu, Xiaoxue; Chen, Yang; Du, Shuyan; Liu, Xudong; Liu, Nan; Yu, Shuang; Chen, Dong; Jiang, Yi			Association between Polymorphisms of the IKZF3 Gene and Systemic Lupus Erythematosus in a Chinese Han Population	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; AIOLOS; IKAROS; VARIANTS	Objective: It has been reported that IKAROS family of zinc finger 3 (IKZF3)-deficient mice spontaneously develop human systemic lupus erythematosus (SLE)-like phenotypes and produce anti-dsDNA Ab leading to immune complex-mediated glomerulonephritis. Polymorphism of the IKZF3 gene corresponds with the susceptibility to several immune-related diseases. Our intention was to establish an association between polymorphisms in the IKZF3 gene and SLE in the Chinese Han population. Methods: The study involved obtaining blood samples for DNA extraction and genotyping the 4 selected single-nucleotide polymorphisms (SNPs) in IKZF3, including rs12150079, rs9909593, rs907091, and rs2872507, by performing PCR restriction fragment length polymorphism analysis (PCR-RFLP). A group of 366 SLE patients were compared to 455 healthy controls. Results: A significant decrease in frequencies of the rs907091 CC genotype and C allele appeared in the SLE patients unlike that observed in the controls (p = 0.001 and 0.015, respectively). The frequencies of the rs12150079 genotype and allele were different between the SLE patients and the control individuals, although the significance was only marginal (p = 0.046 and 0.049, respectively). In addition, a significantly low frequency of the GGCG haplotype was observed in the SLE patients, suggesting that it may provide protection against SLE (p = 0.011). Conclusion: To the best of our knowledge, this is the first study to demonstrate an important association between polymorphisms in IKZF3 and SLE in the Chinese Han population. A strong association between rs907091 in the IKZF3 gene and SLE was identified.	[Cai, Xinze; Qiao, Ying; Diao, Cheng; Xu, Xiaoxue; Chen, Yang; Du, Shuyan; Liu, Xudong; Liu, Nan; Yu, Shuang; Chen, Dong; Jiang, Yi] China Med Univ, Affiliated Hosp 1, Cent Lab, Shenyang, Peoples R China; [Cai, Xinze; Jiang, Yi] China Med Univ, Dept Immunol, Coll Basic Med Sci, Shenyang, Peoples R China; [Jiang, Yi] China Med Univ, Affiliated Hosp 1, Dept Dermatol, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Jiang, Y (corresponding author), China Med Univ, Affiliated Hosp 1, Cent Lab, Shenyang, Peoples R China.	xzcai@mail.cmu.edu.cn			National Natural Science Foundation of China [30571701, 30600541, 81401330]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by a grant from the National Natural Science Foundation of China (No. 30571701; 30600541; 81401330). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahoshi M, 2008, LUPUS, V17, P568, DOI 10.1177/0961203308089340; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; De S, 2014, CLIN IMMUNOL, V152, P140, DOI 10.1016/j.clim.2014.03.009; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Kurreeman FAS, 2012, AM J HUM GENET, V90, P524, DOI 10.1016/j.ajhg.2012.01.010; Lessard CJ, 2012, AM J HUM GENET, V90, P648, DOI 10.1016/j.ajhg.2012.02.023; Li Yajuan, 2013, Genomics Proteomics & Bioinformatics, V11, P158, DOI 10.1016/j.gpb.2013.05.003; Lim LS, 2014, ARTHRITIS CARE RES H; Marinho S, 2012, ANN ALLERG ASTHMA IM, V108, P402, DOI 10.1016/j.anai.2012.03.002; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Narvi E, 2007, SCAND J IMMUNOL, V65, P503, DOI 10.1111/j.1365-3083.2007.01929.x; Qiu R, 2013, SCAND J RHEUMATOL, V42, P469, DOI 10.3109/03009742.2013.786755; Schmitt C, 2002, APOPTOSIS, V7, P277, DOI 10.1023/A:1015372322419; Sun J, 2003, J IMMUNOL, V170, P1699, DOI 10.4049/jimmunol.170.4.1699; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; WILSON A, 1992, J ROY SOC MED, V85, P1; Yu C, 2014, J AUTOIMMUN, V48-49, P10, DOI 10.1016/j.jaut.2014.01.004; Zhang JH, 2014, GENE, V533, P385, DOI 10.1016/j.gene.2013.08.051; Zhang J, 2014, HUM MOL GENET, V23, P524, DOI 10.1093/hmg/ddt424	20	15	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108661	10.1371/journal.pone.0108661	http://dx.doi.org/10.1371/journal.pone.0108661			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271777	Green Submitted, Green Published, gold			2022-12-27	WOS:000343729600054
J	Mayer, C; Call, J; Albiach-Serrano, A; Visalberghi, E; Sabbatini, G; Seed, A				Mayer, Carolina; Call, Josep; Albiach-Serrano, Anna; Visalberghi, Elisabetta; Sabbatini, Gloria; Seed, Amanda			Abstract Knowledge in the Broken-String Problem: Evidence from Nonhuman Primates and Pre-Schoolers	PLOS ONE			English	Article							MONKEYS CEBUS-APELLA; TOOL-USE; CAPUCHIN MONKEYS; GORILLA-GORILLA; PAN-PANISCUS; SAGUINUS-OEDIPUS; PONGO-ABELII; TROGLODYTES; RIGIDITY; CHILDREN	There is still large controversy about whether abstract knowledge of physical problems is uniquely human. We presented 9 capuchin monkeys, 6 bonobos, 6 chimpanzees and 48 children with two versions of a broken-string problem. In the standard condition, participants had to choose between an intact and a broken string as means to a reward. In the critical condition, the functional parts of the strings were covered up and replaced by perceptually similar, but non-functional cues. Apes, monkeys and young children performed significantly better in the standard condition in which the cues played a functional role, indicating knowledge of the functional properties involved. Moreover, a control experiment with chimpanzees and young children ruled out that this difference in performance could be accounted for by differences of perceptual feedback in the two conditions. We suggest that, similar to humans, nonhuman primates partly rely on abstract concepts in physical problem-solving.	[Mayer, Carolina; Call, Josep; Seed, Amanda] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Call, Josep; Albiach-Serrano, Anna; Seed, Amanda] Max Planck Inst Evolutionary Anthropol, Dept Comparat & Dev Psychol, Leipzig, Germany; [Albiach-Serrano, Anna] Univ CEU Cardenal Herrera, Ethol & Anim Welf Sect, Valencia, Spain; [Visalberghi, Elisabetta; Sabbatini, Gloria] CNR, Unit Cognit Primatol, Rome, Italy; [Visalberghi, Elisabetta; Sabbatini, Gloria] CNR, Ctr Primate, Ist Sci & Tecnol Cogniz, Rome, Italy	University of St Andrews; Max Planck Society; Universidad CEU Cardenal Herrera; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Mayer, C (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland.	cpm2@st-andrews.ac.uk	Serrano, Anna Albiach/M-2251-2017; Seed, Amanda M/E-7285-2010; Sabbatini, Gloria/AAY-7349-2020	Seed, Amanda M/0000-0002-3867-3003; Sabbatini, Gloria/0000-0002-5028-4326; Call Balaguer, Josep/0000-0002-8597-8336; Visalberghi, Elisabetta/0000-0001-7407-5468	Royal Commission [1851]	Royal Commission	There was funding from the Royal Commission for the Exhibition of 1851. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiach-Serrano A, 2012, J COMP PSYCHOL, V126, P355, DOI 10.1037/a0028050; Call J., 2010, ENCY ANIMAL BEHAV, P778, DOI [10.1016/B978-0-08-045337-8.00090-5, DOI 10.1016/B978-0-08-045337-8.00090-5]; Chappell J, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0409; DeLoache JS, 1999, COGNITIVE DEV, V14, P299, DOI 10.1016/S0885-2014(99)00006-4; Fujita K, 2003, J EXP PSYCHOL ANIM B, V29, P233, DOI 10.1037/0097-7403.29.3.233; Fujita K, 2011, J EXP PSYCHOL ANIM B, V37, P10, DOI 10.1037/a0020274; Gopnik A, 2004, PSYCHOL REV, V111, P3, DOI 10.1037/0033-295X.111.1.3; Gopnik A, 2001, DEV PSYCHOL, V37, P620, DOI 10.1037//0012-1649.37.5.620; Hanus D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019555; Haun DBM, 2009, COGNITION, V110, P147, DOI 10.1016/j.cognition.2008.10.012; Hauser M, 2002, ANIM BEHAV, V64, P299, DOI 10.1006/anbe.2002.3068; Herrmann E, 2008, J COMP PSYCHOL, V122, P220, DOI 10.1037/0735-7036.122.2.220; Keen R, 2008, INFANT CHILD DEV, V17, P249, DOI 10.1002/icd.550; Manrique HM, 2011, ANIM COGN, V14, P775, DOI 10.1007/s10071-011-0410-9; Manrique HM, 2010, J EXP PSYCHOL ANIM B, V36, P409, DOI 10.1037/a0019296; Martin-Ordas G, 2009, J COMP PSYCHOL, V22, P43; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Penn DC, 2007, ANNU REV PSYCHOL, V58, P97, DOI 10.1146/annurev.psych.58.110405.085555; Povinelli D.J., 2000, FOLK PHYS APES CHIMP; Santos LR, 2006, ANIM COGN, V9, P94, DOI 10.1007/s10071-005-0001-8; Seed A., 2011, TOOL USE CAUSAL COGN, P89, DOI DOI 10.1093/ACPROF:OSO/9780199571154.003.0005; Seed A, 2012, PHILOS T R SOC B, V367, P2743, DOI 10.1098/rstb.2012.0222; Seed A, 2010, CURR BIOL, V20, pR1032, DOI 10.1016/j.cub.2010.09.042; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; Volter CJ, 2012, ANIM COGN, V15, P923, DOI 10.1007/s10071-012-0519-5; Vonk J., 2006, OXFORD HDB COMP COGN, P363; Yocom AM, 2010, J COMP PSYCHOL, V124, P271, DOI 10.1037/a0019369	27	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108597	10.1371/journal.pone.0108597	http://dx.doi.org/10.1371/journal.pone.0108597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272161	Green Submitted, Green Published, gold			2022-12-27	WOS:000343729600051
J	Zhao, JB; Wang, YC; Wakeham, A; Hao, ZY; Toba, H; Bai, XH; Keshavjee, S; Mak, TW; Liu, MY				Zhao, Jinbo; Wang, Yingchun; Wakeham, Andrew; Hao, Zhenyue; Toba, Hiroaki; Bai, Xiaohui; Keshavjee, Shaf; Mak, Tak W.; Liu, Mingyao			XB130 Deficiency Affects Tracheal Epithelial Differentiation during Airway Repair	PLOS ONE			English	Article							OBLITERATIVE BRONCHIOLITIS; ADAPTER PROTEIN; CELL-POPULATION; BASAL-CELLS; CLARA CELLS; STEM-CELLS; LUNG; PROLIFERATION; REGENERATION; MIGRATION	The repair and regeneration of airway epithelium is important for maintaining homeostasis of the respiratory system. XB130 is an adaptor protein involved in the regulation of cell proliferation, survival and migration. In the human trachea, XB130 is expressed on the apical site of ciliated epithelial cells. We hypothesize that XB130 may play a role in epithelial repair and regeneration after injury. Xb130 knockout (KO) mice were generated, and a mouse isogenic tracheal transplantation model was used. Adult Xb130 KO mice did not show any significant anatomical and physiological phenotypes in comparison with their wild type (WT) littermates. The tracheal epithelium in Xb130 KO mice, however, was significantly thicker than that in WT mice. Severe ischemic epithelial injury was observed immediately after the tracheal transplantation, which was followed by epithelial cell flattening, proliferation and differentiation. No significant differences were observed in terms of initial airway injury and apoptosis. However, at Day 10 after transplantation, the epithelial layer was significantly thicker in Xb130 KO mice, and associated with greater proliferative (Ki67+) and basal (CK5+) cells, as well as thickening of the connective tissue and fibroblast layer between the epithelium and tracheal cartilages. These results suggest that XB130 is involved in the regulation of airway epithelial differentiation, especially during airway repair after injury.	[Zhao, Jinbo; Wang, Yingchun; Toba, Hiroaki; Bai, Xiaohui; Keshavjee, Shaf; Liu, Mingyao] Univ Hlth Network, Toronto Gen Res Inst, Latner Thorac Surg Res Labs, Toronto, ON, Canada; [Zhao, Jinbo] Forth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian, Shaanxi, Peoples R China; [Wakeham, Andrew; Hao, Zhenyue; Mak, Tak W.] Univ Toronto, Fac Med, Adv Med Discovery Inst, Toronto, ON, Canada; [Keshavjee, Shaf; Liu, Mingyao] Univ Toronto, Fac Med, Dept Surg, Toronto, ON M5S 1A1, Canada; [Keshavjee, Shaf; Mak, Tak W.; Liu, Mingyao] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Air Force Military Medical University; University of Toronto; University of Toronto; University of Toronto	Liu, MY (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Latner Thorac Surg Res Labs, Toronto, ON, Canada.	mingyao.liu@utoronto.ca		Liu, Mingyao/0000-0002-9188-8417; Keshavjee, Shaf/0000-0003-4547-8094	Canadian Institutes of Health Research (CIHR) [MOP-13270, MOP-42546, MOP-119514]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (CIHR) operating grants MOP-13270, MOP-42546 and MOP-119514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beers MF, 2011, J CLIN INVEST, V121, P2065, DOI 10.1172/JCI45961; Boers JE, 1998, AM J RESP CRIT CARE, V157, P2000, DOI 10.1164/ajrccm.157.6.9707011; Boers JE, 1999, AM J RESP CRIT CARE, V159, P1585, DOI 10.1164/ajrccm.159.5.9806044; Daniely Y, 2004, AM J PHYSIOL-CELL PH, V287, pC171, DOI 10.1152/ajpcell.00226.2003; Gomperts BN, 2006, J IMMUNOL, V176, P1916, DOI 10.4049/jimmunol.176.3.1916; Grove DA, 2011, J HEART LUNG TRANSPL, V30, P341, DOI 10.1016/j.healun.2010.09.012; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Hackett TL, 2011, AM J RESP CELL MOL, V45, P1090, DOI 10.1165/rcmb.2011-0031OC; Hegab AE, 2012, RESPIROLOGY, V17, P1101, DOI 10.1111/j.1440-1843.2012.02204.x; Hegab AE, 2011, STEM CELLS, V29, P1283, DOI 10.1002/stem.680; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Hyde DM, 2007, TOXICOL PATHOL, V35, P41, DOI 10.1080/01926230601059977; Kida H, 2008, AM J PATHOL, V172, P1542, DOI 10.2353/ajpath.2008.071052; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lodyga M, 2009, ONCOGENE, V28, P937, DOI 10.1038/onc.2008.447; Lodyga M, 2010, J CELL SCI, V123, P4156, DOI 10.1242/jcs.071050; Oliver JR, 2011, LAB INVEST, V91, P1514, DOI 10.1038/labinvest.2011.100; Puchelle Edith, 2006, Proc Am Thorac Soc, V3, P726, DOI 10.1513/pats.200605-126SF; Rackley CR, 2012, J CLIN INVEST, V122, P2724, DOI 10.1172/JCI60519; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Ramirez AM, 2004, AM J PATHOL, V165, P1223, DOI 10.1016/S0002-9440(10)63382-2; Rawlins EL, 2007, P NATL ACAD SCI USA, V104, P410, DOI 10.1073/pnas.0610770104; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sato M, 2009, AM J TRANSPLANT, V9, P1981, DOI 10.1111/j.1600-6143.2009.02770.x; Shi MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041292; Shiozaki A, 2012, ANN SURG ONCOL; Shiozaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043646; Shiozaki Atsushi, 2011, J Clin Bioinforma, V1, P10, DOI 10.1186/2043-9113-1-10; Shiozaki A, 2011, AM J PATHOL, V178, P391, DOI 10.1016/j.ajpath.2010.11.024; Snyder BN, 2011, EUR J CELL BIOL, V90, P376, DOI 10.1016/j.ejcb.2010.11.016; Takeshita H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059057; Van Winkle LS, 2004, J APPL PHYSIOL, V97, P2355, DOI 10.1152/japplphysiol.00470.2004; Volckaert T, 2011, J CLIN INVEST, V121, P4409, DOI 10.1172/JCI58097; Voynow JA, 2005, AM J RESP CRIT CARE, V172, P1013, DOI 10.1164/rccm.200410-1398OC; Xiao HL, 2012, CELL MOL LIFE SCI, V69, P4149, DOI 10.1007/s00018-012-1044-z; Xu JG, 2008, J HEART LUNG TRANSPL, V27, P1302, DOI 10.1016/j.healun.2008.08.010; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200; Yamanaka D, 2012, MOL ENDOCRINOL, V26, P1043, DOI 10.1210/me.2011-1349; Zuo Q, 2012, ANAT REC, V295, P423, DOI 10.1002/ar.21531	42	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108952	10.1371/journal.pone.0108952	http://dx.doi.org/10.1371/journal.pone.0108952			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272040	gold, Green Submitted, Green Published			2022-12-27	WOS:000343729600082
J	Hautala, J; Parviainen, T				Hautala, Jarkko; Parviainen, Tiina			Gaze Position Reveals Impaired Attentional Shift during Visual Word Recognition in Dysfluent Readers	PLOS ONE			English	Article							EYE-MOVEMENTS; DEVELOPMENTAL DYSLEXIA; ORTHOGRAPHIC UNIQUENESS; REGULAR ORTHOGRAPHY; MODEL; LENGTH; FIXATION; DYNAMICS; MICROSACCADES; LEXICALITY	Effects reflecting serial within-word processing are frequently found in pseudo-and non-word recognition tasks not only among fluent, but especially among dyslexic readers. However, the time course and locus of these serial within-word processing effects in the cognitive hierarchy (i.e., orthographic, phonological, lexical) have remained elusive. We studied whether a subject's eye movements during a lexical decision task would provide information about the temporal dynamics of serial within-word processing. We assumed that if there is serial within-word processing proceeding from left to right, items with informative beginnings would attract the gaze position and (micro-) saccadic eye movements earlier in time relative to those with informative endings. In addition, we compared responses to word, non-word, and pseudo-word items to study whether serial within-word processing stems mainly from a lexical, orthographic, or phonological processing level, respectively. Gaze positions showed earlier responses to anomalies located at pseudo-and non-word beginnings rather than endings, whereas informative word beginnings or endings did not affect gaze positions. The overall pattern of results suggests parallel letter processing of real words and rapid serial within-word processing when reading novel words. Dysfluent readers' gaze position responses toward anomalies located at pseudo-and non-word endings were delayed substantially, suggesting impairment in serial processing at an orthographic processing level.	[Hautala, Jarkko] Univ Jyvaskyla, Agora Ctr, Jyvaskyla, Finland; [Parviainen, Tiina] Univ Jyvaskyla, Ctr Interdisciplinary Brain Res, Dept Psychol, Jyvaskyla, Finland	University of Jyvaskyla; University of Jyvaskyla	Hautala, J (corresponding author), Univ Jyvaskyla, Agora Ctr, Jyvaskyla, Finland.	jarkko.v.hautala@jyu.fi	Parviainen, Tiina/I-4803-2016	Parviainen, Tiina/0000-0001-6992-5157				Adelman JS, 2010, PSYCHOL SCI, V21, P1799, DOI 10.1177/0956797610387442; Bergmann J, 2008, COGN NEUROPSYCHOL, V25, P653, DOI 10.1080/02643290802221404; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; Ciuffreda KJ, 1995, EYE MOVEMENT BASICS; Clark JJ, 1999, VISION RES, V39, P843, DOI 10.1016/S0042-6989(98)00203-X; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; CONNOLLY JF, 1994, J COGNITIVE NEUROSCI, V6, P256, DOI 10.1162/jocn.1994.6.3.256; CUNITZ RJ, 1969, VISION RES, V9, P683, DOI 10.1016/0042-6989(69)90125-4; De Luca M, 1999, NEUROPSYCHOLOGIA, V37, P1407, DOI 10.1016/S0028-3932(99)00038-X; De Luca M, 2010, CORTEX, V46, P1272, DOI 10.1016/j.cortex.2009.06.007; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Engbert R, 2011, P NATL ACAD SCI USA, V108, pE765, DOI 10.1073/pnas.1102730108; Ferrand L, 2003, ACTA PSYCHOL, V113, P167, DOI 10.1016/S0001-6918(03)00031-3; GRAINGER J, 1994, J MEM LANG, V33, P218, DOI 10.1006/jmla.1994.1011; Grainger J, 2009, LANG LINGUIST COMPAS, V3, P128, DOI 10.1111/j.1749-818x.2008.00121.x; HADDAD GM, 1973, VISION RES, V13, P1075, DOI 10.1016/0042-6989(73)90145-4; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1518, DOI 10.1016/S0028-3932(00)00052-X; Halgren E, 2002, NEUROIMAGE, V17, P1101, DOI 10.1006/nimg.2002.1268; Hautala J, 2013, READ WRIT, V26, P845, DOI 10.1007/s11145-012-9394-3; Hawelka S, 2010, COGNITION, V115, P367, DOI 10.1016/j.cognition.2009.11.004; Helenius P, 1999, CEREB CORTEX, V9, P476, DOI 10.1093/cercor/9.5.476; Helenius P, 1998, BRAIN, V121, P1133, DOI 10.1093/brain/121.6.1133; Horowitz TS, 2007, PSYCHOL SCI, V18, P356, DOI 10.1111/j.1467-9280.2007.01903.x; Hutzler F, 2004, BRAIN LANG, V89, P235, DOI 10.1016/S0093-934X(03)00401-2; HYONA J, 1995, J EXP PSYCHOL HUMAN, V21, P68, DOI 10.1037/0096-1523.21.1.68; HYONA J, 1989, J EXP PSYCHOL HUMAN, V15, P142, DOI 10.1037/0096-1523.15.1.142; Inhoff AW, 2008, VISION RES, V48, P1027, DOI 10.1016/j.visres.2008.01.012; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Kiefer M, 2002, COGNITIVE BRAIN RES, V13, P27, DOI 10.1016/S0926-6410(01)00085-4; Kotimaisten kielten tutkimuskeskus [Research Institute for the Languages of Finland], 2007, KOTIMAISTEN KIELTEN; Kuperman V, 2009, J EXP PSYCHOL HUMAN, V35, P876, DOI 10.1037/a0013484; Kwantes PJ, 1999, J EXP PSYCHOL HUMAN, V25, P376, DOI 10.1037/0096-1523.25.2.376; Laubrock J, 2005, VISION RES, V45, P721, DOI 10.1016/j.visres.2004.09.029; Lindell AK, 2005, BRAIN LANG, V93, P160, DOI 10.1016/j.bandl.2004.09.006; Lindell AK, 2003, Q J EXP PSYCHOL-A, V56, P287, DOI 10.1080/02724980244000341; Lyytinen H., 2011, PSYCHOL LANG COMMUNI, V15, P129, DOI [DOI 10.2478/V10057-011-0009-X, 10.2478/v10057-011-0009-x]; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; Martinez-Conde S, 2013, NAT REV NEUROSCI, V14, P83, DOI 10.1038/nrn3405; Miller B, 2006, BRIT J PSYCHOL, V97, P191, DOI 10.1348/000712605X66845; Moll K, 2005, NEUROCASE, V11, P433, DOI 10.1080/13554790500263537; Nevala J, 2007, LUKEMIS JAKIRJOITTAM; NOBRE AC, 1994, J COGNITIVE NEUROSCI, V6, P233, DOI 10.1162/jocn.1994.6.3.233; OREGAN JK, 1984, J EXP PSYCHOL HUMAN, V10, P250, DOI 10.1037/0096-1523.10.2.250; Perry C, 2007, PSYCHOL REV, V114, P273, DOI 10.1037/0033-295X.114.2.273; Pugh KR, 2000, MENT RETARD DEV D R, V6, P207, DOI 10.1002/1098-2779(2000)6:3<207::AID-MRDD8>3.0.CO;2-P; Pulvermuller F, 2009, BRAIN LANG, V110, P81, DOI 10.1016/j.bandl.2008.12.001; Pylkkanen L., 2006, HDB PSYCHOLINGUISTIC; Raven J, 1998, MANUAL RAVENS PROGR; REICHER GM, 1969, J EXP PSYCHOL, V81, P275, DOI 10.1037/h0027768; RIGGS LA, 1953, J OPT SOC AM, V43, P495, DOI 10.1364/JOSA.43.000495; Salmelin R, 1996, ANN NEUROL, V40, P157, DOI 10.1002/ana.410400206; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; Share DL, 2008, PSYCHOL BULL, V134, P584, DOI 10.1037/0033-2909.134.4.584; Suokas M, 2008, LUKUSUJUVUUSTESTIN K; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; Woodcock R. W., 2001, WOODCOCK JOHNSON; Wydell TN, 2003, J COGNITIVE NEUROSCI, V15, P1052, DOI 10.1162/089892903770007434; Zoccolotti P, 2008, EXP BRAIN RES, V186, P551, DOI 10.1007/s00221-007-1257-9; Zoccolotti P, 2009, READ WRIT, V22, P1053, DOI 10.1007/s11145-008-9144-8	60	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108937	10.1371/journal.pone.0108937	http://dx.doi.org/10.1371/journal.pone.0108937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268909	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700196
J	Lang, TG; Yin, KQ; Liu, JY; Cao, KF; Cannon, CH; Du, FK				Lang, Tiange; Yin, Kangquan; Liu, Jinyu; Cao, Kunfang; Cannon, Charles H.; Du, Fang K.			Protein Domain Analysis of Genomic Sequence Data Reveals Regulation of LRR Related Domains in Plant Transpiration in Ficus	PLOS ONE			English	Article								Predicting protein domains is essential for understanding a protein's function at the molecular level. However, up till now, there has been no direct and straightforward method for predicting protein domains in species without a reference genome sequence. In this study, we developed a functionality with a set of programs that can predict protein domains directly from genomic sequence data without a reference genome. Using whole genome sequence data, the programming functionality mainly comprised DNA assembly in combination with next-generation sequencing (NGS) assembly methods and traditional methods, peptide prediction and protein domain prediction. The proposed new functionality avoids problems associated with de novo assembly due to micro reads and small single repeats. Furthermore, we applied our functionality for the prediction of leucine rich repeat (LRR) domains in four species of Ficus with no reference genome, based on NGS genomic data. We found that the LRRNT_2 and LRR_8 domains are related to plant transpiration efficiency, as indicated by the stomata index, in the four species of Ficus. The programming functionality established in this study provides new insights for protein domain prediction, which is particularly timely in the current age of NGS data expansion.	[Lang, Tiange; Liu, Jinyu; Cao, Kunfang; Cannon, Charles H.] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan Province, Peoples R China; [Yin, Kangquan; Du, Fang K.] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Yin, Kangquan] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Cao, Kunfang] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China; [Cao, Kunfang] Guangxi Univ, Coll Forestry, Nanning 530004, Peoples R China; [Cannon, Charles H.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Beijing Forestry University; Tsinghua University; Guangxi University; Guangxi University; Texas Tech University System; Texas Tech University	Du, FK (corresponding author), Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China.	dufang325@gmail.com	Cao, Kun-Fang/D-2157-2009; Cannon, Charles H/D-7186-2012; Yin, Kangquan/T-4452-2019; Cannon, Charles/AAE-7715-2019	Cao, Kun-Fang/0000-0002-2253-7189; Cannon, Charles H/0000-0003-1901-0420; Yin, Kangquan/0000-0002-4627-6585; Cannon, Charles/0000-0003-1901-0420; Du, Fang/0000-0002-7377-5259	National Natural Science Foundation of China [61271447, 41201051]; 111 Project [B13007]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was funded by National Natural Science Foundation of China (grant number 61271447) to TL; National Natural Science Foundation of China (grant number 41201051), 111 Project (grant number B13007) and Program for Changjiang Scholars and Innovative Research Team in University (grant number IRT13047) to FKD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG CC, 1989, EXPERIENTIA, V45, P605, DOI 10.1007/BF01975677; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Corpet F, 2000, NUCLEIC ACIDS RES, V28, P267, DOI 10.1093/nar/28.1.267; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hamanishi ET, 2012, J EXP BOT, V63, P4959, DOI 10.1093/jxb/ers177; Hao GY, 2010, FUNCT ECOL, V24, P731, DOI 10.1111/j.1365-2435.2010.01724.x; Hara K, 2009, PLANT CELL PHYSIOL, V50, P1019, DOI 10.1093/pcp/pcp068; Harrison RD, 2005, BIOSCIENCE, V55, P1053, DOI 10.1641/0006-3568(2005)055[1053:FATDOT]2.0.CO;2; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Machado Moara, 2011, Investig Genet, V2, P3, DOI 10.1186/2041-2223-2-3; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; Ohri D, 1998, ANN BOT-LONDON, V82, P75, DOI 10.1006/anbo.1998.0765; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; SHAH D M, 1983, Journal of Molecular and Applied Genetics, V2, P111; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Wei T, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-47; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; ZY Wu, 2004, FLORA CHINA, V5	23	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108719	10.1371/journal.pone.0108719	http://dx.doi.org/10.1371/journal.pone.0108719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25269070	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700147
J	Phelan, MM; McLean, L; Armstrong, SD; Hurst, JL; Beynon, RJ; Lian, LY				Phelan, Marie M.; McLean, Lynn; Armstrong, Stuart D.; Hurst, Jane L.; Beynon, Robert J.; Lian, Lu-Yun			The Structure, Stability and Pheromone Binding of the Male Mouse Protein Sex Pheromone Darcin	PLOS ONE			English	Article							MAJOR URINARY PROTEINS; IN-HOUSE MICE; SECONDARY STRUCTURE ASSIGNMENT; MUS-MUSCULUS; INDIVIDUAL-RECOGNITION; RESONANCE ASSIGNMENT; AGGRESSIVE-BEHAVIOR; GENETIC-BASIS; FEMALE MICE; WEB SERVER	Mouse urine contains highly polymorphic major urinary proteins that have multiple functions in scent communication through their abilities to bind, transport and release hydrophobic volatile pheromones. The mouse genome encodes for about 20 of these proteins and are classified, based on amino acid sequence similarity and tissue expression patterns, as either central or peripheral major urinary proteins. Darcin is a male specific peripheral major urinary protein and is distinctive in its role in inherent female attraction. A comparison of the structure and biophysical properties of darcin with MUP11, which belongs to the central class, highlights similarity in the overall structure between the two proteins. The thermodynamic stability, however, differs between the two proteins, with darcin being much more stable. Furthermore, the affinity of a small pheromone mimetic is higher for darcin, although darcin is more discriminatory, being unable to bind bulkier ligands. These attributes are due to the hydrophobic ligand binding cavity of darcin being smaller, caused by the presence of larger amino acid side chains. Thus, the physical and chemical characteristics of the binding cavity, together with its extreme stability, are consistent with darcin being able to exert its function after release into the environment.	[Phelan, Marie M.; Lian, Lu-Yun] Univ Liverpool, NMR Ctr Struct Biol, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [McLean, Lynn; Armstrong, Stuart D.; Beynon, Robert J.] Univ Liverpool, Inst Integrat Biol, Prot Funct Grp, Liverpool L69 3BX, Merseyside, England; [Hurst, Jane L.] Univ Liverpool, Inst Integrat Biol, Mammalian Behaviour & Evolut Grp, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool; University of Liverpool	Lian, LY (corresponding author), Univ Liverpool, NMR Ctr Struct Biol, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	Lu-Yun.Lian@liverpool.ac.uk	Hurst, Jane L/G-8793-2015; Beynon, Robert/K-1408-2014	Hurst, Jane L/0000-0002-3728-9624; Beynon, Robert/0000-0003-0857-495X	BBSRC LOLA grant [BB/J002631/1]; Biotechnology and Biological Sciences Research Council [BB/J002631/1] Funding Source: researchfish; BBSRC [BB/J002631/1] Funding Source: UKRI	BBSRC LOLA grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by BBSRC LOLA grant [BB/J002631/1] to JLH, RJB and LYL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SD, 2005, BIOCHEM J, V391, P343, DOI 10.1042/BJ20050404; BACCHINI A, 1992, EXPERIENTIA, V48, P419, DOI 10.1007/BF01923448; Barratt E, 2005, J AM CHEM SOC, V127, P11827, DOI 10.1021/ja0527525; Barratt E, 2006, J MOL BIOL, V362, P994, DOI 10.1016/j.jmb.2006.07.067; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Beynon R, 2003, BIOCHEM SOC T, V32, P393; Beynon RJ, 2002, J CHEM ECOL, V28, P1429, DOI 10.1023/A:1016252703836; Bingham RJ, 2004, J AM CHEM SOC, V126, P1675, DOI 10.1021/ja038461i; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Brechuhl J, 2013, P NATL ACAD SCI USA, V110, P4762, DOI 10.1073/pnas.1214249110; BRUCE HM, 1959, NATURE, V184, P105, DOI 10.1038/184105a0; Cavaggioni A, 2000, BBA-PROTEIN STRUCT M, V1482, P218, DOI 10.1016/S0167-4838(00)00149-7; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chamero P, 2011, P NATL ACAD SCI USA, V108, P12898, DOI 10.1073/pnas.1107770108; Cheetham SA, 2007, CURR BIOL, V17, P1771, DOI 10.1016/j.cub.2007.10.007; Cheetham SA, 2009, PHYSIOL BEHAV, V96, P253, DOI 10.1016/j.physbeh.2008.10.005; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Doreleijers JF, 2012, NUCLEIC ACIDS RES, V40, pD519, DOI 10.1093/nar/gkr1134; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Flower DR, 1996, BIOCHEM J, V318, P1; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Garratt M, 2011, J EVOLUTION BIOL, V24, P2398, DOI 10.1111/j.1420-9101.2011.02367.x; Garratt M, 2011, P ROY SOC B-BIOL SCI, V278, P1098, DOI 10.1098/rspb.2010.1818; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwak J, 2012, PHYSIOL BEHAV, V107, P112, DOI 10.1016/j.physbeh.2012.06.008; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leopold M. F., 1994, Molecular Biotechnology, V2, P61, DOI 10.1007/BF02789290; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Macek P, 2006, FEBS LETT, V580, P682, DOI 10.1016/j.febslet.2005.12.088; Malham R, 2005, J AM CHEM SOC, V127, P17061, DOI 10.1021/ja055454g; Marie AD, 2001, PROTEIN SCI, V10, P411, DOI 10.1110/ps.31701; Mudge JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r91; Novotny MV, 1999, CHEM BIOL, V6, P377, DOI 10.1016/S1074-5521(99)80049-0; Parfentjev A, 1932, J BIOL CHEM, P551; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Perez-Miller S, 2010, PROTEIN SCI, V19, P1469, DOI 10.1002/pro.426; Pertinhez TA, 2009, BIOCHEM BIOPH RES CO, V390, P1266, DOI 10.1016/j.bbrc.2009.10.133; Phelan MM, 2010, BIOMOL NMR ASSIGN, V4, P239, DOI 10.1007/s12104-010-9253-6; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Roberts SA, 2012, SCIENCE, V338, P1462, DOI 10.1126/science.1225638; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; ROBERTSON DHL, 1993, J CHEM ECOL, V19, P1405, DOI 10.1007/BF00984885; SHAHAN K, 1987, MOL CELL BIOL, V7, P1947, DOI 10.1128/MCB.7.5.1947; Sharrow SD, 2002, PROTEIN SCI, V11, P2247, DOI 10.1110/ps.0204202; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Sherborne AL, 2007, CURR BIOL, V17, P2061, DOI 10.1016/j.cub.2007.10.041; Stopkova R, 2007, J CHEM ECOL, V33, P861, DOI 10.1007/s10886-007-9262-9; Syme NR, 2007, CHEMBIOCHEM, V8, P1509, DOI 10.1002/cbic.200700281; Timm DE, 2001, PROTEIN SCI, V10, P997, DOI 10.1110/ps.52201; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; VANDENBERGH JG, 1967, ENDOCRINOLOGY, V81, P345, DOI 10.1210/endo-81-2-345; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	59	20	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108415	10.1371/journal.pone.0108415	http://dx.doi.org/10.1371/journal.pone.0108415			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279835	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800014
J	Sarma, RK; Gogoi, A; Dehury, B; Debnath, R; Bora, TC; Saikia, R				Sarma, Rupak K.; Gogoi, Animesh; Dehury, Budheswar; Debnath, Rajal; Bora, Tarun C.; Saikia, Ratul			Community Profiling of Culturable Fluorescent Pseudomonads in the Rhizosphere of Green Gram (Vigna radiata L.)	PLOS ONE			English	Article							GROWTH-PROMOTING RHIZOBACTERIA; POLYMERASE-CHAIN-REACTION; INDUCED SYSTEMIC RESISTANCE; BLACK ROOT-ROT; PLANT-GROWTH; GENETIC DIVERSITY; BIOLOGICAL-CONTROL; PHENAZINE-1-CARBOXYLIC ACID; PHOSPHATE-SOLUBILIZATION; FUNCTIONAL DIVERSITY	Study on microbial diversity in the unexplored rhizosphere is important to understand their community structure, biology and ecological interaction with the host plant. This research assessed the genetic and functional diversity of fluorescent pseudomonads [FP] in the green gram rhizophere. One hundred and twenty types of morphologically distinct fluorescent pseudomonads were isolated during vegetative as well as reproductive growth phase of green gram. Rep PCR, ARDRA and RISA revealed two distinct clusters in each case at 75, 61 and 70% similarity coefficient index respectively. 16S rRNA partial sequencing analysis of 85 distantly related fluorescent pseudomonads depicted Pseudomonas aeruginosa as the dominant group. Out of 120 isolates, 23 (19%) showed antagonistic activity towards phytopathogenic fungi. These bacterial isolates showed varied production of salicylic acid, HCN and chitinase, 2, 4-diacetylphloroglucinol (DAPG), phenazine-1-carboxylic acid (PCA) and pyoluteorin (PLT). Production efficiency of inherent level of plant growth promoting (PGP) traits among the 120 isolates demonstrated that 10 (8%) solubilised inorganic phosphates, 25 (20%) produced indoles and 5 (4%) retained ACC deaminase activity. Pseudomonas aeruginosa GGRJ21 showed the highest production of all antagonistic and plant growth promoting (PGP) traits. In a greenhouse experiment, GGRJ21 suppressed root rot disease of green gram by 28-93% (p = 0.05). Consistent up regulation of three important stress responsive genes, i.e., acdS, KatA and gbsA and elevated production efficiency of different PGP traits could promote GGRJ21 as a potent plant growth regulator.	[Sarma, Rupak K.; Gogoi, Animesh; Debnath, Rajal; Bora, Tarun C.; Saikia, Ratul] North East Inst Sci & Technol, CSIR, Div Biotechnol, Jorhat, Assam, India; [Dehury, Budheswar] Assam Agr Univ, Dept Agr Biotechnol, Jorhat, Assam, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - North East Institute of Science & Technology (NEIST); Assam Agricultural University	Saikia, R (corresponding author), North East Inst Sci & Technol, CSIR, Div Biotechnol, Jorhat, Assam, India.	rsaikia19@gmail.com	Debnath, Rajal/AAX-5042-2020; DEHURY, BUDHESWAR/G-9330-2017; DEBNATH, RAJAL/N-2687-2017	Debnath, Rajal/0000-0002-7675-3856; DEHURY, BUDHESWAR/0000-0002-9726-8454; DEBNATH, RAJAL/0000-0002-7675-3856	Network Project (AMAAS) - Indian Council of Agricultural Research (ICAR), Government of India, New Delhi	Network Project (AMAAS) - Indian Council of Agricultural Research (ICAR), Government of India, New Delhi	The work is supported by a Network Project (AMAAS), sponsored by Indian Council of Agricultural Research (ICAR), Government of India, New Delhi. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram A, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-113; ALEXANDER DB, 1991, BIOL FERT SOILS, V12, P39, DOI 10.1007/BF00369386; Aspedon A, 2006, J BACTERIOL, V188, P2721, DOI 10.1128/JB.188.7.2721-2725.2006; Ayyadurai N, 2007, J MICROBIOL BIOTECHN, V17, P919; Basha TS, 2012, INT J FOOD AGR VET S, V2, P134; Bashan Y, 2013, BIOL FERT SOILS, V49, P465, DOI 10.1007/s00374-012-0737-7; Belimov AA, 2001, CAN J MICROBIOL, V47, P642, DOI 10.1139/cjm-47-7-642; Bergey DH., 1994, BERGEYS MANUAL DETER, pp. 395; Bharucha U, 2013, AGR RES, V2, P215, DOI 10.1007/s40003-013-0065-7; Brimecombe MJ, 2001, BOOKS SOIL PLANT ENV, P95; Campbell BG, 1996, FEMS MICROBIOL LETT, V138, P207, DOI 10.1016/0378-1097(96)00108-5; Castagno LN, 2011, J APPL MICROBIOL, V110, P1151, DOI 10.1111/j.1365-2672.2011.04968.x; Chancey ST, 1999, APPL ENVIRON MICROB, V65, P2294; Cordero P, 2012, SYST APPL MICROBIOL, V35, P342, DOI 10.1016/j.syapm.2012.04.005; Debnath R, 2013, EXTREMOPHILES, V17, P1045, DOI 10.1007/s00792-013-0587-8; DEBRUIJN FJ, 1992, APPL ENVIRON MICROB, V58, P2180, DOI 10.1128/AEM.58.7.2180-2187.1992; Diby P, 2005, ANN MICROBIOL, V55, P129; DSOUZAAULT MR, 1993, APPL ENVIRON MICROB, V59, P473, DOI 10.1128/AEM.59.2.473-478.1993; Duffy BK, 1997, PHYTOPATHOLOGY, V87, P1250, DOI 10.1094/PHYTO.1997.87.12.1250; DUTRECQ A, 1991, P252; DWORKIN M, 1958, J BACTERIOL, V75, P592, DOI 10.1128/JB.75.5.592-603.1958; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fiske CH, 1925, J BIOL CHEM, V66, P375; Garagulia A D, 1974, Mikrobiol Zh, V36, P197; Gardener BBM, 2000, APPL ENVIRON MICROB, V66, P1939, DOI 10.1128/AEM.66.5.1939-1946.2000; Gardener BBM, 2007, PHYTOPATHOLOGY, V97, P221, DOI 10.1094/PHYTO-97-2-0221; Gollnick P, 2005, ANNU REV GENET, V39, P47, DOI 10.1146/annurev.genet.39.073003.093745; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; GURUSIDDAIAH S, 1986, ANTIMICROB AGENTS CH, V29, P488, DOI 10.1128/AAC.29.3.488; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hofte M, 2010, RES MICROBIOL, V161, P464, DOI 10.1016/j.resmic.2010.04.007; HONMA M, 1978, AGR BIOL CHEM TOKYO, V42, P1825, DOI 10.1080/00021369.1978.10863261; Hu HB, 2005, J MICROBIOL BIOTECHN, V15, P86; Jalal M, 1991, HDB MICROBIAL IRON C, P235; JENSEN MA, 1993, APPL ENVIRON MICROB, V59, P945, DOI 10.1128/AEM.59.4.945-952.1993; KEEL C, 1992, MOL PLANT MICROBE IN, V5, P4, DOI 10.1094/MPMI-5-004; Kerr J.R., 2000, INFECT DIS REV, V2, P184; Khalid A, 2004, J APPL MICROBIOL, V96, P473, DOI 10.1046/j.1365-2672.2003.02161.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KLOEPPER JW, 1980, CURR MICROBIOL, V4, P317, DOI 10.1007/BF02602840; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; Kremer RJ, 2001, CURR MICROBIOL, V43, P182, DOI 10.1007/s002840010284; LAMBERT B, 1987, APPL ENVIRON MICROB, V53, P1866, DOI 10.1128/AEM.53.8.1866-1871.1987; LEMANCEAU P, 1995, APPL ENVIRON MICROB, V61, P1004, DOI 10.1128/AEM.61.3.1004-1012.1995; Ligon JM, 2000, PEST MANAG SCI, V56, P688, DOI 10.1002/1526-4998(200008)56:8<688::AID-PS186>3.3.CO;2-M; Lottmann J, 2001, MICROBIOL RES, V156, P75, DOI 10.1078/0944-5013-00086; LOUWS FJ, 1994, APPL ENVIRON MICROB, V60, P2286, DOI 10.1128/AEM.60.7.2286-2295.1994; Maksimov IV, 2011, APPL BIOCHEM MICRO+, V47, P333, DOI 10.1134/S0003683811040090; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Mavrodi OV, 2001, PHYTOPATHOLOGY, V91, P35, DOI 10.1094/PHYTO.2001.91.1.35; Mayak S, 2004, PLANT SCI, V166, P525, DOI 10.1016/j.plantsci.2003.10.025; MCARTHUR JV, 1988, P NATL ACAD SCI USA, V85, P9621, DOI 10.1073/pnas.85.24.9621; Meyer JB, 2011, APPL ENVIRON MICROB, V77, P7345, DOI 10.1128/AEM.05434-11; MICHEL BE, 1973, PLANT PHYSIOL, V51, P914, DOI 10.1104/pp.51.5.914; Misko AL, 2002, FEMS MICROBIOL ECOL, V42, P399, DOI 10.1111/j.1574-6941.2002.tb01029.x; Nahas E, 1996, WORLD J MICROB BIOT, V12, P567, DOI 10.1007/BF00327716; Naik PR, 2008, MICROB ECOL, V56, P492, DOI 10.1007/s00248-008-9368-9; Naik PR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-230; Park KH, 2009, LETT APPL MICROBIOL, V49, P222, DOI 10.1111/j.1472-765X.2009.02642.x; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Pettersson M, 2004, SOIL BIOL BIOCHEM, V36, P1383, DOI 10.1016/j.soilbio.2004.02.028; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PFENDER WF, 1993, PHYTOPATHOLOGY, V83, P1223, DOI 10.1094/Phyto-83-1223; PIERSON LS, 1992, MOL PLANT MICROBE IN, V5, P330, DOI 10.1094/MPMI-5-330; Pieterse CMJ, 1998, PLANT CELL, V10, P1571, DOI 10.1105/tpc.10.9.1571; Podile AR, 2006, PLANT GROWTH PROMOTI; Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764; Puopolo G, 2013, NAT PROD RES, V27, P956, DOI 10.1080/14786419.2012.696257; Raaijmakers JM, 1997, APPL ENVIRON MICROB, V63, P881, DOI 10.1128/AEM.63.3.881-887.1997; Raaijmakers JM, 1999, PHYTOPATHOLOGY, V89, P470, DOI 10.1094/PHYTO.1999.89.6.470; Ramette A, 2006, FEMS MICROBIOL ECOL, V55, P369, DOI 10.1111/j.1574-6941.2005.00052.x; Rangarajan S, 2002, MICROBIAL ECOL, V43, P280, DOI 10.1007/s00248-002-2004-1; Reddi TK, 1970, ANTIBIOTIKI MOSCOW, P19; REEVES MW, 1983, J BACTERIOL, V154, P324, DOI 10.1128/JB.154.1.324-329.1983; Riley MA, 1999, TRENDS MICROBIOL, V7, P129, DOI 10.1016/S0966-842X(99)01459-6; Saikia R, 2011, MICROBIOL RES, V166, P216, DOI 10.1016/j.micres.2010.03.002; Saikia R, 2003, MICROBIOL RES, V158, P203, DOI 10.1078/0944-5013-00202; Salman M, 2010, BIOL CONTROL, V53, P161, DOI 10.1016/j.biocontrol.2010.01.007; Sandhya V, 2009, BIOL FERT SOILS, V46, P17, DOI 10.1007/s00374-009-0401-z; Saravanakumar D, 2007, J APPL MICROBIOL, V102, P1283, DOI 10.1111/j.1365-2672.2006.03179.x; Saravanakumar D, 2011, ACTA PHYSIOL PLANT, V33, P203, DOI 10.1007/s11738-010-0539-1; Sarma RK, 2014, PLANT SOIL, V377, P111, DOI 10.1007/s11104-013-1981-9; Sarma RK, 2012, FOLIA MICROBIOL, V57, P129, DOI 10.1007/s12223-012-0097-6; Sarniguet A, 1995, P NATL ACAD SCI USA, V92, P12255, DOI 10.1073/pnas.92.26.12255; SCHILLINGER U, 1989, APPL ENVIRON MICROB, V55, P1901, DOI 10.1128/AEM.55.8.1901-1906.1989; Someya Nobutaka, 2007, Biocontrol Science, V12, P1; Subba Rao NS, 1982, ADV AGR MICROBIOLOGY, P229; THOMASHOW LS, 1990, APPL ENVIRON MICROB, V56, P908, DOI 10.1128/AEM.56.4.908-912.1990; Thomashow LS, 1996, PLANT MICROBE INTERA, V1, P187; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VOISARD C, 1989, EMBO J, V8, P351, DOI 10.1002/j.1460-2075.1989.tb03384.x; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557; Wang CX, 2001, FEMS MICROBIOL ECOL, V37, P105, DOI 10.1111/j.1574-6941.2001.tb00858.x; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Weller DM, 2007, PHYTOPATHOLOGY, V97, P250, DOI 10.1094/PHYTO-97-2-0250; WELLER DM, 1988, ANNU REV PHYTOPATHOL, V26, P379, DOI 10.1146/annurev.py.26.090188.002115; Widmer F, 1998, APPL ENVIRON MICROB, V64, P2545; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Wright CA, 2004, P NATL ACAD SCI USA, V101, P3269, DOI 10.1073/pnas.0400461101; YALPANI N, 1991, PLANT CELL, V3, P809, DOI 10.1105/tpc.3.8.809	102	5	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108378	10.1371/journal.pone.0108378	http://dx.doi.org/10.1371/journal.pone.0108378			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279790	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800013
J	Stoeckel, LE; Palley, LS; Gollub, RL; Niemi, SM; Evins, AE				Stoeckel, Luke E.; Palley, Lori S.; Gollub, Randy L.; Niemi, Steven M.; Evins, Anne Eden			Patterns of Brain Activation when Mothers View Their Own Child and Dog: An fMRI Study	PLOS ONE			English	Article							OXYTOCIN-DOPAMINE INTERACTIONS; AINSWORTHS STRANGE SITUATION; FUSIFORM FACE AREA; ROMANTIC LOVE; ORBITOFRONTAL CORTEX; MATERNAL-BEHAVIOR; NEURAL ACTIVATION; CANIS-FAMILIARIS; PET OWNERSHIP; ATTACHMENT	Neural substrates underlying the human-pet relationship are largely unknown. We examined fMRI brain activation patterns as mothers viewed images of their own child and dog and an unfamiliar child and dog. There was a common network of brain regions involved in emotion, reward, affiliation, visual processing and social cognition when mothers viewed images of both their child and dog. Viewing images of their child resulted in brain activity in the midbrain (ventral tegmental area/substantia nigra involved in reward/affiliation), while a more posterior cortical brain activation pattern involving fusiform gyrus (visual processing of faces and social cognition) characterized a mother's response to her dog. Mothers also rated images of their child and dog as eliciting similar levels of excitement (arousal) and pleasantness (valence), although the difference in the own vs. unfamiliar child comparison was larger than the own vs. unfamiliar dog comparison for arousal. Valence ratings of their dog were also positively correlated with ratings of the attachment to their dog. Although there are similarities in the perceived emotional experience and brain function associated with the mother-child and mother-dog bond, there are also key differences that may reflect variance in the evolutionary course and function of these relationships.	[Stoeckel, Luke E.; Gollub, Randy L.; Evins, Anne Eden] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Palley, Lori S.] Massachusetts Gen Hosp, Ctr Comparat Med, Boston, MA USA; [Stoeckel, Luke E.; Gollub, Randy L.; Evins, Anne Eden] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Niemi, Steven M.] Harvard Univ, Fac Arts & Sci, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University	Stoeckel, LE (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.	lpalley@partners.org; lstoeckel@mgh.harvard.edu	Stoeckel, Luke/AAT-1742-2020	Stoeckel, Luke/0000-0002-7837-7487; Gollub, Randy L./0000-0002-9434-4044	Massachusetts General Hospital Center for Comparative Medicine; Athinoula A. Martinos Center for Biomedical Imaging at the Massachusetts General Hospital; Biomedical Technology Program of the National Institutes of Health National Center for Research Resources (NCRR); Harvard Catalyst \ The Harvard Clinical and Translational Science Center [NIH UL1 RR 025758]; Harvard University; Charles A. King Trust; NIH [K23DA032612, K24 DA030443]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075, UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA032612, K24DA030443] Funding Source: NIH RePORTER	Massachusetts General Hospital Center for Comparative Medicine; Athinoula A. Martinos Center for Biomedical Imaging at the Massachusetts General Hospital; Biomedical Technology Program of the National Institutes of Health National Center for Research Resources (NCRR); Harvard Catalyst \ The Harvard Clinical and Translational Science Center; Harvard University; Charles A. King Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded by the Massachusetts General Hospital Center for Comparative Medicine, with additional support from the Athinoula A. Martinos Center for Biomedical Imaging at the Massachusetts General Hospital, using resources provided by the Center for Functional Neuroimaging Technologies, P41RR14075, a P41 Regional Resource supported by the Biomedical Technology Program of the National Institutes of Health National Center for Research Resources (NCRR). This work was also conducted with support from Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (NIH UL1 RR 025758) and financial contributions from Harvard University and its affiliated academic health care centers. Finally, the study was supported by the Charles A. King Trust (LES), by NIH K23DA032612 (LES) and by NIH K24 DA030443 (AEE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo BP, 2012, SOC COGN AFFECT NEUR, V7, P145, DOI 10.1093/scan/nsq092; Aggleton JP, 2010, EUR J NEUROSCI, V31, P2292, DOI 10.1111/j.1460-9568.2010.07251.x; AINSWORTH MDS, 1989, AM PSYCHOL, V44, P709, DOI 10.1037/0003-066X.44.4.709; Aron A, 2005, J NEUROPHYSIOL, V94, P327, DOI 10.1152/jn.00838.2004; Atzil S, 2011, NEUROPSYCHOPHARMACOL, V36, P2603, DOI 10.1038/npp.2011.172; Barrett J, 2011, J CHILD PSYCHOL PSYC, V52, P368, DOI 10.1111/j.1469-7610.2010.02306.x; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Blackford JU, 2013, SOC COGN AFFECT NEUR, V8, P143, DOI 10.1093/scan/nsr078; Bloom T, 2013, BEHAV PROCESS, V96, P1, DOI 10.1016/j.beproc.2013.02.010; Dahlstroem A., 1964, ACTA PHYSL SCAND S, V232, P231; Douglas AJ, 2010, ENDOCRINOLOGY, V151, P1978, DOI 10.1210/en.2010-0259; Dreher JC, 2007, P NATL ACAD SCI USA, V104, P2465, DOI 10.1073/pnas.0605569104; Elliott R, 2003, J NEUROSCI, V23, P303; Everitt B.J., 2013, NEUROSCI BIOBEHAV RE; Fine AH., 2006, HDB ANIMAL ASSISTED; Fisher H, 2005, J COMP NEUROL, V493, P58, DOI 10.1002/cne.20772; Fisher HE, 2002, ARCH SEX BEHAV, V31, P413, DOI 10.1023/A:1019888024255; Fisher Helen, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P92; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gobbini MI, 2004, NEUROIMAGE, V22, P1628, DOI 10.1016/j.neuroimage.2004.03.049; Grabka, 2011, ANIMALS AFFECT US EX, P153, DOI [10.1037/12301-008, DOI 10.1037/12301-008]; Handlin L, 2011, ANTHROZOOS, V24, P301, DOI 10.2752/175303711X13045914865385; Haskett ME, 2006, J CLIN CHILD ADOLESC, V35, P302, DOI 10.1207/s15374424jccp3502_14; Holdnack H. A., 2001, WECHSLER TEST ADULT; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Horn L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065296; JOHNSON TP, 1992, ANTHROZOOS, V5, P160, DOI 10.2752/089279392787011395; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kurdek LA, 2009, J FAM PSYCHOL, V23, P439, DOI 10.1037/a0014979; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; Lang P.J., 2008, A8 U FLOR; Lang PJ, 1998, PSYCHOPHYSIOLOGY, V35, P199, DOI 10.1017/S0048577298001991; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Leopold DA, 2010, J COMP PSYCHOL, V124, P233, DOI 10.1037/a0019460; Lorberbaum JP, 2002, BIOL PSYCHIAT, V51, P431, DOI 10.1016/S0006-3223(01)01284-7; LOUP F, 1991, BRAIN RES, V555, P220, DOI 10.1016/0006-8993(91)90345-V; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Marcus DA, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0376-1; McConnell AR, 2011, J PERS SOC PSYCHOL, V101, P1239, DOI 10.1037/a0024506; McNicholas J, 2005, BMJ-BRIT MED J, V331, P1252, DOI 10.1136/bmj.331.7527.1252; Miller SC, 2009, ANTHROZOOS, V22, P31, DOI 10.2752/175303708X390455; Nagasawa M, 2009, HORM BEHAV, V55, P434, DOI 10.1016/j.yhbeh.2008.12.002; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Nitschke JB, 2004, NEUROIMAGE, V21, P583, DOI 10.1016/j.neuroimage.2003.10.005; Odendaal JSJ, 2003, VET J, V165, P296, DOI 10.1016/S1090-0233(02)00237-X; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palmer R, 2008, APPL ANIM BEHAV SCI, V109, P306, DOI 10.1016/j.applanim.2007.04.002; Parsons CE, 2010, PROG NEUROBIOL, V91, P220, DOI 10.1016/j.pneurobio.2010.03.001; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Prato-Previde E, 2003, BEHAVIOUR, V140, P225, DOI 10.1163/156853903321671514; Ranote S, 2004, NEUROREPORT, V15, P1825, DOI 10.1097/01.wnr.0000137078.64128.6a; RUSSELL JA, 1979, J PERS SOC PSYCHOL, V37, P345, DOI 10.1037/0022-3514.37.3.345; Schultz RT, 2003, PHILOS T R SOC B, V358, P415, DOI 10.1098/rstb.2002.1208; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Shahrokh DK, 2010, ENDOCRINOLOGY, V151, P2276, DOI 10.1210/en.2009-1271; Shipman P, 2010, CURR ANTHROPOL, V51, P519, DOI 10.1086/653816; Siniscalchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078455; Strathearn L, 2008, PEDIATRICS, V122, P40, DOI 10.1542/peds.2007-1566; Swain JE, 2007, J CHILD PSYCHOL PSYC, V48, P262, DOI 10.1111/j.1469-7610.2007.01731.x; Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650; Topal J, 1998, J COMP PSYCHOL, V112, P219, DOI 10.1037/0735-7036.112.3.219; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wood L, 2005, SOC SCI MED, V61, P1159, DOI 10.1016/j.socscimed.2005.01.017; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zilcha-Mano S, 2011, ATTACH HUM DEV, V13, P541, DOI 10.1080/14616734.2011.608987	66	50	50	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e107205	10.1371/journal.pone.0107205	http://dx.doi.org/10.1371/journal.pone.0107205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279788	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800005
J	Wallace, AA; Hollander, DJ; Peebles, EB				Wallace, Amy A.; Hollander, David J.; Peebles, Ernst B.			Stable Isotopes in Fish Eye Lenses as Potential Recorders of Trophic and Geographic History	PLOS ONE			English	Article							FIBER CELL-DIFFERENTIATION; AGE-DETERMINATION; DELTA-C-13; DELTA-N-15; TURNOVER; MODELS; FRACTIONATION; POPULATIONS; VERTEBRAE; PATTERNS	We evaluated eye lenses as potential recorders of stable isotope histories in fish because they consist of metabolically inert optical proteins that are deposited in successive, concentric circles (laminae) much like otolith circuli and tree rings. We conducted four different tests on lenses from red snapper, red grouper, gag, and white grunt. The first test was a low-resolution screening of multiple individuals (4-5 radial groups of laminae per lens, all species except white grunt). Along the radial axis, all individuals exhibited substantial isotopic variability. Red snapper individuals separated into two groups based on delta N-15 and gag separated into two groups based on delta C-13. Two gag with the greatest variation were chosen for high-resolution temporal analysis using individual laminae from their second eye lenses. The first-order patterns from the high-resolution analysis generally mimicked patterns from the low-resolution screening of grouped laminae, yet the high-resolution plots revealed early-life details that were not apparent in the low-resolution screenings. For the third test, left-versus right-eye variation was compared using high-resolution methods. White grunt left-and right-eye radial isotopic patterns were almost identical for both delta C-13 and delta N-15, suggesting the variations observed among individual fish were not artifacts. The final test evaluated intra-laminar variation; multiple samples were analyzed from different parts of the same lamina. Seven laminae from three individuals of two species were analyzed in this manner; variations among laminae were found to be much higher than variations within laminae. However, nominal intra-laminar variations were comparable to nominal differences between left and right lenses, suggesting intra-laminar variation established measurement precision. Eye lens isotopes appear to be useful for reconstructing the isotopic histories of individual fish; these histories can be compared with spatially-derived isoscapes to reconstruct individual histories for site fidelity, movement and trophic position.	[Wallace, Amy A.; Hollander, David J.; Peebles, Ernst B.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA	State University System of Florida; University of South Florida	Wallace, AA (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	awallac4@mail.usf.edu		Chiaradia, Andre/0000-0002-6178-4211	National Oceanic and Atmospheric Administration (NOAA) Fisheries [NA10NMF4550468]; Gulf of Mexico Research Initiative	National Oceanic and Atmospheric Administration (NOAA) Fisheries; Gulf of Mexico Research Initiative	AAW was supported by a fellowship from National Oceanic and Atmospheric Administration (NOAA) Fisheries (grant NA10NMF4550468). The research was also supported by the Gulf of Mexico Research Initiative through an award to C-IMAGE, the Center for Integrated Modeling and Analysis of the Gulf Ecosystem. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Al-Hassan Laith A. J., 1994, Pakistan Journal of Zoology, V26, P81; Al-Mamry Juma, 2012, Natura Montenegrina, V11, P73; BLOEMENDAL H, 1982, CRC CR REV BIOCH MOL, V12, P1, DOI 10.3109/10409238209105849; BURKETT RD, 1971, AM MIDL NAT, V85, P222, DOI 10.2307/2423924; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; Dahm R, 1999, OPHTHALMIC RES, V31, P163, DOI 10.1159/000055530; Dahm R, 2007, EXP EYE RES, V85, P74, DOI 10.1016/j.exer.2007.02.015; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; del Rio CM, 2012, J MAMMAL, V93, P353, DOI 10.1644/11-MAMM-S-165.1; Ellis G, 2012, THESIS U S FLORIDA T; Estrada JA, 2006, ECOLOGY, V87, P829, DOI 10.1890/0012-9658(2006)87[829:UOIAOV]2.0.CO;2; Ethier DM, 2010, CAN J ZOOL, V88, P1043, DOI 10.1139/Z10-073; Fitzhugh GR, 2005, B MAR SCI, V77, P377; FRY B, 1982, OECOLOGIA, V54, P200, DOI 10.1007/BF00378393; Hache S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094437; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; Hobson KA, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P273, DOI 10.1007/978-90-481-3354-3_13; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Hunsicker ME, 2010, MAR ECOL PROG SER, V415, P91, DOI 10.3354/meps08750; Hutchinson JJ, 2006, J FISH BIOL, V69, P1874, DOI 10.1111/j.1095-8649.2006.01234.x; JONES C, 1986, FISH B-NOAA, V84, P91; Karpouzi VS, 2003, J FISH BIOL, V62, P1353, DOI 10.1046/j.1095-8649.2003.00118.x; Kerr LA, 2006, ENVIRON BIOL FISH, V77, P337, DOI 10.1007/s10641-006-9125-1; McMahon KW, 2013, OCEANOGR MAR BIOL, V51, P327; NICOL JAC, 1989, EYES FISHES; Parry M. P., 2003, THESIS U HAWAII MANO; Phillips DL, 2006, OECOLOGIA, V147, P195, DOI 10.1007/s00442-005-0292-0; Popp BN, 2007, TERR ECOL SER, V1, P173; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Radabaugh KR, 2014, CONT SHELF RES, V84, P158, DOI 10.1016/j.csr.2014.05.002; Radabaugh KR, 2013, CONT SHELF RES, V68, P112, DOI 10.1016/j.csr.2013.08.010; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; SIEZEN RJ, 1989, CURR EYE RES, V8, P707, DOI 10.3109/02713688909025805; THOMPSON RC, 1956, J BIOL CHEM, V223, P795; Thorrold SR, 1997, GEOCHIM COSMOCHIM AC, V61, P2909, DOI 10.1016/S0016-7037(97)00141-5; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Trueman CN, 2007, TERR ECOL SER, V1, P145; Vihtelic TS, 2008, INT REV CEL MOL BIO, V269, P341, DOI 10.1016/S1937-6448(08)01006-X; Walker JL, 1999, MAR MAMMAL SCI, V15, P314, DOI 10.1111/j.1748-7692.1999.tb00804.x; Werry JM, 2011, MAR FRESHWATER RES, V62, P1421, DOI 10.1071/MF11136; West JB, 2010, ISOSCAPES UNDERSTAND, pv; Woodcock SH, 2014, FISH RES, V153, P9, DOI 10.1016/j.fishres.2014.01.003; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324	47	32	36	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108935	10.1371/journal.pone.0108935	http://dx.doi.org/10.1371/journal.pone.0108935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279946	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800039
J	Liu, Y; Gupta, P; Lapointe, M; Yotsapon, T; Sarat, S; Cianflone, K				Liu, Yan; Gupta, Priyanka; Lapointe, Marc; Yotsapon, Thewjitcharoen; Sarat, Sunthornyothin; Cianflone, Katherine			Acylation Stimulating Protein, Complement C3 and Lipid Metabolism in Ketosis-Prone Diabetic Subjects	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; POSTPRANDIAL TRIGLYCERIDE CLEARANCE; ORAL FAT LOAD; INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; CLINICAL CHARACTERISTICS; ASP PRODUCTION; OBESE WOMEN; ACID; COMPONENT-3	Background: Ketosis-prone diabetes (KPDM) is new-onset diabetic ketoacidosis without precipitating factors in non-type 1 diabetic patients; after management, some are withdrawn from exogenous insulin, although determining factors remain unclear. Methods: Twenty KPDM patients and twelve type 1 diabetic patients (T1DM), evaluated at baseline, 12 and 24 months with/without insulin maintenance underwent a standardized mixed-meal tolerance test (MMTT) for 2 h. Results: At baseline, triglyceride and C3 were higher during MMTT in KPDM vs. T1DM (p<0.0001) with no differences in non-esterified fatty acids (NEFA) while Acylation Stimulating Protein (ASP) tended to be higher. Within 12 months, 11 KPDM were withdrawn from insulin treatment (KPDM-ins), while 9 were maintained (KPDM+ins). NEFA was lower in KPDM-ins vs. KPDM+ins at baseline (p = 0.0006), 12 months (p<0.0001) and 24 months (p<0.0001) during MMTT. NEFA in KPDM-ins decreased over 30-120 minutes (p, 0.05), but not in KPDM+ins. Overall, C3 was higher in KPDM-ins vs KPDM+ins at 12 months (p = 0.0081) and 24 months (p = 0.0019), while ASP was lower at baseline (p = 0.0024) and 12 months (p = 0.0281), with a decrease in ASP/C3 ratio. Conclusions: Notwithstanding greater adiposity in KPDM-ins, greater NEFA decreases and lower ASP levels during MMTT suggest better insulin and ASP sensitivity in these patients.	[Liu, Yan; Gupta, Priyanka; Lapointe, Marc; Cianflone, Katherine] Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Liu, Yan] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Pediat, Wuhan 430074, Hubei, Peoples R China; [Yotsapon, Thewjitcharoen; Sarat, Sunthornyothin] Chulalongkorn Univ, Fac Med, Dept Med, Div Endocrinol & Metab, Bangkok 10330, Thailand	Laval University; Huazhong University of Science & Technology; Chulalongkorn University	Cianflone, K (corresponding author), Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	katherine.cianflone@criucpq.ulaval.ca	Yotsapon, Thewjitcharoen/GMW-8914-2022; 艳, 刘/HGC-6167-2022	Yotsapon, Thewjitcharoen/0000-0002-2317-4041; Lapointe, Marc/0000-0003-0461-2576	Diabetes Research Grant from The Endocrine Society of Thailand, GlaxoSmithKline; Ratchadapiseksompotch Research Fund from Faculty of Medicine, Chulalongkorn University, Thailand; Canadian Institutes of Health Research (CIHR)	Diabetes Research Grant from The Endocrine Society of Thailand, GlaxoSmithKline; Ratchadapiseksompotch Research Fund from Faculty of Medicine, Chulalongkorn University, Thailand; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by a Diabetes Research Grant from The Endocrine Society of Thailand (sponsored by GlaxoSmithKline), Ratchadapiseksompotch Research Fund from Faculty of Medicine, Chulalongkorn University, Thailand a grant from the Canadian Institutes of Health Research (CIHR to KC). KC holds a Canada Research Chair in Adipose Tissue. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2003, INT J OBESITY, V27, P1037, DOI 10.1038/sj.ijo.0802369; Cianflone K, 2004, J LIPID RES, V45, P124, DOI 10.1194/jlr.M300214-JLR200; Cianflone K, 2003, BBA-BIOMEMBRANES, V1609, P127, DOI 10.1016/S0005-2736(02)00686-7; Cianflone K, 1999, SEMIN CELL DEV BIOL, V10, P31, DOI 10.1006/scdb.1998.0272; Delaney ME, 2000, ENDOCRIN METAB CLIN, V29, P683, DOI 10.1016/S0889-8529(05)70159-6; Engstrom G, 2005, DIABETES, V54, P570, DOI 10.2337/diabetes.54.2.570; Evans K, 2002, DIABETES, V51, P2684, DOI 10.2337/diabetes.51.9.2684; Faraj M, 2004, J LIPID RES, V45, P657, DOI 10.1194/jlr.M300299-JLR200; Faraj M, 2004, BIOCHEM CELL BIOL, V82, P170, DOI 10.1139/o03-078; Fisette A, 2013, BIOCHEM BIOPH RES CO, V437, P403, DOI 10.1016/j.bbrc.2013.06.090; Gao Y, 2011, ACTA BIOCH BIOPH SIN, V43, P154, DOI 10.1093/abbs/gmq124; Gao Y, 2010, J CELL BIOCHEM, V109, P896, DOI 10.1002/jcb.22464; Halkes CJM, 2001, ARTERIOSCL THROM VAS, V21, P1526, DOI 10.1161/hq0901.095276; Horakova D, 2010, BIOMED PAP, V154, P245, DOI 10.5507/bp.2010.037; Kalant D, 2000, J LIPID RES, V41, P1963; Kalant D, 2005, J BIOL CHEM, V280, P23936, DOI 10.1074/jbc.M406921200; Kitabchi AE, 2003, J CLIN ENDOCR METAB, V88, P5087, DOI 10.1210/jc.2003-031656; Koistinen HA, 2001, ARTERIOSCL THROM VAS, V21, P1034, DOI 10.1161/01.ATV.21.6.1034; Li LX, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-18; Maldonado M, 2003, J CLIN ENDOCR METAB, V88, P5090, DOI 10.1210/jc.2003-030180; Maldonado MR, 2005, DIABETIC MED, V22, P1744, DOI 10.1111/j.1464-5491.2005.01724.x; Maldonado MR, 2004, ETHNIC DIS, V14, P243; Marcil M, 2006, ARTERIOSCL THROM VAS, V26, P1619, DOI 10.1161/01.ATV.0000222907.72985.0b; Maslowska M, 1999, EUR J CLIN INVEST, V29, P679, DOI 10.1046/j.1365-2362.1999.00514.x; Mauvais-Jarvis F, 2004, DIABETES, V53, P645, DOI 10.2337/diabetes.53.3.645; Munkonda MN, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.13; Murray I, 1999, J LIPID RES, V40, P1671; Muscari A, 2007, DIABETES CARE, V30, P2362, DOI 10.2337/dc07-0637; Paglialunga S, 2007, J ENDOCRINOL, V194, P293, DOI 10.1677/JOE-07-0205; Peake PW, 2005, INT J OBESITY, V29, P429, DOI 10.1038/sj.ijo.0802644; Rosenbloom A, 2000, PEDIATRICS, V105, P671; Scantlebury T, 2001, BIOCHEM J, V356, P445, DOI 10.1042/0264-6021:3560445; Seok H, 2013, DIABETES-METAB RES, V29, P507, DOI 10.1002/dmrr.2421; Smiley Dawn, 2011, Diabetes Manag (Lond), V1, P589; Sobngwi E, 2002, DIABETIC MED, V19, P832, DOI 10.1046/j.1464-5491.2002.00802.x; Sodowski K, 2008, J PHYSIOL PHARMACOL, V59, P33; St-Pierre DH, 2009, CLIN ENDOCRINOL, V70, P539, DOI 10.1111/j.1365-2265.2008.03353.x; Tahiri Y, 2007, NUTR METABOLISM, V4, DOI 10.1186/1743-7075-4-11; TASKINEN M-R, 1987, Diabetes Metabolism Reviews, V3, P551; Umpierrez GE, 2006, ANN INTERN MED, V144, P350, DOI 10.7326/0003-4819-144-5-200603070-00011; Umpierrez GE, 1999, DIABETES CARE, V22, P1517, DOI 10.2337/diacare.22.9.1517; van Oostrom AJ, 2004, AM J CLIN NUTR, V79, P510; van Oostrom AJHHM, 2007, ATHEROSCLEROSIS, V190, P167, DOI 10.1016/j.atherosclerosis.2006.01.009; Verseyden C, 2003, J LIPID RES, V44, P2100, DOI 10.1194/jlr.M300201-JLR200; Wen Y, 2008, J CELL BIOCHEM, V104, P391, DOI 10.1002/jcb.21631; Yang Y, 2006, INT J OBESITY, V30, P439, DOI 10.1038/sj.ijo.0803173	46	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109237	10.1371/journal.pone.0109237	http://dx.doi.org/10.1371/journal.pone.0109237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275325	Green Submitted, gold, Green Published			2022-12-27	WOS:000342591500079
J	Liu, YY; Xue, YC; Ridley, S; Zhang, D; Rezvani, K; Fu, XD; Wang, HM				Liu, Yanying; Xue, Yuanchao; Ridley, Samantha; Zhang, Dong; Rezvani, Khosrow; Fu, Xiang-Dong; Wang, Hongmin			Direct Reprogramming of Huntington's Disease Patient Fibroblasts into Neuron-Like Cells Leads to Abnormal Neurite Outgrowth, Increased Cell Death, and Aggregate Formation	PLOS ONE			English	Article							FUNCTIONAL-NEURONS; MUTANT HUNTINGTIN; DIRECT CONVERSION; EXPRESSION; INTERACTS; PROTEINS; NUCLEAR	Recent advances in trans-differentiation of one type cell to another have made it possible to directly convert Huntington's disease (HD) patient fibroblasts into neurons by modulation of cell-lineage-specific transcription factors or RNA processing. However, this possibility has not been examined. Here, we demonstrate that HD patient-derived fibroblasts can be directly trans-differentiated into neuron-like cells by knockdown of the expression of a single gene encoding the polypyrimidine-tract-binding protein. The directly converted HD neuron-like cells were positive in expression of Tuj1, NeuN, DARPP-32, and c-aminobutyric acid and exhibited neuritic breakdown, abnormal neuritic branching, increased cell death, and aggregation of mutant huntingtin. These observations indicate that the neuron-like cells directly converted from HD patient fibroblasts recapitulate the major aspects of neuropathological characteristics of HD and thus provide an additional model for understanding the disorder and validation of therapeutic reagents.	[Liu, Yanying; Ridley, Samantha; Zhang, Dong; Rezvani, Khosrow; Wang, Hongmin] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA; [Xue, Yuanchao; Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of South Dakota; University of California System; University of California San Diego	Wang, HM (corresponding author), Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA.	Hongmin.Wang@usd.edu		Zhang, Dong/0000-0002-4515-2070	University of South Dakota; NIH [1R15NS071459-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS071459] Funding Source: NIH RePORTER	University of South Dakota; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Start-up Funds from the University of South Dakota. HW was supported in part by the NIH grant 1R15NS071459-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Chan AWS, 2010, CELL REPROGRAM, V12, P509, DOI 10.1089/cell.2010.0019; Dong G, 2011, CELL MOL NEUROBIOL, V31, P737, DOI 10.1007/s10571-011-9679-0; Dong GF, 2012, J NEUROCHEM, V123, P437, DOI 10.1111/j.1471-4159.2012.07919.x; Dong GF, 2012, J BIOL CHEM, V287, P1279, DOI 10.1074/jbc.M111.294280; FERRANTE RJ, 1991, J NEUROSCI, V11, P3877; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Kaye JA, 2013, MOL CELL NEUROSCI, V56, P50, DOI 10.1016/j.mcn.2013.02.005; Lavezzi AM, 2013, J NEUROL SCI, V329, P45, DOI 10.1016/j.jns.2013.03.012; Li SH, 2004, NEUROSCIENTIST, V10, P467, DOI 10.1177/1073858404266777; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Rong J, 2006, J NEUROSCI, V26, P6019, DOI 10.1523/JNEUROSCI.1251-06.2006; Sipione S, 2001, MOL NEUROBIOL, V23, P21; Valcarcel J, 1997, CURR BIOL, V7, pR705, DOI 10.1016/S0960-9822(06)00361-7; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Zhou H, 2003, J CELL BIOL, V163, P109, DOI 10.1083/jcb.200306038	29	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109621	10.1371/journal.pone.0109621	http://dx.doi.org/10.1371/journal.pone.0109621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275533	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500109
J	Zhang, DG; Feygelman, V; Moros, EG; Latifi, K; Zhang, GG				Zhang, Daniel G.; Feygelman, Vladimir; Moros, Eduardo G.; Latifi, Kujtim; Zhang, Geoffrey G.			Monte Carlo Study of Radiation Dose Enhancement by Gadolinium in Megavoltage and High Dose Rate Radiotherapy	PLOS ONE			English	Article							FLATTENING FILTER-FREE; GOLD NANOPARTICLES; MOTEXAFIN GADOLINIUM; IN-VIVO; THERAPY; BRACHYTHERAPY; MRI; SIMULATION; CONTRAST; CANCER	MRI is often used in tumor localization for radiotherapy treatment planning, with gadolinium (Gd)-containing materials often introduced as a contrast agent. Motexafin gadolinium is a novel radiosensitizer currently being studied in clinical trials. The nanoparticle technologies can target tumors with high concentration of high-Z materials. This Monte Carlo study is the first detailed quantitative investigation of high-Z material Gd-induced dose enhancement in megavoltage external beam photon therapy. BEAMnrc, a radiotherapy Monte Carlo simulation package, was used to calculate dose enhancement as a function of Gd concentration. Published phase space files for the TrueBeam flattening filter free (FFF) and conventional flattened 6MV photon beams were used. High dose rate (HDR) brachytherapy with Ir-192 source was also investigated as a reference. The energy spectra difference caused a dose enhancement difference between the two beams. Since the Ir-192 photons have lower energy yet, the photoelectric effect in the presence of Gd leads to even higher dose enhancement in HDR. At depth of 1.8 cm, the percent mean dose enhancement for the FFF beam was 0.38 +/- 0.12, 1.39 +/- 0.21, 2.51 +/- 0.34, 3.59 +/- 0.26, and 4.59 +/- 0.34 for Gd concentrations of 1, 5, 10, 15, and 20 mg/mL, respectively. The corresponding values for the flattened beam were 0.09 +/- 0.14, 0.50 +/- 0.28, 1.19 +/- 0.29, 1.68 +/- 0.39, and 2.34 +/- 0.24. For Ir-192 with direct contact, the enhanced were 0.50 +/- 0.14, 2.79 +/- 0.17, 5.49 +/- 0.12, 8.19 +/- 0.14, and 10.80 +/- 0.13. Gd-containing materials used in MRI as contrast agents can also potentially serve as radiosensitizers in radiotherapy. This study demonstrates that Gd can be used to enhance radiation dose in target volumes not only in HDR brachytherapy, but also in 6 MV FFF external beam radiotherapy, but higher than the currently used clinical concentration (>5 mg/mL) would be needed.	[Zhang, Daniel G.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Feygelman, Vladimir; Moros, Eduardo G.; Latifi, Kujtim; Zhang, Geoffrey G.] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA	University of California System; University of California Berkeley; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Zhang, GG (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA.	Geoffrey.zhang@moffitt.org	Moros, Eduardo G./AAY-2771-2020	Moros, Eduardo G./0000-0003-1964-2460				Amirbekian V, 2007, P NATL ACAD SCI USA, V104, P961, DOI 10.1073/pnas.0606281104; Berbeco RI, 2011, INT J RADIAT ONCOL, V81, P270, DOI 10.1016/j.ijrobp.2010.10.022; Berndt C, 2011, CANCER LETT, V307, P119, DOI 10.1016/j.canlet.2011.03.023; Carde P, 2001, J CLIN ONCOL, V19, P2074, DOI 10.1200/JCO.2001.19.7.2074; Cho SH, 2005, PHYS MED BIOL, V50, pN163, DOI 10.1088/0031-9155/50/15/N01; Constantin M, 2011, MED PHYS, V38, P4018, DOI 10.1118/1.3598439; Dalaryd M, 2010, PHYS MED BIOL, V55, P7333, DOI 10.1088/0031-9155/55/23/010; de Rochefort L, 2008, MED PHYS, V35, P5328, DOI 10.1118/1.3002309; Donnelly ET, 2004, INT J RADIAT ONCOL, V58, P1570, DOI 10.1016/j.ijrobp.2003.12.017; Evens AM, 2004, CURR OPIN ONCOL, V16, P576, DOI 10.1097/01.cco.0000142073.29850.98; Forouzannia A, 2007, EXPERT REV ANTICANC, V7, P785, DOI 10.1586/14737140.7.6.785; Hainfeld JF, 2004, PHYS MED BIOL, V49, pN309, DOI 10.1088/0031-9155/49/18/N03; Hashemy SI, 2006, J BIOL CHEM, V281, P10691, DOI 10.1074/jbc.M511373200; Hsu SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044528; Javedan K, 2014, PHYS MEDICA, V30, P503, DOI 10.1016/j.ejmp.2014.03.001; Joh DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062425; Jones BL, 2010, MED PHYS, V37, P3809, DOI 10.1118/1.3455703; Kawrakow I, 2006, MED PHYS, V33, P3046, DOI 10.1118/1.2219778; Kawrakow I, 2000, MED PHYS, V27, P485, DOI 10.1118/1.598917; Leung MKK, 2011, MED PHYS, V38, P624, DOI 10.1118/1.3539623; Nasongkla N, 2006, NANO LETT, V6, P2427, DOI 10.1021/nl061412u; NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458; Oerlemans C, 2010, PHARM RES-DORDR, V27, P2569, DOI 10.1007/s11095-010-0233-4; Prezado Y, 2009, MED PHYS, V36, P3568, DOI 10.1118/1.3166186; Rahman WN, 2009, NANOMED-NANOTECHNOL, V5, P136, DOI 10.1016/j.nano.2009.01.014; ROGERS DWO, 1995, MED PHYS, V22, P503, DOI 10.1118/1.597552; Saini AS, 2011, INT J RADIAT ONCOL, V80, P1263, DOI 10.1016/j.ijrobp.2010.08.033; Toossi MTB, 2012, AUSTRALAS PHYS ENG S, V35, P177, DOI 10.1007/s13246-012-0143-3; Zhang RR, 2013, J APPL CLIN MED PHYS, V14, P92, DOI 10.1120/jacmp.v14i1.3991	29	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109389	10.1371/journal.pone.0109389	http://dx.doi.org/10.1371/journal.pone.0109389			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275550	Green Submitted, gold, Green Published			2022-12-27	WOS:000342591500100
J	Isabel, C; Lecler, A; Turc, G; Naggara, O; Schmitt, E; Belkacem, S; Oppenheim, C; Touze, E				Isabel, Clothilde; Lecler, Augustin; Turc, Guillaume; Naggara, Olivier; Schmitt, Emmanuelle; Belkacem, Samia; Oppenheim, Catherine; Touze, Emmanuel			Relationship between Watershed Infarcts and Recent Intra Plaque Haemorrhage in Carotid Atherosclerotic Plaque	PLOS ONE			English	Article							ARTERY-DISEASE; PROGNOSIS; PERFUSION; EMBOLISM; STENOSIS; STROKE; MRI	Objective: Watershed infarcts (WSI) are thought to result from hemodynamic mechanism, but studies have suggested that microemboli from unstable carotid plaques may distribute preferentially in watershed areas, i.e., between two cerebral arterial territories. Intraplaque haemorrhage (IPH) is an emerging marker of plaque instability and microembolic activity. We assessed the association between WSI and IPH in patients with recently symptomatic moderate carotid stenosis. Methods and Results: We selected 65 patients with symptomatic moderate (median NASCET degree of stenosis = 31%) carotid stenosis and brain infarct on Diffusion-Weighted Imaging (DWI) on Magnetic Resonance Imaging (MRI) from a multicentre prospective study. Fourteen (22%) had WSI (cortical, n = 8; internal, n = 4; cortical and internal, n = 2). Patients with WSI were more likely to have IPH than those without WSI although the difference was not significant (50% vs. 31%, OR = 2.19; 95% CI, 0.66-7.29; P = 0.20). After adjustment for degree of stenosis, age and gender, the results remained unchanged. Conclusion: About one in fifth of brain infarcts occurring in patients with moderate carotid stenosis were distributed in watershed areas. Albeit not significant, an association between IPH - more generally plaque component - and WSI, still remains possible.	[Isabel, Clothilde; Turc, Guillaume; Touze, Emmanuel] Univ Paris 05, Serv Neurol, INSERM, U894, Paris, France; [Lecler, Augustin; Naggara, Olivier; Oppenheim, Catherine] Univ Paris 05, Serv Neuroradiol, INSERM, U894, Paris, France; [Schmitt, Emmanuelle] CHRU Nancy, Serv Neurol, Nancy, France; [Belkacem, Samia] Grp Hosp Pitie Salpetriere, Serv Neurol, F-75634 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Touze, E (corresponding author), Univ Caen Basse Normandie, CHU Cote Nacre, INSERM, U919, Caen, France.	touze@cyceron.fr	Lecler, Augustin/AFT-7756-2022; Naggara, Olivier/R-3939-2017; Oppenheim, Catherine/N-1635-2018	Lecler, Augustin/0000-0001-7869-1815; Turc, Guillaume/0000-0001-5059-4095; Naggara, Olivier/0000-0002-9544-379X; Oppenheim, Catherine/0000-0003-3410-0862; Touze, Emmanuel/0000-0002-7254-2162				Caplan LR, 1998, ARCH NEUROL-CHICAGO, V55, P1475, DOI 10.1001/archneur.55.11.1475; Chaves CJ, 2000, STROKE, V31, P1090, DOI 10.1161/01.STR.31.5.1090; Del Sette M, 2000, STROKE, V31, P631, DOI 10.1161/01.STR.31.3.631; Derdeyn CP, 2001, RADIOLOGY, V220, P195, DOI 10.1148/radiology.220.1.r01jl09195; Gupta A, STROKE, V44, P3071; Hellings WE, 2010, CIRCULATION, V121, P1941, DOI 10.1161/CIRCULATIONAHA.109.887497; Hiramatsu Kazuhisa, 2003, J Stroke Cerebrovasc Dis, V12, P51, DOI 10.1053/jscd.2003.17; JORGENSEN L, 1969, J NEUROL SCI, V9, P285, DOI 10.1016/0022-510X(69)90078-1; Klijn CJM, 2010, LANCET NEUROL, V9, P1008, DOI 10.1016/S1474-4422(10)70185-X; Mangla R, 2011, RADIOGRAPHICS, V31, P1201, DOI 10.1148/rg.315105014; MASUDA J, 1994, NEUROLOGY, V44, P1231, DOI 10.1212/WNL.44.7.1231; McMillan HJ, 2008, NEUROLOGY, V70, P80, DOI 10.1212/01.wnl.0000277656.36206.ca; Momjian-Mayor I, 2005, STROKE, V36, P567, DOI 10.1161/01.STR.0000155727.82242.e1; POLLANEN MS, 1989, ARCH PATHOL LAB MED, V113, P1139; POLLANEN MS, 1990, CAN J NEUROL SCI, V17, P395, DOI 10.1017/S031716710003095X; Touze E, 2007, STROKE, V38, P1812, DOI 10.1161/STROKEAHA.106.479139; Turc G, ARTERIOSCLER THROMB, V32, P492; Zhang CM, 2009, SCAND CARDIOVASC J, V43, P345, DOI 10.1080/14017430802699232	18	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108712	10.1371/journal.pone.0108712	http://dx.doi.org/10.1371/journal.pone.0108712			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272160	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600058
J	Liu, YJ; Zhu, GX; Yang, J; Yuan, AH; Shen, XP				Liu, Yuanjun; Zhu, Guoxing; Yang, Jing; Yuan, Aihua; Shen, Xiaoping			Peroxidase-Like Catalytic Activity of Ag3PO4 Nanocrystals Prepared by a Colloidal Route	PLOS ONE			English	Article							ENHANCED PHOTOCATALYTIC ACTIVITY; FE3O4 MAGNETIC NANOPARTICLES; GLUCOSE DETECTION; VISIBLE-LIGHT; COLORIMETRIC DETECTION; OXIDE NANOPARTICLES; HYDROGEN-PEROXIDE; HIGHLY EFFICIENT; GRAPHENE OXIDE; SUB-MICROCRYSTALS	Nearly monodispersed Ag3PO4 nanocrystals with size of 10 nm were prepared through a colloidal chemical route. It was proven that the synthesized Ag3PO4 nanoparticles have intrinsic peroxidase-like catalytic activity. They can quickly catalyze oxidation of the peroxidase substrate 3, 3, 5, 5-tetramethylbenzidine (TMB) in the presence of H2O2, producing a blue color. The catalysis reaction follows Michaelis-Menten kinetics. The calculated kinetic parameters indicate a high catalytic activity and the strong affinity of Ag3PO4 nanocrystals to the substrate (TMB). These results suggest the potential applications of Ag3PO4 nanocrystals in fields such as biotechnology, environmental chemistry, and medicine.	[Liu, Yuanjun; Yuan, Aihua] Jiangsu Univ Sci & Technol, Sch Environm & Chem Engn, Zhenjiang, Peoples R China; [Zhu, Guoxing; Yang, Jing; Shen, Xiaoping] Jiangsu Univ, Sch Chem & Chem Engn, Zhenjiang, Peoples R China; [Zhu, Guoxing] Nanjing Univ, State Key Lab Coordinat Chem, Nanjing 210008, Jiangsu, Peoples R China	Jiangsu University of Science & Technology; Jiangsu University; Nanjing University	Zhu, GX (corresponding author), Jiangsu Univ, Sch Chem & Chem Engn, Zhenjiang, Peoples R China.	zhuguoxing@ujs.edu.cn; aihuayuan@just.edu.cn	Nanozymes, Nanozymes/D-8197-2019; Shen, Xiao Ping/AAA-1973-2022; shen, xiaoping/ABF-7863-2021	shen, xiaoping/0000-0003-0366-6433	National Natural Science Foundation of China [51203069, 51102117, 51072071]; China Postdoctoral Science Foundation [2012T50439]; Jiangsu Natural Science Foundation of China [BK2012276]; Cultivating Project of Young Academic Leader from Jiangsu University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Natural Science Foundation of China(Natural Science Foundation of Jiangsu Province); Cultivating Project of Young Academic Leader from Jiangsu University	Financial support was provided by the National Natural Science Foundation of China (No. 51203069, 51102117, 51072071), China Postdoctoral Science Foundation (2012T50439), Jiangsu Natural Science Foundation of China (No. BK2012276), and Cultivating Project of Young Academic Leader from Jiangsu University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre R, 2011, ADV FUNCT MATER, V21, P501, DOI 10.1002/adfm.201001302; Asati A, 2009, ANGEW CHEM INT EDIT, V48, P2308, DOI 10.1002/anie.200805279; Bi YP, 2012, CHEM COMMUN, V48, P3748, DOI 10.1039/c2cc30363a; Bi YP, 2011, PHYS CHEM CHEM PHYS, V13, P10071, DOI 10.1039/c1cp20488b; Bi Y, 2011, J AM CHEM SOC, V133, P6490, DOI 10.1021/ja2002132; Dinh CT, 2011, CHEM COMMUN, V47, P7797, DOI 10.1039/c1cc12014j; Chen W, 2012, ANALYST, V137, P1706, DOI 10.1039/c2an35072f; Cui RJ, 2011, CHEM-EUR J, V17, P9377, DOI 10.1002/chem.201100478; Dong YL, 2012, NANOSCALE, V4, P3969, DOI 10.1039/c2nr12109c; Dutta AK, 2012, ACS APPL MATER INTER, V4, P1919, DOI 10.1021/am300408r; Fan J, 2011, BIOMATERIALS, V32, P1611, DOI 10.1016/j.biomaterials.2010.11.004; Gao LZ, 2007, NAT NANOTECHNOL, V2, P577, DOI 10.1038/nnano.2007.260; He SH, 2010, TALANTA, V82, P377, DOI 10.1016/j.talanta.2010.04.055; He WW, 2011, BIOMATERIALS, V32, P1139, DOI 10.1016/j.biomaterials.2010.09.040; He WW, 2010, CHEM MATER, V22, P2988, DOI 10.1021/cm100393v; Heckert EG, 2008, BIOMATERIALS, V29, P2705, DOI 10.1016/j.biomaterials.2008.03.014; Jiang H, 2012, ANALYST, V137, P5560, DOI 10.1039/c2an35911a; JOSEPHY PD, 1982, J BIOL CHEM, V257, P3669; Jv Y, 2010, CHEM COMMUN, V46, P8017, DOI 10.1039/c0cc02698k; Karaseva EI, 2002, RUSS J BIOORG CHEM+, V28, P128, DOI 10.1023/A:1015069424251; Katsumata H, 2013, CATAL COMMUN, V34, P30, DOI 10.1016/j.catcom.2013.01.012; Korsvik C, 2007, CHEM COMMUN, P1056, DOI 10.1039/b615134e; Li GP, 2012, RSC ADV, V2, P5108, DOI 10.1039/c2ra20504a; Liang QH, 2012, CRYSTENGCOMM, V14, P2966, DOI 10.1039/c2ce06425a; Liu JB, 2012, SENSOR ACTUAT B-CHEM, V166, P708, DOI 10.1016/j.snb.2012.03.045; Liu JB, 2011, CHEM COMMUN, V47, P10981, DOI 10.1039/c1cc14346h; Liu L, 2012, CATAL SCI TECHNOL, V2, P2525, DOI 10.1039/c2cy20483e; Liu SH, 2011, CHEM-EUR J, V17, P620, DOI 10.1002/chem.201001789; Ma M, 2011, COLLOID SURFACE A, V373, P6, DOI 10.1016/j.colsurfa.2010.08.007; Niu HY, 2011, J HAZARD MATER, V190, P559, DOI 10.1016/j.jhazmat.2011.03.086; Park KS, 2011, SMALL, V7, P1521, DOI 10.1002/smll.201001886; Pirmohamed T, 2010, CHEM COMMUN, V46, P2736, DOI 10.1039/b922024k; Qu FL, 2011, BIOSENS BIOELECTRON, V26, P3927, DOI 10.1016/j.bios.2011.03.013; Shi WB, 2011, CHEM COMMUN, V47, P10785, DOI 10.1039/c1cc14300j; Shi WB, 2011, CHEM COMMUN, V47, P6695, DOI 10.1039/c1cc11943e; Song YJ, 2011, ADV MATER, V23, P4215, DOI 10.1002/adma.201101853; Song YJ, 2011, CHEM COMMUN, V47, P4436, DOI 10.1039/c0cc05533f; Song YJ, 2010, ADV MATER, V22, P2206, DOI 10.1002/adma.200903783; Song YJ, 2010, CHEM-EUR J, V16, P3617, DOI 10.1002/chem.200902643; Sun XL, 2013, ADV MATER, V25, P132, DOI 10.1002/adma.201203218; Tian JQ, 2012, CATAL SCI TECHNOL, V2, P432, DOI 10.1039/c1cy00360g; Tian QW, 2011, ACS NANO, V5, P9761, DOI 10.1021/nn203293t; Umezawa N, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.035202; Wang N, 2010, ULTRASON SONOCHEM, V17, P526, DOI 10.1016/j.ultsonch.2009.11.001; Wang Q, 2014, IND ENG CHEM RES, V53, P7917, DOI 10.1021/ie403554v; Wang XX, 2011, BIOSENS BIOELECTRON, V26, P3614, DOI 10.1016/j.bios.2011.02.014; Wang XH, 2011, NANO RES, V4, P908, DOI 10.1007/s12274-011-0147-4; Wei H, 2008, ANAL CHEM, V80, P2250, DOI 10.1021/ac702203f; Yi ZG, 2010, NAT MATER, V9, P559, DOI [10.1038/NMAT2780, 10.1038/nmat2780]; Yu FQ, 2009, BIOMATERIALS, V30, P4716, DOI 10.1016/j.biomaterials.2009.05.005; Zhang HC, 2012, J MATER CHEM, V22, P10501, DOI 10.1039/c2jm30703k; Zhang LL, 2012, NEW J CHEM, V36, P1541, DOI 10.1039/c2nj40206h; Zhang XQ, 2010, J MATER CHEM, V20, P5110, DOI 10.1039/c0jm00174k; Zuo XL, 2009, NANO RES, V2, P617, DOI [10.1007/S12274-009-9062-3, 10.1007/s12274-009-9062-3]	54	24	24	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109158	10.1371/journal.pone.0109158	http://dx.doi.org/10.1371/journal.pone.0109158			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271632	Green Submitted, Green Published, gold			2022-12-27	WOS:000343729600101
J	Chen, GY; Feng, LN; Liu, Z; Sun, YZ; Chang, HF; Cui, PC				Chen, Guanyin; Feng, Lining; Liu, Zhi; Sun, Yongzhu; Chang, Haifeng; Cui, Pengcheng			Both Central and Peripheral Auditory Systems Are Involved in Salicylate-Induced Tinnitus in Rats: A Behavioral Study	PLOS ONE			English	Article							INHIBITORY POSTSYNAPTIC CURRENTS; SODIUM-SALICYLATE; BRAIN-SLICES; ANIMAL-MODEL; NEURONS; CORTEX; OTOTOXICITY; PERCEPTION; RESPONSES; PARADIGM	Objective: This study was designed to establish a low dose salicylate-induced tinnitus rat model and to investigate whether central or peripheral auditory system is involved in tinnitus. Methods: Lick suppression ratio (R), lick count and lick latency of conditioned rats in salicylate group (120 mg/kg, intraperitoneally) and saline group were first compared. Bilateral auditory nerves were ablated in unconditioned rats and lick count and lick latency were compared before and after ablation. The ablation was then performed in conditioned rats and lick count and lick latency were compared between salicylate group and saline group and between ablated and unablated salicylate groups. Results: Both the R value and the lick count in salicylate group were significantly higher than those in saline group and lick latency in salicylate group was significantly shorter than that in saline group. No significant changes were observed in lick count and lick latency before and after ablation. After ablation, lick count and lick latency in salicylate group were significantly higher and shorter respectively than those in saline group, but they were significantly lower and longer respectively than those in unablated salicylate group. Conclusion: A low dose of salicylate (120 mg/kg) can induce tinnitus in rats and both central and peripheral auditory systems participate in the generation of salicylate-induced tinnitus.	[Chen, Guanyin; Liu, Zhi; Sun, Yongzhu; Cui, Pengcheng] Fourth Mil Med Univ, Tangdu Hosp, Dept Otolaryngol Head & Neck Surg, Xian 710032, Peoples R China; [Feng, Lining] Fourth Mil Med Univ, Fac Aerosp Med, Dept Clin Med, Xian 710032, Peoples R China; [Chang, Haifeng] Fourth Mil Med Univ, Tangdu Hosp, Dept Radiol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Cui, PC (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Otolaryngol Head & Neck Surg, Xian 710032, Peoples R China.	cuipc@fmmu.edu.cn		Cui, Pengcheng/0000-0002-0078-2888				AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Basta D, 2004, NEUROSCI RES, V50, P237, DOI 10.1016/j.neures.2004.07.003; Basta D, 2008, HEARING RES, V240, P42, DOI 10.1016/j.heares.2008.02.005; Bauer CA, 1999, OTOLARYNG HEAD NECK, V121, P457, DOI 10.1016/S0194-5998(99)70237-8; DAY RO, 1989, BRIT J CLIN PHARMACO, V28, P695, DOI 10.1111/j.1365-2125.1989.tb03562.x; Evans E F, 1982, Br J Audiol, V16, P101, DOI 10.3109/03005368209081454; Guitton MJ, 2003, J NEUROSCI, V23, P3944; HALLA JT, 1991, ANN RHEUM DIS, V50, P682, DOI 10.1136/ard.50.10.682; Henry JA, 2005, J SPEECH LANG HEAR R, V48, P1204, DOI 10.1044/1092-4388(2005/084); JASTREBOFF PJ, 1986, ARCH OTOLARYNGOL, V112, P1050; JASTREBOFF PJ, 1988, BEHAV NEUROSCI, V102, P811, DOI 10.1037/0735-7044.102.6.811; JASTREBOFF PJ, 1994, AUDIOLOGY, V33, P202; KAUER JS, 1982, LARYNGOSCOPE, V92, P1401; KUMAGAI M, 1992, Hokkaido Journal of Medical Science, V67, P216; Lobarinas E, 2004, HEARING RES, V190, P109, DOI 10.1016/S0378-5955(04)00019-X; Lobarinas Edward, 2008, Seminars in Hearing, V29, P333, DOI 10.1055/s-0028-1095893; Panford-Walsh R, 2008, MOL PHARMACOL, V74, P595, DOI 10.1124/mol.108.046375; Peng BG, 2003, NEUROSCI LETT, V343, P21, DOI 10.1016/S0304-3940(03)00296-9; Ruel J, 2008, J NEUROSCI, V28, P7313, DOI 10.1523/JNEUROSCI.5335-07.2008; Ruttiger L, 2003, HEARING RES, V180, P39, DOI 10.1016/S0378-5955(03)00075-3; SASAKI CT, 1981, LARYNGOSCOPE, V91, P2018; Stolzberg D, 2011, NEUROSCIENCE, V180, P157, DOI 10.1016/j.neuroscience.2011.02.005; Su YY, 2009, HEARING RES, V253, P60, DOI 10.1016/j.heares.2009.03.007; Sun W, 2009, NEUROSCIENCE, V159, P325, DOI 10.1016/j.neuroscience.2008.12.024; Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Wang HT, 2008, HEARING RES, V236, P42, DOI 10.1016/j.heares.2007.11.015; Wang HT, 2006, HEARING RES, V215, P77, DOI 10.1016/j.heares.2006.03.004; Zhang FQ, 2006, J NEUROSCI METH, V155, P194, DOI 10.1016/j.jneumeth.2006.01.004	28	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108659	10.1371/journal.pone.0108659	http://dx.doi.org/10.1371/journal.pone.0108659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25269067	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700137
J	Ding, L; Gysemans, CA; Stange, G; Heremans, Y; Yuchi, Y; Takiishi, T; Korf, H; Chintinne, M; Carr, RD; Heimberg, H; Pipeleers, D; Mathieu, C				Ding, Lei; Gysemans, Conny A.; Stange, Geert; Heremans, Yves; Yuchi, Yixing; Takiishi, Tatiana; Korf, Hannelie; Chintinne, Marie; Carr, Richard D.; Heimberg, Harry; Pipeleers, Daniel; Mathieu, Chantal			Combining MK626, a Novel DPP-4 Inhibitor, and Low-Dose Monoclonal CD3 Antibody for Stable Remission of New-Onset Diabetes in Mice	PLOS ONE			English	Article							DIPEPTIDYL-PEPTIDASE-IV; GLUCAGON-LIKE PEPTIDE-1; BETA-CELL REPLICATION; NOD MICE; COMBINATION THERAPY; MOUSE MODEL; TGF-BETA; T-CELLS; ANTI-CD3; CD26	Combining immune intervention with therapies that directly influence the functional state of the beta-cells is an interesting strategy in type 1 diabetes cure. Dipeptidyl peptidase-4 (DPP-4) inhibitors elevate circulating levels of active incretins, which have been reported to enhance insulin secretion and synthesis, can support beta-cell survival and possibly stimulate beta-cell proliferation and neogenesis. In the current study, we demonstrate that the DPP-4 inhibitor MK626, which has appropriate pharmacokinetics in mice, preceded by a short-course of low-dose anti-CD3 generated durable diabetes remission in new-onset diabetic non-obese diabetic (NOD) mice. Induction of remission involved recovery of beta-cell secretory function with resolution of destructive insulitis and preservation of beta-cell volume/mass, along with repair of the islet angioarchitecture via SDF-1- and VEGF-dependent actions. Combination therapy temporarily reduced the CD4-to-CD8 distribution in spleen although not in pancreatic draining lymph nodes (PLN) and increased the proportion of effector/memory T cells as did anti-CD3 alone. In contrast, only combination therapy amplified Foxp3+ regulatory T cells in PLN and locally in pancreas. These findings open new opportunities for the treatment of new-onset type 1 diabetes by introducing DPP-4 inhibitors in human CD3-directed clinical trials.	[Ding, Lei; Gysemans, Conny A.; Takiishi, Tatiana; Korf, Hannelie; Mathieu, Chantal] Katholieke Univ Leuven, KU LEUVEN, Fac Med, Lab Clin & Expt Endocrinol, Leuven, Belgium; [Stange, Geert; Chintinne, Marie; Pipeleers, Daniel] Vrije Univ Brussel, Fac Med & Pharm, Diabet Res Ctr, Lab Diabet Pathol & Therapy, Brussels, Belgium; [Heremans, Yves; Yuchi, Yixing; Heimberg, Harry] Vrije Univ Brussel, Fac Med & Pharm, Diabet Res Ctr, Lab Beta Cell Neogenesis BENE, Brussels, Belgium; [Carr, Richard D.] MSD A S, Ballerup, Denmark	KU Leuven; Vrije Universiteit Brussel; Vrije Universiteit Brussel	Gysemans, CA (corresponding author), Katholieke Univ Leuven, KU LEUVEN, Fac Med, Lab Clin & Expt Endocrinol, Campus Gasthuisberg O&N1, Leuven, Belgium.	Conny.Gysemans@med.kuleuven.be; chantal.mathieu@med.kuleuven.be	mathieu, chantal/ABD-5505-2021; Yuchi, Yixing/Q-1899-2016; Takiishi, t T/H-1758-2016; stange, geert m/C-1092-2009	mathieu, chantal/0000-0002-4055-5233; Yuchi, Yixing/0000-0002-9439-0913; Takiishi, t T/0000-0003-2112-809X; stange, geert m/0000-0003-3148-1372; gysemans, conny/0000-0003-3559-6089; Korf, Hannelie/0000-0003-3540-0138; Pipeleers, Daniel/0000-0002-6440-2485; Heimberg, Harry/0000-0003-1954-7375	Fund for Scientific Research Flanders (FWO-Vlaanderen) [G.0734.10]; University of Leuven (KU LEUVEN GOA); European Community (FP7) [241883]; KU LEUVEN; FWO Vlaanderen; BETACELLTHERAPY	Fund for Scientific Research Flanders (FWO-Vlaanderen)(FWO); University of Leuven (KU LEUVEN GOA); European Community (FP7); KU LEUVEN(KU Leuven); FWO Vlaanderen(FWO); BETACELLTHERAPY	This work was supported by grants from the Fund for Scientific Research Flanders (FWO-Vlaanderen G.0734.10), the University of Leuven (KU LEUVEN GOA 2009/10 and 2014/10), the European Community's Health Seventh Framework Programme (FP7/2010-2014 under grant agreement 241883 with acronym BETACELLTHERAPY). LD is supported through an IRO fellowship of the KU LEUVEN. YH, YY and HH are researchers from Vrije Universiteit Brussel, Diabetes Research Center. HK and CM have a postdoctoral and clinical researcher grant of the FWO Vlaanderen, respectively. CAG is a researcher from KU LEUVEN. DP is director of Diabetes Research Center, Vrije Universiteit Brussel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Ansarullah, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053345; Baeke F, 2012, DIABETOLOGIA, V55, P2723, DOI 10.1007/s00125-012-2630-1; Bhattacharjee A, 2012, CAN J PHYSIOL PHARM, V90, P663, DOI [10.1139/Y2012-039, 10.1139/y2012-039]; Bresson D, 2006, J CLIN INVEST, V116, P1371, DOI 10.1172/JCI27191; Busso N, 2005, AM J PATHOL, V166, P433, DOI 10.1016/S0002-9440(10)62266-3; Cabrera SM, 2013, CLIN EXP IMMUNOL, V172, P375, DOI 10.1111/cei.12068; Chatenoud L, 1997, J IMMUNOL, V158, P2947; Chen GJ, 2008, J LEUKOCYTE BIOL, V83, P280, DOI 10.1189/jlb.0707498; Chintinne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043959; Deacon CF, 1998, DIABETES, V47, P764, DOI 10.2337/diabetes.47.5.764; DEMEESTER IA, 1995, J LEUKOCYTE BIOL, V58, P325, DOI 10.1002/jlb.58.3.325; Edmondson SD, 2006, J MED CHEM, V49, P3614, DOI 10.1021/jm060015t; Fadini GP, 2010, DIABETES CARE, V33, P1607, DOI 10.2337/dc10-0187; Fang ST, 2012, ANGIOGENESIS, V15, P511, DOI 10.1007/s10456-012-9278-9; Herold KC, 2005, DIABETES, V54, P1763, DOI 10.2337/diabetes.54.6.1763; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Herold KC, 2013, DIABETES, V62, P3766, DOI 10.2337/db13-0345; Irving-Rodgers HF, 2008, DIABETOLOGIA, V51, P1680, DOI 10.1007/s00125-008-1085-x; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Keymeulen B, 2010, DIABETOLOGIA, V53, P614, DOI 10.1007/s00125-009-1644-9; Kim SJ, 2009, DIABETES, V58, P641, DOI 10.2337/db08-1101; Kumar KVSH, 2013, DIABETES RES CLIN PR, V100, pE55, DOI 10.1016/j.diabres.2013.01.020; Lambeir AM, 2001, FEBS LETT, V507, P327, DOI 10.1016/S0014-5793(01)02982-9; Lambeir AM, 1997, BBA-PROTEIN STRUCT M, V1340, P215, DOI 10.1016/S0167-4838(97)00045-9; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Mandapathil M, 2010, J BIOL CHEM, V285, P7176, DOI 10.1074/jbc.M109.047423; Masuyama J, 1999, J EXP MED, V189, P979, DOI 10.1084/jem.189.6.979; Matteucci E, 2009, CURR MED CHEM, V16, P2943, DOI 10.2174/092986709788803114; Matteucci E, 2011, J CLIN IMMUNOL, V31, P977, DOI 10.1007/s10875-011-9573-z; Nikolova G, 2007, TRENDS CELL BIOL, V17, P19, DOI 10.1016/j.tcb.2006.11.005; Ohnuma K, 2004, P NATL ACAD SCI USA, V101, P14186, DOI 10.1073/pnas.0405266101; Ohnuma K, 2008, FRONT BIOSCI-LANDMRK, V13, P2299, DOI 10.2741/2844; Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426; Pospisilik JA, 2003, DIABETES, V52, P741, DOI 10.2337/diabetes.52.3.741; Robert S, 2014, DIABETES; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Sherry NA, 2007, ENDOCRINOLOGY, V148, P5136, DOI 10.1210/en.2007-0358; Sherry NA, 2006, DIABETES, V55, P3238, DOI 10.2337/db05-1034; Shevach EM, 2008, J CLIN IMMUNOL, V28, P640, DOI 10.1007/s10875-008-9240-1; Steinbrecher A, 2001, J IMMUNOL, V166, P2041, DOI 10.4049/jimmunol.166.3.2041; Strojek K, 2014, ENDOKRYNOL POL, V65, P78, DOI 10.5603/EP.2014.0011; Suarez-Pinzon WL, 2009, DIABETOLOGIA, V52, P1680, DOI 10.1007/s00125-009-1390-z; Takiishi T, 2012, J CLIN INVEST, V122, P1717, DOI 10.1172/JCI60530; Tian L, 2010, ENDOCRINOLOGY, V151, P3049, DOI 10.1210/en.2010-0068; Van De Casteele M, 2013, DIABETOLOGIA, V56, P2647, DOI 10.1007/s00125-013-3049-z; Vargova L, 2013, FOLIA BIOL-PRAGUE, V59, P116; Wan XX, 2013, DIABETES, V62, P2879, DOI 10.2337/db12-1281; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270	49	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107935	10.1371/journal.pone.0107935	http://dx.doi.org/10.1371/journal.pone.0107935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268801	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700054
J	Iacovelli, R; Pietrantonio, F; Farcomeni, A; Maggi, C; Palazzo, A; Ricchini, F; de Braud, F; Di Bartolomeo, M				Iacovelli, Roberto; Pietrantonio, Filippo; Farcomeni, Alessio; Maggi, Claudia; Palazzo, Antonella; Ricchini, Francesca; de Braud, Filippo; Di Bartolomeo, Maria			Chemotherapy or Targeted Therapy as Second-Line Treatment of Advanced Gastric Cancer. A Systematic Review and Meta-Analysis of Published Studies	PLOS ONE			English	Review							RANDOMIZED PHASE-III; RETROSPECTIVE ANALYSIS; SUPPORTIVE CARE; IRINOTECAN; DOCETAXEL; PLUS; MONOTHERAPY; TRIAL	Chemotherapy is a cornerstone in treatments of gastric cancer, but despite its benefit, less than 60% of patients receive salvage therapy in clinical practice. We performed a systematic review and meta-analysis based on trial data on the role of second-line treatment of advanced gastric cancer. MEDLINE/PubMed and Cochrane Library were searched for randomized phase III trials that compared active therapy to best supportive care in advanced gastric cancer. Data extraction was conducted according to the PRISMA statement. Summary HR for OS was calculated using a hierarchical Bayesian model and subgroup analysis was performed based on baseline Eastern Cooperative Oncology Group Performance Status (ECOG) performance status (0 vs. 1 or more). A total of 1,407 patients were evaluable for efficacy, 908 were treated in the experimental arms, with chemotherapy (231 pts) or with targeted therapies (677 pts). The risk of death was decreased by 18% (HR = 0.82; 95% CI, 0.79-0.85; posterior probability HR >= 1: <0.00001) with active therapies. Chemotherapy and ramucirumab were able to decrease this risk by 27% and 22%, respectively. No differences were found between chemotherapy and ramucirumab. In patients with ECOG = 0 a greater benefit was found for chemotherapy with a reduction of the risk of death by 43% and no benefits were found for ramucirumab or everolimus. In patients with ECOG = 1 or more a significant reduction of the risk of death by 32% was reported in patients treated with ramucirumab, even if no significant difference was reported between chemotherapy and ramucirumab. This analysis reports that active and available therapies are able to prolong survival in patients with advanced gastric cancer with a different outcome based on initial patient's performance status. New trials based on a better patient stratification are awaited.	[Iacovelli, Roberto; Pietrantonio, Filippo; Maggi, Claudia; Palazzo, Antonella; Ricchini, Francesca; de Braud, Filippo; Di Bartolomeo, Maria] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy; [Iacovelli, Roberto; Palazzo, Antonella] Univ Roma La Sapienza, Dept Radiol Oncol & Human Pathol, PhD Program, I-00185 Rome, Italy; [Farcomeni, Alessio] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Stat Sect, I-00185 Rome, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Sapienza University Rome; Sapienza University Rome	Iacovelli, R (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy.	roberto.iacovelli@istitutotumori.mi.it	Farcomeni, Alessio/K-8719-2016; Di Bartolomeo, Maria/D-1655-2017; maggi, claudia/J-6831-2018; Palazzo, Antonella/AFK-5140-2022; Iacovelli, Roberto/AAB-9850-2019; de Braud, Filippo/B-9997-2017; Ricchini, Francesca/K-6688-2016; Pietrantonio, Filippo/C-2180-2017; Palazzo, Antonella/AAG-3737-2022	Farcomeni, Alessio/0000-0002-7104-5826; Di Bartolomeo, Maria/0000-0002-7954-6609; maggi, claudia/0000-0001-8780-0606; Iacovelli, Roberto/0000-0002-1750-2117; de Braud, Filippo/0000-0003-0103-730X; Ricchini, Francesca/0000-0002-5868-3954; Pietrantonio, Filippo/0000-0002-8530-8420; 				Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Elsing C, 2013, ONCOLOGY-BASEL, V85, P262, DOI 10.1159/000355690; Ford HER, 2014, LANCET ONCOL, V15, P78, DOI 10.1016/S1470-2045(13)70549-7; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Globocan, 2012, EST CANC INC MORT PR; Han FH, 2010, EJSO-EUR J SURG ONC, V36, P1172, DOI 10.1016/j.ejso.2010.09.002; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kang JH, 2012, J CLIN ONCOL, V30, P1513, DOI 10.1200/JCO.2011.39.4585; Kasper S, 2014, EUR J CANCER, V50, P1247, DOI 10.1016/j.ejca.2014.01.009; Kim HS, 2013, ANN ONCOL, V24, P2850, DOI 10.1093/annonc/mdt351; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-2045(08)70035-4; Li J, 2013, J CLIN ONCOL, V31, P3219, DOI 10.1200/JCO.2013.48.8585; Maruta F, 2007, MED ONCOL, V24, P71, DOI 10.1007/BF02685905; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Monti M, 2013, TUMORI J, V99, P583, DOI 10.1700/1377.15306; Ohtsu A, 2013, J CLIN ONCOL, V31, P3935, DOI 10.1200/JCO.2012.48.3552; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; R Core Team, 2021, R LANGUAGE ENV STAT; Roy AC, 2013, ANN ONCOL, V24, P1567, DOI 10.1093/annonc/mdt002; Sym SJ, 2013, CANCER CHEMOTH PHARM, V71, P481, DOI 10.1007/s00280-012-2027-3; Thuss-Patience PC, 2011, EUR J CANCER, V47, P2306, DOI 10.1016/j.ejca.2011.06.002; Ueda S, 2012, J CLIN ONCOL, V30; Wagner AD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub3; Wilke H, 2014, J CLIN ONCOL, V32	25	41	46	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108940	10.1371/journal.pone.0108940	http://dx.doi.org/10.1371/journal.pone.0108940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268988	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700197
J	Sarker, B; Singh, R; Silva, R; Roether, JA; Kaschta, J; Detsch, R; Schubert, DW; Cicha, I; Boccaccini, AR				Sarker, Bapi; Singh, Raminder; Silva, Raquel; Roether, Judith A.; Kaschta, Joachim; Detsch, Rainer; Schubert, Dirk W.; Cicha, Iwona; Boccaccini, Aldo R.			Evaluation of Fibroblasts Adhesion and Proliferation on Alginate-Gelatin Crosslinked Hydrogel	PLOS ONE			English	Article							ACID-BASED HYDROGELS; CELL-ADHESION; OXIDIZED ALGINATE; DERMAL FIBROBLAST; MOLECULAR-WEIGHT; RGD-PEPTIDES; TGF-BETA; DEGRADATION; SURFACE; GROWTH	Due to the relatively poor cell-material interaction of alginate hydrogel, alginate-gelatin crosslinked (ADA-GEL) hydrogel was synthesized through covalent crosslinking of alginate di-aldehyde (ADA) with gelatin that supported cell attachment, spreading and proliferation. This study highlights the evaluation of the physico-chemical properties of synthesized ADA-GEL hydrogels of different compositions compared to alginate in the form of films. Moreover, in vitro cell-material interaction on ADA-GEL hydrogels of different compositions compared to alginate was investigated by using normal human dermal fibroblasts. Viability, attachment, spreading and proliferation of fibroblasts were significantly increased on ADA-GEL hydrogels compared to alginate. Moreover, in vitro cytocompatibility of ADA-GEL hydrogels was found to be increased with increasing gelatin content. These findings indicate that ADA-GEL hydrogel is a promising material for the biomedical applications in tissue-engineering and regeneration.	[Sarker, Bapi; Silva, Raquel; Detsch, Rainer; Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Biomat, D-91054 Erlangen, Germany; [Singh, Raminder; Cicha, Iwona] Univ Hosp Erlangen, Dept Cardiol & Angiol, Erlangen, Germany; [Roether, Judith A.; Kaschta, Joachim; Schubert, Dirk W.] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Polymer Mat, D-91054 Erlangen, Germany; [Cicha, Iwona] Univ Hosp, ENT Dept, Sect Expt Oncol & Nanomed, Cardiovasc Nanomed Unit, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Boccaccini, AR (corresponding author), Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Biomat, D-91054 Erlangen, Germany.	aldo.boccaccini@ww.uni-erlangen.de	Singh, Raminder/ABC-7146-2020; Boccaccini, Aldo R/C-7905-2013; Boccaccini, Aldo R./N-9782-2019	Singh, Raminder/0000-0003-3233-8412; Boccaccini, Aldo R./0000-0002-7377-2955; Silva, Raquel/0000-0001-7648-9146; Detsch, Rainer/0000-0001-9383-428X; Cicha, Iwona/0000-0002-7399-5307	Emerging Fields Initiative (EFI) of the University of Erlangen-Nuremberg (project TOPbiomat); German Academic Exchange Service (DAAD)	Emerging Fields Initiative (EFI) of the University of Erlangen-Nuremberg (project TOPbiomat); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the Emerging Fields Initiative (EFI) of the University of Erlangen-Nuremberg (project TOPbiomat) (http://www.efi.unierlangen.org/projects/topbiomat/) and the German Academic Exchange Service (DAAD) (https://www.daad.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan B, 2005, BIOMATERIALS, V26, P6335, DOI 10.1016/j.biomaterials.2005.04.012; Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005; Boanini E, 2010, ACTA BIOMATER, V6, P383, DOI 10.1016/j.actbio.2009.06.015; Bondar B, 2008, BIOMATERIALS, V29, P561, DOI 10.1016/j.biomaterials.2007.10.002; Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044; Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p; Cai K, 2007, ADV ENG MATER, V9, P1082, DOI 10.1002/adem.200700222; Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514; Dhote V, 2013, J MECH BEHAV BIOMED, V19, P61, DOI 10.1016/j.jmbbm.2012.10.016; Diener A, 2005, BIOMATERIALS, V26, P383, DOI 10.1016/j.biomaterials.2004.02.019; DRAGET KI, 1994, CARBOHYD POLYM, V25, P31, DOI 10.1016/0144-8617(94)90159-7; ELSDALE TR, 1968, EXP CELL RES, V51, P439, DOI 10.1016/0014-4827(68)90134-1; Elvira C, 2003, J MATER SCI-MATER M, V14, P187, DOI 10.1023/A:1022036300783; Gomez CG, 2007, CARBOHYD POLYM, V67, P296, DOI 10.1016/j.carbpol.2006.05.025; Gornall JL, 2008, SOFT MATTER, V4, P544, DOI 10.1039/b713075a; Grigore A, 2014, TISSUE ENG PT A, V20, P2140, DOI 10.1089/ten.tea.2013.0416; Guan SX, 2009, J INVEST DERMATOL, V129, P1909, DOI 10.1038/jid.2008.457; Guerreiro SG, 2013, CELL TRANSPLANT, P1; Guerreiro Susana G, 2012, Biomatter, V2, P43, DOI 10.4161/biom.20063; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hennessy KM, 2008, BIOMATERIALS, V29, P3075, DOI 10.1016/j.biomaterials.2008.04.014; Hwang DS, 2007, BIOMATERIALS, V28, P4039, DOI 10.1016/j.biomaterials.2007.05.028; Ioannou YA, 1996, NUCLEIC ACIDS RES, V24, P992; Joshi C, 2012, CURR MICROSC CONTRIB, V1, P756; Kammerer PW, 2011, EUR CELLS MATER, V21, P364; Kidoaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078067; Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakshman N, 2010, EXP EYE RES, V90, P350, DOI 10.1016/j.exer.2009.11.016; Leadsham JE, 2010, CELL DEATH DIFFER, V17, P754, DOI 10.1038/cdd.2009.196; Leal-Egana A, 2013, ADV MATER, V25, P4049, DOI 10.1002/adma.201301227; Leal-Egana A, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-24; Liao HJ, 2009, J MATER SCI-MATER M, V20, P1263, DOI 10.1007/s10856-009-3694-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026; MARTINSEN A, 1991, CARBOHYD POLYM, V15, P171, DOI 10.1016/0144-8617(91)90031-7; Nur Azira T., 2012, International Food Research Journal, V19, P1175; Pawlicka A, 2008, MOL CRYST LIQ CRYST, V485, P804, DOI 10.1080/15421400801918138; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Rosellini E, 2009, J BIOMED MATER RES A, V91A, P447, DOI 10.1002/jbm.a.32216; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Sarker B, 2014, J MATER CHEM B, V2, P1470, DOI 10.1039/c3tb21509a; Shu XZ, 2004, J BIOMED MATER RES A, V68A, P365, DOI 10.1002/jbm.a.20002; SMIDSROD O, 1970, CARBOHYD RES, V13, P359, DOI 10.1016/S0008-6215(00)80593-5; Stevenson S, 2008, J BIOMAT SCI-POLYM E, V19, P1097, DOI 10.1163/156856208784909354; Stickley FL, 1987, P 5 RPS S 1985, P107; Sutherland IW., 1991, BIOMATERIALS NOVEL M; TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705; Tan HP, 2010, ORGANOGENESIS, V6, P173, DOI 10.4161/org.6.3.12037; Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080; Nguyen TP, 2012, J BIOMATER APPL, V27, P311, DOI 10.1177/0885328211404265; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; Vignaud T, 2012, J CELL SCI, V125, P2134, DOI 10.1242/jcs.104901; Vladkova TG, 2010, INT J POLYM SCI, V2010, DOI 10.1155/2010/296094; Wang YW, 2012, J ZHEJIANG UNIV-SC B, V13, P997, DOI 10.1631/jzus.B1200055; Weber P, 2010, FOOD ADDIT CONTAM A, V27, P273, DOI 10.1080/02652030903030397; Wei JH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045002; Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069; Wu SC, 2011, J BIOACT COMPAT POL, V26, P565, DOI 10.1177/0883911511423563; Yu HQ, 2003, WATER RES, V37, P55, DOI 10.1016/S0043-1354(02)00256-7	61	150	153	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107952	10.1371/journal.pone.0107952	http://dx.doi.org/10.1371/journal.pone.0107952			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268892	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700055
J	Wang, WR; Elkins, K; Oh, A; Ho, YC; Wu, JS; Li, H; Xiao, Y; Kwong, M; Coons, M; Brillantes, B; Cheng, E; Crocker, L; Dragovich, PS; Sampath, D; Zheng, XZ; Bair, KW; O'Brien, T; Belmont, LD				Wang, Weiru; Elkins, Kristi; Oh, Angela; Ho, Yen-Ching; Wu, Jiansheng; Li, Hong; Xiao, Yang; Kwong, Mandy; Coons, Mary; Brillantes, Bobby; Cheng, Eric; Crocker, Lisa; Dragovich, Peter S.; Sampath, Deepak; Zheng, Xiaozhang; Bair, Kenneth W.; O'Brien, Thomas; Belmont, Lisa D.			Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors	PLOS ONE			English	Article							NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE NAMPT; PHASE-I; PHARMACOLOGICAL INHIBITION; MOLECULAR-BASIS; CHS 828; ACID; BIOSYNTHESIS; CHS-828; NAD(+); POTENT	Inhibiting NAD biosynthesis by blocking the function of nicotinamide phosphoribosyl transferase (NAMPT) is an attractive therapeutic strategy for targeting tumor metabolism. However, the development of drug resistance commonly limits the efficacy of cancer therapeutics. This study identifies mutations in NAMPT that confer resistance to a novel NAMPT inhibitor, GNE-618, in cell culture and in vivo, thus demonstrating that the cytotoxicity of GNE-618 is on target. We determine the crystal structures of six NAMPT mutants in the apo form and in complex with various inhibitors and use cellular, biochemical and structural data to elucidate two resistance mechanisms. One is the surprising finding of allosteric modulation by mutation of residue Ser165, resulting in unwinding of an a-helix that binds the NAMPT substrate 5-phosphoribosyl-1-pyrophosphate (PRPP). The other mechanism is orthosteric blocking of inhibitor binding by mutations of Gly217. Furthermore, by evaluating a panel of diverse small molecule inhibitors, we unravel inhibitor structure activity relationships on the mutant enzymes. These results provide valuable insights into the design of next generation NAMPT inhibitors that offer improved therapeutic potential by evading certain mechanisms of resistance.	[Wang, Weiru; Elkins, Kristi; Oh, Angela; Wu, Jiansheng; Li, Hong; Xiao, Yang; Kwong, Mandy; Coons, Mary; Brillantes, Bobby; Cheng, Eric; Crocker, Lisa; Dragovich, Peter S.; Sampath, Deepak; O'Brien, Thomas; Belmont, Lisa D.] Genentech Inc, San Francisco, CA 94080 USA; [Ho, Yen-Ching; Zheng, Xiaozhang; Bair, Kenneth W.] Forma Therapeut Inc, Watertown, MA USA	Roche Holding; Genentech	Belmont, LD (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	belmont.lisa@gene.com	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wang, Weiru/0000-0001-8845-301X; O'Brien, Thomas/0000-0002-9161-8070; Wu, Jian/0000-0002-3394-1507	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	The authors received no specific funding for this work. Forma Therapeutics provided support in the form of salaries for Y-CH, XZ and KWB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author ontributions' section. Genentech, Inc. provided support in the form of salaries for WW, KE, AO, JW, HL, YX, MK, MC, BB, EC, LC, PSD, DS, TO'B, LDB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bi TQ, 2010, CANCER BIOL THER, V10, P119, DOI 10.4161/cbt.10.2.12581; Burgos ES, 2011, CURR MED CHEM, V18, P1947; Burgos ES, 2009, P NATL ACAD SCI USA, V106, P13748, DOI 10.1073/pnas.0903898106; Christensen MK, 2012, PYRIDINYL DERIVATIVE; COPLEY RR, 1994, J MOL BIOL, V242, P321; Dahl TB, 2012, ANNU REV NUTR, V32, P229, DOI 10.1146/annurev-nutr-071811-150746; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Giannetti AM, 2014, J MED CHEM, V57, P770, DOI 10.1021/jm4015108; Gunzner-Toste J, 2013, BIOORG MED CHEM LETT, V23, P3531, DOI 10.1016/j.bmcl.2013.04.040; Hara N, 2007, J BIOL CHEM, V282, P24574, DOI 10.1074/jbc.M610357200; Hasmann M, 2003, CANCER RES, V63, P7436; Hjarnaa PJV, 1999, CANCER RES, V59, P5751; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Hovstadius P, 2002, CLIN CANCER RES, V8, P2843; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Brien T, 2013, NEOPLASIA, V15, P1314, DOI [10.1593/neo.131184, 10.1593/neo.131718]; Oh A, 2014, CHEMBIOCHEM, V15, P1121, DOI 10.1002/cbic.201402023; Olesen UH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-677; Olesen UH, 2008, BIOCHEM BIOPH RES CO, V367, P799, DOI 10.1016/j.bbrc.2008.01.019; Olesen UH, 2010, MOL CANCER THER, V9, P1609, DOI 10.1158/1535-7163.MCT-09-1130; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PREISS J, 1957, J BIOL CHEM, V225, P759; Ravaud A, 2005, EUR J CANCER, V41, P702, DOI 10.1016/j.ejca.2004.12.023; Shames DS, 2013, CLIN CANC RES; Takahashi R, 2010, J BIOCHEM, V147, P95, DOI 10.1093/jb/mvp152; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; von Heideman A, 2010, CANCER CHEMOTH PHARM, V65, P1165, DOI 10.1007/s00280-009-1125-3; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; Xiao Y, 2013, NEOPLASIA, V15, P1137, DOI 10.1593/neo.131304; Zheng XZ, 2013, BIOORG MED CHEM LETT, V23, P5488, DOI 10.1016/j.bmcl.2013.08.074; Zheng XZ, 2013, J MED CHEM, V56, P6413, DOI 10.1021/jm4008664; Zheng XZ, 2013, J MED CHEM, V56, P4921, DOI 10.1021/jm400186h	38	24	24	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109366	10.1371/journal.pone.0109366	http://dx.doi.org/10.1371/journal.pone.0109366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285661	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700060
J	Bardi, DA; Halabi, MF; Hassandarvish, P; Rouhollahi, E; Paydar, M; Moghadamtousi, SZ; Al-Wajeeh, NS; Ablat, A; Abdullah, NA; Abdulla, MA				Bardi, Daleya Abdulaziz; Halabi, Mohammed Farouq; Hassandarvish, Pouya; Rouhollahi, Elham; Paydar, Mohammadjavad; Moghadamtousi, Soheil Zorofchian; Al-Wajeeh, Nahla Saeed; Ablat, Abdulwali; Abdullah, Nor Azizan; Abdulla, Mahmood Ameen			Andrographis paniculata Leaf Extract Prevents Thioacetamide-Induced Liver Cirrhosis in Rats	PLOS ONE			English	Article							CELL-CYCLE ARREST; MITOCHONDRIAL-MEDIATED APOPTOSIS; NITRIC-OXIDE SYNTHASE; TOXICITY; ANTIOXIDANT; EXPRESSION; INDUCTION	This study investigated the hepatoprotective effects of ethanolic Andrographis paniculata leaf extract (ELAP) on thioacetamide-induced hepatotoxicity in rats. An acute toxicity study proved that ELAP is not toxic in rats. To examine the effects of ELAP in vivo, male Sprague Dawley rats were given intraperitoneal injections of vehicle 10% Tween-20, 5 mL/kg (normal control) or 200 mg/kg TAA thioacetamide (to induce liver cirrhosis) three times per week. Three additional groups were treated with thioacetamide plus daily oral silymarin (50 mg/kg) or ELAP (250 or 500 mg/kg). Liver injury was assessed using biochemical tests, macroscopic and microscopic tissue analysis, histopathology, and immunohistochemistry. In addition, HepG2 and WRL-68 cells were treated in vitro with ELAP fractions to test cytotoxicity. Rats treated with ELAP exhibited significantly lower liver/body weight ratios and smoother, more normal liver surfaces compared with the cirrhosis group. Histopathology using Hematoxylin and Eosin along with Masson's Trichrome stain showed minimal disruption of hepatic cellular structure, minor fibrotic septa, a low degree of lymphocyte infiltration, and minimal collagen deposition after ELAP treatment. Immunohistochemistry indicated that ELAP induced down regulation of proliferating cell nuclear antigen. Also, hepatic antioxidant enzymes and oxidative stress parameters in ELAP-treated rats were comparable to silymarin-treated rats. ELAP administration reduced levels of altered serum liver biomarkers. ELAP fractions were non-cytotoxic to WRL-68 cells, but possessed anti-proliferative activity on HepG2 cells, which was confirmed by a significant elevation of lactate dehydrogenase, reactive oxygen species, cell membrane permeability, cytochrome c, and caspase-8,-9, and, -3/7 activity in HepG2 cells. A reduction of mitochondrial membrane potential was also detected in ELAP-treated HepG2 cells. The hepatoprotective effect of 500 mg/kg of ELAP is proposed to result from the reduction of thioacetamide-induced toxicity, normalizing reactive oxygen species levels, inhibiting cellular proliferation, and inducing apoptosis in HepG2 cells.	[Bardi, Daleya Abdulaziz; Halabi, Mohammed Farouq; Al-Wajeeh, Nahla Saeed; Abdulla, Mahmood Ameen] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia; [Hassandarvish, Pouya] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Rouhollahi, Elham; Paydar, Mohammadjavad] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Moghadamtousi, Soheil Zorofchian] Univ Malaya, Fac Sci, Inst Biol Sci, Biomol Res Grp,Biochem Program, Kuala Lumpur, Malaysia; [Ablat, Abdulwali] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Abdulla, MA (corresponding author), Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia.	ammeen@um.edu.my	Halabi, Mohammed/N-4574-2019; Bardi, Daleya Abdulaziz M/C-9901-2010; Hassandarvish, Pouya/K-8112-2012; ABDULLAH, NOR AZIZAN/B-9302-2010; Paydar, Mohammadjavad/V-4800-2018; Bardi/ABD-2699-2020	Halabi, Mohammed/0000-0001-7114-515X; Bardi, Daleya Abdulaziz M/0000-0001-9091-2908; Hassandarvish, Pouya/0000-0003-0364-5587; Paydar, Mohammadjavad/0000-0002-0569-7017; 	University of Malaya [PV046/2012A]; Ministry of Higher Education Malaysia [UM.C/625/1/HIR/MOHE/SC/09]	University of Malaya(Universiti Malaya); Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	This research is supported by University of Malaya grant PV046/2012A, and High Impact Research Grant UM-MOHE UM.C/625/1/HIR/MOHE/SC/09 from the Ministry of Higher Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bayaty FH, 2012, NAT PROD RES, V26, P423, DOI 10.1080/14786419.2010.496114; Alkiyumi SS, 2012, MOLECULES, V17, P6146, DOI 10.3390/molecules17056146; Alshawsh MA, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/103039; Amin ZA, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/241583; Aoyama T, 2010, HEPATOLOGY, V52, P1390, DOI 10.1002/hep.23795; Arunadevi R, 2010, J THEORETICAL EXPT B, V6; Bardi DA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/918460; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Chandrasekaran CV, 2009, FOOD CHEM TOXICOL, V47, P1892, DOI 10.1016/j.fct.2009.05.006; Chao WW, 2012, CHIN MED-UK, V3, P136; Cheung HY, 2005, PLANTA MED, V71, P1106, DOI 10.1055/s-2005-873128; Chiou WF, 1998, BRIT J PHARMACOL, V125, P327, DOI 10.1038/sj.bjp.0702073; Chiou WF, 2000, BRIT J PHARMACOL, V129, P1553, DOI 10.1038/sj.bjp.0703191; Garber J, 2010, GUIDE CARE USE LAB A, V8, P220; Geethangilil M, 2008, PHYTOTHER RES, V22, P1336, DOI 10.1002/ptr.2493; Ghosh MN., 2005, FUNDAMENTALS EXPT PH, V3rd; Govindarajan M, 2011, ASIAN PAC J TROP MED, V4, P176, DOI 10.1016/S1995-7645(11)60064-3; Hsiao TJ, 2007, ANN EPIDEMIOL, V17, P479, DOI 10.1016/j.annepidem.2006.12.007; Jarukamjorn K, 2008, J HEALTH SCI, V54, P370, DOI 10.1248/jhs.54.370; Kadir FA, 2014, SCI WORLD J, DOI 10.1155/2014/301879; Kadir FA, 2011, INDIAN J PHARMACOL, V43, P64, DOI 10.4103/0253-7613.75673; Karunagaran D, 2005, CURR CANCER DRUG TAR, V5, P117, DOI 10.2174/1568009053202081; Kisseleva T, 2011, BEST PRACT RES CL GA, V25, P305, DOI 10.1016/j.bpg.2011.02.011; Kumar RA, 2004, J ETHNOPHARMACOL, V92, P291, DOI 10.1016/j.jep.2004.03.004; Lee TY, 2010, APOPTOSIS, V15, P904, DOI 10.1007/s10495-010-0502-z; Li JL, 2007, EUR J PHARMACOL, V568, P31, DOI 10.1016/j.ejphar.2007.04.027; Ljubuncic P, 2005, J ETHNOPHARMACOL, V100, P198, DOI 10.1016/j.jep.2005.03.006; Luo WM, 2013, EXP THER MED, V6, P743, DOI 10.3892/etm.2013.1196; Mandal S, 2013, FOOD CHEM TOXICOLOGY; Mittal DK, 2012, INT J PHARM SCI, V3, P150; Murugan K, 2011, WORLD J MICROB BIOT, V27, P1661, DOI 10.1007/s11274-010-0620-3; Nagalekshmi R, 2011, FOOD CHEM TOXICOL, V49, P3367, DOI 10.1016/j.fct.2011.09.026; Natarajan SK, 2006, J GASTROEN HEPATOL, V21, P947, DOI 10.1111/j.1440-1746.2006.04231.x; Ng IOL, 2006, CANCER, V73, P2268; OECD, 2002, OECD ENV HLTH SAF MO, V01-24; Oyewo EB, 2012, NATURE SCI, V10, P91; Paik Yong Han, 2011, Korean J Hepatol, V17, P251, DOI 10.3350/kjhep.2011.17.4.251; Parra AL, 2001, PHYTOMEDICINE, V8, P395, DOI 10.1078/0944-7113-00044; Poli G, 1997, FREE RADICAL BIO MED, V22, P287, DOI 10.1016/S0891-5849(96)00327-9; Qader SW, 2011, MOLECULES, V16, P3433, DOI 10.3390/molecules16043433; Rajalakshmi G., 2012, Journal of Pharmacy Research, V5, P2983; Ramya M, 2012, INT J PHYTOPHARMACY, V3, P83; Salama SM, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/137083; Saraswat Binduja, 1996, Indian Journal of Pharmacology, V28, P232; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Sheeja B. D., 2012, Asian Pacific Journal of Tropical Disease, pS574; Shivaprakash G., 2011, Journal of Pharmacy Research, V4, P3375; Singha PK, 2003, FITOTERAPIA, V74, P692, DOI [10.1016/S0367-326X(03)00159-X, 10.1016/s0367-326X(03)00159-X]; Singha PK, 2007, J ETHNOPHARMACOL, V111, P13, DOI 10.1016/j.jep.2006.10.026; Sivaraj A., 2011, Journal of Applied Pharmaceutical Science, V1, P204; Stankova P, 2010, TOXICOL IN VITRO, V24, P2097, DOI 10.1016/j.tiv.2010.06.011; Takasaki Yoshinari, 2010, Nihon Rinsho, V68 Suppl 6, P578; Tan SL, 1998, J CELL BIOL, V141, P1423, DOI 10.1083/jcb.141.6.1423; Varma A, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep135; Wang JH, 1998, AM J PHYSIOL-GASTR L, V275, pG1117, DOI 10.1152/ajpgi.1998.275.5.G1117; Wasman SQ, 2011, INDIAN J EXP BIOL, V49, P767; Wong WL, 2012, EVID-BASED COMPL ALT, V2012, P10; Yang S, 2010, CLIN CANCER RES, V16, P4755, DOI 10.1158/1078-0432.CCR-10-0883; Yen TL, 2013, PHARM BIOL, V51, P1150, DOI 10.3109/13880209.2013.782051; Zhang CY, 1999, PHYTOTHER RES, V13, P157, DOI 10.1002/(SICI)1099-1573(199903)13:2&lt;157::AID-PTR388&gt;3.0.CO;2-B	60	34	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109424	10.1371/journal.pone.0109424	http://dx.doi.org/10.1371/journal.pone.0109424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25280007	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800080
J	Martiez-Cabrera, HI; Estrada-Ruiz, E				Martinez-Cabrera, Hugo I.; Estrada-Ruiz, Emilio			Wood Anatomy Reveals High Theoretical Hydraulic Conductivity and Low Resistance to Vessel Implosion in a Cretaceous Fossil Forest from Northern Mexico	PLOS ONE			English	Article							WATER RELATIONS; XYLEM EMBOLISM; CAVITATION; DENSITY; STRESS; GAS; TRANSPIRATION; VULNERABILITY; ARCHITECTURE; PERFORMANCE	The Olmos Formation (upper Campanian), with over 60 angiosperm leaf morphotypes, is Mexico's richest Cretaceous flora. Paleoclimate leaf physiognomy estimates indicate that the Olmos paleoforest grew under wet and warm conditions, similar to those present in modern tropical rainforests. Leaf surface area, tree size and climate reconstructions suggest that this was a highly productive system. Efficient carbon fixation requires hydraulic efficiency to meet the evaporative demands of the photosynthetic surface, but it comes at the expense of increased risk of drought-induced cavitation. Here we tested the hypothesis that the Olmos paleoforest had high hydraulic efficiency, but was prone to cavitation. We characterized the hydraulic properties of the Olmos paleoforest using theoretical conductivity (K-s), vessel composition (S) and vessel fraction (F), and measured drought resistance using vessel implosion resistance (t/b)(h)(2) and the water potential at which there is 50% loss of hydraulic conductivity (P-50). We found that the Olmos paleoforest had high hydraulic efficiency, similar to that present in several extant tropical-wet or semi-deciduous forest communities. Remarkably, the fossil flora had the lowest (t/b)(h)(2), which, together with low median P-50 (-1.9 MPa), indicate that the Olmos paleoforest species were extremely vulnerable to drought-induced cavitation. Our findings support paleoclimate inferences from leaf physiognomy and paleoclimatic models suggesting it represented a highly productive wet tropical rainforest. Our results also indicate that the Olmos Formation plants had a large range of water conduction strategies, but more restricted variation in cavitation resistance. These straightforward methods for measuring hydraulic properties, used herein for the first time, can provide useful information on the ecological strategies of paleofloras and on temporal shifts in ecological function of fossil forests chronosequences.	[Martinez-Cabrera, Hugo I.] Univ Nacl Autonoma Mexico, Inst Geol, Estac Reg Noroeste, Hermosillo, Sonora, Mexico; [Estrada-Ruiz, Emilio] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Zool, Ecol Lab, Ciudad Mexico, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico	Martiez-Cabrera, HI (corresponding author), Univ Nacl Autonoma Mexico, Inst Geol, Estac Reg Noroeste, Hermosillo, Sonora, Mexico.	hugomartinez2w@gmail.com.mx			"Apoyos Complementarios para la Consolidacion Institucional de Grupos de Investigacion'' CONACYT	"Apoyos Complementarios para la Consolidacion Institucional de Grupos de Investigacion'' CONACYT	This work was supported by funds from "Apoyos Complementarios para la Consolidacion Institucional de Grupos de Investigacion'' CONACYT to HIMC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, COMP WOOD ANATOMY; [Anonymous], 1978, COUR FORSCH SENCKENB, V30, P38; Baty F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-422; Brodribb TJ, 2000, PLANT CELL ENVIRON, V23, P1381, DOI 10.1046/j.1365-3040.2000.00647.x; Carlquist S, 1975, ECOLOGICAL STRATEGIE; Chessel D., 2004, R NEWS, V4, P5; Davis SD, 1999, AM J BOT, V86, P1367, DOI 10.2307/2656919; DOLEDEC S, 1987, ACTA OECOL-OEC GEN, V8, P403; Eguiluz de Antunano S., 2001, AAPG MEMOIR, V75, P241, DOI 10.1306/M75768C10; Estrada-Ruiz E, 2010, COAHUILA MEXICO, V97, P1179; Estrada-Ruiz E, 2009, THESIS U NACL AUTONO; Estrada-Ruiz E., 2008, GULF COAST ASS GEOLO, V58, P273; Estrada-Ruiz E, 2007, REV PALAEOBOT PALYNO, V145, P123, DOI 10.1016/j.revpalbo.2006.09.003; Estrada-Ruiz E, 2011, SYST BOT, V36, P337, DOI 10.1600/036364411X569525; Feild TS, 2012, INT J PLANT SCI, V173, P596, DOI 10.1086/666099; Feild TS, 2011, P NATL ACAD SCI USA, V108, P8363, DOI 10.1073/pnas.1014456108; Flores Espinoza E, 1989, STRATIGRAPHY SEDIMEN; Gartner BL, 2004, TREE PHYSIOL, V24, P1239, DOI 10.1093/treephys/24.11.1239; GREENWOOD DR, 1995, GEOLOGY, V23, P1044, DOI 10.1130/0091-7613(1995)023<1044:ECCALT>2.3.CO;2; Hacke UG, 2001, PERSPECT PLANT ECOL, V4, P97, DOI 10.1078/1433-8319-00017; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; Jacobsen AL, 2005, PLANT PHYSIOL, V139, P546, DOI 10.1104/pp.104.058404; Jaramillo C, 2013, ANNU REV EARTH PL SC, V41, P741, DOI 10.1146/annurev-earth-042711-105403; JARBEAU JA, 1995, PLANT CELL ENVIRON, V18, P189, DOI 10.1111/j.1365-3040.1995.tb00352.x; Johnson KR., 2003, ROCKY MT GEOL, V38, P101; Kolb KJ, 1999, ECOLOGY, V80, P2373, DOI 10.1890/0012-9658(1999)080[2373:DIDABS]2.0.CO;2; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Lomax BH, 2000, GEOPHYS RES LETT, V27, P2149, DOI 10.1029/1999GL011097; MACHADO JL, 1994, TREE PHYSIOL, V14, P219, DOI 10.1093/treephys/14.3.219; Maherali H, 2004, ECOLOGY, V85, P2184, DOI 10.1890/02-0538; Martinez-Cabrera HI, 2008, REV PALAEOBOT PALYNO, V150, P154, DOI 10.1016/j.revpalbo.2008.01.010; Martinez-Cabrera HI, 2012, REV PALAEOBOT PALYNO, V187, P1, DOI 10.1016/j.revpalbo.2012.08.005; Martinez-Cabrera HI, 2009, AM J BOT, V96, P1388, DOI 10.3732/ajb.0800237; Meinzer FC, 2001, ENVIRON EXP BOT, V45, P239, DOI 10.1016/S0098-8472(01)00074-0; Poorter L, 2008, ANN BOT-LONDON, V102, P367, DOI 10.1093/aob/mcn103; Pratt RB, 2005, AM J BOT, V92, P1102, DOI 10.3732/ajb.92.7.1102; Preston KA, 2006, NEW PHYTOL, V170, P807, DOI 10.1111/j.1469-8137.2006.01712.x; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; Robeck R. C., 1956, 20 C GEOL INT MEX, P109; Royer DL, 2007, PALEOBIOLOGY, V33, P574, DOI 10.1666/07001.1; Santiago LS, 2004, OECOLOGIA, V140, P543, DOI 10.1007/s00442-004-1624-1; Schenk HJ, 2008, P NATL ACAD SCI USA, V105, P11248, DOI 10.1073/pnas.0804294105; SERLIN BS, 1981, REV PALAEOBOT PALYNO, V31, P241; SPERRY JS, 1992, PLANT PHYSIOL, V100, P605, DOI 10.1104/pp.100.2.605; SPERRY JS, 1993, PLANT CELL ENVIRON, V16, P279, DOI 10.1111/j.1365-3040.1993.tb00870.x; SPICER RA, 1986, GEOLOGY, V14, P703, DOI 10.1130/0091-7613(1986)14<703:PEFCNP>2.0.CO;2; TYREE MT, 1989, ANNU REV PLANT PHYS, V40, P19, DOI 10.1146/annurev.pp.40.060189.000315; Tyree MT, 2003, TREES-STRUCT FUNCT, V17, P95, DOI 10.1007/s00468-002-0227-x; TYREE MT, 1991, PLANT PHYSIOL, V96, P1105, DOI 10.1104/pp.96.4.1105; Upchurch GR, 1998, PHILOS T R SOC B, V353, P97, DOI 10.1098/rstb.1998.0194; Upchurch Jr G.R., 1993, EVOLUTION W INTERIOR, P243; WANG J, 1992, FUNCT ECOL, V6, P469, DOI 10.2307/2389285; WEBER R, 1973, Ameghiniana, V10, P173; Weber R., 1975, PALAEONTOGR B, V152, P76; Weber R., 1972, B SOC GEOL OGICA MEX, V33, P5; Wheeler EA, 2007, IAWA J, V28, P229, DOI 10.1163/22941932-90001638; Wheeler JK, 2005, PLANT CELL ENVIRON, V28, P800, DOI 10.1111/j.1365-3040.2005.01330.x; Wilf P, 1998, GEOLOGY, V26, P203, DOI 10.1130/0091-7613(1998)026<0203:UFLAPI>2.3.CO;2; WOLFE JA, 1971, PALAEOGEOGR PALAEOCL, V9, P27, DOI 10.1016/0031-0182(71)90016-2; WOLFE JA, 1990, NATURE, V343, P153, DOI 10.1038/343153a0; WOLFE JA, 1987, PALAEOGEOGR PALAEOCL, V61, P33, DOI 10.1016/0031-0182(87)90040-X; Zanne AE, 2010, AM J BOT, V97, P207, DOI 10.3732/ajb.0900178; Zimmermann M. H., 1983, Xylem structure and the ascent of sap.	64	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108866	10.1371/journal.pone.0108866	http://dx.doi.org/10.1371/journal.pone.0108866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279992	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800031
J	Davies, AC; Nicol, CJ; Persson, ME; Radford, AN				Davies, Anna C.; Nicol, Christine J.; Persson, Mia E.; Radford, Andrew N.			Behavioural and Physiological Effects of Finely Balanced Decision-Making in Chickens	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; LAYING HENS; ANTICIPATION; PREFERENCES; MOTIVATION; ANIMALS; AROUSAL; STRESS; CHOICE; TESTS	In humans, more difficult decisions result in behavioural and physiological changes suggestive of increased arousal, but little is known about the effect of decision difficulty in other species. A difficult decision can have a number of characteristics; we aimed to monitor how finely balanced decisions, compared to unbalanced ones, affected the behaviour and physiology of chickens. An unbalanced decision was one in which the two options were of unequal net value (1 (Q1) vs. 6 (Q6) pieces of sweetcorn with no cost associated with either option); a finely balanced decision was one in which the options were of equal net value (i.e. hens were "indifferent" to both options). To identify hens' indifference, a titration procedure was used in which a cost (electromagnetic weight on an access door) was applied to the Q6 option, to find the individual point at which hens chose this option approximately equally to Q1 via a non-weighted door. We then compared behavioural and physiological indicators of arousal (head movements, latency to choose, heart-rate variability and surface body temperature) when chickens made decisions that were unbalanced or finely balanced. Significant physiological (heart-rate variability) and behavioural (latency to pen) differences were found between the finely balanced and balanced conditions, but these were likely to be artefacts of the greater time and effort required to push through the weighted doors. No other behavioural and physiological measures were significantly different between the decision categories. We suggest that more information is needed on when best to monitor likely changes in arousal during decision-making and that future studies should consider decisions defined as difficult in other ways.	[Davies, Anna C.; Nicol, Christine J.] Univ Bristol, Sch Clin Vet Sci, Bristol, Avon, England; [Persson, Mia E.] Linkoping Univ, Avian Behav Genom & Physiol Grp, Linkoping, Sweden; [Radford, Andrew N.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Bristol; Linkoping University; University of Bristol	Davies, AC (corresponding author), Univ Bristol, Sch Clin Vet Sci, Bristol, Avon, England.	Anna.c.davies@bristol.ac.uk	Nicol, Christine J/B-4841-2011	Nicol, Christine J/0000-0001-6734-2177; Persson, Mia/0000-0002-6115-7517; Radford, Andrew N/0000-0001-5470-3463; Trevarthen, Anna/0000-0001-9575-7150	BBSRC [BB/F016662/1]; Biotechnology and Biological Sciences Research Council [BB/K00042X/1, 1057027] Funding Source: researchfish; BBSRC [BB/K00042X/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the BBSRC (Grant reference: BB/F016662/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateson M, 2004, ANIM WELFARE, V13, pS115; Browne WJ, 2011, APPL ANIM BEHAV SCI, V134, P152, DOI 10.1016/j.applanim.2011.07.004; Bruce EH, 2003, BRIT POULTRY SCI, V44, P345, DOI 10.1080/0007166031000085490; Cabanac M, 2000, PHYSIOL BEHAV, V69, P541, DOI 10.1016/S0031-9384(00)00227-4; Camm AJ, 1996, CIRCULATION, V93, P1043; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Cooper JJ, 2000, APPL ANIM BEHAV SCI, V66, P135, DOI 10.1016/S0168-1591(99)00069-6; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Crone EA, 2004, PSYCHOPHYSIOLOGY, V41, P531, DOI 10.1111/j.1469-8986.2004.00197.x; Cyr NE, 2009, PHYSIOL BIOCHEM ZOOL, V82, P332, DOI 10.1086/589839; Danan E, 2010, MANAGE SCI, V56, P503, DOI 10.1287/mnsc.1090.1116; Davies AC, 2014, PHYSIOL BEHAV, V123, P93, DOI 10.1016/j.physbeh.2013.10.008; Edgar JL, 2013, PHYSIOL BEHAV, V119, P195, DOI 10.1016/j.physbeh.2013.06.020; Edgar JL, 2011, P ROY SOC B-BIOL SCI, V278, P3129, DOI 10.1098/rspb.2010.2701; Eliaz K, 2006, GAME ECON BEHAV, V56, P61, DOI 10.1016/j.geb.2005.06.007; Fraser D., 2011, Animal welfare, P183, DOI 10.1079/9781845936594.0183; GERARD HB, 1967, J PERS, V35, P91, DOI 10.1111/j.1467-6494.1967.tb01417.x; Jensen MB, 2008, APPL ANIM BEHAV SCI, V113, P340, DOI 10.1016/j.applanim.2008.02.001; Kirkden RD, 2006, APPL ANIM BEHAV SCI, V100, P29, DOI 10.1016/j.applanim.2006.04.009; Kjaer JB, 2011, GENES BRAIN BEHAV, V10, P747, DOI 10.1111/j.1601-183X.2011.00713.x; Korte SM, 1999, PHYSIOL BEHAV, V65, P649; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lowe JC, 2007, COMPUT ELECTRON AGR, V57, P74, DOI 10.1016/j.compag.2007.02.003; Mandler M, 2005, GAME ECON BEHAV, V50, P255, DOI 10.1016/j.geb.2004.02.007; MANN L, 1969, J PERS SOC PSYCHOL, V11, P10, DOI 10.1037/h0026967; Manski C. F., 1975, J ECONOMETRICS, V3, P205, DOI [DOI 10.1016/0304-4076(75)90032-9, 10.1016/0304-4076(75)90032-9]; MCFARLAND DJ, 1977, NATURE, V269, P15, DOI 10.1038/269015a0; Moe RO, 2012, PHYSIOL BEHAV, V106, P527, DOI 10.1016/j.physbeh.2012.03.032; Moe RO, 2009, APPL ANIM BEHAV SCI, V121, P171, DOI 10.1016/j.applanim.2009.10.002; Moffatt PG, 2005, EXP ECON, V8, P369, DOI 10.1007/s10683-005-5375-6; Perry CJ, 2013, P NATL ACAD SCI USA, V110, P19155, DOI 10.1073/pnas.1314571110; Saaty TL., 1988, MATH MODELS DECISION, P109, DOI DOI 10.1007/978-3-642-83555-1_5; Shields SJ, 2004, APPL ANIM BEHAV SCI, V87, P69, DOI 10.1016/j.applanim.2004.01.003; SMITH JD, 1995, J EXP PSYCHOL GEN, V124, P391, DOI 10.1037/0096-3445.124.4.391; Sorensen DB, 2004, ANIM BEHAV, V68, P949, DOI 10.1016/j.anbehav.2003.12.017; Suda-King C, 2013, ANIM COGN, V16, P65, DOI 10.1007/s10071-012-0551-5; van Harreveld F, 2009, J EXP SOC PSYCHOL, V45, P167, DOI 10.1016/j.jesp.2008.08.015; VARIAN HR, 1990, J ECONOMETRICS, V46, P125, DOI 10.1016/0304-4076(90)90051-T; Ventricelli M, 2013, BEHAV PROCESS, V100, P146, DOI 10.1016/j.beproc.2013.09.001; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; WIDOWSKI TM, 1992, CAN J ANIM SCI, V72, P203, DOI 10.4141/cjas92-027; Zimmerman PH, 2011, ANIM BEHAV, V81, P569, DOI 10.1016/j.anbehav.2010.11.028	42	4	4	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108809	10.1371/journal.pone.0108809	http://dx.doi.org/10.1371/journal.pone.0108809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ2BX	25275440	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500033
J	Dumcke, S; Mansmann, U; Tresch, A				Duemcke, Sebastian; Mansmann, Ulrich; Tresch, Achim			A Novel Test for Independence Derived from an Exact Distribution of ith Nearest Neighbours	PLOS ONE			English	Article								Dependence measures and tests for independence have recently attracted a lot of attention, because they are the cornerstone of algorithms for network inference in probabilistic graphical models. Pearson's product moment correlation coefficient is still by far the most widely used statistic yet it is largely constrained to detecting linear relationships. In this work we provide an exact formula for the ith nearest neighbor distance distribution of rank-transformed data. Based on that, we propose two novel tests for independence. An implementation of these tests, together with a general benchmark framework for independence testing, are freely available as a CRAN software package (http://cran.r-project.org/web/packages/knnIndep). In this paper we have benchmarked Pearson's correlation, Hoeffding's D, dcor, Kraskov's estimator for mutual information, maximal information criterion and our two tests. We conclude that no particular method is generally superior to all other methods. However, dcor and Hoeffding's D are the most powerful tests for many different types of dependence.	[Duemcke, Sebastian; Tresch, Achim] Univ Cologne, Inst Genet, Cologne, Germany; [Duemcke, Sebastian; Tresch, Achim] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Mansmann, Ulrich] Univ Munich, IBE, Munich, Germany	University of Cologne; Max Planck Society; University of Munich	Tresch, A (corresponding author), Univ Cologne, Inst Genet, Weyertal 121, Cologne, Germany.	tresch@mpipz.mpg.de			Bundesministerium fur Bildung und Forschung (BMBF); Max Planck Institute for Plant Breeding Research; University of Cologne	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Institute for Plant Breeding Research(Max Planck Society); University of Cologne	AT was supported by the Bundesministerium fur Bildung und Forschung (BMBF) e: Bio Syscore grant and by a Jeff Schell professorship from the Max Planck Institute for Plant Breeding Research and the University of Cologne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON TW, 1952, ANN MATH STAT, V23, P193, DOI 10.1214/aoms/1177729437; Eser P, 2014, MOL SYSTEMS BIOL, V10; HOEFFDING W, 1948, ANN MATH STAT, V19, P546, DOI 10.1214/aoms/1177730150; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; R Core Team, 2021, R LANGUAGE ENV STAT; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Simon N., 2014, SCIENCE         1216; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Speed T, 2011, SCIENCE, V334, P1502, DOI 10.1126/science.1215894; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505	12	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e107955	10.1371/journal.pone.0107955	http://dx.doi.org/10.1371/journal.pone.0107955			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275469	gold, Green Submitted, Green Published			2022-12-27	WOS:000342591500010
J	Fichna, J; Bawa, M; Thakur, GA; Tichkule, R; Makriyannis, A; McCafferty, DM; Sharkey, KA; Storr, M				Fichna, Jakub; Bawa, Misha; Thakur, Ganesh A.; Tichkule, Ritesh; Makriyannis, Alexandros; McCafferty, Donna-Marie; Sharkey, Keith A.; Storr, Martin			Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-TREATED RATS; ENTERIC NERVOUS-SYSTEM; EXPERIMENTAL COLITIS; BOWEL-DISEASE; GASTROINTESTINAL MOTILITY; DIFFERENTIAL EXPRESSION; NEUTROPHIL CHEMOTAXIS; MACROPHAGES; CB2; ACTIVATION	Background and Aims: In an attempt to further investigate the role of cannabinoid (CB) system in the pathogenesis of inflammatory bowel diseases, we employed two recently developed ligands, AM841 (a covalently acting CB agonist) and CB13 (a peripherally-restricted CB agonist) to establish whether central and peripheral CB sites are involved in the anti-inflammatory action in the intestine. Methods and Results: AM841 (0.01, 0.1 and 1 mg/kg, i.p.) significantly decreased inflammation scores in dextran sulfate sodium (DSS)- and 2,4,6-trinitrobenzene sulfonic acid (TNBS)-treated mice when administered before induction of colitis or as a treatment of existing intestinal inflammation. The effect was absent in CB1, CB2 and CB1/2-deficient mice. A peripherally-restricted agonist CB13 did not alleviate colitis when given i.p. (0.1 mg/kg), but significantly decreased inflammation score after central administration (0.1 mu g/animal). Conclusions: This is the first evidence that central and peripheral CB receptors are responsible for the protective and therapeutic action of cannabinoids in mouse models of colitis. Our observations provide new insight to CB pharmacology and validate the use of novel ligands AM841 and CB13 as potent tools in CB-related research.	[Fichna, Jakub; Sharkey, Keith A.; Storr, Martin] Univ Calgary, Dept Med, Snyder Inst Chron Dis, Calgary, AB, Canada; [Bawa, Misha; McCafferty, Donna-Marie; Sharkey, Keith A.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Sharkey, Keith A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Fichna, Jakub] Med Univ Lodz, Dept Biochem, Lodz, Poland; [Thakur, Ganesh A.; Tichkule, Ritesh; Makriyannis, Alexandros] Northeastern Univ, Ctr Drug Discovery, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Storr, Martin] Univ Munich, Dept Med, Div Gastroenterol, Munich, Germany	University of Calgary; University of Calgary; University of Calgary; Medical University Lodz; Northeastern University; University of Munich	Storr, M (corresponding author), Univ Calgary, Dept Med, Snyder Inst Chron Dis, Calgary, AB, Canada.	Martin.Storr@med.uni-muenchen.de	Makriyannis, Alexandros/GRF-1518-2022; Fichna, Jakub/S-6641-2016	Makriyannis, Alexandros/0000-0003-3272-3687; Fichna, Jakub/0000-0002-8443-4417; Sharkey, Keith/0000-0001-9560-1711	Crohn's and Colitis Foundation of Canada (CCFC); Iuventus Plus program of the Polish Ministry of Science and Higher Education [0107/IP1/2013/72]; Killam Annual Professorship at the University of Calgary; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA023142, P01DA009158] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of Canada (CCFC); Iuventus Plus program of the Polish Ministry of Science and Higher Education; Killam Annual Professorship at the University of Calgary; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by a grant from the Crohn's and Colitis Foundation of Canada (CCFC, to MS & KAS) and the Iuventus Plus program of the Polish Ministry of Science and Higher Education (0107/IP1/2013/72 to JF). The authors thank Ms. Winnie Ho for performing the genotyping of the CB receptor gene deficient mouse colony. This study was supported by a grant from the Crohn's and Colitis Foundation of Canada (CCFC, to MS & KAS). KAS holds the Crohn's and Colitis Foundation of Canada (CCFC) Chair in Inflammatory Bowel Disease Research and is the recipient of a Killam Annual Professorship at the University of Calgary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARATA S, 1991, LIFE SCI, V49, P473, DOI 10.1016/0024-3205(91)90590-8; BOUABOULA M, 1993, EUR J BIOCHEM, V214, P173, DOI 10.1111/j.1432-1033.1993.tb17910.x; BURNETTECURLEY D, 1993, INT J IMMUNOPHARMACO, V15, P371, DOI 10.1016/0192-0561(93)90048-4; Bussolaro D, 2008, TOXICOL IN VITRO, V22, P254, DOI 10.1016/j.tiv.2007.09.003; CABRAL GA, 1989, J TOXICOL ENV HEALTH, V26, P175, DOI 10.1080/15287398909531243; Carballo E, 1999, AM J PHYSIOL-CELL PH, V277, pC163, DOI 10.1152/ajpcell.1999.277.1.C163; Carlisle SJ, 2002, INT IMMUNOPHARMACOL, V2, P69, DOI 10.1016/S1567-5769(01)00147-3; Cheifetz AS, 2013, JAMA-J AM MED ASSOC, V309, P2150, DOI 10.1001/jama.2013.4466; Cluny NL, 2010, J PHARMACOL EXP THER, V334, P973, DOI 10.1124/jpet.110.169946; Coutts AA, 2002, J COMP NEUROL, V448, P410, DOI 10.1002/cne.10270; Di Marzo V, 2002, PROSTAG LEUKOTR ESS, V66, P377, DOI 10.1054/plef.2001.0349; Dignass AU, 2004, ALIMENT PHARM THER, V20, P9, DOI 10.1111/j.1365-2036.2004.02047.x; Duncan M, 2008, AM J PHYSIOL-GASTR L, V295, pG78, DOI 10.1152/ajpgi.90285.2008; Dziadulewicz EK, 2007, J MED CHEM, V50, P3851, DOI 10.1021/jm070317a; Fichna J, 2012, INFLAMM BOWEL DIS, V18, P1137, DOI 10.1002/ibd.21873; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; HERKENHAM M, 1991, BRAIN RES, V547, P267, DOI 10.1016/0006-8993(91)90970-7; Ihenetu K, 2003, EUR J PHARMACOL, V458, P207, DOI 10.1016/S0014-2999(02)02698-5; Izzo AA, 2001, BRIT J PHARMACOL, V134, P563, DOI 10.1038/sj.bjp.0704293; Izzo AA, 2010, PHARMACOL THERAPEUT, V126, P21, DOI 10.1016/j.pharmthera.2009.12.005; KAMINSKI NE, 1992, MOL PHARMACOL, V42, P736; Khan AI, 2005, MICROCIRCULATION, V12, P421, DOI 10.1080/10739680590960368; Kimball ES, 2006, AM J PHYSIOL-GASTR L, V291, pG364, DOI 10.1152/ajpgi.00407.2005; KLEIN TW, 1991, J TOXICOL ENV HEALTH, V32, P465, DOI 10.1080/15287399109531496; Kulkarni-Narla A, 2000, CELL TISSUE RES, V302, P73, DOI 10.1007/s004410000261; Kurihara R, 2006, J BIOL CHEM, V281, P12908, DOI 10.1074/jbc.M510871200; LOPEZCEPERO M, 1986, J LEUKOCYTE BIOL, V39, P679, DOI 10.1002/jlb.39.6.679; LUO YD, 1992, INT J IMMUNOPHARMACO, V14, P49, DOI 10.1016/0192-0561(92)90104-S; MANN PEG, 1971, LAB INVEST, V25, P111; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Mathison R, 2004, BRIT J PHARMACOL, V142, P1247, DOI 10.1038/sj.bjp.0705889; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; Mawe GM, 2009, NEUROGASTROENT MOTIL, V21, P481, DOI 10.1111/j.1365-2982.2009.01291.x; MCCOY KL, 1995, J PHARMACOL EXP THER, V273, P1216; McHugh D, 2008, MOL PHARMACOL, V73, P441, DOI 10.1124/mol.107.041863; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nilsson O, 2006, EUR J PHARMACOL, V547, P165, DOI 10.1016/j.ejphar.2006.07.016; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Pei Y, 2008, CHEM BIOL, V15, P1207, DOI 10.1016/j.chembiol.2008.10.011; Picone RP, 2005, MOL PHARMACOL, V68, P1623, DOI 10.1124/mol.105.014407; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Schatz AR, 1997, TOXICOL APPL PHARM, V142, P278, DOI 10.1006/taap.1996.8034; SCHWARZ H, 1994, J NEUROIMMUNOL, V55, P107, DOI 10.1016/0165-5728(94)90152-X; Storr MA, 2008, J MOL MED, V86, P925, DOI 10.1007/s00109-008-0359-6; Storr MA, 2009, INFLAMM BOWEL DIS, V15, P1678, DOI 10.1002/ibd.20960; STROBACH RS, 1990, MODERN PATHOL, V3, P488; Szymanski DW, 2011, J PROTEOME RES, V10, P4789, DOI 10.1021/pr2005583; Wright K, 2005, GASTROENTEROLOGY, V129, P437, DOI 10.1053/j.gastro.2005.05.026	48	48	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109115	10.1371/journal.pone.0109115	http://dx.doi.org/10.1371/journal.pone.0109115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275313	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500063
J	Kuntamallappanavar, G; Toro, L; Dopico, AM				Kuntamallappanavar, Guruprasad; Toro, Ligia; Dopico, Alex M.			Both Transmembrane Domains of BK beta 1 Subunits Are Essential to Confer the Normal Phenotype of beta 1-Containing BK Channels	PLOS ONE			English	Article							CA2+-SENSITIVE K+ CHANNELS; VOLTAGE SENSOR ACTIVATION; LARGE-CONDUCTANCE; POTASSIUM CHANNEL; BETA(1) SUBUNIT; SMOOTH-MUSCLE; ALPHA-SUBUNIT; CALCIUM; CA2+; BETA-1-SUBUNIT	Voltage/Ca-i(2+)-gated, large conductance K+ (BK) channels result from tetrameric association of a (slo1) subunits. In most tissues, BK protein complexes include regulatory beta subunits that contain two transmembrane domains (TM1, TM2), an extracellular loop, and two short intracellular termini. Four BK b types have been identified, each presenting a rather selective tissue-specific expression profile. Thus, BK b modifies current phenotype to suit physiology in a tissue-specific manner. The smooth muscle-abundant BK beta 1 drastically increases the channel's apparent Ca-i(2+) sensitivity. The resulting phenotype is critical for BK channel activity to increase in response to Ca2+ levels reached near the channel during depolarization-induced Ca2+ influx and myocyte contraction. The eventual BK channel activation generates outward K+ currents that drive the membrane potential in the negative direction and eventually counteract depolarization-induced Ca2+ influx. The BK beta 1 regions responsible for the characteristic phenotype of beta 1-containing BK channels remain to be identified. We used patch-clamp electrophysiology on channels resulting from the combination of smooth muscle slo1 (cbv1) subunits with smooth muscle-abundant beta 1, neuron-abundant beta 4, or chimeras constructed by swapping beta 1 and beta 4 regions, and determined the contribution of specific beta 1 regions to the BK phenotype. At Ca2+ levels found near the channel during myocyte contraction (10 mu M), channel complexes that included chimeras having both TMs from beta 1 and the remaining regions ("background") from beta 4 showed a phenotype (V-half, tau(act), tau(deact)) identical to that of complexes containing wt beta 1. This phenotype could not be evoked by complexes that included chimeras combining either beta 1 TM1 or beta 1 TM2 with a beta 4 background. Likewise, beta "halves" (each including beta 1 TM1 or beta 1 TM2) resulting from interrupting the continuity of the EC loop failed to render the normal phenotype, indicating that physical connection between beta 1 TMs via the EC loop is also necessary for proper channel function.	[Kuntamallappanavar, Guruprasad; Dopico, Alex M.] Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Pharmacol, Memphis, TN 38163 USA; [Toro, Ligia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Toro, Ligia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dopico, AM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Pharmacol, Memphis, TN 38163 USA.	adopico@uthsc.edu			National Institute on Alcohol Abuse and Alcoholism [R37 AA11560]; National Heart, Lung, and Blood Institute [R01 HL104631, R01 HL107418]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107418, R01HL104631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA011560] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work is supported by R37 AA11560 (AMD) from the National Institute on Alcohol Abuse and Alcoholism, www.niaaa.nih.gov, R01 HL104631 (AMD) from the National Heart, Lung, and Blood Institute, www.nhlbi.nih.gov, Predoctoral Fellowship (GK) from the American Heart Association, www.aha.org, and R01 HL107418 (LT) from the National Heart, Lung, and Blood Institute, www.nhlbi.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2005, J GEN PHYSIOL, V126, P393, DOI 10.1085/jgp.200509346; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Bukiya AN, 2008, FEBS LETT, V582, P673, DOI 10.1016/j.febslet.2008.01.036; Bukiya AN, 2013, MOL PHARMACOL, V83, P1030, DOI 10.1124/mol.112.083519; Bukiya AN, 2011, P NATL ACAD SCI USA, V108, P20207, DOI 10.1073/pnas.1112901108; Bukiya AN, 2009, FEBS LETT, V583, P2779, DOI 10.1016/j.febslet.2009.07.019; Contreras GF, 2012, P NATL ACAD SCI USA, V109, P18991, DOI 10.1073/pnas.1216953109; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Dopico AM, 2012, PHARMACOL THERAPEUT, V135, P133, DOI 10.1016/j.pharmthera.2012.05.002; Dopico AM, 2003, AM J PHYSIOL-CELL PH, V284, pC1468, DOI 10.1152/ajpcell.00421.2002; Glantz SA, 2001, PRIMER BIOSTATISTICS; Gruslova A, 2012, J GEN PHYSIOL, V139, P57, DOI 10.1085/jgp.201110698; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Jaggar JH, 2005, CIRC RES, V97, P805, DOI 10.1161/01.RES.0000186180.47148.7b; Koval OM, 2007, J GEN PHYSIOL, V129, P209, DOI 10.1085/jgp.200609662; Latorre R, 2010, J PHYSIOL-LONDON, V588, P3141, DOI 10.1113/jphysiol.2010.191999; Lee US, 2010, J NEUROSCI, V30, P16170, DOI 10.1523/JNEUROSCI.2323-10.2010; Liu GX, 2008, P NATL ACAD SCI USA, V105, P10727, DOI 10.1073/pnas.0805212105; Liu GX, 2010, J GEN PHYSIOL, V135, P449, DOI 10.1085/jgp.201010417; Meera P, 1996, FEBS LETT, V382, P84, DOI 10.1016/0014-5793(96)00151-2; Morera FJ, 2012, FEBS LETT, V586, P2287, DOI 10.1016/j.febslet.2012.05.066; Morrow JP, 2006, P NATL ACAD SCI USA, V103, P5096, DOI 10.1073/pnas.0600907103; Nimigean CM, 2000, J GEN PHYSIOL, V115, P719, DOI 10.1085/jgp.115.6.719; Orio P, 2006, J GEN PHYSIOL, V127, P191, DOI 10.1085/jgp.200509370; Orio P, 2005, J GEN PHYSIOL, V125, P395, DOI 10.1085/jgp.200409236; Orio P, 2002, NEWS PHYSIOL SCI, V17, P156, DOI 10.1152/nips.01387.2002; Pantazis A, 2010, J GEN PHYSIOL, V136, P645, DOI 10.1085/jgp.201010503; Perez GJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1769, DOI 10.1152/ajpcell.2001.281.6.C1769; Semenova NP, 2009, J BIOL CHEM, V284, P10684, DOI 10.1074/jbc.M808891200; Valverde MA, 1999, SCIENCE, V285, P1929, DOI 10.1126/science.285.5435.1929; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wang B, 2006, J GEN PHYSIOL, V128, P731, DOI 10.1085/jgp.200609596; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Wu RS, 2013, J GEN PHYSIOL, V141, P105, DOI 10.1085/jgp.201210891; Wu RS, 2009, J NEUROSCI, V29, P8321, DOI 10.1523/JNEUROSCI.6191-08.2009	36	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109306	10.1371/journal.pone.0109306	http://dx.doi.org/10.1371/journal.pone.0109306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275635	gold, Green Submitted, Green Published			2022-12-27	WOS:000342591500094
J	Stockinger, H; Peyret-Guzzon, M; Koegel, S; Bouffaud, ML; Redecker, D				Stockinger, Herbert; Peyret-Guzzon, Marine; Koegel, Sally; Bouffaud, Marie-Lara; Redecker, Dirk			The Largest Subunit of RNA Polymerase II as a New Marker Gene to Study Assemblages of Arbuscular Mycorrhizal Fungi in the Field	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; GLOMUS-INTRARADICES; MAXIMUM-LIKELIHOOD; BARCODED PRIMERS; RIBOSOMAL-RNA; DIVERSITY; PHYLOGENY; SOIL; POPULATION; GLOMEROMYCOTA	Due to the potential of arbuscular mycorrhizal fungi (AMF, Glomeromycota) to improve plant growth and soil quality, the influence of agricultural practice on their diversity continues to be an important research question. Up to now studies of community diversity in AMF have exclusively been based on nuclear ribosomal gene regions, which in AMF show high intra-organism polymorphism, seriously complicating interpretation of these data. We designed specific PCR primers for 454 sequencing of a region of the largest subunit of RNA polymerase II gene, and established a new reference dataset comprising all major AMF lineages. This gene is known to be monomorphic within fungal isolates but shows an excellent barcode gap between species. We designed a primer set to amplify all known lineages of AMF and demonstrated its applicability in combination with high-throughput sequencing in a long-term tillage experiment. The PCR primers showed a specificity of 99.94% for glomeromycotan sequences. We found evidence of significant shifts of the AMF communities caused by soil management and showed that tillage effects on different AMF taxa are clearly more complex than previously thought. The high resolving power of high-throughput sequencing highlights the need for quantitative measurements to efficiently detect these effects.	[Stockinger, Herbert; Redecker, Dirk] Univ Bourgogne, Agroecol UMR1347, Dijon, France; [Stockinger, Herbert; Peyret-Guzzon, Marine; Bouffaud, Marie-Lara] INRA, Agroecol UMR1347, F-21034 Dijon, France; [Koegel, Sally] Univ Basel, Inst Bot, CH-4056 Basel, Switzerland	Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; University of Basel	Redecker, D (corresponding author), Univ Bourgogne, Agroecol UMR1347, Dijon, France.	dirk.redecker@dijon.inra.fr		Bouffaud, Marie-Lara/0000-0001-6112-2982	Swiss National Science Foundation [3100A-124966]; Conseil Regional de Bourgogne (Agrale 8) [2011-9201 AA 0049 S0 5523]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Conseil Regional de Bourgogne (Agrale 8)(Region Bourgogne-Franche-Comte)	This study was funded by grant number 3100A-124966 from the Swiss National Science Foundation (www.snf.ch) and the Conseil Regional de Bourgogne (Agrale 8 - n<SUP>o</SUP> 2011-9201 AA 0049 S0 5523) to DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alguacil MM, 2008, ECOL APPL, V18, P527, DOI 10.1890/07-0521.1; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Anken T, 1997, BERICHTE SWISS FEDER, V501, P1; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Berry D, 2011, APPL ENVIRON MICROB, V77, P7846, DOI 10.1128/AEM.05220-11; Borstler B, 2010, MOL ECOL, V19, P1497, DOI 10.1111/j.1365-294X.2010.04590.x; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Borriello R, 2012, BIOL FERT SOILS, V48, P911, DOI 10.1007/s00374-012-0683-4; Borriello R, 2014, MOL PHYLOGENET EVOL, V75, P1, DOI 10.1016/j.ympev.2014.02.012; Brito I, 2012, SOIL TILL RES, V121, P63, DOI 10.1016/j.still.2012.01.012; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Corradi N, 2007, APPL ENVIRON MICROB, V73, P366, DOI 10.1128/AEM.01574-06; Croll D, 2008, NEW PHYTOL, V180, P564, DOI 10.1111/j.1469-8137.2008.02602.x; Croll D, 2008, NEW PHYTOL, V178, P672, DOI 10.1111/j.1469-8137.2008.02381.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emerson BC, 2011, PHILOS T R SOC B, V366, P2391, DOI 10.1098/rstb.2011.0057; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Hao XL, 2011, BIOINFORMATICS, V27, P611, DOI 10.1093/bioinformatics/btq725; Harris JK, 2010, APPL ENVIRON MICROB, V76, P3863, DOI 10.1128/AEM.02585-09; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Hempel S, 2007, ENVIRON MICROBIOL, V9, P1930, DOI 10.1111/j.1462-2920.2007.01309.x; Hijri I, 2006, MOL ECOL, V15, P2277, DOI 10.1111/j.1365-294X.2006.02921.x; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jansa J, 2002, MYCORRHIZA, V12, P225, DOI [10.1007/s005572-002-0163-z, 10.1007/s00572-002-0163-z]; Jansa J, 2003, ECOL APPL, V13, P1164, DOI 10.1890/1051-0761(2003)13[1164:STATCS]2.0.CO;2; Kohout P, 2014, SOIL BIOL BIOCHEM, V68, P482, DOI 10.1016/j.soilbio.2013.08.027; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Lin XG, 2012, ENVIRON SCI TECHNOL, V46, P5764, DOI 10.1021/es3001695; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Naumann M, 2010, ISME J, V4, P862, DOI 10.1038/ismej.2010.21; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ranwez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022594; Redecker D, 2006, MYCOLOGIA, V98, P885, DOI 10.3852/mycologia.98.6.885; Redecker D, 2013, MYCORRHIZA, V23, P515, DOI 10.1007/s00572-013-0486-y; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosendahl S, 2008, NEW PHYTOL, V179, P1154, DOI 10.1111/j.1469-8137.2008.02535.x; Rosendahl S, 2009, MOL ECOL, V18, P4316, DOI 10.1111/j.1365-294X.2009.04359.x; Schloss PD, 2008, ISME J, V2, P265, DOI 10.1038/ismej.2008.5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Schussler A, 2010, SPECIES LIST NEW FAM; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stockinger H, 2010, NEW PHYTOL, V187, P461, DOI 10.1111/j.1469-8137.2010.03262.x; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Sykorova Z, 2007, MYCORRHIZA, V18, P1, DOI 10.1007/s00572-007-0147-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thonar C, 2012, MOL ECOL RESOUR, V12, P219, DOI 10.1111/j.1755-0998.2011.03086.x; Tisserant E, 2013, P NATL ACAD SCI USA, V110, P20117, DOI 10.1073/pnas.1313452110; VanKuren NW, 2013, EVOLUTION, V67, P207, DOI 10.1111/j.1558-5646.2012.01747.x; Verbruggen E, 2010, EVOL APPL, V3, P547, DOI 10.1111/j.1752-4571.2010.00145.x; Walker C, 2007, MYCOL RES, V111, P137, DOI 10.1016/j.mycres.2006.11.008; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x	63	48	51	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e107783	10.1371/journal.pone.0107783	http://dx.doi.org/10.1371/journal.pone.0107783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275381	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500008
J	Zhou, W; Tan, XB; Shan, JJ; Wang, SC; Yin, AL; Cai, BC; Di, LQ				Zhou, Wei; Tan, Xiaobin; Shan, Jinjun; Wang, Shouchuan; Yin, Ailing; Cai, Baochang; Di, Liuqing			Study on the Main Components Interaction from Flos Lonicerae and Fructus Forsythiae and Their Dissolution In Vitro and Intestinal Absorption in Rats	PLOS ONE			English	Article							COMBINATION; EXTRACT; BLOOD	The Flos Lonicerae-Fructus Forsythiae herb couple is the basic components of Chinese herbal preparations (Shuang-HuangLian tablet, Yin-Qiao-Jie-Du tablet and Fufang Qin-Lan oral liquid), and its pharmacological effects were significantly higher than that in Flos Lonicerae or Fructus Forsythiae, but the reasons remained unknown. In the present study, pattern recognition analysis (hierarchical cluster analysis (HCA) and principal component analysis (PCA)) combined with UHPLC-ESI/LTQ-Orbitrap MS system were performed to study the chemical constitution difference between co-decoction and mixed decoction in the term of chemistry. Besides, the pharmacokinetics in vivo and intestinal absorption in vitro combined with pattern recognition analysis were used to reveal the discrepancy between herb couple and single herbs in the view of biology. The observation from the chemical view in vitro showed that there was significant difference in quantity between co-decoction and mixed decoction by HCA, and the exposure level of isoforsythoside and 3, 5-dicaffeoylquinic acid in codecoction, higher than that in mixed decoction, directly resulted in the discrepancy between co-decoction and mixed decoction using both PCA and HCA. The observation from the pharmacokinetics displayed that the exposure level in vivo of neochlorogenic acid, 3, 4-dicaffeoylquinic acid, isoforsythoside and forsythoside A, higher than that in single herbs, was the main factor contributing to the difference by both PCA and HCA, interestingly consistent with the results obtained from Caco-2 cells in vitro, which indicated that it was because of intestinal absorption improvement of neochlorogenic acid, 3, 4-dicaffeoylquinic acid, isoforsythoside and forsythoside A that resulted in a better efficacy of herb couple than that of single herbs from the perspective of biology. The results above illustrated that caffeic acid derivatives in Flos Lonicerae-Fructus Forsythiae herb couple could be considered as chemical markers for quality control of its preparations.	[Zhou, Wei; Yin, Ailing; Cai, Baochang; Di, Liuqing] Nanjing Univ Chinese Med, Coll Pharm, Nanjing, Jiangsu, Peoples R China; [Zhou, Wei; Di, Liuqing] Jiangsu Engn Res Ctr Efficient Delivery Syst TCM, Nanjing, Jiangsu, Peoples R China; [Zhou, Wei; Di, Liuqing] Nanjing Engn Res Ctr Industrializat Chinese Med P, Nanjing, Jiangsu, Peoples R China; [Tan, Xiaobin] Jiangsu Provin Acad Chinese Med, Lab New Drug Delivery Syst Chinese Meteria Med, Nanjing, Jiangsu, Peoples R China; [Shan, Jinjun; Wang, Shouchuan] Nanjing Univ Chinese Med, Inst Paediat, Jiangsu Key Lab Pediat Resp Dis, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Di, LQ (corresponding author), Nanjing Univ Chinese Med, Coll Pharm, Nanjing, Jiangsu, Peoples R China.	diliuqing@hotmail.com	Zhou, Wei/I-5964-2014; tan, xiao/GZL-0264-2022		National Natural Science Foundation of China [81001499]; Jiangsu Natural Science Foundation [BK2010560]; "Qing Lan" Project from Jiangsu Provincial Technology Innovation Team Support Scheme; priority Academic Program Development of Jiangsu Higher Education Institution [ysxk-2010]; program sponsored for scientific innovation research of college graduate in Jiangsu province [623]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); "Qing Lan" Project from Jiangsu Provincial Technology Innovation Team Support Scheme; priority Academic Program Development of Jiangsu Higher Education Institution; program sponsored for scientific innovation research of college graduate in Jiangsu province	The present study is supported financially by the National Natural Science Foundation of China (81001499), the Jiangsu Natural Science Foundation (BK2010560), "Qing Lan" Project from Jiangsu Provincial Technology Innovation Team Support Scheme, the priority Academic Program Development of Jiangsu Higher Education Institution (No. ysxk-2010), and 2012 program sponsored for scientific innovation research of college graduate in Jiangsu province (623). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Huang Mei-Yan, 2013, Zhongguo Zhong Yao Za Zhi, V38, P234; Huang Mei-yan, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P516; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Li YY, 2008, THESIS ACAD CHINESE; Lin LM, 2008, THESIS CHINA ACAD CH; PAN SY, 2011, EVID-BASED COMPL ALT, DOI DOI 10.1093/ECAM/NEQ056; Shang XF, 2011, J ETHNOPHARMACOL, V138, P1, DOI 10.1016/j.jep.2011.08.016; Shi Xu-qin, 2012, Yaoxue Xuebao, V47, P1375; Wang L., 2010, THESIS CHENGDU U TRA; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; WANG LQ, 2008, THESIS AGR U HENAN; Wang XJ, 2005, BIOL PHARM BULL, V28, P1106, DOI 10.1248/bpb.28.1106; Wang ZP, 2011, THESIS GUANGZHOU U C; Xia BH, 2009, CHIN J EXPT TRAD MED, V15, P80; Zhang LW, 2002, THESIS SHANXI U; Zhou W, 2014, PHYTOMEDICINE, V21, P1549, DOI 10.1016/j.phymed.2014.06.016; Zhou W, 2014, PHYTOMEDICINE, V21, P184, DOI 10.1016/j.phymed.2013.08.001; Zhou W, 2014, J CHROMATOGR B, V949, P7, DOI 10.1016/j.jchromb.2013.12.035; Zhou W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063348; Zhou W, 2012, PHYTOMEDICINE, V20, P47, DOI 10.1016/j.phymed.2012.09.014; 李建波, 2013, [中医杂志, Journal of Traditional Chinese Medicine], V54, P1335	22	10	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109619	10.1371/journal.pone.0109619	http://dx.doi.org/10.1371/journal.pone.0109619			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275510	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500108
J	Kahn, HS; Gu, QP; Bullard, KM; Freedman, DS; Ahluwalia, N; Ogden, CL				Kahn, Henry S.; Gu, Qiuping; Bullard, Kai McKeever; Freedman, David S.; Ahluwalia, Namanjeet; Ogden, Cynthia L.			Population Distribution of the Sagittal Abdominal Diameter (SAD) from a Representative Sample of US Adults: Comparison of SAD, Waist Circumference and Body Mass Index for Identifying Dysglycemia	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; SIMPLE ANTHROPOMETRIC INDEXES; X-RAY ABSORPTIOMETRY; CARDIOVASCULAR RISK; COMPUTED-TOMOGRAPHY; INSULIN-RESISTANCE; VISCERAL FAT; HEART-DISEASE; MEN; OBESITY	Background: The sagittal abdominal diameter (SAD) measured in supine position is an alternative adiposity indicator that estimates the quantity of dysfunctional adipose tissue in the visceral depot. However, supine SAD's distribution and its association with health risk at the population level are unknown. Here we describe standardized measurements of SAD, provide the first, national estimates of the SAD distribution among US adults, and test associations of SAD and other adiposity indicators with prevalent dysglycemia. Methods and Findings: In the 2011-2012 National Health and Nutrition Examination Survey, supine SAD was measured ("abdominal height") between arms of a sliding-beam caliper at the level of the iliac crests. From 4817 non-pregnant adults (age >= 20; response rate 88%) we used sample weights to estimate SAD's population distribution by sex and age groups. SAD's population mean was 22.5 cm [95% confidence interval 22.2-22.8]; median was 21.9 cm [21.6-22.4]. The mean and median values of SAD were greater for men than women. For the subpopulation without diagnosed diabetes, we compared the abilities of SAD, waist circumference (WC), and body mass index (BMI, kg/m(2)) to identify prevalent dysglycemia (HbA1c >= 5.7%). For age-adjusted, logistic-regression models in which sex-specific quartiles of SAD were considered simultaneously with quartiles of either WC or BMI, only SAD quartiles 3 (p<0.05 vs quartile 1) and 4 (p<0.001 vs quartile 1) remained associated with increased dysglycemia. Based on continuous adiposity indicators, analyses of the area under the receiver operating characteristic curve (AUC) indicated that the dysglycemia model fit for SAD (age-adjusted) was 0.734 for men (greater than the AUC for WC, p<0.001) and 0.764 for women (greater than the AUC for WC or BMI, p<0.001). Conclusions: Measured inexpensively by bedside caliper, SAD was associated with dysglycemia independently of WC or BMI. Standardized SAD measurements may enhance assessment of dysfunctional adiposity.	[Kahn, Henry S.; Bullard, Kai McKeever] Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; [Gu, Qiuping; Ahluwalia, Namanjeet; Ogden, Cynthia L.] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Div Hlth & Nutr Examinat Surveys, Hyattsville, MD 20782 USA; [Freedman, David S.] Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); Centers for Disease Control & Prevention - USA	Kahn, HS (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.	hkahn@cdc.gov	Kahn, Henry S/A-6946-2009	Kahn, Henry S/0000-0003-2533-1562; Freedman, David/0000-0001-8014-0289				Ackermann RT, 2011, AM J PREV MED, V40, P11, DOI 10.1016/j.amepre.2010.09.022; Ahima RS, 2013, SCIENCE, V341, P856, DOI 10.1126/science.1241244; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Andersson K, 2008, FOOD NUTR RES, P52; Anjana M, 2004, DIABETES CARE, V27, P2948, DOI 10.2337/diacare.27.12.2948; Anunciacao PC, 2014, J HUM NUTR DIET; CDC/National Center for Health Statistics, 2013, NAT HLTH NUTR EX SUR; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Paula HAD, 2012, J HUM NUTR DIET, V25, P563, DOI 10.1111/j.1365-277X.2012.01267.x; de Souza NC, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-41; Ebbert JO, 2013, NUTRIENTS, V5, P498, DOI 10.3390/nu5020498; Ehrlich AC, 2011, INT J OBESITY, V35, P409, DOI 10.1038/ijo.2010.143; Empana JP, 2004, CIRCULATION, V110, P2781, DOI 10.1161/01.CIR.0000146395.64065.BA; Gastaldelli A, 2011, DIABETES RES CLIN PR, V93, pS60, DOI 10.1016/S0168-8227(11)70015-8; Gletsu-Miller N, 2013, OBES SURG, V23, P874, DOI 10.1007/s11695-013-0874-6; Golan R, 2012, DIABETES CARE, V35, P640, DOI 10.2337/dc11-1583; Gustat J, 2000, AM J EPIDEMIOL, V151, P885, DOI 10.1093/oxfordjournals.aje.a010292; Guzzaloni G, 2009, INT J OBESITY, V33, P233, DOI 10.1038/ijo.2008.271; Hoenig MR, 2010, VASC HEALTH RISK MAN, V6, P629; HOUMARD JA, 1994, INT J OBESITY, V18, P243; Iribarren C, 2006, AM J EPIDEMIOL, V164, P1150, DOI 10.1093/aje/kwj341; JENSEN MD, 1995, AM J CLIN NUTR, V61, P274, DOI 10.1093/ajcn/61.2.274; Kahn HS, 1996, J CLIN EPIDEMIOL, V49, P1017, DOI 10.1016/0895-4356(96)00113-8; Kantartzis K, 2010, DIABETOLOGIA, V53, P882, DOI 10.1007/s00125-010-1663-6; Kullberg J, 2007, CLIN PHYSIOL FUNCT I, V27, P148, DOI 10.1111/j.1475-097X.2007.00728.x; KVIST H, 1988, AM J CLIN NUTR, V48, P1351, DOI 10.1093/ajcn/48.6.1351; Lenters-Westra E, 2013, DIABETES RES CLIN PR, V99, P75, DOI 10.1016/j.diabres.2012.10.007; Lumley T., 2013, SURVEY ANAL COMPLEX; Marinou K, 2014, DIABETES CARE, V37, P821, DOI 10.2337/dc13-1353; National Center for Health Statistics, 2013, ANTHR PROC MAN NAT H; National Center for Health Statistics, 2013, NCHS DAT LINK MORT F; National Center for Health Statistics, 2010, NHANES I EP FOLL STU; National Center for Health Statistics Centers for Disease Control and Prevention (CDC), 2013, NHANES 2011 2012 DAT; Neeland IJ, 2013, OBESITY, V21, pE439, DOI [10.1002/oby.20135, 10.1038/oby.20135]; Neeland IJ, 2012, JAMA-J AM MED ASSOC, V308, P1150, DOI 10.1001/2012.jama.11132; Pajunen P, 2013, DIABETES CARE, V36, P283, DOI 10.2337/dc11-2451; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; R Development Core Team, 2014, R PROJ STAT COMP; Riserus U, 2004, DIABETES CARE, V27, P2041, DOI 10.2337/diacare.27.8.2041; SEIDELL JC, 1994, INT J OBESITY, V18, P61; SJOSTROM L, 1991, INT J OBESITY, V15, P19; Sjostrom L, 1988, Acta Med Scand Suppl, V723, P169; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Valsamakis G, 2004, DIABETIC MED, V21, P1339, DOI 10.1111/j.1464-5491.2004.01361.x; WesVar Development Team, 2007, WESVAR 4 3 USERS GUI; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; World Health Organization, 2011, WAIST CIRC WAIST HIP	49	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108707	10.1371/journal.pone.0108707	http://dx.doi.org/10.1371/journal.pone.0108707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272003	Green Submitted, Green Published, gold			2022-12-27	WOS:000343729600056
J	Kimata-Ariga, Y; Hase, T				Kimata-Ariga, Yoko; Hase, Toshiharu			Multiple Complexes of Nitrogen Assimilatory Enzymes in Spinach Chloroplasts: Possible Mechanisms for the Regulation of Enzyme Function	PLOS ONE			English	Article							GLUTAMATE SYNTHASE; MEDICAGO-TRUNCATULA; NITRITE REDUCTASE; ROOT-NODULES; IRON-SULFUR; SYNTHETASE; LIGHT; OXIDOREDUCTASE; DISSOCIATION; EXPRESSION	Assimilation of nitrogen is an essential biological process for plant growth and productivity. Here we show that three chloroplast enzymes involved in nitrogen assimilation, glutamate synthase (GOGAT), nitrite reductase (NiR) and glutamine synthetase (GS), separately assemble into distinct protein complexes in spinach chloroplasts, as analyzed by western blots under blue native electrophoresis (BN-PAGE). GOGAT and NiR were present not only as monomers, but also as novel complexes with a discrete size (730 kDa) and multiple sizes (>120 kDa), respectively, in the stromal fraction of chloroplasts. These complexes showed the same mobility as each monomer on two-dimensional (2D) SDS-PAGE after BN-PAGE. The 730 kDa complex containing GOGAT dissociated into monomers, and multiple complexes of NiR reversibly converted into monomers, in response to the changes in the pH of the stromal solvent. On the other hand, the bands detected by anti-GS antibody were present not only in stroma as a conventional decameric holoenzyme complex of 420 kDa, but also in thylakoids as a novel complex of 560 kDa. The polypeptide in the 560 kDa complex showed slower mobility than that of the 420 kDa complex on the 2D SDS-PAGE, implying the assembly of distinct GS isoforms or a post-translational modification of the same GS protein. The function of these multiple complexes was evaluated by in-gel GS activity under native conditions and by the binding ability of NiR and GOGAT with their physiological electron donor, ferredoxin. The results indicate that these multiplicities in size and localization of the three nitrogen assimilatory enzymes may be involved in the physiological regulation of their enzyme function, in a similar way as recently described cases of carbon assimilatory enzymes.	[Kimata-Ariga, Yoko; Hase, Toshiharu] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan	Osaka University	Kimata-Ariga, Y (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan.	a-yoko@protein.osaka-u.ac.jp	Kimata-Ariga, Yoko/AHE-7497-2022		Japan Society for the Promotion of Science [23570165]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants-in-aid for Scientific Research on Priority Areas (23570165) from the Japan Society for the Promotion of Science (to YKA), www.jsps.go.jp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz JP, 2010, TRENDS PLANT SCI, V15, P608, DOI 10.1016/j.tplants.2010.08.008; Binda C, 2000, STRUCTURE, V8, P1299, DOI 10.1016/S0969-2126(00)00540-2; BUCHANAN BB, 1984, BIOSCIENCE, V34, P378, DOI 10.2307/1309730; Elrouby N, 2010, P NATL ACAD SCI USA, V107, P17415, DOI 10.1073/pnas.1005452107; Forde BG, 1989, OXFORD SURVEYS PLANT, V6, P247; Howard TP, 2008, P NATL ACAD SCI USA, V105, P4056, DOI 10.1073/pnas.0710518105; Juric S, 2009, PLANT J, V60, P783, DOI 10.1111/j.1365-313X.2009.03999.x; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; MACH J, 2002, ARABIDOPSIS LAB MANU, P217; MARQUES S, 1992, EUR J BIOCHEM, V206, P69, DOI 10.1111/j.1432-1033.1992.tb16902.x; Masalkar P, 2010, J BIOL CHEM, V285, P23880, DOI 10.1074/jbc.M110.135657; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Melo PM, 2003, PLANT PHYSIOL, V132, P390, DOI 10.1104/pp.102.016675; Petoukhov MV, 2003, J BIOL CHEM, V278, P29933, DOI 10.1074/jbc.M304147200; Sakakibara Y, 2012, J BIOCHEM, V151, P483, DOI 10.1093/jb/mvs028; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHEIBE R, 1991, PLANT PHYSIOL, V96, P1, DOI 10.1104/pp.96.1.1; Seabra AR, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-137; Stabile H, 2000, EUR J BIOCHEM, V267, P2720, DOI 10.1046/j.1432-1327.2000.01289.x; Stengel A, 2008, J BIOL CHEM, V283, P6656, DOI 10.1074/jbc.M706719200; Suzuki A, 2005, PHOTOSYNTH RES, V83, P191, DOI 10.1007/s11120-004-3478-0; Swamy U, 2005, BIOCHEMISTRY-US, V44, P16054, DOI 10.1021/bi050981y; Torreira E, 2014, ACTA CRYSTALLOGR D, V70, P981, DOI 10.1107/S1399004713034718; Unno H, 2006, J BIOL CHEM, V281, P29287, DOI 10.1074/jbc.M601497200; van den Heuvel RHH, 2002, J BIOL CHEM, V277, P24579, DOI 10.1074/jbc.M202541200; Wedel N, 1998, P NATL ACAD SCI USA, V95, P9699, DOI 10.1073/pnas.95.16.9699; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Xu GH, 2012, ANNU REV PLANT BIOL, V63, P153, DOI 10.1146/annurev-arplant-042811-105532	28	11	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108965	10.1371/journal.pone.0108965	http://dx.doi.org/10.1371/journal.pone.0108965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271437	gold, Green Published, Green Submitted			2022-12-27	WOS:000343729600084
J	Meng, L; Zhu, Y; Zhang, N; Liu, WJ; Liu, Y; Shao, CW; Wang, N; Chen, SL				Meng, Liang; Zhu, Ying; Zhang, Ning; Liu, Wanjun; Liu, Yang; Shao, Changwei; Wang, Na; Chen, Songlin			Cloning and Characterization of tesk1, a Novel Spermatogenesis-Related Gene, in the Tongue Sole (Cynoglossus semilaevis)	PLOS ONE			English	Article							PROTEIN-KINASE; SEX; IDENTIFICATION; MOUSE	Testis-specific protein kinase 1 (Tesk1) is a serine/threonine kinase with unique structural features. In the present study, we cloned and characterized the tesk1 gene of tongue sole, Cynoglossus semilaevis. The full-length tesk1 cDNA consists of 1,672 nucleotides, encoding a 331 amino acid polypeptide with a characteristic structure composed of an N-terminal kinase domain and a C-terminal proline-rich domain. The tesk1 genomic sequence contains eight exons and seven introns. Real-time quantitative PCR revealed that tesk1 mRNA is expressed predominantly in the testis, though the level of expression varied throughout development. We used in situ hybridization to show that tesk1 mRNA is expressed in the spermatids of males and pseudo-males, but not in triploid males. Our results suggest that tongue sole Tesk1 may play a role in spermatogenesis.	[Meng, Liang] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China; [Meng, Liang; Zhu, Ying; Zhang, Ning; Liu, Wanjun; Liu, Yang; Shao, Changwei; Wang, Na; Chen, Songlin] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China	Ocean University of China; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS	Chen, SL (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China.	chensl@ysfri.ac.cn	Shao, Changwei/I-2054-2016	Shao, Changwei/0000-0002-6953-2203; Meng, Liang/0000-0003-2642-8446	State 863 High-Technology R&D Project of China [2012AA10A403-2, 2012AA092203]; National Nature Science Foundation of China [31130057, 31472269]; Taishan Scholar Project Fund of Shandong of China	State 863 High-Technology R&D Project of China(National High Technology Research and Development Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Project Fund of Shandong of China	This work received funding from State 863 High-Technology R&D Project of China (2012AA10A403-2, 2012AA092203), National Nature Science Foundation of China (31130057, 31472269) and Taishan Scholar Project Fund of Shandong of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BELLVE AR, 1977, J HISTOCHEM CYTOCHEM, V25, P480, DOI 10.1177/25.7.893996; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Chen SL, 2007, MAR BIOTECHNOL, V9, P273, DOI 10.1007/s10126-006-6081-x; Chen SL, 2012, MAR BIOTECHNOL, V14, P120, DOI 10.1007/s10126-011-9395-2; Chen SL, 2009, MAR BIOTECHNOL, V11, P243, DOI 10.1007/s10126-008-9139-0; Chen SL, 2014, NAT GENET, V46, P253, DOI 10.1038/ng.2890; Chen SongLin, 2011, Journal of Fisheries of China, V35, P925; Grootegoed JA, 2000, BEST PRACT RES CL EN, V14, P331, DOI 10.1053/beem.2000.0083; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hu QM, 2014, AQUACULT INT, V22, P1437, DOI 10.1007/s10499-014-9757-7; HUNTER T, 1991, CELL, V66, P1071, DOI 10.1016/0092-8674(91)90028-W; JIRO T, 1995, J BIO CHEM, V270, P31331; JIRO T, 1998, GENE, V206, P237; JIRO T, 1998, BIOCHEM BIOPH RES CO, V249, P107; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li ZJ, 2010, FISH SHELLFISH IMMUN, V29, P89, DOI 10.1016/j.fsi.2010.02.021; Liang Zhuo, 2012, Nanfang Nongye Xuebao, V43, P2074; [马学坤 MA Xuekun], 2006, [海洋水产研究, Marine Fisheries Research], V27, P55; MIZUNO K, 1994, ONCOGENE, V9, P1605; MONESI V, 1964, J CELL BIOL, V22, P521, DOI 10.1083/jcb.22.3.521; OHASHI K, 1994, J BIOCHEM, V116, P636, DOI 10.1093/oxfordjournals.jbchem.a124573; PEREY B, 1961, AM J ANAT, V108, P47, DOI 10.1002/aja.1001080105; SassoneCorsi P, 1997, CELL, V88, P163, DOI 10.1016/S0092-8674(00)81834-6; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Shao CW, 2010, MAR BIOTECHNOL, V12, P558, DOI 10.1007/s10126-009-9242-x; Shao CW, 2010, MICRON, V41, P47, DOI 10.1016/j.micron.2009.08.002; Shao CW, 2014, GENOME RES, V24, P604, DOI 10.1101/gr.162172.113; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WILLISON K, 1987, TRENDS GENET, V3, P351, DOI 10.1016/0168-9525(87)90296-4	32	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e107922	10.1371/journal.pone.0107922	http://dx.doi.org/10.1371/journal.pone.0107922			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271995	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600024
J	Sugita, C; Komura, Y; Tanaka, K; Kometani, K; Satoh, H; Sugita, M				Sugita, Chieko; Komura, Yoshihiro; Tanaka, Korechika; Kometani, Kazuki; Satoh, Hiroyuki; Sugita, Mamoru			Molecular Characterization of Three PRORP Proteins in the Moss Physcomitrella patens: Nuclear PRORP Protein Is Not Essential for Moss Viability	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; RNA PROCESSING ENZYME; RIBONUCLEASE-P; NUCLEOTIDE-SEQUENCE; GENE FAMILY; GENOME; ARABIDOPSIS; CHLOROPLAST; DIVERSITY; EVOLUTION	RNase P is a ubiquitous endonuclease that removes the 5' leader sequence from pre-tRNAs in all organisms. In Arabidopsis thaliana, RNA-free proteinaceous RNase Ps (PRORPs) seem to be enzyme(s) for pre-tRNA 5'-end processing in organelles and the nucleus and are thought to have replaced the ribonucleoprotein RNase P variant. However, the evolution and function of plant PRORPs are not fully understood. Here, we identified and characterized three PRORP-like proteins, PpPPR_63, 67, and 104, in the basal land plant, the moss Physcomitrella patens. PpPPR_63 localizes to the nucleus, while PpPPR_67 and PpPPR_104 are found in both the mitochondria and chloroplasts. The three proteins displayed pre-tRNA 5'-end processing activity in vitro. Mutants with knockout (KO) of the PpPPR_63 gene displayed growth retardation of protonemal colonies, indicating that, unlike Arabidopsis nuclear RPORPs, the moss nuclear PpPPR_63 is not essential for viability. In the KO mutant, nuclear-encoded tRNA(Asp) (GUC) levels were slightly decreased, whereas most nuclear-encoded tRNA levels were not altered. This indicated that most of the cytosolic mature tRNAs were produced normally without proteinaceous RNase P-like PpPPR_63. Single PpPPR_67 or 104 gene KO mutants displayed different phenotypes of protonemal growth and chloroplast tRNA(Arg) (ACG) accumulation. However, the levels of all other tRNAs were not altered in the KO mutants. In addition, in vitro RNase P assays showed that PpPPR_67 and PpPPR_104 efficiently cleaved chloroplast pre-tRNA(Arg) (CCG) and pre-tRNA(Arg) (UCU) but they cleaved pre-tRNA(Arg) (ACG) with different efficiency. This suggests that the two proteins have overlapping function but their substrate specificity is not identical.	[Sugita, Chieko; Komura, Yoshihiro; Tanaka, Korechika; Kometani, Kazuki; Sugita, Mamoru] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 46401, Japan; [Satoh, Hiroyuki] Toho Univ, Dept Biomol Sci, Funabashi, Chiba 274, Japan	Nagoya University; Toho University	Sugita, M (corresponding author), Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 46401, Japan.	sugita@gene.nagoya-u.ac.jp			JSPS KAKENHI [2057003, 23657003, 25291059, 25660292]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 2057003, 23657003, 25291059, 25660292 (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman Vivek, 2006, RNA Biol, V3, P18; Baum M, 1996, J MOL BIOL, V257, P43, DOI 10.1006/jmbi.1996.0145; Cordier A, 1999, J MOL BIOL, V289, P9, DOI 10.1006/jmbi.1999.2762; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; Gobert A, 2010, NAT STRUCT MOL BIOL, V17, P740, DOI 10.1038/nsmb.1812; Gutmann B, 2012, GENE DEV, V26, P1022, DOI 10.1101/gad.189514.112; Hartmann E, 2003, TRENDS GENET, V19, P561, DOI 10.1016/j.tig.2003.08.007; Hattori M, 2007, J BIOL CHEM, V282, P10773, DOI 10.1074/jbc.M608034200; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Howard MJ, 2012, P NATL ACAD SCI USA, V109, P16149, DOI 10.1073/pnas.1209062109; Lai LB, 2011, MOL GENET GENOMICS, V286, P359, DOI 10.1007/s00438-011-0651-y; Lai LB, 2010, FEBS LETT, V584, P287, DOI 10.1016/j.febslet.2009.11.048; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; Reith M, 1995, PLANT MOL BIOL REP, V13, P333, DOI 10.1007/BF02669187; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rosenblad MA, 2006, NUCLEIC ACIDS RES, V34, P5145, DOI 10.1093/nar/gkl626; Schon A, 1999, FEMS MICROBIOL REV, V23, P391, DOI 10.1016/S0168-6445(99)00014-5; Stirewalt VL, 1995, PLANT MOL BIOL REP, V13, P327, DOI 10.1007/BF02669186; Sugita C, 2012, PLANT CELL PHYSIOL, V53, P1124, DOI 10.1093/pcp/pcs058; Sugita M, 2013, RNA BIOL, V10, P1439, DOI 10.4161/rna.24772; Sugiura C, 2003, NUCLEIC ACIDS RES, V31, P5324, DOI 10.1093/nar/gkg726; Sugiura C, 2004, PLANT J, V40, P314, DOI 10.1111/j.1365-313X.2004.02202.x; Tasaki E, 2010, PLANT J, V62, P560, DOI 10.1111/j.1365-313X.2010.04175.x; Turmel M, 1999, PLANT CELL, V11, P1717, DOI 10.1105/tpc.11.9.1717; Uchida M, 2011, FEBS LETT, V585, P2367, DOI 10.1016/j.febslet.2011.06.009	25	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108962	10.1371/journal.pone.0108962	http://dx.doi.org/10.1371/journal.pone.0108962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272157	gold, Green Submitted, Green Published			2022-12-27	WOS:000343729600083
J	van Staa, TP; Gulliford, M; Ng, ESW; Goldacre, B; Smeeth, L				van Staa, Tjeerd-Pieter; Gulliford, Martin; Ng, Edmond S. -W.; Goldacre, Ben; Smeeth, Liam			Prediction of Cardiovascular Risk Using Framingham, ASSIGN and QRISK2: How Well Do They Predict Individual Rather than Population Risk?	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; VALIDATION; SCORE; DERIVATION; ENGLAND	Background: The objective of this study was to evaluate the performance of risk scores (Framingham, Assign and QRISK2) in predicting high cardiovascular disease (CVD) risk in individuals rather than populations. Methods and findings: This study included 1.8 million persons without CVD and prior statin prescribing using the Clinical Practice Research Datalink. This contains electronic medical records of the general population registered with a UK general practice. Individual CVD risks were estimated using competing risk regression models. Individual differences in the 10-year CVD risks as predicted by risk scores and competing risk models were estimated; the population was divided into 20 subgroups based on predicted risk. CVD outcomes occurred in 69,870 persons. In the subgroup with lowest risks, risk predictions by QRISK2 were similar to individual risks predicted using our competing risk model (99.9% of people had differences of less than 2%); in the subgroup with highest risks, risk predictions varied greatly (only 13.3% of people had differences of less than 2%). Larger deviations between QRISK2 and our individual predicted risks occurred with calendar year, different ethnicities, diabetes mellitus and number of records for medical events in the electronic health records in the year before the index date. A QRISK2 estimate of low 10-year CVD risk (<15%) was confirmed by Framingham, ASSIGN and our individual predicted risks in 89.8% while an estimate of high 10-year CVD risk (>= 20%) was confirmed in only 48.6% of people. The majority of cases occurred in people who had predicted 10-year CVD risk of less than 20%. Conclusions: Application of existing CVD risk scores may result in considerable misclassification of high risk status. Current practice to use a constant threshold level for intervention for all patients, together with the use of different scoring methods, may inadvertently create an arbitrary classification of high CVD risk.	[van Staa, Tjeerd-Pieter] Univ Manchester, Farr Inst Hlth Informat Res, Hlth eRes Ctr, Manchester, Lancs, England; [van Staa, Tjeerd-Pieter; Ng, Edmond S. -W.; Goldacre, Ben; Smeeth, Liam] London Sch Hyg & Trop Med, Dept Noncommunicable Dis, London WC1, England; [van Staa, Tjeerd-Pieter] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Gulliford, Martin] Kings Coll London, London WC2R 2LS, England	University of Manchester; University of London; London School of Hygiene & Tropical Medicine; Utrecht University; University of London; King's College London	van Staa, TP (corresponding author), Univ Manchester, Farr Inst Hlth Informat Res, Hlth eRes Ctr, Manchester, Lancs, England.	tjeerd.vanstaa@manchester.ac.uk	Ng, Edmond/L-5871-2019; Gulliford, Martin C/I-8606-2018; Smeeth, Liam/X-5862-2018	Gulliford, Martin C/0000-0003-1898-9075; Smeeth, Liam/0000-0002-9168-6022; van Staa, Tjeerd/0000-0001-9363-742X; Goldacre, Ben/0000-0002-5127-4728	Wellcome Trust; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's; St Thomas' NHS Foundation Trust and King's College London; Medical Research Council [MC_PC_13042, MR/K006665/1, MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish; MRC [MR/K006665/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's(National Institute for Health Research (NIHR)); St Thomas' NHS Foundation Trust and King's College London; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Wellcome Trust as part of a programme to evaluate the feasibility of conducting pragmatic randomised trials within CPRD; this work was done as part of the assessment of eligibility for a trial comparing simvastatin and atorvastatin. LS is supported by a Senior Clinical Fellowship from the Wellcome Trust. MG was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CPRD is owned by the UK Department of Health and operates within the Medicines and Healthcare products Regulatory Agency (MHRA). CPRD has received funding from the MHRA, Wellcome Trust, Medical Research Council, NIHR Health Technology Assessment programme, Innovative Medicine Initiative, UK Department of Health, Technology Strategy Board, Seventh Framework Programme EU, various universities, contract research organisations and pharmaceutical companies. The department of Pharmacoepidemiology & Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences has received unrestricted funding for pharmacoepidemiological research from GlaxoSmithKline, Novo Nordisk, the private-public funded Top Institute Pharma (www.tipharma.nl, includes co-funding from universities, government, and industry), the Dutch Medicines Evaluation Board, and the Dutch Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Anderson KM, CARDIOVASCULAR DIS R; [Anonymous], 2012, BRIT MED J, DOI DOI 10.1136/BMJ.E4181; Cheng SC, 1998, BIOMETRICS, V54, P219, DOI 10.2307/2534009; Collins GS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2442; Cooper A, 2007, CLIN GUIDELINES EVID; Davies M, 2012, UPDATED HDB VASCULAR; Delaney Joseph A C, 2007, BMC Cardiovasc Disord, V7, P38, DOI 10.1186/1471-2261-7-38; Djulbegovic B, 2011, JAMA-J AM MED ASSOC, V305, P2005, DOI 10.1001/jama.2011.650; Ebrahim S, 2012, LANCET, V380, P545, DOI 10.1016/S0140-6736(12)60694-1; Gulliford MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007168; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Matheny M, 2011, SYSTEMATIC REV CARDI; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Rose G., 2008, ROSES STRATEGY PREVE; Royston P., 2008, MULTIVARIABLE MODEL; Rubin DB, 2004, MULTIPLE IMPUTATION; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Smolina K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8059; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Williams T, 2012, THER ADV DRUG SAF, V3, P89, DOI 10.1177/2042098611435911; Wolbers M, 2009, EPIDEMIOLOGY, V20, P555, DOI 10.1097/EDE.0b013e3181a39056; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	27	46	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e106455	10.1371/journal.pone.0106455	http://dx.doi.org/10.1371/journal.pone.0106455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271417	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000343729600004
J	Wang, YF; Kuramitsu, Y; Tokuda, K; Baron, B; Kitagawa, T; Akada, J; Maehara, S; Maehara, Y; Nakamura, K				Wang, Yufeng; Kuramitsu, Yasuhiro; Tokuda, Kazuhiro; Baron, Byron; Kitagawa, Takao; Akada, Junko; Maehara, Shin-ichiro; Maehara, Yoshihiko; Nakamura, Kazuyuki			Gemcitabine Induces Poly (ADP-Ribose) Polymerase-1 (PARP-1) Degradation through Autophagy in Pancreatic Cancer	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; POLY(ADP-RIBOSE) POLYMERASE; RESISTANCE; REPAIR; ACTIVATION; CELLS; ESTABLISHMENT; SENSITIZATION; INHIBITION	Poly (ADP-ribose) polymerase-1 (PARP-1) and autophagy play increasingly important roles in DNA damage repair and cell death. Gemcitabine (GEM) remains the first-line chemotherapeutic drug for pancreatic cancer (PC). However, little is known about the relationship between PARP-1 expression and autophagy in response to GEM. Here we demonstrate that GEM induces DNA-damage response and degradation of mono-ADP ribosylated PARP-1 through the autophagy pathway in PC cells, which is rescued by inhibiting autophagy. Hypoxia and serum starvation inhibit autophagic activity due to abrogated GEM-induced mono-ADP-ribosylated PARP-1 degradation. Activation of extracellular regulated protein kinases (ERK) induced by serum starvation shows differences in intracellular localization as well as modulation of autophagy and PARP-1 degradation in GEM-sensitive KLM1 and - resistant KLM1-R cells. Our study has revealed a novel role of autophagy in PARP-1 degradation in response to GEM, and the different impacts of MEK/ERK signaling pathway on autophagy between GEMsensitive and -resistant PC cells.	[Wang, Yufeng; Kuramitsu, Yasuhiro; Tokuda, Kazuhiro; Baron, Byron; Kitagawa, Takao; Akada, Junko; Nakamura, Kazuyuki] Yamaguchi Univ, Grad Sch Med, Dept Biochem & Funct Prote, Ube, Yamaguchi 755, Japan; [Maehara, Shin-ichiro; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan; [Nakamura, Kazuyuki] Tokuyama Med Assoc Hosp, Ctr Clin Labs, Shunan, Japan	Yamaguchi University; Kyushu University	Kuramitsu, Y (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Biochem & Funct Prote, Ube, Yamaguchi 755, Japan.	climates@yamaguchi-u.ac.jp	Baron, Byron/J-7915-2019; Wang, Yufeng/N-9531-2019	Baron, Byron/0000-0001-5722-6295; Wang, Yufeng/0000-0002-4576-1984	 [24501352]		The work was supported by grant no. 24501352, www.jsps.go.jp/g-grantsinaid. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Quesada R, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-29; BAKER CH, 1991, J MED CHEM, V34, P1879, DOI 10.1021/jm00110a019; Bauer I, 2012, J BIOL CHEM, V287, P40924, DOI 10.1074/jbc.M112.405837; Botrugno OA, 2012, CLIN CANCER RES, V18, P2436, DOI 10.1158/1078-0432.CCR-11-0767; Calabrese CR, 2004, J NATL CANCER I, V96, P56, DOI 10.1093/jnci/djh005; Chen SN, 2010, BBA-REV CANCER, V1806, P220, DOI 10.1016/j.bbcan.2010.07.003; Dai PG, 2006, J BIOL CHEM, V281, P927, DOI 10.1074/jbc.M507360200; De Soto Joseph A, 2006, Int J Med Sci, V3, P117; El-Rayes Basil F, 2003, Clin Adv Hematol Oncol, V1, P430; Ewald B, 2008, CANCER RES, V68, P7947, DOI 10.1158/0008-5472.CAN-08-0971; Godon C, 2008, NUCLEIC ACIDS RES, V36, P4454, DOI 10.1093/nar/gkn403; Heinemann V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-82; HUANG P, 1991, CANCER RES, V51, P6110; Iwasaki I, 2002, CANCER CHEMOTH PHARM, V49, P438, DOI 10.1007/s00280-002-0452-4; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Karnitz LM, 2005, MOL PHARMACOL, V68, P1636, DOI 10.1124/mol.105.012716; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kimura Y, 1996, INT J PANCREATOL, V20, P43; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lee YR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056284, 10.1371/journal.pone.0063255]; Maehara S, 2004, INT J CANCER, V112, P184, DOI 10.1002/ijc.20304; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Matthews DJ, 2007, CELL CYCLE, V6, P104, DOI 10.4161/cc.6.1.3699; Meijer AJ, 2004, BIOCHEM BIOPH RES CO, V313, P397, DOI 10.1016/j.bbrc.2003.07.012; Mizuno S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-17; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Mori-Iwamoto S, 2007, INT J ONCOL, V31, P1345; Mori-Iwamoto S, 2008, MOL MED REP, V1, P429; Pardo R, 2010, PANCREATOLOGY, V10, P19, DOI 10.1159/000264680; Parsels LA, 2009, MOL CANCER THER, V8, P45, DOI 10.1158/1535-7163.MCT-08-0662; Patel AG, 2011, P NATL ACAD SCI USA, V108, P3406, DOI 10.1073/pnas.1013715108; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Schultz N, 2003, NUCLEIC ACIDS RES, V31, P4959, DOI 10.1093/nar/gkg703; Shi M, 2013, INT J CARDIOL, V167, P1570, DOI 10.1016/j.ijcard.2012.04.093; Taba K, 2010, ANTICANCER RES, V30, P2539; Vara D, 2011, CELL DEATH DIFFER, V18, P1099, DOI 10.1038/cdd.2011.32; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Wheatley SP, 2005, INT REV CYTOL, V247, P35, DOI 10.1016/S0074-7696(05)47002-3; Yang YG, 2004, ONCOGENE, V23, P3872, DOI 10.1038/sj.onc.1207491	41	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109076	10.1371/journal.pone.0109076	http://dx.doi.org/10.1371/journal.pone.0109076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271986	gold, Green Published, Green Submitted			2022-12-27	WOS:000343729600096
J	Coast, E; Jones, E; Portela, A; Lattof, SR				Coast, Ernestina; Jones, Eleri; Portela, Anayda; Lattof, Samantha R.			Maternity Care Services and Culture: A Systematic Global Mapping of Interventions	PLOS ONE			English	Article							EMERGENCY OBSTETRIC SERVICES; SKILLED BIRTH ATTENDANTS; HEALTH-CARE; SAFE MOTHERHOOD; COMMUNITY EFFECTIVENESS; PERINATAL DEPRESSION; TRAINING-PROGRAM; POSTPARTUM CARE; WOMEN; PREGNANCY	Background: A vast body of global research shows that cultural factors affect the use of skilled maternity care services in diverse contexts. While interventions have sought to address this issue, the literature on these efforts has not been synthesised. This paper presents a systematic mapping of interventions that have been implemented to address cultural factors that affect women's use of skilled maternity care. It identifies and develops a map of the literature; describes the range of interventions, types of literature and study designs; and identifies knowledge gaps. Methods and Findings: Searches conducted systematically in ten electronic databases and two websites for literature published between 01/01/1990 and 28/02/2013 were combined with expert-recommended references. Potentially eligible literature included journal articles and grey literature published in English, French or Spanish. Items were screened against inclusion and exclusion criteria, yielding 96 items in the final map. Data extracted from the full text documents are presented in tables and a narrative synthesis. The results show that a diverse range of interventions has been implemented in 35 countries to address cultural factors that affect the use of skilled maternity care. Items are classified as follows: (1) service delivery models; (2) service provider interventions; (3) health education interventions; (4) participatory approaches; and (5) mental health interventions. Conclusions: The map provides a rich source of information on interventions attempted in diverse settings that might have relevance elsewhere. A range of literature was identified, from narrative descriptions of interventions to studies using randomised controlled trials to evaluate impact. Only 23 items describe studies that aim to measure intervention impact through the use of experimental or observational-analytic designs. Based on the findings, we identify avenues for further research in order to better document and measure the impact of interventions to address cultural factors that affect use of skilled maternity care.	[Coast, Ernestina; Jones, Eleri; Lattof, Samantha R.] London Sch Econ & Polit Sci, Dept Social Policy, London, England; [Portela, Anayda] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland	University of London; London School Economics & Political Science; World Health Organization	Coast, E (corresponding author), London Sch Econ & Polit Sci, Dept Social Policy, London, England.	e.coast@lse.ac.uk		coast, ernestina/0000-0002-8703-307X; Lattof, Samantha R./0000-0003-0934-1488; Portela, Anayda/0000-0001-6368-1585	WHO Department of Maternal, Newborn, Child, and Adolescent Health; UN Population Fund; The Norwegian Agency for Development	WHO Department of Maternal, Newborn, Child, and Adolescent Health; UN Population Fund; The Norwegian Agency for Development	The study was funded by the WHO Department of Maternal, Newborn, Child, and Adolescent Health, the UN Population Fund and The Norwegian Agency for Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami PC, 2006, EVID POLICY, V2, P417, DOI DOI 10.1332/174426406778881737; Acsadi GT, 1991, SOCIAL CULTURAL FACT, P73; Adams Vincanne, 2005, Health Care Women Int, V26, P821, DOI 10.1080/07399330500230920; Affonso D D, 1993, J Obstet Gynecol Neonatal Nurs, V22, P320, DOI 10.1111/j.1552-6909.1993.tb01812.x; Afsana K, 2012, EMPOWERING COMMUNITY, P170; Ahluwalia IB, 2003, INT J GYNECOL OBSTET, V82, P231, DOI 10.1016/S0020-7292(03)00081-X; Ahmed T, 2009, REPROD HEALTH MATTER, V17, P45, DOI 10.1016/S0968-8080(09)33446-1; Allegheny County Pennsylvania Maternal and Child Health Care Leadership Collaborative, 2010, Prog Community Health Partnersh, V4, P105, DOI 10.1353/cpr.0.0119; ALTO WA, 1991, SOC SCI MED, V32, P613, DOI 10.1016/0277-9536(91)90296-O; Andrus N C, 1997, J Health Hum Serv Adm, V20, P230; Azad K, 2010, LANCET, V375, P1193, DOI 10.1016/S0140-6736(10)60142-0; Bailey Patricia E., 2002, Rev Panam Salud Publica, V11, P15, DOI 10.1590/S1020-49892002000100003; Baker-Ericzen MJ, 2012, FAM SYST HEALTH, V30, P224, DOI 10.1037/a0028750; BARDACK MA, 1993, PUBLIC HEALTH REP, V108, P161; BELIZAN JM, 1995, AM J OBSTET GYNECOL, V173, P894, DOI 10.1016/0002-9378(95)90362-3; Bender D, 1995, REPROD HEALTH MATTER, V3, P52; Bhagat R, 2002, PUBLIC HEALTH NURS, V19, P209, DOI 10.1046/j.0737-1209.2002.19309.x; Bhattacharyya K, 2000, HUM ORGAN, V59, P255, DOI 10.17730/humo.59.2.u358524238l71mm6; Bilenko N, 2007, MATERN CHILD HLTH J, V11, P425, DOI 10.1007/s10995-007-0193-4; Blum LS, 2006, REPROD HEALTH MATTER, V14, P51, DOI 10.1016/S0968-8080(06)27234-3; Camacho AV, 2006, INT J GYNECOL OBSTET, V94, P357, DOI 10.1016/j.ijgo.2006.04.028; Castro MD, 2012, SISTEMATIZACION BUEN; Chowdhury M, 1998, TROP DOCT, V28, P104, DOI 10.1177/004947559802800219; Clapham S, 2008, TROP DOCT, V38, P197, DOI 10.1258/td.2008.070291; Clemmons L, 1999, CULTURAL RESOURCES M; Clemmons L, 1999, TURNING ORDINARY EXT, P15; Clemmons L, 1995, PVO CHILD SURVIVAL T, V4, P5; Coast E, 2012, POVERTY POSTNATAL DE; Coley S.L., 2012, INT J CHILDBIRTH ED, V27, P57; Dehne K L, 1995, World Health Forum, V16, P415; DeStephano CC, 2010, PATIENT EDUC COUNS, V81, P137, DOI 10.1016/j.pec.2009.12.003; Dickerson T, 2010, J PERINAT NEONAT NUR, V24, P113, DOI 10.1097/JPN.0b013e3181cc01f1; Doctor HV, 2012, REPROD HEALTH MATTER, V20, P104, DOI 10.1016/S0968-8080(12)39615-8; Dundek LH, 2006, J PERINAT NEONAT NUR, V20, P128, DOI 10.1097/00005237-200604000-00006; Dynes M, 2011, MIDWIFERY, V27, P15, DOI 10.1016/j.midw.2009.07.009; Eckermann E, 2008, J OBSTET GYNAECOL RE, V34, P767, DOI 10.1111/j.1447-0756.2008.00924.x; Evans EC, 2012, REV CULTURAL INFLUEN; Fahey JO, 2013, J PERINAT NEONAT NUR, V27, P36, DOI 10.1097/JPN.0b013e31827e478d; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; Fisher TL, 2007, MED CARE RES REV, V64, p243S, DOI 10.1177/1077558707305414; Friedsam D, 2003, AM J PUBLIC HEALTH, V93, P1634, DOI 10.2105/AJPH.93.10.1634; Gabrysch S, 2009, B WORLD HEALTH ORGAN, V87, P724, DOI 10.2471/BLT.08.057794; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gennaro S, 2001, J Obstet Gynecol Neonatal Nurs, V30, P224, DOI 10.1111/j.1552-6909.2001.tb01539.x; Gies S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-180; Glei DA, 2003, SOC SCI MED, V57, P2447, DOI 10.1016/S0277-9536(03)00140-0; Goodburn E, 2001, SOC SCI MED, V35, P967; Greenberg E L, 1996, J Public Health Manag Pract, V2, P66; Greenhalgh T, 2005, SOC SCI MED, V61, P417, DOI 10.1016/j.socscimed.2004.12.001; Grote NK, 2004, CLIN SOC WORK J, V32, P327, DOI 10.1023/B:CSOW.0000035111.81205.5b; Gummi FB, 1997, INT J GYNECOL OBSTET, V59, pS191, DOI 10.1016/S0020-7292(97)00165-3; Hall, 1984, DANCE LIFE OTHER DIM; Hazard CJ, 2009, MCN-AM J MATERN-CHIL, V34, P115, DOI 10.1097/01.NMC.0000347306.15950.ae; Helman, 2000, CULTURE HLTH ILLNESS; Hicks C, 1991, Health Serv Manage Res, V4, P89; Hoff W, 1997, TROP DOCT, V27, P52, DOI 10.1177/00494755970270S116; Homer CSE, 2012, MIDWIFERY, V28, pE509, DOI 10.1016/j.midw.2011.06.004; Hounton S, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1947; Jan Stephen, 2004, J Health Serv Res Policy, V9, P14, DOI 10.1258/135581904322716067; Jewell N A, 2000, J Community Health Nurs, V17, P93, DOI 10.1207/S15327655JCHN1702_4; Julnes G, 1994, J Community Health, V19, P41, DOI 10.1007/BF02260520; Karl-Trummer U, 2006, DIVERSITY HLTH SOCIA, V3, P55; Kaseje D, 2010, GLOB PUBLIC HEALTH, V5, P595, DOI 10.1080/17441690903418969; Kaur P, 1994, Plan Parent Chall, P23; Kenney AM, 2005, TECHNICAL REPORT INT; Kim J, 2003, WOMEN HEALTH, V38, P107, DOI 10.1300/J013v38n02_08; Kreiner Meta, 2009, J Midwifery Womens Health, V54, pe1, DOI 10.1016/j.jmwh.2008.07.002; Kreuter MW, 2003, HEALTH EDUC BEHAV, V30, P133, DOI 10.1177/1090198102251021; KWAST BE, 1995, INT J GYNECOL OBSTET, V48, pS67, DOI 10.1016/0020-7292(95)02321-3; Larson K, 1992, J Rural Health, V8, P128, DOI 10.1111/j.1748-0361.1992.tb00338.x; Le HN, 2010, AM J ORTHOPSYCHIAT, V80, P34, DOI 10.1111/j.1939-0025.2010.01005.x; Leone T, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-39; Lewycka S, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-88; Ley CE, 2011, SOC WORK PUBLIC HLTH, V26, P17, DOI 10.1080/10911350902986906; MacKian S, 2004, HEALTH POLICY PLANN, V19, P137, DOI 10.1093/heapol/czh017; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Marsiglia FF, 2010, J HEALTH CARE POOR U, V21, P119, DOI 10.1353/hpu.0.0355; Mattson S, 1992, J Obstet Gynecol Neonatal Nurs, V21, P48, DOI 10.1111/j.1552-6909.1992.tb01721.x; Mayberry LJ, 1999, J PERINAT NEONAT NUR, V13, P15, DOI 10.1097/00005237-199906000-00003; McAree T., 2010, EVIDENCE BASED MIDWI, V8, P91; Meister J S, 1992, J Community Health, V17, P37, DOI 10.1007/BF01321723; Midhet F, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-30; MILLER T, 1995, WOMEN STUD INT FORUM, V18, P299, DOI 10.1016/0277-5395(95)00026-9; More NS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001257; Moreno E, 2013, B MED MUNDI SCHWEIZ, V127; Morrison J, 2008, J PERINATOL, V28, pS14, DOI 10.1038/jp.2008.171; Morrison J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-128; Mushi D, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-14; Nauman T, 1995, POPULI, V22, P8; Nel Pieter, 2003, Aust Fam Physician, V32, P127; Nurena CR, 2009, REV PANAM SALUD PUBL, V26, P368; O'Rourke K, 1998, Rev Panam Salud Publica, V3, P9; Oakley Ann., 2005, EVID POLICY, V1, P5, DOI [10.1332/1744264052703168, DOI 10.1332/1744264052703168]; Olaniran N, 1997, INT J GYNECOL OBSTET, V59, pS181, DOI 10.1016/S0020-7292(97)00164-1; Omer K, 2008, PATIENT EDUC COUNS, V72, P178, DOI 10.1016/j.pec.2008.02.018; Opoku SA, 1997, INT J GYNECOL OBSTET, V59, pS201, DOI 10.1016/S0020-7292(97)00166-5; Orozco-Nunez E, 2009, SALUD PUBLICA MEXICO, V51, P104, DOI 10.1590/S0036-36342009000200005; Osrin D, 2003, T ROY SOC TROP MED H, V97, P18, DOI 10.1016/S0035-9203(03)90008-3; Panaretto KS, 2007, MED J AUSTRALIA, V187, P18, DOI 10.5694/j.1326-5377.2007.tb01109.x; Panaretto KS, 2005, MED J AUSTRALIA, V182, P514, DOI 10.5694/j.1326-5377.2005.tb00017.x; PARSONS L, 1992, J PUBLIC HEALTH MED, V14, P183; Pell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053747; Perreira Krista M, 2002, Matern Child Health J, V6, P19, DOI 10.1023/A:1014360015605; Rath S, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-25; Ratnaike R N, 1992, J Community Health, V17, P87, DOI 10.1007/BF01321577; Reavy K, 2012, RURAL REMOTE HEALTH, V12; Rowen T, 2011, MIDWIFERY, V27, P229, DOI 10.1016/j.midw.2009.06.003; Sathar Z, 2005, STUD FAMILY PLANN, V36, P221, DOI 10.1111/j.1728-4465.2005.00063.x; Schooley J, 2009, MIDWIFERY, V25, P411, DOI 10.1016/j.midw.2007.07.011; Sibley L, 2001, J MIDWIFERY WOM HEAL, V46, P258, DOI 10.1016/S1526-9523(01)00139-8; Simwaka BN, 2005, BMJ-BRIT MED J, V331, P708, DOI 10.1136/bmj.331.7519.708; Skinner J, 2009, MIDWIFERY, V25, P738, DOI 10.1016/j.midw.2008.01.006; Smit J J, 1994, Curationis, V17, P25; Smith Dawn, 2006, Can Nurse, V102, P36; Stamp GE, 2008, RURAL REMOTE HEALTH, V8; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Thompson M, 1998, PUBLIC HEALTH NURS, V15, P82, DOI 10.1111/j.1525-1446.1998.tb00326.x; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; Tucker K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-94; Turan JM, 2011, J MIDWIFERY WOM HEAL, V56, P8, DOI 10.1111/j.1542-2011.2010.00001.x; UNFPA, 2005, CULT PROGR REPR HLTH; UNFPA, 2011, SOC CULT DET SEX REP; UNFPA, 2008, CULT MATT LESS LEG E; UNFPA, 2005, CULT MATT WORK COMM; UNFPA, 2010, PROM EQ REC DIV INT; Warrick L H, 1992, J Community Health, V17, P13, DOI 10.1007/BF01321721; WHO, 2004, CRIT ROL SKILL ATT; WHO, 2003, WORK IND FAM COMM IM; WOODARD GRB, 1992, CAN J PUBLIC HEALTH, V83, P188; World Health Organization, 2007, MAT MORT 2005 EST DE; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 2007, ENG MEN BOYS CHANG G; World Health Organization, 2010, WORK IND FAM COMM IM; Yeshi C, 2009, DEV PRACT, V19, P396, DOI 10.1080/09614520902808266; Zangari A, 2009, YACHAY TINKUY SALUD, P454	135	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108130	10.1371/journal.pone.0108130	http://dx.doi.org/10.1371/journal.pone.0108130			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268940	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000343671700066
J	Xu, ZP; Li, L; Bao, J; Wang, ZH; Zeng, J; Liu, EJ; Li, XG; Huang, RX; Gao, D; Li, MZ; Zhang, Y; Liu, GP; Wang, JZ				Xu, Zhi-Peng; Li, Li; Bao, Jian; Wang, Zhi-Hao; Zeng, Juan; Liu, En-Jie; Li, Xiao-Guang; Huang, Rong-Xi; Gao, Di; Li, Meng-Zhu; Zhang, Yao; Liu, Gong-Ping; Wang, Jian-Zhi			Magnesium Protects Cognitive Functions and Synaptic Plasticity in Streptozotocin-Induced Sporadic Alzheimer's Model	PLOS ONE			English	Article							LONG-TERM POTENTIATION; INTRACEREBROVENTRICULAR-STREPTOZOTOCIN; AMYLOID-BETA; TAU HYPERPHOSPHORYLATION; MEMORY DEFICITS; DISEASE; INSULIN; RISK; ENHANCEMENT; DEMENTIA	Alzheimer's disease (AD) is characterized by profound synapse loss and impairments of learning and memory. Magnesium affects many biochemical mechanisms that are vital for neuronal properties and synaptic plasticity. Recent studies have demonstrated that the serum and brain magnesium levels are decreased in AD patients; however, the exact role of magnesium in AD pathogenesis remains unclear. Here, we found that the intraperitoneal administration of magnesium sulfate increased the brain magnesium levels and protected learning and memory capacities in streptozotocin-induced sporadic AD model rats. We also found that magnesium sulfate reversed impairments in long-term potentiation (LTP), dendritic abnormalities, and the impaired recruitment of synaptic proteins. Magnesium sulfate treatment also decreased tau hyperphosphorylation by increasing the inhibitory phosphorylation of GSK-3 beta at serine 9, thereby increasing the activity of Akt at Ser473 and PI3K at Tyr458/199, and improving insulin sensitivity. We conclude that magnesium treatment protects cognitive function and synaptic plasticity by inhibiting GSK-3 beta in sporadic AD model rats, which suggests a potential role for magnesium in AD therapy.	[Xu, Zhi-Peng; Li, Li; Bao, Jian; Wang, Zhi-Hao; Zeng, Juan; Liu, En-Jie; Li, Xiao-Guang; Huang, Rong-Xi; Gao, Di; Li, Meng-Zhu; Zhang, Yao; Liu, Gong-Ping; Wang, Jian-Zhi] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathophysiol, Wuhan 430074, Peoples R China; [Xu, Zhi-Peng; Li, Li; Bao, Jian; Wang, Zhi-Hao; Zeng, Juan; Liu, En-Jie; Li, Xiao-Guang; Huang, Rong-Xi; Gao, Di; Li, Meng-Zhu; Liu, Gong-Ping; Wang, Jian-Zhi] Huazhong Univ Sci & Technol, Tongji Med Coll, Key Lab Neurol Dis Natl, Educ Minist, Wuhan 430074, Peoples R China; [Zhang, Yao] Huazhong Univ Sci & Technol, Tongji Med Coll, Li Yuan Hosp, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, JZ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathophysiol, Wuhan 430074, Peoples R China.	wangjz@mail.hust.edu.cn	Liu, Enjie/AHD-1743-2022	Gao, Di/0000-0003-2616-6079	Natural Science Foundation of China [81261120570]; Science and Technology Committee of China [2013DFG32670]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Committee of China	This work was supported in part by grants from Natural Science Foundation of China (81261120570) and Science and Technology Committee of China (2013DFG32670). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2011, EUR NEUROPSYCHOPHARM, V21, P261, DOI 10.1016/j.euroneuro.2010.11.009; Andrasi E, 2000, MAGNESIUM RES, V13, P189; Aso E, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00037; Bannerman DM, 2014, NAT REV NEUROSCI, V15, P181, DOI 10.1038/nrn3677; Barbagallo M, 2011, MAGNESIUM RES, V24, pS115, DOI 10.1684/mrh.2011.0287; Bardgett ME, 2005, BRAIN RES, V1038, P100, DOI 10.1016/j.brainres.2005.01.020; Bitel CL, 2012, J ALZHEIMERS DIS, V32, P291, DOI 10.3233/JAD-2012-120571; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carro E, 2004, EUR J PHARMACOL, V490, P127, DOI 10.1016/j.ejphar.2004.02.050; Chai GS, 2013, J NEUROCHEM, V124, P388, DOI 10.1111/jnc.12094; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101; Deng YQ, 2009, AM J PATHOL, V175, P2089, DOI 10.2353/ajpath.2009.090157; Durlach J, 1990, Magnes Res, V3, P217; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; Ferrer I, 2012, PROG NEUROBIOL, V97, P38, DOI 10.1016/j.pneurobio.2012.03.005; Fitsanakis VA, 2008, TOXICOL SCI, V103, P116, DOI 10.1093/toxsci/kfn019; GANDY S, 1992, TRENDS PHARMACOL SCI, V13, P108, DOI 10.1016/0165-6147(92)90039-9; Garg M, 2011, AM J BIOMED SCI, V3, P11; Glick JL, 1990, MED SCI RES; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Gunther T, 2010, MAGNESIUM RES, V23, P5, DOI 10.1684/mrh.2009.0195; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Hartwig A, 2001, MUTAT RES-FUND MOL M, V475, P113, DOI 10.1016/S0027-5107(01)00074-4; Heo JH, 2011, J ALZHEIMERS DIS, V25, P517, DOI 10.3233/JAD-2011-102079; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kaytor MD, 2002, CURR OPIN NEUROBIOL, V12, P275, DOI 10.1016/S0959-4388(02)00320-3; Kloppenborg RP, 2008, EUR J PHARMACOL, V585, P97, DOI 10.1016/j.ejphar.2008.02.049; Kroner Z, 2009, ALTERN MED REV, V14, P373; LaFerla FM, 2005, TRENDS MOL MED, V11, P170, DOI 10.1016/j.molmed.2005.02.009; Lai KO, 2012, NAT NEUROSCI, V15, P1506, DOI 10.1038/nn.3237; LANDFIELD PW, 1984, BRAIN RES, V322, P167, DOI 10.1016/0006-8993(84)91199-5; Lannert H, 1998, BEHAV NEUROSCI, V112, P1199, DOI 10.1037/0735-7044.112.5.1199; Li W, 2013, J NEUROSCI, V33, P8423, DOI 10.1523/JNEUROSCI.4610-12.2013; Li ZG, 2007, DIABETES, V56, P1817, DOI 10.2337/db07-0171; Liu P, 2014, PSYCHOPHARMACOLOGY, V231, P345, DOI 10.1007/s00213-013-3240-4; Lopez-Ridaura R, 2004, DIABETES CARE, V27, P134, DOI 10.2337/diacare.27.1.134; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Maula MG, 2013, DINAJPUR MED COL J, V6, P123; Medina M, 2014, EXPERT OPINION THERA, P1; Mehla J, 2013, J ALZHEIMERS DIS, V33, P17, DOI 10.3233/JAD-2012-120958; Moosavi M, 2014, EUR J PHARMACOL, V736, P107, DOI 10.1016/j.ejphar.2014.03.041; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Park SA, 2011, J CLIN NEUROL, V7, P10, DOI 10.3988/jcn.2011.7.1.10; Ponce-Lopez T, 2011, BRAIN RES, V1426, P73, DOI 10.1016/j.brainres.2011.09.056; Pooler AM, 2014, NEUROPHARMACOLOGY, V76, P1, DOI 10.1016/j.neuropharm.2013.09.018; Rickle A, 2004, NEUROREPORT, V15, P955, DOI 10.1097/00001756-200404290-00005; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Salkovic-Petrisic M, 2006, J NEUROCHEM, V96, P1005, DOI 10.1111/j.1471-4159.2005.03637.x; Salkovic-Petrisic M, 2009, J ALZHEIMERS DIS, V18, P729, DOI 10.3233/JAD-2009-1184; Salmani M, 2014, COPPER ZINC YOUNG CO, V3, P102; Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541; Slutsky I, 2004, NEURON, V44, P835, DOI 10.1016/j.neuron.2004.11.013; Slutsky I, 2010, NEURON, V65, P165, DOI 10.1016/j.neuron.2009.12.026; Strachan MWJ, 2011, NAT REV ENDOCRINOL, V7, P108, DOI 10.1038/nrendo.2010.228; Su NY, 2013, J SURG RES, V185, P726, DOI 10.1016/j.jss.2013.06.030; Szewczyk B, 2008, PHARMACOL REP, V60, P588; Talbot K, 2014, ALZHEIMERS DEMENT, V10, pS12, DOI 10.1016/j.jalz.2013.12.007; Valente T, 2010, NEUROBIOL DIS, V37, P67, DOI 10.1016/j.nbd.2009.09.008; Velayudhan L, 2010, BRIT J PSYCHIAT, V196, P36, DOI 10.1192/bjp.bp.109.067942; Vural H, 2010, J TRACE ELEM MED BIO, V24, P169, DOI 10.1016/j.jtemb.2010.02.002; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Wang X, 2014, NEUROPHARMACOLOGY, V76, P80, DOI 10.1016/j.neuropharm.2013.08.022; Wuwongse S, 2013, BBA-MOL BASIS DIS, V1832, P2245, DOI 10.1016/j.bbadis.2013.07.022; Yin F, 2014, ANTIOXID REDOX SIGN, V20, P353, DOI 10.1089/ars.2012.4774; Yu J, 2010, J ALZHEIMERS DIS, V20, P1091, DOI 10.3233/JAD-2010-091444; Zhao J, 2011, LIFE SCI J, V8, P27; Zhou SS, 2013, NEUROTOXICOLOGY, V38, P136, DOI 10.1016/j.neuro.2013.07.007	72	55	56	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108645	10.1371/journal.pone.0108645	http://dx.doi.org/10.1371/journal.pone.0108645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268773	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700134
J	Rao, HL; Yadav, RK; Addepalli, UK; Chaudhary, S; Senthil, S; Choudhari, NS; Garudadri, CS				Rao, Harsha L.; Yadav, Ravi K.; Addepalli, Uday K.; Chaudhary, Shashikant; Senthil, Sirisha; Choudhari, Nikhil S.; Garudadri, Chandra S.			Peripapillary Retinal Nerve Fiber Layer Assessment of Spectral Domain Optical Coherence Tomography and Scanning Laser Polarimetry to Diagnose Preperimetric Glaucoma	PLOS ONE			English	Article							VARIABLE CORNEAL COMPENSATION; STRATUS OCT; EYES; ACCURACY; PERFORMANCE; RESOLUTION; PATTERN; ABILITY; SIZE; DISC	Purpose: To compare the abilities of peripapillary retinal nerve fiber layer (RNFL) parameters of spectral domain optical coherence tomograph (SDOCT) and scanning laser polarimeter (GDx enhanced corneal compensation; ECC) in detecting preperimetric glaucoma. Methods: In a cross-sectional study, 35 preperimetric glaucoma eyes (32 subjects) and 94 control eyes (74 subjects) underwent digital optic disc photography and RNFL imaging with SDOCT and GDx ECC. Ability of RNFL parameters of SDOCT and GDx ECC to discriminate preperimetric glaucoma eyes from control eyes was compared using area under receiver operating characteristic curves (AUC), sensitivities at fixed specificities and likelihood ratios (LR). Results: AUC of the global average RNFL thickness of SDOCT (0.786) was significantly greater (p<0.001) than that of GDx ECC (0.627). Sensitivities at 95% specificity of the corresponding parameters were 20% and 8.6% respectively. AUCs of the inferior, superior and temporal quadrant RNFL thickness parameters of SDOCT were also significantly (p<0.05) greater than the respective RNFL parameters of GDx ECC. LRs of outside normal limits category of SDOCT parameters ranged between 3.3 and 4.0 while the same of GDx ECC parameters ranged between 1.2 and 2.1. LRs of within normal limits category of SDOCT parameters ranged between 0.4 and 0.7 while the same of GDx ECC parameters ranged between 0.7 and 1.0. Conclusions: Abilities of the RNFL parameters of SDOCT and GDx ECC to diagnose preperimetric glaucoma were only moderate. Diagnostic abilities of the RNFL parameters of SDOCT were significantly better than that of GDx ECC in preperimetric glaucoma.	[Rao, Harsha L.; Yadav, Ravi K.; Addepalli, Uday K.; Chaudhary, Shashikant; Senthil, Sirisha; Choudhari, Nikhil S.; Garudadri, Chandra S.] LV Prasad Eye Inst, VST Glaucoma Ctr, Hyderabad, Andhra Pradesh, India	L. V. Prasad Eye Institute	Rao, HL (corresponding author), LV Prasad Eye Inst, VST Glaucoma Ctr, Banjara Hills, Hyderabad, Andhra Pradesh, India.	harshalaxmanarao@gmail.com	Choudhari, Nikhil/AAD-7157-2019	Rao, Harsha/0000-0001-5866-9856; Chaudhary, Shashi Kant/0000-0002-3761-2954				Alonzo TA, 2002, BIOSTATISTICS, V3, P421, DOI 10.1093/biostatistics/3.3.421; Anderson DR., 1999, AUTOMATED STATIC PER; Arintawati P, 2013, J GLAUCOMA, V22, P713, DOI 10.1097/IJG.0b013e318259b2e1; Benitez-del-Castillo J, 2011, EUR J OPHTHALMOL, V21, P228, DOI 10.5301/EJO.2010.5586; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Garas A, 2012, EUR J OPHTHALMOL, V22, P45, DOI 10.5301/ejo.5000011; Garway-Heath DF, 1998, BRIT J OPHTHALMOL, V82, P986, DOI 10.1136/bjo.82.9.986; GLYNN RJ, 1992, ARCH OPHTHALMOL-CHIC, V110, P381, DOI 10.1001/archopht.1992.01080150079033; Hirashima T, 2013, GRAEF ARCH CLIN EXP, V251, P129, DOI 10.1007/s00417-012-2076-7; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Jeoung JW, 2010, INVEST OPHTH VIS SCI, V51, P938, DOI 10.1167/iovs.08-3335; Knight OJ, 2009, OPHTHALMOLOGY, V116, P1271, DOI 10.1016/j.ophtha.2008.12.032; Langlotz CP, 2003, RADIOLOGY, V228, P3, DOI 10.1148/radiol.2281011106; Leung CKS, 2009, OPHTHALMOLOGY, V116, P1257, DOI 10.1016/j.ophtha.2009.04.013; Lisboa R, 2012, OPHTHALMOLOGY, V119, P2261, DOI 10.1016/j.ophtha.2012.06.009; Mai TA, 2007, OPHTHALMOLOGY, V114, P1988, DOI 10.1016/j.ophtha.2007.01.022; Medeiros FA, 2004, ARCH OPHTHALMOL-CHIC, V122, P827, DOI 10.1001/archopht.122.6.827; Medeiros FA, 2007, INVEST OPHTH VIS SCI, V48, P3146, DOI 10.1167/iovs.06-1139; Nassif NA, 2004, OPT EXPRESS, V12, P367, DOI 10.1364/OPEX.12.000367; Nukada M, 2014, J GLAUCOMA, V23, P150, DOI 10.1097/IJG.0b013e3182707456; Pepe MS., 2003, STAT EVALUATION MED, P130; RADACK KL, 1986, ARCH PATHOL LAB MED, V110, P689; Rao HL, 2014, EYE, V28, P654, DOI 10.1038/eye.2014.46; Rao HL, 2012, EYE, V26, P133, DOI 10.1038/eye.2011.277; Rao HL, 2013, INVEST OPHTH VIS SCI, V54, P7252, DOI 10.1167/iovs.13-12731; Rao HL, 2012, INVEST OPHTH VIS SCI, V53, P1058, DOI 10.1167/iovs.11-8463; Rao HL, 2011, INVEST OPHTH VIS SCI, V52, P1103, DOI 10.1167/iovs.10-5997; Rao HL, 2010, OPHTHALMOLOGY, V117, P1692, DOI 10.1016/j.ophtha.2010.01.031; Reus NJ, 2006, INVEST OPHTH VIS SCI, V47, P3870, DOI 10.1167/iovs.05-0067; Rolle T, 2011, CLIN OPHTHALMOL, V5, P961, DOI 10.2147/OPTH.S20249; Sehi M, 2006, BRIT J OPHTHALMOL, V90, P749, DOI 10.1136/bjo.2005.086447; Sehi M, 2007, AM J OPHTHALMOL, V143, P272, DOI 10.1016/j.ajo.2006.09.049; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Sung KR, 2009, OPHTHALMOLOGY, V116, P1264, DOI 10.1016/j.ophtha.2008.12.045; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Toth M, 2005, BRIT J OPHTHALMOL, V89, P1139, DOI 10.1136/bjo.2005.070011; WEINREB RN, 1995, AM J OPHTHALMOL, V119, P627, DOI 10.1016/S0002-9394(14)70221-1; Wojtkowski M, 2004, OPT EXPRESS, V12, P2404, DOI 10.1364/OPEX.12.002404; Zangwill LM, 2007, INVEST OPHTH VIS SCI, V48, P2653, DOI 10.1167/iovs.06-1314; Zhou X. H., 2002, STAT METHODS DIAGNOS, P274	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108992	10.1371/journal.pone.0108992	http://dx.doi.org/10.1371/journal.pone.0108992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279801	gold, Green Published, Green Submitted			2022-12-27	WOS:000342670800045
J	Ryu, H; Kim, TR; Ahn, S; Ji, S; Lee, J				Ryu, Hyojung; Kim, Tae-Rae; Ahn, SeonJoo; Ji, Sunyoung; Lee, Jinhyuk			Protein NMR Structures Refined without NOE Data	PLOS ONE			English	Article							MACROMOLECULAR STRUCTURE DETERMINATION; MOLECULAR-DYNAMICS; STRUCTURE PREDICTION; STATISTICAL POTENTIALS; IMPLICIT SOLVENT; ENERGY FUNCTION; QUALITY; MODELS; BIOMAGRESBANK; SIMULATIONS	The refinement of low-quality structures is an important challenge in protein structure prediction. Many studies have been conducted on protein structure refinement; the refinement of structures derived from NMR spectroscopy has been especially intensively studied. In this study, we generated flat-bottom distance potential instead of NOE data because NOE data have ambiguity and uncertainty. The potential was derived from distance information from given structures and prevented structural dislocation during the refinement process. A simulated annealing protocol was used to minimize the potential energy of the structure. The protocol was tested on 134 NMR structures in the Protein Data Bank (PDB) that also have X-ray structures. Among them, 50 structures were used as a training set to find the optimal "width'' parameter in the flat-bottom distance potential functions. In the validation set (the other 84 structures), most of the 12 quality assessment scores of the refined structures were significantly improved (total score increased from 1.215 to 2.044). Moreover, the secondary structure similarity of the refined structure was improved over that of the original structure. Finally, we demonstrate that the combination of two energy potentials, statistical torsion angle potential (STAP) and the flat-bottom distance potential, can drive the refinement of NMR structures.	[Ryu, Hyojung; Ahn, SeonJoo; Ji, Sunyoung; Lee, Jinhyuk] Korea Res Inst Bioscience & Biotechnol, Korean Bioinformat Ctr KOBIC, Taejon, South Korea; [Ryu, Hyojung; Ji, Sunyoung; Lee, Jinhyuk] Univ Sci & Technol, Dept Bioinformat, Taejon, South Korea; [Kim, Tae-Rae] Seoul Natl Univ, Dept Chem, Seoul, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU)	Lee, J (corresponding author), Korea Res Inst Bioscience & Biotechnol, Korean Bioinformat Ctr KOBIC, Taejon, South Korea.	jinhyuk@kribb.re.kr			Korean Research Institute of Bioscience and Biotechnology Research Initiative Program; Korean Ministry of Education, Science and Technology (MEST) [2012R1A1A2002676, 2012-0006002, 20120006011]; Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [2013M3C1A3064780]	Korean Research Institute of Bioscience and Biotechnology Research Initiative Program; Korean Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning(National Research Foundation of Korea)	This study was supported by grants from the Korean Research Institute of Bioscience and Biotechnology Research Initiative Program. The Korean Ministry of Education, Science and Technology (MEST) under grant numbers 2012R1A1A2002676, 2012-0006002, and 20120006011. The Pioneer Research Center Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2013M3C1A3064780). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruunger AT, 1992, X PLOR VERSION 3 1 S; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen H, 2008, PROTEINS, V71, P1255, DOI 10.1002/prot.21819; Chen JH, 2004, J AM CHEM SOC, V126, P16038, DOI 10.1021/ja047624f; Chen JH, 2005, J BIOMOL NMR, V31, P59, DOI 10.1007/s10858-004-6056-z; Chen JH, 2008, CURR OPIN STRUC BIOL, V18, P140, DOI 10.1016/j.sbi.2008.01.003; Chen JH, 2007, PROTEINS, V67, P922, DOI 10.1002/prot.21345; Chopra G, 2010, PROTEINS, V78, P2668, DOI 10.1002/prot.22781; Chopra G, 2008, P NATL ACAD SCI USA, V105, P20239, DOI 10.1073/pnas.0810818105; CLORE GM, 1986, EMBO J, V5, P2729, DOI 10.1002/j.1460-2075.1986.tb04557.x; Clore GM, 1998, P NATL ACAD SCI USA, V95, P5891, DOI 10.1073/pnas.95.11.5891; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Doreleijers JF, 1999, J BIOMOL NMR, V14, P123, DOI 10.1023/A:1008335423527; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Isralewitz B, 2001, J MOL GRAPH MODEL, V19, P13, DOI 10.1016/S1093-3263(00)00133-9; Jagielska A, 2008, P NATL ACAD SCI USA, V105, P8268, DOI 10.1073/pnas.0800054105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim TR, 2013, PROTEINS, V81, P1156, DOI 10.1002/prot.24265; Kim TR, 2012, J COMPUT CHEM, V33, P1927, DOI 10.1002/jcc.23024; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Lee MR, 2001, J MOL BIOL, V313, P417, DOI 10.1006/jmbi.2001.5032; Lin MS, 2011, J COMPUT CHEM, V32, P709, DOI 10.1002/jcc.21664; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lu H, 2003, BIOPOLYMERS, V70, P575, DOI 10.1002/bip.10537; MacKerell Jr AD, 1998, J PHYS CHEM B; Mao BC, 2014, J AM CHEM SOC, V136, P1893, DOI 10.1021/ja409845w; Melnik BS, 2005, MOL BIOL; Nabuurs SB, 2004, PROTEINS, V55, P483, DOI 10.1002/prot.20118; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Nilges M, 1997, FOLD DES, V2, pS53, DOI 10.1016/S1359-0278(97)00064-3; Nugent T, 2013, PROTEINS; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Ramelot TA, 2009, PROTEINS, V75, P147, DOI 10.1002/prot.22229; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; Summa CM, 2007, P NATL ACAD SCI USA, V104, P3177, DOI 10.1073/pnas.0611593104; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Yang JS, 2012, NUCLEIC ACIDS RES, V40, pD525, DOI 10.1093/nar/gkr1021; Yang YD, 2008, PROTEINS, V72, P793, DOI 10.1002/prot.21968; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2009, CURR OPIN STRUC BIOL, V19, P145, DOI 10.1016/j.sbi.2009.02.005; Zhu J, 2008, PROTEINS, V72, P1171, DOI 10.1002/prot.22005	47	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108888	10.1371/journal.pone.0108888	http://dx.doi.org/10.1371/journal.pone.0108888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279564	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800034
J	Shimizu, K; Matsumoto, K; Noma, N; Matsuura, S; Ohara, K; Komiya, H; Watase, T; Ogiso, B; Tsuboi, Y; Shinoda, M; Hatori, K; Nakaya, Y; Iwata, K				Shimizu, Kohei; Matsumoto, Kunihito; Noma, Noboru; Matsuura, Shingo; Ohara, Kinuyo; Komiya, Hiroki; Watase, Tetsuro; Ogiso, Bunnai; Tsuboi, Yoshiyuki; Shinoda, Masamichi; Hatori, Keisuke; Nakaya, Yuka; Iwata, Koichi			Involvement of Trigeminal Transition Zone and Laminated Subnucleus Caudalis in Masseter Muscle Hypersensitivity Associated with Tooth Inflammation	PLOS ONE			English	Article							MEDULLARY DORSAL-HORN; SIGNAL-REGULATED KINASE; C-FOS; PULP STIMULATION; NERVE INJURY; SPINAL-CORD; FACIAL-PAIN; NEURONS; PROTEIN; INDUCTION	A rat model of pulpitis/periapical periodontitis was used to study mechanisms underlying extraterritorial enhancement of masseter response associated with tooth inflammation. Periapical bone loss gradually increased and peaked at 6 weeks after complete Freund's adjuvant (CFA) application to the upper molar tooth pulp (M1). On day 3, the number of Fosimmunoreactive (IR) cells was significantly larger in M1 CFA rats compared with M1 vehicle (veh) rats in the trigeminal subnucleus interpolaris/caudalis transition zone (Vi/Vc). The number of Fos-IR cells was significantly larger in M1 CFA and masseter (Mass) capsaicin applied (M1 CFA/Mass cap) rats compared with M1 veh/Mass veh rats in the contralateral Vc and Vi/Vc. The number of phosphorylated extracellular signal-regulated kinase (pERK)-IR cells was significantly larger in M1 CFA/Mass cap and M1 veh/Mass cap rats compared to Mass-vehicle applied rats with M1 vehicle or CFA in the Vi/Vc. Pulpal CFA application caused significant increase in the number of Fos-IR cells in the Vi/Vc but not Vc on week 6. The number of pERK-IR cells was significantly lager in the rats with capsaicin application to the Mass compared to Mass-vehicle treated rats after pulpal CFA- or vehicle-application. However, capsaicin application to the Mass did not further affect the number of Fos-IR cells in the Vi/Vc in pulpal CFA-applied rats. The digastric electromyographic (d-EMG) activity after Mass-capsaicin application was significantly increased on day 3 and lasted longer at 6 weeks after pulpal CFA application, and these increase and duration were significantly attenuated by i.t. PD98059, a MEK1 inhibitor. These findings suggest that Vi/Vc and Vc neuronal excitation is involved in the facilitation of extraterritorial hyperalgesia for Mass primed with periapical periodontitis or acute pulpal-inflammation. Furthermore, phosphorylation of ERK in the Vi/Vc and Vc play pivotal roles in masseter hyperalgesia after pulpitis or periapical periodontitis.	[Shimizu, Kohei; Matsuura, Shingo; Ohara, Kinuyo; Komiya, Hiroki; Watase, Tetsuro; Ogiso, Bunnai; Hatori, Keisuke] Nihon Univ, Sch Dent, Dept Endodont, Tokyo 101, Japan; [Matsumoto, Kunihito] Nihon Univ, Sch Dent, Dept Radiol, Tokyo 101, Japan; [Shimizu, Kohei; Matsumoto, Kunihito; Ogiso, Bunnai; Hatori, Keisuke] Nihon Univ, Sch Dent, Dent Res Ctr, Div Adv Dent Treatment, Tokyo 101, Japan; [Noma, Noboru; Nakaya, Yuka] Nihon Univ, Sch Dent, Dept Oral Diag, Tokyo 101, Japan; [Noma, Noboru] Nihon Univ, Sch Dent, Dent Res Ctr, Div Clin Res, Tokyo 101, Japan; [Tsuboi, Yoshiyuki; Shinoda, Masamichi; Iwata, Koichi] Nihon Univ, Sch Dent, Dept Physiol, Tokyo 101, Japan; [Tsuboi, Yoshiyuki; Shinoda, Masamichi; Iwata, Koichi] Nihon Univ, Sch Dent, Dent Res Ctr, Div Funct Morphol, Tokyo 101, Japan; [Iwata, Koichi] Nihon Univ, Grad Sch Med Sci, Neurosci Adv Med Res Ctr, Div Appl Syst, Tokyo 101, Japan	Nihon University; Nihon University; Nihon University; Nihon University; Nihon University; Nihon University; Nihon University; Nihon University	Shimizu, K (corresponding author), Nihon Univ, Sch Dent, Dept Endodont, Tokyo 101, Japan.	shimizu.kouhei01@nihon-u.ac.jp			Uemura Funds from Nihon University School of Dentistry; Dental Research Center, Nihon University School of Dentistry; Nihon University multidisciplinary research grant; Individual Research Grant; Ministry of Education, Culture, Sports, Science and Technology (KAKENHI) [21791868, 23792192, 22792021]; KAKENHI (Challenging Exploratory Research) [24659832]; Ministry of Education, Culture, Sports, Science, Technology to promote multidisciplinary research project "Brain Mechanisms for Cognition, Memory and Behavior''; Ministry of Education, Culture, Sports, Science, Technology to promote multidisciplinary research project "Translational Research Network on Orofacial Neurological Disorders'' at Nihon University; Sato from Nihon University School of Dentistry; Grants-in-Aid for Scientific Research [25462968] Funding Source: KAKEN	Uemura Funds from Nihon University School of Dentistry; Dental Research Center, Nihon University School of Dentistry; Nihon University multidisciplinary research grant; Individual Research Grant; Ministry of Education, Culture, Sports, Science and Technology (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); KAKENHI (Challenging Exploratory Research); Ministry of Education, Culture, Sports, Science, Technology to promote multidisciplinary research project "Brain Mechanisms for Cognition, Memory and Behavior''; Ministry of Education, Culture, Sports, Science, Technology to promote multidisciplinary research project "Translational Research Network on Orofacial Neurological Disorders'' at Nihon University; Sato from Nihon University School of Dentistry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Research grants from Sato and Uemura Funds from Nihon University School of Dentistry, and Grant from Dental Research Center, Nihon University School of Dentistry; Nihon University multidisciplinary research grant and Individual Research Grant; a Grant from the Ministry of Education, Culture, Sports, Science and Technology to promote multi-disciplinary research Projects (KAKENHI (Grant-in-Aid for Young Scientist (B)) # 21791868 and # 23792192 to KS, # 22792021 to MS, KAKENHI (Challenging Exploratory Research) # 24659832 to KI); grants from the Ministry of Education, Culture, Sports, Science, Technology to promote multidisciplinary research projects "Brain Mechanisms for Cognition, Memory and Behavior'' and "Translational Research Network on Orofacial Neurological Disorders'' at Nihon University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANO N, 1986, J NEUROPHYSIOL, V55, P227, DOI 10.1152/jn.1986.55.2.227; Bender IB, 2000, J ENDODONT, V26, P175, DOI 10.1097/00004770-200003000-00012; BEREITER DA, 1994, BRAIN RES, V657, P73, DOI 10.1016/0006-8993(94)90955-5; Dai Y, 2002, J NEUROSCI, V22, P7737; Ertekin C, 2004, CLIN NEUROL NEUROSUR, V107, P32, DOI 10.1016/j.clineuro.2004.02.024; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; GRUSHKA M, 1984, PAIN, V19, P49, DOI 10.1016/0304-3959(84)90064-2; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; Hasegawa M, 2012, J DENT RES, V91, P1141, DOI 10.1177/0022034512462397; Honda K, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-75; Honda K, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-59; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Imbe H, 1999, BRAIN RES, V845, P165, DOI 10.1016/S0006-8993(99)01913-7; Iwata K, 1998, PAIN, V75, P27, DOI 10.1016/S0304-3959(97)00201-7; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Kobayashi A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-12; MORSE DR, 1977, ORAL SURG ORAL MED O, V43, P436, DOI 10.1016/0030-4220(77)90331-0; Noma N, 2008, J COMP NEUROL, V507, P1428, DOI 10.1002/cne.21620; Ren K, 2011, INT REV NEUROBIOL, V97, P207, DOI 10.1016/B978-0-12-385198-7.00008-4; SESSLE BJ, 1978, INT DENT J, V28, P28; SESSLE BJ, 1987, J DENT RES, V66, P962, DOI 10.1177/00220345870660052201; SESSLE BJ, 1986, PAIN, V27, P219, DOI 10.1016/0304-3959(86)90213-7; Shimizu K, 2006, BRAIN RES, V1072, P99, DOI 10.1016/j.brainres.2005.12.040; Shoda E, 2009, J PAIN, V10, P573, DOI 10.1016/j.jpain.2008.11.013; STASHENKO P, 1992, J ENDODONT, V18, P422, DOI 10.1016/S0099-2399(06)80841-1; Sunakawa M, 1999, PAIN, V80, P493, DOI 10.1016/S0304-3959(98)00241-3; Terayama R, 2008, NEUROSCIENCE, V153, P1245, DOI 10.1016/j.neuroscience.2008.03.041; Wang H, 2006, J COMP NEUROL, V498, P390, DOI 10.1002/cne.21062; WILLIAMS S, 1990, NEUROSCIENCE, V36, P73, DOI 10.1016/0306-4522(90)90352-5; Wright EF, 2008, J AM DENT ASSOC, V139, P436, DOI 10.14219/jada.archive.2008.0186; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	31	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109168	10.1371/journal.pone.0109168	http://dx.doi.org/10.1371/journal.pone.0109168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279551	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800058
J	Tsai, YC; Chiu, YW; Tsai, JC; Kuo, HT; Lee, SC; Hung, CC; Lin, MY; Hwang, SJ; Kuo, MC; Chen, HC				Tsai, Yi-Chun; Chiu, Yi-Wen; Tsai, Jer-Chia; Kuo, Hung-Tien; Lee, Su-Chu; Hung, Chi-Chih; Lin, Ming-Yen; Hwang, Shang-Jyh; Kuo, Mei-Chuan; Chen, Hung-Chun			Association of Angiopoietin-2 with Renal Outcome in Chronic Kidney Disease	PLOS ONE			English	Article							EXCESS CIRCULATING ANGIOPOIETIN-2; GROWTH-FACTOR LEVELS; RECEPTOR TIE-2; PLASMA ANGIOPOIETIN-1; DIABETES-MELLITUS; EXPRESSION; ANGIOGENESIS; HYPERTENSION; PROTEINURIA; MORTALITY	Background: The pathophysiological mechanisms of renal function progression in chronic kidney disease (CKD) have still not been completely explored. In addition to well-known traditional risk factors, non-traditional risk factors, such as endothelial dysfunction, have gradually attracted physicians' attention. Angiopoietin-2 (Ang-2) impairs endothelial function through preventing angiopoietin-1 from binding to Tie2 receptor. Whether Ang-2 is associated with renal function progression in CKD is unknown. Methods: This study enrolled 621 patients with stages 3-5 CKD to assess the association of circulating Ang-2 with commencing dialysis, doubling creatinine and rapid decline in renal function (the slope of estimated glomerular filtration rate (eGFR) greater than 5 ml/min per 1.73 m(2)/y) over follow-up of more than 3 years. Results: Of all patients, 224 patients (36.1%) progressed to commencing dialysis and 165 (26.6%) reached doubling creatinine. 85 subjects (13.9%) had rapid decline in renal function. Ang-2 quartile was divided at 1494.1, 1948.8, and 2593.1 pg/ml. The adjusted HR of composite outcomes, either commencing dialysis or doubling creatinine was 1.53 (95% CI: 1.06-2.23) for subjects of quartile 4 compared with those of quartile 1. The adjusted OR for rapid decline in renal function was 2.96 (95% CI: 1.13-7.76) for subjects of quartile 4 compared with those of quartile 1. The linear mixed-effects model shows a more rapid decrease in eGFR over time in patients with quartile 3 or more of Ang-2 than those with the lowest quartile of Ang-2. Conclusions: Ang-2 is an independent predictor of adverse renal outcome in CKD. Further study is needed to identify the pathogenic role of Ang-2 in CKD progression.	[Tsai, Yi-Chun; Hwang, Shang-Jyh; Kuo, Mei-Chuan] Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan; [Tsai, Yi-Chun; Chiu, Yi-Wen; Tsai, Jer-Chia; Kuo, Hung-Tien; Lee, Su-Chu; Hung, Chi-Chih; Hwang, Shang-Jyh; Kuo, Mei-Chuan; Chen, Hung-Chun] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Tsai, Yi-Chun; Chiu, Yi-Wen; Tsai, Jer-Chia; Kuo, Hung-Tien; Hung, Chi-Chih; Lin, Ming-Yen; Hwang, Shang-Jyh; Kuo, Mei-Chuan; Chen, Hung-Chun] Kaohsiung Med Univ, Coll Med, Fac Renal Care, Kaohsiung, Taiwan; [Hwang, Shang-Jyh] Natl Hlth Res Inst, Inst Populat Sci, Miaoli, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Health Research Institutes - Taiwan	Kuo, MC (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan.	mechku@cc.kmu.edu.tw	Lin, Ming Yen/A-8637-2010	Lin, Ming Yen/0000-0002-8194-4833; lee, su-chu/0000-0002-8587-7324; Kuo, Hung-Tien/0000-0002-9931-4354	Kaohsiung Medical University Faculty of Renal Care	Kaohsiung Medical University Faculty of Renal Care	Dr. Tsai's research was supported by the Kaohsiung Medical University Faculty of Renal Care.	Anuradha S, 2010, METABOLISM, V59, P774, DOI 10.1016/j.metabol.2009.09.022; Baylis C, 2012, CURR OPIN NEPHROL HY, V21, P1, DOI 10.1097/MNH.0b013e32834d54ca; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Chang FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054668; Chang FC, 2013, J FORMOS MED ASSOC, V112, P175, DOI 10.1016/j.jfma.2012.07.028; Chen JX, 2012, AM J PHYSIOL-HEART C, V302, pH1003, DOI 10.1152/ajpheart.00866.2011; Chong AY, 2004, J AM COLL CARDIOL, V43, P423, DOI 10.1016/j.jacc.2003.08.042; Cui X, 2011, NEUROBIOL DIS, V43, P285, DOI 10.1016/j.nbd.2011.04.005; David S, 2012, NEPHROL DIAL TRANSPL, V27, P1867, DOI 10.1093/ndt/gfr551; David S, 2010, NEPHROL DIAL TRANSPL, V25, P2571, DOI 10.1093/ndt/gfq060; David S, 2009, AM J KIDNEY DIS, V53, P770, DOI 10.1053/j.ajkd.2008.11.030; Davis B, 2007, J AM SOC NEPHROL, V18, P2320, DOI 10.1681/ASN.2006101093; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Fam NP, 2003, CIRCULATION, V108, P2613, DOI 10.1161/01.CIR.0000102939.04279.75; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Futrakul N, 2008, CLIN HEMORHEOL MICRO, V38, P201; Huang YQ, 2002, BLOOD, V99, P1646, DOI 10.1182/blood.V99.5.1646; Kielstein JT, 2005, AM J KIDNEY DIS, V46, P186, DOI 10.1053/j.ajkd.2005.05.009; Kumpers P, 2010, INTENS CARE MED, V36, P462, DOI 10.1007/s00134-009-1726-7; Kumpers P, 2008, CRIT CARE, V12, DOI 10.1186/cc7130; Lee KW, 2004, CIRCULATION, V110, P2355, DOI 10.1161/01.CIR.0000138112.90641.7F; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2014, KIDNEY INT, V85, P49, DOI 10.1038/ki.2013.444; Lim HS, 2005, ATHEROSCLEROSIS, V180, P113, DOI 10.1016/j.atherosclerosis.2004.11.004; Nadar SK, 2005, J INTERN MED, V258, P336, DOI 10.1111/j.1365-2796.2005.01550.x; Nugent RA, 2011, NEPHRON CLIN PRACT, V118, pC269, DOI 10.1159/000321382; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Rengo G, 2013, CIRC-HEART FAIL, V6, P1259, DOI 10.1161/CIRCHEARTFAILURE.113.000329; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; SERON D, 1990, NEPHROL DIAL TRANSPL, V5, P889, DOI 10.1093/ndt/5.10.889; Shroff RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056273; Shurraw S, 2011, ARCH INTERN MED, V171, P1920, DOI 10.1001/archinternmed.2011.537; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Tsai YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052775; Wever R, 1999, ARTERIOSCL THROM VAS, V19, P1168, DOI 10.1161/01.ATV.19.5.1168; Woolf AS, 2009, J AM SOC NEPHROL, V20, P239, DOI 10.1681/ASN.2008020243	38	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108862	10.1371/journal.pone.0108862	http://dx.doi.org/10.1371/journal.pone.0108862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279852	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800030
J	Gonzalez, C; Ornelas, JF				Gonzalez, Clementina; Francisco Ornelas, Juan			Acoustic Divergence with Gene Flow in a Lekking Hummingbird with Complex Songs	PLOS ONE			English	Article							POPULATION-STRUCTURE; GEOGRAPHIC-VARIATION; BIRD SONG; SEXUAL SELECTION; VOCAL DIALECTS; EVOLUTION; SPECIATION; PATTERNS; ECOLOGY; DIFFERENTIATION	Hummingbirds have developed a remarkable diversity of learned vocalizations, from single-note songs to phonologically and syntactically complex songs. In this study we evaluated if geographic song variation of wedge-tailed sabrewings (Campylopterus curvipennis) is correlated with genetic divergence, and examined processes that explain best the origin of intraspecific song variation. We contrasted estimates of genetic differentiation, genetic structure, and gene flow across leks from microsatellite loci of wedge-tailed sabrewings with measures for acoustic signals involved in mating derived from recordings of males singing at leks throughout eastern Mexico. We found a strong acoustic structure across leks and geography, where lek members had an exclusive assemblage of syllable types, differed in spectral and temporal measurements of song, and song sharing decreased with geographic distance. However, neutral genetic and song divergence were not correlated, and measures of genetic differentiation and migration estimates indicated gene flow across leks. The persistence of acoustic structuring in wedge-tailed sabrewings may thus best be explained by stochastic processes across leks, in which intraspecific vocal variation is maintained in the absence of genetic differentiation by postdispersal learning and social conditions, and by geographical isolation due to the accumulation of small differences, producing most dramatic changes between populations further apart.	[Gonzalez, Clementina; Francisco Ornelas, Juan] Inst Ecol AC, Dept Biol Evolutiva, Xalapa, Veracruz, Mexico	Instituto de Ecologia - Mexico	Ornelas, JF (corresponding author), Inst Ecol AC, Dept Biol Evolutiva, Xalapa, Veracruz, Mexico.	francisco.ornelas@inecol.mx	Ornelas, Juan Francisco/A-2250-2014	Ornelas, Juan Francisco/0000-0002-1124-1163	Departamento de Biologia Evolutiva, Instituto de Ecologia [902-12-563]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [61710, 203259]	Departamento de Biologia Evolutiva, Instituto de Ecologia; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funds were provided by the Departamento de Biologia Evolutiva, Instituto de Ecologia (902-12-563), and by a research grant (61710) to JFO and a doctoral scholarship (203259) to CG from the Consejo Nacional de Ciencia y Tecnologia (CONACyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoullaye D, 2010, MOL ECOL RESOUR, V10, P232, DOI 10.1111/j.1755-0998.2009.02796.x; ANDREW RJ, 1962, SCIENCE, V137, P585, DOI 10.1126/science.137.3530.585; Araya-Salas M, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0625; ATWOOD JL, 1991, WILSON BULL, V103, P373; BAKER MC, 1982, AM ZOOL, V22, P561; Baker MC, 2006, BIOL J LINN SOC, V89, P331, DOI 10.1111/j.1095-8312.2006.00677.x; BAPTISTA LF, 1990, ETHOLOGY, V84, P15; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Boul KE, 2007, P ROY SOC B-BIOL SCI, V274, P399, DOI 10.1098/rspb.2006.3736; Campbell P, 2010, EVOLUTION, V64, P1955, DOI 10.1111/j.1558-5646.2010.00962.x; Colwell R.K., 2006, ESTIMATES STAT ESTIM; Coyne J.A., 2004, SPECIATION; Dingle C, 2008, J EVOLUTION BIOL, V21, P1079, DOI 10.1111/j.1420-9101.2008.01536.x; Edwards SV, 2005, P NATL ACAD SCI USA, V102, P6550, DOI 10.1073/pnas.0501846102; Ellers J, 2003, ANIM BEHAV, V65, P671, DOI 10.1006/anbe.2003.2081; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ferreira ARJ, 2006, AUK, V123, P1129, DOI 10.1642/0004-8038(2006)123[1129:VAABOT]2.0.CO;2; Ficken MS, 2000, AUK, V117, P120; Fisher RA, 1930, GENETICAL THEORY NAT; Forchler MI, 2007, J BIOGEOGR, V34, P1591, DOI 10.1111/j.1365-2699.2007.01722.x; GAUNT SLL, 1994, AUK, V111, P87; Gonzalez C, 2005, AUK, V122, P593, DOI 10.1642/0004-8038(2005)122[0593:SSAMSV]2.0.CO;2; Gonzalez C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-38; Gonzalez C, 2009, CONDOR, V111, P633, DOI 10.1525/cond.2009.090029; Goodman SJ, 1997, MOL ECOL, V6, P881, DOI 10.1046/j.1365-294X.1997.00260.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Howell S. N. G., 1995, GUIDE BIRDS MEXICO N; Irwin DE, 2008, J EVOLUTION BIOL, V21, P435, DOI 10.1111/j.1420-9101.2007.01499.x; Irwin DE, 2000, EVOLUTION, V54, P998; Irwin DE, 2001, NATURE, V409, P333, DOI 10.1038/35053059; Jarvis ED, 2000, NATURE, V406, P628, DOI 10.1038/35020570; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Koetz AH, 2007, ANIM BEHAV, V74, P1573, DOI 10.1016/j.anbehav.2007.03.022; Kroodsma Donald E., 1996, P269; Leader N, 2008, BEHAV ECOL SOCIOBIOL, V62, P1299, DOI 10.1007/s00265-008-0558-8; Lynch Alejandro, 1996, P181; MacDougall-Shackleton EA, 2001, EVOLUTION, V55, P2568, DOI 10.1111/j.0014-3820.2001.tb00769.x; MARLER P., 1962, CONDOR, V64, P368, DOI 10.2307/1365545; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; McDonald DB, 2003, CONDOR, V105, P580, DOI 10.1650/7022; MORIN PA, 1994, J SCI SOC THAILAND, V20, P31; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; MUNDINGER PC, 1980, ETHOL SOCIOBIOL, V1, P183, DOI 10.1016/0162-3095(80)90008-4; Mundinger PC., 1982, ACOUSTIC COMMUNICATI, Vvol. 2, P147; Nelson DA, 2001, BEHAVIOUR, V138, P1137, DOI 10.1163/156853901753287172; Nicholls JA, 2006, EVOLUTION, V60, P1279; NOTTEBOHM F, 1969, CONDOR, V71, P299, DOI 10.2307/1366306; Ornelas JF, 2002, AUK, V119, P1141, DOI 10.1642/0004-8038(2002)119[1141:CVAADO]2.0.CO;2; Orr MR, 1998, TRENDS ECOL EVOL, V13, P502, DOI 10.1016/S0169-5347(98)01511-0; Patten MA, 2004, EVOLUTION, V58, P2144; Payne R.B., 1981, P108; Planque R, 2014, J MATH BIOL, V68, P505, DOI 10.1007/s00285-012-0632-8; Podos J, 2004, ANNU REV ECOL EVOL S, V35, P55, DOI 10.1146/annurev.ecolsys.35.021103.105719; Podos J, 2007, ADV STUD BEHAV, V37, P403, DOI 10.1016/S0065-3454(07)37009-5; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reesink G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000241; Ritchie MG, 2007, J EVOLUTION BIOL, V20, P2048, DOI 10.1111/j.1420-9101.2007.01357.x; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Ruegg K, 2006, MOL ECOL, V15, P3147, DOI 10.1111/j.1365-294X.2006.03011.x; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; Saranathan V, 2007, MOL ECOL, V16, P3689, DOI 10.1111/j.1365-294X.2007.03415.x; Searcy William A., 1996, P454; Seddon N, 2005, EVOLUTION, V59, P200; Slabbekoorn H, 2002, CONDOR, V104, P564, DOI 10.1650/0010-5422(2002)104[0564:BASTTB]2.0.CO;2; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Slabbekoorn H, 2002, EVOLUTION, V56, P1849; SLATKIN M, 1995, GENETICS, V139, P457; Soha JA, 2000, ANIM BEHAV, V60, P297, DOI 10.1006/anbe.2000.1499; Soha JA, 2004, BEHAV ECOL, V15, P636, DOI 10.1093/beheco/arh055; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wright TF, 2005, MOL ECOL, V14, P1197, DOI 10.1111/j.1365-294X.2005.02466.x; Wright TF, 2001, P ROY SOC B-BIOL SCI, V268, P609, DOI 10.1098/rspb.2000.1403; Yoktan K, 2011, BEHAV ECOL SOCIOBIOL, V65, P1389, DOI 10.1007/s00265-011-1149-7	75	17	17	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109241	10.1371/journal.pone.0109241	http://dx.doi.org/10.1371/journal.pone.0109241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271429	Green Submitted, Green Published, gold			2022-12-27	WOS:000343729600108
J	Gray, AL; Stephens, CA; Bigelow, RLH; Coleman, DT; Cardelli, JA				Gray, Alana L.; Stephens, Charles A.; Bigelow, Rebecca L. H.; Coleman, David T.; Cardelli, James A.			The Polyphenols (-)-Epigallocatechin-3-Gallate and Luteolin Synergistically Inhibit TGF-beta-Induced Myofibroblast Phenotypes through RhoA and ERK Inhibition	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PROSTATE-SPECIFIC ANTIGEN; FATTY-ACID SYNTHASE; REACTIVE STROMA; CANCER-CELLS; C-MET; FIBROBLASTS; ACTIVATION; EXPRESSION; INDUCTION	The presence of reactive stroma, predominantly composed of myofibroblasts, is directly associated with and drives prostate cancer progression. We have previously shown that (-)-Epigallocatechin-3-gallate (EGCG), in the form of Polyphenon E, significantly decreases serum levels of HGF and VEGF in prostate cancer patients. Given that HGF and VEGF are secreted from surrounding tumor myofibroblasts, these observations suggested that EGCG may inhibit prostate cancer-associated myofibroblast differentiation. Herein, we demonstrate that micromolar combinations of EGCG and a second polyphenol, luteolin, synergistically inhibit TGF-beta-induced myofibroblast phenotypes in prostate fibroblast cell lines, as observed primarily by potentiation of fibronectin expression. Functionally, EGCG and luteolin inhibited TGF-beta-induced extracellular matrix contraction, an enhancer of tumor cell invasion. EGCG and luteolin inhibited downstream TGF-beta-induced signaling, including activation of ERK and AKT, respectively, but mechanistically, only ERK appeared to be necessary for TGF-beta-induced fibronectin expression. Furthermore, neither EGCG nor luteolin affected Smad signaling or nuclear translocation. Rho signaling was found to be necessary for TGF-beta-induced fibronectin expression and EGCG and luteolin each reduced RhoA activation. Finally, EGCG and luteolin were shown to reverse TGF-beta-induced fibronectin expression, implicating that these natural compounds may be useful not only in preventing but also in treating already activated myofibroblasts and the diseases they cause, including cancer. The ability of EGCG and luteolin to synergistically target myofibroblasts suggests that combined clinical use of these compounds could prevent or reverse cancer progression through targeting the tumor microenvironment, in addition to the tumor itself.	[Gray, Alana L.; Stephens, Charles A.; Bigelow, Rebecca L. H.; Coleman, David T.; Cardelli, James A.] Louisiana State Univ, Hlth Sci Ctr, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Cardelli, JA (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Shreveport, LA 71105 USA.	jcarde@lsuhsc.edu			Feist-Weiller Cancer Center Idea Award	Feist-Weiller Cancer Center Idea Award	This work was funded by a Feist-Weiller Cancer Center Idea Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2007, CANCER RES, V67, P6493, DOI 10.1158/0008-5472.CAN-07-0411; Amin ARMR, 2010, J BIOL CHEM, V285, P34557, DOI 10.1074/jbc.M110.141135; [Anonymous], SEER CANC STAT FACTS; Ayala G, 2003, CLIN CANCER RES, V9, P4792; Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145; Bigelow RLH, 2006, ONCOGENE, V25, P1922, DOI 10.1038/sj.onc.1209227; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Brusselmans K, 2005, J BIOL CHEM, V280, P5636, DOI 10.1074/jbc.M408177200; Cali G, 1999, J CELL SCI, V112, P957; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Castelletti F, 2008, P NATL ACAD SCI USA, V105, P2538, DOI 10.1073/pnas.0707730105; Chen CL, 2008, J CELL PHYSIOL, V215, P223, DOI 10.1002/jcp.21303; Chen JLY, 2013, CLIN CANCER RES, V19, P5127, DOI 10.1158/1078-0432.CCR-12-3127; Chen YH, 2013, ACTA OPHTHALMOL, V91, pE506, DOI 10.1111/aos.12160; Chou T.-C., 2007, COMPUSYN SOFTWARE DR; Chuu CP, 2009, CANCER LETT, V275, P86, DOI 10.1016/j.canlet.2008.10.001; Coleman DT, 2009, MOL CANCER THER, V8, P214, DOI 10.1158/1535-7163.MCT-08-0722; Dakhova O, 2014, CLIN CANCER RES, V20, P100, DOI 10.1158/1078-0432.CCR-13-1184; Ding Q, 2008, J BIOL CHEM, V283, P26839, DOI 10.1074/jbc.M803645200; Dooley A, 2010, RHEUMATOLOGY, V49, P2024, DOI 10.1093/rheumatology/keq208; Duhon D, 2010, MOL CARCINOGEN, V49, P739, DOI 10.1002/mc.20649; Finger EC, 2008, J BIOL CHEM, V283, P34808, DOI 10.1074/jbc.M804741200; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Gutierrez-Venegas G, 2013, MICROBIOL IMMUNOL, V57, P849, DOI 10.1111/1348-0421.12103; Jain RK, 2013, J CLIN ONCOL, V31, P2205, DOI 10.1200/JCO.2012.46.3653; Johnson JL, 2013, FOOD CHEM TOXICOL, V60, P83, DOI 10.1016/j.fct.2013.07.036; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kang JS, 2014, PHYTOTHER RES, V28, P98, DOI 10.1002/ptr.4971; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Lamy S, 2008, CANCER PREV RES, V1, P452, DOI 10.1158/1940-6207.CAPR-08-0072; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; Majumdar D, 2014, CANCER PREV RES, V7, P65, DOI 10.1158/1940-6207.CAPR-13-0230; McLarty J, 2009, CANCER PREV RES, V2, P673, DOI 10.1158/1940-6207.CAPR-08-0167; Milligan SA, 2009, CLIN CANCER RES, V15, P4885, DOI 10.1158/1078-0432.CCR-09-0109; Nazaruk J, 2014, PHYTOTHER RES, V28, P1399, DOI 10.1002/ptr.5143; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Peng FF, 2008, DIABETES, V57, P1683, DOI 10.2337/db07-1149; Peng FF, 2007, J AM SOC NEPHROL, V18, P189, DOI 10.1681/ASN.2006050498; Polanska UM, 2013, J CELL PHYSIOL, V228, P1651, DOI 10.1002/jcp.24347; Porter KE, 2004, CARDIOVASC RES, V61, P745, DOI 10.1016/j.cardiores.2003.11.032; Relat J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-280; RONNOVJESSEN L, 1993, LAB INVEST, V68, P696; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Sah JF, 2004, J BIOL CHEM, V279, P12755, DOI 10.1074/jbc.M312333200; Schauer IG, 2008, UROLOGY, V72, P205, DOI 10.1016/j.urology.2007.11.083; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shukla R, 2012, P NATL ACAD SCI USA, V109, P12426, DOI 10.1073/pnas.1121174109; Siddiqui IA, 2011, FASEB J, V25, P1198, DOI 10.1096/fj.10-167924; Stipcevic T, 2006, PLANT FOOD HUM NUTR, V61, P29, DOI 10.1007/s11130-006-0006-8; Stylianopoulos T, 2012, P NATL ACAD SCI USA, V109, P15101, DOI 10.1073/pnas.1213353109; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Thomas PE, 2007, AM J PHYSIOL-LUNG C, V293, pL417, DOI 10.1152/ajplung.00489.2006; Tse JM, 2012, P NATL ACAD SCI USA, V109, P911, DOI 10.1073/pnas.1118910109; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Webber MM, 1999, CARCINOGENESIS, V20, P1185, DOI 10.1093/carcin/20.7.1185; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wojcik KA, 2013, PHARMACOL REP, V65, P164, DOI 10.1016/S1734-1140(13)70974-5; Yumei F, 2006, LAB INVEST, V86, P697, DOI 10.1038/labinvest.3700425	59	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109208	10.1371/journal.pone.0109208	http://dx.doi.org/10.1371/journal.pone.0109208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272043	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600106
J	Toda, R; Okano, K; Takeuchi, Y; Yamauchi, C; Fukushiro, M; Takemura, A; Okano, T				Toda, Riko; Okano, Keiko; Takeuchi, Yuki; Yamauchi, Chihiro; Fukushiro, Masato; Takemura, Akihiro; Okano, Toshiyuki			Hypothalamic Expression and Moonlight-Independent Changes of Cry3 and Per4 Implicate Their Roles in Lunar Clock Oscillators of the Lunar-Responsive Goldlined Spinefoot	PLOS ONE			English	Article							MOLECULAR-CLONING; BRAIN; IDENTIFICATION; CHICKEN; OPSIN; GENE	Lunar cycle-associated physiology has been found in a wide variety of organisms. Studies suggest the presence of a circalunar clock in some animals, but the location of the lunar clock is unclear. We previously found lunar-associated expression of transcripts for Cryptochrome3 gene (SgCry3) in the brain of a lunar phase-responsive fish, the Goldlined spinefoot (Siganus guttatus). Then we proposed a photoperiodic model for the lunar phase response, in which SgCry3 might function as a phase-specific light response gene and/or an oscillatory factor in unidentified circalunar clock. In this study, we have developed an anti-SgCRY3 antibody to identify SgCRY3-immunoreactive cells in the brain. We found immunoreactions in the subependymal cells located in the mediobasal region of the diencephalon, a crucial site for photoperiodic seasonal responses in birds. For further assessment of the lunar-responding mechanism and the circalunar clock, we investigated mRNA levels of Cry3 as well as those of the other clock(-related) genes, Period (Per2 and Per4), in S. guttatus reared under nocturnal moonlight interruption or natural conditions. Not only SgCry3 but SgPer4 mRNA levels showed lunar phase-dependent variations in the diencephalon without depending on light condition during the night. These results suggest that the expressions of SgCry3 and SgPer4 are not directly regulated by moonlight stimulation but endogenously mediated in the brain, and implicate that circadian clock(-related) genes may be involved in the circalunar clock locating within the mediobasal region of the diencephalon.	[Toda, Riko; Okano, Keiko; Fukushiro, Masato; Okano, Toshiyuki] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Elect Engn & Biosci, TWIns, Tokyo, Japan; [Takeuchi, Yuki; Yamauchi, Chihiro; Takemura, Akihiro] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 90301, Japan	Waseda University; University of the Ryukyus	Okano, T (corresponding author), Waseda Univ, Grad Sch Adv Sci & Engn, Dept Elect Engn & Biosci, TWIns, Tokyo, Japan.	okano@waseda.jp	Takeuchi, Yuki/B-2643-2018	Takeuchi, Yuki/0000-0002-8480-5206; Okano, Toshiyuki/0000-0001-6740-6265	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japanese Society for the Promotion of Science (JSPS) of Japan [23248033, 24657109, 26650024]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science (JSPS) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by the Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and the Japanese Society for the Promotion of Science (JSPS, No. 23248033, 24657109, 26650024) of Japan awarded to TO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL B, 1966, J GEOPHYS RES, V71, P951, DOI 10.1029/JZ071i003p00951; Fukushiro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028643; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; JOKIEL PL, 1985, MAR BIOL, V88, P167, DOI 10.1007/BF00397164; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Maruska KP, 2011, PHYSIOLOGY, V26, P412, DOI 10.1152/physiol.00032.2011; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; OHTA M, 1987, GEN COMP ENDOCR, V68, P286, DOI 10.1016/0016-6480(87)90040-2; Okano T, 1997, MOL BRAIN RES, V50, P190, DOI 10.1016/S0169-328X(97)00184-8; Park JG, 2007, J COMP PHYSIOL A, V193, P403, DOI 10.1007/s00359-006-0194-6; Rahman MS, 2000, COMP BIOCHEM PHYS B, V127, P113, DOI 10.1016/S0305-0491(00)00240-6; Slattery M, 1999, CORAL REEFS, V18, P75, DOI 10.1007/s003380050158; Sugama N, 2008, J PINEAL RES, V45, P133, DOI 10.1111/j.1600-079X.2008.00566.x; Takemura A, 2004, FISH FISH, V5, P317, DOI 10.1111/j.1467-2679.2004.00164.x; Takemura A, 2004, J EXP ZOOL PART A, V301A, P844, DOI 10.1002/jez.a.105; Takeuchi Y, 2011, COMP BIOCHEM PHYS A, V160, P486, DOI 10.1016/j.cbpa.2011.08.007; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Vize PD, 2005, GULF MEXICO SCI, V23, P107, DOI DOI 10.18785/G0MS.2301.08; Wada Y, 1998, FEBS LETT, V424, P53, DOI 10.1016/S0014-5793(98)00138-0; Watari R, 2012, J BIOL CHEM, V287, P42634, DOI 10.1074/jbc.M112.395731; Yasuo S, 2008, EUR J NEUROSCI, V28, P2443, DOI 10.1111/j.1460-9568.2008.06541.x; Yoshikawa T, 1998, FEBS LETT, V424, P69, DOI 10.1016/S0014-5793(98)00139-2; Yoshimura T, 2006, COMP BIOCHEM PHYS A, V144, P345, DOI 10.1016/j.cbpa.2005.09.009; Zantke J, 2013, CELL REP, V5, P99, DOI 10.1016/j.celrep.2013.08.031	27	12	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109119	10.1371/journal.pone.0109119	http://dx.doi.org/10.1371/journal.pone.0109119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272159	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600099
J	Urgoiti, GBR; Gustafson, K; Klimowicz, AC; Petrillo, SK; Magliocco, AM; Doll, CM				Urgoiti, Gloria B. Roldan; Gustafson, Karla; Klimowicz, Alexander C.; Petrillo, Stephanie K.; Magliocco, Anthony M.; Doll, Corinne M.			The Prognostic Value of HPV Status and p16 Expression in Patients with Carcinoma of the Anal Canal	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; SURVIVAL; BIOMARKERS; INFECTION; HEAD; P16(INK4A); GENOTYPES; DISEASE; CANCERS; IMPACT	Background: In anal cancer studies, the detection frequency of high-risk HPV (human papillomavirus) is variable, depending on the method used. There are limited data reporting results of different HPV detection techniques in the same clinical series, and very few correlating results with clinical outcome. Objectives: To evaluate tumor expression of p16/HPV16 using three different methods, and to determine their association with clinical outcome in patients with anal canal squamous cell carcinomas (SCC). Design: This retrospective study included patients with anal canal SCC treated with definitive radiotherapy or chemoradiotherapy at a single institution between 1992 and 2005. Formalin-fixed paraffin-embedded tumor samples from 53 of the 89 (60%) patient pre-treatment biopsies were adequate for tissue microarray construction. HPV status was determined using: p16 expression by conventional immunohistochemistry (IHC) and quantitative IHC (AQUA), HPV genotype analysis by chromogenic in situ hybridization (CISH) and HPV linear array sub-typing. Expression status was correlated with clinical outcome. Results: 80% (28/35) of patient tumors had high p16 expression using conventional IHC. HPV16 CISH was positive in 81% (34/42) of tumors, and 78% (28/36) of tumors were HPV subtype 16. HPV16 CISH correlated with p16 evaluated by conventional IHC (correlation coefficient 0.46; p = 0.01) and by p16 AQUA score (correlation coefficient 0.49; p = 0.001). A subset of cases (15%) had very high p16 quantitative IHC scores (>244) and were associated with a higher incidence of local or distant recurrence (p = 0.04). Conclusions: The vast majority (80%) of anal canal SCC in our series were positive for HPV16/p16, regardless of the testing method used. The exploratory analysis of automated quantitative IHC scoring was the only technique to define a subset of patients with a worse prognosis by p16 expression status on univariate analysis. Further exploration of the molecular mechanisms of treatment resistance in association with very high p16 expression is warranted.	[Urgoiti, Gloria B. Roldan; Doll, Corinne M.] Univ Calgary, Dept Med & Oncol, Calgary, AB, Canada; [Gustafson, Karla; Klimowicz, Alexander C.; Petrillo, Stephanie K.] Tom Baker Canc Clin, Dept Oncol, Calgary, AB, Canada; [Magliocco, Anthony M.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Anat Pathol, Tampa, FL 33682 USA	University of Calgary; Tom Baker Cancer Clinic; University of Calgary; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Doll, CM (corresponding author), Univ Calgary, Dept Med & Oncol, Calgary, AB, Canada.	Corinne.Doll@albertahealthservices.ca			Alberta Cancer Foundation (ACF); ACF "Underwear Affair''	Alberta Cancer Foundation (ACF); ACF "Underwear Affair''	This project was supported by the Alberta Cancer Foundation (ACF), and the ACF "Underwear Affair''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 2010, DIGEST DIS SCI, V55, P1098, DOI 10.1007/s10620-009-0812-6; Arnott SJ, 1996, LANCET, V348, P1049; Berois N, 2013, INT J GYNECOL CANCER, V23, P527, DOI 10.1097/IGC.0b013e318285e753; Brambilla E, 1999, J PATHOL, V188, P351, DOI 10.1002/(SICI)1096-9896(199908)188:4<351::AID-PATH385>3.0.CO;2-W; Bruland O, 2008, BRIT J CANCER, V98, P1264, DOI 10.1038/sj.bjc.6604285; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Chaturvedi AK, 2010, J ADOLESCENT HEALTH, V46, pS20, DOI 10.1016/j.jadohealth.2010.01.016; Cuzick J, 2013, BRIT J CANCER, V108, P908, DOI 10.1038/bjc.2013.22; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Frisch M, 1999, CANCER RES, V59, P753; Giltnane JM, 2004, NAT CLIN PRACT ONCOL, V1, P104, DOI 10.1038/ncponc0046; Gunderson LL, 2013, INT J RADIAT ONCOL, V87, P638, DOI 10.1016/j.ijrobp.2013.07.035; Jordan RC, 2012, AM J SURG PATHOL, V36, P945, DOI 10.1097/PAS.0b013e318253a2d1; Keating JT, 2001, ADV ANAT PATHOL, V8, P83, DOI 10.1097/00125480-200103000-00004; Lu DW, 2003, MODERN PATHOL, V16, P692, DOI 10.1097/01.MP.0000077417.08371.CE; O'Rorke MA, 2012, ORAL ONCOL, V48, P1191, DOI 10.1016/j.oraloncology.2012.06.019; Ramamoorthy S, 2010, INFECT AGENT CANC, V5; Salit IE, 2009, CANCER EPIDEM BIOMAR, V18, P1986, DOI 10.1158/1055-9965.EPI-08-1141; Sano T, 2002, PATHOL INT, V52, P375, DOI 10.1046/j.1440-1827.2002.01359.x; Shukla S, 2009, INDIAN J MED RES, V130, P222; Sias C, 2013, APMIS, V121, P1054, DOI 10.1111/apm.12054; Valmary-Degano S, 2013, HUM PATHOL, V44, P992, DOI 10.1016/j.humpath.2012.08.019; Varnai AD, 2006, INT J COLORECTAL DIS, V21, P135, DOI 10.1007/s00384-005-0777-7; Wong AK, 2008, J CLIN MICROBIOL, V46, P869, DOI 10.1128/JCM.01424-07; Yhim HY, 2011, INT J CANCER, V129, P1752, DOI 10.1002/ijc.25825; Young RJ, 2011, CANCER EPIDEM BIOMAR, V20, P1230, DOI 10.1158/1055-9965.EPI-10-1262	26	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108790	10.1371/journal.pone.0108790	http://dx.doi.org/10.1371/journal.pone.0108790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271758	Green Submitted, Green Published, gold			2022-12-27	WOS:000343729600062
J	Zhang, Q; An, SL; Chen, ZY; Fu, FH; Jiang, B; Zhi, FC; Bai, Y; Gong, W				Zhang, Qiang; An, Sheng Li; Chen, Zhen Yu; Fu, Feng-Hua; Jiang, Bo; Zhi, Fa Chao; Bai, Yang; Gong, Wei			Assessment of Risk Factors for Delayed Colonic Post-Polypectomy Hemorrhage: A Study of 15553 Polypectomies from 2005 to 2013	PLOS ONE			English	Article							COLONOSCOPIC POLYPECTOMY; POSTPOLYPECTOMY; COMPLICATIONS; MULTICENTER; ASPIRIN	Background and Aim: Delayed colonic postpolypectomy bleeding is the commonest serious complication after polypectomy. This study aimed to utilize massive sampling data of polypectomy to analyze risk factors for delayed postpolypectomy bleeding. Patients and Methods: The endoscopic data of 5600 patients with 15553 polyps removed (2005 to 2013) were analyzed retrospectively through univariate analysis and multiple logistic regression analysis to evaluate the risk factors for delayed bleeding. Results: Delayed postpolypectomy bleeding occurred in 99 polyps (0.6%). The rates of bleeding for different polypectomy methods including hot biopsy forcep, biopsy forcep, Argon Plasma Coagulation (APC), Endoscopy piecemeal mucosal resection (EPMR), Endoscopic Mucosal Resection (EMR), and snare polypectomy were 0.1%, 0.0%, 0.0%, 6.9%, 0.9% and 1.0%, respectively. The risk factors for delayed bleeding were the size of polyps over 10 mm (odds ratio [OR] = 4.6, 95% CI, 2.9-7.2), pathology of colonic polyps (inflammatory/hyperplastic, OR = 1; adenomatous, OR = 1.4, 95% CI, 0.7-2.6; serrated, OR = 1.5, 95% CI, 0.2-11.9; juvenile, OR = 4.3, 95% CI, 1.8-11.0; Peutz-Jegher, OR = 3.3, 95% CI, 1.0-10.7), and immediate postpolypectomy bleeding (OR = 2.9, 95% CI, 1.4-5.9). In addition, although polypectomy method was not a risk factor, compared with hot biopsy forcep, snare polypectomy, EMR, and EPMR had increased risks of delayed bleeding, with ORs of 3.2 (0.4-23.3), 2.8 (0.4-21.7) and 5.1 (0.5-47.7), respectively. Conclusion: Polyp size over 10 mm, pathology of colonic polyps (especially juvenile, Peutz-Jegher), and immediate postpolypectomy bleeding were significant risk factors for delayed postpolypectomy bleeding.	[Zhang, Qiang; Chen, Zhen Yu; Fu, Feng-Hua; Jiang, Bo; Zhi, Fa Chao; Bai, Yang; Gong, Wei] Southen Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China; [An, Sheng Li] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Biostat, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Gong, W (corresponding author), Southen Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China.	179346561@qq.com						BINMOELLER KF, 1993, ENDOSCOPY, V25, P167, DOI 10.1055/s-2007-1010277; Buddingh KT, 2011, AM J GASTROENTEROL, V106, P1119, DOI 10.1038/ajg.2010.507; Consolo P, 2008, WORLD J GASTROENTERO, V14, P2364, DOI 10.3748/wjg.14.2364; Dafnis G, 2001, GASTROINTEST ENDOSC, V54, P302, DOI 10.1067/mge.2001.117545; Dominitz JA, 2003, GASTROINTEST ENDOSC, V57, P441; Hachisu T, 1988, Surg Endosc, V2, P13, DOI 10.1007/BF00591392; Hong SP, 2012, CLIN ENDOSC, V45, P282, DOI 10.5946/ce.2012.45.3.282; Hui AJ, 2004, GASTROINTEST ENDOSC, V59, P44, DOI 10.1016/S0016-5107(03)02307-1; Kim HS, 2006, AM J GASTROENTEROL, V101, P1333, DOI 10.1111/j.1572-0241.2006.00638.x; Kim JH, 2013, J GASTROEN HEPATOL, V28, P645, DOI 10.1111/jgh.12132; Luigiano C, 2010, DIGEST DIS SCI, V55, P1726, DOI 10.1007/s10620-009-0905-2; MACRAE FA, 1983, GUT, V24, P376, DOI 10.1136/gut.24.5.376; Parra-Blanco A, 2000, GASTROINTEST ENDOSC, V51, P37, DOI 10.1016/S0016-5107(00)70384-1; Rathgaber SW, 2006, GASTROINTEST ENDOSC, V64, P556, DOI 10.1016/j.gie.2006.03.014; REX DK, 1992, GASTROINTEST ENDOSC, V38, P127, DOI 10.1016/S0016-5107(92)70376-9; Sawhney MS, 2008, ENDOSCOPY, V40, P115, DOI 10.1055/s-2007-966959; SHIFFMAN ML, 1994, GASTROINTEST ENDOSC, V40, P458, DOI 10.1016/S0016-5107(94)70210-1; Shioji K, 2003, GASTROINTEST ENDOSC, V57, P691, DOI 10.1067/mge.2003.193; SINGARAM C, 1995, AM J GASTROENTEROL, V90, P146; Sorbi D, 2000, GASTROINTEST ENDOSC, V51, P690, DOI 10.1067/mge.2000.105773; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316; Watabe H, 2006, GASTROINTEST ENDOSC, V64, P73, DOI 10.1016/j.gie.2006.02.054; Yousfi M, 2004, AM J GASTROENTEROL, V99, P1785, DOI 10.1111/j.1572-0241.2004.30368.x	23	47	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108290	10.1371/journal.pone.0108290	http://dx.doi.org/10.1371/journal.pone.0108290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271734	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600038
J	Besseris, GJ				Besseris, George J.			A Fast-and-Robust Profiler for Improving Polymerase Chain Reaction Diagnostics	PLOS ONE			English	Article							PCR; DNA; OPTIMIZATION; TIME; DESIGN; AMPLIFICATION; POWER	Polymerase chain reaction (PCR) is an in vitro technology in molecular genetics that progressively amplifies minimal copies of short DNA sequences in a fast and inexpensive manner. However, PCR performance is sensitive to suboptimal processing conditions. Compromised PCR conditions lead to artifacts and bias that downgrade the discriminatory power and reproducibility of the results. Promising attempts to resolve the PCR performance optimization issue have been guided by quality improvement tactics adopted in the past for industrial trials. Thus, orthogonal arrays (OAs) have been employed to program quick-and-easy structured experiments. Profiling of influences facilitates the quantification of effects that may counteract the detectability of amplified DNA fragments. Nevertheless, the attractive feature of reducing greatly the amount of work and expenditures by planning trials with saturated-unreplicated OA schemes is known to be relinquished in the subsequent analysis phase. This is because of an inherent incompatibility of ordinary multi-factorial comparison techniques to convert small yet dense datasets. Treating unreplicated-saturated data with either the analysis of variance (ANOVA) or regression models destroys the information extraction process. Both of those mentioned approaches are rendered blind to error since the examined effects absorb all available degrees of freedom. Therefore, in lack of approximating an experimental uncertainty, any outcome interpretation is rendered subjective. We propose a profiling method that permits the non-linear maximization of amplicon resolution by eliminating the necessity for direct error estimation. Our approach is distribution-free, calibration-free, simulation-free and sparsity-free with well-known power properties. It is also user-friendly by promoting rudimentary analytics. Testing our method on published amplicon count data, we found that the preponderant effect is the concentration of MgCl2 (p < 0.05) followed by the primer content (p < 0.1) whilst the effects due to either the content of the deoxynucleotide (dNTP) or DNA remained dormant (p > 0.1). Comparison of the proposed method with other stochastic approaches is also discussed. Our technique is expected to have extensive applications in genetics and biotechnology where there is a demand for cheap, expedient, and robust information.	City Univ Seattle, Technol Management Dept, Bellevue, WA 98005 USA	Seattle University	Besseris, GJ (corresponding author), City Univ Seattle, Technol Management Dept, Bellevue, WA 98005 USA.	besseris@cityu.edu						Asiello PJ, 2011, LAB CHIP, V11, P1420, DOI 10.1039/c0lc00666a; Baker M, 2010, NAT METHODS, V7, P351, DOI 10.1038/nmeth0510-351; Ballantyne KN, 2008, FORENS SCI INT-GEN S, V1, P7, DOI 10.1016/j.fsigss.2007.10.050; Benes V, 2010, METHODS, V50, P244, DOI 10.1016/j.ymeth.2010.01.026; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Besseris GJ, 2010, INT J QUAL RELIAB MA, V27, P893, DOI 10.1108/02656711011075107; Besseris GJ, 2012, CHEMOMETR INTELL LAB, V116, P47, DOI 10.1016/j.chemolab.2012.04.009; Bonetta L, 2005, NAT METHODS, V2, P305, DOI 10.1038/nmeth0405-305; BOX G.E.P., 2005, STAT EXPT DESIGN INN; Byrne A., 2012, LEAN TURNAROUND BUSI; Caetano-Anolles G, 1998, BIOTECHNIQUES, V25, P472, DOI 10.2144/98253rr03; Carr AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037640; de Souza HJC, 2011, MOL CELL PROBE, V25, P231, DOI 10.1016/j.mcp.2011.08.001; COBB BD, 1994, NUCLEIC ACIDS RES, V22, P3801, DOI 10.1093/nar/22.18.3801; Dabrowski W, 2003, FEMS MICROBIOL LETT, V218, P51, DOI 10.1016/S0378-1097(02)01183-7; Demeke T, 2010, ANAL BIOANAL CHEM, V396, P1977, DOI 10.1007/s00216-009-3150-9; Egger G, 2012, EXPERT REV MOL DIAGN, V12, P75, DOI 10.1586/ERM.11.90; FURRER B, 1990, NATURE, V346, P324, DOI 10.1038/346324b0; Hedman Johannes, 2013, Methods Mol Biol, V943, P17, DOI 10.1007/978-1-60327-353-4_2; Hoaglin D. C, 2000, UNDERSTANDING ROBUST; Ilzarbe L, 2008, QUAL RELIAB ENG INT, V24, P417, DOI 10.1002/qre.909; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Kim J, 2011, BIOANALYSIS, V3, P227, DOI 10.4155/BIO.10.172; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Mahoney M, 1996, BIOMETRICAL J, V38, P613, DOI 10.1002/bimj.4710380510; Mann K, 2012, PRENATAL DIAG, V32, P309, DOI 10.1002/pd.2945; Maronna R.A., 2006, ROBUST STAT; Marx V, 2013, NAT METHODS, V10, P391, DOI 10.1038/nmeth.2443; MOORE P, 2005, NATURE, V435, P235; Niens M, 2005, BIOTECHNOL APPL BIOC, V42, P157, DOI 10.1042/BA20040192; Nong RY, 2012, EXPERT REV PROTEOMIC, V9, P21, DOI [10.1586/epr.11.78, 10.1586/EPR.11.78]; PAABO S, 1988, NATURE, V334, P387, DOI 10.1038/334387b0; Pavlov AR, 2004, TRENDS BIOTECHNOL, V22, P253, DOI 10.1016/j.tibtech.2004.02.011; Pearson R.K., 2005, MINING IMPERFECT DAT, DOI DOI 10.1137/1.9780898717884; Peccoud J, 1996, BIOPHYS J, V71, P101, DOI 10.1016/S0006-3495(96)79205-6; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ramakrishna US, 2013, FEMS MICROBIOL LETT, V340, P93, DOI 10.1111/1574-6968.12070; Rao Ravella Sreenivas, 2008, Biotechnology Journal, V3, P510, DOI 10.1002/biot.200700201; Rebrikov DV, 2006, APPL BIOCHEM MICRO+, V42, P455, DOI 10.1134/S0003683806050024; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Taguchi G., 2000, ROBUST ENG LEARN BOO; Tanco M, 2009, APPL STOCH MODEL BUS, V25, P478, DOI 10.1002/asmb.779; Thanakiatkrai P, 2012, INT J LEGAL MED, V126, P161, DOI 10.1007/s00414-011-0558-5; Voehl F., 2013, LEAN 6 SIGMA BLACK B; Wang X, 2012, BIOTECHNOL BIOENG, V109, P307, DOI 10.1002/bit.23343; Ye KQ, 2000, J QUAL TECHNOL, V32, P57	48	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108973	10.1371/journal.pone.0108973	http://dx.doi.org/10.1371/journal.pone.0108973			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25269015	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700207
J	Ge, JP; Zhao, JW; Zhang, LY; Zhang, MY; Ping, WX				Ge, Jingping; Zhao, Jingwen; Zhang, Luyan; Zhang, Mengyun; Ping, Wenxiang			Construction and Analysis of High-Ethanol-Producing Fusants with Co-Fermentation Ability through Protoplast Fusion and Double Labeling Technology	PLOS ONE			English	Article							RECOMBINANT SACCHAROMYCES-CEREVISIAE; XYLOSE	Double labeling of resistance markers and report genes can be used to breed engineered Saccharomyces cerevisiae strains that can assimilate xylose and glucose as a mixed carbon source for ethanol fermentation and increased ethanol production. In this study Saccharomyces cerevisiae W5 and Candida shehatae 20335 were used as parent strains to conduct protoplast fusion and the resulting fusants were screened by double labeling. High performance liquid chromatography (HPLC) was used to assess the ethanol yield following the fermentation of xylose and glucose, as both single and mixed carbon sources, by the fusants. Interestingly, one fusant (ZLYRHZ7) was demonstrated to have an excellent fermentation performance, with an ethanol yield using the mixed carbon source of 0.424 g g(-1), which compares with 0.240 g g(-1) (W5) and 0.353 g g(-1) (20335) for the parent strains. This indicates an improvement in the ethanol yield of 43.4% and 16.7%, respectively.	[Ge, Jingping; Zhao, Jingwen; Zhang, Luyan; Zhang, Mengyun; Ping, Wenxiang] Heilongjiang Univ, Coll Life Sci, Key Lab Microbiol, Harbin, Peoples R China	Heilongjiang University	Ping, WX (corresponding author), Heilongjiang Univ, Coll Life Sci, Key Lab Microbiol, Harbin, Peoples R China.	wenxiangp@aliyun.com			Educational Commission of Heilongjiang Province of China [11551z011]; National Natural Science Foundation of China [31270534, 31270143]; National Science Foundation for Distinguished Young Scholars of China [31300355]; High-level Talents (Innovation Team) Projects of Heilongjiang University of China [Hdtd 2010-17]; Science and Technology Innovation Team Construction Project of Heilongjiang Province [2012td009]; Key project of science and technology of Heilongjiang Province [GB09C302]	Educational Commission of Heilongjiang Province of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); High-level Talents (Innovation Team) Projects of Heilongjiang University of China; Science and Technology Innovation Team Construction Project of Heilongjiang Province; Key project of science and technology of Heilongjiang Province	The research was supported by grants from Educational Commission of Heilongjiang Province of China (11551z011), the National Natural Science Foundation of China (No. 31270534), the National Natural Science Foundation of China (No. 31270143), and National Science Foundation for Distinguished Young Scholars of China (31300355), the High-level Talents (Innovation Team) Projects of Heilongjiang University of China (No. Hdtd 2010-17), the Science and Technology Innovation Team Construction Project of Heilongjiang Province (2012td009), and Key project of science and technology of Heilongjiang Province (GB09C302). The funders had a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JieNan, 2007, Scientia Silvae Sinicae, V43, P99; Chen LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084853; Choi GW, 2010, BIOMASS BIOENERG, V34, P1232, DOI 10.1016/j.biombioe.2010.03.018; Coyle W., 2007, Amber Waves, V5, P24; [冯玉杰 Feng Yujie], 2007, [太阳能学报, Acta Energiae Solaris Sinica], V28, P375; Ge JP, 2011, AFR J MICROBIOL RES, V5, P1163; Ge JingPing, 2012, African Journal of Biotechnology, V11, P16772; Ge JP, 2012, J IND MICROBIOL BIOT, V39, P777, DOI 10.1007/s10295-011-1076-7; Grotkjaer T, 2005, METAB ENG, V7, P437, DOI 10.1016/j.ymben.2005.07.003; Hou X, 2012, APPL MICROBIOL BIOT, V94, P205, DOI 10.1007/s00253-011-3694-4; Hou XR, 2012, APPL MICROBIOL BIOT, V93, P2591, DOI 10.1007/s00253-011-3693-5; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jeffries TW, 2006, CURR OPIN BIOTECH, V17, P320, DOI 10.1016/j.copbio.2006.05.008; Lee SH, 2012, J BIOTECHNOL, V158, P184, DOI 10.1016/j.jbiotec.2011.06.005; Li FF, 2010, BIOTECHNOLOGY B, V6, P212; Nakazawa N, 2004, J BIOSCI BIOENG, V98, P353, DOI 10.1016/S1389-1723(04)00295-6; Sanchez OJ, 2008, BIORESOURCE TECHNOL, V99, P5270, DOI 10.1016/j.biortech.2007.11.013; Sukumaran RK, 2010, BIORESOURCE TECHNOL, V101, P4826, DOI 10.1016/j.biortech.2009.11.049; [孙红兵 Sun Hongbing], 2010, [微生物学杂志, Journal of Mirobiology], V30, P68; Wang PM, 2012, BIORESOURCE TECHNOL, V108, P203, DOI 10.1016/j.biortech.2011.12.147; Wang YH, 2007, J BIOTECHNOL, V129, P510, DOI 10.1016/j.jbiotec.2007.01.011; Winkler AA, 2007, ADV BIOCHEM ENG BIOT, V10, P57, DOI DOI 10.1007/10_; Zhang M, 2009, RENEWABLE ENERGY RES, V27, P52; Zhang XX, 2009, BIORESOURCE TECHNOL, V100, P1910, DOI 10.1016/j.biortech.2008.10.012	24	4	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108311	10.1371/journal.pone.0108311	http://dx.doi.org/10.1371/journal.pone.0108311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268957	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700076
J	Canepa, MJ; Ortega, NM; Monteleone, MC; Mucci, N; Kaiser, GG; Brocco, M; Mutto, A				Jesus Canepa, Maria; Matias Ortega, Nicolas; Carolina Monteleone, Melisa; Mucci, Nicolas; Gustavo Kaiser, German; Brocco, Marcela; Mutto, Adrian			Expression Profile of Genes as Indicators of Developmental Competence and Quality of In Vitro Fertilization and Somatic Cell Nuclear Transfer Bovine Embryos	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; HEAT-SHOCK; BLASTOCYST DEVELOPMENT; CULTURE-CONDITIONS; INDUCED APOPTOSIS; SERUM; STAGE; CRYOTOLERANCE; PATTERN; SYSTEM	Reproductive biotechnologies such as in vitro fertilization (IVF) and somatic cell nuclear transfer (SCNT) enable improved reproductive efficiency of animals. However, the birth rate of in vitro-derived embryos still lags behind that of their in vivo counterparts. Thus, it is critical to develop an accurate evaluation and prediction system of embryo competence, both for commercial purposes and for scientific research. Previous works have demonstrated that in vitro culture systems induce alterations in the relative abundance (RA) of diverse transcripts and thus compromise embryo quality. The aim of this work was to analyze the RA of a set of genes involved in cellular stress (heat shock protein 70-kDa, HSP70), endoplasmic reticulum (ER) stress (immunoglobulin heavy chain binding protein, Bip; proteasome subunit beta 5, PSMB5) and apoptosis (BCL-2 associated X protein, Bax; cysteine aspartate protease-3, Caspase-3) in bovine blastocysts produced by IVF or SCNT and compare it with that of their in vivo counterparts. Poly (A) (+) mRNA was isolated from three pools of 10 blastocysts per treatment and analyzed by real-time RT-PCR. The RA of three of the stress indicators analyzed (Bax, PSMB5 and Bip) was significantly increased in SCNT embryos as compared with that of in vivo-derived blastocysts. No significant differences were found in the RA of HSP70 and Caspase-3 gene transcripts. This study could potentially complement morphological analyses in the development of an effective and accurate technique for the diagnosis of embryo quality, ultimately aiding to improve the efficiency of assisted reproductive techniques (ART).	[Jesus Canepa, Maria; Matias Ortega, Nicolas; Carolina Monteleone, Melisa; Brocco, Marcela; Mutto, Adrian] Univ Nacl San Martin, Inst Invest Biotecnol, Lab Biotecnol Reprod & Mejoramiento Genet Anim, Gen San Martin, Buenos Aires, Argentina; [Mucci, Nicolas; Gustavo Kaiser, German] INTA Balcarce, Inst Nacl Tecnol Agr, Lab Biotecnol & Reprod, San Martin, Buenos Aires, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA)	Mutto, A (corresponding author), Univ Nacl San Martin, Inst Invest Biotecnol, Lab Biotecnol Reprod & Mejoramiento Genet Anim, Gen San Martin, Buenos Aires, Argentina.	aamutto@gmail.com		Mutto, Adrian/0000-0002-6887-7082; Monteleone, Melisa Carolina/0000-0002-6282-4019	Universidad Nacional de San Martin [002/2011]	Universidad Nacional de San Martin	Funding support by grant of Universidad Nacional de San Martin, number 002/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo-Garcia R., 2001, Theriogenology, V55, P409; Badr H, 2007, ZYGOTE, V15, P355, DOI 10.1017/S0967199407004315; Baldassarre H, 2004, CLONING STEM CELLS, V6, P25, DOI 10.1089/15362300460743808; Beyhan Z, 2007, MOL REPROD DEV, V74, P18, DOI 10.1002/mrd.20618; Brocco M, 2003, J NEUROSCI RES, V74, P744, DOI 10.1002/jnr.10781; Corcoran D, 2005, REPROD BIOMED ONLINE, V11, P340, DOI 10.1016/S1472-6483(10)60842-5; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Eckert J, 1998, MOL HUM REPROD, V4, P957, DOI 10.1093/molehr/4.10.957; Fear JM, 2011, BIOL REPROD, V84, P43, DOI 10.1095/biolreprod.110.086249; Feugang JM, 2004, THERIOGENOLOGY, V61, P71, DOI 10.1016/S0093-691X(03)00191-2; Gething MJ, 1999, SEMINARS CELL DEV BI, V10; Gutierrez-Adan A, 2004, MOL REPROD DEV, V68, P441, DOI 10.1002/mrd.20113; Jousan FD, 2008, J REPROD DEV, V54; Krininger CE, 2002, MOL REPROD DEV, V63, P335, DOI 10.1002/mrd.90017; Lazzari G, 2002, BIOL REPROD, V67, P767, DOI 10.1095/biolreprod.102.004481; Lee KF, 2001, BIOL REPROD, V64, P910, DOI 10.1095/biolreprod64.3.910; Lequarre AS, 2001, MOL REPROD DEV, V58, P45, DOI 10.1002/1098-2795(200101)58:1&lt;45::AID-MRD7&gt;3.0.CO;2-J; Lonergan P., 2003, Theriogenology, V59, P493; Lonergan P, 2003, REPROD DOMEST ANIM, V38, P259, DOI 10.1046/j.1439-0531.2003.00437.x; Lonergan P, 2003, BIOL REPROD, V69, P1424, DOI 10.1095/biolreprod.103.018168; Melka MG, 2010, REPROD DOMEST ANIM, V45, P915, DOI 10.1111/j.1439-0531.2009.01463.x; Minami N, 2001, BIOL REPROD, V64, P30, DOI 10.1095/biolreprod64.1.30; Mucci N, 2006, THERIOGENOLOGY, V65, P1551, DOI 10.1016/j.theriogenology.2005.08.020; Niemann H., 2002, Cloning and Stem Cells, V4, P29, DOI 10.1089/153623002753632020; Niemann H, 2000, THERIOGENOLOGY, V53, P21, DOI 10.1016/S0093-691X(99)00237-X; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Paula-Lopes FF, 2002, BIOCHEM BIOPH RES CO, V295, P37, DOI 10.1016/S0006-291X(02)00619-8; Paula-Lopes FF, 2002, BIOL REPROD, V66, P1169, DOI 10.1093/biolreprod/66.4.1169; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Rief S, 2002, REPRODUCTION, V124, P543, DOI 10.1530/rep.0.1240543; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Rizos D, 2003, BIOL REPROD, V68, P236, DOI 10.1095/biolreprod.102.007799; Rizos D, 2002, BIOL REPROD, V66, P589, DOI 10.1095/biolreprod66.3.589; Robert C, 2002, BIOL REPROD, V67, P1456, DOI 10.1095/biolreprod.102.002147; Smith SL, 2009, MOL REPROD DEV, V76, P38, DOI 10.1002/mrd.20927; Smith SL, 2005, P NATL ACAD SCI USA, V102, P17582, DOI 10.1073/pnas.0508952102; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Takayama S, 2003, ONCOGENE, V22, P9041, DOI 10.1038/sj.onc.1207114; Vandaele L, 2008, ANIM REPROD SCI, V106, P168, DOI 10.1016/j.anireprosci.2007.12.016; Wrenzycki C, 2001, HUM REPROD, V16, P893, DOI 10.1093/humrep/16.5.893; Wrenzycki C, 2004, ANIM REPROD SCI, V82-3, P593, DOI 10.1016/j.anireprosci.2004.05.009; Wrenzycki C, 2007, THERIOGENOLOGY, V68, pS77, DOI 10.1016/j.theriogenology.2007.04.028; Wrenzycki C, 1999, MOL REPROD DEV, V53, P8, DOI 10.1002/(SICI)1098-2795(199905)53:1&lt;8::AID-MRD2&gt;3.0.CO;2-K; Yang MY, 1999, THERIOGENOLOGY, V51, P336, DOI 10.1016/S0093-691X(99)91895-2	44	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108139	10.1371/journal.pone.0108139	http://dx.doi.org/10.1371/journal.pone.0108139			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25269019	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700067
J	Dunham, CM; Hoffman, DA; Huang, GS; Omert, LA; Gemmel, DJ; Merrell, R				Dunham, C. Michael; Hoffman, David A.; Huang, Gregory S.; Omert, Laurel A.; Gemmel, David J.; Merrell, Renee			Traumatic Intracranial Hemorrhage Correlates with Preinjury Brain Atrophy, but Not with Antithrombotic Agent Use: A Retrospective Study	PLOS ONE			English	Article							BLUNT HEAD TRAUMA; LOW-DOSE ASPIRIN; WARFARIN USE; ANTIPLATELET AGENTS; PREOPERATIVE ASPIRIN; CORONARY-ANGIOGRAPHY; ATRIAL-FIBRILLATION; CEREBRAL ATROPHY; PATIENTS OLDER; INJURY	Background: The impact of antithrombotic agents (warfarin, clopidogrel, ASA) on traumatic brain injury outcomes is highly controversial. Although cerebral atrophy is speculated as a risk for acute intracranial hemorrhage, there is no objective literature evidence. Materials and Methods: This is a retrospective, consecutive investigation of patients with signs of external head trauma and age >= 60 years. Outcomes were correlated with antithrombotic-agent status, coagulation test results, admission neurologic function, and CT-based cerebral atrophy dimensions. Results: Of 198 consecutive patients, 36% were antithrombotic-negative and 64% antithrombotic-positive. ASA patients had higher arachidonic acid inhibition (p = 0.04) and warfarin patients had higher INR (p < 0.001), compared to antithrombotic-negative patients. Antithrombotic-positive intracranial hemorrhage rate (38.9%) was similar to the antithrombotic-negative rate (31.9%; p = 0.3285). Coagulopathy was not present on the ten standard coagulation, thromboelastography, and platelet mapping tests with intracranial hemorrhage and results were similar to those without hemorrhage (p >= 0.1354). Hemorrhagic-neurologic complication (intracranial hemorrhage progression, need for craniotomy, neurologic deterioration, or death) rates were similar for antithrombotic-negative (6.9%) and antithrombotic-positive (8.7%; p = 0.6574) patients. The hemorrhagic-neurologic complication rate was increased when admission major neurologic dysfunction was present (63.2% versus 2.2%; RR = 28.3; p < 0.001). Age correlated inversely with brain parenchymal width (p < 0.001) and positively with lateral ventricular width (p = 0.047) and cortical atrophy (p < 0.001). Intracranial hemorrhage correlated with cortical atrophy (p < 0.001) and ventricular width (p < 0.001). Conclusions: Intracranial hemorrhage is not associated with antithrombotic agent use. Intracranial hemorrhage patients have no demonstrable coagulopathy. The association of preinjury brain atrophy with acute intracranial hemorrhage is a novel finding. Contrary to antithrombotic agent status, admission neurologic abnormality is a predictor of adverse post-admission outcomes. Study findings indicate that effective hemostasis is maintained with antithrombotic therapy.	[Dunham, C. Michael; Huang, Gregory S.; Merrell, Renee] St Elizabeth Hlth Ctr, Trauma Crit Care Serv, Youngstown, OH 44501 USA; [Hoffman, David A.] St Elizabeth Hlth Ctr, Div Cardiol, Youngstown, OH USA; [Omert, Laurel A.] CSL Behring, King Of Prussia, PA USA; [Gemmel, David J.] St Elizabeth Hlth Ctr, Youngstown, OH USA	CSL	Dunham, CM (corresponding author), St Elizabeth Hlth Ctr, Trauma Crit Care Serv, Youngstown, OH 44501 USA.	dunham.michael@sbcglobal.net		Huang, Gregory/0000-0001-6355-6012; Dunham, C. Michael/0000-0002-7842-9750				Ahmed N, 2009, SOUTH MED J, V102, P476, DOI 10.1097/SMJ.0b013e31819f97a3; Akdogan I, 2010, FOLIA MORPHOL, V69, P193; Alghamdi AA, 2007, J CARDIAC SURG, V22, P247, DOI 10.1111/j.1540-8191.2007.00402.x; Annala AP, 2008, AM J CARDIOL, V102, P386, DOI 10.1016/j.amjcard.2008.04.003; Batchelor JS, 2013, BRIT J NEUROSURG, V27, P12, DOI 10.3109/02688697.2012.705361; Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Birnie DH, 2013, NEW ENGL J MED, V368, P2084, DOI 10.1056/NEJMoa1302946; Bonville DJ, 2011, SURGERY, V150, P861, DOI 10.1016/j.surg.2011.07.070; Burger W, 2005, J INTERN MED, V257, P399, DOI 10.1111/j.1365-2796.2005.01477.x; DIETRICH W, 1995, J CARDIOTHOR VASC AN, V9, P250, DOI 10.1016/S1053-0770(05)80316-7; DOHERTY DL, 1988, ARCH PHYS MED REHAB, V69, P542; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Downey DM, 2009, AM SURGEON, V75, P1100; El-Jack SS, 2006, AM J CARDIOL, V97, P485, DOI 10.1016/j.amjcard.2005.09.079; ELLIS G L, 1990, Emergency Medicine Clinics of North America, V8, P281; Fjell AM, 2013, J NEUROSCI, V33, P8237, DOI 10.1523/JNEUROSCI.5506-12.2013; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Furie KL, 2012, STROKE, V43, P3442, DOI 10.1161/STR.0b013e318266722a; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Gage BF, 2005, AM J MED, V118, P612, DOI 10.1016/j.amjmed.2005.02.022; Gangavati AS, 2009, J AM GERIATR SOC, V57, P1470, DOI 10.1111/j.1532-5415.2009.02344.x; GUR RC, 1991, P NATL ACAD SCI USA, V88, P2845, DOI 10.1073/pnas.88.7.2845; Hanif S, 2009, Ir Med J, V102, P255; Holmes JF, 2006, AM J EMERG MED, V24, P167, DOI 10.1016/j.ajem.2005.08.009; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Jamula E, 2009, THROMB RES, V124, P292, DOI 10.1016/j.thromres.2009.01.007; Jennett B, 1981, MANAGEMENT HEAD INJU, P184; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Lippe CM, 2014, CATHETER CARDIOVASC; Manchikanti Laxmaiah, 2013, Pain Physician, V16, pSE261; Matsumae M, 1996, J NEUROSURG, V84, P982, DOI 10.3171/jns.1996.84.6.0982; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Nelson RS, 2008, AM J SURG, V196, P994, DOI 10.1016/j.amjsurg.2008.07.036; Nematullah A, 2009, J CAN DENT ASSOC, V75, P41; Onal IK, 2013, CLIN RES HEPATOL GAS, V37, P171, DOI 10.1016/j.clinre.2012.04.010; Ortel TL, 2012, BLOOD, V120, P4699, DOI 10.1182/blood-2012-05-423228; Otley CC, 2003, MAYO CLIN PROC, V78, P1392, DOI 10.4065/78.11.1392; Ott MM, 2010, J TRAUMA, V68, P560, DOI 10.1097/TA.0b013e3181ad6600; Pasquier F, 1996, EUR NEUROL, V36, P268, DOI 10.1159/000117270; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Poyry T, 2013, J HEAD TRAUMA REHAB, V28, P89, DOI 10.1097/HTR.0b013e318250eadd; Resnick SM, 2003, J NEUROSCI, V23, P3295; Richmond R, 2011, J TRAUMA, V71, pE8, DOI 10.1097/TA.0b013e3181fbaa46; RONTY H, 1993, EUR J CLIN INVEST, V23, P182, DOI 10.1111/j.1365-2362.1993.tb00759.x; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; Sun JCJ, 2008, EUR HEART J, V29, P1057, DOI 10.1093/eurheartj/ehn104; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wallace DL, 2004, J HAND SURG-BRIT EUR, V29B, P203, DOI 10.1016/j.jhsb.2003.12.008; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414; Yelon J, 2013, TRAUMA, P874	56	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109473	10.1371/journal.pone.0109473	http://dx.doi.org/10.1371/journal.pone.0109473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279785	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800085
J	Kolodziejek, J; Marinov, M; Kiss, BJ; Alexe, V; Nowotny, N				Kolodziejek, Jolanta; Marinov, Mihai; Kiss, Botond J.; Alexe, Vasile; Nowotny, Norbert			The Complete Sequence of a West Nile Virus Lineage 2 Strain Detected in a Hyalomma marginatum marginatum Tick Collected from a Song Thrush (Turdus philomelos) in Eastern Romania in 2013 Revealed Closest Genetic Relationship to Strain Volgograd 2007	PLOS ONE			English	Article							MOSQUITO-BORNE FLAVIVIRUS; ENCEPHALITIS-VIRUS; MIGRATORY BIRDS; FEVER; INFECTION; IXODIDAE; REGION; ACARI; PATHOGENS; EPIDEMIC	In this study the first complete sequence of the West Nile virus (WNV) lineage 2 strain currently circulating in Romania was determined. The virus was detected in a Hyalomma marginatum marginatum tick collected from a juvenile song thrush (Turdus philomelos) in the Romanian Danube Delta close to the city of Tulcea, end of August 2013. Our finding emphasizes the role of ticks in introduction and maintenance of WNV infections. Sequence analyses revealed close genetic relationship of the Romanian WNV strain to strain Reb_Volgograd_07_H, which was isolated from human brain tissue during an outbreak of West Nile neuroinvasive disease (WNND) in Russia in 2007. In 2010 the Eastern European lineage 2 WNV caused an outbreak of human WNND in Romania. Partial sequences from subsequent years demonstrated that this WNV strain became endemic in Eastern Europe and has been causing outbreaks of varying sizes in southern Russia since 2007 and in Romania since 2010.	[Kolodziejek, Jolanta; Nowotny, Norbert] Univ Vet Med Vienna, Inst Virol, Viral Zoonoses Emerging & Vector Borne Infect Grp, Vienna, Austria; [Marinov, Mihai; Kiss, Botond J.; Alexe, Vasile] Danube Delta Natl Inst Res & Dev, Tulcea, Romania; [Nowotny, Norbert] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, Muscat, Oman	University of Veterinary Medicine Vienna; Sultan Qaboos University	Nowotny, N (corresponding author), Univ Vet Med Vienna, Inst Virol, Viral Zoonoses Emerging & Vector Borne Infect Grp, Vienna, Austria.	Norbert.Nowotny@vetmeduni.ac.at	Nowotny, Norbert/A-5474-2019	Nowotny, Norbert/0000-0002-3548-571X	European Union [FP7-261504 EDENext, FP7-261391 EuroWestNile]; European Commission	European Union(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was partially supported by the European Union grants FP7-261504 EDENext (www.edenext.eu) to JK, MM, BK, VA, and NN as well as FP7-261391 EuroWestNile (www.eurowestnile.org) to JK and NN. Funder of both grants: European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JF, 2003, J MED ENTOMOL, V40, P528, DOI 10.1603/0022-2585-40.4.528; Bagnarelli P, 2011, EURO SURVEILL, V16; Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005; Beati L, 2001, J PARASITOL, V87, P32, DOI 10.1645/0022-3395(2001)087[0032:AOTSRA]2.0.CO;2; Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097; Bursali A, 2011, J MED ENTOMOL, V48, P85, DOI 10.1603/ME10034; Ciccozzi M, 2013, INFECT GENET EVOL, V17, P46, DOI 10.1016/j.meegid.2013.03.034; Clement P, 2000, THRUSHES HELM IDENTI, P392; Formosinho P, 2006, ACTA VIROL, V50, P175; Hagman Karl, 2014, Infection Ecology & Epidemiology, V4, P20943, DOI 10.3402/iee.v4.20943; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Jameson LJ, 2012, TICKS TICK-BORNE DIS, V3, P95, DOI 10.1016/j.ttbdis.2011.12.002; Kampen H, 2007, EXP APPL ACAROL, V43, P227, DOI 10.1007/s10493-007-9113-y; Keyes B.E., 1982, North American Bird Bander, V7, P2; Kolodziejek J, 2013, J GEN VIROL, V94, P2449, DOI 10.1099/vir.0.056200-0; Kuno G, 1998, J VIROL METHODS, V72, P27, DOI 10.1016/S0166-0934(98)00003-2; Lawrie CH, 2004, EMERG INFECT DIS, V10, P653, DOI 10.3201/eid1004.030517; McMullen AR, 2013, J GEN VIROL, V94, P318, DOI 10.1099/vir.0.046888-0; Moskvitina N. S., 2008, Parazitologiya (St. Petersburg), V42, P210; Movila A, 2013, MED VET ENTOMOL, V27, P113, DOI 10.1111/j.1365-2915.2012.01037.x; Mumcuoglu KY, 2005, VECTOR-BORNE ZOONOT, V5, P65, DOI 10.1089/vbz.2005.5.65; Nijhof AM, 2007, VECTOR-BORNE ZOONOT, V7, P585, DOI 10.1089/vbz.2007.0130; Papa A, 2011, EMERG INFECT DIS, V17, P920, DOI 10.3201/eid1705.101759; Papa A, 2011, VECTOR-BORNE ZOONOT, V11, P539, DOI 10.1089/vbz.2010.0036; Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118; Platonov AE, 2008, PARASITOL RES, V103, pS45, DOI 10.1007/s00436-008-1050-0; Popovic N, 2013, EUROSURVEILLANCE, V18, P18, DOI 10.2807/1560-7917.ES2013.18.43.20613; Reiter P, 2010, EUROSURVEILLANCE, V15, P4; Rushton JO, 2013, EMERG INFECT DIS, V19, P635, DOI 10.3201/eid1904.121450; Savage HM, 1999, AM J TROP MED HYG, V61, P600, DOI 10.4269/ajtmh.1999.61.600; Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001; Sikutova S, 2009, VET MICROBIOL, V135, P267, DOI 10.1016/j.vetmic.2008.09.082; Sirbu A., 2011, EUROSURVEILLANCE, V16; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toma L, 2014, VECTOR-BORNE ZOONOT, V14, P199, DOI 10.1089/vbz.2013.1458; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094	38	36	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109905	10.1371/journal.pone.0109905	http://dx.doi.org/10.1371/journal.pone.0109905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279973	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800104
J	Prochazkova, P; Skanta, F; Roubalova, R; Silerova, M; Dvorak, J; Bilej, M				Prochazkova, Petra; Skanta, Frantisek; Roubalova, Radka; Silerova, Marcela; Dvorak, Jiri; Bilej, Martin			Involvement of the Iron Regulatory Protein from Eisenia andrei Earthworms in the Regulation of Cellular Iron Homeostasis	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; MULTIPLE SEQUENCE ALIGNMENT; RESPONSIVE ELEMENT; MESSENGER-RNA; TRANSLATIONAL REGULATION; NITRIC-OXIDE; FERRITIN; ACONITASE; IDENTIFICATION; STORAGE	Iron homeostasis in cells is regulated by iron regulatory proteins (IRPs) that exist in different organisms. IRPs are cytosolic proteins that bind to iron-responsive elements (IREs) of the 5'- or 3'-untranslated regions (UTR) of mRNAs that encode many proteins involved in iron metabolism. In this study, we have cloned and described a new regulatory protein belonging to the family of IRPs from the earthworm Eisenia andrei (EaIRP). The earthworm IRE site in 5'-UTR of ferritin mRNA most likely folds into a secondary structure that differs from the conventional IRE structures of ferritin due to the absence of a typically unpaired cytosine that participates in protein binding. Prepared recombinant EaIRP and proteins from mammalian liver extracts are able to bind both mammalian and Eisenia IRE structures of ferritin mRNA, although the affinity of the rEaIRP/Eisenia IRE structure is rather low. This result suggests the possible contribution of a conventional IRE structure. When IRP is supplemented with a Fe-S cluster, it can function as a cytosolic aconitase. Cellular cytosolic and mitochondrial fractions, as well as recombinant EaIRP, exhibit aconitase activity that can be abolished by the action of oxygen radicals. The highest expression of EaIRP was detected in parts of the digestive tract. We can assume that earthworms may possess an IRE/IRP regulatory network as a potential mechanism for maintaining cellular iron homeostasis, although the aconitase function of EaIRP is most likely more relevant.	[Prochazkova, Petra; Skanta, Frantisek; Roubalova, Radka; Silerova, Marcela; Dvorak, Jiri; Bilej, Martin] Acad Sci Czech Republ, Inst Microbiol, Vvi, Lab Cellular & Mol Immunol, Prague 4, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Prochazkova, P (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Vvi, Lab Cellular & Mol Immunol, Prague 4, Czech Republic.	kohler@biomed.cas.cz	Roubalová, Radka/H-2501-2014; Dvořák, Jiří/I-1145-2014; Bilej, Martin/I-4564-2014; Škanta, František/H-7931-2014; Prochazkova, Petra/H-2529-2014	Roubalová, Radka/0000-0002-9298-4734; Dvořák, Jiří/0000-0002-3714-7781; 	Ministry of Education, Youth and Sports [CZ.1.07/2.3.00/20.0055, CZ.1.07/2.3.00/30.0003]; RVO [61388971]; project "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University in Vestec'' from the European Regional Development Fund [CZ-1.05/1.1.00/02.0109]	Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); RVO; project "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University in Vestec'' from the European Regional Development Fund	This research was supported by the Ministry of Education, Youth and Sports (CZ.1.07/2.3.00/20.0055 for PP and CZ.1.07/2.3.00/30.0003 for RR), the Institutional Research Concept RVO 61388971 and by the project "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University in Vestec'' (CZ-1.05/1.1.00/02.0109) from the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Aisen P, 1999, CURR OPIN CHEM BIOL, V3, P200, DOI 10.1016/S1367-5931(99)80033-7; Andrews SC, 1998, ADV MICROB PHYSIOL, V40, P281, DOI 10.1016/S0065-2911(08)60134-4; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Baker HM, 2003, P NATL ACAD SCI USA, V100, P3579, DOI 10.1073/pnas.0637295100; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Briat JF, 2010, BBA-GEN SUBJECTS, V1800, P806, DOI 10.1016/j.bbagen.2009.12.003; Brown NM, 1998, P NATL ACAD SCI USA, V95, P15235, DOI 10.1073/pnas.95.26.15235; Butt J, 1996, P NATL ACAD SCI USA, V93, P4345, DOI 10.1073/pnas.93.9.4345; Cairo G, 2000, BIOCHEM J, V352, P241, DOI 10.1042/0264-6021:3520241; Canessa P, 2013, APPL MICROBIOL BIOT, V97, P939, DOI 10.1007/s00253-012-4615-x; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; CAUGHMAN SW, 1988, J BIOL CHEM, V263, P19048; Cmejla R, 2006, BIOCHEM BIOPH RES CO, V341, P158, DOI 10.1016/j.bbrc.2005.12.155; DANDEKAR T, 1991, EMBO J, V10, P1903, DOI 10.1002/j.1460-2075.1991.tb07716.x; EANES RZ, 1971, BIOCHIM BIOPHYS ACTA, V227, P204, DOI 10.1016/0005-2744(71)90181-1; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; EISENSTEIN RS, 1993, J BIOL CHEM, V268, P27363; Gourley BL, 2003, J BIOL CHEM, V278, P3227, DOI 10.1074/jbc.M210333200; GRAY NK, 1994, EMBO J, V13, P3882, DOI 10.1002/j.1460-2075.1994.tb06699.x; Gunshin H, 2001, FEBS LETT, V509, P309, DOI 10.1016/S0014-5793(01)03189-1; GUO B, 1994, J BIOL CHEM, V269, P24252; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; HENDERSON BR, 1994, J BIOL CHEM, V269, P17481; HENTZE MW, 1989, SCIENCE, V244, P357, DOI 10.1126/science.2711187; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Hintze KJ, 2006, CELL MOL LIFE SCI, V63, P591, DOI 10.1007/s00018-005-5285-y; Hsieh SL, 2006, FISH SHELLFISH IMMUN, V21, P279, DOI 10.1016/j.fsi.2005.12.003; Huang TS, 1999, INSECT BIOCHEM MOLEC, V29, P1, DOI 10.1016/S0965-1748(98)00097-6; JAFFREY SR, 1993, NUCLEIC ACIDS RES, V21, P4627, DOI 10.1093/nar/21.19.4627; Jeong BR, 2006, J MICROBIOL, V44, P54; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Melefors O, 1996, BIOCHEM BIOPH RES CO, V221, P437, DOI 10.1006/bbrc.1996.0613; Pantopoulos K, 1998, P NATL ACAD SCI USA, V95, P10559, DOI 10.1073/pnas.95.18.10559; PEYRET P, 1995, J BIOL CHEM, V270, P8131, DOI 10.1074/jbc.270.14.8131; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; Prochazkova P, 2011, GENE, V485, P73, DOI 10.1016/j.gene.2011.06.010; Rozbesky D, 2011, PROTEIN EXPRES PURIF, V77, P178, DOI 10.1016/j.pep.2011.01.013; Sanchez M, 2011, BLOOD, V118, pE168, DOI 10.1182/blood-2011-04-343541; Sanchez M, 2006, J BIOL CHEM, V281, P22865, DOI 10.1074/jbc.M603876200; Schussler P, 1996, EUR J BIOCHEM, V241, P64, DOI 10.1111/j.1432-1033.1996.0064t.x; Soum E, 2003, J BIOL INORG CHEM, V8, P226, DOI 10.1007/s00775-002-0412-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THEIL EC, 1994, BIOCHEM J, V304, P1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Walden WE, 2002, P NATL ACAD SCI USA, V99, P4138, DOI 10.1073/pnas.082108799; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	49	1	1	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109900	10.1371/journal.pone.0109900	http://dx.doi.org/10.1371/journal.pone.0109900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279857	gold, Green Published, Green Submitted			2022-12-27	WOS:000342670800103
J	Vergho, DC; Kneitz, S; Kalogirou, C; Burger, M; Krebs, M; Rosenwald, A; Spahn, M; Loser, A; Kocot, A; Riedmiller, H; Kneitz, B				Vergho, Daniel Claudius; Kneitz, Susanne; Kalogirou, Charis; Burger, Maximilian; Krebs, Markus; Rosenwald, Andreas; Spahn, Martin; Loeser, Andreas; Kocot, Arkadius; Riedmiller, Hubertus; Kneitz, Burkhard			Impact of miR-21, miR-126 and miR-221 as Prognostic Factors of Clear Cell Renal Cell Carcinoma with Tumor Thrombus of the Inferior Vena Cava	PLOS ONE			English	Article							IDENTIFICATION; METASTASIS; MICRORNAS; SURVIVAL; CANCER; EXPRESSION; DISCOVERY; PAPILLARY; MARKER	Clear cell renal cell carcinoma (ccRCC) characterized by a tumor thrombus (TT) extending into the inferior vena cava (IVC) generally indicates poor prognosis. Nevertheless, the risk for tumor recurrence after nephrectomy and thrombectomy varies. An applicable and accurate prediction system to select ccRCC patients with TT of the IVC (ccRCC/TT) at high risk after nephrectomy is urgently needed, but has not been established up to now. To our knowledge, a possible role of microRNAs (miRs) for the development of ccRCC/TT or their impact as prognostic markers in ccRCC/TT has not been explored yet. Therefore, we analyzed the expression of the previously described onco-miRs miR-200c, miR-210, miR-126, miR-221, let-7b, miR-21, miR-143 and miR-141 in a study collective of 74 ccRCC patients. Using the expression profiles of these eight miRs we developed classification systems that accurately differentiate ccRCC from non-cancerous renal tissue and ccRCC/TT from tumors without TT. In the subgroup of 37 ccRCC/TT cases we found that miR-21, miR-126, and miR-221 predicted cancer related death (CRD) accurately and independently from other clinico-pathological features. Furthermore, a combined risk score based on the expression of miR-21, miR-126 and miR-221 was developed and showed high sensitivity and specificity to predict cancer specific survival (CSS) in ccRCC/TT. Using the combined risk score we were able to classify ccRCC/TT patients correctly into high and low risk cases. The risk stratification by the combined risk score (CRS) will benefit from further cohort validation and might have potential for clinical application as a molecular prediction system to identify high-risk ccRCC/TT patients.	[Vergho, Daniel Claudius; Kalogirou, Charis; Krebs, Markus; Loeser, Andreas; Kocot, Arkadius; Riedmiller, Hubertus; Kneitz, Burkhard] Univ Wurzburg, Med Ctr, Dept Urol & Pediat Urol, D-97070 Wurzburg, Germany; [Kneitz, Susanne] Univ Wurzburg, Bioctr, D-97070 Wurzburg, Germany; [Burger, Maximilian] Univ Regensburg, Dept Urol, D-93053 Regensburg, Germany; [Rosenwald, Andreas] Univ Wurzburg, CCCM, Dept Pathol, D-97070 Wurzburg, Germany; [Spahn, Martin] Univ Hosp Bern, Dept Urol, CH-3010 Bern, Switzerland	University of Wurzburg; University of Wurzburg; University of Regensburg; University of Wurzburg; University of Bern; University Hospital of Bern	Vergho, DC (corresponding author), Univ Wurzburg, Med Ctr, Dept Urol & Pediat Urol, D-97070 Wurzburg, Germany.	vergho_d@ukw.de	Spahn, Martin/A-9128-2015; ravegnini, gloria/K-1330-2016	Spahn, Martin/0000-0002-5770-9489; ravegnini, gloria/0000-0002-7774-402X; Krebs, Markus/0000-0003-1625-2061; Krebs, Markus/0000-0002-1154-0964	German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Ciancio G, 2007, EUR UROL, V51, P988, DOI 10.1016/j.eururo.2006.11.055; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Faragalla H, 2012, J MOL DIAGN, V14, P385, DOI 10.1016/j.jmoldx.2012.02.003; Grange C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00049; Haferkamp A, 2007, J UROLOGY, V177, P1703, DOI 10.1016/j.juro.2007.01.039; Heinzelmann J, 2011, WORLD J UROL, V29, P367, DOI 10.1007/s00345-010-0633-4; Hui A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-500; Jiang Z, 2008, CANCER-AM CANCER SOC, V112, P2676, DOI 10.1002/cncr.23484; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Khella HWZ, 2012, TUMOR BIOL, V33, P131, DOI 10.1007/s13277-011-0255-5; Klatte T, 2007, J UROLOGY, V178, P1189, DOI 10.1016/j.juro.2007.05.134; Kneitz B, 2014, CANCER RES, V74, P2591, DOI 10.1158/0008-5472.CAN-13-1606; Laird A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060483; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Martinez-Salamanca JI, 2011, EUR UROL, V59, P120, DOI 10.1016/j.eururo.2010.10.001; NEVES RJ, 1987, BRIT J UROL, V59, P390, DOI 10.1111/j.1464-410X.1987.tb04832.x; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sasahira T, 2012, BRIT J CANCER, V107, P700, DOI 10.1038/bjc.2012.330; Schaefer A, 2010, NAT REV UROL, V7, P286, DOI 10.1038/nrurol.2010.45; Schubert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065064; Slaby O, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-90; Sun M, 2011, EUR UROL, V60, P644, DOI 10.1016/j.eururo.2011.06.041; Therneau T.M., 2000, MODELING SURVIVAL DA; Tilki D, 2014, EUR UROL, V66, P577, DOI 10.1016/j.eururo.2013.06.048; Vergho D, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-25; Vergho DC, 2012, BMC RES NOTES, V5, P5, DOI DOI 10.1186/1756-0500-5-264; Wach S, 2013, BRIT J CANCER, V109, P714, DOI 10.1038/bjc.2013.313; White NMA, 2011, J UROLOGY, V186, P1077, DOI 10.1016/j.juro.2011.04.110; Wotschofsky Z, 2012, INT J BIOL SCI, V8, P1363, DOI 10.7150/ijbs.5106; Wu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035661; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031060	36	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109877	10.1371/journal.pone.0109877	http://dx.doi.org/10.1371/journal.pone.0109877			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279769	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800101
J	Fernandez-Pisonero, I; Lopez, J; Onecha, E; Duenas, AI; Maeso, P; Crespo, MS; Roman, JAS; Garcia-Rodriguez, C				Fernandez-Pisonero, Isabel; Lopez, Javier; Onecha, Esther; Duenas, Ana I.; Maeso, Patricia; Sanchez Crespo, Mariano; San Roman, Jose Alberto; Garcia-Rodriguez, Carmen			Synergy between Sphingosine 1-Phosphate and Lipopolysaccharide Signaling Promotes an Inflammatory, Angiogenic and Osteogenic Response in Human Aortic Valve Interstitial Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ENDOTHELIAL-CELLS; CARDIOVASCULAR-SYSTEM; INNATE IMMUNITY; SPHINGOSINE-1-PHOSPHATE; STENOSIS; CALCIFICATION; HEART; EXPRESSION; PATHWAY	Given that the bioactive lipid sphingosine 1-phosphate is involved in cardiovascular pathophysiology, and since lipid accumulation and inflammation are hallmarks of calcific aortic stenosis, the role of sphingosine 1-phosphate on the pro-inflammatory/pro-osteogenic pathways in human interstitial cells from aortic and pulmonary valves was investigated. Real-time PCR showed sphingosine 1-phosphate receptor expression in aortic valve interstitial cells. Exposure of cells to sphingosine 1-phosphate induced pro-inflammatory responses characterized by interleukin-6, interleukin-8, and cyclooxygenase-2 up-regulations, as observed by ELISA and Western blot. Strikingly, cell treatment with sphingosine 1-phosphate plus lipopolysaccharide resulted in the synergistic induction of cyclooxygenase-2, and intercellular adhesion molecule 1, as well as the secretion of prostaglandin E-2, the soluble form of the intercellular adhesion molecule 1, and the pro-angiogenic factor vascular endothelial growth factor-A. Remarkably, the synergistic effect was significantly higher in aortic valve interstitial cells from stenotic than control valves, and was drastically lower in cells from pulmonary valves, which rarely undergo stenosis. siRNA and pharmacological analysis revealed the involvement of sphingosine 1-phosphate receptors 1/3 and Toll-like receptor-4, and downstream signaling through p38/MAPK, protein kinase C, and NF-kappa B. As regards pro-osteogenic pathways, sphingosine 1-phosphate induced calcium deposition and the expression of the calcification markers bone morphogenetic protein-2 and alkaline phosphatase, and enhanced the effect of lipopolysaccharide, an effect that was partially blocked by inhibition of sphingosine 1-phosphate receptors 3/2 signaling. In conclusion, the interplay between sphingosine 1-phosphate receptors and Toll-like receptor 4 signaling leads to a cooperative up-regulation of inflammatory, angiogenic, and osteogenic pathways in aortic valve interstitial cells that seems relevant to the pathogenesis of aortic stenosis and may allow the inception of new therapeutic approaches.	[Fernandez-Pisonero, Isabel; Onecha, Esther; Maeso, Patricia; Sanchez Crespo, Mariano; Garcia-Rodriguez, Carmen] Univ Valladolid, CSIC, Inst Biol & Genet Mol, Valladolid, Spain; [Lopez, Javier; San Roman, Jose Alberto] Hosp Clin Univ, Inst Ciencias Corazon ICICOR, Dept Cardiol, Valladolid, Spain; [Duenas, Ana I.] Hosp Clin Univ, Res Unit, Valladolid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Universidad de la Laguna	Garcia-Rodriguez, C (corresponding author), Univ Valladolid, CSIC, Inst Biol & Genet Mol, Valladolid, Spain.	cgarcia@ibgm.uva.es	Garcia, Carmen/L-9961-2017; San Roman, Jose A/A-9963-2012; Onecha, Esther/AAG-6438-2019	Garcia, Carmen/0000-0002-7205-4572; Lopez Diaz, Javier/0000-0002-9811-9872; Fernandez-Pisonero, Isabel/0000-0002-5130-2143; Onecha, Esther/0000-0002-8631-3555; Sanchez Crespo, Mariano/0000-0002-6149-154X; San Roman Calvar, Jose Alberto/0000-0003-0764-0839; Maeso Hernandez, Patricia/0000-0001-5424-6864	Spanish Ministry of Science, Plan Nacional de Salud y Farmacia - European FEDER [SAF2006/08031, SAF2009/08692, FSE2000/2006]; Junta de Castilla y Leon [BIO39/VA28/10, GR230]; Fundacion Caja Burgos; Instituto de Salud Carlos III (Spanish Ministry of Health) [FIS PI11/00264]; RECAVA network; FPI Program (Ministry of Science)	Spanish Ministry of Science, Plan Nacional de Salud y Farmacia - European FEDER; Junta de Castilla y Leon(Junta de Castilla y Leon); Fundacion Caja Burgos; Instituto de Salud Carlos III (Spanish Ministry of Health)(Instituto de Salud Carlos IIISpanish Government); RECAVA network(Instituto de Salud Carlos III); FPI Program (Ministry of Science)	This study was supported by grants from Spanish Ministry of Science, Plan Nacional de Salud y Farmacia SAF2006/08031 (co-funded by European FEDER-FSE2000/2006), and SAF2009/08692; Junta de Castilla y Leon (Regional Funding) BIO39/VA28/10 and GR230; Fundacion Caja Burgos 2010; and the Instituto de Salud Carlos III (Spanish Ministry of Health): FIS PI11/00264, RECAVA network. IFP was a fellow from the FPI Program (Ministry of Science). AID was a Miguel Servet researcher (ISCIII). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alewijnse AE, 2008, EUR J PHARMACOL, V585, P292, DOI 10.1016/j.ejphar.2008.02.089; BENAV P, 1995, FEBS LETT, V372, P83, DOI 10.1016/0014-5793(95)00956-A; Bourantas CV, 2013, INT J CARDIOL, V168, P11, DOI 10.1016/j.ijcard.2013.03.065; Chalajour F, 2004, EXP CELL RES, V298, P455, DOI 10.1016/j.yexcr.2004.04.034; Curtiss LK, 2009, J LIPID RES, V50, pS340, DOI 10.1194/jlr.R800056-JLR200; Duenas AI, 2008, CARDIOVASC RES, V79, P537, DOI 10.1093/cvr/cvn087; Eskan MA, 2008, EUR J IMMUNOL, V38, P1138, DOI 10.1002/eji.200737898; Fernandez-Pisonero I, 2012, J IMMUNOL, V189, P5402, DOI 10.4049/jimmunol.1201309; Ge H, 2010, J CLIN PHARM THER, V35, P385, DOI 10.1111/j.1365-2710.2009.01137.x; Gu XX, 2009, AM J PHYSIOL-HEART C, V296, pH1748, DOI 10.1152/ajpheart.00099.2009; Ikeda H, 2009, J LIPID RES, V50, P556, DOI 10.1194/jlr.M800496-JLR200; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; Karliner JS, 2009, J CARDIOVASC PHARM, V53, P189, DOI 10.1097/FJC.0b013e3181926706; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Keller CD, 2007, AM J PATHOL, V170, P281, DOI 10.2353/ajpath.2007.060485; Kennedy S, 2009, CURR OPIN PHARMACOL, V9, P194, DOI 10.1016/j.coph.2008.11.002; Keul P, 2011, CIRC RES, V108, P314, DOI 10.1161/CIRCRESAHA.110.235028; Lim JY, 2005, J MOL CELL CARDIOL, V39, P627, DOI 10.1016/j.yjmcc.2005.06.016; Lopez J, 2012, INT J CARDIOL, V158, P18, DOI 10.1016/j.ijcard.2010.12.089; Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936; Marber MS, 2011, J MOL CELL CARDIOL, V51, P485, DOI 10.1016/j.yjmcc.2010.10.021; Mathieu P, 2005, J HEART VALVE DIS, V14, P353; Means CK, 2009, CARDIOVASC RES, V82, P193, DOI 10.1093/cvr/cvp086; Merryman WD, 2010, J BIOMECH, V43, P87, DOI 10.1016/j.jbiomech.2009.09.013; Miller JD, 2011, CIRC RES, V108, P1392, DOI 10.1161/CIRCRESAHA.110.234138; Nagy E, 2011, CIRCULATION, V123, P1316, DOI 10.1161/CIRCULATIONAHA.110.966846; New SEP, 2011, CIRC RES, V108, P1381, DOI 10.1161/CIRCRESAHA.110.234146; O'Brien KD, 2006, ARTERIOSCL THROM VAS, V26, P1721, DOI 10.1161/01.ATV.0000227513.13697.ac; Obinata H, 2012, SEMIN IMMUNOPATHOL, V34, P73, DOI 10.1007/s00281-011-0287-3; Rajamannan NM, 2007, NAT CLIN PRACT CARD, V4, P254, DOI 10.1038/ncpcardio0827; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Shavelle DM, 2008, J HEART VALVE DIS, V17, P388; Shea BS, 2010, AM J RESP CELL MOL, V43, P662, DOI 10.1165/rcmb.2009-0345OC; Soini Y, 2003, HUM PATHOL, V34, P756, DOI 10.1016/S0046-8177(03)00245-4; Song R, 2012, ARTERIOSCL THROM VAS, V32, P2711, DOI 10.1161/ATVBAHA.112.300116; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Syvaranta S, 2010, ARTERIOSCL THROM VAS, V30, P1220, DOI 10.1161/ATVBAHA.109.198267; Takuwa Y, 2008, BBA-MOL CELL BIOL L, V1781, P483, DOI 10.1016/j.bbalip.2008.04.003; Taylor PM, 2000, J HEART VALVE DIS, V9, P150; Witt W, 2012, CARDIOVASC RES, V93, P490, DOI 10.1093/cvr/cvs002; Yang XP, 2009, J AM COLL CARDIOL, V53, P491, DOI 10.1016/j.jacc.2008.09.052; Yao JHS, 2006, BIOCHEM BIOPH RES CO, V342, P1396, DOI 10.1016/j.bbrc.2006.02.100; Yetkin E, 2009, INT J CARDIOL, V135, P4, DOI 10.1016/j.ijcard.2009.03.108; Zeng QC, 2012, CIRCULATION, V126, pS222, DOI 10.1161/CIRCULATIONAHA.111.083675	45	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109081	10.1371/journal.pone.0109081	http://dx.doi.org/10.1371/journal.pone.0109081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275309	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500055
J	Kin, A; Blazejowski, B				Kin, Adrian; Blazejowski, Blazej			The Horseshoe Crab of the Genus Limulus: Living Fossil or Stabilomorph?	PLOS ONE			English	Article							TACHYPLEUS-TRIDENTATUS; CONTINENTAL-SHELF; NEW-JERSEY; POLYPHEMUS; BAY; PALEOENVIRONMENT; ARAUCARIACEAE; LAGERSTATTEN; MORPHOLOGY; XIPHOSURA	A new horseshoe crab species, Limulus darwini, is described from the uppermost Jurassic (ca. 148 Ma) near-shore sediments of the Kcynia Formation, central Poland. The only extant species Limulus polyphemus (Linnaeus) inhabits brackish-marine, shallow water environments of the east coast of the United States. Here it is shown that there are no important morphological differences between the Kcynia Formation specimens and extant juvenile representatives of the genus Limulus. The palaeoecological setting inhabited by the new species and the trophic relationships of extant horseshoe crabs are discussed in an attempt to determine the potential range of food items ingested by these Mesozoic xiphosurans. In this paper we propose the adoption of a new term stabilomorphism, this being: an effect of a specific formula of adaptative strategy among organisms whose taxonomic status does not exceed genus-level. A high effectiveness of adaptation significantly reduces the need for differentiated phenotypic variants in response to environmental changes and provides for long-term evolutionary success.	[Kin, Adrian] Soc Friends Earth Sci PHACOPS, Warsaw, Poland; [Blazejowski, Blazej] Polish Acad Sci, Inst Paleobiol, Warsaw, Poland	Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences	Blazejowski, B (corresponding author), Polish Acad Sci, Inst Paleobiol, Warsaw, Poland.	bblazej@twarda.pan.pl	Błażejowski, Błażej/AAX-7872-2020	Błażejowski, Błażej/0000-0001-6320-9870	Polish National Science Centre [2012/07/B/ST10/04175]	Polish National Science Centre	This work was supported by the Polish National Science Centre (grant no. 2012/07/B/ST10/04175).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LC, 2003, J PALEONTOL, V77, P1086, DOI 10.1666/0022-3360(2003)077<1086:EAPRON>2.0.CO;2; Annandale N., 1909, Records of the Indian Museum, V3; Annandale N., 1922, Bijdragen tot de Dierkunde, V1922, P143; AVISE JC, 1994, EVOLUTION, V48, P1986, DOI 10.1111/j.1558-5646.1994.tb02228.x; Babcock LE, 2000, LETHAIA, V33, P129; BARTHEL KW, 1974, NATURWISSENSCHAFTEN, V61, P428, DOI 10.1007/BF00597201; Bechly G, 2013, ACTA PALAEONTOL POL, V58, P121, DOI 10.4202/app.2011.0194; BOTTON ML, 1984, MAR BIOL, V81, P199, DOI 10.1007/BF00393118; BOTTON ML, 1984, J MAR RES, V42, P139, DOI 10.1357/002224084788506086; BOTTON ML, 1989, B MAR SCI, V45, P637; BOTTON ML, 1984, FISH B-NOAA, V82, P383; Braun CF, 1860, ZOOL FUNDAMENTA; Bruguiere M, 1791, TABLEAU ENCY METHODI, P96; CARLTON JT, 1990, MAR ECOL PROG SER, V66, P81, DOI 10.3354/meps066081; Carmichael RH, 2003, MAR ECOL PROG SER, V246, P225, DOI 10.3354/meps246225; CHATTERJI A, 1992, HYDROBIOLOGIA, V246, P41, DOI 10.1007/BF00005621; CHATTERJI A, 1988, Pakistan Journal of Scientific and Industrial Research, V31, P352; Chatterji A, 1994, HORSESHOE CRAB LIVIN; Chiu HMC, 2004, HYDROBIOLOGIA, V523, P29, DOI 10.1023/B:HYDR.0000033085.71861.63; Chiu HMC, 2003, J NAT HIST, V37, P2369, DOI 10.1080/00222930210149753; Darwin C, 1859, ORIGIN SPECIES MEANS, P1, DOI DOI 10.1001/JAMA.1950.02920110083052; Debnath R, 1992, THESIS U CALCUTTA CA, P1; Desmarest A.-G., 1822, HIST NATURELLE CRUST, P67, DOI DOI 10.5962/BHL.TITLE.66799; Ehlinger GS, 2009, BIOLOGY AND CONSERVATION OF HORSESHOE CRABS, P149, DOI 10.1007/978-0-387-89959-6_9; EMIG C. C., 2003, CARNETS GEOL, V1, P1, DOI DOI 10.4267/2042/303; Feldmann RM, 2011, PALAEONTOLOGY, V54, P1337, DOI 10.1111/j.1475-4983.2011.01103.x; Fisher D.C., 1984, P196; Forey PL, 1998, HIST COELACANTH FISH, P1; Fraas O, 1855, JAHRESHEFTE VEREINS, V11, P76; Frickhinger Karl Albert, 1994, P1; Gaillard C, 2010, SWISS J GEOSCI, V103, P1; Giribet G, 2003, SM S COMP E, P45; GOULD SJ, 1989, NAT HIST, P16; Harper EM, 2002, PALAEONTOLOGY, V45, P759, DOI 10.1111/1475-4983.00259; Hauschke N., 1991, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V183, P391; HOLLAND F D JR, 1975, Bulletins of American Paleontology, V67, P235; Holmes SP, 2006, MAR ECOL PROG SER, V315, P129, DOI 10.3354/meps315129; HUOVINEN P, 1990, J MICROBIOL METH, V11, P107, DOI 10.1016/0167-7012(90)90010-4; Iwanaga S., 1998, FRONT BIOSCI-LANDMRK, V3, P973; Jeffries WB, 1996, P 10 INT BRYOZ C WEL; Jussieu AL, 1789, GENERA PLANTARUM SEC, P1; Karaszewski W, 1975, PRZEGLAD GEOL, V23, P500; Kin A, 2013, LETHAIA, V46, P71, DOI 10.1111/j.1502-3931.2012.00322.x; Kolb A., 1963, Geologische Blaetter fuer Nordost-Bayern, V13, P73; Kutek Jan, 1994, Acta Geologica Polonica, V44, P1; Lamarck JB, 1818, HIST NATURELLE ANIMA, V5, P1; Lamsdell JC, 2013, ZOOL J LINN SOC-LOND, V167, P1, DOI 10.1111/j.1096-3642.2012.00874.x; Latreille P, 1802, HIST NATURELLE GEN P, DOI [DOI 10.5962/BHL.TITLE.15764, 10.5962/bhl.title.11138]; Latreille PA, 1829, REGNE ANIMAL, V4; Leach WE, 1819, DICT SCI NATURELLES, V14, P537; Leibovitz Louis, 2003, P245; LEWY Z, 1979, LETHAIA, V12, P341, DOI 10.1111/j.1502-3931.1979.tb01019.x; Linnaeus C, 1771, MANTISSA PLANTARUM A, P1; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Luchetti A, 2006, GENOME, V49, P888, DOI 10.1139/G06-047; Mandic O, 2002, GEOBIOS-LYON, V35, P193, DOI 10.1016/S0016-6995(02)00059-1; Manton SM, 1977, ARTHROPODA HABITS FU, P1; Merchant ME, 2006, VET IMMUNOL IMMUNOP, V110, P221, DOI 10.1016/j.vetimm.2005.10.001; Mikkelsen T., 1988, P1; MOORE KS, 1993, P NATL ACAD SCI USA, V90, P1354, DOI 10.1073/pnas.90.4.1354; Muller O.F., 1785, ENTOMOSTRACA SEU INS, P1; Munster G, 1840, BEITRAGE PETREFACTEN, V3, P26; Nicolini Mary Helen, 2000, Pacific Science, V54, P377; NOVITSKY TJ, 1984, OCEANUS, V27, P13; Ogilby JD, 1907, P ROYAL SOC QUEENSLA, V20, P27; Olivi G, 1792, ZOOLOGIA ADRIATICA O, DOI [DOI 10.5962/BHL.TITLE.60887, 10.5962/bhl.title.60887]; Oppel A, 1862, PALAONTOLOGISCHE MIT, V1, P121; PICKETT JW, 1984, PALAEONTOLOGY, V27, P609; Pocock R. I., 1902, Annals of Natural History, V(7), P256; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Reeside J. B. Jr., 1952, Journal of the Washington Academy of Sciences, V42, P174; RIEK E F, 1971, Palaeontology (Oxford), V14, P206; RISKA B, 1981, EVOLUTION, V35, P647, DOI 10.1111/j.1558-5646.1981.tb04926.x; Roper M, 1996, PLATTENKALKE BRUNN, P1; Rudkin DM, 2008, PALAEONTOLOGY, V51, P1, DOI 10.1111/j.1475-4983.2007.00746.x; Ruedemann R, 1922, AM NAT, V56, P256, DOI 10.1086/279864; Ruedemann R, 1922, P NATL ACAD SCI USA, V8, P54, DOI 10.1073/pnas.8.3.54; Salamon M, 2006, FREIBERGER FORSCH C, V511, P29; Samsonowicz J, 1952, ZARYS GEOLOGII POLSK, P90; Sanders WB, 2010, NAUTILUS BIOL PALEOB, P1; Scholz Annemarie, 2008, Palaeodiversity, P111; Schrank F von P, 1803, DURCHGEDACHTE GESCH, V3, P1; Schrenck L, 1867, MOLLUSKEN AMUR LANDE, V2, P259; Schweigert G, 2002, LIMULIDEN JBER MITT, V84, P323; Schweigert Gunter, 1998, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V262, P1; SEKIGUCHI K, 1988, BIOL BULL, V174, P337, DOI 10.2307/1541959; Sekiguchi K., 1976, Proceedings of the Japanese Society for Systematic Zoology, VNo. 12, P13; Sekiguchi K, 2009, BIOLOGY AND CONSERVATION OF HORSESHOE CRABS, P5, DOI 10.1007/978-0-387-89959-6_1; SELANDER RK, 1970, EVOLUTION, V24, P402, DOI 10.1111/j.1558-5646.1970.tb01771.x; Semenov VP, 1898, JEZEG GEOL MINER ROS, V2; Sepkoski J.J., 2002, B AM PALEONTOL, V363, P1; Shopf JW, 1987, J VERTEBR PALEONT S3, V7, P25; Shuster C.N. Jr, 1982, Progress in Clinical and Biological Research, V81, P1; Simpson G. G., 1944, P1; Simpson GG, 1953, MAJOR FEATURES EVOLU, P1; SMITH J. L. B., 1939, TRANS ROY SOC S AFRICA, V27, P47; SMITH OR, 1953, ECOLOGY, V34, P636, DOI 10.2307/1929737; SOKOLOFF A, 1978, RES POPUL ECOL, V19, P222, DOI 10.1007/BF02518829; Srijaya T.C., 2010, Our Nature, V8, P204; STOCKEY RA, 1994, J PLANT RES, V107, P493, DOI 10.1007/BF02344070; STOCKEY RA, 1982, REV PALAEOBOT PALYNO, V37, P133, DOI 10.1016/0034-6667(82)90041-0; Stoliczka F., 1870, MEMOIRS GEOLOGICAL S, V6, P1; Stormer L., 1952, Journal of Paleontology, V26, P630; Suess E., 1865, SITZUNGSBERICHTE MN, V52; Tan A.N., 2011, Our Nature, V9, P9; Taylor JD, 2007, ZOOL SCR, V36, P587, DOI 10.1111/j.1463-6409.2007.00299.x; Van Roy P, 2010, NATURE, V465, P215, DOI 10.1038/nature09038; Via Boada L, 1977, CUADERNOS GEOLOGIA I, V4, P247; Vokes H. E., 1945, Bulletin of the American Museum of Natural History, V86, P1; von Zittel K, 1881, PALAEOZOOL, V2, P640; Walliser O.H., 1996, GLOBAL EVENTS EVENT, P225, DOI [10.1007/978-3-642-79634-0_11, DOI 10.1007/978-3-642-79634-0_11]; Walls EA, 2002, REV FISH SCI, V10, P39, DOI 10.1080/20026491051677; Walls Elizabeth A., 2000, Virginia Journal of Science, V51, P195; Wesselingh F., 1996, Documenta Naturae, V100, P7; Yamasaki T., 1988, P69; Yang MC, 2009, BIOLOGY AND CONSERVATION OF HORSESHOE CRABS, P163, DOI 10.1007/978-0-387-89959-6_10; YIN J, 1991, Palaeontologische Zeitschrift, V65, P105; Yin J., 1988, Earth Science (Wuhan), V13, P553; Yin J.-r., 1989, Acta Palaeontologica Sinica, V28, P415; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zhou H, 2004, J NAT HIST, V38, P1915, DOI 10.1080/0022293031000155377; Zhou ZY, 2006, GEOL J, V41, P363, DOI 10.1002/gj.1049; 张启跃, 2009, [自然科学进展, Progress in Natural Science], V19, P1090	123	62	65	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108036	10.1371/journal.pone.0108036	http://dx.doi.org/10.1371/journal.pone.0108036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275563	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500013
J	Nagata, T; Shirakawa, K; Kobayashi, N; Shiheido, H; Tabata, N; Sakuma-Yonemura, Y; Horisawa, K; Katahira, M; Doi, N; Yanagawa, H				Nagata, Takashi; Shirakawa, Kie; Kobayashi, Naohiro; Shiheido, Hirokazu; Tabata, Noriko; Sakuma-Yonemura, Yuko; Horisawa, Kenichi; Katahira, Masato; Doi, Nobuhide; Yanagawa, Hiroshi			Structural Basis for Inhibition of the MDM2:p53 Interaction by an Optimized MDM2-Binding Peptide Selected with mRNA Display	PLOS ONE			English	Article							TORSION ANGLE DYNAMICS; RING-FINGER DOMAIN; SECONDARY STRUCTURE; NMR STRUCTURE; HIGH-AFFINITY; IN-VITRO; CANCER-THERAPY; UCSF CHIMERA; P53 PATHWAY; PROTEIN	The oncoprotein MDM2 binds to tumor suppressor protein p53 and inhibits its anticancer activity, which leads to promotion of tumor cell growth and tumor survival. Abrogation of the p53:MDM2 interaction reportedly results in reactivation of the p53 pathway and inhibition of tumor cell proliferation. We recently performed rigorous selection of MDM2-binding peptides by means of mRNA display and identified an optimal 12-mer peptide (PRFWEYWLRLME), named MDM2 Inhibitory Peptide (MIP), which shows higher affinity for MDM2 (and also its homolog, MDMX) and higher tumor cell proliferation suppression activity than known peptides. Here we determined the NMR solution structure of a MIP-MDM2 fusion protein to elucidate the structural basis of the tight binding of MIP to MDM2. A region spanning from Phe(3) to Met 11 of MIP forms a single alpha-helix, which is longer than those of the other MDM2-binding peptides. MIP shares a conserved Phe(3)-Trp(7) -Leu(10) triad, whose side chains are oriented towards and fit into the hydrophobic pockets of MDM2. Additionally, hydrophobic surface patches that surround the hydrophobic pockets of MDM2 are covered by solvent-exposed MIP residues, Trp(4), Tyr(6), and Met(11). Their hydrophobic interactions extend the interface of the two molecules and contribute to the strong binding. The potential MDM2 inhibition activity observed for MIP turned out to originate from its enlarged binding interface. The structural information obtained in the present study provides a road map for the rational design of strong inhibitors of MDM2:p53 binding.	[Nagata, Takashi; Katahira, Masato] Kyoto Univ, Inst Adv Energy, Uji, Kyoto, Japan; [Nagata, Takashi; Katahira, Masato] Kyoto Univ, Grad Sch Energy Sci, Uji, Kyoto, Japan; [Shirakawa, Kie; Shiheido, Hirokazu; Tabata, Noriko; Sakuma-Yonemura, Yuko; Horisawa, Kenichi; Doi, Nobuhide; Yanagawa, Hiroshi] Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan; [Kobayashi, Naohiro] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan	Kyoto University; Kyoto University; Keio University; Osaka University	Nagata, T (corresponding author), Kyoto Univ, Inst Adv Energy, Uji, Kyoto, Japan.	nagata.takashi.6w@kyoto-u.ac.jp; hyana@bio.keio.ac.jp	Nagata, Takashi/D-4547-2018	Nagata, Takashi/0000-0002-3733-2709; Doi, Nobuhide/0000-0002-2402-6390; Shiheido, Hirokazu/0000-0002-1415-2019	Ministry of Education, Culture, Sports, Science and Technology of Japan [S0801008]; Core Research for Evolutionary Science and Technology (CREST) of the Japan Science and Technology Agency;  [23570146];  [26440026];  [25115507];  [25291013];  [26104520];  [26650014];  [22310121];  [22360351];  [25289298]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutionary Science and Technology (CREST) of the Japan Science and Technology Agency; ; ; ; ; ; ; ; ; 	This work was supported by Grants-in-Aid for Scientific Research (23570146 and 26440026 to T.N.; 25115507, 25291013, 26104520, and 26650014 to M.K.; and 22310121, 22360351, and 25289298 to N.D. and H.Y.), the Strategic Research Foundation Grant-aided Project for Private Universities (S0801008) of the Ministry of Education, Culture, Sports, Science and Technology of Japan (to N.D. and H.Y.), and a grant for Core Research for Evolutionary Science and Technology (CREST) of the Japan Science and Technology Agency (to N.D. and H.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chene P, 2002, FEBS LETT, V529, P293, DOI 10.1016/S0014-5793(02)03362-8; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Czarna A, 2009, CELL CYCLE, V8, P1176, DOI 10.4161/cc.8.8.8185; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Goddard T. D., 2006, SPARKY 3; Gopalakrishnan K, 2007, PROTEIN PEPTIDE LETT, V14, P669; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HARRIS CC, 1993, SCIENCE, V262, P1980, DOI 10.1126/science.8266092; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Horisawa K, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh167; Hu B, 2007, CANCER RES, V67, P8810, DOI 10.1158/0008-5472.CAN-07-1140; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Li C, 2010, J MOL BIOL, V398, P200, DOI 10.1016/j.jmb.2010.03.005; Matsumura N, 2010, FASEB J, V24, P2201, DOI 10.1096/fj.09-143008; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Miyamoto-Sato E, 2005, GENOME RES, V15, P710, DOI 10.1101/gr.3510505; Miyamoto-Sato E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009289; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nagata T, 2008, NUCLEIC ACIDS RES, V36, P4754, DOI 10.1093/nar/gkn458; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nemoto N, 1997, FEBS LETT, V414, P405, DOI 10.1016/S0014-5793(97)01026-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phan J, 2010, J BIOL CHEM, V285, P2174, DOI 10.1074/jbc.M109.073056; Popowicz GM, 2011, ANGEW CHEM INT EDIT, V50, P2680, DOI 10.1002/anie.201003863; Shangary S, 2008, MOL CANCER THER, V7, P1533, DOI 10.1158/1535-7163.MCT-08-0140; Shangary S, 2008, CLIN CANCER RES, V14, P5318, DOI 10.1158/1078-0432.CCR-07-5136; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Shiheido H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017898; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; Sugase K, 2008, PROTEIN EXPRES PURIF, V57, P108, DOI 10.1016/j.pep.2007.10.018; Tsuji T, 1999, J MOL BIOL, V286, P1581, DOI 10.1006/jmbi.1998.2558; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; VUILLEUMIER S, 1993, BIOCHEMISTRY-US, V32, P10303, DOI 10.1021/bi00090a005; Wasylyk C, 1999, ONCOGENE, V18, P1921, DOI 10.1038/sj.onc.1202528; WATERHOUS DV, 1994, BIOCHEMISTRY-US, V33, P2121, DOI 10.1021/bi00174a019; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yanagawa H, 2013, BIOCHEMISTRY-US, V52, P3841, DOI 10.1021/bi301704x; ZHONG LX, 1992, P NATL ACAD SCI USA, V89, P4462, DOI 10.1073/pnas.89.10.4462; Zondlo SC, 2006, BIOCHEMISTRY-US, V45, P11945, DOI 10.1021/bi060309g	55	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109163	10.1371/journal.pone.0109163	http://dx.doi.org/10.1371/journal.pone.0109163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275651	gold, Green Published, Green Submitted			2022-12-27	WOS:000342591500070
J	ten Haaf, T; Weijs, PJM				ten Haaf, Twan; Weijs, Peter J. M.			Resting Energy Expenditure Prediction in Recreational Athletes of 18-35 Years: Confirmation of Cunningham Equation and an Improved Weight-Based Alternative	PLOS ONE			English	Article							DIET-INDUCED THERMOGENESIS; BASAL METABOLIC-RATE; CALORIC REQUIREMENTS; REAPPRAISAL; EXERCISE; ADULTS; VALIDATION	Introduction: Resting energy expenditure (REE) is expected to be higher in athletes because of their relatively high fat free mass (FFM). Therefore, REE predictive equation for recreational athletes may be required. The aim of this study was to validate existing REE predictive equations and to develop a new recreational athlete specific equation. Methods: 90 (53M, 37F) adult athletes, exercising on average 9.1 +/- 5.0 hours a week and 5.0 +/- 1.8 times a week, were included. REE was measured using indirect calorimetry (Vmax Encore n29), FFM and FM were measured using air displacement plethysmography. Multiple linear regression analysis was used to develop a new FFM-based and weight-based REE predictive equation. The percentage accurate predictions (within 10% of measured REE), percentage bias, root mean square error and limits of agreement were calculated. Results: The Cunningham equation and the new weight-based equation REE(kJ/d) = 49:940* weight(kg) | 2459:053* height(m) - 34:014* age(y) + 799:257* sex(M = 1, F = 0) + 122:502 and the new FFM-based equation REE(kJ/d)* 95:272* FFM(kg) + 2026:161 performed equally well. De Lorenzo's equation predicted REE less accurate, but better than the other generally used REE predictive equations. Harris-Benedict, WHO, Schofield, Mifflin and Owen all showed less than 50% accuracy. Conclusion: For a population of (Dutch) recreational athletes, the REE can accurately be predicted with the existing Cunningham equation. Since body composition measurement is not always possible, and other generally used equations fail, the new weight-based equation is advised for use in sports nutrition.	[ten Haaf, Twan; Weijs, Peter J. M.] Amsterdam Univ Appl Sci, Sch Sports & Nutr, Dept Nutr & Dietet, Amsterdam, Netherlands; [Weijs, Peter J. M.] Vrije Univ Amsterdam Med Ctr, Dept Nutr & Dietet, Amsterdam, Netherlands; [Weijs, Peter J. M.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Weijs, PJM (corresponding author), Amsterdam Univ Appl Sci, Sch Sports & Nutr, Dept Nutr & Dietet, Amsterdam, Netherlands.	p.j.m.weijs@hva.nl		Weijs, Peter/0000-0001-8281-0426				Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009; CUNNINGHAM JJ, 1980, AM J CLIN NUTR, V33, P2372, DOI 10.1093/ajcn/33.11.2372; da Rocha EEM, 2005, CURR OPIN CLIN NUTR, V8, P319, DOI 10.1097/01.mco.0000165012.77567.1e; De Lorenzo A, 1999, J SPORT MED PHYS FIT, V39, P213; Dunford M, 2006, SPORTS NUTR; FAO/WHO/UNU, 1985, EN PROT REQ, P1; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Harris JA., 1919, BIOMETRIC STUDY BASA; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Henry CJK, 2003, BRIT J NUTR, V89, P811, DOI 10.1079/BJN2003839; Hofsteenge GH, 2010, AM J CLIN NUTR, V91, P1244, DOI 10.3945/ajcn.2009.28330; HORTON TJ, 1994, AM J CLIN NUTR, V59, P13, DOI 10.1093/ajcn/59.1.13; Korth O, 2007, EUR J CLIN NUTR, V61, P582, DOI 10.1038/sj.ejcn.1602556; LaForgia J, 2000, P NUTR SOC AUST, V24, P127; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; OWEN OE, 1986, AM J CLIN NUTR, V44, P1; OWEN OE, 1987, AM J CLIN NUTR, V46, P875, DOI 10.1093/ajcn/46.6.875; POEHLMAN ET, 1988, AM J CLIN NUTR, V47, P793, DOI 10.1093/ajcn/47.5.793; Short KR, 1996, INT J SPORTS MED, V17, P559, DOI 10.1055/s-2007-972895; Thompson J, 1996, J AM DIET ASSOC, V96, P30, DOI 10.1016/S0002-8223(96)00010-7; Trexler ET, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-7; Weijs PJM, 2008, AM J CLIN NUTR, V88, P959, DOI 10.1093/ajcn/88.4.959; Weijs PJM, 2008, CLIN NUTR, V27, P150, DOI 10.1016/j.clnu.2007.09.001; Weijs PJM, 2010, CLIN NUTR, V29, P347, DOI 10.1016/j.clnu.2009.09.009; WESTSTRATE JA, 1993, AM J CLIN NUTR, V58, P592, DOI 10.1093/ajcn/58.5.592; WESTSTRATE JA, 1989, AM J CLIN NUTR, V50, P908, DOI 10.1093/ajcn/50.5.908; WESTSTRATE JA, 1990, EUR J CLIN NUTR, V44, P91	27	39	39	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108460	10.1371/journal.pone.0108460	http://dx.doi.org/10.1371/journal.pone.0108460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275434	Green Submitted, Green Published, gold			2022-12-27	WOS:000342591500017
J	Baldo, B; Cheong, RY; Petersen, A				Baldo, Barbara; Cheong, Rachel Y.; Petersen, Asa			Effects of Deletion of Mutant Huntingtin in Steroidogenic Factor 1 Neurons on the Psychiatric and Metabolic Phenotype in the BACHD Mouse Model of Huntington Disease	PLOS ONE			English	Article							VENTROMEDIAL HYPOTHALAMIC NUCLEUS; CENTRAL-NERVOUS-SYSTEM; FULL-LENGTH HUNTINGTIN; BODY-WEIGHT; FOOD-INTAKE; MICE; EXPRESSION; BEHAVIOR; ANXIETY; LESIONS	Psychiatric and metabolic features appear several years before motor disturbances in the neurodegenerative Huntington's disease (HD), caused by an expanded CAG repeat in the huntingtin (HTT) gene. Although the mechanisms leading to these aspects are unknown, dysfunction in the hypothalamus, a brain region controlling emotion and metabolism, has been suggested. A direct link between the expression of the disease causing protein, huntingtin (HTT), in the hypothalamus and the development of metabolic and psychiatric-like features have been shown in the BACHD mouse model of HD. However, precisely which circuitry in the hypothalamus is critical for these features is not known. We hypothesized that expression of mutant HTT in the ventromedial hypothalamus, an area involved in the regulation of metabolism and emotion would be important for the development of these non-motor aspects. Therefore, we inactivated mutant HTT in a specific neuronal population of the ventromedial hypothalamus expressing the transcription factor steroidogenic factor 1 (SF1) in the BACHD mouse using cross-breeding based on a Cre-loxP system. Effects on anxiety-like behavior were assessed using the elevated plus maze and novelty-induced suppressed feeding test. Depressive-like behavior was assessed using the Porsolt forced swim test. Effects on the metabolic phenotype were analyzed using measurements of body weight and body fat, as well as serum insulin and leptin levels. Interestingly, the inactivation of mutant HTT in SF1-expressing neurons exerted a partial positive effect on the depressive-like behavior in female BACHD mice at 4 months of age. In this cohort of mice, no anxiety-like behavior was detected. The deletion of mutant HTT in SF1 neurons did not have any effect on the development of metabolic features in BACHD mice. Taken together, our results indicate that mutant HTT regulates metabolic networks by affecting hypothalamic circuitries that do not involve the SF1 neurons of the ventromedial hypothalamus.	[Baldo, Barbara; Cheong, Rachel Y.; Petersen, Asa] Lund Univ, Dept Expt Med Sci, Translat Neuroendocrine Res Unit, Lund, Sweden	Lund University	Baldo, B (corresponding author), Lund Univ, Dept Expt Med Sci, Translat Neuroendocrine Res Unit, Lund, Sweden.	barbara.baldo@med.lu.se		Cheong, Rachel/0000-0003-0264-7636	Swedish Medical Research Council [K2011-62X-20404-05-6]; Ragnar Soderberg foundation; province of Skane ALF grant; Kungliga Fysiografiska foundation; Blanceflor Boncompagni Ludovisi foundation	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Ragnar Soderberg foundation; province of Skane ALF grant; Kungliga Fysiografiska foundation; Blanceflor Boncompagni Ludovisi foundation	This work was supported by grants from the Swedish Medical Research Council (K2011-62X-20404-05-6), the Ragnar Soderberg foundation, the province of Skane ALF grant, the Kungliga Fysiografiska foundation and the Blanceflor Boncompagni Ludovisi foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abada YSK, 2013, BEHAV BRAIN RES, V238, P243, DOI 10.1016/j.bbr.2012.10.039; Aziz A, 2008, BRAIN PATHOL, V18, P474, DOI 10.1111/j.1750-3639.2008.00135.x; Bingham NC, 2008, ENDOCRINOLOGY, V149, P2138, DOI 10.1210/en.2007-1200; Budefeld T, 2012, J NEUROENDOCRINOL, V24, P225, DOI 10.1111/j.1365-2826.2011.02174.x; Bueno CH, 2007, BRAIN RES BULL, V74, P134, DOI 10.1016/j.brainresbull.2007.06.003; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; Cheung CC, 2013, J COMP NEUROL, V521, P1268, DOI 10.1002/cne.23226; Choi YH, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00071; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Du X, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00081; Gabery S, 2010, ACTA NEUROPATHOL, V120, P777, DOI 10.1007/s00401-010-0742-6; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Hetherington AW, 1940, ANAT REC, V78, P149, DOI 10.1002/ar.1090780203; Hult S, 2011, CELL METAB, V13, P428, DOI 10.1016/j.cmet.2011.02.013; Ikeda Y, 2001, DEV DYNAM, V220, P363, DOI 10.1002/dvdy.1116; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; Kim KW, 2008, MOL ENDOCRINOL, V22, P1950, DOI 10.1210/me.2008-0127; Kim KW, 2011, MOL CELL ENDOCRINOL, V336, P219, DOI 10.1016/j.mce.2010.11.019; Kim Kwang Young, 2011, Algae, V26, P1, DOI 10.4490/algae.2011.26.1.001; Lloret A, 2006, HUM MOL GENET, V15, P2015, DOI 10.1093/hmg/ddl125; Lundh SH, 2013, HUM MOL GENET, V22, P3485, DOI 10.1093/hmg/ddt203; Lundh SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051168; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; McClellan KM, 2006, FRONT NEUROENDOCRIN, V27, P193, DOI 10.1016/j.yfrne.2006.02.002; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Myers MG, 2012, NATURE, V491, P357, DOI 10.1038/nature11705; Pang TYC, 2009, HUM MOL GENET, V18, P753, DOI 10.1093/hmg/ddn385; Parker KL, 2002, RECENT PROG HORM RES, V57, P19, DOI 10.1210/rp.57.1.19; Petersen A, 2005, HUM MOL GENET, V14, P39, DOI 10.1093/hmg/ddi004; Petersen A, 2012, J HUNTINGTONS DIS, V1, P5, DOI 10.3233/JHD-2012-120006; Pla P, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00135; Politis M, 2008, BRAIN, V131, P2860, DOI 10.1093/brain/awn244; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Pouladi MA, 2013, NAT REV NEUROSCI, V14, P708, DOI 10.1038/nrn3570; Pouladi MA, 2012, HUM MOL GENET, V21, P2219, DOI 10.1093/hmg/dds037; Pouladi MA, 2010, HUM MOL GENET, V19, P1528, DOI 10.1093/hmg/ddq026; RABIN BM, 1974, PHYSIOL BEHAV, V13, P769, DOI 10.1016/0031-9384(74)90260-1; Renoir T, 2013, J PHYSIOL-LONDON, V591, P41, DOI 10.1113/jphysiol.2012.239798; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; SAKAGUCHI T, 1988, INT J OBESITY, V12, P285; Soneson C, 2010, NEUROBIOL DIS, V40, P531, DOI 10.1016/j.nbd.2010.07.013; Sturrock A, 2010, J GERIATR PSYCH NEUR, V23, P243, DOI 10.1177/0891988710383573; Suwanai AS, 2013, CLIN ENDOCRINOL, V78, P957, DOI 10.1111/cen.12054; Swaab DF, 2004, INT REV CYTOL, V240, P305, DOI 10.1016/S0074-7696(04)40003-5; Timmers HJLM, 1996, BRAIN RES, V728, P141, DOI 10.1016/0006-8993(96)00080-7; Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P189, DOI 10.1016/j.nbd.2006.12.010; Van Raamsdonk JM, 2006, HUM MOL GENET, V15, P1513, DOI 10.1093/hmg/ddl072; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang N, 2014, NAT MED, V20, P540, DOI 10.1038/nm.3514; Zhao LP, 2008, MOL ENDOCRINOL, V22, P1403, DOI 10.1210/me.2008-0034	52	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e107691	10.1371/journal.pone.0107691	http://dx.doi.org/10.1371/journal.pone.0107691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271967	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600016
J	Jiang, XY; Wang, HM; Edwards, TC; Chen, YP; Lv, YR; Patrick, DL				Jiang, Xiao-Ying; Wang, Hong-Mei; Edwards, Todd C.; Chen, Ying-Ping; Lv, Yi-Ran; Patrick, Donald L.			Measurement Properties of the Chinese Version of the Youth Quality of Life Instrument-Weight Module (YQOL-W)	PLOS ONE			English	Article							OBESE CHILDREN; OVERWEIGHT; CHILDHOOD; RELIABILITY; ADOLESCENTS; VALIDITY	Background: Childhood obesity is a growing public health concern in China. It not only compromises physical health, but also has negative impacts on psychosocial well-being. As obesity rates increase, finding out what the perceptions of Chinese youth are regarding their weight is important for intervention planning and evaluation. However, there is a paucity of available obesity-specific instruments for children and adolescents in China and youth weight-specific quality of life (QOL) has been little reported. This study aimed to evaluate the measurement properties of the Chinese version of the Youth Quality of Life Instrument - Weight Module (YQOL-W). Methods: The Chinese version of the YQOL-W was administered to 840 youth aged 11-18 from nine schools. Measurement properties including measurement model, reliability, validity and burden were evaluated. Results: Confirmatory factor analysis showed that a three-factor model had acceptable model fit. The instrument had robust internal consistency reliability with Cronbach's a ranging from 0.84 to 0.96 and acceptable test-retest reliability with the intraclass correlation coefficients (ICCs) all higher than 0.7. The standard error of measurement (SEM) values for the Self, Social and Environment factors and total score were 10.352, 9.526, 12.086 and 8.425, respectively. The small real differences (SRDs) for the Self, Social and Environment factors and total score were 28.675, 26.387, 33.478, and 23.337, respectively. The Pearson's correlation coefficients between the YQOL-W and the PedsQL4.0 General Core Scales were stronger between comparable dimensions than those between less comparable dimensions, demonstrating convergent and discriminant evidence of construct validity. Significant differences were found in subscale and total scores across weight status, age and genders (P<0.01), supporting the known-groups validity of the instrument. Conclusion: The Chinese version of the YQOL-W has acceptable measurement properties and can be used to assess the weight-specific QOL of children and adolescents in China.	[Jiang, Xiao-Ying; Wang, Hong-Mei; Chen, Ying-Ping; Lv, Yi-Ran] Zhejiang Univ, Sch Med, Inst Social Med & Family Med, Hangzhou 310003, Zhejiang, Peoples R China; [Edwards, Todd C.; Patrick, Donald L.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA	Zhejiang University; University of Washington; University of Washington Seattle	Wang, HM (corresponding author), Zhejiang Univ, Sch Med, Inst Social Med & Family Med, Hangzhou 310003, Zhejiang, Peoples R China.	rosa@zju.edu.cn	Patrick, Donald/Y-2460-2019	Patrick, Donald/0000-0003-0756-0492	Health Policy and Systems Sciences (HPSS) Grants for Young Faculty Partnerships of the China Medical Board [11-043]; NATIONAL CANCER INSTITUTE [R25CA092408] Funding Source: NIH RePORTER	Health Policy and Systems Sciences (HPSS) Grants for Young Faculty Partnerships of the China Medical Board; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by Health Policy and Systems Sciences (HPSS) Grants for Young Faculty Partnerships of the China Medical Board (11-043, http://chinamedicalboard.org.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson N, 2002, QUAL LIFE RES, V11, P193; Ahuja B, 2014, QUAL LIFE RES, V23, P759, DOI 10.1007/s11136-013-0459-9; BARTKO JJ, 1991, SCHIZOPHRENIA BULL, V17, P483, DOI 10.1093/schbul/17.3.483; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Bentler P.M., 2005, EQS STRUCTURAL EQUAT; Berkes A, 2001, HEALTH QUAL LIFE OUT, V8, P14; Brazier J, 1999, HEALTH ECON, V8, P41, DOI 10.1002/(SICI)1099-1050(199902)8:1<41::AID-HEC395>3.0.CO;2-#; Chang JW, 2010, PREVENTION TREATMENT, V18, P613; Chen R, 2011, HEALTH QUAL LIFE OUT, V23, P9; Chen YX, 2010, CHINESE J SCH HLTH, V31, P522; Choudhary AK, 2007, AM J ROENTGENOL, V188, P1118, DOI 10.2214/AJR.06.0651; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; CY Ji, 2008, CHIN J SCH HLTH, V29, P106; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Edwards TC, 2002, J ADOLESCENCE, V25, P275, DOI 10.1006/jado.2002.0470; Eisenberg ME, 2003, ARCH PEDIAT ADOL MED, V157, P733, DOI 10.1001/archpedi.157.8.733; Fabrigar LR, 1999, J AUTISM DEV DISORD, V40, P8; Group of China Obesity Task Force, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P97; Hao YT, 2010, QUAL LIFE RES, V19, P1229, DOI 10.1007/s11136-010-9672-y; Janicke DM, 2007, OBESITY, V15, P1799, DOI 10.1038/oby.2007.214; Ji CY, 2013, BIOMED ENVIRON SCI, V26, P1, DOI 10.3967/0895-3988.2013.01.001; Kottner J, 2009, INT J NURS STUD, V46, P141, DOI 10.1016/j.ijnurstu.2008.04.001; Li SY, 2009, CHINESE J SCH HLTH, V30, P1112; Liu TL, 2010, PLA MED J, V35, P588; Morales LS, 2011, QUAL LIFE RES, V20, P215, DOI 10.1007/s11136-010-9735-0; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Patrick DL, 2002, J ADOLESCENCE, V25, P287, DOI 10.1006/jado.2002.0471; Ravens-Sieberer U, 2001, INT J OBESITY, V25, pS63, DOI 10.1038/sj.ijo.0801702; Research Group on Chinese Students' Physical Fitness and Health, 2011, CHINESE J SCH HLTH, V32, P1026; Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813; Solans M, 2008, VALUE HEALTH, V11, P742, DOI 10.1111/j.1524-4733.2007.00293.x; Staquet MJ, 1998, OX MED PUBL, P337; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tsiros MD, 2009, INT J OBESITY, V33, P387, DOI 10.1038/ijo.2009.42; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Wang HM, 2012, PRO NEWSLETTER, V47, P7; Wang HM, 2012, QUAL LIFE RES, V21, P155, DOI 10.1007/s11136-011-9915-6; Wang XD, 2008, CHINESE ARCH OTOLARY, V15, P219; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wille N, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-36; World Health Organization, 2012, PUP BAS APPR CHILDH; Wu HR, 2006, CHIN J SCH HLTH, V27, P18, DOI DOI 10.3969/J.ISSN.1000-9817.2006.01.017.CHI-NESE; Wu ML, 2010, STRUCTURAL EQUATIONS; Yang SX, 2009, PRACTICAL PREVENTIVE, V16, P347; Yang YL, 2013, QUAL LIFE RES, V22, P2813, DOI 10.1007/s11136-013-0417-6; Yuan KH, 1998, BRIT J MATH STAT PSY, V51, P289, DOI 10.1111/j.2044-8317.1998.tb00682.x; Yuca SA, 2012, CHILDHOOD OBESITY, P3; Zeller MH, 2009, OBESITY, V17, P1171, DOI 10.1038/oby.2009.47; 方敏, 2010, [中国卫生统计, Chinese Journal of Health Statistics], V27, P84	51	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e109221	10.1371/journal.pone.0109221	http://dx.doi.org/10.1371/journal.pone.0109221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268884	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700225
J	Lirman, D; Schopmeyer, S; Galvan, V; Drury, C; Baker, AC; Baums, IB				Lirman, Diego; Schopmeyer, Stephanie; Galvan, Victor; Drury, Crawford; Baker, Andrew C.; Baums, Iliana B.			Growth Dynamics of the Threatened Caribbean Staghorn Coral Acropora cervicornis: Influence of Host Genotype, Symbiont Identity, Colony Size, and Environmental Setting	PLOS ONE			English	Article							REEF RESTORATION; TRANSPLANTATION; PALMATA; QUANTIFICATION; PROPAGATION; FLORIDA; AGE	Background: The drastic decline in the abundance of Caribbean acroporid corals (Acropora cervicornis, A. palmata) has prompted the listing of this genus as threatened as well as the development of a regional propagation and restoration program. Using in situ underwater nurseries, we documented the influence of coral genotype and symbiont identity, colony size, and propagation method on the growth and branching patterns of staghorn corals in Florida and the Dominican Republic. Methodology/Principal Findings: Individual tracking of> 1700 nursery-grown staghorn fragments and colonies from 37 distinct genotypes (identified using microsatellites) in Florida and the Dominican Republic revealed a significant positive relationship between size and growth, but a decreasing rate of productivity with increasing size. Pruning vigor (enhanced growth after fragmentation) was documented even in colonies that lost 95% of their coral tissue/skeleton, indicating that high productivity can be maintained within nurseries by sequentially fragmenting corals. A significant effect of coral genotype was documented for corals grown in a common-garden setting, with fast-growing genotypes growing up to an order of magnitude faster than slow-growing genotypes. Algal-symbiont identity established using qPCR techniques showed that clade A (likely Symbiodinium A3) was the dominant symbiont type for all coral genotypes, except for one coral genotype in the DR and two in Florida that were dominated by clade C, with A- and C-dominated genotypes having similar growth rates. Conclusion/Significance: The threatened Caribbean staghorn coral is capable of extremely fast growth, with annual productivity rates exceeding 5 cm of new coral produced for every cm of existing coral. This species benefits from high fragment survivorship coupled by the pruning vigor experienced by the parent colonies after fragmentation. These life-history characteristics make A. cervicornis a successful candidate nursery species and provide optimism for the potential role that active propagation can play in the recovery of this keystone species.	[Lirman, Diego; Schopmeyer, Stephanie; Drury, Crawford; Baker, Andrew C.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Galvan, Victor] Punta Cana Ecol Fdn, Punta Cana, Dominican Rep; [Baums, Iliana B.] Penn State Univ, State Coll, PA USA	University of Miami; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Lirman, D (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	dlirman@rsmas.miami.edu	Drury, Crawford/AAR-5935-2020; Baums, Iliana Brigitta/G-6435-2010	Drury, Crawford/0000-0001-8853-416X; Baums, Iliana Brigitta/0000-0001-6463-7308; Baker, Andrew/0000-0002-7866-2587; Schopmeyer, Stephanie/0000-0003-4717-465X	NOAA's Coral Reef Conservation Program; NOAA's American Recovery and Reinvestment Act; Nature Conservancy; US ARRA Program, Counterpart International; Frohring Foundation; Directorate For Geosciences [1358699] Funding Source: National Science Foundation	NOAA's Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA's American Recovery and Reinvestment Act; Nature Conservancy; US ARRA Program, Counterpart International; Frohring Foundation; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This publication was made possible with support from NOAA's Coral Reef Conservation Program, NOAA's American Recovery and Reinvestment Act, The Nature Conservancy, the US ARRA Program, Counterpart International, and the Frohring Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak RPM, 2009, B MAR SCI, V84, P287; Baker Andrew C., 1997, P1295; Baums IB, 2009, MOL ECOL RESOUR, V9, P1155, DOI 10.1111/j.1755-0998.2009.02581.x; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Baums IB, 2008, MOL ECOL, V17, P2796, DOI 10.1111/j.1365-294X.2008.03787.x; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Becker LC, 2001, B MAR SCI, V69, P881; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; BOTTJER DJ, 1980, J PALEONTOL, V54, P1102; Bowden-Kerby A, 2012, P 12 INT COR REEF A, p20A; Bruckner AW, 2002, ACROPRA WORKSHOP POT; Bruno JF, 1997, ECOLOGY, V78, P2177, DOI 10.2307/2265954; Clark S, 1995, CORAL REEFS, V14, P201, DOI 10.1007/BF00334342; Courtney LA, 2007, J EXP MAR BIOL ECOL, V351, P234, DOI 10.1016/j.jembe.2007.06.021; Cunning R, 2013, NAT CLIM CHANGE, V3, P259, DOI [10.1038/NCLIMATE1711, 10.1038/nclimate1711]; Enochs IC, 2014, CORAL REEFS, V33, P477, DOI 10.1007/s00338-014-1132-7; Fisher WS, 2008, MAR POLLUT BULL, V56, P1737, DOI 10.1016/j.marpolbul.2008.07.002; Forsman ZH, 2006, AQUACULTURE, V261, P89, DOI 10.1016/j.aquaculture.2006.06.040; GLADFELTER WB, 1982, B MAR SCI, V32, P639; Glynn PW, 2001, B MAR SCI, V69, P79; Griffin S, 2012, P 12 INT COR REEF A, p20A; Herlan J, 2009, P 11 INT COR REEF S, V24, P1244; Hogarth W.T., 2006, FED REGISTER, V71, P26852; HUDSON JH, 1976, GEOLOGY, V4, P361, DOI 10.1130/0091-7613(1976)4<361:SATFIP>2.0.CO;2; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; HUGHES TP, 1987, AM NAT, V129, P818, DOI 10.1086/284677; Huntington BE, 2014, RESTOR ECOL, V22, P299, DOI 10.1111/rec.12057; Jaap WC, 1988, P 6 INT COR REEF S, V2, P237; Johnson M.E., 2011, CARIBBEAN ACROPORA R; JOKIEL PL, 1978, J EXP MAR BIOL ECOL, V35, P87, DOI 10.1016/0022-0981(78)90092-8; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2009, P ROY SOC B-BIOL SCI, V276, P4139, DOI 10.1098/rspb.2009.1405; Lirman D, 2003, ECOL MODEL, V161, P169, DOI 10.1016/S0304-3800(02)00346-0; Lirman D, 2010, CORAL REEFS, V29, P729, DOI 10.1007/s00338-010-0621-6; Lirman D, 2000, J EXP MAR BIOL ECOL, V251, P41, DOI 10.1016/S0022-0981(00)00205-7; Lirman D, 2007, MAR POLLUT BULL, V54, P779, DOI 10.1016/j.marpolbul.2006.12.014; Mieog JC, 2009, MOL ECOL RESOUR, V9, P74, DOI 10.1111/j.1755-0998.2008.02222.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PORTER JW, 1992, AM ZOOL, V32, P625; Precht WF, 2002, CORAL REEFS, V21, P41, DOI 10.1007/s00338-001-0209-2; Rinkevich B, 2000, MAR BIOL, V136, P807, DOI 10.1007/s002270000293; Rinkevich B, 2014, CURR OPIN ENV SUST, V7, P28, DOI 10.1016/j.cosust.2013.11.018; Shaish L, 2008, J EXP MAR BIOL ECOL, V358, P86, DOI 10.1016/j.jembe.2008.01.024; SHINN E. A., 1966, J PALEONTOL, V40, P233; SHINN EA, 1976, ENVIRON GEOL, V1, P241, DOI 10.1007/BF02407510; Silverstein RN, 2012, P ROY SOC B-BIOL SCI, V279, P2609, DOI 10.1098/rspb.2012.0055; Soong K, 2003, RESTOR ECOL, V11, P62, DOI 10.1046/j.1526-100X.2003.00100.x; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Todd PA, 2004, MAR ECOL PROG SER, V271, P167, DOI 10.3354/meps271167; Yap HT, 1998, J EXP MAR BIOL ECOL, V229, P69, DOI 10.1016/S0022-0981(98)00041-0; Young CN, 2012, B MAR SCI, V88, P1075, DOI 10.5343/bms.2011.1143	52	82	81	4	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107253	10.1371/journal.pone.0107253	http://dx.doi.org/10.1371/journal.pone.0107253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268812	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700034
J	Sankaran, N; Leung, J; Carlile, S				Sankaran, Narayan; Leung, Johahn; Carlile, Simon			Effects of Virtual Speaker Density and Room Reverberation on Spatiotemporal Thresholds of Audio-Visual Motion Coherence	PLOS ONE			English	Article							AUDIBLE MOVEMENT ANGLE; PSYCHOMETRIC FUNCTION; STIMULUS FREQUENCY; SOUND LOCALIZATION; PERCEPTION; DISCRIMINATION; INTEGRATION; HUMANS; VELOCITY; SIGNALS	The present study examined the effects of spatial sound-source density and reverberation on the spatiotemporal window for audio-visual motion coherence. Three different acoustic stimuli were generated in Virtual Auditory Space: two acoustically "dry" stimuli via the measurement of anechoic head-related impulse responses recorded at either 1 degrees or 5 degrees spatial intervals (Experiment 1), and a reverberant stimulus rendered from binaural room impulse responses recorded at 5 degrees intervals in situ in order to capture reverberant acoustics in addition to head-related cues (Experiment 2). A moving visual stimulus with invariant localization cues was generated by sequentially activating LED's along the same radial path as the virtual auditory motion. Stimuli were presented at 25 degrees/s, 50 degrees/s and 100 degrees/s with a random spatial offset between audition and vision. In a 2AFC task, subjects made a judgment of the leading modality (auditory or visual). No significant differences were observed in the spatial threshold based on the point of subjective equivalence (PSE) or the slope of psychometric functions (beta) across all three acoustic conditions. Additionally, both the PSE and beta did not significantly differ across velocity, suggesting a fixed spatial window of audio-visual separation. Findings suggest that there was no loss in spatial information accompanying the reduction in spatial cues and reverberation levels tested, and establish a perceptual measure for assessing the veracity of motion generated from discrete locations and in echoic environments.	[Sankaran, Narayan; Leung, Johahn; Carlile, Simon] Univ Sydney, Sch Med Sci, Auditory Neurosci Lab, Sydney, NSW 2006, Australia	University of Sydney	Sankaran, N (corresponding author), Univ Sydney, Sch Med Sci, Auditory Neurosci Lab, Sydney, NSW 2006, Australia.	narayan.sankaran@sydney.edu.au	Sankaran, Narayan/AAI-1430-2021	Sankaran, Narayan/0000-0002-6788-3878	Australian Research Council [DP110104579]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council Grants DP110104579 http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; ALBRIGHT TD, 1995, P NATL ACAD SCI USA, V92, P2433, DOI 10.1073/pnas.92.7.2433; Alink A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00391; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; Blauert J., 1997, SPATIAL HEARING PSYC; Boucher L, 2004, J PHYSIOL-PARIS, V98, P235, DOI 10.1016/j.jphysparis.2004.03.010; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brooks A, 2007, NEUROPSYCHOLOGIA, V45, P523, DOI 10.1016/j.neuropsychologia.2005.12.012; Burr D, 2006, PROG BRAIN RES, V155, P243, DOI 10.1016/S0079-6123(06)55014-9; Carlile S, 2002, J ACOUST SOC AM, V111, P1026, DOI 10.1121/1.1436067; CARLILE S, 1996, VIRTUAL AUDITORY SPA; CHANDLER DW, 1992, J ACOUST SOC AM, V91, P1624, DOI 10.1121/1.402443; Clifton RK, 2002, PERCEPT PSYCHOPHYS, V64, P180, DOI 10.3758/BF03195784; EFRON B, 1978, BIOMETRIKA, V65, P457, DOI 10.2307/2335893; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Farina A, 2007, AES 122 CONV VIENN A; Feinkohl A, 2014, J ACOUST SOC AM, V136, pEL20, DOI 10.1121/1.4881318; Freeman TCA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102864; Getzmann S, 2004, PERCEPTION, V33, P591, DOI 10.1068/p5093; GIGUERE C, 1993, J ACOUST SOC AM, V94, P769, DOI 10.1121/1.408206; Grantham D.W., 1997, BINAURAL SPATIAL HEA, P295; GRANTHAM DW, 1986, J ACOUST SOC AM, V79, P1939, DOI 10.1121/1.393201; Griffiths TD, 2004, NAT REV NEUROSCI, V5, P887, DOI 10.1038/nrn1538; Hairston WD, 2003, J COGNITIVE NEUROSCI, V15, P20, DOI 10.1162/089892903321107792; HARTMANN WM, 1983, J ACOUST SOC AM, V74, P1380, DOI 10.1121/1.390163; Jain A, 2008, J VISION, V8, DOI 10.1167/8.15.7; Jeub M, 2011, P 19 EUR SIGN PROC C; Kleiner M, 2007, PERCEPTION, V36, P14; Lewald J, 2013, NEUROPSYCHOLOGIA, V51, P181, DOI 10.1016/j.neuropsychologia.2012.11.017; Litovsky RY, 1999, J ACOUST SOC AM, V106, P1633, DOI 10.1121/1.427914; MERSHON DH, 1975, PERCEPT PSYCHOPHYS, V18, P409, DOI 10.3758/BF03204113; Meyer GF, 2001, NEUROREPORT, V12, P2557, DOI 10.1097/00001756-200108080-00053; MIDDLEBROOKS JC, 1992, J ACOUST SOC AM, V92, P2607, DOI 10.1121/1.404400; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PERROTT DR, 1977, J ACOUST SOC AM, V62, P1463, DOI 10.1121/1.381675; PERROTT DR, 1989, J ACOUST SOC AM, V85, P1773, DOI 10.1121/1.397968; Saberi K, 2006, ACOUST PHYS+, V52, P87, DOI 10.1134/S106377100601012X; Sanabria D, 2007, EXP BRAIN RES, V178, P415, DOI 10.1007/s00221-007-0919-y; Schmiedchen K, 2012, BRAIN RES, V1466, P99, DOI 10.1016/j.brainres.2012.05.015; Shinn-Cunningham B, 2013, AUDITORY PRECEDENCE, DOI [10.1007/978-1-4614-7320-6_101-5, DOI 10.1007/978-1-4614-7320-6_101-5]; Shinn-Cunningham Barbara G, 2000, P IEEE PCM, V2000, P227, DOI 10.1.1.73.2560; Stein BE., 1993, MERGING SENSES; Wallace MT, 2004, EXP BRAIN RES, V158, P252, DOI 10.1007/s00221-004-1899-9; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wuerger S, 2010, INFORM FUSION, V11, P45, DOI 10.1016/j.inffus.2009.04.005; Zahorik P, 2005, ACTA ACUST UNITED AC, V91, P409; Zahorik P, 2002, J ACOUST SOC AM, V112, P2110, DOI 10.1121/1.1506692; ZUREK PM, 1980, J ACOUST SOC AM, V67, P952, DOI 10.1121/1.383974; Zurek PM, 2004, J ACOUST SOC AM, V115, P1609, DOI 10.1121/1.1650333	50	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108437	10.1371/journal.pone.0108437	http://dx.doi.org/10.1371/journal.pone.0108437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25269061	gold, Green Submitted, Green Published			2022-12-27	WOS:000343671700097
J	Tenin, G; Clowes, C; Wolton, K; Krejci, E; Wright, JA; Lovell, SC; Sedmera, D; Hentges, KE				Tenin, Gennadiy; Clowes, Christopher; Wolton, Kathryn; Krejci, Eliska; Wright, Jayne A.; Lovell, Simon C.; Sedmera, David; Hentges, Kathryn E.			Erbb2 Is Required for Cardiac Atrial Electrical Activity during Development	PLOS ONE			English	Article							VENTRICULAR CONDUCTION SYSTEM; DILATED CARDIOMYOPATHY; NEUREGULIN RECEPTOR; DEFICIENT MICE; EGF RECEPTOR; DUAL ROLE; HEART; ACTIVATION; CONNEXIN40; HEREGULIN	The heart is the first organ required to function during embryonic development and is absolutely necessary for embryo survival. Cardiac activity is dependent on both the sinoatrial node (SAN), which is the pacemaker of heart's electrical activity, and the cardiac conduction system which transduces the electrical signal though the heart tissue, leading to heart muscle contractions. Defects in the development of cardiac electrical function may lead to severe heart disorders. The Erbb2 (Epidermal Growth Factor Receptor 2) gene encodes a member of the EGF receptor family of receptor tyrosine kinases. The Erbb2 receptor lacks ligand-binding activity but forms heterodimers with other EGF receptors, stabilising their ligand binding and enhancing kinase-mediated activation of downstream signalling pathways. Erbb2 is absolutely necessary in normal embryonic development and homozygous mouse knock-out Erbb2 embryos die at embryonic day (E)10.5 due to severe cardiac defects. We have isolated a mouse line, l11Jus8, from a random chemical mutagenesis screen, which carries a hypomorphic missense mutation in the Erbb2 gene. Homozygous mutant embryos exhibit embryonic lethality by E12.5-13. The l11Jus8 mutants display cardiac haemorrhage and a failure of atrial function due to defects in atrial electrical signal propagation, leading to an atrial-specific conduction block, which does not affect ventricular conduction. The l11Jus8 mutant phenotype is distinct from those reported for Erbb2 knockout mouse mutants. Thus, the l11Jus8 mouse reveals a novel function of Erbb2 during atrial conduction system development, which when disrupted causes death at midgestation.	[Tenin, Gennadiy; Clowes, Christopher; Wolton, Kathryn; Lovell, Simon C.; Hentges, Kathryn E.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Krejci, Eliska; Sedmera, David] Charles Univ Prague, Inst Anat, Fac Med 1, Prague, Czech Republic; [Krejci, Eliska; Sedmera, David] Acad Sci Czech Republic, Inst Physiol, Prague, Czech Republic; [Wright, Jayne A.] Syngenta Ltd, Jeallots Hill, England	University of Manchester; Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Syngenta	Hentges, KE (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	kathryn.hentges@manchester.ac.uk	Krejci, Eliska/G-3034-2014; Sedmera, David/C-2146-2012; Sedmera, David/AAL-2968-2020	Krejci, Eliska/0000-0002-3394-9971; Sedmera, David/0000-0002-6828-3671; Wright, Jayne/0000-0003-2246-8555; Lovell, Simon/0000-0002-4092-8458; Hentges, Kathryn/0000-0001-8917-3765; Tenin, Gennadiy/0000-0002-1600-4124	British Heart Foundation [PG/08/007/24400]; Wellcome Trust [097820/Z/11/Z]; BBSRC [BB/I020489/1]; Grant Agency of the Czech Republic [P302/11/1308, 13-12312S]; Ministry of Education [PRVOUK P35/LF1/5]; Academy of Sciences [RVO: 67985823]; BBSRC Industrial CASE studentship; MRC pump-priming grant from the Liverpool Centre for Genomic Research; Biotechnology and Biological Sciences Research Council [1118618, BB/I020489/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education; Academy of Sciences(Egyptian Academy of Scientific Research & Technology (ASRT)); BBSRC Industrial CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC pump-priming grant from the Liverpool Centre for Genomic Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by British Heart Foundation (www.bhf.org/uk) Project Grant PG/08/007/24400, Wellcome Trust (http://www.wellcome.ac.uk/funding/) grant 097820/Z/11/Z to KEH, BBSRC (http://www.bbsrc.ac.uk/home/home.aspx) project grant BB/I020489/1 to SCL, and Grant Agency of the Czech Republic grants P302/11/1308 and 13-12312S to DS, who is additionally supported by Ministry of Education PRVOUK P35/LF1/5 and Academy of Sciences RVO: 67985823. KW was supported by a BBSRC Industrial CASE studentship to Syngenta UK. Exome sequencing was supported by an MRC (http://www.mrc.ac.uk/index.htm) pump-priming grant from the Liverpool Centre for Genomic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alcolea S, 1999, CIRC RES, V84, P1365; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 2002, CURR PROTOC BIOINFOR; Benes J, 2014, FEBS LETT, V588, P1465, DOI 10.1016/j.febslet.2014.01.032; Blankenberg D, 2010, CURR PROTOC MOL BIOL, V10, P11; Boles MK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000759; Britto JM, 2004, MOL CELL BIOL, V24, P8221, DOI 10.1128/MCB.24.18.8221-8226.2004; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; Chan R, 2004, DEVELOPMENT, V131, P5551, DOI 10.1242/dev.01425; Chen VB, 2009, PROTEIN SCI, V18, P2403, DOI 10.1002/pro.250; Christoffels VM, 2010, CIRC RES, V106, P240, DOI 10.1161/CIRCRESAHA.109.205419; Christoffels VM, 2009, CIRC-ARRHYTHMIA ELEC, V2, P195, DOI 10.1161/CIRCEP.108.829341; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Dobrzynski H, 2007, CIRCULATION, V115, P1921, DOI 10.1161/CIRCULATIONAHA.106.616011; Doggen K, 2009, J MOL CELL CARDIOL, V46, P33, DOI 10.1016/j.yjmcc.2008.10.010; Erickson SL, 1997, DEVELOPMENT, V124, P4999; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hentges KE, 2006, GENE EXPR PATTERNS, V6, P653, DOI 10.1016/j.modgep.2005.11.015; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Ishikawa T, 2011, J MED CHEM, V54, P8030, DOI 10.1021/jm2008634; Kile BT, 2003, NATURE, V425, P81, DOI 10.1038/nature01865; Kirchhoff S, 2000, CIRC RES, V87, P399; Kumai M, 2000, DEVELOPMENT, V127, P3501; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kuramochi Y, 2006, J MOL CELL CARDIOL, V41, P228, DOI 10.1016/j.yjmcc.2006.04.007; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu JD, 2010, DEVELOPMENT, V137, P3867, DOI 10.1242/dev.053736; Lodish H., 2004, MOL CELL BIOL; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Miquerol L, 2010, CIRC RES, V107, P153, DOI 10.1161/CIRCRESAHA.110.218156; Negro A, 2004, RECENT PROG HORM RES, V59, P1, DOI 10.1210/rp.59.1.1; Nielsen DL, 2013, BREAST, V22, P1, DOI 10.1016/j.breast.2012.09.008; Olayioye MA, 2001, BREAST CANCER RES, V3, P385, DOI 10.1186/bcr327; Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299; Pentassuglia L, 2009, EXP CELL RES, V315, P627, DOI 10.1016/j.yexcr.2008.08.015; Reckova M, 2003, CIRC RES, V93, P77, DOI 10.1161/01.RES.0000079488.91342.B7; Rentschler S, 2002, P NATL ACAD SCI USA, V99, P10464, DOI 10.1073/pnas.162301699; Salameh A, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00070; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sankova B, 2012, CARDIOVASC RES, V95, P469, DOI 10.1093/cvr/cvs210; Sedmera D, 2003, ANAT REC PART A, V274A, P773, DOI 10.1002/ar.a.10085; Sedmera D, 2006, AM J PHYSIOL-HEART C, V291, pH1646, DOI 10.1152/ajpheart.01007.2005; Severs NJ, 2004, CARDIOVASC RES, V62, P368, DOI 10.1016/j.cardiores.2003.12.007; Sharial MSNM, 2012, ANN ONCOL, V23, P3007, DOI 10.1093/annonc/mds200; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; TZAHAR E, 1994, J BIOL CHEM, V269, P25226; Vaidya D, 2001, CIRC RES, V88, P1196, DOI 10.1161/hh1101.091107; VANKEMPEN MJA, 1995, MICROSC RES TECHNIQ, V31, P420, DOI 10.1002/jemt.1070310511; Wolf CM, 2006, J CARDIOVASC ELECTR, V17, P446, DOI 10.1111/j.1540-8167.2006.00427.x; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400	67	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e107041	10.1371/journal.pone.0107041	http://dx.doi.org/10.1371/journal.pone.0107041			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25269082	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700027
J	Trujillo, ME; Bacigalupe, R; Pujic, P; Igarashi, Y; Benito, P; Riesco, R; Medigue, C; Normand, P				Trujillo, Martha E.; Bacigalupe, Rodrigo; Pujic, Petar; Igarashi, Yasuhiro; Benito, Patricia; Riesco, Raul; Medigue, Claudine; Normand, Philippe			Genome Features of the Endophytic Actinobacterium Micromonospora lupini Strain Lupac 08: On the Process of Adaptation to an Endophytic Life Style?	PLOS ONE			English	Article							ROOT-NODULES; MAXIMUM-LIKELIHOOD; BACTERIAL EXPANSIN; PROTEIN SECRETION; VII SECRETION; FRESH-WATER; CELL-WALLS; SEQUENCE; FRANKIA; STREPTOMYCES	Endophytic microorganisms live inside plants for at least part of their life cycle. According to their life strategies, bacterial endophytes can be classified as "obligate'' or "facultative''. Reports that members of the genus Micromonospora, Gram-positive Actinobacteria, are normal occupants of nitrogen-fixing nodules has opened up a question as to what is the ecological role of these bacteria in interactions with nitrogen-fixing plants and whether it is in a process of adaptation from a terrestrial to a facultative endophytic life. The aim of this work was to analyse the genome sequence of Micromonospora lupini Lupac 08 isolated from a nitrogen fixing nodule of the legume Lupinus angustifolius and to identify genomic traits that provide information on this new plant-microbe interaction. The genome of M. lupini contains a diverse array of genes that may help its survival in soil or in plant tissues, while the high number of putative plant degrading enzyme genes identified is quite surprising since this bacterium is not considered a plant-pathogen. Functionality of several of these genes was demonstrated in vitro, showing that Lupac 08 degraded carboxymethylcellulose, starch and xylan. In addition, the production of chitinases detected in vitro, indicates that strain Lupac 08 may also confer protection to the plant. Micromonospora species appears as new candidates in plant-microbe interactions with an important potential in agriculture and biotechnology. The current data strongly suggests that a beneficial effect is produced on the host-plant.	[Trujillo, Martha E.; Bacigalupe, Rodrigo; Benito, Patricia; Riesco, Raul] Univ Salamanca, Dept Genet & Microbiol, E-37008 Salamanca, Spain; [Pujic, Petar; Normand, Philippe] Univ Lyon 1, CNRS Ecol Microbienne UMR5557, F-69622 Villeurbanne, France; [Igarashi, Yasuhiro] Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama, Japan; [Medigue, Claudine] Genoscope, Atelier Genom Comparat, CNRS UMR 8030, Evry, France	University of Salamanca; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Toyama Prefectural University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA	Trujillo, ME (corresponding author), Univ Salamanca, Dept Genet & Microbiol, Edificio Dept,Campus Miguel de Unamuno, E-37008 Salamanca, Spain.	mett@usal.es	Pujic, Petar/ACY-1850-2022; Santano, Patricia Benito/G-6968-2015; Jarrín, Raúl Riesco/B-1327-2016; Trujillo, Martha E./L-1763-2014; Normand, Philippe/ABD-2235-2020	Pujic, Petar/0000-0003-1957-8534; Santano, Patricia Benito/0000-0002-9060-235X; Jarrín, Raúl Riesco/0000-0001-8257-7601; Trujillo, Martha E./0000-0002-9193-1673; Normand, Philippe/0000-0002-2139-2141; Bacigalupe, Rodrigo/0000-0001-7310-997X	Spanish Ministerio de Economia y Competitividad [CGL2009-07287]; ANR (Sesam)	Spanish Ministerio de Economia y Competitividad(Spanish Government); ANR (Sesam)(French National Research Agency (ANR))	MET received financial support from the Spanish Ministerio de Economia y Competitividad under project CGL2009-07287. PN acknowledges financial support from the ANR (Sesam). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Abdel-Lateif K, 2012, PLANT SIGNAL BEHAV, V7, P636, DOI 10.4161/psb.20039; Aeschbacher RA, 1999, PLANT PHYSIOL, V119, P489, DOI 10.1104/pp.119.2.489; Alonso-Vega P, 2012, J BACTERIOL, V194, P4135, DOI 10.1128/JB.00628-12; Altamirano-Hernandez J, 2007, CROP SCI, V47, P1193, DOI 10.2135/cropsci2006.09.0569; Anderson I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039331; Barraza A, 2013, NEW PHYTOL, V197, P194, DOI 10.1111/nph.12002; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bignell DRD, 2010, ANTON LEEUW INT J G, V98, P179, DOI 10.1007/s10482-010-9429-1; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Carro L, 2013, J BIOSCIENCES, V38, P685, DOI 10.1007/s12038-013-9359-y; Carro L, 2012, SYST APPL MICROBIOL, V35, P73, DOI 10.1016/j.syapm.2011.11.003; Cases I, 2003, TRENDS MICROBIOL, V11, P248, DOI 10.1016/S0966-842X(03)00103-3; Cerda ME, 2008, THESIS U SALAMANCA S; Chi F, 2005, APPL ENVIRON MICROB, V71, P7271, DOI 10.1128/AEM.71.11.7271-7278.2005; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Conn VM, 2004, APPL ENVIRON MICROB, V70, P1787, DOI 10.1128/AEM.70.3.1787-1794.2004; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Cuiv PO, 2004, J BACTERIOL, V186, P2996, DOI 10.1128/JB.186.10.2996-3005.2004; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; de Menezes AB, 2008, APPL ENVIRON MICROB, V74, P7080, DOI 10.1128/AEM.01092-08; DeShazer D, 1999, J BACTERIOL, V181, P4661, DOI 10.1128/JB.181.15.4661-4664.1999; Dethlefsen L, 2007, J BACTERIOL, V189, P3237, DOI 10.1128/JB.01686-06; DOW JM, 1989, J CELL SCI, P59; Duca D, 2014, ANTON LEEUW INT J G, V106, P85, DOI 10.1007/s10482-013-0095-y; Dudeja SS, 2012, J BASIC MICROB, V52, P248, DOI 10.1002/jobm.201100063; Farias-Rodriguez R, 1998, PHYSIOL PLANTARUM, V102, P353, DOI 10.1034/j.1399-3054.1998.1020303.x; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FILLOUX A, 1990, EMBO J, V9, P4323, DOI 10.1002/j.1460-2075.1990.tb07881.x; Frederiksen RF, 2013, MICROBIOL-SGM, V159, P833, DOI 10.1099/mic.0.051839-0; Fyans JK, 2013, MOL PLANT PATHOL, V14, P119, DOI 10.1111/j.1364-3703.2012.00835.x; Genilloud O, 2014, ANTON LEEUW INT J G, V106, P173, DOI 10.1007/s10482-014-0204-6; Georgelis N, 2011, J BIOL CHEM, V286, P16814, DOI 10.1074/jbc.M111.225037; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Gtari M, 2012, ARCH MICROBIOL, V194, P3, DOI 10.1007/s00203-011-0733-6; Hammad Y, 2003, PLANT SOIL, V254, P193, DOI 10.1023/A:1024971417777; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; HARDY RWF, 1968, PLANT PHYSIOL, V43, P1185, DOI 10.1104/pp.43.8.1185; Hirsch AM, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00759-13; Hubber A, 2004, MOL MICROBIOL, V54, P561, DOI 10.1111/j.1365-2958.2004.04292.x; Igarashi Y, 2007, BIOORG MED CHEM LETT, V17, P3702, DOI 10.1016/j.bmcl.2007.04.039; Igarashi Y, 2011, J NAT PROD, V74, P670, DOI 10.1021/np100727h; Igarashi Y, 2011, J NAT PROD, V74, P862, DOI 10.1021/np100779t; Jahr H, 2000, MOL PLANT MICROBE IN, V13, P703, DOI 10.1094/MPMI.2000.13.7.703; Jakob K, 2007, MOL PLANT MICROBE IN, V20, P146, DOI 10.1094/MPMI-20-2-0146; Jayani RS, 2005, PROCESS BIOCHEM, V40, P2931, DOI 10.1016/j.procbio.2005.03.026; Jendrossek D, 1997, FEMS MICROBIOL LETT, V150, P179, DOI 10.1111/j.1574-6968.1997.tb10368.x; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; Kaewkla O, 2013, MICROB ECOL, V65, P384, DOI 10.1007/s00248-012-0113-z; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; Kerff F, 2008, P NATL ACAD SCI USA, V105, P16876, DOI 10.1073/pnas.0809382105; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOBAYASHI M, 1995, P NATL ACAD SCI USA, V92, P714, DOI 10.1073/pnas.92.3.714; KOBAYASHI M, 1993, P NATL ACAD SCI USA, V90, P247, DOI 10.1073/pnas.90.1.247; Krause A, 2006, NAT BIOTECHNOL, V24, P1385, DOI 10.1038/nbt1243; Laine MJ, 2000, PHYSIOL MOL PLANT P, V57, P221, DOI 10.1006/pmpp.2000.0301; Lopes-Santos C, 2009, PLOS ONE, V7; Lykidis A, 2007, J BACTERIOL, V189, P2477, DOI 10.1128/JB.01899-06; Marchetti M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000280; Mastronunzio JE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-47; MATEOS PF, 1992, APPL ENVIRON MICROB, V58, P1816, DOI 10.1128/AEM.58.6.1816-1822.1992; MCCARTHY AJ, 1984, J GEN MICROBIOL, V130, P2905; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; Medie FM, 2012, NAT REV MICROBIOL, V10, P227, DOI 10.1038/nrmicro2729; Miele V, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-116; Milagres AMF, 1999, J MICROBIOL METH, V37, P1, DOI 10.1016/S0167-7012(99)00028-7; Mukherjee PK, 2012, MICROBIOL-SGM, V158, P155, DOI 10.1099/mic.0.052159-0; Muller J, 2001, J EXP BOT, V52, P943, DOI 10.1093/jexbot/52.358.943; Murthy N., 2012, INTERNET J MICROBIOL, V10, P1937, DOI [10.5580/2bc3, DOI 10.5580/2BC3]; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Normand P, 2007, GENOME RES, V17, P7, DOI 10.1101/gr.5798407; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Orskov J, 1923, COPENHAGEN; Patankar AV, 2009, FEMS MICROBIOL REV, V33, P739, DOI 10.1111/j.1574-6976.2009.00163.x; Pedrosa FO, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002064; Penn K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-86; Pujic P, 2012, ARCH MICROBIOL, V194, P47, DOI 10.1007/s00203-011-0770-1; REEVES PJ, 1993, MOL MICROBIOL, V8, P443, DOI 10.1111/j.1365-2958.1993.tb01589.x; Reinhold-Hurek B, 1998, TRENDS MICROBIOL, V6, P139, DOI 10.1016/S0966-842X(98)01229-3; Ren QH, 2005, PLOS COMPUT BIOL, V1, P190, DOI 10.1371/journal.pcbi.0010027; Ren QH, 2007, J MOL MICROB BIOTECH, V12, P165, DOI 10.1159/000099639; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; RIGAUD J, 1975, J GEN MICROBIOL, V88, P223, DOI 10.1099/00221287-88-2-223; ROWBOTHAM TJ, 1977, J GEN MICROBIOL, V100, P231, DOI 10.1099/00221287-100-2-231; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; SANDRAK N A, 1977, Mikrobiologiya, V46, P478; Scott JR, 2006, ANNU REV MICROBIOL, V60, P397, DOI 10.1146/annurev.micro.60.080805.142256; Smith SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050070; Smits THM, 2010, MOL PLANT MICROBE IN, V23, P384, DOI 10.1094/MPMI-23-4-0384; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; STREETER JG, 1985, J BACTERIOL, V164, P78, DOI 10.1128/JB.164.1.78-84.1985; Sutcliffe IC, 2011, ANTON LEEUW INT J G, V99, P127, DOI 10.1007/s10482-010-9507-4; Tadra-Sfeir MZ, 2011, APPL ENVIRON MICROB, V77, P2180, DOI 10.1128/AEM.02071-10; Taghavi S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000943; Taguchi F, 2010, J BACTERIOL, V192, P117, DOI 10.1128/JB.00689-09; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tivendale KA, 2004, INFECT IMMUN, V72, P6554, DOI 10.1128/IAI.72.11.6554-6560.2004; Tornus D, 2001, J ANTIBIOT, V54, P91, DOI 10.7164/antibiotics.54.91; Trujillo ME, 2007, INT J SYST EVOL MICR, V57, P2799, DOI 10.1099/ijs.0.65192-0; Trujillo ME, 2010, ISME J, V4, P1265, DOI 10.1038/ismej.2010.55; Udwary DW, 2007, P NATL ACAD SCI USA, V104, P10376, DOI 10.1073/pnas.0700962104; Udwary DW, 2011, APPL ENVIRON MICROB, V77, P3617, DOI 10.1128/AEM.00038-11; Valdes M, 2005, APPL ENVIRON MICROB, V71, P460, DOI 10.1128/AEM.71.1.460-466.2005; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Velazquez-Robledo R, 2011, MOL PLANT MICROBE IN, V24, P1459, DOI 10.1094/MPMI-02-11-0045; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Vicente-Villardon J.L., 2010, MULTBIPLOT PACKAGE M; WILLIAMS ST, 1983, J GEN MICROBIOL, V129, P1743; Wisniewski-Dye F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002430; Yano K, 2013, MICROBIOL-SGM, V159, P2225, DOI 10.1099/mic.0.067025-0; Zakhia F, 2006, MICROB ECOL, V51, P375, DOI 10.1007/s00248-006-9025-0	115	42	43	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108522	10.1371/journal.pone.0108522	http://dx.doi.org/10.1371/journal.pone.0108522			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268993	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700107
J	Guan, Z; Liu, JC; Bai, WH; Lv, ZZ; Jiang, XL; Yang, SM; Chen, AL; Lv, GY				Guan, Zheng; Liu, Jinchuan; Bai, Wenhui; Lv, Zhenzhen; Jiang, Xiaoling; Yang, Shuming; Chen, Ailiang; Lv, Guiyuan			Label-Free and Sensitive Fluorescent Detection of Sequence-Specific Single-Strand DNA Based on S1 Nuclease Cleavage Effects	PLOS ONE			English	Article							GRAPHENE OXIDE; ASSAY	The ability to detect sequence-specific single-strand DNA (ssDNA) in complex, contaminant-ridden samples, using a fluorescent method directly without a DNA extraction and PCR step could simplify the detection of pathogens in the field and in the clinic. Here, we have demonstrated a simple label-free sensing strategy to detect ssDNA by employing its complementary ssDNA, S1 nuclease and nucleic acid fluorescent dyes. Upon clearing away redundant complementary ssDNA and possibly mismatched double strand DNA by using S1 nuclease, the fluorescent signal-to-noise ratio could be increased dramatically. It enabled the method to be adaptable to three different types of DNA fluorescent dyes and the ability to detect target ssDNA in complex, multicomponent samples, like tissue homogenate. The method can distinguish a two-base mismatch from avian influenza A (H1N1) virus. Also, it can detect the appearance of 50 pM target ssDNA in 0.5 mu g.mL(-1) Lambda DNA, and 50 nM target ssDNA in 5 mu g.mL(-1) Lambda DNA or in tissue homogenate. It is facile and cost-effective, and could be easily extended to detect other ssDNA with many common nucleic acid fluorescent dyes.	[Guan, Zheng; Liu, Jinchuan; Bai, Wenhui; Lv, Zhenzhen; Jiang, Xiaoling; Yang, Shuming; Chen, Ailiang] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Key Lab Agroprod Qual & Safety, Beijing 100193, Peoples R China; [Guan, Zheng; Liu, Jinchuan; Bai, Wenhui; Lv, Zhenzhen; Jiang, Xiaoling; Yang, Shuming; Chen, Ailiang] Minist Agr, Key Lab Agrofood Qual & Safety, Beijing, Peoples R China; [Guan, Zheng; Lv, Guiyuan] Zhejiang Chinese Med Univ, Inst Mat Med, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS; Ministry of Agriculture & Rural Affairs; Zhejiang Chinese Medical University	Chen, AL (corresponding author), Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Key Lab Agroprod Qual & Safety, Beijing 100193, Peoples R China.	ailiang.chen@gmail.com; guiyuan_lv@yeah.net	Guan, Zheng/L-7701-2018; Chen, Ailiang/AAA-6470-2022	Guan, Zheng/0000-0001-8617-8114; 	Special Fund for Agro scientific Research in the Public Interest [201203046]	Special Fund for Agro scientific Research in the Public Interest	Funding provided by The Special Fund for Agro scientific Research in the Public Interest (201203046) (http://119.253.58.231/hykj). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaglia C, 2000, BIOTECHNIQUES, V29, P78, DOI 10.2144/00291st01; Cosa G, 2001, PHOTOCHEM PHOTOBIOL, V73, P585, DOI 10.1562/0031-8655(2001)073<0585:PPOFDD>2.0.CO;2; DEMIDOV V, 1993, NUCLEIC ACIDS RES, V21, P2103, DOI 10.1093/nar/21.9.2103; Dong HF, 2012, ANAL CHEM, V84, P4587, DOI 10.1021/ac300721u; Doyle SR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-83; Du M, 2012, TALANTA, V88, P439, DOI 10.1016/j.talanta.2011.10.054; Hu YW, 2012, ANAL CHIM ACTA, V753, P82, DOI 10.1016/j.aca.2012.09.038; Liu MY, 2011, BIOSENS BIOELECTRON, V26, P4294, DOI 10.1016/j.bios.2011.04.014; Papadopoulou E, 2012, CHEM-EUR J, V18, P5394, DOI 10.1002/chem.201103520; Sun W, 2012, ANAL CHIM ACTA, V752, P39, DOI 10.1016/j.aca.2012.09.009; Tian JP, 2012, ANAL CHIM ACTA, V723, P83, DOI 10.1016/j.aca.2012.02.030; Tuma RS, 1999, ANAL BIOCHEM, V268, P278, DOI 10.1006/abio.1998.3067; Zeng GP, 2012, ANAL LETT, V45, P2334, DOI 10.1080/00032719.2012.691591; Zeng GP, 2011, ACTA CHIM SINICA, V69, P1450; Zhang YW, 2012, ACS COMB SCI, V14, P191, DOI 10.1021/co2001394; Zhou WJ, 2011, ABSTR PAP AM CHEM S, V241	16	5	6	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108401	10.1371/journal.pone.0108401	http://dx.doi.org/10.1371/journal.pone.0108401			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285445	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700018
J	Huang, WD; Liu, GX; Zhang, X; Fu, WQ; Zheng, S; Wu, QH; Liu, CJ; Liu, Y; Cai, SR; Huang, YQ				Huang, Weidong; Liu, Guoxiang; Zhang, Xin; Fu, Wenqi; Zheng, Shu; Wu, Qunhong; Liu, Chaojie; Liu, Yang; Cai, Shanrong; Huang, Yanqin			Cost-Effectiveness of Colorectal Cancer Screening Protocols in Urban Chinese Populations	PLOS ONE			English	Article							COLONOSCOPY; GUIDELINES; RISK	Colorectal cancer (CRC) takes a second and fourth position in the incidence and mortality lists respectively among all malignant tumors in urban populations in China. This study was designed to evaluate the cost-effectiveness of two different CRC screening protocols: faecal occult blood test (FOBT) alone, and FOBT plus a high-risk factor questionnaire (HRFQ) as the respective initial screens, followed by colonoscopy. We developed a Markov model to simulate the progression of a cohort of 100,000 average risk asymptomatic individuals moving through a defined series of states between the ages of 40 to 74 years. The parameters used for the modeling came from the CESP (Comparison and Evaluation of Screening Programs for Colorectal Cancer in Urban Communities in China) study and published literature. Eight CRC screening scenarios were tested in the Markov model. The cost-effectiveness of CRC screening under each scenario was measured by an incremental cost-effectiveness ratio (ICER) compared with a scenario without CRC screening. The study revealed that a combined use of FOBT and HRFQ is preferable in CRC screening programs as an initial screening instrument. Annual FOBT+HRFQ screening is recommended for those who have a negative initial result and those who have a positive result but have failed to continue to colonoscopic examination. Repeated colonoscopy (for those with a positive result in initial screening but a negative colonoscopy result) should be performed at a ten-year interval instead of one-year. Such a protocol would cost 7732 Yuan per life year saved, which is the most cost-effective option. In conclusion, the current Chinese Trial Version for CRC Screening Strategy should be revised in line with the most cost-effective protocol identified in this study.	[Huang, Weidong; Liu, Guoxiang; Zhang, Xin; Fu, Wenqi; Wu, Qunhong; Liu, Yang] Harbin Med Univ, Sch Hlth Management, Harbin, Peoples R China; [Zheng, Shu; Cai, Shanrong; Huang, Yanqin] Zhejiang Univ, Sch Med, Key Lab Canc Prevent & Intervent,Affliated Hosp 2, Key Lab Mol Biol Med Sci,Minist Educ China,Canc I, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Chaojie] La Trobe Univ, Sch Publ Hlth, Melbourne, Vic, Australia	Harbin Medical University; Ministry of Education, China; Zhejiang University; La Trobe University	Liu, GX (corresponding author), Harbin Med Univ, Sch Hlth Management, Harbin, Peoples R China.	lgx6301@163.com; zhengshu@zju.edu.cn; wuqunhong@163.com	Liu, Chaojie/Q-6915-2018	Liu, Chaojie/0000-0003-0877-0424	China National Fiscal Supplement National Cancer Early Detection and Treatment Program (Ministry of Health and Ministry of Finance, China); Health and Family Planning Commission of Heilongjiang Province [2012-776]; Education Office of Heilongjiang province [12531373]	China National Fiscal Supplement National Cancer Early Detection and Treatment Program (Ministry of Health and Ministry of Finance, China); Health and Family Planning Commission of Heilongjiang Province; Education Office of Heilongjiang province	This investigation was supported by a special fund to Local Public Health by the China National Fiscal Supplement National Cancer Early Detection and Treatment Program (2006-2009, Ministry of Health and Ministry of Finance, China). The study was partially funded by Health and Family Planning Commission of Heilongjiang Province (project NO. 2012-776) and Education Office of Heilongjiang province (project NO. 12531373). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananda SS, 2009, MED J AUSTRALIA, V191, P378, DOI 10.5694/j.1326-5377.2009.tb02843.x; [Anonymous], TABULATION 2000 POPU; [Anonymous], 2004, CHINA CANC, V13, P65; Arbyn M, 2003, BMJ-BRIT MED J, V327, P289, DOI 10.1136/bmj.327.7409.289-b; Ascunce N, 2010, ANN ONCOL S3, piii43; Berchi C, 2004, HEALTH ECON, V13, P227, DOI 10.1002/hec.819; Cai SR, 2009, WORLD J GASTROENTERO, V15, P2531, DOI 10.3748/wjg.15.2531; Canfell K, 2011, VACCINE, V29, P2487, DOI 10.1016/j.vaccine.2010.12.085; Chen K, 1988, J ZHEJIANG MED U, V17, P49; Choi KS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-265; Dong ZW, 2009, GUIDELINES CANC SCRE, P123; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lansdorp-Vogelaar I, 2010, BEST PRACT RES CL GA, V24, P439, DOI 10.1016/j.bpg.2010.04.004; Liu XY, 1997, CANC RES PREVENTION, V24, P197; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Masseria C, 2010, EUR J HEALTH ECON, V10, P41, DOI 10.1007/s10198-009-0191-0; Meng W, 2009, WORLD J GASTROENTERO, V15, P3920, DOI 10.3748/wjg.15.3920; Micheli A, 2002, ANN ONCOL, V13, P840, DOI 10.1093/annonc/mdf127; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Saito H, 2006, J MED SCREEN, V13, pS6; Shi JF, 2011, BMC CANCER, V11, DOI [10.1186/1471-2407-11-239, 10.1186/1472-6750-11-77]; Sonnenberg A, 2000, ANN INTERN MED, V133, P573, DOI 10.7326/0003-4819-133-8-200010170-00007; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316; Towler B, 1998, BRIT MED J, V317, P559, DOI 10.1136/bmj.317.7158.559; Tsoi KKF, 2008, ALIMENT PHARM THER, V28, P353, DOI 10.1111/j.1365-2036.2008.03726.x; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Wu GHM, 2006, BMC CANCER, V6, P1, DOI 10.1186/1471-2407-6-136; Zhao P, 2011, CHINESE CANC REGISTE, P32; Zheng S, 2003, DIS COLON RECTUM, V46, P51, DOI 10.1007/s10350-004-6496-2; Zheng S, 2009, CHINA CANC, V18, P700; Zheng S, 1991, CHINESE MED J, V71, P381	37	22	25	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109150	10.1371/journal.pone.0109150	http://dx.doi.org/10.1371/journal.pone.0109150			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285526	Green Submitted, Green Published, gold			2022-12-27	WOS:000345743700049
J	Mlynarski, W; Jost, J				Mlynarski, Wiktor; Jost, Juergen			Statistics of Natural Binaural Sounds	PLOS ONE			English	Article							LOW-FREQUENCY NEURONS; NEURAL REPRESENTATION; LOCALIZATION CUES; AUDITORY SPACE; PHASE; PERCEPTION; SPECTRA; MAMMALS; SPEECH	Binaural sound localization is usually considered a discrimination task, where interaural phase (IPD) and level (ILD) disparities at narrowly tuned frequency channels are utilized to identify a position of a sound source. In natural conditions however, binaural circuits are exposed to a stimulation by sound waves originating from multiple, often moving and overlapping sources. Therefore statistics of binaural cues depend on acoustic properties and the spatial configuration of the environment. Distribution of cues encountered naturally and their dependence on physical properties of an auditory scene have not been studied before. In the present work we analyzed statistics of naturally encountered binaural sounds. We performed binaural recordings of three auditory scenes with varying spatial configuration and analyzed empirical cue distributions from each scene. We have found that certain properties such as the spread of IPD distributions as well as an overall shape of ILD distributions do not vary strongly between different auditory scenes. Moreover, we found that ILD distributions vary much weaker across frequency channels and IPDs often attain much higher values, than can be predicted from head filtering properties. In order to understand the complexity of the binaural hearing task in the natural environment, sound waveforms were analyzed by performing Independent Component Analysis (ICA). Properties of learned basis functions indicate that in natural conditions soundwaves in each ear are predominantly generated by independent sources. This implies that the real-world sound localization must rely on mechanisms more complex than a mere cue extraction.	[Mlynarski, Wiktor; Jost, Juergen] Max Planck Inst Math Sci, Leipzig, Germany; [Jost, Juergen] Santa Fe Inst, Santa Fe, NM 87501 USA	Max Planck Society; The Santa Fe Institute	Mlynarski, W (corresponding author), Max Planck Inst Math Sci, Leipzig, Germany.	mlynar@mis.mpg.de		Jost, Juergen/0000-0001-5258-6590	DFG Graduate College InterNeuro	DFG Graduate College InterNeuro(German Research Foundation (DFG))	This work was funded by the DFG Graduate College InterNeuro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah S., 2001, P ICA SAN DIEG US, P534; Attias H, 1997, ADV NEUR IN, V9, P27; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bialek W., 2012, BIOPHYSICS SEARCHING; Blauert J., 1997, SPATIAL HEARING PSYC; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Browns GJ, 2005, SIG COM TEC, P371, DOI 10.1007/3-540-27489-8_16; Brungart DS, 1999, J ACOUST SOC AM, V106, P1465, DOI 10.1121/1.427180; Cadieu C, 2009, THESIS U CALIFORNIA; Cadieu CF, 2010, NEURAL COMPUT, V22, P3107, DOI 10.1162/NECO_a_00048; Carlson NL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002594; Dahmen JC, 2010, NEURON, V66, P937, DOI 10.1016/j.neuron.2010.05.018; Fischer BJ, 2007, ADV NEURAL INFORM PR, P449; Fischer BJ, 2011, NAT NEUROSCI, V14, P1061, DOI 10.1038/nn.2872; Gourevitch B, 2012, J ACOUST SOC AM, V132, P9, DOI 10.1121/1.4726052; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Hancock KE, 2004, J NEUROSCI, V24, P7110, DOI 10.1523/JNEUROSCI.0762-04.2004; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; Hofman PM, 2002, BIOL CYBERN, V86, P305, DOI 10.1007/s00422-001-0294-x; Hsu A, 2004, J NEUROSCI, V24, P9201, DOI 10.1523/JNEUROSCI.2449-04.2004; Hunt JJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003005; Hyvarinen A, 2009, COMPUT IMAGING VIS, V39, P1; King AJ, 2001, TRENDS COGN SCI, V5, P261, DOI 10.1016/S1364-6613(00)01660-0; KUWADA S, 1983, J NEUROPHYSIOL, V50, P981, DOI 10.1152/jn.1983.50.4.981; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Lewicki MS, 2014, FRONTIERS PSYCHOL, V5; Maier JK, 2012, J NEUROPHYSIOL, V108, P1856, DOI 10.1152/jn.00652.2011; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; McDermott JH, 2009, CURR BIOL, V19, pR1024, DOI 10.1016/j.cub.2009.09.005; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Olshausen BA, 2004, PROBLEMS SYSTEMS NEU, V4, P182, DOI DOI 10.1093/ACPROF:OSO/9780195148220.003.0010; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Rieke F., 1999, SPIKES EXPLORING NEU; Shinn-Cunningham BG, 2000, J ACOUST SOC AM, V107, P1627, DOI 10.1121/1.428447; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Strutt J, 1875, P MUS ASS, V2, P75; Tollin DJ, 2005, J NEUROSCI, V25, P10648, DOI 10.1523/JNEUROSCI.1609-05.2005; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0	42	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108968	10.1371/journal.pone.0108968	http://dx.doi.org/10.1371/journal.pone.0108968			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285658	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700040
J	Arruti, A; Cearreta, I; Alvarez, A; Lazkano, E; Sierra, B				Arruti, Andoni; Cearreta, Idoia; Alvarez, Aitor; Lazkano, Elena; Sierra, Basilio			Feature Selection for Speech Emotion Recognition in Spanish and Basque: On the Use of Machine Learning to Improve Human-Computer Interaction	PLOS ONE			English	Article							STANDARD BASQUE; PARAMETERS	Study of emotions in human-computer interaction is a growing research area. This paper shows an attempt to select the most significant features for emotion recognition in spoken Basque and Spanish Languages using different methods for feature selection. RekEmozio database was used as the experimental data set. Several Machine Learning paradigms were used for the emotion classification task. Experiments were executed in three phases, using different sets of features as classification variables in each phase. Moreover, feature subset selection was applied at each phase in order to seek for the most relevant feature subset. The three phases approach was selected to check the validity of the proposed approach. Achieved results show that an instance-based learning algorithm using feature subset selection techniques based on evolutionary algorithms is the best Machine Learning paradigm in automatic emotion recognition, with all different feature sets, obtaining a mean of 80,05% emotion recognition rate in Basque and a 74,82% in Spanish. In order to check the goodness of the proposed process, a greedy searching approach (FSS-Forward) has been applied and a comparison between them is provided. Based on achieved results, a set of most relevant non-speaker dependent features is proposed for both languages and new perspectives are suggested.	[Arruti, Andoni; Cearreta, Idoia; Lazkano, Elena; Sierra, Basilio] Univ Basque Country, Fac Comp Sci, San Sebastian, Spain; [Alvarez, Aitor] Vicomtech IK4 Res Alliance, San Sebastian, Spain	University of Basque Country	Arruti, A (corresponding author), Univ Basque Country, Fac Comp Sci, San Sebastian, Spain.	andoni.arruti@ehu.es	Arruti, Andoni/G-2404-2016; Sierra, Basilio/AAX-9544-2020; Sierra, Basilio/L-3160-2014; Lazkano, Elena/AAX-9542-2020	Arruti, Andoni/0000-0002-5324-4215; Sierra, Basilio/0000-0001-8062-9332; Alvarez, Aitor/0000-0002-7938-4486	Basque Government Research Team under Spanish Ministry [TIN2010-15549]; University of the Basque Country UPV/EHU [UFI11/45]	Basque Government Research Team under Spanish Ministry; University of the Basque Country UPV/EHU	This work has been done within the Basque Government Research Team grant under project TIN2010-15549 of the Spanish Ministry and the University of the Basque Country UPV/EHU, under grant UFI11/45 (BAILab). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelin Asa, 2000, P ISCA WS SPEECH EMO, P110; Aha D.W., 1994, P AAAI 94 WORKSH CAS, VVolume 106, P112; AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1007/BF00153759; Alonso-Arbiol I, 2006, COGNITION EMOTION, V20, P836, DOI 10.1080/02699930500405469; Alvarez A, 2007, LECT NOTES ARTIF INT, V4629, P423; Alvarez A, 2006, LECT NOTES ARTIF INT, V4188, P565; Athanaselis T, 2005, NEURAL NETWORKS, V18, P437, DOI 10.1016/j.neunet.2005.03.008; Baluja S., 1994, CMUCS94163, DOI [10.5555/865123, DOI 10.5555/865123]; BATLINER A, 2000, P ISCA WORKSH SPEECH, P195; Bradley MM, 1997, AFFECTIVE NORMS ENGL; Caballero-Morales SO, 2013, SCI WORLD J, V13; Cordoba R, 2002, COMPUT SPEECH LANG, V16, P183, DOI 10.1006/csla.2002.0190; Cowie R, 2005, NEURAL NETWORKS, V18, P371, DOI 10.1016/j.neunet.2005.03.002; Cowie R, 2001, IEEE SIGNAL PROC MAG, V18, P32, DOI 10.1109/79.911197; Dellaert F, 1996, P 4 INT C SPOK LANG; Demsar J, 2006, J MACH LEARN RES, V7, P1; Ekman P, 1984, APPROACHES EMOTION; Ekman P., 1976, PICTURES FACIAL AFFE; Fragopanagos N, 2005, NEURAL NETWORKS, V18, P389, DOI 10.1016/j.neunet.2005.03.006; Garay N, 2006, HUMAN TECHNOLOGY, V2, P55, DOI DOI 10.17011/ht/urn.2006159; Gharavian D, 2012, NEURAL COMPUT APPL, V21, P2115, DOI 10.1007/s00521-011-0643-1; Harik GR, 1997, 97006 ILLIGAL U ILL; Holland J.H., 1975, ADAPTATION NATURAL A; Hozjan V., 2003, International Journal of Speech Technology, V6, P311, DOI 10.1023/A:1023426522496; Huber R., 2000, P INT C SPOK LANG PR, P665; Iriondo I., 2000, P ISCA WORKSH SPEECH, P161; Kohavi J., 1994, P 11 INT C MACH LEAR, P121, DOI [DOI 10.1016/B978-1-55860-335-6.50023-4, 10.1016/B978-1-55860-335-6.50023-4]; Kohavi R., 1997, International Journal on Artificial Intelligence Tools (Architectures, Languages, Algorithms), V6, P537, DOI 10.1142/S021821309700027X; Koolagudi SG, 2012, INT J SPEECH TECHNOL, V15, P495, DOI 10.1007/s10772-012-9150-8; Koolagudi SG, 2012, INT J SPEECH TECHNOL, V15, P99, DOI 10.1007/s10772-011-9125-1; LANG PJ, 1979, PSYCHOPHYSIOLOGY, V16, P495, DOI 10.1111/j.1469-8986.1979.tb01511.x; Larranaga P, 1999, P 2 S ART INT CIMAF, P314; Laukka P, 2004, THESIS UPPSALA U; Liu H, 1998, FEATURE EXTRACTION C, DOI 10. 1007/978-1-4615-5725-8; Liu HA, 1998, APPL INTELL, V9, P217, DOI 10.1023/A:1008363719778; Lopez JM, 2006, P 7 SPAN HUM COMP IN, P55; Lopez JM, 2007, LECT NOTES COMPUT SC, V4560, P422; Luengo I., 2005, P INTERSPEECH, P493; Martin JK, 1997, MACH LEARN, V28, P257, DOI 10.1023/A:1007367629006; Mingers J, 1988, TECHNICAL REPORT; MINSKY M, 1961, P IRE, V49, P8, DOI 10.1109/JRPROC.1961.287775; Montero JM, 1999, P 14 INT C PHON SCI, P957; Muhlenbein H, 1997, EVOL COMPUT, V5, P303, DOI 10.1162/evco.1997.5.3.303; Muhlenbein H, 1996, LECT NOTES COMPUTER, V1411, P188; NARENDRA P, 1977, IEEE T COMPUT, V26, P917, DOI 10.1109/TC.1977.1674939; Navas E, 2004, LECT NOTES COMPUT SC, V3287, P386; Navas E, 2004, LECT NOTES COMPUT SC, V3206, P393; Nogueira A., 2001, P EUR, P2679; Partila P., 2013, NOSTRADAMUS 2013 PRE, V210, P221; Pelikan M., 1999, 99018 ILLIGAL U ILL; Petrushin V., 1999, P ART NEUR NETW ENG, P7; Picard R. W., 1997, AFFECTIVE COMPUTING; Picard RW, 2001, IEEE T PATTERN ANAL, V23, P1175, DOI 10.1109/34.954607; Picard RW, 1998, P IMAGINA, P153; Pierre-Yves O, 2003, INT J HUM-COMPUT ST, V59, P157, DOI [10.1016/S1071-5819(02)00141-6, 10.1016/S1071-5819(03)00141-6]; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Ramakrishnan S, 2013, TELECOMMUN SYST, V52, P1467, DOI 10.1007/s11235-011-9624-z; Rani P, 2006, PATTERN ANAL APPL, V9, P58, DOI 10.1007/s10044-006-0025-y; SCHERER KR, 1986, PSYCHOL BULL, V99, P143, DOI 10.1037/0033-2909.99.2.143; Schroder M., 2004, THESIS SAARLAND U SA; Shami M, 2007, SPEECH COMMUN, V49, P201, DOI 10.1016/j.specom.2007.01.006; Tao JH, 2005, LECT NOTES COMPUT SC, V3784, P981; Tato R., 2002, P INT C SPOK LANG PR, V3, P2029; Taylor JG, 2005, NEURAL NETWORKS, V18, P313, DOI 10.1016/j.neunet.2005.04.001; Tickle A, 2000, P ISCA WORKSH SPEECH, P104; Ting KM, 1995, THESIS U SIDNEY BASS; Truong KP, 2007, SPEECH COMMUN, V49, P144, DOI 10.1016/j.specom.2007.01.001; Wettschereck D., 1994, STUDY DISTANCE BASED; Yixiong Pan, 2012, INT J SMART HOME, V6; Zhang SQ, 2013, MULTIMED TOOLS APPL, V63, P615, DOI 10.1007/s11042-011-0887-x	71	11	11	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108975	10.1371/journal.pone.0108975	http://dx.doi.org/10.1371/journal.pone.0108975			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279686	gold, Green Published			2022-12-27	WOS:000342670800043
J	Chang, CH; Fan, PC; Chang, MY; Tian, YC; Hung, CC; Fang, JT; Yang, CW; Chen, YC				Chang, Chih-Hsiang; Fan, Pei-Chun; Chang, Ming-Yang; Tian, Ya-Chung; Hung, Cheng-Chieh; Fang, Ji-Tseng; Yang, Chih-Wei; Chen, Yung-Chang			Acute Kidney Injury Enhances Outcome Prediction Ability of Sequential Organ Failure Assessment Score in Critically Ill Patients	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CHRONIC-HEALTH-EVALUATION; ACUTE PHYSIOLOGY SCORE; INTENSIVE-CARE-UNIT; HOSPITAL MORTALITY; CONSENSUS CONFERENCE; CARDIAC-SURGERY; HEART-FAILURE; RISK; CLASSIFICATION	Introduction: Acute kidney injury (AKI) is a common and serious complication in intensive care unit (ICU) patients and also often part of a multiple organ failure syndrome. The sequential organ failure assessment (SOFA) score is an excellent tool for assessing the extent of organ dysfunction in critically ill patients. This study aimed to evaluate the outcome prediction ability of SOFA and Acute Physiology and Chronic Health Evaluation (APACHE) III score in ICU patients with AKI. Methods: A total of 543 critically ill patients were admitted to the medical ICU of a tertiary-care hospital from July 2007 to June 2008. Demographic, clinical and laboratory variables were prospectively recorded for post hoc analysis as predictors of survival on the first day of ICU admission. Results: One hundred and eighty-seven (34.4%) patients presented with AKI on the first day of ICU admission based on the risk of renal failure, injury to kidney, failure of kidney function, loss of kidney function, and end-stage renal failure (RIFLE) classification. Major causes of the ICU admissions involved respiratory failure (58%). Overall in-ICU mortality was 37.9% and the hospital mortality was 44.7%. The predictive accuracy for ICU mortality of SOFA (areas under the receiver operating characteristic curves: 0.815 +/- 0.032) was as good as APACHE III in the AKI group. However, cumulative survival rates at 6-month follow-up following hospital discharge differed significantly (p<0.001) for SOFA score <= 10 vs. >= 11 in these ICU patients with AKI. Conclusions: For patients coexisting with AKI admitted to ICU, this work recommends application of SOFA by physicians to assess ICU mortality because of its practicality and low cost. A SOFA score of >= "11'' on ICU day 1 should be considered an indicator of negative short-term outcome.	[Chang, Chih-Hsiang; Fan, Pei-Chun; Chang, Ming-Yang; Tian, Ya-Chung; Hung, Cheng-Chieh; Fang, Ji-Tseng; Yang, Chih-Wei; Chen, Yung-Chang] Taiwan Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Kidney Res Ctr,Dept Nephrol, Taoyuan, Taiwan; [Chang, Chih-Hsiang; Fan, Pei-Chun; Chang, Ming-Yang; Tian, Ya-Chung; Hung, Cheng-Chieh; Fang, Ji-Tseng; Yang, Chih-Wei; Chen, Yung-Chang] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Chen, YC (corresponding author), Taiwan Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Kidney Res Ctr,Dept Nephrol, Taoyuan, Taiwan.	cyc2356@adm.cgmh.org.tw	Chang, Jason Chih-Hsiang/P-8662-2017; Chang, Ming-Yang/AGH-5397-2022	Chang, Jason Chih-Hsiang/0000-0002-7342-335X; Chang, Ming-Yang/0000-0001-8899-0376				Abosaif NY, 2005, AM J KIDNEY DIS, V46, P1038, DOI 10.1053/j.ajkd.2005.08.033; Ahlstrom A, 2006, AM J KIDNEY DIS, V48, P262, DOI 10.1053/j.ajkd.2006.04.086; Anker SD, 2009, EUR HEART J, V30, P1331, DOI 10.1093/eurheartj/ehp116; Aronson D, 2007, EUR HEART J, V28, P1289, DOI 10.1093/eurheartj/ehm013; Barrantes F, 2008, CRIT CARE MED, V36, P1397, DOI 10.1097/CCM.0b013e318168fbe0; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Chen TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032328; Chen YC, 2006, INT J CLIN PRACT, V60, P160, DOI 10.1111/j.1368-5031.2005.00634.x; Chertow GM, 2006, KIDNEY INT, V70, P1120, DOI 10.1038/sj.ki.5001579; Cooke CR, 2008, CRIT CARE MED, V36, P1412, DOI 10.1097/CCM.0b013e318170a375; Das V, 2010, CRIT CARE MED, V38, P2108, DOI 10.1097/CCM.0b013e3181f3dea9; de Mendonca A, 2000, INTENS CARE MED, V26, P915, DOI 10.1007/s001340051281; du Cheyron D, 2005, INTENS CARE MED, V31, P1693, DOI 10.1007/s00134-005-2842-7; Groenveld HF, 2008, J AM COLL CARDIOL, V52, P818, DOI 10.1016/j.jacc.2008.04.061; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Hsu RK, 2013, CLIN J AM SOC NEPHRO, V8, P1476, DOI 10.2215/CJN.12611212; Jenq CC, 2007, INTENS CARE MED, V33, P1921, DOI 10.1007/s00134-007-0760-6; Keegan MT, 2011, CRIT CARE MED, V39, P163, DOI 10.1097/CCM.0b013e3181f96f81; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEGALL JR, 1984, CRIT CARE MED, V12, P975; Lin CY, 2010, SHOCK, V34, P352, DOI 10.1097/SHK.0b013e3181d8e61d; Lin YF, 2008, BLOOD PURIFICAT, V26, P547, DOI 10.1159/000178771; Liu KD, 2008, CLIN J AM SOC NEPHRO, V3, P578, DOI 10.2215/CJN.01630407; Liu KD, 2009, CRIT CARE, V13, DOI 10.1186/cc7940; Maraldi C, 2006, J CARD FAIL, V12, P533, DOI 10.1016/j.cardfail.2006.05.002; Mehta RL, 2003, SEMIN NEPHROL, V23, P283, DOI 10.1016/S0270-9295(03)00064-0; ROCKWOOD K, 1993, CRIT CARE MED, V21, P687, DOI 10.1097/00003246-199305000-00011; Scott RA, 2013, FRONTLINE GASTROENTE, V4, P191, DOI 10.1136/flgastro-2012-100291; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Van Den Noortgate N, 2003, NEPHROL DIAL TRANSPL, V18, P732, DOI 10.1093/ndt/gfg043; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	40	26	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109649	10.1371/journal.pone.0109649	http://dx.doi.org/10.1371/journal.pone.0109649			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279844	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800094
J	Darnaude, AM; Sturrock, A; Trueman, CN; Mouillot, D; Campana, SE; Hunter, E				Darnaude, Audrey M.; Sturrock, Anna; Trueman, Clive N.; Mouillot, David; Campana, Steven E.; Hunter, Ewan		EIMF	Listening In on the Past: What Can Otolith delta O-18 Values Really Tell Us about the Environmental History of Fishes?	PLOS ONE			English	Article							OXYGEN-ISOTOPE FRACTIONATION; CARBON STABLE-ISOTOPES; NORTH-SEA PLAICE; COD GADUS-MORHUA; TEMPERATURE-DEPENDENT BIOGEOGRAPHY; PLEURONECTES-PLATESSA; STOCK STRUCTURE; THERMAL TOLERANCE; CLIMATE-CHANGE; BLUEFIN TUNA	Oxygen isotope ratios from fish otoliths are used to discriminate marine stocks and reconstruct past climate, assuming that variations in otolith delta O-18 values closely reflect differences in temperature history of fish when accounting for salinity induced variability in water delta O-18. To investigate this, we exploited the environmental and migratory data gathered from a decade using archival tags to study the behaviour of adult plaice (Pleuronectes platessa L.) in the North Sea. Based on the tag-derived monthly distributions of the fish and corresponding temperature and salinity estimates modelled across three consecutive years, we first predicted annual otolith delta O-18 values for three geographically discrete offshore sub-stocks, using three alternative plausible scenarios for otolith growth. Comparison of predicted vs. measured annual delta O-18 values demonstrated >96% correct prediction of sub-stock membership, irrespective of the otolith growth scenario. Pronounced inter-stock differences in delta O-18 values, notably in summer, provide a robust marker for reconstructing broad-scale plaice distribution in the North Sea. However, although largely congruent, measured and predicted annual delta O-18 values of did not fully match. Small, but consistent, offsets were also observed between individual high-resolution otolith delta O-18 values measured during tag recording time and corresponding delta O-18 predictions using concomitant tag-recorded temperatures and location-specific salinity estimates. The nature of the shifts differed among sub-stocks, suggesting specific vital effects linked to variation in physiological response to temperature. Therefore, although otolith delta O-18 in free-ranging fish largely reflects environmental temperature and salinity, we counsel prudence when interpreting otolith delta O-18 data for stock discrimination or temperature reconstruction until the mechanisms underpinning otolith delta O-18 signature acquisition, and associated variation, are clarified.	[Darnaude, Audrey M.; Mouillot, David] Univ Montpellier 2, UMR CNRS UM2 UM1 IFREMER, IRD Ecol Syst Marins Cotiers 5119, Montpellier, France; [Darnaude, Audrey M.; Sturrock, Anna; Hunter, Ewan] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Lowestoft, Suffolk, England; [Sturrock, Anna; Trueman, Clive N.] Univ Southampton, Ocean & Earth Sci Natl Oceanog Ctr, Southampton, Hants, England; [EIMF] Univ Edinburgh, Sch Geosci, Edinburgh Ion Microprobe Facil, Edinburgh, Midlothian, Scotland; [Campana, Steven E.] Fisheries & Oceans Canada, Bedford Inst Oceanog, Populat Ecol Div, Dartmouth, NS B2Y 4A2, Canada	Universite de Montpellier; Centre for Environment Fisheries & Aquaculture Science; NERC National Oceanography Centre; University of Southampton; University of Edinburgh; Bedford Institute of Oceanography; Fisheries & Oceans Canada	Darnaude, AM (corresponding author), Univ Montpellier 2, UMR CNRS UM2 UM1 IFREMER, IRD Ecol Syst Marins Cotiers 5119, Montpellier, France.	darnaude@univ-montp2.fr	Campana, Steven/L-7918-2019; Darnaude, Audrey M/AAH-9026-2020; Trueman, Clive/E-6925-2011; Darnaude, Audrey M/D-1745-2014	Campana, Steven/0000-0002-7453-3761; Darnaude, Audrey M/0000-0001-7129-3902; Sturrock, Anna/0000-0001-9423-9845; Hunter, Ewan/0000-0003-0140-2928	European Commission Marie-Curie Intra-European Fellowship Program (EU) [MEIF-CT-2003-501391 PlaiceLifeline]; Natural Environment Research Council (DEFRA) [MF0152, M1102]; Natural Environment Research Council [IMF010001] Funding Source: researchfish; NERC [IMF010001] Funding Source: UKRI	European Commission Marie-Curie Intra-European Fellowship Program (EU); Natural Environment Research Council (DEFRA)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)Department for Environment, Food & Rural Affairs (DEFRA)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funders for this work were: (1) European Commission Marie-Curie Intra-European Fellowship Program (MEIF-CT-2003-501391 PlaiceLifeline, EU, 2004-2005), (2) Natural Environment Research Council (DEFRA contracts MF0152 "Validation and testing of biologically-based movement models for North Sea plaice and implementation in management and assessment", 2003-2007 and DEFRA contract M1102 "Macro-ecology of marine finfish in UK waters", 2007-2012). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson T.F., 1990, P403; Andrus CFT, 2002, SCIENCE, V295, P1508, DOI 10.1126/science.1062004; Ashford J, 2007, GEOCHIM COSMOCHIM AC, V71, P87, DOI 10.1016/j.gca.2006.08.030; Ayvazian SG, 2004, FISH RES, V67, P39, DOI 10.1016/j.fishres.2003.08.003; Bastow TP, 2002, MAR BIOL, V141, P801, DOI 10.1007/s00227-002-0884-8; Beck WC, 2005, GEOCHIM COSMOCHIM AC, V69, P3493, DOI 10.1016/j.gca.2005.02.003; Begg GA, 2001, MAR ECOL PROG SER, V216, P223, DOI 10.3354/meps216223; Bromley PJ, 2000, J SEA RES, V44, P27, DOI 10.1016/S1385-1101(00)00043-5; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campana SE, 2000, FISH RES, V46, P343, DOI 10.1016/S0165-7836(00)00158-2; Carpenter SJ, 2003, NATURE, V423, P70, DOI 10.1038/nature01575; Craig H., 1965, DEUTERIUM OXYGEN 18, P9, DOI DOI 10.1109/ISSRE.1993.624301; DEGENS ET, 1969, MAR BIOL, V2, P105, DOI 10.1007/BF00347005; DEVEREUX I, 1967, SCIENCE, V155, P1684, DOI 10.1126/science.155.3770.1684; Dorval E, 2007, CAN J FISH AQUAT SCI, V64, P411, DOI 10.1139/F07-015; Edmonds JS, 1999, J FISH BIOL, V55, P243, DOI 10.1111/j.1095-8649.1999.tb00676.x; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; FONDS M, 1992, NETH J SEA RES, V29, P127, DOI 10.1016/0077-7579(92)90014-6; Friedman I., 1977, COMPILATION STABLE I, P1; Gabitov RI, 2013, CHEM GEOL, V351, P268, DOI 10.1016/j.chemgeo.2013.05.015; Gao YW, 2002, ISOT ENVIRON HEALT S, V38, P251, DOI 10.1080/1025601021000065038; Gao YW, 2001, CAN J FISH AQUAT SCI, V58, P2113, DOI 10.1139/cjfas-58-11-2113; Gao YW, 2001, ENVIRON BIOL FISH, V61, P445, DOI 10.1023/A:1011654403034; GAULDIE RW, 1990, COMP BIOCHEM PHYS A, V97, P119, DOI 10.1016/0300-9629(90)90159-P; Geffen AJ, 2012, ENVIRON BIOL FISH, V95, P419, DOI 10.1007/s10641-012-0033-2; Ghosh P, 2007, GEOCHIM COSMOCHIM AC, V71, P2736, DOI 10.1016/j.gca.2007.03.015; Godiksen JA, 2011, POLAR BIOL, V34, P591, DOI 10.1007/s00300-010-0907-8; Godiksen J, 2010, HYDROBIOLOGIA, V650, P67, DOI 10.1007/s10750-009-0056-7; Graham CM, 1996, GEOCHIM COSMOCHIM AC, V60, P5101, DOI 10.1016/S0016-7037(96)00286-4; Harding D., 1978, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V172, P102; Harwood AJP, 2008, ESTUAR COAST SHELF S, V78, P353, DOI 10.1016/j.ecss.2007.12.010; Hickson JA, 1999, PALAEOGEOGR PALAEOCL, V154, P325, DOI 10.1016/S0031-0182(99)00120-0; Hobson KA, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P273, DOI 10.1007/978-90-481-3354-3_13; Hoie H, 2004, MAR BIOL, V144, P1039, DOI 10.1007/s00227-003-1275-5; Hoie H, 2004, ICES J MAR SCI, V61, P243, DOI 10.1016/j.icesjms.2003.11.006; Hoie H, 2003, J EXP MAR BIOL ECOL, V289, P41, DOI 10.1016/S0022-0981(03)00034-0; Hunter E, 2004, J ANIM ECOL, V73, P377, DOI 10.1111/j.0021-8790.2004.00801.x; Hunter E, 2003, P ROY SOC B-BIOL SCI, V270, P2097, DOI 10.1098/rspb.2003.2473; Hunter E, 2003, MAR BIOL, V142, P601, DOI 10.1007/s00227-002-0984-5; Hunter E, 2009, MAR ECOL PROG SER, V392, P167, DOI 10.3354/meps08213; Jones JB, 2009, ECOL APPL, V19, P1500, DOI 10.1890/07-2002.1; KALISH JM, 1991, MAR ECOL PROG SER, V75, P191, DOI 10.3354/meps075191; KALISH JM, 1991, MAR BIOL, V110, P37, DOI 10.1007/BF01313090; Kell LT, 2004, J SEA RES, V51, P287, DOI 10.1016/j.seares.2003.10.004; Kerr L.A., 2014, STOCK IDENTIFICATION, P205, DOI DOI 10.1016/B978-0-12-397003-9.00011-4; Kim ST, 2007, GEOCHIM COSMOCHIM AC, V71, P4704, DOI 10.1016/j.gca.2007.04.019; Kim ST, 1997, GEOCHIM COSMOCHIM AC, V61, P3461, DOI 10.1016/S0016-7037(97)00169-5; Lardies MA, 2004, EVOL ECOL RES, V6, P567; LeGrande AN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026011; Levitus S, 1995, CLIMATIC CHANGE, V31, P495, DOI 10.1007/BF01095159; Lychakov DV, 2008, J FISH BIOL, V72, P2579, DOI 10.1111/j.1095-8649.2008.01869.x; Metcalfe JD, 2006, J FISH BIOL, V69, P48, DOI 10.1111/j.1095-8649.2006.01275.x; Mikalsen G, 2000, ESTUAR COAST SHELF S, V50, P441, DOI 10.1006/ecss.1999.0581; Millero F. J., 1996, CHEM OCEANOGRAPHY; Morrongiello JR, 2012, NAT CLIM CHANGE, V2, P849, DOI [10.1038/NCLIMATE1616, 10.1038/nclimate1616]; Newman SJ, 2010, ENVIRON BIOL FISH, V89, P357, DOI 10.1007/s10641-010-9668-z; Newton JR, 2010, AQUACULTURE, V308, pS128, DOI 10.1016/j.aquaculture.2010.05.040; Nolf D, 1995, BEL BAR LIB, P513; Owen EF, 2008, GEOCHIM COSMOCHIM AC, V72, P4687, DOI 10.1016/j.gca.2008.06.029; Panfili J, 2002, MANUAL FISH SCLEROCH; Portner HO, 2010, J FISH BIOL, V77, P1745, DOI 10.1111/j.1095-8649.2010.02783.x; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2008, CLIM RES, V37, P253, DOI 10.3354/cr00766; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2005, SCI MAR, V69, P271; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Price GD, 2009, GEOLOGY, V37, P215, DOI 10.1130/G25377A.1; Pulgar JM, 2006, J FISH BIOL, V68, P975, DOI 10.1111/j.1095-8649.2006.00979.x; Radtke RL, 1998, MAR BIOL, V132, P347; Radtke RL, 1996, MAR BIOL, V127, P161, DOI 10.1007/BF00993656; RIJNSDORP AD, 1989, J FISH BIOL, V35, P401, DOI 10.1111/j.1095-8649.1989.tb02992.x; RIJNSDORP AD, 1989, J CONSEIL, V46, P35; Rooker JR, 2008, MAR ECOL PROG SER, V368, P231, DOI 10.3354/meps07602; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Rye D.M., 1980, Topics in Geobiology, V1, P169; SCHOLANDER PF, 1953, PHYSIOL ZOOL, V26, P67, DOI 10.1086/physzool.26.1.30152151; Stephenson PC, 2001, J FISH BIOL, V58, P126, DOI 10.1006/jfbi.2000.1437; Stips A, 2004, OCEAN DYNAM, V54, P266, DOI 10.1007/s10236-003-0077-0; Storm-Suke A, 2007, RAPID COMMUN MASS SP, V21, P4109, DOI 10.1002/rcm.3320; Sturrock AM, 2014, MAR ECOL PROG SER, V500, P245, DOI 10.3354/meps10699; Surge D, 2005, PALAEOGEOGR PALAEOCL, V228, P179, DOI 10.1016/j.palaeo.2005.03.051; SWART PK, 1983, EARTH-SCI REV, V19, P51, DOI 10.1016/0012-8252(83)90076-4; Thorrold SR, 1997, GEOCHIM COSMOCHIM AC, V61, P2909, DOI 10.1016/S0016-7037(97)00141-5; Tohse H, 2008, AQUAT BIOL, V1, P259, DOI 10.3354/ab00029; Trueman CN, 2012, J FISH BIOL, V81, P826, DOI 10.1111/j.1095-8649.2012.03361.x; Van Neer W, 2004, INT J OSTEOARCHAEOL, V14, P457, DOI 10.1002/oa.727; Weidel BC, 2007, CAN J FISH AQUAT SCI, V64, P1641, DOI 10.1139/F07-157; Weidman CR, 2000, FISH RES, V46, P327, DOI 10.1016/S0165-7836(00)00157-0; West CF, 2012, J ARCHAEOL SCI, V39, P3277, DOI 10.1016/j.jas.2012.05.009; Wright JD, 2013, QUATERNARY GEOCHRONO, P671; Wright PJ, 2001, J FISH BIOL, V59, P657, DOI 10.1111/j.1095-8649.2001.tb02369.x; Zazzo A, 2006, EARTH PLANET SC LETT, V249, P200, DOI 10.1016/j.epsl.2006.07.003; Ziveri P, 2003, EARTH PLANET SC LETT, V210, P137, DOI 10.1016/S0012-821X(03)00101-8	93	39	39	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108539	10.1371/journal.pone.0108539	http://dx.doi.org/10.1371/journal.pone.0108539			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279667	Green Published, gold, Green Accepted			2022-12-27	WOS:000342670800019
J	Gao, MJ; Yang, G; Tompkins, VS; Gao, L; Wu, XS; Tao, Y; Hu, XJ; Hou, J; Han, Y; Xu, HW; Zhan, FH; Shi, JM				Gao, Minjie; Yang, Guang; Tompkins, Van S.; Gao, Lu; Wu, Xiaosong; Tao, Yi; Hu, Xiaojing; Hou, Jun; Han, Ying; Xu, Hongwei; Zhan, Fenghuang; Shi, Jumei			Early versus Deferred Treatment for Smoldering Multiple Myeloma: A Meta-Analysis of Randomized, Controlled Trials	PLOS ONE			English	Article							UNDETERMINED SIGNIFICANCE; MONOCLONAL GAMMOPATHY; STAGE-I; THERAPY; CHEMOTHERAPY; THALIDOMIDE; PROGRESSION; STRATEGIES; DIAGNOSIS; DISEASE	Purpose: Whether patients with smoldering multiple myeloma (SMM) needed to receive early interventional treatment remains controversial. Herein, we conducted a meta-analysis comparing the efficacy and safety of early treatment over deferred treatment for patients with SMM. Methods: MEDLINE and Cochrane Library were searched to May 2014 for randomized controlled trials (RCTs) that assessed the effect of early treatment over deferred treatment. Primary outcome measure was mortality, and secondary outcome measures were progression, response rate, and adverse events. Results: Overall, 5 trials including 449 patients were identified. There was a markedly reduced risk of disease progression with early treatment (Odds Ratio [OR] = 0.13, 95% confidence interval [CI] = 0.07 to 0.24). There were no significant differences in mortality and response rate (OR = 0.85, 95%CI = 0.45 to 1.60, and OR = 0.63, 95%CI = 0.32 to 1.23, respectively). More patients in the early treatment arm experienced gastrointestinal toxicities (OR = 10.02, 95%CI = 4.32 to 23.23), constipation (OR = 8.58, 95%CI = 3.20 to 23.00) and fatigue or asthenia (OR = 2.72, 95%CI = 1.30 to 5.67). No significant differences were seen with the development of acute leukemia (OR = 2.80, 95%CI = 0.42 to 18.81), hematologic cancer (OR = 2.07, 95%CI = 0.43 to 10.01), second primary tumors (OR = 3.45, 95%CI = 0.81 to 14.68), nor vertebral compression (OR = 0.18, 95%CI = 0.02 to 1.59). Conclusions: Early treatment delayed disease progression but increased the risk of gastrointestinal toxicities, constipation and fatigue or asthenia. The differences on vertebral compression, acute leukemia, hematological cancer and second primary tumors were not statistically significant. Based on the current evidence, early treatment didn't significantly affect mortality and response rate. However, further much larger trials were needed to provide more evidence.	[Gao, Minjie; Yang, Guang; Gao, Lu; Wu, Xiaosong; Tao, Yi; Hu, Xiaojing; Hou, Jun; Han, Ying; Shi, Jumei] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Hematol, Shanghai 200092, Peoples R China; [Tompkins, Van S.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA USA; [Xu, Hongwei; Zhan, Fenghuang] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA	Tongji University; University of Iowa; University of Iowa	Zhan, FH (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	fenghuang-zhan@uiowa.edu; shijumei@hotmail.com	xu, hong/GSD-8903-2022; Tompkins, Van/A-5757-2018	Tompkins, Van/0000-0003-1279-8075; Tao, Yi/0000-0002-7361-6063; Zhan, Fenghuang/0000-0001-6208-1676	National Natural Science Foundation of China [81372391, 81071856, 81000199, 81250110552, 81228016]; Shanghai Science and Technology Program [12410705100]; Shanghai Tenth People's Hospital Funds [040113015]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007344] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Program; Shanghai Tenth People's Hospital Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Natural Science Foundation of China (No. 81372391, 81071856 to J.S., 81000199 to X. H., 81250110552 to T. V., and 81228016 to F.Z.), Shanghai Science and Technology Program (No. 12410705100 to J.S.), Shanghai Tenth People's Hospital Funds (No. 040113015 to J.S.). The funders conceived and designed the experiments, contributed reagents/materials/analysis tools, drafted the paper, and read and approved the final paper.	Bianchi G, 2013, LEUKEMIA, V27, P680, DOI 10.1038/leu.2012.237; Blade J, 2010, J CLIN ONCOL, V28, P690, DOI 10.1200/JCO.2009.22.2257; Dolloff NG, 2013, ADV EXP MED BIOL, V779, P197, DOI 10.1007/978-1-4614-6176-0_9; Fouquet G, 2013, REV MED INTERNE; Ghobrial IM, 2013, LEUKEMIA LYMPHOMA, V54, P2328, DOI 10.3109/10428194.2013.788699; Harousseau JL, 2010, CANCER TREAT REV, V36, pS33, DOI 10.1016/S0305-7372(10)70010-4; He Y, 2003, COCHRANE DATABASE D, pD4023; HJORTH M, 1993, EUR J HAEMATOL, V50, P95; Korde N, 2011, BLOOD, V117, P5573, DOI 10.1182/blood-2011-01-270140; Kyle RA, 2007, BRIT J HAEMATOL, V139, P730, DOI 10.1111/j.1365-2141.2007.06873.x; Kyle RA, 2007, NEW ENGL J MED, V356, P2582, DOI 10.1056/NEJMoa070389; Larsen JT, 2013, LEUKEMIA, V27, P941, DOI 10.1038/leu.2012.296; Mateos MV, 2013, NEW ENGL J MED, V369, P438, DOI 10.1056/NEJMoa1300439; Mhaskar AR, 2010, CANCER TREAT REV, V36, P621, DOI 10.1016/j.ctrv.2010.04.001; Palumbo A, 2009, LEUKEMIA, V23, P1716, DOI 10.1038/leu.2009.122; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Rajkumar SV, 2012, AM J HEMATOL, V87, P453, DOI 10.1002/ajh.23204; Rajkumar SV, 2011, NEW ENGL J MED, V365, P474, DOI 10.1056/NEJMc1106428; Rajkumar SV, 2003, LEUKEMIA, V17, P775, DOI 10.1038/sj.leu.2402866; RICCARDI A, 1994, BRIT J CANCER, V70, P1203, DOI 10.1038/bjc.1994.474; Riccardi A, 2000, BRIT J CANCER, V82, P1254; Smith D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3863; Waxman AJ, 2010, CL LYMPH MYELOM LEUK, V10, P248, DOI 10.3816/CLML.2010.n.053; Witzig TE, 2013, LEUKEMIA, V27, P220, DOI 10.1038/leu.2012.236	24	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109758	10.1371/journal.pone.0109758	http://dx.doi.org/10.1371/journal.pone.0109758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279718	Green Submitted, gold, Green Published			2022-12-27	WOS:000342670800100
J	Lin, Z; Xu, YN; Namgoong, S; Kim, NH				Lin, Zili; Xu, Yong-Nan; Namgoong, Suk; Kim, Nam-Hyung			JMY Functions as Actin Nucleation-Promoting Factor and Mediator for p53-Mediated DNA Damage in Porcine Oocytes	PLOS ONE			English	Article							MOUSE OOCYTES; ASYMMETRIC DIVISION; MEIOTIC SPINDLE; P53 RESPONSE; MATURATION; COFACTOR; INDUCTION; FORMIN-2; KINASE; P300	Junction-mediating and regulatory protein(JMY) is a multifunctional protein with roles in the transcriptional co-activation of p53 and the regulation of actin nucleation promoting factors and, hence, cell migration; however, its role in the maturation of porcine oocytes is unclear. In the current study, we investigated functional roles of JMY in porcine oocytes. Porcine oocytes expressed JMY mRNA and protein, and the mRNA expression level decreased during oocyte maturation. Knockdown of JMY by RNA interference decreased the rate of polar body extrusion, validating its role in the asymmetric division of porcine oocytes. JMY knockdown also down-regulated the mRNA and protein levels of actin and Arp2/3. Furthermore, JMY accumulated in the nucleus in response to DNA damage, and JMY knockdown suppressed DNA damage-mediated p53 activation. In conclusion, our results show that JMY has important roles in oocyte maturation as a regulator of actin nucleation-promoting factors and an activator of p53 during DNA damage during DNA damages in porcine oocytes.	[Lin, Zili; Xu, Yong-Nan; Namgoong, Suk; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea	Chungbuk National University	Namgoong, S (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea.	suknamgoong@chungbuk.ac.kr; nhkim@chungbuk.ac.kr			Next Generation Biogreen 21 Program, RDA, Republic of Korea [PJ009080, PJ009594]	Next Generation Biogreen 21 Program, RDA, Republic of Korea	This study was supported by a grant from the Next Generation Biogreen 21 Program (PJ009080 and PJ009594), RDA, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Carroll John, 2013, Frontiers in Genetics, V4, P117, DOI 10.3389/fgene.2013.00117; Coutts AS, 2011, ONCOGENE, V30, P4835, DOI 10.1038/onc.2011.188; Coutts AS, 2007, EMBO REP, V8, P84, DOI 10.1038/sj.embor.7400855; Demonacos C, 2004, NAT CELL BIOL, V6, P968, DOI 10.1038/ncb1170; Demonacos C, 2001, MOL CELL, V8, P71, DOI 10.1016/S1097-2765(01)00277-5; FRITSCHE M, 1993, ONCOGENE, V8, P307; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Li YH, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109850; Lin ZL, 2014, REPROD DOMEST ANIM, V49, P219, DOI 10.1111/rda.12254; Liu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052277; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marangos P, 2012, CURR BIOL, V22, P989, DOI 10.1016/j.cub.2012.03.063; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Roadcap DW, 2009, NAT CELL BIOL, V11, P375, DOI 10.1038/ncb0409-375; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Sun QY, 2006, REPRODUCTION, V131, P193, DOI 10.1530/rep.1.00847; Sun SC, 2011, MOL HUM REPROD, V17, P296, DOI 10.1093/molehr/gar006; Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392; Tanaka T, 2007, CELL CYCLE, V6, P371, DOI 10.4161/cc.6.3.3835; Wang QC, 2013, MICROSC MICROANAL, V19, P559, DOI 10.1017/S1431927613000032; Wrighton Katharine H, 2009, Nat Rev Mol Cell Biol, V10, P304, DOI 10.1038/nrm2678; Yi KX, 2012, CYTOSKELETON, V69, P727, DOI 10.1002/cm.21048; Yi K, 2011, NAT CELL BIOL, V13, P1252, DOI 10.1038/ncb2320; Yuen WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043875; Zuchero JB, 2012, MOL BIOL CELL, V23, P853, DOI 10.1091/mbc.E11-12-0992; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	30	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109385	10.1371/journal.pone.0109385	http://dx.doi.org/10.1371/journal.pone.0109385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279558	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800074
J	Masurekar, AN; Parker, CA; Shanyinde, M; Moorman, AV; Hancock, JP; Sutton, R; Ancliff, PJ; Morgan, M; Goulden, NJ; Fraser, C; Hoogerbrugge, PM; Revesz, T; Darbyshire, PJ; Krishnan, S; Love, SB; Saha, V				Masurekar, Ashish Narayan; Parker, Catriona A.; Shanyinde, Milensu; Moorman, Anthony V.; Hancock, Jeremy P.; Sutton, Rosemary; Ancliff, Philip J.; Morgan, Mary; Goulden, Nicholas J.; Fraser, Chris; Hoogerbrugge, Peter M.; Revesz, Tamas; Darbyshire, Philip J.; Krishnan, Shekhar; Love, Sharon B.; Saha, Vaskar			Outcome of Central Nervous System Relapses In Childhood Acute Lymphoblastic Leukaemia - Prospective Open Cohort Analyses of the ALLR3 Trial	PLOS ONE			English	Article							CHILDRENS ONCOLOGY GROUP; ISOLATED CNS RELAPSE; BFM STUDY-GROUP; 1ST RELAPSE; RANDOMIZED-TRIAL; DISEASE; TRANSPLANTATION; SURVIVAL; CHEMOTHERAPY; ADULTS	The outcomes of Central Nervous System (CNS) relapses in children with acute lymphoblastic leukaemia (ALL) treated in the ALL R3 trial, between January 2003 and March 2011 were analysed. Patients were risk stratified, to receive a matched donor allogeneic transplant or fractionated cranial irradiation with continued treatment for two years. A randomisation of Idarubicin with Mitoxantrone closed in December 2007 in favour of Mitoxantrone. The estimated 3-year progression free survival for combined and isolated CNS disease were 40.6% (25.1, 55.6) and 38.0% (26.2, 49.7) respectively. Univariate analysis showed a significantly better survival for age <10 years, progenitor-B cell disease, good-risk cytogenetics and those receiving Mitoxantrone. Adjusting for these variables (age, time to relapse, cytogenetics, treatment drug and gender) a multivariate analysis, showed a poorer outcome for those with combined CNS relapse (HR 2.64, 95% CI 1.32, 5.31, p = 0.006 for OS). ALL R3 showed an improvement in outcome for CNS relapses treated with Mitoxantrone compared to Idarubicin; a potential benefit for matched donor transplant for those with very early and early isolated-CNS relapses.	[Masurekar, Ashish Narayan; Parker, Catriona A.] Univ Manchester, Cent Manchester Univ Hosp Fdn Trust, Manchester Acad Hlth Sci Ctr,Childrens Canc Grp, Ctr Paediat Teenage & Young Adult Canc,Inst Canc, Manchester, Lancs, England; [Shanyinde, Milensu] Univ Oxford, Ctr Stat Med, Oxford, England; [Moorman, Anthony V.] Newcastle Univ, Northern Inst Canc Res, Leukaemia Res Cytogenet Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Hancock, Jeremy P.] Southmead Hosp, Bristol Genet Lab, Bristol, Avon, England; [Sutton, Rosemary] Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia, Sydney, NSW, Australia; [Ancliff, Philip J.; Goulden, Nicholas J.] Great Ormond St Hosp Sick Children, London, England; [Morgan, Mary] Southampton Gen Hosp, Child Oncol & Haematol Ctr, Southampton SO9 4XY, Hants, England; [Fraser, Chris] Queensland Childrens Canc Ctr, Brisbane, Qld, Australia; [Hoogerbrugge, Peter M.] Radboud Univ Nijmegen, Childrens Hosp, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Revesz, Tamas] Womens & Childrens Hosp, Dept Haematol Oncol SA Pathol, Adelaide, SA, Australia; [Revesz, Tamas] Univ Adelaide, Adelaide, SA, Australia; [Darbyshire, Philip J.] Birmingham Childrens Hosp, Dept Haematol, Birmingham, W Midlands, England; [Saha, Vaskar] Tata Translat Canc Res Ctr, Kolkata, India	University of Manchester; University of Oxford; Newcastle University - UK; Southmead Hospital; Children's Cancer Institute; University of New South Wales Sydney; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Southampton; Radboud University Nijmegen; SA Pathology; University of Adelaide; University of Birmingham	Saha, V (corresponding author), Tata Translat Canc Res Ctr, Kolkata, India.	vaskar.saha@manchester.ac.uk	Moorman, Anthony/F-5518-2010; Sutton, Rosemary/J-3784-2014; Hoogerbrugge, Peter M./H-8049-2014; Moorman, Anthony/G-1468-2014	Sutton, Rosemary/0000-0002-0188-6005; Parker, Catriona/0000-0002-3826-2554; Moorman, Anthony/0000-0002-9781-6107; Saha, Vaskar/0000-0002-2916-9649	Cancer Research UK [C8230]; Leukaemia Lymphoma Research; Leukaemia Research Cytogenetics Group [11004]; Cancer Council NSW [PG11-06]; Sporting Chance Cancer Foundation Cancer Fund; NHMRC [1024232]; CCIA (RS); Cancer Research UK [16895, 14840] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Leukaemia Lymphoma Research; Leukaemia Research Cytogenetics Group; Cancer Council NSW(Cancer Council New South Wales); Sporting Chance Cancer Foundation Cancer Fund; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CCIA (RS); Cancer Research UK(Cancer Research UK)	This study was funded in part by a programme grant from Cancer Research UK [http://www.cancerresearchuk.org/] (VS - programme grant C8230); grants from Leukaemia Lymphoma Research [http://leukaemialymphomaresearch.org.uk/] funded the Leukaemia Research Cytogenetics Group (AVM - programme grant 11004). The Cancer Council NSW (PG11-06) [http://www.cancercouncil.com.au/], Sporting Chance Cancer Foundation Cancer Fund 2011 [http:// sportingchance.com.au/] and NH&MRC grant (1024232) [http://www.nhmrc.gov.au/] funded analysis of minimal residual disease at CCIA (RS). Hospira provided a non-conditional educational grant for ANZCHOG data management (TR). The authors confirm the funders had no role in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers SM, 2011, LEUKEMIA RES, V35, P705, DOI 10.1016/j.leukres.2010.12.031; Conter V, 2010, LEUKEMIA, V24, P255, DOI 10.1038/leu.2009.250; Eapen M, 2008, LEUKEMIA, V22, P281, DOI 10.1038/sj.leu.2405037; Gaynon PS, 2010, LEUKEMIA, V24, P285, DOI 10.1038/leu.2009.262; Gaynon PS, 1998, CANCER, V82, P1387, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1387::AID-CNCR24>3.0.CO;2-1; Hagedorn N, 2007, BLOOD, V110, P4022, DOI 10.1182/blood-2007-04-082040; Harker-Murray PD, 2008, BIOL BLOOD MARROW TR, V14, P685, DOI 10.1016/j.bbmt.2008.03.011; Holland M, 2011, BLOOD, V118, P638, DOI 10.1182/blood-2010-09-307330; Huguet F, 2009, J CLIN ONCOL, V27, P911, DOI 10.1200/JCO.2008.18.6916; Kamps WA, 2010, LEUKEMIA, V24, P309, DOI 10.1038/leu.2009.258; Krishnan S, 2010, LEUKEMIA, V24, P450, DOI 10.1038/leu.2009.264; Mitchell C, 2010, LEUKEMIA, V24, P406, DOI 10.1038/leu.2009.256; Mitchell CD, 2005, BRIT J HAEMATOL, V129, P734, DOI 10.1111/j.1365-2141.2005.05509.x; Moricke A, 2010, LEUKEMIA, V24, P265, DOI 10.1038/leu.2009.257; Moorman AV, 2010, BLOOD, V115, P206, DOI 10.1182/blood-2009-07-232124; Nguyen K, 2008, LEUKEMIA, V22, P2142, DOI 10.1038/leu.2008.251; Parker C, 2010, LANCET, V376, P2009, DOI 10.1016/S0140-6736(10)62002-8; Pui CH, 2011, J CLIN ONCOL, V29, P386, DOI 10.1200/JCO.2010.32.0325; Pui CH, 2009, SEMIN ONCOL, V36, pS2, DOI 10.1053/j.seminoncol.2009.05.002; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; RIBEIRO RC, 1995, J CLIN ONCOL, V13, P333, DOI 10.1200/JCO.1995.13.2.333; Rijneveld AW, 2011, LEUKEMIA, V25, P1697, DOI 10.1038/leu.2011.141; Ritchey AK, 1999, J CLIN ONCOL, V17, P3745, DOI 10.1200/JCO.1999.17.12.3745; Roy A, 2005, BRIT J HAEMATOL, V130, P67, DOI 10.1111/j.1365-2141.2005.05572.x; Schmiegelow K, 2010, LEUKEMIA, V24, P345, DOI 10.1038/leu.2009.251; Silverman LB, 2010, LEUKEMIA, V24, P320, DOI 10.1038/leu.2009.253; Tallen G, 2010, J CLIN ONCOLOGY OFFI, DOI [10.1200/JCO.2009.1225.1983, DOI 10.1200/JCO.2009.1225.1983]; Tsurusawa M, 2010, LEUKEMIA, V24, P335, DOI 10.1038/leu.2009.259; Vora A, 2013, LANCET ONCOL, V14, P199, DOI 10.1016/S1470-2045(12)70600-9	29	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108107	10.1371/journal.pone.0108107	http://dx.doi.org/10.1371/journal.pone.0108107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279465	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800009
J	de Mendonca, POR; Costa, IC; Lotfi, CFP				Ribeiro de Mendonca, Pedro Omori; Costa, Ismael Cabral; Pacicco Lotfi, Claudimara Ferini			The Involvement of Nek2 and Notch in the Proliferation of Rat Adrenal Cortex Triggered by POMC-Derived Peptides	PLOS ONE			English	Article							CELL-CYCLE; HYPOPHYSECTOMIZED RATS; PROTEIN-KINASES; ACTH; PROOPIOMELANOCORTIN; STEROIDOGENESIS; ACTIVATION; EXPRESSION; HORMONE; GROWTH	The adrenal gland is a dynamic organ that undergoes constant cell turnover. This allows for rapid organ remodeling in response to the physiological demands of the HPA axis, which is controlled by proopiomelanocortin (POMC)-derived peptides, such as adrenocorticotropic hormone (ACTH) and N-Terminal peptides (N-POMC). In the rat adrenal cortex, POMC-derived peptides trigger a mitogenic effect, and this process increases cyclins D and E, while inhibiting p27Kip1. The goal of the present study was to further explore the mitogenic effect of ACTH and synthetic N-POMC1-28 peptides by investigating the differences in the expression of key genes involved in the cell cycle of the rat adrenal cortex, following inhibition of the HPA axis. Moreover, we evaluated the differences between the inner and outer fractions of the adrenal cortex (ZF-fraction and ZG-fraction) in terms of their response patterns to different stimuli. In the current study, the inhibition of the HPA axis repressed the expression of Ccnb2, Camk2a, and Nek2 genes throughout the adrenal cortex, while treatments with POMC-derived peptides stimulated Nek2, gene and protein expression, and Notch2 gene expression. Furthermore, Notch1 protein expression was restricted to the subcapsular region of the cortex, an area of the adrenal cortex that is well-known for proliferation. We also showed that different regions of the adrenal cortex respond to HPA-axis inhibition and to induction with POMC-derived peptides at different times. These results suggest that cells in the ZG and ZF fractions could be at different phases of the cell cycle. Our results contribute to the understanding of the mechanisms involved in cell cycle regulation in adrenocortical cells triggered by N-POMC peptides and ACTH, and highlight the involvement of genes such as Nek2 and Notch.	[Ribeiro de Mendonca, Pedro Omori; Costa, Ismael Cabral; Pacicco Lotfi, Claudimara Ferini] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil	Universidade de Sao Paulo	Lotfi, CFP (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil.	clotfi@usp.br	Lotfi, Claudimara/B-7354-2011	Lotfi, Claudimara/0000-0002-9881-7099	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, the State of Sao Paulo Research Foundation); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development); FAPESP [20091337-3]; Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (Dean's Office of the University of Sao Paulo)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, the State of Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (Dean's Office of the University of Sao Paulo)	PORM is recipient of a scholarship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, the State of Sao Paulo Research Foundation); ICC is recipient of a scholarship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development); CFPL received funding from FAPESP (no 20091337-3), from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development), and from Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (Dean's Office of the University of Sao Paulo for Research Projects). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Bassett JR, 1997, MICROSC RES TECHNIQ, V36, P546, DOI 10.1002/(SICI)1097-0029(19970315)36:6<546::AID-JEMT11>3.0.CO;2-O; Bellanger S, 2007, ONCOGENE, V26, P7175, DOI 10.1038/sj.onc.1210539; CECCATELLI S, 1995, NEUROREPORT, V6, P342, DOI 10.1097/00001756-199501000-00029; Coll AP, 2006, J ENDOCRINOL, V190, P515, DOI 10.1677/joe.1.06749; Davis KT, 2000, ENDOCR RES, V26, P561, DOI 10.3109/07435800009048571; de Mendonca POR, 2011, MOL CELL ENDOCRINOL, V336, P156, DOI 10.1016/j.mce.2010.12.012; Denef C, 2001, CLIN EXP PHARMACOL P, V28, P239, DOI 10.1046/j.1440-1681.2001.03421.x; Ehrhart-Bornstein M, 2010, CELL MOL NEUROBIOL, V30, P1417, DOI 10.1007/s10571-010-9571-3; ESTIVARIZ FE, 1988, J ENDOCRINOL, V116, P201, DOI 10.1677/joe.0.1160201; ESTIVARIZ FE, 1982, NATURE, V297, P419, DOI 10.1038/297419a0; FARESE RV, 1983, ENDOCRINOLOGY, V112, P129, DOI 10.1210/endo-112-1-129; Fassnacht M, 2003, J CLIN ENDOCR METAB, V88, P2171, DOI 10.1210/jc.2002-021318; Fernandez-Ranvier GG, 2008, ARCH SURG-CHICAGO, V143, P841, DOI 10.1001/archsurg.143.9.841; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Gambaryan S, 2006, AM J PHYSIOL-ENDOC M, V290, pE423, DOI 10.1152/ajpendo.00128.2005; Giordano TJ, 2009, CLIN CANCER RES, V15, P668, DOI 10.1158/1078-0432.CCR-08-1067; Guasti L, 2013, ENDOCRINOLOGY, V154, P4675, DOI 10.1210/en.2013-1211; LOWRY PJ, 1983, NATURE, V306, P70, DOI 10.1038/306070a0; Mattos GE, 2011, CELL TISSUE RES, V345, P343, DOI 10.1007/s00441-011-1220-8; Mehta GD, 2012, BBA-MOL CELL RES, V1823, P1324, DOI 10.1016/j.bbamcr.2012.05.027; Mendonca de PO, 2012, MOL CELL ENDOCRINOL; Otis M, 2007, J ENDOCRINOL, V193, P331, DOI 10.1677/JOE-07-0055; PEDERSEN RC, 1980, SCIENCE, V208, P1044, DOI 10.1126/science.6246578; PEDERSEN RC, 1980, P NATL ACAD SCI-BIOL, V77, P2239, DOI 10.1073/pnas.77.4.2239; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Ronchi CL, 2012, NEOPLASIA, V14, P206, DOI 10.1593/neo.111758; SEGER MA, 1986, J STEROID BIOCHEM, V25, P703, DOI 10.1016/0022-4731(86)90298-0; Skelding KA, 2011, CELL CYCLE, V10, P631, DOI 10.4161/cc.10.4.14798; Squire CJ, 2005, STRUCTURE, V13, P541, DOI 10.1016/j.str.2004.12.017; TCHEN TT, 1977, MOL CELL BIOCHEM, V15, P79, DOI 10.1007/BF01793330; Torres TEP, 2007, CELL TISSUE RES, V329, P443, DOI 10.1007/s00441-007-0436-0; Tsunoda N, 2009, CANCER SCI, V100, P111, DOI 10.1111/j.1349-7006.2008.01007.x; Vinson GP, 2003, MICROSC RES TECHNIQ, V61, P227, DOI 10.1002/jemt.10331; Wood MA, 2011, MOL CELL ENDOCRINOL, V336, P206, DOI 10.1016/j.mce.2010.11.012; Yao JL, 2006, J CLIN INVEST, V116, P2403, DOI 10.1172/JCI27918	36	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108657	10.1371/journal.pone.0108657	http://dx.doi.org/10.1371/journal.pone.0108657			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279464	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800025
J	Suzuki, M; Takahashi, M; Muneoka, K; Sato, K; Hashimoto, K; Shirayama, Y				Suzuki, Masatoshi; Takahashi, Michio; Muneoka, Katsumasa; Sato, Koichi; Hashimoto, Kenji; Shirayama, Yukihiko			A Study of Remitted and Treatment-Resistant Depression Using MMPI and Including Pessimism and Optimism Scales	PLOS ONE			English	Article							MAJOR DEPRESSION; PERSONALITY; DISORDER; TEMPERAMENT; CHARACTER; DIAGNOSIS; TRAITS; ONSET	Background: The psychological aspects of treatment-resistant and remitted depression are not well documented. Methods: We administered the Minnesota Multiphasic Personality Inventory (MMPI) to patients with treatment-resistant depression (n = 34), remitted depression (n = 25), acute depression (n = 21), and healthy controls (n = 64). Pessimism and optimism were also evaluated by MMPI. Results: ANOVA and post-hoc tests demonstrated that patients with treatment-resistant and acute depression showed similarly high scores for frequent scale (F), hypochondriasis, depression, conversion hysteria, psychopathic device, paranoia, psychasthenia and schizophrenia on the MMPI compared with normal controls. Patients with treatment-resistant depression, but not acute depression registered high on the scale for cannot say answer. Using Student's t-test, patients with remitted depression registered higher on depression and social introversion scales, compared with normal controls. For pessimism and optimism, patients with treatment-resistant depression demonstrated similar changes to acutely depressed patients. Remitted depression patients showed lower optimism than normal controls by Student's t-test, even though these patients were deemed recovered from depression using HAM-D. Conclusions: The patients with remitted depression and treatment-resistant depression showed subtle alterations on the MMPI, which may explain the hidden psychological features in these cohorts.	[Suzuki, Masatoshi; Takahashi, Michio; Muneoka, Katsumasa; Sato, Koichi; Shirayama, Yukihiko] Teikyo Univ, Chiba Med Ctr, Dept Psychiat, Ichihara, Chiba, Japan; [Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan	Teikyo University; Chiba University	Shirayama, Y (corresponding author), Teikyo Univ, Chiba Med Ctr, Dept Psychiat, Ichihara, Chiba, Japan.	shirayama@rapid.ocn.ne.jp	Takahashi, Michio/R-2889-2019; Hashimoto, Kenji/I-5800-2015	Takahashi, Michio/0000-0002-7151-1364; Hashimoto, Kenji/0000-0002-8892-0439	Teikyo University Chiba Medical Center, Ichihara, Japan	Teikyo University Chiba Medical Center, Ichihara, Japan	Funding for this study was provided by Teikyo University Chiba Medical Center, Ichihara, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bagby RM, 2005, J PERS ASSESS, V84, P89, DOI 10.1207/s15327752jpa8401_15; BREMS C, 1991, J CLIN PSYCHOL, V47, P669, DOI 10.1002/1097-4679(199109)47:5<669::AID-JCLP2270470507>3.0.CO;2-9; COLLIGAN RC, 1994, J CLIN PSYCHOL, V50, P71, DOI 10.1002/1097-4679(199401)50:1<71::AID-JCLP2270500107>3.0.CO;2-8; Ganellen RJ, 1996, J PERS ASSESS, V67, P219, DOI 10.1207/s15327752jpa6702_1; Goekoop JG, 2011, DEPRESSION RES TREAT, DOI DOI 10.1155/2011/749640; Gross K, 2000, J PERS ASSESS, V75, P464, DOI 10.1207/S15327752JPA7503_07; Grossardt BR, 2009, PSYCHOSOM MED, V71, P491, DOI 10.1097/PSY.0b013e31819e67db; Hathaway SR, 1940, J PSYCHOL, V10, P249, DOI 10.1080/00223980.1940.9917000; Klonsky ED, 2000, ASSESSMENT, V7, P143, DOI 10.1177/107319110000700205; LEVENSON JL, 1991, PSYCHOSOMATICS, V32, P124, DOI 10.1016/S0033-3182(91)72083-5; MOLDIN SO, 1987, PSYCHIAT RES, V22, P159, DOI 10.1016/0165-1781(87)90103-X; Nery FG, 2009, DEPRESS ANXIETY, V26, P382, DOI 10.1002/da.20478; NORMAN WH, 1985, J AFFECT DISORDERS, V9, P97, DOI 10.1016/0165-0327(85)90015-1; PETERSON C, 1984, PSYCHOL REV, V91, P347, DOI 10.1037/0033-295X.91.3.347; PLUTCHIK R, 1987, PSYCHIAT RES, V22, P243, DOI 10.1016/0165-1781(87)90039-4; Richter J, 2000, EUR ARCH PSY CLIN N, V250, P40, DOI 10.1007/PL00007538; Shea MT, 1996, AM J PSYCHIAT, V153, P1404; Smith DJ, 2005, J AFFECT DISORDERS, V87, P83, DOI 10.1016/j.jad.2005.03.014; Souery D, 2007, J CLIN PSYCHIAT, V68, P1062, DOI 10.4088/JCP.v68n0713; Takahashi M, 2013, PLOS ONE, V9; Takahashi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063756; Thase Michael E., 1995, P1081; Wetzel RD, 1999, PSYCHOL REP, V85, P341; WETZLER S, 1995, J PERS ASSESS, V65, P557, DOI 10.1207/s15327752jpa6503_14; WETZLER S, 1989, J PERS ASSESS, V53, P22, DOI 10.1207/s15327752jpa5301_3; WETZLER S, 1994, PSYCHOL REP, V75, P755, DOI 10.2466/pr0.1994.75.2.755; Zimmerman M, 2012, J CLIN PSYCHIAT, V73, P790, DOI 10.4088/JCP.11m07203	28	1	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109137	10.1371/journal.pone.0109137	http://dx.doi.org/10.1371/journal.pone.0109137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3DZ	25279466	Green Submitted, gold, Green Published			2022-12-27	WOS:000342670800057
J	Wang, Q; Chen, DC; Nicholson, P; Cheng, SM; Alen, M; Mao, LJ; Cheng, SL				Wang, Qin; Chen, Decai; Nicholson, Patrick; Cheng, Shumei; Alen, Markku; Mao, Lijian; Cheng, Sulin			The Associations of Serum Serotonin with Bone Traits Are Age- and Gender-Specific	PLOS ONE			English	Article							REUPTAKE INHIBITORS; BODY-COMPOSITION; ANTIDEPRESSANTS; TRANSPORTER; GIRLS; RISK; 5-HYDROXYTRYPTAMINE; EXPRESSION; FRACTURE; PRODUCT	Context: Serotonin plays a potential role in bone metabolism, but the nature and extent of this relationship is unclear and human studies directly addressing the skeletal effect of circulating serotonin are rare. Objective: The study aimed to investigate the associations between serum serotonin and bone traits at multiple skeletal sites in women and men. Subjects and Methods: Subjects were part of the CALEX-family study and comprised 235 young women, 121 premenopausal women, 124 postmenopausal women, and 168 men. Body composition was assessed using DXA, as was areal bone mineral density (aBMD) of spine, femur and whole body. In addition, pQCT was used to determine bone properties at tibial midshaft and distal radius. Fasting serum serotonin concentration was assessed using a competitive enzyme-linked immunosorbent assay. Results: Serum serotonin declined with advancing age both in females and males (all p < 0.01). Serotonin was negatively correlated with weight, BMI, lean and fat mass in women (r = -0.22 to -0.39, all p < 0.001), but positively with height and lean mass in men (all p, 0.01). In the premenopausal women, serotonin was negatively correlated with lumbar spine aBMD (r = -0.23, p < 0.05) but the statistical significance disappeared after adjustment for weight. Conversely, in postmenopausal women, serotonin was positively correlated with whole body and femur aBMD, as well as with distal radius bone mineral content and volumetric BMD (r = 0.20 to 0.30, all p < 0.05), and these associations remained significant after adjustment for weight. In men, no significant associations were found between serotonin and bone traits. Conclusion: Serum serotonin is positively associated with bone traits in postmenopausal women, but not in premenopausal women or men. This partially supports the idea of circulating serotonin playing a role in the regulation of bone metabolism, but also indicates the importance of gender and age specific factors.	[Wang, Qin; Chen, Decai] Sichuan Univ, West China Hosp, Dept Endocrinol, Sichuan, Peoples R China; [Wang, Qin; Nicholson, Patrick; Cheng, Shumei; Cheng, Sulin] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland; [Alen, Markku] Oulu Univ Hosp, Dept Rehabil Med, Oulu, Finland; [Alen, Markku] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Mao, Lijian; Cheng, Sulin] Shanghai Jiao Tong Univ, Dept Sport & Phys Educ, Shanghai 200030, Peoples R China	Sichuan University; University of Jyvaskyla; University of Oulu; University of Oulu; Shanghai Jiao Tong University	Cheng, SL (corresponding author), Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland.	sulin.cheng@jyu.fi			academy of Finland SKID-KIDS program [135038]; Chinese National Science and Technology Infrastructure Program [2012BAK21B00, 2012BAK21B03-4]	academy of Finland SKID-KIDS program; Chinese National Science and Technology Infrastructure Program	This study was financially supported by the academy of Finland SKID-KIDS program (No. 135038) and the 2012 Chinese National Science and Technology Infrastructure Program (Grant No. 2012BAK21B00), project code 2012BAK21B03-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bliziotes M, 2006, BONE, V39, P1313, DOI 10.1016/j.bone.2006.06.009; BLUNDELL JE, 1984, NEUROPHARMACOLOGY, V23, P1537, DOI 10.1016/0028-3908(84)90098-4; Cheng S, 2005, AM J CLIN NUTR, V82, P1115, DOI 10.1093/ajcn/82.5.1115; Cheng SL, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-5; Collet C, 2008, FASEB J, V22, P418, DOI 10.1096/fj.07-9209com; Currey J., 2002, BONE STRUCTURE MECH; CURZON G, 1990, ANN NY ACAD SCI, V600, P521; Diem SJ, 2007, ARCH INTERN MED, V167, P1240, DOI 10.1001/archinte.167.12.1240; Gustafsson BI, 2006, J CELL BIOCHEM, V98, P139, DOI 10.1002/jcb.20734; Kakonen SM, 2000, CLIN CHEM, V46, P332; KAREGE F, 1994, NEUROPSYCHOPHARMACOL, V10, P207, DOI 10.1038/npp.1994.23; LEIBOWITZ SF, 1990, PHARMACOL BIOCHEM BE, V37, P735, DOI 10.1016/0091-3057(90)90556-W; Liu B, 1998, LANCET, V351, P1303, DOI 10.1016/S0140-6736(97)09528-7; Lyytikainen A, 2005, PUBLIC HEALTH NUTR, V8, P284, DOI 10.1079/PHN2004703; Modder UI, 2009, J BONE MINER RES; Richards JB, 2007, ARCH INTERN MED, V167, P188, DOI 10.1001/archinte.167.2.188; Rothman RB, 2008, ANN NY ACAD SCI, V1139, P268, DOI 10.1196/annals.1432.042; Spigset O, 1990, Nord Med, V105, P292; Turner CH, 2006, ANN NY ACAD SCI, V1068, P429, DOI 10.1196/annals.1346.039; Vestergaard P, 2006, OSTEOPOROSIS INT, V17, P807, DOI 10.1007/s00198-005-0065-y; Warden SJ, 2005, ENDOCRINOLOGY, V146, P685, DOI 10.1210/en.2004-1259; Westbroek I, 2001, J BIOL CHEM, V276, P28961, DOI 10.1074/jbc.M101824200; Williams LJ, 2008, INT CLIN PSYCHOPHARM, V23, P84, DOI 10.1097/YIC.0b013e3282f2b3bb; Yadav VK, 2010, NAT MED, V16, P308, DOI 10.1038/nm.2098; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Zolkowska D, 2008, J PHARMACOL EXP THER, V324, P791, DOI 10.1124/jpet.107.132654	26	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109028	10.1371/journal.pone.0109028	http://dx.doi.org/10.1371/journal.pone.0109028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279460	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800049
J	Zhou, WM; Zhu, M; Gui, M; Huang, LH; Long, Z; Wang, L; Chen, H; Yin, YH; Jiang, XZ; Dai, YB; Tang, YX; He, LY; Zhong, KB				Zhou, Weimin; Zhu, Min; Gui, Ming; Huang, Lihua; Long, Zhi; Wang, Li; Chen, Hui; Yin, Yinghao; Jiang, Xianzhen; Dai, Yingbo; Tang, Yuxin; He, Leye; Zhong, Kuangbiao			Peripheral Blood Mitochondrial DNA Copy Number Is Associated with Prostate Cancer Risk and Tumor Burden	PLOS ONE			English	Article							OXIDATIVE STRESS; CELLS; PROGRESSION; ACTIVATION; DEPLETION; SURVIVAL	Alterations of mitochondrial DNA (mtDNA) have been associated with the risk of a number of human cancers; however, the relationship between mtDNA copy number in peripheral blood leukocytes (PBLs) and the risk of prostate cancer (PCa) has not been investigated. In a case-control study of 196 PCa patients and 196 age-paired healthy controls in a Chinese Han population, the association between mtDNA copy number in PBLs and PCa risk was evaluated. The relative mtDNA copy number was measured using quantitative real-time PCR; samples from three cases and two controls could not be assayed, leaving 193 cases and 194 controls for analysis. PCa patients had significantly higher mtDNA copy numbers than controls (medians 0.91 and 0.82, respectively; P < 0.001). Dichotomized at the median value of mtDNA copy number in the controls, high mtDNA copy number was significantly associated with an increased risk of PCa (adjusted odds ratio = 1.85, 95% confidence interval: 1.21-2.83). A significant dose-response relationship was observed between mtDNA copy number and risk of PCa in quartile analysis (P-trend = 0.011). Clinicopathological analysis showed that high mtDNA copy numbers in PCa patients were significantly associated with high Gleason score and advanced tumor stage, but not serum prostate-specific antigen level (P = 0.002, 0.012 and 0.544, respectively). These findings of the present study indicate that increased mtDNA copy number in PBLs is significantly associated with an increased risk of PCa and may be a reflection of tumor burden.	[Zhou, Weimin; Long, Zhi; Yin, Yinghao; Jiang, Xianzhen; Dai, Yingbo; Tang, Yuxin; He, Leye; Zhong, Kuangbiao] Cent South Univ, Xiangya Hosp 3, Dept Urol, Changsha, Hunan, Peoples R China; [Zhou, Weimin] Jiangxi Canc Hosp, Dept Abdominal Surg, Nanchang, Peoples R China; [Zhu, Min] Cent South Univ, Xiangya Sch Med, Mol Biol Res Ctr, Changsha, Hunan, Peoples R China; [Gui, Ming; Wang, Li] Cent South Univ, Xiangya Hosp 3, Dept Nephrol, Changsha, Hunan, Peoples R China; [Huang, Lihua] Cent South Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha, Hunan, Peoples R China; [Chen, Hui] Cent South Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University; Central South University	Zhong, KB (corresponding author), Cent South Univ, Xiangya Hosp 3, Dept Urol, Changsha, Hunan, Peoples R China.	zkbgm@126.com	tang, yuxin/GZN-2336-2022; Tang, YX/E-1967-2011	Tang, YX/0000-0001-9348-323X	Fundamental Research Funds for the Central Universities of Central South University [72150050368]	Fundamental Research Funds for the Central Universities of Central South University	This research was supported by the Fundamental Research Funds for the Central Universities of Central South University (72150050368). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; Chinese Nutrition Association, 2000, CHIN DIET REF INT; Cook CC, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.141; Croswell JM, 2011, ONCOLOGY-NY, V25, P452; Ellinger J, 2012, UROL ONCOL-SEMIN ORI, V30, P509, DOI 10.1016/j.urolonc.2010.03.004; Gupta-Elera G, 2012, EUR J CANCER PREV, V21, P155, DOI 10.1097/CEJ.0b013e32834a8002; Higuchi M, 2006, ONCOGENE, V25, P1437, DOI 10.1038/sj.onc.1209190; Hofmann JN, 2014, CARCINOGENESIS; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Hosgood HD, 2010, CARCINOGENESIS, V31, P847, DOI 10.1093/carcin/bgq045; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Lan Q, 2008, BLOOD, V112, P4247, DOI 10.1182/blood-2008-05-157974; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Liao LM, 2011, CANCER EPIDEM BIOMAR, V20, P1944, DOI 10.1158/1055-9965.EPI-11-0379; Lin PH, 2003, FREE RADICAL BIO MED, V35, P1310, DOI 10.1016/j.freeradbiomed.2003.07.002; Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342; Lynch SM, 2011, CANCER PREV RES, V4, P1912, DOI 10.1158/1940-6207.CAPR-11-0002; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Mehra N, 2007, CLIN CANCER RES, V13, P421, DOI 10.1158/1078-0432.CCR-06-1087; Mizumachi T, 2008, PROSTATE, V68, P408, DOI 10.1002/pros.20697; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Moro L, 2009, CELL DEATH DIFFER, V16, P571, DOI 10.1038/cdd.2008.178; Naito A, 2008, CANCER SCI, V99, P1584, DOI 10.1111/j.1349-7006.2008.00879.x; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Pinz KG, 1998, MOL CELL BIOL, V18, P1257, DOI 10.1128/MCB.18.3.1257; Purdue MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043149; Qu FL, 2011, CANCER-AM CANCER SOC, V117, P3148, DOI 10.1002/cncr.25906; Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Shen J, 2010, MITOCHONDRION, V10, P62, DOI 10.1016/j.mito.2009.09.004; Thyagarajan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065968; Thyagarajan B, 2012, CANCER EPIDEM BIOMAR, V21, P1574, DOI 10.1158/1055-9965.EPI-12-0138-T; Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Xia P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-454; Xie CH, 2007, BIOCHEM BIOPH RES CO, V364, P656, DOI 10.1016/j.bbrc.2007.10.047; Xie H, 2013, CARCINOGENESIS, V34, P1039, DOI 10.1093/carcin/bgt023; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Xu E, 2013, CARCINOGENESIS; Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955; Zhao SY, 2011, CANCER SCI, V102, P1553, DOI 10.1111/j.1349-7006.2011.01968.x	45	45	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109470	10.1371/journal.pone.0109470	http://dx.doi.org/10.1371/journal.pone.0109470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279731	Green Submitted, gold, Green Published			2022-12-27	WOS:000342670800084
J	Allaeys, I; Gymninova, I; Canet-Jourdan, C; Poubelle, PE				Allaeys, Isabelle; Gymninova, Irina; Canet-Jourdan, Charlotte; Poubelle, Patrice E.			IL-32 gamma Delays Spontaneous Apoptosis of Human Neutrophils through MCL-1, Regulated Primarily by the p38 MAPK Pathway	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; PROGRAMMED CELL-DEATH; PHOSPHATIDYLINOSITOL 3-KINASE; CPP32 CASPASE-3; EXPRESSION; SURVIVAL; INHIBITION; CYTOKINE	IL-32 gamma is a multifunctional cytokine involved in various inflammatory and auto-immune diseases in which neutrophils can affect the evolution of these diseases. To persist at inflammatory sites, neutrophils require inhibition of their rapid and constitutive apoptosis, an inhibitory effect that phlogogenic cytokines support. To date, the effects of IL-32 gamma on neutrophils remain unknown. We demonstrate that IL-32 gamma delays, in a dose-dependent manner, the spontaneous apoptosis of human blood neutrophils by activating mainly p38 MAPK through rapid p38 phosphorylation. PI3-K and ERK1/2 MAPK are also involved, but to a lesser extent. Most of cytokines that induce retardation of neutrophil apoptosis activate the expression of MCL-1 at both mRNA and protein levels. IL-32 gamma added to human blood neutrophils in vitro is associated with sustained levels of MCL-1 protein. This effect in neutrophils corresponds to a decrease of MCL-1 protein degradation without any effect on MCL-1 mRNA levels. The sustained levels of MCL-1 induced by IL-32 gamma are only abrogated by the p38 beta MAPK inhibitor SB202190. Additionally, IL-32 gamma induces a reduction in caspase 3 activity in neutrophils. In conclusion, IL-32 gamma affects human blood neutrophils in vitro by increasing their survival, suggesting that this cytokine could have profound effects on the deleterious functions of neutrophils in several diseases.	[Allaeys, Isabelle; Gymninova, Irina; Canet-Jourdan, Charlotte; Poubelle, Patrice E.] Univ Laval, Dept Med, Ctr Rech, Ctr Rech Rhumatol & Immunol,CHU Quebec, Quebec City, PQ G1K 7P4, Canada	Laval University	Poubelle, PE (corresponding author), Univ Laval, Dept Med, Ctr Rech, Ctr Rech Rhumatol & Immunol,CHU Quebec, Quebec City, PQ G1K 7P4, Canada.	Patrice.Poubelle@crchul.ulaval.ca			Canadian Institutes of Health Research [MOP-208613]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (MOP-208613). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul C, 2001, FEBS LETT, V487, P318, DOI 10.1016/S0014-5793(00)02324-3; Akgul C, 2000, CELL MOL LIFE SCI, V57, P684, DOI 10.1007/PL00000728; Alvarado-Kristensson M, 2004, J EXP MED, V199, P449, DOI 10.1084/jem.20031771; Alvarado-Kristensson M, 2001, FASEB J, V15, P129, DOI 10.1096/fj.01-0817fje; Aoshiba K, 1999, J IMMUNOL, V162, P1692; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BRACH MA, 1992, BLOOD, V80, P2920; Chang HY, 2000, MICROBIOL MOL BIOL R, V64, P821, DOI 10.1128/MMBR.64.4.821-846.2000; Chao JR, 1998, MOL CELL BIOL, V18, P4883, DOI 10.1128/MCB.18.8.4883; Choi JD, 2009, IMMUNOLOGY, V126, P535, DOI 10.1111/j.1365-2567.2008.02917.x; COLOTTA F, 1992, BLOOD, V80, P2012; Cowburn AS, 2002, BLOOD, V100, P2607, DOI 10.1182/blood-2001-11-0122; Craig RW, 2002, LEUKEMIA, V16, P444, DOI 10.1038/sj.leu.2402416; Cross A, 2008, BLOOD, V111, P878, DOI 10.1182/blood-2007-05-087833; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; DAHL CA, 1992, J IMMUNOL, V148, P597; Daigle I, 2001, INT ARCH ALLERGY IMM, V126, P147, DOI 10.1159/000049506; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; Dolado Ignacio, 2008, V20, P99, DOI 10.1007/4735_2007_0245; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Dyugovskaya L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-211; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Edwards SW, 2004, BIOCHEM SOC T, V32, P489, DOI 10.1042/BST0320489; Epling-Burnette PK, 2001, J IMMUNOL, V166, P7486, DOI 10.4049/jimmunol.166.12.7486; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Felaco P, 2009, J BIOL REG HOMEOS AG, V23, P141; Fischer CD, 2011, ANTIMICROB AGENTS CH, V55, P338, DOI 10.1128/AAC.01052-10; Francois S, 2005, J IMMUNOL, V174, P3633, DOI 10.4049/jimmunol.174.6.3633; Fujita E, 1998, CELL DEATH DIFFER, V5, P289, DOI 10.1038/sj.cdd.4400355; Galdiero MR, 2013, IMMUNOBIOLOGY, V218, P1402, DOI 10.1016/j.imbio.2013.06.003; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Geering B, 2011, CELL DEATH DIFFER, V18, P1457, DOI 10.1038/cdd.2011.75; Girard D, 1997, BIOCHEM J, V325, P147, DOI 10.1042/bj3250147; Goda C, 2006, INT IMMUNOL, V18, P233, DOI 10.1093/intimm/dxh339; Hao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038317; Heinhuis B, 2011, ANN RHEUM DIS, V70, P660, DOI 10.1136/ard.2010.139196; Hofman Paul, 2004, Current Drug Targets - Inflammation and Allergy, V3, P1, DOI 10.2174/1568010043483935; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Jung MY, 2011, J IMMUNOL, V186, P6848, DOI 10.4049/jimmunol.1003996; Kim HP, 2005, J IMMUNOL, V175, P2622, DOI 10.4049/jimmunol.175.4.2622; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Klein JB, 2000, J IMMUNOL, V164, P4286, DOI 10.4049/jimmunol.164.8.4286; Kobayashi SD, 2005, J LEUKOCYTE BIOL, V78, P1408, DOI 10.1189/jlb.0605289; Koedel U, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000461; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Krajewska M, 1997, CANCER RES, V57, P1605; Gabelloni ML, 2013, SEMIN IMMUNOPATHOL, V35, P423, DOI 10.1007/s00281-013-0364-x; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; Leuenroth SJ, 2000, J LEUKOCYTE BIOL, V68, P158; Luo HBR, 2008, AM J HEMATOL, V83, P288, DOI 10.1002/ajh.21078; Maianski NA, 2003, ACTA HAEMATOL-BASEL, V111, P56, DOI 10.1159/000074486; Manthey CL, 1998, J LEUKOCYTE BIOL, V64, P409, DOI 10.1002/jlb.64.3.409; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Milot E, 2011, THESCIENTIFICWORLDJO, V11, P1948, DOI 10.1100/2011/131539; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; Moulding DA, 2001, J LEUKOCYTE BIOL, V70, P783; Nakayama M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02960; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Nishida A, 2009, J BIOL CHEM, V284, P17868, DOI 10.1074/jbc.M900368200; Nold MF, 2008, J IMMUNOL, V181, P557, DOI 10.4049/jimmunol.181.1.557; Oh JH, 2011, ONCOGENE, V30, P3345, DOI 10.1038/onc.2011.52; Petrin D, 2006, CELL SIGNAL, V18, P479, DOI 10.1016/j.cellsig.2005.05.021; ROBERGE CJ, 1994, J IMMUNOL, V152, P5485; Sakitani K, 2012, INFECT IMMUN, V80, P3795, DOI 10.1128/IAI.00637-12; Salamone GV, 2010, LAB INVEST, V90, P1049, DOI 10.1038/labinvest.2010.77; Segel GB, 2011, J LEUKOCYTE BIOL, V89, P359, DOI 10.1189/jlb.0910538; Shioya M, 2007, CLIN EXP IMMUNOL, V149, P480, DOI 10.1111/j.1365-2249.2007.03439.x; Sorrentino C, 2009, AM J RESP CRIT CARE, V180, P769, DOI 10.1164/rccm.200903-0400OC; Suzuki K, 1999, BLOOD, V93, P341, DOI 10.1182/blood.V93.1.341.401k09_341_349; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Torsteinsdottir I, 1999, SCAND J IMMUNOL, V50, P433, DOI 10.1046/j.1365-3083.1999.00602.x; Turner-Brannen E, 2011, J IMMUNOL, V186, P7127, DOI 10.4049/jimmunol.1002306; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Ward C, 1999, J BIOL CHEM, V274, P4309, DOI 10.1074/jbc.274.7.4309; Wardle DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015768; Witko-Sarsat V, 2010, J EXP MED, V207, P2631, DOI 10.1084/jem.20092241; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045	81	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109256	10.1371/journal.pone.0109256	http://dx.doi.org/10.1371/journal.pone.0109256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275312	Green Submitted, Green Published, gold			2022-12-27	WOS:000342591500087
J	Cheng, SW; LeBlanc, KJ; Li, L				Cheng, Shaowu; LeBlanc, Kyle J.; Li, Ling			Triptolide Preserves Cognitive Function and Reduces Neuropathology in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							NATURAL-PRODUCT TRIPTOLIDE; C-TERMINAL FRAGMENT; PROTEIN-PRECURSOR; AMYLOID PROTEIN; TNF-ALPHA; BETA; MICROGLIA; PEPTIDE; GAMMA; INFLAMMATION	Triptolide, a major bioactive ingredient of a widely used herbal medicine, has been shown to possess multiple pharmacological functions, including potential neuroprotective effects pertinent to Alzheimer's disease (AD) in vitro. However, the therapeutic potential of triptolide for AD in vivo has not been thoroughly evaluated. In the present study, we investigated the impact of peripherally administered triptolide on AD-related behavior and neuropathology in APP(swe)/PS1(AE9) (APP/PS1) mice, an established model of AD. Our results showed that two-month treatment with triptolide rescued cognitive function in APP/PS1 mice. Immunohistochemical analyses indicated that triptolide treatment led to a significant decrease in amyloid-beta (A beta) deposition and neuroinflammation in treated mice. In contrast to previous findings in vitro, biochemical analyses showed that triptolide treatment did not significantly affect the production pathway of A beta in vivo. Intriguingly, further analyses revealed that triptolide treatment upregulated the level of insulin-degrading enzyme, a major A beta-degrading enzyme in the brain, indicating that triptolide treatment reduced A beta pathology by enhancing the proteolytic degradation of A beta. Our findings demonstrate that triptolide treatment ameliorates key behavioral and neuropathological changes found in AD, suggesting that triptolide may serve as a potential therapeutic agent for AD.	[Cheng, Shaowu; LeBlanc, Kyle J.; Li, Ling] Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Li, L (corresponding author), Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA.	lil@umn.edu		cheng, shaowu/0000-0001-9059-4727	National Institutes of Health [AG031846]; Academic Health Center (Faculty Research Development Program); College of Pharmacy (Engebretson/Bighley Drug Design and Development Program) of the University of Minnesota; NATIONAL INSTITUTE ON AGING [R01AG031846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academic Health Center (Faculty Research Development Program); College of Pharmacy (Engebretson/Bighley Drug Design and Development Program) of the University of Minnesota; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by grants from the National Institutes of Health (AG031846), the Academic Health Center (Faculty Research Development Program) and the College of Pharmacy (Engebretson/Bighley Drug Design and Development Program) of the University of Minnesota to LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgess BL, 2006, NEUROBIOL DIS, V24, P114, DOI 10.1016/j.nbd.2006.06.007; Bustamante HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083096; Cheng SW, 2013, J BIOL CHEM, V288, P35952, DOI 10.1074/jbc.M113.503904; Chugh R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004334; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Flammang B, 2012, J ALZHEIMERS DIS, V30, P145, DOI 10.3233/JAD-2012-112186; Gao Jun-Peng, 2008, Neurosci Bull, V24, P133, DOI 10.1007/s12264-008-1225-9; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Gong YT, 2008, J NEUROCHEM, V107, P779, DOI 10.1111/j.1471-4159.2008.05653.x; Gu Ming, 2004, Shengli Xuebao, V56, P73; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; He Qihua, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P252; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Izco M, 2014, NEUROSCIENCE, V263, P269, DOI 10.1016/j.neuroscience.2014.01.003; Jager S, 2009, J NEUROCHEM, V111, P1369, DOI 10.1111/j.1471-4159.2009.06420.x; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jiao J, 2008, J NEUROIMMUNOL, V205, P32, DOI 10.1016/j.jneuroim.2008.08.006; Kizelsztein P, 2009, J NEUROIMMUNOL, V217, P28, DOI 10.1016/j.jneuroim.2009.08.017; Kummer MP, 2012, J NEUROIMMUNE PHARM, V7, P165, DOI 10.1007/s11481-011-9339-7; Lewis TL, 2010, J BIOL CHEM, V285, P36958, DOI 10.1074/jbc.M110.127829; Liu QY, 2011, INT IMMUNOPHARMACOL, V11, P377, DOI 10.1016/j.intimp.2011.01.012; Mandrekar-Colucci S, 2010, CNS NEUROL DISORD-DR, V9, P156, DOI 10.2174/187152710791012071; Manzo SG, 2012, CANCER RES, V72, P5363, DOI 10.1158/0008-5472.CAN-12-1006; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Nie J, 2012, INT IMMUNOPHARMACOL, V13, P175, DOI 10.1016/j.intimp.2012.03.021; Nunan J, 2001, EUR J BIOCHEM, V268, P5329, DOI 10.1046/j.0014-2956.2001.02465.x; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Tian Y, 2011, FASEB J, V25, P1934, DOI 10.1096/fj.10-175158; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Vodovotz Y, 1996, J EXP MED, V184, P1425, DOI 10.1084/jem.184.4.1425; Wang J, 2013, J ALZHEIMERS DIS, V33, P217, DOI 10.3233/JAD-2012-120841; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Xue B, 2007, NEUROCHEM RES, V32, P1113, DOI 10.1007/s11064-006-9253-1; Zheng Y, 2013, CNS NEUROSCI THER, V19, P76, DOI 10.1111/cns.12039; Zhou HF, 2003, NEUROREPORT, V14, P1091, DOI 10.1097/01.wnr.0000073682.00308.47	37	28	32	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108845	10.1371/journal.pone.0108845	http://dx.doi.org/10.1371/journal.pone.0108845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275487	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500035
J	Elias, D; Bernot, MJ				Elias, Daniel; Bernot, Melody J.			Effects of Atrazine, Metolachlor, Carbaryl and Chlorothalonil on Benthic Microbes and Their Nutrient Dynamics	PLOS ONE			English	Article							MESOCOSM EXPERIMENTS; PESTICIDES; NITROGEN; PHOSPHORUS; NITRATE; BIODIVERSITY; COMMUNITIES; SATURATION; RETENTION; AMMONIUM	Atrazine, metolachlor, carbaryl, and chlorothalonil are detected in streams throughout the U.S. at concentrations that may have adverse effects on benthic microbes. Sediment samples were exposed to these pesticides to quantify responses of ammonium, nitrate, and phosphate uptake by the benthic microbial community. Control uptake rates of sediments had net remineralization of nitrate (-1.58 NO3 mu g gdm(-1) h(-1)), and net assimilation of phosphate (1.34 PO4 mu g gdm(-1) h(-1)) and ammonium (0.03 NH4 mu g gdm(-1) h(-1)). Metolachlor decreased ammonium and phosphate uptake. Chlorothalonil decreased nitrate remineralization and phosphate uptake. Nitrate, ammonium, and phosphate uptake rates are more pronounced in the presence of these pesticides due to microbial adaptations to toxicants. Our interpretation of pesticide availability based on their water/solid affinities supports no effects for atrazine and carbaryl, decreasing nitrate remineralization, and phosphate assimilation in response to chlorothalonil. Further, decreased ammonium and phosphate uptake in response to metolachlor is likely due to affinity. Because atrazine target autotrophs, and carbaryl synaptic activity, effects on benthic microbes were not hypothesized, consistent with results. Metolachlor and chlorothalonil (non-specific modes of action) had significant effects on sediment microbial nutrient dynamics. Thus, pesticides with a higher affinity to sediments and/or broad modes of action are likely to affect sediment microbes' nutrient dynamics than pesticides dissolved in water or specific modes of action. Predicted nutrient uptake rates were calculated at mean and peak concentrations of metolachlor and chlorothalonil in freshwaters using polynomial equations generated in this experiment. We concluded that in natural ecosystems, peak chlorothalonil and metolachlor concentrations could affect phosphate and ammonium by decreasing net assimilation, and nitrate uptake rates by decreasing remineralization, relative to mean concentrations of metolachlor and chlorothalonil. Our regression equations can complement models of nitrogen and phosphorus availability in streams to predict potential changes in nutrient dynamics in response to pesticides in freshwaters.	[Elias, Daniel; Bernot, Melody J.] Ball State Univ, Dept Biol, Muncie, IN 47306 USA	Ball State University	Elias, D (corresponding author), Ball State Univ, Dept Biol, Muncie, IN 47306 USA.	delias@bsu.edu	Elias, Daniel/I-2754-2019	Elias, Daniel/0000-0002-4257-6804	Indiana Water Resources Research Consortium subaward from the United States Department of Interior; United States Geological Survey, federal Water Resources Research Act [104B]	Indiana Water Resources Research Consortium subaward from the United States Department of Interior; United States Geological Survey, federal Water Resources Research Act	Funding provided by Indiana Water Resources Research Consortium subaward from the United States Department of Interior, United States Geological Survey as part of the federal Water Resources Research Act of 1984 (Program 104B)"(MJB, DE), http://www.iwrrc.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association A., 1995, STANDARD METHODS EXA; Aminot A, 1997, MAR CHEM, V56, P59, DOI 10.1016/S0304-4203(96)00080-1; Beketov MA, 2013, P NATL ACAD SCI USA, V110, P11039, DOI 10.1073/pnas.1305618110; Bernot MJ, 2005, ECOSYSTEMS, V8, P442, DOI 10.1007/s10021-003-0143-y; Bronk DA, 1999, LIMNOL OCEANOGR, V44, P573, DOI 10.4319/lo.1999.44.3.0573; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bunch ND, 2012, RES MICROBIOL, V163, P137, DOI 10.1016/j.resmic.2011.11.004; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; COOK AM, 1978, APPL ENVIRON MICROB, V36, P668, DOI 10.1128/AEM.36.5.668-672.1978; Correll DL, 1999, POULTRY SCI, V78, P674, DOI 10.1093/ps/78.5.674; Covich AP, 1999, BIOSCIENCE, V49, P119, DOI 10.2307/1313537; Davis JC, 1999, OECOLOGIA, V119, P247, DOI 10.1007/s004420050783; Doddamani HP, 2001, CURR MICROBIOL, V43, P69, DOI 10.1007/s002840010262; Dodds WK, 2002, J N AM BENTHOL SOC, V21, P206, DOI 10.2307/1468410; Durieux EDH, 2011, FISH PHYSIOL BIOCHEM, V37, P21, DOI 10.1007/s10695-010-9412-9; Earl SR, 2006, ECOLOGY, V87, P3140, DOI 10.1890/0012-9658(2006)87[3140:NSISE]2.0.CO;2; Enserink M, 2013, SCIENCE, V341, P729, DOI 10.1126/science.341.6147.728; Frost TM, 2001, COM ECO SYS, P253; GACHTER R, 1993, HYDROBIOLOGIA, V253, P103, DOI 10.1007/BF00050731; Gilliom R. J, 2006, 1291 USGS; GRAMLICH JV, 1967, WEEDS-U, V15, P157, DOI 10.2307/4041188; Kashian DR, 2002, TOXICOL IND HEALTH, V18, P225, DOI 10.1191/0748233702th146oa; Kemp MJ, 2002, LIMNOL OCEANOGR, V47, P1380, DOI 10.4319/lo.2002.47.5.1380; KLOTZ RL, 1985, LIMNOL OCEANOGR, V30, P543, DOI 10.4319/lo.1985.30.3.0543; Kohler HR, 2013, SCIENCE, V341, P759, DOI 10.1126/science.1237591; Kolpin DW, 1998, ENVIRON SCI TECHNOL, V32, P558, DOI 10.1021/es970412g; Kruger EL, 1996, ENVIRON TOXICOL CHEM, V15, P691, DOI [10.1897/1551-5028(1996)015&lt;0691:RMOAFA&gt;2.3.CO;2, 10.1002/etc.5620150512]; Larson S. J., 1999, PESTICIDES STREAMS U; Liess M, 2005, ENVIRON TOXICOL CHEM, V24, P954, DOI 10.1897/03-652.1; McMahon TA, 2012, ECOL LETT, V15, P714, DOI 10.1111/j.1461-0248.2012.01790.x; MUNN M. D., 2001, WATER RESOURCES INVE, P66; Murray KE, 2010, ENVIRON POLLUT, V158, P3462, DOI 10.1016/j.envpol.2010.08.009; Neumann M, 2002, WATER RES, V36, P3103, DOI 10.1016/S0043-1354(01)00540-1; Pester M, 2004, APPL ENVIRON MICROB, V70, P3138, DOI 10.1128/AEM.70.5.3138-3142.2004; Relyea RA, 2006, ECOTOXICOLOGY, V15, P503, DOI 10.1007/s10646-006-0086-0; Rinella FA, 1998, SEASONAL AND SPATIAL; Satsuma K, 2006, PEST MANAG SCI, V62, P340, DOI 10.1002/ps.1172; Spivak AC, 2011, FRESHWATER BIOL, V56, P279, DOI 10.1111/j.1365-2427.2010.02495.x; Stewart RIA, 2013, ADV ECOL RES, V48, P71, DOI 10.1016/B978-0-12-417199-2.00002-1; Tappin AD, 2012, ENVIRON CHEM LETT, V10, P89, DOI 10.1007/s10311-011-0332-4; United States Environmental Protection Agency, 1987, CHLOROTHALONIL HEALT; University of Hertfordshire, 2013, THE PESTICIDE PROPER; Wauchope RD, 2002, PEST MANAG SCI, V58, P419, DOI 10.1002/ps.489; Zogg GP, 2000, ECOLOGY, V81, P1858, DOI 10.1890/0012-9658(2000)081[1858:MIATRO]2.0.CO;2	44	12	12	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109190	10.1371/journal.pone.0109190	http://dx.doi.org/10.1371/journal.pone.0109190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275369	Green Submitted, gold, Green Published			2022-12-27	WOS:000342591500072
J	Harata, K; Kubo, Y				Harata, Ken; Kubo, Yasuyuki			Ras GTPase Activating Protein CoIra1 Is Involved in Infection-Related Morphogenesis by Regulating cAMP and MAPK Signaling Pathways through CoRas2 in Colletotrichum orbiculare	PLOS ONE			English	Article							RICE BLAST FUNGUS; MEMBRANE LOCALIZATION; PLANT INFECTION; PLASMA-MEMBRANE; KINASE; GROWTH; PATHOGENESIS; PKA; PENETRATION; ASSOCIATION	Colletotrichum orbiculare is the causative agent of anthracnose disease on cucurbitaceous plants. Several signaling pathways, including cAMP-PKA and mitogen-activating protein kinase (MAPK) pathways are involved in the infection-related morphogenesis and pathogenicity of C. orbiculare. However, upstream regulators of these pathways for this species remain unidentified. In this study, CoIRA1, encoding RAS GTPase activating protein, was identified by screening the Agrobacterium tumefaciens-mediated transformation (AtMT) mutant, which was defective in the pathogenesis of C. orbiculare. The coira1 disrupted mutant showed an abnormal infection-related morphogenesis and attenuated pathogenesis. In Saccharomyces cerevisiae, Ira1/2 inactivates Ras1/2, which activates adenylate cyclase, leading to the synthesis of cAMP. Increase in the intracellular cAMP levels in coira1 mutants and dominant active forms of CoRAS2 introduced transformants indicated that CoIra1 regulates intracellular cAMP levels through CoRas2. Moreover, the phenotypic analysis of transformants that express dominant active form CoRAS2 in the comekk1 mutant or a dominant active form CoMEKK1 in the coras2 mutant indicated that CoRas2 regulates the MAPK CoMekk1-Cmk1 signaling pathway. The CoRas2 localization pattern in vegetative hyphae of the coira1 mutant was similar to that of the wild-type, expressing a dominant active form of RFP-CoRAS2. Moreover, we demonstrated that bimolecular fluorescence complementation (BiFC) signals between CoIra1 and CoRas2 were detected in the plasma membrane of vegetative hyphae. Therefore, it is likely that CoIra1 negatively regulates CoRas2 in vegetative hyphae. Furthermore, cytological analysis of the localization of CoIra1 and CoRas2 revealed the dynamic cellular localization of the proteins that leads to proper assembly of F-actin at appressorial pore required for successful penetration peg formation through the pore. Thus, our results indicated that CoIra1 is involved in infection-related morphogenesis and pathogenicity by proper regulation of cAMP and MAPK signaling pathways through CoRas2.	[Harata, Ken; Kubo, Yasuyuki] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Plant Pathol Lab, Kyoto 606, Japan	Kyoto Prefectural University	Kubo, Y (corresponding author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Plant Pathol Lab, Kyoto 606, Japan.	y_kubo@kpu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [24248009]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grants-in-Aid for scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (Grant number 24248009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 1998, PLANT CELL, V10, P1361, DOI 10.1105/tpc.10.8.1361; Ballou ER, 2013, FUNGAL GENET BIOL, V57, P58, DOI 10.1016/j.fgb.2013.05.006; Bechinger C, 1999, SCIENCE, V285, P1896, DOI 10.1126/science.285.5435.1896; Belotti F, 2012, BBA-MOL CELL RES, V1823, P1208, DOI 10.1016/j.bbamcr.2012.04.016; Belotti F, 2011, FEBS LETT, V585, P3914, DOI 10.1016/j.febslet.2011.10.032; Bluhm BH, 2007, MOL PLANT MICROBE IN, V20, P627, DOI 10.1094/MPMI-20-6-0627; Broggi S, 2013, INT J BIOCHEM CELL B, V45, P384, DOI 10.1016/j.biocel.2012.10.013; Bruno KS, 2004, EUKARYOT CELL, V3, P1525, DOI 10.1128/EC.3.6.1525-1532.2004; Cherkasova VA, 2003, CURR BIOL, V13, P1220, DOI 10.1016/S0960-9822(03)00490-1; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; Dagdas YF, 2012, SCIENCE, V336, P1590, DOI 10.1126/science.1222934; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Feng QH, 1999, J BACTERIOL, V181, P6339, DOI 10.1128/JB.181.20.6339-6346.1999; Fortwendel JR, 2012, EUKARYOT CELL, V11, P966, DOI 10.1128/EC.00091-12; Fujihara N, 2010, MOL PLANT MICROBE IN, V23, P436, DOI 10.1094/MPMI-23-4-0436; Gan P, 2013, NEW PHYTOL, V197, P1236, DOI 10.1111/nph.12085; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIBBS JB, 1991, CELL, V65, P1, DOI 10.1016/0092-8674(91)90352-Y; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Gourlay CW, 2006, MOL CELL BIOL, V26, P6487, DOI 10.1128/MCB.00117-06; Ha YS, 2003, FEMS MICROBIOL LETT, V226, P315, DOI 10.1016/S0378-1097(03)00589-5; Harashima T, 2006, MOL CELL, V22, P819, DOI 10.1016/j.molcel.2006.05.011; Herrera Federico, 2011, PLoS Curr, V3, pRRN1210, DOI 10.1371/currents.RRN1210; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Kaffarnik F, 2003, EMBO J, V22, P5817, DOI 10.1093/emboj/cdg554; Kubo Y, 2013, J GEN PLANT PATHOL, V79, P233, DOI 10.1007/s10327-013-0451-9; Lee N, 2003, ANNU REV PHYTOPATHOL, V41, P399, DOI 10.1146/annurev.phyto.41.052002.095728; Lee N, 2002, EUKARYOT CELL, V1, P954, DOI 10.1128/EC.1.6.954-966.2002; LEE YH, 1993, PLANT CELL, V5, P693, DOI 10.1105/tpc.5.6.693; Magee T, 1999, CELL, V98, P9, DOI 10.1016/S0092-8674(00)80601-7; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Pan XW, 1999, MOL CELL BIOL, V19, P4874; Park G, 2006, PLANT CELL, V18, P2822, DOI 10.1105/tpc.105.038422; Phan VT, 2010, MOL CELL BIOL, V30, P2264, DOI 10.1128/MCB.01450-08; Piispanen AE, 2011, EUKARYOT CELL, V10, P1473, DOI 10.1128/EC.05153-11; Ryder LS, 2013, P NATL ACAD SCI USA, V110, P3179, DOI 10.1073/pnas.1217470110; Sakaguchi A, 2010, MOL PLANT MICROBE IN, V23, P1563, DOI 10.1094/MPMI-03-10-0051; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; Takano Y, 2001, MOL PLANT MICROBE IN, V14, P1149, DOI 10.1094/MPMI.2001.14.10.1149; Takano Y, 1997, FUNGAL GENET BIOL, V21, P131, DOI 10.1006/fgbi.1997.0963; Takano Y, 2000, MOL PLANT MICROBE IN, V13, P374, DOI 10.1094/MPMI.2000.13.4.374; Tamanoi Fuyuhiko, 2011, Genes Cancer, V2, P210, DOI 10.1177/1947601911407322; Tanaka A, 2008, MOL MICROBIOL, V68, P1165, DOI 10.1111/j.1365-2958.2008.06217.x; Tanaka S, 2009, PLANT CELL, V21, P2517, DOI 10.1105/tpc.109.068023; Tsuji G, 1997, PESTIC BIOCHEM PHYS, V57, P211, DOI 10.1006/pest.1997.2272; Tsuji G, 2003, MOL PLANT MICROBE IN, V16, P315, DOI 10.1094/MPMI.2003.16.4.315; Tsuji Gento, 2003, Journal of General Plant Pathology, V69, P230, DOI 10.1007/s10327-003-0040-4; Vinod PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001663; Yamauchi J, 2004, MOL PLANT MICROBE IN, V17, P1355, DOI 10.1094/MPMI.2004.17.12.1355; Zhao XH, 2005, PLANT CELL, V17, P1317, DOI 10.1105/tpc.104.029116; Zhou XY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002911	52	24	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109045	10.1371/journal.pone.0109045	http://dx.doi.org/10.1371/journal.pone.0109045			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275394	Green Submitted, Green Published, gold			2022-12-27	WOS:000342591500048
J	McDavid, S; Bauer, MB; Brindley, RL; Jewell, ML; Currie, KPM				McDavid, Sarah; Bauer, Mary Beth; Brindley, Rebecca L.; Jewell, Mark L.; Currie, Kevin P. M.			Butanol Isomers Exert Distinct Effects on Voltage-Gated Calcium Channel Currents and Thus Catecholamine Secretion in Adrenal Chromaffin Cells	PLOS ONE			English	Article							NEUROTRANSMITTER RELEASE MACHINERY; T-TYPE CHANNELS; PHOSPHOLIPASE-D; N-ALKANOLS; REGULATED EXOCYTOSIS; VOLATILE ANESTHETICS; NEUROENDOCRINE CELLS; GENERAL-ANESTHETICS; ETHANOL SENSITIVITY; INHALED ANESTHETICS	Butanol (C4H10OH) has been used both to dissect the molecular targets of alcohols/general anesthetics and to implicate phospholipase D (PLD) signaling in a variety of cellular functions including neurotransmitter and hormone exocytosis. Like other primary alcohols, 1-butanol is a substrate for PLD and thereby disrupts formation of the intracellular signaling lipid phosphatidic acid. Because secondary and tertiary butanols do not undergo this transphosphatidylation, they have been used as controls for 1-butanol to implicate PLD signaling. Recently, selective pharmacological inhibitors of PLD have been developed and, in some cases, fail to block cellular functions previously ascribed to PLD using primary alcohols. For example, exocytosis of insulin and degranulation of mast cells are blocked by primary alcohols, but not by the PLD inhibitor FIPI. In this study we show that 1-butanol reduces catecholamine secretion from adrenal chromaffin cells to a much greater extent than tert-butanol, and that the PLD inhibitor VU0155056 has no effect. Using fluorescent imaging we show the effect of these drugs on depolarization-evoked calcium entry parallel those on secretion. Patch-clamp electrophysiology confirmed the peak amplitude of voltage-gated calcium channel currents (I-Ca) is inhibited by 1-butanol, with little or no block by secondary or tert-butanol. Detailed comparison shows for the first time that the different butanol isomers exert distinct, and sometimes opposing, effects on the voltage-dependence and gating kinetics of I-Ca. We discuss these data with regard to PLD signaling in cellular physiology and the molecular targets of general anesthetics.	[McDavid, Sarah; Bauer, Mary Beth; Brindley, Rebecca L.] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA; [Jewell, Mark L.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Currie, Kevin P. M.] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Dept Pharmacol, Nashville, TN 37212 USA; [Currie, Kevin P. M.] Vanderbilt Univ, Sch Med, Vanderbilt Brain Inst, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Currie, KPM (corresponding author), Vanderbilt Univ, Sch Med, Dept Anesthesiol, Dept Pharmacol, Nashville, TN 37212 USA.	kevin.currie@vanderbilt.edu	Currie, Kevin P/J-9561-2019	Currie, Kevin P/0000-0002-0861-423X; Brindley, Rebecca/0000-0002-4357-4413	Vanderbilt Diabetes Research and Training Center [P30 DK20593]; National Institutes of Health [R01 NS052446]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052446] Funding Source: NIH RePORTER	Vanderbilt Diabetes Research and Training Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by a pilot and feasibility grant from the Vanderbilt Diabetes Research and Training Center to KC [Grant P30 DK20593], and by the National Institutes of Health [Grant R01 NS052446] to KC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIFIMOFF JK, 1989, BRIT J PHARMACOL, V96, P9, DOI 10.1111/j.1476-5381.1989.tb11777.x; Bader MF, 2009, BBA-MOL CELL BIOL L, V1791, P936, DOI 10.1016/j.bbalip.2009.02.016; Barber AF, 2014, P NATL ACAD SCI USA, V111, P6726, DOI 10.1073/pnas.1405768111; Barber AF, 2012, J BIOL CHEM, V287, P40425, DOI 10.1074/jbc.M112.405787; Barber AF, 2011, BIOPHYS J, V101, P1613, DOI 10.1016/j.bpj.2011.08.026; Barclay JW, 2010, BIOCHEM SOC T, V38, P172, DOI 10.1042/BST0380172; Bhattacharji A, 2010, BRIT J PHARMACOL, V159, P1475, DOI 10.1111/j.1476-5381.2010.00642.x; Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; Carabelli V, 2007, J PHYSIOL-LONDON, V584, P149, DOI 10.1113/jphysiol.2007.132274; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Cockcroft S, 2001, CELL MOL LIFE SCI, V58, P1674, DOI 10.1007/PL00000805; Coorssen JR, 1996, AM J PHYSIOL-CELL PH, V270, pC1153, DOI 10.1152/ajpcell.1996.270.4.C1153; COVARRUBIAS M, 1995, J BIOL CHEM, V270, P19408, DOI 10.1074/jbc.270.33.19408; Currie KPM, 2010, CELL MOL NEUROBIOL, V30, P1201, DOI 10.1007/s10571-010-9596-7; Currie KPM, 1997, J NEUROSCI, V17, P4570; Currie KPM, 1996, NEURON, V16, P1027, DOI 10.1016/S0896-6273(00)80126-9; Dopico AM, 2009, PHARMACOL REV, V61, P98, DOI 10.1124/pr.108.000430; DOUGLAS WW, 1968, BRIT J PHARMACOL, V34, P451, DOI 10.1111/j.1476-5381.1968.tb08474.x; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Exton JH, 2000, ANN NY ACAD SCI, V905, P61; Fang Z, 1997, ANESTH ANALG, V84, P1042, DOI 10.1097/00000539-199705000-00017; FIRESTONE S, 1995, ALCOHOL CLIN EXP RES, V19, P416, DOI 10.1111/j.1530-0277.1995.tb01524.x; Fox AP, 2008, ACTA PHYSIOL, V192, P247, DOI 10.1111/j.1748-1716.2007.01817.x; Franks NP, 2006, BRIT J PHARMACOL, V147, pS72, DOI 10.1038/sj.bjp.0706441; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; Garcia PS, 2010, CURR NEUROPHARMACOL, V8, P2, DOI 10.2174/157015910790909502; Glenn DE, 1998, J NEUROCHEM, V71, P2023; Gomez-Cambronero J, 2010, THESCIENTIFICWORLDJO, V10, P1356, DOI 10.1100/tsw.2010.116; Graham ME, 2009, MOL BIOL CELL, V20, P43, DOI 10.1091/mbc.E08-07-0689; HAWTHORN MH, 1992, EUR J PHARMACOL, V229, P143, DOI 10.1016/0014-2999(92)90548-I; Hemmings HC, 2009, BRIT J ANAESTH, V103, P61, DOI 10.1093/bja/aep144; Herold KE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00050; Herring BE, 2009, J NEUROPHYSIOL, V102, P1265, DOI 10.1152/jn.00252.2009; Hill J, 2011, J BIOL CHEM, V286, P42459, DOI 10.1074/jbc.M111.289389; Horishita T, 2008, J PHARMACOL EXP THER, V326, P270, DOI 10.1124/jpet.108.138370; Howard RJ, 2014, PHARMACOL REV, V66, P396, DOI 10.1124/pr.113.007468; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Jewell M.L., 2013, MODULATION PRESYNAPT, P01; Krasowski MD, 2000, BRIT J PHARMACOL, V129, P731, DOI 10.1038/sj.bjp.0703087; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Mahapatra S, 2012, CELL CALCIUM, V51, P321, DOI 10.1016/j.ceca.2012.01.005; Marcantoni A, 2008, ACTA PHYSIOL, V192, P233, DOI 10.1111/j.1748-1716.2007.01815.x; Marcantoni A, 2010, J NEUROSCI, V30, P491, DOI 10.1523/JNEUROSCI.4961-09.2010; McDavid S, 2006, J NEUROSCI, V26, P13373, DOI 10.1523/JNEUROSCI.3332-06.2006; Nagele P, 2005, ANESTHESIOLOGY, V103, P768, DOI 10.1097/00000542-200510000-00015; Novara M, 2004, J PHYSIOL-LONDON, V558, P433, DOI 10.1113/jphysiol.2004.061184; Orestes P, 2010, CHANNELS, V4, P518, DOI 10.4161/chan.4.6.12873; OYAMA Y, 1986, BRAIN RES, V376, P280, DOI 10.1016/0006-8993(86)90190-3; Oz M, 2001, EUR J PHARMACOL, V418, P169, DOI 10.1016/S0014-2999(01)00945-1; Peng X, 2012, ACTA PHYSIOL, V204, P219, DOI 10.1111/j.1748-1716.2011.02298.x; PURKISS J, 1991, J NEUROCHEM, V57, P1084, DOI 10.1111/j.1471-4159.1991.tb08262.x; Rudge SA, 2009, BBA-MOL CELL BIOL L, V1791, P856, DOI 10.1016/j.bbalip.2009.04.008; Scott SA, 2014, BIOCH BIOPHYS ACTA; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Siggins GR, 2005, PHARMACOL THERAPEUT, V107, P80, DOI 10.1016/j.pharmthera.2005.01.006; Souvannakitti D, 2010, J NEUROSCI, V30, P10763, DOI 10.1523/JNEUROSCI.2307-10.2010; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Todd RD, 2012, ANESTHESIOLOGY, V116, P1013, DOI 10.1097/ALN.0b013e31825153ea; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Vitale N, 2010, BIOCHEM SOC T, V38, P167, DOI 10.1042/BST0380167; Xie Z, 2013, J NEUROPHYSIOL, V109, P758, DOI 10.1152/jn.00666.2012; Yanase Y, 2010, BIOCHEM J, V425, P179, DOI 10.1042/BJ20091122	64	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109203	10.1371/journal.pone.0109203	http://dx.doi.org/10.1371/journal.pone.0109203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275439	gold, Green Published, Green Submitted			2022-12-27	WOS:000342591500073
J	Xue, J; Moyer, A; Peng, B; Wu, JC; Hannafon, BN; Ding, WQ				Xue, Jing; Moyer, Amanda; Peng, Bing; Wu, Jinchang; Hannafon, Bethany N.; Ding, Wei-Qun			Chloroquine Is a Zinc Ionophore	PLOS ONE			English	Article							CELL LUNG-CANCER; AUTOPHAGY INHIBITION; TUMOR-CELLS; CLIOQUINOL; DISEASE; HYDROXYCHLOROQUINE; ERLOTINIB; THERAPY; MODELS; DRUGS	Chloroquine is an established antimalarial agent that has been recently tested in clinical trials for its anticancer activity. The favorable effect of chloroquine appears to be due to its ability to sensitize cancerous cells to chemotherapy, radiation therapy, and induce apoptosis. The present study investigated the interaction of zinc ions with chloroquine in a human ovarian cancer cell line (A2780). Chloroquine enhanced zinc uptake by A2780 cells in a concentration-dependent manner, as assayed using a fluorescent zinc probe. This enhancement was attenuated by TPEN, a high affinity metal-binding compound, indicating the specificity of the zinc uptake. Furthermore, addition of copper or iron ions had no effect on chloroquine-induced zinc uptake. Fluorescent microscopic examination of intracellular zinc distribution demonstrated that free zinc ions are more concentrated in the lysosomes after addition of chloroquine, which is consistent with previous reports showing that chloroquine inhibits lysosome function. The combination of chloroquine with zinc enhanced chloroquine's cytotoxicity and induced apoptosis in A2780 cells. Thus chloroquine is a zinc ionophore, a property that may contribute to chloroquine's anticancer activity.	[Xue, Jing; Moyer, Amanda; Peng, Bing; Hannafon, Bethany N.; Ding, Wei-Qun] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73106 USA; [Xue, Jing; Wu, Jinchang] Nanjing Med Univ, Affiliated Suzhou Hosp, Dept Radio Oncol, Suzhou, Peoples R China; [Peng, Bing] Xuzhou Med Coll, Sch Pharm, Dept Pharmacol, Xuzhou, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center; Nanjing Medical University; Xuzhou Medical University	Ding, WQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73106 USA.	weiqun-ding@ouhsc.edu	Hannafon, Bethany N./R-1233-2019	Hannafon, Bethany N./0000-0003-0596-9171; Moyer, Amanda/0000-0002-7831-4224	American Cancer Society [CNE-117557]; Susan G. Komen for the Cure Foundation [KG081083]; NIH OK-INBRE program [3P20RR016478-09S2]; Oklahoma Center for the Advancement of Science and Technology [HR09-025]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103447] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); NIH OK-INBRE program; Oklahoma Center for the Advancement of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the American Cancer Society (CNE-117557); the Susan G. Komen for the Cure Foundation (KG081083); the NIH OK-INBRE program (3P20RR016478-09S2); and the Oklahoma Center for the Advancement of Science and Technology (HR09-025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba I, 2013, J NEUROCHEM, V125, P822, DOI 10.1111/jnc.12246; Baum L, 2004, J ALZHEIMERS DIS, V6, P367; Bincoletto C, 2013, CHEM-BIOL INTERACT, V206, P279, DOI 10.1016/j.cbi.2013.09.018; Blackie MAL, 2013, MINI-REV MED CHEM, V13, P597; Bristol ML, 2013, J PHARMACOL EXP THER, V344, P544, DOI 10.1124/jpet.112.199802; Canzoniero LM, 2003, MEMBRANEPERMEANT CHE; Ding WQ, 2008, CANCER LETT, V271, P251, DOI 10.1016/j.canlet.2008.06.011; Ding WQ, 2006, MOL CANCER THER, V5, P1864, DOI 10.1158/1535-7163.MCT-06-0067; Ding WQ, 2009, IUBMB LIFE, V61, P1013, DOI 10.1002/iub.253; Ding WQ, 2005, CANCER RES, V65, P3389, DOI 10.1158/0008-5472.CAN-04-3577; Eldredge H. B., 2013, J RAD ONCOL, V2; Goldberg SB, 2012, J THORAC ONCOL, V7, P1602, DOI 10.1097/JTO.0b013e318262de4a; Kimura T, 2013, CANCER RES, V73, P3, DOI 10.1158/0008-5472.CAN-12-2464; Krafts K, 2012, PARASITOL RES, V111, P1, DOI 10.1007/s00436-012-2886-x; Lamoureux F, 2013, AUTOPHAGY, V9, P1119, DOI 10.4161/auto.24921; Lamoureux F, 2013, CLIN CANCER RES, V19, P833, DOI 10.1158/1078-0432.CCR-12-3114; Li M, 2013, J BIOL CHEM; Liuzzi JP, 2013, BIOL TRACE ELEM RES; Maycotte P, 2012, AUTOPHAGY, V8, P200, DOI 10.4161/auto.8.2.18554; Mercer E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3868; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Qin Y, 2008, J NEUROCHEM, V107, P1304, DOI 10.1111/j.1471-4159.2008.05700.x; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Rojas-Puentes LL, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-209; Selvakumaran M, 2013, CLIN CANCER RES, V19, P2995, DOI 10.1158/1078-0432.CCR-12-1542; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Yu HJ, 2009, BIOCHEM J, V417, P133, DOI 10.1042/BJ20081421; Zheng J, 2012, CELL PHYSIOL BIOCHEM, V29, P181, DOI 10.1159/000337599; Zinn RL, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-16; Zou YY, 2013, J THORAC ONCOL, V8, P693, DOI 10.1097/JTO.0b013e31828c7210	31	139	141	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109180	10.1371/journal.pone.0109180	http://dx.doi.org/10.1371/journal.pone.0109180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271834	Green Submitted, gold, Green Published			2022-12-27	WOS:000343729600103
J	Wang, XG; Durosier, LD; Ross, MG; Richardson, BS; Frasch, MG				Wang, Xiaogang; Durosier, L. Daniel; Ross, Michael G.; Richardson, Bryan S.; Frasch, Martin G.			Online Detection of Fetal Acidemia during Labour by Testing Synchronization of EEG and Heart Rate: A Prospective Study in Fetal Sheep	PLOS ONE			English	Article							UMBILICAL-CORD OCCLUSION; NEAR-TERM; OVINE FETUS; ASPHYXIA; BLOOD; CHORIOAMNIONITIS; COMPLICATIONS; EPIDEMIOLOGY; METABOLISM; BRAIN	Severe fetal acidemia during labour can result in life-lasting neurological deficits, but the timely detection of this condition is often not possible. This is because the positive predictive value (PPV) of fetal heart rate (FHR) monitoring, the mainstay of fetal health surveillance during labour, to detect concerning fetal acidemia is around 50%. In fetal sheep model of human labour, we reported that severe fetal acidemia(pH<7.00) during repetitive umbilical cord occlusions (UCOs) is preceded similar to 60 minutes by the synchronization of electroencephalogram (EEG) and FHR. However, EEG and FHR are cyclic and noisy, and although the synchronization might be visually evident, it is challenging to detect automatically, a necessary condition for bedside utility. Here we present and validate a novel non-parametric statistical method to detect fetal acidemia during labour by using EEG and FHR. The underlying algorithm handles non-stationary and noisy data by recording number of abnormal episodes in both EEG and FHR. A logistic regression is then deployed to test whether these episodes are significantly related to each other. We then apply the method in a prospective study of human labour using fetal sheep model (n=20). Our results render a PPV of 68% for detecting impending severe fetal acidemia similar to 60 min prior to pH drop to less than 7.00 with 100% negative predictive value. We conclude that this method has a great potential to improve PPV for detection of fetal acidemia when it is implemented at the bedside. We outline directions for further refinement of the algorithm that will be achieved by analyzing larger data sets acquired in prospective human pilot studies.	[Wang, Xiaogang] York Univ, Dept Math & Stat, Toronto, ON M3J 2R7, Canada; [Durosier, L. Daniel; Frasch, Martin G.] Univ Montreal, CHU St Justine, Dept Obstet & Gynecol, Montreal, PQ, Canada; [Durosier, L. Daniel; Frasch, Martin G.] Univ Montreal, CHU St Justine, Res Ctr, Dept Neurosci, Montreal, PQ, Canada; [Ross, Michael G.] Harbor UCLA Med Ctr, Dept Obstet & Gynecol, LA BioMed, Torrance, CA 90509 USA; [Richardson, Bryan S.] Univ Western Ontario, Dept Obstet & Gynecol, London, ON, Canada; [Frasch, Martin G.] Univ Montreal, Anim Reprod Res Ctr CRRA, Fac Vet Med, Montreal, PQ, Canada	York University - Canada; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Western University (University of Western Ontario); Universite de Montreal	Frasch, MG (corresponding author), Univ Montreal, CHU St Justine, Dept Obstet & Gynecol, Montreal, PQ, Canada.	martin.frasch@recherche-ste-justine.qc.ca	Frasch, Martin/AAN-8507-2020	Frasch, Martin/0000-0003-3159-6321	Canada Research Chair Tier 1 in Fetal and Neonatal Health and Development; CIHR; Women's Development Council, London Health Sciences Centre, London, ON, Canada; NeuroDevNet/MITACS; FRSQ; QTNPR (CIHR)	Canada Research Chair Tier 1 in Fetal and Neonatal Health and Development; CIHR(Canadian Institutes of Health Research (CIHR)); Women's Development Council, London Health Sciences Centre, London, ON, Canada; NeuroDevNet/MITACS; FRSQ(Fonds de la Recherche en Sante du Quebec); QTNPR (CIHR)(Canadian Institutes of Health Research (CIHR))	The authors report the following sources of funding: Canada Research Chair Tier 1 in Fetal and Neonatal Health and Development (BSR); CIHR and FRSQ (MGF); Women's Development Council, London Health Sciences Centre, London, ON, Canada (BSR, MGR, MGF); and NeuroDevNet/MITACS and QTNPR (CIHR) to LDD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2007, INTRO CATEGORICAL DA; [Anonymous], 2014, Obstet Gynecol, V123, P896, DOI 10.1097/01.AOG.0000445580.65983.d2; ASTRUP J, 1977, STROKE, V8, P51, DOI 10.1161/01.STR.8.1.51; Becroft DMO, 2010, PEDIATR DEVEL PATHOL, V13, P282, DOI 10.2350/09-06-0659-OA.1; BROCK W, 1992, J FINANC, V47, P1731, DOI 10.2307/2328994; Brown G, 2004, SMOOTHING FORCASTING; Chan CJ, 2013, EARLY HUM DEV, V89, P1005, DOI 10.1016/j.earlhumdev.2013.08.017; Cheah FC, 2008, PEDIATR RES, V63, P274, DOI 10.1203/PDR.0b013e31815f653b; COX WL, 1988, AM J OBSTET GYNECOL, V159, P36, DOI 10.1016/0002-9378(88)90490-5; DeHaan HH, 1997, PEDIATR RES, V41, P96, DOI 10.1203/00006450-199701000-00015; Duncombe G, 2010, EARLY HUM DEV, V86, P113, DOI 10.1016/j.earlhumdev.2010.01.027; Frasch M, 2012, REPROD SCI, V19; Frasch M. G, 2010, REPROD SCI, V17, p51A; Frasch MG, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00150; Frasch MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022100; Frasch MG, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.022; GOLDABER KG, 1991, OBSTET GYNECOL, V78, P1103; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hunter CJ, 2003, STROKE, V34, P2240, DOI 10.1161/01.STR.0000083623.77327.CE; Kaneko M, 2003, AM J OBSTET GYNECOL, V188, P961, DOI 10.1067/mob.2003.219; Kawagoe Y, 1999, AM J OBSTET GYNECOL, V181, P1520, DOI 10.1016/S0002-9378(99)70399-6; Liston R, 2007, J OBSTET GYNAECOL CA, V29, pS3, DOI 10.1016/S1701-2163(16)32615-9; Liston Robert, 2002, J Obstet Gynaecol Can, V24, P342; LOW JA, 1972, AM J OBSTET GYNECOL, V113, P351, DOI 10.1016/0002-9378(72)90683-7; LOW JA, 1995, AM J OBSTET GYNECOL, V172, P805, DOI 10.1016/0002-9378(95)90003-9; LOW JA, 1984, AM J OBSTET GYNECOL, V148, P533, DOI 10.1016/0002-9378(84)90742-7; MATSUDA Y, 1994, AM J OBSTET GYNECOL, V170, P1433; Prout AP, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.020; Ross MG, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.10.883; SOOTHILL PW, 1987, BRIT MED J, V294, P1051, DOI 10.1136/bmj.294.6579.1051; Wassink G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073895; WINKLER CL, 1991, AM J OBSTET GYNECOL, V164, P637, DOI 10.1016/S0002-9378(11)80038-4	32	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108119	10.1371/journal.pone.0108119	http://dx.doi.org/10.1371/journal.pone.0108119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268842	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700065
J	Yang, XT; Yan, DF; Liu, CR				Yang, Xitian; Yan, Dongfeng; Liu, Canran			Natural Regeneration of Trees in Three Types of Afforested Stands in the Taihang Mountains, China	PLOS ONE			English	Article							SEEDLING REGENERATION; BEECH SEEDLINGS; GROWTH; FOREST; IRRADIANCE; VEGETATION; WOODLAND; DYNAMICS; CANOPY; LITTER	Natural regeneration is the natural process by which plants replace themselves. It is a cost-effective way to re-establish vegetation, and it helps to preserve genetic identity and diversity. In this study, we investigated the natural regeneration of trees in three types of afforested stands in the Taihang Mountains, China, which were dominated by Robinia pseudoacacia (black locust), Quercus variabilis (Chinese cork oak) and Platycladus orientalis (Chinese arborvitae) respectively. A consistent pattern was found among the three types of stands, being that the density of seedlings was positively correlated with the overstory canopy cover and negatively correlated with the covers of shrub, herb and litter layers. While a positive correlation between the density of seedlings and stand age was found for the conifer stands, negative correlations were found for the two types of broadleaf stands. Correlations between the density of saplings and the stand attributes were not consistent among the three types of stands. The two types of broadleaf stands had higher densities of seedlings and saplings than the conifer stands. While the broadleaf stands had adequate recruits for regeneration, the conifer stands did not have enough recruits. Our findings suggest that the overstory canopy should be prevented from being disturbed, any reduction of the canopy cover will decrease the recruits and affect the regeneration.	[Yang, Xitian; Yan, Dongfeng] Henan Agr Univ, Coll Forestry, Zhengzhou, Henan, Peoples R China; [Liu, Canran] Arthur Rylah Inst Environm Res, Dept Environm & Primary Ind, Heidelberg, Vic, Australia	Henan Agricultural University; Arthur Rylah Institute for Environmental Research (ARI)	Yang, XT (corresponding author), Henan Agr Univ, Coll Forestry, Zhengzhou, Henan, Peoples R China.	xitianyang@aliyun.com	Liu, Canran/AAI-1872-2020		National Natural Science Foundation of China [31170580]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 31170580) awarded to XY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TG, 2012, FOREST ECOL MANAG, V269, P229, DOI 10.1016/j.foreco.2011.12.021; Bloor JMG, 2008, PLANT ECOL, V194, P293, DOI 10.1007/s11258-007-9292-y; Catovsky S, 2002, OIKOS, V98, P403, DOI 10.1034/j.1600-0706.2002.980305.x; [陈桢 Chen Zhen], 2011, [中国水土保持科学, Science of Soil and Water Conservation], V9, P86; Coll L, 2003, ANN FOREST SCI, V60, P593, DOI 10.1051/forest:2003051; Collet C, 2001, ANN FOR SCI, V58, P127, DOI 10.1051/forest:2001112; Comita LS, 2007, J VEG SCI, V18, P163, DOI 10.1658/1100-9233(2007)18[163:POWPSA]2.0.CO;2; Duan Y, 2008, HENAN SCI, V26, P792; Dzwonko Z, 2002, ANN BOT-LONDON, V90, P245, DOI 10.1093/aob/mcf178; FACELLI JM, 1991, BOT REV, V57, P1, DOI 10.1007/BF02858763; Grubb PJ, 1996, J ECOL, V84, P827, DOI 10.2307/2960555; Han Y.Z., 2002, CHINESE J APPL ECOLO, V13, P615; Harmer R, 2012, EUR J FOREST RES, V131, P1833, DOI 10.1007/s10342-012-0636-3; Herault B, 2004, ANN FOREST SCI, V61, P711, DOI 10.1051/forest:2004057; Hou Y, 1999, J HEBEI U NATURAL SC, V20, P266; Laliberte E, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008019; Li WH, 2004, FOREST ECOL MANAG, V201, P33, DOI 10.1016/j.foreco.2004.06.010; Liira J, 2011, J FOREST RES-JPN, V16, P184, DOI 10.1007/s10310-011-0257-6; Luo Mei, 2012, Journal of Northwest A & F University - Natural Science Edition, V40, P73; Mwavu EN, 2009, J VEG SCI, V20, P791, DOI 10.1111/j.1654-1103.2009.01084.x; Perez-Ramos IM, 2012, J VEG SCI, V23, P526, DOI 10.1111/j.1654-1103.2011.01365.x; Pickup M, 2013, AUSTRAL ECOL, V38, P300, DOI 10.1111/j.1442-9993.2012.02404.x; Puhlick JJ, 2012, FOREST ECOL MANAG, V264, P10, DOI 10.1016/j.foreco.2011.10.002; Qu F, 2010, B SOIL WATER CONSERV, V6, P41; Sack L, 2001, FUNCT ECOL, V15, P145, DOI 10.1046/j.1365-2435.2001.00507.x; Sanchez-Gomez D, 2006, NEW PHYTOL, V170, P795, DOI 10.1111/j.1469-8137.2006.01711.x; Seiwa K, 1996, VEGETATIO, V123, P51, DOI 10.1007/BF00044887; Siebel HN, 1998, J VEG SCI, V9, P623, DOI 10.2307/3237280; Smith D.M., 1997, PRACTICE SILVICULTUR; Wang He-xin, 2008, Shengtaixue Zazhi, V27, P83; Wu Min, 2013, Yingyong Shengtai Xuebao, V24, P2106; Yang Xi-tian, 2006, Yingyong Shengtai Xuebao, V17, P1761; Yang YH, 2006, FORESTRY, V79, P135, DOI 10.1093/forestry/cpi062; Zeng Xin-hua, 2013, Shengtaixue Zazhi, V32, P852; Zhao Y, 2009, SCI SOIL WATER CONSE, V7, P111; Zhao Y., 2009, SCI SOIL WATER CONSE, V7, P66, DOI [10.3969/j.issn.1672, DOI 10.3969/J.ISSN.1672-3007.2009.04.012]; [赵勇 ZHAO Yong], 2009, [自然资源学报, Journal of Natural Resources], V24, P1616; [赵勇 ZHAO Yong], 2009, [水土保持学报, Journal of Soil and Water Conservation], V23, P208; [赵勇 ZHAO Yong], 2007, [南水北调与水利科技, South-to-North Water Transfers and Water Science & Technology], V5, P64; Zhu Jiao-jun, 2005, Journal of Forestry Research (Harbin), V16, P253, DOI 10.1007/BF02858184	40	9	10	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108744	10.1371/journal.pone.0108744	http://dx.doi.org/10.1371/journal.pone.0108744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268793	gold, Green Submitted, Green Published			2022-12-27	WOS:000343671700154
J	Barnes, HE; Liu, GH; Weston, CQ; King, P; Pham, LK; Waltz, S; Helzer, KT; Day, L; Sphar, D; Yamamoto, RT; Forsyth, RA				Barnes, Helen E.; Liu, Guohong; Weston, Christopher Q.; King, Paula; Pham, Long K.; Waltz, Shannon; Helzer, Kimberly T.; Day, Laura; Sphar, Dan; Yamamoto, Robert T.; Forsyth, R. Allyn			Selective Microbial Genomic DNA Isolation Using Restriction Endonucleases	PLOS ONE			English	Article							ADENINE METHYLATION; ENZYMES; SEQUENCES; DATABASE; PROTEIN; ROLES	To improve the metagenomic analysis of complex microbiomes, we have repurposed restriction endonucleases as methyl specific DNA binding proteins. As an example, we use DpnI immobilized on magnetic beads. The ten minute extraction technique allows specific binding of genomes containing the DpnI G(m6) ATC motif common in the genomic DNA of many bacteria including gamma-proteobacteria. Using synthetic genome mixtures, we demonstrate 80% recovery of Escherichia coli genomic DNA even when only femtogram quantities are spiked into 10 mu g of human DNA background. Binding is very specific with less than 0.5% of human DNA bound. Next Generation Sequencing of input and enriched synthetic mixtures results in over 100-fold enrichment of target genomes relative to human and plant DNA. We also show comparable enrichment when sequencing complex microbiomes such as those from creek water and human saliva. The technique can be broadened to other restriction enzymes allowing for the selective enrichment of trace and unculturable organisms from complex microbiomes and the stratification of organisms according to restriction enzyme enrichment.	[Barnes, Helen E.; Liu, Guohong; Weston, Christopher Q.; King, Paula; Pham, Long K.; Waltz, Shannon; Helzer, Kimberly T.; Day, Laura; Sphar, Dan; Yamamoto, Robert T.; Forsyth, R. Allyn] FLIR Syst Inc, La Jolla, CA 92037 USA		Forsyth, RA (corresponding author), FLIR Syst Inc, La Jolla, CA 92037 USA.	rforsyth@mail.sdsu.edu		King, Paula/0000-0002-3876-2655	Department of Homeland Security, Science and Technology Directorate [HSHQDC-10-C-00019]	Department of Homeland Security, Science and Technology Directorate(United States Department of Homeland Security (DHS))	Funding for this research was provided in full through contract HSHQDC-10-C-00019 to FLIR Systems Inc. by the Department of Homeland Security, Science and Technology Directorate, http://www.dhs.gov/. Dr. Hultgren was the DHS technical representative who reviewed and approved the manuscript for publication. The funders had no additional roles in study design, data collection, analysis or preparation of the manuscript.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Alvarez B, 2007, APPL ENVIRON MICROB, V73, P7210, DOI 10.1128/AEM.00960-07; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bispo PJ, 2010, INVEST OPHTH VIS SCI, V52, P873; Bonnet I, 2008, NUCLEIC ACIDS RES, V36, P4118, DOI 10.1093/nar/gkn376; Carr R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003292; DELACAMPA AG, 1988, J BIOL CHEM, V263, P14696; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Feehery GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076096; Herlemann DPR, 2013, MBIO, V4, DOI 10.1128/mBio.00569-12; Kingston IJ, 2003, NUCLEIC ACIDS RES, V31, P5221, DOI 10.1093/nar/gkg743; Kostic AD, 2013, GENE DEV, V27, P701, DOI 10.1101/gad.212522.112; LACKS S, 1975, J BIOL CHEM, V250, P4060; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P56, DOI 10.1093/nar/gkt747; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; Lynch TW, 2002, BIOPHYS J, V82, P93, DOI 10.1016/S0006-3495(02)75376-9; Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Ntougias S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/784591; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Ratel D, 2006, BIOESSAYS, V28, P309, DOI 10.1002/bies.20342; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Sachse S, 2009, J CLIN MICROBIOL, V47, P1050, DOI 10.1128/JCM.02242-08; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Seshasayee ASN, 2012, NUCLEIC ACIDS RES, V40, P7066, DOI 10.1093/nar/gks390; Siwek W, 2012, NUCLEIC ACIDS RES, V40, P7563, DOI 10.1093/nar/gks428; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; Sud'ina AE, 2005, BIOCHEMISTRY-MOSCOW+, V70, P941, DOI 10.1007/s10541-005-0206-0; TAYLOR JD, 1991, BIOCHEMISTRY-US, V30, P8743, DOI 10.1021/bi00100a005; Vartoukian SR, 2010, FEMS MICROBIOL LETT, V309, P1, DOI 10.1111/j.1574-6968.2010.02000.x; Vasu K, 2013, MICROBIOL MOL BIOL R, V77, P53, DOI 10.1128/MMBR.00044-12; VOVIS GF, 1977, J MOL BIOL, V115, P525, DOI 10.1016/0022-2836(77)90169-3; Wong DL, 1998, NUCLEIC ACIDS RES, V26, P645, DOI 10.1093/nar/26.2.645; XU SY, 1991, J BIOL CHEM, V266, P4425; YAGUPSKY P, 1990, CLIN MICROBIOL REV, V3, P269, DOI 10.1128/CMR.3.3.269-279.1990; Yang F, 2012, ISME J, V6, P1, DOI 10.1038/ismej.2011.71; Zhang L, 2009, PERIODONTOL 2000, V51, P25, DOI 10.1111/j.1600-0757.2009.00315.x	41	8	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109061	10.1371/journal.pone.0109061	http://dx.doi.org/10.1371/journal.pone.0109061			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279840	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800054
J	Jorgensen, NP; Meyer, R; Dagnaes-Hansen, F; Fuursted, K; Petersen, E				Jorgensen, Nis Pedersen; Meyer, Rikke; Dagnaes-Hansen, Frederik; Fuursted, Kurt; Petersen, Eskild			A Modified Chronic Infection Model for Testing Treatment of Staphylococcus aureus Biofilms on Implants	PLOS ONE			English	Article							MOUSE MODEL; IN-VITRO; OSTEOMYELITIS; VANCOMYCIN; VIVO; DAPTOMYCIN; SONICATION; DIAGNOSIS; EFFICACY; RELEASE	Bacterial biofilms causing implant-associated osteomyelitis is a severe complication with limited antimicrobial therapy options. We designed an animal model, in which implant associated osteomyelitis arise from a Staphylococcus aureus biofilm on a tibia implant. Two bioluminescently engineered (luxA-E transformed), strains of S. aureus were utilized, Xen29 and Xen31. Biofilm formation was assessed with epifluorescence microscopy. Quantitative measurements were performed day 4, 6, 8, 11 and 15 post-surgery. Bacteria were extracted from the biofilm by sonication and the bacterial load quantified by culturing. Biofilm formation was evident from day 6 post-implantation. Mean bacterial load from implants was similar to 1x10(4) CFU/implant, while mean bacterial load from infected tibias were 1x10(6) CFU/bone. Bioluminesence imaging revealed decreasing activity throughout the 15-day observation period, with signal intensity for both strains reaching that of the negative control by day 15 while there was no significant reduction in bacterial load. The model is suitable for testing antimicrobial treatment options for implant associated OM, as treatment efficacy on both biofilm and viable counts can be assessed.	[Jorgensen, Nis Pedersen; Petersen, Eskild] Aarhus Univ Hosp, Dept Infect Dis, Inst Clin Med, DK-8000 Aarhus, Denmark; [Jorgensen, Nis Pedersen] Aarhus Univ Hosp, Dept Clin Microbiol, DK-8000 Aarhus, Denmark; [Meyer, Rikke] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark; [Dagnaes-Hansen, Frederik] Aarhus Univ, Fac Hlth Sci, Dept Biomed, Aarhus, Denmark; [Fuursted, Kurt] Statens Serum Inst, DK-2300 Copenhagen, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Statens Serum Institut	Petersen, E (corresponding author), Aarhus Univ Hosp, Dept Infect Dis, Inst Clin Med, DK-8000 Aarhus, Denmark.	joepeter@rm.dk	Meyer, Rikke Louise/AAB-5377-2021	Meyer, Rikke Louise/0000-0002-6485-5134; Dagnaes-Hansen, Frederik/0000-0002-6622-0853	Faculty of Health Science, University of Aarhus, Denmark	Faculty of Health Science, University of Aarhus, Denmark	Nis Jorgensen is supported by a PhD grant from the Faculty of Health Science, University of Aarhus, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091, DOI 10.1177/039139880502801106; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Bernthal NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012580; Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fujimura S, 2009, J ORTHOP SCI, V14, P658, DOI 10.1007/s00776-009-1366-3; Funao H, 2012, INFECT IMMUN, V80, P733, DOI 10.1128/IAI.06166-11; Hegde SS, 2008, J ANTIMICROB CHEMOTH, V61, P169, DOI 10.1093/jac/dkm417; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003; Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042; LaPlante KL, 2008, ANTIMICROB AGENTS CH, V52, P2156, DOI 10.1128/AAC.01046-07; Li D, 2008, J ORTHOP RES, V26, P96, DOI 10.1002/jor.20452; Liang XR, 2011, BIOANALYSIS, V3, P1923, DOI [10.4155/BIO.11.181, 10.4155/bio.11.181]; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Monsen T, 2009, J CLIN MICROBIOL, V47, P2496, DOI 10.1128/JCM.02316-08; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Pribaz JR, 2012, J ORTHOP RES, V30, P335, DOI 10.1002/jor.21519; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Tafin UF, 2011, ANTIMICROB AGENTS CH, V55, P4821, DOI 10.1128/AAC.00141-11; Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588; Vuong C, 2004, J INFECT DIS, V190, P1498, DOI 10.1086/424487; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004	24	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e103688	10.1371/journal.pone.0103688	http://dx.doi.org/10.1371/journal.pone.0103688			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279456	gold, Green Submitted, Green Published			2022-12-27	WOS:000342670800001
J	Lowenthal, ED; Marukutira, TC; Chapman, J; Mokete, K; Riva, K; Tshume, O; Eby, J; Matshaba, M; Anabwani, GM; Gross, R; Glanz, K				Lowenthal, Elizabeth D.; Marukutira, Tafireyi C.; Chapman, Jennifer; Mokete, Keboletse; Riva, Katherine; Tshume, Ontibile; Eby, Jessica; Matshaba, Mogomotsi; Anabwani, Gabriel M.; Gross, Robert; Glanz, Karen			Psychosocial Assessments for HIV plus African Adolescents: Establishing Construct Validity and Exploring Under-Appreciated Correlates of Adherence	PLOS ONE			English	Article							CROSS-CULTURAL ADAPTATION; ANTIRETROVIRAL TREATMENT; PSYCHOLOGICAL REACTANCE; SOCIAL SUPPORT; SELF-EFFICACY; SCALE; CHILDREN; TRANSLATION; INVOLVEMENT; VALIDATION	Study Objectives: Psychosocial factors such as outcome expectancy, perceived stigma, socio-emotional support, consideration of future consequences, and psychological reactance likely influence adolescent adherence to antiretroviral treatments. Culturally-adapted and validated tools for measuring these factors in African adolescents are lacking. We aimed to identify culturally-specific factors of importance to establishing local construct validity in Botswana. Methods: Using in-depth interviews of 34 HIV+ adolescents, we explored how the psychosocial factors listed above are perceived in this cultural context. We evaluated six scales that have been validated in other contexts. We also probed for additional factors that the adolescents considered important to their HIV medication adherence. Analyses were conducted with an analytic framework approach using NVivo9 software. Results: While the construct validity of some Western-derived assessment tools was confirmed, other tools were poorly representative of their constructs in this cultural context. Tools chosen to evaluate HIV-related outcome expectancy and perceived stigma were well-understood and relevant to the adolescents. Feedback from the adolescents suggested that tools to measure all other constructs need major modifications to obtain construct validity in Botswana. The scale regarding future consequences was poorly understood and contained several items that lacked relevance for the Batswana adolescents. They thought psychological reactance played an important role in adherence, but did not relate well to many components of the reactance scale. Measurement of socio-emotional support needs to focus on the adolescent-parent relationship, rather than peer-support in this cultural context. Denial of being HIV-infected was an unexpectedly common theme. Ambivalence about taking medicines was also expressed. Discussion: In-depth interviews of Batswana adolescents confirmed the construct validity of some Western-developed psychosocial assessment tools, but demonstrated limitations in others. Previously underappreciated factors related to HIV medication adherence, such as denial and ambivalence, should be further explored.	[Lowenthal, Elizabeth D.] Univ Penn, Perelman Sch Med, Dept Pediat & Epidemiol, Philadelphia, PA 19104 USA; [Lowenthal, Elizabeth D.; Chapman, Jennifer; Eby, Jessica] Childrens Hosp Philadelphia, Dept Gen Pediat, Philadelphia, PA 19104 USA; [Lowenthal, Elizabeth D.; Riva, Katherine; Gross, Robert] Botswana UPenn Partnership, Gaborone, Botswana; [Marukutira, Tafireyi C.; Mokete, Keboletse; Tshume, Ontibile; Matshaba, Mogomotsi; Anabwani, Gabriel M.] Botswana Baylor Childrens Clin Ctr Excellence, Gaborone, Botswana; [Riva, Katherine] Univ Penn, Perelman Sch Med, Doris Duke Clin Res Program, Philadelphia, PA 19104 USA; [Riva, Katherine] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Eby, Jessica] Villanova Univ, Villanova, PA 19085 USA; [Anabwani, Gabriel M.] Baylor Coll Med Int Pediat AIDS Initiat, Houston, TX USA; [Gross, Robert] Univ Penn, Perelman Sch Med, Dept Med & Epidemiol, Philadelphia, PA 19104 USA; [Glanz, Karen] Univ Penn, Perelman Sch Med & Sch Nursing, Dept Epidemiol & Nursing, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Baylor College of Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Massachusetts System; University of Massachusetts Worcester; Villanova University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Lowenthal, ED (corresponding author), Univ Penn, Perelman Sch Med, Dept Pediat & Epidemiol, Philadelphia, PA 19104 USA.	lowenthale@email.chop.edu	; Anabwani, Gabriel/I-2371-2016	Chapman, Jennifer/0000-0001-7065-311X; Anabwani, Gabriel/0000-0002-8555-4373; Matshaba, Mogomotsi/0000-0002-6441-1218; Marukutira, Tafireyi/0000-0003-1142-6114	NIH K23 Career Development Award [K23MH095669]; Penn Center for AIDS Research [P30 AI 045008]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH097488, K23MH095669] Funding Source: NIH RePORTER	NIH K23 Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by NIH K23 Career Development Award K23MH095669 (EL). This study was supported in part by the Penn Center for AIDS Research (P30 AI 045008) (RG). The Botswana-UPenn Partnership (http://www.med.upenn.edu/botswana/) helped to support study site visits (EL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz S, 2009, AIDS PATIENT CARE ST, V23, P323, DOI 10.1089/apc.2008.0194; Agwu AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18579; Ali R, 2002, ADDICTION, V97, P1183; Arciniega LM, 2009, SPAN J PSYCHOL, V12, P767, DOI 10.1017/S1138741600002134; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Berg CA, 2011, J PEDIATR PSYCHOL, V36, P329, DOI 10.1093/jpepsy/jsq088; Blakemore SJ, 2012, NAT NEUROSCI, V15, P1184, DOI 10.1038/nn.3177; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Darkoh Ernest, 2004, JAMA, V292, P2565; Dawes J, 2008, INT J MARKET RES, V50, P61, DOI 10.1177/147078530805000106; Erlen JA, 2010, J ADV NURS, V66, P2560, DOI 10.1111/j.1365-2648.2010.05400.x; Ferrand RA, 2009, AIDS, V23, P2039, DOI 10.1097/QAD.0b013e32833016ce; Fitzgerald A, 2012, J ADOLESCENCE, V35, P941, DOI 10.1016/j.adolescence.2012.01.002; Forbes EE, 2010, BRAIN COGNITION, V72, P66, DOI 10.1016/j.bandc.2009.10.007; Gale NK, 2013, DROP, V13, P117; Glick ID, 2011, J CLIN PSYCHOPHARM, V31, P82, DOI 10.1097/JCP.0b013e31820597fa; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hambleton RK, 2001, EUR J PSYCHOL ASSESS, V17, P164, DOI 10.1027//1015-5759.17.3.164; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Humeniuk R, 2008, ADDICTION, V103, P1039, DOI 10.1111/j.1360-0443.2007.02114.x; Judd T, 2009, ARCH CLIN NEUROPSYCH, V24, P127, DOI 10.1093/arclin/acp016; Khan M, 2009, ARCH DIS CHILD, V94, P970, DOI 10.1136/adc.2008.156232; Koenig LJ, 2011, CURR OPIN OBSTET GYN, V23, P321, DOI 10.1097/GCO.0b013e32834a581b; Ledlie SW, 2001, AIDS PATIENT CARE ST, V15, P231, DOI 10.1089/10872910152050748; Lowenthal E, 2011, SCREENING DEPRESSION; Lowenthal ED, 2014, LANCET INFECT DIS; Lowenthal ED, 2013, JAMA-J AM MED ASSOC, V309, P1803, DOI 10.1001/jama.2013.3710; Malecki CK, 2002, PSYCHOL SCHOOLS, V39, P1; Miller CH, 2010, HEALTH COMMUN, V25, P266, DOI 10.1080/10410231003698945; Murphy DA, 2005, ARCH PEDIAT ADOL MED, V159, P764, DOI 10.1001/archpedi.159.8.764; Murphy DA, 2003, ARCH PEDIAT ADOL MED, V157, P249, DOI 10.1001/archpedi.157.3.249; Naar-King S, 2010, AIDS CARE, V22, P475, DOI 10.1080/09540120903220279; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Ntsayagae Esther, 2008, Issues Ment Health Nurs, V29, P165, DOI 10.1080/01612840701792571; Perneger TV, 1999, J CLIN EPIDEMIOL, V52, P1037, DOI 10.1016/S0895-4356(99)00088-8; Prince M, 2008, EPIDEMIOL PSICHIAT S, V17, P211, DOI 10.1017/S1121189X00001305; QSR International, 1999, NVIVO QUAL DAT AN SO; Reise SP, 2000, PSYCHOL ASSESSMENT, V12, P287, DOI 10.1037//1040-3590.12.3.287; Rueger SY, 2010, J YOUTH ADOLESCENCE, V39, P47, DOI 10.1007/s10964-008-9368-6; Seipone K., 2004, Morbidity and Mortality Weekly Report, V53, P1083; Shen LJ, 2005, J PERS ASSESS, V85, P74, DOI 10.1207/s15327752jpa8501_07; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; StataCorp, 2009, STAT STAT SOFTW REL; STRATHMAN A, 1994, J PERS SOC PSYCHOL, V66, P742, DOI 10.1037/0022-3514.66.4.742; Tanney MR, 2010, J ADOLESCENT HEALTH, V46, P11, DOI 10.1016/j.jadohealth.2009.05.017; Tassiopoulos K, 2013, CLIN INFECT DIS, V56, P283, DOI 10.1093/cid/cis816; Tong A, 2009, J PEDIATR-US, V155, P542, DOI 10.1016/j.jpeds.2009.04.009; U. J. P. o. H. A. (UNAIDS), 2012, 2012 REP GLOB AIDS E; van Widenfelt BM, 2005, CLIN CHILD FAM PSYCH, V8, P135, DOI 10.1007/s10567-005-4752-1; Viswanathan H, 2005, AIDS PATIENT CARE ST, V19, P306, DOI 10.1089/apc.2005.19.306; Wester CW, 2005, CLIN INFECT DIS, V40, P1041, DOI 10.1086/428352; Wright K, 2007, J ADOLESCENT HEALTH, V40, P96, DOI 10.1016/j.jadohealth.2006.08.001	52	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109302	10.1371/journal.pone.0109302	http://dx.doi.org/10.1371/journal.pone.0109302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3DZ	25279938	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800071
J	Woo, YS; Jun, TY; Jeon, YH; Song, HR; Kim, TS; Kim, JB; Lee, MS; Kim, JM; Jo, SJ				Woo, Young Sup; Jun, Tae-Youn; Jeon, Yang-Hwan; Song, Hoo Rim; Kim, Tae-Suk; Kim, Jung-Bum; Lee, Min-Soo; Kim, Jae-Min; Jo, Sun-Jin			Relationship of Temperament and Character in Remitted Depressed Patients with Suicidal Ideation and Suicide Attempts-Results from the CRESCEND Study	PLOS ONE			English	Article							MAJOR DEPRESSION; PERSONALITY-DISORDERS; PSYCHIATRIC-PATIENTS; ANOREXIA-NERVOSA; NOVELTY SEEKING; BULIMIA-NERVOSA; HARM AVOIDANCE; IMPULSIVITY; INVENTORY; BEHAVIOR	The aim of this study was to evaluate the Temperament and Character Inventory (TCI) scores of a sample of Korean patients with remitted depression who had attempted suicide and reported suicidal ideation and to compare their scores with those of remitted depressed patients without suicidal ideation. Adult depression patients who had completed 12 weeks of follow-up (N = 138) were divided into three groups: patients with a history of suicide attempts (N = 23); patients with current suicidal ideation (N = 59); and patients without current suicidal ideation (N = 56). After controlling for covariates, no significant differences were found among the three groups on any measure of temperament or character except self-directedness and self-transcendence. The self-transcendence scores of the lifetime suicide-attempt group were significantly higher compared with those of the suicidal-ideation group; post hoc analysis revealed that self-directedness was significantly lower in the suicide-attempt group compared with the non-suicidal group. The results from the present study suggest that remitted depression patients with a history of suicide attempts do not differ from non-attempters in temperament, but do differ in certain character traits.	[Woo, Young Sup; Jun, Tae-Youn; Jeon, Yang-Hwan; Song, Hoo Rim; Kim, Tae-Suk] Catholic Univ, Sch Med, Dept Psychiat, Seoul, South Korea; [Kim, Jung-Bum] Keimyung Univ, Sch Med, Dept Psychiat, Taegu, South Korea; [Lee, Min-Soo] Korea Univ, Coll Med, Dept Psychiat, Seoul 136705, South Korea; [Kim, Jae-Min] Chonnam Natl Univ, Sch Med, Dept Psychiat, Kwangju, South Korea; [Jo, Sun-Jin] Catholic Univ, Sch Med, Dept Prevent Med, Seoul, South Korea	Catholic University of Korea; Keimyung University; Korea University; Korea University Medicine (KU Medicine); Chonnam National University; Catholic University of Korea	Jun, TY (corresponding author), Catholic Univ, Sch Med, Dept Psychiat, Seoul, South Korea.	tyjun@catholic.ac.kr	KIM, Jae-Min/S-7637-2019; LEE, MINSOO/HGE-5845-2022		Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea	This research was supported by a grant of the Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea (HI10C2020). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate-Daga G, 2005, PSYCHIAT RES, V134, P75, DOI 10.1016/j.psychres.2004.01.013; Abbate-Daga G, 2007, PSYCHIAT RES, V149, P215, DOI 10.1016/j.psychres.2005.10.017; Allen MH, 2005, SUICIDE LIFE-THREAT, V35, P671, DOI 10.1521/suli.2005.35.6.671; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderson Charles B, 2002, Eat Disord, V10, P227; [Anonymous], 2003, AM J PSYCHIAT, V160, P1; APTER A, 1993, ACTA PSYCHIAT SCAND, V87, P1, DOI 10.1111/j.1600-0447.1993.tb03321.x; Becerra B, 2005, ACTAS ESP PSIQUIATRI, V33, P117; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Brezo J, 2006, ACTA PSYCHIAT SCAND, V113, P180, DOI 10.1111/j.1600-0447.2005.00702.x; Bulik CM, 1999, ACTA PSYCHIAT SCAND, V100, P27, DOI 10.1111/j.1600-0447.1999.tb10910.x; Calati R, 2008, J PSYCHIATR RES, V42, P938, DOI 10.1016/j.jpsychires.2007.10.006; Casey JE, 1999, ACTA PSYCHIAT SCAND, V100, P302, DOI 10.1111/j.1600-0447.1999.tb10865.x; Claassen CA, 2007, J AFFECT DISORDERS, V97, P77, DOI 10.1016/j.jad.2006.05.026; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Conrad R, 2009, PSYCHIAT RES, V170, P212, DOI 10.1016/j.psychres.2008.09.008; Corruble E, 2002, PSYCHIAT RES, V109, P17, DOI 10.1016/S0165-1781(01)00366-3; Csorba J, 2010, J AFFECT DISORDERS, V120, P217, DOI 10.1016/j.jad.2009.03.008; de la Rie SM, 1998, J PERS DISORD, V12, P362, DOI 10.1521/pedi.1998.12.4.362; Ekinci O, 2012, PSYCHIAT INVEST, V9, P119, DOI 10.4306/pi.2012.9.2.119; Ekinci O, 2011, J NERV MENT DIS, V199, P454, DOI 10.1097/NMD.0b013e3182214116; Engstrom C, 2004, BIPOLAR DISORD, V6, P130, DOI 10.1111/j.1399-5618.2004.00101.x; Evren C, 2006, NORD J PSYCHIAT, V60, P263, DOI 10.1080/08039480600790051; Farmer A, 2003, ARCH GEN PSYCHIAT, V60, P490, DOI 10.1001/archpsyc.60.5.490; Farmer RF, 1998, J CLIN PSYCHOL, V54, P129, DOI 10.1002/(SICI)1097-4679(199802)54:2<129::AID-JCLP1>3.3.CO;2-X; Grucza RA, 2005, COMPR PSYCHIAT, V46, P214, DOI 10.1016/j.comppsych.2004.08.006; Grucza RA, 2003, J AFFECT DISORDERS, V74, P123, DOI 10.1016/S0165-0327(02)00303-8; Guillem E, 2002, PSYCHIAT RES, V112, P83, DOI 10.1016/S0165-1781(02)00193-2; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hansenne M, 1999, J PSYCHIATR RES, V33, P31, DOI 10.1016/S0022-3956(98)00036-3; Heeringen Kv, 2001, UNDERSTANDING SUICID, Vxiv; Hirano S, 2002, J AFFECT DISORDERS, V69, P31, DOI 10.1016/S0165-0327(00)00329-3; Horesh N, 1997, PSYCHOTHER PSYCHOSOM, V66, P92, DOI 10.1159/000289115; Kampman O, 2011, J AFFECT DISORDERS, V135, P20, DOI 10.1016/j.jad.2010.12.021; Kim JM, 2011, J AFFECT DISORDERS, V129, P183, DOI 10.1016/j.jad.2010.09.007; Korea S, 2013, CAUSES DEATH STAT 20; MALONE KM, 1995, J AFFECT DISORDERS, V34, P173, DOI 10.1016/0165-0327(95)00015-F; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Margetic BA, 2011, PSYCHIAT RES, V186, P141, DOI 10.1016/j.psychres.2010.06.013; Miettunen J, 2006, PERS INDIV DIFFER, V41, P1515, DOI 10.1016/j.paid.2006.06.006; Oquendo MA, 2000, PSYCHIAT CLIN N AM, V23, P11, DOI 10.1016/S0193-953X(05)70140-4; Oquendo MA, 2000, J AFFECT DISORDERS, V59, P107, DOI 10.1016/S0165-0327(99)00129-9; POKORNY AD, 1983, ARCH GEN PSYCHIAT, V40, P249; Rothenhausler HB, 2006, SUICIDE LIFE-THREAT, V36, P455, DOI 10.1521/suli.2006.36.4.455; Sadock B.J., 2007, KAPLAN SADOCKS SYNOP, V10th; Schaefer KE, 2012, J AFFECT DISORDERS, V143, P95, DOI 10.1016/j.jad.2012.05.034; Seo HJ, 2014, J AFFECT DISORDERS, V155, P208, DOI 10.1016/j.jad.2013.11.002; Smith DJ, 2005, J AFFECT DISORDERS, V87, P83, DOI 10.1016/j.jad.2005.03.014; STEER RA, 1993, J CLIN PSYCHOL, V49, P603, DOI 10.1002/1097-4679(199309)49:5<603::AID-JCLP2270490502>3.0.CO;2-Y; Sudak HS, 2009, KAPLAN SADOCKS COMPR, P2723; SVRAKIC DM, 1993, ARCH GEN PSYCHIAT, V50, P991; van Heeringen C, 2003, J AFFECT DISORDERS, V74, P149, DOI 10.1016/S0165-0327(01)00482-7; van Heeringen K, 2000, J AFFECT DISORDERS, V60, P181, DOI 10.1016/S0165-0327(99)00180-9; World Health Organisation, 2006, WORLD MENT HLTH DAY	56	8	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e105860	10.1371/journal.pone.0105860	http://dx.doi.org/10.1371/journal.pone.0105860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3DZ	25279671	gold, Green Published, Green Submitted			2022-12-27	WOS:000342670800003
J	Zeng, H; Shu, WQ; Chen, JA; Liu, L; Wang, DH; Fu, WJ; Wang, LQ; Luo, JH; Zhang, L; Tan, Y; Qiu, ZQ; Huang, YJ				Zeng, Hui; Shu, Wei-qun; Chen, Ji-an; Liu, Lin; Wang, Da-hua; Fu, Wen-juan; Wang, Ling-qiao; Luo, Jiao-hua; Zhang, Liang; Tan, Yao; Qiu, Zhi-qun; Huang, Yu-jing			Experimental Comparison of the Reproductive Outcomes and Early Development of the Offspring of Rats Given Five Common Types of Drinking Water	PLOS ONE			English	Article							DISINFECTION BY-PRODUCTS; LOW-BIRTH-WEIGHT; SPATIAL MEMORY; EXPOSURE; LEAD; ASSOCIATION; MAGNESIUM; CONTAMINANTS; MODEL; RISK	Tap water (unfiltered), filtered tap water and processed bottled water (purified water, artificial mineralized water, or natural water) are now the five most widely consumed types of drinking water in China. However, the constituents (organic chemicals and inorganic ingredients) of the five waters differ, which may cause them to have different long-term health effects on those who drink them, especially sensitive children. In order to determine which type of water among the five waters is the most beneficial regarding reproductive outcomes and the developmental behaviors of offspring, two generations of Sprague-Dawley rats were given these five waters separately, and their reproductive outcomes and the developmental behaviors of their offspring were observed and compared. The results showed that the unfiltered tap water group had the lowest values for the maternal gestation index (MGI) and offspring's learning and memory abilities (OLMA); the lowest offspring survival rate was found in the purified water group; and the highest OLMA were found in the filtered tap water group. Thus, the best reproductive and offspring early developmental outcomes were found in the group that drank filtered tap water, which had the lowest levels of pollutants and the richest minerals. Therefore, thoroughly removing toxic contaminants and retaining the beneficial minerals in drinking water may be important for both pregnant women and children, and the best way to treat water may be with granular activated carbon and ion exchange by copper zinc alloy.	[Zeng, Hui; Shu, Wei-qun; Chen, Ji-an; Wang, Da-hua; Fu, Wen-juan; Wang, Ling-qiao; Luo, Jiao-hua; Zhang, Liang; Tan, Yao; Qiu, Zhi-qun; Huang, Yu-jing] Third Mil Med Univ, Coll Prevent Med, Dept Environm Hyg, Chongqing, Peoples R China; [Liu, Lin] Oklahoma State Univ, Dept Physiol Sci, Lundberg Kienlen Lung Biol & Toxicol Lab, Stillwater, OK 74078 USA	Army Medical University; Oklahoma State University System; Oklahoma State University - Stillwater	Shu, WQ (corresponding author), Third Mil Med Univ, Coll Prevent Med, Dept Environm Hyg, Chongqing, Peoples R China.	xm0630@sina.com			National Natural Science Foundation of China [81001234]; Project of Chongqing Municipal Health Bureau [2012-2-447]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Chongqing Municipal Health Bureau	This project was supported by National Natural Science Foundation of China ( No. 81001234) and the Project of Chongqing Municipal Health Bureau (Grant No. 2012-2-447). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, POPULAR STANDARDIZAT, V9, P6; Bloom MS, 2010, INT J HYG ENVIR HEAL, V213, P401, DOI 10.1016/j.ijheh.2010.09.001; Cao B, 2009, ENVIRON TOXICOL PHAR, V27, P357, DOI 10.1016/j.etap.2008.12.002; Cartier C, 2012, WATER RES, V46, P5205, DOI 10.1016/j.watres.2012.07.002; Cheng Fang, 2012, Journal of Chongqing Medical University, V37, P89; Chinese Ministry of Health and China National Standardization Management Committee, 2007, 575062007 GBT; Clement M, 2000, WATER RES, V34, P1533, DOI 10.1016/S0043-1354(99)00277-8; Deng XQ, 2001, FOOD FERMENTAT ION I, V27, P70; Devi R, 2006, WATER AIR SOIL POLL, V174, P33, DOI 10.1007/s11270-005-9022-9; DUTT B, 1960, J Comp Pathol, V70, P120, DOI 10.1016/S0368-1742(60)80010-0; Fertmann R, 2004, INT J HYG ENVIR HEAL, V207, P235, DOI 10.1078/1438-4639-00285; Frantisek K, HLTH RISKS DRINKING; GILLIES ME, 1982, HUM NUTR-APPL NUTR, V36, P287; [郭志顺 GUO Zhishun], 2006, [中国环境监测, Environmental Monitoring in China], V22, P45; Janulewicz PA, 2008, NEUROTOXICOL TERATOL, V30, P175, DOI 10.1016/j.ntt.2008.01.007; Jing JF, 2012, NEUROTOXICOLOGY, V33, P1230, DOI 10.1016/j.neuro.2012.07.003; Kim EJ, 2011, WATER RES, V45, P2763, DOI 10.1016/j.watres.2011.02.023; Linkous DH, 2004, METAL IONS BIOL MED, V8, P390; Mao YX, 2003, CHINESE J BIRTH HLTH, V11, P73; Maret W, 2006, J TRACE ELEM MED BIO, V20, P3, DOI 10.1016/j.jtemb.2006.01.006; Ministry of Health of China Standardization Administration of China, GBT57502006 MIN HLTH; Ministry of Health of China Standardization Administration of China, 2003, GB15193152003 MIN HL; Ministry of Health of China Standardization Administration of China, 2003, GB192982003 MIN HLTH; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nakashima AS, 2009, BRAIN RES REV, V59, P347, DOI 10.1016/j.brainresrev.2008.10.003; O'Bryant SE, 2011, INT J ENV RES PUB HE, V8, P861, DOI 10.3390/ijerph8030861; OECD Publishing, 1983, OECD GUID TEST CHEM; PANTALEONI G, 1988, FUND APPL TOXICOL, V11, P440, DOI 10.1016/0272-0590(88)90108-X; [任谦 Ren Qian], 2005, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V27, P1012; Richard H., 2012, GLOB BOTTL WAT C MAR; Richardson SD, 2003, TRAC-TREND ANAL CHEM, V22, P666, DOI 10.1016/S0165-9936(03)01003-3; Richardson SD, 2007, MUTAT RES-REV MUTAT, V636, P178, DOI 10.1016/j.mrrev.2007.09.001; Rosa C, 2011, J FOOD COMPOS ANAL, V24, P184; Sabatier M, 2002, AM J CLIN NUTR, V75, P65, DOI 10.1093/ajcn/75.1.65; Teakle JT, 1997, PRETREATMENT REVERSE, P1; Tian HJ, 2002, RESOURCES ENV YANGTZ, V24, P226; Widdowson EM, 1944, BRIT MED B, V10, P221; Wolf A, 2013, ENVIRON SCI POLLUT R, V20, P7124, DOI 10.1007/s11356-013-1929-x; Wright JM, 2003, OCCUP ENVIRON MED, V60, P173, DOI 10.1136/oem.60.3.173; Xiong RJ., 2004, IND SAF ENV PROT, V30, P5; Xu W, 2011, OCCUP HEMTH, V27, P2004; Yang CY, 2000, ENVIRON HEALTH PERSP, V108, P765, DOI 10.2307/3434730; Yang CY, 2002, MAGNESIUM RES, V15, P207; Yang CY, 2002, ENVIRON RES, V89, P189, DOI 10.1006/enrs.2002.4369; ZBINDEN G, 1981, ARCH TOXICOL, V48, P69, DOI 10.1007/BF00310480; Zeng H, 2008, FOOD CHEM TOXICOL, V46, P1495, DOI 10.1016/j.fct.2007.12.010	46	6	11	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108955	10.1371/journal.pone.0108955	http://dx.doi.org/10.1371/journal.pone.0108955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279561	gold, Green Published, Green Submitted			2022-12-27	WOS:000342670800042
J	Chen, YH; Chen, CJ; Yeh, SY; Lin, YN; Wu, YC; Hsieh, WT; Wu, BT; Ma, WL; Chen, WC; Chang, CS; Chen, HY				Chen, Yung-Hsiang; Chen, Chao-Jung; Yeh, Shuyuan; Lin, Yu-Ning; Wu, Yang-Chang; Hsieh, Wen-Tsong; Wu, Bor-Tsang; Ma, Wen-Lung; Chen, Wen-Chi; Chang, Chawnshang; Chen, Huey-Yi			Urethral Dysfunction in Female Mice with Estrogen Receptor beta Deficiency	PLOS ONE			English	Article							STRESS URINARY-INCONTINENCE; PELVIC ORGAN PROLAPSE; TUMOR-CELL INVASIVENESS; PROTEOMIC ANALYSIS; VAGINAL TRAUMA; LUNG-CANCER; ER-BETA; EXPRESSION; ALPHA; WOMEN	Estrogen has various regulatory functions in the growth, development, and differentiation of the female urogenital system. This study investigated the roles of ER beta in stress urinary incontinence (SUI). Wild-type (ER beta(+/+)) and knockout (ER beta(-/-)) female mice were generated (aged 6-8 weeks, n = 6) and urethral function and protein expression were measured. Leak point pressures (LPP) and maximum urethral closure pressure (MUCP) were assessed in mice under urethane anesthesia. After the measurements, the urethras were removed for proteomic analysis using label-free quantitative proteomics by nano-liquid chromatography-mass spectrometry (LC-MS/MS) analysis. The interaction between these proteins was further analysed using MetaCore. Lastly, Western blot was used to confirm the candidate proteins. Compared with the ER beta(+/+) group, the LPP and MUCP values of the ER beta(-/-) group were significantly decreased. Additionally, we identified 85 differentially expressed proteins in the urethra of ER beta(-/-) female mice; 57 proteins were up-regulated and 28 were downregulated. The majority of the ER beta knockout-modified proteins were involved in cell-matrix adhesion, metabolism, immune response, signal transduction, nuclear receptor translational regelation, and muscle contraction and development. Western blot confirmed the up-regulation of myosin and collagen in urethra. By contrast, elastin was down-regulated in the ER beta(-/-) mice. This study is the first study to estimate protein expression changes in urethras from ER beta(-/-) female mice. These changes could be related to the molecular mechanism of ER beta in SUI.	[Chen, Yung-Hsiang; Chen, Chao-Jung; Lin, Yu-Ning; Wu, Yang-Chang; Hsieh, Wen-Tsong; Wu, Bor-Tsang; Chen, Wen-Chi; Chen, Huey-Yi] China Med Univ, Grad Inst Integrated Med,Grad Inst Rehabil Sci, Coll Chinese Med,Dept Phys Therapy, Sch Pharm,Coll Pharm,Dept Pharmacol, Taichung, Taiwan; [Chen, Yung-Hsiang; Chen, Chao-Jung; Ma, Wen-Lung; Chen, Wen-Chi; Chang, Chawnshang; Chen, Huey-Yi] China Med Univ Hosp, Sex Hormone Res Ctr, Dept Med Res, Taichung, Taiwan; [Chen, Yung-Hsiang; Chen, Chao-Jung; Ma, Wen-Lung; Chen, Wen-Chi; Chang, Chawnshang; Chen, Huey-Yi] China Med Univ Hosp, Sex Hormone Res Ctr, Dept Urol, Taichung, Taiwan; [Chen, Yung-Hsiang; Chen, Chao-Jung; Ma, Wen-Lung; Chen, Wen-Chi; Chang, Chawnshang; Chen, Huey-Yi] China Med Univ Hosp, Sex Hormone Res Ctr, Dept Obstet & Gynecol, Taichung, Taiwan; [Yeh, Shuyuan; Chang, Chawnshang] Univ Rochester, Med Ctr, Wilmot Canc Ctr, Dept Urol,George H Whipple Lab Canc Res, Rochester, NY 14642 USA	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Rochester	Chang, CS (corresponding author), China Med Univ Hosp, Sex Hormone Res Ctr, Dept Med Res, Taichung, Taiwan.	chang@urmc.rochester.edu; d888208@ms45.hinet.net	Chen, Chao-Jung/E-5481-2011; Chen, Yung-Hsiang/K-6766-2015; Hsieh, Wen-Tsong/AAY-3089-2020; Wu, Yang-Chang/C-5682-2009; Ma, Wen-Lung/O-2745-2015	Chen, Chao-Jung/0000-0003-3834-9243; Chen, Yung-Hsiang/0000-0002-8756-5113; Hsieh, Wen-Tsong/0000-0002-2330-8898; Wu, Yang-Chang/0000-0001-7815-2686; Ma, Wen-Lung/0000-0002-5571-3302; Chang, Chawnshang/0000-0001-8510-3516	Taiwan National Science Council [NSC101-2314-B-039-018, NSC102-2320-B-039-025]; China Medical University Hospital [DMR-103-063]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); China Medical University Hospital; Taiwan Department of Health Clinical Trial and Research Center of Excellence	This work was supported in part by Taiwan National Science Council (NSC101-2314-B-039-018 and NSC102-2320-B-039-025), China Medical University Hospital (DMR-103-063), and Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada H, 2008, MOL HUM REPROD, V14, P539, DOI 10.1093/molehr/gan045; Athanasiou S, 2010, INT UROGYNECOL J, V21, P1377, DOI 10.1007/s00192-010-1203-4; Cannon TW, 2002, BJU INT, V90, P403, DOI 10.1046/j.1464-410X.2002.02918.x; Chen CJ, 2012, ANAL CHEM, V84, P297, DOI 10.1021/ac202549y; Chen HY, 2013, EUR J OBSTET GYN R B, V171, P171, DOI 10.1016/j.ejogrb.2013.08.034; Chen HY, 2012, EUR J OBSTET GYN R B, V163, P224, DOI 10.1016/j.ejogrb.2012.04.012; Chen HY, 2010, EUR J OBSTET GYN R B, V149, P222, DOI 10.1016/j.ejogrb.2009.12.014; Chen YH, 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1155/2014/280204; Chen YH, 2014, AM J CHINESE MED, V42, P817, DOI 10.1142/S0192415X14500529; Cheng CL, 2014, AM J PHYSIOL-RENAL, V306, pF181, DOI 10.1152/ajprenal.00298.2013; CHEW S Y, 1989, SMJ Singapore Medical Journal, V30, P396; Crivellaro S, 2009, THESCIENTIFICWORLDJO, V9, P466, DOI 10.1100/tsw.2009.53; Cunningham M, 2011, CLIN REV ALLERG IMMU, V40, P66, DOI 10.1007/s12016-010-8203-5; Deroo BJ, 2010, MOL ENDOCRINOL, V24, P1703, DOI 10.1210/me.2009-0288; Drewes PG, 2007, AM J PATHOL, V170, P578, DOI 10.2353/ajpath.2007.060662; Feifer A, 2007, INT UROGYNECOL J, V18, P1087, DOI 10.1007/s00192-007-0347-3; Game X, 2008, AM J PHYSIOL-REG I, V294, pR851, DOI 10.1152/ajpregu.00467.2007; Gunetti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045538; Hammack BN, 2004, MULT SCLER, V10, P245, DOI 10.1191/1352458504ms1023oa; Hijaz A, 2005, J UROLOGY, V174, P771, DOI 10.1097/01.ju.0000164721.52278.29; Hijaz A, 2008, J UROLOGY, V179, P2103, DOI 10.1016/j.juro.2008.01.096; HILTON P, 1983, BRIT J OBSTET GYNAEC, V90, P919, DOI 10.1111/j.1471-0528.1983.tb06764.x; Hirai K, 2009, INT J UROL, V16, P45, DOI 10.1111/j.1442-2042.2008.02164.x; Hsu I, 2014, CARCINOGENESIS, V35, P651, DOI 10.1093/carcin/bgt348; Jackson S, 2002, BJOG-INT J OBSTET GY, V109, P339; Kamiya Y, 2013, J BONE MINER RES, V28, P1127, DOI 10.1002/jbmr.1835; KAUR J, 1991, MECH AGEING DEV, V57, P111, DOI 10.1016/0047-6374(91)90028-X; Klutke J, 2010, INT UROGYNECOL J, V21, P869, DOI 10.1007/s00192-010-1108-2; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Lan Z, 2004, INT UROGYNECOL J, V15, P340, DOI 10.1007/s00192-004-1178-0; Levin RM, 1999, SCAND J UROL NEPHROL, V33, P59, DOI 10.1080/003655999750042169; Li CC, 2012, BIOMEDICINE-TAIWAN, V2, P10, DOI 10.1016/j.biomed.2012.02.002; Liao WL, 2013, BIOMEDICINE-TAIWAN, V3, P66, DOI 10.1016/j.biomed.2012.12.005; Lin DY, 2011, BIOMEDICINE-TAIWAN, V1, P21, DOI 10.1016/j.biomed.2011.10.004; Lin FY, 2011, J IMMUNOL, V186, P4405, DOI 10.4049/jimmunol.1003116; Lindberg MK, 2001, J ENDOCRINOL, V171, P229, DOI 10.1677/joe.0.1710229; Liu PL, 2010, AM J RESP CELL MOL, V43, P530, DOI 10.1165/rcmb.2009-0269OC; Liu PL, 2010, MOL CARCINOGEN, V49, P874, DOI 10.1002/mc.20663; Ma WL, 2012, BIOMEDICINE-TAIWAN, V2, P155, DOI 10.1016/j.biomed.2012.09.001; Markiewicz M, 2013, J INVEST DERMATOL, V133, P120, DOI 10.1038/jid.2012.264; Martinez-Gonzalez NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089181; McLennan Mary T, 2007, Mo Med, V104, P77; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Pedram A, 2010, MOL ENDOCRINOL, V24, P2152, DOI 10.1210/me.2010-0154; Shah AD, 2008, INT UROGYNECOL J, V19, P1085, DOI 10.1007/s00192-008-0580-4; Sievert KD, 2001, J UROLOGY, V166, P311, DOI 10.1016/S0022-5347(05)66151-4; Skala CE, 2011, INT UROGYNECOL J, V22, P705, DOI 10.1007/s00192-010-1327-6; Visco AG, 2003, AM J OBSTET GYNECOL, V189, P102, DOI 10.1067/mob.2003.372; Wang XXX, 2010, NAT REV NEPHROL, V6, P342, DOI 10.1038/nrneph.2010.56; Wu CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089213; Yang TL, 2011, J SCI FOOD AGR, V91, P134, DOI 10.1002/jsfa.4163; Yin WH, 2011, CARDIOLOGY, V118, P207, DOI 10.1159/000328780	52	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109058	10.1371/journal.pone.0109058	http://dx.doi.org/10.1371/journal.pone.0109058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275480	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500050
J	Debusschere, E; De Coensel, B; Bajek, A; Botteldooren, D; Hostens, K; Vanaverbeke, J; Vandendriessche, S; Van Ginderdeuren, K; Vincx, M; Degraer, S				Debusschere, Elisabeth; De Coensel, Bert; Bajek, Aline; Botteldooren, Dick; Hostens, Kris; Vanaverbeke, Jan; Vandendriessche, Sofie; Van Ginderdeuren, Karl; Vincx, Magda; Degraer, Steven			In Situ Mortality Experiments with Juvenile Sea Bass (Dicentrarchus labrax) in Relation to Impulsive Sound Levels Caused by Pile Driving of Windmill Foundations	PLOS ONE			English	Article							PRESSURE; NOISE	Impact assessments of offshore wind farm installations and operations on the marine fauna are performed in many countries. Yet, only limited quantitative data on the physiological impact of impulsive sounds on (juvenile) fishes during pile driving of offshore wind farm foundations are available. Our current knowledge on fish injury and mortality due to pile driving is mainly based on laboratory experiments, in which high-intensity pile driving sounds are generated inside acoustic chambers. To validate these lab results, an in situ field experiment was carried out on board of a pile driving vessel. Juvenile European sea bass (Dicentrarchus labrax) of 68 and 115 days post hatching were exposed to pile-driving sounds as close as 45 m from the actual pile driving activity. Fish were exposed to strikes with a sound exposure level between 181 and 188 dB re 1 mu Pa-2.s. The number of strikes ranged from 1739 to 3067, resulting in a cumulative sound exposure level between 215 and 222 dB re 1 mu Pa-2.s. Control treatments consisted of fish not exposed to pile driving sounds. No differences in immediate mortality were found between exposed and control fish groups. Also no differences were noted in the delayed mortality up to 14 days after exposure between both groups. Our in situ experiments largely confirm the mortality results of the lab experiments found in other studies.	[Debusschere, Elisabeth; Hostens, Kris; Vandendriessche, Sofie; Van Ginderdeuren, Karl] Inst Agr & Fisheries Res, Bioenvironm Res Grp, Oostende, Belgium; [Debusschere, Elisabeth; Vanaverbeke, Jan; Vincx, Magda; Degraer, Steven] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; [De Coensel, Bert; Botteldooren, Dick] Univ Ghent, Dept Informat Technol, B-9000 Ghent, Belgium; [Bajek, Aline] Ecloserie Marine Gravelines, Gravelines, France; [Degraer, Steven] Royal Belgian Inst Nat Sci, Operat Directorate Nat Environm OD Nat, Brussels, Belgium	Institute For Agricultural & Fisheries Research; Ghent University; Ghent University; Royal Belgian Institute of Natural Sciences	Debusschere, E (corresponding author), Inst Agr & Fisheries Res, Bioenvironm Res Grp, Oostende, Belgium.	Elisabeth.Debusschere@ilvo.vlaanderen.be	Botteldooren, Dick/H-2608-2013; De Coensel, Bert/C-2364-2008; Botteldooren, Dick/P-1506-2019	Botteldooren, Dick/0000-0002-7756-7238; De Coensel, Bert/0000-0003-1815-6436; Botteldooren, Dick/0000-0002-7756-7238; Debusschere, Elisabeth/0000-0002-5595-0295; Bajek, Anna/0000-0002-7720-8542	IWT predoctoral grant (Agency for Innovation by Science and Technology) [111217]; Ecloserie Marine de Gravelines	IWT predoctoral grant (Agency for Innovation by Science and Technology); Ecloserie Marine de Gravelines	Elisabeth Debusschere acknowledges an IWT predoctoral grant (Agency for Innovation by Science and Technology, 111217). http://www.iwt.be/subsidies/sb/steun. Bert De Coensel is a postdoctoral fellow of the Research Foundation-Flanders (FWO-Vlaanderen) http://www.fwo.be/. Co-author Aline Bajek is employed by Ecloserie Marine de Gravelines. Ecloserie Marine de Gravelines provided support in the form of salary for author Aline Bajek, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie M., 2009, ASSESSMENT NATURAL A; Anderson MJ, 2005, PERMANOVA FORTRAN CO; [Anonymous], 2008, MER OFFSHORE WINDTUR; Bolle LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033052; Bradley DL, 1966, ACOUSTIC IMPEDANCE P, P66; Casper BM, 2012, PLOS ONE, V7; Casper BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073844; Gorley C.K., 2006, GETTING STARTED PRIM; Haelters J., 2009, OFFSHORE WIND FARMS, P17; Halvorsen MB, 2012, P ROY SOC B-BIOL SCI, V279, P4705, DOI 10.1098/rspb.2012.1544; Halvorsen MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038968; Hastings M. C., 2005, EFFECTS SOUND FISH; Koumoundouros G, 2002, AQUACULTURE, V209, P49, DOI 10.1016/S0044-8486(01)00821-3; Lang, 2010, MARINE STRATEGY FRAM; Mann DA, 2007, FISH BIOACOUSTICS, P279; Neo YY, 2014, BIOL CONSERV, V178, P65, DOI 10.1016/j.biocon.2014.07.012; Oestman R, 2011, TECHNICAL GUIDANCE A; Popper AN, 2009, J FISH BIOL, V75, P455, DOI 10.1111/j.1095-8649.2009.02319.x; Popper AN, 2011, HEARING RES, V273, P25, DOI 10.1016/j.heares.2009.12.023; Popper AN, 2009, INTEGR ZOOL, V4, P43, DOI 10.1111/j.1749-4877.2008.00134.x; Roncarati A, 2001, J APPL ICHTHYOL, V17, P244, DOI 10.1046/j.1439-0426.2001.00286.x; Sfakianakis DG, 2006, AQUACULTURE, V256, P27, DOI 10.1016/j.aquaculture.2006.01.037; Sfakianakis DG, 2013, J APPL ICHTHYOL, V29, P1015, DOI 10.1111/jai.12248; Southall BL, 2007, AQUAT MAMM, V33, P121; THOMPSON CM, 1990, J ACOUST SOC AM, V87, P1138, DOI 10.1121/1.398787; van der Graaf A.J., 2012, EUROPEAN MARINE STRA; van der Kooij J, 2007, ICES J MAR SCI, V64, P1293, DOI 10.1093/icesjms/fsm119; Wysocki LE, 2007, AQUACULTURE, V272, P687, DOI 10.1016/j.aquaculture.2007.07.225; Wysocki LE, 2009, J ACOUST SOC AM, V126, P2100, DOI 10.1121/1.3203562; Zouiten D, 2011, AQUAC RES, V42, P1723, DOI 10.1111/j.1365-2109.2010.02773.x	30	9	11	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109280	10.1371/journal.pone.0109280	http://dx.doi.org/10.1371/journal.pone.0109280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275508	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500091
J	Ladinig, A; Foxcroft, G; Ashley, C; Lunney, JK; Plastow, G; Harding, JCS				Ladinig, Andrea; Foxcroft, George; Ashley, Carolyn; Lunney, Joan K.; Plastow, Graham; Harding, John C. S.			Birth Weight, Intrauterine Growth Retardation and Fetal Susceptibility to Porcine Reproductive and Respiratory Syndrome Virus	PLOS ONE			English	Article							PRENATAL UNDERNUTRITION; OVARIAN DEVELOPMENT; IMPLANTATION SITES; MUSCLE DEVELOPMENT; GENE-EXPRESSION; LATE-GESTATION; NEONATAL PIGS; VACCINATION; NUTRITION; RESPONSES	The severity of porcine reproductive and respiratory syndrome was compared in pregnant gilts originating from high and low birth weight litters. One-hundred and eleven pregnant gilts experimentally infected with porcine reproductive and respiratory syndrome virus on gestation day 85 (+/- 1) were necropsied along with their fetuses 21 days later. Ovulation rates and litter size did not differ between groups, but fetuses from low birth weight gilts were shorter, lighter and demonstrated evidence of asymmetric growth with large brain: organ weight ratios (i.e. brain sparing). The number of intrauterine growth retarded fetuses, defined by brain: organ weight ratios greater than 1 standard deviation from the mean, was significantly greater in low, compared to high, birth weight gilts. Although gamma delta T cells significantly decreased over time in high compared to low birth weight gilts, viral load in serum and tissues, gilt serum cytokine levels, and litter outcome, including the percent dead fetuses per litter, did not differ by birth weight group. Thus, this study provided no substantive evidence that the severity of porcine reproductive and respiratory syndrome is affected by dam birth weight. However, intrauterine growth retarded fetuses had lower viral loads in both fetal thymus and in endometrium adjacent to the umbilical stump. Crown rump length did not significantly differ between fetuses that survived and those that died at least one week prior to termination. Taken together, this study clearly demonstrates that birth weight is a transgenerational trait in pigs, and provides evidence that larger fetuses are more susceptible to transplacental PRRSv infection.	[Ladinig, Andrea; Ashley, Carolyn; Harding, John C. S.] Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK S7N 0W0, Canada; [Foxcroft, George; Plastow, Graham] Univ Alberta, Fac Agr Life & Environm Sci, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Lunney, Joan K.] ARS, Anim Parasit Dis Lab, Beltsville Agr Res Ctr, USDA, Beltsville, MD USA	University of Saskatchewan; University of Alberta; United States Department of Agriculture (USDA)	Ladinig, A (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK S7N 0W0, Canada.	andrea.ladinig@usask.ca		Plastow, Graham/0000-0002-3774-3110; Ladinig, Andrea/0000-0001-5037-7269	Genome Canada; Genome Prairie [2209-F]	Genome Canada(Genome Canada); Genome Prairie	Funding for the project was generously provided by grants from Genome Canada and Genome Prairie (grant number 2209-F), with administrative support by Genome Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer R, 1998, EXP TOXICOL PATHOL, V50, P59, DOI 10.1016/S0940-2993(98)80071-7; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Biensen NJ, 1999, J ANIM SCI, V77, P954; BROOKE OG, 1984, EARLY HUM DEV, V10, P85, DOI 10.1016/0378-3782(84)90114-2; Cano JP, 2009, CAN J VET RES, V73, P303; Cheon DS, 2001, J COMP PATHOL, V124, P231, DOI 10.1053/jcpa.2000.0457; Collier CT, 2011, DOMEST ANIM ENDOCRIN, V40, P40, DOI 10.1016/j.domaniend.2010.08.005; CRANE JP, 1980, AM J OBSTET GYNECOL, V138, P518, DOI 10.1016/0002-9378(80)90279-3; Da Silva P, 2002, REPRODUCTION, V123, P769, DOI 10.1530/rep.0.1230769; Da Silva-Buttkus P, 2003, REPRODUCTION, V126, P249, DOI 10.1530/rep.0.1260249; Detmer SE, 2013, INFLUENZA OTHER RESP, V7, P2, DOI 10.1111/irv.12199; EMANUEL I, 1992, BRIT J OBSTET GYNAEC, V99, P67, DOI 10.1111/j.1471-0528.1992.tb14396.x; FERGUSON AC, 1978, J PEDIATR-US, V93, P52, DOI 10.1016/S0022-3476(78)80599-X; Ford SP, 2012, REPROD FERT DEVELOP, V24, P105, DOI 10.1071/RD11911; Foxcroft GR, 2013, MANIPULATING PIG PRO, P138; Funston RN, 2013, VET CLIN N AM-FOOD A, V29, P517, DOI 10.1016/j.cvfa.2013.07.001; Godfrey K M, 2001, Public Health Nutr, V4, P611; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Han K, 2013, J COMP PATHOL, V148, P396, DOI 10.1016/j.jcpa.2012.09.004; Haussmann MF, 2000, J ANIM SCI, V78, P2399; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jammes H, 2011, REPROD FERT DEVELOP, V23, P64, DOI 10.1071/RD10259; Johnson RK, 1999, J ANIM SCI, V77, P541; Karniychuk UU, 2012, THERIOGENOLOGY, V78, P1527, DOI 10.1016/j.theriogenology.2012.06.015; Karniychuk UU, 2009, PLACENTA, V30, P497, DOI 10.1016/j.placenta.2009.03.016; Karniychuk UU, 2011, MICROB PATHOGENESIS, V51, P194, DOI 10.1016/j.micpath.2011.04.001; KNIGHT JW, 1977, J ANIM SCI, V44, P620, DOI 10.2527/jas1977.444620x; Ladinig A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096104; Lawson S, 2010, VACCINE, V28, P5356, DOI 10.1016/j.vaccine.2010.05.016; Lay DC, 2011, J ANIM SCI, V89, P1787, DOI 10.2527/jas.2010-3612; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li SS, 2014, REV MED VIROL, V24, P223, DOI 10.1002/rmv.1783; Manickam C, 2013, VET MICROBIOL, V162, P68, DOI 10.1016/j.vetmic.2012.08.021; McDade TW, 2001, J NUTR, V131, P1225, DOI 10.1093/jn/131.4.1225; McDade TW, 2001, AM J CLIN NUTR, V74, P543; Milligan BN, 2002, LIVEST PROD SCI, V76, P181, DOI 10.1016/S0301-6226(02)00012-X; Moore SE, 2004, AM J CLIN NUTR, V80, P453, DOI 10.1093/ajcn/80.2.453; Moore SE, 1997, NATURE, V388, P434, DOI 10.1038/41245; Moore SE, 1998, P NUTR SOC, V57, P241, DOI 10.1079/PNS19980038; Moore SE, 1999, INT J EPIDEMIOL, V28, P1088, DOI 10.1093/ije/28.6.1088; Oliver G, 2013, 9 INT C PIG REPR, P19; Rowland RRR, 2010, VIRUS RES, V154, P114, DOI 10.1016/j.virusres.2010.09.001; Sookoian S, 2013, PEDIATR RES, V73, P531, DOI 10.1038/pr.2013.2; STEWART RJC, 1980, BRIT J NUTR, V43, P403, DOI 10.1079/BJN19800108; SUSSER M, 1994, NUTR REV, V52, P84, DOI 10.1111/j.1753-4887.1994.tb01395.x; Talker SC, 2013, DEV COMP IMMUNOL, V40, P51, DOI 10.1016/j.dci.2013.01.003; THORNBURY JC, 1993, PEDIATR PATHOL, V13, P59, DOI 10.3109/15513819309048193; Town SC, 2005, ANIM REPROD SCI, V85, P301, DOI 10.1016/j.anireprosci.2004.05.019; Town SC, 2004, REPRODUCTION, V128, P443, DOI 10.1530/rep.1.00069; Tuchscherer M, 2002, VET IMMUNOL IMMUNOP, V86, P195, DOI 10.1016/S0165-2427(02)00035-1; van Rens BTTM, 2005, J ANIM SCI, V83, P144; Wang T, 2005, BIOL NEONATE, V88, P66, DOI 10.1159/000084645; WIGMORE PMC, 1983, J ANAT, V137, P235; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Yang H, 1996, IMMUNOLOGY, V89, P76, DOI 10.1046/j.1365-2567.1996.d01-705.x; ZAMENHOF S, 1971, SCIENCE, V172, P850, DOI 10.1126/science.172.3985.850	56	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109541	10.1371/journal.pone.0109541	http://dx.doi.org/10.1371/journal.pone.0109541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275491	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500107
J	McGregor, S; Henderson, KJ; Kaldor, JM				McGregor, Skye; Henderson, Klara J.; Kaldor, John M.			How Are Health Research Priorities Set in Low and Middle Income Countries? A Systematic Review of Published Reports	PLOS ONE			English	Article							SETTING PRIORITIES; CHILD HEALTH; RESEARCH INVESTMENTS; LATIN-AMERICA; DELPHI METHOD; BURDEN; CHALLENGES	Background: Priority setting is increasingly recognised as essential for directing finite resources to support research that maximizes public health benefits and drives health equity. Priority setting processes have been undertaken in a number of low-and middle-income country (LMIC) settings, using a variety of methods. We undertook a critical review of reports of these processes. Methods and Findings: We searched electronic databases and online for peer reviewed and non-peer reviewed literature. We found 91 initiatives that met inclusion criteria. The majority took place at the global level (46%). For regional or national initiatives, most focused on Sub Saharan Africa (49%), followed by East Asia and Pacific (20%) and Latin America and the Caribbean (18%). A quarter of initiatives aimed to cover all areas of health research, with a further 20% covering communicable diseases. The most frequently used process was a conference or workshop to determine priorities (24%), followed by the Child Health and Nutrition Initiative (CHNRI) method (18%). The majority were initiated by an international organization or collaboration (46%). Researchers and government were the most frequently represented stakeholders. There was limited evidence of any implementation or follow-up strategies. Challenges in priority setting included engagement with stakeholders, data availability, and capacity constraints. Conclusions: Health research priority setting (HRPS) has been undertaken in a variety of LMIC settings. While not consistently used, the application of established methods provides a means of identifying health research priorities in a repeatable and transparent manner. In the absence of published information on implementation or evaluation, it is not possible to assess what the impact and effectiveness of health research priority setting may have been.	[McGregor, Skye; Henderson, Klara J.; Kaldor, John M.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute	McGregor, S (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	smcgregor@kirby.unsw.edu.au		Henderson, Klara/0000-0003-4468-1306; McGregor, Skye/0000-0002-8116-4319	Australian Government Department of Health and Ageing; National Health and Medical Research Council Fellowship	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); National Health and Medical Research Council Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	No specific funding was received for the work presented here. The Kirby Institute is funded by the Australian Government Department of Health and Ageing. John Kaldor is supported by a National Health and Medical Research Council Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali N, 2006, WHAT FACTORS INFLUEN; Anuglo A, 2006, 1 COHRED; Bahl Rajiv, 2012, J Glob Health, V2, P010403, DOI 10.7189/jogh.02.010403; Bates DW, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1775; Bigdeli M, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-37; Boerma JT, 2007, LANCET, V369, P779, DOI 10.1016/S0140-6736(07)60364-X; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Brown KH, 2009, PUBLIC HEALTH NUTR, V12, P389, DOI 10.1017/S1368980008002188; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Council on Health Research for Development (COHRED), 2007, AR INT HLTH RES PROG; Cresswell KM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001554; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; Directorate Research Coordination and Management Department of National Health, 1996, P 1 ESS NAT HLTH RES; Doyle J, 2005, J EPIDEMIOL COMMUN H, V59, P193, DOI 10.1136/jech.2003.019547; Dye C, 2013, WORLD HLTH REPORT 20; Figueroa J, 2002, W INDIAN MED J, V51, P97; Global Forum for Health Research, 2000, 10 90 REP HLTH RES; Global Forum for Health Research, 2009, 3D COMB APPR MATR IM; Global Forum for Health Research, 2004, COMB MATR APPR PRIOR; Gonzalez-Block MA, 2004, HLTH RES POLICY SYST, V2; Kapiriri L, 2007, CROAT MED J, V48, P618; Kitua AY, 2000, BRIT MED J, V321, P821, DOI 10.1136/bmj.321.7264.821; Kosek M, 2009, J HEALTH POPUL NUTR, V27, P319; Lachat C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001593; Lansang MA, 2000, HEALTH POLICY PLANN, V15, P130, DOI 10.1093/heapol/15.2.130; Meremikwu M, 2011, HEALTH POLICY, V99, P244, DOI 10.1016/j.healthpol.2010.11.004; Ministry of Health, 2006, NAT AG PRIOR HLTH RE; Ministry of Health, 2012, NAT HLTH RES AG 2012; Montorzi G, 2010, PRIORITY SETTING RES; National Institute of Public Health, 2007, 4 5 YEAR HLTH RES MA; National Research Council of Kosovon, 2010, NAT RES PROGR REP KO; Nuyens Y, 2005, NO DEV RES CHALLENGE; Okello D, 2000, MANUAL RES PRIORITY; Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002; Ranson K, 2010, SOC SCI MED, V70, P1933, DOI 10.1016/j.socscimed.2010.01.051; Ranson Michael K., 2009, HLTH RES POLICY SYST, V7; Reveiz L, 2013, REV PANAM SALUD PUBL, V34, P1; Rudan I, 2012, PUBLIC HEALTH, V126, P237, DOI 10.1016/j.puhe.2011.12.001; Rudan I, 2006, SYSTEMATIC METHODOLO, P1; Rudan I, 2008, CROAT MED J, V49, P307, DOI 10.3325/cmj.2008.3.307; Rudan I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000308; Rylance J, 2010, LANCET INFECT DIS, V10, P886, DOI 10.1016/S1473-3099(10)70201-2; Sharan P, 2009, BRIT J PSYCHIAT, V195, P354, DOI 10.1192/bjp.bp.108.050187; Sitthi-amorn C, 2000, BRIT MED J, V321, P813, DOI 10.1136/bmj.321.7264.813; Sridhar D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001312; Swingler GH, 2005, HLTH RES POLICY SYST, V3; TDR Disease Reference Group on Chagas Disease Human African Trypanosomiasis and Leishmaniasis, 2013, RES PRIOR CHAG DIS H; TDR Thematic Reference Group on Environment Agriculture and Infectious Diseases of Poverty, 2013, RES PRIOR ENV AGR IN; The Commission on Health Research for Development, 1990, HLTH RES ESS LINK EQ; Tomlinson M, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-19; Tomlinson M, 2009, B WORLD HEALTH ORGAN, V87, P438, DOI 10.2471/BLT.08.054353; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; Viergever RF, 2013, DEV PAPUA NEW GUINEA; Viergever RF, 2010, HLTH RES PRIORITIZAT; Viergever RF, 2013, NATURE, V502, P171, DOI 10.1038/502171c; Viergever RF, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-36; Wazny K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001446; WHO, 2008, PRIOR SETT METH HLTH; World Bank, 2012, COUNTR LEND GROUPS; Yasamy MT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001126	60	72	73	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108787	10.1371/journal.pone.0108787	http://dx.doi.org/10.1371/journal.pone.0108787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ2BX	25275315	Green Submitted, Green Published, gold			2022-12-27	WOS:000342591500031
J	Reimert, I; Rodenburg, TB; Ursinus, WW; Kemp, B; Bolhuis, JE				Reimert, Inonge; Rodenburg, T. Bas; Ursinus, Winanda W.; Kemp, Bas; Bolhuis, J. Elizabeth			Selection Based on Indirect Genetic Effects for Growth, Environmental Enrichment and Coping Style Affect the Immune Status of Pigs	PLOS ONE			English	Article							INDIVIDUAL BEHAVIORAL-CHARACTERISTICS; SOCIAL BREEDING VALUES; PHASE PROTEIN-LEVELS; MULTILEVEL SELECTION; COMPLEMENT ACTIVITY; NATURAL ANTIBODIES; HOUSING CONDITION; FINISHING TRAITS; HUMORAL IMMUNITY; TAIL DOCKING	Pigs living in intensive husbandry systems may experience both acute and chronic stress through standard management procedures and limitations in their physical and social environment, which may have implications for their immune status. Here, the effect of a new breeding method where pigs were selected on their heritable influence on their pen mates' growth, and environmental enrichment on the immune status of pigs was investigated. Hereto, 240 pigs with a relatively positive genetic effect on the growth of their pen mates (+SBV) and 240 pigs with a relatively negative genetic effect on the growth of their pen mates (-SBV) were housed in barren or straw-enriched pens from 4 to 23 weeks of age (n = 80 pens in total). A blood sample was taken from the pigs before, three days after a 24 h regrouping test, and at week 22. In addition, effects of coping style, as assessed in a backtest, and gender were also investigated. Mainly, +SBV were found to have lower leukocyte, lymphocyte and haptoglobin concentrations than -SBV pigs. Enriched housed pigs had a lower neutrophil to lymphocyte (N:L) ratio and lower haptoglobin concentrations, but had higher antibody titers specific for Keyhole Limpet Hemocyanin (KLH) than barren housed pigs. No interactions were found between SBV class and housing. Furthermore, pigs with a proactive coping style had higher alternative complement activity and, in the enriched pens, higher antibody titers specific for KLH than pigs with a reactive coping style. Lastly, females tended to have lower leukocyte, but higher haptoglobin concentrations than castrated males. Overall, these results suggest that +SBV pigs and enriched housed pigs were less affected by stress than -SBV and barren housed pigs, respectively. Moreover, immune activation might be differently organized in individuals with different coping styles and to a lesser extent in individuals of opposite genders.	[Reimert, Inonge; Ursinus, Winanda W.; Kemp, Bas; Bolhuis, J. Elizabeth] Wageningen Univ, Dept Anim Sci, Adaptat Physiol Grp, NL-6700 AP Wageningen, Netherlands; [Rodenburg, T. Bas] Wageningen Univ, Dept Anim Sci, Behav Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Ursinus, Winanda W.] Wageningen UR Livestock Res Anim Behav & Welf, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Reimert, I (corresponding author), Wageningen Univ, Dept Anim Sci, Adaptat Physiol Grp, NL-6700 AP Wageningen, Netherlands.	inonge.reimert@wur.nl	Bolhuis, J. Elizabeth/P-7978-2015; Rodenburg, Bas/AAV-5612-2020; Rodenburg, Bas/D-9115-2012	Bolhuis, J. Elizabeth/0000-0002-5172-7635; Rodenburg, Bas/0000-0002-3371-1461; Ursinus, Winanda/0000-0002-3186-6793	program "The Value of Animal Welfare" of the Netherlands Organization for Scientific Research (NWO); Dutch Ministry of Economic Affairs	program "The Value of Animal Welfare" of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This experiment is part of the project "Seeking sociable swine? Incorporating social genetic effects into pig breeding programs to achieve balanced improvement in productivity and welfare,"which is financially supported by the program "The Value of Animal Welfare" of the Netherlands Organization for Scientific Research (NWO) and the Dutch Ministry of Economic Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averos X, 2010, APPL ANIM BEHAV SCI, V127, P73, DOI 10.1016/j.applanim.2010.09.010; AYENSU WK, 1995, PHYSIOL BEHAV, V57, P165, DOI 10.1016/0031-9384(94)00204-I; Barber I, 2010, PHILOS T R SOC B, V365, P4077, DOI 10.1098/rstb.2010.0182; BAUM A, 1991, HEALTH PSYCHOL, V10, P80, DOI 10.1037/0278-6133.10.2.80; Beattie VE, 2000, ANIM SCI, V70, P443, DOI 10.1017/S1357729800051791; BEATTIE VE, 1995, ANIM WELFARE, V4, P207; Bergsma R, 2008, GENETICS, V178, P1559, DOI 10.1534/genetics.107.084236; Bergsma R, 2013, J ANIM SCI, V91, P3601, DOI 10.2527/jas.2012-6200; Bijma P., 2012, ENCY SUSTAINABILITY, P9358; Bijma P, 2007, GENETICS, V175, P277, DOI 10.1534/genetics.106.062711; Bijma P, 2007, GENETICS, V175, P289, DOI 10.1534/genetics.106.062729; Blount DG, 2005, VET IMMUNOL IMMUNOP, V108, P399, DOI 10.1016/j.vetimm.2005.06.015; Bolhuis J.E., 2002, P 36 INT C INT SOC A, P172; Bolhuis JE, 2013, ANIM COGN, V16, P845, DOI 10.1007/s10071-013-0646-7; Bolhuis JE, 2006, APPL ANIM BEHAV SCI, V101, P68, DOI 10.1016/j.applanim.2006.01.001; Bolhuis JE, 2005, APPL ANIM BEHAV SCI, V93, P213, DOI 10.1016/j.applanim.2005.01.006; Bolhuis JE, 2005, ANIM BEHAV, V69, P1085, DOI 10.1016/j.anbehav.2004.09.013; Bolhuis JE, 2004, BEHAV BRAIN RES, V152, P351, DOI 10.1016/j.bbr.2003.10.024; Bolhuis JE, 2003, PHYSIOL BEHAV, V79, P289, DOI 10.1016/S0031-9384(03)00090-8; Bolhuis JE, 2000, PSYCHOPHARMACOLOGY, V152, P24, DOI 10.1007/s002130000516; Boscarino JA, 1999, PSYCHOSOM MED, V61, P378, DOI 10.1097/00006842-199905000-00019; Camerlink I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065136; Campisi J, 2003, J APPL PHYSIOL, V94, P43, DOI 10.1152/japplphysiol.00681.2002; Carere C, 2010, CURR ZOOL, V56, P728, DOI 10.1093/czoolo/56.6.728; Chen CY, 2007, GENET MOL RES, V6, P594; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Clapperton M, 2005, ANIM SCI, V81, P213, DOI 10.1079/ASC50180213; Coppens CM, 2010, PHILOS T R SOC B, V365, P4021, DOI 10.1098/rstb.2010.0217; Cray C, 2012, PROG MOL BIOL TRANSL, V105, P113, DOI 10.1016/B978-0-12-394596-9.00005-6; Cray C, 2009, COMPARATIVE MED, V59, P517; Darnall BD, 2009, BRAIN BEHAV IMMUN, V23, P595, DOI 10.1016/j.bbi.2009.02.019; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Day JEL, 2002, APPL ANIM BEHAV SCI, V75, P177, DOI 10.1016/S0168-1591(01)00199-X; de Groot J, 2001, PHYSIOL BEHAV, V73, P145, DOI 10.1016/S0031-9384(01)00472-3; de Jong IC, 2000, PHYSIOL BEHAV, V68, P571, DOI 10.1016/S0031-9384(99)00212-7; DEMEY F, 1993, VET RES COMMUN, V17, P37, DOI 10.1007/BF01839178; Dhabhar FS, 2002, BRAIN BEHAV IMMUN, V16, P785, DOI 10.1016/S0889-1591(02)00036-3; Dudink S, 2006, APPL ANIM BEHAV SCI, V101, P86, DOI 10.1016/j.applanim.2005.12.008; EKKEL ED, 1995, J ANIM SCI, V73, P1544; Ernst K, 2006, PHYSIOL BEHAV, V89, P448, DOI 10.1016/j.physbeh.2006.07.001; Friedman HS, 2008, BRAIN BEHAV IMMUN, V22, P668, DOI 10.1016/j.bbi.2007.09.004; Geverink NA, 2004, J ANIM SCI, V82, P1227; Geverink NA, 2004, PHYSIOL BEHAV, V80, P541, DOI 10.1016/j.physbeh.2003.10.013; Geverink NA, 2003, APPL ANIM BEHAV SCI, V81, P29, DOI 10.1016/S0168-1591(02)00253-8; Geverink NA, 2002, PHYSIOL BEHAV, V77, P451, DOI 10.1016/S0031-9384(02)00877-6; Geverink NA, 1998, PHYSIOL BEHAV, V63, P667, DOI 10.1016/S0031-9384(97)00513-1; GRIFFING B, 1967, AUST J BIOL SCI, V20, P127, DOI 10.1071/BI9670127; HESSING MJC, 1995, VET IMMUNOL IMMUNOP, V45, P97, DOI 10.1016/0165-2427(94)05338-S; HESSING MJC, 1993, APPL ANIM BEHAV SCI, V37, P285, DOI 10.1016/0168-1591(93)90118-9; HESSING MJC, 1994, PHYSIOL BEHAV, V55, P39, DOI 10.1016/0031-9384(94)90007-8; Huff GR, 2003, BRAIN BEHAV IMMUN, V17, P339, DOI 10.1016/S0889-1591(03)00035-7; Hyun Y, 1998, J ANIM SCI, V76, P721; Jansen J, 2009, ANIM COGN, V12, P303, DOI 10.1007/s10071-008-0191-y; Juul-Madsen HR, 2010, VET IMMUNOL IMMUNOP, V133, P95, DOI 10.1016/j.vetimm.2009.07.006; Kanitz E, 2004, BRAIN BEHAV IMMUN, V18, P35, DOI 10.1016/S0889-1591(03)00085-0; KHANSARI DN, 1990, IMMUNOL TODAY, V11, P170, DOI 10.1016/0167-5699(90)90069-L; Koolhaas JM, 2008, BRAIN BEHAV IMMUN, V22, P662, DOI 10.1016/j.bbi.2007.11.006; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Kortet R, 2010, ECOL LETT, V13, P1449, DOI 10.1111/j.1461-0248.2010.01536.x; Kurtz J, 2000, DEV COMP IMMUNOL, V24, P1, DOI 10.1016/S0145-305X(99)00057-9; Lammers A, 2004, DEV COMP IMMUNOL, V28, P51, DOI 10.1016/S0145-305X(03)00102-2; Lewis CRG, 2008, LIVEST SCI, V116, P338, DOI 10.1016/j.livsci.2008.02.014; Lutgendorf SK, 2003, BRAIN BEHAV IMMUN, V17, P225, DOI 10.1016/S0889-1591(03)00033-3; Manciocco A, 2011, ITAL J ANIM SCI, V10, DOI 10.4081/ijas.2011.e52; Marashi V, 2003, HORM BEHAV, V43, P281, DOI 10.1016/S0018-506X(03)00002-3; Mehta PH, 2008, BRAIN BEHAV IMMUN, V22, P651, DOI 10.1016/j.bbi.2008.01.008; Merlot E, 2004, APPL ANIM BEHAV SCI, V85, P247, DOI 10.1016/j.applanim.2003.11.002; Merlot E, 2012, APPL ANIM BEHAV SCI, V85, P247; Moynihan JA, 2003, BRAIN BEHAV IMMUN, V17, pS11; Muir WM, 2005, GENETICS, V170, P1247, DOI 10.1534/genetics.104.035956; Muir WM, 1996, POULTRY SCI, V75, P447, DOI 10.3382/ps.0750447; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Niemela PT, 2013, BEHAV ECOL, V24, P935, DOI 10.1093/beheco/art014; NOONAN GJ, 1994, APPL ANIM BEHAV SCI, V39, P203, DOI 10.1016/0168-1591(94)90156-2; Oostindjer M, 2010, J ANIM SCI, V88, P3554, DOI 10.2527/jas.2010-2940; Oostindjer M, 2013, P 47 INT C INT SOC A, P126; Ots I, 1998, FUNCT ECOL, V12, P700, DOI 10.1046/j.1365-2435.1998.00219.x; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Parmentier HK, 2004, DEV COMP IMMUNOL, V28, P39, DOI 10.1016/S0145-305X(03)00087-9; Petersen HH, 2002, VET REC, V151, P85, DOI 10.1136/vr.151.3.85; Pineiro C, 2007, ANIMAL, V1, P133, DOI 10.1017/S1751731107283909; Pineiro C, 2009, VET J, V179, P78, DOI 10.1016/j.tvjl.2007.08.010; Pineiro M, 2007, VET J, V173, P669, DOI 10.1016/j.tvjl.2006.02.006; Prunier A, 2006, ANIM WELFARE, V15, P277; Prunier A, 2010, ANIMAL, V4, P886, DOI 10.1017/S175173111000008X; Rault JL, 2011, APPL ANIM BEHAV SCI, V135, P214, DOI 10.1016/j.applanim.2011.10.017; Rauw WM, 1998, LIVEST PROD SCI, V56, P15, DOI 10.1016/S0301-6226(98)00147-X; Reimert I, 2013, J ANIM SCI, V91, P4589, DOI 10.2527/jas.2013-6673; Reimert I, 2014, APPL ANIM BEHAV SCI, V151, P24, DOI 10.1016/j.applanim.2013.11.015; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rodenburg T. B., 2012, Animal Frontiers, V2, P16, DOI 10.2527/af.2012-0044; Rodenburg TB, 2010, ANIM WELFARE, V19, P77; Ruis MAW, 2002, APPL ANIM BEHAV SCI, V75, P207, DOI 10.1016/S0168-1591(01)00191-5; Ruis MAW, 2000, APPL ANIM BEHAV SCI, V66, P31, DOI 10.1016/S0168-1591(99)00070-2; Salak-Johnson JL, 2007, J ANIM SCI, V85, pE81, DOI 10.2527/jas.2006-538; Salamano G, 2008, VET J, V177, P110, DOI 10.1016/j.tvjl.2007.03.015; Sanders VM, 2006, BRAIN BEHAV IMMUN, V20, P317, DOI 10.1016/j.bbi.2005.08.005; Schrama JW, 1997, J ANIM SCI, V75, P2588; Schroder-Petersen DL, 2001, VET J, V162, P196, DOI 10.1053/tvjl.2001.0605; Scollo A, 2013, RES VET SCI, V95, P825, DOI 10.1016/j.rvsc.2013.06.019; Scott K, 2006, LIVEST SCI, V103, P104, DOI 10.1016/j.livsci.2006.01.008; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sild E, 2011, BRAIN BEHAV IMMUN, V25, P1349, DOI 10.1016/j.bbi.2011.03.020; Sneddon IA, 2000, ANIM WELFARE, V9, P373; Sorrells SF, 2007, BRAIN BEHAV IMMUN, V21, P259, DOI 10.1016/j.bbi.2006.11.006; Star L, 2008, J AGR ENVIRON ETHIC, V21, P109, DOI 10.1007/s10806-007-9072-7; Star L, 2007, POULTRY SCI, V86, P1090, DOI 10.1093/ps/86.6.1090; Stefanski V, 2006, BRAIN BEHAV IMMUN, V20, P369, DOI 10.1016/j.bbi.2005.11.001; STOOKEY JM, 1994, J ANIM SCI, V72, P2804, DOI 10.2527/1994.72112804x; Studnitz M, 2007, APPL ANIM BEHAV SCI, V107, P183, DOI 10.1016/j.applanim.2006.11.013; Sun Y, 2013, POULTRY SCI, V92, P2024, DOI 10.3382/ps.2013-03144; Taylor NR, 2010, VET J, V186, P137, DOI 10.1016/j.tvjl.2009.08.028; Turner SP, 2009, J ANIM SCI, V87, P3076, DOI 10.2527/jas.2008-1558; Turner SP, 2013, APPL ANIM BEHAV SCI, V146, P26, DOI 10.1016/j.applanim.2013.03.012; Turner SP, 2011, APPL ANIM BEHAV SCI, V134, P1, DOI 10.1016/j.applanim.2011.06.001; Tuyttens FAM, 2005, APPL ANIM BEHAV SCI, V92, P261, DOI 10.1016/j.applanim.2005.05.007; Ursinus WW, 2014, APPL ANIM BEHAV SCI, V156, P22, DOI 10.1016/j.applanim.2014.04.001; Van de Kampman-van de Hoek E, 2013, P 4 EAAP INT S EN PR, P237; van de Weerd HA, 2009, APPL ANIM BEHAV SCI, V116, P1, DOI 10.1016/j.applanim.2008.08.001; van Erp-van der Kooij E, 2000, APPL ANIM BEHAV SCI, V66, P171, DOI 10.1016/S0168-1591(99)00094-5; Von Borell E., 2001, ANIM SCI J, V79, pE260, DOI [10.2527/jas2001.79E-SupplE260x, DOI 10.2527/JAS2001.79E-SUPPLE260X, DOI 10.2527/jas2001.79E-SupplE260x]; von Krogh M, 1916, J INFECT DIS, V19, P452, DOI 10.1093/infdis/19.3.452; WIEPKEMA PR, 1993, ANIM WELFARE, V2, P195; Wolf JB, 1998, TRENDS ECOL EVOL, V13, P64, DOI 10.1016/S0169-5347(97)01233-0	124	35	36	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108700	10.1371/journal.pone.0108700	http://dx.doi.org/10.1371/journal.pone.0108700			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275507	Green Submitted, gold, Green Published			2022-12-27	WOS:000342591500027
J	Wu, HQ; Zhang, F; Williamson, N; Jian, J; Zhang, L; Liang, ZQ; Wang, JY; An, LK; Tunnacliffe, A; Zheng, YZ				Wu, Haiqiang; Zhang, Fang; Williamson, Neil; Jian, Jie; Zhang, Liao; Liang, Zeqiu; Wang, Jinyu; An, Linkun; Tunnacliffe, Alan; Zheng, Yizhi			Effects of Secondary Metabolite Extract from Phomopsis occulta on beta-Amyloid Aggregation	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; A-BETA; NATURAL-PRODUCTS; PEPTIDE; OLIGOMERS; INHIBITORS; DISCOVERY; TOXICITY; THERAPEUTICS; SOLUBILITY	Inhibition of beta-amyloid (A beta) aggregation is an attractive therapeutic and preventive strategy for the discovery of disease-modifying agents in Alzheimer's disease (AD). Phomopsis occulta is a new, salt-tolerant fungus isolated from mangrove Pongamia pinnata (L.) Pierre. We report here the inhibitory effects of secondary metabolites from Ph. occulta on the aggregation of A beta 42. It was found that mycelia extracts (MEs) from Ph. occulta cultured with 0, 2, and 3 M NaCl exhibited inhibitory activity in an E. coli model of A beta aggregation. A water-soluble fraction, ME0-W-F1, composed of mainly small peptides, was able to reduce aggregation of an A beta 42-EGFP fusion protein and an early onset familial mutation A beta 42E22G-mCherry fusion protein in transfected HEK293 cells. ME0-W-F1 also antagonized the cytotoxicity of A beta 42 in the neural cell line SH-SY5Y in dose-dependent manner. Moreover, SDS-PAGE and FT-IR analysis confirmed an inhibitory effect of ME0-W-F1 on the aggregation of A beta 42 in vitro. ME0-W-F1 blocked the conformational transition of A beta 42 from alpha-helix/random coil to beta-sheet, and thereby inhibited formation of A beta 42 tetramers and high molecular weight oligomers. ME0-W-F1 and other water-soluble secondary metabolites from Ph. occulta therefore represent new candidate natural products against aggregation of A beta 42, and illustrate the potential of salt tolerant fungi from mangrove as resources for the treatment of AD and other diseases.	[Wu, Haiqiang; Zhang, Fang; Zhang, Liao; Liang, Zeqiu; Wang, Jinyu; Zheng, Yizhi] Shenzhen Univ, Coll Life Sci, Shenzhen, Peoples R China; [Williamson, Neil; Jian, Jie; Tunnacliffe, Alan] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [Jian, Jie] Guilin Med Univ, Coll Pharm, Guilin, Peoples R China; [An, Linkun] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China	Shenzhen University; University of Cambridge; Guilin Medical University; Sun Yat Sen University	Tunnacliffe, A (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England.	at10004@cam.ac.uk; yzzheng@szu.edu.cn		Tunnacliffe, Alan/0000-0001-8570-125X	Shenzhen City, China [JCYJ2012061408533365]; European Research Council [233232]; Infinitus (China) Company Limited	Shenzhen City, China; European Research Council(European Research Council (ERC)European Commission); Infinitus (China) Company Limited	Work in China was supported by Shenzhen City, China (Grant No. JCYJ2012061408533365, http://www.szsti.gov.cn/, YZ). Work in Cambridge was funded by the European Research Council (Advanced Investigator Grant 233232, http://erc.europa.eu/,AT) and Infinitus (China) Company Limited (http://www.infinitus.com.cn/, AT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Amijee H, 2012, BIOCHEMISTRY-US, V51, P8338, DOI 10.1021/bi300415v; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bruce NJ, 2010, PEPTIDES, V31, P2100, DOI 10.1016/j.peptides.2010.07.015; Calcul L, 2013, MAR DRUGS, V11, P5036, DOI 10.3390/md11125036; Chakrabortee S, 2012, BIOCHEM J, V442, P507, DOI 10.1042/BJ20111661; Corbett A, 2012, NAT REV DRUG DISCOV, V11, P833, DOI 10.1038/nrd3869; Dostal V, 2010, GENETICS, V186, P857, DOI 10.1534/genetics.110.120436; Ebada SS, 2008, NAT PROTOC, V3, P1820, DOI 10.1038/nprot.2008.182; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Fandrich M, 2011, TRENDS BIOCHEM SCI, V36, P338, DOI 10.1016/j.tibs.2011.02.002; Fisher AC, 2006, PROTEIN SCI, V15, P449, DOI 10.1110/ps.051902606; Fujiwara H, 2011, NEUROSCIENCE, V180, P305, DOI 10.1016/j.neuroscience.2011.01.064; Fujiwara H, 2009, J NEUROCHEM, V109, P1648, DOI 10.1111/j.1471-4159.2009.06069.x; Galimberti Daniela, 2011, Ther Adv Neurol Disord, V4, P203, DOI 10.1177/1756285611404470; Gessel MM, 2012, BIOCHEMISTRY-US, V51, P108, DOI 10.1021/bi201520b; Gutierrez RMP, 2012, CURR MED CHEM, V19, P2992; HAASS C, 1993, ANN NY ACAD SCI, V695, P109, DOI 10.1111/j.1749-6632.1993.tb23037.x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harun A, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-79; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; JENSEN PR, 1994, ANNU REV MICROBIOL, V48, P559, DOI 10.1146/annurev.mi.48.100194.003015; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim HG, 2010, J ETHNOPHARMACOL, V130, P625, DOI 10.1016/j.jep.2010.05.040; Lee LL, 2009, PROTEIN SCI, V18, P277, DOI 10.1002/pro.33; LeVine H, 2006, ANAL BIOCHEM, V356, P265, DOI 10.1016/j.ab.2006.04.036; Lin SY, 2003, INT J BIOL MACROMOL, V32, P173, DOI 10.1016/S0141-8130(03)00051-5; Luo Y, 2002, P NATL ACAD SCI USA, V99, P12197, DOI 10.1073/pnas.182425199; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; Ray B, 2011, CURR MED CHEM, V18, P3306, DOI 10.2174/092986711796504664; Reinke AA, 2007, CHEM BIOL DRUG DES, V70, P206, DOI 10.1111/j.1747-0285.2007.00557.x; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Singh JCH, 2011, J ETHNOPHARMACOL, V138, P85, DOI 10.1016/j.jep.2011.08.048; Sun YD, 2008, BIOORGAN MED CHEM, V16, P7177, DOI 10.1016/j.bmc.2008.06.045; Szabo Z, 1999, BIOCHEM BIOPH RES CO, V265, P297, DOI 10.1006/bbrc.1999.1667; Tian JZ, 2009, CURR ALZHEIMER RES, V6, P118, DOI 10.2174/156720509787602942; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Williams P, 2010, CURR ALZHEIMER RES, V7, P210, DOI 10.2174/156720510791050812; Wurth C, 2002, J MOL BIOL, V319, P1279, DOI 10.1016/S0022-2836(02)00399-6; Xu YC, 2005, P NATL ACAD SCI USA, V102, P5403, DOI 10.1073/pnas.0501218102; YOUNKIN SG, 1995, ANN NEUROL, V37, P287, DOI 10.1002/ana.410370303; Zhang Y, 2009, HYBRIDOMA, V28, P349, DOI 10.1089/hyb.2009.0015	42	12	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109438	10.1371/journal.pone.0109438	http://dx.doi.org/10.1371/journal.pone.0109438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275648	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500102
J	Kim, MJ; Kim, KM; Kim, J; Kim, KN				Kim, Mi-joo; Kim, Kwang-mahn; Kim, Jin; Kim, Kyoung-nam			BMP-2 Promotes Oral Squamous Carcinoma Cell Invasion by Inducing CCL5 Release	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; MESENCHYMAL STEM-CELLS; BREAST-CANCER CELLS; IN-VITRO; EXPRESSION; FIBROBLASTS; RHBMP-2; GROWTH; OVEREXPRESSION; PROLIFERATION	Bone morphogenetic protein-2 (BMP-2)-containing bone grafts are useful regenerative materials for oral and maxillofacial surgery; however, several in vitro and in vivo studies previously reported cancer progression-related adverse effects caused by BMP-2. In this study, by quantifying the rhBMP-2 content released from bone grafts, the rhBMP-2 concentration that did not show cytotoxicity in each cell line was determined and applied to the in vitro monoculture or coculture model in the invasion assay. Our results showed that 1 ng/ml rhBMP-2, while not affecting cancer cell viability, significantly increased the invasion ability of the cancer cells cocultured with fibroblasts. Cocultured medium with rhBMP-2 also contained increased levels of matrix metalloproteinases. rhBMP-2-treated cocultured fibroblasts did not show a prominent difference in mRNA expression profile. Some cytokines, however, were detected in the conditioned medium by a human cytokine antibody array. Among them, the cancer invasion-related factor CCL5 was quantified by ELISA. Interestingly, CCL5 neutralizing antibodies significantly reduced the invasion of oral cancer cells. In conclusion, our results suggest that 1 ng/ml rhBMP-2 may induce invasion of oral squamous cell carcinoma (OSCC) cells by CCL5 release in coculture models. Therefore, we propose that a careful clinical examination before the use of rhBMP-2-containing biomaterials is indispensable for using rhBMP-2 treatment to prevent cancer progression.	[Kim, Mi-joo; Kim, Kwang-mahn; Kim, Kyoung-nam] Yonsei Univ, Dept & Res Inst Dent Biomat & Bioengn, Dent Devices Testing & Evaluat Ctr, Coll Dent,Brain Korea Plus Project 21, Seoul 120749, South Korea; [Kim, Jin] Yonsei Univ, Coll Dent, Oral Canc Res Inst, Dept Oral Pathol,Brain Korea Plus Project 21, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, J (corresponding author), Yonsei Univ, Coll Dent, Oral Canc Res Inst, Dept Oral Pathol,Brain Korea Plus Project 21, Seoul 120749, South Korea.	jink@yuhs.ac; kimkn@yuhs.ac		KIM, KWANG-MAHN/0000-0002-5235-0294; Kim, Mijoo/0000-0003-0445-9567	Dental Devices Testing & Evaluation Center, College of Dentistry, Yonsei University	Dental Devices Testing & Evaluation Center, College of Dentistry, Yonsei University	This study was supported by the Dental Devices Testing & Evaluation Center, College of Dentistry, Yonsei University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvim-Pereira F, 2008, INT J ORAL MAX IMPL, V23, P409; Borsig L, 2013, ONCOGENE; Braig S, 2009, EXP DERMATOL, V18, P312; Brzak BL, 2012, COLLEGIUM ANTROPOL, V36, P773; Cambien B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028842; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Chang KP, 2013, ORAL ONCOL, V49, P802, DOI 10.1016/j.oraloncology.2013.05.006; Che ZM, 2006, BIOCHEM BIOPH RES CO, V346, P268, DOI 10.1016/j.bbrc.2006.05.111; Clement JH, 2005, INT J ONCOL, V27, P401; Deraz EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025438; Feeley BT, 2005, J BONE MINER RES, V20, P2189, DOI 10.1359/JBMR.050802; Finkenzeller G, 2012, MICROVASC RES, V84, P81, DOI 10.1016/j.mvr.2012.03.010; Illeperuma RP, 2012, J MATER SCI-MATER M, V23, P753, DOI 10.1007/s10856-011-4473-6; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin H, 2012, APPL MICROBIOL BIOT, V93, P1715, DOI 10.1007/s00253-011-3865-3; Jordan RCK, 2004, CLIN CANCER RES, V10, P6460, DOI 10.1158/1078-0432.CCR-04-0656; Jung Young Suk, 2012, PLoS One, V7, pe38773, DOI 10.1371/journal.pone.0038773; Kapoor Prakhar, 2012, J Oral Maxillofac Pathol, V16, P330, DOI 10.4103/0973-029X.102478; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kato T, 2013, CYTOKINE; Katsuno Y, 2008, ONCOGENE, V27, P6322, DOI 10.1038/onc.2008.232; Kellermann MG, 2008, ORAL ONCOL, V44, P509, DOI 10.1016/j.oraloncology.2007.07.001; Kisiel M, 2012, J CONTROL RELEASE, V162, P646, DOI 10.1016/j.jconrel.2012.08.004; Kokorina NA, 2011, LARYNGOSCOPE, V121, P1876, DOI 10.1002/lary.21914; Kroiss A, 2014, ONCOGENE; Kudo Y, 2012, J BIOL CHEM, V287, P38716, DOI 10.1074/jbc.M112.373159; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Langenfeld EM, 2003, CARCINOGENESIS, V24, P1445, DOI 10.1093/carcin/bgg100; Liu J, 2012, FRONT BIOSCI-LANDMRK, V17, P2541, DOI 10.2741/4069; Long HX, 2012, STEM CELLS, V30, P2309, DOI 10.1002/stem.1194; Lopiz-Morales Y, 2010, EUR CELLS MATER, V20, P367; Miki Y, 2007, CANCER RES, V67, P3945, DOI 10.1158/0008-5472.CAN-06-3105; Onoue T, 2006, INT J ONCOL, V29, P1133; Park Y, 2010, MED ONCOL, V27, P1192, DOI 10.1007/s12032-009-9358-x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pfammatter C, 2012, QUINTESSENCE INT, V43, P563; Rothhammer T, 2005, CANCER RES, V65, P448; Salo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077692; Salo T, 2014, EXP CELL RES, V325, P58, DOI 10.1016/j.yexcr.2013.12.029; SHIGEYAMA Y, 1995, J PERIODONTOL, V66, P478, DOI 10.1902/jop.1995.66.6.478; Siddiqi A, 2011, CLIN ORAL IMPLAN RES, V22, P673, DOI 10.1111/j.1600-0501.2010.02081.x; Skowronki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103243; Soria G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-130; Sun XJ, 2013, CELL SIGNAL, V25, P1279, DOI 10.1016/j.cellsig.2013.01.029; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Velasco-Velazquez M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23660; Wildemann B., 2007, Cell and Tissue Banking, V8, P107, DOI 10.1007/s10561-006-9021-0; Woo EJ, 2012, SPINE J, V12, P894, DOI 10.1016/j.spinee.2012.09.052; Wurtz SO, 2008, ACTA ONCOL, V47, P580, DOI 10.1080/02841860802022976; Ye S, 2013, SPINE, V38, pE143, DOI 10.1097/BRS.0b013e31827db4c6; Youngs SJ, 1997, INT J CANCER, V71, P257, DOI 10.1002/(SICI)1097-0215(19970410)71:2<257::AID-IJC22>3.0.CO;2-D; Zhang JJ, 2012, INT J MED SCI, V9, P184, DOI 10.7150/ijms.3859; Zheng GP, 2009, AM J PATHOL, V175, P580, DOI 10.2353/ajpath.2009.080983; Zhou XF, 2006, NEOPLASIA, V8, P925, DOI 10.1593/neo.06430	54	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108170	10.1371/journal.pone.0108170	http://dx.doi.org/10.1371/journal.pone.0108170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271422	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600028
J	Murakami, CA; Attia, D; Carter-Monroe, N; Lucas, GM; Estrella, MM; Fine, DM; Atta, MG				Murakami, Christine A.; Attia, Doaa; Carter-Monroe, Naima; Lucas, Gregory M.; Estrella, Michelle M.; Fine, Derek M.; Atta, Mohamed G.			The Clinical Characteristics and Pathological Patterns of Postinfectious Glomerulonephritis in HIV-Infected Patients	PLOS ONE			English	Article							LONG-TERM PROGNOSIS; ANTIRETROVIRAL THERAPY; KIDNEY-DISEASE; SPECTRUM; EXPERIENCE; NEPHROPATHY; OUTCOMES	Background: Postinfectious glomerulonephritis (PIGN), a form of immune complex GN, is not well-defined in HIV-infected patients. This study characterizes PIGN in this patients' population and determine the impact of histopathological patterns on renal outcome and mortality. Methods: HIV-infected patients with PIGN from September 1998 to July 2013 were identified. Archived slides were reviewed by a blinded renal pathologist, classified into acute, persistent and healed PIGN. Groups were compared using Wilcoxon rank-sum and Fisher's exact test. Survival analyses were performed to determine association of histopathological pattern with renal outcome and mortality. Results: Seventy-two HIV-infected predominantly African American males were identified with PIGN. Median (interquartile range) age and creatinine at the time of renal biopsy was 48 years (41, 53) and 2.5 mg/dl (1.5, 4.9) respectively. Only 2 (3%) had acute PIGN, 42 (58%) had persistent PIGN and 28 (39%) had healed PIGN. Three patients (4%) had IgA-dominant PIGN. Only 46% of the patients had confirmed positive cultures with Staphylococcus the most common infectious agent. During a median follow up of 17 months, the pathological pattern had no impact on renal outcome (P = 0.95). Overall mortality was high occurring in 14 patients (19%); patients with healed PIGN had significantly increased mortality (P = 0.05). Conclusion: In HIV-infected patients, Staphylococcus is the most common cause of PIGN. Renal outcome was not influenced by the histopathological pattern but those with healed PIGN had greater mortality which was potentially due to a confounder not accounted for in the study.	[Murakami, Christine A.; Lucas, Gregory M.; Estrella, Michelle M.; Fine, Derek M.; Atta, Mohamed G.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Attia, Doaa] Fac Med, Alexandria, Egypt; [Carter-Monroe, Naima] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Egyptian Knowledge Bank (EKB); Alexandria University; Johns Hopkins University	Atta, MG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	matta1@jhmi.edu	Attia, Doaa/ABC-6851-2021		National Institute of Diabetes and Digestive and Kidney Diseases [P01DK056492]; National Institute on Drug Abuse [K24 DA035684, R01 DA026770]; Johns Hopkins University Center for AIDS Research [P30 AI094189]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA035684, R01DA026770] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Johns Hopkins University Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Mohamed G. Atta is supported by the National Institute of Diabetes and Digestive and Kidney Diseases grant P01DK056492. Dr. Lucas was supported by the National Institute on Drug Abuse (K24 DA035684 and R01 DA026770) and by the Johns Hopkins University Center for AIDS Research (P30 AI094189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atta MG, 2006, NEPHROL DIAL TRANSPL, V21, P2809, DOI 10.1093/ndt/gfl337; Berliner AR, 2008, AM J NEPHROL, V28, P478, DOI 10.1159/000112851; Cohen SD, 2008, SEMIN NEPHROL, V28, P535, DOI 10.1016/j.semnephrol.2008.08.006; Estrella Michelle M., 2010, HIV Therapy, V4, P589, DOI 10.2217/HIV.10.42; Foy MC, 2013, CLIN J AM SOC NEPHRO, V8, P1524, DOI 10.2215/CJN.10991012; George E, 2011, MEDICINE, V90, P289, DOI 10.1097/MD.0b013e31822f5915; Gerntholtz TE, 2006, KIDNEY INT, V69, P1885, DOI 10.1038/sj.ki.5000351; Haas M, 2003, HUM PATHOL, V34, P3, DOI 10.1053/hupa.2003.53; Haas M, 2008, HUM PATHOL, V39, P1309, DOI 10.1016/j.humpath.2008.02.015; KIMMEL PL, 1993, KIDNEY INT, V44, P1327, DOI 10.1038/ki.1993.386; Lucas GM, 2004, AIDS, V18, P541, DOI 10.1097/00002030-200402200-00022; MONTSENY JJ, 1995, MEDICINE, V74, P63, DOI 10.1097/00005792-199503000-00001; Moroni G, 2002, NEPHROL DIAL TRANSPL, V17, P1204, DOI 10.1093/ndt/17.7.1204; Nasr SH, 2008, MEDICINE, V87, P21, DOI [10.1097/MD.0b013e318161b0fc, 10.1097/md.0b013e318161b0fc]; Nasr SH, 2011, NEPHRON CLIN PRACT, V119, pC18, DOI 10.1159/000324180; Nasr SH, 2011, J AM SOC NEPHROL, V22, P187, DOI 10.1681/ASN.2010060611; Nast CC, 2012, ADV CHRONIC KIDNEY D, V19, P68, DOI 10.1053/j.ackd.2012.02.014; Nebuloni M, 2009, CLIN NEPHROL, V72, P38; Szczech LA, 2004, KIDNEY INT, V66, P1145, DOI 10.1111/j.1523-1755.2004.00865.x; VOGL W, 1986, NEPHRON, V44, P58, DOI 10.1159/000183913; Wearne N, 2012, NEPHROL DIAL TRANSPL, V27, P4109, DOI 10.1093/ndt/gfr702; Wen YK, 2009, RENAL FAILURE, V31, P676, DOI 10.3109/08860220903118616; ZENT R, 1994, CLIN NEPHROL, V42, P22	23	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108398	10.1371/journal.pone.0108398	http://dx.doi.org/10.1371/journal.pone.0108398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272150	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600043
J	Nenert, R; Allendorfer, JB; Szaflarski, JP				Nenert, Rodolphe; Allendorfer, Jane B.; Szaflarski, Jerzy P.			A Model for Visual Memory Encoding	PLOS ONE			English	Article							GRANGER CAUSALITY; FUNCTIONAL MRI; RESPONSE-INHIBITION; INDEPENDENT COMPONENTS; CONNECTIVITY CHANGES; PREFRONTAL CORTEX; SPATIAL ATTENTION; NEURAL FRAMEWORK; DEFAULT NETWORK; BRAIN NETWORKS	Memory encoding engages multiple concurrent and sequential processes. While the individual processes involved in successful encoding have been examined in many studies, a sequence of events and the importance of modules associated with memory encoding has not been established. For this reason, we sought to perform a comprehensive examination of the network for memory encoding using data driven methods and to determine the directionality of the information flow in order to build a viable model of visual memory encoding. Forty healthy controls ages 19-59 performed a visual scene encoding task. FMRI data were preprocessed using SPM8 and then processed using independent component analysis (ICA) with the reliability of the identified components confirmed using ICASSO as implemented in GIFT. The directionality of the information flow was examined using Granger causality analyses (GCA). All participants performed the fMRI task well above the chance level (>90% correct on both active and control conditions) and the post-fMRI testing recall revealed correct memory encoding at 86.33 +/- 5.83%. ICA identified involvement of components of five different networks in the process of memory encoding, and the GCA allowed for the directionality of the information flow to be assessed, from visual cortex via ventral stream to the attention network and then to the default mode network (DMN). Two additional networks involved in this process were the cerebellar and the auditory-insular network. This study provides evidence that successful visual memory encoding is dependent on multiple modules that are part of other networks that are only indirectly related to the main process. This model may help to identify the node(s) of the network that are affected by a specific disease processes and explain the presence of memory encoding difficulties in patients in whom focal or global network dysfunction exists.	[Nenert, Rodolphe; Allendorfer, Jane B.; Szaflarski, Jerzy P.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Szaflarski, Jerzy P.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Szaflarski, Jerzy P.] Univ Cincinnati, Dept Neurol, Acad Hlth Ctr, Cincinnati, OH USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University System of Ohio; University of Cincinnati	Nenert, R (corresponding author), Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA.	rodolphe@uab.edu			UC Neuroscience Institute [R01 NS048281]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048281] Funding Source: NIH RePORTER	UC Neuroscience Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by The UC Neuroscience Institute (JPS) and in part by R01 NS048281 (JPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorfer JB, 2012, MED SCI MONITOR, V18, pCR135, DOI 10.12659/MSM.882518; Bamiou DE, 2003, BRAIN RES REV, V42, P143, DOI 10.1016/S0165-0173(03)00172-3; Barch DM, 2009, SCHIZOPHRENIA BULL, V35, P115, DOI 10.1093/schbul/sbn154; Barnett L, 2011, J NEUROSCI METH, V201, P404, DOI 10.1016/j.jneumeth.2011.08.010; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Benson NC, 2012, CURR BIOL, V22, P2081, DOI 10.1016/j.cub.2012.09.014; Bigras C, 2013, EPILEPSY BEHAV, V26, P11, DOI 10.1016/j.yebeh.2012.10.017; Binder JR, 2005, EPILEPSIA, V46, P1061, DOI 10.1111/j.1528-1167.2005.62004.x; Boly M, 2012, J NEUROSCI, V32, P7082, DOI 10.1523/JNEUROSCI.3769-11.2012; Bressler SL, 2008, J NEUROSCI, V28, P10056, DOI 10.1523/JNEUROSCI.1776-08.2008; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Carrasco M, 2004, VISION RES, V44, P1351, DOI 10.1016/j.visres.2003.11.026; Carrasco M, 2006, PERCEPT PSYCHOPHYS, V68, P1004, DOI 10.3758/BF03193361; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Chen LM, 2007, INT ANESTHESIOL CLIN, V45, P39, DOI 10.1097/AIA.0b013e31803419d3; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; Ciccarelli O, 2005, EXP BRAIN RES, V166, P31, DOI 10.1007/s00221-005-2335-5; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Demirci O, 2009, NEUROIMAGE, V46, P419, DOI 10.1016/j.neuroimage.2009.02.014; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Detre JA, 1998, NEUROLOGY, V50, P926, DOI 10.1212/WNL.50.4.926; Ding X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059331; Donnelly KM, 2011, BRAIN RES, V1419, P105, DOI 10.1016/j.brainres.2011.08.065; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Duncan J, 2013, NEURON, V80, P35, DOI 10.1016/j.neuron.2013.09.015; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Frot M, 2007, CEREB CORTEX, V17, P610, DOI 10.1093/cercor/bhk007; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gilbert SJ, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1140801; Gilbert SJ, 2006, J EXP PSYCHOL HUMAN, V32, P45, DOI 10.1037/0096-1523.32.1.45; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hahn B, 2007, CEREB CORTEX, V17, P1664, DOI 10.1093/cercor/bhl075; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Jiao Q, 2011, HUM BRAIN MAPP, V32, P154, DOI 10.1002/hbm.21065; Johansen-Berg H, 2002, EXP BRAIN RES, V142, P13, DOI 10.1007/s00221-001-0905-8; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Karunanayaka P, 2011, EPILEPSY BEHAV, V20, P623, DOI 10.1016/j.yebeh.2010.12.029; Karunanayaka P, 2010, NEUROIMAGE, V51, P472, DOI 10.1016/j.neuroimage.2009.12.108; Karunanayaka PR, 2007, NEUROIMAGE, V34, P349, DOI 10.1016/j.neuroimage.2006.08.028; Kay BP, 2012, BRAIN RES, V1447, P53, DOI 10.1016/j.brainres.2012.01.064; Kim KK, 2011, EPILEPSY BEHAV, V20, P613, DOI 10.1016/j.yebeh.2010.11.010; Kim SG, 2012, J CEREBR BLOOD F MET, V32, P1188, DOI 10.1038/jcbfm.2012.23; Kitada R, 2005, NEUROIMAGE, V25, P90, DOI 10.1016/j.neuroimage.2004.11.026; Koziol L. F., 2013, CEREBELLUM; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Kurth F, 2010, CEREB CORTEX, V20, P1448, DOI 10.1093/cercor/bhp208; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Leech R, 2013, ROLE POSTERIOR CINGU; Li CSR, 2006, J NEUROSCI, V26, P186, DOI 10.1523/JNEUROSCI.3741-05.2006; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Liu TS, 2003, CEREB CORTEX, V13, P1334, DOI 10.1093/cercor/bhg080; Liu ZY, 2012, IEEE ENG MED BIO, P5454, DOI 10.1109/EMBC.2012.6347228; Londei A, 2007, BRAIN RES BULL, V72, P284, DOI 10.1016/j.brainresbull.2007.01.008; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; MacWhinney B, 1997, SPATIAL VISION, V11, P99, DOI 10.1163/156856897X00113; Marien P, 2013, CEREBELLUM; McIntosh AR, 2000, NEURAL NETWORKS, V13, P861, DOI 10.1016/S0893-6080(00)00059-9; Mechanic-Hamilton D, 2009, EPILEPSY BEHAV, V16, P128, DOI 10.1016/j.yebeh.2009.07.012; Mengarelli F, 2013, CEREB CORTEX; Menzies L, 2007, BRAIN, V130, P3223, DOI 10.1093/brain/awm205; Mostofsky SH, 2008, J COGNITIVE NEUROSCI, V20, P751, DOI 10.1162/jocn.2008.20500; Nenert R, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00127; Norman-Haignere SV, 2012, CEREB CORTEX, V22, P391, DOI 10.1093/cercor/bhr118; Pearson JM, 2011, TRENDS COGN SCI, V15, P143, DOI 10.1016/j.tics.2011.02.002; Poline JB, 2012, NEUROIMAGE, V62, P871, DOI 10.1016/j.neuroimage.2012.01.133; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Scherf KS, 2011, CEREB CORTEX, V21, P1963, DOI 10.1093/cercor/bhq269; Schutter DJLG, 2009, CEREBELLUM, V8, P28, DOI 10.1007/s12311-008-0056-6; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; Seth AK, 2013, NEUROIMAGE, V65, P540, DOI 10.1016/j.neuroimage.2012.09.049; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; SHIU LP, 1995, VISION RES, V35, P337, DOI 10.1016/0042-6989(94)00148-F; Shulman GL, 2010, J NEUROSCI, V30, P3640, DOI 10.1523/JNEUROSCI.4085-09.2010; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stevens MC, 2009, HUM BRAIN MAPP, V30, P2356, DOI 10.1002/hbm.20673; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Szaflarski JP, 2014, EPILEPSY BEHAV, V32, P92, DOI 10.1016/j.yebeh.2014.01.012; Szaflarski JP, 2010, EPILEPSY BEHAV, V18, P404, DOI 10.1016/j.yebeh.2010.05.009; Szaflarski JP, 2006, HUM BRAIN MAPP, V27, P202, DOI 10.1002/hbm.20177; Szaflarski JP, 2004, EPILEPSY BEHAV, V5, P244, DOI 10.1016/j.yebeh.2004.01.002; Thiel CM, 2004, NEUROIMAGE, V21, P318, DOI 10.1016/j.neuroimage.2003.08.044; Tomlinson SP, 2013, CEREBELLUM; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; Vannest J, 2008, EPILEPSY BEHAV, V12, P410, DOI 10.1016/j.yebeh.2007.11.012; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Wandell BA, 2011, VISION RES, V51, P718, DOI 10.1016/j.visres.2010.08.004; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Wen XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067428; Wen XT, 2012, J NEUROSCI, V32, P1284, DOI 10.1523/JNEUROSCI.2817-11.2012; Zanto TP, 2011, NAT NEUROSCI, V14, P656, DOI 10.1038/nn.2773	106	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e107761	10.1371/journal.pone.0107761	http://dx.doi.org/10.1371/journal.pone.0107761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272154	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600019
J	Schakner, ZA; Lunsford, C; Straley, J; Eguchi, T; Mesnick, SL				Schakner, Zachary A.; Lunsford, Chris; Straley, Janice; Eguchi, Tomoharu; Mesnick, Sarah L.			Using Models of Social Transmission to Examine the Spread of Longline Depredation Behavior among Sperm Whales in the Gulf of Alaska	PLOS ONE			English	Article							ACCELERATING LEARNING RATES; PHYSETER-MACROCEPHALUS; CULTURAL TRANSMISSION; DIFFUSION DYNAMICS; FISHERIES	Fishing, farming and ranching provide opportunities for predators to prey on resources concentrated by humans, a behavior termed depredation. In the Gulf of Alaska, observations of sperm whales depredating on fish caught on demersal longline gear dates back to the 1970s, with reported incidents increasing in the mid-1990s. Sperm whale depredation provides an opportunity to study the spread of a novel foraging behavior within a population. Data were collected during National Marine Fisheries Service longline surveys using demersal longline gear in waters off Alaska from 1998 to 2010. We evaluated whether observations of depredation fit predictions of social transmission by fitting the temporal and spatial spread of new observations of depredation to the Wave of Advance model. We found a significant, positive relationship between time and the distance of new observations from the diffusion center (r(2) = 0.55, p-value = 0.003). The data provide circumstantial evidence for social transmission of depredation. We discuss how changes in human activities in the region (fishing methods and regulations) have created a situation in which there is spatial-temporal overlap with foraging sperm whales, likely influencing when and how the behavior spread among the population.	[Schakner, Zachary A.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Lunsford, Chris] Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, NOAA, Auke Bay Labs, Juneau, AK USA; [Straley, Janice] Univ Alaska Southeast, Sitka, AK USA; [Eguchi, Tomoharu; Mesnick, Sarah L.] Natl Marine Fisheries Serv, SW Fisheries Sci Ctr, NOAA, La Jolla, CA 92038 USA	University of California System; University of California Los Angeles; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; University of Alaska System; University of Alaska Southeastern; National Oceanic Atmospheric Admin (NOAA) - USA	Schakner, ZA (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.	zschakner@ucla.edu; sarah.mesnick@noaa.gov	, Sarah/AAZ-8821-2021	, Sarah/0000-0003-0544-4666	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	Z.A.S. is supported by a National Science Foundation Graduate Research Fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2013, SCIENCE, V340, P485, DOI 10.1126/science.1231976; AMMERMAN AJ, 1971, MAN, V6, P674, DOI 10.2307/2799190; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; [Anonymous], 2014, R LANG ENV STAT COMP; Arangio R, 2012, MINIMISING WHA UNPUB; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Donaldson R, 2012, ANIM CONSERV, V15, P427, DOI 10.1111/j.1469-1795.2012.00548.x; Franz M, 2009, P R SOC B, V276, P1829, DOI 10.1098/rspb.2008.1824; Hamer DJ, 2012, MAR MAMMAL SCI, V28, pE345, DOI 10.1111/j.1748-7692.2011.00544.x; Hanselman DH, 2011, ALASKA STOCK ASSESSM, P329; Hill P. S., 1999, NMFSAFSC108 NOAA US; Hoppitt W, 2010, LEARN BEHAV, V38, P243, DOI 10.3758/LB.38.3.243; Kawakami T, 1980, SCI REP WHALES RES I; Kendal RL, 2010, LEARN BEHAV, V38, P187, DOI 10.3758/LB.38.3.187; LEFEBVRE L, 1995, BEHAV PROCESS, V34, P43, DOI 10.1016/0376-6357(94)00051-H; LEFEBVRE L, 1995, PRIMATES, V36, P227, DOI 10.1007/BF02381348; Madsen PT, 2002, BEHAV ECOL SOCIOBIOL, V53, P31, DOI 10.1007/s00265-002-0548-1; Mathias D, 2012, J ACOUST SOC AM, V132, P518, DOI 10.1121/1.4726005; Powell JR, 2011, MAR MAMMAL SCI, V27, P111, DOI 10.1111/j.1748-7692.2010.00401.x; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Reader SM, 2004, LEARN BEHAV, V32, P90; Sigler MF, 2008, MAR MAMMAL SCI, V24, P16, DOI 10.1111/j.1748-7692.2007.00149.x; Straley J.M., 2005, R0309 N PAC RES BOAR; Straley JM, 2014, END SPEC RES; Whitehead H., 2003, SPERM WHALES SOCIAL	25	25	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109079	10.1371/journal.pone.0109079	http://dx.doi.org/10.1371/journal.pone.0109079			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272019	Green Submitted, Green Published, gold			2022-12-27	WOS:000343729600097
J	Stears, K; Kerley, GIH; Shrader, AM				Stears, Keenan; Kerley, Graham I. H.; Shrader, Adrian M.			Group-Living Herbivores Weigh Up Food Availability and Dominance Status when Making Patch-Joining Decisions	PLOS ONE			English	Article							SCROUNGING BEHAVIOR; SOCIAL INFORMATION; GRAZING BEHAVIOR; PREDATION RISK; GROUP-SIZE; GOATS; COMPETITION; HIERARCHY; SELECTION; CHOICE	Two key factors that influence the foraging behaviour of group-living herbivores are food availability and individual dominance status. Yet, how the combination of these factors influences the patch-joining decisions of individuals foraging within groups has scarcely been explored. To address this, we focused on the patch-joining decisions of group-living domestic goats (Capra hircus). When individuals were tested against the top four ranked goats of the herd, we found that at patches with low food availability they avoided these dominant patch-holders and only joined subordinates (i.e. costs outweighed benefits). However, as the amount of food increased, the avoidance of the top ranked individuals declined. Specifically, goats shifted and joined the patch of an individual one dominance rank higher than the previous dominant patch holder when the initial quantity of food in the new patch was twice that of the lower ranking individual's patch (i.e. benefits outweighed costs). In contrast, when individuals chose between patches held by dominant goats, other than the top four ranked goats, and subordinate individuals, we found that they equally joined the dominant and subordinate patch-holders. This joining was irrespective of the dominance gap, absolute rank of the dominant patch-holder, sex or food availability (i.e. benefits outweighed costs). Ultimately, our results highlight that herbivores weigh up the costs and benefits of both food availability and patch-holder dominance status when making patch-joining decisions. Furthermore, as the initial quantity of food increases, food availability becomes more important than dominance with regard to influencing patch-joining decisions.	[Stears, Keenan; Shrader, Adrian M.] Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa; [Kerley, Graham I. H.] Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, Port Elizabeth, South Africa	University of Kwazulu Natal; Nelson Mandela University	Stears, K (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa.	keenan.stears@gmail.com	Shrader, Adrian M/E-9472-2010	Shrader, Adrian M/0000-0002-6451-6132; Stears, Keenan/0000-0003-1012-5838	University of KwaZulu-Natal, School of Life Sciences; South African National Research Foundation	University of KwaZulu-Natal, School of Life Sciences; South African National Research Foundation(National Research Foundation - South Africa)	KS received funding from the University of KwaZulu-Natal, School of Life Sciences (http://lifesciences.ukzn.ac.za/Homepage.aspx). AMS received funding from the South African National Research Foundation (http://www.nrf.ac.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschwanden J, 2008, APPL ANIM BEHAV SCI, V114, P116, DOI 10.1016/j.applanim.2008.02.002; Baciadonna L, 2013, PEERJ, V1, DOI 10.7717/peerj.172; Bang A, 2010, ANIM BEHAV, V79, P631, DOI 10.1016/j.anbehav.2009.12.009; BARNARD CJ, 1981, ANIM BEHAV, V29, P543, DOI 10.1016/S0003-3472(81)80117-0; Barroso FG, 2000, APPL ANIM BEHAV SCI, V69, P35, DOI 10.1016/S0168-1591(00)00113-1; Barta Z, 1998, BEHAV ECOL SOCIOBIOL, V42, P217, DOI 10.1007/s002650050433; Beauchamp G, 2006, ETHOLOGY, V112, P873, DOI 10.1111/j.1439-0310.2006.01241.x; Beauchamp G, 2001, CAN J ZOOL, V79, P540, DOI 10.1139/cjz-79-3-540; BIQUAND S, 1992, APPL ANIM BEHAV SCI, V34, P231, DOI 10.1016/S0168-1591(05)80118-2; Boissy A, 2002, APPL ANIM BEHAV SCI, V79, P233, DOI 10.1016/S0168-1591(02)00152-1; Briefer EF, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-20; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; BROWN JS, 1992, ANN ZOOL FENN, V29, P301; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; Cote SD, 2000, BEHAVIOUR, V137, P1541, DOI 10.1163/156853900502718; DAVID HA, 1987, BIOMETRIKA, V74, P432, DOI 10.2307/2336160; de Garine-Wichatitsky M, 2004, OECOLOGIA, V141, P66, DOI 10.1007/s00442-004-1630-3; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; DISTEL RA, 1995, APPL ANIM BEHAV SCI, V45, P11, DOI 10.1016/0168-1591(95)00593-H; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; Dubois FD, 2005, ECOLOGY, V86, P3, DOI 10.1890/04-0566; Dumont B, 2000, BEHAV PROCESS, V49, P131, DOI 10.1016/S0376-6357(00)00082-6; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; FOURNIER F, 1995, ANIM BEHAV, V49, P1449, DOI 10.1016/0003-3472(95)90066-7; Gammell MP, 2003, ANIM BEHAV, V66, P601, DOI 10.1006/anbe.2003.2226; Giraldeau L.A., 2000, MG BEH ECOL; GIRALDEAU LA, 1990, ETHOLOGY, V85, P132; GIRALDEAU LA, 1987, ANIM BEHAV, V35, P387, DOI 10.1016/S0003-3472(87)80262-2; Giraldeau LA, 2008, ADV STUD BEHAV, V38, P59, DOI 10.1016/S0065-3454(08)00002-8; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hardin J.W., 2013, GEN ESTIMATING EQUAT, V2nd, DOI [10.1201/b13880, DOI 10.1201/B13880]; IHOBE H, 1989, PRIMATES, V30, P17, DOI 10.1007/BF02381207; ILLIUS AW, 1992, J ANIM ECOL, V61, P183, DOI 10.2307/5521; King AJ, 2009, BEHAV ECOL, V20, P1039, DOI 10.1093/beheco/arp095; Kotler BP, 1995, OIKOS, V74, P251, DOI 10.2307/3545654; KOTLER BP, 1990, J MAMMAL, V71, P591, DOI 10.2307/1381798; KOTLER BP, 1994, J WILDLIFE MANAGE, V58, P299, DOI 10.2307/3809395; Langbein J, 2008, BEHAV PROCESS, V79, P156, DOI 10.1016/j.beproc.2008.07.004; Lendvai AZ, 2006, ANIM BEHAV, V72, P747, DOI 10.1016/j.anbehav.2005.10.032; Liker A, 2002, BEHAVIOUR, V139, P1061, DOI 10.1163/15685390260337903; LIMA SL, 1985, OECOLOGIA, V66, P60, DOI 10.1007/BF00378552; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; McCormack JE, 2007, BEHAVIOUR, V144, P967, DOI 10.1163/156853907781492717; Miranda-de la Lama GC, 2010, SMALL RUMINANT RES, V90, P1, DOI 10.1016/j.smallrumres.2010.01.006; MOORING MS, 1992, BEHAVIOUR, V123, P173, DOI 10.1163/156853992X00011; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; REINHARDT V, 1983, BEHAVIOUR, V87, P1, DOI 10.1163/156853983X00093; Schmid VS, 2013, ANIM BEHAV, V86, P1097, DOI 10.1016/j.anbehav.2013.08.019; SCOTT CB, 1995, APPL ANIM BEHAV SCI, V45, P225, DOI 10.1016/0168-1591(95)00605-R; Shrader AM, 2008, J ARID ENVIRON, V72, P1811, DOI 10.1016/j.jaridenv.2008.05.004; Shrader AM, 2007, BEHAV ECOL, V18, P103, DOI 10.1093/beheco/arl057; SIH A, 1980, SCIENCE, V210, P1041, DOI 10.1126/science.210.4473.1041; Stillman RA, 1997, J ANIM ECOL, V66, P692, DOI 10.2307/5922; THEIMER TC, 1987, ANIM BEHAV, V35, P1883, DOI 10.1016/S0003-3472(87)80081-7; THOULESS CR, 1990, ANIM BEHAV, V40, P105, DOI 10.1016/S0003-3472(05)80669-4; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; VALONE TJ, 1993, OIKOS, V68, P258, DOI 10.2307/3544838; Van DTT, 2007, SMALL RUMINANT RES, V72, P187, DOI 10.1016/j.smallrumres.2006.10.010; VICKERY WL, 1991, AM NAT, V137, P847, DOI 10.1086/285197; Wittig RM, 2003, INT J PRIMATOL, V24, P847, DOI 10.1023/A:1024632923180	60	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109011	10.1371/journal.pone.0109011	http://dx.doi.org/10.1371/journal.pone.0109011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271889	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600087
J	Verdu, CF; Guyot, S; Childebrand, N; Bahut, M; Celton, JM; Gaillard, S; Lasserre-Zuber, P; Troggio, M; Guilet, D; Laurens, F				Verdu, Cindy F.; Guyot, Sylvain; Childebrand, Nicolas; Bahut, Muriel; Celton, Jean-Marc; Gaillard, Sylvain; Lasserre-Zuber, Pauline; Troggio, Michela; Guilet, David; Laurens, Francois			QTL Analysis and Candidate Gene Mapping for the Polyphenol Content in Cider Apple	PLOS ONE			English	Article							MYB TRANSCRIPTION FACTOR; FLAVONOID BIOSYNTHESIS; MICROSATELLITE MARKERS; PHENOLIC-COMPOUNDS; RED COLORATION; LINKAGE MAPS; ANTHOCYANIN; EXPRESSION; LIGHT; FRUIT	Polyphenols have favorable antioxidant potential on human health suggesting that their high content is responsible for the beneficial effects of apple consumption. They control the quality of ciders as they predominantly account for astringency, bitterness, color and aroma. In this study, we identified QTLs controlling phenolic compound concentrations and the average polymerization degree of flavanols in a cider apple progeny. Thirty-two compounds belonging to five groups of phenolic compounds were identified and quantified by reversed phase liquid chromatography on both fruit extract and juice, over three years. The average polymerization degree of flavanols was estimated in fruit by phloroglucinolysis coupled to HPLC. Parental maps were built using SSR and SNP markers and used for the QTL analysis. Sixty-nine and 72 QTLs were detected on 14 and 11 linkage groups of the female and male maps, respectively. A majority of the QTLs identified in this study are specific to this population, while others are consistent with previous studies. This study presents for the first time in apple, QTLs for the mean polymerization degree of procyanidins, for which the mechanisms involved remains unknown to this day. Identification of candidate genes underlying major QTLs was then performed in silico and permitted the identification of 18 enzymes of the polyphenol pathway and six transcription factors involved in the apple anthocyanin regulation. New markers were designed from sequences of the most interesting candidate genes in order to confirm their co-localization with underlying QTLs by genetic mapping. Finally, the potential use of these QTLs in breeding programs is discussed.	[Verdu, Cindy F.; Childebrand, Nicolas; Bahut, Muriel; Celton, Jean-Marc; Gaillard, Sylvain; Laurens, Francois] INRA, UMR1345, Inst Rech Hort & Semences, Beaucouze, France; [Verdu, Cindy F.; Childebrand, Nicolas; Bahut, Muriel; Celton, Jean-Marc; Gaillard, Sylvain; Laurens, Francois] Univ Angers, UMR1345, Inst Rech Hort & Semences, SFR QUASAV 4207,PRES LUNAM, Angers, France; [Verdu, Cindy F.; Childebrand, Nicolas; Bahut, Muriel; Celton, Jean-Marc; Gaillard, Sylvain; Laurens, Francois] AgroCampus Ouest, Inst Rech Hort & Semences, UMR1345, Angers, France; [Verdu, Cindy F.; Guilet, David] Univ Angers, Lab Subst Origine Nat & Analogues Struct EA921, SFR Quasav 4207, PRES LUNAM, Angers, France; [Guyot, Sylvain] INRA, Biopolymeres Interact & Assemblages UR1268, Equipe Polyphenols React & Proc, Le Rheu, France; [Lasserre-Zuber, Pauline] INRA UBP, Genet Diver & Ecophysiol Cereals UMR1095, Clermont Ferrand, France; [Troggio, Michela] Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, TN, Italy	INRAE; Universite d'Angers; Institut Agro; Agrocampus Ouest; Universite d'Angers; Universite d'Angers; INRAE; INRAE; Universite Clermont Auvergne (UCA); Fondazione Edmund Mach	Verdu, CF (corresponding author), INRA, UMR1345, Inst Rech Hort & Semences, Beaucouze, France.	cindyverdu@gmail.com	Gaillard, Sylvain/F-8087-2011	Celton, Jean-Marc/0000-0002-1452-4812; Guilet, David/0000-0003-2828-7755; Gaillard, Sylvain/0000-0002-1802-169X	Qualite et Sante du Vegetal [SFR 149]	Qualite et Sante du Vegetal	This work was supported by the SFR 149 'Qualite et Sante du Vegetal' through a PhD grant and the transregional INNOVACIDRE project for the consumables and travel expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Salces RM, 2004, ANAL BIOANAL CHEM, V379, P464, DOI 10.1007/s00216-004-2625-y; An XH, 2012, J PLANT PHYSIOL, V169, P710, DOI 10.1016/j.jplph.2012.01.015; Aprikian O, 2003, J NUTR, V133, P1860, DOI 10.1093/jn/133.6.1860; Ban Y, 2007, PLANT CELL PHYSIOL, V48, P958, DOI 10.1093/pcp/pcm066; Boyer J, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-5; Caffier V, 2005, PLANT PATHOL, V54, P116, DOI 10.1111/j.1365-3059.2005.01147.x; Calenge F, 2004, PHYTOPATHOLOGY, V94, P370, DOI 10.1094/PHYTO.2004.94.4.370; Celton JM, 2009, TREE GENET GENOMES, V5, P93, DOI 10.1007/s11295-008-0171-z; Celton JM, 2011, NEW PHYTOL, V192, P378, DOI 10.1111/j.1469-8137.2011.03823.x; Chagne D, 2013, PLANT PHYSIOL, V161, P225, DOI 10.1104/pp.112.206771; Chagne D, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-12; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Dutheil J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-188; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Fowler ZL, 2009, APPL MICROBIOL BIOT, V83, P799, DOI 10.1007/s00253-009-2039-z; Gianfranceschi L, 2004, ACTA HORTIC, P327, DOI 10.17660/ActaHortic.2004.663.55; Gosch C, 2009, PLANT SCI, V176, P223, DOI 10.1016/j.plantsci.2008.10.011; Guyot S, 2003, J AGR FOOD CHEM, V51, P6240, DOI 10.1021/jf0301798; Han YP, 2012, J EXP BOT, V63, P2437, DOI 10.1093/jxb/err415; He F, 2008, MOLECULES, V13, P2674, DOI 10.3390/molecules13102674; Herrero M, 1999, J I BREWING, V105, P191, DOI 10.1002/j.2050-0416.1999.tb00019.x; Hichri I, 2010, MOL PLANT, V3, P509, DOI 10.1093/mp/ssp118; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Jakopic J, 2009, SCI HORTIC-AMSTERDAM, V123, P234, DOI 10.1016/j.scienta.2009.09.004; Kahle K, 2005, MOL NUTR FOOD RES, V49, P797, DOI 10.1002/mnfr.200500064; Kanehisa M, 2000, DATABASE KEGG KYOTO; Khan SA, 2012, J EXP BOT, V63, P2895, DOI 10.1093/jxb/err464; Koyama K, 2012, PHYTOCHEMISTRY, V78, P54, DOI 10.1016/j.phytochem.2012.02.026; LEA AGH, 1978, J SCI FOOD AGR, V29, P478, DOI 10.1002/jsfa.2740290512; Li HH, 2007, PLANTA, V226, P1243, DOI 10.1007/s00425-007-0573-4; Liebhard R, 2003, THEOR APPL GENET, V106, P1497, DOI 10.1007/s00122-003-1209-0; Lotito SB, 2006, FREE RADICAL BIO MED, V41, P1727, DOI 10.1016/j.freeradbiomed.2006.04.033; Lovdal T, 2010, PHYTOCHEMISTRY, V71, P605, DOI 10.1016/j.phytochem.2009.12.014; Lu YR, 1997, FOOD CHEM, V59, P187, DOI 10.1016/S0308-8146(96)00287-7; MacLean DD, 2006, J AGR FOOD CHEM, V54, P870, DOI 10.1021/jf0525075; McDougall GJ, 1996, J SCI FOOD AGR, V70, P133, DOI [10.1002/(SICI)1097-0010(199602)70:2&lt;133::AID-JSFA495&gt;3.0.CO;2-4, 10.1002/(SICI)1097-0010(199602)70:2<133::AID-JSFA495>3.3.CO;2-W]; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Micheletti D, 2011, TREE GENET GENOMES, V7, P857, DOI 10.1007/s11295-011-0380-8; OSZMIANSKI J, 1990, J AGR FOOD CHEM, V38, P1202, DOI 10.1021/jf00095a009; Oyant LHS, 2008, TREE GENET GENOMES, V4, P11, DOI 10.1007/s11295-007-0084-2; Pang YZ, 2009, PLANT PHYSIOL, V151, P1114, DOI 10.1104/pp.109.144022; R Core Team, 2018, R LANG ENV STAT COMP; Rebai A, 1997, GENET RES, V69, P69, DOI 10.1017/S0016672396002558; Silfverberg-Dilworth E, 2006, TREE GENET GENOMES, V2, P202, DOI 10.1007/s11295-006-0045-1; Song Ye, 2007, Agricultural Sciences in China, V6, P607, DOI 10.1016/S1671-2927(07)60089-3; Szankowski I, 2009, PLANTA, V229, P681, DOI 10.1007/s00425-008-0864-4; Tai T., 1990, PLANT MOL BIOL REP, V8, P297, DOI [10.1007/BF02668766, DOI 10.1007/BF02668766]; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Tsao R, 2003, J AGR FOOD CHEM, V51, P6347, DOI 10.1021/jf0346298; Ubi BE, 2006, PLANT SCI, V170, P571, DOI 10.1016/j.plantsci.2005.10.009; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Verdu CF, 2014, J SCI FOOD AGR, V94, P1305, DOI 10.1002/jsfa.6411; VILLEGAS RJA, 1986, J BIOL CHEM, V261, P8729; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Winkel BSJ, 2006, SCI FLAVONOIDS, P26; Xie XB, 2012, PLANT CELL ENVIRON, V35, P1884, DOI 10.1111/j.1365-3040.2012.02523.x; XU SH, 1995, GENETICS, V141, P1657; Zhang YA, 2010, J AGR FOOD CHEM, V58, P12168, DOI 10.1021/jf103203e	60	27	28	6	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e107103	10.1371/journal.pone.0107103	http://dx.doi.org/10.1371/journal.pone.0107103			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271925	gold, Green Published, Green Submitted			2022-12-27	WOS:000343729600008
J	Flores-Mateo, G; Elosua, R; Rodriguez-Blanco, T; Basora-Gallisa, J; Bullo, M; Salas-Salvado, J; Martinez-Gonzalez, MA; Estruch, R; Corella, D; Fito, M; Fiol, M; Aros, F; Gomez-Gracia, E; Subirana, I; Lapetra, J; Ruiz-Gutierrez, V; Saez, GT; Covas, MI				Flores-Mateo, Gemma; Elosua, Roberto; Rodriguez-Blanco, Teresa; Basora-Gallisa, Josep; Bullo, Monica; Salas-Salvado, Jordi; Angel Martinez-Gonzalez, Miguel; Estruch, Ramon; Corella, Dolores; Fito, Montserrat; Fiol, Miquel; Aros, Fernando; Gomez-Gracia, Enrique; Subirana, Isaac; Lapetra, Jose; Ruiz-Gutierrez, Valentina; Saez, Guillermo T.; Covas, Maria-Isabel		PREDIMED Study Investigators	Oxidative Stress Is Associated with an Increased Antioxidant Defense in Elderly Subjects: A Multilevel Approach	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; CORONARY-HEART-DISEASE; GLUTATHIONE-PEROXIDASE; LIPID-PEROXIDATION; DIABETIC-PATIENTS; RISK-FACTORS; SPANISH MEN; VALIDATION; ENZYME; WOMEN	Background: Studies of associations between plasma GSH-Px activity and cardiovascular risk factors have been done in humans, and contradictory results have been reported. The aim of our study was to assess the association between the scavenger antioxidant enzyme glutathione peroxidase (GSH-Px) activity in plasma and the presence of novel and classical cardiovascular risk factors in elderly patients. Methods: We performed a cross-sectional study with baseline data from a subsample of the PREDIMED (PREvencion con DIeta MEDiterranea) study in Spain. Participants were 1,060 asymptomatic subjects at high risk for cardiovascular disease (CVD), aged 55 to 80, selected from 8 primary health care centers (PHCCs). We assessed classical CVD risk factors, plasma oxidized low-density lipoproteins (ox-LDL), and glutathione peroxidase (GSH-Px) using multilevel statistical procedures. Results: Mean GSH-Px value was 612 U/L (SE: 12 U/L), with variation between PHCCs ranging from 549 to 674 U/L (Variance = 1013.5; P < 0.001). Between-participants variability within a PHCC accounted for 89% of the total variation. Both glucose and oxidized LDL were positively associated with GSH-Px activity after adjustment for possible confounder variables (P = 0.03 and P = 0.01, respectively). Conclusion: In a population at high cardiovascular risk, a positive linear association was observed between plasma GSH-Px activity and both glucose and ox-LDL levels. The high GSH-Px activity observed when an oxidative stress situation occurred, such as hyperglycemia and lipid oxidative damage, could be interpreted as a healthy defensive response against oxidative injury in our cardiovascular risk population.	[Flores-Mateo, Gemma; Basora-Gallisa, Josep] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Tarragona Reus, Tarragona, Spain; [Flores-Mateo, Gemma; Basora-Gallisa, Josep; Bullo, Monica; Salas-Salvado, Jordi; Estruch, Ramon; Corella, Dolores; Fito, Montserrat; Fiol, Miquel; Ruiz-Gutierrez, Valentina; Saez, Guillermo T.; Covas, Maria-Isabel] CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain; [Elosua, Roberto] Inst Municipal Invest Med, Epidemiol & Cardiovasc Genet Res Grp, E-08003 Barcelona, Spain; [Elosua, Roberto; Subirana, Isaac] CIBER Epidemiol & Salud Publ, Madrid, Spain; [Rodriguez-Blanco, Teresa; Subirana, Isaac] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Barcelona, Spain; [Bullo, Monica; Salas-Salvado, Jordi] Univ Rovira & Virgili, Sch Med, Human Nutr Unit, E-43201 Reus, Spain; [Angel Martinez-Gonzalez, Miguel] Univ Navarra Osasunbidea, Serv Navarro Salud, Dept Prevent Med & Publ Hlth, Pamplona, Spain; [Estruch, Ramon] Hosp Clin Barcelona, Inst Invest Biomed August Pi Sunyer IDIBAPS, Dept Internal Med, Barcelona, Spain; [Corella, Dolores] Univ Valencia, Dept Prevent Med & Publ Hlth, Valencia, Spain; [Fito, Montserrat; Covas, Maria-Isabel] Inst Municipal Invest Med, Cardiovasc Risk & Nutr Res Unit, E-08003 Barcelona, Spain; [Fiol, Miquel] IdISPa, Inst Hlth Sci Invest, Palma de Mallorca, Spain; [Aros, Fernando] Hosp Txangorritxu, Dept Cardiol, Vitoria, Spain; [Gomez-Gracia, Enrique] Sch Med Malaga, Dept Epidemiol, Malaga, Spain; [Lapetra, Jose] San Pablo Hlth Ctr, Dept Family Med, Primary Care Div Sevilla, Seville, Spain; [Ruiz-Gutierrez, Valentina] CSIC, Inst Grasa, E-41080 Seville, Spain; [Saez, Guillermo T.] Univ Valencia, Doctor Peset Univ Hosp, Serv Clin Anal, Dept Biochem & Mol Biol,Fac Med, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universitat Rovira i Virgili; Servicio Navarro de Salud - Osasunbidea; University of Navarra; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Valencia; Institut Investigacio Sanitaria Illes Balears (IdISBa); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de la Grasa (IG); University of Valencia	Flores-Mateo, G (corresponding author), Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Tarragona Reus, Tarragona, Spain.	gflores@idiapjgol.org	Algorta, Jaime/CAF-7793-2022; Estruch, Ramon/AAZ-3723-2020; Fiol, Miguel/F-6793-2016; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Guasch-Ferre, Marta/H-6680-2019; IBIS, ATENCION PRIMARIA/I-3524-2016; Martín, Teresa Rodríguez/GZL-1938-2022; Fito, Montserrat/C-1822-2012; Santos-Lozano, JM/J-9312-2018; Casas, Rosa/ABD-1915-2020; Bulló, Mònica/F-2925-2016; Salas-Salvado, Jordi/C-7229-2017; Lapetra, Jose/F-2552-2015; Sanchez-Villegas, Almudena/T-6733-2019; TORMO, GUILLERMO SÁEZ/AAB-2592-2019; Toledo, Estefania/H-6211-2014; ZAZPE, ITZIAR/B-1970-2017	Algorta, Jaime/0000-0002-7042-5675; Fiol, Miguel/0000-0002-5370-1391; Guasch-Ferre, Marta/0000-0001-8525-1404; Fito, Montserrat/0000-0002-1817-483X; Santos-Lozano, JM/0000-0001-7097-5653; Casas, Rosa/0000-0002-0211-9166; Bulló, Mònica/0000-0002-0218-7046; Salas-Salvado, Jordi/0000-0003-2700-7459; Sanchez-Villegas, Almudena/0000-0001-7733-9238; Toledo, Estefania/0000-0002-6263-4434; Flores-Mateo, Gemma/0000-0001-6901-7327; ELOSUA, ROBERTO/0000-0001-8235-0095; Saez, Guillermo/0000-0002-8164-4048; Bautista-Castano, Inmaculada/0000-0001-9257-8739; Rodriguez-Blanco, Teresa/0000-0003-1395-9723; ZAZPE, ITZIAR/0000-0002-8787-2981; Basora, Josep/0000-0003-0278-1149; Fernandez-Ballart, Joan D./0000-0002-1320-6484	Spanish Ministry of Health [G03/140, RD06/0045, PI040233, PI070240, CP06/00100]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	This study was funded by the Spanish Ministry of Health (Networks G03/140, RD06/0045 and by the research grants PI040233, PI070240 and Miguel Servet SNS Contract CP06/00100 of the Instituto de Salud Carlos III). The CIBER Fisiopatologia de la Obesidad y Nutrition and the CIBER Epidemiologia y Salud Publica are initiatives of the Instituto de Salud Carlos III, Madrid, Spain, and the European Union (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Amirkhizi F, 2014, OBES RES CLIN PRACT, V8, pE26, DOI 10.1016/j.orcp.2012.07.004; Martinez-Gonzalez MA, 2012, INT J EPIDEMIOL, V41, P377, DOI 10.1093/ije/dyq250; Baez-Duarte BG, 2014, ARCH MED RES, V45, P375, DOI 10.1016/j.arcmed.2014.05.001; Bandeira SD, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/819310; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Ceriello A, 2002, CIRCULATION, V106, P1211, DOI 10.1161/01.CIR.0000027569.76671.A8; Covas MI, 2006, ANN INTERN MED, V145, P333, DOI 10.7326/0003-4819-145-5-200609050-00006; Ferro FED, 2011, BIOL TRACE ELEM RES, V143, P787, DOI 10.1007/s12011-010-8940-6; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Elosua R, 2000, MED SCI SPORT EXER, V32, P1431, DOI 10.1097/00005768-200008000-00011; Goldstein, 2003, MULTILEVEL STAT MODE; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; Guxens M, 2009, AM J HYPERTENS, V22, P68, DOI 10.1038/ajh.2008.313; Harani H, 2012, ANN BIOL CLIN-PARIS, V70, P669, DOI 10.1684/abc.2012.0763; HOLM S, 1979, SCAND J STAT, V6, P65; Huang HL, 2008, DIS MARKERS, V24, P341, DOI 10.1155/2008/371314; Jablonska E, 2009, EUR J NUTR, V48, P383, DOI 10.1007/s00394-009-0023-0; Karunakaran U, 2013, DIABETES METAB J, V37, P106, DOI 10.4093/dmj.2013.37.2.106; Kesavulu MM, 2001, DIABETES RES CLIN PR, V53, P33, DOI 10.1016/S0168-8227(01)00238-8; Levin B, 1996, AM J PUBLIC HEALTH, V86, P628, DOI 10.2105/AJPH.86.5.628; Likidlilid Atip, 2010, Journal of the Medical Association of Thailand, V93, P682; Likidlilid Atip, 2007, Journal of the Medical Association of Thailand, V90, P1759; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; Mataix J., 2003, TABLA COMPOSICION AL, V4th; Mital R, 2011, AM J PHYSIOL-HEART C, V300, pH1960, DOI 10.1152/ajpheart.01285.2010; Monget AL, 1996, EUR J CLIN NUTR, V50, P443; Navarro-Alarcon M, 2008, SCI TOTAL ENVIRON, V400, P115, DOI 10.1016/j.scitotenv.2008.06.024; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Rybka J, 2011, REDOX REP, V16, P71, DOI 10.1179/174329211X13002357050897; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; SHAMBERGER RJ, 1980, J ENVIRON PATHOL TOX, V4, P305; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Stranges S, 2010, NUTR METAB CARDIOVAS, V20, P754, DOI 10.1016/j.numecd.2010.10.001; Taheri E, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-3; Weinbrenner T, 2003, ATHEROSCLEROSIS, V168, P99, DOI 10.1016/S0021-9150(03)00053-4; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Zhou XB, 1996, CIRCULATION, V93, P1177, DOI 10.1161/01.CIR.93.6.1177	39	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e105881	10.1371/journal.pone.0105881	http://dx.doi.org/10.1371/journal.pone.0105881			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25269026	Green Published, Green Submitted, gold			2022-12-27	WOS:000343671700007
J	Tsai, YK; Liou, CH; Lin, JC; Ma, L; Fung, CP; Chang, FY; Siu, LK				Tsai, Yu-Kuo; Liou, Ci-Hong; Lin, Jung-Chung; Ma, Ling; Fung, Chang-Phone; Chang, Feng-Yee; Siu, L. Kristopher			A Suitable Streptomycin-Resistant Mutant for Constructing Unmarked In-Frame Gene Deletions Using rpsL as a Counter-Selection Marker	PLOS ONE			English	Article							ALTERNATIVE COMPLEMENT PATHWAY; PNEUMONIAE LIVER-ABSCESS; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; SEROTYPE K1; SALMONELLA-TYPHIMURIUM; VIRULENCE DETERMINANT; SELECTABLE MARKER; ALLELIC EXCHANGE	The streptomycin counter-selection system is a useful tool for constructing unmarked in-frame gene deletions, which is a fundamental approach to study bacteria and their pathogenicity at the molecular level. A prerequisite for this system is acquiring a streptomycin-resistant strain due to rpsL mutations, which encodes the ribosomal protein S12. However, in this study no streptomycin resistance was found to be caused by rpsL mutations in all 127 clinical strains of Klebsiella pneumoniae isolated from liver abscess patients. By screening 107 spontaneous mutants of streptomycin resistance from a clinical strain of K. pneumoniae, nucleotide substitution or insertion located within the rpsL was detected in each of these strains. Thirteen different mutants with varied S12 proteins were obtained, including nine streptomycin-dependent mutants. The virulence of all four streptomycin-resistant mutants was further evaluated. Compared with the parental strain, the K42N, K42T and K87R mutants showed a reduction in growth rate, and the K42N and K42T mutants became susceptible to normal human serum. In the mice LD50 (the bacterial dose that caused 50% death) assay, the K42N and K42T mutants were similar to 1,000-fold less lethal (similar to 2 x 10(5) CFU) and the K87R mutant was similar to 50-fold less lethal (similar to 1 x 10(4) CFU) than the parental strain (similar to 2 x 10(2) CFU). A K42R mutant showed non-observable effects on the above assays, while this mutant exhibited a small cost (P<0.01) in an in vitro growth competition experiment. In summary, most of the K. pneumoniae strains with streptomycin resistance caused by rpsL mutations are less virulent than their parental strain in the absence of streptomycin. The K42R mutant showed similar pathogenicity to its parental strain and should be one of the best choices when using rpsL as a counter-selection marker.	[Tsai, Yu-Kuo; Ma, Ling; Siu, L. Kristopher] Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Miaoli, Taiwan; [Liou, Ci-Hong; Lin, Jung-Chung; Chang, Feng-Yee; Siu, L. Kristopher] Natl Def Med Ctr, Div Infect Dis & Trop Med, Dept Internal Med, Triserv Gen Hosp, Taipei, Taiwan; [Fung, Chang-Phone] Taipei Vet Gen Hosp, Infect Dis Sect, Dept Med, Taipei, Taiwan; [Fung, Chang-Phone] Natl Yang Ming Univ, Taipei 112, Taiwan; [Chang, Feng-Yee] Taiwan Ctr Dis Control, Taipei, Taiwan; [Siu, L. Kristopher] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Defense Medical Center; Tri-Service General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan	Chang, FY (corresponding author), Natl Def Med Ctr, Div Infect Dis & Trop Med, Dept Internal Med, Triserv Gen Hosp, Taipei, Taiwan.	fychang@ndmctsgh.edu.tw; lksiu@nhri.org.tw	Siu, Leung-Kei/C-1368-2010		National Health Research Institutes; National Science Council of Taiwan [NSC 102-2314-B-016-053-MY3]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Health Research Institutes and the National Science Council of Taiwan (NSC 102-2314-B-016-053-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard AML, 2010, MICROBIOL-SGM, V156, P1030, DOI 10.1099/mic.0.034595-0; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Bjorkman J, 1998, P NATL ACAD SCI USA, V95, P3949, DOI 10.1073/pnas.95.7.3949; Bugla-Ploskonska G, 2011, MICROB ECOL, V61, P41, DOI 10.1007/s00248-010-9677-7; Campbell PA, 1996, ISOLATION FUNCTIONAL; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cheng HY, 2010, J BACTERIOL, V192, P3144, DOI 10.1128/JB.00031-10; Chiang MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022248; CHIOU CS, 1995, PHYTOPATHOLOGY, V85, P324, DOI 10.1094/Phyto-85-324; Chumpolkulwong N, 2004, EUR J BIOCHEM, V271, P1127, DOI 10.1111/j.1432-1033.2004.04016.x; Doi Y, 2007, CLIN INFECT DIS, V45, P88, DOI 10.1086/518605; Drecktrah D, 2010, APPL ENVIRON MICROB, V76, P985, DOI 10.1128/AEM.02172-09; Durante-Mangoni E, 2009, INT J ANTIMICROB AG, V33, P201, DOI 10.1016/j.ijantimicag.2008.09.001; EIDINGER D, 1977, CELL IMMUNOL, V29, P174, DOI 10.1016/0008-8749(77)90286-6; Enne VI, 2005, J ANTIMICROB CHEMOTH, V56, P544, DOI 10.1093/jac/dki255; FINE DP, 1972, J IMMUNOL, V109, P807; FINE DP, 1977, INFECT IMMUN, V16, P124, DOI 10.1128/IAI.16.1.124-128.1977; FINKEN M, 1993, MOL MICROBIOL, V9, P1239, DOI 10.1111/j.1365-2958.1993.tb01253.x; Galimand A, 2005, ANTIMICROB AGENTS CH, V49, P2949, DOI 10.1128/AAC.49.7.2949-2953.2005; Garcia-Migura L, 2012, MICROB DRUG RESIST, V18, P88, DOI 10.1089/mdr.2011.0064; Gebreyes WA, 2002, J CLIN MICROBIOL, V40, P2813, DOI 10.1128/JCM.40.8.2813-2822.2002; Heinzelmann M, 1999, MICROBIOL IMMUNOL, V43, P505, DOI 10.1111/j.1348-0421.1999.tb02435.x; Huang CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066740; Hughes D, 2001, ANTIBIOTIC DEV RESIS, P23; Kim IK, 2011, J MICROBIOL METH, V84, P128, DOI 10.1016/j.mimet.2010.10.007; Lai YC, 2003, J BACTERIOL, V185, P788, DOI 10.1128/JB.185.3.788-800.2003; Lin JC, 2004, MICROBES INFECT, V6, P1191, DOI 10.1016/j.micinf.2004.06.003; Madsen L, 2000, VET MICROBIOL, V75, P73, DOI 10.1016/S0378-1135(00)00207-8; Nhu NTQ, 2012, INT J TUBERC LUNG D, V16, P527, DOI 10.5588/ijtld.11.0202; Nielsen KL, 2012, J ANTIMICROB CHEMOTH, V67, P1325, DOI 10.1093/jac/dks051; Ohtomo R., 2003, MICROBES ENVIRON, V18, P138, DOI [10.1264/jsme2.18.138, DOI 10.1264/JSME2.18.138]; PODSCHUN R, 1993, J INFECT DIS, V168, P1415, DOI 10.1093/infdis/168.6.1415; Reyrat JM, 1998, INFECT IMMUN, V66, P4011; SANDER P, 1995, MOL MICROBIOL, V16, P991, DOI 10.1111/j.1365-2958.1995.tb02324.x; Sander P, 2001, Methods Mol Med, V54, P93, DOI 10.1385/1-59259-147-7:093; Sander P, 2002, ANTIMICROB AGENTS CH, V46, P1204, DOI 10.1128/AAC.46.5.1204-1211.2002; Schatz A, 1944, P SOC EXP BIOL MED, V55, P66, DOI 10.3181/00379727-55-14461; Siu LK, 2012, LANCET INFECT DIS, V12, P881, DOI 10.1016/S1473-3099(12)70205-0; Siu LK, 2011, J CLIN MICROBIOL, V49, P3761, DOI 10.1128/JCM.00977-11; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Sunde M, 2005, J ANTIMICROB CHEMOTH, V56, P87, DOI 10.1093/jac/dki150; Sunde M, 2005, J ANTIMICROB CHEMOTH, V56, P1019, DOI 10.1093/jac/dki377; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Tsai YK, 2011, ANTIMICROB AGENTS CH, V55, P1485, DOI 10.1128/AAC.01275-10; Wu QT, 1998, J BACTERIOL, V180, P1311, DOI 10.1128/JB.180.5.1311-1322.1998; Yeh KM, 2007, J CLIN MICROBIOL, V45, P466, DOI 10.1128/JCM.01150-06; Yeh KM, 2010, J INFECT DIS, V201, P1259, DOI 10.1086/606010	47	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e109258	10.1371/journal.pone.0109258	http://dx.doi.org/10.1371/journal.pone.0109258			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268958	gold, Green Submitted, Green Published			2022-12-27	WOS:000343671700226
J	Flothe, CR; John, U; Molis, M				Floethe, Carla R.; John, Uwe; Molis, Markus			Comparing the Relative Importance of Water-Borne Cues and Direct Grazing for the Induction of Defenses in the Brown Seaweed Fucus vesiculosus	PLOS ONE			English	Article							FEEDING-PREFERENCE EXPERIMENTS; INDUCED HERBIVORE RESISTANCE; ISOPOD IDOTEA-BALTICA; ASCOPHYLLUM-NODOSUM; TEMPORAL DYNAMICS; PLANT VARIATION; PHAEOPHYCEAE; SIGNALS; COMMUNICATION; PALATABILITY	Some seaweed species have been shown to release water-borne cues after herbivore attack, for example, to attract natural enemies of the herbivore. These cues may also be sensed by neighboring seaweeds and used to adjust their defenses in anticipation of a possible herbivore attack. Several studies indicated information transfer between seaweed individuals in the past, including the brown seaweed Fucus vesiculosus. Previous work showed induction of defenses in F. vesiculosus in response to water-borne cues released by isopod-grazed conspecifics. In contrast, another study on induced responses after exposure to cues from isopod-grazed neighbors using the same seaweed species yielded contradictory results. This study reassessed the ability of F. vesiculosus individuals to sense water-borne cues released by isopod-grazed neighbors in a series of experiments that monitored F. vesiculosus palatability in response to direct grazing by Idotea baltica and water-borne cues from isopod-grazed neighbors relative to unmanipulated seaweed pieces. Two-choice feeding assays were conducted with both fresh and reconstituted seaweed pieces. Direct grazing by I. baltica induced a chemical defense in F. vesiculosus, confirming results of previous studies. In contrast, evidence for increased herbivore resistance in seaweed pieces that were located downstream of isopod-grazed F. vesiculosus could not be provided. The lack of defense induction in response to grazing of conspecific neighbors may be explained by the environmental conditions and the scattered distribution of F. vesiculosus individuals in the intertidal zone of Helgoland, which may render resource investment in the emission and/or response to water-borne cues at this site unprofitable.	[Floethe, Carla R.; John, Uwe] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Sect Ecol Chem, Bremerhaven, Germany; [Molis, Markus] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Sect Funct Ecol, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Flothe, CR (corresponding author), Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Sect Ecol Chem, Bremerhaven, Germany.	carla.floethe@awi.de	john, uwe/S-3009-2016	john, uwe/0000-0002-1297-4086	PACES research program of the Alfred-Wegener-Institut Helmholtz-Zentrum fur Polar- und Meeresforschung; Rosa Luxemburg Foundation	PACES research program of the Alfred-Wegener-Institut Helmholtz-Zentrum fur Polar- und Meeresforschung; Rosa Luxemburg Foundation	Financial support was provided by the PACES research program of the Alfred-Wegener-Institut Helmholtz-Zentrum fur Polar- und Meeresforschung. CRF was financially supported by the Rosa Luxemburg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN IT, 1983, SCIENCE, V221, P277, DOI 10.1126/science.221.4607.277; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; BRUIN J, 1995, TRENDS ECOL EVOL, V10, P167, DOI 10.1016/S0169-5347(00)89033-3; Bruin J, 2001, BIOCHEM SYST ECOL, V29, P1103, DOI 10.1016/S0305-1978(01)00053-9; Coleman RA, 2007, OECOLOGIA, V151, P454, DOI 10.1007/s00442-006-0601-2; Cronin G, 1996, OECOLOGIA, V105, P361, DOI 10.1007/BF00328739; Diaz E, 2006, MAR BIOL, V149, P1301, DOI 10.1007/s00227-006-0320-6; Dicke M., 1989, CAUSES CONSEQUENCES, P341; Edwards M.S., 2012, SEAWEED BIOL, V135-156, DOI [10.1007/978-3-642-28451-9_7, DOI 10.1007/978-3-642-28451-9]; Eschweiler N, 2009, HELGOLAND MAR RES, V63, P119, DOI 10.1007/s10152-008-0131-x; Flothe CR, 2014, EUR J PHYCOL, V49, P356, DOI 10.1080/09670262.2014.946452; Flothe CR, 2014, J PHYCOL, V50, P564, DOI 10.1111/jpy.12186; Flothe CR, 2013, J PHYCOL, V49, P468, DOI 10.1111/jpy.12059; Franke HD, 2007, MAR BIOL, V150, P929, DOI 10.1007/s00227-006-0421-2; Haavisto F, 2010, OECOLOGIA, V162, P685, DOI 10.1007/s00442-009-1494-7; HAY ME, 1994, ECOLOGY, V75, P1714, DOI 10.2307/1939631; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; Hemmi A, 2004, MAR ECOL PROG SER, V273, P109, DOI 10.3354/meps273109; Hoffmann A, 2011, THESIS KARLSRUHER I; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; JORMALAINEN V, 1989, OPHELIA, V30, P213, DOI 10.1080/00785326.1989.10430845; Jormalainen V, 2001, MAR ECOL PROG SER, V220, P219, DOI 10.3354/meps220219; Kalberer NM, 2001, J CHEM ECOL, V27, P647, DOI 10.1023/A:1010389500009; Kersen P, 2011, MAR ECOL-EVOL PERSP, V32, P87, DOI 10.1111/j.1439-0485.2010.00418.x; Long JD, 2007, ECOLOGY, V88, P1232, DOI 10.1890/06-1585; Long JD, 2013, MAR ECOL PROG SER, V493, P83, DOI 10.3354/meps10511; Luning, 1985, MEERESBOTANIK VERBRE; Macaya EC, 2005, J EXP MAR BIOL ECOL, V325, P214, DOI 10.1016/j.jembe.2005.05.004; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Orav-Kotta H, 2004, HYDROBIOLOGIA, V514, P79, DOI 10.1023/B:hydr.0000018208.72394.09; PETERSON CH, 1989, OECOLOGIA, V80, P82, DOI 10.1007/BF00789935; Quinn GP, 2003, EXPT DESIGN DATA ANA; ROA R, 1992, OECOLOGIA, V89, P509, DOI 10.1007/BF00317157; Rohde S, 2004, J ECOL, V92, P1011, DOI 10.1111/j.0022-0477.2004.00936.x; Rohde S, 2008, J EXP MAR BIOL ECOL, V367, P227, DOI 10.1016/j.jembe.2008.10.003; Sabelis M. W., 1992, INSECT CHEM ECOLOGY, P122; Sotka EE, 2002, J EXP MAR BIOL ECOL, V277, P1, DOI 10.1016/S0022-0981(02)00128-4; Tatarenkov A, 2007, J PHYCOL, V43, P675, DOI 10.1111/j.1529-8817.2007.00369.x; Toth GB, 2000, P NATL ACAD SCI USA, V97, P14418, DOI 10.1073/pnas.250226997; Toth GB, 2007, MAR BIOL, V151, P1597, DOI 10.1007/s00227-007-0605-4; Toth GB, 2007, J ECOL, V95, P425, DOI 10.1111/j.1365-2745.2007.01224.x; TUOMI J, 1989, BOT MAR, V32, P505, DOI 10.1515/botm.1989.32.6.505; Winer B.J., 1991, STAT PRINCIPLES EXPT; Yun HY, 2007, HELGOLAND MAR RES, V61, P203, DOI 10.1007/s10152-007-0067-6; Yun HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038804; Yun HY, 2010, MAR ECOL PROG SER, V408, P47, DOI 10.3354/meps08561	46	4	4	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109247	10.1371/journal.pone.0109247	http://dx.doi.org/10.1371/journal.pone.0109247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279662	gold, Green Published			2022-12-27	WOS:000342670800067
J	Li, ZQ; Xu, LF; He, DL; Yang, LS; Liu, C; Chen, YX; Shih, JWK; Zhang, J; Zhao, QJ; Cheng, T; Xia, NS				Li, Zhiqun; Xu, Longfa; He, Delei; Yang, Lisheng; Liu, Che; Chen, Yixin; Shih, James Wai Kuo; Zhang, Jun; Zhao, Qinjian; Cheng, Tong; Xia, Ningshao			In Vivo Time-Related Evaluation of a Therapeutic Neutralization Monoclonal Antibody against Lethal Enterovirus 71 Infection in a Mouse Model	PLOS ONE			English	Article							BRAIN-STEM ENCEPHALITIS; MOUTH-DISEASE; VIRUS; MICE; ENCEPHALOMYELITIS; CHALLENGE; EPIDEMIC; OUTBREAK; CHILDREN; HAND	Enterovirus 71 (EV71) is a neurotropic virus capable of inducing severe neurological symptoms and death. No direct targeting antivirals are useful in the treatment of severe EV71 infection. Because of low toxicity and good specificity, monoclonal antibodies (MAb) are a potential candidate for the treatment of viral infections. Therefore, we developed an EV71-specific conformational MAb with high in vitro cross-neutralization activity to heterologous EV71 subgenotypes. The in vivo treatment experiment at different days post-infection indicated that a single treatment of MAb CT11F9 within day 3 post-infection fully protected mice from morbidity and mortality (0% PBS vs. 100% at 10 mg/g per body weight ***P<0.0001). Immunohistochemical and histological analysis confirmed that CT11F9 significantly prohibited EV71 VP1 expression in various tissues and prevented EV71-induced myonecrosis. Moreover, thrice-treatment at day 4, 5, 6 post-infection was associated with an increased survival rate (18.2% single vs. 50% thrice at 20 mg/g per body weight), and the mice recovered from limb paralysis. Competitive ELISA also confirmed that CT11F9-recognized epitopes were immunodominant in humans. In conclusion, MAb CT11F9 is an ideal candidate to be humanized and used in severe EV71 infection.	[Li, Zhiqun; Xu, Longfa; He, Delei; Yang, Lisheng; Liu, Che; Chen, Yixin; Shih, James Wai Kuo; Zhang, Jun; Zhao, Qinjian; Cheng, Tong; Xia, Ningshao] Xiamen Univ, Sch Life Sci, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen, Fujian, Peoples R China; [Xu, Longfa; He, Delei; Chen, Yixin; Shih, James Wai Kuo; Zhang, Jun; Zhao, Qinjian; Cheng, Tong; Xia, Ningshao] Xiamen Univ, Sch Publ Hlth, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Cheng, T (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen, Fujian, Peoples R China.	tcheng@xmu.edu.cn; nsxia@xmu.edu.cn	Zhang, Jun/G-4598-2010	Zhang, Jun/0000-0002-6601-9180; Cheng, Tong/0000-0002-1638-6214; Xia, Ningshao/0000-0003-0179-5266	National Science and Technology Major Project of the Ministry of Science and Technology of China [2010ZX09401-403]; National Natural Science Foundation of China [30972826]; National Natural Science Fund for Distinguished Young Scholars [30925030]	National Science and Technology Major Project of the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by National Science and Technology Major Project of the Ministry of Science and Technology of China (No. 2010ZX09401-403), National Natural Science Foundation of China (No. 30972826), and National Natural Science Fund for Distinguished Young Scholars (No. 30925030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Cao RY, 2011, J CLIN VIROL, V51, P242, DOI 10.1016/j.jcv.2011.05.002; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang GH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-106; Chen CS, 2007, J VIROL, V81, P8996, DOI 10.1128/JVI.00236-07; Chen YX, 2013, VACCINE, V31, P425, DOI 10.1016/j.vaccine.2012.10.032; He F, 2013, ANTIVIR RES, V100, P207, DOI 10.1016/j.antiviral.2013.08.003; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hunt AR, 2011, VIROLOGY, V414, P146, DOI 10.1016/j.virol.2011.03.016; Khong WX, 2011, J VIROL, V85, P3067, DOI 10.1128/JVI.01779-10; Lim XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029751; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Reading SA, 2007, ARCH VIROL, V152, P1047, DOI 10.1007/s00705-006-0923-8; Smeraski CA, 2011, ANTIVIR RES, V91, P43, DOI 10.1016/j.antiviral.2011.04.011; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Wang SM, 2008, J INFECT DIS, V198, P1002, DOI 10.1086/591462; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Wu KX, 2010, DRUG DISCOV TODAY, V15, P1041, DOI 10.1016/j.drudis.2010.10.008; Xu FH, 2011, J VIROL METHODS, V171, P107, DOI 10.1016/j.jviromet.2010.10.009; Xu FH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011388; Xu LF, 2014, THERANOSTICS, V4, P498, DOI 10.7150/thno.7457; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yang LS, 2014, CLIN VACCINE IMMUNOL, V21, P312, DOI 10.1128/CVI.00359-13; Zheng QB, 2011, ANTIMICROB AGENTS CH, V55, P1349, DOI 10.1128/AAC.01436-10	28	13	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109391	10.1371/journal.pone.0109391	http://dx.doi.org/10.1371/journal.pone.0109391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279734	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800076
J	Niu, SC; Lv, ZZ; Liu, JC; Bai, WH; Yang, SM; Chen, AL				Niu, Shucao; Lv, Zhenzhen; Liu, Jinchuan; Bai, Wenhui; Yang, Shuming; Chen, Ailiang			Colorimetric Aptasensor Using Unmodified Gold Nanoparticles for Homogeneous Multiplex Detection	PLOS ONE			English	Article							RAPID VISUAL DETECTION; LABEL-FREE APTASENSOR; DNA APTAMERS; POTASSIUM; SENSORS; SULFADIMETHOXINE; SEQUENCES; ADENOSINE; STEP	Colorimetric aptasensors using unmodified gold nanoparticles (AuNPs) have attracted much attention because of their low cost, simplicity, and practicality, and they have been developed for various targets in the past several years. However, previous research has focused on developing single-target assays. Here, we report the development of a homogeneous multiplex aptasensor by using more than one class of aptamers to stabilize AuNPs. Using sulfadimethoxine (SDM), kanamycin (KAN) and adenosine (ADE) as example targets, a KAN aptamer (750 nM), an SDM aptamer (250 nM) and an ADE aptamer (500 nM) were mixed at a 1:1:1 volume ratio and adsorbed directly onto the surface of unmodified AuNPs by electrostatic interaction. Upon the addition of any of the three targets, the conformation of the corresponding aptamer changed from a random coil structure to a rigid folded structure, which could not adsorb and stabilize AuNPs. The AuNPs aggregated in a specific reaction buffer (20 mM Tris-HCl containing 20 mM NaCl and 5 mM KCl), which led to a color change from red to purple/blue. These results demonstrate that the multiplex colorimetric aptasensor detected three targets simultaneously while maintaining the same sensitivity as a single-target aptasensor for each individual target. The multiplex aptasensor could be extended to other aptamers for various molecular detection events. Due to its simple design, easy operation, fast response, cost effectiveness and lack of need for sophisticated instrumentation, the proposed strategy provides a powerful tool to examine large numbers of samples to screen for a small number of potentially positive samples containing more than one analyte, which can be further validated using sophisticated instruments.	[Niu, Shucao; Lv, Zhenzhen; Liu, Jinchuan; Bai, Wenhui; Yang, Shuming; Chen, Ailiang] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Key Lab Agroprod Qual & Safety, Beijing 100193, Peoples R China; [Niu, Shucao; Lv, Zhenzhen; Liu, Jinchuan; Bai, Wenhui; Yang, Shuming; Chen, Ailiang] Minist Agr, Key Lab Agrifood Qual & Safety, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS; Ministry of Agriculture & Rural Affairs	Chen, AL (corresponding author), Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Key Lab Agroprod Qual & Safety, Beijing 100193, Peoples R China.	ailiang.chen@gmail.com	Chen, Ailiang/AAA-6470-2022		 [2012DFA31140]		This work was funded by 2012DFA31140, http://www.istcp.org.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen AL, 2013, BIOSENS BIOELECTRON, V42, P419, DOI 10.1016/j.bios.2012.10.059; Ghosh SK, 2007, CHEM REV, V107, P4797, DOI 10.1021/cr0680282; Ho HA, 2004, J AM CHEM SOC, V126, P1384, DOI 10.1021/ja037289f; HUIZENGA DE, 1995, BIOCHEMISTRY-US, V34, P656, DOI 10.1021/bi00002a033; Kim YS, 2010, BIOSENS BIOELECTRON, V26, P1644, DOI 10.1016/j.bios.2010.08.046; Li D, 2010, ACCOUNTS CHEM RES, V43, P631, DOI 10.1021/ar900245u; Li HX, 2004, P NATL ACAD SCI USA, V101, P14036, DOI 10.1073/pnas.0406115101; Li HX, 2004, J AM CHEM SOC, V126, P10958, DOI 10.1021/ja048749n; Liu JW, 2009, CHEM REV, V109, P1948, DOI 10.1021/cr030183i; Liu JW, 2004, ANAL CHEM, V76, P1627, DOI 10.1021/ac0351769; Maye MM, 2003, ANAL CHIM ACTA, V496, P17, DOI 10.1016/S0003-2670(03)00986-3; Mayer Gn, 2009, NUCL ACID PEPTIDE AP; Mei ZL, 2013, BIOSENS BIOELECTRON, V39, P26, DOI 10.1016/j.bios.2012.06.027; Rex M, 2006, ANAL CHEM, V78, P445, DOI 10.1021/ac051166r; Song KM, 2012, BIOSENS BIOELECTRON, V33, P113, DOI 10.1016/j.bios.2011.12.034; Song KM, 2012, ANAL BIOANAL CHEM, V402, P2153, DOI 10.1007/s00216-011-5662-3; Song KM, 2011, ANAL BIOCHEM, V415, P175, DOI 10.1016/j.ab.2011.04.007; Wang LH, 2006, CHEM COMMUN, P3780, DOI 10.1039/b607448k; Wu ZS, 2008, BIOMATERIALS, V29, P2689, DOI 10.1016/j.biomaterials.2008.02.024; Yang C, 2011, BIOSENS BIOELECTRON, V26, P2724, DOI 10.1016/j.bios.2010.09.032; Zhang X, 2012, LANGMUIR, V28, P3896, DOI 10.1021/la205036p; Zhao W, 2008, CHEMBIOCHEM, V9, P2363, DOI 10.1002/cbic.200800282; Zhou ND, 2013, TALANTA, V108, P109, DOI 10.1016/j.talanta.2013.01.064; Zhu XL, 2011, ANAL CHEM, V83, P4085, DOI 10.1021/ac200058r	24	54	55	6	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109263	10.1371/journal.pone.0109263	http://dx.doi.org/10.1371/journal.pone.0109263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279730	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800068
J	van Vonderen, JJ; Witlox, RS; Kraaij, S; te Pas, AB				van Vonderen, Jeroen J.; Witlox, Ruben S.; Kraaij, Sascha; te Pas, Arjan B.			Two-Minute Training for Improving Neonatal Bag and Mask Ventilation	PLOS ONE			English	Article							NEWBORN MORTALITY; RESUSCITATION; BABIES; OBSTRUCTION; GUIDELINES; STILLBIRTH; LEAK	Objectives: To test effectivity of a two-minute training consisting of a few key-points in ventilation using the self-inflating bag (SIB). Study Design: Experienced and inexperienced caregivers were asked to mask ventilate a leak free manikin using the SIB before and after the training. Mask leak and pressures were measured using respiratory function monitoring. Pressures above 35 cm H2O were considered excessive. Parameters were compared using a Wilcoxon non-parametric test. Results: Before and after the short training, experienced caregivers had minimal median (IQR) mask leak (14 (3-75) vs. 3 (0-53)%; p<0.01). Inexperienced users had large leak which reduced from 51 (7-91)% before to 11 (2-71)% after training (p<0.01). Pressures above 35 cm H2O hardly occurred in experienced caregivers (0 (0-5) vs. 0 (0-0)%; ns). In inexperienced caregivers this frequently occurred but decreased considerably after training (94 (46-100) vs. 2 (0-70)%; p<0.01). Conclusion: A two-minute training of bag and mask ventilation was effective. This training could be incorporated into any training program.	[van Vonderen, Jeroen J.; Witlox, Ruben S.; Kraaij, Sascha; te Pas, Arjan B.] Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	te Pas, AB (corresponding author), Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands.	a.b.te_pas@lumc.nl	pas, arjan te/AAA-9019-2020; van Vonderen, Jeroen J./L-4067-2019; Witlox, Ruben/AAN-3877-2021	pas, arjan te/0000-0001-7831-8797; van Vonderen, Jeroen J./0000-0002-1258-5224; Witlox, Ruben/0000-0002-5063-1316	Veni-grant, The Netherlands Organisation for Health Research and Development (ZonMw) [91612027]	Veni-grant, The Netherlands Organisation for Health Research and Development (ZonMw)	A.B. te Pas is recipient of a Veni-grant, The Netherlands Organisation for Health Research and Development (ZonMw), part of the Innovational Research Incentives Scheme Veni-Vidi-Vici, project number 91612027. J.J. van Vonderen is recipient of a Willem-Alexander Children's Foundation scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Finer NN, 2009, PEDIATRICS, V123, P865, DOI 10.1542/peds.2008-0560; Finer NN, 2001, RESUSCITATION, V49, P299, DOI 10.1016/S0300-9572(01)00311-2; Fuchs H, 2012, NEOREVIEWS, V13, pe353, DOI DOI 10.1542/NEO.13-6-E363.; Goudar SS, 2013, PEDIATRICS, V131, pE344, DOI 10.1542/peds.2012-2112; Kattwinkel J, 2000, TXB NEONATAL RESUSCI, V4th ed.; Kattwinkel J, 2010, CIRCULATION, V122, pS909, DOI 10.1161/CIRCULATIONAHA.110.971119; Keszler Martin, 2005, J Perinatol, V25 Suppl 2, pS19, DOI 10.1038/sj.jp.7211313; Klimek J, 2006, J PAEDIATR CHILD H, V42, P140, DOI 10.1111/j.1440-1754.2006.00813.x; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S12; Mduma E, 2013, LOW DOSE HIGH FREQUE; Msemo G, 2013, PEDIATRICS, V131, pE353, DOI 10.1542/peds.2012-1795; Richmond S, 2010, RESUSCITATION, V81, P1389, DOI 10.1016/j.resuscitation.2010.08.018; Roehr CC, 2010, AM J PERINAT, V27, P753, DOI 10.1055/s-0030-1254236; Roehr CC, 2010, RESUSCITATION, V81, P202, DOI 10.1016/j.resuscitation.2009.10.008; Schilleman K, 2010, ARCH DIS CHILD-FETAL, V95, pF398, DOI 10.1136/adc.2009.182162; Singhal N, 2006, CLIN PERINATOL, V33, P219, DOI 10.1016/j.clp.2005.11.009; SOUTH M, 1986, ARCH DIS CHILD, V61, P291, DOI 10.1136/adc.61.3.291; Tracy MB, 2011, ARCH DIS CHILD-FETAL, V96, pF195, DOI 10.1136/adc.2009.169847; Wall SN, 2009, INT J GYNECOL OBSTET, V107, pS47, DOI 10.1016/j.ijgo.2009.07.013; Wilson EV, 2014, ARCH DIS CHILD-FETAL, V99, pF169, DOI 10.1136/archdischild-2013-304582; Wood FE, 2008, ARCH DIS CHILD-FETAL, V93, pF380, DOI 10.1136/adc.2007.120097; Wood FE, 2008, ARCH DIS CHILD-FETAL, V93, pF230, DOI 10.1136/adc.2007.117788; Wood FE, 2013, SEMIN FETAL NEONAT M, V18, P344, DOI 10.1016/j.siny.2013.08.009	24	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109049	10.1371/journal.pone.0109049	http://dx.doi.org/10.1371/journal.pone.0109049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279800	gold, Green Published, Green Submitted			2022-12-27	WOS:000342670800053
J	Cui, WT; Chen, HP; Zhu, KK; Jin, QJ; Xie, YJ; Cui, J; Xia, Y; Zhang, J; Shen, WB				Cui, Weiti; Chen, Huiping; Zhu, Kaikai; Jin, Qijiang; Xie, Yanjie; Cui, Jin; Xia, Yan; Zhang, Jing; Shen, Wenbiao			Cadmium-Induced Hydrogen Sulfide Synthesis Is Involved in Cadmium Tolerance in Medicago sativa by Reestablishment of Reduced (Homo) glutathione and Reactive Oxygen Species Homeostases	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; OXIDATIVE STRESS; SEED-GERMINATION; RESPIRATORY OSCILLATION; H2S PRODUCTION; PLANTS; EMISSION; EXPRESSION; TOXICITY; SULFUR	Until now, physiological mechanisms and downstream targets responsible for the cadmium (Cd) tolerance mediated by endogenous hydrogen sulfide (H2S) have been elusive. To address this gap, a combination of pharmacological, histochemical, biochemical and molecular approaches was applied. The perturbation of reduced (homo) glutathione homeostasis and increased H2S production as well as the activation of two H2S-synthetic enzymes activities, including L-cysteine desulfhydrase (LCD) and D-cysteine desulfhydrase (DCD), in alfalfa seedling roots were early responses to the exposure of Cd. The application of H2S donor sodium hydrosulfide (NaHS), not only mimicked intracellular H2S production triggered by Cd, but also alleviated Cd toxicity in a H2S-dependent fashion. By contrast, the inhibition of H2S production caused by the application of its synthetic inhibitor blocked NaHS-induced Cd tolerance, and destroyed reduced (homo) glutathione and reactive oxygen species (ROS) homeostases. Above mentioned inhibitory responses were further rescued by exogenously applied glutathione (GSH). Meanwhile, NaHS responses were sensitive to a (homo) glutathione synthetic inhibitor, but reversed by the cotreatment with GSH. The possible involvement of cyclic AMP (cAMP) signaling in NaHS responses was also suggested. In summary, LCD/DCD-mediated H2S might be an important signaling molecule in the enhancement of Cd toxicity in alfalfa seedlings mainly by governing reduced (homo) glutathione and ROS homeostases.	[Cui, Weiti; Zhu, Kaikai; Jin, Qijiang; Xie, Yanjie; Cui, Jin; Xia, Yan; Zhang, Jing; Shen, Wenbiao] Nanjing Agr Univ, Lab Ctr Life Sci, Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Chen, Huiping] Hainan Univ, Key Lab Protect & Dev Utilizat Trop Crop Germplas, Haikou, Peoples R China	Nanjing Agricultural University; Hainan University	Shen, WB (corresponding author), Nanjing Agr Univ, Lab Ctr Life Sci, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	wbshenh@njau.edu.cn	Cui, Jin/I-4496-2016	Zhu, Kaikai/0000-0002-4575-3431	Fundamental Research Funds for the Central Universities [KYZ201316]; National Natural Science Foundation of China [30971711, J1210056, J1310015]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This research was supported by the Fundamental Research Funds for the Central Universities (KYZ201316), the National Natural Science Foundation of China (grants no. 30971711, J1210056, J1310015), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Alvarez C, 2010, PLANT PHYSIOL, V152, P656, DOI 10.1104/pp.109.147975; Bloem E, 2004, J EXP BOT, V55, P2305, DOI 10.1093/jxb/erh236; Chen J, 2011, J EXP BOT, V62, P4481, DOI 10.1093/jxb/err145; Christou A, 2013, J EXP BOT, V64, P1953, DOI 10.1093/jxb/ert055; Cobbett CS, 1998, PLANT J, V16, P73, DOI 10.1046/j.1365-313x.1998.00262.x; Cui W, 2008, J HAZARD MATER, V260, P715; Cui WT, 2012, J EXP BOT, V63, P5521, DOI 10.1093/jxb/ers201; Dawood M, 2012, J HAZARD MATER, V209, P121, DOI 10.1016/j.jhazmat.2011.12.076; de Carvalho MHC, 2010, J PLANT PHYSIOL, V167, P480, DOI 10.1016/j.jplph.2009.10.023; Dixit P, 2013, PLOS ONE, V6; Du JB, 2004, HEART VESSELS, V19, P75, DOI 10.1007/s00380-003-0743-7; Dubreuil-Maurizi C, 2011, PLANT PHYSIOL, V157, P2000, DOI 10.1104/pp.111.182667; Fang T, 2014, PLANT PHYSIOL BIOCH, V76, P44, DOI 10.1016/j.plaphy.2013.12.024; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Gao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064643; Garcia-Mata C, 2013, PLANT SCI, V201, P66, DOI 10.1016/j.plantsci.2012.11.007; Garcia-Mata C, 2010, NEW PHYTOL, V188, P977, DOI 10.1111/j.1469-8137.2010.03465.x; GRILL E, 1989, P NATL ACAD SCI USA, V86, P6838, DOI 10.1073/pnas.86.18.6838; HALLGREN JE, 1982, PLANT PHYSIOL, V70, P456, DOI 10.1104/pp.70.2.456; Herschbach C, 2002, NEW PHYTOL, V153, P73, DOI 10.1046/j.0028-646X.2001.00295.x; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1067, DOI 10.1104/pp.107.4.1067; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1059, DOI 10.1104/pp.107.4.1059; Jin CW, 2013, PLANT SOIL, V371, P387, DOI 10.1007/s11104-013-1699-8; Jin XC, 1999, PLANT CELL PHYSIOL, V40, P1127, DOI 10.1093/oxfordjournals.pcp.a029497; Jin ZP, 2011, BIOCHEM BIOPH RES CO, V414, P481, DOI 10.1016/j.bbrc.2011.09.090; Kimura H, 2000, BIOCHEM BIOPH RES CO, V267, P129, DOI 10.1006/bbrc.1999.1915; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Kovacik J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091685; Kwak WJ, 2003, FEMS MICROBIOL LETT, V219, P99, DOI 10.1016/S0378-1097(02)01198-9; Lagorce A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041935; Leon S, 2002, BIOCHEM J, V366, P557, DOI 10.1042/BJ20020322; Li L, 2012, BIOMETALS, V25, P617, DOI 10.1007/s10534-012-9551-9; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Li ZG, 2012, ACTA PHYSIOL PLANT, V34, P2207, DOI 10.1007/s11738-012-1021-z; Li ZG, 2012, PLANT SCI, V185, P185, DOI 10.1016/j.plantsci.2011.10.006; Lin YT, 2012, J PLANT GROWTH REGUL, V31, P519, DOI 10.1007/s00344-012-9262-z; Lisjak M, 2010, PLANT PHYSIOL BIOCH, V48, P931, DOI 10.1016/j.plaphy.2010.09.016; Lisjak M, 2013, PLANT CELL ENVIRON, V36, P1607, DOI 10.1111/pce.12073; Lu M, 2012, AM J PHYSIOL-CELL PH, V302, pC59, DOI 10.1152/ajpcell.00341.2010; Ma W, 2009, P NATL ACAD SCI USA, V106, P20995, DOI 10.1073/pnas.0905831106; Matamoros MA, 1999, PLANT PHYSIOL, V121, P879, DOI 10.1104/pp.121.3.879; Metwally A, 2005, J EXP BOT, V56, P167; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Mishra S, 2006, PLANT PHYSIOL BIOCH, V44, P25, DOI 10.1016/j.plaphy.2006.01.007; Ortega-Villasante C, 2005, J EXP BOT, V56, P2239, DOI 10.1093/jxb/eri223; Papenbrock J, 2007, PLANT BIOLOGY, V9, P582, DOI 10.1055/s-2007-965424; RENNENBERG H, 1982, PLANT PHYSIOL, V69, P766, DOI 10.1104/pp.69.4.766; Riemenschneider A, 2005, FEBS J, V272, P1291, DOI 10.1111/j.1742-4658.2005.04567.x; RUEGSEGGER A, 1990, PLANT PHYSIOL, V93, P1579, DOI 10.1104/pp.93.4.1579; SEKIYA J, 1982, PLANT PHYSIOL, V70, P430, DOI 10.1104/pp.70.2.430; Shao JL, 2011, J MOL NEUROSCI, V43, P453, DOI 10.1007/s12031-010-9464-4; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Shi HT, 2014, PLANT PHYSIOL BIOCH, V74, P99, DOI 10.1016/j.plaphy.2013.11.001; SMITH IK, 1985, PLANT PHYSIOL, V79, P1044, DOI 10.1104/pp.79.4.1044; Sohn HY, 2005, BIOSCI BIOTECH BIOCH, V69, P2450, DOI 10.1271/bbb.69.2450; Sohn HY, 2001, ARCH MICROBIOL, V176, P69, DOI 10.1007/s002030100295; Sun J, 2013, PLANT PHYSIOL BIOCH, V65, P67, DOI 10.1016/j.plaphy.2013.01.003; Thapa G, 2012, BIOMETALS, V25, P489, DOI 10.1007/s10534-012-9541-y; Tkalec M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087582; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verbruggen N, 2013, BIOMETALS, V26, P633, DOI 10.1007/s10534-013-9659-6; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang YQ, 2012, PLANT SOIL, V351, P107, DOI 10.1007/s11104-011-0936-2; WILSON LG, 1978, PLANT PHYSIOL, V61, P184, DOI 10.1104/pp.61.2.184; Xie YJ, 2013, MOL BIOTECHNOL, V54, P737, DOI 10.1007/s12033-012-9621-9; Yang GD, 2004, FASEB J, V18, P1782, DOI 10.1096/fj.04-2279fje; Ye Y, 2013, PLANT CELL ENVIRON, V36, P1, DOI 10.1111/j.1365-3040.2012.02543.x; Zhang H, 2008, J INTEGR PLANT BIOL, V50, P1518, DOI 10.1111/j.1744-7909.2008.00769.x; Zhang H, 2011, POSTHARVEST BIOL TEC, V60, P251, DOI 10.1016/j.postharvbio.2011.01.006; Zhang H, 2010, ACTA PHYSIOL PLANT, V32, P849, DOI 10.1007/s11738-010-0469-y	73	54	66	7	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109669	10.1371/journal.pone.0109669	http://dx.doi.org/10.1371/journal.pone.0109669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275379	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500112
J	Hassanpour, S; Jiang, HW; Wang, YQ; Kuiper, JWP; Glogauer, M				Hassanpour, Siavash; Jiang, Hongwei; Wang, Yongqiang; Kuiper, Johannes W. P.; Glogauer, Michael			The Actin Binding Protein Adseverin Regulates Osteoclastogenesis	PLOS ONE			English	Article							SCINDERIN REDISTRIBUTION; MACROPHAGE FUSION; SEVERING PROTEIN; DC-STAMP; GELSOLIN; DIFFERENTIATION; CELLS; EXPRESSION; SECRETION; STIMULATION	Adseverin (Ads), a member of the Gelsolin superfamily of actin binding proteins, regulates the actin cytoskeleton architecture by severing and capping existing filamentous actin (F-actin) strands and nucleating the assembly of new F-actin filaments. Ads has been implicated in cellular secretion, exocytosis and has also been shown to regulate chondrogenesis and megakaryoblastic leukemia cell differentiation. Here we report for the first time that Ads is involved in regulating osteoclastogenesis (OCG). Ads is induced during OCG downstream of RANK-ligand (RANKL) stimulation and is highly expressed in mature osteoclasts. The D5 isoform of Ads is not involved in regulating OCG, as its expression is not induced in response to RANKL. Three clonal Ads knockdown RAW264.7 (RAW) macrophage cell lines with varying degrees of Ads expression and OCG deficiency were generated. The most drastic OCG defect was noted in the clonal cell line with the greatest degree of Ads knockdown as indicated by a lack of TRAcP staining and multinucleation. RNAi mediated knockdown of Ads in osteoclast precursors resulted in distinct morphological changes characterized by altered F-actin distribution and increased filopodia formation. Ads knockdown precursor cells experienced enhanced migration while fusion of knockdown precursors cells was limited. Transient reintroduction of de novo Ads back into the knockdown system was capable of rescuing TRAcP expression but not osteoclast multinucleation most likely due to the transient nature of Ads expression. This preliminary study allows us to conclude that Ads is a RANKL induced early regulator of OCG with a potential role in pre-osteoclast differentiation and fusion.	[Hassanpour, Siavash; Jiang, Hongwei; Wang, Yongqiang; Kuiper, Johannes W. P.; Glogauer, Michael] Univ Toronto, Fac Dent, Matrix Dynam Grp, Toronto, ON, Canada; [Jiang, Hongwei] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guanghua Sch Stomatol, Dept Operat Dent & Endodont, Guangzhou 510275, Guangdong, Peoples R China	University of Toronto; Sun Yat Sen University	Glogauer, M (corresponding author), Univ Toronto, Fac Dent, Matrix Dynam Grp, Toronto, ON, Canada.	michael.glogauer@utoronto.ca	Glogauer, Michael/D-2504-2011		Canadian Institute of Health Research (CIHR) [MOP-384254]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work is supported by a Canadian Institute of Health Research (CIHR) team research grant (MOP-384254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allori AC, 2008, TISSUE ENG PART B-RE, V14, P275, DOI 10.1089/ten.teb.2008.0083; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Beaulieu V, 2005, J BIOL CHEM, V280, P8452, DOI 10.1074/jbc.M412750200; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bruun TZ, 2000, EUR J PHARMACOL, V403, P221, DOI 10.1016/S0014-2999(00)00602-6; Carlier MF, 1997, J MOL BIOL, V269, P459, DOI 10.1006/jmbi.1997.1062; CHEEK TR, 1986, FEBS LETT, V207, P110, DOI 10.1016/0014-5793(86)80022-9; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Chellaiah M, 1998, J BIOL CHEM, V273, P11908, DOI 10.1074/jbc.273.19.11908; Chumnarnsilpa S, 2009, P NATL ACAD SCI USA, V106, P13719, DOI 10.1073/pnas.0812383106; Cuchillo-Ibanez I, 2004, J PHYSIOL-LONDON, V560, P63, DOI 10.1113/jphysiol.2004.064063; Ehre C, 2005, AM J PHYSIOL-CELL PH, V288, pC46, DOI 10.1152/ajpcell.00397.2004; FULLER K, 1993, J EXP MED, V178, P1733, DOI 10.1084/jem.178.5.1733; Gimona M, 2006, INT J BIOCHEM CELL B, V38, P1875, DOI 10.1016/j.biocel.2006.05.003; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Janmey PA, 1987, MODULATION GELSOLIN; Kondo Y, 2001, J BONE MINER METAB, V19, P352, DOI 10.1007/s007740170004; Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8; Lejen T, 2001, J NEUROCHEM, V76, P768, DOI 10.1046/j.1471-4159.2001.00024.x; Leung R, 2010, J BONE MINER RES, V25, P1077, DOI 10.1359/jbmr.091114; Lueck A, 2000, BIOCHEMISTRY-US, V39, P5274, DOI 10.1021/bi992871v; MAEKAWA S, 1990, J BIOL CHEM, V265, P10940; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Marcu MG, 1996, BLOOD, V87, P20; Muller S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073439; Noda Y, 2005, BIOCHEM BIOPH RES CO, V330, P1041, DOI 10.1016/j.bbrc.2005.03.079; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Nurminsky D, 2007, DEV BIOL, V302, P427, DOI 10.1016/j.ydbio.2006.09.052; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Robbens J, 1998, MOL CELL BIOL, V18, P4589, DOI 10.1128/MCB.18.8.4589; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SAKURAI T, 1991, J BIOL CHEM, V266, P15979; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Schafer DA, 1995, ANNU REV CELL DEV BI, V11, P497, DOI 10.1146/annurev.cellbio.11.1.497; Sheetz Michael P., 1999, P233; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; Svensson C, 2002, BIOCHEM BIOPH RES CO, V291, P1194, DOI 10.1006/bbrc.2002.6582; TAKAHASHI N, 1988, ENDOCRINOLOGY, V122, P1373, DOI 10.1210/endo-122-4-1373; Takahashi N, 2007, ODONTOLOGY, V95, P1, DOI 10.1007/s10266-007-0071-y; Tolar J, 2004, NEW ENGL J MED, V351, P2839, DOI 10.1056/NEJMra040952; Trifaro JM, 2008, ACTA PHYSIOL, V192, P165, DOI 10.1111/j.1748-1716.2007.01808.x; Trifaro JM, 2000, BIOCHIMIE, V82, P339, DOI 10.1016/S0300-9084(00)00193-0; Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123; VITALE ML, 1991, J CELL BIOL, V113, P1057, DOI 10.1083/jcb.113.5.1057; Walker DG, 1975, SCIENCE; Wang Q, 2003, J CELL BIOL, V160, P565, DOI 10.1083/jcb.200207036; Wang YQ, 2008, J BONE MINER RES, V23, P260, DOI 10.1359/JBMR.071013; Wang YQ, 2009, CALCIFIED TISSUE INT, V85, P257, DOI 10.1007/s00223-009-9274-2; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yagi M, 2006, J BONE MINER METAB, V24, P355, DOI 10.1007/s00774-006-0697-9; Yang GZ, 2008, BIOCHEM BIOPH RES CO, V366, P352, DOI 10.1016/j.bbrc.2007.11.106; ZHANG L, 1995, J NEUROCHEM, V65, P1297; Zunino R, 2001, BLOOD, V98, P2210, DOI 10.1182/blood.V98.7.2210	56	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109078	10.1371/journal.pone.0109078	http://dx.doi.org/10.1371/journal.pone.0109078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275604	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500054
J	Aimola, E; Valle, MS; Casabona, A				Aimola, Ettore; Valle, Maria Stella; Casabona, Antonino			Effects of Predictability of Load Magnitude on the Response of the Flexor Digitorum Superficialis to a Sudden Fingers Extension	PLOS ONE			English	Article							LONG-LATENCY REFLEX; HUMAN STRETCH REFLEX; INTERNAL-MODEL; LIMB DYNAMICS; MOTOR CONTROL; HAND MUSCLES; HUMAN ARM; MODULATION; EMG; HUMANS	Muscle reflexes, evoked by opposing a sudden joint displacement, may be modulated by several factors associated with the features of the mechanical perturbation. We investigated the variations of muscle reflex response in relation to the predictability of load magnitude during a reactive grasping task. Subjects were instructed to flex the fingers 2-5 very quickly after a stretching was exerted by a handle pulled by loads of 750 or 1250 g. Two blocks of trials, one for each load (predictable condition), and one block of trials with a randomized distribution of the loads (unpredictable condition) were performed. Kinematic data were collected by an electrogoniometer attached to the middle phalanx of the digit III while the electromyography of the Flexor Digitorum Superficialis muscle was recorded by surface electrodes. For each trial we measured the kinematics of the finger angular rotation, the latency of muscle response and the level of muscle activation recorded below 50 ms (short-latency reflex), between 50 and 100 ms (long-latency reflex) and between 100 and 140 ms (initial portion of voluntary response) from the movement onset. We found that the latency of the muscle response lengthened from predictable (35.5 +/- 1.3 ms for 750 g and 35.5 +/- 2.5 ms for 1250 g) to unpredictable condition (43.6 +/- 1.3 ms for 750 g and 40.9 +/- 2.1 ms for 1250 g) and the level of muscle activation increased with load magnitude. The parallel increasing of muscle activation and load magnitude occurred within the window of the long-latency reflex during the predictable condition, and later, at the earliest portion of the voluntary response, in the unpredictable condition. Therefore, these results indicate that when the amount of an upcoming perturbation is known in advance, the muscle response improves, shortening the latency and modulating the muscle activity in relation to the mechanical demand.	[Aimola, Ettore; Valle, Maria Stella; Casabona, Antonino] Univ Catania, Dept Biomed Sci, Physiol Sect, Catania, Italy	University of Catania	Casabona, A (corresponding author), Univ Catania, Dept Biomed Sci, Physiol Sect, Catania, Italy.	casabona@unict.it		Casabona, Antonino/0000-0003-0180-4695; VALLE, Maria Stella/0000-0001-9728-3542	University of Catania	University of Catania	Ettore Aimola was supported by a PostDoc grant provided by the University of Catania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi-Pajouh MA, 2012, J NEUROSCI, V32, P9537, DOI 10.1523/JNEUROSCI.4275-11.2012; Aimola E, 2011, NEUROSCI LETT, V502, P84, DOI 10.1016/j.neulet.2011.07.027; AKAZAWA K, 1983, J NEUROPHYSIOL, V49, P16, DOI 10.1152/jn.1983.49.1.16; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Berardelli A, 1996, BRAIN, V119, P661, DOI 10.1093/brain/119.2.661; Bodofsky EB, 1999, ARCH PHYS MED REHAB, V80, P562, DOI 10.1016/S0003-9993(99)90200-9; Casabona A, 2012, J APPL PHYSIOL, V113, P1747, DOI 10.1152/japplphysiol.00960.2012; CHENEY PD, 1984, J PHYSIOL-LONDON, V349, P249, DOI 10.1113/jphysiol.1984.sp015155; Corden DM, 2000, J NEUROPHYSIOL, V84, P184, DOI 10.1152/jn.2000.84.1.184; CRAGO PE, 1976, J NEUROPHYSIOL, V39, P925, DOI 10.1152/jn.1976.39.5.925; DICK JPR, 1987, NEUROSCI LETT, V75, P349, DOI 10.1016/0304-3940(87)90548-9; DIETZ V, 1994, ELECTROEN CLIN NEURO, V93, P49, DOI 10.1016/0168-5597(94)90091-4; DOEMGES F, 1992, J PHYSIOL-LONDON, V447, P563, DOI 10.1113/jphysiol.1992.sp019018; GOODIN DS, 1990, BRAIN, V113, P1075, DOI 10.1093/brain/113.4.1075; HOWELL JN, 1995, J NEUROPHYSIOL, V74, P901, DOI 10.1152/jn.1995.74.2.901; Kimura T, 2006, J NEUROSCI, V26, P9272, DOI 10.1523/JNEUROSCI.3886-05.2006; Koike T, 2007, NEUROSCI LETT, V412, P56, DOI 10.1016/j.neulet.2006.10.058; Kostyukov AI, 2010, EXP BRAIN RES, V203, P711, DOI 10.1007/s00221-010-2285-4; Krakauer JW, 2006, TRENDS NEUROSCI, V29, P58, DOI 10.1016/j.tins.2005.10.003; Krutky MA, 2010, J NEUROPHYSIOL, V103, P429, DOI 10.1152/jn.00679.2009; Kuramochi R, 2004, NEUROSCI LETT, V366, P206, DOI 10.1016/j.neulet.2004.05.040; Kurtzer IL, 2008, CURR BIOL, V18, P449, DOI 10.1016/j.cub.2008.02.053; Lauer RT, 2009, ANN BIOMED ENG, V37, P1584, DOI 10.1007/s10439-009-9727-9; Leinonen V, 2002, EUR J APPL PHYSIOL, V88, P42, DOI 10.1007/s00421-002-0664-7; Li S, 2004, J NEUROSCI, V24, P9674, DOI 10.1523/JNEUROSCI.2781-04.2004; Li XY, 2007, ANN BIOMED ENG, V35, P1532, DOI 10.1007/s10439-007-9320-z; Macefield VG, 2003, EXP BRAIN RES, V152, P143, DOI 10.1007/s00221-003-1421-9; Malone A, 2011, J ELECTROMYOGR KINES, V21, P1004, DOI 10.1016/j.jelekin.2011.09.003; Manning CD, 2012, EXP BRAIN RES, V221, P155, DOI 10.1007/s00221-012-3157-x; Marchand-Pauvert V, 2000, J PHYSIOL-LONDON, V525, P241, DOI 10.1111/j.1469-7793.2000.t01-1-00241.x; MARSDEN CD, 1978, CEREBRAL MOTOR CONTR, P167; MATTHEWS PBC, 1988, J PHYSIOL-LONDON, V404, P515, DOI 10.1113/jphysiol.1988.sp017303; MATTHEWS PBC, 1991, TRENDS NEUROSCI, V14, P87, DOI 10.1016/0166-2236(91)90064-2; MATTHEWS PBC, 1989, J PHYSIOL-LONDON, V419, P519, DOI 10.1113/jphysiol.1989.sp017884; McNulty PA, 2004, J ELECTROMYOGR KINES, V14, P369, DOI 10.1016/j.jelekin.2003.10.003; McNulty PA, 2001, J PHYSIOL-LONDON, V537, P1021; Patla AE, 2002, EXP BRAIN RES, V143, P318, DOI 10.1007/s00221-001-0968-6; Perreault EJ, 2008, J NEUROPHYSIOL, V99, P2101, DOI 10.1152/jn.01094.2007; Pruszynski JA, 2008, J NEUROPHYSIOL, V100, P224, DOI 10.1152/jn.90262.2008; Pruszynski JA, 2011, J NEUROPHYSIOL, V106, P449, DOI 10.1152/jn.01052.2010; Prut Y, 1999, NATURE, V401, P590, DOI 10.1038/44145; ROTHWELL JC, 1980, NATURE, V286, P496, DOI 10.1038/286496a0; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Shimansky YP, 2000, BIOL CYBERN, V83, P379, DOI 10.1007/s004220000159; Solnik S, 2010, EUR J APPL PHYSIOL, V110, P489, DOI 10.1007/s00421-010-1521-8; TAYLOR JL, 1995, J PHYSIOL-LONDON, V488, P821, DOI 10.1113/jphysiol.1995.sp021014; Valle MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081053; Wang T, 2001, BIOL CYBERN, V85, P437, DOI 10.1007/s004220100277; Winter D., 2009, BIOMECHANICS MOTOR C, V4th ed, P82; Winter EM, 2001, J SPORT SCI, V19, P761, DOI 10.1080/026404101317015429; Wolpaw JR, 2010, NEUROSCIENTIST, V16, P532, DOI 10.1177/1073858410368314; Wolpert DM, 2001, TRENDS COGN SCI, V5, P487, DOI 10.1016/S1364-6613(00)01773-3	52	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109067	10.1371/journal.pone.0109067	http://dx.doi.org/10.1371/journal.pone.0109067			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271638	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600093
J	Serra, D; Rufino, AT; Mendes, AF; Almeida, LM; Dinis, TCP				Serra, Diana; Rufino, Ana T.; Mendes, Alexandrina F.; Almeida, Leonor M.; Dinis, Teresa C. P.			Resveratrol Modulates Cytokine-Induced JAK/STAT Activation More Efficiently than 5-Aminosalicylic Acid: An In Vitro Approach	PLOS ONE			English	Article							NF-KAPPA-B; DIETARY POLYPHENOLS; TRANSCRIPTION STAT; ENDOTHELIAL-CELLS; PROTEIN-KINASES; PHOSPHORYLATION; INFLAMMATION; SIGNAL; SYNTHASE; PATHWAY	Background: Many advances have been recently made focused on the valuable help of dietary polyphenols in chronic inflammatory diseases. On the other hand, current treatment options for intestinal bowel disease patients are unsatisfying and, for this reason, it is estimated that many patients use dietary supplements to achieve extra benefits. Aim: The aim of this work was to analyze under a mechanistic perspective the anti-inflammatory potential of resveratrol, a natural polyphenolic compound, and to compare it with a pharmaceutical agent, 5-aminosalicylic acid, using the intestinal HT-29 cell line, as a cellular model. Methodology and Principal Findings: In the present study, HT-29 colon epithelial cells were pre-treated with 25 mu M resveratrol and/or 500 mM 5-aminosalicylic acid and then exposed to a combination of cytokines (IL-1 alpha, TNF-alpha, IFN-gamma) for a certain period of time. Our data showed that resveratrol, used in a concentration 20 times lower than 5-aminosalicylic acid, was able to significantly reduce NO and PGE(2) production, iNOS and COX-2 expression and reactive oxidant species formation induced by the cytokine challenge. However, as already verified with 5-aminosalicylic acid, in spite of not exhibiting any effect on IkB-alpha degradation, resveratrol down-regulated JAK-STAT pathway, decreasing the levels of activated STAT1 in the nucleus. Additionally, resveratrol decreased the cytokine-stimulated activation of SAPK/JNK pathway but did not counteract the cytokine-triggered negative feedback mechanism of STAT1, through p38 MAPK. Conclusion/Significance: Taken together, our results show that resveratrol may be considered a future nutraceutical approach, promoting remission periods, limiting the inflammatory process and preventing colorectal cancer, which is common in these patients.	[Serra, Diana; Rufino, Ana T.; Mendes, Alexandrina F.; Almeida, Leonor M.; Dinis, Teresa C. P.] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Serra, Diana; Rufino, Ana T.; Mendes, Alexandrina F.; Almeida, Leonor M.; Dinis, Teresa C. P.] Univ Coimbra, Fac Pharm, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra	Dinis, TCP (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.	tcpdinis@ci.uc.pt	Mendes, Alexandrina Ferreira/B-4833-2014; Rufino, Ana T/S-8758-2016; Serra, Diana/M-4062-2017	Mendes, Alexandrina Ferreira/0000-0001-5511-7132; Rufino, Ana T/0000-0002-8800-9020; Serra, Diana/0000-0002-5965-0281; Dinis, Teresa/0000-0001-6350-5741; Almeida, Leonor Martins/0000-0002-7769-4712	FCT (Portuguese Foundation for Science and Technology); FEDER/COMPETE (European Fund of Regional Development/Operational Program Factors of Competitiveness); FCT [SFRH/BD/7541/2010];  [PTDC/SAU-OSM/102907/2008];  [PEst-C/SAU/LA0001/2013-2014]	FCT (Portuguese Foundation for Science and Technology)(Portuguese Foundation for Science and Technology); FEDER/COMPETE (European Fund of Regional Development/Operational Program Factors of Competitiveness); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); ; 	This work was supported by the grants PTDC/SAU-OSM/102907/2008 and PEst-C/SAU/LA0001/2013-2014, funded by FCT (Portuguese Foundation for Science and Technology) and FEDER/COMPETE (European Fund of Regional Development/Operational Program Factors of Competitiveness). Diana Serra is a recipient of the grant SFRH/BD/7541/2010 from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Bahadoran Z, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-43; Beck PL, 1997, MEDIAT INFLAMM, V6, P95, DOI 10.1080/09629359791785; Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Broom OJ, 2009, CLIN EXP IMMUNOL, V158, P272, DOI 10.1111/j.1365-2249.2009.04033.x; Capiralla H, 2012, J NEUROCHEM, V120, P461, DOI 10.1111/j.1471-4159.2011.07594.x; Cianciulli A, 2012, TOXICOL IN VITRO, V26, P1122, DOI 10.1016/j.tiv.2012.06.015; Cottart CH, 2010, MOL NUTR FOOD RES, V54, P7, DOI 10.1002/mnfr.200900437; Droescher M, 2011, J BIOL CHEM, V286, P18731, DOI 10.1074/jbc.M111.235978; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; Feng YJ, 2011, J DIGEST DIS, V12, P327, DOI 10.1111/j.1751-2980.2011.00525.x; Frontela C, 2010, GASTROENT HEPAT-BARC, V33, P307, DOI 10.1016/j.gastrohep.2009.09.006; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; Gronholm J, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-20; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Hassan-Khabbar S, 2008, LIVER TRANSPLANT, V14, P451, DOI 10.1002/lt.21405; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kersting S, 2013, J INFLAMM RES, V6, P71, DOI 10.2147/JIR.S40092; Kolios G, 2006, EUR J CLIN INVEST, V36, P720, DOI 10.1111/j.1365-2362.2006.01710.x; KOLIOS G, 1995, BRIT J PHARMACOL, V116, P2866, DOI 10.1111/j.1476-5381.1995.tb15938.x; Kuhnle G, 2000, BIOCHEM BIOPH RES CO, V272, P212, DOI 10.1006/bbrc.2000.2750; Larrosa M, 2010, J MED CHEM, V53, P7365, DOI 10.1021/jm1007006; Larrosa M, 2009, J AGR FOOD CHEM, V57, P2211, DOI 10.1021/jf803638d; Lippi G, 2010, SEMIN THROMB HEMOST, V36, P59, DOI 10.1055/s-0030-1248725; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Martin AR, 2006, BRIT J PHARMACOL, V147, P873, DOI 10.1038/sj.bjp.0706469; Martin KR, 2010, NUTR DIET SUPPL, V2, P1; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Paixao J, 2012, CHEM-BIOL INTERACT, V199, P192, DOI 10.1016/j.cbi.2012.08.013; Paixao J, 2011, APOPTOSIS, V16, P976, DOI 10.1007/s10495-011-0632-y; Paul S, 2009, CANCER PREV RES, V2, P650, DOI 10.1158/1940-6207.CAPR-08-0224; Rahal K, 2012, INFLAMM BOWEL DIS, V18, P613, DOI 10.1002/ibd.21843; Reinecke K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030985; Romier B, 2009, NUTR REV, V67, P363, DOI 10.1111/j.1753-4887.2009.00210.x; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Roy PK, 2008, WORLD J GASTROENTERO, V14, P200, DOI 10.3748/wjg.14.200; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Schreiber S, 2002, GUT, V51, P379, DOI 10.1136/gut.51.3.379; Serra FCO, 2013, PLOS ONE, V8, P1, DOI [10.1371/journal.pone.0063915, 10.1371/journal.pone.0073001]; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Surh YJ, 2005, J NUTR, V135, p2993S, DOI 10.1093/jn/135.12.2993S; Triantafillidis JK, 2011, DRUG DES DEV THER, V5, P185, DOI 10.2147/DDDT.S11290; Udenigwe CC, 2008, NUTR REV, V66, P445, DOI 10.1111/j.1753-4887.2008.00076.x; Vanhatupa S, 2008, BIOCHEM J, V409, P179, DOI 10.1042/BJ20070620; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; Vauzour D, 2010, NUTRIENTS, V2, P1106, DOI 10.3390/nu2111106; Walle T, 2011, ANN NY ACAD SCI, V1215, P9, DOI 10.1111/j.1749-6632.2010.05842.x; Williams Chadwick, 2011, Therap Adv Gastroenterol, V4, P237, DOI 10.1177/1756283X11405250; Wright K, 1997, J BIOL CHEM, V272, P12626, DOI 10.1074/jbc.272.19.12626; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zhang YG, 2004, CARCINOGENESIS, V25, P1165, DOI 10.1093/carcin/bgh115; Zhong LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032195; Zong Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044107	54	38	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109048	10.1371/journal.pone.0109048	http://dx.doi.org/10.1371/journal.pone.0109048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271420	Green Submitted, Green Published, gold			2022-12-27	WOS:000343729600092
J	Tamanai-Shacoori, Z; Chandad, F; Rebillard, A; Cillard, J; Bonnaure-Mallet, M				Tamanai-Shacoori, Zohreh; Chandad, Fatiha; Rebillard, Amelie; Cillard, Josiane; Bonnaure-Mallet, Martine			Silver-Zeolite Combined to Polyphenol-Rich Extracts of Ascophyllum nodosum: Potential Active Role in Prevention of Periodontal Diseases	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; BACTERICIDAL ACTIVITY; ESCHERICHIA-COLI; OXIDATIVE STRESS; BROWN ALGA; ANTIOXIDANT; LIPOPOLYSACCHARIDE; HEALTH; NANOPARTICLES; INFLAMMATION	The purpose of this study was to evaluate various biological effects of silver-zeolite and a polyphenol-rich extract of A. nodosum (ASCOP) to prevent and/or treat biofilm-related oral diseases. Porphyromonas gingivalis and Streptococcus gordonii contribute to the biofilm formation associated with chronic periodontitis. In this study, we evaluated in vitro antibacterial and anti-biofilm effects of silver-zeolite (Ag-zeolite) combined to ASCOP on P. gingivalis and S. gordonii growth and biofilm formation capacity. We also studied the anti-inflammatory and antioxidant capacities of ASCOP in cell culture models. While Ag-zeolite combined with ASCOP was ineffective against the growth of S. gordonii, it showed a strong bactericidal effect on P. gingivalis growth. Ag-zeolite combined with ASCOP was able to completely inhibit S. gordonii monospecies biofilm formation as well as to reduce the formation of a bi-species S. gordonii/P. gingivalis biofilm. ASCOP alone was ineffective towards the growth and/or biofilm formation of S. gordonii and P. gingivalis while it significantly reduced the secretion of inflammatory cytokines (TNF alpha and IL-6) by LPS-stimulated human like-macrophages. It also exhibited antioxidant properties and decreased LPS induced lipid peroxidation in gingival epithelial cells. These findings support promising use of these products in future preventive or therapeutic strategies against periodontal diseases.	[Tamanai-Shacoori, Zohreh; Bonnaure-Mallet, Martine] Univ Rennes 1, Equipe Microbiol, EA 1254, UEB, Rennes, France; [Chandad, Fatiha] Univ Laval, Grp Rech Ecol Buccale, Fac Med Dent, Quebec City, PQ, Canada; [Rebillard, Amelie; Cillard, Josiane] Univ Rennes 2, EA 1274, UEB, Lab Mouvement,Univ Rennes 1, F-35043 Rennes, France; [Bonnaure-Mallet, Martine] Ctr Hosp Univ, Rennes, France	Universite de Rennes; Laval University; Universite de Rennes; Universite Rennes 2; CHU Rennes	Tamanai-Shacoori, Z (corresponding author), Univ Rennes 1, Equipe Microbiol, EA 1254, UEB, Rennes, France.	zohreh.shacoori@univ-rennes1.fr		Bonnaure-Mallet, martine/0000-0001-5214-7803; TAMANAI-SHACOORI, Zohreh/0000-0003-2287-3438	Region Bretagne; Conseil General du Finistere; OSEO Innovation	Region Bretagne(Region Bretagne); Conseil General du Finistere(Region Bretagne); OSEO Innovation	Region Bretagne, Conseil General du Finistere and OSEO Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu R, 2013, INT J BIOL MACROMOL, V59, P305, DOI 10.1016/j.ijbiomac.2013.04.035; Bahar B, 2012, J ANIM SCI, V90, P46, DOI 10.2527/jas.53944; Cha B, 2010, INT J BIOCHEM CELL B, V42, P1455, DOI 10.1016/j.biocel.2010.04.015; CHANDLER S F, 1983, Plant Cell Reports, V2, P205, DOI 10.1007/BF00270105; Choi EM, 2005, J MED FOOD, V8, P446, DOI 10.1089/jmf.2005.8.446; Darveau RP, 1998, INFECT IMMUN, V66, P1660, DOI 10.1128/IAI.66.4.1660-1665.1998; De la Rosa-Gomez I, 2008, J ENVIRON MANAGE, V88, P853, DOI 10.1016/j.jenvman.2007.04.005; De Muynck W, 2010, J APPL MICROBIOL, V108, P62, DOI 10.1111/j.1365-2672.2009.04395.x; Dixon DR, 2004, PERIODONTOL 2000, V35, P53, DOI 10.1111/j.0906-6713.2004.003556.x; Dutot M, 2012, APPL BIOCHEM BIOTECH, V167, P2234, DOI 10.1007/s12010-012-9761-1; Fravalo P, 1996, INFECT IMMUN, V64, P4940, DOI 10.1128/IAI.64.12.4940-4945.1996; Guerra R, 2012, MICROPOR MESOPOR MAT, V147, P267, DOI 10.1016/j.micromeso.2011.06.031; HARTFORD CE, 1972, J TRAUM, V12, P682, DOI 10.1097/00005373-197208000-00005; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Huang GTJ, 2001, INFECT IMMUN, V69, P1364, DOI 10.1128/IAI.69.3.1364-1372.2001; Inoue Y, 2002, J INORG BIOCHEM, V92, P37, DOI 10.1016/S0162-0134(02)00489-0; Kantarci A, 2006, PERIODONTOL 2000, V40, P144, DOI 10.1111/j.1600-0757.2005.00145.x; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kornman KS, 1999, CLIN INFECT DIS, V28, P520, DOI 10.1086/515165; Lamont RJ, 2000, ORAL MICROBIOL IMMUN, V15, P341, DOI 10.1034/j.1399-302x.2000.150601.x; LAMONT RJ, 1993, ORAL MICROBIOL IMMUN, V8, P272, DOI 10.1111/j.1399-302X.1993.tb00573.x; Lamont RJ, 2002, PERIODONTOL 2000, V30, P61, DOI 10.1034/j.1600-0757.2002.03006.x; Lima E, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-11; MARSH PD, 1992, J DENT RES, V71, P1431, DOI 10.1177/00220345920710071501; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mizuno M, 2009, BIOSCI BIOTECH BIOCH, V73, P2324, DOI 10.1271/bbb.90326; Mourao PAS, 2004, CURR PHARM DESIGN, V10, P967, DOI 10.2174/1381612043452730; Nagayama K, 2002, J ANTIMICROB CHEMOTH, V50, P889, DOI 10.1093/jac/dkf222; Nishio K, 2013, REDOX BIOL, V1, P97, DOI 10.1016/j.redox.2012.10.002; O'Sullivan AM, 2011, FOOD CHEM, V126, P1064, DOI 10.1016/j.foodchem.2010.11.127; Odabas ME, 2011, DENT TRAUMATOL, V27, P189, DOI 10.1111/j.1600-9657.2011.00986.x; Okada H, 1998, CRIT REV ORAL BIOL M, V9, P248, DOI 10.1177/10454411980090030101; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P3; Prior RL, 2003, J AGR FOOD CHEM, V51, P3273, DOI 10.1021/jf0262256; Qi HM, 2005, INT J BIOL MACROMOL, V37, P195, DOI 10.1016/j.ijbiomac.2005.10.008; Sabbani S, 2010, MICROPOR MESOPOR MAT, V135, P131, DOI 10.1016/j.micromeso.2010.06.020; Sandsdalen E, 2003, WORLD J MICROB BIOT, V19, P777, DOI 10.1023/A:1026052715260; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Takai K, 2002, MICROBIOL IMMUNOL, V46, P75, DOI 10.1111/j.1348-0421.2002.tb02661.x; TOKUMARU T, 1974, RES COMMUN CHEM PATH, V8, P151; Tonetti MS, 2011, J CLIN PERIODONTOL, V38, P114, DOI 10.1111/j.1600-051X.2010.01675.x; Travis J, 2000, BBA-PROTEIN STRUCT M, V1477, P35, DOI 10.1016/S0167-4838(99)00278-2; Trinchero J, 2009, PHYTOTHER RES, V23, P707, DOI 10.1002/ptr.2723; Wang Q, 2009, MED HYPOTHESES, V72, P71, DOI 10.1016/j.mehy.2008.04.030; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P648, DOI 10.1034/j.1600-051x.2000.027009648.x; Yoshida K, 1999, J BIOMED MATER RES, V47, P516, DOI 10.1002/(SICI)1097-4636(19991215)47:4<516::AID-JBM7>3.0.CO;2-E; Youssef H, 2009, INT J OBESITY, V33, P447, DOI 10.1038/ijo.2009.49; Zdarilova A, 2010, FOOD CHEM TOXICOL, V48, P1555, DOI 10.1016/j.fct.2010.03.024	49	12	12	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e105475	10.1371/journal.pone.0105475	http://dx.doi.org/10.1371/journal.pone.0105475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272151	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600003
J	Eger, G; Papadopoulos, N; Lennartsson, J; Heldin, CH				Eger, Glenda; Papadopoulos, Natalia; Lennartsson, Johan; Heldin, Carl-Henrik			NR4A1 Promotes PDGF-BB-Induced Cell Colony Formation in Soft Agar	PLOS ONE			English	Article							ORPHAN RECEPTOR TR3; NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; GASTRIC-CANCER CELLS; NUCLEAR RECEPTORS; TERMINAL KINASE; NUR77; APOPTOSIS; TRANSCRIPTION; EXPRESSION	The fibroblast mitogen platelet-derived growth factor -BB (PDGF-BB) induces a transient expression of the orphan nuclear receptor NR4A1 (also named Nur77, TR3 or NGFIB). The aim of the present study was to investigate the pathways through which NR4A1 is induced by PDGF-BB and its functional role. We demonstrate that in PDGF-BB stimulated NIH3T3 cells, the MEK1/2 inhibitor CI-1040 strongly represses NR4A1 expression, whereas Erk5 downregulation delays the expression, but does not block it. Moreover, we report that treatment with the NF-kappa B inhibitor BAY11-7082 suppresses NR4A1 mRNA and protein expression. The majority of NR4A1 in NIH3T3 was found to be localized in the cytoplasm and only a fraction was translocated to the nucleus after continued PDGF-BB treatment. Silencing NR4A1 slightly increased the proliferation rate of NIH3T3 cells; however, it did not affect the chemotactic or survival abilities conferred by PDGF-BB. Moreover, overexpression of NR4A1 promoted anchorage-independent growth of NIH3T3 cells and the glioblastoma cell lines U-105MG and U-251MG. Thus, whereas NR4A1, induced by PDGF-BB, suppresses cell growth on a solid surface, it increases anchorage-independent growth.	[Eger, Glenda; Papadopoulos, Natalia; Lennartsson, Johan; Heldin, Carl-Henrik] Uppsala Univ, Ludwig Inst Canc Res, Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University	Lennartsson, J (corresponding author), Uppsala Univ, Ludwig Inst Canc Res, Uppsala, Sweden.	Johan.Lennartsson@licr.uu.se			Ludwig Institute for Cancer Research; Swedish Research Council [K2011-67X-21859-01-6]; Swedish Cancer Society [130519]	Ludwig Institute for Cancer Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by the Ludwig Institute for Cancer Research (www.licr.org), the Swedish Research Council (K2011-67X-21859-01-6, www.vr.se) and the Swedish Cancer Society (130519, www. cancerfonden.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou AN, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2610; Arkenbout EK, 2003, ARTERIOSCL THROM VAS, V23, P1535, DOI 10.1161/01.ATV.0000084639.16462.7A; Arkenbout EK, 2003, THROMB HAEMOSTASIS, V89, P522, DOI 10.1055/s-0037-1613383; Bras A, 2000, CELL DEATH DIFFER, V7, P262, DOI 10.1038/sj.cdd.4400653; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; Darragh J, 2005, BIOCHEM J, V390, P749, DOI 10.1042/BJ20050196; de Leseleuc L, 2006, CELL DEATH DIFFER, V13, P293, DOI 10.1038/sj.cdd.4401737; Deutsch AJ, ANTICANCER AGENTS ME, V12, P1001; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Han YH, 2006, ONCOGENE, V25, P2974, DOI 10.1038/sj.onc.1209358; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hinze AV, 2013, PURINERG SIGNAL, V9, P677, DOI 10.1007/s11302-013-9380-5; Inaoka Y, 2008, MOL REPROD DEV, V75, P931, DOI 10.1002/mrd.20788; Jurek A, 2009, J BIOL CHEM, V284, P4626, DOI 10.1074/jbc.M808490200; Kang SA, 2010, BIOCHEM PHARMACOL, V80, P867, DOI 10.1016/j.bcp.2010.04.026; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Kondoh K, 2006, MOL CELL BIOL, V26, P1679, DOI 10.1128/MCB.26.5.1679-1690.2006; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Lee SO, 2010, CANCER RES, V70, P6824, DOI 10.1158/0008-5472.CAN-10-1992; Li ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054592; Liu B, 2007, ENDOCRINOLOGY, V148, P34, DOI 10.1210/en.2006-0800; Liu Y, 2014, AM J RESP CELL MOL, V50, P379, DOI 10.1165/rcmb.2013-0198OC; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Maijenburg MW, 2012, STEM CELLS DEV, V21, P19, DOI 10.1089/scd.2011.0270; Martin LJ, 2005, ENDOCRINOLOGY, V146, P861, DOI 10.1210/en.2004-0859; McEvoy AN, 2002, J IMMUNOL, V168, P2979, DOI 10.4049/jimmunol.168.6.2979; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Ostman A, 2007, ADV CANCER RES, V97, P247, DOI 10.1016/S0065-230X(06)97011-0; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Safe S, 2014, MOL ENDOCRINOL, V28, P157, DOI 10.1210/me.2013-1291; Sakaue M, 2001, CELL DEATH DIFFER, V8, P411, DOI 10.1038/sj.cdd.4400818; Smith AG, 2011, PIGM CELL MELANOMA R, V24, P551, DOI 10.1111/j.1755-148X.2011.00843.x; Sohn SJ, 2005, MOL CELL BIOL, V25, P8553, DOI 10.1128/MCB.25.19.8553-8566.2005; Stocco CO, 2000, J BIOL CHEM, V275, P37202, DOI 10.1074/jbc.M006016200; Suzuki S, 2003, P NATL ACAD SCI USA, V100, P8276, DOI 10.1073/pnas.0932598100; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; To SKY, 2012, EXPERT OPIN THER TAR, V16, P573, DOI 10.1517/14728222.2012.680958; Wang LY, 2010, MOL CELL BIOCHEM, V341, P159, DOI 10.1007/s11010-010-0447-0; Wang XC, 2012, J ALZHEIMERS DIS, V32, P77, DOI 10.3233/JAD-2012-120526; Wilson AJ, 2003, CANCER RES, V63, P5401; Wingate AD, 2006, BIOCHEM SOC T, V34, P1107, DOI 10.1042/BST0341107; Wingate AD, 2006, BIOCHEM J, V393, P715, DOI 10.1042/BJ20050967; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Wu H, 2011, FASEB J, V25, P192, DOI 10.1096/fj.10-166462; Wu Q, 2002, CARCINOGENESIS, V23, P1583, DOI 10.1093/carcin/23.10.1583; Yoon K, 2011, CARCINOGENESIS, V32, P836, DOI 10.1093/carcin/bgr040; You B, 2009, CIRC RES, V104, P742, DOI 10.1161/CIRCRESAHA.108.192286; Zeng HY, 2006, J EXP MED, V203, P719, DOI 10.1084/jem.20051523; Zhan YY, 2013, CANCER LETT, V329, P37, DOI 10.1016/j.canlet.2012.09.022; Zhang XK, 2007, EXPERT OPIN THER TAR, V11, P69, DOI 10.1517/14728222.11.1.69; Zhao BX, 2011, MOL ENDOCRINOL, V25, P1337, DOI 10.1210/me.2011-0081; Zhao DZ, 2011, P NATL ACAD SCI USA, V108, P12066, DOI 10.1073/pnas.1018438108; Zhou FF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4388	59	11	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e109047	10.1371/journal.pone.0109047	http://dx.doi.org/10.1371/journal.pone.0109047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25269081	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700217
J	Jia, LF; Wei, SB; Mitchelson, K; Gao, Y; Zheng, YF; Meng, Z; Gan, YH; Yu, GY				Jia, Ling-fei; Wei, Su-bi; Mitchelson, Keith; Gao, Yan; Zheng, Yun-fei; Meng, Zhen; Gan, Ye-hua; Yu, Guang-yan			miR-34a Inhibits Migration and Invasion of Tongue Squamous Cell Carcinoma via Targeting MMP9 and MMP14	PLOS ONE			English	Article							DOWN-REGULATION; MICRORNA TARGETS; TUMOR-SUPPRESSOR; MESSENGER-RNAS; CANCER; METASTASIS; EXPRESSION; CHORIOCARCINOMA; PROLIFERATION; DISSECTION	Background: miR-34a is an important tumor suppressor gene in various cancer types. But little is known about the dysregulation of miR-34a in tongue squamous cell carcinoma (TSCC). In this study, we investigate the expression and potential role of miR-34a in TSCC. Methods: We evaluated miR-34a expression and its relationship with clinicopathological characters in 75 pairs of TSCC samples, and confirmed the role of miR-34a for predicting lymph node metastases from a further 15 pairs of paraffin-embedded TSCC specimens with stringent clinicopathological recruitment criteria using quantitative reverse transcription polymerase chain reaction (qRT-PCR). The effects of miR-34a on cell proliferation, migration and invasion were examined in TSCC cell lines using Cell Counting Kit-8 assay, wound healing assay and transwell assay, respectively. The effects of miR-34a on the expression of matrix metalloproteinase (MMP) 9 and 14 were detected by luciferase reporter assays and Western blot analysis. The expression of miR-34a, MMP9 and MMP14 were also confirmed in TSCC samples by in situ hybridization and immunohistochemistry. Results: miR-34a expression in tumor tissues from TSCC patients with positive lymph node metastases was significantly lower than that with negative lymph node metastases. Overexpression of miR-34a significantly suppressed migration and invasion in TSCC cells and simultaneously inhibited the expression of MMP9 and MMP14 through targeting the coding region and the 3'untranslated region, respectively. Moreover, miR-34a expression in TSCC was inversely correlated with protein expression of MMP9 and MMP14 in the TSCC samples. Conclusions: miR-34a plays an important role in lymph node metastases of TSCC through targeting MMP9 and MMP14 and may have potential applications in prognosis prediction and gene therapy for lymph node metastases of TSCC patients.	[Jia, Ling-fei; Zheng, Yun-fei; Meng, Zhen; Gan, Ye-hua; Yu, Guang-yan] Peking Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Beijing 100871, Peoples R China; [Wei, Su-bi; Mitchelson, Keith] Tsinghua Univ, Med Syst Biol Res Ctr, Beijing 100084, Peoples R China; [Gao, Yan] Peking Univ, Sch & Hosp Stomatol, Dept Oral Pathol, Beijing 100871, Peoples R China; [Jia, Ling-fei; Gan, Ye-hua] Peking Univ, Sch & Hosp Stomatol, Cent Lab, Beijing 100871, Peoples R China; [Mitchelson, Keith] CapitalBio Corp, Beijing, Peoples R China	Peking University; Tsinghua University; Peking University; Peking University	Gan, YH (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Beijing 100871, Peoples R China.	kqyehuagan@bjmu.edu.cn; gyyu@263.net	zheng, yunfei/M-4172-2018		National Natural Science Foundation of China [81402235, 81472527]; Foundation of Peking University School and Hospital of Stomatology [PKUSS20140104]; CapitalBio Corporation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Peking University School and Hospital of Stomatology; CapitalBio Corporation	This study was supported by National Natural Science Foundation of China (81402235, 81472527), and Foundation of Peking University School and Hospital of Stomatology (PKUSS20140104). Co-author Keith Mitchelson is employed by CapitalBio Corporation, Beijing, China. CapitalBio Corporation provided support in the form of salary for author KM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	Akanuma N, 2014, BRIT J CANCER, V110, P189, DOI 10.1038/bjc.2013.676; [Anonymous], 2010, TNM CLASSIFICATION M; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cao WG, 2014, TUMOR BIOL, V35, P1287, DOI 10.1007/s13277-013-1171-7; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; FAKIH AR, 1989, AM J SURG, V158, P309, DOI 10.1016/0002-9610(89)90122-0; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; GRANDI C, 1985, HEAD NECK SURG, V8, P67, DOI 10.1002/hed.2890080202; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; HO CM, 1992, HEAD NECK-J SCI SPEC, V14, P359, DOI 10.1002/hed.2880140504; Huang SF, 2008, CANCER, V112, P1066, DOI 10.1002/cncr.23278; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jia CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027008; Jia LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056634; Jiang L, 2010, INT J CANCER, V127, P505, DOI 10.1002/ijc.25320; Jin J, 2013, ASIAN PAC J CANCER P, V14, P3681, DOI 10.7314/APJCP.2013.14.6.3681; Jin WL, 2008, CHINESE MED J-PEKING, V121, P1871, DOI 10.1097/00029330-200810010-00004; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kovacs AF, 2006, CANCER BIOTHER RADIO, V21, P535, DOI 10.1089/cbr.2006.21.535; Kumar B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037601; LEEMANS CR, 1993, CANCER, V71, P452, DOI 10.1002/1097-0142(19930115)71:2<452::AID-CNCR2820710228>3.0.CO;2-B; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Li LJ, 2003, J CELL SCI, V116, P3687, DOI 10.1242/jcs.00644; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; MARX J, 1994, SCIENCE, V263, P319, DOI 10.1126/science.8278804; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; David MM, 2008, J ORAL MAXIL SURG, V66, P762, DOI 10.1016/j.joms.2007.12.017; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pang RTK, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-25; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Sano D, 2007, CANCER METAST REV, V26, P645, DOI 10.1007/s10555-007-9082-y; Standart N, 2007, GENE DEV, V21, P1975, DOI 10.1101/gad.1591507; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Sun LH, 2011, BRAIN RES, V1389, P9, DOI 10.1016/j.brainres.2011.03.013; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wu JM, 2012, CARCINOGENESIS, V33, P519, DOI 10.1093/carcin/bgr304; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yan DS, 2009, INVEST OPHTH VIS SCI, V50, P1559, DOI 10.1167/iovs.08-2681; Zhang HY, 2012, MOL CANCER THER, V11, P1454, DOI 10.1158/1535-7163.MCT-12-0001	48	52	56	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108435	10.1371/journal.pone.0108435	http://dx.doi.org/10.1371/journal.pone.0108435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268950	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700096
J	Colangelo, V; Francois, S; Solda, G; Picco, R; Roma, F; Ginelli, E; Meneveri, R				Colangelo, Veronica; Francois, Stephanie; Solda, Giulia; Picco, Raffaella; Roma, Francesca; Ginelli, Enrico; Meneveri, Raffaella			Next-Generation Sequencing Analysis of MiRNA Expression in Control and FSHD Myogenesis	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; MUSCLE DIFFERENTIATION; MICRORNA EXPRESSION; UP-REGULATION; TARGET GENES; SKELETAL; PROLIFERATION; MYOBLASTS; SUPPORTS; LIBRARY	Emerging evidence has demonstrated that miRNA sequences can regulate skeletal myogenesis by controlling the process of myoblast proliferation and differentiation. However, at present a deep analysis of miRNA expression in control and FSHD myoblasts during differentiation has not yet been derived. To close this gap, we used a next-generation sequencing (NGS) approach applied to in vitro myogenesis. Furthermore, to minimize sample genetic heterogeneity and muscle-type specific patterns of gene expression, miRNA profiling from NGS data was filtered with FC >= 4 (log(2)FC >= 2) and p-value <0.05, and its validation was derived by qRT-PCR on myoblasts from seven muscle districts. In particular, control myogenesis showed the modulation of 38 miRNAs, the majority of which (34 out 38) were up-regulated, including myomiRs (miR-1, -133a, -133b and -206). Approximately one third of the modulated miRNAs were not previously reported to be involved in muscle differentiation, and interestingly some of these (i.e. miR-874, -1290, -95 and -146a) were previously shown to regulate cell proliferation and differentiation. FSHD myogenesis evidenced a reduced number of modulated miRNAs than healthy muscle cells. The two processes shared nine miRNAs, including myomiRs, although with FC values lower in FSHD than in control cells. In addition, FSHD cells showed the modulation of six miRNAs (miR-1268, -1268b, -1908, 4258, -4508- and -4516) not evidenced in control cells and that therefore could be considered FSHD-specific, likewise three novel miRNAs that seem to be specifically expressed in FSHD myotubes. These data further clarify the impact of miRNA regulation during control myogenesis and strongly suggest that a complex dysregulation of miRNA expression characterizes FSHD, impairing two important features of myogenesis: cell cycle and muscle development. The derived miRNA profiling could represent a novel molecular signature for FSHD that includes diagnostic biomarkers and possibly therapeutic targets.	[Colangelo, Veronica; Francois, Stephanie; Meneveri, Raffaella] Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy; [Solda, Giulia; Roma, Francesca; Ginelli, Enrico] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Picco, Raffaella] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy	University of Milano-Bicocca; University of Milan; University of Udine	Meneveri, R (corresponding author), Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy.	raffaella.meneveri@unimib.it	Soldà, Giulia/AAG-3589-2020; Solda', Giulia/A-4053-2011	Soldà, Giulia/0000-0003-0972-610X; Solda', Giulia/0000-0003-0972-610X	AFMTelethon [16547]; Italian Ministry of University and Research [PRIN 2008BEYKL8_002]	AFMTelethon(Association Francaise contre les Myopathies); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the AFMTelethon (reference Number 16547), http://www.afm-telethon.com, and the Italian Ministry of University and Research (PRIN 2008BEYKL8_002), www.prin.miur.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MS, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-27; Arashiro P, 2009, P NATL ACAD SCI USA, V106, P6220, DOI 10.1073/pnas.0901573106; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bodega B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-41; Broucqsault N, 2013, HUM MOL GENET, V22, P4206, DOI 10.1093/hmg/ddt272; Brunelli S, 2004, CIRC RES, V94, P1571, DOI 10.1161/01.RES.0000132747.12860.10; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Callis TE, 2008, EXP BIOL MED, V233, P131, DOI 10.3181/0709-MR-237; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; Cheli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020966; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cordero F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031630; Dmitriev P, 2013, J BIOL CHEM, V288, P34989, DOI 10.1074/jbc.M113.504522; Dmitriev P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-265; Dong SH, 2013, MOL MED REP, V8, P407, DOI 10.3892/mmr.2013.1538; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Ferreboeuf M, 2014, HUM MOL GENET, V23, P171, DOI 10.1093/hmg/ddt409; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Goljanek-Whysall K, 2012, CLIN SCI, V123, P611, DOI 10.1042/CS20110634; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Homma S, 2012, EUR J HUM GENET, V20, P404, DOI 10.1038/ejhg.2011.213; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Luo W, 2013, J GENET GENOMICS, V40, P107, DOI 10.1016/j.jgg.2013.02.002; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nohata N, 2013, BRIT J CANCER, V108, P1648, DOI 10.1038/bjc.2013.122; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Ottaviani A, 2009, EMBO J, V28, P2428, DOI 10.1038/emboj.2009.201; Padberg GW, 1992, NEUROMUSCULAR DISORD, V1, P231; Pisconti A, 2006, J CELL BIOL, V172, P233, DOI 10.1083/jcb.200507083; Rahimov F, 2012, P NATL ACAD SCI USA, V109, P16234, DOI 10.1073/pnas.1209508109; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Ryu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016403; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Schee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066165; Scionti I, 2012, AM J HUM GENET, V90, P628, DOI 10.1016/j.ajhg.2012.02.019; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Tsumagari K, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-67; Tupler R, 2004, CELL MOL LIFE SCI, V61, P557, DOI 10.1007/s00018-003-3285-3; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Witkos TM, 2011, CURR MOL MED, V11, P93; Wu J, 2013, CANCER LETT, V329, P155, DOI 10.1016/j.canlet.2012.10.038; Xu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015519; Yamanaka G, 2004, J NEUROL SCI, V219, P89, DOI 10.1016/j.jns.2003.12.010; Yang QL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066809; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	55	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108411	10.1371/journal.pone.0108411	http://dx.doi.org/10.1371/journal.pone.0108411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285664	Green Submitted, Green Published, gold			2022-12-27	WOS:000345743700020
J	Finseth, FR; Harrison, RG				Finseth, Findley R.; Harrison, Richard G.			A Comparison of Next Generation Sequencing Technologies for Transcriptome Assembly and Utility for RNA-Seq in a Non-Model Bird	PLOS ONE			English	Article							QUAIL COTURNIX-JAPONICA; PROCTODEAL GLAND FOAM; MALE JAPANESE-QUAIL; REFERENCE GENOME; SEXUAL-BEHAVIOR; EXPRESSION; MORPHOLOGY; LENGTH; DIVERGENCE; CHALLENGES	De novo assembled transcriptomes, in combination with RNA-Seq, are powerful tools to explore gene sequence and expression level in organisms without reference genomes. Investigators must first choose which high throughput sequencing platforms will provide data most suitable for their experimental goals. In this study, we explore the utility of 454 and Illumina sequences for de novo transcriptome assembly and downstream RNA-Seq applications in a reproductive gland from a non-model bird species, the Japanese quail (Coturnix japonica). Four transcriptomes composed of either pure 454 or Illumina reads or mixtures of read types were assembled and evaluated for the same cost. Illumina assemblies performed best for de novo transcriptome characterization in terms of contig length, transcriptome coverage, and complete assembly of gene transcripts. Improvements over the Hybrid assembly were marginal, with the exception that the addition of 454 data significantly increased the number of genes annotated. The Illumina assembly provided the best reference to align an independent set of RNA-Seq data as similar to 84% of reads mapped to single genes in the transcriptome. Contigs constructed solely from 454 data may impose problems for RNA-Seq as our 454 transcriptome revealed a high number of indels and many ambiguously mapped reads. Correcting the 454 transcriptome with Illumina reads was an effective strategy to deal with indel and frameshift errors inherent to the 454 transcriptome, but at the cost of transcriptome coverage. In the absence of a reference genome, we find that Illumina reads alone produced a high quality transcriptome appropriate for RNA-Seq gene expression analyses.	[Finseth, Findley R.; Harrison, Richard G.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	Cornell University	Finseth, FR (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	far25@cornell.edu			NSF DDIG [DEB-1010757]; P.E.O. Scholar award; Cornell Sigma Xi award; Andrew W. Mellon award; Paul. F. Feeny award	NSF DDIG(National Science Foundation (NSF)); P.E.O. Scholar award; Cornell Sigma Xi award; Andrew W. Mellon award; Paul. F. Feeny award	This research was funded by an NSF DDIG DEB-1010757 to FRF and RGH, P.E.O. Scholar, Cornell Sigma Xi, Andrew W. Mellon, and Paul. F. Feeny awards to FRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINS EK, 1977, HORM BEHAV, V8, P201, DOI 10.1016/0018-506X(77)90037-X; Adkins-Regan E, 1999, AUK, V116, P184, DOI 10.2307/4089465; Birzele F, 2010, NUCLEIC ACIDS RES, V38, P3999, DOI 10.1093/nar/gkq116; Bork P, 1998, NAT GENET, V18, P313, DOI 10.1038/ng0498-313; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; CHENG KM, 1989, AUK, V106, P286; CHENG KM, 1989, AUK, V106, P279; COIL W. H., 1959, OHIO JOUR SCI, V59, P268; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; DESJARDINS P, 1991, J MOL EVOL, V32, P153, DOI 10.1007/BF02515387; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Ekblom R, 2012, ECOL EVOL, V2, P2485, DOI 10.1002/ece3.370; Ellegren H, 2008, MOL ECOL, V17, P1629, DOI 10.1111/j.1365-294X.2008.03699.x; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Fang ZD, 2011, BRIEF BIOINFORM, V12, P280, DOI 10.1093/bib/bbr004; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Finseth FR, 2013, J EVOLUTION BIOL, V26, P1875, DOI 10.1111/jeb.12189; FUJIHARA N, 1992, WORLD POULTRY SCI J, V48, P39, DOI 10.1079/WPS19920005; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hornett EA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-361; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Jensen JK, 2012, MOL PLANT, V5, P984, DOI 10.1093/mp/sss032; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Kayang BB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-101; KLEMM RD, 1973, J MORPHOL, V141, P171, DOI 10.1002/jmor.1051410205; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Milano I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028008; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Moghadam HK, 2013, MOL ECOL RESOUR, V13, P696, DOI 10.1111/1755-0998.12096; O'Neil ST, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-465; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rawat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030370; Reading Benjamin J., 2012, BMC Research Notes, V5, P111, DOI 10.1186/1756-0500-5-111; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Sasazaki S, 2006, ANIM GENET, V37, P316, DOI 10.1111/j.1365-2052.2006.01454.x; Sasazaki S, 2006, ANIM SCI J, V77, P42, DOI 10.1111/j.1740-0929.2006.00318.x; SCHUMACHER M, 1983, PHYSIOL BEHAV, V30, P335, DOI 10.1016/0031-9384(83)90135-X; Schwartz TS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-694; Seiwert CM, 1998, BRAIN BEHAV EVOLUT, V52, P61, DOI 10.1159/000006553; Singh RP, 2012, REPROD FERT DEVELOP, V24, P405, DOI 10.1071/RD11057; Singh RP, 2011, THERIOGENOLOGY, V75, P563, DOI 10.1016/j.theriogenology.2010.09.028; Singhal S, 2013, MOL ECOL RESOUR, V13, P403, DOI 10.1111/1755-0998.12077; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Toung JM, 2011, GENOME RES, V21, P991, DOI 10.1101/gr.116335.110; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S5; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wolf JBW, 2013, MOL ECOL RESOUR, V13, P559, DOI 10.1111/1755-0998.12109; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Xu L, 2006, MOL BIOL EVOL, V23, P1107, DOI 10.1093/molbev/msk019; Zheng Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-453	68	29	30	6	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108550	10.1371/journal.pone.0108550	http://dx.doi.org/10.1371/journal.pone.0108550			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279728	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800020
J	Montastruc, F; Moulis, G; Palmaro, A; Gardette, V; Durrieu, G; Montastruc, JL				Montastruc, Francois; Moulis, Guillaume; Palmaro, Aurore; Gardette, Virginie; Durrieu, Genevieve; Montastruc, Jean-Louis			Interactions between Medical Residents and Drug Companies: A National Survey after the Mediator (R) Affair	PLOS ONE			English	Article							PHARMACEUTICAL SALES REPRESENTATIVES; STUDENTS EXPOSURE; INDUSTRY; PHYSICIANS; QUALITY; GIFTS; BENFLUOREX; ATTITUDES	Background: The present study aimed to describe exposure and attitudes of French medical residents towards pharmaceutical industry. The study was performed shortly after the Mediator affair which revealed several serious conflicts of interest inside the French health system. Methods and Findings: A cross-sectional study was implemented among residents from 6 French medical faculties. Independent education in pharmacology, attitudes towards the practices of pharmaceutical sales representatives, opinions concerning the pharmaceutical industry, quality of information provided by the pharmaceutical industry, and opinions about pharmaceutical company sponsorship were investigated through a web-based questionnaire. We also assessed potential changes in resident attitudes following the Mediator affair. The mean value of exposure to drug companies was 1.9 times per month. Global opinions towards drug company information were negative for 42.7% of the residents and positive for only 8.2%. Surprisingly, 81.6% of residents claimed that they had not changed their practices regarding drug information since the Mediator affair. Multivariate analyses found that residents in anesthesiology were less likely to be exposed than others (OR = 0.17 CI95% [0.05-0.61]), exposure was significantly higher at the beginning of residence (p<0.001) and residents who had a more positive opinion were more frequently exposed to drug companies (OR = 2.12 CI95% [1.07-4.22]). Conclusions: Resident exposure to drug companies is around 1 contact every 2 weeks. Global opinion towards drug information provided by pharmaceutical companies was negative for around 1 out of 2 residents. In contrast, residents tend to consider the influences of the Mediator affair on their practice as relatively low. This survey enabled us to identify profiles of residents who are obviously less exposed to pharmaceutical industry. Current regulatory provisions are not sufficient, indicating that further efforts are necessary to develop a culture of disclosure of conflict of interest and of transparency in residents.	[Montastruc, Francois; Moulis, Guillaume; Palmaro, Aurore; Durrieu, Genevieve; Montastruc, Jean-Louis] Univ Toulouse, Fac Med, Lab Pharmacol Med & Clin, Toulouse, France; [Montastruc, Francois; Palmaro, Aurore; Durrieu, Genevieve; Montastruc, Jean-Louis] Ctr Hosp Univ, Ctr Midi Pyrenees PharmacoVigilance Pharmacoepide, Serv Pharmacol Med & Clin, Toulouse, France; [Montastruc, Francois; Moulis, Guillaume; Palmaro, Aurore; Gardette, Virginie; Durrieu, Genevieve; Montastruc, Jean-Louis] Univ Toulouse, INSERM, U1027, Toulouse, France; [Montastruc, Francois; Gardette, Virginie] Univ Toulouse, Fac Med, Dept Univ Epidemiol Econ Sante & Sante Publ, Toulouse, France; [Montastruc, Francois; Gardette, Virginie] Ctr Hosp Univ, Serv Epidemiol, Toulouse, France; [Moulis, Guillaume] Ctr Hosp Univ, Serv Med Interne, Toulouse, France	Universite de Toulouse; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite de Toulouse; CHU de Toulouse; CHU de Toulouse	Montastruc, F (corresponding author), Univ Toulouse, Fac Med, Lab Pharmacol Med & Clin, Toulouse, France.	francoismontastruc@hotmail.fr	Montastruc, François/ABE-9903-2020; Palmaro, Aurore/N-3112-2015	Montastruc, François/0000-0001-7056-8126; Palmaro, Aurore/0000-0002-5660-9224; Gardette, Virginie/0000-0003-3442-4971				Abou Taam M, 2014, J CLIN PHARM THER, V39, P53, DOI 10.1111/jcpt.12103; [Anonymous], 2014, ASS CONFL INT POL AC; Austad KE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001037; Bellin M, 2004, ACAD MED, V79, P1041, DOI 10.1097/00001888-200411000-00005; Bowman M A, 1988, J Contin Educ Health Prof, V8, P13, DOI 10.1002/chp.4750080104; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Caudill TS, 1996, ARCH FAM MED, V5, P201, DOI 10.1001/archfami.5.4.201; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Dalkey N., 1969, DELPHI METHOD; Dana J, 2003, JAMA-J AM MED ASSOC, V290, P252, DOI 10.1001/jama.290.2.252; Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Fabbri A, 2008, RICERCA CAMPO, V24, P242; Fauvet L, 2010, AFFECTATIONS ETUDIAN; Fournier A, 2012, PHARMACOEPIDEM DR S, V21, P343, DOI 10.1002/pds.3213; Halperin EC, 2004, INT J RADIAT ONCOL, V59, P1477, DOI 10.1016/j.ijrobp.2004.01.052; Heerwegh D, 2008, PUBLIC OPIN QUART, V72, P836, DOI 10.1093/poq/nfn045; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Lea D, 2010, EUR J CLIN PHARMACOL, V66, P727, DOI 10.1007/s00228-010-0805-6; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Likert R., 1932, ARCH PSYCHOL, V22, P55, DOI DOI 10.1037/H0053694; MCKINNEY WP, 1990, JAMA-J AM MED ASSOC, V264, P1693, DOI 10.1001/jama.264.13.1693; Menard J, 2011, DIABETES METAB, V37, P169, DOI 10.1016/j.diabet.2011.04.001; Ministere des Affaires sociales et de la Sante, 2011, RAPP 2010 2011 MIN A; Ministere des Affaires sociales et de la Sante, 2010, CHART VIS MED; Mintzes B, 2013, J GEN INTERN MED, V28, P1368, DOI 10.1007/s11606-013-2411-7; Monaghan MS, 2003, TEACH LEARN MED, V15, P14, DOI 10.1207/S15328015TLM1501_04; Mullard A, 2011, LANCET, V377, P890, DOI 10.1016/S0140-6736(11)60334-6; ORLOWSKI JP, 1992, CHEST, V102, P270, DOI 10.1378/chest.102.1.270; Prosser H, 2003, FAM PRACT, V20, P61, DOI 10.1093/fampra/20.1.61; Sandberg WS, 1997, ACAD MED, V72, P916, DOI 10.1097/00001888-199710000-00018; Sierles FS, 2005, JAMA-J AM MED ASSOC, V294, P1034, DOI 10.1001/jama.294.9.1034; Villanueva P, 2003, LANCET, V361, P27, DOI 10.1016/S0140-6736(03)12118-6; Vuorenkoski L, 2008, MED EDUC, V42, P1172, DOI 10.1111/j.1365-2923.2008.03169.x; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; WMA Declaration of Helsinki, 2008, ETH PRINC MED RES IN	36	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e104828	10.1371/journal.pone.0104828	http://dx.doi.org/10.1371/journal.pone.0104828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279555	Green Submitted, gold, Green Published			2022-12-27	WOS:000342670800002
J	Santiago, JA; Scherzer, CR; Potashkin, JA				Santiago, Jose A.; Scherzer, Clemens R.; Potashkin, Judith A.			Network Analysis Identifies SOD2 mRNA as a Potential Biomarker for Parkinson's Disease	PLOS ONE			English	Article							GENE-EXPRESSION; INSULIN-RESISTANCE; CYTOSCAPE PLUGIN; RISK; PRIORITIZATION; INFLAMMATION; GENOME; BLOOD; CELLS	Increasing evidence indicates that Parkinson's disease (PD) and type 2 diabetes (T2DM) share dysregulated molecular networks. We identified 84 genes shared between PD and T2DM from curated disease-gene databases. Nitric oxide biosynthesis, lipid and carbohydrate metabolism, insulin secretion and inflammation were identified as common dysregulated pathways. A network prioritization approach was implemented to rank genes according to their distance to seed genes and their involvement in common biological pathways. Quantitative polymerase chain reaction assays revealed that a highly ranked gene, superoxide dismutase 2 (SOD2), is upregulated in PD patients compared to healthy controls in 192 whole blood samples from two independent clinical trials, the Harvard Biomarker Study (HBS) and the Diagnostic and Prognostic Biomarkers in Parkinson's disease (PROBE). The results from this study reinforce the idea that shared molecular networks between PD and T2DM provides an additional source of biologically meaningful biomarkers. Evaluation of this biomarker in de novo PD patients and in a larger prospective longitudinal study is warranted.	[Santiago, Jose A.; Potashkin, Judith A.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Cellular & Mol Pharmacol Dept, N Chicago, IL 60064 USA; [Scherzer, Clemens R.] Brigham & Womens Hosp, Neurogen Lab, Cambridge, MA USA; [Scherzer, Clemens R.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Harvard University; Brigham & Women's Hospital; Harvard University	Potashkin, JA (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Cellular & Mol Pharmacol Dept, N Chicago, IL 60064 USA.	judy.potashkin@rosalindfranklin.edu	Santiago, Jose A./CAJ-2999-2022	Scherzer, Clemens/0000-0002-0567-9193; Santiago, Jose A./0000-0002-1431-5789	U.S. Army Medical Research and Materiel Command [W81XWH-09-0708, W81XWH13-1-0025]; National Institutes of Health (NIH) [R01 NS064155, R01 AG044113, U01 NS082157, U01 AT000613, P01 NS058793]; Harvard NeuroDiscovery Center; Michael J. Fox Foundation; M.E.M.O. Hoffman Foundation; Harvard NeuroDiscovery Center (HNDC); Parkinson's Disease Biomarkers Program (PDBP) of the National Institute of Neurological Disorders and Stroke (NINDS) [U01 NS082157]; Massachusetts Alzheimer's Disease Research Center (ADRC) of the National Institute on Aging [P50 AG005134]; National Center for Complementary & Integrative Health [U01AT000613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS082080, U01NS082157, R01NS064155, P01NS058793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG044113, P50AG005134] Funding Source: NIH RePORTER	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard NeuroDiscovery Center; Michael J. Fox Foundation; M.E.M.O. Hoffman Foundation; Harvard NeuroDiscovery Center (HNDC); Parkinson's Disease Biomarkers Program (PDBP) of the National Institute of Neurological Disorders and Stroke (NINDS); Massachusetts Alzheimer's Disease Research Center (ADRC) of the National Institute on Aging; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the U.S. Army Medical Research and Materiel Command under award numbers W81XWH-09-0708 and W81XWH13-1-0025 to J.A.P. C. R. S. is funded by National Institutes of Health (NIH) grants R01 NS064155, R01 AG044113, U01 NS082157, U01 AT000613, P01 NS058793, the Harvard NeuroDiscovery Center, the Michael J. Fox Foundation, and the M.E.M.O. Hoffman Foundation. The Harvard Biomarker Study is supported by the Harvard NeuroDiscovery Center (HNDC), the Parkinson's Disease Biomarkers Program (PDBP) grant U01 NS082157 of the National Institute of Neurological Disorders and Stroke (NINDS), and the Massachusetts Alzheimer's Disease Research Center (ADRC) P50 AG005134 grant of the National Institute on Aging. C. R. S. has collaborated with DiaGenic, Pfizer, Opko, and Proteome Sciences. Opinions, conclusions, interpretations and recommendations are those of the authors and are not necessarily endorsed by the U. S. Army. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler C. H., 2014, NEUROLOGY; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Aviles-Olmos I, 2014, J PARKINSONS DIS; Aviles-Olmos I, 2013, J CLIN INVEST, V123, P2730, DOI 10.1172/JCI68295; Aviles-Olmos I, 2013, BRAIN, V136, P374, DOI 10.1093/brain/aws009; Bauer-Mehren A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020284; Belluzzi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038026; Bosco D, 2012, J NEUROL SCI, V315, P39, DOI 10.1016/j.jns.2011.12.008; Bragina EY, 2014, IMMUNOGENETICS, V66, P457, DOI 10.1007/s00251-014-0786-1; Cereda E, 2013, MOVEMENT DISORD, V28, P257, DOI 10.1002/mds.25211; Cereda E, 2011, DIABETES CARE, V34, P2614, DOI 10.2337/dc11-1584; D'Amelio M, 2009, PARKINSONISM RELAT D, V15, P660, DOI 10.1016/j.parkreldis.2009.02.013; Ding HL, 2011, MOVEMENT DISORD, V26, P2283, DOI 10.1002/mds.23934; Doonan F, 2009, J NEUROCHEM, V109, P631, DOI 10.1111/j.1471-4159.2009.05995.x; Le DH, 2012, COMPUT BIOL CHEM, V37, P17, DOI 10.1016/j.compbiolchem.2012.02.004; Dunn L, 2014, NEUROBIOL AGING, V35, P1111, DOI 10.1016/j.neurobiolaging.2013.11.001; Dzamko N, 2013, J PARKINSON DIS, V3, P145, DOI 10.3233/JPD-130174; Ferrer I, 2007, NEUROSCI LETT, V415, P205, DOI 10.1016/j.neulet.2007.01.026; Gao L, 2013, FEBS J; Gupta A, 2014, J RECEPT SIG TRANSD, P1; Huttenhower C, 2009, GENOME RES, V19, P1093, DOI 10.1101/gr.082214.108; Kang L, 2014, DIABETES; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kotagal V, 2013, PARKINSONISM RELAT D, V19, P522, DOI 10.1016/j.parkreldis.2013.01.016; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Lauer B, 2009, CHEM-BIOL INTERACT, V179, P17, DOI 10.1016/j.cbi.2008.10.031; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Lin XM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00954; Lu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085781; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Marcil V, 2010, J BIOL CHEM, V285, P40448, DOI 10.1074/jbc.M110.155358; Menon R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018660; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Nolan YM, 2013, TRENDS MOL MED, V19, P187, DOI 10.1016/j.molmed.2012.12.003; Novelli G, 2008, CLIN CASES MINER BON, V5, P149; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; Onozato ML, 2004, KIDNEY INT, V65, P951, DOI 10.1111/j.1523-1755.2004.00470.x; Palacios N, 2011, MOVEMENT DISORD, V26, P2253, DOI 10.1002/mds.23855; Peng K, 2013, NUCLEIC ACIDS RES, V41, pD553, DOI 10.1093/nar/gks1244; Potashkin JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043595; Przedborski S, 2010, MOVEMENT DISORD, V25, pS55, DOI 10.1002/mds.22638; Rajput AH, 2014, NEUROLOGY; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Santiago JA, 2014, NEUROBIOLOGY DIS; Santiago Jose A, 2014, Mov Disord, V29, P550, DOI 10.1002/mds.25761; Santiago JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083940; Santiago JA, 2013, MOVEMENT DISORD, V28, P1724, DOI 10.1002/mds.25635; Santiago JA, 2013, TRENDS MOL MED, V19, P176, DOI 10.1016/j.molmed.2013.01.002; Santos RX, 2014, MOL CELLULAR BIOCH; Scheele C, 2007, FASEB J, V21, P3653, DOI 10.1096/fj.07-8520com; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Schramm F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040046; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh BK, 2011, FREE RADICAL RES, V45, P1207, DOI 10.3109/10715762.2011.607164; Soderberg JAE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019866; Stamova BS, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-49; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wahlqvist ML, 2012, PARKINSONISM RELAT D, V18, P753, DOI 10.1016/j.parkreldis.2012.03.010; Wang LL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-380; Wang L, 2014, EXP NEUROL, V251, P22, DOI 10.1016/j.expneurol.2013.11.001	61	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109042	10.1371/journal.pone.0109042	http://dx.doi.org/10.1371/journal.pone.0109042			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279756	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800052
J	Van Belle, TL; Vanherwegen, AS; Feyaerts, D; De Clercq, P; Verstuyf, A; Korf, H; Gysemans, C; Mathieu, C				Van Belle, Tom L.; Vanherwegen, An-Sofie; Feyaerts, Dorien; De Clercq, Pierre; Verstuyf, Annemieke; Korf, Hannelie; Gysemans, Conny; Mathieu, Chantal			1,25-Dihydroxyvitamin D-3 and Its Analog TX527 Promote a Stable Regulatory T Cell Phenotype in T Cells from Type 1 Diabetes Patients	PLOS ONE			English	Article							VITAMIN-D; RECEPTOR; IMMUNOMODULATION; PATHOGENESIS; EXPRESSION; FREQUENCY; EXPANSION; DEFECTS; FOXP3	The emergence of regulatory T cells (Tregs) as central mediators of peripheral tolerance in the immune system has led to an important area of clinical investigation to target these cells for the treatment of autoimmune diseases such as type 1 diabetes. We have demonstrated earlier that in vitro treatment of T cells from healthy individuals with TX527, a low-calcemic analog of bioactive vitamin D, can promote a CD4(+)CD25(high)CD127(low) regulatory profile and imprint a migratory signature specific for homing to sites of inflammation. Towards clinical application of vitamin D-induced Tregs in autologous adoptive immunotherapy for type 1 diabetes, we show here that 1,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3] and TX527 similarly imprint T cells from type 1 diabetes patients with a CD4(+)CD25(high)CD127(low) regulatory profile, modulate surface expression of skin- and inflammation-homing receptors, and increase expression of CTLA-4 and OX-40. Also, 1,25(OH)(2)D-3 and TX527 treatment inhibit the production of effector cytokines IFN-gamma, IL-9, and IL-17. Importantly, 1,25(OH)(2)D-3 and TX527 promote the induction of IL-10-producing CD4(+)CD25(high)CD127(low) T cells with a stable phenotype and the functional capacity to suppress proliferation of autologous responder T cells in vitro. These findings warrant additional validation of vitamin D-induced Tregs in view of future autologous adoptive immunotherapy in type 1 diabetes.	[Van Belle, Tom L.; Vanherwegen, An-Sofie; Feyaerts, Dorien; Verstuyf, Annemieke; Korf, Hannelie; Gysemans, Conny; Mathieu, Chantal] Katholieke Univ Leuven, Leuven, Belgium; [De Clercq, Pierre] Univ Ghent, Dept Organ Chem, Organ Synth Lab, B-9000 Ghent, Belgium	KU Leuven; Ghent University	Gysemans, C (corresponding author), Katholieke Univ Leuven, Leuven, Belgium.	conny.gysemans@med.kuleuven.be; chantal.mathieu@med.kuleuven.be	Feyaerts, Dorien/G-4184-2016; mathieu, chantal/ABD-5505-2021; Feyaerts, Dorien/S-2663-2017	mathieu, chantal/0000-0002-4055-5233; Vanherwegen, An-Sofie/0000-0002-0195-3060; Feyaerts, Dorien/0000-0002-0795-6625; Verstuyf, Annemieke/0000-0003-3193-2698; gysemans, conny/0000-0003-3559-6089; Korf, Hannelie/0000-0003-3540-0138	European Fund for the Study of Diabetes (EFSD); KU Leuven [KU LEUVEN GOA 2009/10, KU LEUVEN GOA 2014/10]; European Community's Health Seventh Framework Programme (FP7) [241447]; NAIMIT	European Fund for the Study of Diabetes (EFSD); KU Leuven(KU Leuven); European Community's Health Seventh Framework Programme (FP7); NAIMIT	TVB and this work were supported by grants from the European Fund for the Study of Diabetes (EFSD), the KU Leuven (KU LEUVEN GOA 2009/10 and 2014/10), and the European Community's Health Seventh Framework Programme (FP7/2009-2014 under grant agreement 241447 with acronym NAIMIT). CM is a clinical researcher of FWO (Flemish Research Council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Adorini L, 2004, J STEROID BIOCHEM, V89-90, P437, DOI 10.1016/j.jsbmb.2004.03.013; Adorini L, 2009, HUM IMMUNOL, V70, P345, DOI 10.1016/j.humimm.2009.01.016; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Baeke F, 2011, J IMMUNOL, V186, P132, DOI 10.4049/jimmunol.1000695; Baeke F, 2010, J STEROID BIOCHEM, V121, P221, DOI 10.1016/j.jsbmb.2010.03.037; Baeke F, 2008, MOL ASPECTS MED, V29, P376, DOI 10.1016/j.mam.2008.05.004; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Brusko T, 2007, DIABETES, V56, P604, DOI 10.2337/db06-1248; Brusko TM, 2008, IMMUNOL REV, V223, P371, DOI 10.1111/j.1600-065X.2008.00637.x; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Lawson JM, 2008, CLIN EXP IMMUNOL, V154, P353, DOI 10.1111/j.1365-2249.2008.03810.x; Lee WW, 2010, BLOOD, V115, P530, DOI 10.1182/blood-2009-08-236521; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Overbergh L, 2000, CLIN EXP IMMUNOL, V120, P139, DOI 10.1046/j.1365-2249.2000.01204.x; Putnam AL, 2005, J AUTOIMMUN, V24, P55, DOI 10.1016/j.jaut.2004.11.004; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; Roep BO, 2003, DIABETOLOGIA, V46, P305, DOI 10.1007/s00125-003-1089-5; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; Scotta C, 2013, HAEMATOLOGICA, V98, P1291, DOI 10.3324/haematol.2012.074088; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Spach KM, 2006, J IMMUNOL, V177, P6030, DOI 10.4049/jimmunol.177.9.6030; Staeva-Vieira TP, 2002, J IMMUNOL, V168, P1181, DOI 10.4049/jimmunol.168.3.1181; Takiishi T, 2013, PEDIATR DIABETES, V14, P81, DOI 10.1111/j.1399-5448.2012.00923.x; Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Van Belle TL, 2013, TRENDS ENDOCRIN MET, V24, P561, DOI 10.1016/j.tem.2013.07.002; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605	42	39	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109194	10.1371/journal.pone.0109194	http://dx.doi.org/10.1371/journal.pone.0109194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279717	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800060
J	Bloemen, M; Van Stappen, T; Willot, P; Lammertyn, J; Koeckelberghs, G; Geukens, N; Gils, A; Verbiest, T				Bloemen, Maarten; Van Stappen, Thomas; Willot, Pieter; Lammertyn, Jeroen; Koeckelberghs, Guy; Geukens, Nick; Gils, Ann; Verbiest, Thierry			Heterobifunctional PEG Ligands for Bioconjugation Reactions on Iron Oxide Nanoparticles	PLOS ONE			English	Article							CLICK CHEMISTRY; MAGNETITE NANOPARTICLES; ENDOTHELIAL-CELLS; CELLULAR UPTAKE; SURFACE-CHARGE; IMMOBILIZATION; NANOCRYSTALS; LIPASE; SIZE; STABILITY	Ever since iron oxide nanoparticles have been recognized as promising scaffolds for biomedical applications, their surface functionalization has become even more important. We report the synthesis of a novel polyethylene glycol-based ligand that combines multiple advantageous properties for these applications. The ligand is covalently bound to the surface via a siloxane group, while its polyethylene glycol backbone significantly improves the colloidal stability of the particle in complex environments. End-capping the molecule with a carboxylic acid introduces a variety of coupling chemistry possibilities. In this study an antibody targeting plasminogen activator inhibitor-1 was coupled to the surface and its presence and binding activity was assessed by enzyme-linked immunosorbent assay and surface plasmon resonance experiments. The results indicate that the ligand has high potential towards biomedical applications where colloidal stability and advanced functionality is crucial.	[Bloemen, Maarten; Willot, Pieter; Koeckelberghs, Guy; Verbiest, Thierry] Katholieke Univ Leuven, Dept Chem, Heverlee, Leuven, Belgium; [Van Stappen, Thomas; Gils, Ann] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium; [Lammertyn, Jeroen] Katholieke Univ Leuven, BIOSYST MeBioS, Heverlee, Leuven, Belgium; [Geukens, Nick] Katholieke Univ Leuven, KU Leuven Antibody Ctr, PharmAbs, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven	Bloemen, M (corresponding author), Katholieke Univ Leuven, Dept Chem, Heverlee, Leuven, Belgium.	maarten.bloemen@fys.kuleuven.be	Verbiest, Thierry/A-4393-2019	Verbiest, Thierry/0000-0002-0822-176X; Willot, Pieter/0000-0002-7554-2205; Koeckelberghs, Guy/0000-0003-1412-8454	Fund for Scientific Research Flanders (FWO-V) [G.0618.11 N]; Agency for Innovation by Science and Technology in Flanders (IWT); KU Leuven (GOA)	Fund for Scientific Research Flanders (FWO-V)(FWO); Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KU Leuven (GOA)(KU Leuven)	This work was financially supported by grant G.0618.11 N of the Fund for Scientific Research Flanders (FWO-V, www.fwo.be); the Agency for Innovation by Science and Technology in Flanders (IWT, www.iwt.be, MB TVS PW); and the KU Leuven (GOA, www.kuleuven.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bijnens AP, 2000, J BIOL CHEM, V275, P6375, DOI 10.1074/jbc.275.9.6375; Bloemen M, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1100-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brullot W, 2012, NANOMED-NANOTECHNOL, V8, P559, DOI 10.1016/j.nano.2011.09.004; Cao HN, 2009, APPL SURF SCI, V255, P7974, DOI 10.1016/j.apsusc.2009.04.199; Casals E, 2010, ACS NANO, V4, P3623, DOI 10.1021/nn901372t; Cui MH, 2014, NANO RES, V7, P345, DOI 10.1007/s12274-013-0400-0; Cui YJ, 2010, J BIOTECHNOL, V150, P171, DOI 10.1016/j.jbiotec.2010.07.013; Tran DT, 2012, J BIOTECHNOL, V158, P112, DOI 10.1016/j.jbiotec.2012.01.018; Declerck PJ, 2013, SEMIN THROMB HEMOST, V39, P356, DOI 10.1055/s-0033-1334487; Dixit CK, 2011, NAT PROTOC, V6, P439, DOI 10.1038/nprot.2011.304; Ge YQ, 2009, COLLOID SURFACE B, V73, P294, DOI 10.1016/j.colsurfb.2009.05.031; Gerion D, 2001, J PHYS CHEM B, V105, P8861, DOI 10.1021/jp0105488; Gils A, 2005, J THROMB HAEMOST, V3, P2745, DOI 10.1111/j.1538-7836.2005.01629.x; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Hoyle CE, 2010, ANGEW CHEM INT EDIT, V49, P1540, DOI 10.1002/anie.200903924; Jeong U, 2007, ADV MATER, V19, P33, DOI 10.1002/adma.200600674; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Larsen EKU, 2009, ACS NANO, V3, P1947, DOI 10.1021/nn900330m; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Lee N, 2012, CHEM SOC REV, V41, P2575, DOI 10.1039/c1cs15248c; Lin FH, 2011, NANO RES, V4, P1223, DOI 10.1007/s12274-011-0173-2; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynch I, 2008, NANO TODAY, V3, P40, DOI 10.1016/S1748-0132(08)70014-8; Mendoza A, 2014, CELL STRESS CHAPERON; Montenegro JM, 2013, ADV DRUG DELIVER REV, V65, P677, DOI 10.1016/j.addr.2012.12.003; Moses JE, 2007, CHEM SOC REV, V36, P1249, DOI 10.1039/b613014n; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Osaka T, 2009, COLLOID SURFACE B, V71, P325, DOI 10.1016/j.colsurfb.2009.03.004; Park EJ, 2010, TOXICOLOGY, V275, P65, DOI 10.1016/j.tox.2010.06.002; Park J, 2005, ANGEW CHEM INT EDIT, V44, P2872, DOI 10.1002/anie.200461665; Park J, 2004, NAT MATER, V3, P891, DOI 10.1038/nmat1251; Park J, 2007, ANGEW CHEM INT EDIT, V46, P4630, DOI 10.1002/anie.200603148; Petri-Fink A, 2008, EUR J PHARM BIOPHARM, V68, P129, DOI 10.1016/j.ejpb.2007.02.024; Pollet J, 2009, BIOSENS BIOELECTRON, V25, P864, DOI 10.1016/j.bios.2009.08.045; Ranjbakhsh E, 2012, CHEM ENG J, V179, P272, DOI 10.1016/j.cej.2011.10.097; Sapsford KE, 2013, CHEM REV, V113, P1904, DOI 10.1021/cr300143v; Shi BF, 2010, J MOL CATAL B-ENZYM, V63, P50, DOI 10.1016/j.molcatb.2009.12.003; Spivey AC, 2004, ANGEW CHEM INT EDIT, V43, P5436, DOI 10.1002/anie.200460373; Sun SH, 2004, J AM CHEM SOC, V126, P273, DOI 10.1021/ja0380852; Tartaj P, 2003, J PHYS D APPL PHYS, V36, pR182, DOI 10.1088/0022-3727/36/13/202; Trickler WJ, 2010, TOXICOL SCI, V118, P160, DOI 10.1093/toxsci/kfq244; Tucker-Schwartz AK, 2011, J AM CHEM SOC, V133, P11026, DOI 10.1021/ja202292q; Wang X, 2005, NATURE, V437, P121, DOI 10.1038/nature03968; Zhang S, 2011, J NANOPART RES, V13, P3867, DOI 10.1007/s11051-011-0339-6	46	25	26	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109475	10.1371/journal.pone.0109475	http://dx.doi.org/10.1371/journal.pone.0109475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275378	gold, Green Published, Green Submitted			2022-12-27	WOS:000342591500104
J	Cencic, R; Miura, H; Malina, A; Robert, F; Ethier, S; Schmeing, TM; Dostie, J; Pelletier, J				Cencic, Regina; Miura, Hisashi; Malina, Abba; Robert, Francis; Ethier, Sylvain; Schmeing, T. Martin; Dostie, Josee; Pelletier, Jerry			Protospacer Adjacent Motif (PAM)-Distal Sequences Engage CRISPR Cas9 DNA Target Cleavage	PLOS ONE			English	Article							NUCLEASE SPECIFICITY; ENDONUCLEASE CAS9; RNA; SYSTEMS; NICKASES; GENES; CELLS	The clustered regularly interspaced short palindromic repeat (CRISPR)-associated enzyme Cas9 is an RNA-guided nuclease that has been widely adapted for genome editing in eukaryotic cells. However, the in vivo target specificity of Cas9 is poorly understood and most studies rely on in silico predictions to define the potential off-target editing spectrum. Using chromatin immunoprecipitation followed by sequencing (ChIP-seq), we delineate the genome-wide binding panorama of catalytically inactive Cas9 directed by two different single guide (sg) RNAs targeting the Trp53 locus. Cas9: sgRNA complexes are able to load onto multiple sites with short seed regions adjacent to (5')NGG(3') protospacer adjacent motifs (PAM). Yet among 43 ChIP-seq sites harboring seed regions analyzed for mutational status, we find editing only at the intended on-target locus and one off-target site. In vitro analysis of target site recognition revealed that interactions between the 59 end of the guide and PAM-distal target sequences are necessary to efficiently engage Cas9 nucleolytic activity, providing an explanation for why off-target editing is significantly lower than expected from ChIP-seq data.	[Cencic, Regina; Miura, Hisashi; Malina, Abba; Robert, Francis; Ethier, Sylvain; Schmeing, T. Martin; Dostie, Josee; Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Miura, Hisashi; Dostie, Josee; Pelletier, Jerry] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada; [Pelletier, Jerry] McGill Univ, Dept Oncol, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Pelletier, J (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	jerry.pelletier@mcgill.ca		Malina, Abba/0000-0002-8511-9005	Canadian Institutes of Health Research (CIHR) [MOP-106615, MOP-86716]; CIHR [MOP-106530]; Richard and Edith Strauss Canada Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Richard and Edith Strauss Canada Foundation	This work is supported by the Canadian Institutes of Health Research (CIHR) to T.M.S. (MOP-106615) and J.D. (MOP-86716) and from CIHR (MOP-106530) and the Richard and Edith Strauss Canada Foundation to J.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiu H, 2013, GENETICS, V195, P1167, DOI 10.1534/genetics.113.155879; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malina A, 2013, GENE DEV, V27, P2602, DOI 10.1101/gad.227132.113; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rousseau M, 2014, NUCLEIC ACIDS RES, V42, P1524, DOI 10.1093/nar/gkt998; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	33	74	104	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109213	10.1371/journal.pone.0109213	http://dx.doi.org/10.1371/journal.pone.0109213			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275497	Green Submitted, Green Published, gold			2022-12-27	WOS:000342591500075
J	Dedeken, L; Chapusette, R; Le, PQ; Heijmans, C; Devalck, C; Huybrechts, S; Ziereisen, F; Hanssens, L; Rozen, L; Noubouossie, D; Mujinga, MN; Ferster, A				Dedeken, Laurence; Chapusette, Rudy; Phu Quoc Le; Heijmans, Catherine; Devalck, Christine; Huybrechts, Sophie; Ziereisen, France; Hanssens, Laurence; Rozen, Laurence; Noubouossie, Denis; Mujinga, Malou Ngalula; Ferster, Alina			Reduction of the Six-Minute Walk Distance in Children with Sickle Cell Disease Is Correlated with Silent Infarct: Results from a Cross-Sectional Evaluation in a Single Center in Belgium	PLOS ONE			English	Article							REGURGITANT JET VELOCITY; EXERCISE CAPACITY; PULMONARY-HYPERTENSION; FETAL-HEMOGLOBIN; ANEMIA; ADOLESCENTS; HEMOLYSIS; DESATURATION; BIOMARKER; DEATH	Background: The 6-minute walk test (6MWT) is used in adults and children affected by a wide range of chronic diseases to evaluate their sub-maximal exercise capacity. It reflects the global response of various physiological systems in a situation simulating a daily life activity. Methods: We analyzed factors affecting the 6MWT in 46 Sickle Cell Disease children. Forty-two were treated with hydroxyurea (HU). Patients with normal test (>80% of the age-standardized predicted value) were compared to patients with abnormal test (<= 80%). Baseline hematological values, clinical events, cerebrovascular disease, cardio-pulmonary parameters and disease-modifying treatment were compared according to the performance of the test. Results: Among the 46 patients, 14 had an abnormal 6MWT. In univariate analysis, both groups were similar for biological and clinical data. Six of the 14 patients with an abnormal 6MWT had silent infarct (SI) compared to 6/32 with a normal test (P = 0.09). When excluding chronically transfused patients, 4 of the 11 patients with an abnormal 6MWT had SI compared to 1/26 (P = 0.02). Baseline pulse oximetry was normal in both groups but slightly lower in patients with abnormal 6MWT (P = 0.02). No patient presented exercise-induced desaturation. In multivariate analysis, the only factor associated with abnormal 6MWT was the presence of SI (P = 0.045). Conclusions: In our cohort of 46 patients characterized by high exposure rate to HU and by the absence of severe cardiopulmonary disease, the sole factor independently associated with 6MWT was the presence of SI. The lower exercise capacity of children with SI may reflect some subclinical neurological impairment as they do not differ by hemoglobin level or cardiopulmonary parameters.	[Dedeken, Laurence; Chapusette, Rudy; Phu Quoc Le; Heijmans, Catherine; Devalck, Christine; Huybrechts, Sophie; Mujinga, Malou Ngalula; Ferster, Alina] Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, Dept Hematol & Oncol, Brussels, Belgium; [Ziereisen, France] Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, Dept Radiol, Brussels, Belgium; [Hanssens, Laurence] Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, Dept Pneumol & Allergol, Brussels, Belgium; [Rozen, Laurence; Noubouossie, Denis] Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, Ctr Hosp Univ Brugmann, Hematol Lab, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Dedeken, L (corresponding author), Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, Dept Hematol & Oncol, Brussels, Belgium.	laurence.dedeken@huderf.be	Noubouossie, Denis/AAH-9064-2020; Dedeken, Laurence/AAE-1120-2021	LE, PHU QUOC/0000-0003-3944-3012; Dedeken, Laurence/0000-0001-7829-6428; Hanssens, Laurence/0000-0002-5074-6711; Rozen, Laurence/0000-0003-4345-7409				Akinsheye I, 2011, BLOOD, V118, P19, DOI 10.1182/blood-2011-03-325258; Alameri HE, 2008, SAUDI MED J, V29, P707; Caboot JB, 2008, CURR OPIN PEDIATR, V20, P279, DOI 10.1097/MOP.0b013e3282ff62c4; Campbell A, 2009, BRIT J HAEMATOL, V147, P352, DOI 10.1111/j.1365-2141.2009.07854.x; Connes P, 2013, BRIT J HAEMATOL, V161, P484, DOI 10.1111/bjh.12300; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; DeBaun MR, 2012, BLOOD, V119, P3684, DOI 10.1182/blood-2011-05-349621; Desai PC, 2013, BRIT J HAEMATOL, V162, P836, DOI 10.1111/bjh.12453; Dham N, 2009, AM J CARDIOL, V104, P713, DOI 10.1016/j.amjcard.2009.04.034; Enright Paul L, 2003, Respir Care, V48, P783; Geiger R, 2007, J PEDIATR-US, V150, P395, DOI 10.1016/j.jpeds.2006.12.052; Goel R, 2011, ASH ANN M EXP 2011; Gordeuk VR, 2011, HAEMATOL-HEMATOL J, V96, P33, DOI 10.3324/haematol.2010.030767; Gordeuk VR, 2009, BLOOD, V114, P4639, DOI 10.1182/blood-2009-04-218040; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Lammers AE, 2011, ARCH DIS CHILD, V96, P141, DOI 10.1136/adc.2009.169904; Machado RF, 2011, BLOOD, V118, P855, DOI 10.1182/blood-2010-09-306167; MAIERREDELSPERGER M, 1994, BLOOD, V84, P3182, DOI 10.1182/blood.V84.9.3182.bloodjournal8493182; Minniti CR, 2009, HAEMATOL-HEMATOL J, V94, P340, DOI 10.3324/haematol.13812; Nourale M, 2013, HAEMATOLOGICA, V98, P464, DOI 10.3324/haematol.2012.068965; Quinn CT, 2005, BRIT J HAEMATOL, V131, P129, DOI 10.1111/j.1365-2141.2005.05738.x; Sachdev V, 2011, CIRCULATION, V124, P1452, DOI 10.1161/CIRCULATIONAHA.111.032920; Setty BNY, 2003, LANCET, V362, P1450, DOI 10.1016/S0140-6736(03)14689-2; Waltz X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077830	25	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108922	10.1371/journal.pone.0108922	http://dx.doi.org/10.1371/journal.pone.0108922			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275451	gold, Green Submitted, Green Published			2022-12-27	WOS:000342591500041
J	Kasoju, N; Kubies, D; Kumorek, MM; Kriz, J; Fabryova, E; Machova, L; Kovarova, J; Rypacek, F				Kasoju, Naresh; Kubies, Dana; Kumorek, Marta M.; Kriz, Jan; Fabryova, Eva; Machova, Lud'ka; Kovarova, Jana; Rypacek, Frantisek			Dip TIPS as a Facile and Versatile Method for Fabrication of Polymer Foams with Controlled Shape, Size and Pore Architecture for Bioengineering Applications	PLOS ONE			English	Article							HONEYCOMB MONOLITH STRUCTURE; PHASE-SEPARATION; SILK FIBROIN; SCAFFOLDS; MORPHOLOGY; DESIGN; POLYLACTIDE; TEMPERATURE; EVOLUTION; ACID	The porous polymer foams act as a template for neotissuegenesis in tissue engineering, and, as a reservoir for cell transplants such as pancreatic islets while simultaneously providing a functional interface with the host body. The fabrication of foams with the controlled shape, size and pore structure is of prime importance in various bioengineering applications. To this end, here we demonstrate a thermally induced phase separation (TIPS) based facile process for the fabrication of polymer foams with a controlled architecture. The setup comprises of a metallic template bar (T), a metallic conducting block (C) and a non-metallic reservoir tube (R), connected in sequence T-C-R. The process hereinafter termed as Dip TIPS, involves the dipping of the T-bar into a polymer solution, followed by filling of the R-tube with a freezing mixture to induce the phase separation of a polymer solution in the immediate vicinity of T-bar; Subsequent free-drying or freeze-extraction steps produced the polymer foams. An easy exchange of the T-bar of a spherical or rectangular shape allowed the fabrication of tubular, open-capsular and flat-sheet shaped foams. A mere change in the quenching time produced the foams with a thickness ranging from hundreds of microns to several millimeters. And, the pore size was conveniently controlled by varying either the polymer concentration or the quenching temperature. Subsequent in vivo studies in brown Norway rats for 4-weeks demonstrated the guided cell infiltration and homogenous cell distribution through the polymer matrix, without any fibrous capsule and necrotic core. In conclusion, the results show the "Dip TIPS" as a facile and adaptable process for the fabrication of anisotropic channeled porous polymer foams of various shapes and sizes for potential applications in tissue engineering, cell transplantation and other related fields.	[Kasoju, Naresh; Kubies, Dana; Kumorek, Marta M.; Machova, Lud'ka; Rypacek, Frantisek] Acad Sci Czech Republ, Inst Macromol Chem, Vvi, Dept Biomat & Bioanalogous Polymer Syst, Prague, Czech Republic; [Kriz, Jan; Fabryova, Eva] Inst Clin & Expt Med, Lab Islets Langerhans, Prague, Czech Republic; [Kovarova, Jana] Acad Sci Czech Republ, Inst Macromol Chem, Dept Polymer Proc, Vvi, Prague, Czech Republic	Czech Academy of Sciences; Institute of Macromolecular Chemistry of the Czech Academy of Sciences; Institute for Clinical & Experimental Medicine (IKEM); Czech Academy of Sciences; Institute of Macromolecular Chemistry of the Czech Academy of Sciences	Kubies, D (corresponding author), Acad Sci Czech Republ, Inst Macromol Chem, Vvi, Dept Biomat & Bioanalogous Polymer Syst, Prague, Czech Republic.	kubies@imc.cas.cz	Rypacek, Frantisek/G-7872-2014; Kriz, Jan/G-1067-2019; Kumorek, Marta/H-7374-2014; Kubies, Dana/H-7307-2014; Kasoju, Naresh/A-5295-2009; Machova, Ludka/O-4767-2015; Kovářová, Jana/H-1992-2014	Kriz, Jan/0000-0001-7695-3885; Kasoju, Naresh/0000-0002-8700-0729; 	Ministry of Education, Youth and Sports, Czech Republic [EE2.3.30.0029]; Ministry of Health, Czech Republic [00023001]; European Regional Development Fund (Project BIOCEV: Biotechnology and Biomedicine Centre of the Academy of Science and Charles University) [CZ.1.05/1.1.00/02.0109]	Ministry of Education, Youth and Sports, Czech Republic(Ministry of Education, Youth & Sports - Czech RepublicCzech Republic Government); Ministry of Health, Czech Republic(Ministry of Health, Czech RepublicCzech Republic Government); European Regional Development Fund (Project BIOCEV: Biotechnology and Biomedicine Centre of the Academy of Science and Charles University)	The study was funded by the Ministry of Education, Youth and Sports, Czech Republic (grant number EE2.3.30.0029, awarded to IMC, Prague), by the Ministry of Health, Czech Republic (grant number 00023001, awarded to ICEM, Prague as an institutional support for the development of research organization), and by the European Regional Development Fund (Project BIOCEV: Biotechnology and Biomedicine Centre of the Academy of Science and Charles University, grant number CZ.1.05/1.1.00/02.0109, awarded to IMC, Prague). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ARTIF ORGANS; Berthiaume F, 2011, ANNU REV CHEM BIOMOL, V2, P403, DOI 10.1146/annurev-chembioeng-061010-114257; BEYSENS D, 1995, PHYSICA A, V213, P71, DOI 10.1016/0378-4371(94)00149-N; Bhardwaj R, 2007, BIOMACROMOLECULES, V8, P2476, DOI 10.1021/bm070367x; Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3; Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F; Chen JS, 2010, J TAIWAN INST CHEM E, V41, P229, DOI 10.1016/j.jtice.2009.08.008; Fernandez J, 2012, J MECH BEHAV BIOMED, V9, P100, DOI 10.1016/j.jmbbm.2012.01.003; Goh YQ, 2008, J MATER SCI-MATER M, V19, P2445, DOI 10.1007/s10856-008-3366-9; Guarino V, 2012, J BIOMATER APPL, V27, P241, DOI 10.1177/0885328211401056; Gugerell A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090676; Hu XX, 2008, BIOMATERIALS, V29, P3128, DOI 10.1016/j.biomaterials.2008.04.010; Hua FJ, 2003, POLYMER, V44, P1911, DOI 10.1016/S0032-3861(03)00025-9; Jana S, 2013, ADV HEALTHC MATER, V2, P557, DOI 10.1002/adhm.201200177; Kasoju N, 2012, ADV HEALTHC MATER, V1, P393, DOI 10.1002/adhm.201200097; Kasoju N, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045004; Kasoju N, 2010, ADV ENG MATER, V12, pB139, DOI 10.1002/adem.200980055; Kennedy JP, 2011, ACTA BIOMATER, V7, P3896, DOI 10.1016/j.actbio.2011.06.037; Kim JW, 2008, CHEM ENG SCI, V63, P3858, DOI 10.1016/j.ces.2008.04.036; Kim JW, 2009, LANGMUIR, V25, P5304, DOI 10.1021/la804057e; Kotek J, 2011, EUR POLYM J, V47, P2197, DOI 10.1016/j.eurpolymj.2011.09.005; Kriz J, 2012, AM J SURG, V203, P793, DOI 10.1016/j.amjsurg.2011.02.009; Kubies D, 2000, BIOMATERIALS, V21, P529, DOI 10.1016/S0142-9612(99)00219-7; LACASTA AM, 1994, EUROPHYS LETT, V27, P291, DOI 10.1209/0295-5075/27/4/007; Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI 10.1205/cherd06196; Ma HY, 2010, ADV FUNCT MATER, V20, P2833, DOI 10.1002/adfm.201000922; Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H; Martinez-Perez CA, 2011, ADVANCES IN REGENERATIVE MEDICINE, P275; Masaeli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057157; Matsumura G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035760; Mitchell GR, 2013, PROCEDIA ENGINEER, V59, P117, DOI 10.1016/j.proeng.2013.05.100; Moriya A, 2009, J MEMBRANE SCI, V342, P307, DOI 10.1016/j.memsci.2009.07.005; Nagarani N, 2014, RENEW SUST ENERG REV, V29, P604, DOI 10.1016/j.rser.2013.08.068; Nam YS, 1999, BIOMATERIALS, V20, P1783, DOI 10.1016/S0142-9612(99)00073-3; Pang YY, 2011, J APPL POLYM SCI, V121, P445, DOI 10.1002/app.33686; Ravari F, 2013, POLYM BULL, V70, P2569, DOI 10.1007/s00289-013-0972-6; Rigby SP, 2003, APPL CATAL A-GEN, V238, P303, DOI 10.1016/S0926-860X(02)00348-4; Sakiyama-Elbert SE, 2001, ANNU REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183; Shastri VP, 2000, P NATL ACAD SCI USA, V97, P1970, DOI 10.1073/pnas.97.5.1970; Silva MMCG, 2006, BIOMATERIALS, V27, P5909, DOI 10.1016/j.biomaterials.2006.08.010; Sun CH, 2012, MACROMOL BIOSCI, V12, P761, DOI 10.1002/mabi.201200004; Thirumaleshwar M, 2009, FUNDAMENTALS HEAT MA, P221; Vrana NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020480; Wang H, 2000, EUROPHYS LETT, V50, P622, DOI 10.1209/epl/i2000-00315-2; Wang HLS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055241, 10.1371/journal.pone.0056330]; Xiao L, 2012, BIOMED SCI ENG TECHN, P247, DOI [DOI 10.5772/23927, 10.5772/23927]; Yang F, 2006, BIOMATERIALS, V27, P4923, DOI 10.1016/j.biomaterials.2006.05.028; Yang MC, 1998, J POLYM RES-TAIWAN, V5, P213, DOI 10.1007/s10965-006-0059-2; Zhai WT, 2009, INT J MOL SCI, V10, P5381, DOI 10.3390/ijms10125381; Zhu JZ, 2001, MODEL SIMUL MATER SC, V9, P499, DOI 10.1088/0965-0393/9/6/303	50	12	12	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108792	10.1371/journal.pone.0108792	http://dx.doi.org/10.1371/journal.pone.0108792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275373	Green Submitted, Green Published, gold			2022-12-27	WOS:000342591500032
J	Liu, J; Wang, LY; Liu, WJ; Li, Q; Jin, ZL; Jin, Y				Liu, Jia; Wang, Liying; Liu, Wenjia; Li, Qiang; Jin, Zuolin; Jin, Yan			Dental Follicle Cells Rescue the Regenerative Capacity of Periodontal Ligament Stem Cells in an Inflammatory Microenvironment	PLOS ONE			English	Article							OSTEOGENIC DIFFERENTIATION; TISSUE REGENERATION; ENDOTHELIAL-CELLS; PROLIFERATION; PROTEINS; DELIVERY	Aims: Periodontal ligament stem cells (PDLSCs) are one of the best candidates for periodontal regeneration. Their function could be impaired in periodontitis microenvironment. Dental follicle cells (DFCs), serving as precursor cells and mesenchymal stem cells, have intimate connection with PDLSCs. However, it is still unknown whether DFCs could provide a favorable microenvironment to improve the proliferation and differentiation capacity of PDLSCs from healthy subjects (HPDLSCs) and patients diagnosed with periodontitis (PPDLSCs). Methods: HPDLSCs, PPDLSCs and DFCs were harvested and identified using microscopic and flow cytometric analysis. Then, the coculture systems of DFCs/HPDLSCs and DFCs/PPDLSCs were established with 0.4 mu m transwell, in which all the detection indexs were obtained from HPDLSCs and PPDLSCs. The expression of stemness-associated genes was detected by real-time PCR, and the proliferation ability was assessed using colony formation and cell cycle assays. The osteogenic differentiation capacity was evaluated by real-time PCR, western blot, ALP activity, Alizarin Red S staining and calcium level analysis, while the adipogenic differentiation capacity was determined by real-time PCR and Oil Red O staining. The cell sheet formation in vitro was observed by HE staining and SEM, and the implantation effect in vivo was evaluated using HE staining and Masson's trichrome staining. Results: PPDLSCs had a greater proliferation capability but lower osteogenic and adipogenic potential than HPDLSCs. DFCs enhanced the proliferation and osteogenic/adipogenic differentiation of HPDLSCs and PPDLSCs to different degrees. Moreover, coculture with DFCs increased cell layers and extracellular matrix of HPDLSCs/PPDLSCs cell sheets in vitro and improved periodontal regeneration by HPDLSCs/PPDLSCs in vivo. Conclusions: Our data suggest that the function of PPDLSCs could be damaged in the periodontitis microenvironment. DFCs appear to enhance the self-renewal and multi-differentiation capacity of both HPDLSCs and PPDLSCs, which indicates that DFCs could provide a beneficial microenvironment for periodontal regeneration using PDLSCs.	[Liu, Jia; Wang, Liying; Jin, Zuolin] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Orthodont, Sch Stomatol, Xian 710032, Shaanxi, Peoples R China; [Liu, Jia; Wang, Liying; Liu, Wenjia; Jin, Yan] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Ctr Tissue Engn, Sch Stomatol, Xian 710032, Shaanxi, Peoples R China; [Liu, Wenjia; Jin, Yan] Fourth Mil Med Univ, Res & Dev Ctr Tissue Engn, Xian 710032, Shaanxi, Peoples R China; [Li, Qiang] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Gen Dent & Emergency, Sch Stomatol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Jin, Y (corresponding author), Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Orthodont, Sch Stomatol, Xian 710032, Shaanxi, Peoples R China.	zuolinj@fmmu.edu.cn; yanjin@fmmu.edu.cn	Jin, Yan/I-4204-2013	Liu, Jia/0000-0002-3510-0082	Nature Science Foundation of China [31030033, 81271176]; National Basic Research Program (973 Program) [2010CB944800, 2011CB964700]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program)(National Basic Research Program of China)	This work was supported by grants from the Nature Science Foundation of China (31030033 and 81271176) and the National Basic Research Program (973 Program) (2010CB944800 and 2011CB964700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005; Bai YD, 2011, BONE, V48, P1417, DOI 10.1016/j.bone.2011.02.016; Chen FM, 2006, J CONTROL RELEASE, V114, P209, DOI 10.1016/j.jconrel.2006.05.014; Chen FM, 2010, TISSUE ENG PART B-RE, V16, P219, DOI [10.1089/ten.teb.2009.0562, 10.1089/ten.TEB.2009.0562]; Chen FM, 2012, BIOMATERIALS, V33, P6320, DOI 10.1016/j.biomaterials.2012.05.048; Chen FM, 2010, BIOMATERIALS, V31, P7892, DOI 10.1016/j.biomaterials.2010.07.019; Douglass Gordon L, 2005, J Calif Dent Assoc, V33, P203; Grzesik WJ, 2002, CRIT REV ORAL BIOL M, V13, P474, DOI 10.1177/154411130201300605; Guo WH, 2009, BIOMATERIALS, V30, P6708, DOI 10.1016/j.biomaterials.2009.08.034; Kin T, 2003, AM J TRANSPLANT, V3, P281, DOI 10.1034/j.1600-6143.2003.00049.x; Lin NH, 2009, PERIODONTOL 2000, V51, P239, DOI 10.1111/j.1600-0757.2009.00303.x; Liu N, 2011, J BONE MINER RES, V26, P2082, DOI 10.1002/jbmr.440; Liu W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.65; Ma ZF, 2008, TISSUE ENG PT A, V14, P2059, DOI 10.1089/ten.tea.2008.0021; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Mizuno N, 2008, J PERIODONTOL, V79, P2361, DOI [10.1902/jop.2008.070577, 10.1902/jop.2008.070577 ]; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Morsczeck C, 2010, J DENT RES, V89, P445, DOI 10.1177/0022034510366899; Nanci A, 2006, PERIODONTOL 2000, V40, P11, DOI 10.1111/j.1600-0757.2005.00141.x; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Peng L, 2009, INT J ORAL SCI, V1, P6, DOI 10.4248/ijos.08032; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Plotnikov M, 2008, B EXP BIOL MED+, V146, P45, DOI 10.1007/s10517-008-0202-7; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; Pandula PKC, 2014, J PERIODONTAL RES, V49, P299, DOI 10.1111/jre.12107; Pricola KL, 2009, J CELL BIOCHEM, V108, P577, DOI 10.1002/jcb.22289; Rajnicek AM, 2008, BIOMATERIALS, V29, P2082, DOI 10.1016/j.biomaterials.2008.01.015; Ramseier Christoph A, 2006, Dent Clin North Am, V50, P245, DOI 10.1016/j.cden.2005.12.001; Rios HF, 2011, J PERIODONTOL, V82, P1223, DOI 10.1902/jop.2011.100710; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Soleymaninejadian E, 2012, AM J REPROD IMMUNOL, V67, P1, DOI 10.1111/j.1600-0897.2011.01069.x; Song AM, 2007, CELL PROLIFERAT, V40, P381, DOI 10.1111/j.1365-2184.2007.00441.x; Trottier V, 2008, STEM CELLS, V26, P2713, DOI 10.1634/stemcells.2008-0031; von Bahr L, 2012, BIOL BLOOD MARROW TR, V18, P557, DOI 10.1016/j.bbmt.2011.07.023; Wu JY, 2012, J ENDODONT, V38, P614, DOI 10.1016/j.joen.2012.01.014; Wu Y, 2013, J PERIODONTAL RES, V48, P52, DOI 10.1111/j.1600-0765.2012.01503.x; Yang ZH, 2009, TISSUE ENG PART C-ME, V15, P571, DOI 10.1089/ten.tec.2008.0561; Zhang J, 2012, BIOMATERIALS, V33, P6974, DOI 10.1016/j.biomaterials.2012.06.032; Zhang WB, 2009, METHODS, V47, P122, DOI 10.1016/j.ymeth.2008.09.004; Zheng W, 2009, TISSUE ENG PT A, V15, P2363, DOI 10.1089/ten.tea.2008.0562	40	26	31	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e108752	10.1371/journal.pone.0108752	http://dx.doi.org/10.1371/journal.pone.0108752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275580	gold, Green Submitted, Green Published			2022-12-27	WOS:000342591500029
J	Wuethrich, I; Peeters, JGC; Blom, AEM; Theile, CS; Li, ZY; Spooner, E; Ploegh, HL; Guimaraes, CP				Wuethrich, Irene; Peeters, Janneke G. C.; Blom, Annet E. M.; Theile, Christopher S.; Li, Zeyang; Spooner, Eric; Ploegh, Hidde L.; Guimaraes, Carla P.			Site-Specific Chemoenzymatic Labeling of Aerolysin Enables the Identification of New Aerolysin Receptors	PLOS ONE			English	Article							FORMING TOXIN AEROLYSIN; GPI-ANCHORED PROTEINS; CHANNEL; SORTASE; ACTIVATION; BINDING; OLIGOMERIZATION; TRANSMEMBRANE; INTOXICATION; PROAEROLYSIN	Aerolysin is a secreted bacterial toxin that perforates the plasma membrane of a target cell with lethal consequences. Previously explored native and epitope-tagged forms of the toxin do not allow site-specific modification of the mature toxin with a probe of choice. We explore sortase-mediated transpeptidation reactions (sortagging) to install fluorophores and biotin at three distinct sites in aerolysin, without impairing binding of the toxin to the cell membrane and with minimal impact on toxicity. Using a version of aerolysin labeled with different fluorophores at two distinct sites we followed the fate of the C-terminal peptide independently from the N-terminal part of the toxin, and show its loss in the course of intoxication. Making use of the biotinylated version of aerolysin, we identify mesothelin, urokinase plasminogen activator surface receptor (uPAR, CD87), glypican-1, and CD59 glycoprotein as aerolysin receptors, all predicted or known to be modified with a glycosylphosphatidylinositol anchor. The sortase-mediated reactions reported here can be readily extended to other pore forming proteins.	[Wuethrich, Irene; Peeters, Janneke G. C.; Blom, Annet E. M.; Theile, Christopher S.; Li, Zeyang; Spooner, Eric; Ploegh, Hidde L.; Guimaraes, Carla P.] MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Ploegh, HL (corresponding author), MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA.	ploegh@wi.mit.edu	Blom, Annet/S-8615-2019; Li, Zeyang/AAS-2294-2021; Li, Zeyang/I-8901-2019	Peeters, Janneke/0000-0002-5777-4352	 [R01 AI087879]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087879] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by R01 AI087879, http://grants.nih.gov/grants/funding/r01.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2002, FEBS LETT, V512, P249, DOI 10.1016/S0014-5793(02)02274-3; Abrami L, 1998, J BIOL CHEM, V273, P32656, DOI 10.1074/jbc.273.49.32656; Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Abrami L, 1999, J CELL BIOL, V147, P175, DOI 10.1083/jcb.147.1.175; Alouf J., 2005, COMPREHENSIVE SOURCE; Andrew AJ, 2011, J BIOL CHEM, V286, P39967, DOI 10.1074/jbc.M111.287011; Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Barry R, 2001, J BIOL CHEM, V276, P551, DOI 10.1074/jbc.M008097200; BERNHEIMER AW, 1974, INFECT IMMUN, V9, P1016, DOI 10.1128/IAI.9.6.1016-1021.1974; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Cowell S, 1997, MOL MICROBIOL, V25, P343, DOI 10.1046/j.1365-2958.1997.4691828.x; Degiacomi MT, 2013, NAT CHEM BIOL, V9, P623, DOI [10.1038/NCHEMBIO.1312, 10.1038/nchembio.1312]; Diep DB, 1998, J BIOL CHEM, V273, P2355, DOI 10.1074/jbc.273.4.2355; Diep DB, 1998, MOL MICROBIOL, V30, P341, DOI 10.1046/j.1365-2958.1998.01068.x; Fennessey CM, 2012, MOL BIOSYST, V8, P2097, DOI 10.1039/c2mb25142f; Fivaz M, 1999, J BIOL CHEM, V274, P37705, DOI 10.1074/jbc.274.53.37705; Guimaraes CP, 2013, NAT PROTOC, V8, P1787, DOI 10.1038/nprot.2013.101; Guimaraes CP, 2011, J CELL BIOL, V195, P751, DOI 10.1083/jcb.201108103; Hess GT, 2013, ACS SYNTH BIOL, V2, P490, DOI 10.1021/sb400019s; Hess GT, 2012, BIOCONJUGATE CHEM, V23, P1478, DOI 10.1021/bc300130z; Hirakawa H, 2012, BIOTECHNOL BIOENG, V109, P2955, DOI 10.1002/bit.24585; Hong YJ, 2002, EMBO J, V21, P5047, DOI 10.1093/emboj/cdf508; HOWARD SP, 1985, J BACTERIOL, V163, P336, DOI 10.1128/JB.163.1.336-340.1985; HOWARD SP, 1982, BIOCHEMISTRY-US, V21, P1662, DOI 10.1021/bi00536a029; Iacovache I, 2006, EMBO J, V25, P457, DOI 10.1038/sj.emboj.7600959; Iacovache I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002135; Krause KH, 1998, J BIOL CHEM, V273, P18122, DOI 10.1074/jbc.273.29.18122; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MacKenzie CR, 1999, J BIOL CHEM, V274, P22604, DOI 10.1074/jbc.274.32.22604; Moniatte M, 1996, FEBS LETT, V384, P269, DOI 10.1016/0014-5793(96)00328-6; Nelson KL, 1997, J BIOL CHEM, V272, P12170, DOI 10.1074/jbc.272.18.12170; Pernot L, 2010, ACTA CRYSTALLOGR F, V66, P1626, DOI 10.1107/S1744309110041035; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Popp Maximilian Wei-Lin, 2009, Curr Protoc Protein Sci, VChapter 15, DOI 10.1002/0471140864.ps1503s56; Popp MWL, 2011, ANGEW CHEM INT EDIT, V50, P5024, DOI 10.1002/anie.201008267; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Theile CS, 2013, NAT PROTOC, V8, P1800, DOI 10.1038/nprot.2013.102; Tsitrin Y, 2002, NAT STRUCT BIOL, V9, P729, DOI 10.1038/nsb839; TUCKER AD, 1990, J MOL BIOL, V212, P561, DOI 10.1016/0022-2836(90)90222-8; VANDERGOOT FG, 1992, BIOCHEMISTRY-US, V31, P8566, DOI 10.1021/bi00151a026; VANDERGOOT FG, 1994, J BIOL CHEM, V269, P30496; VANDERGOOT FG, 1993, J BIOL CHEM, V268, P18272; VANDERGOOT FG, 1993, BIOCHEMISTRY-US, V32, P2636, DOI 10.1021/bi00061a023; WILMSEN HU, 1990, J MEMBRANE BIOL, V115, P71, DOI 10.1007/BF01869107; WILMSEN HU, 1992, EMBO J, V11, P2457, DOI 10.1002/j.1460-2075.1992.tb05310.x; Witte MD, 2013, NAT PROTOC, V8, P1808, DOI 10.1038/nprot.2013.103	48	33	33	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109883	10.1371/journal.pone.0109883	http://dx.doi.org/10.1371/journal.pone.0109883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275512	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500115
J	Zheng, BH; Huang, ZY; Li, JL				Zheng, Buhong; Huang, Zhiyu; Li, Jinluan			The Effects of the Shape and Size of the Clinical Target Volume on the Planning Target Volume Margin	PLOS ONE			English	Article							GEOMETRICAL UNCERTAINTIES; RADIOTHERAPY; PROBABILITY	Purpose: To investigate the impact of clinical target volume (CTV) shape and size on CTV to planning target volume (PTV) margin expansion. Methods and Materials: Using numerical integration methods, margins accounting for random errors and systematic errors were calculated for CTVs of different shapes and sizes. We use k(r-95) and k(s-95) to represent the coefficients, for random errors and systematic errors, respectively, that ensure that every point of the CTV receives >= 95% of the prescribed dose. Results: The part of the margin accounting for random errors depends on CTV shape and size; generally, a convex part of a CTV would have a larger margin than a concave part. However, the part of the margin accounting for systematic errors is independent of CTV shape and size. Conclusions: CTV shape and size should be considered when generating a PTV. For a complex CTV, the margins of the various parts of the CTV are different and related to local forms.	[Zheng, Buhong; Huang, Zhiyu; Li, Jinluan] Fujian Med Univ, Teaching Hosp, Dept Radiat Oncol, Fujian Prov Canc Hosp, Fuzhou, Fujian, Peoples R China	Fujian Medical University	Li, JL (corresponding author), Fujian Med Univ, Teaching Hosp, Dept Radiat Oncol, Fujian Prov Canc Hosp, Fuzhou, Fujian, Peoples R China.	lijinluan@pku.org.cn	Li, Jinluan/J-8096-2013	Li, Jinluan/0000-0002-3533-898X; Zheng, Buhong/0000-0003-2886-2270	National Clinical Key Specialty Construction Program; Key Clinical Specialty Discipline Construction Program of Fujian, P. R. China; Fujian Province Natural Science Foundation [2012J05139]	National Clinical Key Specialty Construction Program; Key Clinical Specialty Discipline Construction Program of Fujian, P. R. China; Fujian Province Natural Science Foundation(Natural Science Foundation of Fujian Province)	This work was supported by National Clinical Key Specialty Construction Program, Key Clinical Specialty Discipline Construction Program of Fujian, P. R. China and Fujian Province Natural Science Foundation (No. 2012J05139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolak JA, 1999, INT J RADIAT ONCOL, V44, P1165, DOI 10.1016/S0360-3016(99)00117-0; Antolak JA, 1998, INT J RADIAT ONCOL, V42, P661, DOI 10.1016/S0360-3016(98)00248-X; AustinSeymour M, 1995, INT J RADIAT ONCOL, V33, P1073, DOI 10.1016/0360-3016(95)00217-0; Craig T, 2001, INT J RADIAT ONCOL, V49, P241, DOI 10.1016/S0360-3016(00)01354-7; Hodapp N, 2012, STRAHLENTHER ONKOL, V188, P97, DOI 10.1007/s00066-011-0015-x; Kutcher, 1995, Semin Radiat Oncol, V5, P134, DOI 10.1016/S1053-4296(95)80006-9; Mageras GS, 1999, INT J RADIAT ONCOL, V43, P437, DOI 10.1016/S0360-3016(98)00386-1; Stroom JC, 1999, INT J RADIAT ONCOL, V43, P905, DOI 10.1016/S0360-3016(98)00468-4; Stroom JC, 2002, RADIOTHER ONCOL, V64, P75, DOI 10.1016/S0167-8140(02)00140-8; van Herk M, 2000, INT J RADIAT ONCOL, V47, P1121, DOI 10.1016/S0360-3016(00)00518-6; Witte MG, 2004, MED PHYS, V31, P3068, DOI 10.1118/1.1809991; Zhang Q, 2012, IJMPCERO, V1, P15, DOI [10.4236/ijmpcero.2012.12003, DOI 10.4236/IJMPCERO.2012.12003]; Zhang QH, 2013, MED PHYS, V40, DOI 10.1118/1.4829517	13	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109244	10.1371/journal.pone.0109244	http://dx.doi.org/10.1371/journal.pone.0109244			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275442	Green Published, gold, Green Submitted			2022-12-27	WOS:000342591500081
J	Carneiro, E; Mielke, OHH; Casagrande, MM; Fiedler, K				Carneiro, Eduardo; Hendrik Mielke, Olaf Hermann; Casagrande, Mirna Martins; Fiedler, Konrad			Community Structure of Skipper Butterflies (Lepidoptera, Hesperiidae) along Elevational Gradients in Brazilian Atlantic Forest Reflects Vegetation Type Rather than Altitude	PLOS ONE			English	Article							PHYLOGENETIC BETA DIVERSITY; SPECIES-RICHNESS; DISTRIBUTION PATTERNS; GEOMETRID MOTHS; SCALE; NYMPHALIDAE; SATYRINAE; HABITAT; PAPILIONOIDEA; DETERMINANTS	Species turnover across elevational gradients has matured into an important paradigm of community ecology. Here, we tested whether ecological and phylogenetic structure of skipper butterfly assemblages is more strongly structured according to altitude or vegetation type along three elevation gradients of moderate extent in Serra do Mar, Southern Brazil. Skippers were surveyed along three different mountain transects, and data on altitude and vegetation type of every collection site were recorded. NMDS ordination plots were used to assess community turnover and the influence of phylogenetic distance between species on apparent community patterns. Ordinations based on ecological similarity (Bray-Curtis index) were compared to those based on phylogenetic distance measures (MPD and MNTD) derived from a supertree. In the absence of a well-resolved phylogeny, various branch length transformation methods were applied together with four different null models, aiming to assess if results were confounded by low-resolution trees. Species composition as well as phylogenetic community structure of skipper butterflies were more prominently related to vegetation type instead of altitude per se. Phylogenetic distances reflected spatial community patterns less clearly than species composition, but revealed a more distinct fauna of monocot feeders associated with grassland habitats, implying that historical factors have played a fundamental role in shaping species composition across elevation gradients. Phylogenetic structure of community turned out to be a relevant additional tool which was even superior to identify faunal contrasts between forest and grassland habitats related to deep evolutionary splits. Since endemic skippers tend to occur in grassland habitats in the Serra do Mar, inclusion of phylogenetic diversity may also be important for conservation decisions.	[Carneiro, Eduardo; Hendrik Mielke, Olaf Hermann; Casagrande, Mirna Martins] UFPR, Dept Zool, Lab Estudos Lepidoptera Neotrop, Curitiba, Parana, Brazil; [Fiedler, Konrad] Univ Vienna, Div Trop Ecol & Anim Biodivers, Vienna, Austria	Universidade Federal do Parana; University of Vienna	Carneiro, E (corresponding author), UFPR, Dept Zool, Lab Estudos Lepidoptera Neotrop, Curitiba, Parana, Brazil.	carneiroeduardo@hotmail.com	Casagrande, Mirna M/C-4590-2013; Fiedler, Konrad/H-8788-2019; Carneiro, Eduardo/C-6739-2013; Carneiro, Eduardo/AAO-4991-2020; Mielke, Olaf H H/C-4986-2013; Casagrande, Mirna Martins/AAG-6074-2020	Casagrande, Mirna M/0000-0002-6076-8463; Fiedler, Konrad/0000-0002-4789-3753; Carneiro, Eduardo/0000-0002-4796-0020; Carneiro, Eduardo/0000-0002-4796-0020; Mielke, Olaf H H/0000-0003-3655-4606; Casagrande, Mirna Martins/0000-0002-6076-8463	CNPq; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding was provided by CNPq and CAPES to EC as a doctoral scholarship. OHHM and MMC are granted with "Produtividade de Pesquisa"; see (http://www.cnpq.br/web/guest/apresentacao13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abilhoa V, 2004, LIVRO VERMELHO FAUNA, P581; Axmacher JC, 2008, TROP ZOOL, V21, P243; Axmacher JC, 2009, J BIOGEOGR, V36, P337, DOI 10.1111/j.1365-2699.2008.01997.x; Beccaloni George W., 2008, m3m Monografias Tercer Milenio, V8, P1; Beck J, 2007, J ANIM ECOL, V76, P230, DOI 10.1111/j.1365-2656.2006.01189.x; Behling H, 2002, PALAEOGEOGR PALAEOCL, V177, P19, DOI 10.1016/S0031-0182(01)00349-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brehm G, 2004, J TROP ECOL, V20, P165, DOI 10.1017/S0266467403001184; Brehm G, 2013, ECOGRAPHY, V36, P1247, DOI 10.1111/j.1600-0587.2013.00030.x; Brown KS, 2000, BIOTROPICA, V32, P934, DOI 10.1646/0006-3606(2000)032[0934:AFBIFL]2.0.CO;2; Cadotte MW, 2010, DIVERS DISTRIB, V16, P892, DOI 10.1111/j.1472-4642.2010.00700.x; Carneiro E, 2014, NEOTROP ENTOMOL, V43, P27, DOI 10.1007/s13744-013-0175-8; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 2009, PRIMER WINDOWS; de Almeida FFM, 2000, EARTH-SCI REV, V50, P77, DOI 10.1016/S0012-8252(99)00072-0; Dolibaina Diego Rodrigo, 2011, Biota Neotropica, V11, P1; Evans WH, 1955, CATALOGUE AM HESPERI; Forster J. R., 1778, OBSERVATIONS MADE VO; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Gutierrez D, 1997, J BIOGEOGR, V24, P77, DOI 10.1111/j.1365-2699.1997.tb00052.x; Illan JG, 2010, J BIOGEOGR, V37, P1706, DOI 10.1111/j.1365-2699.2010.02314.x; Hawkins BA, 2010, J BIOGEOGR, V37, P647, DOI 10.1111/j.1365-2699.2009.02250.x; Heikkila M, 2012, P ROY SOC B-BIOL SCI, V279, P1093, DOI 10.1098/rspb.2011.1430; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Hoiss B, 2012, P ROY SOC B-BIOL SCI, V279, P4447, DOI 10.1098/rspb.2012.1581; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Legendre P, 2013, NUMERICAL ECOLOGY; Lien VV, 2003, BIODIVERS CONSERV, V12, P1099, DOI 10.1023/A:1023038923000; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Machac A, 2011, ECOGRAPHY, V34, P364, DOI 10.1111/j.1600-0587.2010.06629.x; Machado ABM, 2008, LIVRO VERMELHO FAUNA; MADDISON W.P., 2001, MESQUITE MODULAR SYS; Martinelli Gustavo, 2007, Braz. J. Bot., V30, P587, DOI 10.1590/S0100-84042007000400005; Midford PE, 2009, PDAP PDTREE PACKAGE; MINCHIN PR, 1987, VEGETATIO, V69, P89, DOI 10.1007/BF00038690; Munoz A, 2010, REV COLOMB ENTOMOL, V36, P292; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; Novotny V, 2005, ANN ZOOL FENN, V42, P463; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; Pe'er G, 2013, OIKOS, V122, P1483, DOI 10.1111/j.1600-0706.2013.00198.x; Pellissier L, 2013, ECOL LETT, V16, P600, DOI 10.1111/ele.12083; Pellissier L, 2012, ECOGRAPHY, V35, P684, DOI 10.1111/j.1600-0587.2011.07047.x; Pena C, 2006, MOL PHYLOGENET EVOL, V40, P29, DOI 10.1016/j.ympev.2006.02.007; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Pyrcz TW, 2009, NEOTROP ENTOMOL, V38, P716, DOI 10.1590/S1519-566X2009000600003; Pyrcz TW, 2002, GLOBAL ECOL BIOGEOGR, V11, P211, DOI 10.1046/j.1466-822X.2002.00285.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Robinson GS, 2010, DATABASE WORLDS LEPI; Roderjan CV, 1992, CARACTERIZACAO PROPO; Roderjan CV, 2002, CIENC E AMBIENTE, V26, P693; Sanderson MJ, 1998, TRENDS ECOL EVOL, V13, P105, DOI 10.1016/S0169-5347(97)01242-1; Storch D, 2003, J BIOGEOGR, V30, P1195, DOI 10.1046/j.1365-2699.2003.00917.x; Suttie J. M., 2006, P1; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Von Humboldt A., 1849, ASPECTS NATURE DIFFE; Wahlberg N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080875; Warren AD, 2008, CLADISTICS, V24, P642, DOI 10.1111/j.1096-0031.2008.00218.x; Warren AD, 2009, SYST ENTOMOL, V34, P467, DOI 10.1111/j.1365-3113.2008.00463.x; Webb C. O., 2011, PHYLOCOM SOFTWARE AN; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; WHITTAKER RH, 1952, ECOL MONOGR, V22, P1, DOI 10.2307/1948527	69	15	18	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108207	10.1371/journal.pone.0108207	http://dx.doi.org/10.1371/journal.pone.0108207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272004	gold, Green Published, Green Submitted			2022-12-27	WOS:000343729600032
J	Rossow, H; Forbes, KM; Tarkka, E; Kinnunen, PM; Hemmila, H; Huitu, O; Nikkari, S; Henttonen, H; Kipar, A; Vapalahti, O				Rossow, Heidi; Forbes, Kristian M.; Tarkka, Eveliina; Kinnunen, Paula M.; Hemmila, Heidi; Huitu, Otso; Nikkari, Simo; Henttonen, Heikki; Kipar, Anja; Vapalahti, Olli			Experimental Infection of Voles with Francisella tularensis Indicates Their Amplification Role in Tularemia Outbreaks	PLOS ONE			English	Article							EPIDEMIOLOGY; TRANSMISSION; HOLARCTICA; MOSQUITOS; SURVIVAL; RISK	Tularemia outbreaks in humans have been linked to fluctuations in rodent population density, but the mode of bacterial maintenance in nature is unclear. Here we report on an experiment to investigate the pathogenesis of Francisella tularensis infection in wild rodents, and thereby assess their potential to spread the bacterium. We infected 20 field voles (Microtus agrestis) and 12 bank voles (Myodes glareolus) with a strain of F. tularensis ssp. holarctica isolated from a human patient. Upon euthanasia or death, voles were necropsied and specimens collected for histological assessment and identification of bacteria by immunohistology and PCR. Bacterial excretion and a rapid lethal clinical course with pathological changes consistent with bacteremia and tissue necrosis were observed in infected animals. The results support a role for voles as an amplification host of F. tularensis, as excreta and, in particular, carcasses with high bacterial burden could serve as a source for environmental contamination.	[Rossow, Heidi; Kipar, Anja; Vapalahti, Olli] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland; [Forbes, Kristian M.] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Tarkka, Eveliina; Vapalahti, Olli] Univ Helsinki, Hosp Lab HUSLAB, Div Clin Microbiol, Helsinki, Finland; [Kinnunen, Paula M.; Hemmila, Heidi; Nikkari, Simo] Finnish Def Forces, Ctr Mil Med, Ctr Biothreat Preparedness, Helsinki, Finland; [Forbes, Kristian M.; Huitu, Otso; Henttonen, Heikki] Finnish Forest Res Inst, FIN-01301 Vantaa, Finland; [Kipar, Anja] Univ Helsinki, Fac Vet Med, Finnish Ctr Lab Anim Pathol, Helsinki, Finland; [Kipar, Anja] Univ Liverpool, Sch Vet Sci, Liverpool L69 3BX, Merseyside, England; [Kipar, Anja] Univ Liverpool, Dept Infect Biol, Inst Global Hlth, Liverpool L69 3BX, Merseyside, England; [Vapalahti, Olli] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland	University of Helsinki; University of Jyvaskyla; University of Helsinki; Natural Resources Institute Finland (Luke); University of Helsinki; University of Liverpool; University of Liverpool; University of Helsinki	Rossow, H (corresponding author), Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland.	heidi.rossow@helsinki.fi	Kipar, Anja/L-7214-2014	Kipar, Anja/0000-0001-7289-3459; Vapalahti, Olli/0000-0003-2270-6824	Hospital district of Helsinki and Uusimaa [EVO TYH20113]; Academy of Finland [251836, 133495]; Finnish Foundation of Veterinary Research; EU grant [FP7-261504EDENext]	Hospital district of Helsinki and Uusimaa; Academy of Finland(Academy of Finland); Finnish Foundation of Veterinary Research; EU grant(European Commission)	The study was partially funded by the Hospital district of Helsinki and Uusimaa (EVO TYH20113 to OV, http://www.hus.fi/Sivut/default.aspx), the Academy of Finland (grants no. 251836 to OV and 133495 to OH, http://www.aka.fi/fi/A/), the Finnish Foundation of Veterinary Research (to HR in 2013, http://www.sels.fi/). EU grant FP7-261504EDENext, and the paper is catalogued by the EDENext Steering Committee as EDENext 254 (http://www.edenext.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd H, 2003, APPL ENVIRON MICROB, V69, P600, DOI 10.1128/AEM.69.1.600-606.2003; Allue M, 2008, Euro Surveill, V13; BELL J F, 1975, Journal of Wildlife Diseases, V11, P421; Broman T, 2011, Int J Microbiol, V2011, DOI 10.1155/2011/851946; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P239, DOI 10.1016/S0882-4010(03)00046-9; DAHLSTRAND S, 1971, Scandinavian Journal of Infectious Diseases, V3, P7; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Eliasson H, 2002, EMERG INFECT DIS, V8, P956, DOI 10.3201/eid0809.020051; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Feldman KA, 2001, NEW ENGL J MED, V345, P1601, DOI 10.1056/NEJMoa011374; Forsman M, 2000, FEMS MICROBIOL ECOL, V31, P217, DOI 10.1111/j.1574-6941.2000.tb00686.x; Gilbert SE, 2012, LETT APPL MICROBIOL, V55, P189, DOI 10.1111/j.1472-765X.2012.03277.x; Grunow R, 2012, EUROSURVEILLANCE, V17, P18; Hanski I, 1996, J ANIM ECOL, V65, P220, DOI 10.2307/5725; Hauri AM, 2010, EMERG INFECT DIS, V16, P238, DOI 10.3201/eid1602.081727; Kaysser P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-157; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Lundstrom JO, 2011, EMERG INFECT DIS, V17, P794, DOI 10.3201/eid1705.100426; MCCARTHY VP, 1990, PEDIATR INFECT DIS J, V9, P298, DOI 10.1097/00006454-199004000-00018; MORNER T, 1988, J WILDLIFE DIS, V24, P422; Navarro P, 2011, PATHOL RES PRACT, V207, P63, DOI 10.1016/j.prp.2010.07.002; Nelson DD, 2014, J VET DIAGN INVEST, V26, P312, DOI 10.1177/1040638713520541; OLSUFJEV N G, 1984, Journal of Hygiene Epidemiology Microbiology and Immunology (Prague), V28, P441; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; POMANSKAIA L. A., 1957, Journal of Microbiology, Epidemiology and Immunobiology, V28, P597; Reintjes R, 2002, EMERG INFECT DIS, V8, P69, DOI 10.3201/eid0801.010131; Rossow H, 2013, EPIDEMIOL INFECT, V141, P2286; Rossow H, 2014, VECTOR-BORNE ZOONOT, V14, P193, DOI 10.1089/vbz.2012.1255; Siret V, 2006, Euro Surveill, V11, P58, DOI 10.2807/esm.11.02.00598-en; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Skottman T, 2007, EUR J CLIN MICROBIOL, V26, P207, DOI 10.1007/s10096-007-0262-z; Splettstoesser WD, 2009, EPIDEMIOL INFECT, V137, P736, DOI 10.1017/S0950268808001192; SYRJALA H, 1985, SCAND J INFECT DIS, V17, P371; SYRJALA H, 1986, J LARYNGOL OTOL, V100, P1169, DOI 10.1017/S0022215100100775; Tarnvik A, 1996, FEMS IMMUNOL MED MIC, V13, P201, DOI 10.1016/0928-8244(95)00104-2; Tarnvik A, 2003, EUR RESPIR J, V21, P361, DOI 10.1183/09031936.03.00088903; Tarnvik A, 2007, ANN NY ACAD SCI, V1105, P378, DOI 10.1196/annals.1409.017; Thelaus J, 2014, MICROB ECOL, V67, P96, DOI 10.1007/s00248-013-0285-1; Thomas LD, 2010, INFECT DIS CLIN N AM, V24, P43, DOI 10.1016/j.idc.2009.10.012; Twenhafel NA, 2009, VET PATHOL, V46, P698, DOI 10.1354/vp.08-VP-0302-T-AM; Vapalahti K, 1999, AM J EPIDEMIOL, V149, P1142, DOI 10.1093/oxfordjournals.aje.a009769; Wobeser G, 2007, J WILDLIFE DIS, V43, P23, DOI 10.7589/0090-3558-43.1.23	42	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108864	10.1371/journal.pone.0108864	http://dx.doi.org/10.1371/journal.pone.0108864			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271640	gold, Green Published, Green Accepted			2022-12-27	WOS:000343729600069
J	Schaeffer, RN; Phillips, CR; Duryea, MC; Andicoechea, J; Irwin, RE				Schaeffer, Robert N.; Phillips, Cody R.; Duryea, M. Catherine; Andicoechea, Jonathan; Irwin, Rebecca E.			Nectar Yeasts in the Tall Larkspur Delphinium barbeyi (Ranunculaceae) and Effects on Components of Pollinator Foraging Behavior	PLOS ONE			English	Article							SOUTHERN SPANISH PLANTS; FLORAL NECTAR; EPHEMERAL FLOWERS; METSCHNIKOWIA REUKAUFII; SP NOV.; COMMUNITIES; BUMBLEBEES; HERB; INFLORESCENCES; VISITATION	Microorganisms frequently colonize the nectar of angiosperm species. Though capable of altering a suite of traits important for pollinator attraction, few studies exist that test the degree to which they mediate pollinator foraging behavior. The objective of our study was to fill this gap by assessing the abundance and diversity of yeasts associated with the perennial larkspur Delphinium barbeyi (Ranunculaceae) and testing whether their presence affected components of pollinator foraging behavior. Yeasts frequently colonized D. barbeyi nectar, populating 54-77% of flowers examined depending on site. Though common, the yeast community was species-poor, represented by a single species, Metschnikowia reukaufii. Female-phase flowers of D. barbeyi were more likely to have higher densities of yeasts in comparison to male-phase flowers. Pollinators were likely vectors of yeasts, as virgin (unvisited) flowers rarely contained yeasts compared to flowers open to pollinator visitation, which were frequently colonized. Finally, pollinators responded positively to the presence of yeasts. Bombus foragers both visited and probed more flowers inoculated with yeasts in comparison to uninoculated controls. Taken together, our results suggest that variation in the occurrence and density of nectar-inhabiting yeasts have the potential to alter components of pollinator foraging behavior linked to pollen transfer and plant fitness.	[Schaeffer, Robert N.; Duryea, M. Catherine; Andicoechea, Jonathan; Irwin, Rebecca E.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Schaeffer, Robert N.; Phillips, Cody R.; Andicoechea, Jonathan; Irwin, Rebecca E.] Rocky Mt Biol Labs, Gothic, CO USA	Dartmouth College	Schaeffer, RN (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	Robert.Schaeffer@Tufts.edu	Schaeffer, Robert/R-7577-2019		Dartmouth College Cramer Fund; RMBL; National Science Foundation [DEB-0841862, DEB-1311156]	Dartmouth College Cramer Fund; RMBL; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Dartmouth College Cramer Fund, the Jean H. Langenheim graduate fellowship from the RMBL, and the National Science Foundation (DEB-0841862 and DEB-1311156). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Alvarez-Perez S, 2012, FEMS MICROBIOL ECOL, V80, P591, DOI 10.1111/j.1574-6941.2012.01329.x; Belisle M, 2012, MICROB ECOL, V63, P711, DOI 10.1007/s00248-011-9975-8; Benson DA, 2012, GENBANK NUCL ACIDS R; Brysch-Herzberg M, 2004, FEMS MICROBIOL ECOL, V50, P87, DOI 10.1016/j.femsec.2004.06.003; Canto A, 2012, ANN BOT-LONDON, V110, P1173, DOI 10.1093/aob/mcs183; Clay K, 2002, AM NAT, V160, pS99, DOI 10.1086/342161; Cnaani J, 2006, ETHOLOGY, V112, P278, DOI 10.1111/j.1439-0310.2006.01174.x; Cook D, 2013, BIOCHEM SYST ECOL, V48, P123, DOI 10.1016/j.bse.2012.11.015; Cook D, 2011, AM J VET RES, V72, P706, DOI 10.2460/ajvr.72.5.706; de Vega C, 2012, OIKOS, V121, P1878, DOI 10.1111/j.1600-0706.2012.20295.x; Elliott SE, 2008, RECIPROCAL BENEFITS; Elliott SE, 2009, AM J BOT, V96, P912, DOI 10.3732/ajb.0800260; Fridman S, 2012, ENV MICROBIOL REP, V4, P97, DOI 10.1111/j.1758-2229.2011.00309.x; Golonka AM, 2002, SILENCE LATIFOLIA; Golonka AM, 2013, AM MIDL NAT, V169, P235, DOI 10.1674/0003-0031-169.2.235; Good AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086494; Goodrich KR, 2006, INT J PLANT SCI, V167, P33, DOI 10.1086/498351; Graham L, 1996, AM MIDL NAT, V136, P401, DOI 10.2307/2426743; HEINRICH B, 1975, ANNU REV ECOL SYST, V6, P139, DOI 10.1146/annurev.es.06.110175.001035; Herrera CM, 2008, ECOLOGY, V89, P2369, DOI 10.1890/08-0241.1; Herrera CM, 2014, FEMS MICROBIOL ECOL, V88, P250, DOI 10.1111/1574-6941.12284; Herrera CM, 2014, FEMS MICROBIOL ECOL, V87, P568, DOI 10.1111/1574-6941.12245; Herrera CM, 2013, ECOLOGY, V94, P273, DOI 10.1890/12-0595.1; Herrera CM, 2010, P ROY SOC B-BIOL SCI, V277, P1827, DOI 10.1098/rspb.2009.2252; Herrera CM, 2010, P ROY SOC B-BIOL SCI, V277, P747, DOI 10.1098/rspb.2009.1485; Herrera CM, 2009, ANN BOT-LONDON, V103, P1415, DOI 10.1093/aob/mcp026; HERRERA CM, 1988, BIOL J LINN SOC, V35, P95, DOI 10.1111/j.1095-8312.1988.tb00461.x; HORVITZ CC, 1990, ECOLOGY, V71, P1085, DOI 10.2307/1937377; Humphrey PT, 2014, MOL ECOL, V23, P1497, DOI 10.1111/mec.12657; INOUYE DW, 1978, ECOLOGY, V59, P672, DOI 10.2307/1938769; Jacquemyn H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056917; JENNINGS KR, 1986, EXPERIENTIA, V42, P611, DOI 10.1007/BF01955557; Junker RR, 2014, APIDOLOGIE, V45, P467, DOI 10.1007/s13592-013-0262-1; KEVAN PG, 1988, J APICULT RES, V27, P26, DOI 10.1080/00218839.1988.11100777; KLINKHAMER PGL, 1990, OIKOS, V57, P399, DOI 10.2307/3565970; Kotliar NB, 1996, VEGETATIO, V127, P117, DOI 10.1007/BF00044636; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lachance MA, 1998, CAN J MICROBIOL, V44, P279, DOI 10.1139/cjm-44-3-279; Lachance MA, 2001, FEMS YEAST RES, V1, P1; Manson JS, 2007, ANTON LEEUW INT J G, V92, P37, DOI 10.1007/s10482-006-9132-4; MARSCHNER H, 1994, PLANT SOIL, V159, P89, DOI 10.1007/BF00000098; Mommaerts V, 2013, CHEM SENSES; Nelson RA, 1979, HDB ROCKY MOUNTAIN P; Omacini M, 2001, NATURE, V409, P78, DOI 10.1038/35051070; Peay KG, 2012, P ROY SOC B-BIOL SCI, V279, P749, DOI 10.1098/rspb.2011.1230; Pozo MI, 2012, FEMS MICROBIOL ECOL, V80, P281, DOI 10.1111/j.1574-6941.2011.01286.x; Pozo MI, 2011, MICROB ECOL, V61, P82, DOI 10.1007/s00248-010-9682-x; PYKE GH, 1978, THEOR POPUL BIOL, V13, P72, DOI 10.1016/0040-5809(78)90036-9; PYKE GH, 1979, ANIM BEHAV, V27, P1167, DOI 10.1016/0003-3472(79)90064-2; R Core Development Team, 2011, R LANG ENV STAT COMP; Raguso RA, 2004, ECOLOGY, V85, P1486, DOI 10.1890/03-0410; Rosa CA, 2007, INT J SYST EVOL MICR, V57, P161, DOI 10.1099/ijs.0.64624-0; SANDHU DK, 1985, MICROB ECOL, V11, P51, DOI 10.1007/BF02015108; Schaeffer RN, 2014, ECOLOGY, V95, P1792, DOI 10.1890/13-1740.1; Simpson B.B., 1983, P142; Vannette RL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2601; WASER NM, 1982, OECOLOGIA, V55, P251, DOI 10.1007/BF00384496; Wiens F, 2008, P NATL ACAD SCI USA, V105, P10426, DOI 10.1073/pnas.0801628105; Williams CF, 2001, AM J BOT, V88, P1623, DOI 10.2307/3558407; WRIGHT DH, 1988, SOUTHWEST NAT, V33, P219, DOI 10.2307/3671898	61	30	31	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108214	10.1371/journal.pone.0108214	http://dx.doi.org/10.1371/journal.pone.0108214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272164	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600034
J	Sparla, F; Falini, G; Botticella, E; Pirone, C; Talame, V; Bovina, R; Salvi, S; Tuberosa, R; Sestili, F; Trost, P				Sparla, Francesca; Falini, Giuseppe; Botticella, Ermelinda; Pirone, Claudia; Talame, Valentina; Bovina, Riccardo; Salvi, Silvio; Tuberosa, Roberto; Sestili, Francesco; Trost, Paolo			New Starch Phenotypes Produced by TILLING in Barley	PLOS ONE			English	Article							SYNTHASE-I; HIGH-AMYLOSE; LIMIT DEXTRINASE; GRANULE SIZE; HUMAN HEALTH; DURUM-WHEAT; MUTANTS; WAXY; ENDOSPERM; BIOSYNTHESIS	Barley grain starch is formed by amylose and amylopectin in a 1:3 ratio, and is packed into granules of different dimensions. The distribution of granule dimension is bimodal, with a majority of small spherical B-granules and a smaller amount of large discoidal A-granules containing the majority of the starch. Starch granules are semi-crystalline structures with characteristic X-ray diffraction patterns. Distinct features of starch granules are controlled by different enzymes and are relevant for nutritional value or industrial applications. Here, the Targeting-Induced Local Lesions IN Genomes (TILLING) approach was applied on the barley TILLMore TILLING population to identify 29 new alleles in five genes related to starch metabolism known to be expressed in the endosperm during grain filling: BMY1 (Beta-amylase 1), GBSSI (Granule Bound Starch Synthase I), LDA1 (Limit Dextrinase 1), SSI (Starch Synthase I), SSIIa (Starch Synthase IIa). Reserve starch of nine M3 mutant lines carrying missense or nonsense mutations was analysed for granule size, crystallinity and amylose/amylopectin content. Seven mutant lines presented starches with different features in respect to the wild-type: (i) a mutant line with a missense mutation in GBSSI showed a 4-fold reduced amylose/amylopectin ratio; (ii) a missense mutations in SSI resulted in 2-fold increase in A:B granule ratio; (iii) a nonsense mutation in SSIIa was associated with shrunken seeds with a 2-fold increased amylose/amylopectin ratio and different type of crystal packing in the granule; (iv) the remaining four missense mutations suggested a role of LDA1 in granule initiation, and of SSIIa in determining the size of A-granules. We demonstrate the feasibility of the TILLING approach to identify new alleles in genes related to starch metabolism in barley. Based on their novel physicochemical properties, some of the identified new mutations may have nutritional and/or industrial applications.	[Sparla, Francesca; Pirone, Claudia; Trost, Paolo] Univ Bologna, Dept Pharm & Biotechnol FABIT, Bologna, Italy; [Falini, Giuseppe] Univ Bologna, Dept Chem G Ciamician, Bologna, Italy; [Botticella, Ermelinda; Sestili, Francesco] Univ Tuscia, Dept Agr Forestry Nat & Energy, Viterbo, Italy; [Talame, Valentina; Bovina, Riccardo; Salvi, Silvio; Tuberosa, Roberto] Univ Bologna, Dept Agr Sci, Bologna, Italy	University of Bologna; University of Bologna; Tuscia University; University of Bologna	Trost, P (corresponding author), Univ Bologna, Dept Pharm & Biotechnol FABIT, Bologna, Italy.	paolo.trost@unibo.it	Tuberosa, Roberto/A-2781-2016; agraria, ermelinda botticella/AAF-9630-2019	Tuberosa, Roberto/0000-0001-9143-9569; agraria, ermelinda botticella/0000-0002-2532-033X; Trost, Paolo/0000-0002-6347-8701; Sparla, Francesca/0000-0002-2103-4870; Sestili, Francesco/0000-0002-9653-8002	University of Bologna, Progetto Strategico STARCHitecture	University of Bologna, Progetto Strategico STARCHitecture	Work funded by The University of Bologna, Progetto Strategico STARCHitecture (F. Sparla, GF, VT, RB, SS, RT, and PT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asare EK, 2012, J AGR FOOD CHEM, V60, P10082, DOI 10.1021/jf302291t; Asare EK, 2011, J AGR FOOD CHEM, V59, P4743, DOI 10.1021/jf200054e; Baik BK, 2008, J CEREAL SCI, V48, P233, DOI 10.1016/j.jcs.2008.02.002; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Bird AR, 2008, BRIT J NUTR, V99, P1032, DOI 10.1017/S000711450783902X; Botticella E, BMC PLANT BIOL, V10, P156; Bovina R, 2014, CROP PASTURE SCI, V65, P112, DOI 10.1071/CP13226; Bovina R, 2011, PLANT GENET RESOUR-C, V9, P170, DOI 10.1017/S147926211100044X; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Burton RA, 2002, PLANT J, V31, P97, DOI 10.1046/j.1365-313X.2002.01339.x; Collins HM, 2010, CEREAL CHEM, V87, P272, DOI 10.1094/CCHEM-87-4-0272; Cuesta-Seijo JA, 2013, ACTA CRYSTALLOGR D, V69, P1013, DOI 10.1107/S090744491300440X; Damiran D, 2010, J AGR FOOD CHEM, V58, P10553, DOI 10.1021/jf101624a; Denyer K, 1999, BIOCHEM J, V342, P647, DOI 10.1042/0264-6021:3420647; Dhital S, 2011, J AGR FOOD CHEM, V59, P10151, DOI 10.1021/jf202293s; Fujita N, 2006, PLANT PHYSIOL, V140, P1070, DOI 10.1104/pp.105.071845; Fujita N, 2009, J EXP BOT, V60, P1009, DOI 10.1093/jxb/ern349; Hazard B, 2012, CROP SCI, V52, P1754, DOI 10.2135/cropsci2012.02.0126; Howard T, 2011, J EXP BOT, V62, P2217, DOI 10.1093/jxb/erq423; Howard TP, 2014, J CEREAL SCI, V59, P196, DOI 10.1016/j.jcs.2013.12.012; Huang YQ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-117; James MG, 2003, CURR OPIN PLANT BIOL, V6, P215, DOI 10.1016/S1369-5266(03)00042-6; JANE JL, 1994, STARCH-STARKE, V46, P121, DOI 10.1002/star.19940460402; Jeon JS, 2010, PLANT PHYSIOL BIOCH, V48, P383, DOI 10.1016/j.plaphy.2010.03.006; Jobling S, 2004, CURR OPIN PLANT BIOL, V7, P210, DOI 10.1016/j.pbi.2003.12.001; Kim W, 2003, J CEREAL SCI, V37, P195, DOI 10.1006/jcrs.2002.0494; Lafiandra D, 2010, CEREAL CHEM, V87, P28, DOI 10.1094/CCHEM-87-1-0028; Li ZY, 2011, J EXP BOT, V62, P5217, DOI 10.1093/jxb/err239; MacGregor A.W., 1991, P 23 EUR BREW CONV C, P37; MADDELEIN ML, 1994, J BIOL CHEM, V269, P25150; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Mazanec K, 2011, J SCI FOOD AGR, V91, P2756, DOI 10.1002/jsfa.4518; McMaugh SJ, 2014, J EXP BOT, V65, P2189, DOI 10.1093/jxb/eru095; Mohammadkhani A, 1999, STARCH-STARKE, V51, P62, DOI [10.1002/(SICI)1521-379X(199903)51:2&lt;62::AID-STAR62&gt;3.0.CO;2-G, 10.1002/(SICI)1521-379X(199903)51:2<62::AID-STAR62>3.0.CO;2-G]; Momma M, 2012, BIOSCI BIOTECH BIOCH, V76, P1591, DOI 10.1271/bbb.120305; Morell MK, 2005, CURR OPIN PLANT BIOL, V8, P204, DOI 10.1016/j.pbi.2005.01.009; Morell MK, 2003, PLANT J, V34, P172, DOI 10.1046/j.1365-313X.2003.01712.x; Naguleswaran S, 2013, FOOD RES INT, V51, P771, DOI 10.1016/j.foodres.2013.01.057; NARA S, 1983, STARKE, V35, P407, DOI 10.1002/star.19830351202; NELSON OE, 1962, BIOCHEM BIOPH RES CO, V9, P297, DOI 10.1016/0006-291X(62)90043-8; Nugent AP, 2005, NUTR BULL, V30, P27, DOI 10.1111/j.1467-3010.2005.00481.x; Patron NJ, 2002, PLANT PHYSIOL, V130, P190, DOI 10.1104/pp.005454; Radchuk VV, 2009, PLANT PHYSIOL, V150, P190, DOI 10.1104/pp.108.133520; Roldan I, 2007, PLANT J, V49, P492, DOI 10.1111/j.1365-313X.2006.02968.x; Sestili F, 2010, MOL BREEDING, V25, P145, DOI 10.1007/s11032-009-9314-7; Sestili F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-144; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Slade AJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-69; Stahl Y, 2004, PLANT J, V39, P599, DOI 10.1111/j.1365-313X.2004.02159.x; Talame V, 2008, PLANT BIOTECHNOL J, V6, P477, DOI 10.1111/j.1467-7652.2008.00341.x; Topping D, 2007, J CEREAL SCI, V46, P220, DOI 10.1016/j.jcs.2007.06.004; Vester-Christensen MB, 2010, J MOL BIOL, V403, P739, DOI 10.1016/j.jmb.2010.09.031; Vriet C, 2010, PLANT PHYSIOL, V154, P643, DOI 10.1104/pp.110.161844; Waduge RN, 2006, FOOD RES INT, V39, P59, DOI 10.1016/j.foodres.2005.05.008; Yamamori M, 2000, THEOR APPL GENET, V101, P21, DOI 10.1007/s001220051444; Yoo SH, 2002, CARBOHYD POLYM, V49, P297, DOI 10.1016/S0144-8617(01)00338-1; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zhao XC, 1996, J CEREAL SCI, V23, P191, DOI 10.1006/jcrs.1996.0019	58	33	34	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e107779	10.1371/journal.pone.0107779	http://dx.doi.org/10.1371/journal.pone.0107779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271438	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600020
J	Wang, CX; Fu, KL; Liu, HJ; Xing, F; Zhang, SY				Wang, Chun-Xia; Fu, Kai-Liang; Liu, Huai-Jun; Xing, Fei; Zhang, Song-Yun			Spontaneous Brain Activity in Type 2 Diabetics Revealed by Amplitude of Low-Frequency Fluctuations and Its Association with Diabetic Vascular Disease: A Resting-State fMRI Study	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; MILD COGNITIVE IMPAIRMENT; RISK-FACTOR; DYSFUNCTION; DEMENTIA; DECLINE; MRI; COMPLICATIONS; CONNECTIVITY; CORRELATE	Purpose: To investigate correlations between altered spontaneous brain activity, diabetic vascular disease, and cognitive function for patients with type 2 diabetes mellitus (T2DM) using resting-state functional magnetic resonance imaging (rs-fMRI). Methods: Rs-fMRI was performed for T2DM patients (n = 26) and age-, gender-, and education-matched non-diabetic control subjects (n = 26). Amplitude of low frequency fluctuations (ALFF) were computed from fMRI signals to measure spontaneous neuronal activity. Differences in the ALFF patterns between patients and controls, as well as their correlations with clinical variables, were evaluated. Results: Compared with healthy controls, T2DM patients exhibited significantly decreased ALFF values mainly in the frontal and parietal lobes, the bilateral thalumi, the posterior lobe of the cerebellum, and increased ALFF values mainly in the visual cortices. Furthermore, lower ALFF values in the left subcallosal gyrus correlated with lower ankle-brachial index values (r = 0.481, p = 0.020), while lower ALFF values in the bilateral medial prefrontal gyri correlated with higher urinary albumin-creatinine ratio (r = -0.418, p = 0.047). In addition, most of the regions with increased ALFF values in the visual cortices were found to negatively correlate with MoCA scores. Conclusions: These results confirm that ALFF are altered in many brain regions in T2DM patients, and this is associated with the presence of diabetic vascular disease and poor cognitive performance. These findings may provide additional insight into the neurophysiological mechanisms that mediate T2DM-related cognitive dysfunction, and may also serve as a reference for future research.	[Wang, Chun-Xia; Fu, Kai-Liang; Liu, Huai-Jun; Xing, Fei] Hebei Med Univ, Hosp 2, Dept Med Imaging, Shijiazhuang, Hebei, Peoples R China; [Zhang, Song-Yun] Hebei Med Univ, Hosp 2, Dept Endocrinol, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University	Liu, HJ (corresponding author), Hebei Med Univ, Hosp 2, Dept Med Imaging, Shijiazhuang, Hebei, Peoples R China.	huaijunliu2@126.com						Alagiakrishnan K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/186106; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bai F, 2011, J ALZHEIMERS DIS, V23, P87, DOI 10.3233/JAD-2010-101533; Barzilay JI, 2011, ARCH INTERN MED, V171, P142, DOI 10.1001/archinternmed.2010.502; Baumgartner I, 2005, ANNU REV MED, V56, P249, DOI 10.1146/annurev.med.56.082103.104649; Baxter MG, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00038; Biessels GJ, 2008, LANCET NEUROL, V7, P184, DOI 10.1016/S1474-4422(08)70021-8; Bruehl Hannah, 2011, Neurosci Med, V2, P34; Bruehl H, 2009, BRAIN RES, V1280, P186, DOI 10.1016/j.brainres.2009.05.032; Chen ZY, 2012, EUR J RADIOL, V81, P1870, DOI 10.1016/j.ejrad.2011.04.025; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Cui Y, 2014, DIABETES, V63, P749, DOI 10.2337/db13-0519; de Paula JJ, 2013, ARQ NEURO-PSIQUIAT, V71, P763, DOI 10.1590/0004-282X20130118; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Exalto LG, 2012, EXP GERONTOL, V47, P858, DOI 10.1016/j.exger.2012.07.014; Gold SM, 2007, DIABETOLOGIA, V50, P711, DOI 10.1007/s00125-007-0602-7; Guerchet M, 2011, ATHEROSCLEROSIS, V216, P251, DOI 10.1016/j.atherosclerosis.2011.03.024; Imamine R, 2011, DIABETES RES CLIN PR, V94, P91, DOI 10.1016/j.diabres.2011.06.014; Kelleher RJ, 2013, AM J CARDIOVASC DIS, V3, P197; Kodl CT, 2008, DIABETES, V57, P3083, DOI 10.2337/db08-0724; Koski L, 2013, CEREBROVASC DIS, V36, P6, DOI 10.1159/000352051; Last D, 2007, DIABETES CARE, V30, P1193, DOI 10.2337/dc06-2052; Laurin D, 2007, CIRCULATION, V116, P2269, DOI 10.1161/CIRCULATIONAHA.106.686477; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; McCrimmon RJ, 2012, LANCET, V379, P2291, DOI 10.1016/S0140-6736(12)60360-2; MENDEZ MF, 1992, J AM GERIATR SOC, V40, P1095, DOI 10.1111/j.1532-5415.1992.tb01796.x; Musen G, 2012, DIABETES, V61, P2375, DOI 10.2337/db11-1669; Naka A, 2010, EUR ARCH OTO-RHINO-L, V267, P547, DOI 10.1007/s00405-009-1123-4; Prins ND, 2005, BRAIN, V128, P2034, DOI 10.1093/brain/awh553; Rafnsson SB, 2009, VASC MED, V14, P51, DOI 10.1177/1358863X08095027; Reijmer YD, 2013, DIABETES CARE, V36, P137, DOI 10.2337/dc12-0493; Reijmer YD, 2010, DIABETES-METAB RES, V26, P507, DOI 10.1002/dmrr.1112; Ryan CM, 2000, DIABETES CARE, V23, P1486, DOI 10.2337/diacare.23.10.1486; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Schmahmann JD, 2007, CEREBELLUM, V6, P254, DOI 10.1080/14734220701490995; Shoyama M, 2011, APPL NEUROPSYCHOL, V18, P243, DOI 10.1080/09084282.2011.595450; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Soran B, 2012, IEEE ENG MED BIO, P3219, DOI 10.1109/EMBC.2012.6346650; Svacina S, 2007, Vnitr Lek, V53, P483; Takayama S, 2003, J INT MED RES, V31, P466, DOI 10.1177/147323000303100516; Tedesco AM, 2011, BRAIN, V134, P3669, DOI 10.1093/brain/awr266; Tildesley HD, 2007, INT J CARDIOL, V115, P312, DOI 10.1016/j.ijcard.2006.03.014; Tuchscherer V, 2010, EPILEPSY BEHAV, V17, P478, DOI 10.1016/j.yebeh.2010.01.019; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Umemura T, 2013, DEMENT GER COGN D EX, V3, P212, DOI 10.1159/000351424; Vagelatos NT, 2013, EPIDEMIOL REV, V35, P152, DOI 10.1093/epirev/mxs012; van Dijk EJ, 2008, STROKE, V39, P2712, DOI 10.1161/STROKEAHA.107.513176; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; WEINSTOCK RS, 1993, PHYSIOL BEHAV, V53, P17, DOI 10.1016/0031-9384(93)90005-Z; Whitmer RA, 2007, CURR NEUROL NEUROSCI, V7, P373, DOI 10.1007/s11910-007-0058-7; Xia WQ, 2013, PSYCHONEUROENDOCRINO, V38, P2493, DOI 10.1016/j.psyneuen.2013.05.012; Xu Q, 2014, EUR NEUROL, V71, P106, DOI 10.1159/000353988; Yamada SM, 2012, J NIPPON MED SCH, V79, P85, DOI 10.1272/jnms.79.85; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang S, 2014, BRAIN CONNECT, V4, P53, DOI 10.1089/brain.2013.0191; Zhang ZQ, 2010, HUM BRAIN MAPP, V31, P1851, DOI 10.1002/hbm.20982; Zhou H, 2010, NEUROSCI LETT, V473, P5, DOI 10.1016/j.neulet.2009.12.057	63	39	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e108883	10.1371/journal.pone.0108883	http://dx.doi.org/10.1371/journal.pone.0108883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272033	Green Published, gold, Green Submitted			2022-12-27	WOS:000343729600073
J	Gezmu, T; Schneider, D; Demissie, K; Lin, Y; Gizzi, MS				Gezmu, Tefera; Schneider, Dona; Demissie, Kitaw; Lin, Yong; Gizzi, Martin S.			Risk Factors for Acute Stroke among South Asians Compared to Other Racial/Ethnic Groups	PLOS ONE			English	Article							ISCHEMIC-STROKE; DISPARITIES; POPULATION; ETHNICITY; SUBTYPE; RACE	Background: Studies of racial/ethnic variations in stroke rarely consider the South Asian population, one of the fastest growing sub-groups in the United States. This study compared risk factors for stroke among South Asians with those for whites, African-Americans, and Hispanics. Methods: Data on 3290 stroke patients were analyzed to examine risk differences among the four racial/ethnic groups. Data on 3290 patients admitted to a regional stroke center were analyzed to examine risk differences for ischemic stroke (including subtypes of small and large vessel disease) among South Asians, whites, African Americans and Hispanics. Results: South Asians were younger and had higher rates of diabetes mellitus, blood pressure, and fasting blood glucose levels than other race/ethnicities. Prevalence of diabetic and antiplatelet medication use, as well as the incidence of small-artery occlusion ischemic stroke was also higher among South Asians. South Asians were almost a decade younger and had comparable socioeconomic levels as whites; however, their stroke risk factors were comparable to that of African Americans and Hispanics. Discussion: Observed differences in stroke may be explained by dietary and life style choices of South Asian-Americans, risk factors that are potentially modifiable. Future population and epidemiologic studies should consider growing ethnic minority groups in the examination of the nature, outcome, and medical care profiles of stroke.	[Gezmu, Tefera; Schneider, Dona] Rutgers State Univ, Edward J Bloustein Sch Planning & Publ Policy, New Brunswick, NJ 08903 USA; [Demissie, Kitaw; Lin, Yong] Rutgers Sch Publ Hlth, Dept Epidemiol, Piscataway, NJ USA; [Gizzi, Martin S.] John F Kennedy Med Ctr, New Jersey Neurosci Inst, Edison, NJ USA; [Gizzi, Martin S.] Seton Hall Univ, Edison, NJ USA	Rutgers State University New Brunswick; Seton Hall University	Gezmu, T (corresponding author), Rutgers State Univ, Edward J Bloustein Sch Planning & Publ Policy, New Brunswick, NJ 08903 USA.	gezmu@rutgers.edu		Schneider, Dona/0000-0002-1589-011X				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Boden-Albala B, 2008, STROKE, V39, P30, DOI 10.1161/STROKEAHA.107.496588; Elliott MN, 2008, HEALTH SERV RES, V43, P1722, DOI 10.1111/j.1475-6773.2008.00854.x; Fang J, 2001, STROKE, V32, P2221, DOI 10.1161/hs1001.096193; Goldstein LB, 1997, STROKE, V28, P307, DOI 10.1161/01.STR.28.2.307; JNC-7 Guidelines, 2003, 7 JOINT NAT COMM PRE; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; Lauderdale DS, 2000, POPUL RES POLICY REV, V19, P283, DOI 10.1023/A:1026582308352; Liao YL, 2009, STROKE, V40, P3336, DOI 10.1161/STROKEAHA.109.561688; McAlpine DD, 2007, HEALTH SERV RES, V42, P2373, DOI 10.1111/j.1475-6773.2007.00771.x; Muir KW, 1996, STROKE, V27, P1817, DOI 10.1161/01.STR.27.10.1817; Pathak EB, 2009, NEUROEPIDEMIOLOGY, V32, P302, DOI 10.1159/000208795; Sacco RL, 1997, STROKE, V28, P1507, DOI 10.1161/01.STR.28.7.1507; Sacco RL, 1997, STROKE, V28, P929, DOI 10.1161/01.STR.28.5.929; U.S. Census Bureau AFF, AS POP US CENS 2010; U.S. Census Bureau AFF, RAC DAT CENS 2010 CE; United States Department of Health and Human Services (US DHHS) Centers for Disease Control and Prevention (CDC), 2008, BRIDG RAC INT POP ES; White H, 2005, CIRCULATION, V111, P1327, DOI 10.1161/01.CIR.0000157736.19739.D0; Wong EC, 2010, MED CARE, V48, P540, DOI 10.1097/MLR.0b013e3181d559e9	20	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108901	10.1371/journal.pone.0108901	http://dx.doi.org/10.1371/journal.pone.0108901			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268987	Green Published, gold, Green Submitted			2022-12-27	WOS:000343671700186
J	Miura, K; Turrell, G				Miura, Kyoko; Turrell, Gavin			Contribution of Psychosocial Factors to the Association between Socioeconomic Position and Takeaway Food Consumption	PLOS ONE			English	Article							NUTRITION KNOWLEDGE; REPORTED CONSUMPTION; PURCHASING BEHAVIOR; VEGETABLE INTAKE; DIETARY-INTAKE; UNITED-STATES; US ADULTS; HEALTH; DETERMINANTS; INEQUALITIES	Objective: To examine whether psychosocial factors mediate (explain) the association between socioeconomic position and takeaway food consumption. Design: A cross-sectional postal survey conducted in 2009. Setting: Participants reported their usual consumption of 22 takeaway food items, and these were grouped into a "healthy'' and "less healthy'' index based on each items' nutritional properties. Principal Components Analysis was used to derive three psychosocial scales that measured beliefs about the relationship between diet and health (alpha = 0.73), and perceptions about the value (alpha = 0.79) and pleasure (alpha = 0.61) of takeaway food. A nutrition knowledge index was also used. Socioeconomic position was measured by highest attained education level. Subjects: Randomly selected adults (n = 1,500) aged between 25-64 years in Brisbane, Australia (response rate = 63.7%, N = 903). Results: Compared with those with a bachelor degree or higher, participants with a diploma level of education were more likely to consume "healthy'' takeaway food (p = 0.023) whereas the least educated (high school only) were more likely to consume "less healthy'' choices (p = 0.002). The least educated were less likely to believe in a relationship between diet and health (p<0.001), and more likely to have lower nutritional knowledge compared with their highly educated counterparts (p<0.001). Education differences in beliefs about the relationship between diet and health partly and significantly mediated the association between education and "healthy'' takeaway food consumption. Diet-and health-related beliefs and nutritional knowledge partly and significantly mediated the education differences in "less healthy'' takeaway food consumption. Conclusions: Interventions that target beliefs about the relationship between diet and health, and nutritional knowledge may reduce socioeconomic differences in takeaway food consumption, particularly for "less healthy'' options.	[Miura, Kyoko; Turrell, Gavin] Queensland Univ Technol, Fac Hlth, Sch Publ Hlth & Social Work, Kelvin Grove, Qld, Australia; [Miura, Kyoko] QIMR Berghofer Med Res Inst, Canc & Populat Studies Grp, Herston, Qld, Australia	Queensland University of Technology (QUT); QIMR Berghofer Medical Research Institute	Miura, K (corresponding author), Queensland Univ Technol, Fac Hlth, Sch Publ Hlth & Social Work, Kelvin Grove, Qld, Australia.	Kyoko.Miura@qimrberghofer.edu.au	Matsuo, Keitaro/H-6758-2019; Miura, Kyoko/B-9874-2012	Matsuo, Keitaro/0000-0003-1761-6314; Miura, Kyoko/0000-0002-2805-7522; Turrell, Gavin/0000-0002-3576-8744	Queensland University of Technology; National Health and Medical Research Council of Australia (NHMRC) Senior Research Fellowship [APP1003710]	Queensland University of Technology; National Health and Medical Research Council of Australia (NHMRC) Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by Queensland University of Technology (operational aspects of the study). GT is supported by the National Health and Medical Research Council of Australia (NHMRC) Senior Research Fellowship (APP1003710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Aikman SN, 2006, APPETITE, V47, P111, DOI 10.1016/j.appet.2006.02.004; Ball K, 2006, PUBLIC HEALTH NUTR, V9, P623, DOI 10.1079/PHN2005897; Batty GD, 2009, J EPIDEMIOL COMMUN H, V63, P952, DOI 10.1136/jech.2008.086892; Beck ME, 2007, BRIT FOOD J, V109, P531, DOI 10.1108/00070700710761527; Beydoun MA, 2008, PREV MED, V46, P145, DOI 10.1016/j.ypmed.2007.06.016; Beydoun MA, 2009, PUBLIC HEALTH NUTR, V12, P369, DOI 10.1017/S1368980008002140; Blanck HM, 2009, HEALTH EDUC BEHAV, V36, P289, DOI 10.1177/1090198107303308; Burns CM, 2007, HEALTH PLACE, V13, P877, DOI 10.1016/j.healthplace.2007.02.005; Chand A, 2012, APPETITE, V58, P227, DOI 10.1016/j.appet.2011.10.006; Conner M, 2006, FRONT NUTR SCI, P41, DOI 10.1079/9780851990323.0041; Dave JM, 2009, OBESITY, V17, P1164, DOI 10.1038/oby.2009.26; Devine CM, 2005, J NUTR EDUC BEHAV, V37, P121, DOI 10.1016/S1499-4046(06)60266-2; Dillman D. A., 2000, MAIL INTERNET SURVEY, V2; Dunford E, 2010, APPETITE, V55, P484, DOI 10.1016/j.appet.2010.08.015; Dunn KI, 2008, APPETITE, V51, P331, DOI 10.1016/j.appet.2008.03.003; Dunn KI, 2011, APPETITE, V57, P349, DOI 10.1016/j.appet.2011.06.004; Dutton T., 2005, MEASURING SOCIOECONO; Galobardes B, 2001, INT J EPIDEMIOL, V30, P334, DOI 10.1093/ije/30.2.334; Girois SB, 2001, AM J PUBLIC HEALTH, V91, P418, DOI 10.2105/AJPH.91.3.418; Giskes K, 2006, PUBLIC HEALTH NUTR, V9, P75, DOI 10.1079/PHN2005758; GLANZ K, 1998, J AM DIET ASSOC, V98, P1118; Guillaumie L, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-12; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; James WPT, 1997, BMJ-BRIT MED J, V314, P1545, DOI 10.1136/bmj.314.7093.1545; Jaworowska A, 2013, NUTR REV, V71, P310, DOI 10.1111/nure.12031; Kawachi I, 1999, HEALTH SERV RES, V34, P215; Kearney M, 2000, PUBLIC HEALTH NUTR, V3, P219; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Le J, 2013, EUR J CLIN NUTR, V67, P808, DOI 10.1038/ejcn.2013.110; Lea EJ, 2006, EUR J CLIN NUTR, V60, P828, DOI 10.1038/sj.ejcn.1602387; Lynch JW, 1997, SOC SCI MED, V44, P809, DOI 10.1016/S0277-9536(96)00191-8; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Mahon D, 2006, FOOD QUAL PREFER, V17, P474, DOI 10.1016/j.foodqual.2005.06.001; Miura K, 2014, APPETITE, V74, P116, DOI 10.1016/j.appet.2013.12.007; Miura K, 2012, PUBLIC HEALTH NUTR, V15, P218, DOI 10.1017/S136898001100139X; Miura K, 2011, J AM DIET ASSOC, V111, P1556, DOI 10.1016/j.jada.2011.07.009; New South Wales Health and New South Wales Department of Education and Training, 2006, FRESH TAST SCH NSW H; Parmenter K, 2000, HEALTH EDUC RES, V15, P163, DOI 10.1093/her/15.2.163; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Pujades-Rodriguez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104671; Queensland Health, 2007, BETT CHOIC HLTH FOOD; Reidpath DD, 2002, HEALTH PLACE, V8, P141, DOI 10.1016/S1353-8292(01)00028-4; Rydell SA, 2008, J AM DIET ASSOC, V108, P2066, DOI 10.1016/j.jada.2008.09.008; Saelens BE, 2007, AM J PREV MED, V32, P273, DOI 10.1016/j.amepre.2006.12.022; Satia JA, 2004, PUBLIC HEALTH NUTR, V7, P1089, DOI 10.1079/PHN2004662; Shepherd R, 1999, P NUTR SOC, V58, P807, DOI 10.1017/S0029665199001093; Smith GD, 1997, P NUTR SOC, V56, P75, DOI 10.1079/PNS19970011; The Commonwealth Department of Health and Family Services, 1998, AUSTR GUID HLTH EAT; Thornton LE, 2011, J EPIDEMIOL COMMUN H, V65, P873, DOI 10.1136/jech.2009.099614; Tolonen H, 2005, EUR J EPIDEMIOL, V20, P887, DOI 10.1007/s10654-005-2672-5; TUORILA H, 1988, APPETITE, V11, P81, DOI 10.1016/S0195-6663(88)80008-4; Turrell G, 2003, PUBLIC HEALTH NUTR, V6, P191, DOI 10.1079/PHN2002416; Turrell G, 2006, PUBLIC HEALTH NUTR, V9, P375, DOI 10.1079/PHN2006850; Turrell G, 2002, J HUM NUTR DIET, V15, P355, DOI 10.1046/j.1365-277X.2002.00384.x; Turrell G, 1998, J HUM NUTR DIET, V11, P135, DOI 10.1046/j.1365-277X.1998.00084.x; van der Horst K, 2011, J HUM NUTR DIET, V24, P596, DOI 10.1111/j.1365-277X.2011.01206.x; Vue H, 2008, J NUTR EDUC BEHAV, V40, P378, DOI 10.1016/j.jneb.2007.09.009; Wang YF, 2011, J AM DIET ASSOC, V111, P1904, DOI 10.1016/j.jada.2011.09.036; Wardle J, 2003, J EPIDEMIOL COMMUN H, V57, P440, DOI 10.1136/jech.57.6.440; Wardle J, 2000, APPETITE, V34, P269, DOI 10.1006/appe.1999.0311	62	7	7	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108799	10.1371/journal.pone.0108799	http://dx.doi.org/10.1371/journal.pone.0108799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	25268899	Green Published, gold			2022-12-27	WOS:000343671700165
J	Zeng, SD; Sun, P; Chen, ZM; Mao, JX; Wang, JY; Wang, B; Liu, L				Zeng, Shuaidan; Sun, Peng; Chen, Zimin; Mao, Jianxiong; Wang, Jianyao; Wang, Bin; Liu, Lei			Association between Single Nucleotide Polymorphisms in the ADD3 Gene and Susceptibility to Biliary Atresia	PLOS ONE			English	Article							NEONATAL CHOLESTASIS; BILE CANALICULI	Background and Objectives: Based on the results of previous studies, the ADD3 gene, located in the 10q24.2 region, may be a susceptibility gene of biliary atresia (BA). In this study, two single nucleotide polymorphisms (SNPs) in the ADD3 gene, rs17095355 C/T and rs10509906 G/C, were selected to investigate whether there is an association between these SNPs and susceptibility to BA in a Chinese population. Methods: A total of 752 Han Chinese (134 BA cases and 618 ethnically matched healthy controls) were included in the present study. The ADD3 gene polymorphisms were genotyped using a TaqMan genotyping assay. Results: Positive associations were found for the SNp rs17095355 in the codominant model; specifically, the frequencies of the CT and TT genotypes and the T allele were higher in the cases than the controls, demonstrating a significant risk for BA (odds ratio [OR] = 1.62, 95% confidence interval [CI] = 1.02-2.58; OR = 2.89, 95% CI = 1.72-4.86; and OR = 1.75, 95% CI = 1.34-2.29, respectively). Regarding rs10509906, the per-C-allele conferred an OR of 0.70 (95% CI = 0.49-1.00) under the additive model. A greater risk of BA was associated with the T-a-(G)b (a for rs17095355 and b for rs10509906) haplotype (OR = 1.82, 95% CI = 1.27-2.61) compared with the C-a-C-b haplotype. Conclusion: This study suggests that the ADD3 gene plays an important role in BA pathogenesis and reveals a significant association between two SNPs, rs17095355 and rs10509906, and BA.	[Zeng, Shuaidan; Sun, Peng; Liu, Lei] Zunyi Med Coll, Zhuhai, Guangdong, Peoples R China; [Zeng, Shuaidan; Sun, Peng; Chen, Zimin; Mao, Jianxiong; Wang, Jianyao; Wang, Bin; Liu, Lei] Shenzhen Childrens Hosp, Dept Gen Surg, Shenzhen, Guangdong, Peoples R China	Zunyi Medical University	Wang, B (corresponding author), Shenzhen Childrens Hosp, Dept Gen Surg, Shenzhen, Guangdong, Peoples R China.	szwb1967@126.com; liulei3322@aliyun.com	Liu, lei/V-9405-2018	Liu, lei/0000-0001-9612-6844				Arikan C, 2006, J PEDIATR GASTR NUTR, V42, P77, DOI 10.1097/01.mpg.0000192247.55583.fa; Arikan C, 2008, DIGEST DIS SCI, V53, P2000, DOI 10.1007/s10620-007-9914-1; Cheng G, 2013, J HEPATOL, V59, P1285, DOI 10.1016/j.jhep.2013.07.021; Chuang Jiin-Haur, 2006, Chang Gung Med J, V29, P240; Fischler B, 1998, J PEDIATR GASTR NUTR, V27, P57, DOI 10.1097/00005176-199807000-00010; Garcia-Barcelo MM, 2010, HUM MOL GENET, V19, P2917, DOI 10.1093/hmg/ddq196; Kaewkiattiyot S, 2011, HEPATOL RES, V41, P1249, DOI 10.1111/j.1872-034X.2011.00870.x; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; OSHIO C, 1981, SCIENCE, V212, P1041, DOI 10.1126/science.7015506; Puri PHM, 2009, PEDIAT SURG DIAGNOSI, P537; SEGAWA O, 1993, J PEDIATR SURG, V28, P851, DOI 10.1016/0022-3468(93)90344-K; Shih HH, 2005, PEDIATRICS, V116, P437, DOI 10.1542/peds.2004-1900; Shteyer E, 2006, J PEDIATR GASTR NUTR, V42, P93, DOI 10.1097/01.mpg.0000189324.80323.a6; SILVEIRA TR, 1993, J PEDIATR GASTR NUTR, V16, P114, DOI 10.1097/00005176-199302000-00002; SMITH BM, 1991, J PEDIATR SURG, V26, P1331, DOI 10.1016/0022-3468(91)90613-X; Suskind DL, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-14; Tsai EA, 2014, HUM GENET, V133, P235, DOI 10.1007/s00439-013-1368-2; Tyler KL, 1998, HEPATOLOGY, V27, P1475, DOI 10.1002/hep.510270603; Udomsinprasert W, 2012, WORLD J PEDIATR, V8, P328, DOI 10.1007/s12519-012-0377-x; Vijayan V, 2000, J PEDIATR SURG, V35, P1230, DOI 10.1053/jpsu.2000.8760; Zhao R, 2013, DIGESTION, V88, P65, DOI 10.1159/000352025	21	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e107977	10.1371/journal.pone.0107977	http://dx.doi.org/10.1371/journal.pone.0107977			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285724	Green Submitted, gold, Green Published			2022-12-27	WOS:000345743700010
J	de Pedro-Cuesta, J; Mahillo-Fernandez, I; Calero, M; Rabano, A; Cruz, M; Siden, A; Martinez-Martin, P; Laursen, H; Ruiz-Tovar, M; Molbak, K				de Pedro-Cuesta, Jesus; Mahillo-Fernandez, Ignacio; Calero, Miguel; Rabano, Alberto; Cruz, Mabel; Siden, Ake; Martinez-Martin, Pablo; Laursen, Henning; Ruiz-Tovar, Maria; Molbak, Kare		EUROSURGYCJD Res Grp	Towards an Age-Dependent Transmission Model of Acquired and Sporadic Creutzfeldt-Jakob Disease	PLOS ONE			English	Article							EPIDEMIOLOGIC ASSESSMENT; UNITED-KINGDOM; RISK-FACTORS; SURGERY; SUSCEPTIBILITY; CLASSIFICATION; VCJD	Introduction: Sporadic Creutzfeldt-Jakob disease (sCJD) might be transmitted by surgery. The purpose of this study was to investigate potential susceptibility to sCJD from surgery at juvenile age and in early adulthood. Methods: From Danish and Swedish national registries we identified 167 definite and probable sCJD cases with onset from 1987 through 2003, and 835 age-, sex- and residence-matched controls along with their surgical histories. Main, anatomically or etiologically classified surgical procedures followed by a >= 20-year lag were analyzed using logistic regression, and stratified by age at first-registered surgical discharge. Results: The risk of having a diagnosis of CJD depended strongly on age at first surgery with odds ratio (OR) of 12.80 (95% CI 2.56-64.0) in patients <30 years, 3.04 (95% 1.26-7.33) in 30-39 years, and 1.75 (95% CI 0.89-3.45) in >= 40 years, for anatomically classified surgical procedures. Similar figures were obtained for etiologically classified surgical procedures. Conclusions: Risk of surgical-acquired sCJD depends on age at exposure; this pattern is similar to age-specific profiles reported for CJD accidentally transmitted by human pituitary-derived growth hormone and susceptibility curves for variant CJD estimated after adjustment for dietary exposure to bovine spongiform encephalopathy. There might be an age-at-exposure-related susceptibility to acquire all CJD forms, including sCJD from routine surgery.	[de Pedro-Cuesta, Jesus; Mahillo-Fernandez, Ignacio; Martinez-Martin, Pablo; Ruiz-Tovar, Maria] Natl Ctr Epidemiol, Carlos Inst Hlth 3, Dept Appl Epidemiol, Madrid, Spain; [de Pedro-Cuesta, Jesus; Mahillo-Fernandez, Ignacio; Calero, Miguel; Martinez-Martin, Pablo; Ruiz-Tovar, Maria] Consortium Biomed Res Neurodegenerat Dis CIBERNED, Madrid, Spain; [Calero, Miguel] Carlos III Inst Hlth, Majadahonda, Spain; [Calero, Miguel; Rabano, Alberto] Reina Sofia Fdn, Alzheimers Dis Ctr, Madrid, Spain; [Cruz, Mabel; Siden, Ake] Karolinska Inst, Div Neurol, Stockholm, Sweden; [Laursen, Henning] Natl Hosp, Copenhagen, Denmark; [Molbak, Kare] Statens Serum Inst, DK-2300 Copenhagen, Denmark	CIBERNED; Instituto de Salud Carlos III; Karolinska Institutet; Rigshospitalet; Statens Serum Institut	de Pedro-Cuesta, J (corresponding author), Natl Ctr Epidemiol, Carlos Inst Hlth 3, Dept Appl Epidemiol, Madrid, Spain.	jpedro@isciii.es	Martinez-Martin, Pablo/N-9909-2019; Calero, Miguel/H-5691-2015; Ruiz-Tovar, Maria/F-4631-2016; Mahillo-Fernandez, Ignacio/T-2042-2018	Martinez-Martin, Pablo/0000-0003-0837-5280; Calero, Miguel/0000-0001-5366-3324; Ruiz-Tovar, Maria/0000-0002-5102-4905; Mahillo-Fernandez, Ignacio/0000-0003-0558-6541; Molbak, Kare/0000-0002-3100-4990	EU Research Commission [QLRG3-CT-2002-81223]; NEUROPRION; Spanish Centro de Investigaciones en enfermedades Neurologicas [CIEN C03-06]; Consortium for Biomedical Research in Neurodegenerative Diseases (CIBERNED) networks; Carlos III National Health Institute; Karolinska Institute	EU Research Commission; NEUROPRION; Spanish Centro de Investigaciones en enfermedades Neurologicas; Consortium for Biomedical Research in Neurodegenerative Diseases (CIBERNED) networks; Carlos III National Health Institute; Karolinska Institute(Karolinska Institutet)	Funding was obtained from the EU Research Commission, Concerted Action QLRG3-CT-2002-81223, NEUROPRION and the Spanish Centro de Investigaciones en enfermedades Neurologicas (CIEN C03-06), and Consortium for Biomedical Research in Neurodegenerative Diseases (CIBERNED) networks, and from the Karolinska and Carlos III National Health Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boelle PY, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-26; Cruz M, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-5; Cuesta JD, 2012, NEUROEPIDEMIOLOGY, V39, P1, DOI 10.1159/000339318; de Pedro-Cuesta J, 2006, EUR J EPIDEMIOL, V21, P595, DOI 10.1007/s10654-006-9044-7; de Pedro-Cuesta J, 2011, J NEUROL NEUROSUR PS, V82, P204, DOI 10.1136/jnnp.2009.188425; Ghani AC, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-4; Glatzel M, 2005, ARCH NEUROL-CHICAGO, V62, P545, DOI 10.1001/archneur.62.4.545; Hamaguchi T, 2009, NEUROPATHOLOGY, V29, P625, DOI 10.1111/j.1440-1789.2009.01023.x; KHOURY MJ, 1989, AM J EPIDEMIOL, V129, P183, DOI 10.1093/oxfordjournals.aje.a115107; Laske C, 1999, EUR J EPIDEMIOL, V15, P631, DOI 10.1023/A:1007683208121; Mahillo-Fernandez I, 2008, NEUROEPIDEMIOLOGY, V31, P229, DOI 10.1159/000163097; Molesworth AM, 2011, TRANSFUSION, V51, P1872, DOI 10.1111/j.1537-2995.2011.03198.x; Nakamura Y, 2000, J Epidemiol, V10, P399; Puopolo M, 2011, TRANSFUSION, V51, P1556, DOI 10.1111/j.1537-2995.2010.03004.x; Rabano A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-9; Ruiz-Tovar M, 2011, REV GUIDELINES PREVE; Sanchez-Juan P, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.011; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Socialstyrelsen, 2009, KVAL INN PAT HOSP DI; Swerdlow AJ, 2003, NEUROLOGY, V61, P783, DOI 10.1212/01.WNL.0000084000.27403.15; Ward HJT, 2008, NEUROEPIDEMIOLOGY, V31, P241, DOI 10.1159/000163098; Ward HJT, 2008, ANN NEUROL, V63, P347, DOI 10.1002/ana.21294; Ward HJT, 2006, ANN NEUROL, V59, P111, DOI 10.1002/ana.20708; Weissmann C, 2002, P NATL ACAD SCI USA, V99, P16378, DOI 10.1073/pnas.172403799	24	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109412	10.1371/journal.pone.0109412	http://dx.doi.org/10.1371/journal.pone.0109412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279832	gold, Green Published, Green Submitted			2022-12-27	WOS:000342670800078
J	Facchini, A; Cetrullo, S; D'Adamo, S; Guidotti, S; Minguzzi, M; Facchini, A; Borzi, RM; Flamigni, F				Facchini, Annalisa; Cetrullo, Silvia; D'Adamo, Stefania; Guidotti, Serena; Minguzzi, Manuela; Facchini, Andrea; Borzi, Rosa Maria; Flamigni, Flavio			Hydroxytyrosol Prevents Increase of Osteoarthritis Markers in Human Chondrocytes Treated with Hydrogen Peroxide or Growth-Related Oncogene alpha	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; VIRGIN OLIVE OIL; OXIDATIVE STRESS; DNA-DAMAGE; EXTRACELLULAR-MATRIX; IN-VITRO; CARTILAGE; POLYPHENOLS; APOPTOSIS; COMPOUND	Hydroxytyrosol (HT), a phenolic compound mainly derived from olives, has been proposed as a nutraceutical useful in prevention or treatment of degenerative diseases. In the present study we have evaluated the ability of HT to counteract the appearance of osteoarthritis (OA) features in human chondrocytes. Pre-treatment of monolayer cultures of chondrocytes with HT was effective in preventing accumulation of reactive oxidant species (ROS), DNA damage and cell death induced by H2O2 exposure, as well as the increase in the mRNA level of pro-inflammatory, matrix-degrading and hypertrophy marker genes, such as iNOS, COX-2, MMP-13, RUNX-2 and VEGF. HT alone slightly enhanced ROS production, but did not enhance cell damage and death or the expression of OA-related genes. Moreover HT was tested in an in vitro model of OA, i.e. three-dimensional micromass cultures of chondrocytes stimulated with growth-related oncogene alpha (GRO alpha), a chemokine involved in OA pathogenesis and known to promote hypertrophy and terminal differentiation of chondrocytes. In micromass constructs, HT pre-treatment inhibited the increases in caspase activity and the level of the messengers for iNOS, COX-2, MMP-13, RUNX-2 and VEGF elicited by GRO alpha. In addition, HT significantly increased the level of SIRT-1 mRNA in the presence of GRO alpha. In conclusion, the present study shows that HT reduces oxidative stress and damage, exerts pro-survival and anti-apoptotic actions and favourably influences the expression of critical OA-related genes in human chondrocytes treated with stressors promoting OA-like features.	[Facchini, Annalisa; Guidotti, Serena; Minguzzi, Manuela; Facchini, Andrea] Univ Bologna, Dipartimento Sci Med & Chirurg, Bologna, Italy; [Facchini, Annalisa; Cetrullo, Silvia; D'Adamo, Stefania; Flamigni, Flavio] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie, Bologna, Italy; [Guidotti, Serena; Minguzzi, Manuela; Facchini, Andrea; Borzi, Rosa Maria] Ist Ortoped Rizzoli, Lab RAMSES, Lab Immunoreumatol & Rigeneraz Tissutale, Bologna, Italy	University of Bologna; University of Bologna; IRCCS Istituto Ortopedico Rizzoli	Flamigni, F (corresponding author), Univ Bologna, Dipartimento Sci Biomed & Neuromotorie, Bologna, Italy.	flavio.flamigni@unibo.it	D'Adamo, Stefania/AAB-7723-2019; Borzì, Rosa Maria/ABI-2279-2020; Minguzzi, Manuela/J-8172-2017	D'Adamo, Stefania/0000-0002-2209-9158; Borzì, Rosa Maria/0000-0003-4133-4894; 	FIRB (Ministero dell'istruzione, dell'Universita e della Ricerca, Italy) [RBAP10KCNS]; RFO (University of Bologna); Fondi cinque per mille (Ministero della Salute, Italy)	FIRB (Ministero dell'istruzione, dell'Universita e della Ricerca, Italy); RFO (University of Bologna); Fondi cinque per mille (Ministero della Salute, Italy)	This work was supported by FIRB (Ministero dell'istruzione, dell'Universita e della Ricerca, Italy) grant RBAP10KCNS (AndreaF, FF, RMB), RFO (University of Bologna) (FF, AndreaF) and Fondi cinque per mille (Ministero della Salute, Italy) (AndreaF, RMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 2007, CURR DRUG TARGETS, V8, P377, DOI 10.2174/138945007779940052; Martin MA, 2010, MOL NUTR FOOD RES, V54, P956, DOI 10.1002/mnfr.200900159; Attur MG, 2002, OSTEOARTHR CARTILAGE, V10, P1, DOI 10.1053/joca.2001.0488; Bayram B, 2012, REJUV RES, V15, P71, DOI 10.1089/rej.2011.1245; Bider CM, 2007, NUTR RES, V27, P470, DOI 10.1016/j.nutres.2007.06.003; Bitler CM, 2005, J NUTR, V135, P1475, DOI 10.1093/jn/135.6.1475; Borzi RM, 2004, CLIN ORTHOP RELAT R, pS53, DOI 10.1097/01.blo.0000143805.64755.4f; Borzi RM, 2010, ARTHRITIS RHEUM-US, V62, P2370, DOI 10.1002/art.27512; Burattini S, 2013, FOOD CHEM TOXICOL, V55, P248, DOI 10.1016/j.fct.2012.12.049; Chung SW, 2010, ARCH BIOCHEM BIOPHYS, V501, P79, DOI 10.1016/j.abb.2010.05.003; Davidson RK, 2013, ARTHRITIS RHEUM-US, V65, P3130, DOI 10.1002/art.38133; Dudley JI, 2008, J AGR FOOD CHEM, V56, P9362, DOI 10.1021/jf801791d; Facchini A, 2011, J CELL PHYSIOL, V226, P1771, DOI 10.1002/jcp.22506; Gabay O, 2012, JOINT BONE SPINE, V79, P570, DOI 10.1016/j.jbspin.2012.04.005; Goldring MB, 2011, EUR CELLS MATER, V21, P202, DOI 10.22203/eCM.v021a16; Granados-Principal S, 2010, NUTR REV, V68, P191, DOI 10.1111/j.1753-4887.2010.00278.x; Green JA, 2014, P NUTR SOC, P1; Guo W, 2010, PHYTOTHER RES, V24, P352, DOI 10.1002/ptr.2943; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Iacono A, 2010, ARTHRITIS RHEUM-US, V62, P1675, DOI 10.1002/art.27437; Ilavarasi K, 2011, CHEMOSPHERE, V84, P888, DOI 10.1016/j.chemosphere.2011.06.017; Impellizzeri D, 2011, J PHARMACOL EXP THER, V339, P859, DOI 10.1124/jpet.111.182808; Kim HA, 2009, RHEUMATOLOGY, V48, P932, DOI 10.1093/rheumatology/kep132; Kim HA, 2012, RHEUMATOLOGY, V51, P1006, DOI 10.1093/rheumatology/ker525; Lotz MK, 2011, NAT REV RHEUMATOL, V7, P579, DOI 10.1038/nrrheum.2011.109; Menendez JA, 2013, CELL CYCLE, V12, P555, DOI 10.4161/cc.23756; Mukherjee S, 2009, FREE RADICAL BIO MED, V46, P573, DOI 10.1016/j.freeradbiomed.2008.11.005; Musumeci G, 2013, J NUTR BIOCHEM, V24, P2064, DOI 10.1016/j.jnutbio.2013.07.007; Olivotto E, 2008, ARTHRITIS RHEUM-US, V58, P227, DOI 10.1002/art.23211; Olivotto E, 2007, J CELL PHYSIOL, V210, P417, DOI 10.1002/jcp.20864; Richard N, 2011, PLANTA MED, V77, P1890, DOI 10.1055/s-0031-1280022; Scoditti E, 2012, ARCH BIOCHEM BIOPHYS, V527, P81, DOI 10.1016/j.abb.2012.05.003; Scotece M, 2012, LIFE SCI, V91, P1229, DOI 10.1016/j.lfs.2012.09.012; Shen CL, 2012, J NUTR BIOCHEM, V23, P1367, DOI 10.1016/j.jnutbio.2012.04.001; Stanic I, 2006, J CELL PHYSIOL, V206, P138, DOI 10.1002/jcp.20446; Svetlova MP, 2010, MUTAT RES-FUND MOL M, V685, P54, DOI 10.1016/j.mrfmmm.2009.08.001; Warleta F, 2011, NUTRIENTS, V3, P839, DOI 10.3390/nu3100839; Yang CL, 1997, EXP CELL RES, V235, P370, DOI 10.1006/excr.1997.3692; Zhang XM, 2009, N-S ARCH PHARMACOL, V379, P581, DOI 10.1007/s00210-009-0399-7; Zhang XM, 2009, BIOL PHARM BULL, V32, P578, DOI 10.1248/bpb.32.578; Zhuo Q, 2012, NAT REV RHEUMATOL, V8, P729, DOI 10.1038/nrrheum.2012.135; Zrelli H, 2011, EUR J PHARMACOL, V660, P275, DOI 10.1016/j.ejphar.2011.03.045; Zrelli H, 2011, J AGR FOOD CHEM, V59, P4473, DOI 10.1021/jf104151d	44	29	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109724	10.1371/journal.pone.0109724	http://dx.doi.org/10.1371/journal.pone.0109724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279550	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800098
J	Vaitkeviciute, D; Latt, E; Maestu, J; Jurimae, T; Saar, M; Purge, P; Maasalu, K; Jurimae, J				Vaitkeviciute, Donvina; Laett, Evelin; Maeestu, Jarek; Juerimaee, Toivo; Saar, Meeli; Purge, Priit; Maasalu, Katre; Juerimaee, Jaak			Physical Activity and Bone Mineral Accrual in Boys with Different Body Mass Parameters during Puberty: A Longitudinal Study	PLOS ONE			English	Article							CARDIORESPIRATORY FITNESS; ADOLESCENT BOYS; CHILDREN; DENSITY; EXERCISE; FAT; CHILDHOOD; OBESITY; WEIGHT; SCHOOL	The aim of our longitudinal study was to investigate the relationships between physical activity and bone mass in boys with different body mass status during the years surrounding pubertal growth spurt. Two hundred and six boys entering puberty took part in this study. The subjects were divided into underweight (BMI<15.35), normal weight (BMI >= 15.35-21.22), overweight (BMI >= 21.22-26.02) and obese (BMI>26.02) groups at baseline according to age related categories. Whole-body DXA scans were performed at baseline, after 12 and 24 months to assess body composition (lean body mass, fat mass), and total body (TB), lumbar spine (LS) and femoral neck (FN) bone mineral density (BMD) parameters. Physical activity was measured by 7-day accelerometry. For longitudinal analysis, multilevel fixed effects regression models were constructed. Biological age, height and lean body mass had an effect for explanation of TB BMD, FN BMD and LS BMD. Moderate to vigorous physical activity (MVPA), vigorous physical activity (VPA) and sedentary time (SED) had the significant effect only on FN BMD. Being an underweight boy at the baseline indicated greater chance (p<0.01) to have lower TB BMD in the future (2 years at follow up) development, compared to normal weight (estimates = -0.038), overweight (estimates = -0.061) and obese boys (estimates = -0.106).	[Vaitkeviciute, Donvina; Laett, Evelin; Maeestu, Jarek; Juerimaee, Toivo; Saar, Meeli; Purge, Priit; Juerimaee, Jaak] Univ Tartu, Fac Exercise & Sport Sci, Ctr Behav Social & Hlth Sci, Inst Sport Pedag & Coaching Sci, EE-50090 Tartu, Estonia; [Maasalu, Katre] Univ Tartu, Fac Med, Dept Traumatol & Orthoped, EE-50090 Tartu, Estonia	University of Tartu; University of Tartu	Jurimae, J (corresponding author), Univ Tartu, Fac Exercise & Sport Sci, Ctr Behav Social & Hlth Sci, Inst Sport Pedag & Coaching Sci, Ulikooli 18, EE-50090 Tartu, Estonia.	jaak.jurimae@ut.ee	Mäestu, Evelin/B-7826-2019; Jürimäe, Jaak/G-9692-2016; Purge, Priit/AAI-7359-2020; , jarek/AAG-5620-2021	Mäestu, Evelin/0000-0002-2939-9890; Jurimae, Jaak/0000-0003-4819-5241	Estonian Research Council [IUT20-58, SKKSP13188]	Estonian Research Council	This study was supported by grant of Estonian Research Council IUT20-58 and SKKSP13188, http://www.etag.ee/en/, JJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey DA, 2000, J BONE MINER RES, V15, P2245, DOI 10.1359/jbmr.2000.15.11.2245; Bailey DA, 1997, INT J SPORTS MED, V18, pS191, DOI 10.1055/s-2007-972713; Bailey DA, 1999, J BONE MINER RES, V14, P1672, DOI 10.1359/jbmr.1999.14.10.1672; Baptista F, 2012, J BONE MINER METAB, V30, P100, DOI 10.1007/s00774-011-0294-4; Baxter-Jones ADG, 2003, ANN HUM BIOL, V30, P160, DOI 10.1080/0301446021000034642; Cardadeiro G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050657; Castro J, 2002, J AM ACAD CHILD PSY, V41, P613, DOI 10.1097/00004583-200205000-00019; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; DHHS, KEY GUID CHILDR AD; Dimitri P, 2012, BONE, V50, P457, DOI 10.1016/j.bone.2011.05.011; Dimitri P, 2010, J BONE MINER RES, V25, P527, DOI 10.1359/jbmr.090823; Ekelund U, 2007, DIABETOLOGIA, V50, P1832, DOI 10.1007/s00125-007-0762-5; Farr JN, 2011, OSTEOPOROSIS INT, V22, P1419, DOI 10.1007/s00198-010-1361-8; Fintini D, 2011, J ENDOCRINOL INVEST, V34, pE86, DOI [10.1007/BF03347097, 10.3275/7265]; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Fuchs RK, 2001, J BONE MINER RES, V16, P148, DOI 10.1359/jbmr.2001.16.1.148; Galusca B, 2008, J CLIN ENDOCR METAB, V93, P110, DOI 10.1210/jc.2007-1591; Gracia-Marco L, 2012, OSTEOPOROSIS INT, V23, P937, DOI 10.1007/s00198-011-1649-3; Gracia-Marco L, 2012, BMC PUBLIC HEALTH, V4, P628; Gracia-Marco L, 2011, AM J PREV MED, V40, P599, DOI 10.1016/j.amepre.2011.03.001; Hasanoglu A, 2000, J PEDIATR ENDOCR MET, V13, P307; Heidemann M, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-32; Ivuskans A, PEDIAT INT IN PRESS; Ivuskans A, J BONE MINE IN PRESS; Ivuskans A, 2013, RHEUMATOL INT, V33, P1681, DOI 10.1007/s00296-012-2612-0; Knuth AG, 2009, J PHYS ACT HEALTH, V6, P548, DOI 10.1123/jpah.6.5.548; Kriemler S, 2008, OSTEOPOROSIS INT, V19, P1749, DOI 10.1007/s00198-008-0611-5; Leonard MB, 2004, AM J CLIN NUTR, V80, P514, DOI 10.1093/ajcn/80.2.514; MacKelvie KJ, 2004, BONE, V34, P755, DOI 10.1016/j.bone.2003.12.017; Martinez-Gomez D, 2010, AM J HUM BIOL, V22, P750, DOI 10.1002/ajhb.21076; McKay HA, 2000, J PEDIATR-US, V136, P156, DOI 10.1016/S0022-3476(00)70095-3; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Misra M, 2008, J CLIN ENDOCR METAB, V93, P3029, DOI 10.1210/jc.2008-0170; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Pietrobelli A, 2002, OBES RES, V10, P56, DOI 10.1038/oby.2002.8; Rizzo NS, 2008, AM J CLIN NUTR, V87, P586, DOI 10.1093/ajcn/87.3.586; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; Rocher E, 2008, J BONE MINER METAB, V26, P73, DOI 10.1007/s00774-007-0786-4; Sayers A, 2011, J CLIN ENDOCR METAB, V96, pE793, DOI 10.1210/jc.2010-2550; Sherar LB, 2007, MED SCI SPORT EXER, V39, P830, DOI 10.1249/mss.0b013e3180335c3c; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Tobias JH, 2007, J BONE MINER RES, V22, P101, DOI 10.1359/JBMR.060913; Tremblay MS, 2008, APPL PHYSIOL NUTR ME, V35, P725; Vandewalle S, 2013, J CLIN ENDOCR METAB, V98, P3019, DOI 10.1210/jc.2012-3914; Vicente-Rodriguez G, 2009, BONE, V45, P925, DOI 10.1016/j.bone.2009.07.084; Vicente-Rodriguez G, 2006, SPORTS MED, V36, P561, DOI 10.2165/00007256-200636070-00002; Weeks BK, 2008, J BONE MINER RES, V23, P1002, DOI 10.1359/JBMR.080226; WELK GJ, 2002, PHYS ACTIVITY ASSESS, P125	48	45	45	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e107759	10.1371/journal.pone.0107759	http://dx.doi.org/10.1371/journal.pone.0107759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279833	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800006
J	Wartman, BC; Gabel, J; Holahan, MR				Wartman, Brianne C.; Gabel, Jennifer; Holahan, Matthew R.			Inactivation of the Anterior Cingulate Reveals Enhanced Reliance on Cortical Networks for Remote Spatial Memory Retrieval after Sequential Memory Processing	PLOS ONE			English	Article							GRADED RETROGRADE-AMNESIA; CONTEXT-SHOCK PAIRINGS; MEDIAL TEMPORAL-LOBE; HIPPOCAMPAL DAMAGE; OLD MEMORIES; CORTEX; FEAR; RATS; CONSOLIDATION; SYSTEMS	One system consolidation model suggests that as time passes, ensembles of cortical neurons form strong connections to represent remote memories. In this model, the anterior cingulate cortex (ACC) serves as a cortical region that represents remote memories. However, there is debate as to whether remote spatial memories go through this systems consolidation process and come to rely on the ACC. The present experiment examined whether increasing the processing demand on the hippocampus, by sequential training on two spatial tasks, would more fully engage the ACC during retrieval of a remote spatial memory. In this scenario, inactivation of the ACC at a remote time point was hypothesized to produce a severe memory deficit if rats had been trained on two, sequential spatial tasks. Rats were trained on a water maze (WM) task only or a WM task followed by a radial arm maze task. A WM probe test was given recently or remotely to all rats. Prior to the probe test, rats received an injection of saline or muscimol into the ACC. A subtle deficit in probe performance was found at the remote time point in the group trained on only one spatial task and treated with muscimol. In the group trained on two spatial tasks and treated with muscimol, a subtle deficit in probe performance was noted at the recent time point and a substantial deficit in probe performance was observed at the remote time point. c-Fos labeling in the hippocampus revealed more labeling in the CA1 region in all remotely tested groups than recently tested groups. Findings suggest that spatial remote memories come to rely more fully on the ACC when hippocampal processing requirements are increased. Results also suggest continued involvement of the hippocampus in spatial memory retrieval along with a progressive strengthening of cortical connections as time progresses.	[Wartman, Brianne C.; Gabel, Jennifer; Holahan, Matthew R.] Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada	Carleton University	Holahan, MR (corresponding author), Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada.	matthew_holahan@carleton.ca	Holahan, Matthew/GZK-5814-2022	Holahan, Matthew/0000-0001-7653-9262	National Science and Engineering Research Council of Canada [RGPIN 341673]; Canadian Foundation for Innovation [335892]; Alexander Graham Bell Post-Graduate Scholarship from the National Science and Engineering Research Council of Canada	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Alexander Graham Bell Post-Graduate Scholarship from the National Science and Engineering Research Council of Canada	This research was supported by National Science and Engineering Research Council of Canada Discovery grants to MRH (RGPIN 341673) and a Canadian Foundation for Innovation grant (335892) to MRH. BCW was supported by an Alexander Graham Bell Post-Graduate Scholarship from the National Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Bayley PJ, 2006, J NEUROSCI, V26, P13311, DOI 10.1523/JNEUROSCI.4262-06.2006; Blum ID, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036117; Bonaccorsi J, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/956312; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Broadbent NJ, 2006, LEARN MEMORY, V13, P187, DOI 10.1101/lm.134706; Clark RE, 2005, HIPPOCAMPUS, V15, P340, DOI 10.1002/hipo.20076; Clark RE, 2005, HIPPOCAMPUS, V15, P260, DOI 10.1002/hipo.20056; Clark RE, 2007, J NEUROSCI, V27, P6647, DOI 10.1523/JNEUROSCI.0913-07.2007; Ding HK, 2008, LEARN MEMORY, V15, P290, DOI 10.1101/lm.905008; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dudai Y, 2012, ANNU REV NEUROSCI, V35, P227, DOI 10.1146/annurev-neuro-062111-150500; Dudai Y, 2009, PHILOS T R SOC B, V364, P1255, DOI 10.1098/rstb.2008.0320; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Epp J, 2008, LEARN MEMORY, V15, P214, DOI 10.1101/lm.788008; Frankland PW, 2006, P NATL ACAD SCI USA, V103, P509, DOI 10.1073/pnas.0510133103; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Holahan MR, 2007, HIPPOCAMPUS, V17, P93, DOI 10.1002/hipo.20245; Holahan MR, 2004, LEARN MEMORY, V11, P436, DOI 10.1101/lm.64704; Kapur N, 1999, HIPPOCAMPUS, V9, P247, DOI 10.1002/(SICI)1098-1063(1999)9:3<247::AID-HIPO5>3.0.CO;2-W; Kassardjian CD, 2005, J NEUROSCI, V25, P7979, DOI 10.1523/JNEUROSCI.2215-05.2005; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Lehmann H, 2007, EUR J NEUROSCI, V25, P1278, DOI 10.1111/j.1460-9568.2007.05374.x; Lehmann H, 2013, NEUROBIOL LEARN MEM, V106, P294, DOI 10.1016/j.nlm.2012.10.011; Lopez Joelle, 2012, Hippocampus, V22, P827, DOI 10.1002/hipo.20943; Manns JR, 2003, NEURON, V38, P127, DOI 10.1016/S0896-6273(03)00146-6; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1986, Q J EXP PSYCHOL-B, V38, P365; Mumby DG, 1999, BEHAV BRAIN RES, V106, P97, DOI 10.1016/S0166-4328(99)00097-2; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.3.CO;2-4; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Paxinos G, 1998, RAT BRAIN ATLAS STER; Restivo L, 2009, J NEUROSCI, V29, P8206, DOI 10.1523/JNEUROSCI.0966-09.2009; Rosenbaum RS, 2000, NAT NEUROSCI, V3, P1044, DOI 10.1038/79867; Roxin A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003146; Rudy JW, 2005, LEARN MEMORY, V12, P172, DOI 10.1101/lm.84005; Schlesiger MI, 2013, NEUROBIOL LEARN MEM, V106, P324, DOI 10.1016/j.nlm.2013.05.007; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sparks FT, 2013, NEUROBIOL LEARN MEM, V106, P309, DOI 10.1016/j.nlm.2013.05.008; Sparks FT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027426; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Sutherland RJ, 2001, HIPPOCAMPUS, V11, P27, DOI 10.1002/1098-1063(2001)11:1<27::AID-HIPO1017>3.0.CO;2-4; Sutherland RJ, 2008, HIPPOCAMPUS, V18, P710, DOI 10.1002/hipo.20431; Teixeira CM, 2006, J NEUROSCI, V26, P7555, DOI 10.1523/JNEUROSCI.1068-06.2006; Teng E, 1999, NATURE, V400, P675, DOI 10.1038/23276; Vetere G, 2011, P NATL ACAD SCI USA, V108, P8456, DOI 10.1073/pnas.1016275108; Wang S, 1997, NEUROSCIENCE, V81, P967, DOI 10.1016/S0306-4522(97)00191-7; Wartman BC, 2013, NEUROBIOL LEARN MEM, V106, P334, DOI 10.1016/j.nlm.2013.08.011; Weible AP, 2013, BEHAV BRAIN RES, V245, P63, DOI 10.1016/j.bbr.2013.02.010; Weible AP, 2012, J NEUROSCI, V32, P5598, DOI 10.1523/JNEUROSCI.5265-11.2012; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Winocur G, 2013, HIPPOCAMPUS, V23, P330, DOI 10.1002/hipo.22093; Winocur G, 2011, J INT NEUROPSYCH SOC, V17, P766, DOI 10.1017/S1355617711000683; Winocur G, 2010, NEUROPSYCHOLOGIA, V48, P2339, DOI 10.1016/j.neuropsychologia.2010.04.016; Wolfer DP, 2001, PHYSIOL BEHAV, V73, P745, DOI 10.1016/S0031-9384(01)00531-5; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	65	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e108711	10.1371/journal.pone.0108711	http://dx.doi.org/10.1371/journal.pone.0108711			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279556	Green Published, Green Submitted, gold			2022-12-27	WOS:000342670800026
J	Zhang, MD; Zhang, YH; Zhu, EJ; Qiao, SB; Lv, SZ; Zhao, QM				Zhang, Ming-duo; Zhang, Yu-hui; Zhu, En-jun; Qiao, Shi-bin; Lv, Shu-zheng; Zhao, Quan-ming			Effect of Pioglitazone on In-Stent Restenosis after Coronary Drug-Eluting Stent Implantation: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							MUSCLE-CELL PROLIFERATION; TYPE-2 DIABETES-MELLITUS; ACTIVATED RECEPTOR-GAMMA; PPAR-GAMMA; MYOCARDIAL-INFARCTION; DOUBLE-BLIND; PREVENTION; APOPTOSIS; RISK; THIAZOLIDINEDIONES	Background: In-stent restenosis (ISR) remains a common life-threatening complication and some studies have shown that pioglitazone can reduce the incidence of ISR in patients with drug-eluting stents (DES) implantation. We conducted a meta-analysis to assess the effect of pioglitazone in preventing ISR after DES implantation. Methods: Randomized controlled trials (RCTs) investigating the effects of pioglitazone for ISR after DES implantation were identified by systematic searches of multiple online databases and manual searches of related reference lists of identified trials through May 2014. The primary endpoint was the rate of ISR. Secondary endpoints included minimum lumen diameter, percentage stenosis of stented vessels, late loss, in-stent neointimal volume, target vessel revascularization (TVR), target lesion revascularization, myocardial infarction, stent thrombosis and death. Results: Five studies, comprising 255 pioglitazone-treated patients and 245 controls, were identified in the current meta-analysis. Pioglitazone did not significantly reduce the rate of ISR (P = 0.20) with low heterogeneity (I-2 = 13.3%, P = 0.32). For the secondary outcomes, pioglitazone did not substantially affect the pooled estimates of these endpoints except late loss (P = 0.01) and TVR (P = 0.04). Conclusions: The limited evidence indicates that pioglitazone does not demonstrate markedly beneficial effect in patients subjected to coronary DES implantation. However, the results should be interpreted with care given the small sample size. Further large-scale RCTs are needed.	[Zhang, Ming-duo; Zhang, Yu-hui; Lv, Shu-zheng; Zhao, Quan-ming] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China; [Zhang, Ming-duo; Zhang, Yu-hui; Lv, Shu-zheng; Zhao, Quan-ming] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Zhu, En-jun] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China; [Qiao, Shi-bin] Rizhao Peoples Hosp, Dept Cardiol, Rizhao, Shandong, Peoples R China	Capital Medical University; Capital Medical University	Lv, SZ (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China.	cardio_anzhen@hotmail.com; cardio_zqm@hotmail.com		Zhang, Mingduo/0000-0003-0111-4088	"Twelve Five'' National Key Technology R&D Program of China [2011BAI11B05]; Beijing Natural Science Foundation of China [7132078]	"Twelve Five'' National Key Technology R&D Program of China; Beijing Natural Science Foundation of China(Beijing Natural Science Foundation)	This study is supported by "Twelve Five'' National Key Technology R&D Program of China (Grant No. 2011BAI11B05, http://www.most.gov.cn/eng/programmes1/200610/t20061009_36224.htm) and Beijing Natural Science Foundation of China (Grant No. 7132078, http://www.bjkw.gov.cn/n244495/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa Y, 2001, CIRCULATION, V104, P455, DOI 10.1161/hc3001.092040; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; D'Ascenzo F, 2013, INT J CARDIOL, V167, P575, DOI 10.1016/j.ijcard.2012.01.080; Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028; Deftereos S, 2013, J AM COLL CARDIOL, V61, P1679, DOI 10.1016/j.jacc.2013.01.055; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dihu JB, 2011, J AM COLL CARDIOL, V57, P2035, DOI 10.1016/j.jacc.2011.01.022; Douglas JS, 2005, CIRCULATION, V112, P2826, DOI 10.1161/CIRCULATIONAHA.104.530097; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Geng DF, 2009, ATHEROSCLEROSIS, V202, P521, DOI 10.1016/j.atherosclerosis.2008.05.029; Gensch C, 2007, ATHEROSCLEROSIS, V192, P67, DOI 10.1016/j.atherosclerosis.2006.06.026; Hausleiter J, 2004, CIRCULATION, V110, P790, DOI 10.1161/01.CIR.0000138935.17503.35; Henney JE, 2000, JAMA-J AM MED ASSOC, V283, P2228, DOI 10.1001/jama.283.17.2228-b; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hong SJ, 2010, ARTERIOSCL THROM VAS, V30, P2655, DOI 10.1161/ATVBAHA.110.212670; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Joner M, 2007, ARTERIOSCL THROM VAS, V27, P182, DOI 10.1161/01.ATV.0000251021.28725.e8; Jukema JW, 2012, NAT REV CARDIOL, V9, P53, DOI 10.1038/nrcardio.2011.132; Kaneda H, 2009, HEART, V95, P1079, DOI 10.1136/hrt.2008.162842; Kasai T, 2008, ATHEROSCLEROSIS, V197, P612, DOI 10.1016/j.atherosclerosis.2007.08.030; Katayama T, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2007.02.022; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6; Law RE, 2000, CIRCULATION, V101, P1311, DOI 10.1161/01.CIR.101.11.1311; Lee HW, 2013, YONSEI MED J, V54, P1313, DOI 10.3349/ymj.2013.54.6.1313; Li RJ, 2009, J GUANGDONG MED COLL, V27, P620, DOI DOI 10.3969/J.ISSN.1005-4057.2009.06.006; Lim S, 2006, ARTERIOSCL THROM VAS, V26, P808, DOI 10.1161/01.ATV.0000204634.26163.a7; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Marx N, 2005, CIRCULATION, V112, P2792, DOI 10.1161/CIRCULATIONAHA.105.535484; Marx SO, 2011, CIRC-CARDIOVASC INTE, V4, P104, DOI 10.1161/CIRCINTERVENTIONS.110.957332; Mauri L, 2005, CIRCULATION, V111, P321, DOI 10.1161/01.CIR.0000153356.72810.97; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Monraats PS, 2005, CIRCULATION, V112, P2417, DOI 10.1161/CIRCULATIONAHA.105.536268; Nishio K, 2006, DIABETES CARE, V29, P101, DOI 10.2337/diacare.29.1.101; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Pakala R, 2006, J CARDIOVASC PHARM, V48, P299, DOI 10.1097/01.fjc.0000249891.40714.2a; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Patel D, 2011, JACC-CARDIOVASC INTE, V4, P353, DOI 10.1016/j.jcin.2010.10.016; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Rathore S, 2009, EUROINTERVENTION, V5, P349, DOI 10.4244/V5I3A55; Riche DM, 2007, DIABETES CARE, V30, P384, DOI 10.2337/dc06-1854; Roiron C, 2006, HEART, V92, P641, DOI 10.1136/hrt.2005.061622; Rosmarakis ES, 2007, AM HEART J, V154, P144, DOI 10.1016/j.ahj.2007.04.005; Takagi T, 2003, AM HEART J, V146, DOI 10.1016/S0002-8703(03)00146-7; Takagi T, 2009, JACC-CARDIOVASC INTE, V2, P524, DOI 10.1016/j.jcin.2009.04.007; [魏广和 Wei Guanghe], 2012, [临床心血管病杂志, Journal of Clinical Cardiology], V28, P445; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zhang YJ, 2013, MED PHILOS, V34, P26	49	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109614	10.1371/journal.pone.0109614	http://dx.doi.org/10.1371/journal.pone.0109614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25279761	Green Published, gold, Green Submitted			2022-12-27	WOS:000342670800092
J	Zheng, LF; Sun, PP; Zheng, SJ; Han, YD; Zhang, GX				Zheng, Linfeng; Sun, Pengpeng; Zheng, Sujuan; Han, Yuedong; Zhang, Guixiang			Functional Dynamic Contrast-Enhanced Magnetic Resonance Imaging in an Animal Model of Brain Metastases: A Pilot Study	PLOS ONE			English	Article							FDG PET; MANAGEMENT; RABBIT; PATHOBIOLOGY; TUMORS; MRI; CT	Background: Brain metastasis is a common disease with a poor prognosis. The purpose of this study is to test feasibility and safety of the animal models for brain metastases and to use dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to enhance detection of brain metastases. Methods: With approval from the institutional animal ethics committee, 18 New Zealand rabbits were randomly divided into three groups: Group A received an intra-carotid infusion (ICI) of mannitol followed by VX2 cells; group B received successive ICI of mannitol and heparin followed by VX2 cells; and group C received an ICI of normal saline. The survival rate and clinical symptoms were recorded after inoculation. After two weeks, conventional MRI and DCE-MRI were performed using 3.0 Tesla scanner. The number of tumors and detection rate were analyzed. After MRI measurements, the tumors were stained with hematoxylin-eosin. Results: No rabbits died during the procedure. The rabbits had common symptoms, including loss of appetite, lassitude and lethargy, etc. at 10.8 +/- 1.8 days and 8.4 +/- 1.5 days post-inoculation in group A and B, respectively. Each animal in groups A and B re-gained the lost weight within 14 days. Brain metastases could be detected by MRI at 14 days post-inoculation in both groups A and B, with metastases manifesting as nodules in the brain parenchyma and thickening in the meninges. DCE-MRI increased the total detection of tumors compared to non-contrast MRI (P<0.05). The detection rates of T1-weighted image, T2-weighted image and DCE-MRI were 12%, 32% and 100%, respectively (P<0.05). Necropsy revealed nodules or thickening meninges in the gross samples and VX2 tumor cytomorphologic features in the slides, which were consistent with the MRI results. Conclusions: The VX2 rabbit model of brain metastases is feasible, as verified by MRI and pathologic findings, and may be a suitable platform for future studies of brain metastases. Functional DCE-MRI can be used to evaluate brain metastases in a rabbit model.	[Zheng, Linfeng; Sun, Pengpeng; Zhang, Guixiang] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Radiol, Shanghai, Peoples R China; [Sun, Pengpeng] Binzhou Med Univ, Affiliated Hosp, Dept Radiol, Binzhou, Shandong, Peoples R China; [Zheng, Sujuan] Dengfeng Peoples Hosp Zhengzhou, Zhengzhou, Henan, Peoples R China; [Han, Yuedong] Gen Hosp Lanzhou Mil Reg, Dept Radiol, Lanzhou, Gansu, Peoples R China	Shanghai Jiao Tong University; Binzhou Medical University	Zhang, GX (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Radiol, Shanghai, Peoples R China.	guixiangzhang@sina.com			National Natural Science Foundation of China [81271384, 81371623]; Natural Science Foundation of Shanghai Science and Technology Commission [12ZR1424900]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai Science and Technology Commission(Natural Science Foundation of Shanghai); China Scholarship Council(China Scholarship Council)	This research is supported by the National Natural Science Foundation of China (No. 81271384, for LZ; No. 81371623, for GZ), the Natural Science Foundation of Shanghai Science and Technology Commission (No. 12ZR1424900, for LZ), and the State Scholarship Fund by China Scholarship Council (for LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, 508 IRSA; Bergamino Maurizio, 2013, ISRN Neurosci, V2013, P905279, DOI 10.1155/2013/905279; Bhangoo SS, 2011, NEUROSURG CLIN N AM, V22, P97, DOI 10.1016/j.nec.2010.09.001; Biswas G, 2006, J Cancer Res Ther, V2, P5; Blasiak B, 2014, J NEUROSCI METH, V226, P132, DOI 10.1016/j.jneumeth.2014.01.034; Bochev P, 2012, HELL J NUCL MED, V15, P125, DOI 10.1967/s002449910030; Brastianos PK, 2012, J NEURO-ONCOL, V106, P81, DOI 10.1007/s11060-011-0655-9; Calasans-Maia MD, 2009, ACTA CIR BRAS, V24, P325, DOI 10.1590/S0102-86502009000400014; Cha S, 2006, AM J NEURORADIOL, V27, P475; Conti P, 2007, ANN CLIN LAB SCI, V37, P315; Cuaron J, 2013, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00208; Daphu I, 2013, CLIN EXP METASTAS, V30, P695, DOI 10.1007/s10585-013-9566-9; De Wever W, 2010, JBR-BTR, V93, P71, DOI 10.5334/jbr-btr.122; DELATTRE JY, 1988, ARCH NEUROL-CHICAGO, V45, P741, DOI 10.1001/archneur.1988.00520310047016; Fink Kathleen R, 2013, Surg Neurol Int, V4, pS209, DOI 10.4103/2152-7806.111298; Gallego Perez-Larraya Jaime, 2014, Handb Clin Neurol, V121, P1143, DOI 10.1016/B978-0-7020-4088-7.00077-8; HIESIGER EM, 1986, ANN NEUROL, V19, P50, DOI 10.1002/ana.410190110; Hylton N, 2006, J CLIN ONCOL, V24, P3293, DOI 10.1200/JCO.2006.06.8080; Jenkinson MD, 2011, EUR J CANCER, V47, P649, DOI 10.1016/j.ejca.2010.11.033; Li KA, 2011, MAGN RESON IMAGING, V29, P1101, DOI 10.1016/j.mri.2011.07.003; Li KG, 2011, MED ONCOL, V28, P1116, DOI 10.1007/s12032-010-9580-6; Lin NU, 2013, LANCET ONCOL, V14, pE396, DOI 10.1016/S1470-2045(13)70311-5; Lorger M, 2010, AM J PATHOL, V176, P2958, DOI 10.2353/ajpath.2010.090838; Mapara Manjeet, 2012, Dent Res J (Isfahan), V9, P111, DOI 10.4103/1735-3327.92960; Muldoon LL, 2011, NEURO-ONCOLOGY, V13, P51, DOI 10.1093/neuonc/noq150; Nathoo N, 2005, J CLIN PATHOL, V58, P237, DOI 10.1136/jcp.2003.013623; NOMOTO Y, 1994, JPN J CLIN ONCOL, V24, P258; Preusser M, 2012, ACTA NEUROPATHOL, V123, P205, DOI 10.1007/s00401-011-0933-9; Rohren EM, 2003, RADIOLOGY, V226, P181, DOI 10.1148/radiol.2261010920; Saito N, 2008, INT J EXP PATHOL, V89, P38, DOI 10.1111/j.1365-2613.2007.00563.x; Schrevens L, 2004, ONCOLOGIST, V9, P633, DOI 10.1634/theoncologist.9-6-633; Serres S, 2012, P NATL ACAD SCI USA, V109, P6674, DOI 10.1073/pnas.1117412109; Soffietti R, 2010, EUROPEAN HDB NEUROLO, V1, P437; Tsao MN, 2012, PRACT RADIAT ONCOL, V2, P210, DOI 10.1016/j.prro.2011.12.004; Wang J, 2011, NEUROPATH APPL NEURO, V37, P189, DOI 10.1111/j.1365-2990.2010.01119.x; Zhang Gui-Xiang, 2008, Zhonghua Yi Xue Za Zhi, V88, P3369; Zhang ZL, 2013, J IMMUNOL METHODS, V400, P23, DOI 10.1016/j.jim.2013.06.013; Zheng LF, 2011, EUR J RADIOL, V78, P272, DOI 10.1016/j.ejrad.2010.11.036	38	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109308	10.1371/journal.pone.0109308	http://dx.doi.org/10.1371/journal.pone.0109308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	25280000	Green Submitted, Green Published, gold			2022-12-27	WOS:000342670800072
J	Chang, TI; Kang, HY; Kim, KS; Lee, SH; Nam, BY; Paeng, J; Kim, S; Park, JT; Yoo, TH; Kang, SW; Han, SH				Chang, Tae Ik; Kang, Hye-Young; Kim, Kyung Sik; Lee, Sun Ha; Nam, Bo Young; Paeng, Jisun; Kim, Seonghun; Park, Jung Tak; Yoo, Tae-Hyun; Kang, Shin-Wook; Han, Seung Hyeok			The Effect of Statin on Epithelial-Mesenchymal Transition in Peritoneal Mesothelial Cells	PLOS ONE			English	Article							INCREASES FIBRINOLYTIC-ACTIVITY; GROWTH-FACTOR; PLASMINOGEN-ACTIVATOR; RHO GTPASES; INTERSTITIAL FIBROSIS; REDUCTASE INHIBITORS; ANGIOTENSIN-II; SIMVASTATIN; DIALYSIS; EXPRESSION	Background: Statins have recently been highlighted for their pleiotropic actions distinct from cholesterol-lowering effects. Despite this interest, it is currently unknown whether statin therapy inhibits peritoneal dialysis (PD)-related epithelial-mesenchymal transition (EMT). Methods: In vitro, human peritoneal mesothelial cells (HPMCs) were exposed to 5.6 mM glucose (NG) or 100 mM glucose (HG) with or without simvastatin (1 mu M). In vivo, PD catheters were inserted into 32 Sprague-Dawley rats, and saline (C, n = 16) or 4.25% peritoneal dialysis fluid (PDF) (PD, n = 16) was infused for 4 weeks. Eight rats from each group were treated with 5 mg/kg/day of simvastatin intraperitoneally. Changes in the protein expression of EMT markers such as E-cadherin, alpha-SMA, Snail, and fibronectin in HPMCs and the peritoneum were evaluated by Western blot analysis and immunofluorescence or immunohistochemical staining. We also explored whether activation of the mevalonate pathway and its downstream small GTPases were involved in dialysis-related peritoneal EMT and could be inhibited by statin treatment. Results: Compared to NG cells, E-cadherin expression was significantly decreased, while alpha-SMA, Snail, and fibronectin expression were significantly increased in HPMCs exposed to HG, and these changes were abrogated by simvastatin (p, 0.05). In addition, the cobblestone-like appearance of normal HPMCs was converted into a fibroblast-like morphology after HG treatment, which was reversed by simvastatin. These EMT-like changes were also observed in HPMCs treated with geranyl-geranyl pyrophosphate (5 mu M). HG significantly increased the protein expression of RhoA and Rac1 in the membrane fractions, and these increases were ameliorated by simvastatin (p, 0.05). In PD rats, E-cadherin in the peritoneum was significantly decreased, whereas alpha-SMA, Snail, and fibronectin expression were significantly increased (p, 0.05) compared to C rats. The thickness of the mesothelial layer in the peritoneum were also significantly greater in PD rats than in C rats (p, 0.05). These changes of the peritoneum in PD rats were significantly attenuated by simvastatin. Conclusion: This study demonstrated that PD-related EMT was mediated via the mevalonate pathway, and statin treatment inhibited the EMT changes in HG-treated HPMCs and PDF-stimulated PD rats. These findings suggest that statins may be a promising therapeutic strategy for preservation of peritoneal membrane integrity in long-term PD patients.	[Chang, Tae Ik; Kang, Hye-Young; Lee, Sun Ha; Nam, Bo Young; Paeng, Jisun; Kim, Seonghun; Park, Jung Tak; Yoo, Tae-Hyun; Kang, Shin-Wook; Han, Seung Hyeok] Yonsei Univ, Coll Med, Dept Internal Med, Severance Biomed Sci Inst,Brain Korea Project Med, Seoul, South Korea; [Chang, Tae Ik] Ilsan Hosp, NHIS Med Ctr, Dept Internal Med, Goyang Shi, Gyeonggi Do, South Korea; [Kim, Kyung Sik] Yonsei Univ, Coll Med, Dept Surg, Brain Korea Project Med Sci 21, Seoul, South Korea	Yonsei University; Yonsei University Health System; NHIS Ilsan Hospital; Yonsei University; Yonsei University Health System	Han, SH (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Severance Biomed Sci Inst,Brain Korea Project Med, Seoul, South Korea.	hansh@yuhs.ac	Han, Seung Hyeok/K-4559-2018; Han, Seung Hyeok/W-8825-2019; Kim, Seonghun/AFK-2465-2022; Kim, Kyung Sik/I-5501-2015	Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Kim, Kyung Sik/0000-0001-9498-284X; Kang, Shin-Wook/0000-0002-5677-4756; Yoo, Tae-Hyun/0000-0002-9183-4507; Park, Jung Tak/0000-0002-2325-8982	Korean Society of Nephrology research grant [7-2012-0465]; new faculty research seed money grant of Yonsei University College of Medicine [8-2012-0064]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2011-0027214]; BK21 (Brain Korea 21) Project for Medical Sciences, Yonsei University	Korean Society of Nephrology research grant; new faculty research seed money grant of Yonsei University College of Medicine; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology; BK21 (Brain Korea 21) Project for Medical Sciences, Yonsei University(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This study was supported by a Korean Society of Nephrology research grant (7-2012-0465), a new faculty research seed money grant of Yonsei University College of Medicine for 2012 (8-2012-0064), and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2011-0027214), the BK21 (Brain Korea 21) Project for Medical Sciences, Yonsei University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroeira LS, 2005, AM J KIDNEY DIS, V46, P938, DOI 10.1053/j.ajkd.2005.08.011; Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Banes-Berceli AK, 2006, AM J PHYSIOL-RENAL, V291, pF116, DOI 10.1152/ajprenal.00502.2005; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Blanco-Colio LM, 2002, ATHEROSCLEROSIS, V161, P17, DOI 10.1016/S0021-9150(01)00613-X; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Cho HJ, 2007, CELL BIOL INT, V31, P1225, DOI 10.1016/j.cellbi.2007.04.006; DOBBIE JW, 1992, PERITON DIALYSIS INT, V12, P14; Floege J, 2008, J AM SOC NEPHROL, V19, P12, DOI 10.1681/ASN.2007050532; Fried LF, 2008, KIDNEY INT, V74, P571, DOI 10.1038/ki.2008.231; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haslinger B, 2003, KIDNEY INT, V63, P2065, DOI 10.1046/j.1523-1755.2003.t01-2-00004.x; Haslinger B, 2002, KIDNEY INT, V62, P1611, DOI 10.1046/j.1523-1755.2002.00601.x; Heusinger-Ribeiro J, 2004, KIDNEY INT, V66, P187, DOI 10.1111/j.1523-1755.2004.00710.x; Higuchi C, 2006, THER APHER DIAL, V10, P372, DOI 10.1111/j.1744-9987.2006.00391.x; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Hu YB, 2013, BIOMED ENVIRON SCI, V26, P571, DOI [10.3967/0895-3988.2013.07.008, 10.3967/0895-3988.2013.07.012]; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Katsutani M, 2007, THER APHER DIAL, V11, P94, DOI 10.1111/j.1744-9987.2007.00423.x; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kiribayashi I, 2005, KIDNEY INT, V67, P1126, DOI 10.1111/j.1523-1755.2005.00179.x; Laufs U, 2000, TRENDS CARDIOVAS MED, V10, P143, DOI 10.1016/S1050-1738(00)00044-X; Lee HB, 2007, J KOREAN MED SCI, V22, P943, DOI 10.3346/jkms.2007.22.6.943; Lee SH, 2012, LAB INVEST, V92, P1698, DOI 10.1038/labinvest.2012.132; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; MAIELLO M, 1992, DIABETES, V41, P1009, DOI 10.2337/diabetes.41.8.1009; Margetts PJ, 2003, PERITON DIALYSIS INT, V23, P530; Margetts PJ, 2005, J AM SOC NEPHROL, V16, P425, DOI 10.1681/ASN.2004060436; Masszi A, 2003, AM J PHYSIOL-RENAL, V284, pF911, DOI 10.1152/ajprenal.00183.2002; Mateijsen MAM, 1999, PERITON DIALYSIS INT, V19, P517; Musi B, 2004, PERITON DIALYSIS INT, V24, P37; Nam BY, 2012, APOPTOSIS, V17, P1, DOI 10.1007/s10495-011-0661-6; Patel S, 2005, J AM SOC NEPHROL, V16, P1977, DOI 10.1681/ASN.2004110943; Patel S, 2006, AM J NEPHROL, V26, P381, DOI 10.1159/000094780; Ramseyer VD, 2012, HYPERTENSION, V59, P1145, DOI 10.1161/HYPERTENSIONAHA.111.189761; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Rodrigues-Diez R, 2008, PHARM RES-DORDR, V25, P2447, DOI 10.1007/s11095-008-9636-x; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; STYLIANOU E, 1990, KIDNEY INT, V37, P1563, DOI 10.1038/ki.1990.150; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Topley N, 1998, Adv Ren Replace Ther, V5, P179; Usui H, 2003, NEPHROL DIAL TRANSPL, V18, P265, DOI 10.1093/ndt/18.2.265; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vecchione C, 2007, DIABETOLOGIA, V50, P874, DOI 10.1007/s00125-007-0597-0; Vieira JM, 2005, NEPHROL DIAL TRANSPL, V20, P1582, DOI 10.1093/ndt/gfh859; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yang JW, 2002, J CLIN INVEST, V110, P1525, DOI 10.1172/JC1200216219; Yoshimura A, 1998, J AM SOC NEPHROL, V9, P2027; Zhang H, 2011, IN VITRO CELL DEV-AN, V47, P165, DOI 10.1007/s11626-010-9369-0; Zhuang SG, 2005, J BIOL CHEM, V280, P21036, DOI 10.1074/jbc.M413300200; Zoja C, 2002, KIDNEY INT, V61, P1635, DOI 10.1046/j.1523-1755.2002.00332.x; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	55	17	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109628	10.1371/journal.pone.0109628	http://dx.doi.org/10.1371/journal.pone.0109628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275561	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500110
J	Choi, SG; Lee, SE; Kang, BS; Ng, CL; Davaa, E; Park, JS				Choi, Soon Gil; Lee, Sang-Eun; Kang, Bong-Seok; Ng, Choon Lian; Davaa, Enkhzaya; Park, Jeong-Sook			Thermosensitive and Mucoadhesive Sol-Gel Composites of Paclitaxel/Dimethyl-beta-Cyclodextrin for Buccal Delivery	PLOS ONE			English	Article							CANCER-CELLS; IN-VITRO; ANTITUMOR-ACTIVITY; HYDROGEL; CURCUMIN; RELEASE; COMPLEXATION; CARRIER; SYSTEM; VIVO	The purpose of this study was to develop a buccal paclitaxel delivery system using the thermosensitive polymer Pluronic F127 (PF127) and the mucoadhesive polymer polyethylene oxide (PEO). The anticancer agent paclitaxel is usually used to treat ovarian, breast, and non-small-cell lung cancer. To improve its aqueous solubility, paclitaxel was incorporated into an inclusion complex with (2,6-di-O-methyl)-beta-cyclodextrin (DM beta CD). The formation of the paclitaxel inclusion complex was evaluated using various techniques, including x-ray diffractometry (XRD), Fourier-transform infrared (FT-IR) spectrophotometry, differential scanning calorimetry (DSC), and scanning electron microscopy (SEM). Hydrogels were prepared using a cold method. Concentrations of 18, 20, and 23% (w/v) PF127 were dissolved in distilled water including paclitaxel and stored overnight in a refrigerator at 4 degrees C. PEO was added at concentrations of 0.1, 0.2, 0.4, 0.8, and 1% (w/v). Each formulation included paclitaxel (0.5 mg/mL). The sol-gel transition temperature of the hydrogels was measured using the tube-inverting method. Drug release from the hydrogels was measured using a Franz diffusion cell containing pH 7.4 phosphate-buffered solution (PBS) buffer at 37 degrees C. The cytotoxicity of each formulation was measured using the MTT assay with a human oral cancer cell (KB cell). The sol-gel transition temperature of the hydrogel decreased when PF127 was present and varied according to the presence of mucoadhesive polymers. The in vitro release was sustained and the release rate was slowed by the addition of the mucoadhesive polymer. The cytotoxicity of the blank formulation was low, although the drug-loaded hydrogel showed acceptable cytotoxicity. The results of our study suggest that the combination of a PF 127-based mucoadhesive hydrogel formulation and inclusion complexes improves the in vitro release and cytotoxic effect of paclitaxel.	[Choi, Soon Gil; Lee, Sang-Eun; Kang, Bong-Seok; Ng, Choon Lian; Davaa, Enkhzaya; Park, Jeong-Sook] Chungnam Natl Univ, Coll Pharm, Taejon, South Korea	Chungnam National University	Park, JS (corresponding author), Chungnam Natl Univ, Coll Pharm, Taejon, South Korea.	eicosa@cnu.ac.kr		Park, Jeong-Sook/0000-0002-4081-213X	Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2012-0006681]	Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Priority Research Centers Program (No. 2012-0006681) through the National Research Foundation of Korea (NRF), funded by the Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeid AH, 2014, PHARM RES-DORDR, V31, P1938, DOI 10.1007/s11095-013-1295-x; Ahn Byeong Kil, 2013, Journal of Pharmaceutical Investigation, V43, P453, DOI 10.1007/s40005-013-0089-9; Al-Marzouqi AH, 2009, J PHARMACEUT BIOMED, V49, P227, DOI 10.1016/j.jpba.2008.10.032; Baek JS, 2013, J PHARM PHARMACOL, V65, P72, DOI 10.1111/j.2042-7158.2012.01578.x; Boztas AO, 2013, MOL PHARMACEUT, V10, P2676, DOI 10.1021/mp400101k; Calleja P, 2014, NANOMEDICIN IN PRESS; Choi SG, 2013, INT J PHARMACEUT, V447, P102, DOI 10.1016/j.ijpharm.2013.02.053; Choudhury H, 2014, INT J PHARMACEUT, V460, P131, DOI 10.1016/j.ijpharm.2013.10.055; Feng SS, 2001, J CONTROL RELEASE, V71, P53, DOI 10.1016/S0168-3659(00)00364-3; Groo AC, 2014, PHARM RES-DORDR, V31, P1753, DOI 10.1007/s11095-013-1280-4; He HM, 2013, BIOMATERIALS, V34, P5344, DOI 10.1016/j.biomaterials.2013.03.068; Hedges AR, 1998, CHEM REV, V98, P2035, DOI 10.1021/cr970014w; Hiremath JG, 2013, SAUDI PHARM J, V21, P85, DOI 10.1016/j.jsps.2011.12.002; Ju CY, 2013, J PHARM SCI-US, V102, P2707, DOI 10.1002/jps.23649; Kim YT, 2010, EUR J PHARM SCI, V41, P399, DOI 10.1016/j.ejps.2010.07.009; Lin ZQ, 2014, J CONTROL RELEASE, V174, P161, DOI 10.1016/j.jconrel.2013.10.026; Mitra A, 2003, J PHARM PHARMACOL, V55, P895, DOI 10.1211/0022357021341; Okamatsu A, 2013, BIOCONJUGATE CHEM, V24, P724, DOI 10.1021/bc400015r; Park JS, 2002, J BIOMED MATER RES, V59, P144, DOI 10.1002/jbm.1227; Rowinsky EK, 1997, ANNU REV MED, V48, P353; Sharma A, 2010, J GLOBAL PHARM TECH, V2, P18; Shin BK, 2013, DRUG DEV IND PHARM, V39, P1874, DOI 10.3109/03639045.2012.665925; Singh S, 2010, CHEM PHARM BULL, V58, P307, DOI 10.1248/cpb.58.307; Tong LX, 2014, ANTI-CANCER DRUG, V25, P244, DOI 10.1097/CAD.0000000000000047; Tonnesen HH, 2002, INT J PHARMACEUT, V244, P127, DOI 10.1016/S0378-5173(02)00323-X; Yallapu MM, 2010, COLLOID SURFACE B, V79, P113, DOI 10.1016/j.colsurfb.2010.03.039; YEH MK, 1995, J CONTROL RELEASE, V33, P437, DOI 10.1016/0168-3659(94)00123-C; Yu SL, 2013, ANGEW CHEM INT EDIT, V52, P7272, DOI 10.1002/anie.201301397; Zarei M, 2013, Pak J Biol Sci, V16, P295, DOI 10.3923/pjbs.2013.295.298	29	34	34	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109090	10.1371/journal.pone.0109090	http://dx.doi.org/10.1371/journal.pone.0109090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275485	Green Published, Green Submitted, gold			2022-12-27	WOS:000342591500057
J	Kim, HR; Kim, JH; Choi, EJ; Lee, YK; Kie, JH; Jang, MH; Seoh, JY				Kim, Hyung-Ran; Kim, Jung-Hwan; Choi, Eun-Jeong; Lee, Yeo Kyong; Kie, Jeong-Hae; Jang, Myoung Ho; Seoh, Ju-Young			Hyperoxygenation Attenuated a Murine Model of Atopic Dermatitis through Raising Skin Level of ROS	PLOS ONE			English	Article							HYPERBARIC-OXYGEN THERAPY; REGULATORY T-CELLS; CHRONIC GRANULOMATOUS-DISEASE; TRYPTOPHAN CATABOLISM; INDOLEAMINE 2,3-DIOXYGENASE; GLUTATHIONE PEROXIDASE-1; EXPERIMENTAL COLITIS; AUTOIMMUNE-DISEASE; OXIDATIVE DAMAGE; MICE DEFICIENT	Atopic dermatitis (AD) is a chronic inflammatory skin disease resulting from excessive stimulation of immune cells. Traditionally, reactive oxygen species (ROS) have been implicated in the progression of inflammatory diseases, but several opposing observations suggest the protective role of ROS in inflammatory disease. Recently, we demonstrated ROS prevented imiquimod-induced psoriatic dermatitis through enhancing regulatory T cell function. Thus, we hypothesized AD might also be attenuated in elevated levels of ROS through tissue hyperoxygenation, such as by hyperbaric oxygen therapy (HBOT) or applying an oxygen-carrying chemical, perfluorodecalin (PFD). Elevated levels of ROS in the skin have been demonstrated directly by staining with dihydroethidum as well as indirectly by immunohistochemistry (IHC) for indoleamine 2,3-dioxygenase (IDO). A murine model of AD was developed by repeated application of a chemical irritant (1% 2,4-dinitrochlorobenzene) and house dust mite (Dermatophagoide farinae) extract on one ear of BALB/c mice. The results showed treatment with HBOT or PFD significantly attenuated AD, comparably with 0.1% prednicarbate without any signs of side effects, such as telangiectasia. The expressions of interleukin-17A and interferon-gamma were also decreased in the AD lesions by treatment with HBOT or PFD. Enhanced expression of IDO and reduced level of hypoxia-inducible factor-1 alpha, in association with increased frequency of FoxP3(+) regulatory T cells in the AD lesions, might be involved in the underlying mechanism of oxygen therapy. Taken together, it was suggested that tissue hyperoxygenation, by HBOT or treatment with PFD, might attenuate AD through enhancing skin ROS level.	[Kim, Hyung-Ran; Choi, Eun-Jeong; Seoh, Ju-Young] Ewha Womans Univ, Grad Sch Med, Dept Microbiol, Seoul, South Korea; [Kim, Jung-Hwan; Jang, Myoung Ho] Inst for Basic Sci Korea, Acad Immunol & Microbiol, Pohang, South Korea; [Kim, Jung-Hwan; Jang, Myoung Ho] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol IBB, Pohang, South Korea; [Lee, Yeo Kyong] Ewha Womans Univ, High Sch, Seoul, South Korea; [Kie, Jeong-Hae] Ilsan Hosp, Natl Hlth Insurance Cooperat, Koyang, South Korea	Ewha Womans University; Institute for Basic Science - Korea (IBS); Pohang University of Science & Technology (POSTECH); Ewha Womans University; NHIS Ilsan Hospital	Jang, MH (corresponding author), Inst for Basic Sci Korea, Acad Immunol & Microbiol, Pohang, South Korea.	jangmh@ibs.re.kr; jyseoh@ewha.ac.kr	Jang, Myoung Ho/D-1714-2009	Jang, Myoung Ho/0000-0001-8909-4725; Kie, Jeong Hae/0000-0003-1782-5650	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013R1A1A2008077]; Ewha Womans University; Institute for Basic Science (IBS)	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Ewha Womans University; Institute for Basic Science (IBS)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013R1A1A2008077), RP-Grant 2010 of Ewha Womans University and Institute for Basic Science (IBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berke R, 2012, AM FAM PHYSICIAN, V86, P35; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Buchman AL, 2001, J CLIN GASTROENTEROL, V33, P337, DOI 10.1097/00004836-200110000-00018; Butler Glenn, 2009, J Med Case Rep, V3, P7023, DOI 10.4076/1752-1947-3-7023; Chen SY, 2003, CLIN IMMUNOL, V108, P103, DOI 10.1016/S1521-6616(03)00091-3; Choi EJ, 2011, INT IMMUNOPHARMACOL, V11, P1260, DOI 10.1016/j.intimp.2011.04.005; CLARK LC, 1966, SCIENCE, V152, P1755, DOI 10.1126/science.152.3730.1755; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; de Haan JB, 2006, J LIPID RES, V47, P1157, DOI 10.1194/jlr.M500377-JLR200; De Ravin SS, 2008, J ALLERGY CLIN IMMUN, V122, P1097, DOI 10.1016/j.jaci.2008.07.050; Del Rosso J, 2005, J AM ACAD DERMATOL, V53, pS50, DOI 10.1016/j.jaad.2005.04.030; Dennog C, 1996, MUTAGENESIS, V11, P605, DOI 10.1093/mutage/11.6.605; Dennog C, 1999, MUTAT RES-FUND MOL M, V431, P351, DOI 10.1016/S0027-5107(99)00178-5; Di Cesare A, 2008, J INVEST DERMATOL, V128, P2569, DOI 10.1038/jid.2008.283; Efimova O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016013; Esworthy RS, 2001, AM J PHYSIOL-GASTR L, V281, pG848, DOI 10.1152/ajpgi.2001.281.3.G848; Faleo G, 2012, DIABETES, V61, P1769, DOI 10.2337/db11-0516; Fallarino F, 2006, TRANSPL IMMUNOL, V17, P58, DOI 10.1016/j.trim.2006.09.017; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; George-Chandy A, 2008, EUR J IMMUNOL, V38, P1118, DOI 10.1002/eji.200737348; GEWIESE BKO, 1992, RADIOLOGY, V185, P131, DOI 10.1148/radiology.185.1.1523296; Gorlach A, 2009, CURR PHARM DESIGN, V15, P3844, DOI 10.2174/138161209789649420; Guzman JA, 2012, CRIT CARE CLIN, V28, P537, DOI 10.1016/j.ccc.2012.07.007; Harden JL, 2011, J IMMUNOL, V187, P126, DOI 10.4049/jimmunol.1100168; Ho YS, 1997, J BIOL CHEM, V272, P16644, DOI 10.1074/jbc.272.26.16644; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; Hultqvist M, 2009, TRENDS IMMUNOL, V30, P201, DOI 10.1016/j.it.2009.03.004; Jang MH, 2011, REGULATORY T CELLS, P201; Jung YJ, 2009, IMMUNOBIOLOGY, V214, P291, DOI 10.1016/j.imbio.2008.09.004; Kim HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091146; Korhonen K, 2000, ANN CHIR GYNAEC S214, V89, P7; Kraaij MD, 2011, MOL IMMUNOL, V49, P549, DOI 10.1016/j.molimm.2011.10.002; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Kudchodkar B, 2008, CLIN IMMUNOL, V128, P435, DOI 10.1016/j.clim.2008.05.004; Kurien BT, 2008, AUTOIMMUN REV, V7, P567, DOI 10.1016/j.autrev.2008.04.019; Lee K, 2011, P NATL ACAD SCI USA, V108, P9548, DOI 10.1073/pnas.1012645108; Liu R, 2013, MAYO CLIN PROC, V88, P166, DOI 10.1016/j.mayocp.2012.10.021; Lowe KC, 2003, TISSUE ENG, V9, P389, DOI 10.1089/107632703322066570; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Nagatomo F, 2010, CLIN EXP MED, V10, P7, DOI 10.1007/s10238-009-0064-y; NARKOWICZ CK, 1993, FREE RADICAL RES COM, V19, P71, DOI 10.3109/10715769309056501; Ogasawara N, 2009, J CELL BIOCHEM, V108, P716, DOI 10.1002/jcb.22308; Olivieri AN, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-72; Olszanski Romuald, 1992, Bulletin of the Institute of Maritime and Tropical Medicine in Gdynia, V43, P79; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; Rachmilewitz D, 1998, GUT, V43, P512, DOI 10.1136/gut.43.4.512; Rezvani HR, 2011, J INVEST DERMATOL, V131, P1793, DOI 10.1038/jid.2011.141; Rizzo S, 2012, GRAEF ARCH CLIN EXP, V250, P653, DOI 10.1007/s00417-011-1874-7; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Stanzl K., 1996, International Journal of Cosmetic Science, V18, P137, DOI 10.1111/j.1467-2494.1996.tb00143.x; Takeshima F, 1999, AM J GASTROENTEROL, V94, P3374, DOI 10.1111/j.1572-0241.1999.03374.x; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf; Thom SR, 2009, J APPL PHYSIOL, V106, P988, DOI 10.1152/japplphysiol.91004.2008; Thomas SR, 1999, REDOX REP, V4, P199, DOI 10.1179/135100099101534927; Vann RD, 2011, LANCET, V377, P153, DOI 10.1016/S0140-6736(10)61085-9; Won HY, 2013, J IMMUNOL, V191, P4029, DOI 10.4049/jimmunol.1203247; Won Hee Yeon, 2011, Immune Netw, V11, P169, DOI 10.4110/in.2011.11.3.169; Won HY, 2010, ANTIOXID REDOX SIGN, V13, P575, DOI 10.1089/ars.2009.2989; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628; Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132	63	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109297	10.1371/journal.pone.0109297	http://dx.doi.org/10.1371/journal.pone.0109297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25275529	Green Submitted, Green Published, gold			2022-12-27	WOS:000342591500092
J	Wiswede, D; Taubner, S; Buchheim, A; Munte, TF; Stasch, M; Cierpka, M; Kachele, H; Roth, G; Erhard, P; Kessler, H				Wiswede, Daniel; Taubner, Svenja; Buchheim, Anna; Muente, Thomas F.; Stasch, Michael; Cierpka, Manfred; Kaechele, Horst; Roth, Gerhard; Erhard, Peter; Kessler, Henrik			Tracking Functional Brain Changes in Patients with Depression under Psychodynamic Psychotherapy Using Individualized Stimuli	PLOS ONE			English	Article							MAJOR DEPRESSION; MOOD DISORDERS; AMYGDALA; ABNORMALITIES; METAANALYSIS; MECHANISMS; RESPONSES; OUTCOMES; THERAPY	Objective: Neurobiological models of depression posit limbic hyperactivity that should normalize after successful treatment. For psychotherapy, though, brain changes in patients with depression show substantial variability. Two critical issues in relevant studies concern the use of unspecific stimulation experiments and relatively short treatment protocols. Therefore changes in brain reactions to individualized stimuli were studied in patients with depression after eight months of psychodynamic psychotherapy. Methods: 18 unmedicated patients with recurrent major depressive disorder were confronted with individualized and clinically derived content in a functional MRI experiment before (T1) and after eight months (T2) of psychodynamic therapy. A control group of 17 healthy subjects was also tested twice without intervention. The experimental stimuli were sentences describing each participant's dysfunctional interpersonal relationship patterns derived from clinical interviews based on Operationalized Psychodynamic Diagnostics (OPD). Results: At T1 patients showed enhanced activation compared to controls in several limbic and subcortical regions, including amygdala and basal ganglia, when confronted with OPD sentences. At T2 the differences in brain activity between patients and controls were no longer apparent. Concurrently, patients had improved significantly in depression scores. Conclusions: Using ecologically valid stimuli, this study supports the model of limbic hyperactivity in depression that normalizes after treatment. Without a control group of untreated patients measured twice, though, changes in patients' brain activity could also be attributed to other factors than psychodynamic therapy.	[Wiswede, Daniel; Muente, Thomas F.] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Taubner, Svenja] Alpen Adria Univ Klagenfurt, Dept Psychol, Klagenfurt, Austria; [Buchheim, Anna] Univ Innsbruck, Inst Psychol, A-6020 Innsbruck, Austria; [Stasch, Michael; Cierpka, Manfred] Heidelberg Univ, Inst Psychosomat Cooperat Res & Family Therapy, Heidelberg, Germany; [Kaechele, Horst] Univ Ulm, Dept Psychosomat Med & Psychotherapy, D-89069 Ulm, Germany; [Roth, Gerhard; Erhard, Peter] Univ Bremen, Brain Res Inst, D-28359 Bremen, Germany; [Kessler, Henrik] Ruhr Univ Bochum, Dept Psychosomat Med & Psychotherapy, LWL Univ Hosp, Bochum, Germany; [Wiswede, Daniel; Taubner, Svenja; Buchheim, Anna; Kaechele, Horst; Roth, Gerhard; Kessler, Henrik] Hanse Inst Adv Study, Delmenhorst, Germany	University of Lubeck; University of Klagenfurt; University of Innsbruck; Ruprecht Karls University Heidelberg; Ulm University; University of Bremen; Ruhr University Bochum	Wiswede, D (corresponding author), Univ Lubeck, Dept Neurol, Lubeck, Germany.	Daniel.wiswede@neuro.uni-luebeck.de	Taubner, Svenja/AAY-5144-2020	Taubner, Svenja/0000-0001-8058-762X; Wiswede, Daniel/0000-0002-2702-8316; Buchheim, Anna/0000-0002-1339-5246	Hanse Institute for Advanced Study Delmenhorst (HWK); City of Delmenhorst	Hanse Institute for Advanced Study Delmenhorst (HWK); City of Delmenhorst	The study was financially supported by the Hanse Institute for Advanced Study Delmenhorst (HWK), a non-profit foundation by the German federal states of Lower Saxony and Bremen and by the City of Delmenhorst. The authors DW, ST, AB, MC, H. Kachele, H. Kessler have been fellows of the HWK and used their fellowship to conduct this study. The authors also thank Matthias von der Tann, London, for his financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors report no biomedical financial interests or potential conflicts of interest. DW, H. Kessler, and ST had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.	Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Beutel M E, 2006, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V49, P749, DOI 10.1007/s00103-006-0005-9; Bhar SS, 2010, PSYCHOTHER PSYCHOSOM, V79, P208, DOI 10.1159/000313689; Buchheim A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033745; Camara E, 2009, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.019.2008; DeRubeis RJ, 2008, NAT REV NEUROSCI, V9, P788, DOI 10.1038/nrn2345; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 2003, ANN NY ACAD SCI, V985, P420, DOI 10.1111/j.1749-6632.2003.tb07098.x; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Frewen PA, 2008, CLIN PSYCHOL REV, V28, P228, DOI 10.1016/j.cpr.2007.05.002; Fu CHY, 2008, BIOL PSYCHIAT, V64, P505, DOI 10.1016/j.biopsych.2008.04.033; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Hautzinger M, 1994, BECK DEPRESSIONS INV; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Kessler H, 2011, PSYCHOSOC MED, V8; Kessler H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015712; Kopell BH, 2008, NEUROSCI BIOBEHAV R, V32, P408, DOI 10.1016/j.neubiorev.2007.07.004; Kumari V, 2006, ACTA NEUROPSYCHIATR, V18, P61, DOI 10.1111/j.1601-5215.2006.00127.x; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Leichsenring F, 2004, ARCH GEN PSYCHIAT, V61, P1208, DOI 10.1001/archpsyc.61.12.1208; Leichsenring F, 2008, JAMA-J AM MED ASSOC, V300, P1551, DOI 10.1001/jama.300.13.1551; Lemogne C, 2012, J AFFECT DISORDERS, V136, pE1, DOI 10.1016/j.jad.2010.11.034; Lewis DA, 2000, AM J PSYCHIAT, V157, P1; Linden DEJ, 2008, EUR ARCH PSY CLIN N, V258, P71, DOI 10.1007/s00406-008-5023-1; Linden DEJ, 2006, MOL PSYCHIATR, V11, P528, DOI 10.1038/sj.mp.4001816; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; OPD Task Force, 2008, OP PSYCH DIAGN OPD 2; Roffman JL, 2005, PSYCHOL MED, V35, P1385, DOI 10.1017/S0033291705005064; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; Talairach J, 1988, CO PLANAR STEREOTAXI; Taubner Svenja, 2012, Am J Psychoanal, V72, P269, DOI 10.1057/ajp.2012.17; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; Whalen Paul J, 2002, Semin Clin Neuropsychiatry, V7, P234, DOI 10.1053/scnp.2002.35219; Wittchen H.-U., 1997, SKID STRUKTURIERTES; Yoshimura S, 2014, SOC COGN AFFECT NEUR, V9, P487, DOI 10.1093/scan/nst009	39	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e109037	10.1371/journal.pone.0109037	http://dx.doi.org/10.1371/journal.pone.0109037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ2BX	25275317	gold, Green Submitted, Green Published			2022-12-27	WOS:000342591500047
J	Dora, NJ; Collinson, JM; Hill, RE; West, JD				Dora, Natalie J.; Collinson, J. Martin; Hill, Robert E.; West, John D.			Hemizygous Le-Cre Transgenic Mice Have Severe Eye Abnormalities on Some Genetic Backgrounds in the Absence of LoxP Sites	PLOS ONE			English	Article							PAX6(+/-) MOUSE MODEL; CELL-MIGRATION; MAMMALIAN GENOMES; ANTERIOR SEGMENT; PAX6 EXPRESSION; DNA-DAMAGE; RECOMBINASE; CORNEA; DELETION; DEFECTS	Eye phenotypes were investigated in Le-Cre(Tg/-); Pax6(fl/+) mice, which were expected to show tissue-specific reduction of Pax6 in surface ectoderm derivatives. To provide a better comparison with our previous studies of Pax6(+/-) eye phenotypes, hemizygous Le-Cre(Tg/-) and heterozygous Pax6(fl/+) mice were crossed onto the CBA/Ca genetic background. After the Le-Cre transgene had been backcrossed to CBA/Ca for seven generations, significant eye abnormalities occurred in some hemizygous Le-Cre(Tg/-); Pax6(+/+) controls (without a floxed Pax6(fl) allele) as well as experimental Le-Cre(Tg/-); Pax6(fl/+) mice. However, no abnormalities were seen in Le-Cre(-/-); Pax6(fl/+) or Le-Cre(-/-); Pax6(+/+) controls (without the Le-Cre transgene). The severity and frequency of the eye abnormalities in Le-Cre(Tg/-); Pax6(+/+) control mice diminished after backcrossing Le-Cre(Tg/-) mice to the original FVB/N strain for two generations, showing that the effect was reversible. This genetic background effect suggests that the eye abnormalities are a consequence of an interaction between the Le-Cre transgene and alleles of unknown modifier genes present in certain genetic backgrounds. The abnormalities were also ameliorated by introducing additional Pax6 gene copies on a CBA/Ca background, suggesting involvement of Pax6 depletion in Le-Cre(Tg/-); Pax6(+/+) mice rather than direct action of Cre recombinase on cryptic pseudo-loxP sites. One possibility is that expression of Cre recombinase from the Pax6-Le regulatory sequences in the Le-Cre transgene depletes cofactors required for endogenous Pax6 gene expression. Our observation that eye abnormalities can occur in hemizygous Le-Cre(Tg/-); Pax6(+/+) mice, in the absence of a floxed allele, demonstrates the importance of including all the relevant genetic controls in Cre-loxP experiments.	[Dora, Natalie J.; West, John D.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Collinson, J. Martin] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Hill, Robert E.] Univ Edinburgh, Human Genet Unit, Inst Genet & Mol Med, MRC, Edinburgh EH8 9YL, Midlothian, Scotland	University of Edinburgh; University of Aberdeen; University of Edinburgh	West, JD (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	John.West@ed.ac.uk	Collinson, Jon Martin/I-9997-2019	West, John/0000-0002-5886-0359	Wellcome Trust [088876/Z/09/Z]; Biotechnology and Biological Sciences Research Council [BB/J015237/1] Funding Source: researchfish; Medical Research Council [G1002033, MC_U127584494, MC_PC_U127584494] Funding Source: researchfish; BBSRC [BB/J015237/1] Funding Source: UKRI; MRC [G1002033, MC_PC_U127584494, MC_U127584494] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported the Wellcome Trust (http://www.wellcome.ac.uk/); grant reference 088876/Z/09/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Baba Y, 2005, MICROBIOL IMMUNOL, V49, P559, DOI 10.1111/j.1348-0421.2005.tb03753.x; Beebe DC, 2000, DEV BIOL, V220, P424, DOI 10.1006/dbio.2000.9638; Buerger A, 2006, J CARD FAIL, V12, P392, DOI 10.1016/j.cardfail.2006.03.002; Cammas L, 2012, INVEST OPHTH VIS SCI, V53, P3067, DOI 10.1167/iovs.11-9128; Chanas SA, 2009, INVEST OPHTH VIS SCI, V50, P4045, DOI 10.1167/iovs.07-1630; Chen Y, 2008, DEVELOPMENT, V135, P2939, DOI 10.1242/dev.021097; Chen Y, 2009, DEV BIOL, V334, P243, DOI 10.1016/j.ydbio.2009.07.028; Collinson JM, 2004, INVEST OPHTH VIS SCI, V45, P1101, DOI 10.1167/iovs.03-1118; Collinson JM, 2001, P NATL ACAD SCI USA, V98, P9688, DOI 10.1073/pnas.161144098; Davis J, 2003, J CELL SCI, V116, P2157, DOI 10.1242/jcs.00441; Davis-Silberman N, 2005, HUM MOL GENET, V14, P2265, DOI 10.1093/hmg/ddi231; Di Lullo E, 2011, DEVELOPMENT, V138, P4991, DOI 10.1242/dev.066282; Dora N, 2008, DEV DYNAM, V237, P1295, DOI 10.1002/dvdy.21528; Douvaras P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071117; Dwivedi DJ, 2005, INVEST OPHTH VIS SCI, V46, P3623, DOI 10.1167/iovs.05-0028; Festing MFW, 1979, INBRED STRAINS BIOME; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Garcia CM, 2009, EXP EYE RES, V88, P270, DOI 10.1016/j.exer.2008.07.017; Garcia CM, 2005, DEV DYNAM, V233, P516, DOI 10.1002/dvdy.20356; Harno E, 2013, CELL METAB, V18, P21, DOI 10.1016/j.cmet.2013.05.019; Hazlett L, 1996, OPHTHALMIC RES, V28, P50, DOI 10.1159/000267873; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Higashi AY, 2009, J IMMUNOL, V182, P5633, DOI 10.4049/jimmunol.0802413; Huang TQ, 2012, MOL VIS, V18, P1260; Janbandhu VC, 2014, CELL CYCLE, V13, P462, DOI 10.4161/cc.27271; Joo JH, 2010, INVEST OPHTH VIS SCI, V51, P1927, DOI 10.1167/iovs.09-4591; Kanakubo S, 2006, GENES CELLS, V11, P919, DOI 10.1111/j.1365-2443.2006.00992.x; Kenchegowda D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044771; Kenchegowda D, 2011, DEV BIOL, V356, P5, DOI 10.1016/j.ydbio.2011.05.005; Kroeber M, 2010, HUM MOL GENET, V19, P3332, DOI 10.1093/hmg/ddq237; Kuracha MR, 2011, INVEST OPHTH VIS SCI, V52, P6887, DOI 10.1167/iovs.11-7531; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Leiper LJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-27; LIU CY, 1993, CURR EYE RES, V12, P963, DOI 10.3109/02713689309029222; Liu JJ, 1999, EXP EYE RES, V68, P295, DOI 10.1006/exer.1998.0593; Liu W, 2006, EMBO J, V25, P5383, DOI 10.1038/sj.emboj.7601398; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Maddala R, 2011, DEV BIOL, V360, P30, DOI 10.1016/j.ydbio.2011.09.004; Mort RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028895; Moyer PD, 1996, DIFFERENTIATION, V60, P31, DOI 10.1046/j.1432-0436.1996.6010031.x; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Qu XX, 2011, DEV BIOL, V355, P12, DOI 10.1016/j.ydbio.2011.04.007; Quinn JC, 1996, GENE DEV, V10, P435, DOI 10.1101/gad.10.4.435; Quinn JC, 1997, ANAT EMBRYOL, V196, P311, DOI 10.1007/s004290050100; Ramaesh T, 2005, EXP EYE RES, V81, P224, DOI 10.1016/j.exer.2005.02.002; Ramaesh T, 2003, INVEST OPHTH VIS SCI, V44, P1871, DOI 10.1167/iovs.02-0576; Ramaesh T, 2006, INVEST OPHTH VIS SCI, V47, P1911, DOI 10.1167/iovs.05-1028; Ramaesh T, 2009, EXP EYE RES, V89, P263, DOI 10.1016/j.exer.2009.03.016; Rempe D, 2006, GENESIS, V44, P44, DOI 10.1002/gene.20183; Robinson ML, 2005, INVEST OPHTHALMOL S, V46; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Semprini S, 2007, NUCLEIC ACIDS RES, V35, P1402, DOI 10.1093/nar/gkl1108; Shiraishi A, 1998, INVEST OPHTH VIS SCI, V39, P2554; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Simpson TI, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-19; Smith AN, 2005, DEV BIOL, V285, P477, DOI 10.1016/j.ydbio.2005.07.019; Smith L, 2011, REPRODUCTION, V141, P151, DOI 10.1530/REP-10-0404; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Swamynathan S, 2011, INVEST OPHTH VIS SCI, V52, P1762, DOI 10.1167/iovs.10-6134; Thanos A, 2012, AM J PATHOL, V180, P1917, DOI 10.1016/j.ajpath.2012.01.017; Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1; van Raamsdonk CD, 2000, DEVELOPMENT, V127, P5439; Weng DY, 2008, MOL VIS, V14, P562; Yoshida S, 2006, INVEST OPHTH VIS SCI, V47, P4780, DOI 10.1167/iovs.06-0574	69	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109193	10.1371/journal.pone.0109193	http://dx.doi.org/10.1371/journal.pone.0109193			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25272013	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600105
J	Kokontis, JM; Lin, HP; Jiang, SS; Lin, CY; Fukuchi, J; Hiipakka, RA; Chung, CJ; Chan, TM; Liao, S; Chang, CH; Chuu, CP				Kokontis, John M.; Lin, Hui-Ping; Jiang, Shih Sheng; Lin, Ching-Yu; Fukuchi, Junichi; Hiipakka, Richard A.; Chung, Chi-Jung; Chan, Tzu-Min; Liao, Shutsung; Chang, Chung-Ho; Chuu, Chih-Pin			Androgen Suppresses the Proliferation of Androgen Receptor-Positive Castration-Resistant Prostate Cancer Cells via Inhibition of Cdk2, CyclinA, and Skp2	PLOS ONE			English	Article							TESTOSTERONE REPLACEMENT THERAPY; PHENETHYL ESTER SUPPRESSES; GENE-EXPRESSION; DEPENDENT KINASES; UBIQUITIN LIGASE; TUMOR-CELLS; HISTONE H1; PHOSPHORYLATION; PROGRESSION; LOCALIZATION	The majority of prostate cancer (PCa) patient receiving androgen ablation therapy eventually develop castration-resistant prostate cancer (CRPC). We previously reported that androgen treatment suppresses Skp2 and c-Myc through androgen receptor (AR) and induced G1 cell cycle arrest in androgen-independent LNCaP 104-R2 cells, a late stage CRPC cell line model. However, the mechanism of androgenic regulation of Skp2 in CRPC cells was not fully understood. In this study, we investigated the androgenic regulation of Skp2 in two AR-positive CRPC cell line models, the LNCaP 104-R1 and PC-3(AR) Cells. The former one is an early stage androgen-independent LNCaP cells, while the later one is PC-3 cells re-expressing either wild type AR or mutant LNCaP AR. Proliferation of LNCaP 104-R1 and PC-3(AR) cells is not dependent on but is suppressed by androgen. We observed in this study that androgen treatment reduced protein expression of Cdk2, Cdk7, Cyclin A, cyclin H, Skp2, c-Myc, and E2F-1; lessened phosphorylation of Thr14, Tyr15, and Thr160 on Cdk2; decreased activity of Cdk2; induced protein level of p27(Kip1); and caused G1 cell cycle arrest in LNCaP 104-R1 cells and PC-3(AR) cells. Overexpression of Skp2 protein in LNCaP 104-R1 or PC-3(AR) cells partially blocked accumulation of p27(Kip1) and increased Cdk2 activity under androgen treatment, which partially blocked the androgenic suppressive effects on proliferation and cell cycle. Analyzing on-line gene array data of 214 normal and PCa samples indicated that gene expression of Skp2, Cdk2, and cyclin A positively correlates to each other, while Cdk7 negatively correlates to these genes. These observations suggested that androgen suppresses the proliferation of CRPC cells partially through inhibition of Cyclin A, Cdk2, and Skp2.	[Kokontis, John M.; Fukuchi, Junichi; Hiipakka, Richard A.; Liao, Shutsung] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Lin, Hui-Ping; Jiang, Shih Sheng] Natl Inst Canc Res, Natl Hlth Res Inst, Taipei, Miaoli County, Taiwan; [Lin, Ching-Yu] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan; [Fukuchi, Junichi; Chang, Chung-Ho; Chuu, Chih-Pin] Pharmaceut & Med Devises Agcy, Tokyo, Japan; [Chung, Chi-Jung] China Med Univ, Dept Hlth Risk Management, Taichung, Taiwan; [Chan, Tzu-Min] China Med Univ, Dept Med Educ & Res, Beigang Hosp, Yunlin, Taiwan; [Chan, Tzu-Min] China Med Univ, Dept Med Educ & Res, Tainan Municipal An Nan Hosp, Tainan, Taiwan; [Chuu, Chih-Pin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chuu, Chih-Pin] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan; [Chuu, Chih-Pin] Kaohsiung Med Univ, PhD Program Environm & Occupat Med, Kaohsiung, Taiwan	University of Chicago; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; National Chung Hsing University; Kaohsiung Medical University	Chuu, CP (corresponding author), Pharmaceut & Med Devises Agcy, Tokyo, Japan.	cpchuu@nhri.org.tw	Chuu, Chih-Pin/B-1086-2010; Chuu, Chih-Pin/N-6697-2019; Lin, Ching Yu/AAN-9581-2020; Jiang, Shih Sheng/C-6187-2011; Jiang, Shih Sheng/J-9671-2019; Chang, Chung-Ho/B-1068-2010	Lin, Ching Yu/0000-0001-9041-5653; Jiang, Shih Sheng/0000-0003-1909-437X; Chan, Tzu-Min/0000-0002-0140-5240	National Institute of Health in U.S.A. [CA58073, AT00850]; National Health Research Institutes in Taiwan [CS-103-PP-14]; Ministry of Health and Welfare in Taiwan [CA-103-SP-01]; Ministry of Science and Technology in Taiwan [MOST 103-2325-B-400-001]; National Core Facility Program for Biotechnology from Taiwan [NSC 102-2319-B-400-001]; NATIONAL CANCER INSTITUTE [R01CA058073] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT000850] Funding Source: NIH RePORTER	National Institute of Health in U.S.A.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan); Ministry of Health and Welfare in Taiwan; Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan); National Core Facility Program for Biotechnology from Taiwan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This study was supported by CA58073 and AT00850 from National Institute of Health in U.S.A. for SL; CS-103-PP-14 (National Health Research Institutes), CA-103-SP-01 (Ministry of Health and Welfare), MOST 103-2325-B-400-001 (Ministry of Science and Technology) in Taiwan for CPC, and National Core Facility Program for Biotechnology from Taiwan (NSC 102-2319-B-400-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2005, J UROLOGY, V173, P533, DOI 10.1097/01.ju.0000143942.55896.64; Antony L, 2014, PROSTATE, V74, P1118, DOI 10.1002/pros.22828; Barfeld SJ, 2014, ENDOCR-RELAT CANCER, V21, pT57, DOI 10.1530/ERC-13-0515; Bashir T, 2010, CELL CYCLE, V9, P971, DOI 10.4161/cc.9.5.10914; Bhattacharjee RN, 2001, MOL CELL BIOL, V21, P5417, DOI 10.1128/MCB.21.16.5417-5425.2001; Boutonnet C, 2010, CELL CYCLE, V9, P975, DOI 10.4161/cc.9.5.10915; Chadee DN, 2002, ONCOGENE, V21, P8397, DOI 10.1038/sj.onc.1206029; Chandramohan V, 2008, J CELL BIOCHEM, V104, P2091, DOI 10.1002/jcb.21765; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chuu CP, 2007, J BIOMED SCI, V14, P543, DOI 10.1007/s11373-007-9160-8; Chuu CP, 2007, BIOCHEM BIOPH RES CO, V357, P341, DOI 10.1016/j.bbrc.2007.03.116; Chuu CP, 2012, CANCER PREV RES, V5, P788, DOI 10.1158/1940-6207.CAPR-12-0004-T; Chuu CP, 2011, CANCER SCI, V102, P2022, DOI 10.1111/j.1349-7006.2011.02043.x; Chuu CP, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-63; Chuu CP, 2010, ANTICANCER RES, V30, P3643; Chuu CP, 2009, CANCER LETT, V275, P86, DOI 10.1016/j.canlet.2008.10.001; Chuu CP, 2005, CANCER RES, V65, P2082, DOI 10.1158/0008-5472.CAN-04-3992; Contreras A, 2003, MOL CELL BIOL, V23, P8626, DOI 10.1128/MCB.23.23.8626-8636.2003; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Ferreira U, 2006, PROSTATE CANCER P D, V9, P39, DOI 10.1038/sj.pcan.4500833; FESQUET D, 1993, EMBO J, V12, P3111, DOI 10.1002/j.1460-2075.1993.tb05980.x; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Hellerstedt BA, 2002, CA-CANCER J CLIN, V52, P154, DOI 10.3322/canjclin.52.3.154; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P15; Keating NL, 2010, J NATL CANCER I, V102, P39, DOI 10.1093/jnci/djp404; Kokontis J, 1991, Receptor, V1, P271; KOKONTIS J, 1994, CANCER RES, V54, P1566; Kokontis JM, 2005, PROSTATE, V65, P287, DOI 10.1002/pros.20285; Kokontis JM, 1998, MOL ENDOCRINOL, V12, P941, DOI 10.1210/me.12.7.941; Kuo YY, 2013, INT J MOL SCI, V14, P8801, DOI 10.3390/ijms14058801; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Lin HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082625; Lin HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031286, 10.1371/journal.pone.0035240]; Lin HP, 2012, PHYTOTHER RES, V26, P122, DOI 10.1002/ptr.3523; Lolli G, 2004, STRUCTURE, V12, P2067, DOI 10.1016/j.str.2004.08.013; Lu LF, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-22; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; Mathew P, 2008, ANN ONCOL, V19, P395, DOI 10.1093/annonc/mdm568; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nguyen PL, 2011, UROL ONCOL-SEMIN ORI, V29, P302, DOI 10.1016/j.urolonc.2009.03.022; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Rodier G, 2008, EMBO J, V27, P679, DOI 10.1038/emboj.2008.6; Seruga B, 2008, NAT CLIN PRACT ONCOL, V5, P574, DOI 10.1038/ncponc1180; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Soucek T, 1997, ONCOGENE, V14, P2251, DOI 10.1038/sj.onc.1201061; Szmulewitz R, 2009, EUR UROL, V56, P97, DOI 10.1016/j.eururo.2009.02.022; Vander Griend DJ, 2014, INT J BIOL SCI, V10, P627, DOI 10.7150/ijbs.8756; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang ZW, 2012, BBA-REV CANCER, V1825, P11, DOI 10.1016/j.bbcan.2011.09.002; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wu L, 2012, CHEM BIOL, V19, P1515, DOI 10.1016/j.chembiol.2012.09.015; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420; Yang G, 2002, CLIN CANCER RES, V8, P3419; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6	63	32	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e109170	10.1371/journal.pone.0109170	http://dx.doi.org/10.1371/journal.pone.0109170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271736	Green Published, Green Submitted, gold			2022-12-27	WOS:000343729600102
J	Nahar, Q; Sultana, F; Alam, A; Islam, JY; Rahman, M; Khatun, F; Alam, N; Dasgupta, SK; Marions, L; Ashrafunnessa; Kamal, M; Cravioto, A; Reichenbach, L				Nahar, Quamrun; Sultana, Farhana; Alam, Anadil; Islam, Jessica Yasmine; Rahman, Mustafizur; Khatun, Fatema; Alam, Nazmul; Dasgupta, Sushil Kanta; Marions, Lena; Ashrafunnessa; Kamal, Mohammed; Cravioto, Alejandro; Reichenbach, Laura			Genital Human Papillomavirus Infection among Women in Bangladesh: Findings from a Population-Based Survey	PLOS ONE			English	Article							CERVICAL-CANCER PREVENTION; HPV VACCINATION PROGRAM; HIGH-RISK; PAP-SMEAR; PREVALENCE; ABNORMALITIES; DETERMINANTS; METAANALYSIS; WORKERS; COHORT	Background: There has been no population-based study on human papillomavirus (HPV) prevalence or its genotypes in Bangladesh; a country eligible for GAVI funding for HPV vaccine. Methods: We used baseline survey data of a prospective cohort study that was conducted in one urban and one rural area of Bangladesh. A total of 997 urban and 905 rural married women, aged 13 to 64 years, were enrolled in the baseline during July-December, 2011. Information was collected on socio-demographic characteristics and potential risk factors for HPV infection followed by gynecological examination and collection of endocervical samples using the cervical cytobrush (Digene cervical sampler). HPV DNA testing was done by Polymerase Chain Reaction (PCR) using a consensus primer set. Results: Prevalence of any HPV infection was 7.7% with no significant difference between urban and rural women. Most common high-risk genotypes were HPV16, HPV66, HPV18, HPV45, HPV31 and HPV53. Urban women working as housemaids or garment workers were at higher risk of any HPV infection (OR = 2.15, 95% CI: 1.13-4.11) compared to housewives. Rural women whose husband lived overseas were almost two times more likely to have any HPV infection (OR = 1.93; 95% CI 1.05-3.55) compared to women whose husbands lived with them. Conclusion: The prevalence of HPV infection among Bangladeshi women is similar to other regions of Asia. However, type-specific patterns are different. The study findings will inform the formulation of HPV vaccination policies in Bangladesh, monitoring the impact of vaccination programmes, and the identification of target populations for screening.	[Nahar, Quamrun; Sultana, Farhana; Alam, Anadil; Rahman, Mustafizur; Khatun, Fatema; Alam, Nazmul; Dasgupta, Sushil Kanta] Int Ctr Diarrhoeal Dis Res, Bangladesh Icddr B, Ctr Populat Urbanizat & Climate Change, Dhaka 1000, Bangladesh; [Sultana, Farhana] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Biostat & Epidemiol, Parkville, Vic 3052, Australia; [Islam, Jessica Yasmine] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Alam, Nazmul] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [Marions, Lena] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Ashrafunnessa] Bangabandhu Sheikh Mujib Med Univ, Dept Obstet & Gynecol, Dhaka, Bangladesh; [Kamal, Mohammed] Bangabandhu Sheikh Mujib Med Univ, Dept Pathol, Dhaka, Bangladesh; [Cravioto, Alejandro] Int Vaccine Inst, Seoul, South Korea; [Reichenbach, Laura] Populat Council, Washington, DC USA	International Centre for Diarrhoeal Disease Research (ICDDR); University of Melbourne; Vanderbilt University; Universite de Montreal; Karolinska Institutet; Bangabandhu Sheikh Mujib Medical University (BSMMU); Bangabandhu Sheikh Mujib Medical University (BSMMU); International Vaccine Institute; Population Council	Nahar, Q (corresponding author), Int Ctr Diarrhoeal Dis Res, Bangladesh Icddr B, Ctr Populat Urbanizat & Climate Change, GPO Box 128, Dhaka 1000, Bangladesh.	quamrun@icddrb.org		Marions, Lena/0000-0002-5930-4485; Alam, Nazmul/0000-0001-6119-8178; Islam, Jessica/0000-0002-3690-3848	Swedish International Development Cooperation Agency (Sida) [54100020, 51060029]	Swedish International Development Cooperation Agency (Sida)	This work was funded by the Swedish International Development Cooperation Agency (Sida, www.sida.org): Sida contribution numbers 54100020 and 51060029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2004, WOMEN WORKERS VOICE, V16, P34; Akter N, 2006, DOMESTIC MAIDS BANGL; Asiaf A, 2014, EUR J CANCER PREV, V23, P206, DOI 10.1097/CEJ.0b013e328364f273; Bahmanyar ER, 2012, GYNECOL ONCOL, V127, P440, DOI 10.1016/j.ygyno.2012.08.033; Bangladesh Bureau of Statistics, 2012, BANGL BUR STAT EC SU; Banik U, 2013, CYTOJOURNAL, V10, DOI 10.4103/1742-6413.115088; Baseman JG, 2005, J CLIN VIROL, V32, pS16, DOI 10.1016/j.jcv.2004.12.008; BAUER HM, 1992, DIAGNOSTIC MOL PATHO, P132; Bhatla N, 2008, VACCINE, V26, P2811, DOI 10.1016/j.vaccine.2008.03.047; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Chelimo C, 2013, J INFECTION, V66, P207, DOI 10.1016/j.jinf.2012.10.024; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Cotton SC, 2007, BRIT J CANCER, V97, P133, DOI 10.1038/sj.bjc.6603822; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Franceschi S, 2006, INT J CANCER, V119, P2677, DOI 10.1002/ijc.22241; Franco EL, 2006, VACCINE, V24, P171, DOI 10.1016/j.vaccine.2006.05.061; Garland SM, 2008, VACCINE, V26, pM89, DOI 10.1016/j.vaccine.2008.06.020; Gertig DM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-227; GLOBOCAN, 2012, GLOBOCAN 2012 POP FA; Hossain NKN, 2004, ECON POLIT WEEKLY, V39, P4093; Huq M, 2012, INT J STD AIDS, V23, P151, DOI 10.1258/ijsa.2011.011240; Insinga RP, 2004, AM J OBSTET GYNECOL, V191, P105, DOI 10.1016/j.ajog.2004.01.043; Jacobs MV, 1997, J CLIN MICROBIOL, V35, P791, DOI 10.1128/JCM.35.3.791-795.1997; Kamal SM, 2013, ASIA PACIFIC J PUBLI; Khatun S, 2009, BANGLADESH MED J, V38, P18; KIBRIA N, 1995, GENDER SOC, V9, P289, DOI 10.1177/089124395009003003; Kjaer SK, 1997, CANCER EPIDEM BIOMAR, V6, P799; Kouros Nicole, 2013, Monash Bioeth Rev, V31, P8; Liao SF, 2012, CANCER CAUSE CONTROL, V23, P703, DOI 10.1007/s10552-012-9939-4; Macartney KK, 2013, DRUG SAFETY, V36, P393, DOI 10.1007/s40264-013-0039-5; Manhart LE, 2002, SEX TRANSM DIS, V29, P725, DOI 10.1097/00007435-200211000-00018; Marks M, 2011, J INFECT DIS, V204, P1505, DOI 10.1093/infdis/jir560; Mitchell SM, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.08.038; Moscicki AB, 2001, JAMA-J AM MED ASSOC, V285, P2995, DOI 10.1001/jama.285.23.2995; Muna L., 2005, ROMANCE PLEASURE UND; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Nazneen SHN, 2011, NATL DISCOURSES WOME, P41; Richardson H, 2000, SEX TRANSM DIS, V27, P79, DOI 10.1097/00007435-200002000-00005; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; Sankaranarayanan R, 2008, VACCINE, V26, pM43, DOI 10.1016/j.vaccine.2008.05.005; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Selim N, 2009, DOMESTIC SERVICE BAN; Sherpa ATL, 2010, CANCER CAUSE CONTROL, V21, P323, DOI 10.1007/s10552-009-9467-z; Smith JS, 2008, J ADOLESCENT HEALTH, V43, pS5, DOI 10.1016/j.jadohealth.2008.07.009; Sukvirach S, 2003, J INFECT DIS, V187, P1246, DOI 10.1086/373901; Sun LL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-153; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; UNICEF, 2008, BANGL UN CHILDR, P19; Vaccarella S, 2006, CANCER EPIDEM BIOMAR, V15, P326, DOI 10.1158/1055-9965.EPI-05-0577; Vet JNI, 2008, BRIT J CANCER, V99, P214, DOI 10.1038/sj.bjc.6604417; Vinodhini K, 2012, ARCH GYNECOL OBSTET, V285, P771, DOI 10.1007/s00404-011-2155-8; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Zhao FH, 2006, INT J CANCER, V118, P442, DOI 10.1002/ijc.21327; Zhao R, 2009, BRIT J CANCER, V101, P1635, DOI 10.1038/sj.bjc.6605351	58	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2014	9	10							e107675	10.1371/journal.pone.0107675	http://dx.doi.org/10.1371/journal.pone.0107675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZM	25271836	Green Published, gold			2022-12-27	WOS:000343729600015
J	Wang, SF; Shi, X; Sun, HJ; Chen, YT; Pan, HW; Yang, X; Rafiq, T				Wang, Shufeng; Shi, Xiang; Sun, Haijing; Chen, Yitai; Pan, Hongwei; Yang, Xiaoe; Rafiq, Tariq			Variations in Metal Tolerance and Accumulation in Three Hydroponically Cultivated Varieties of Salix integra Treated with Lead	PLOS ONE			English	Article							HEAVY-METALS; CONTAMINATED SOILS; ROOT-GROWTH; CADMIUM ACCUMULATION; ANTIOXIDANT ENZYMES; RICE PLANTS; ALLIUM-CEPA; PHYTOREMEDIATION; WILLOW; PHYTOEXTRACTION	Willow species have been suggested for use in the remediation of contaminated soils due to their high biomass production, fast growth, and high accumulation of heavy metals. The tolerance and accumulation of metals may vary among willow species and varieties, and the assessment of this variability is vital for selecting willow species/varieties for phytoremediation applications. Here, we examined the variations in lead (Pb) tolerance and accumulation of three cultivated varieties of Salix integra (Weishanhu, Yizhibi and Dahongtou), a shrub willow native to northeastern China, using hydroponic culture in a greenhouse. In general, the tolerance and accumulation of Pb varied among the three willow varieties depending on the Pb concentration. All three varieties had a high tolerance index (TI) and EC50 value (the effective concentration of Pb in the nutrient solution that caused a 50% inhibition on biomass production), but a low translocation factor (TF), indicating that Pb sequestration is mainly restricted in the roots of S. integra. Among the three varieties, Dahogntou was more sensitive to the increased Pb concentration than the other two varieties, with the lowest EC50 and TI for root and above-ground tissues. In this respect, Weishanhu and Yizhibi were more suitable for phytostabilization of Pb-contaminated soils. However, our findings also indicated the importance of considering the toxicity symptoms when selecting willow varieties for the use of phytoremediation, since we also found that the three varieties revealed various toxicity symptoms of leaf wilting, chlorosis and inhibition of shoot and root growth under the higher Pb concentrations. Such symptoms could be considered as a supplementary index in screening tests.	[Wang, Shufeng; Yang, Xiaoe; Rafiq, Tariq] Zhejiang Univ, Coll Environm & Resource Sci, MOE Key Lab Environm Remediat & Ecosyst Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Shufeng; Shi, Xiang; Sun, Haijing; Chen, Yitai; Pan, Hongwei] Chinese Acad Forestry, Res Inst Subtrop Forestry, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Sun, HJ (corresponding author), Chinese Acad Forestry, Res Inst Subtrop Forestry, Hangzhou, Zhejiang, Peoples R China.	sunhaijing@163.com; xyang@zju.edu.cn			Ministry of Science and Technology of China [2010DFB33960, 2012AA100602]; National Natural Science Foundation of China [31400526]; Fundamental Research Funds from the Central Universities [2014FZA6000]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds from the Central Universities	This work was financially supported by Ministry of Science and Technology of China (#2010DFB33960 and #2012AA100602), the National Natural Science Foundation of China (#31400526), and the Fundamental Research Funds from the Central Universities (#2014FZA6000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2013, CHEMOSPHERE, V91, P869, DOI 10.1016/j.chemosphere.2013.01.075; Ali MB, 2003, B ENVIRON CONTAM TOX, V70, P462, DOI 10.1007/s00128-003-0009-1; BAKER AJM, 1991, IN SITU BIORECLAMATION, P600; Borisev M, 2009, POL J ENVIRON STUD, V18, P553; BURZYNSKI M, 1987, ACTA PHYSIOL PLANT, V9, P229; Chehregani A., 2007, International Journal of Agriculture and Biology, V9, P462; Cheng SP, 2003, ENVIRON SCI POLLUT R, V10, P192, DOI 10.1065/espr2002.11.141.1; DRAZKIEWICZ M, 1994, PHOTOSYNTHETICA, V30, P321; Ebbs SD, 1997, J ENVIRON QUAL, V26, P776, DOI 10.2134/jeq1997.00472425002600030026x; Eun SO, 2000, PHYSIOL PLANTARUM, V110, P357, DOI 10.1034/j.1399-3054.2000.1100310.x; Evangelou MWH, 2012, J HAZARD MATER, V209, P233, DOI 10.1016/j.jhazmat.2012.01.008; Freitas EV, 2013, CHEMOSPHERE, V92, P213, DOI 10.1016/j.chemosphere.2013.01.103; Fulekar MH, 2009, AFR J BIOTECHNOL, V8, P529; Geebelen W, 2002, PHYSIOL PLANTARUM, V115, P377, DOI 10.1034/j.1399-3054.2002.1150307.x; Ghosh M., 2005, Applied Ecology and Environmental Research, V3, P67; GODBOLD DL, 1991, J PLANT PHYSIOL, V139, P95, DOI 10.1016/S0176-1617(11)80172-0; Grejtovsky A, 2008, PLANT SOIL ENVIRON, V54, P47, DOI 10.17221/2784-PSE; Harada E, 2010, PLANT CELL PHYSIOL, V51, P848, DOI 10.1093/pcp/pcq039; Islam E, 2007, J HAZARD MATER, V147, P806, DOI 10.1016/j.jhazmat.2007.01.117; Jensen JK, 2009, ENVIRON POLLUT, V157, P931, DOI 10.1016/j.envpol.2008.10.024; K_ohl K., 1999, EXPT CHARACTERIZATIO, P371; Kachenko AG, 2007, AUST J BOT, V55, P63, DOI 10.1071/BT06063; Komives T., 2006, POLLUTED SOILS, P23, DOI [10.1007/978-1-4020-4999-4_3, DOI 10.1007/978-1-4020-4999-4_3]; KUMAR PBAN, 1995, ENVIRON SCI TECHNOL, V29, P1232, DOI 10.1021/es00005a014; Kupper H, 2017, METAL IONS LIFE SCI, V17, P491, DOI [10.1590/S1677-04202005000100004, 10.1515/9783110434330-015]; Kuzovkina YA, 2004, INT J PHYTOREMEDIAT, V6, P269, DOI 10.1080/16226510490496726; Kuzovkina YA, 2010, REMEDIATION, V20, P93, DOI 10.1002/rem.20242; Kuzovkina YA, 2009, ECOL ENG, V35, P1178, DOI 10.1016/j.ecoleng.2009.03.010; Li XD, 2000, APPL GEOCHEM, V15, P567, DOI 10.1016/S0883-2927(99)00072-4; Liu WT, 2010, J ENVIRON MANAGE, V91, P781, DOI 10.1016/j.jenvman.2009.10.009; Liu YQ, 2011, AFR J BIOTECHNOL, V10, P16209, DOI 10.5897/AJB11.2027; Lux A, 2004, PHYSIOL PLANTARUM, V120, P537, DOI 10.1111/j.0031-9317.2004.0275.x; Magdziak Z, 2011, ECOTOX ENVIRON SAFE, V74, P33, DOI 10.1016/j.ecoenv.2010.09.003; Marques APGC, 2009, CRIT REV ENV SCI TEC, V39, P622, DOI 10.1080/10643380701798272; Mleczek M, 2009, ENVIRON EXP BOT, V65, P48, DOI 10.1016/j.envexpbot.2008.03.003; Mun HW, 2008, J ENVIRON SCI, V20, P1341, DOI 10.1016/S1001-0742(08)62231-7; Neter J., 1996, APPL LINEAR STAT MOD; Obroucheva NV, 1998, PLANT SOIL, V200, P55, DOI 10.1023/A:1004204605833; Piechalak A, 2002, PHYTOCHEMISTRY, V60, P153, DOI 10.1016/S0031-9422(02)00067-5; Pulford ID, 2003, ENVIRON INT, V29, P529, DOI 10.1016/S0160-4120(02)00152-6; Punshon T, 1999, INT J PHYTOREMEDIAT, V1, P361, DOI 10.1080/15226519908500025; Purdy JJ, 2008, INT J PHYTOREMEDIAT, V10, P515, DOI 10.1080/15226510802115000; Rezvani M., 2011, AUSTR J AGR ENG AJAE, V2, P114; Rockwood DL, 2004, AGROFOREST SYST, V61-2, P51, DOI 10.1023/B:AGFO.0000028989.72186.e6; RUDAKOVA EV, 1988, FIZIOL BIOKHIM KULT+, V20, P3; Sabiha-Javied, 2009, MICROCHEM J, V91, P94, DOI 10.1016/j.microc.2008.08.009; Schabenberger O, 1999, AGRON J, V91, P713, DOI 10.2134/agronj1999.914713x; Seregin IV, 1997, RUSS J PLANT PHYSL+, V44, P791; Su SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002365; Suresh B, 2004, CRIT REV BIOTECHNOL, V24, P97, DOI 10.1080/07388550490493627; Tian Y L WW, 2012, CHINESE J NANJING FO, V36, P86; Tlustos P, 2007, CENT EUR J BIOL, V2, P254, DOI 10.2478/s11535-007-0012-3; Utmazian MND, 2007, ENVIRON POLLUT, V148, P155, DOI 10.1016/j.envpol.2006.10.045; Verma S, 2003, PLANT SCI, V164, P645, DOI 10.1016/S0168-9452(03)00022-0; [王树凤 Wang Shufeng], 2013, [生态学报, Acta Ecologica Sinica], V33, P6065; Wierzbicka M, 1999, ENVIRON POLLUT, V104, P41, DOI 10.1016/S0269-7491(98)00156-0; WIERZBICKA M, 1994, ENVIRON EXP BOT, V34, P173, DOI 10.1016/0098-8472(94)90036-1; WILKINS DA, 1978, NEW PHYTOL, V80, P623, DOI 10.1111/j.1469-8137.1978.tb01595.x; Wuana RA, 2011, ISRN ECOL, V2011, P1, DOI [10.5402/2011/402647, DOI 10.5402/2011/402647]; Yang QW, 2004, ENVIRON INT, V30, P883, DOI 10.1016/j.envint.2004.02.002; Yang Wei-dong, 2008, Forest Research, V21, P857; Yang WeiDong, 2009, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V17, P1182, DOI 10.3724/SP.J.1011.2009.01182; Yang YY, 2000, PLANT PHYSIOL, V124, P1019, DOI 10.1104/pp.124.3.1019; Yoon J, 2006, SCI TOTAL ENVIRON, V368, P456, DOI 10.1016/j.scitotenv.2006.01.016; Zacchini M, 2009, WATER AIR SOIL POLL, V197, P23, DOI 10.1007/s11270-008-9788-7; Zhivotovsky OP, 2011, INT J PHYTOREMEDIAT, V13, P75, DOI 10.1080/15226511003671361; Zimmer D, 2011, SCI TOTAL ENVIRON, V409, P4094, DOI 10.1016/j.scitotenv.2011.06.038	67	74	80	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108568	10.1371/journal.pone.0108568	http://dx.doi.org/10.1371/journal.pone.0108568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268840	gold, Green Published, Green Submitted			2022-12-27	WOS:000343671700115
J	Hou, X; Zhang, JF; Ahmad, H; Zhang, H; Xu, ZW; Wang, T				Hou, Xiang; Zhang, Jingfei; Ahmad, Hussain; Zhang, Hao; Xu, Ziwei; Wang, Tian			Evaluation of Antioxidant Activities of Ampelopsin and Its Protective Effect in Lipopolysaccharide-Induced Oxidative Stress Piglets	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; LIVER-INJURY; ENDOTOXIN; DAMAGE; ERYTHROCYTES; EXTRACT; CELL; HEMOLYSIS; TOXICITY; FRUITS	The aim of this study was to investigate the antioxidant potential of ampelopsin (APS) by using various methods in vitro, as well as to determine effects of APS on LPS-induced oxidative stress in piglets. The results showed that APS exhibited excellent free radical scavenging by DPPH, ABTS, O-2 center dot(-), H2O2 and ferric reducing antioxidant power. Ampelopsin also protected pig erythrocytes against AAPH-induced apoptosis and hemolysis, decreased total superoxide dismutase activity, and increased lipid peroxidation. Furthermore the results demonstrated that APS enhanced the total antioxidant capacity and decreased the malondialdehyde and protein carbonyl contents in LPS-treated piglets. The results of the present investigation suggest that APS possesses a strong antioxidant activity and alleviates LPS-induced oxidative stress, possibly due to its ability to prevent reactive oxygen species.	[Hou, Xiang; Zhang, Jingfei; Ahmad, Hussain; Zhang, Hao; Xu, Ziwei; Wang, Tian] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Xu, Ziwei] Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Sci, Hangzhou, Zhejiang, Peoples R China	Nanjing Agricultural University; Zhejiang Academy of Agricultural Sciences	Xu, ZW (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	xzwfyz@sina.com	Ahmad, hussain/AAP-9386-2020; Zhang, Jing/HII-4294-2022	hou, xinguo/0000-0003-2045-1290	Science Technology Department of Zhejiang Province; Modern Agro-industry Technology Research Sytem of China [CARS-36]	Science Technology Department of Zhejiang Province; Modern Agro-industry Technology Research Sytem of China	This study was funded by the Science Technology Department of Zhejiang Province, and the Modern Agro-industry Technology Research Sytem of China (CARS-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalakova NI, 2011, TOXICOL IN VITRO, V25, P1609, DOI 10.1016/j.tiv.2011.06.006; Ahmad H, 2012, J AGR FOOD CHEM, V60, P7111, DOI 10.1021/jf3017207; Ak T, 2008, CHEM-BIOL INTERACT, V174, P27, DOI 10.1016/j.cbi.2008.05.003; Alvarez-Suarez JM, 2012, FOOD CHEM TOXICOL, V50, P1508, DOI 10.1016/j.fct.2012.01.042; Arora A, 2000, ARCH BIOCHEM BIOPHYS, V373, P102, DOI 10.1006/abbi.1999.1525; Bae SH, 2007, LWT-FOOD SCI TECHNOL, V40, P955, DOI 10.1016/j.lwt.2006.06.007; Bagchi D, 1995, TOXICOLOGY, V104, P129, DOI 10.1016/0300-483X(95)03156-A; Ben-Shaul V, 2001, TOXICOL LETT, V123, P1, DOI 10.1016/S0378-4274(01)00369-1; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Cadenas S, 1998, PHARMACOL TOXICOL, V82, P11, DOI 10.1111/j.1600-0773.1998.tb01391.x; Dai F, 2006, LIFE SCI, V78, P2488, DOI 10.1016/j.lfs.2005.10.009; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; Diplock AT, 1998, BRIT J NUTR, V80, pS77, DOI 10.1079/BJN19980106; Dudonne S, 2009, J AGR FOOD CHEM, V57, P1768, DOI 10.1021/jf803011r; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Feng LJ, 2011, FOOD RES INT, V44, P404, DOI 10.1016/j.foodres.2010.09.035; GALANOS C, 1993, MEDIAT INFLAMM, V2, pS11, DOI 10.1155/S0962935193000687; Gunduz K, 2004, CLIN EXP DERMATOL, V29, P176, DOI 10.1111/j.1365-2230.2004.01488.x; Guo CJ, 2003, NUTR RES, V23, P1719, DOI 10.1016/j.nutres.2003.08.005; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; HEWETT JA, 1992, LAB INVEST, V66, P347; Kang KS, 2007, PHYTOMEDICINE, V14, P840, DOI 10.1016/j.phymed.2007.01.002; Kaur G, 2006, CLIN EXP IMMUNOL, V145, P313, DOI 10.1111/j.1365-2249.2006.03108.x; Kaur G, 2006, TOXICOLOGY, V226, P152, DOI 10.1016/j.tox.2006.06.018; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; Lopez-Revuelta A, 2006, CHEM-BIOL INTERACT, V161, P79, DOI 10.1016/j.cbi.2006.03.004; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Ma J, 2004, J AGR FOOD CHEM, V52, P5873, DOI 10.1021/jf049950k; Martinez V, 2012, J AGR FOOD CHEM, V60, P4090, DOI 10.1021/jf2051784; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miliauskas G, 2004, FOOD CHEM, V85, P231, DOI 10.1016/j.foodchem.2003.05.007; Minetti M, 2008, METHOD ENZYMOL, V440, P253, DOI [10.1016/S0076-6879(07)00816-6, 10.1016/S0076-6879(07)00876-6]; Murakami T, 2004, BIOFACTORS, V21, P175, DOI 10.1002/biof.552210136; Nemzek JA, 2008, COMPARATIVE MED, V58, P120; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Okoko T, 2009, TROP J PHARM RES, V8, P27; Persinger RL, 2002, MOL CELL BIOCHEM, V234, P71, DOI 10.1023/A:1015973530559; Pulido R, 2000, J AGR FOOD CHEM, V48, P3396, DOI 10.1021/jf9913458; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Roberts RA, 2007, TOXICOL SCI, V96, P2, DOI 10.1093/toxsci/kfl173; SATO Y, 1995, BIOCHEMISTRY-US, V34, P8940, DOI 10.1021/bi00028a002; Sautebin L, 2004, PLANTA MED, V70, P745, DOI 10.1055/s-2004-827206; SUGINO K, 1987, SURGERY, V101, P746; WALLING C, 1975, ACCOUNTS CHEM RES, V8, P125, DOI 10.1021/ar50088a003; Wang X, 2010, J ETHNOPHARMACOL, V127, P424, DOI 10.1016/j.jep.2009.10.022; Westphal M, 2003, INTENS CARE MED, V29, P301, DOI 10.1007/s00134-002-1546-5; Xu RH, 2011, EUR FOOD RES TECHNOL, V232, P231, DOI 10.1007/s00217-010-1382-8; YEAGLE PL, 1982, BIOPHYS J, V37, P227, DOI 10.1016/S0006-3495(82)84672-9; YEN GC, 1995, J AGR FOOD CHEM, V43, P27, DOI 10.1021/jf00049a007; Yu R, 2000, MOL PHARMACOL, V58, P431, DOI 10.1124/mol.58.2.431	52	65	70	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108314	10.1371/journal.pone.0108314	http://dx.doi.org/10.1371/journal.pone.0108314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	25268121	Green Submitted, Green Published, gold			2022-12-27	WOS:000343671700078
J	Sharfi, K; Rosenblum, S				Sharfi, Kineret; Rosenblum, Sara			Activity and Participation Characteristics of Adults with Learning Disabilities - A Systematic Review	PLOS ONE			English	Article							SOCIAL-EMOTIONAL SIDE; YOUNG-ADULTS; FOLLOW-UP; POSTSECONDARY EDUCATION; EMPLOYMENT OUTCOMES; LITERACY SURVEY; SCHOOL-AGE; STUDENTS; LANGUAGE; SELF	Background: 'Learning disabilities' (LD) refer to a wide group of neurological disorders caused by deficits in the central nervous system which influence the individual's ability to maintain-, process or convey information to others in an efficient way. A worldwide discussion about the definitions of LD continues while a conceptual framework for studying the diverse life outcomes of adults with LD is still missing. Objective: The aim was to review the literature on the activity and participation of adults with LD based on the International Classification of Functioning, Disability and Health (ICF) concepts. Methods: "PsychInfo'', "Eric'' and "PubMed'' were searched for relevant literature according to the guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). After a three-stage process, 62 articles relevant for domains of activity and participation of adults with LD were included in the review. Results: Thirty-two articles focused on the domain of major life areas of education, work and employment and twelve articles focused on the domain of learning and applying knowledge. Limitations in activity and participation of the population with LD in these domains are recognized and discussed. Eighteen additional articles demonstrated that adults with LD confront difficulties in various life domains (e.g., communication, interpersonal interactions, mobility, and domestic life), however literature concerning these domains is scarce. Conclusions: The ICF can be useful for further exploration of activity and participation characteristics of adults with LD in various life domains. Such exploration is required in order to gain a wider perspective of their functional characteristics and daily needs.	[Sharfi, Kineret; Rosenblum, Sara] Univ Haifa, Lab Complex Human Act & Participat, Dept Occupat Therapy, IL-31999 Haifa, Israel	University of Haifa	Sharfi, K (corresponding author), Univ Haifa, Lab Complex Human Act & Participat, Dept Occupat Therapy, IL-31999 Haifa, Israel.	kineretsharfi@gmail.com	Smith, Matthew E./A-8115-2012	Smith, Matthew E./0000-0002-0878-0932	Israeli Ministry of Science and Technology	Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel)	This work was supported by the Israeli Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELMAN PB, 1993, LEARN DISABILITY Q, V16, P219, DOI 10.2307/1511328; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bahl M, 2009, J COMMUN DISORD, V42, P313, DOI 10.1016/j.jcomdis.2009.02.001; Brueggemann AE, 2008, PROF PSYCHOL-RES PR, V39, P424, DOI 10.1037/0735-7028.39.4.424; Bryan T, 2004, LEARN DISABILITY Q, V27, P45, DOI 10.2307/1593631; BUTLER DL, 1995, J LEARN DISABIL-US, V28, P170, DOI 10.1177/002221949502800306; Cameto R, 2011, LEARN DISABIL-MULTI, V17, P45; Cavendish W, 2013, J LEARN DISABIL-US, V46, P52, DOI 10.1177/0022219412464352; Chapman JW, 2003, DYSLEXIA, V9, P75, DOI 10.1002/dys.238; CLEMENTHEIST K, 1992, EXCEPT CHILDREN, V58, P336, DOI 10.1177/001440299205800406; Coleman C, 2009, ASSES EFF INTERV, V34, P94, DOI 10.1177/1534508408318808; Dickinson DL, 2002, J LEARN DISABIL-US, V35, P175, DOI 10.1177/002221940203500208; Dijkers MP, 2010, ARCH PHYS MED REHAB, V91, pS5, DOI 10.1016/j.apmr.2009.10.036; Dombrowski SC, 2004, PROF PSYCHOL-RES PR, V35, P364, DOI 10.1037/0735-7028.35.4.364; Doren B, 2007, CAREER DEV TRANSIT E, V30, P171, DOI 10.1177/08857288070300030601; Duquette C, 2009, EXCEPTIONALITY ED IN, V19, P51; Einat T, 2008, INT J OFFENDER THER, V52, P416, DOI 10.1177/0306624X07307352; Elksnin LK, 2004, LEARN DISABILITY Q, V27, P3, DOI 10.2307/1593627; FAFARD MB, 1981, LEARN DISABILITY Q, V4, P122, DOI 10.2307/1510997; FOURQUREAN JM, 1991, J LEARN DISABIL, V24, P400, DOI 10.1177/002221949102400704; Gerber P.J., 2003, LEARN DISABIL RES PR, V18, P132; Gerber P. J., 2008, LEARNING DISABILITIE, V15, P21; Gerber PJ, 2012, J LEARN DISABIL-US, V45, P31, DOI 10.1177/0022219411426858; GERBER PJ, 1990, J LEARN DISABIL, V23, P570, DOI 10.1177/002221949002300907; Gerber PJ, 2004, J LEARN DISABIL-US, V37, P283, DOI 10.1177/00222194040370040101; Gilger JW, 2001, DEV NEUROPSYCHOL, V20, P465, DOI 10.1207/S15326942DN2002_2; Goldstein DE, 1998, LEARNING DISABILITIE, V13, P53; GOODMAN NC, 1987, J CLIN CHILD PSYCHOL, V16, P290, DOI 10.1207/s15374424jccp1604_1; Greenbaum B, 1996, J LEARN DISABIL, V29, P167, DOI 10.1177/002221949602900206; Gregg N, 2008, REM SPEC EDUC, V29, P175, DOI 10.1177/0741932508315951; Grunow H, 2006, J COMMUN DISORD, V39, P158, DOI 10.1016/j.jcomdis.2005.11.004; HARING KA, 1990, J SPEC EDUC, V23, P463, DOI 10.1177/002246699002300409; HARING KA, 1990, J LEARN DISABIL, V23, P108, DOI 10.1177/002221949002300206; Heiman T, 2006, LEARN DISABILITY Q, V29, P55, DOI 10.2307/30035532; HOFFMANN FJ, 1987, J LEARN DISABIL, V20, P43, DOI 10.1177/002221948702000107; Hutchinson N. L., 2004, ALBERTA J EDUC RES, V50, P5; HYND GW, 1991, LEARN DISABILITY Q, V14, P283, DOI 10.2307/1510664; Isaki E, 2008, J COMMUN DISORD, V41, P512, DOI 10.1016/j.jcomdis.2008.03.006; JARVIS PA, 1992, ADOLESCENCE, V27, P977; Jongmans MJ, 2003, J LEARN DISABIL-US, V36, P528, DOI 10.1177/00222194030360060401; Josman  N., 2011, COGNITION OCCUPATION, P223; Kavale KA, 2000, J LEARN DISABIL-US, V33, P239, DOI 10.1177/002221940003300303; Kavale KA, 2009, LEARN DISABILITY Q, V32, P39, DOI 10.2307/25474661; KLEIN HB, 1988, J COMMUN DISORD, V21, P423, DOI 10.1016/0021-9924(88)90027-5; Learning Disabilities Association of Canada (LDA Canada), 2002, OFF DEF LEARN DIS; LEVINE P, 1995, EXCEPT CHILDREN, V61, P282; Luftig RL, 2005, RES DEV DISABIL, V26, P317, DOI 10.1016/j.ridd.2003.08.001; Macdonald SJ, 2009, DYSLEXIA, V15, P347, DOI 10.1002/dys.391; Madaus J.W., 2008, LEARN DISABIL RES PR, V23, P148, DOI [DOI 10.1111/J.1540-5826.2008.00272, 10.1111/j.1540-5826.2008.00272.x, DOI 10.1111/J.1540-5826.2008.00272.X]; Madaus JW, 2008, REM SPEC EDUC, V29, P323, DOI 10.1177/0741932507312012; Madaus JW, 2006, LEARN DISABILITY Q, V29, P19, DOI 10.2307/30035529; Magajna L, 2003, DYSLEXIA, V9, P229, DOI 10.1002/dys.242; MALCOLM CB, 1990, J LEARN DISABIL, V23, P518, DOI 10.1177/002221949002300811; Mangina CA, 2009, INT J PSYCHOPHYSIOL, V73, P170, DOI 10.1016/j.ijpsycho.2009.03.008; Mathis L.M., 2010, J APPL REHABIL COUNS, V41, P3, DOI [10.1891/0047-2220.41.1.3, DOI 10.1891/0047-2220.41.1.3]; McCue M, 1986, Arch Clin Neuropsychol, V1, P13, DOI 10.1016/0887-6177(86)90022-3; Mellard DF, 2008, REM SPEC EDUC, V29, P133, DOI 10.1177/0741932508315053; MELLARD DF, 1992, LEARN DISABILITY Q, V15, P251, DOI 10.2307/1511317; MILLER RJ, 1990, J LEARN DISABIL, V23, P349, DOI 10.1177/002221949002300605; MILLER RJ, 1991, J LEARN DISABIL, V24, P188, DOI 10.1177/002221949102400307; Murray C., 2000, LEARN DISABIL RES PR, V15, P119, DOI DOI 10.1207/SLDRP1503_1; Patterson ML, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001586; POSTHILL SM, 1991, J LEARN DISABIL, V24, P619, DOI 10.1177/002221949102401005; Raskind M.H., 1999, LEARN DISABIL RES PR, V14, P35, DOI [10.1207/sldrp1401_4, DOI 10.1207/SLDRP1401_4]; Reis SM, 2000, GIFTED CHILD QUART, V44, P123, DOI 10.1177/001698620004400205; Resnik L, 2009, ARCH PHYS MED REHAB, V90, P856, DOI 10.1016/j.apmr.2008.11.010; Richardson J, 2006, J SPEECH LANG HEAR R, V49, P1257, DOI 10.1044/1092-4388(2006/090); Roffman AJ, 2000, M CHALLENGES LEARNIN; Scanlon D, 2002, EXCEPT CHILDREN, V68, P239, DOI 10.1177/001440290206800206; Scanlon D, 2013, J LEARN DISABIL-US, V46, P26, DOI 10.1177/0022219412464342; Seo Y, 2008, J LEARN DISABIL-US, V41, P300, DOI 10.1177/0022219407311308; SHAFRIR U, 1994, J LEARN DISABIL-US, V27, P123, DOI 10.1177/002221949402700207; SHAPIRO ES, 1991, EXCEPT CHILDREN, V58, P47, DOI 10.1177/001440299105800105; Shessel I, 1999, LEARN DISABILITY Q, V22, P305, DOI 10.2307/1511264; SIEGEL S, 1991, J LEARN DISABIL, V24, P40, DOI 10.1177/002221949102400108; SITLINGTON PL, 1993, EXCEPT CHILDREN, V59, P221; Sitlington PL, 1996, J LEARN DISABIL, V29, P31, DOI 10.1177/002221949602900106; Sparks RL, 2009, J LEARN DISABIL-US, V42, P230, DOI 10.1177/0022219408331040; WELLER C, 1994, LEARN DISABILITY Q, V17, P282, DOI 10.2307/1511125; Werner EE, 1993, LEARNING DISABILITIE, V8, P28; WHITE WJ, 1992, J LEARN DISABIL, V25, P448, DOI 10.1177/002221949202500705; WHO, 2001, WHO INT CLASS FUNCT; Wilson AM, 2009, J LEARN DISABIL-US, V42, P24, DOI 10.1177/0022219408326216; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn; Young AR, 2002, J CHILD PSYCHOL PSYC, V43, P635, DOI 10.1111/1469-7610.00052	85	18	19	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106657	10.1371/journal.pone.0106657	http://dx.doi.org/10.1371/journal.pone.0106657			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3TB	25285444	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700097
J	Hou, XG; Wang, C; Zhang, XP; Zhao, XM; Wang, YL; Li, CQ; Li, M; Wang, SY; Yang, WF; Ma, ZQ; Ma, AX; Zheng, HZ; Wu, JH; Sun, Y; Song, J; Lin, P; Liang, K; Gong, L; Wang, MJ; Liu, FQ; Li, WJ; Xiao, J; Yan, F; Yang, JP; Wang, LS; Tian, M; Liu, JD; Zhao, RX; Chen, SH; Chen, L				Hou, Xinguo; Wang, Chuan; Zhang, Xiuping; Zhao, Xiangmin; Wang, Yulian; Li, Chengqiao; Li, Mei; Wang, Shaoyuan; Yang, Weifang; Ma, Zeqiang; Ma, Aixia; Zheng, Huizhen; Wu, Jiahui; Sun, Yu; Song, Jun; Lin, Peng; Liang, Kai; Gong, Lei; Wang, Meijian; Liu, Fuqiang; Li, Wenjuan; Xiao, Juan; Yan, Fei; Yang, Junpeng; Wang, Lingshu; Tian, Meng; Liu, Jidong; Zhao, Ruxing; Chen, Shihong; Chen, Li			Triglyceride Levels Are Closely Associated with Mild Declines in Estimated Glomerular Filtration Rates in Middle-Aged and Elderly Chinese with Normal Serum Lipid Levels	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RISK-FACTORS; DIABETIC INDIVIDUALS; POPULATION; PREVALENCE; MORTALITY; PREDICTION; CREATININE; CANCERS; CKD	Objective: To investigate the relationship between lipid profiles [including total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C)] and a mild decline in the estimated glomerular filtration rate (eGFR) in subjects with normal serum lipid levels. Design and Methods: In this study, we included 2647 participants who were >= 40 years old and had normal serum lipid levels. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation was used to estimate the GFR. A mildly reduced eGFR was defined as 60-90 mL/min/1.73 m(2). First, multiple linear regression analysis was used to estimate the association of lipid profiles with the eGFR. Then, the levels of each lipid component were divided into four groups, using the 25th, 50th and 75th percentiles as cut-off points. Finally, multiple logistic regression analysis was used to investigate the association of different lipid components with the risk of mildly reduced eGFR. Results: In the group with a mildly reduced eGFR, TG and LDL-C levels were significantly increased, but HDL-C levels were significantly decreased. After adjusting for age, gender, body mass index (BMI), systolic blood pressure (SBP), glycated hemoglobin (HbA(1c)), smoking and drinking, only TC and TG were independently related to the eGFR. Additionally, only TG showed a linear relationship with an increased risk of a mildly reduced eGFR, with the highest quartile group (TG: 108-150 mg/dl [1.22-1.70 mmol/L]) having a significantly increased risk after adjusting for the above factors. Conclusions: Triglyceride levels are closely associated with a mildly reduced eGFR in subjects with normal serum lipid levels. Dyslipidemia with lower TG levels could be used as new diagnostic criteria for subjects with mildly reduced renal function.	[Hou, Xinguo; Wang, Chuan; Ma, Aixia; Zheng, Huizhen; Wu, Jiahui; Sun, Yu; Song, Jun; Lin, Peng; Liang, Kai; Gong, Lei; Wang, Meijian; Liu, Fuqiang; Li, Wenjuan; Xiao, Juan; Yan, Fei; Yang, Junpeng; Wang, Lingshu; Tian, Meng; Liu, Jidong; Zhao, Ruxing] Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan, Shandong, Peoples R China; [Hou, Xinguo; Wang, Chuan; Ma, Aixia; Zheng, Huizhen; Wu, Jiahui; Sun, Yu; Song, Jun; Lin, Peng; Liang, Kai; Gong, Lei; Wang, Meijian; Liu, Fuqiang; Li, Wenjuan; Xiao, Juan; Yan, Fei; Yang, Junpeng; Wang, Lingshu; Tian, Meng; Liu, Jidong; Zhao, Ruxing; Chen, Li] Shandong Univ, Inst Endocrinol & Metab, Jinan, Shandong, Peoples R China; [Zhang, Xiuping; Zhao, Xiangmin] Shantui Community Hlth Ctr, Jining, Shandong, Peoples R China; [Wang, Yulian; Li, Chengqiao; Li, Mei] Second Peoples Hosp Jining, Dept Endocrinol, Jining, Shandong, Peoples R China; [Wang, Shaoyuan; Yang, Weifang] Lukang Hosp Jining, Jining, Shandong, Peoples R China; [Ma, Zeqiang] Corp Hosp, China Natl Heavy Duty Truck Grp, Jinan, Shandong, Peoples R China; [Chen, Shihong] Shandong Univ, Hosp 2, Dept Endocrinol, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Chen, SH (corresponding author), Shandong Univ, Hosp 2, Dept Endocrinol, Jinan, Shandong, Peoples R China.	515751512@qq.com; wangchuansdu.edu@163.com	Ahmad, hussain/AAP-9386-2020; Zhang, Jing/HII-4294-2022	hou, xinguo/0000-0003-2045-1290	Chinese Society of Endocrinology; National Natural Science Foundation of China [81100617]; Medical and Health Science and Technology Development Projects of Shandong Province [2011HD005]; National Science and Technology Support Plan [2009BAI80B04]; Natural Science Foundation of Shandong Province [ZR2012HM014]; International Science and Technology Projects of Shandong Province [2012GGE27126]; Business Plan of Jinan Students Studying Abroad [20110407]; special scientific research fund of clinical medicine of Chinese Medical Association [12030420342]	Chinese Society of Endocrinology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical and Health Science and Technology Development Projects of Shandong Province; National Science and Technology Support Plan; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); International Science and Technology Projects of Shandong Province; Business Plan of Jinan Students Studying Abroad; special scientific research fund of clinical medicine of Chinese Medical Association	This study was supported by grants from the Chinese Society of Endocrinology, the National Natural Science Foundation of China (No. 81100617), the Medical and Health Science and Technology Development Projects of Shandong Province (2011HD005), the National Science and Technology Support Plan (2009BAI80B04), the Natural Science Foundation of Shandong Province (ZR2012HM014), the International Science and Technology Projects of Shandong Province (2012GGE27126), the Business Plan of Jinan Students Studying Abroad (20110407), and the special scientific research fund of clinical medicine of Chinese Medical Association (12030420342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Bi YF, 2014, J DIABETES, V6, P147, DOI 10.1111/1753-0407.12108; Campbell NG, 2012, HEART, V98, P42, DOI 10.1136/heartjnl-2011-300024; Chen W, 2009, NEPHROL DIAL TRANSPL, V24, P1205, DOI 10.1093/ndt/gfn604; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036332; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Delanaye P, 2013, NAT REV NEPHROL, V9, P513, DOI 10.1038/nrneph.2013.143; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Henry RMA, 2002, KIDNEY INT, V62, P1402, DOI 10.1046/j.1523-1755.2002.00571.x; Hermans MMH, 2007, J AM SOC NEPHROL, V18, P1942, DOI 10.1681/ASN.2006111217; Iseki Kunitoshi, 2014, Clin Exp Nephrol, V18, P185, DOI 10.1007/s10157-013-0891-8; Jessani S, 2014, AM J KIDNEY DIS, V63, P49, DOI 10.1053/j.ajkd.2013.07.023; Ji BL, 2013, CLIN BIOCHEM, V46, P750, DOI 10.1016/j.clinbiochem.2013.01.011; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Natali A, 2013, NUTR METAB CARDIOVAS; Ning G, 2012, J DIABETES, V4, P172, DOI 10.1111/j.1753-0407.2012.00182.x; Noborisaka Yuka, 2013, Nephrourol Mon, V5, P655, DOI 10.5812/numonthly.3527; Roy SK, 2011, VASC HEALTH RISK MAN, V7, P719, DOI 10.2147/VHRM.S24536; Shankar A, 2006, AM J EPIDEMIOL, V164, P263, DOI 10.1093/aje/kwj173; Tomonaga Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067848; Tonelli M, 2014, ANN INTERN MED, V160, P182, DOI 10.7326/M13-2453; Upadhyay A, 2012, ANN INTERN MED, V157, P251, DOI 10.7326/0003-4819-157-4-201208210-00005; Vaziri ND, 2011, BLOOD PURIFICAT, V31, P189, DOI 10.1159/000321845; Wang F, 2010, NEPHROL DIAL TRANSPL, V25, P3924, DOI 10.1093/ndt/gfq327; Wanner C, 2014, KIDNEY INT, V85, P1303, DOI 10.1038/ki.2014.31; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang X, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-19	33	65	70	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2014	9	10							e106778	10.1371/journal.pone.0106778	http://dx.doi.org/10.1371/journal.pone.0106778			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ2BX	25268121	Green Submitted, Green Published, gold			2022-12-27	WOS:000342591500005
J	Hu, JH; Liu, Y				Hu, Junhua; Liu, Yang			Unveiling the Conservation Biogeography of a Data-Deficient Endangered Bird Species under Climate Change	PLOS ONE			English	Article							HERON GORSACHIUS-MAGNIFICUS; RANGE SHIFTS; COUPLED MODEL; IMPROVE; NICHE; UNCERTAINTIES; DISTRIBUTIONS; PREDICTION; PATTERNS; MAXIMUM	It remains a challenge to identify the geographical patterns and underlying environmental associations of species with unique ecological niches and distinct behaviors. This in turn hinders our understanding of the ecology as well as effective conservation management of threatened species. The white-eared night heron (Gorsachius magnificus) is a non-migratory nocturnal bird species that has a patchy distribution in the mountainous forests of East Asia. It is currently categorized as "Endangered'' on the IUCN Red List, primarily due to its restricted range and fragmented habitat. To improve our knowledge of the biogeography and conservation of this species, we modeled the geographical pattern of its suitable habitat and evaluated the potential impacts of climate change using ecological niche modeling with a maximum entropy approach implemented in Maxent. Our results indicated that the amount of suitable habitat in all of East Asia was about 130 000 km(2), which can be spatially subdivided into several mountain ranges in southern and southwestern China and northern Vietnam. The extent of suitable habitat range may shrink by more than 35% under a predicted changing climate when assuming the most pessimistic condition of dispersal, while some more suitable habitat would be available if the heron could disperse unrestrainedly. The significant future changes in habitat suitability suggested for Gorsachius magnificus urge caution in any downgrading of Red List status that may be considered. Our results also discern potentially suitable areas for future survey efforts on new populations. Overall, this study demonstrates that ecological niche modeling offers an important tool for evaluating the habitat suitability and potential impacts of climate change on an enigmatic and endangered species based on limited presence data.	[Hu, Junhua] Chinese Acad Sci, Chengdu Inst Biol, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu, Peoples R China; [Hu, Junhua] Chinese Acad Sci, Chengdu Inst Biol, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Chengdu, Peoples R China; [Liu, Yang] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yang] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Sun Yat Sen University; Sun Yat Sen University	Liu, Y (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	liuy353@mail.sysu.edu.cn	hu, jh/B-4853-2010	hu, jh/0000-0002-6669-8443	National Natural Science Foundation of China [31270568, 31301875]; Sun Yat-sen University, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sun Yat-sen University, China	This project was supported by the National Natural Science Foundation of China (No. 31270568 to JHH; 31301875 to YL), and the "The One Hundred Talents Project (Bai Ren Ji Hua)" of Sun Yat-sen University, China to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; BirdLife International, 2012, IUCN 2012 IUCN RED L; Bosso L, 2013, J NAT CONSERV, V21, P72, DOI 10.1016/j.jnc.2012.10.003; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Carvalho SB, 2010, BIOL CONSERV, V143, P426, DOI 10.1016/j.biocon.2009.11.010; Collins M, 2001, CLIM DYNAM, V17, P61, DOI 10.1007/s003820000094; CRETE M, 1991, ARCTIC, V44, P275; Crosby M, 2003, SAVING ASIAS THREATE; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; Doko T, 2011, ECOL MODEL, V222, P748, DOI 10.1016/j.ecolmodel.2010.11.005; Dong L, 2010, CONSERV GENET, V11, P2231, DOI 10.1007/s10592-010-0108-6; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Fellowes JR, 2001, BIRD CONSERV INT, V11, P101; Gao Jianyun, 2013, Chinese Birds, V4, P254; Gao Yu-Ren, 2000, Chinese Journal of Zoology, V35, P39; Gordon HB, 1997, MON WEATHER REV, V125, P875, DOI 10.1175/1520-0493(1997)125<0875:TCCITC>2.0.CO;2; Gu LY, 2013, MOL PHYLOGENET EVOL, V67, P129, DOI 10.1016/j.ympev.2012.12.013; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; He FQ, 2007, BIRD CONSERV INT, V17, P93, DOI 10.1017/S0959270906000566; He Fen-Qi, 2007, Acta Zootaxonomica Sinica, V32, P802; He Fengqi, 2011, Chinese Birds, V2, P163; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hof AR, 2012, ECOL MODEL, V246, P86, DOI 10.1016/j.ecolmodel.2012.07.028; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; Hu J, 2010, J ZOOL, V282, P54, DOI 10.1111/j.1469-7998.2010.00715.x; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Hu JH, 2010, OECOLOGIA, V164, P555, DOI 10.1007/s00442-010-1732-z; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; Jackson RM, 2006, WILDLIFE SOC B, V34, P772, DOI 10.2193/0091-7648(2006)34[772:ESLPAU]2.0.CO;2; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Kim SJ, 2003, CLIM DYNAM, V20, P635, DOI 10.1007/s00382-002-0292-2; La Sorte FA, 2007, ECOLOGY, V88, P1803, DOI 10.1890/06-1072.1; Ladle R. J., 2011, CONSERVATION BIOGEOG, DOI 10.1002/9781444390001; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Li BC, 2007, WATERBIRDS, V30, P301, DOI 10.1675/1524-4695(2007)30[301:FBOAAN]2.0.CO;2; Liu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046761; Liu Y, 2008, FORKTAIL, P80; Lu N, 2012, CONDOR, V114, P365, DOI 10.1525/cond.2012.110030; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pilgrim JD, 2009, FORKTAIL, P142; Poncet S, 2006, POLAR BIOL, V29, P772, DOI 10.1007/s00300-006-0114-9; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Richardson DM, 2010, DIVERS DISTRIB, V16, P313, DOI 10.1111/j.1472-4642.2010.00660.x; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sattler T, 2007, J APPL ECOL, V44, P1188, DOI 10.1111/j.1365-2664.2007.01328.x; Solomon S., 2007, PHYS SCI BASIS WORKI; Synes NW, 2011, GLOBAL ECOL BIOGEOGR, V20, P904, DOI 10.1111/j.1466-8238.2010.00635.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2006, GLOBAL CHANGE BIOL, V12, P424, DOI 10.1111/j.1365-2486.2006.01115.x; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Virkkala R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063376; White C.M., 1994, NEW WORLD VULTURES G; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Zhou F, 2002, CHINA CRANE NEWS, V6, P30; Zhou GY, 2013, GLOBAL CHANGE BIOL, V19, P1197, DOI 10.1111/gcb.12128; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106; 李筑眉, 2008, [动物学杂志, Chinese Journal of Zoology], V43, P139	73	66	73	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84529	10.1371/journal.pone.0084529	http://dx.doi.org/10.1371/journal.pone.0084529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404169	gold, Green Submitted, Green Published			2022-12-27	WOS:000329460800048
J	Pane, M; Mazzone, ES; Sormani, MP; Messina, S; Vita, GL; Fanelli, L; Berardinelli, A; Torrente, Y; D'Amico, A; Lanzillotta, V; Viggiano, E; D'Ambrosio, P; Cavallaro, F; Frosini, S; Bello, L; Bonfiglio, S; Scalise, R; De Sanctis, R; Rolle, E; Bianco, F; Van der Haawue, M; Magri, F; Palermo, C; Rossi, F; Donati, MA; Alfonsi, C; Sacchini, M; Arnoldi, MT; Baranello, G; Mongini, T; Pini, A; Battini, R; Pegoraro, E; Previtali, SC; Napolitano, S; Bruno, C; Politano, L; Comi, GP; Bertini, E; Morandi, L; Gualandi, F; Ferlini, A; Goemans, N; Mercuri, E				Pane, Marika; Mazzone, Elena S.; Sormani, Maria Pia; Messina, Sonia; Vita, Gian Luca; Fanelli, Lavinia; Berardinelli, Angela; Torrente, Yvan; D'Amico, Adele; Lanzillotta, Valentina; Viggiano, Emanuela; D'Ambrosio, Paola; Cavallaro, Filippo; Frosini, Silvia; Bello, Luca; Bonfiglio, Serena; Scalise, Roberta; De Sanctis, Roberto; Rolle, Enrica; Bianco, Flaviana; Van der Haawue, Marlene; Magri, Francesca; Palermo, Concetta; Rossi, Francesca; Donati, Maria Alice; Alfonsi, Chiara; Sacchini, Michele; Arnoldi, Maria Teresa; Baranello, Giovanni; Mongini, Tiziana; Pini, Antonella; Battini, Roberta; Pegoraro, Elena; Previtali, Stefano C.; Napolitano, Sara; Bruno, Claudio; Politano, Luisa; Comi, Giacomo P.; Bertini, Enrico; Morandi, Lucia; Gualandi, Francesca; Ferlini, Alessandra; Goemans, Nathalie; Mercuri, Eugenio			6 Minute Walk Test in Duchenne MD Patients with Different Mutations: 12 Month Changes	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; RESTORATION; PROTEIN	Objective: In the last few years some of the therapeutical approaches for Duchenne muscular dystrophy (DMD) are specifically targeting distinct groups of mutations, such as deletions eligible for skipping of individual exons. The aim of this observational study was to establish whether patients with distinct groups of mutations have different profiles of changes on the 6 minute walk test (6MWT) over a 12 month period. Methods: The 6MWT was performed in 191 ambulant DMD boys at baseline and 12 months later. The results were analysed using a test for heterogeneity in order to establish possible differences among different types of mutations (deletions, duplications, point mutations) and among subgroups of deletions eligible to skip individual exons. Results: At baseline the 6MWD ranged between 180 and 560,80 metres (mean 378,06, SD 74,13). The 12 month changes ranged between -325 and 175 (mean -10.8 meters, SD 69.2). Although boys with duplications had better results than those with the other types of mutations, the difference was not significant. Similarly, boys eligible for skipping of the exon 44 had better baseline results and less drastic changes than those eligible for skipping exon 45 or 53, but the difference was not significant. Conclusions: even if there are some differences among subgroups, the mean 12 month changes in each subgroup were all within a narrow Range: from the mean of the whole DMD cohort. This information will be of help at the time of designing clinical trials with small numbers of eligible patients.	[Pane, Marika; Mazzone, Elena S.; Fanelli, Lavinia; Scalise, Roberta; De Sanctis, Roberto; Bianco, Flaviana; Palermo, Concetta; Alfonsi, Chiara; Mercuri, Eugenio] Univ Cattolica Sacro Cuore, Dept Paediat Neurol, I-00168 Rome, Italy; [Sormani, Maria Pia] Univ Genoa, Dept Hlth Sci, Biostat Unit, I-16126 Genoa, Italy; [Messina, Sonia; Vita, Gian Luca; Cavallaro, Filippo] Univ Messina, Dept Neurosci Psychiat & Anaesthesiol, Messina, Italy; [Berardinelli, Angela] C Mondino Fdn, Child Neurol & Psychiat Unit, Pavia, Italy; [Torrente, Yvan; Magri, Francesca; Comi, Giacomo P.] Univ Milan, Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat DEPT, Dino Ferrari Ctr,Neurosci Sect,Neurol Unit, Milan, Italy; [D'Amico, Adele; Bertini, Enrico] Bambino Gesu Pediat Hosp, Dept Neurosci, Unit Neuromuscular & Neurodegenerat Dis, Rome, Italy; [Lanzillotta, Valentina; Bruno, Claudio] G Gaslini Inst Children, Neuromuscular Dis Unit, Genoa, Italy; [Viggiano, Emanuela; D'Ambrosio, Paola; Politano, Luisa] Univ Naples 2, Dipartimento Med Sperimentale, Naples, Italy; [Frosini, Silvia; Battini, Roberta] Univ Pisa, Stella Maris Inst, Dept Dev Neurosci, Pisa, Italy; [Bello, Luca; Pegoraro, Elena] Univ Padua, Dept Neurosci, Padua, Italy; [Bonfiglio, Serena; Pini, Antonella] IRCCS Ist Sci Neurol, Child Neurol & Psychiat Unit, Bologna, Italy; [Rolle, Enrica; Mongini, Tiziana] Univ Turin, SG Battista Hosp, Neuromuscular Ctr, Turin, Italy; [Van der Haawue, Marlene; Rossi, Francesca; Goemans, Nathalie] Pediat Neurol KU Gasthuisberg, Louvain, Belgium; [Donati, Maria Alice; Sacchini, Michele] Meyer Hosp, Metab & Neuromuscular Unit, Florence, Italy; [Arnoldi, Maria Teresa; Baranello, Giovanni] Ist Neurol Besta, Dev Neurol Unit, Milan, Italy; [Previtali, Stefano C.; Napolitano, Sara] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy; [Morandi, Lucia] Ist Neurol Besta, Neuromuscular Dis & Immunol Unit, Milan, Italy; [Gualandi, Francesca; Ferlini, Alessandra] Univ Ferrara, Dept Expt & Diagnost Med, Med Genet Sect, I-44100 Ferrara, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Genoa; University of Messina; IRCCS Fondazione Casimiro Mondino; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Bambino Gesu; University of Genoa; IRCCS Istituto Giannina Gaslini; Universita della Campania Vanvitelli; IRCCS Fondazione Stella Maris; University of Pisa; University of Padua; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; IRCCS Istituto Neurologico Besta; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Istituto Neurologico Besta; University of Ferrara	Mercuri, E (corresponding author), Univ Cattolica Sacro Cuore, Dept Paediat Neurol, I-00168 Rome, Italy.	mercuri@rm.unicatt.it	D'Ambrosio, Paola/AAC-6109-2021; pini, antonella/AAB-9171-2020; Viggiano, Emanuela/T-5332-2019; Bertini, Enrico/ABG-1278-2020; Gualandi, Francesca/K-7513-2016; Sormani, Maria Pia/ABH-8756-2020; Berardinelli, angela/AAA-9496-2019; Previtali, Stefano/Z-1962-2019; Comi, Giacomo P/K-5702-2016; d'amico, adele/J-9203-2016; Vita, Gianluca/AAR-4587-2020; Bruno, Claudio/A-3148-2015; Bertini, Enrico/A-2284-2014; Scalise, Roberta/AAC-2345-2022; Arnoldi, Maria Teresa/AAJ-2217-2021; Mazzone, Elena/AAF-4444-2020; Magri, Francesca/K-5739-2016; POLITANO, LUISA/AAK-6885-2020; battini, roberta/P-9095-2017; Mercuri, Eugenio/G-1351-2015	D'Ambrosio, Paola/0000-0002-9204-5622; pini, antonella/0000-0003-3603-5478; Gualandi, Francesca/0000-0001-9551-057X; Previtali, Stefano/0000-0003-2546-4357; Comi, Giacomo P/0000-0002-1383-5248; d'amico, adele/0000-0003-2438-2624; Vita, Gianluca/0000-0003-4190-8042; Bruno, Claudio/0000-0002-3426-2901; Bertini, Enrico/0000-0001-9276-4590; Scalise, Roberta/0000-0002-9141-7842; Arnoldi, Maria Teresa/0000-0002-3920-5869; Magri, Francesca/0000-0001-8974-9453; battini, roberta/0000-0002-7889-1355; SORMANI, MARIA PIA/0000-0001-6892-104X; Viggiano, Emanuela/0000-0002-9864-2620; Messina, Sonia/0000-0001-7994-3391; Bello, Luca/0000-0002-3075-6525; Mercuri, Eugenio/0000-0002-9851-5365; FERLINI, ALESSANDRA/0000-0001-8385-9870; Frosini, Silvia/0000-0001-6169-4382; Napolitano, Sara/0000-0003-2145-7395; berardinelli, angela/0000-0002-4645-8055; Pane, Marika/0000-0002-4851-6124; Rossi, Francesca/0000-0002-1335-5121; MARIA ALICE, DONATI/0000-0003-4769-5025	Telethon Italy; Telethon UILDM Grant [GUP07009, GUP9010]	Telethon Italy(Fondazione Telethon); Telethon UILDM Grant(Fondazione Telethon)	Elena Mazzone is a TREAT NMD research fellow funded by Telethon Italy. These data were collected in the context of the DMD Italian Network, supported by the Telethon UILDM Grant GUP07009 (to E. Mercuri) and GUP9010 (to S. Messina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2012, METHODS MOL BIOL, V867, P97, DOI 10.1007/978-1-61779-767-5_7; Aartsma-Rus A, 2010, ANN NY ACAD SCI, V1214, P199, DOI 10.1111/j.1749-6632.2010.05836.x; Arechavala-Gomeza V, 2012, CURR GENE THER, V12, P152, DOI 10.2174/156652312800840621; Cirak S, 2012, MOL THER, V20, P462, DOI 10.1038/mt.2011.248; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Deburgrave N, 2007, HUM MUTAT, V28, P183, DOI 10.1002/humu.20422; Flanigan KM, 2012, ANN NEUROL; Foster H, 2012, HUM GENE THER, V23, P676, DOI 10.1089/hum.2012.099; Geiger R, 2007, J PEDIATR-US, V150, P395, DOI 10.1016/j.jpeds.2006.12.052; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Henricson E, 2012, PLOS CURR, V4; Kesari A, 2008, HUM MUTAT, V29, P728, DOI 10.1002/humu.20722; Laing Nigel G, 2011, Clin Biochem Rev, V32, P129; Lourbakos A, 2011, NEUROMUSCULAR DISORD, V21, P643, DOI 10.1016/j.nmd.2011.06.766; Magri F, 2011, J NEUROL, V258, P1610, DOI 10.1007/s00415-011-5979-z; Mazzone E, 2011, NEUROLOGY, V77, P250, DOI 10.1212/WNL.0b013e318225ab2e; Mazzone ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052512; Mcdonald CM, 2013, MUSCLE NERVE, V48, P343, DOI 10.1002/mus.23902; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Muntoni F, 2010, Neuromuscul Disord, V20, P355, DOI 10.1016/j.nmd.2010.03.005; Muntoni F, 2011, NAT REV DRUG DISCOV, V10, P621, DOI 10.1038/nrd3459; Pegoraro E, 2011, NEUROLOGY, V76, P219, DOI 10.1212/WNL.0b013e318207afeb; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; van Ommen GJ, 2008, CURR OPIN MOL THER, V10, P140	26	65	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83400	10.1371/journal.pone.0083400	http://dx.doi.org/10.1371/journal.pone.0083400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421885	Green Published, gold			2022-12-27	WOS:000329862500046
J	Chen, YP; Chiao, CC				Chen, Yin-Peng; Chiao, Chuan-Chin			Spatial Distribution of Excitatory Synapses on the Dendrites of Ganglion Cells in the Mouse Retina	PLOS ONE			English	Article							PRIMATE RETINA; CAT RETINA; POSTSYNAPTIC DENSITIES; DIRECTION-SELECTIVITY; QUANTITATIVE-ANALYSIS; RECEPTOR SUBUNITS; MACAQUE RETINA; RABBIT RETINA; BIPOLAR CELLS; TOTAL NUMBER	Excitatory glutamatergic inputs from bipolar cells affect the physiological properties of ganglion cells in the mammalian retina. The spatial distribution of these excitatory synapses on the dendrites of retinal ganglion cells thus may shape their distinct functions. To visualize the spatial pattern of excitatory glutamatergic input into the ganglion cells in the mouse retina, particle-mediated gene transfer of plasmids expressing postsynaptic density 95-green fluorescent fusion protein (PSD95-GFP) was used to label the excitatory synapses. Despite wide variation in the size and morphology of the retinal ganglion cells, the expression of PSD95 puncta was found to follow two general rules. Firstly, the PSD95 puncta are regularly spaced, at 1-2 mu m intervals, along the dendrites, whereby the presence of an excitatory synapse creates an exclusion zone that rules out the presence of other glutamatergic synaptic inputs. Secondly, the spatial distribution of PSD95 puncta on the dendrites of diverse retinal ganglion cells are similar in that the number of excitatory synapses appears to be less on primary dendrites and to increase to a plateau on higher branch order dendrites. These observations suggest that synaptogenesis is spatially regulated along the dendritic segments and that the number of synaptic contacts is relatively constant beyond the primary dendrites. Interestingly, we also found that the linear puncta density is slightly higher in large cells than in small cells. This may suggest that retinal ganglion cells with a large dendritic field tend to show an increased connectivity of excitatory synapses that makes up for their reduced dendrite density. Mapping the spatial distribution pattern of the excitatory synapses on retinal ganglion cells thus provides explicit structural information that is essential for our understanding of how excitatory glutamatergic inputs shape neuronal responses.	[Chen, Yin-Peng; Chiao, Chuan-Chin] Natl Tsing Hua Univ, Inst Syst Neurosci, Hsinchu, Taiwan; [Chiao, Chuan-Chin] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University	Chiao, CC (corresponding author), Natl Tsing Hua Univ, Inst Syst Neurosci, Hsinchu, Taiwan.	ccchiao@life.nthu.edu.tw	Chiao, Chuan-Chin/L-7708-2019; Chen, Yeng/A-6873-2011	Chen, Yeng/0000-0002-0064-7678	National Science Council of Taiwan [NSC-98-2311-B-007-004-MY3, NSC-101-2628-B-007-001-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council of Taiwan NSC-98-2311-B-007-004-MY3 and NSC-101-2628-B-007-001-MY3 (to CCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Calkins DJ, 1998, J NEUROSCI, V18, P3373; Calkins DJ, 1996, NATURE, V381, P613, DOI 10.1038/381613a0; Chen YP, 2012, BRAIN RES, V1427, P10, DOI 10.1016/j.brainres.2011.10.019; COHEN E, 1991, J NEUROPHYSIOL, V65, P352, DOI 10.1152/jn.1991.65.2.352; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; De la Huerta I, 2012, P NATL ACAD SCI USA, V109, P17663, DOI 10.1073/pnas.1215806109; Ebihara T, 2003, J NEUROSCI, V23, P2170; FREED MA, 1988, J NEUROSCI, V8, P2303; Garcia-Lopez P, 2006, J NEUROSCI, V26, P11249, DOI 10.1523/JNEUROSCI.3543-06.2006; Gartland AJ, 2011, J NEUROSCI, V31, P18353, DOI 10.1523/JNEUROSCI.4212-11.2011; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Jacoby R, 1996, J NEUROSCI, V16, P8041; Jakobs TC, 2008, J COMP NEUROL, V510, P221, DOI 10.1002/cne.21795; Jeon CJ, 2002, J COMP NEUROL, V449, P195, DOI 10.1002/cne.10288; Jusuf PR, 2006, J COMP NEUROL, V494, P260, DOI 10.1002/cne.20804; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Klug K, 2003, J NEUROSCI, V23, P9881; Koizumi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000221; Koizumi A, 2011, J COMP NEUROL, V519, P341, DOI 10.1002/cne.22522; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Lin B, 2002, VISUAL NEUROSCI, V19, P453, DOI 10.1017/S0952523802194077; Lin B, 2000, EUR J NEUROSCI, V12, P4155, DOI 10.1111/j.1460-9568.2000.01311.x; Lye Ming H, 2007, J Vis Exp, P190, DOI 10.3791/190; MacNeil MA, 2004, J COMP NEUROL, V472, P73, DOI 10.1002/cne.20063; Macri J, 2000, VISUAL NEUROSCI, V17, P437, DOI 10.1017/S0952523800173109; Marshak DW, 2002, VISUAL NEUROSCI, V19, P299, DOI 10.1017/S0952523802192078; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; MCGUIRE BA, 1986, J NEUROSCI, V6, P907; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Morgan JL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-8; Moritoh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054667; Moritoh S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012917; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; Qin LX, 2001, J COMP NEUROL, V440, P284, DOI 10.1002/cne.1386; Sanchez AL, 2006, DEVELOPMENT, V133, P2477, DOI 10.1242/dev.02409; Schubert T, 2005, J COMP NEUROL, V490, P29, DOI 10.1002/cne.20621; Schubert T, 2005, J COMP NEUROL, V485, P191, DOI 10.1002/cne.20510; Soto F, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-31; STERLING P, 1983, ANNU REV NEUROSCI, V6, P149, DOI 10.1146/annurev.ne.06.030183.001053; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Taylor W, 2011, CURR OPIN NEUROBIOL; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Volgyi B, 2005, J COMP NEUROL, V492, P66, DOI 10.1002/cne.20700; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; Xu Y, 2008, J COMP NEUROL, V507, P1871, DOI 10.1002/cne.21644; Zhang J, 2006, J COMP NEUROL, V498, P810, DOI 10.1002/cne.21089	53	84	87	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86159	10.1371/journal.pone.0086159	http://dx.doi.org/10.1371/journal.pone.0086159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465934	Green Published, gold, Green Submitted			2022-12-27	WOS:000330237000088
J	Liu, N; Lin, ZF; Guan, LL; Gaughan, G; Lin, GZ				Liu, Nan; Lin, Zhifang; Guan, Lanlan; Gaughan, Gerald; Lin, Guizhu			Antioxidant Enzymes Regulate Reactive Oxygen Species during Pod Elongation in Pisum sativum and Brassica chinensis	PLOS ONE			English	Article							HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CELL-WALL; ROOT; SUPEROXIDE; GROWTH; LEAVES; H2O2	Previous research has focused on the involvement of reactive oxygen species (ROS) in cell wall loosening and cell extension in plant vegetative growth, but few studies have investigated ROS functions specifically in plant reproductive organs. In this study, ROS levels and antioxidant enzyme activities were assessed in Pisum sativum and Brassica chinensis pods at five developmental stages. In juvenile pods, the high levels of O-2(-) and OH indicates that they had functions in cell wall loosening and cell elongation. In later developmental stages, high levels of. OH were also related to increases in cell wall thickness in lignified tissues. Throughout pod development, most of the O-2(-) was detected on plasma membranes of parenchyma cells and outer epidermis cells of the mesocarp, while most of the H2O2 was detected on plasma membranes of most cells throughout the mesocarp. This suggests that these sites are presumably the locations of ROS generation. The antioxidant enzymes superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT) apparently contributed to ROS accumulation in pod wall tissues. Furthermore, specifically SOD and POD were found to be associated with pod growth through the regulation of ROS generation and transformation. Throughout pod development, O-2(-) decreases were associated with increased SOD activity, while changes in H2O2 accumulation were associated with changes in CAT and POD activities. Additionally, high POD activity may contribute to the generation of. OH in the early development of pods. It is concluded that the ROS are produced in different sites of plasma membranes with the regulation of antioxidant enzymes, and that substantial ROS generation and accumulation are evident in cell elongation and cell wall loosening in pod wall cells.	[Liu, Nan; Lin, Zhifang; Guan, Lanlan; Lin, Guizhu] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Gaughan, Gerald] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, ZF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linzhif@scbg.ac.cn	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	China Scholarship Council [201204910138]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The current study was supported by China Scholarship Council (No. 201204910138, http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; BARRETO JC, 1994, LIFE SCI, V56, pPL89, DOI 10.1016/0024-3205(94)00925-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GILBERT DL, 1981, OXYGEN LIVING PROCES; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Ivanchenko MG, 2013, ANN BOT, DOI [10.1093/aob/mct181, DOI 10.1093/A0B/MCT181]; Johnansen DA, 1940, PLANT MICROTECHNIQUE; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu N, 2013, J PLANT GROWTH REGUL, V32, P83, DOI 10.1007/s00344-012-9278-4; Liu N, 2010, ECOTOX ENVIRON SAFE, V73, P1238, DOI 10.1016/j.ecoenv.2010.06.017; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Perl RT., 2002, OXIDATIVE STRESS PLA, P1; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Barcelo AR, 2009, SIGNAL COMMUN PLANTS, P73, DOI 10.1007/978-3-642-00390-5_5; Schopfer P, 2006, BIOFACTORS, V28, P73, DOI 10.1002/biof.5520280202; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Yang XF, 2001, ANALYST, V126, P928, DOI 10.1039/b100085n; ZENG S-X, 1991, Acta Phytophysiologica Sinica, V17, P177; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5	32	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87588	10.1371/journal.pone.0087588	http://dx.doi.org/10.1371/journal.pone.0087588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24671213	Green Published, gold, Green Submitted			2022-12-27	WOS:000330631800048
J	Hobbelen, PHF; Paveley, ND; van den Bosch, F				Hobbelen, Peter H. F.; Paveley, Neil D.; van den Bosch, Frank			The Emergence of Resistance to Fungicides	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; MYCOSPHAERELLA-GRAMINICOLA; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; SEPTORIA-TRITICI; SELECTION; MIXTURES; PATHOGEN; MODEL; POPULATIONS	Many studies exist about the selection phase of fungicide resistance evolution, where a resistant strain is present in a pathogen population and is differentially selected for by the application of fungicides. The emergence phase of the evolution of fungicide resistance - where the resistant strain is not present in the population and has to arise through mutation and subsequently invade the population - has not been studied to date. Here, we derive a model which describes the emergence of resistance in pathogen populations of crops. There are several important examples where a single mutation, affecting binding of a fungicide with the target protein, shifts the sensitivity phenotype of the resistant strain to such an extent that it cannot be controlled effectively('qualitative' or 'single-step' resistance). The model was parameterized for this scenario for Mycosphaerella graminicola on winter wheat and used to evaluate the effect of fungicide dose rate on the time to emergence of resistance for a range of mutation probabilities, fitness costs of resistance and sensitivity levels of the resistant strain. We also evaluated the usefulness of mixing two fungicides of differing modes of action for delaying the emergence of resistance. The results suggest that it is unlikely that a resistant strain will already have emerged when a fungicide with a new mode of action is introduced. Hence, 'anti-emergence' strategies should be identified and implemented. For all simulated scenarios, the median emergence time of a resistant strain was affected little by changing the dose rate applied, within the range of doses typically used on commercial crops. Mixing a single-site acting fungicide with a multi-site acting fungicide delayed the emergence of resistance to the single-site component. Combining the findings with previous work on the selection phase will enable us to develop more efficient anti-resistance strategies.	[Hobbelen, Peter H. F.; van den Bosch, Frank] Rothamsted Res, Harpenden, Herts, England; [Paveley, Neil D.] ADAS UK Ltd, Malton, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Bosch, F (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.vandenbosch@rothamsted.ac.uk	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Biological and Biotechnological Research Council of the United Kingdom; Department for Environment, Food and Rural Affairs of the United Kingdom [PS2712]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Biological and Biotechnological Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives support from the Biological and Biotechnological Research Council of the United Kingdom. Part of this research was funded by the Department for Environment, Food and Rural Affairs of the United Kingdom (project number PS2712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Carnegie SF, 2008, POTATO RES, V51, P113, DOI 10.1007/s11540-008-9094-1; DOSTER MA, 1990, PHYTOPATHOLOGY, V80, P1190, DOI 10.1094/Phyto-80-1190; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Grabski C., 1985, BRIT CROP PROT C MON, V31, P315; Grimmer M, 2011, RESISTANCE 2011, P94; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; HOARE FA, 1986, PLANT PATHOL, V35, P506, DOI 10.1111/j.1365-3059.1986.tb02048.x; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Horsten JAHM, 1979, THESIS WAGENINGEN U; HUNTER T, 1987, ANN APPL BIOL, V110, P515, DOI 10.1111/j.1744-7348.1987.tb04169.x; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; JOSEPOVITS G, 1989, CROP PROT, V8, P106, DOI 10.1016/0261-2194(89)90084-7; Kang JM, 2006, FASEB J, V20, P2476, DOI 10.1096/fj.06-6209com; LaMondia J. A., 2001, Journal of Environmental Horticulture, V19, P51; Mavroeidi VI, 2006, PLANT PATHOL, V55, P715, DOI 10.1111/j.1365-3059.2006.01441.x; McCartney C, 2007, CROP PROT, V26, P1272, DOI 10.1016/j.cropro.2006.10.027; Metcalfe RJ, 2000, PLANT PATHOL, V49, P546, DOI 10.1046/j.1365-3059.2000.00486.x; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley ND, 2011, HGCA WHEAT DIS MANAG; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; SANDERS PL, 1985, PLANT DIS, V69, P939; SANOAMUANG N, 1995, MYCOL RES, V99, P677, DOI 10.1016/S0953-7562(09)80527-3; Serra MC, 2007, THEOR POPUL BIOL, V72, P167, DOI 10.1016/j.tpb.2007.01.005; Serra MC, 2006, J APPL PROBAB, V43, P296, DOI 10.1239/jap/1143936262; Shaw MW, 2000, PHYTOPATHOLOGY, V90, P333, DOI 10.1094/PHYTO.2000.90.4.333; SHAW MW, 1993, CROP PROT, V12, P120, DOI 10.1016/0261-2194(93)90138-9; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Thornley JHM., 1990, PLANT CROP MODELLING; Thygesen K, 2009, EUR J PLANT PATHOL, V123, P435, DOI 10.1007/s10658-008-9381-3; Turechek WW, 2004, PLANT HLTH PROG; VALI RJ, 1992, PLANT DIS, V76, P919, DOI 10.1094/PD-76-0919; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393; Zhang CQ, 2008, ANN APPL BIOL, V153, P205, DOI 10.1111/j.1744-7348.2008.00248.x	48	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91910	10.1371/journal.pone.0091910	http://dx.doi.org/10.1371/journal.pone.0091910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24671213	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300044
J	da Silva, VCP; Bertin, A; Blin, A; Germain, JF; Bernardi, D; Rignol, G; Botton, M; Malausa, T				Pacheco da Silva, Vitor C.; Bertin, Aline; Blin, Aurelie; Germain, Jean-Francois; Bernardi, Daniel; Rignol, Guylene; Botton, Marcos; Malausa, Thibaut			Molecular and Morphological Identification of Mealybug Species (Hemiptera: Pseudococcidae) in Brazilian Vineyards	PLOS ONE			English	Article							FERRISIA FULLAWAY HEMIPTERA; SCALE INSECTS HEMIPTERA; EXPORT GRAPE PRODUCTION; MULTIPLEX PCR; PEST; PHYLOGENY; MARKERS	Mealybugs (Hemiptera: Pseudococcidae) are pests constraining the international trade of Brazilian table grapes. They damage grapes by transmitting viruses and toxins, causing defoliation, chlorosis, and vigor losses and favoring the development of sooty mold. Difficulties in mealybug identification remain an obstacle to the adequate management of these pests. In this study, our primary aim was to identify the principal mealybug species infesting the major table grape-producing regions in Brazil, by morphological and molecular characterization. Our secondary aim was to develop a rapid identification kit based on species-specific Polymerase Chain Reactions, to facilitate the routine identification of the most common pest species. We surveyed 40 sites infested with mealybugs and identified 17 species: Dysmicoccus brevipes (Cockerell), Dysmicoccus sylvarum Williams and Granara de Willink, Dysmicoccus texensis (Tinsley), Ferrisia cristinae Kaydan and Gullan, Ferrisia meridionalis Williams, Ferrisia terani Williams and Granara de Willink, Phenacoccus baccharidis Williams, Phenacoccus parvus Morrison, Phenacoccus solenopsis Tinsley, Planococcus citri (Risso), Pseudococcus viburni (Signoret), Pseudococcus cryptus Hempel, four taxa closely related each of to Pseudococcus viburni, Pseudococcus sociabilis Hambleton, Pseudococcus maritimus (Ehrhorn) and Pseudococcus meridionalis Prado, and one specimen from the genus Pseudococcus Westwood. The PCR method developed effectively identified five mealybug species of economic interest on grape in Brazil: D. brevipes, Pl. citri, Ps. viburni, Ph. solenopsis and Planococcus ficus (Signoret). Nevertheless, it is not possible to assure that this procedure is reliable for taxa that have not been sampled already and might be very closely related to the target species.	[Pacheco da Silva, Vitor C.; Botton, Marcos] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Bertin, Aline; Bernardi, Daniel] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Blin, Aurelie; Rignol, Guylene; Malausa, Thibaut] INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, F-06903 Sophia Antipolis, France; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, Montferrier Sur Lez, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, BP 167, F-06903 Sophia Antipolis, France.	tmalausa@sophia.inra.fr	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	European Union [265865, 269196, 324475]; French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS) [1001001]; Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	European Union(European Commission); French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS); Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Seventh Framework Programme FP7-KBBE #265865 "PURE'', FP7-IRSES #269196 "IPRABIO'' and FP7-IAPP #324475 "COLBICS'' and by the French grants Agropolis Fondation (http://www.agropolis-fondation.fr/) (RTRA - Montpellier, BIOFIS project number 1001001) and 'Bibliotheque du Vivant'. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y, 2012, SCALENET DATABASE SC; Bertin S, 2010, PHYTOPARASITICA, V38, P401, DOI 10.1007/s12600-010-0109-5; Beuning LL, 1999, J ECON ENTOMOL, V92, P463, DOI 10.1093/jee/92.2.463; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa L. R. B., 2005, Laranja, V26, P265; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Santa-Cecilia LVC, 2009, ACTA SCI-AGRON, V31, P13, DOI 10.4025/actasciagron.v31i1.6603; Culik Mark Paul, 2007, Biota Neotrop., V7, P61, DOI 10.1590/S1676-06032007000300006; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2008, CALIF AGR, V62, P167, DOI 10.3733/ca.v062n04p167; Daane Kent M., 2012, P271; Daane KM, 2011, ENVIRON ENTOMOL, V40, P1595, DOI 10.1603/EN11075; Granara De Willink María Cristina, 2007, Rev. Soc. Entomol. Argent., V66, P29; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Foldi Imre, 2005, Nouvelle Revue d'Entomologie, V22, P305; GARAU R, 1995, VITIS, V34, P67; Gimpel William F. Jr, 1996, Contributions on Entomology International, V2, P1; Golino D. A., 2002, California Agriculture, V56, P196, DOI 10.3733/ca.v056n06p196; Gonzalez R. H., 2004, Revista Fruticola, V25, P41; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kaydan MB, 2012, ZOOTAXA, P1; Kuniyuki Hugo, 2006, Summa phytopathol., V32, P151, DOI 10.1590/S0100-54052006000200009; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Mello LMR, 2013, VITICULTURA BRASILEI; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Morandi Filho WJ, 2008, ARQ I BIOL-SAO PAULO, V76, P427; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SANTA-CECÍLIA LENIRA V.C., 2002, Neotrop. entomol., V31, P333, DOI 10.1590/S1519-566X2002000200024; Selwyn B, 2007, J AGRAR CHANGE, V7, P526, DOI 10.1111/j.1471-0366.2007.00155.x; Selwyn B, 2010, J AGRAR CHANGE, V10, P537, DOI 10.1111/j.1471-0366.2009.00245.x; Souza B., 2008, Coffee Science, V3, P104; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villard P, 2013, MOL ECOL RESOUR, V13, P755, DOI 10.1111/1755-0998.12116; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Walton VM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4701; Willians DJ, 1992, MEALYBUGS CENTRAL S; Yokogawa T, 2009, GENES GENET SYST, V84, P57, DOI 10.1266/ggs.84.57	50	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103267	10.1371/journal.pone.0103267	http://dx.doi.org/10.1371/journal.pone.0103267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	24671213	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992600050
J	Ramos, JE; Pecl, GT; Moltschaniwskyj, NA; Strugnell, JM; Leon, RI; Semmens, JM				Ramos, Jorge E.; Pecl, Gretta T.; Moltschaniwskyj, Natalie A.; Strugnell, Jan M.; Leon, Rafael I.; Semmens, Jayson M.			Body Size, Growth and Life Span: Implications for the Polewards Range Shift of Octopus tetricus in South-Eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMON OCTOPUS; REPRODUCTIVE-CYCLE; UPWELLING SYSTEM; VULGARIS; SQUID; EVOLUTIONARY; ECOLOGY; AGE; TEMPERATURE	Understanding the response of any species to climate change can be challenging. However, in short-lived species the faster turnover of generations may facilitate the examination of responses associated with longer-term environmental change. Octopus tetricus, a commercially important species, has undergone a recent polewards range shift in the coastal waters of south-eastern Australia, thought to be associated with the southerly extension of the warm East Australian Current. At the cooler temperatures of a polewards distribution limit, growth of a species could be slower, potentially leading to a bigger body size and resulting in a slower population turnover, affecting population viability at the extreme of the distribution. Growth rates, body size, and life span of O. tetricus were examined at the leading edge of a polewards range shift in Tasmanian waters (40 degrees S and 147 degrees E) throughout 2011. Octopus tetricus had a relatively small body size and short lifespan of approximately 11 months that, despite cooler temperatures, would allow a high rate of population turnover and may facilitate the population increase necessary for successful establishment in the new extended area of the range. Temperature, food availability and gender appear to influence growth rate. Individuals that hatched during cooler and more productive conditions, but grew during warming conditions, exhibited faster growth rates and reached smaller body sizes than individuals that hatched into warmer waters but grew during cooling conditions. This study suggests that fast growth, small body size and associated rapid population turnover may facilitate the range shift of O. tetricus into Tasmanian waters.	[Ramos, Jorge E.; Pecl, Gretta T.; Leon, Rafael I.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	University of Tasmania; University of Newcastle; La Trobe University	Ramos, JE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jeramos@utas.edu.au	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Consejo Nacional de Ciencia y Tecnologia of Mexico [308672]; University of Tasmania; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Tasmania; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. Ramos was awarded the scholarship 308672 by Consejo Nacional de Ciencia y Tecnologia of Mexico, a Tasmania Graduate Research scholarship from the University of Tasmania and a Bookend Lynchpin Ocean Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P371, DOI 10.1071/MF04274; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Calosi P, 2013, INTEGR COMP BIOL, V53, P660, DOI 10.1093/icb/ict041; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dia M.A., 1988, THESIS U W BRITTANY THESIS U W BRITTANY; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Edgar G, 2000, AUSTR MARINE LIFE PL; Engel Katharina, 2011, Communicative & Integrative Biology, V4, P247, DOI 10.4161/cib.4.3.14885; Forsythe J.W., 1987, P135; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Fox J., 2019, R COMPANION APPL REG, V.; Fulton EA, 2011, ICES J MAR SCI, V68, P1329, DOI 10.1093/icesjms/fsr032; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hanlon RT, 1996, CEPHALOPOD BEHAV; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Jackson GD, 2004, MAR FRESHWATER RES, V55, P357, DOI 10.1071/MF03152; Jackson GD, 2003, MAR BIOL, V142, P925, DOI 10.1007/s00227-002-1005-4; Jackson GD, 2001, MAR ECOL PROG SER, V218, P167, DOI 10.3354/meps218167; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2008, MAR BIOL, V155, P375, DOI 10.1007/s00227-008-1033-9; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Lourenco S, 2012, FISH RES, V127, P116, DOI 10.1016/j.fishres.2012.04.006; Mangold K., 1983, P335; Mangold K., 1987, P157; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moreno A, 2012, J MAR BIOL ASSOC UK, V92, P1619, DOI 10.1017/S0025315411002141; Norman M.D., 2000, GUIDE SQUID CUTTLEFI; Okei N, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P468; Oosthuizen A, 2003, J MAR BIOL ASSOC UK, V83, P535, DOI 10.1017/S0025315403007458h; Otero J, 2008, MAR ECOL PROG SER, V362, P181, DOI 10.3354/meps07437; Otero J, 2007, FISH RES, V85, P122, DOI 10.1016/j.fishres.2007.01.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; R Core Team, 2021, R LANGUAGE ENV STAT; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosas C, 2008, AQUACULTURE, V275, P291, DOI 10.1016/j.aquaculture.2008.01.015; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Scandol J, 2008, STATUS FISHERIES RES, P193; Schwarz R, 2010, FISH RES, V106, P177, DOI 10.1016/j.fishres.2010.06.008; Semmens J, 2011, J EXP BIOL, V214, P2799, DOI 10.1242/jeb.051631; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiess A, 2013, QPCR MODELLING ANAL; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tasmania Wild Fisheries Management Branch Tasmania Department of Primary Industries and Water, 2009, SACL FISH MAN PLAN R; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; VILLANUEVA R, 1992, J EXP MAR BIOL ECOL, V159, P157, DOI 10.1016/0022-0981(92)90034-8; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf BM, 1997, J SHELLFISH RES, V16, P533	85	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103480	10.1371/journal.pone.0103480	http://dx.doi.org/10.1371/journal.pone.0103480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	24671213	Green Accepted, Green Published, gold			2022-12-27	WOS:000339812700029
J	Wu, KL; Zeng, SJ; Lin, DI; da Silva, JAT; Bu, ZY; Zhang, JX; Duan, J				Wu, Kunlin; Zeng, Songjun; Lin, Danni; da Silva, Jaime A. Teixeira; Bu, Zhaoyang; Zhang, Jianxia; Duan, Ju			In Vitro Propagation and Reintroduction of the Endangered Renanthera imschootiana Rolfe	PLOS ONE			English	Article							ASYMBIOTIC SEED-GERMINATION; CALCIUM HYPOCHLORITE; ESTABLISHMENT; REGENERATION; GROWTH; ORCHID	Renanthera imschootiana Rolfe is an endangered tropical epiphytic orchid that is threatened with extinction due to over-collection and the loss of suitable habitats. In vitro propagation is a useful way to mass produce plants for re-establishment in the wild and for commercial propagation. Seeds collected 150 days after pollination (DAP) were the optimum stage for in vitro culture. Seed germination reached 93.1% on quarter-strength MS (i.e., MS containing a quarter of macro-and micronutrients) medium containing 0.5 mg l(-1) a-naphthaleneacetic acid (NAA), 20% coconut water (CW), 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 1.0 g l(-1) activated charcoal (AC). Quarter-strength MS medium supplemented with 1.0 mg l(-1) BA, 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 20% CW was suitable for the sub-culture of protocorm-like bodies (PLBs) in which the PLB proliferation ratio was 2.88. Quarter-strength MS medium containing 1.0 mg l(-1) NAA, 1.0 g l(-1) peptone, 100 g l(-1) banana homogenate (BH), and 1.0 g l(-1) AC was suitable for plantlet formation and 95.67% of plantlets developed from PLBs within 60 days of culture. Hyponex N016 medium supplemented with 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 20 g l(-1) sucrose, 150 g l(-1) BH, and 1.0 g l(-1) AC was suitable for the in vitro growth of plantlets about 2-cm in height. Plantlets 3-cm in height or taller were transplanted to Chilean sphagnum moss, and 95% of plantlets survived after 60 days in a greenhouse. Three hundred transplanted of seedlings 360-days old were reintroduced into three natural habitats. Highest percentage survival (79.67%) was observed in Yuanjiang Nature Reserve two years after reintroduction, followed by Huolu Mountain forest park (71.33%). This protocol is an efficient means for the large-scale propagation and in vitro and in vivo germplasm conservation of R. imschootiana.	[Wu, Kunlin; Zeng, Songjun; Lin, Danni; Zhang, Jianxia] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Duan, Ju] Chinese Acad Sci, South China Bot Garden, Key Lab S China Agr Plant Mol Anal & Gene Improve, Guangzhou, Guangdong, Peoples R China; [da Silva, Jaime A. Teixeira] Kagawa Ken, Takamatsu, Kagawa, Japan; [Bu, Zhaoyang] Guangxi Acad Agr Sci, Flower Res Inst, Nanning 150931, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Guangxi Academy of Agricultural Sciences	Zeng, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	zengsongjun@scib.ac.cn; yangnv@126.com	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [211026]; Guangzhou Key Technology Research and Development Program [Y233051001]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Guangzhou Key Technology Research and Development Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a fund of the Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (No. 211026), and the Guangzhou Key Technology Research and Development Program (Y233051001). Songjun Zeng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], 2014, WORLD CHECKLIST SELE; Arditti J., 1993, MICROPROPAGATION ORC; Arditti J, 1982, ORCHID BIOL REV PERS, P352; Chu Chin-Chang, 1994, Lindleyana, V9, P153; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; da Silva JAT, 2006, PLANT CELL TISS ORG, V84, P135, DOI 10.1007/s11240-005-9003-0; da Silva JAT, 2005, PROPAG ORNAM PLANTS, V5, P129; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; DeMarie E., 1991, HORTSCIENCE, V26, P272; Dix L., 1982, PLANT CELL TISSUE OR, V12, P39; Ernst R., 1975, American Orchid Society Bulletin, V44, P12; Ernst R., 1974, American Orchid Society Bulletin, V43, P35; Goh C. J., 1982, Orchid Review, V90, P295; GOH CJ, 1990, SCI HORTIC-AMSTERDAM, V44, P315, DOI 10.1016/0304-4238(90)90132-X; HARVAIS G, 1973, CAN J BOT, V51, P327, DOI 10.1139/b73-040; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Kishor R, 2009, EUPHYTICA, V165, P247, DOI 10.1007/s10681-008-9755-9; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Lee YI, 2006, ANN BOT-LONDON, V98, P1311, DOI 10.1093/aob/mcl222; Lin DL, 2008, J FOOD DRUG ANAL, V16, P1; Lo SF, 2004, IN VITRO CELL DEV-PL, V40, P528, DOI 10.1079/IVP2004571; McNaughton S.J., 1989, P109; Miyoshi K, 1998, PHYSIOL PLANTARUM, V102, P481, DOI 10.1034/j.1399-3054.1998.1020401.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; NAGASHIMA T, 1982, J JPN SOC HORTIC SCI, V51, P94, DOI 10.2503/jjshs.51.94; PIERIK RLM, 1988, SCI HORTIC-AMSTERDAM, V34, P139, DOI 10.1016/0304-4238(88)90084-2; Raghavan V., 1977, CRC HDB SERIES NUTR, P361; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; SEENI S, 1992, PLANT CELL TISS ORG, V29, P167, DOI 10.1007/BF00034349; Seeni S, 2000, PLANT CELL TISS ORG, V61, P1, DOI 10.1023/A:1006444614657; Teixeira da Silva J., 2013, FLORIC ORNAM BIOTECH, V7, P1, DOI DOI 10.1016/0168-1656(90)90117-T; Thomale H., 1954, ORCHIDEEN, P62; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsi Z. H., 1999, FLORA REIPUBLICAE PO, V19, P291; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; van der Kinderen G., 1987, LINDLEYANA, V2, P84; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; Wu KL, 2012, SCI HORTIC-AMSTERDAM, V135, P194, DOI 10.1016/j.scienta.2011.11.028; Wu KunLin, 2010, Acta Horticulturae Sinica, V37, P685; Wu Z.Y., 2009, FLORA CHINA, V25; YAM T W, 1990, Lindleyana, V5, P256; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144; Zeng SJ, 2015, CRIT REV BIOTECHNOL, V35, P279; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026	51	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110033	10.1371/journal.pone.0110033	http://dx.doi.org/10.1371/journal.pone.0110033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	24671213	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100017
